Citrus Sinensis ID: 019780
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 336 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.627 | 0.541 | 0.344 | 6e-32 | |
| Q54XQ2 | 1125 | RGS domain-containing ser | yes | no | 0.764 | 0.228 | 0.299 | 3e-26 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.672 | 0.169 | 0.305 | 7e-25 | |
| Q95UN8 | 1161 | Mitogen-activated protein | yes | no | 0.625 | 0.180 | 0.302 | 1e-24 | |
| A2VDU3 | 579 | Mitogen-activated protein | yes | no | 0.645 | 0.374 | 0.270 | 4e-24 | |
| O43318 | 606 | Mitogen-activated protein | no | no | 0.645 | 0.358 | 0.270 | 4e-24 | |
| Q62073 | 579 | Mitogen-activated protein | yes | no | 0.645 | 0.374 | 0.270 | 5e-24 | |
| Q5RFL3 | 606 | Mitogen-activated protein | yes | no | 0.645 | 0.358 | 0.270 | 5e-24 | |
| P0C8E4 | 606 | Mitogen-activated protein | yes | no | 0.645 | 0.358 | 0.270 | 5e-24 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.595 | 0.218 | 0.305 | 2e-23 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 138 bits (347), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 90/261 (34%), Positives = 129/261 (49%), Gaps = 50/261 (19%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQ-PCNALAVSREHKEKFQREVTLLS 117
D + + G++S +Y+G Y VAVK+++ P + + +++F+ EV LLS
Sbjct: 81 ADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVALLS 140
Query: 118 KMKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
++ H NI++F+ A +P + IITE M L+ YL P L ++ + ALDISR M
Sbjct: 141 RLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGM 200
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA-REEVMDEMTCEAGTYRWMAPE--- 232
EYLH+ VIHRDLK +NLLL D+ +VK+ADFG + E E GTYRWMAPE
Sbjct: 201 EYLHSQGVIHRDLKSNNLLLN-DEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPEMIK 259
Query: 233 ------------------------------------------NERPSLENLSEDMVA-LL 249
NERP L + +A L+
Sbjct: 260 EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHLI 319
Query: 250 KSCWAEDPKVRPEFAEITITL 270
K CW+E+P RP+F+ I L
Sbjct: 320 KRCWSENPSKRPDFSNIVAVL 340
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q54XQ2|RCKA_DICDI RGS domain-containing serine/threonine-protein kinase A OS=Dictyostelium discoideum GN=rckA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 119 bits (298), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 94/314 (29%), Positives = 138/314 (43%), Gaps = 57/314 (18%)
Query: 8 KEGESFELSFPLFDDNTGDTSCPLTKACDADDDDDEEYDNEFVFD-IDASVLVDHRSVLL 66
K+ + +LS + DN D + D+ D E E V D I + + V +
Sbjct: 790 KDSNNSQLSISITLDNDEDPTI-----FHLDESDMESLIEEVVKDNISVHTEISYSDVSI 844
Query: 67 QKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILK 126
K I GS VY G Y + VA+KV+ P + V + E F+REV L+S KH+N+ +
Sbjct: 845 HKWIASGSSGRVYNGQYKGKDVAIKVLGP--EVCVHFDLNE-FKREVALMSIFKHDNLAR 901
Query: 127 FVGAS-VQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVI 185
+GA +TE +L YL R + + FAL I+R M YLH+ S+I
Sbjct: 902 CLGAGQYDDKYFHLTEYCHNGSLFSYLRDQR-NNISFGQRLHFALGIARGMRYLHSMSII 960
Query: 186 HRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE------------- 232
HRDLK N+LLT+ + ++K+ DFG +R MT GT WMAPE
Sbjct: 961 HRDLKSMNILLTK-RLKIKIVDFGTSRVANKYNMTTHVGTQAWMAPEIFTSRTYTNKVDV 1019
Query: 233 -------------------------------NERPSL-ENLSEDMVALLKSCWAEDPKVR 260
ERP L +++ + ++K CW + P R
Sbjct: 1020 YSYAIILFEIFTRKSAYDENANINIPNMVMKGERPELPKDMQTSISNIIKKCWQQKPSNR 1079
Query: 261 PEFAEITITLTNIL 274
P F +I L +I+
Sbjct: 1080 PSFIKIVAYLESII 1093
|
Serine/threonine kinase involved in negative regulation of chemotaxis. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 114 bits (286), Expect = 7e-25, Method: Composition-based stats.
Identities = 87/285 (30%), Positives = 132/285 (46%), Gaps = 59/285 (20%)
Query: 41 DDEEYDNEFVFDIDASV-LVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNAL 99
DD + N I +SV ++++ + + K IG+G +S V KG + + VAVK + N
Sbjct: 1049 DDIWFVNTVTLPISSSVTMINYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNS-NKD 1107
Query: 100 AVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPK- 158
E ++F+ EV LL ++H N++ G S+ P +++ L G + L ++P
Sbjct: 1108 KAREEMIQEFKAEVELLGSLQHPNLVTCYGYSLNPMCIVMEFLPSGNLFE--LIHSKPSE 1165
Query: 159 -----RLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK-QVKLADFGLAR 212
+LD ++ A DI+R M++LH ++IHRDLK SNLL+ DK +K+AD G+AR
Sbjct: 1166 QQQSIKLDSTLILAIAFDIARGMQHLHTRNIIHRDLKSSNLLM--DKHFNIKIADLGIAR 1223
Query: 213 EEVMDEMTCEAGTYRWMAPE-------NE------------------------------- 234
E + GT W APE N+
Sbjct: 1224 ETSFTQTMTTIGTVAWTAPEILRHESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGI 1283
Query: 235 -------RPSL-ENLSEDMVALLKSCWAEDPKVRPEFAEITITLT 271
RP L +N + L+ CW+EDP RP F EIT LT
Sbjct: 1284 LVASKGLRPELPDNCDPNWKKLVVWCWSEDPNKRPSFEEITNYLT 1328
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q95UN8|M3KSL_DROME Mitogen-activated protein kinase kinase kinase OS=Drosophila melanogaster GN=slpr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 114 bits (284), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 82/271 (30%), Positives = 119/271 (43%), Gaps = 61/271 (22%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+++ + ++++IG G + V++G+Y E VA+K+ + R Q E L
Sbjct: 137 IEYNELDIKEVIGSGGFCKVHRGYYDGEEVAIKIAHQTGEDDMQRMRDNVLQ-EAKLFWA 195
Query: 119 MKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
+KHENI G + + ++ E RG +L R L P + +++A+ I+R M Y
Sbjct: 196 LKHENIAALRGVCLNTKLCLVMEYARGGSLNRILAGKIPPDV----LVNWAIQIARGMNY 251
Query: 179 LHAN---SVIHRDLKPSNLLLTE-------DKKQVKLADFGLAREEVMDEMTCEAGTYRW 228
LH S+IHRDLK SN+L+ E +K +K+ DFGLARE + AGTY W
Sbjct: 252 LHNEAPMSIIHRDLKSSNVLIYEAIEGNHLQQKTLKITDFGLAREMYNTQRMSAAGTYAW 311
Query: 229 MAPE-------------------------NERP--SLENLS------------------- 242
M PE E P + LS
Sbjct: 312 MPPEVISVSTYSKFSDVWSYGVLLWELITGETPYKGFDPLSVAYGVAVNTLTLPIPKTCP 371
Query: 243 EDMVALLKSCWAEDPKVRPEFAEITITLTNI 273
E AL+KSCW DP RP F EI L +I
Sbjct: 372 ETWGALMKSCWQTDPHKRPGFKEILKQLESI 402
|
Activates the JUN N-terminal pathway during dorsal closure. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|A2VDU3|M3K7_BOVIN Mitogen-activated protein kinase kinase kinase 7 OS=Bos taurus GN=MAP3K7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 112 bits (280), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 60/277 (21%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+D++ + +++++G G++ +V K + + VA+K I+ S ++ F E+ LS+
Sbjct: 31 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE-------SESERKAFIVELRQLSR 83
Query: 119 MKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRP-KRLDLKHSISFALDISRAME 177
+ H NI+K GA + P +++ E G +L L P H++S+ L S+ +
Sbjct: 84 VNHPNIVKLYGACLNPVCLVM-EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 142
Query: 178 YLHA---NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE-- 232
YLH+ ++IHRDLKP NLLL +K+ DFG A ++ MT G+ WMAPE
Sbjct: 143 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-DIQTHMTNNKGSAAWMAPEVF 201
Query: 233 --------------------------------------------NERPSL-ENLSEDMVA 247
RP L +NL + + +
Sbjct: 202 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 261
Query: 248 LLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPI 284
L+ CW++DP RP EI +T++++ AD P+
Sbjct: 262 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 298
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|O43318|M3K7_HUMAN Mitogen-activated protein kinase kinase kinase 7 OS=Homo sapiens GN=MAP3K7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 112 bits (280), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 60/277 (21%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+D++ + +++++G G++ +V K + + VA+K I+ S ++ F E+ LS+
Sbjct: 31 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE-------SESERKAFIVELRQLSR 83
Query: 119 MKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRP-KRLDLKHSISFALDISRAME 177
+ H NI+K GA + P +++ E G +L L P H++S+ L S+ +
Sbjct: 84 VNHPNIVKLYGACLNPVCLVM-EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 142
Query: 178 YLHA---NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE-- 232
YLH+ ++IHRDLKP NLLL +K+ DFG A ++ MT G+ WMAPE
Sbjct: 143 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-DIQTHMTNNKGSAAWMAPEVF 201
Query: 233 --------------------------------------------NERPSL-ENLSEDMVA 247
RP L +NL + + +
Sbjct: 202 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 261
Query: 248 LLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPI 284
L+ CW++DP RP EI +T++++ AD P+
Sbjct: 262 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 298
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q62073|M3K7_MOUSE Mitogen-activated protein kinase kinase kinase 7 OS=Mus musculus GN=Map3k7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 112 bits (279), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 60/277 (21%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+D++ + +++++G G++ +V K + + VA+K I+ S ++ F E+ LS+
Sbjct: 31 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE-------SESERKAFIVELRQLSR 83
Query: 119 MKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRP-KRLDLKHSISFALDISRAME 177
+ H NI+K GA + P +++ E G +L L P H++S+ L S+ +
Sbjct: 84 VNHPNIVKLYGACLNPVCLVM-EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 142
Query: 178 YLHA---NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE-- 232
YLH+ ++IHRDLKP NLLL +K+ DFG A ++ MT G+ WMAPE
Sbjct: 143 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-DIQTHMTNNKGSAAWMAPEVF 201
Query: 233 --------------------------------------------NERPSL-ENLSEDMVA 247
RP L +NL + + +
Sbjct: 202 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 261
Query: 248 LLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPI 284
L+ CW++DP RP EI +T++++ AD P+
Sbjct: 262 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 298
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q5RFL3|M3K7_PONAB Mitogen-activated protein kinase kinase kinase 7 OS=Pongo abelii GN=MAP3K7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 112 bits (279), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 60/277 (21%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+D++ + +++++G G++ +V K + + VA+K I+ S ++ F E+ LS+
Sbjct: 31 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE-------SESERKAFIVELRQLSR 83
Query: 119 MKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRP-KRLDLKHSISFALDISRAME 177
+ H NI+K GA + P +++ E G +L L P H++S+ L S+ +
Sbjct: 84 VNHPNIVKLYGACLNPVCLVM-EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 142
Query: 178 YLHA---NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE-- 232
YLH+ ++IHRDLKP NLLL +K+ DFG A ++ MT G+ WMAPE
Sbjct: 143 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-DIQTHMTNNKGSAAWMAPEVF 201
Query: 233 --------------------------------------------NERPSL-ENLSEDMVA 247
RP L +NL + + +
Sbjct: 202 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 261
Query: 248 LLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPI 284
L+ CW++DP RP EI +T++++ AD P+
Sbjct: 262 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 298
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|P0C8E4|M3K7_RAT Mitogen-activated protein kinase kinase kinase 7 OS=Rattus norvegicus GN=Map3k7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 112 bits (279), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 60/277 (21%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+D++ + +++++G G++ +V K + + VA+K I+ S ++ F E+ LS+
Sbjct: 31 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE-------SESERKAFIVELRQLSR 83
Query: 119 MKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRP-KRLDLKHSISFALDISRAME 177
+ H NI+K GA + P +++ E G +L L P H++S+ L S+ +
Sbjct: 84 VNHPNIVKLYGACLNPVCLVM-EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 142
Query: 178 YLHA---NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE-- 232
YLH+ ++IHRDLKP NLLL +K+ DFG A ++ MT G+ WMAPE
Sbjct: 143 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-DIQTHMTNNKGSAAWMAPEVF 201
Query: 233 --------------------------------------------NERPSL-ENLSEDMVA 247
RP L +NL + + +
Sbjct: 202 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 261
Query: 248 LLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPI 284
L+ CW++DP RP EI +T++++ AD P+
Sbjct: 262 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 298
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 109 bits (273), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 77/252 (30%), Positives = 123/252 (48%), Gaps = 52/252 (20%)
Query: 70 IGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVG 129
+GEG++ +VYKG + VA+K I+ V+ + E+F++E+T+LS+++H NI+ +
Sbjct: 668 LGEGTFGVVYKGLWRGSSVAIKQIKINED--VNNQVLEEFRKELTILSRLRHPNIVLLMA 725
Query: 130 A-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRD 188
A + P + ITE + G +L L S + K ++++ A+ I++ M YLH + VIHRD
Sbjct: 726 ACTAPPNLCFITEYLPGGSLYDALHSKKIK-MNMQLYKKLAIQIAQGMNYLHLSGVIHRD 784
Query: 189 LKPSNLLLTEDKKQVKLADFGLAR-EEVMDEMTCEAGTYRWMAPE--------------- 232
+K NLLL E VK+ DFGL++ + EMT G+ WM+PE
Sbjct: 785 IKSLNLLLDE-HMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELLMGEDYTEKVDVYA 843
Query: 233 ------------------------------NERPSLEN-LSEDMVALLKSCWAEDPKVRP 261
+ RP + N + L+++CW +DP RP
Sbjct: 844 FGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRP 903
Query: 262 EFAEITITLTNI 273
F EI L I
Sbjct: 904 SFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 336 | ||||||
| 255568261 | 410 | Serine/threonine-protein kinase HT1, put | 0.75 | 0.614 | 0.538 | 1e-88 | |
| 225430828 | 364 | PREDICTED: serine/threonine-protein kina | 0.842 | 0.777 | 0.510 | 7e-86 | |
| 147859359 | 356 | hypothetical protein VITISV_043906 [Viti | 0.818 | 0.772 | 0.501 | 1e-81 | |
| 297797719 | 406 | hypothetical protein ARALYDRAFT_496930 [ | 0.708 | 0.586 | 0.530 | 5e-78 | |
| 449451659 | 374 | PREDICTED: serine/threonine-protein kina | 0.705 | 0.633 | 0.515 | 6e-78 | |
| 297735197 | 301 | unnamed protein product [Vitis vinifera] | 0.732 | 0.817 | 0.526 | 2e-77 | |
| 15240070 | 405 | protein kinase family protein [Arabidops | 0.702 | 0.582 | 0.503 | 6e-73 | |
| 116643272 | 416 | flag-tagged protein kinase domain of put | 0.702 | 0.567 | 0.503 | 7e-73 | |
| 156070802 | 372 | unknown [Solanum bulbocastanum] | 0.726 | 0.655 | 0.489 | 3e-71 | |
| 156070765 | 372 | unknown [Solanum melongena] | 0.761 | 0.688 | 0.488 | 3e-70 |
| >gi|255568261|ref|XP_002525105.1| Serine/threonine-protein kinase HT1, putative [Ricinus communis] gi|223535564|gb|EEF37232.1| Serine/threonine-protein kinase HT1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 332 bits (851), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 167/310 (53%), Positives = 213/310 (68%), Gaps = 58/310 (18%)
Query: 39 DDDDEEYD----NEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQ 94
DD++EE + N+FVF+ID S+L+D R VL++++I EGSYS+VY+G + +PVAVK+IQ
Sbjct: 5 DDEEEEINAVLRNDFVFNIDESLLIDPRRVLVRRLIAEGSYSLVYEGEFESKPVAVKIIQ 64
Query: 95 PCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWS 154
P AV EHKEKFQREV L S+MKH N++K +GASV+P M +ITEL+RG+TLQ+YLWS
Sbjct: 65 PMKTSAVILEHKEKFQREVVLQSRMKHVNVVKLIGASVEPAMFLITELLRGDTLQKYLWS 124
Query: 155 TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214
RPKRLDL+ +I+FALDI RAMEYLH N +IHRDLKPSNLLLT+D+KQ+K+ADFGLAREE
Sbjct: 125 IRPKRLDLRLAITFALDICRAMEYLHDNGIIHRDLKPSNLLLTDDRKQIKVADFGLAREE 184
Query: 215 VMDEMTCEAGTYRWMAPE------------------------------------------ 232
+M+EMTCEAGTYRWMAPE
Sbjct: 185 IMNEMTCEAGTYRWMAPELFSKEALRIGMKKHYDHKVDVYSFSIVLWELLTNKAPFKGRD 244
Query: 233 -----------NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSAD 281
NERPSLEN+ E++ LL+SCW+EDP +RPEF EIT LTN + +L A+
Sbjct: 245 NITVAYAAAANNERPSLENVPEELATLLQSCWSEDPALRPEFTEITKYLTNFMHSLWPAE 304
Query: 282 TPIPPKLVEI 291
PP ++EI
Sbjct: 305 M-TPPIVMEI 313
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225430828|ref|XP_002268484.1| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 323 bits (828), Expect = 7e-86, Method: Compositional matrix adjust.
Identities = 172/337 (51%), Positives = 211/337 (62%), Gaps = 54/337 (16%)
Query: 50 VFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKF 109
V +D S+L+D S+ + MI EG S+V++G Y PVA+K+IQP AVS + KEKF
Sbjct: 28 VIKLDRSLLIDLSSLRIGSMISEGRLSVVHEGLYKSMPVAIKMIQPNKTSAVSPDRKEKF 87
Query: 110 QREVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
QREVT+LS++KHENI+KF+GAS++PTMMIITELM+G TLQ+YLWS RP DLK S+SFA
Sbjct: 88 QREVTILSRVKHENIVKFIGASIEPTMMIITELMKGGTLQQYLWSIRPNSPDLKLSLSFA 147
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWM 229
LDISR MEYLHAN +IHRDLKPSNLLLTEDKKQ+K+ DFGLAREE +MT EAGTYRWM
Sbjct: 148 LDISRVMEYLHANGIIHRDLKPSNLLLTEDKKQIKVCDFGLAREETAGDMTTEAGTYRWM 207
Query: 230 APE----------------------------------------------------NERPS 237
APE NERPS
Sbjct: 208 APELFSTVPLPRGAKIHYDHKVDVYSFAIILWELLTNRTPFKGVQSILIAYAAANNERPS 267
Query: 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVEIVDPKST 297
+EN+ +D+ L+SCWAEDP RPEF +IT L + LQNL SA P + EI P+S
Sbjct: 268 VENIPQDIAPFLQSCWAEDPANRPEFMQITNFLVDFLQNLCSAQI-TPAQTFEIEHPRSN 326
Query: 298 MNNDCMATVHAITKFNEKGKKRRSYLPSFLKRFAGCF 334
+ D + H I+K + K K RS LP FL+ F C
Sbjct: 327 VTADSAGSNHPISKVSGK-MKARSPLPCFLRCFDDCL 362
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147859359|emb|CAN83950.1| hypothetical protein VITISV_043906 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 309 bits (791), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 169/337 (50%), Positives = 206/337 (61%), Gaps = 62/337 (18%)
Query: 50 VFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKF 109
V +D S+L+D S+ + MI EG Y + PVA+K+IQP AVS + KEKF
Sbjct: 28 VIKLDRSLLIDLSSLRIGSMISEGRYKSM--------PVAIKMIQPNKTSAVSPDRKEKF 79
Query: 110 QREVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
QREVT+LS++KHENI+KF+GAS++PTMMIITELM+G TLQ+YLWS RP DLK S+SFA
Sbjct: 80 QREVTILSRVKHENIVKFIGASIEPTMMIITELMKGGTLQQYLWSIRPNSPDLKLSLSFA 139
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWM 229
LDISR MEYLHAN +IHRDLKPSNLLLTEDKKQ+K+ DFGLAREE +MT EAGTYRWM
Sbjct: 140 LDISRVMEYLHANGIIHRDLKPSNLLLTEDKKQIKVCDFGLAREETAGDMTTEAGTYRWM 199
Query: 230 APE----------------------------------------------------NERPS 237
APE NERPS
Sbjct: 200 APELFSTVPLPRGAKIHYDHKVDVYSFAIILWELLTNRTPFKGVQSILIAYAAANNERPS 259
Query: 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVEIVDPKST 297
+EN+ +D+ L+SCWAEDP RPEF +IT L + LQNL SA P + EI P+S
Sbjct: 260 VENIPQDIAPFLQSCWAEDPANRPEFMQITNFLVDFLQNLCSAQI-TPAQTFEIEHPRSN 318
Query: 298 MNNDCMATVHAITKFNEKGKKRRSYLPSFLKRFAGCF 334
+ D + H I+K + K K RS LP FL+ F C
Sbjct: 319 VTADSAGSNHPISKVSGK-MKARSPLPCFLRCFDDCL 354
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297797719|ref|XP_002866744.1| hypothetical protein ARALYDRAFT_496930 [Arabidopsis lyrata subsp. lyrata] gi|297312579|gb|EFH43003.1| hypothetical protein ARALYDRAFT_496930 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 297 bits (760), Expect = 5e-78, Method: Compositional matrix adjust.
Identities = 155/292 (53%), Positives = 195/292 (66%), Gaps = 54/292 (18%)
Query: 44 EYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKG-FYGCEPVAVKVIQPCNALAVS 102
E +++F F I +LVD + V ++++IGEGS SIVYKG F PV+VK+ QP AVS
Sbjct: 52 ESNDQFAFSISTDLLVDVKDVSIEEVIGEGSSSIVYKGLFMRFIPVSVKIFQPKRTSAVS 111
Query: 103 REHKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDL 162
E K+KFQREV LLSK KHENI++F+GA ++P +MIITELM G TLQ+++ STRPK LDL
Sbjct: 112 IEQKKKFQREVLLLSKFKHENIVQFIGACIEPKLMIITELMEGNTLQKFMLSTRPKPLDL 171
Query: 163 KHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE 222
K SISFALDI+R ME+L+AN +IHRDLKPSN+LLT D+K+VKLADFGLAREE MTCE
Sbjct: 172 KLSISFALDIARGMEFLNANGIIHRDLKPSNMLLTGDQKRVKLADFGLAREETKGFMTCE 231
Query: 223 AGTYRWMAPE-------------------------------------------------- 232
AGTYRWMAPE
Sbjct: 232 AGTYRWMAPELFSYDPLQIGEKKHYDHKVDVYSFAIVFWELLTNKTPFKGKNNIFVAYAA 291
Query: 233 --NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADT 282
N+RPS+ENL E + ++L+SCWAEDP RPEF EIT++LTN+L++L S+DT
Sbjct: 292 SKNQRPSVENLPEGVASILQSCWAEDPDARPEFKEITVSLTNLLRSL-SSDT 342
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449451659|ref|XP_004143579.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 297 bits (760), Expect = 6e-78, Method: Compositional matrix adjust.
Identities = 149/289 (51%), Positives = 191/289 (66%), Gaps = 52/289 (17%)
Query: 49 FVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEK 108
FVF I+ ++L+D + + ++IGEGS SIVY+G Y +PVAVK+IQP A A+S E KE+
Sbjct: 34 FVFSIEPTLLIDPHCLKIGEVIGEGSCSIVYEGLYDYQPVAVKIIQPIRASAISPEKKER 93
Query: 109 FQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISF 168
FQREVTLL+++ HENI+KF+GAS++PT+MIITELMRG TLQ+YLWS RP+ D K S+S
Sbjct: 94 FQREVTLLARLNHENIIKFIGASIEPTLMIITELMRGGTLQKYLWSIRPETPDSKFSLSL 153
Query: 169 ALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRW 228
ALD+SR M YLH+N +I+RDLKPSNLLLTEDK+++KLA+FGLAREE+ EMT EAGTYRW
Sbjct: 154 ALDLSRVMTYLHSNGIIYRDLKPSNLLLTEDKQRIKLANFGLAREEISGEMTTEAGTYRW 213
Query: 229 MAPE----------------------------------------------------NERP 236
MAPE N RP
Sbjct: 214 MAPELFSIDPLPVGCKKCYDHKADVYSFSIILWELLTNKTPFKGRNDIMVAYAVAKNIRP 273
Query: 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIP 285
LE + EDM LL+SCWAEDP RPEF E+T L+N+LQ+ ++ +P
Sbjct: 274 CLEEIPEDMAPLLQSCWAEDPNSRPEFTEVTDYLSNLLQSFVLKESSLP 322
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297735197|emb|CBI17559.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 295 bits (755), Expect = 2e-77, Method: Compositional matrix adjust.
Identities = 158/300 (52%), Positives = 189/300 (63%), Gaps = 54/300 (18%)
Query: 87 PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGE 146
PVA+K+IQP AVS + KEKFQREVT+LS++KHENI+KF+GAS++PTMMIITELM+G
Sbjct: 2 PVAIKMIQPNKTSAVSPDRKEKFQREVTILSRVKHENIVKFIGASIEPTMMIITELMKGG 61
Query: 147 TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLA 206
TLQ+YLWS RP DLK S+SFALDISR MEYLHAN +IHRDLKPSNLLLTEDKKQ+K+
Sbjct: 62 TLQQYLWSIRPNSPDLKLSLSFALDISRVMEYLHANGIIHRDLKPSNLLLTEDKKQIKVC 121
Query: 207 DFGLAREEVMDEMTCEAGTYRWMAPE---------------------------------- 232
DFGLAREE +MT EAGTYRWMAPE
Sbjct: 122 DFGLAREETAGDMTTEAGTYRWMAPELFSTVPLPRGAKIHYDHKVDVYSFAIILWELLTN 181
Query: 233 ------------------NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274
NERPS+EN+ +D+ L+SCWAEDP RPEF +IT L + L
Sbjct: 182 RTPFKGVQSILIAYAAANNERPSVENIPQDIAPFLQSCWAEDPANRPEFMQITNFLVDFL 241
Query: 275 QNLRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGKKRRSYLPSFLKRFAGCF 334
QNL SA P + EI P+S + D + H I+K + K K RS LP FL+ F C
Sbjct: 242 QNLCSAQI-TPAQTFEIEHPRSNVTADSAGSNHPISKVSGK-MKARSPLPCFLRCFDDCL 299
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15240070|ref|NP_201472.1| protein kinase family protein [Arabidopsis thaliana] gi|8843729|dbj|BAA97277.1| protein kinase ATN1-like protein [Arabidopsis thaliana] gi|332010871|gb|AED98254.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 280 bits (716), Expect = 6e-73, Method: Compositional matrix adjust.
Identities = 146/290 (50%), Positives = 188/290 (64%), Gaps = 54/290 (18%)
Query: 46 DNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKG-FYGCEPVAVKVIQPCNALAVSRE 104
+++F F I+ +LVD + + + IGEGS S VY+G F PV+VK+ QP A+S E
Sbjct: 53 NDQFAFTINTELLVDVKDISIGDFIGEGSSSTVYRGLFRRVVPVSVKIFQPKRTSALSIE 112
Query: 105 HKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKH 164
++KFQREV LLSK +HENI++F+GA ++P +MIITELM G TLQ+++ S RPK LDLK
Sbjct: 113 QRKKFQREVLLLSKFRHENIVRFIGACIEPKLMIITELMEGNTLQKFMLSVRPKPLDLKL 172
Query: 165 SISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAG 224
SISFALDI+R ME+L+AN +IHRDLKPSN+LLT D+K VKLADFGLAREE MT EAG
Sbjct: 173 SISFALDIARGMEFLNANGIIHRDLKPSNMLLTGDQKHVKLADFGLAREETKGFMTFEAG 232
Query: 225 TYRWMAPE---------------------------------------------------- 232
TYRWMAPE
Sbjct: 233 TYRWMAPELFSYDTLEIGEKKHYDHKVDVYSFAIVFWELLTNKTPFKGKNNIFVAYAASK 292
Query: 233 NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADT 282
N+RPS+ENL E +V++L+SCWAE+P RPEF EIT +LTN+L++L S+DT
Sbjct: 293 NQRPSVENLPEGVVSILQSCWAENPDARPEFKEITYSLTNLLRSL-SSDT 341
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116643272|gb|ABK06444.1| flag-tagged protein kinase domain of putative mitogen-activated protein kinase kinase kinase [synthetic construct] | Back alignment and taxonomy information |
|---|
Score = 280 bits (716), Expect = 7e-73, Method: Compositional matrix adjust.
Identities = 146/290 (50%), Positives = 188/290 (64%), Gaps = 54/290 (18%)
Query: 46 DNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKG-FYGCEPVAVKVIQPCNALAVSRE 104
+++F F I+ +LVD + + + IGEGS S VY+G F PV+VK+ QP A+S E
Sbjct: 53 NDQFAFTINTELLVDVKDISIGDFIGEGSSSTVYRGLFRRVVPVSVKIFQPKRTSALSIE 112
Query: 105 HKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKH 164
++KFQREV LLSK +HENI++F+GA ++P +MIITELM G TLQ+++ S RPK LDLK
Sbjct: 113 QRKKFQREVLLLSKFRHENIVRFIGACIEPKLMIITELMEGNTLQKFMLSVRPKPLDLKL 172
Query: 165 SISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAG 224
SISFALDI+R ME+L+AN +IHRDLKPSN+LLT D+K VKLADFGLAREE MT EAG
Sbjct: 173 SISFALDIARGMEFLNANGIIHRDLKPSNMLLTGDQKHVKLADFGLAREETKGFMTFEAG 232
Query: 225 TYRWMAPE---------------------------------------------------- 232
TYRWMAPE
Sbjct: 233 TYRWMAPELFSYDTLEIGEKKHYDHKVDVYSFAIVFWELLTNKTPFKGKNNIFVAYAASK 292
Query: 233 NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADT 282
N+RPS+ENL E +V++L+SCWAE+P RPEF EIT +LTN+L++L S+DT
Sbjct: 293 NQRPSVENLPEGVVSILQSCWAENPDARPEFKEITYSLTNLLRSL-SSDT 341
|
Source: synthetic construct Species: synthetic construct Genus: N/A Family: N/A Order: N/A Class: N/A Phylum: N/A Superkingdom: |
| >gi|156070802|gb|ABU45214.1| unknown [Solanum bulbocastanum] | Back alignment and taxonomy information |
|---|
Score = 275 bits (702), Expect = 3e-71, Method: Compositional matrix adjust.
Identities = 145/296 (48%), Positives = 188/296 (63%), Gaps = 52/296 (17%)
Query: 42 DEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAV 101
D+++ + ID +L+D + + + +I EG YS+VY+G Y PVA+K+IQP + V
Sbjct: 28 DDDFSAQNSVSIDKKLLIDLQHLSIGHVISEGPYSVVYEGLYKSMPVAIKIIQPDMSANV 87
Query: 102 SREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLD 161
S E K KFQREVTLLSK+KHENI+KF+GAS++PT+M++TELM+G TLQ++LWSTRP+ D
Sbjct: 88 SPERKVKFQREVTLLSKVKHENIVKFIGASMEPTLMLVTELMKGGTLQKFLWSTRPQCPD 147
Query: 162 LKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTC 221
LK S+SFAL+ISRAMEYLHA +IHRDLKPSNLLLTEDK +K+ADFGLARE+ EMT
Sbjct: 148 LKLSLSFALEISRAMEYLHAIGIIHRDLKPSNLLLTEDKTIIKIADFGLAREDAEAEMTT 207
Query: 222 EAGTYRWMAPE---------------------------------NERP------------ 236
EAGTYRWMAPE N P
Sbjct: 208 EAGTYRWMAPEMFSMDPIRIGVKKYYNHKVDVYSFSMILWELLTNSTPFKGRSNIMVAYA 267
Query: 237 -------SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIP 285
S++N+ ++ LL SCWAEDP RPEF +I+ L NIL+N+ + T P
Sbjct: 268 TATKMRPSMDNIPSEIEPLLSSCWAEDPAERPEFEQISDFLANILRNVCGSLTSSP 323
|
Source: Solanum bulbocastanum Species: Solanum bulbocastanum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|156070765|gb|ABU45180.1| unknown [Solanum melongena] | Back alignment and taxonomy information |
|---|
Score = 271 bits (693), Expect = 3e-70, Method: Compositional matrix adjust.
Identities = 152/311 (48%), Positives = 191/311 (61%), Gaps = 55/311 (17%)
Query: 28 SCPLTKACDADDDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEP 87
S P K D DD + ++ V ID +L+D + + + +I EG YSIVY+G Y P
Sbjct: 15 SNPFGKFSDGCAMDD--FSSQNVVTIDNKLLIDLQHLFIGPVISEGLYSIVYEGEYKSMP 72
Query: 88 VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGET 147
VA+K+IQP + VS E KFQREVTLLSK++H+NI+KF+GAS++P +M++TELM+G T
Sbjct: 73 VAIKIIQPDMSANVSPERIVKFQREVTLLSKVQHDNIVKFIGASMEPALMLVTELMKGGT 132
Query: 148 LQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLAD 207
LQRYLWS RP+ DLK S+SFALDISRAMEYLHA +IHRDLKPSNLLL+EDK VKLAD
Sbjct: 133 LQRYLWSIRPQCPDLKLSLSFALDISRAMEYLHAIGIIHRDLKPSNLLLSEDKMIVKLAD 192
Query: 208 FGLAREEVMDEMTCEAGTYRWMAPE---------------------------------NE 234
FGLAREE EMT EAGTYRWMAPE N
Sbjct: 193 FGLAREETDSEMTTEAGTYRWMAPEMFSMEPLKIGVKKCYNHKVDVYSFSLILWELLTNN 252
Query: 235 RP--------------------SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274
P S++N+ ++ LL SCWAEDP RPEF +I+ TL NIL
Sbjct: 253 TPFKGRNNILVAYATTATKLRPSMDNIPGEIEPLLSSCWAEDPAERPEFEQISDTLANIL 312
Query: 275 QNLRSADTPIP 285
+++ + T P
Sbjct: 313 RDVCRSSTCSP 323
|
Source: Solanum melongena Species: Solanum melongena Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 336 | ||||||
| TAIR|locus:2173674 | 405 | AT5G66710 [Arabidopsis thalian | 0.547 | 0.454 | 0.621 | 1.2e-73 | |
| TAIR|locus:2101689 | 377 | AT3G50720 [Arabidopsis thalian | 0.547 | 0.488 | 0.6 | 2.9e-66 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.541 | 0.511 | 0.524 | 1.3e-57 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.544 | 0.518 | 0.494 | 1.4e-56 | |
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.535 | 0.540 | 0.524 | 2.6e-55 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.541 | 0.526 | 0.486 | 1.1e-54 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.514 | 0.420 | 0.412 | 2.2e-38 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.526 | 0.429 | 0.393 | 2.2e-38 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.502 | 0.296 | 0.380 | 1.4e-35 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.502 | 0.309 | 0.386 | 8.2e-35 |
| TAIR|locus:2173674 AT5G66710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 579 (208.9 bits), Expect = 1.2e-73, Sum P(2) = 1.2e-73
Identities = 115/185 (62%), Positives = 142/185 (76%)
Query: 49 FVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKG-FYGCEPVAVKVIQPCNALAVSREHKE 107
F F I+ +LVD + + + IGEGS S VY+G F PV+VK+ QP A+S E ++
Sbjct: 56 FAFTINTELLVDVKDISIGDFIGEGSSSTVYRGLFRRVVPVSVKIFQPKRTSALSIEQRK 115
Query: 108 KFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSIS 167
KFQREV LLSK +HENI++F+GA ++P +MIITELM G TLQ+++ S RPK LDLK SIS
Sbjct: 116 KFQREVLLLSKFRHENIVRFIGACIEPKLMIITELMEGNTLQKFMLSVRPKPLDLKLSIS 175
Query: 168 FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYR 227
FALDI+R ME+L+AN +IHRDLKPSN+LLT D+K VKLADFGLAREE MT EAGTYR
Sbjct: 176 FALDIARGMEFLNANGIIHRDLKPSNMLLTGDQKHVKLADFGLAREETKGFMTFEAGTYR 235
Query: 228 WMAPE 232
WMAPE
Sbjct: 236 WMAPE 240
|
|
| TAIR|locus:2101689 AT3G50720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 575 (207.5 bits), Expect = 2.9e-66, Sum P(2) = 2.9e-66
Identities = 111/185 (60%), Positives = 144/185 (77%)
Query: 49 FVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKG-FYGCEPVAVKVIQPCNALAVSREHKE 107
F F+I +L++ + ++ +MIGEG SIVYKG PVAVK++QP AVS + K+
Sbjct: 33 FDFNISRELLLNPKDIMRGEMIGEGGNSIVYKGRLKNIVPVAVKIVQPGKTSAVSIQDKQ 92
Query: 108 KFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSIS 167
+FQ+EV +LS MKHENI++FVGA ++P +MI+TEL+RG TLQR++ ++RP LDLK S+S
Sbjct: 93 QFQKEVLVLSSMKHENIVRFVGACIEPQLMIVTELVRGGTLQRFMLNSRPSPLDLKVSLS 152
Query: 168 FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYR 227
FALDISRAMEYLH+ +IHRDL P N+L+T D K VKLADFGLARE+ + MTCEAGTYR
Sbjct: 153 FALDISRAMEYLHSKGIIHRDLNPRNVLVTGDMKHVKLADFGLAREKTLGGMTCEAGTYR 212
Query: 228 WMAPE 232
WMAPE
Sbjct: 213 WMAPE 217
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 1.3e-57, Sum P(2) = 1.3e-57
Identities = 96/183 (52%), Positives = 136/183 (74%)
Query: 51 FDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQ 110
F++D LVD R + + IGEG+++ VY+G Y + VA+K+I+ + + +F
Sbjct: 13 FELDPKWLVDPRHLFVGPKIGEGAHAKVYEGKYRNQTVAIKIIKRGESPEEIAKRDNRFA 72
Query: 111 REVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFAL 170
RE+ +LSK++H+N++KF+GA +P M+I+TEL+ G TL++YL S RPKRLD++ ++ FAL
Sbjct: 73 REIAMLSKVQHKNLVKFIGACKEPMMVIVTELLLGGTLRKYLVSLRPKRLDIRLAVGFAL 132
Query: 171 DISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM-TCEAGTYRWM 229
DI+RAME LH++ +IHRDLKP NL+L+ D K VKLADFGLAREE + EM T E GTYRWM
Sbjct: 133 DIARAMECLHSHGIIHRDLKPENLILSADHKTVKLADFGLAREESLTEMMTAETGTYRWM 192
Query: 230 APE 232
APE
Sbjct: 193 APE 195
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 476 (172.6 bits), Expect = 1.4e-56, Sum P(2) = 1.4e-56
Identities = 91/184 (49%), Positives = 137/184 (74%)
Query: 50 VFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKF 109
VF++D +VD + + + IGEG+++ +Y+G Y + VA+K+++ + + + +F
Sbjct: 12 VFELDPKWVVDPQHLFVGPKIGEGAHAKIYEGKYKNKTVAIKIVKRGESPEEIAKRESRF 71
Query: 110 QREVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
REV++LS+++H+N++KF+GA +P M+I+TEL+ G TL++YL S RP LD++ ++ +A
Sbjct: 72 AREVSMLSRVQHKNLVKFIGACKEPIMVIVTELLLGGTLRKYLVSLRPGSLDIRVAVGYA 131
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM-TCEAGTYRW 228
LDI+RAME LH++ VIHRDLKP +L+LT D K VKLADFGLAREE + EM T E GTYRW
Sbjct: 132 LDIARAMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTEMMTAETGTYRW 191
Query: 229 MAPE 232
MAPE
Sbjct: 192 MAPE 195
|
|
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 476 (172.6 bits), Expect = 2.6e-55, Sum P(2) = 2.6e-55
Identities = 95/181 (52%), Positives = 131/181 (72%)
Query: 53 IDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQRE 112
I+ S+LVD + + + IGEG++ VY+G YG + VA+KV+ + + +F RE
Sbjct: 7 IEESLLVDPKLLFIGSKIGEGAHGKVYQGRYGRQIVAIKVVNRGSKPDQQSSLESRFVRE 66
Query: 113 VTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDI 172
V ++S+++H N++KF+GA P M+I+TEL+ G +L++YL S RP+ L L ++SFALDI
Sbjct: 67 VNMMSRVQHHNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPQLLHLPLALSFALDI 126
Query: 173 SRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM-TCEAGTYRWMAP 231
+RA+ LHAN +IHRDLKP NLLLTE+ K VKLADFGLAREE + EM T E GTYRWMAP
Sbjct: 127 ARALHCLHANGIIHRDLKPDNLLLTENHKSVKLADFGLAREESVTEMMTAETGTYRWMAP 186
Query: 232 E 232
E
Sbjct: 187 E 187
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 454 (164.9 bits), Expect = 1.1e-54, Sum P(2) = 1.1e-54
Identities = 89/183 (48%), Positives = 129/183 (70%)
Query: 51 FDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQ 110
F ++ +D + + + IGEG+++ VY+G Y + VA+K++ + +F
Sbjct: 7 FRMEPKWQIDPQLLFVGPKIGEGAHAKVYEGKYKNQTVAIKIVHRGETPEEIAKRDSRFL 66
Query: 111 REVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFAL 170
REV +LS+++H+N++KF+GA +P M+I+TEL++G TL++YL + RP L+ + +I FAL
Sbjct: 67 REVEMLSRVQHKNLVKFIGACKEPVMVIVTELLQGGTLRKYLLNLRPACLETRVAIGFAL 126
Query: 171 DISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM-TCEAGTYRWM 229
DI+R ME LH++ +IHRDLKP NLLLT D K VKLADFGLAREE + EM T E GTYRWM
Sbjct: 127 DIARGMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWM 186
Query: 230 APE 232
APE
Sbjct: 187 APE 189
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 366 (133.9 bits), Expect = 2.2e-38, Sum P(2) = 2.2e-38
Identities = 73/177 (41%), Positives = 121/177 (68%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQ-PCNALAVSREHKEKFQREVTLLS 117
+D R + + +G++ +YKG Y E VA+K+++ P N+ ++ +++FQ+EV++L+
Sbjct: 125 IDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFMEQQFQQEVSMLA 184
Query: 118 KMKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
+KH NI++F+GA +P + I+TE +G +++++L + + + LK ++ ALD++R M
Sbjct: 185 NLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 244
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
Y+H + IHRDLK NLL++ DK +K+ADFG+AR EV E MT E GTYRWMAPE
Sbjct: 245 AYVHGRNFIHRDLKSDNLLISADKS-IKIADFGVARIEVQTEGMTPETGTYRWMAPE 300
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 352 (129.0 bits), Expect = 2.2e-38, Sum P(2) = 2.2e-38
Identities = 72/183 (39%), Positives = 121/183 (66%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEK-FQREVTLLS 117
+D R + + +G++ +Y+G Y E VA+K+++ ++ + E+ FQ+EV++L+
Sbjct: 126 IDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQFQQEVSMLA 185
Query: 118 KMKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
+KH NI++F+GA ++P + I+TE +G +++++L + + + LK ++ ALD++R M
Sbjct: 186 FLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVARGM 245
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE--N 233
Y+H + IHRDLK NLL++ D+ +K+ADFG+AR EV E MT E GTYRWMAPE
Sbjct: 246 AYVHERNFIHRDLKSDNLLISADRS-IKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQ 304
Query: 234 ERP 236
RP
Sbjct: 305 HRP 307
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 329 (120.9 bits), Expect = 1.4e-35, Sum P(2) = 1.4e-35
Identities = 67/176 (38%), Positives = 113/176 (64%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+D + + ++K + GSY +++G Y + VA+K+++P V+ E +F +EV ++ K
Sbjct: 287 IDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKILKPER---VNAEMLREFSQEVYIMRK 343
Query: 119 MKHENILKFVGASVQ-PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
++H+N+++F+GA + P + I+TE M ++ +L + ++ + ALD+S+ M
Sbjct: 344 VRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKGV-FKIQSLLKVALDVSKGMN 402
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
YLH N++IHRDLK +NLL+ E + VK+ADFG+AR + MT E GTYRWMAPE
Sbjct: 403 YLHQNNIIHRDLKTANLLMDEHEV-VKVADFGVARVQTESGVMTAETGTYRWMAPE 457
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 328 (120.5 bits), Expect = 8.2e-35, Sum P(2) = 8.2e-35
Identities = 68/176 (38%), Positives = 112/176 (63%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+D + ++K + GSY +++G Y + VA+K ++P V+ E +F +EV ++ K
Sbjct: 281 IDVTQLKIEKKVASGSYGDLHRGTYCSQEVAIKFLKPDR---VNNEMLREFSQEVFIMRK 337
Query: 119 MKHENILKFVGASVQ-PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
++H+N+++F+GA + PT+ I+TE M ++ +L + L+ + ALD+++ M
Sbjct: 338 VRHKNVVQFLGACTRSPTLCIVTEFMARGSIYDFLHKQKCA-FKLQTLLKVALDVAKGMS 396
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
YLH N++IHRDLK +NLL+ E VK+ADFG+AR ++ MT E GTYRWMAPE
Sbjct: 397 YLHQNNIIHRDLKTANLLMDEHGL-VKVADFGVARVQIESGVMTAETGTYRWMAPE 451
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh2_kg.8__2746__AT5G66710.1 | annotation not avaliable (406 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 336 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-57 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-56 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-34 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-28 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-25 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-22 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-21 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-18 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 3e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-06 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 7e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 3e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.001 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.002 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 6e-57
Identities = 84/263 (31%), Positives = 117/263 (44%), Gaps = 61/263 (23%)
Query: 64 VLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+ L K +GEG++ VYKG VAVK ++ S + E+F RE ++
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED----ASEQQIEEFLREARIMR 56
Query: 118 KMKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
K+ H NI+K +G + +MI+ E M G L YL RPK L L +SFAL I+R M
Sbjct: 57 KLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPE- 232
EYL + + IHRDL N L+ E+ VK++DFGL+R+ D+ G RWMAPE
Sbjct: 117 EYLESKNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 233 ---------------------------------------------NERPSLENLSEDMVA 247
P N ++
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYK 235
Query: 248 LLKSCWAEDPKVRPEFAEITITL 270
L+ CWAEDP+ RP F+E+ L
Sbjct: 236 LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 4e-56
Identities = 82/263 (31%), Positives = 117/263 (44%), Gaps = 62/263 (23%)
Query: 64 VLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+ L K +GEG++ VYKG VAVK ++ S + E+F RE ++
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED----ASEQQIEEFLREARIMR 56
Query: 118 KMKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
K+ H N++K +G + + I+ E M G L YL RPK L L +SFAL I+R M
Sbjct: 57 KLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIARGM 115
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPE- 232
EYL + + IHRDL N L+ E+ VK++DFGL+R+ D+ + G RWMAPE
Sbjct: 116 EYLESKNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPES 174
Query: 233 ---------------------------------------------NERPSLENLSEDMVA 247
P N ++
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYD 234
Query: 248 LLKSCWAEDPKVRPEFAEITITL 270
L+ CWAEDP+ RP F+E+ L
Sbjct: 235 LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 6e-52
Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 70 IGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
+GEG + VY + VA+K+I+ + S E+ RE+ +L K+ H NI+K
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED----SSSLLEELLREIEILKKLNHPNIVKL 56
Query: 128 VGASV-QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIH 186
G + + ++ E G +L+ L +L + L I +EYLH+N +IH
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLL-KENEGKLSEDEILRILLQILEGLEYLHSNGIIH 115
Query: 187 RDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGTYRWMAPE--NERPSLENLS 242
RDLKP N+LL D +VKLADFGL++ + GT +MAPE + S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 243 ------------EDMVALLKSCWAEDPKVRPEFAEI 266
++ L++ +DP+ RP EI
Sbjct: 176 DIWSLGVILYELPELKDLIRKMLQKDPEKRPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-48
Identities = 73/264 (27%), Positives = 114/264 (43%), Gaps = 72/264 (27%)
Query: 68 KMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
K +GEG++ VYKG VAVK ++ S E ++ F +E ++ K+ H
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA----SEEERKDFLKEARVMKKLGHP 56
Query: 123 NILKFVGASVQP-TMMIITELMRGETLQRYLWSTRP-------KRLDLKHSISFALDISR 174
N+++ +G + + ++ E M G L YL +RP L LK +SFA+ I++
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT----YRWMA 230
MEYL + +HRDL N L+ ED VK++DFGL+R+ D+ + RWMA
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 231 PE------------------------------------------------NERPSLENLS 242
PE +P E
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP--EYCP 233
Query: 243 EDMVALLKSCWAEDPKVRPEFAEI 266
+++ L+ SCW DP+ RP F+E+
Sbjct: 234 DELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-48
Identities = 78/258 (30%), Positives = 119/258 (46%), Gaps = 63/258 (24%)
Query: 66 LQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
L K +GEG++ VYKG VAVK ++ S E +E+F E +++ K+
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA----SEEEREEFLEEASIMKKL 58
Query: 120 KHENILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
H NI++ +G Q + I+TE M G L +L ++L LK + AL I++ MEY
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT----YRWMAPE-- 232
L + + +HRDL N L+TE+ VK++DFGL+R+ D+ + G +WMAPE
Sbjct: 118 LESKNFVHRDLAARNCLVTENLV-VKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 233 ---------------------------------NER-----------PSLENLSEDMVAL 248
NE P EN +++ L
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYEL 236
Query: 249 LKSCWAEDPKVRPEFAEI 266
+ CWA DP+ RP F+E+
Sbjct: 237 MLQCWAYDPEDRPTFSEL 254
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 8e-44
Identities = 67/253 (26%), Positives = 103/253 (40%), Gaps = 59/253 (23%)
Query: 66 LQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ + +GEGS+ VY + VA+KVI+ ++ +E+ RE+ +L K+KH N
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIK----KKKIKKDRERILREIKILKKLKHPN 58
Query: 124 ILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
I++ + ++ E G L L + RL + + I A+EYLH+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE-AGTYRWMAPE--------- 232
++HRDLKP N+LL ED VKLADFGLAR+ E GT +MAPE
Sbjct: 117 GIVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 233 ---------------------------------------NERPSLENLSEDMVALLKSCW 253
P ++S + L++
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235
Query: 254 AEDPKVRPEFAEI 266
+DP+ R E
Sbjct: 236 VKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-40
Identities = 65/177 (36%), Positives = 97/177 (54%), Gaps = 18/177 (10%)
Query: 64 VLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQ---REVTLLSK 118
LL+K +G GS+ VYK + + VAVK+++ E +K Q RE+ +L +
Sbjct: 2 ELLRK-LGSGSFGTVYKAKHKGTGKIVAVKILK------KRSEKSKKDQTARREIRILRR 54
Query: 119 MKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+ H NI++ + A + ++ E G L YL +R L + AL I R +E
Sbjct: 55 LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLE 112
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EMTCEAGTYRWMAPE 232
YLH+N +IHRDLKP N+LL E+ VK+ADFGLA++ + +T GT +MAPE
Sbjct: 113 YLHSNGIIHRDLKPENILLDEN-GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPE 168
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 54/175 (30%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 68 KMIGEGSYSIVYKGFY---GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI 124
+++G GS+ VY G +AVK ++ S E E +RE+ +LS ++H NI
Sbjct: 6 ELLGRGSFGSVYLALDKDTGEL-MAVKSVE---LSGDSEEELEALEREIRILSSLQHPNI 61
Query: 125 LKFVGASVQPTMM---IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
+++ G+ I E + G +L L + +L + I + YLH+
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE----EVMDEMTCEAGTYRWMAPE 232
N ++HRD+K +N+L+ D VKLADFG A+ E + GT WMAPE
Sbjct: 120 NGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-34
Identities = 64/174 (36%), Positives = 100/174 (57%), Gaps = 17/174 (9%)
Query: 66 LQKMIGEGSYSIVYKGFY---GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
+ + IG+G + VYK + G E VA+KVI+ S+E KEK E+ +L K KH
Sbjct: 4 ILEKIGKGGFGEVYKARHKRTGKE-VAIKVIKL-----ESKEKKEKIINEIQILKKCKHP 57
Query: 123 NILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISF-ALDISRAMEYLH 180
NI+K+ G+ ++ + I+ E G +L + L + + L I++ ++ + +EYLH
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSL-KDLLKSTNQTLTESQ-IAYVCKELLKGLEYLH 115
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE--AGTYRWMAPE 232
+N +IHRD+K +N+LLT D +VKL DFGL+ ++ D GT WMAPE
Sbjct: 116 SNGIIHRDIKAANILLTSD-GEVKLIDFGLS-AQLSDTKARNTMVGTPYWMAPE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 61/179 (34%), Positives = 88/179 (49%), Gaps = 33/179 (18%)
Query: 70 IGEGSYSIVYKGF--YGCEPVAVKVIQ--------PCNALAVSREHKEKFQREVTLLSKM 119
+GEG+Y +VYK E VA+K I+ P AL RE++LL ++
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL-----------REISLLKEL 55
Query: 120 KHENILKFVGASVQP-TMMIITELMRGET-LQRYLWSTRPKRLDLKHSISFALDISRAME 177
KH NI+K + + ++ E + L++YL RP L S + R +
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYC--DMDLKKYL-DKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV--MDEMTCEAGT--YRWMAPE 232
Y H++ ++HRDLKP N+L+ D +KLADFGLAR + T E T YR APE
Sbjct: 113 YCHSHRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTHEVVTLWYR--APE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-28
Identities = 75/250 (30%), Positives = 114/250 (45%), Gaps = 60/250 (24%)
Query: 70 IGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
IG+G++ VYKG E VAVK C + + K KF +E +L + H NI+K
Sbjct: 3 IGKGNFGDVYKGVLKGNTE-VAVKT---CRSTLPP-DLKRKFLQEAEILKQYDHPNIVKL 57
Query: 128 VGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIH 186
+G VQ + I+ EL+ G +L +L + RL +K + +LD + MEYL + + IH
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 187 RDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT----YRWMAPE---------- 232
RDL N L+ E+ +K++DFG++REE T G +W APE
Sbjct: 117 RDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 233 -------------------------NER-----------PSLENLSEDMVALLKSCWAED 256
N++ P+ + E++ L+ CWA D
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYD 235
Query: 257 PKVRPEFAEI 266
P+ RP F+EI
Sbjct: 236 PENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 75/267 (28%), Positives = 116/267 (43%), Gaps = 62/267 (23%)
Query: 64 VLLQKMIGEGSYSIVYKGFYGCE-----PVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+ L + IGEG + VY+G Y VAVK + C + +V +EKF +E ++ +
Sbjct: 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSV----REKFLQEAYIMRQ 63
Query: 119 MKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
H +I+K +G + + I+ EL L+ YL LDL I ++ +S A+ Y
Sbjct: 64 FDHPHIVKLIGVITENPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAY 122
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYR----WMAPEN- 233
L + +HRD+ N+L++ VKL DFGL+R + DE +A + WMAPE+
Sbjct: 123 LESKRFVHRDIAARNVLVS-SPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESI 180
Query: 234 --------------------------------------------ERPSL-ENLSEDMVAL 248
ER + N + +L
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 240
Query: 249 LKSCWAEDPKVRPEFAEITITLTNILQ 275
+ CWA DP RP F E+ L++ILQ
Sbjct: 241 MTKCWAYDPSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-28
Identities = 67/261 (25%), Positives = 113/261 (43%), Gaps = 59/261 (22%)
Query: 62 RSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121
+ + L IG+G + V G Y + VAVK ++ ++ A + F E ++++ ++H
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLK-DDSTAA-----QAFLAEASVMTTLRH 59
Query: 122 ENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH 180
N+++ +G +Q + I+TE M +L YL S + L + FALD+ MEYL
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTY--RWMAPEN----- 233
+ +HRDL N+L++ED K++DFGLA+E ++G +W APE
Sbjct: 120 EKNFVHRDLAARNVLVSED-LVAKVSDFGLAKEA---SQGQDSGKLPVKWTAPEALREKK 175
Query: 234 -------------------------ERPSLENLSEDMVA----------------LLKSC 252
R L+++ + ++K C
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC 235
Query: 253 WAEDPKVRPEFAEITITLTNI 273
W DP RP F ++ L I
Sbjct: 236 WELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 5e-27
Identities = 56/178 (31%), Positives = 88/178 (49%), Gaps = 14/178 (7%)
Query: 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE-NI 124
+ + +GEGS+ VY + VA+KV+ L + E+F RE+ +L+ + H NI
Sbjct: 4 ILRKLGEGSFGEVYLARDR-KLVALKVLAK--KLESKSKEVERFLREIQILASLNHPPNI 60
Query: 125 LKFVGASVQPT-MMIITELMRGETLQRYL-WSTRPKRLDLKHSISFALDISRAMEYLHAN 182
+K + ++ E + G +L+ L R L ++ I A+EYLH+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLARE--------EVMDEMTCEAGTYRWMAPE 232
+IHRD+KP N+LL D + VKL DFGLA+ + + GT +MAPE
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 57/176 (32%), Positives = 91/176 (51%), Gaps = 17/176 (9%)
Query: 65 LLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
L +IG G++ +VYKG + VA+K I + E + +E+ LL +KH
Sbjct: 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK---IKEEALKSIMQEIDLLKNLKHP 59
Query: 123 NILKFVG-ASVQPTMMIITELMRGETLQRYL--WSTRPKRLDLKHSISFALDISRAMEYL 179
NI+K++G ++ II E +L++ + + P+ L + + + + YL
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYL 115
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLA---REEVMDEMTCEAGTYRWMAPE 232
H VIHRD+K +N+L T+D VKLADFG+A + D+ + GT WMAPE
Sbjct: 116 HEQGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASV-VGTPYWMAPE 169
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 61/173 (35%), Positives = 95/173 (54%), Gaps = 15/173 (8%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
L + IG+GS+ VYK + VA+KVI L + + E Q+E+ LS+ +
Sbjct: 5 LLECIGKGSFGEVYKAIDKRTNQVVAIKVID----LEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 124 ILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFAL-DISRAMEYLHA 181
I K+ G+ ++ + + II E G + L +P +LD + I+F L ++ +EYLH
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETY-IAFILREVLLGLEYLHE 116
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
IHRD+K +N+LL+E+ VKLADFG++ + M + GT WMAPE
Sbjct: 117 EGKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPE 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-26
Identities = 55/172 (31%), Positives = 94/172 (54%), Gaps = 12/172 (6%)
Query: 66 LQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI 124
L++ +G G + V++G + VA+K+++ + L ++ FQ+EV L +++H+++
Sbjct: 10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL-----KQQDFQKEVQALKRLRHKHL 64
Query: 125 LK-FVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS 183
+ F SV + IITELM +L +L S + L + I A ++ M YL +
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN 124
Query: 184 VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPE 232
IHRDL N+L+ ED K+ADFGLAR + +++ + Y+W APE
Sbjct: 125 SIHRDLAARNILVGED-LVCKVADFGLAR-LIKEDVYLSSDKKIPYKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 15/154 (9%)
Query: 68 KMIGEGSYSIVYKGFYG------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121
K +GEG + V Y E VAVK + + F+RE+ +L + H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD----FEREIEILRTLDH 65
Query: 122 ENILKFVGASVQP---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
ENI+K+ G +P ++ +I E + +L+ YL R +++LK + F+ I + M+Y
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDY 124
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
L + IHRDL N+L+ E + VK++DFGLA+
Sbjct: 125 LGSQRYIHRDLAARNILV-ESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 47/178 (26%), Positives = 87/178 (48%), Gaps = 19/178 (10%)
Query: 66 LQKMIGEGSYSIVYK------GFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
+ K IG+GS+ VY G + +K I + +S + +E EV +L K+
Sbjct: 4 IIKQIGKGSFGKVYLVRRKSDG----KLYVLKEI---DLSNMSEKEREDALNEVKILKKL 56
Query: 120 KHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHS--ISFALDISRAM 176
H NI+K+ + + + I+ E G L + + + + + + + + A+
Sbjct: 57 NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGTYRWMAPE 232
+YLH+ ++HRD+KP N+ LT + VKL DFG+++ +D GT +++PE
Sbjct: 117 KYLHSRKILHRDIKPQNIFLTSNGL-VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 63/265 (23%), Positives = 101/265 (38%), Gaps = 78/265 (29%)
Query: 68 KMIGEGSYSIVYKGFYGCE-----PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
K +G+GS+ +V +G + PVAVK ++ + + F +E ++ + HE
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD----FLKEAAIMHSLDHE 56
Query: 123 NILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
N+++ G + +M++TEL +L L + +A+ I+ M YL +
Sbjct: 57 NLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLARE-EVMDEMTCEAGTYR----------WMAP 231
IHRDL N+LL D K VK+ DFGL R ++ Y W AP
Sbjct: 117 RFIHRDLAARNILLASDDK-VKIGDFGLMRALPQNEDH------YVMEEHLKVPFAWCAP 169
Query: 232 EN-------------------------------------------------ERPSLENLS 242
E+ ERP E
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERP--EACP 227
Query: 243 EDMVALLKSCWAEDPKVRPEFAEIT 267
+D+ ++ CWA +P RP FA +
Sbjct: 228 QDIYNVMLQCWAHNPADRPTFAALR 252
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 70/258 (27%), Positives = 110/258 (42%), Gaps = 60/258 (23%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+ S+ L++ +G G + V+ G + G VAVK ++P E F +E ++
Sbjct: 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM------SPEAFLQEAQIMK 56
Query: 118 KMKHENILKF--VGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRA 175
K++H+ +++ V + +P + I+TE M +L +L S K+L L + A I+
Sbjct: 57 KLRHDKLVQLYAVCSEEEP-IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEG 115
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPE 232
M YL + + IHRDL N+L+ E K+ADFGLAR DE T G +W APE
Sbjct: 116 MAYLESRNYIHRDLAARNILVGE-NLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE 174
Query: 233 ----------------------------------NERPSLENLS------------EDMV 246
R LE + E++
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY 234
Query: 247 ALLKSCWAEDPKVRPEFA 264
L+ CW +DP+ RP F
Sbjct: 235 DLMLQCWDKDPEERPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 65/192 (33%), Positives = 86/192 (44%), Gaps = 44/192 (22%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQ---------REVT 114
L K IG G+Y +V VA+K I F RE+
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV------------FDDLIDAKRILREIK 51
Query: 115 LLSKMKHENILKF--VGASVQPTMM----IITELMRGET-LQRYLWSTRPKRLDLKHSIS 167
LL ++HENI+ + P I+TELM ET L + + S +P L H
Sbjct: 52 LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQP--LTDDHIQY 107
Query: 168 FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT-- 225
F I R ++YLH+ +VIHRDLKPSN+L+ + +K+ DFGLAR DE T
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 226 -----YRWMAPE 232
YR APE
Sbjct: 167 VVTRWYR--APE 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-25
Identities = 60/260 (23%), Positives = 113/260 (43%), Gaps = 62/260 (23%)
Query: 68 KMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121
K++G G++ VYKG + PVA+KV++ S + ++ E +++ + H
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE----ETSPKANKEILDEAYVMASVDH 68
Query: 122 ENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
++++ +G + + +IT+LM L Y+ + + + ++ +++ + I++ M YL
Sbjct: 69 PHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEE 127
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGTY--RWMAPEN---- 233
++HRDL N+L+ + + VK+ DFGLA+ + E E G +WMA E+
Sbjct: 128 KRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186
Query: 234 --------------------------------ERPSL----ENLSE------DMVALLKS 251
E P L E L + D+ +L
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVK 246
Query: 252 CWAEDPKVRPEFAEITITLT 271
CW D + RP F E+ +
Sbjct: 247 CWMIDAESRPTFKELINEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-25
Identities = 66/263 (25%), Positives = 109/263 (41%), Gaps = 65/263 (24%)
Query: 70 IGEGSYSIVYKGFY----GCE-PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI 124
+G G++ V KG Y G E VAVK ++ + A K++F RE ++++++ H I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA----GKKEFLREASVMAQLDHPCI 58
Query: 125 LKFVGASVQPTMMIITELMRGETLQRYLWSTRP-KRLDLKHSISFALDISRAMEYLHANS 183
++ +G +M++ EL L +YL R DLK A ++ M YL +
Sbjct: 59 VRLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLESKH 115
Query: 184 VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT-----YRWMAPE------ 232
+HRDL N+LL ++ Q K++DFG++R A T +W APE
Sbjct: 116 FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 233 ---------------------------------------NER-PSLENLSEDMVALLKSC 252
ER P E +++ +++ SC
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSC 234
Query: 253 WAEDPKVRPEFAEITITLTNILQ 275
W P+ RP F+E+ T +
Sbjct: 235 WKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 39/203 (19%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKG-------FYGCEPVAVKVIQPCNALAVSREHKEKFQR 111
V +++L++ +GEG++ V+ G E VAVK ++ S + ++ F+R
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKE----TASNDARKDFER 57
Query: 112 EVTLLSKMKHENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRP------------ 157
E LL+ +HENI+KF G + P +M+ E M L ++L S P
Sbjct: 58 EAELLTNFQHENIVKFYGVCTEGDPPIMVF-EYMEHGDLNKFLRSHGPDAAFLKSPDSPM 116
Query: 158 KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217
L L + A+ I+ M YL + +HRDL N L+ D VK+ DFG++R D
Sbjct: 117 GELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD-LVVKIGDFGMSR----D 171
Query: 218 EMTCE----AGT----YRWMAPE 232
T + G RWM PE
Sbjct: 172 VYTTDYYRVGGHTMLPIRWMPPE 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 12/179 (6%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+D S+ L + +G G + V++G + PVAVK ++P + F E ++
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP------KDFLAEAQIMK 56
Query: 118 KMKHENILK-FVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
K++H +++ + +++ + I+TELM+ +L YL + L L I A ++ M
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPE 232
YL A + IHRDL N+L+ E+ K+ADFGLAR D G +W APE
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNI-CKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-24
Identities = 74/271 (27%), Positives = 114/271 (42%), Gaps = 65/271 (23%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGF---YGCEPVAVKVIQPCNALAVSREHKEKFQREVTL 115
++ + ++ +G G Y VY+G Y VAVK ++ + + V E+F +E +
Sbjct: 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKE-DTMEV-----EEFLKEAAV 55
Query: 116 LSKMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISR 174
+ ++KH N+++ +G + +P IITE M L YL + ++ + A IS
Sbjct: 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 115
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAP 231
AMEYL + IHRDL N L+ E+ VK+ADFGL+R D T AG +W AP
Sbjct: 116 AMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 174
Query: 232 EN------------------------------------------------ERPSLENLSE 243
E+ ERP E
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERP--EGCPP 232
Query: 244 DMVALLKSCWAEDPKVRPEFAEITITLTNIL 274
+ L+++CW +P RP FAEI +
Sbjct: 233 KVYELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-24
Identities = 50/169 (29%), Positives = 89/169 (52%), Gaps = 7/169 (4%)
Query: 68 KMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
+++G GS+ VY+G + AVK + + +E ++ ++E+ LLSK++H NI+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 126 KFVG-ASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSV 184
+++G + + I EL+ G +L + L + + I +EYLH +
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLARE-EVMDEMTCEAGTYRWMAPE 232
+HRD+K +N+L+ + VKLADFG+A++ G+ WMAPE
Sbjct: 124 VHRDIKGANILV-DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE 171
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-24
Identities = 68/256 (26%), Positives = 118/256 (46%), Gaps = 55/256 (21%)
Query: 58 LVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
L++ + + L ++IGEG + V +G Y + VAVK I+ C+ A + F E +++
Sbjct: 2 LLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK-CDVTA------QAFLEETAVMT 54
Query: 118 KMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
K+ H+N+++ +G + + I+ ELM L +L + + + + F+LD++ ME
Sbjct: 55 KLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPEN---- 233
YL + ++HRDL N+L++ED K++DFGLAR M + +W APE
Sbjct: 115 YLESKKLVHRDLAARNILVSED-GVAKVSDFGLARVGSMGVDNSKLPV-KWTAPEALKHK 172
Query: 234 --------------------------ERPSLENLSE----------------DMVALLKS 251
+ SL+ + E D+ L+ S
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTS 232
Query: 252 CWAEDPKVRPEFAEIT 267
CW +PK RP F ++
Sbjct: 233 CWETEPKKRPSFHKLR 248
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-24
Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 63/266 (23%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+D + K +G G + +V+ G + G VA+K+I+ A++ ++ F E ++
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIRE-GAMS-----EDDFIEEAKVMM 54
Query: 118 KMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
K+ H N+++ G + Q + I+TE M L YL R +L + + D+ AM
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAM 113
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPE- 232
EYL +N IHRDL N L+ ED VK++DFGLAR + D+ T GT +W PE
Sbjct: 114 EYLESNGFIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEV 172
Query: 233 ----------------------------------N-------------ERPSLENLSEDM 245
N RP L ++
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKL--APTEV 230
Query: 246 VALLKSCWAEDPKVRPEFAEITITLT 271
++ SCW E P+ RP F ++ LT
Sbjct: 231 YTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 5e-24
Identities = 60/180 (33%), Positives = 94/180 (52%), Gaps = 28/180 (15%)
Query: 68 KMIGEGSYSIVYKGFY---GCEPVAVKVIQPCNALAVSREHKEKFQ--------REVTLL 116
K +GEG+Y++VYK G VA+K I+ +++ + RE+ LL
Sbjct: 6 KKLGEGTYAVVYKARDKETG-RIVAIKKIKLG--------ERKEAKDGINFTALREIKLL 56
Query: 117 SKMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRA 175
++KH NI+ + + + ++ E M + L++ + + L S+ L R
Sbjct: 57 QELKHPNIIGLLDVFGHKSNINLVFEFMETD-LEK-VIKDKSIVLTPADIKSYMLMTLRG 114
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV--MDEMTCEAGTYRWM-APE 232
+EYLH+N ++HRDLKP+NLL+ D +KLADFGLAR +MT + T RW APE
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVVT-RWYRAPE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-24
Identities = 76/275 (27%), Positives = 111/275 (40%), Gaps = 76/275 (27%)
Query: 68 KMIGEGSYSIVYKGFY--------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
+G G++ VY+G G VAVK ++ + + K++F +E L+S
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK----GATDQEKKEFLKEAHLMSNF 56
Query: 120 KHENILKFVGASVQ-PTMMIITELMRGETLQRYLWSTRPKR-----LDLKHSISFALDIS 173
H NI+K +G + II ELM G L YL R +R L LK + LD++
Sbjct: 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 174 RAMEYLHANSVIHRDLKPSNLLLTED----KKQVKLADFGLAREEVMDEMTCEAG----T 225
+ YL IHRDL N L++E + VK+ DFGLAR+ + + G
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 226 YRWMAPEN------------------------------------------------ERPS 237
RWMAPE+ ++P
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP- 235
Query: 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITITLTN 272
EN + + L+ +CWA+DP RP F I L N
Sbjct: 236 -ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 5e-24
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 31/202 (15%)
Query: 46 DNEFVFDIDASVLVDHRSVLLQ--KMIGEGSYSIVYKGFY---GCEPVAVKVIQPCNALA 100
+ E + V L + + IGEG+ VYK G E VA+K ++
Sbjct: 1 EEELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKE-VAIKKMR------ 53
Query: 101 VSREHKEKFQREVTLLSKMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKR 159
+ +++KE E+ ++ KH NI+ + + V + ++ E M G +L +
Sbjct: 54 LRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII---TQNF 110
Query: 160 LDLKHS-ISF-ALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217
+ + I++ ++ + +EYLH+ +VIHRD+K N+LL++D VKLADFG A
Sbjct: 111 VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAA----- 164
Query: 218 EMTCEA-------GTYRWMAPE 232
++T E GT WMAPE
Sbjct: 165 QLTKEKSKRNSVVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 77/277 (27%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGF-YGCEP------VAVKVIQPCNALAVSREHKEKFQR 111
+ + L + +G+GS+ +VY+G G VA+K + A RE E F
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN---ASMRERIE-FLN 58
Query: 112 EVTLLSKMKHENILKFVG--ASVQPTMMIITELMRGETLQRYLWSTRPKR--------LD 161
E +++ + ++++ +G ++ QPT+ ++ ELM L+ YL S RP+
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPT 117
Query: 162 LKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTC 221
L+ I A +I+ M YL A +HRDL N ++ ED VK+ DFG+ R+ +
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT-VKIGDFGMTRDIYETDYYR 176
Query: 222 EAGT----YRWMAPE-----------------------------------NE-------- 234
+ G RWMAPE NE
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236
Query: 235 -----RPSLENLSEDMVALLKSCWAEDPKVRPEFAEI 266
P EN + ++ L++ CW +PK+RP F EI
Sbjct: 237 GGHLDLP--ENCPDKLLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-23
Identities = 70/260 (26%), Positives = 114/260 (43%), Gaps = 57/260 (21%)
Query: 62 RSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121
+ + L + IG+G + V G Y VAVK I+ +A A + F E +++++++H
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN-DATA------QAFLAEASVMTQLRH 58
Query: 122 ENILKFVGASVQP--TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
N+++ +G V+ + I+TE M +L YL S L + F+LD+ AMEYL
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENER---- 235
AN+ +HRDL N+L++ED K++DFGL +E + T + +W APE R
Sbjct: 119 EANNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQDTGKLPV-KWTAPEALREKKF 176
Query: 236 ---------------------------------PSLEN---------LSEDMVALLKSCW 253
P +E + ++K CW
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCW 236
Query: 254 AEDPKVRPEFAEITITLTNI 273
D RP F ++ L +I
Sbjct: 237 HLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-22
Identities = 55/173 (31%), Positives = 83/173 (47%), Gaps = 21/173 (12%)
Query: 70 IGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQ----REVTLLSKMKHEN 123
IGEG+Y +VYK E VA+K I+ R E RE+ LL ++ H N
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKL-------RFESEGIPKTALREIKLLKELNHPN 59
Query: 124 ILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
I+K + + + ++ E M + + L R + L S+ + + + + H++
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDTDLYK--LIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE--MTCEAGTYRWM-APE 232
++HRDLKP NLL+ + +KLADFGLAR T T RW APE
Sbjct: 118 GILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPE 168
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 73/290 (25%), Positives = 118/290 (40%), Gaps = 94/290 (32%)
Query: 66 LQKMIGEGSYSIVYKGFY-GCEP------VAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
L K +GEG++ V K G + VAVK+++ A ++ + L+S+
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK---DDATEKDLSD-------LVSE 65
Query: 119 M-------KHENILKFVGASVQP-TMMIITELMRGETLQRYLWSTRP------------- 157
M KH+NI+ +G Q + ++ E L+ +L + RP
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 158 -KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--- 213
+ L K +SFA ++R ME+L + IHRDL N+L+TED +K+ADFGLAR+
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED-HVMKIADFGLARDIHH 184
Query: 214 -EVMDEMTCEAGTYRWMAPEN--------------------------------------- 233
+ + T +WMAPE
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244
Query: 234 ---------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274
E+P N ++++ L++ CW E P RP F ++ L +L
Sbjct: 245 KLLKEGYRMEKPQ--NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-22
Identities = 74/296 (25%), Positives = 125/296 (42%), Gaps = 89/296 (30%)
Query: 63 SVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQREVTL 115
+++L K +GEG + V K G VAVK+++ + + R+ +F L
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFN----L 56
Query: 116 LSKMKHENILKFVGASVQP-TMMIITELMRGETLQRYLWSTRP----------------- 157
L ++ H +++K GA Q +++I E + +L+ +L +R
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 158 -----KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+ L + ISFA ISR M+YL ++HRDL N+L+ E +K +K++DFGL+R
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK-MKISDFGLSR 175
Query: 213 EEVMDEMTCEAGTYR----WMAPEN----------------------------------- 233
+ ++ + R WMA E+
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 234 -------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
ERP EN SE+M L+ +CW ++P RP FA+I+ L ++
Sbjct: 236 ERLFNLLKTGYRMERP--ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 25/183 (13%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHE 122
L ++IGEG+Y VYK + + VA+K++ + +E+ + E +L K H
Sbjct: 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI------IEDEEEEIKEEYNILRKYSNHP 63
Query: 123 NILKFVGASVQPTMMI-------ITELMRGETLQRYLWSTR--PKRLDLKHSISFAL-DI 172
NI F GA ++ + EL G ++ + R KRL + I++ L +
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK-EEWIAYILRET 122
Query: 173 SRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE---EVMDEMTCEAGTYRWM 229
R + YLH N VIHRD+K N+LLT++ +VKL DFG++ + + T GT WM
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRRNTF-IGTPYWM 180
Query: 230 APE 232
APE
Sbjct: 181 APE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-22
Identities = 70/281 (24%), Positives = 108/281 (38%), Gaps = 79/281 (28%)
Query: 63 SVLLQKMIGEGSYSIVYKG-------FYGCEPVAVKVIQPCNALAVSREHKEKFQREVTL 115
+V + +GEG++ VYKG VA+K ++ V +++F++E L
Sbjct: 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKV----QQEFRQEAEL 61
Query: 116 LSKMKHENILKFVGASV--QPTMMIITELMRGETLQRYLWSTRP--------------KR 159
+S ++H NI+ +G QPT M+ L G L +L P
Sbjct: 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHG-DLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 160 LDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE----EV 215
LD + A+ I+ MEYL ++ +HRDL N L+ E VK++DFGL+R+ +
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE-GLTVKISDFGLSRDIYSADY 179
Query: 216 MDEMTCEAGTYRWMAPE-----------------------------------NER----- 235
+ RWM PE N+
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239
Query: 236 ------PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITL 270
P E+ + AL+ CW E P RP F +I L
Sbjct: 240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-22
Identities = 55/172 (31%), Positives = 90/172 (52%), Gaps = 16/172 (9%)
Query: 69 MIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH---EN 123
+IG G+Y VY+G + VA+K+I L + QREV LLS+++ N
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIIN----LDTPDDDVSDIQREVALLSQLRQSQPPN 63
Query: 124 ILKFVGASVQ-PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
I K+ G+ ++ P + II E G +++ + + + K+ ++ A++Y+H
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
VIHRD+K +N+L+T VKL DFG+A + + + GT WMAPE
Sbjct: 121 GVIHRDIKAANILVTN-TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE 171
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-21
Identities = 68/251 (27%), Positives = 107/251 (42%), Gaps = 61/251 (24%)
Query: 70 IGEGSYSIVYKGFYGCE--PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
IG G++ V+ G + PVAVK + + + K KF +E +L + H NI++
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRE----TLPPDLKAKFLQEARILKQYSHPNIVRL 58
Query: 128 VGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIH 186
+G Q + I+ EL++G +L + P RL +K I + + MEYL + IH
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGP-RLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 187 RDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYR-----WMAPE--------- 232
RDL N L+TE K +K++DFG++REE D + G + W APE
Sbjct: 118 RDLAARNCLVTE-KNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 233 --------------------------NER-----------PSLENLSEDMVALLKSCWAE 255
N++ P E + + L++ CW
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235
Query: 256 DPKVRPEFAEI 266
DP RP F+ +
Sbjct: 236 DPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 74/296 (25%)
Query: 43 EEY-DNEFVFDIDASVL-VDHR------SVLLQKMIGEGSYSIVYKGF-YGCE------P 87
E NE+V+ ID + L D + ++ K +G G++ V + YG
Sbjct: 9 ESINGNEYVY-IDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMK 67
Query: 88 VAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGA-SVQPTMMIITELMRG 145
VAVK+++P +E E+ ++S + HENI+ +GA ++ +++ITE
Sbjct: 68 VAVKMLKP----TAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCY 123
Query: 146 ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKL 205
L +L R L L+ +SF+ +++ M +L + + IHRDL N+LLT K VK+
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKI 182
Query: 206 ADFGLAREEVMDEMTCEAGTYR----WMAPE----------------------------N 233
DFGLAR+ + D G R WMAPE N
Sbjct: 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSN 242
Query: 234 ERPSL-------------------ENLSEDMVALLKSCWAEDPKVRPEFAEITITL 270
P + E+ ++ ++K+CW DP RP F +I +
Sbjct: 243 PYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 67/274 (24%), Positives = 111/274 (40%), Gaps = 66/274 (24%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKG-----FYGCEPVAVKVIQPCNALAVSREHKEKFQREV 113
+D V ++K+IG G + V +G VA+K ++ S + + F E
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA----GSSDKQRLDFLTEA 56
Query: 114 TLLSKMKHENILKFVG--ASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALD 171
+++ + H NI++ G +P +MIITE M +L ++L K + +
Sbjct: 57 SIMGQFDHPNIIRLEGVVTKSRP-VMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRG 114
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAG--TYR 227
I+ M+YL + +HRDL N+L+ + K++DFGL+R E+ T + G R
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRRLEDSEATYTTKGGKIPIR 173
Query: 228 WMAPE--------------------------NERPSLENLSEDMV--------------- 246
W APE ERP ++S V
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP-YWDMSNQDVIKAVEDGYRLPPPMD 232
Query: 247 ------ALLKSCWAEDPKVRPEFAEITITLTNIL 274
L+ CW +D RP F++I TL ++
Sbjct: 233 CPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-21
Identities = 72/284 (25%), Positives = 113/284 (39%), Gaps = 84/284 (29%)
Query: 64 VLLQKMIGEGSYSIVYKGFYGCEP-----VAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+ L K++GEG + V +G + VAVK ++ + E+F E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI---HTYSEIEEFLSEAACMKD 57
Query: 119 MKHENILKFVGASVQ-------PTMMIITELMRGETLQRYLWSTR----PKRLDLKHSIS 167
H N++K +G + P M+I M+ L +L +R P++L L+ +
Sbjct: 58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK 117
Query: 168 FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTY- 226
F +DI+ MEYL + IHRDL N +L ED V +ADFGL++ +G Y
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT-VCVADFGLSK-------KIYSGDYY 169
Query: 227 ----------RWMAPEN----------------------------ERPSLENLS------ 242
+W+A E+ P +EN
Sbjct: 170 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR 229
Query: 243 ------------EDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274
+++ L+ SCW DPK RP F ++ L NIL
Sbjct: 230 HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-21
Identities = 66/255 (25%), Positives = 107/255 (41%), Gaps = 57/255 (22%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
V ++ L K +G G + V+ G+Y G VA+K ++ + E F E L+
Sbjct: 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM------SPEAFLAEANLMK 56
Query: 118 KMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+++H +++ Q + IITE M +L +L + +L + I A I+ M
Sbjct: 57 QLQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPEN- 233
++ + IHRDL+ +N+L++E K+ADFGLAR +E T G +W APE
Sbjct: 117 FIERKNYIHRDLRAANILVSE-TLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 234 -----------------------------------------ER----PSLENLSEDMVAL 248
ER P +N E++ L
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL 235
Query: 249 LKSCWAEDPKVRPEF 263
++ CW E P+ RP F
Sbjct: 236 MRLCWKEKPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 6e-21
Identities = 55/173 (31%), Positives = 89/173 (51%), Gaps = 16/173 (9%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ + +GEGSY VYK + + VA+KV+ P E ++ +E+++L +
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVE------EDLQEIIKEISILKQCDSPY 59
Query: 124 ILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFAL-DISRAMEYLHA 181
I+K+ G+ + I+ E ++ + T K L + I+ L + +EYLH+
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEE-IAAILYQTLKGLEYLHS 117
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGTYRWMAPE 232
N IHRD+K N+LL E+ Q KLADFG++ + M + GT WMAPE
Sbjct: 118 NKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 8e-21
Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 28/180 (15%)
Query: 66 LQKMIGEGSYSIVYKG--FYGCEPVAVKVIQPCNALAVSREHKEKF---QREVTLLSKMK 120
L + IG G+Y VYK E VA+KVI E + F Q+E+++L + +
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVI--------KLEPGDDFEIIQQEISMLKECR 58
Query: 121 HENILKFVGASVQ-PTMMIITELMRGETLQR-YLWSTRPKRLDLKHSISFALDISR---- 174
H NI+ + G+ ++ + I+ E G +LQ Y + P I++ + R
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ---IAY---VCRETLK 112
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
+ YLH IHRD+K +N+LLTED VKLADFG++ + + + GT WMAPE
Sbjct: 113 GLAYLHETGKIHRDIKGANILLTED-GDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPE 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 66/192 (34%), Positives = 94/192 (48%), Gaps = 33/192 (17%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQR---EV 113
V R L IGEG+Y +V + VA+K I P EH+ QR E+
Sbjct: 3 VGPRYQNLSY-IGEGAYGMVCSATHKPTGVKVAIKKISPF-------EHQTFCQRTLREI 54
Query: 114 TLLSKMKHENILKFVGASVQPT------MMIITELMRGET-LQRYLWSTRPKRLDLKHSI 166
+L + KHENI+ + P+ + I+ ELM ET L + + + + L H
Sbjct: 55 KILRRFKHENIIGILDIIRPPSFESFNDVYIVQELM--ETDLYKLI---KTQHLSNDHIQ 109
Query: 167 SFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-----MTC 221
F I R ++Y+H+ +V+HRDLKPSNLLL + +K+ DFGLAR + +T
Sbjct: 110 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN-CDLKICDFGLARIADPEHDHTGFLTE 168
Query: 222 EAGTYRWM-APE 232
T RW APE
Sbjct: 169 YVAT-RWYRAPE 179
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-20
Identities = 55/158 (34%), Positives = 87/158 (55%), Gaps = 25/158 (15%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVIQ-------PCNALAVSREHKEKFQREVTLL 116
L+K+ GEG+Y+ VYKG E VA+K I P A+ RE++L+
Sbjct: 5 LEKL-GEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-----------REISLM 52
Query: 117 SKMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWS-TRPKRLDLKHSISFALDISR 174
++KHENI++ + +M++ E M + L++Y+ + LD SF + +
Sbjct: 53 KELKHENIVRLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPNTVKSFTYQLLK 111
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+ + H N V+HRDLKP NLL+ + + ++KLADFGLAR
Sbjct: 112 GIAFCHENRVLHRDLKPQNLLINK-RGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-20
Identities = 68/265 (25%), Positives = 110/265 (41%), Gaps = 63/265 (23%)
Query: 59 VDHRSVLLQKMIGEGSYSIV-YKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+D + + K +G G + +V Y + G VA+K+I+ + +++F E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMM 54
Query: 118 KMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
K+ HE +++ G + Q + I+TE M L YL KR + D+ M
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGM 113
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPE- 232
YL + IHRDL N L+ +D+ VK++DFGL+R + DE T G+ RW PE
Sbjct: 114 AYLESKQFIHRDLAARNCLV-DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 233 ----------------------------------NE-------------RPSLENLSEDM 245
N RP L SE +
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLA--SEKV 230
Query: 246 VALLKSCWAEDPKVRPEFAEITITL 270
A++ SCW E + RP F ++ ++
Sbjct: 231 YAIMYSCWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-20
Identities = 65/256 (25%), Positives = 111/256 (43%), Gaps = 58/256 (22%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+ S+ L K +G G + V+ G+Y VAVK ++P ++V + F E L+
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSV-----QAFLEEANLMK 56
Query: 118 KMKHENILK-FVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
++H+ +++ + + + + IITE M +L +L S ++ L I F+ I+ M
Sbjct: 57 TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 116
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPEN 233
Y+ + IHRDL+ +N+L++E K+ADFGLAR +E T G +W APE
Sbjct: 117 AYIERKNYIHRDLRAANVLVSE-SLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 234 ----------------------------------------------ERPSLENLSEDMVA 247
P +EN +++
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD 235
Query: 248 LLKSCWAEDPKVRPEF 263
++K+CW E + RP F
Sbjct: 236 IMKTCWKEKAEERPTF 251
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 3e-20
Identities = 49/161 (30%), Positives = 72/161 (44%), Gaps = 37/161 (22%)
Query: 70 IGEGSYSIVYKG--FYGCEPVAVKVIQPCNALAVSREHKEK------FQREVTLLSKMKH 121
IGEG+Y VYK E VA+K I R EK RE+ LL K++H
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI---------RMENEKEGFPITAIREIKLLQKLRH 57
Query: 122 ENILKFVGASVQPTMMIITELMRGET----------LQRYLWSTRPKRLDLKHSISFALD 171
NI++ I+T +G L L + + +
Sbjct: 58 PNIVRLKE--------IVTSKGKGSIYMVFEYMDHDLTGLL-DSPEVKFTESQIKCYMKQ 108
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+ ++YLH+N ++HRD+K SN+L+ + +KLADFGLAR
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILIN-NDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-20
Identities = 73/272 (26%), Positives = 120/272 (44%), Gaps = 67/272 (24%)
Query: 59 VDHRSVLLQKMIGEGSYSIVY----KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVT 114
V + + + +G+GS+ +VY KG EP I+ N A RE E F E +
Sbjct: 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEAS 61
Query: 115 LLSKMKHENILKFVG--ASVQPTMMIITELMRGETLQRYLWSTRPKRLD--------LKH 164
++ + ++++ +G + QPT++I+ + RG+ L+ YL S RP+ + LK
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD-LKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 165 SISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAG 224
I A +I+ M YL+AN +HRDL N ++ ED VK+ DFG+ R+ + + G
Sbjct: 121 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGG 179
Query: 225 T----YRWMAPEN--------------------------ERP------------------ 236
RWM+PE+ E+P
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239
Query: 237 --SLENLSEDMVALLKSCWAEDPKVRPEFAEI 266
+N + + L++ CW +PK+RP F EI
Sbjct: 240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-20
Identities = 59/193 (30%), Positives = 92/193 (47%), Gaps = 23/193 (11%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCE-------PVAVKVIQPCNALAVSREHKEKFQR 111
V S+ L + +G G++ VY+G Y VAVK + + S + + F
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE----SCSEQDESDFLM 58
Query: 112 EVTLLSKMKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPK-----RLDLKHS 165
E ++SK H+NI++ +G S + I+ ELM G L+ +L RP+ L +K
Sbjct: 59 EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118
Query: 166 ISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ--VKLADFGLAREEVMDEMTCEA 223
+ A D+++ +YL N IHRD+ N LLT K+ADFG+AR+ +
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 224 GT----YRWMAPE 232
G +WM PE
Sbjct: 179 GRAMLPIKWMPPE 191
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 54/192 (28%), Positives = 100/192 (52%), Gaps = 14/192 (7%)
Query: 66 LQKMIGEGSYSIVYKGFYGCE--PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
++K IG+G +S+VYK + VA+K +Q + + ++ +E+ LL ++ H N
Sbjct: 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD--AKARQDCLKEIDLLKQLDHPN 63
Query: 124 ILKFVGASVQPTMMII-TELMRGETLQRYLWSTRP-KRLDLKHSI-SFALDISRAMEYLH 180
++K++ + ++ + I EL L R + + KRL + +I + + + A+E++H
Sbjct: 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA----GTYRWMAPENERP 236
+ ++HRD+KP+N+ +T VKL D GL R T A GT +M+PE
Sbjct: 124 SKRIMHRDIKPANVFITAT-GVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 237 SLENLSEDMVAL 248
+ N D+ +L
Sbjct: 181 NGYNFKSDIWSL 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 53/177 (29%), Positives = 84/177 (47%), Gaps = 28/177 (15%)
Query: 70 IGEGSYSIVYK------GFYGCEPVAVKVIQPCNALAVSREHKEKFQ----REVTLLSKM 119
IGEG++ IV+K G E VA+K + A+ R RE+ L
Sbjct: 8 IGEGAHGIVFKAKDRETG----ETVALKKV------ALRRLE-GGIPNQALREIKALQAC 56
Query: 120 KHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
+H ++K + + +++ E M L L + L S+ + + + Y
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAY 114
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR---EEVMDEMTCEAGTYRWMAPE 232
+HAN ++HRDLKP+NLL++ D +K+ADFGLAR EE + + T + APE
Sbjct: 115 MHANGIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 53/172 (30%), Positives = 87/172 (50%), Gaps = 15/172 (8%)
Query: 68 KMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
K++G+GS +VYK + + A+K I + E +++ RE+ L + ++
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIH----VDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 126 KFVGASVQP-TMMIITELMRGETLQRYLWSTRP-KRLDLKHSISFALDISRAMEYLHANS 183
K GA + + I+ E M G +L L L A I + ++YLH
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA---YIARQILKGLDYLHTKR 119
Query: 184 -VIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGTYRWMAPE 232
+IHRD+KPSNLL+ K +VK+ADFG+++ E +D+ GT +M+PE
Sbjct: 120 HIIHRDIKPSNLLINS-KGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-19
Identities = 58/180 (32%), Positives = 88/180 (48%), Gaps = 22/180 (12%)
Query: 68 KMIGEGSYSIVYKGFYGC-EPVAVK--VIQPCNALAVSREHKEKFQREVTLLSKMKHENI 124
+++G+G+Y VY G + +AVK + N LA +E+ EK Q EV LL +KH NI
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEY-EKLQEEVDLLKSLKHVNI 64
Query: 125 LKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISF---ALDISRAMEYLH 180
++++G + T+ I E + G ++ L R F I + YLH
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM--------DEMTCEAGTYRWMAPE 232
N V+HRD+K +N++L + +KL DFG AR + + GT WMAPE
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGI-IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-19
Identities = 54/172 (31%), Positives = 88/172 (51%), Gaps = 20/172 (11%)
Query: 70 IGEGSYSIVYKGFYGCEP----VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
+G G+ +V K + P +AVK I+ L ++ +++ RE+ +L K I+
Sbjct: 9 LGAGNSGVVSKVLH--RPTGKIMAVKTIR----LEINEAIQKQILRELDILHKCNSPYIV 62
Query: 126 KFVGA-SVQPTMMIITELMRGETLQRYLWSTR---PKRLDLKHSISFALDISRAMEYLHA 181
F GA + I E M G +L + L + P+R+ K I+ A + + + YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVA--VLKGLTYLHE 118
Query: 182 N-SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
+IHRD+KPSN+L+ + Q+KL DFG++ + V GT +MAPE
Sbjct: 119 KHKIIHRDVKPSNILVNS-RGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-19
Identities = 55/180 (30%), Positives = 93/180 (51%), Gaps = 21/180 (11%)
Query: 66 LQKMIGEGSYSIVYKGFYGCEP----VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121
L ++IG G+ ++VY C P VA+K I L + ++ ++EV +S+ H
Sbjct: 5 LIEVIGVGATAVVYAAI--CLPNNEKVAIKRID----LEKCQTSVDELRKEVQAMSQCNH 58
Query: 122 ENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFAL-DISRAMEYL 179
N++K+ + V + ++ + G +L + S+ P+ + I+ L ++ + +EYL
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE-------AGTYRWMAPE 232
H+N IHRD+K N+LL ED VK+ADFG++ + D GT WMAPE
Sbjct: 119 HSNGQIHRDIKAGNILLGED-GSVKIADFGVS-ASLADGGDRTRKVRKTFVGTPCWMAPE 176
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 7e-19
Identities = 45/130 (34%), Positives = 74/130 (56%), Gaps = 10/130 (7%)
Query: 86 EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV---QPTMMIITEL 142
E VAVK +Q A EH F+RE+ +L ++H+NI+K+ G + + ++ E
Sbjct: 34 EVVAVKKLQHSTA-----EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY 88
Query: 143 MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ 202
+ +L+ YL R +RLD + + +A I + MEYL + +HRDL N+L+ E + +
Sbjct: 89 LPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV-ESENR 146
Query: 203 VKLADFGLAR 212
VK+ DFGL +
Sbjct: 147 VKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 53/155 (34%), Positives = 86/155 (55%), Gaps = 25/155 (16%)
Query: 70 IGEGSYSIVYKGFYGC--EPVAVKVIQ--------PCNALAVSREHKEKFQREVTLLSKM 119
IGEG+Y +VYKG + VA+K I+ P A+ RE++LL ++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI-----------REISLLKEL 56
Query: 120 KHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRP-KRLDLKHSISFALDISRAME 177
+H NI+ +Q + + +I E + + L++YL S + +D + S+ I + +
Sbjct: 57 QHPNIVCLQDVLMQESRLYLIFEFLSMD-LKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+ H+ V+HRDLKP NLL+ ++K +KLADFGLAR
Sbjct: 116 FCHSRRVLHRDLKPQNLLI-DNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 72/275 (26%), Positives = 111/275 (40%), Gaps = 70/275 (25%)
Query: 66 LQKMIGEGSYSIVYKGFYGCE-----PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK 120
L +M+G+G + V + E VAVK+++ A S E+F RE + +
Sbjct: 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK---ADIFSSSDIEEFLREAACMKEFD 59
Query: 121 HENILKFVGASVQ-------PTMMIITELMRGETLQRYLWSTR----PKRLDLKHSISFA 169
H N++K +G S++ P M+I M+ L +L +R P L L+ + F
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL------------------- 210
+DI+ MEYL + + IHRDL N +L E+ V +ADFGL
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 211 ----AREEVMDEM----------------------TCEAGT-----YRWMAPENERPSLE 239
A E + D + T AG Y ++ N
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238
Query: 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274
+ ED+ L+ CW+ +PK RP F + L I
Sbjct: 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-18
Identities = 52/179 (29%), Positives = 93/179 (51%), Gaps = 13/179 (7%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCE-PVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+ + L + IG G + +V+ G++ + VA+K I+ A+S +E F E ++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG---AMS---EEDFIEEAQVMM 54
Query: 118 KMKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
K+ H +++ G + + + ++ E M L YL + R K + + LD+ M
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGM 113
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPE 232
YL +++VIHRDL N L+ E+ + VK++DFG+ R + D+ T GT +W +PE
Sbjct: 114 AYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE 171
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 74/275 (26%), Positives = 117/275 (42%), Gaps = 73/275 (26%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKG----FYGCEP---VAVKVIQPCNALAVSREHKEKFQR 111
V + L + +G+GS+ +VY+G E VAVK + N A RE E F
Sbjct: 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV---NESASLRERIE-FLN 58
Query: 112 EVTLLSKMKHENILKFVG--ASVQPTMMIITELMRGETLQRYLWSTRPKRLD-------- 161
E +++ ++++ +G + QPT+ ++ ELM L+ YL S RP+ +
Sbjct: 59 EASVMKGFTCHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117
Query: 162 LKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTC 221
L+ I A +I+ M YL+A +HRDL N ++ D VK+ DFG+ R+ +
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT-VKIGDFGMTRDIYETDYYR 176
Query: 222 EAGT----YRWMAPEN--------------------------ERP--------------- 236
+ G RWMAPE+ E+P
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236
Query: 237 -----SLENLSEDMVALLKSCWAEDPKVRPEFAEI 266
+N E + L++ CW +PK+RP F EI
Sbjct: 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 63/182 (34%), Positives = 89/182 (48%), Gaps = 31/182 (17%)
Query: 68 KMIGEGSYSIVYKGFYGC--------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
K IG G+Y IV C E VA+K I NA + K RE+ LL +
Sbjct: 11 KPIGRGAYGIV------CSAKNSETNEKVAIKKIA--NAFDNRIDAKRTL-REIKLLRHL 61
Query: 120 KHENILKFVGASVQPTMM-------IITELMRGETLQRYLWSTRPKRLDLKHSISFALDI 172
HEN++ + + P I+ ELM + L + + S++ L H F +
Sbjct: 62 DHENVIA-IKDIMPPPHREAFNDVYIVYELMDTD-LHQIIRSSQT--LSDDHCQYFLYQL 117
Query: 173 SRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGTYRWMA 230
R ++Y+H+ +V+HRDLKPSNLLL + +K+ DFGLAR E D MT T + A
Sbjct: 118 LRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARTTSEKGDFMTEYVVTRWYRA 176
Query: 231 PE 232
PE
Sbjct: 177 PE 178
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-18
Identities = 52/153 (33%), Positives = 80/153 (52%), Gaps = 24/153 (15%)
Query: 70 IGEGSYSIVYKGFYGC--EPVAVKVIQ-------PCNALAVSREHKEKFQREVTLLSKMK 120
+GEGSY+ VYKG + VA+K I+ P A+ RE +LL +K
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-----------REASLLKDLK 61
Query: 121 HENILKFVG-ASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
H NI+ + T+ ++ E + + L++Y+ L + + F + R + Y
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDTD-LKQYM-DDCGGGLSMHNVRLFLFQLLRGLAYC 119
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
H V+HRDLKP NLL++E + ++KLADFGLAR
Sbjct: 120 HQRRVLHRDLKPQNLLISE-RGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 60/175 (34%), Positives = 90/175 (51%), Gaps = 24/175 (13%)
Query: 70 IGEGSYSIVYKGFYGC--EPVAVK-VIQPCNALAVSREHKEKFQREVTLLSKMKHENILK 126
+G G+Y V F VA+K + +P S H ++ RE+ LL M HEN++
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ----SAIHAKRTYRELRLLKHMDHENVIG 78
Query: 127 FVGASVQPT-------MMIITELMRGETLQRYLWSTRPKRLDLKHSISFAL-DISRAMEY 178
+ + + ++T LM G L + + ++L H I F + I R ++Y
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLM-GADLNNIV---KCQKLSDDH-IQFLVYQILRGLKY 133
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRW-MAPE 232
+H+ +IHRDLKPSN+ + ED ++K+ DFGLAR DEMT T RW APE
Sbjct: 134 IHSAGIIHRDLKPSNIAVNED-CELKILDFGLAR-HTDDEMTGYVAT-RWYRAPE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 4e-18
Identities = 52/174 (29%), Positives = 82/174 (47%), Gaps = 22/174 (12%)
Query: 70 IGEGSYSIVY-------KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
+G+GS+ V Y A+KV++ + R+ E E +LS++ H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLY-----AMKVLK--KKKIIKRKEVEHTLTERNILSRINHP 53
Query: 123 NILKFVGASVQPT--MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH 180
I+K + Q + ++ E G L S R + + +A +I A+EYLH
Sbjct: 54 FIVKLH-YAFQTEEKLYLVLEYAPGGEL-FSHLSKE-GRFSEERARFYAAEIVLALEYLH 110
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE--AGTYRWMAPE 232
+ +I+RDLKP N+LL D +KL DFGLA+E + GT ++APE
Sbjct: 111 SLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPE 163
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-18
Identities = 65/255 (25%), Positives = 109/255 (42%), Gaps = 57/255 (22%)
Query: 68 KMIGEGSYSIVYKG-FYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILK 126
+++G+G++ V+KG PVAVK + + +E K KF E +L + H NI+K
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKE----DLPQELKIKFLSEARILKQYDHPNIVK 56
Query: 127 FVGASVQ-PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVI 185
+G Q + I+ EL+ G +L + L K + FALD + M YL + + I
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115
Query: 186 HRDLKPSNLLLTEDKKQVKLADFGLAREE---VMDEMTCEAGTYRWMAPEN--------- 233
HRDL N L+ E+ +K++DFG++R+E + + +W APE
Sbjct: 116 HRDLAARNCLVGENNV-LKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 234 -------------------ERPSLEN------------------LSEDMVALLKSCWAED 256
P + N +D+ +++ CW
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYK 234
Query: 257 PKVRPEFAEITITLT 271
P+ RP+F+E+ L
Sbjct: 235 PENRPKFSELQKELA 249
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-18
Identities = 69/279 (24%), Positives = 107/279 (38%), Gaps = 83/279 (29%)
Query: 70 IGEGSYSIVYK----GFYGCEP---VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
IG+G++ V++ G EP VAVK+++ S + + FQRE L+++ H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMAEFDHP 68
Query: 123 NILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPK------------------RLDLK 163
NI+K +G +V M ++ E M L +L P+ L L
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 164 --HSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM-- 219
+ A ++ M YL +HRDL N L+ E+ VK+ADFGL+R +
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLSRNIYSADYYK 187
Query: 220 --TCEAGTYRWMAPEN---ERPSLE----------------------------------- 239
+A RWM PE+ R + E
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD 247
Query: 240 --------NLSEDMVALLKSCWAEDPKVRPEFAEITITL 270
N ++ L++ CW++ P RP FA I L
Sbjct: 248 GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 8e-18
Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 35/181 (19%)
Query: 70 IGEGSYSIVYK------GFYGCEPVAVKVIQPCNALAVSREHKEKFQ----REVTLLSKM 119
I EG+Y +VY+ G E VA+K ++ + KE F RE+ +L K+
Sbjct: 13 IEEGTYGVVYRARDKKTG----EIVALKKLK-------MEKEKEGFPITSLREINILLKL 61
Query: 120 KHENILKF----VGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRA 175
+H NI+ VG+++ M++ E + + + L T + L +
Sbjct: 62 QHPNIVTVKEVVVGSNLDKIYMVM-EYVEHDL--KSLMETMKQPFLQSEVKCLMLQLLSG 118
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGT--YRWMAP 231
+ +LH N ++HRDLK SNLLL ++ +K+ DFGLARE + T T YR AP
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYR--AP 175
Query: 232 E 232
E
Sbjct: 176 E 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-17
Identities = 61/184 (33%), Positives = 101/184 (54%), Gaps = 13/184 (7%)
Query: 70 IGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
IG+GS+ VYKG E VA+K+I L + + E Q+E+T+LS+ I ++
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIID----LEEAEDEIEDIQQEITVLSQCDSPYITRY 67
Query: 128 VGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIH 186
G+ ++ T + II E + G + L +P L+ + + +I + ++YLH+ IH
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERKIH 124
Query: 187 RDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPENERPSLENLSED 244
RD+K +N+LL+E + VKLADFG+A + + + GT WMAPE + S + D
Sbjct: 125 RDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183
Query: 245 MVAL 248
+ +L
Sbjct: 184 IWSL 187
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 56/180 (31%), Positives = 79/180 (43%), Gaps = 27/180 (15%)
Query: 68 KMIGEGSYSIVYKGFY--GCEPVAVKVI-----QPCNALAVSREHKEKFQREVTLLSKMK 120
IG G++ VY E +AVK I P + E+ +L +K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEI--------ADEMKVLELLK 57
Query: 121 HENILKFVGASVQPTMMII-TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
H N++K+ G V + I E G TL+ L R LD + L + + YL
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRI--LDEHVIRVYTLQLLEGLAYL 115
Query: 180 HANSVIHRDLKPSNLLLTEDKKQV-KLADFGLA-----REEVMDEMTCE-AGTYRWMAPE 232
H++ ++HRD+KP+N+ L D V KL DFG A M E AGT +MAPE
Sbjct: 116 HSHGIVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 51/181 (28%), Positives = 95/181 (52%), Gaps = 22/181 (12%)
Query: 69 MIGEGSYSIVYKGFYGC--EPVAVK-VIQPCNALAVSREHK---EKFQREVTLLSKMKHE 122
+IG GS+ VY G E +AVK V P + + + + RE+ LL +++HE
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 123 NILKFVGASVQPTMM-IITELMRGETLQRYL--WSTRPKRLDLKHSISFALDISRAMEYL 179
NI++++G+S+ + I E + G ++ L + + L +F I + + YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFVRQILKGLNYL 122
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYR--------WMAP 231
H +IHRD+K +N+L+ ++K +K++DFG++++ + ++ + R WMAP
Sbjct: 123 HNRGIIHRDIKGANILV-DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 232 E 232
E
Sbjct: 182 E 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 36/184 (19%)
Query: 70 IGEGSYSIVYKGFYGCEP--------VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121
IG G+Y +V C VA+K I +A V K RE+ +L KH
Sbjct: 13 IGSGAYGVV------CSAIDTRSGKKVAIKKI--PHAFDVPTLAKRTL-RELKILRHFKH 63
Query: 122 EN------ILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRA 175
+N IL+ GA + + ++ +LM + L + S +P L +H F + R
Sbjct: 64 DNIIAIRDILRPPGADFK-DVYVVMDLMESD-LHHIIHSDQP--LTEEHIRYFLYQLLRG 119
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR------EEVMDEMTCEAGTYRWM 229
++Y+H+ +VIHRDLKPSNLL+ ED ++++ DFG+AR E MT T RW
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RWY 177
Query: 230 -APE 232
APE
Sbjct: 178 RAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-17
Identities = 52/178 (29%), Positives = 89/178 (50%), Gaps = 11/178 (6%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+ S+ L+ +G+G + V+ G + G VA+K ++P E F +E ++
Sbjct: 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP------GTMSPEAFLQEAQVMK 56
Query: 118 KMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
K++HE +++ + + I+TE M +L +L K L L + A I+ M
Sbjct: 57 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPE 232
Y+ + +HRDL+ +N+L+ E+ K+ADFGLAR +E T G +W APE
Sbjct: 117 YVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 61/184 (33%), Positives = 88/184 (47%), Gaps = 41/184 (22%)
Query: 70 IGEGSYSIVYKG--FYGCEPVAVKVIQPCNALAVSREHKEK------FQREVTLLSKMKH 121
IGEG+Y IVY+ E VA+K + R E+ RE+TLL ++H
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKV---------RMDNERDGIPISSLREITLLLNLRH 65
Query: 122 ENILKF----VGASVQPTMMI-------ITELMRGETLQRYLWSTRPKRLDLKHSISFAL 170
NI++ VG + ++ + L+ + + ++ K L L
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTPFSESQVKCL--------ML 115
Query: 171 DISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGTYRW 228
+ R ++YLH N +IHRDLK SNLLLT DK +K+ADFGLAR MT + T +
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVVTLWY 174
Query: 229 MAPE 232
APE
Sbjct: 175 RAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 49/176 (27%), Positives = 87/176 (49%), Gaps = 17/176 (9%)
Query: 68 KMIGEGSYSIVYKGF---YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI 124
K++G+G++ VY + G E +AVK + +++ + E+ LL ++HE I
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRE-LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 125 LKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSIS--FALDISRAMEYLHA 181
+++ G T+ I E M G +++ L + L +++ + I +EYLH+
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA----LTETVTRKYTRQILEGVEYLHS 122
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE-----EVMDEMTCEAGTYRWMAPE 232
N ++HRD+K +N +L + VKL DFG ++ M GT WM+PE
Sbjct: 123 NMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 53/176 (30%), Positives = 90/176 (51%), Gaps = 26/176 (14%)
Query: 70 IGEGSYSIVYKG--FYGCEPVAVKVIQ--------PCNALAVSREHKEKFQREVTLLSKM 119
IGEG+Y +VYK E VA+K I+ P A+ RE++LL ++
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-----------REISLLKEL 56
Query: 120 KHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
H NI+K + + + ++ E + + L++++ ++ + L S+ + + + +
Sbjct: 57 NHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
H++ V+HRDLKP NLL+ + +KLADFGLAR + T E T + APE
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 48/132 (36%), Positives = 73/132 (55%), Gaps = 15/132 (11%)
Query: 111 REVTLLSKMKHENILKFVGASVQPT-------MMIITELMRGETLQRYLWSTRPKRLDLK 163
RE+ +L KH+N+L + +QP + ++TELM+ + L + + P+ L
Sbjct: 48 RELKMLCFFKHDNVLSALDI-LQPPHIDPFEEIYVVTELMQSD-LHKII--VSPQPLSSD 103
Query: 164 HSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE---MT 220
H F I R ++YLH+ ++HRD+KP NLL+ + +K+ DFGLAR E DE MT
Sbjct: 104 HVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDESKHMT 162
Query: 221 CEAGTYRWMAPE 232
E T + APE
Sbjct: 163 QEVVTQYYRAPE 174
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 24/160 (15%)
Query: 70 IGEGSYSIVYK-----GFYGCEPVAVKVIQPCNALAVSREHKEKFQ----REVTLLSKMK 120
IG G+Y VYK G G + A+K + +E RE+ LL ++K
Sbjct: 8 IGRGTYGRVYKAKRKNGKDG-KEYAIKKFKG------DKEQYTGISQSACREIALLRELK 60
Query: 121 HENILKFVGASVQPTMM---IITELMRGETLQRYLWSTRPKRLDLKHSI--SFALDISRA 175
HEN++ V ++ ++ + + Q + + KR+ + S+ S I
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQ---VKLADFGLAR 212
+ YLH+N V+HRDLKP+N+L+ + + VK+ D GLAR
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 52/151 (34%), Positives = 86/151 (56%), Gaps = 15/151 (9%)
Query: 86 EPVAVK-VIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT--MMIITEL 142
+ VA+K +++P + +++ + RE+ LL ++HENI+ + P + +TEL
Sbjct: 36 QNVAIKKIMKPFSTPVLAK----RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91
Query: 143 MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ 202
+ G L R L S + L+ + F I R ++Y+H+ V+HRDLKPSN+L+ E+
Sbjct: 92 L-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN-CD 146
Query: 203 VKLADFGLAREEVMD-EMTCEAGTYRWMAPE 232
+K+ DFGLAR + D +MT T + APE
Sbjct: 147 LKICDFGLAR--IQDPQMTGYVSTRYYRAPE 175
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-17
Identities = 62/278 (22%), Positives = 107/278 (38%), Gaps = 71/278 (25%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYG------CEPVAVK-VIQPCNALAVSREHKEKFQR 111
+ V L ++ EG++ ++ G E V VK V + + V+ +
Sbjct: 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL-----LLQ 57
Query: 112 EVTLLSKMKHENILKFVGASVQPTM--MIITELMRGETLQRYLWSTRPKRLDLKHSIS-- 167
E LL + H+NIL + ++ ++ M L+ +L R + ++S
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 168 ----FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTC-- 221
A+ I+ M YLH VIH+D+ N ++ +++ QVK+ D L+R+ + C
Sbjct: 118 QLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI-DEELQVKITDNALSRDLFPMDYHCLG 176
Query: 222 --EAGTYRWMAPEN--------------------------ERPSLENLSEDMVALLKS-- 251
E +WMA E+ + P +E +M A LK
Sbjct: 177 DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236
Query: 252 ------------------CWAEDPKVRPEFAEITITLT 271
CWA DP+ RP F+++ LT
Sbjct: 237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 48/149 (32%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 89 AVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---TMMIITELMRG 145
A+K I + K+ RE+ + K I+K+ GA + ++ I E G
Sbjct: 30 ALKTITTDPNPDL---QKQIL-RELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85
Query: 146 ETLQRYLWSTRPK--RLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQV 203
+L + + R+ K A + + + YLH+ +IHRD+KPSN+LLT K QV
Sbjct: 86 GSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR-KGQV 144
Query: 204 KLADFGLAREEVMDEMTCEAGTYRWMAPE 232
KL DFG++ E V GT +MAPE
Sbjct: 145 KLCDFGVSGELVNSLAGTFTGTSFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-17
Identities = 59/181 (32%), Positives = 93/181 (51%), Gaps = 30/181 (16%)
Query: 68 KMIGEGSYSIVY--KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
K IGEGS+ +Y K E +K I + + + KE ++EV LL+KMKH NI+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEI---DLTKMPVKEKEASKKEVILLAKMKHPNIV 62
Query: 126 KFVGASVQPT--MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALD--------ISRA 175
F AS Q + I+ E G L KR++ + + F+ D IS
Sbjct: 63 TFF-ASFQENGRLFIVMEYCDGGDLM--------KRINRQRGVLFSEDQILSWFVQISLG 113
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM----TCEAGTYRWMAP 231
++++H ++HRD+K N+ L+++ KL DFG+AR ++ D M TC GT +++P
Sbjct: 114 LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTC-VGTPYYLSP 171
Query: 232 E 232
E
Sbjct: 172 E 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-17
Identities = 48/185 (25%), Positives = 90/185 (48%), Gaps = 7/185 (3%)
Query: 68 KMIGEGSYSIVY--KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
+++G G++ IV+ + + V +K I ++++ + Q E +L + H NI+
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQI---PVEQMTKDERLAAQNECQVLKLLSHPNII 62
Query: 126 KFVGASVQ-PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSV 184
++ ++ +MI+ E G TL Y+ LD + F + I A+ ++H +
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI 122
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLAREEVM-DEMTCEAGTYRWMAPENERPSLENLSE 243
+HRDLK N+LL + K VK+ DFG+++ + GT +++PE N
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKS 182
Query: 244 DMVAL 248
D+ AL
Sbjct: 183 DIWAL 187
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-17
Identities = 64/255 (25%), Positives = 104/255 (40%), Gaps = 57/255 (22%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+ S+ L K +G G + V+ G + G VAVK ++P E F E ++
Sbjct: 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKP------GTMSPESFLEEAQIMK 56
Query: 118 KMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
K++H+ +++ + + I+TE M +L +L + L L + + A ++ M
Sbjct: 57 KLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPE-- 232
Y+ + IHRDL+ +N+L+ D K+ADFGLAR +E T G +W APE
Sbjct: 117 YIERMNYIHRDLRSANILVG-DGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 233 --------------------------------NERPSLENLSE------------DMVAL 248
N R LE + + L
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 235
Query: 249 LKSCWAEDPKVRPEF 263
+ CW +DP+ RP F
Sbjct: 236 MLQCWKKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-17
Identities = 65/273 (23%), Positives = 110/273 (40%), Gaps = 63/273 (23%)
Query: 64 VLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAV-SREHKEKFQREVTLLSKMKHE 122
+ L K +GEG + V +G + +KV +A+ +R E F E + + H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 123 NILKFVGASVQ-------PTMMIITELMRGETLQRYLWSTR----PKRLDLKHSISFALD 171
N+++ +G +Q P+ ++I M+ L +L +R P+ L + + F D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE----EVMDEMTCEAGTYR 227
I+ MEYL + S IHRDL N +L E+ V +ADFGL+++ + + +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 228 WMAPEN----------------------------ERPSLENLS----------------- 242
W+A E+ P +EN
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC 239
Query: 243 -EDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274
+ + +L+ SCW +PK RP F + L L
Sbjct: 240 LDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-17
Identities = 71/259 (27%), Positives = 107/259 (41%), Gaps = 67/259 (25%)
Query: 68 KMIGEGSYSIVYKGFYGCE-PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILK 126
K +G G + +V+ G + + VA+K I N A+S +E F E ++ K+ H +++
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAI---NEGAMS---EEDFIEEAKVMMKLSHPKLVQ 63
Query: 127 FVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSI--SFALDISRAMEYLHANS 183
G Q + I+TE M L YL R ++ L + S D+ MEYL NS
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 184 VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAP--------- 231
IHRDL N L++ VK++DFG+ R + DE T +G +W P
Sbjct: 121 FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 232 -----------------------ENE----------------RPSLENLSEDMVALLKSC 252
E + RP L S + ++ SC
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLA--SMTVYEVMYSC 237
Query: 253 WAEDPKVRPEFAEITITLT 271
W E P+ RP FAE+ +T
Sbjct: 238 WHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 49/163 (30%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 68 KMIGEGSYSIVYKGFYGCE--PVAVKVIQPCNALAVSREHKEKF-QREVTLLSKMK-HEN 123
K+IGEGS+S V A+K+ + + +E K K+ + E +L+++ H
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKI---LDKRQLIKEKKVKYVKIEKEVLTRLNGHPG 63
Query: 124 ILK-FVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
I+K + + + + E L +Y+ + LD K + +A +I A+EYLH+
Sbjct: 64 IIKLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLALEYLHSK 121
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT 225
+IHRDLKP N+LL +D +K+ DFG A+ V+D +
Sbjct: 122 GIIHRDLKPENILLDKDMH-IKITDFGTAK--VLDPNSSPESN 161
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 65/258 (25%), Positives = 106/258 (41%), Gaps = 57/258 (22%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+ S+ L +G+G + V+ G + G VA+K ++P + E F +E ++
Sbjct: 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP------EAFLQEAQIMK 56
Query: 118 KMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
K++H+ ++ + + I+TE M +L +L K L L + A I+ M
Sbjct: 57 KLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPEN- 233
Y+ + IHRDL+ +N+L+ ++ K+ADFGLAR +E T G +W APE
Sbjct: 117 YIERMNYIHRDLRAANILVGDN-LVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 234 -----------------------------------------ER----PSLENLSEDMVAL 248
ER P + E + L
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHEL 235
Query: 249 LKSCWAEDPKVRPEFAEI 266
+K CW +DP RP F I
Sbjct: 236 MKLCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 57/192 (29%), Positives = 96/192 (50%), Gaps = 16/192 (8%)
Query: 52 DIDASVLVDHRSVL-LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQ 110
DID S L D + L +++G G+Y VYKG + V + + V+ + +E+ +
Sbjct: 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRH----VKTGQLAAIKVMDVTEDEEEEIK 60
Query: 111 REVTLLSKMKHE-NILKFVGASVQPT-------MMIITELMRGETLQRYLWSTRPKRLDL 162
E+ +L K H NI + GA ++ + + ++ E ++ + +T+ L
Sbjct: 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120
Query: 163 KHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMT 220
+I R + +LHA+ VIHRD+K N+LLTE+ +VKL DFG++ + +
Sbjct: 121 DWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRN 179
Query: 221 CEAGTYRWMAPE 232
GT WMAPE
Sbjct: 180 TFIGTPYWMAPE 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 49/154 (31%), Positives = 82/154 (53%), Gaps = 25/154 (16%)
Query: 70 IGEGSYSIVYKGF--YGCEPVAVKVIQ--------PCNALAVSREHKEKFQREVTLLSKM 119
IGEG+Y V+K E VA+K ++ P +AL RE+ LL ++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-----------REICLLKEL 56
Query: 120 KHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
KH+NI++ + ++ E + L++Y S +D + SF + + + +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAF 114
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
H+++V+HRDLKP NLL+ ++ ++KLADFGLAR
Sbjct: 115 CHSHNVLHRDLKPQNLLINKN-GELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 51/155 (32%), Positives = 82/155 (52%), Gaps = 26/155 (16%)
Query: 70 IGEGSYSIVYKG--FYGCEPVAVKVIQ--------PCNALAVSREHKEKFQREVTLLSKM 119
IGEG+Y +VYK E VA+K I+ P A+ RE++LL ++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-----------REISLLKEL 55
Query: 120 KHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
H NI++ + + ++ E + + L++Y+ S+ LD S+ + + + Y
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFLDLD-LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQV-KLADFGLAR 212
H++ V+HRDLKP NLL+ D++ KLADFGLAR
Sbjct: 115 CHSHRVLHRDLKPQNLLI--DREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 53/166 (31%), Positives = 84/166 (50%), Gaps = 40/166 (24%)
Query: 70 IGEGSYSIVYKG-------FYGCEPVAVKVIQPCNA---LAVSREHKEKFQREVTLLSKM 119
IGEG+Y VYK F VA+K ++ + + +S RE+ LL ++
Sbjct: 7 IGEGAYGTVYKARDLNTGRF-----VALKKVRVPLSEEGIPLS------TLREIALLKQL 55
Query: 120 K---HENILKFVGASVQP------TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFAL 170
+ H NI++ + P + ++ E + + L YL S PK +I
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYL-SKCPKPGLPPETI---K 110
Query: 171 DISRAM----EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
D+ R + ++LH++ ++HRDLKP N+L+T D QVK+ADFGLAR
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 53/174 (30%), Positives = 88/174 (50%), Gaps = 11/174 (6%)
Query: 63 SVLLQKMIGEGSYSIVYKGFYGCE-PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121
S+ L+K +G G + V+ Y VAVK ++P +++V E F E ++ ++H
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSV-----EAFLAEANVMKTLQH 60
Query: 122 ENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
+ ++K + + IITE M +L +L S + L I F+ I+ M ++
Sbjct: 61 DKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPE 232
+ IHRDL+ +N+L++ K+ADFGLAR +E T G +W APE
Sbjct: 121 RNYIHRDLRAANILVSA-SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-16
Identities = 46/178 (25%), Positives = 89/178 (50%), Gaps = 18/178 (10%)
Query: 68 KMIGEGSYSIVY--KGFYGCEPVAVKVIQPC-NALAVSREHKEKFQREVTLLSKMKHENI 124
+ +G G++S Y + +AVK + N + E E ++E+ L++++ H +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 125 LKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS 183
++ +GA+ + + + E M G ++ L + + I++ + R + YLH N
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAV--IINYTEQLLRGLSYLHENQ 123
Query: 184 VIHRDLKPSNLLLTEDKKQVKLADFGLARE---------EVMDEMTCEAGTYRWMAPE 232
+IHRD+K +NLL+ +++++ADFG A E ++ GT +MAPE
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL---GTIAFMAPE 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-16
Identities = 64/260 (24%), Positives = 97/260 (37%), Gaps = 87/260 (33%)
Query: 88 VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ-PTMMIITELMRGE 146
VAVKV++P S +E F +EV +LS++ NI + +G P + +I E M
Sbjct: 49 VAVKVLRP----DASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104
Query: 147 TLQRYLWSTRPKRLDLKH---SISF------ALDISRAMEYLHANSVIHRDLKPSNLLLT 197
L ++L + L S+SF A I+ M YL + + +HRDL N L+
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164
Query: 198 EDKKQVKLADFGLAREEVMDEMTCEAGTY-----------RWMAPEN------------- 233
+ +K+ADFG++R + Y RWMA E+
Sbjct: 165 K-NYTIKIADFGMSRN-------LYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVW 216
Query: 234 --------------ERP--------SLENLSE-------------------DMVALLKSC 252
E+P +EN D+ L+ C
Sbjct: 217 AFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLEC 276
Query: 253 WAEDPKVRPEFAEITITLTN 272
W D + RP F EI + L
Sbjct: 277 WRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 5e-16
Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 50/273 (18%)
Query: 62 RSVLLQKMIGEGSYSIVYKGFYGCEP--------VAVKVIQPCNALAVSREHKEKFQREV 113
R + +++GEG + V Y +P VAVK ++ +++ +++E+
Sbjct: 4 RYLKKIRVLGEGHFGKV--SLYCYDPANDGTGEMVAVKTLKREC----GQQNTSGWKKEI 57
Query: 114 TLLSKMKHENILKFVGASVQ---PTMMIITELMRGETLQRYLWSTRPK-RLDLKHSISFA 169
+L + HENI+K+ G + + +I E + +L+ YL PK +L+L + FA
Sbjct: 58 NILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFA 113
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWM 229
I M YLH+ IHRDL N+LL D + VK+ DFGLA+ E Y +
Sbjct: 114 QQICEGMAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKA------VPEGHEYYRV 166
Query: 230 APENERP----SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIP 285
+ + P ++E L E+ + W+ +TL +L + S +P P
Sbjct: 167 REDGDSPVFWYAVECLKENKFSYASDVWS-----------FGVTLYELLTHCDSKQSP-P 214
Query: 286 PKLVEIVDPKSTMNNDCMATVHAITKFNEKGKK 318
K E++ PK TV + + E+G +
Sbjct: 215 KKFEEMIGPKQG-----QMTVVRLIELLERGMR 242
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 6e-16
Identities = 60/184 (32%), Positives = 99/184 (53%), Gaps = 13/184 (7%)
Query: 70 IGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
IG+GS+ V+KG + VA+K+I L + + E Q+E+T+LS+ + K+
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 128 VGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIH 186
G+ ++ T + II E + G + L P LD + +I + ++YLH+ IH
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKKIH 124
Query: 187 RDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPENERPSLENLSED 244
RD+K +N+LL+E +VKLADFG+A + + + GT WMAPE + S + D
Sbjct: 125 RDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 245 MVAL 248
+ +L
Sbjct: 184 IWSL 187
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 8e-16
Identities = 55/168 (32%), Positives = 82/168 (48%), Gaps = 12/168 (7%)
Query: 70 IGEGSYSIVYKGFYGCEPV--AVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
+G+G++ VYK + + A K+IQ S E E F E+ +LS+ KH NI+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQ-----IESEEELEDFMVEIDILSECKHPNIVGL 67
Query: 128 VGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIH 186
A + + I+ E G L + + L + A+ +LH++ VIH
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIH 126
Query: 187 RDLKPSNLLLTEDKKQVKLADFGLA--REEVMDEMTCEAGTYRWMAPE 232
RDLK N+LLT D VKLADFG++ + + + GT WMAPE
Sbjct: 127 RDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 9e-16
Identities = 59/186 (31%), Positives = 82/186 (44%), Gaps = 39/186 (20%)
Query: 66 LQKMIGEGSYSIVYKGFY---GCEPVAVKVIQPCNALAVSREHKEKFQ--------REVT 114
+ K +G+G++ VY G E VA+K + K+KF REV
Sbjct: 3 VIKQLGDGTFGSVYLARNKETG-ELVAIKKM------------KKKFYSWEECMNLREVK 49
Query: 115 LLSKMK-HENILK----FVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSI-SF 168
L K+ H NI+K F + + E M G Q L R + + I S
Sbjct: 50 SLRKLNEHPNIVKLKEVFR---ENDELYFVFEYMEGNLYQ--LMKDRKGKPFSESVIRSI 104
Query: 169 ALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE-EVMDEMTCEAGTYR 227
I + + ++H + HRDLKP NLL++ + VK+ADFGLARE T T R
Sbjct: 105 IYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV-VKIADFGLAREIRSRPPYTDYVST-R 162
Query: 228 WM-APE 232
W APE
Sbjct: 163 WYRAPE 168
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 27/198 (13%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCE---PVAVKVIQPCNALA-VSREHKEKFQREVT 114
+ R ++L+ +GEG++ V+ C P K++ AL S ++ FQRE
Sbjct: 2 IKRRDIVLKWELGEGAFGKVF--LAECHNLLPEQDKMLVAVKALKEASESARQDFQREAE 59
Query: 115 LLSKMKHENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRPK-------------R 159
LL+ ++H++I++F G + P +M+ E MR L R+L S P +
Sbjct: 60 LLTVLQHQHIVRFYGVCTEGRPLLMVF-EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ 118
Query: 160 LDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM 219
L L ++ A I+ M YL + +HRDL N L+ + VK+ DFG++R+ +
Sbjct: 119 LTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTDY 177
Query: 220 TCEAG----TYRWMAPEN 233
G RWM PE+
Sbjct: 178 YRVGGRTMLPIRWMPPES 195
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-15
Identities = 62/265 (23%), Positives = 111/265 (41%), Gaps = 62/265 (23%)
Query: 68 KMIGEGSYSIVYKGFYGCE------PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121
K++G G++ VYKG + E PVA+K++ + E F E +++ M H
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE----FMDEALIMASMDH 68
Query: 122 ENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
++++ +G + PT+ ++T+LM L Y+ + + + +++ + I++ M YL
Sbjct: 69 PHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEE 127
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGTY--RWMA------- 230
++HRDL N+L+ + VK+ DFGLAR E E + G +WMA
Sbjct: 128 RRLVHRDLAARNVLV-KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 231 -----------------------------PENERPSLENLSE----------DMVALLKS 251
P E P L E D+ ++
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVK 246
Query: 252 CWAEDPKVRPEFAEITITLTNILQN 276
CW D RP+F E+ + + ++
Sbjct: 247 CWMIDADSRPKFKELAAEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 59/184 (32%), Positives = 98/184 (53%), Gaps = 13/184 (7%)
Query: 70 IGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
IG+GS+ V+KG + VA+K+I L + + E Q+E+T+LS+ + K+
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIID----LEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 128 VGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIH 186
G+ ++ T + II E + G + L R D + +I + ++YLH+ IH
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKGLDYLHSEKKIH 124
Query: 187 RDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA--GTYRWMAPENERPSLENLSED 244
RD+K +N+LL+E + VKLADFG+A + ++ GT WMAPE + S + D
Sbjct: 125 RDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183
Query: 245 MVAL 248
+ +L
Sbjct: 184 IWSL 187
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 26/173 (15%)
Query: 70 IGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
IG G+ VYK + A+KVI + V R+ RE+ +L + H N++K
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ----ICREIEILRDVNHPNVVKC 137
Query: 128 VGASVQP-TMMIITELMRGETLQ-RYLWSTRPKRLDLKHSISFALDISR----AMEYLHA 181
+ ++ E M G +L+ ++ + F D++R + YLH
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ-----------FLADVARQILSGIAYLHR 186
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGTYRWMAPE 232
++HRD+KPSNLL+ K VK+ADFG++R + MD GT +M+PE
Sbjct: 187 RHIVHRDIKPSNLLI-NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 54/169 (31%), Positives = 87/169 (51%), Gaps = 14/169 (8%)
Query: 67 QKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI 124
Q+++G G+ VYK ++ +AVKVI L ++ E +++ E+ +L K I
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVI----PLDITVELQKQIMSELEILYKCDSPYI 61
Query: 125 LKFVGAS-VQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS 183
+ F GA V+ + I TE M G +L Y L A+ + + + YL +
Sbjct: 62 IGFYGAFFVENRISICTEFMDGGSLDVY-RKIPEHVLG-----RIAVAVVKGLTYLWSLK 115
Query: 184 VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
++HRD+KPSN+L+ + QVKL DFG++ + V GT +MAPE
Sbjct: 116 ILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPE 163
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 60/194 (30%)
Query: 69 MIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
++GEG+Y +V K C E VA+K + + K+ REV +L +++HE
Sbjct: 8 VVGEGAYGVVLK----CRNKATGEIVAIKKFK---ESEDDEDVKKTALREVKVLRQLRHE 60
Query: 123 NILKFVGA------------SVQPTMMIITELMRG----ETLQRYLWSTRPKRLDLKHSI 166
NI+ A V+ T++ + E G + ++ Y+W
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ------------ 108
Query: 167 SFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTY 226
+ +A+ Y H++++IHRD+KP N+L++E +KL DFG AR + +
Sbjct: 109 -----LLQAIAYCHSHNIIHRDIKPENILVSESGV-LKLCDFGFAR-----ALRARPASP 157
Query: 227 -------RWM-APE 232
RW APE
Sbjct: 158 LTDYVATRWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-15
Identities = 48/154 (31%), Positives = 81/154 (52%), Gaps = 23/154 (14%)
Query: 70 IGEGSYSIVYKGF--YGCEPVAVKVIQ--------PCNALAVSREHKEKFQREVTLLSKM 119
IGEG+Y +VYK E +A+K I+ P A+ RE++LL +M
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-----------REISLLKEM 58
Query: 120 KHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
+H NI++ + + ++ E + + L++++ S+ + + ++ I R + Y
Sbjct: 59 QHGNIVRLQDVVHSEKRLYLVFEYLDLD-LKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
H++ V+HRDLKP NLL+ +KLADFGLAR
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 56/163 (34%), Positives = 84/163 (51%), Gaps = 14/163 (8%)
Query: 63 SVLLQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQ--REVTLLSK 118
S L + +GEGSY+ VYKG + VA+KVI ++ E F RE +LL
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVI------SMKTEEGVPFTAIREASLLKG 59
Query: 119 MKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+KH NI+ + T+ + E M + L +Y+ P L + F + R +
Sbjct: 60 LKHANIVLLHDIIHTKETLTFVFEYMHTD-LAQYM-IQHPGGLHPYNVRLFMFQLLRGLA 117
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMT 220
Y+H ++HRDLKP NLL++ ++KLADFGLAR + + T
Sbjct: 118 YIHGQHILHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQT 159
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-15
Identities = 64/273 (23%), Positives = 107/273 (39%), Gaps = 71/273 (26%)
Query: 63 SVLLQKMIGEGSYSIVYKGFYGCE-----PVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+ QK+IG G + V++G VA+K ++P + + ++ F E +++
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKP----GYTEKQRQDFLSEASIMG 61
Query: 118 KMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
+ H NI++ G + MIITE M L +YL + I+ M
Sbjct: 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQLVGMLRGIAAGM 120
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTY---------R 227
+YL + +HRDL N+L+ + K++DFGL+R V+++ GTY R
Sbjct: 121 KYLSDMNYVHRDLAARNILVN-SNLECKVSDFGLSR--VLEDDP--EGTYTTSGGKIPIR 175
Query: 228 WMAPE--------------------------NERPSLENLSEDMVA-------------- 247
W APE ERP + + +++
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDC 235
Query: 248 ------LLKSCWAEDPKVRPEFAEITITLTNIL 274
L+ CW +D RP F +I L +L
Sbjct: 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-15
Identities = 41/172 (23%), Positives = 82/172 (47%), Gaps = 9/172 (5%)
Query: 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
+ IG+GS+ +V+K + V ++ + ++R +E+ E +L+K+ I+
Sbjct: 4 ILNKIGKGSFGVVFKVVRKADK-RVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII 62
Query: 126 KFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSV 184
++ + + + I+ E L + L R + L F + I + +LH+ +
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI 122
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA----GTYRWMAPE 232
+HRD+K NL L VK+ D G+A+ ++ + T A GT +++PE
Sbjct: 123 LHRDIKSLNLFLDAY-DNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 34/202 (16%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKG-FYGCEP------VAVKVIQPCNALAVSREHKEKFQR 111
+ R ++L++ +GEG++ V+ Y P VAVK ++ A ++ FQR
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA-----RKDFQR 56
Query: 112 EVTLLSKMKHENILKFVGASV--QPTMMIITELMRGETLQRYLWSTRPK----------- 158
E LL+ ++HE+I+KF G P +M+ E M+ L ++L + P
Sbjct: 57 EAELLTNLQHEHIVKFYGVCGDGDPLIMVF-EYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115
Query: 159 ---RLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215
L L + A I+ M YL + +HRDL N L+ + VK+ DFG++R+
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN-LLVKIGDFGMSRDVY 174
Query: 216 MDEMTCEAG----TYRWMAPEN 233
+ G RWM PE+
Sbjct: 175 STDYYRVGGHTMLPIRWMPPES 196
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 57/183 (31%), Positives = 85/183 (46%), Gaps = 51/183 (27%)
Query: 53 IDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEK---- 108
ID +L R + + +G+G+Y IV+K A+ R KE
Sbjct: 1 IDKHIL---RKYEILQKLGKGAYGIVWK-------------------AIDRRTKEVVALK 38
Query: 109 -----FQ---------REVTLLSKMK-HENILKFVG---ASVQPTMMIITELMRGET-LQ 149
F+ RE+ L ++ H NI+K + A + ++ E M ET L
Sbjct: 39 KIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM--ETDLH 96
Query: 150 RYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209
+ R L+ H + +A++Y+H+ +VIHRDLKPSN+LL D +VKLADFG
Sbjct: 97 AVI---RANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD-CRVKLADFG 152
Query: 210 LAR 212
LAR
Sbjct: 153 LAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 67/281 (23%), Positives = 112/281 (39%), Gaps = 79/281 (28%)
Query: 63 SVLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLL 116
+V + +GE ++ +YKG + VA+K ++ N + + +FQ+E +L+
Sbjct: 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN----NPQQWGEFQQEASLM 61
Query: 117 SKMKHENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRP---------------KR 159
+++ H NI+ +G Q P M+ L +G+ L +L P
Sbjct: 62 AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGD-LHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 160 LDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE-EVMDE 218
LD + A+ I+ MEYL ++ +H+DL N+L+ E + VK++D GL+RE D
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE-QLHVKISDLGLSREIYSADY 179
Query: 219 MTCEAGTY---RWMAPE-----------------------------------NER----- 235
+ + RWM PE N+
Sbjct: 180 YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239
Query: 236 ------PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITL 270
P E+ M +L+ CW E P RP F +I L
Sbjct: 240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 56/173 (32%), Positives = 85/173 (49%), Gaps = 20/173 (11%)
Query: 70 IGEGSYSIVYKGF---YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILK 126
+G G+Y V F G K+ +P ++ H ++ RE+ LL MKHEN++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----HAKRTYRELRLLKHMKHENVIG 80
Query: 127 FVGASVQPTMM-------IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
+ + ++T LM G L + + ++L H I R ++Y+
Sbjct: 81 LLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTDDHVQFLIYQILRGLKYI 136
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
H+ +IHRDLKPSNL + ED ++K+ DFGLAR DEMT T + APE
Sbjct: 137 HSADIIHRDLKPSNLAVNED-CELKILDFGLAR-HTDDEMTGYVATRWYRAPE 187
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 8e-15
Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 15/177 (8%)
Query: 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH-ENI 124
L +++G G+Y VYKG + V + + V+ + +E+ ++E+ +L K H NI
Sbjct: 10 LVELVGNGTYGQVYKGRH----VKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI 65
Query: 125 LKFVGASVQPT-------MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+ GA ++ + ++ E ++ + +T+ L + +I R +
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
+LH + VIHRD+K N+LLTE+ +VKL DFG++ + + GT WMAPE
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 181
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 9e-15
Identities = 50/183 (27%), Positives = 87/183 (47%), Gaps = 30/183 (16%)
Query: 70 IGEGSYSIVYK------GFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
IG+GS+ V K G + + K I N ++ + K++ EV +L ++KH N
Sbjct: 8 IGKGSFGTVRKVRRKSDG----KILVWKEIDYGN---MTEKEKQQLVSEVNILRELKHPN 60
Query: 124 ILKFVGASVQP---TMMIITELMRGETLQRYLWSTRP--KRLDLKHSISFALDISRAMEY 178
I+++ + T+ I+ E G L + + + K ++ + + A+
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 179 LH-----ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTY----RWM 229
H N+V+HRDLKP+N+ L + VKL DFGLA+ ++ + A TY +M
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAK--ILGHDSSFAKTYVGTPYYM 177
Query: 230 APE 232
+PE
Sbjct: 178 SPE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 60/265 (22%), Positives = 116/265 (43%), Gaps = 62/265 (23%)
Query: 68 KMIGEGSYSIVYKGFYGCE------PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121
K++G G++ VYKG + E PVA+K ++ A S + ++ E +++ + +
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDN 68
Query: 122 ENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
++ + +G + T+ +IT+LM L Y+ + + ++ +++ + I++ M YL
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAG----TYRWMA------- 230
++HRDL N+L+ + + VK+ DFGLA+ DE A +WMA
Sbjct: 128 RRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR 186
Query: 231 -----------------------------PENERPSL----ENLSE------DMVALLKS 251
P +E S+ E L + D+ ++
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 246
Query: 252 CWAEDPKVRPEFAEITITLTNILQN 276
CW D RP+F E+ I + + ++
Sbjct: 247 CWMIDADSRPKFRELIIEFSKMARD 271
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 62/184 (33%), Positives = 87/184 (47%), Gaps = 25/184 (13%)
Query: 66 LQKMIGEGSYSIV----YKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK- 120
L K +G+G+Y IV E VA+K I N + K RE+ LL +
Sbjct: 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKIT--NVFSKKILAKRAL-RELKLLRHFRG 60
Query: 121 HENI-----LKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRA 175
H+NI + V + + ELM + L + + S +P L H SF I
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEAD-LHQIIRSGQP--LTDAHFQSFIYQILCG 117
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR------EEVMDEMTCEAGTYRWM 229
++Y+H+ +V+HRDLKP NLL+ D ++K+ DFGLAR E MT E RW
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENAGFMT-EYVATRWY 175
Query: 230 -APE 232
APE
Sbjct: 176 RAPE 179
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 21/194 (10%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKG-FYGCEPVAVKVIQPCNALAVSREHKEK-FQREVTLL 116
+ +++L++ +GEG++ V+ Y P K++ L + ++ K F RE LL
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 117 SKMKHENILKFVGASVQ--PTMMIITELMRGETLQRYLWS-----------TRPKRLDLK 163
+ ++HE+I+KF G V+ P +M+ E M+ L ++L + RP L
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVF-EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 164 HSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA 223
+ A I+ M YL + +HRDL N L+ E+ VK+ DFG++R+ +
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-LLVKIGDFGMSRDVYSTDYYRVG 179
Query: 224 G----TYRWMAPEN 233
G RWM PE+
Sbjct: 180 GHTMLPIRWMPPES 193
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 20/158 (12%)
Query: 86 EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---TMMIITEL 142
E VAVK ++P + H ++E+ +L + HENI+K+ G + + +I E
Sbjct: 34 EQVAVKSLKPESG----GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 89
Query: 143 MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ 202
+ +L+ YL + K ++LK + +A+ I + M+YL + +HRDL N+L+ E + Q
Sbjct: 90 LPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV-ESEHQ 147
Query: 203 VKLADFGLAREEVMDEMTCEAGTYR--------WMAPE 232
VK+ DFGL + D+ E T + W APE
Sbjct: 148 VKIGDFGLTKAIETDK---EYYTVKDDLDSPVFWYAPE 182
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 52/153 (33%), Positives = 81/153 (52%), Gaps = 24/153 (15%)
Query: 70 IGEGSYSIVYKGFYGCEP--VAVKVIQ-------PCNALAVSREHKEKFQREVTLLSKMK 120
+GEG+Y+ VYKG VA+K I+ PC A+ REV+LL +K
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-----------REVSLLKDLK 62
Query: 121 HENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
H NI+ + ++ ++ E + + L++YL +++ + F + R + Y
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
H V+HRDLKP NLL+ E + ++KLADFGLAR
Sbjct: 121 HRRKVLHRDLKPQNLLINE-RGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 62/233 (26%), Positives = 115/233 (49%), Gaps = 17/233 (7%)
Query: 65 LLQKMIGEGSYSIVYKG--FYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
++K IG G +S VY+ +PVA+K +Q + + ++ +E+ LL ++ H
Sbjct: 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM--DAKARQDCVKEIDLLKQLNHP 62
Query: 123 NILKFVGASVQPTMM-IITELMR-GETLQRYLWSTRPKRLDLKHSI-SFALDISRAMEYL 179
N++K++ + ++ + I+ EL G+ Q + + KRL + ++ + + + A+E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA----GTYRWMAPENER 235
H+ V+HRD+KP+N+ +T VKL D GL R T A GT +M+PE
Sbjct: 123 HSRRVMHRDIKPANVFITA-TGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 236 PSLENLSEDMVALLKSCWA-EDPKVRPEFAEITITLTNILQNLRSADTPIPPK 287
+ N D+ +L C E ++ F + L ++ Q + D P P
Sbjct: 180 ENGYNFKSDIWSL--GCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 67/284 (23%), Positives = 114/284 (40%), Gaps = 49/284 (17%)
Query: 65 LLQKMIGEGSYSIVY-------KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
L ++IG+G++ V K + A+K + V + E +L
Sbjct: 3 ELLRVIGKGAFGKVCIVQKRDTKKMF-----AMKYMN--KQKCVEKGSVRNVLNERRILQ 55
Query: 118 KMKHENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRPK------RLDLKHSISFA 169
++ H ++ S Q M ++ +L+ G L RY S + K + +
Sbjct: 56 ELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKF-------WI 106
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE-AGTYRW 228
+I A+EYLH+ +IHRD+KP N+LL E + V + DF +A + D +T +GT +
Sbjct: 107 CEIVLALEYLHSKGIIHRDIKPDNILLDE-QGHVHITDFNIATKVTPDTLTTSTSGTPGY 165
Query: 229 MAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTN-ILQNLRSADTPIPPK 287
MAPE +++ D +L + + RP + + T+ + I +AD P
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP-YRGHSRTIRDQIRAKQETADVLYPA- 223
Query: 288 LVEIVDPKSTMNNDCMATVHAITKFNE-KGKKRRSYLPSFLKRF 330
+ AI K E +KR LK
Sbjct: 224 ------------TWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 54/175 (30%), Positives = 86/175 (49%), Gaps = 24/175 (13%)
Query: 70 IGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSRE-----HKEKFQREVTLLSKMKHENI 124
+G G+Y V C ++ Q +SR H + RE+ LL MKHEN+
Sbjct: 23 VGSGAYGSV------CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 125 LKFVGASVQPT-------MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+ + T + ++T LM G L + + ++L +H + R ++
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIV---KCQKLSDEHVQFLIYQLLRGLK 132
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
Y+H+ +IHRDLKPSN+ + ED ++++ DFGLAR + DEMT T + APE
Sbjct: 133 YIHSAGIIHRDLKPSNVAVNED-CELRILDFGLAR-QADDEMTGYVATRWYRAPE 185
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 72/288 (25%), Positives = 119/288 (41%), Gaps = 84/288 (29%)
Query: 64 VLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQP--CNALAVSREHKEKFQREVT-LLSKM- 119
++L K +GEG + V E + + +P +AV + +++++ L+S+M
Sbjct: 20 LVLGKPLGEGCFGQVVMA----EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 120 ------KHENILKFVGASVQP-TMMIITELMRGETLQRYLWSTRP--------------K 158
KH+NI+ +GA Q + +I E L+ YL + RP +
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 159 RLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE----E 214
+L K +S A ++R MEYL + IHRDL N+L+TED +K+ADFGLAR+ +
Sbjct: 136 QLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHID 194
Query: 215 VMDEMTCEAGTYRWMAPEN----------------------------------------- 233
+ T +WMAPE
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254
Query: 234 -------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274
++PS N + ++ +++ CW P RP F ++ L IL
Sbjct: 255 LKEGHRMDKPS--NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 53/173 (30%), Positives = 81/173 (46%), Gaps = 24/173 (13%)
Query: 70 IGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQR------EVTLLSKMKHEN 123
IGEGS IV +AV + K QR EV ++ +H N
Sbjct: 27 IGEGSTGIV---------CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 124 ILKFVGAS-VQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
I++ + V + ++ E + G L + TR ++ + + L + +A+ +LHA
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLHAQ 134
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE---AGTYRWMAPE 232
VIHRD+K ++LLT D +VKL+DFG +V E+ GT WMAPE
Sbjct: 135 GVIHRDIKSDSILLTSD-GRVKLSDFGFC-AQVSKEVPRRKSLVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 58/160 (36%), Positives = 79/160 (49%), Gaps = 38/160 (23%)
Query: 70 IGEGSYSIVYKGFYGCEP--VAVKVIQ-------PCNALAVSREHKEKFQREVTLLSKMK 120
+GEG+Y+ V+KG VA+K I+ PC A+ REV+LL +K
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-----------REVSLLKNLK 61
Query: 121 HENILKFVGASVQPTMMIITELMRGETLQ-RYLWSTRPKRLD------LKHSIS-FALDI 172
H NI+ T+ I R TL YL S + LD H++ F +
Sbjct: 62 HANIV---------TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQL 112
Query: 173 SRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
R + Y H ++HRDLKP NLL+ E K ++KLADFGLAR
Sbjct: 113 LRGLSYCHKRKILHRDLKPQNLLINE-KGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 15/154 (9%)
Query: 68 KMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSR----EHKEKFQREVTLLSKMKHEN 123
++IG+G + VY G + K+ C +++R E E+F +E ++ H N
Sbjct: 1 RVIGKGHFGCVYHGTL-IDSDGQKI--HCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPN 57
Query: 124 ILKFVGASVQPT---MMIITELMRGETLQRYLWSTR-PKRLDLKHSISFALDISRAMEYL 179
+L +G + ++++ + G+ T P DL I F L +++ MEYL
Sbjct: 58 VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYL 114
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213
+ +HRDL N +L E VK+ADFGLAR+
Sbjct: 115 ASKKFVHRDLAARNCMLDE-SFTVKVADFGLARD 147
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 54/156 (34%), Positives = 83/156 (53%), Gaps = 14/156 (8%)
Query: 70 IGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQ--REVTLLSKMKHENIL 125
+GEGSY+ VYKG + VA+KVI+ + E F RE +LL +KH NI+
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIR------LQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 126 KFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSV 184
+ T+ ++ E + + Q Y+ P L ++ F + R + Y+H +
Sbjct: 67 LLHDIIHTKETLTLVFEYVHTDLCQ-YM-DKHPGGLHPENVKLFLFQLLRGLSYIHQRYI 124
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMT 220
+HRDLKP NLL++ D ++KLADFGLAR + + T
Sbjct: 125 LHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHT 159
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-14
Identities = 46/177 (25%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 66 LQKMIGEGSYSIVYK-------GFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+ K +G+GSY VYK FY A+K + + ++S++ +E E+ +L+
Sbjct: 4 VLKKLGKGSYGSVYKVKRLSDNQFY-----ALKEV---DLGSMSQKEREDAVNEIRILAS 55
Query: 119 MKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSI--SFALDISRA 175
+ H NI+ + A + + I+ E L + + + KR + + + R
Sbjct: 56 VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
++ LH ++HRDLK +N+LL VK+ D G+++ + + GT +MAPE
Sbjct: 116 LQALHEQKILHRDLKSANILLV-ANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 6e-14
Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 70 IGEGSYSIVY---KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILK 126
I +G+Y V+ K G + A+KVI+ + + + ++ E +LS+ + ++K
Sbjct: 1 ISKGAYGRVFLAKKKSTG-DIYAIKVIKKADMIR--KNQVDQVLTERDILSQAQSPYVVK 57
Query: 127 FVGASVQ--PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSV 184
S Q + ++ E + G L L + LD + + +I A+EYLH+N +
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGI 114
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE----------AGTYRWMAPE 232
IHRDLKP N+L+ + +KL DFGL++ ++ GT ++APE
Sbjct: 115 IHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-14
Identities = 60/259 (23%), Positives = 106/259 (40%), Gaps = 63/259 (24%)
Query: 70 IGEGSYSIVYKGFY----GCEPVAVKVIQ-PCNALAVSREHKEKFQREVTLLSKMKHENI 124
+G G++ V KG Y + VAVK+++ N A+ K++ RE ++ ++ + I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPAL----KDELLREANVMQQLDNPYI 58
Query: 125 LKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSV 184
++ +G + M++ EL L ++L + K + K+ +S M+YL +
Sbjct: 59 VRMIGICEAESWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTY-----RWMAPE------- 232
+HRDL N+LL + K++DFGL++ DE +A T+ +W APE
Sbjct: 117 VHRDLAARNVLLVT-QHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 233 -------------------NERPSL--------------------ENLSEDMVALLKSCW 253
++P + +M L+K CW
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCW 235
Query: 254 AEDPKVRPEFAEITITLTN 272
RP FA + + L N
Sbjct: 236 TYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-14
Identities = 58/180 (32%), Positives = 93/180 (51%), Gaps = 20/180 (11%)
Query: 61 HRSVLLQKMIGEGSYSIVYKG--FYGCEPVAVKVI--QPCNALAVSREHKEKFQREVTLL 116
H L+Q+ +G G+Y VYK + E AVK+I +P + ++ Q+E+ ++
Sbjct: 9 HDYELIQR-VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-------IQQEIFMV 60
Query: 117 SKMKHENILKFVGASV-QPTMMIITELMRGETLQRYLWSTRP-KRLDLKHSISFALDISR 174
+ KH NI+ + G+ + + + I E G +LQ T P L + + L +
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---Q 117
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
+ YLH+ +HRD+K +N+LLT D VKLADFG+A + + + GT WMAPE
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 59/194 (30%), Positives = 92/194 (47%), Gaps = 23/194 (11%)
Query: 47 NEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKG--FYGCEPVAVKVIQPCNALAVSRE 104
E+ ++ D + R VL G+G+Y IVY +A+K I ++ V
Sbjct: 1 LEYEYEYDEN---GERVVL-----GKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPL 52
Query: 105 HKEKFQREVTLLSKMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLK 163
H+E + L S +KH NI++++G+ S I E + G +L L S D +
Sbjct: 53 HEE-----IALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE 107
Query: 164 HSISF-ALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG----LAREEVMDE 218
+I F I ++YLH N ++HRD+K N+L+ VK++DFG LA E
Sbjct: 108 QTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167
Query: 219 MTCEAGTYRWMAPE 232
GT ++MAPE
Sbjct: 168 TF--TGTLQYMAPE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 54/192 (28%), Positives = 99/192 (51%), Gaps = 14/192 (7%)
Query: 66 LQKMIGEGSYSIVYKGFYGCE--PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
++K IG G +S VY+ + PVA+K +Q + + + + +E+ LL ++ H N
Sbjct: 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM--DAKARADCIKEIDLLKQLNHPN 63
Query: 124 ILKFVGASVQPTMM-IITELMRGETLQRYLWS-TRPKRLDLKHSI-SFALDISRAMEYLH 180
++K+ + ++ + I+ EL L R + + KRL + ++ + + + A+E++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA----GTYRWMAPENERP 236
+ V+HRD+KP+N+ +T VKL D GL R T A GT +M+PE
Sbjct: 124 SRRVMHRDIKPANVFITA-TGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 237 SLENLSEDMVAL 248
+ N D+ +L
Sbjct: 181 NGYNFKSDIWSL 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 18/175 (10%)
Query: 65 LLQKMIGEGSYSIVYKG--FYGCEPVAVKVI--QPCNALAVSREHKEKFQREVTLLSKMK 120
L+Q+ IG G+Y VYK E A+KVI +P AV Q+E+ ++ K
Sbjct: 13 LIQR-IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-------VQQEIIMMKDCK 64
Query: 121 HENILKFVGASVQ-PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
H NI+ + G+ ++ + I E G +LQ T P L + + + + YL
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYL 122
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
H+ +HRD+K +N+LLT D VKLADFG++ + + + GT WMAPE
Sbjct: 123 HSKGKMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 72/288 (25%), Positives = 118/288 (40%), Gaps = 84/288 (29%)
Query: 64 VLLQKMIGEGSYSIVYKG-FYGCEP--------VAVKVIQPCNALAVSREHKEKFQREVT 114
++L K +GEG + V + YG + VAVK+++ NA + + E+
Sbjct: 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKD-NA---TDKDLADLISEME 69
Query: 115 LLSKM-KHENILKFVGASVQP-TMMIITELMRGETLQRYLWSTRP--------------K 158
L+ + KH+NI+ +G Q + +I E L+ +L + RP +
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129
Query: 159 RLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE----E 214
+L K +S A ++R MEYL + IHRDL N+L+TED +K+ADFGLAR +
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED-NVMKIADFGLARGVHDID 188
Query: 215 VMDEMTCEAGTYRWMAPEN----------------------------------------- 233
+ + +WMAPE
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
Query: 234 -------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274
++PS N + ++ L++ CW P RP F ++ L +L
Sbjct: 249 LREGHRMDKPS--NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 37/128 (28%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 110 QREVTLLSKMKHENILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISF 168
E+ +LS ++H NI+ + + T++I E G TL + + + + + + +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 169 ALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR----EEVMDEMTCEAG 224
I A+ Y+H ++HRD+K N+ LT+ +KL DFG+++ E M E T G
Sbjct: 107 LFQIVSAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYSMAE-TV-VG 163
Query: 225 TYRWMAPE 232
T +M+PE
Sbjct: 164 TPYYMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 60/265 (22%), Positives = 112/265 (42%), Gaps = 62/265 (23%)
Query: 68 KMIGEGSYSIVYKGFYGCE------PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121
K++G G++ VYKG + + PVA+KV++ + ++E E +++ +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE----ILDEAYVMAGVGS 68
Query: 122 ENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
+ + +G + T+ ++T+LM L Y+ + R+ + +++ + I++ M YL
Sbjct: 69 PYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAG----TYRWMA------- 230
++HRDL N+L+ + VK+ DFGLAR +DE A +WMA
Sbjct: 128 VRLVHRDLAARNVLV-KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 231 -----------------------------PENERPSL----ENLSE------DMVALLKS 251
P E P L E L + D+ ++
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVK 246
Query: 252 CWAEDPKVRPEFAEITITLTNILQN 276
CW D + RP F E+ + + ++
Sbjct: 247 CWMIDSECRPRFRELVDEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 28/172 (16%)
Query: 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKF---- 109
S L D+ +L K +GEG++ VYK VA+K I N K+ F
Sbjct: 5 SKLRDYE--ILGK-LGEGTFGEVYKARQIKTGRVVALKKILMHNE-------KDGFPITA 54
Query: 110 QREVTLLSKMKHENILKFVGASVQ---------PTMMIITELMRGETLQRYLWSTRPKRL 160
RE+ +L K+KH N++ + +V+ ++ ++T M + L L + K L
Sbjct: 55 LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHD-LSGLLENPSVK-L 112
Query: 161 DLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+ L + + YLH N ++HRD+K +N+L+ +++ +K+ADFGLAR
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILI-DNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 47/167 (28%), Positives = 71/167 (42%), Gaps = 52/167 (31%)
Query: 160 LDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM 219
L L+ IS++ ++R ME+L + IHRDL N+LL+E VK+ DFGLAR+ D
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPD 228
Query: 220 TCEAGTYR----WMAPEN--------------------ERPSL----------------- 238
G R WMAPE+ E SL
Sbjct: 229 YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR 288
Query: 239 ----------ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275
E + ++ +++ CW +P+ RP F+E+ L ++LQ
Sbjct: 289 LKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 46/132 (34%), Positives = 67/132 (50%), Gaps = 20/132 (15%)
Query: 120 KHENILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLD--------------LKH 164
KH+NI+ +GA Q + ++ E L+ YL + RP +D K
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 165 SISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE----EVMDEMT 220
+S A ++R MEYL + IHRDL N+L+TED +K+ADFGLAR+ + + T
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED-NVMKIADFGLARDVHNIDYYKKTT 194
Query: 221 CEAGTYRWMAPE 232
+WMAPE
Sbjct: 195 NGRLPVKWMAPE 206
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-13
Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 19/179 (10%)
Query: 68 KMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQ-------REVTLLSK 118
++IG+G+Y VY E +AVK ++ A R H + + E+ L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVE-LPATIAGR-HDSRQKDMVKALRSEIETLKD 64
Query: 119 MKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+ H NI++++G + I E + G ++ L R + + F + +
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTEQVLEGLA 122
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV----MDEMTCEAGTYRWMAPE 232
YLH+ ++HRDLK NLL+ D K++DFG++++ D+ G+ WMAPE
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGI-CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 70/287 (24%), Positives = 118/287 (41%), Gaps = 70/287 (24%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKV-IQPCNALAVSREHKEKFQREVTLLS 117
++ + Q +IGEG++ V K + + + I+ A +H++ F E+ +L
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLC 62
Query: 118 KM-KHENILKFVGASVQPTMMIIT-ELMRGETLQRYLWSTRPKRLDLKHSIS-------- 167
K+ H NI+ +GA + + E L +L +R D +I+
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 168 ------FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR-EEVMDEMT 220
FA D++R M+YL IHRDL N+L+ E+ K+ADFGL+R +EV + T
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKT 181
Query: 221 CEAGTYRWMAPEN----------------------------------------------- 233
RWMA E+
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 241
Query: 234 -ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279
E+P N +++ L++ CW E P RP FA+I ++L +L+ ++
Sbjct: 242 LEKPL--NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 51/153 (33%), Positives = 79/153 (51%), Gaps = 24/153 (15%)
Query: 70 IGEGSYSIVYKGFYGCEP--VAVKVIQ-------PCNALAVSREHKEKFQREVTLLSKMK 120
+GEG+Y+ V+KG VA+K I+ PC A+ REV+LL +K
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-----------REVSLLKDLK 62
Query: 121 HENILKFVG-ASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
H NI+ ++ ++ E + + L++Y+ + + + F I R + Y
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYM-DDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
H V+HRDLKP NLL+ E + ++KLADFGLAR
Sbjct: 121 HRRKVLHRDLKPQNLLINE-RGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 53/158 (33%), Positives = 77/158 (48%), Gaps = 24/158 (15%)
Query: 70 IGEGSYSIVYKG-------FYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-- 120
IG G+Y VYK F + V V+ + + L +S REV LL +++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNE--DGLPLST------VREVALLKRLEAF 59
Query: 121 -HENILKF--VGASVQPTMMIITELM---RGETLQRYLWSTRPKRLDLKHSISFALDISR 174
H NI++ V A+ + L+ + L+ YL P L + R
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+++LHAN ++HRDLKP N+L+T QVKLADFGLAR
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTS-GGQVKLADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 67/273 (24%), Positives = 116/273 (42%), Gaps = 78/273 (28%)
Query: 68 KMIGEGSYSIVYKGFYGCE------PVAVKVIQPCNALAVSREHKEKFQREVT----LLS 117
K++G G + V+KG + E PVA+K IQ R ++ FQ E+T +
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ-------DRSGRQTFQ-EITDHMLAMG 64
Query: 118 KMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTR----PKRLDLKHSISFALDIS 173
+ H I++ +G ++ ++T+L +L ++ R P+RL +++ + I+
Sbjct: 65 SLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL-----LNWCVQIA 119
Query: 174 RAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE---MTCEAGT-YRWM 229
+ M YL + ++HR+L N+LL D V++ADFG+A D+ E T +WM
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSD-SIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 230 APEN------------------------------------ERPSL----ENLSE------ 243
A E+ E P L E L++
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTI 238
Query: 244 DMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
D+ ++ CW D VRP F E+ T + ++
Sbjct: 239 DVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-13
Identities = 54/245 (22%), Positives = 94/245 (38%), Gaps = 65/245 (26%)
Query: 87 PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA--SVQPTMMIITELMR 144
V VK +Q + E F+RE+ + K+ H+N+++ +G +P MI+
Sbjct: 37 LVLVKALQKTKDENLQSE----FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDL 92
Query: 145 GETLQRYLWSTR-------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLT 197
G+ L+++L +T+ P L K ++ I+ M++L +HRDL N L++
Sbjct: 93 GD-LKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS 151
Query: 198 EDKKQVKLADFGLAREEVMDEMTCEAGTY---RWMAPEN--------------------- 233
++VK++ L+++ E RW+APE
Sbjct: 152 SQ-REVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWE 210
Query: 234 --------------------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT 267
E P E + L+ CWA +PK RP F+E+
Sbjct: 211 VFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
Query: 268 ITLTN 272
L
Sbjct: 271 SALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 34/196 (17%)
Query: 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNAL--AVSREHKEKFQREVT-LLSKM--- 119
L K +GEG + V E + + +P A+ AV + +++++ L+S+M
Sbjct: 19 LGKPLGEGCFGQVVMA----EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 120 ----KHENILKFVGASVQP-TMMIITELMRGETLQRYLWSTRP--------------KRL 160
KH+NI+ +GA Q + +I E L+ YL + RP +++
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 161 DLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE----EVM 216
K +S ++R MEYL + IHRDL N+L+TE+ +K+ADFGLAR+ +
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDVNNIDYY 193
Query: 217 DEMTCEAGTYRWMAPE 232
+ T +WMAPE
Sbjct: 194 KKTTNGRLPVKWMAPE 209
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-13
Identities = 53/171 (30%), Positives = 80/171 (46%), Gaps = 20/171 (11%)
Query: 70 IGEGSYSIVYKGFYGC----EPVAVKVIQPCNALAVSREHKEKFQ---REVTLLSKMKHE 122
IG GS+ VY F E VA+K ++ EK+Q +EV L +++H
Sbjct: 23 IGHGSFGAVY--FARDVRTNEVVAIK-----KMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 123 NILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
N +++ G ++ T ++ E G +P + +I + + YLH+
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAIC--HGALQGLAYLHS 133
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
+ IHRD+K N+LLTE VKLADFG A ++ GT WMAPE
Sbjct: 134 HERIHRDIKAGNILLTEP-GTVKLADFGSA--SLVSPANSFVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-13
Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 28/149 (18%)
Query: 85 CEPVAVKVIQPCNALAVSREHKEKFQ-REVTLLSKMKHENILKF---VGASVQP------ 134
+ VAVK I ++ K RE+ ++ ++ H+NI+K +G S
Sbjct: 30 DKRVAVKKI------VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83
Query: 135 ------TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRD 188
++ I+ E M + L L L +H+ F + R ++Y+H+ +V+HRD
Sbjct: 84 SLTELNSVYIVQEYMETD-LANVL---EQGPLSEEHARLFMYQLLRGLKYIHSANVLHRD 139
Query: 189 LKPSNLLLTEDKKQVKLADFGLAREEVMD 217
LKP+N+ + + +K+ DFGLAR ++D
Sbjct: 140 LKPANVFINTEDLVLKIGDFGLAR--IVD 166
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 50/175 (28%), Positives = 74/175 (42%), Gaps = 55/175 (31%)
Query: 152 LWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211
LW + DL I ++ ++R ME+L + IHRDL N+LL+E+ VK+ DFGLA
Sbjct: 166 LWKSPLTMEDL---ICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLA 221
Query: 212 REEVMDEMTCEAGTYR----WMAPEN--------------------ERPSL--------- 238
R+ D G+ R WMAPE+ E SL
Sbjct: 222 RDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281
Query: 239 ------------------ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275
EN + ++ ++ +CW DPK RP F+ + L ++LQ
Sbjct: 282 INEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-13
Identities = 67/278 (24%), Positives = 114/278 (41%), Gaps = 70/278 (25%)
Query: 64 VLLQKMIGEGSYSIVYKGFYGCEPVAVKV-IQPCNALAVSREHKEKFQREVTLLSKM-KH 121
+ + +IGEG++ V + + + + I+ A +H++ F E+ +L K+ H
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD-FAGELEVLCKLGHH 62
Query: 122 ENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTR--------------PKRLDLKHSI 166
NI+ +GA + + I E L +L +R L + +
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 167 SFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR-EEVMDEMTCEAGT 225
FA D++ M+YL IHRDL N+L+ E+ K+ADFGL+R EEV + T
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS-KIADFGLSRGEEVYVKKTMGRLP 181
Query: 226 YRWMAPEN------------------------------------------------ERPS 237
RWMA E+ E+P
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKP- 240
Query: 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275
N +++ L++ CW + P RP FA+I++ L+ +L+
Sbjct: 241 -RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 14/184 (7%)
Query: 77 IVYKGFYGCEPVAVK--------VIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFV 128
+V KG YG E V+ VI+ N SR ++ ++E LLS++KH NI+ +
Sbjct: 7 VVGKGSYG-EVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 129 GA--SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIH 186
+ + I+ G L L + K L + + + I+ A++YLH ++H
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILH 125
Query: 187 RDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGTYRWMAPENERPSLENLSED 244
RDLK N+ LT +K+ D G+AR E D + GT +M+PE N D
Sbjct: 126 RDLKTQNVFLTR-TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSD 184
Query: 245 MVAL 248
+ AL
Sbjct: 185 VWAL 188
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 16/171 (9%)
Query: 68 KMIGEGSYSIVY--KGFYGCEPVAVKVIQPCNALAVSREHKEKFQ---REVTLLSKMKHE 122
+ IG GS+ VY + E VA+K + ++ EK+Q +EV L K++H
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMS-----YSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 123 NILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
N +++ G ++ T ++ E G L K L + + + YLH+
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
+++IHRD+K N+LL+E VKL DFG A +M GT WMAPE
Sbjct: 134 HNMIHRDVKAGNILLSE-PGLVKLGDFGSA--SIMAPANXFVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 56/170 (32%), Positives = 85/170 (50%), Gaps = 18/170 (10%)
Query: 70 IGEGSYSIVY--KGFYGCEPVAVKVIQPCNALAVSREHKEKFQ---REVTLLSKMKHENI 124
IG GS+ VY + E VAVK + ++ EK+Q +EV L ++KH N
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMS-----YSGKQTNEKWQDIIKEVKFLQQLKHPNT 83
Query: 125 LKFVGASVQP-TMMIITELMRGETLQRYLWSTRP-KRLDLKHSISFALDISRAMEYLHAN 182
+++ G ++ T ++ E G +P + +++ AL + + YLH++
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSH 140
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
++IHRD+K N+LLTE QVKLADFG A GT WMAPE
Sbjct: 141 NMIHRDIKAGNILLTE-PGQVKLADFGSA--SKSSPANSFVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 38/133 (28%), Positives = 70/133 (52%), Gaps = 5/133 (3%)
Query: 101 VSREHKEKFQREVTLLSKMKHENILKFVGASV-QPTMMIITELMRGETLQRYLWSTRPKR 159
+ + ++ E +L ++ H I++ Q + ++ E + G L YL ++ R
Sbjct: 40 IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG--R 97
Query: 160 LDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM 219
+ +A +I A+EYLH+ +++RDLKP N+LL ++ +KL DFG A+ ++ D
Sbjct: 98 FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE-GHIKLTDFGFAK-KLRDRT 155
Query: 220 TCEAGTYRWMAPE 232
GT ++APE
Sbjct: 156 WTLCGTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 50/171 (29%), Positives = 90/171 (52%), Gaps = 11/171 (6%)
Query: 68 KMIGEGSY--SIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
K IGEGS+ +I+ K + +K I +S + +E+ ++EV +LS MKH NI+
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISK---MSPKEREESRKEVAVLSNMKHPNIV 62
Query: 126 KFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSV 184
++ + + + I+ + G L + + + R + + + I A++++H +
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI 122
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLAR---EEVMDEMTCEAGTYRWMAPE 232
+HRD+K N+ LT+D +KL DFG+AR V TC GT +++PE
Sbjct: 123 LHRDIKSQNIFLTKDGT-IKLGDFGIARVLNSTVELARTC-IGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 38/204 (18%)
Query: 60 DHRSVLLQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQ------- 110
R + +GEG+Y V K + + VA+K ++ +S + + Q
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKII---EISNDVTKDRQLVGMCGI 63
Query: 111 -----REVTLLSKMKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKH 164
RE+ +++++KHENI+ V V+ + ++ ++M + L++ + R RL
Sbjct: 64 HFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV--DRKIRLTESQ 120
Query: 165 SISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD------- 217
L I + LH +HRDL P+N+ + K K+ADFGLAR
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLS 179
Query: 218 ---------EMTCEAGTYRWMAPE 232
EMT + T + APE
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPE 203
|
Length = 335 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 58/181 (32%), Positives = 91/181 (50%), Gaps = 22/181 (12%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALA-VSREHKEKFQREVTLLSKMKHE 122
+Q++IG+GSY +V + E VA+K I + VS + RE+ LL ++H
Sbjct: 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN--DVFEHVSDATR--ILREIKLLRLLRHP 59
Query: 123 NILKFVGASVQPT------MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
+I++ + P+ + ++ ELM + L + + + L +H F + RA+
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKAN--DDLTPEHHQFFLYQLLRAL 116
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT----YRWM-AP 231
+Y+H +V HRDLKP N+L D K +K+ DFGLAR D T T RW AP
Sbjct: 117 KYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 232 E 232
E
Sbjct: 176 E 176
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 51/168 (30%), Positives = 83/168 (49%), Gaps = 14/168 (8%)
Query: 70 IGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
IGEGS IV + + VAVK + ++ +E EV ++ HEN++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD-----LRKQQRRELLFNEVVIMRDYHHENVVDM 84
Query: 128 VGAS-VQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIH 186
+ V + ++ E + G L + TR ++ + + L + RA+ YLH VIH
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQGVIH 141
Query: 187 RDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
RD+K ++LLT D + +KL+DFG + + + + GT WMAPE
Sbjct: 142 RDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPE 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 44/172 (25%), Positives = 88/172 (51%), Gaps = 15/172 (8%)
Query: 70 IGEGSYSIVYKGFYGCEP----VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
+G G++ V KG Y VA+KV++ N +V +++ RE ++ ++ + I+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV----RDEMMREAEIMHQLDNPYIV 58
Query: 126 KFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVI 185
+ +G +M++ E+ G L ++L S + + + + + +S M+YL + +
Sbjct: 59 RMIGVCEAEALMLVMEMASGGPLNKFL-SGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 186 HRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTY-----RWMAPE 232
HRDL N+LL ++ K++DFGL++ D+ +A + +W APE
Sbjct: 118 HRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 25/158 (15%)
Query: 70 IGEGSYSIVYKG--FYGCEPVAVKVIQPCNALAVSREHKEKFQ----REVTLLSKMKHEN 123
IG+G++ V+K + VA+K + N KE F RE+ +L +KHEN
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENE-------KEGFPITALREIKILQLLKHEN 72
Query: 124 ILKFV---------GASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISR 174
++ + + + ++ E + L L S + + L +
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLL-SNKNVKFTLSEIKKVMKMLLN 130
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+ Y+H N ++HRD+K +N+L+T+D +KLADFGLAR
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGI-LKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 5e-12
Identities = 55/171 (32%), Positives = 83/171 (48%), Gaps = 16/171 (9%)
Query: 68 KMIGEGSYSIVY--KGFYGCEPVAVKVIQPCNALAVSREHKEKFQ---REVTLLSKMKHE 122
+ IG GS+ VY + E VA+K + ++ EK+Q +EV L ++KH
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMS-----YSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 123 NILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
N +++ G ++ T ++ E G L K L + + + YLH+
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
+++IHRD+K N+LLTE QVKLADFG A + GT WMAPE
Sbjct: 144 HNMIHRDIKAGNILLTE-PGQVKLADFGSA--SIASPANSFVGTPYWMAPE 191
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-12
Identities = 51/168 (30%), Positives = 86/168 (51%), Gaps = 14/168 (8%)
Query: 70 IGEGSYSIV--YKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILK- 126
IGEGS IV + + VAVK++ ++ +E EV ++ +H+N+++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD-----LRKQQRRELLFNEVVIMRDYQHQNVVEM 83
Query: 127 FVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIH 186
+ V + ++ E ++G L + TR L+ + + + +A+ YLH+ VIH
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLHSQGVIH 140
Query: 187 RDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EMTCEAGTYRWMAPE 232
RD+K ++LLT D + VKL+DFG + D + GT WMAPE
Sbjct: 141 RDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 7e-12
Identities = 29/78 (37%), Positives = 43/78 (55%), Gaps = 4/78 (5%)
Query: 156 RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215
+ R + +A + A+EYLH+ +++RDLKP NLLL D +K+ DFG A+
Sbjct: 94 KSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD-GYIKITDFGFAKRVK 152
Query: 216 MDEMT-CEAGTYRWMAPE 232
T C GT ++APE
Sbjct: 153 GRTYTLC--GTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 8e-12
Identities = 36/74 (48%), Positives = 48/74 (64%), Gaps = 5/74 (6%)
Query: 169 ALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM--TCEAGT 225
A+ I +A+EYLH+ SVIHRD+KPSN+L+ QVKL DFG++ V D + T +AG
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLINR-NGQVKLCDFGISGYLV-DSVAKTIDAGC 166
Query: 226 YRWMAPENERPSLE 239
+MAPE P L
Sbjct: 167 KPYMAPERINPELN 180
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-12
Identities = 68/273 (24%), Positives = 112/273 (41%), Gaps = 70/273 (25%)
Query: 69 MIGEGSYSIVYKGFYGCEPVAVKV-IQPCNALAVSREHKEKFQREVTLLSKMKHE-NILK 126
+IGEG++ V K + + + I+ A +H++ F E+ +L K+ H NI+
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIIN 60
Query: 127 FVGA-SVQPTMMIITELMRGETLQRYLWSTR--------------PKRLDLKHSISFALD 171
+GA + + + E L +L +R L + + FA D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR-EEVMDEMTCEAGTYRWMA 230
++R M+YL IHRDL N+L+ E+ K+ADFGL+R +EV + T RWMA
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVRWMA 179
Query: 231 PEN------------------------------------------------ERPSLENLS 242
E+ E+P N
Sbjct: 180 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP--LNCD 237
Query: 243 EDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275
+++ L++ CW E P RP FA+I ++L +L+
Sbjct: 238 DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 8e-12
Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 68 KMIGEGSY--SIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
+++GEGS+ +++ + + A+K I+ L S E ++E LL+KMKH NI+
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIR----LPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 126 KFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSV 184
F + + I+ E G L + + R K + + + + ++++H V
Sbjct: 62 AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+HRD+K N+ LT++ K VKL DFG AR
Sbjct: 122 LHRDIKSKNIFLTQNGK-VKLGDFGSAR 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 9e-12
Identities = 45/169 (26%), Positives = 67/169 (39%), Gaps = 52/169 (30%)
Query: 158 KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217
K L L+ I ++ +++ ME+L + IHRDL N+LL+E VK+ DFGLAR+ D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKD 232
Query: 218 EMTCEAGTYR----WMAPE----------------------------NERPSL------- 238
G R WMAPE + P +
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292
Query: 239 ------------ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275
+ + +M + CW +P RP F+E+ L N+LQ
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 62/278 (22%), Positives = 111/278 (39%), Gaps = 71/278 (25%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGC-----EPVAVKVIQPCNALAVSREHKEKFQREV 113
+D V ++++IG G + V +G VA+K ++ + + + F E
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS----GYTEKQRRDFLSEA 56
Query: 114 TLLSKMKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDI 172
+++ + H NI+ G + +MIITE M L +L + + + I
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGI 115
Query: 173 SRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTY------ 226
+ M+YL + +HRDL N+L+ + K++DFGL+R +++ T + TY
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSR--FLEDDTSDP-TYTSSLGG 171
Query: 227 ----RWMAPE--------------------------NERPSLENLSEDMV---------- 246
RW APE ERP + ++D++
Sbjct: 172 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP 231
Query: 247 ----------ALLKSCWAEDPKVRPEFAEITITLTNIL 274
L+ CW +D RP+F +I TL ++
Sbjct: 232 PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 23/154 (14%)
Query: 69 MIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
++GEGSY +V K C + VA+K + K+ RE+ +L +++HE
Sbjct: 8 LVGEGSYGMVMK----CKHKETGQIVAIKKFLESED---DKMVKKIAMREIRMLKQLRHE 60
Query: 123 NILKFVGASVQPT-MMIITELMRG---ETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
N++ + + + ++ E + + L++Y P LD + I R +E+
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEF 115
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
H++++IHRD+KP N+L+++ VKL DFG AR
Sbjct: 116 CHSHNIIHRDIKPENILVSQS-GVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 24/173 (13%)
Query: 70 IGEGSYSIVYKGFYGCEPVAVKVIQPCNAL-AVSREHKEKFQR------EVTLLSKMKHE 122
IGEGS IV + ++ L AV + K QR EV ++ +HE
Sbjct: 28 IGEGSTGIV----------CIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE 77
Query: 123 NILKFVGAS-VQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
N+++ + V + ++ E + G L + TR ++ + + L + +A+ LHA
Sbjct: 78 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHA 134
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
VIHRD+K ++LLT D + VKL+DFG + + + GT WMAPE
Sbjct: 135 QGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 68/271 (25%), Positives = 103/271 (38%), Gaps = 103/271 (38%)
Query: 88 VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ--PTMMIITELMRG 145
VAVK+++P ++ + F +EV +LS++K NI++ +G V P M ITE M
Sbjct: 49 VAVKILRP----DANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCM-ITEYMEN 103
Query: 146 ETLQRYLWSTRPKRLDLKHS--------------------ISFALDISRAMEYLHANSVI 185
L ++L S LD K + AL I+ M+YL + + +
Sbjct: 104 GDLNQFLSS---HHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160
Query: 186 HRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTY-----------RWMAPE-- 232
HRDL N L+ E+ +K+ADFG++R AG Y RWMA E
Sbjct: 161 HRDLATRNCLVGEN-LTIKIADFGMSR-------NLYAGDYYRIQGRAVLPIRWMAWECI 212
Query: 233 -------------------------NERPSLENLSEDMV--------------------- 246
E+P E E ++
Sbjct: 213 LMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPP 272
Query: 247 ------ALLKSCWAEDPKVRPEFAEITITLT 271
L+ CW+ D + RP F++I LT
Sbjct: 273 CPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 49/178 (27%), Positives = 92/178 (51%), Gaps = 17/178 (9%)
Query: 70 IGEGSYSIVYKGFYGCEP---VAVKVIQPCNALAVSREHKEKFQR------EVTLLSK-M 119
+G G++ VYK +A+K I N A ++ +E+ + EVT++ + +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHN-PAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 120 KHENILKFVGASVQ-PTMMIITELMRGETLQRYLWSTRPK--RLDLKHSISFALDISRAM 176
+H NI+++ ++ + I+ +L+ G L + S + K R + + + + A+
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 177 EYLHANS-VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
YLH ++HRDL P+N++L ED K V + DFGLA+++ + +T GT + PE
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDK-VTITDFGLAKQKQPESKLTSVVGTILYSCPE 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 55/176 (31%), Positives = 85/176 (48%), Gaps = 21/176 (11%)
Query: 68 KMIGEGSYSIVY-------KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK 120
K+IG+GS+ V FY AVKV+Q A+ +E K LL +K
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFY-----AVKVLQK-KAILKKKEQKHIMAERNVLLKNVK 54
Query: 121 HENILKFVGASVQPT--MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
H L + S Q + + + + G L +L R + + +A +I+ A+ Y
Sbjct: 55 HP-FLVGLHYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAEIASALGY 111
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA--GTYRWMAPE 232
LH+ ++I+RDLKP N+LL + + V L DFGL +E + T GT ++APE
Sbjct: 112 LHSLNIIYRDLKPENILL-DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 40/203 (19%)
Query: 64 VLLQKMIGEGSYSIVY-------KGFYGCEP---------VAVKVIQPCNALAVSREHKE 107
+ L++ +GEG + V+ F G VAVK+++ V++ +
Sbjct: 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRA----DVTKTARN 62
Query: 108 KFQREVTLLSKMKHENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRPKRLDLKHS 165
F +E+ ++S++K+ NI++ +G V P M ITE M L ++L S R H+
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCM-ITEYMENGDLNQFL-SQREIESTFTHA 120
Query: 166 -----------ISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214
+ A+ I+ M+YL + + +HRDL N L+ + +K+ADFG++R
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV-GNHYTIKIADFGMSRNL 179
Query: 215 VMDEMTCEAG----TYRWMAPEN 233
+ G RWMA E+
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWES 202
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 33/197 (16%)
Query: 63 SVLLQKMIGEGSYSIVYKG-FYGCEP------VAVKVIQPCNALAVSREHKEKFQREVTL 115
+V + +GE + VYKG +G P VA+K ++ + +E+F+ E +
Sbjct: 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPL----REEFKHEAMM 61
Query: 116 LSKMKHENILKFVGASV--QPTMMIITELMRGETLQRYLWSTRPKR----LDLKHSISFA 169
S+++H NI+ +G QP MI + + L +L P D ++
Sbjct: 62 RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSD-LHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 170 LD----------ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE----EV 215
L+ I+ ME+L ++ V+H+DL N+L+ DK VK++D GL RE +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF-DKLNVKISDLGLFREVYAADY 179
Query: 216 MDEMTCEAGTYRWMAPE 232
M RWM+PE
Sbjct: 180 YKLMGNSLLPIRWMSPE 196
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 88 VAVKVIQPCNALAVSREHKEK-FQREVTLLSKMKHENILKFVGASVQPTMMIIT--ELMR 144
VA+K+++ A EH+ F+RE L +++ H NI+ + + P ++ E +
Sbjct: 6 VAIKLLR---TDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 145 GETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLL--TEDKKQ 202
G TL+ L + L + L + A+ H ++HRDLKP N+++ T +
Sbjct: 63 GRTLREVLAADGA--LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 203 VKLADFGL------AREEVMDEMTCEA---GTYRWMAPENER 235
K+ DFG+ R+ + +T GT + APE R
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLR 162
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 24/173 (13%)
Query: 70 IGEGSYSIVYKGF---YGCEPVAVKVI----QPCNALAVSREHKEKFQREVTLLSKMKHE 122
IG+G+ VY G E VA+K + QP KE E+ ++ + KH
Sbjct: 27 IGQGASGTVYTAIDVATGQE-VAIKQMNLQQQP---------KKELIINEILVMRENKHP 76
Query: 123 NILKFVGAS-VQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
NI+ ++ + V + ++ E + G +L + T +D + + +A+E+LH+
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHS 133
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE--MTCEAGTYRWMAPE 232
N VIHRD+K N+LL D VKL DFG + ++ + GT WMAPE
Sbjct: 134 NQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 15/178 (8%)
Query: 66 LQKMIGEGSYSIVYKGF---YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
L K++G+G++ VY + G E +AVK +Q + + + E+ LL + HE
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRE-LAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 123 NILKFVGASVQP---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
I+++ G P T+ I E M G +++ L S L + + I + YL
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYL 122
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM-----DEMTCEAGTYRWMAPE 232
H+N ++HRD+K +N +L + VKL DFG ++ M GT WM+PE
Sbjct: 123 HSNMIVHRDIKGAN-ILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 42/163 (25%)
Query: 70 IGEGSYSIVYKG-------FYGCEPVAVKVIQPCNALA-VSREHKEKFQREVTLLSKMK- 120
IGEG++S V K +Y + + + +L V+ RE+ L ++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNN------LREIQALRRLSP 56
Query: 121 HENILKFVGASVQPT----------M-MIITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
H NIL+ + M M + EL++G +R L R K +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGR--KRPLPEKRVKS--------YM 106
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+ ++++++H N + HRD+KP N+L+ +KLADFG R
Sbjct: 107 YQLLKSLDHMHRNGIFHRDIKPENILI--KDDILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 46/165 (27%), Positives = 71/165 (43%), Gaps = 47/165 (28%)
Query: 70 IGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREH----KEKFQREVTLLSKM 119
IGEGSY +V+K C + VA+K V E K+ RE+ +L ++
Sbjct: 9 IGEGSYGVVFK----CRNRETGQIVAIKKF-------VESEDDPVIKKIALREIRMLKQL 57
Query: 120 KHENI------------LKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSIS 167
KH N+ L V T ++ EL + P+ +
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDHT--VLNELEK-----------NPRGVPEHLIKK 104
Query: 168 FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+A+ + H ++ IHRD+KP N+L+T+ Q+KL DFG AR
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-GQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 54/177 (30%), Positives = 86/177 (48%), Gaps = 22/177 (12%)
Query: 70 IGEGSYSIVYK--GFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILK 126
IG+G+Y VYK AVK++ P + E+ + E +L + H N++K
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPI------SDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 127 FVGA------SVQPTMMIITELMRGETLQRYLWS--TRPKRLDLKHSISFAL-DISRAME 177
F G V + ++ EL G ++ + +RLD + IS+ L ++
Sbjct: 84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD-EAMISYILYGALLGLQ 142
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM--TCEAGTYRWMAPE 232
+LH N +IHRD+K +N+LLT + VKL DFG++ + + GT WMAPE
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 51/171 (29%), Positives = 85/171 (49%), Gaps = 11/171 (6%)
Query: 68 KMIGEGSYSIVYKGFYGCEPV--AVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI- 124
K+IG+GS+ V + AVKV+Q L ++ +R V LL +KH +
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59
Query: 125 -LKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS 183
L + + + ++ + GE + R + + +A +++ A+ YLH+ +
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 184 VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA--GTYRWMAPE 232
+I+RDLKP N+LL + + V L DFGL +E V E T GT ++APE
Sbjct: 117 IIYRDLKPENILL-DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 53/174 (30%), Positives = 85/174 (48%), Gaps = 17/174 (9%)
Query: 68 KMIGEGSYSIVYKGFYGCEPV--AVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI- 124
K+IG+GS+ V + E AVKV+Q A+ +E K LL +KH +
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQK-KAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 125 -LKFVGASVQPTMMIITELMRGET---LQRYLWSTRPKRLDLKHSISFALDISRAMEYLH 180
L F + ++ + GE LQR P+ + +A +I+ A+ YLH
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR------ARFYAAEIASALGYLH 113
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA--GTYRWMAPE 232
+ ++++RDLKP N+LL + + + L DFGL +E + T GT ++APE
Sbjct: 114 SLNIVYRDLKPENILL-DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 41/126 (32%), Positives = 66/126 (52%), Gaps = 8/126 (6%)
Query: 111 REVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHS---IS 167
RE+TLL M+HEN++ + V + + E + Y+ + K + S +
Sbjct: 63 RELTLLKHMQHENVIGLL--DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQ 120
Query: 168 FAL-DISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTY 226
+ + + ++Y+H+ +IHRDLKP NL + ED ++K+ DFGLAR EMT T
Sbjct: 121 YLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED-CELKILDFGLARHADA-EMTGYVVTR 178
Query: 227 RWMAPE 232
+ APE
Sbjct: 179 WYRAPE 184
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 62/275 (22%), Positives = 109/275 (39%), Gaps = 67/275 (24%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCE-----PVAVKVIQPCNALAVSREHKEKFQREV 113
+D + ++K+IG G + V G PVA+K ++ + + + F E
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLK----AGYTEKQRRDFLSEA 56
Query: 114 TLLSKMKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDI 172
+++ + H NI+ G + +MI+TE M +L +L + + + I
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQFTVIQLVGMLRGI 115
Query: 173 SRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-----MTCEAGT-- 225
+ M+YL +HRDL N+L+ + K++DFGL+R V+++ T G
Sbjct: 116 ASGMKYLSDMGYVHRDLAARNILVNSN-LVCKVSDFGLSR--VLEDDPEAAYTTRGGKIP 172
Query: 226 YRWMAPE--------------------------NERPSLENLSEDMV------------- 246
RW APE ERP E ++D++
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPM 232
Query: 247 -------ALLKSCWAEDPKVRPEFAEITITLTNIL 274
L+ CW +D RP+F +I L ++
Sbjct: 233 DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 58/176 (32%), Positives = 84/176 (47%), Gaps = 28/176 (15%)
Query: 70 IGEGSYSIVYKGFYGCEPV--AVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
+G+G++ VYK V A KVI S E E + E+ +L+ H NI+K
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVID-----TKSEEELEDYMVEIDILASCDHPNIVKL 67
Query: 128 VGA-SVQPTMMIITELMRGET-------LQRYLWSTRPK-RLDLKHSISFALDISRAMEY 178
+ A + + I+ E G L+R L T P+ R+ K ++ A+ Y
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELERPL--TEPQIRVVCKQTLE-------ALNY 118
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
LH N +IHRDLK N+L T D +KLADFG++ + + GT WMAPE
Sbjct: 119 LHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-10
Identities = 51/178 (28%), Positives = 87/178 (48%), Gaps = 19/178 (10%)
Query: 68 KMIGEGSYSIVYKGF---YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI 124
K++G+G++ VY + G E A +V + S+E + E+ LL ++HE I
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKE-VSALECEIQLLKNLQHERI 66
Query: 125 LKFVGA---SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSIS--FALDISRAMEYL 179
+++ G + T+ I E M G +++ L + L S++ + I M YL
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQILEGMSYL 122
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA-----GTYRWMAPE 232
H+N ++HRD+K +N +L + VKL DFG ++ M+ GT WM+PE
Sbjct: 123 HSNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 52/177 (29%), Positives = 74/177 (41%), Gaps = 27/177 (15%)
Query: 70 IGEGSYSIVYKGFYGCEPVAVKVIQPCNAL-AVSREH------KEKFQREVTLLSKMKHE 122
+G G + V V VK AL V + H +E E +L + H
Sbjct: 1 LGVGGFGRVEL-------VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHP 53
Query: 123 NILKFVGASVQPTMMI--ITELMRGETLQRYLWSTRPK-RLDLKHSISFALDISRAMEYL 179
I+K + + I + E G L L R + D + + + A EYL
Sbjct: 54 FIVKLY-RTFKDKKYIYMLMEYCLGGELWTIL---RDRGLFDEYTARFYIACVVLAFEYL 109
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMT---CEAGTYRWMAPEN 233
H +I+RDLKP NLLL + VKL DFG A++ + T C GT ++APE
Sbjct: 110 HNRGIIYRDLKPENLLL-DSNGYVKLVDFGFAKKLKSGQKTWTFC--GTPEYVAPEI 163
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 12/170 (7%)
Query: 69 MIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILK 126
++GEG+Y +V K + E VA+K + + E KE RE+ +L +K ENI++
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE---NEEVKETTLRELKMLRTLKQENIVE 64
Query: 127 FVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVI 185
A + + ++ E + L+ L P + + S+ + +A+ + H N ++
Sbjct: 65 LKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV 122
Query: 186 HRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGTYRWM-APE 232
HRD+KP NLL++ + +KL DFG AR E + E RW +PE
Sbjct: 123 HRDIKPENLLISHNDV-LKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 31/66 (46%), Positives = 44/66 (66%), Gaps = 7/66 (10%)
Query: 171 DISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-EMT---CEAGTY 226
+IS A+E+LH +I+RDLKP N+LL + + VKL DFGL +E + + +T C GT
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILL-DAQGHVKLTDFGLCKESIHEGTVTHTFC--GTI 164
Query: 227 RWMAPE 232
+MAPE
Sbjct: 165 EYMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 9/175 (5%)
Query: 65 LLQKMIGEGSYSIVY--KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
+LQ+ +G+GS+ VY K +KV++ ++ + +E LLSK+ H
Sbjct: 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 123 NILKFVGASV-QPTMMIITELMRGETLQRYLWSTRP--KRLDLKHSISFALDISRAMEYL 179
I+KF + + + IITE G L L + K L + + + + Y+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV--MDEMTCEAGTYRWMAPE 232
H ++HRDLK N+ L +K+ DFG++R + D T GT +M+PE
Sbjct: 123 HQRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 53/174 (30%), Positives = 82/174 (47%), Gaps = 24/174 (13%)
Query: 70 IGEGSYSIVYKGFYGCEPV--AVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
+G+G++ VYK A KVI+ S E E + E+ +L+ H I+K
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYMVEIEILATCNHPYIVKL 74
Query: 128 VGASV-QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSIS------FALDISRAMEYLH 180
+GA + I+ E G + + L+L ++ + A++YLH
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIM-------LELDRGLTEPQIQVICRQMLEALQYLH 127
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV--MDEMTCEAGTYRWMAPE 232
+ +IHRDLK N+LLT D +KLADFG++ + V + GT WMAPE
Sbjct: 128 SMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 46/169 (27%), Positives = 80/169 (47%), Gaps = 11/169 (6%)
Query: 70 IGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQR----EVTLLSKMKHENIL 125
+G+G + V C+ A + C L R K K ++ E +L K+ I+
Sbjct: 1 LGKGGFGEVC----ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIV 56
Query: 126 KFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSV 184
A + ++ LM G L+ ++++ +I +A I +E+LH +
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLARE-EVMDEMTCEAGTYRWMAPE 232
++RDLKP N+LL + V+++D GLA E + ++ AGT +MAPE
Sbjct: 117 VYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGRAGTPGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 45/158 (28%), Positives = 63/158 (39%), Gaps = 52/158 (32%)
Query: 160 LDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM 219
LD + +SF+ +++ M +L + + IHRDL N+LLT + K+ DFGLAR+ D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI-TKICDFGLARDIRNDSN 269
Query: 220 TCEAGTYR----WMAPEN--------------------ERPSL----------------- 238
G R WMAPE+ E SL
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329
Query: 239 ----------ENLSEDMVALLKSCWAEDPKVRPEFAEI 266
E +M ++KSCW DP RP F +I
Sbjct: 330 IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 11/184 (5%)
Query: 75 YSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQ----REVTLLSKMKHENILK 126
Y ++ KG +G C+ A + C L R K K + E +L K+ ++
Sbjct: 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 127 FVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVI 185
A + + ++ LM G L+ +++ + ++ +A +I +E LH ++
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124
Query: 186 HRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPENERPSLENLSED 244
+RDLKP N+LL +D ++++D GLA + + GT +MAPE + S D
Sbjct: 125 YRDLKPENILL-DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 183
Query: 245 MVAL 248
AL
Sbjct: 184 WWAL 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 53/176 (30%), Positives = 96/176 (54%), Gaps = 20/176 (11%)
Query: 68 KMIGEGSYSIVY-----KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
K++G+GS+ V+ G + A+KV++ L V + K +R++ L+++ H
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA-TLKVRDRVRTKMERDI--LAEVNHP 58
Query: 123 NILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKR--LDLKHSISFAL-DISRAMEY 178
I+K A + + +I + +RG L TR + + + + F L +++ A+++
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDL-----FTRLSKEVMFTEEDVKFYLAELALALDH 113
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA--GTYRWMAPE 232
LH+ +I+RDLKP N+LL E+ +KL DFGL++E + E + GT +MAPE
Sbjct: 114 LHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 48/177 (27%), Positives = 87/177 (49%), Gaps = 14/177 (7%)
Query: 75 YSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQ----REVTLLSKMKHENILK 126
Y ++ KG +G C+ A + C L R K K + E +L K+ ++
Sbjct: 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 127 FVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVI 185
A + + ++ LM G L+ ++++ D + ++ +A +I+ +E LH ++
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV 124
Query: 186 HRDLKPSNLLLTEDKKQVKLADFGLARE-EVMDEMTCEAGTYRWMAPE---NERPSL 238
+RDLKP N+LL +D ++++D GLA E + + GT +MAPE NER +
Sbjct: 125 YRDLKPENILL-DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 51/175 (29%), Positives = 85/175 (48%), Gaps = 19/175 (10%)
Query: 68 KMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
K IG G+ IV F + V V + ++ H ++ RE+ LL + H+NI+
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISL 85
Query: 128 VGA-SVQPTM------MIITELMRGETLQRYLWSTRPKRLDLKHS-ISFAL-DISRAMEY 178
+ + Q ++ ++ ELM Q ++L H +S+ L + +++
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMDANLCQVI-------HMELDHERMSYLLYQMLCGIKH 138
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-EMTCEAGTYRWMAPE 232
LH+ +IHRDLKPSN+++ D +K+ DFGLAR + MT T + APE
Sbjct: 139 LHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 32/163 (19%)
Query: 70 IGEGSYSIVYKG--FYGCEPVAVKVIQ--------PCNALAVSREHKEKFQREVTLLSKM 119
IGEG+Y VYK + VA+K + P AL RE++LL +
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL-----------REISLLQML 57
Query: 120 KHEN-ILKFVGA------SVQPTMMIITELMRGETLQRYLWSTR---PKRLDLKHSISFA 169
I++ + + +P++ ++ E + + L++++ S + L K SF
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+ + + + H + V+HRDLKP NLL+ + K +K+AD GL R
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 42/130 (32%), Positives = 69/130 (53%), Gaps = 7/130 (5%)
Query: 106 KEKFQREVTLLSKMKHENILKFVGAS-VQPTMMIITELMRGETLQRYLWSTRPKRLDLKH 164
KE E+ ++ ++K+ NI+ F+ + V + ++ E + G +L + T +D
Sbjct: 60 KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC---MDEAQ 116
Query: 165 SISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE--MTCE 222
+ + +A+E+LHAN VIHRD+K N+LL D VKL DFG + ++ +
Sbjct: 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRSTM 175
Query: 223 AGTYRWMAPE 232
GT WMAPE
Sbjct: 176 VGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 30/78 (38%), Positives = 46/78 (58%), Gaps = 5/78 (6%)
Query: 160 LDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM 219
LDL + F+ +++ M++L + + IHRD+ N+LLT D + K+ DFGLAR+ + D
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSN 267
Query: 220 TCEAGTYR----WMAPEN 233
G R WMAPE+
Sbjct: 268 YVVKGNARLPVKWMAPES 285
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 27/79 (34%), Positives = 46/79 (58%), Gaps = 3/79 (3%)
Query: 156 RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215
R R D + +A +I +++LH +I+RDLK N+LL + +K+ADFG+ +E +
Sbjct: 89 RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGI 147
Query: 216 MDEMTCEA--GTYRWMAPE 232
+ +T GT ++APE
Sbjct: 148 LGGVTTSTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 20/175 (11%)
Query: 68 KMIGEGSYSIV---YKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI 124
K +G G+Y V G + K+ +P S ++ RE+ LL MKHEN+
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ----SELFAKRAYRELRLLKHMKHENV 76
Query: 125 LKFVGASVQPTMM-------IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+ + + ++ M G L + + + ++L + + ++
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLM---KHEKLSEDRIQFLVYQMLKGLK 132
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
Y+HA +IHRDLKP NL + ED ++K+ DFGLAR + EMT T + APE
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNED-CELKILDFGLAR-QTDSEMTGYVVTRWYRAPE 185
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 8e-10
Identities = 31/98 (31%), Positives = 61/98 (62%), Gaps = 2/98 (2%)
Query: 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLL 195
+ ++ LM G L+ ++++ + L+++ I ++ I+ + +LH+ +++RD+KP N+L
Sbjct: 68 LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127
Query: 196 LTEDKKQVKLADFGLARE-EVMDEMTCEAGTYRWMAPE 232
L +D+ +L+D GLA E + +T AGT +MAPE
Sbjct: 128 L-DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-10
Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 15/178 (8%)
Query: 66 LQKMIGEGSYSIVYKGF---YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
L K++G G++ VY + G E +V ++ S+E + E+ LL ++H+
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHD 64
Query: 123 NILKFVGASVQPT---MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
I+++ G P + I E M G +++ L + L + + I + + YL
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYL 122
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA-----GTYRWMAPE 232
H+N ++HRD+K +N +L + VKL DFG ++ M+ GT WM+PE
Sbjct: 123 HSNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 3/77 (3%)
Query: 158 KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217
R D + +A +I +++LH +I+RDLK N+LL +D +K+ADFG+ +E +
Sbjct: 91 GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNG 149
Query: 218 EMTCEA--GTYRWMAPE 232
E GT ++APE
Sbjct: 150 EGKASTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 53/180 (29%), Positives = 89/180 (49%), Gaps = 29/180 (16%)
Query: 68 KMIGEGSYSIVYKGFYGC--EPVAVKVI-QPCNALAVSREHKEKFQREVTLLSKMKHENI 124
K IG G+ IV + + VA+K + +P + H ++ RE+ L+ + H+NI
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP----FQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 125 LKFVGA-SVQPTM------MIITELMRGETLQRYLWSTRPKRLDLKHS-ISFAL-DISRA 175
+ + + Q ++ ++ ELM Q ++DL H +S+ L +
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-------QMDLDHERMSYLLYQMLCG 130
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR---EEVMDEMTCEAGTYRWMAPE 232
+++LH+ +IHRDLKPSN+++ D +K+ DFGLAR M MT T + APE
Sbjct: 131 IKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPE 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 38/160 (23%), Positives = 69/160 (43%), Gaps = 52/160 (32%)
Query: 166 ISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT 225
+ F+ ++ ME+L + + +HRDL N+L+ E K VK+ DFGLAR+ + D G+
Sbjct: 242 VGFSYQVANGMEFLASKNCVHRDLAARNVLICEG-KLVKICDFGLARDIMRDSNYISKGS 300
Query: 226 ----YRWMAPEN-------------------------------ERPSLENL--------- 241
+WMAPE+ E P E
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360
Query: 242 -------SEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274
S+++ +++ CW E ++RP+F+++ + ++L
Sbjct: 361 MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 53/176 (30%), Positives = 80/176 (45%), Gaps = 15/176 (8%)
Query: 68 KMIGEGSYSIVYKG--FYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
K IG G + V G G P V V++ A +E KF E ++H N+L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQV-VVKELRVSASVQEQM-KFLEEAQPYRSLQHSNLL 58
Query: 126 KFVG--ASVQPTMMIITELMRGETLQRYLWSTRPKRL---DLKHSISFALDISRAMEYLH 180
+ +G V P ++++ G+ L+ YL S R L D A +I+ + +LH
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGD-LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT----YRWMAPE 232
N+ IH DL N LLT D VK+ D+GL+ + ++ RW+APE
Sbjct: 118 KNNFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 45/177 (25%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 75 YSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQ----REVTLLSKMKHENILK 126
Y ++ KG +G C+ A + C L R K K + E +L K+ + ++
Sbjct: 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 127 FVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVI 185
A + + ++ +M G L+ ++++ + + ++ +A +I +E LH + +
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 186 HRDLKPSNLLLTEDKKQVKLADFGLA-REEVMDEMTCEAGTYRWMAPE---NERPSL 238
+RDLKP N+LL +D ++++D GLA + + + GT +MAPE N+R +L
Sbjct: 125 YRDLKPENILL-DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTL 180
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 17/178 (9%)
Query: 70 IGEGSYSIVYKGFY---GCEPVAVKVIQPCNALAVSREHKEKFQREV-TLLSKMKHENIL 125
IG G++ V K + G +AVK I+ +E K + ++ ++ I+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTI-MAVKRIRSTV---DEKEQK-RLLMDLDVVMRSSDCPYIV 66
Query: 126 KFVGASV-QPTMMIITELMRG--ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
KF GA + I ELM + +Y++ + + A+ +A+ YL
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126
Query: 183 -SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM--TCEAGTYRWMAPENERPS 237
+IHRD+KPSN+LL + +KL DFG++ + V D + T +AG +MAPE PS
Sbjct: 127 LKIIHRDVKPSNILL-DRNGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDPS 182
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 53/171 (30%), Positives = 86/171 (50%), Gaps = 11/171 (6%)
Query: 68 KMIGEGSYS--IVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
K+IG+GS+ ++ K + AVKV+Q + +E K LL +KH L
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQK-KIVLNRKEQKHIMAERNVLLKNVKHP-FL 58
Query: 126 KFVGASVQPT--MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS 183
+ S Q T + + + + G L +L R + + +A +I+ A+ YLH+ +
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLHSIN 116
Query: 184 VIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
+++RDLKP N+LL + + V L DFGL +E D T GT ++APE
Sbjct: 117 IVYRDLKPENILL-DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 27/67 (40%), Positives = 43/67 (64%), Gaps = 3/67 (4%)
Query: 168 FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA--GT 225
+ +I A+EYLH+ V++RD+K NL+L +D +K+ DFGL +E + D T + GT
Sbjct: 100 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGT 158
Query: 226 YRWMAPE 232
++APE
Sbjct: 159 PEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 22/177 (12%)
Query: 70 IGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILK 126
IG+G+Y V+K AVK++ P + + E+ + E +L + H N++K
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI------DEEIEAEYNILKALSDHPNVVK 79
Query: 127 FVGASVQP------TMMIITELMRGETLQRYL--WSTRPKRLDLKHSISFAL-DISRAME 177
F G + + ++ EL G ++ + + R +R++ + I++ L + ++
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME-EPIIAYILHEALMGLQ 138
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM--TCEAGTYRWMAPE 232
+LH N IHRD+K +N+LLT + VKL DFG++ + + GT WMAPE
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 29/79 (36%), Positives = 49/79 (62%), Gaps = 3/79 (3%)
Query: 156 RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215
R ++ D S +A +++ A+ +LH + VI+RDLK N+LL + KLADFG+ +E +
Sbjct: 89 RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGI 147
Query: 216 MDEMTCEA--GTYRWMAPE 232
++ +T GT ++APE
Sbjct: 148 LNGVTTTTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 29/72 (40%), Positives = 44/72 (61%), Gaps = 5/72 (6%)
Query: 166 ISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT 225
+SF ++R ME+L + + +HRDL N+LL + K VK+ DFGLAR+ + D G+
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI-VKICDFGLARDIMHDSNYVSKGS 298
Query: 226 ----YRWMAPEN 233
+WMAPE+
Sbjct: 299 TFLPVKWMAPES 310
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 34/122 (27%), Positives = 54/122 (44%), Gaps = 3/122 (2%)
Query: 112 EVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALD 171
E LL + H ++++ V + + L YL + R + L + ++
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYL-TKRSRPLPIDQALIIEKQ 165
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE-AGTYRWMA 230
I + YLHA +IHRD+K N+ + D QV + D G A+ V+ AGT A
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFI-NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNA 224
Query: 231 PE 232
PE
Sbjct: 225 PE 226
|
Length = 357 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 4e-09
Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 14/168 (8%)
Query: 70 IGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
IG+G+ VY + VA+K + + KE E+ ++ + K+ NI+ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMN-----LQQQPKKELIINEILVMRENKNPNIVNY 81
Query: 128 VGAS-VQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIH 186
+ + V + ++ E + G +L + T +D + + +A+++LH+N VIH
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALDFLHSNQVIH 138
Query: 187 RDLKPSNLLLTEDKKQVKLADFGLAREEVMDE--MTCEAGTYRWMAPE 232
RD+K N+LL D VKL DFG + ++ + GT WMAPE
Sbjct: 139 RDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 27/67 (40%), Positives = 42/67 (62%), Gaps = 3/67 (4%)
Query: 168 FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA--GT 225
+ +I A+ YLH+ V++RDLK NL+L +D +K+ DFGL +E + D T + GT
Sbjct: 100 YGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGT 158
Query: 226 YRWMAPE 232
++APE
Sbjct: 159 PEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 48/163 (29%), Positives = 71/163 (43%), Gaps = 33/163 (20%)
Query: 70 IGEGSYSIVYKG--------FYGCEPVAVKVIQPCNALAVSRE-----HKEKFQR----- 111
IGEG+Y V+K F + V V+ + L+ RE H E F+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 112 --EVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
+V +S+ E L V V + L YL + +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVD------------QDLTTYLDKVPEPGVPTETIKDMM 116
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+ R +++LH++ V+HRDLKP N+L+T Q+KLADFGLAR
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLAR 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-09
Identities = 25/73 (34%), Positives = 41/73 (56%), Gaps = 3/73 (4%)
Query: 160 LDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM 219
L + + ++ +E LH +IHRD+KP NLL+ + +KL DFGL+R + ++
Sbjct: 94 LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ-TGHLKLTDFGLSRNGLENKK 152
Query: 220 TCEAGTYRWMAPE 232
GT ++APE
Sbjct: 153 F--VGTPDYLAPE 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 34/128 (26%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 86 EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMI--ITELM 143
+ A+KV+ + ++ + ++E+ L+ + H + AS Q + + +
Sbjct: 27 KLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDHPFLPTLY-ASFQTETYLCLVMDYC 83
Query: 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQV 203
G L R L K L + + +A ++ A+EYLH +++RDLKP N+LL E +
Sbjct: 84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-GHI 142
Query: 204 KLADFGLA 211
L+DF L+
Sbjct: 143 MLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-09
Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 19/178 (10%)
Query: 68 KMIGEGSYSIVYKG-FYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILK 126
IG G + V G + A V++ A A E + F +EV ++ H N+L+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE-QLLFLQEVQPYRELNHPNVLQ 59
Query: 127 FVGASVQPT-MMIITELMRGETLQRYLWSTR-------PKRLDLKHSISFALDISRAMEY 178
+G ++ +++ E L+ YL S R K + + A +++ + +
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR----MACEVASGLLW 115
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA----REEVMDEMTCEAGTYRWMAPE 232
LH IH DL N LT D VK+ D+GLA E+ C A RW+APE
Sbjct: 116 LHQADFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPE 172
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 6e-09
Identities = 41/131 (31%), Positives = 69/131 (52%), Gaps = 9/131 (6%)
Query: 106 KEKFQREVTLLSKMKHENILKFVGAS-VQPTMMIITELMRGETLQRYLWSTRPKRLDLKH 164
KE E+ ++ + K+ NI+ ++ + V + ++ E + G +L + T +D
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQ 117
Query: 165 SISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA- 223
+ + +A+E+LH+N VIHRD+K N+LL D VKL DFG ++ E + +
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFC-AQITPEQSKRST 175
Query: 224 --GTYRWMAPE 232
GT WMAPE
Sbjct: 176 MVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 35/195 (17%)
Query: 70 IGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREH----KEKFQR-----EVTLLSKMK 120
IG G+ VYK ++ + + +AV + KE+ +R +V L S
Sbjct: 23 IGSGTCGQVYK---------MRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS--- 70
Query: 121 HE--NILKFVGASV-QPTMMIITELMRG--ETLQRYLWSTRPKRLDLKHSISFALDISRA 175
H+ I+K G + + I ELM + L + + P+ + K +++ I +A
Sbjct: 71 HDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVA----IVKA 126
Query: 176 MEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM--TCEAGTYRWMAPE 232
+ YL VIHRD+KPSN+LL + VKL DFG++ V D T AG +MAPE
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILL-DASGNVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPE 184
Query: 233 NERPSLENLSEDMVA 247
P N D+ A
Sbjct: 185 RIDPPDPNPKYDIRA 199
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-09
Identities = 35/124 (28%), Positives = 66/124 (53%), Gaps = 5/124 (4%)
Query: 111 REVTLLSKMKHENILKFVGASV-QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
RE+ ++ + + I+ F GA + + + + E M +L R P +++ I A
Sbjct: 52 RELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKI--A 109
Query: 170 LDISRAMEYLH-ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRW 228
+ + + YL+ + ++HRD+KPSN+L+ + Q+KL DFG++ E + GT +
Sbjct: 110 VAVVEGLTYLYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFVGTSTY 168
Query: 229 MAPE 232
M+PE
Sbjct: 169 MSPE 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 43/168 (25%), Positives = 82/168 (48%), Gaps = 11/168 (6%)
Query: 75 YSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQ----REVTLLSKMKHENILK 126
Y ++ KG +G C+ A + C L R K K + E +L K+ ++
Sbjct: 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 127 FVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVI 185
A + + ++ +M G L+ ++++ D + +I +A ++ +E L ++
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124
Query: 186 HRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
+RDLKP N+LL +D+ ++++D GLA + E + GT +MAPE
Sbjct: 125 YRDLKPENILL-DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-09
Identities = 29/58 (50%), Positives = 39/58 (67%), Gaps = 2/58 (3%)
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
A EYLH+ +I+RDLKP NLLL ++K VK+ DFG A+ +V D GT ++APE
Sbjct: 130 AFEYLHSKDIIYRDLKPENLLL-DNKGHVKVTDFGFAK-KVPDRTFTLCGTPEYLAPE 185
|
Length = 329 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 55/171 (32%), Positives = 80/171 (46%), Gaps = 29/171 (16%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQ----RE 112
VD ++ Q IGEG+Y VYK E VA+K ++ N KE F RE
Sbjct: 6 VDKFDIIGQ--IGEGTYGQVYKARDKDTGELVALKKVRLDN-------EKEGFPITAIRE 56
Query: 113 VTLLSKMKHENI--LKFVGASVQPTM---------MIITELMRGETLQRYLWSTRPKRLD 161
+ +L ++ H NI LK + Q + ++ E M + + L +
Sbjct: 57 IKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLESGLVHFS 114
Query: 162 LKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
H SF + + Y H + +HRD+K SN+LL +K Q+KLADFGLAR
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN-NKGQIKLADFGLAR 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 32/99 (32%), Positives = 57/99 (57%), Gaps = 5/99 (5%)
Query: 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLL 195
+ + E + G L ++ S + DL + +A +I +++LH+ +++RDLK N+L
Sbjct: 71 LFFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNIL 128
Query: 196 LTEDKKQVKLADFGLAREEVM-DEMTCE-AGTYRWMAPE 232
L D +K+ADFG+ +E ++ D TC GT ++APE
Sbjct: 129 LDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 30/98 (30%)
Query: 162 LKHSISFALDISR--------AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR- 212
LK+ + +D++R A+EYLH ++HRDLKP NLL+T +KL DFGL++
Sbjct: 92 LKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS-MGHIKLTDFGLSKI 150
Query: 213 ------------------EEVMDEMTCEAGTYRWMAPE 232
E +D+ C GT ++APE
Sbjct: 151 GLMSLTTNLYEGHIEKDTREFLDKQVC--GTPEYIAPE 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 37/136 (27%), Positives = 69/136 (50%), Gaps = 17/136 (12%)
Query: 88 VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ--PTMMIITELMRG 145
VAVK+++ ++ + F +E+ ++S++K NI++ + + P MI TE M
Sbjct: 49 VAVKMLRE----DANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMI-TEYMEN 103
Query: 146 ETLQRYLWSTRPKRLDLKHSISF---------ALDISRAMEYLHANSVIHRDLKPSNLLL 196
L ++L P+ K + A I+ M+YL + + +HRDL N L+
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163
Query: 197 TEDKKQVKLADFGLAR 212
++ +K+ADFG++R
Sbjct: 164 GKNYT-IKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 5/99 (5%)
Query: 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLL 195
+ + E + G L ++ +R R D + +A +I+ A+ +LH +I+RDLK N+L
Sbjct: 71 LFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVL 128
Query: 196 LTEDKKQVKLADFGLAREEVMDEMTCEA--GTYRWMAPE 232
L + KLADFG+ +E + + T GT ++APE
Sbjct: 129 LDHE-GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 52/271 (19%), Positives = 102/271 (37%), Gaps = 61/271 (22%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCE-----PVAVKVIQPCNALAVSREHKEKFQREV 113
+D++S+ +++++G G + + +G PVA+ ++ S + + F E
Sbjct: 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA----GCSDKQRRGFLAEA 57
Query: 114 TLLSKMKHENILKFVGASVQ-PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDI 172
L + H NI++ G + TMMI+TE M L +L +L + +
Sbjct: 58 LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGL 116
Query: 173 SRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYR---WM 229
+ M+YL +H+ L +L+ D K++ F +E+ + + W
Sbjct: 117 ASGMKYLSEMGYVHKGLAAHKVLVNSDLV-CKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175
Query: 230 APE--------------------------NERPSLENLSEDMVA---------------- 247
APE ERP + +D++
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPN 235
Query: 248 ----LLKSCWAEDPKVRPEFAEITITLTNIL 274
L+ CW ++ RP F++I L+ ++
Sbjct: 236 LLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 64/217 (29%), Positives = 93/217 (42%), Gaps = 43/217 (19%)
Query: 68 KMIGEGSYSIVYKGF-YGC-EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
++IG+G VY + C VA+K I+ L+ + K++F RE + + + H I+
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIR--EDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 126 KFV-----GASVQPTMMIITELMRGETLQRYLWSTR-----PKRLDLKHSISFALDI--- 172
G V TM I G TL+ L S K L K S+ L I
Sbjct: 66 PVYSICSDGDPVYYTMPYI----EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 173 -SRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE------------- 218
+EY+H+ V+HRDLKP N+LL + V L D+G A + ++E
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 219 ----MTCEA---GTYRWMAPENERPSLENLSEDMVAL 248
MT GT +MAPE + S D+ AL
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYAL 217
|
Length = 932 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 36/115 (31%), Positives = 62/115 (53%), Gaps = 5/115 (4%)
Query: 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLL 195
+ + E + G L ++ R ++L +H+ ++ +IS A+ YLH +I+RDLK N+L
Sbjct: 71 LFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 128
Query: 196 LTEDKKQVKLADFGLAREEVM--DEMTCEAGTYRWMAPENERPSLENLSEDMVAL 248
L + + +KL D+G+ +E + D + GT ++APE R S D AL
Sbjct: 129 L-DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 26/60 (43%), Positives = 38/60 (63%), Gaps = 3/60 (5%)
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV--MDEMTCEAGTYRWMAPE 232
++YLH N +++RDLK NLLL + VK+ADFGL +E + D + GT ++APE
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 48/170 (28%), Positives = 81/170 (47%), Gaps = 12/170 (7%)
Query: 68 KMIGEGSYSIVYKGFYGCE---PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI 124
+ +G GS+ V Y E PVA+K + + ++ + E +L+ + H
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDHVFSERKILNYINHPFC 93
Query: 125 LKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS 183
+ G+ + + ++ E + G +L R KR +A I EYL + +
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFL--RRNKRFPNDVGCFYAAQIVLIFEYLQSLN 151
Query: 184 VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE-AGTYRWMAPE 232
+++RDLKP NLLL +D +K+ DFG A+ V+D T GT ++APE
Sbjct: 152 IVYRDLKPENLLLDKDGF-IKMTDFGFAK--VVDTRTYTLCGTPEYIAPE 198
|
Length = 340 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 50/188 (26%), Positives = 93/188 (49%), Gaps = 30/188 (15%)
Query: 38 DDDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQP 95
D+D+++ DN DI+ S ++S L +IG GS+ +VY+ E VA+K
Sbjct: 49 DEDEEKMIDN----DINRS---PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK---- 97
Query: 96 CNALAVSREHKEKFQREVTLLSKMKHENIL----KFVGASVQPT-----MMIITELMRGE 146
V ++ + K RE+ ++ + H NI+ + + + ++ E + +
Sbjct: 98 ----KVLQDPQYK-NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-Q 151
Query: 147 TLQRYL--WSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVK 204
T+ +Y+ ++ L L ++ + RA+ Y+H+ + HRDLKP NLL+ + +K
Sbjct: 152 TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLK 211
Query: 205 LADFGLAR 212
L DFG A+
Sbjct: 212 LCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 35/115 (30%), Positives = 61/115 (53%), Gaps = 5/115 (4%)
Query: 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLL 195
+ + E + G L ++ R ++L +H+ ++ +IS A+ +LH +I+RDLK N+L
Sbjct: 71 LFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVL 128
Query: 196 LTEDKKQVKLADFGLAREEVM--DEMTCEAGTYRWMAPENERPSLENLSEDMVAL 248
L + +KL D+G+ +E + D + GT ++APE R S D AL
Sbjct: 129 LDAE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 24/53 (45%), Positives = 37/53 (69%), Gaps = 7/53 (13%)
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA-----RE-EVMDEMTC 221
A++YLH + +IHRDLKP N+L++ ++ +KL DFGL+ RE +MD +T
Sbjct: 116 ALDYLHRHGIIHRDLKPDNMLIS-NEGHIKLTDFGLSKVTLNRELNMMDILTT 167
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 36/115 (31%), Positives = 61/115 (53%), Gaps = 5/115 (4%)
Query: 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLL 195
+ ++ E + G L ++ R ++L +H+ +A +I A+ +LH +I+RDLK N+L
Sbjct: 71 LFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVL 128
Query: 196 LTEDKKQVKLADFGLAREEVM--DEMTCEAGTYRWMAPENERPSLENLSEDMVAL 248
L D +KL D+G+ +E + D + GT ++APE R S D AL
Sbjct: 129 LDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWAL 182
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 24/71 (33%), Positives = 44/71 (61%), Gaps = 3/71 (4%)
Query: 164 HSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA 223
H++ +A +I+ + +LH+ +I+RDLK N++L + +K+ADFG+ +E + T
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRT 160
Query: 224 --GTYRWMAPE 232
GT ++APE
Sbjct: 161 FCGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 27/76 (35%), Positives = 46/76 (60%), Gaps = 3/76 (3%)
Query: 159 RLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218
R DL + +A +I +++LH+ +I+RDLK N++L D +K+ADFG+ +E V +
Sbjct: 92 RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGD 150
Query: 219 --MTCEAGTYRWMAPE 232
+ GT ++APE
Sbjct: 151 NRASTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 26/67 (38%), Positives = 43/67 (64%), Gaps = 3/67 (4%)
Query: 168 FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA--GT 225
+ +I A++YLH+ +++RDLK NL+L +D +K+ DFGL +E + D T + GT
Sbjct: 100 YGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFCGT 158
Query: 226 YRWMAPE 232
++APE
Sbjct: 159 PEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 26/201 (12%)
Query: 46 DNEF-VFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGC--EPVAVKVI-QPCNALAV 101
DN F +I S + K IG G+ IV + VA+K + +P
Sbjct: 7 DNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---- 62
Query: 102 SREHKEKFQREVTLLSKMKHENILKFVGA-SVQPTM------MIITELMRGETLQRYLWS 154
++ H ++ RE+ L+ + H+NI+ + + Q ++ I+ ELM Q
Sbjct: 63 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--- 119
Query: 155 TRPKRLDLKHS-ISFAL-DISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+++L H +S+ L + +++LH+ +IHRDLKPSN+++ D +K+ DFGLAR
Sbjct: 120 ----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLAR 174
Query: 213 EEVMD-EMTCEAGTYRWMAPE 232
MT T + APE
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPE 195
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLL 195
+ ++T+ M G L +L + R + + ++ A+E+LH +++RDLKP N+L
Sbjct: 71 LYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENIL 128
Query: 196 LTEDKKQVKLADFGLAREEVMDEMTCEA--GTYRWMAPE 232
L + L DFGL++ + D T GT ++APE
Sbjct: 129 LDAT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 14/182 (7%)
Query: 80 KGFYG----CEPVAVKVIQPCNALAVSREHKEK-FQR---EVTLLSKMKHENILKFVGA- 130
KG +G C+ A + C L R K K ++ E +L+K+ I+ A
Sbjct: 3 KGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF 62
Query: 131 SVQPTMMIITELMRGETLQRYLWSTRPKR--LDLKHSISFALDISRAMEYLHANSVIHRD 188
+ + ++ +M G L+ ++++ + + + I +E+LH +I+RD
Sbjct: 63 QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRD 122
Query: 189 LKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPENERPSLENLSEDMV 246
LKP N+LL ++ V+++D GLA E + + AGT +MAPE + + S D
Sbjct: 123 LKPENVLL-DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYF 181
Query: 247 AL 248
AL
Sbjct: 182 AL 183
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 26/76 (34%), Positives = 49/76 (64%), Gaps = 3/76 (3%)
Query: 159 RLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218
R H++ +A +I+ + +LH+ +I+RDLK N++L + + +K+ADFG+ +E + D
Sbjct: 97 RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML-DSEGHIKIADFGMCKENMWDG 155
Query: 219 MTCEA--GTYRWMAPE 232
+T + GT ++APE
Sbjct: 156 VTTKTFCGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 10/148 (6%)
Query: 68 KMIGEGSYSIVY--KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
K+IG G++ V+ + + A+KV++ + + R + E +L+ I+
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK--RNQIAHVRAERDILADADSPWIV 64
Query: 126 KFVGASVQPT--MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS 183
K S Q + ++ E M G L L R + + + ++ A++ +H
Sbjct: 65 KLY-YSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARFYIAELVLALDSVHKLG 121
Query: 184 VIHRDLKPSNLLLTEDKKQVKLADFGLA 211
IHRD+KP N+L+ D +KLADFGL
Sbjct: 122 FIHRDIKPDNILIDAD-GHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 36/120 (30%), Positives = 59/120 (49%), Gaps = 24/120 (20%)
Query: 111 REVTLLSKMKHENILK----FVGASVQPTMMIITELMRGETLQRYLW-----------ST 155
RE+ LL ++KH N++ F+ S + ++ + + LW +
Sbjct: 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLF------DYAEHDLWHIIKFHRASKANK 100
Query: 156 RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLT---EDKKQVKLADFGLAR 212
+P +L S I + YLHAN V+HRDLKP+N+L+ ++ +VK+AD G AR
Sbjct: 101 KPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE 198
I +LM G L +L ++ +A +I +E++H V++RDLKP+N+LL E
Sbjct: 75 ILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 132
Query: 199 DKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
V+++D GLA + + GT+ +MAPE
Sbjct: 133 H-GHVRISDLGLACDFSKKKPHASVGTHGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 3/97 (3%)
Query: 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLL 195
+ I +LM G L +L ++ K +A +I +E++H V++RDLKP+N+L
Sbjct: 72 LCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANIL 129
Query: 196 LTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
L E V+++D GLA + + GT+ +MAPE
Sbjct: 130 LDE-HGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 56/248 (22%), Positives = 94/248 (37%), Gaps = 29/248 (11%)
Query: 14 ELSFPLFDDNTGDTSCPLTKACDADDDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEG 73
+ DD T T + + D + E D + +V + +L + G
Sbjct: 46 DELGDS-DDVTHATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNIL-SSLTPG 103
Query: 74 SYSIVY----KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVG 129
S V+ G + V VK + RE+ +L + H I+ +
Sbjct: 104 SEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG----------REIDILKTISHRAIINLIH 153
Query: 130 A-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRD 188
A + T+ ++ M + + R L L+ +I+ + A+ YLH +IHRD
Sbjct: 154 AYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRD 210
Query: 189 LKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVAL 248
+K N+ L E + V L DFG A + +D Y W +LE S +++AL
Sbjct: 211 VKTENIFLDEPENAV-LGDFGAACK--LDAHPDTPQCYGWSG------TLETNSPELLAL 261
Query: 249 LKSCWAED 256
C D
Sbjct: 262 DPYCAKTD 269
|
Length = 392 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 29/111 (26%), Positives = 50/111 (45%), Gaps = 18/111 (16%)
Query: 106 KEKFQREVTLLSKMK----HENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLD 161
+E+ +RE +L+K + I+ V +I+ E + GE L+ L RP L
Sbjct: 43 RERTRREARILAKAREAGVPVPIVYDVDP---DNGLIVMEYIEGELLKDALEEARPDLLR 99
Query: 162 LKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
++ R + LH ++H DL SN++L+ ++ DFGL
Sbjct: 100 ---------EVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 38/126 (30%), Positives = 66/126 (52%), Gaps = 9/126 (7%)
Query: 111 REVTLLSKMKHENILKFVGASVQP-TMMIITELMRGETLQRYLWSTR--PKRLDLKHSIS 167
RE+ +L + I+ F GA + I E M G +L + L + P+ + K SI+
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA 111
Query: 168 FALDISRAMEYL-HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTY 226
+ R + YL + ++HRD+KPSN+L+ + ++KL DFG++ + + GT
Sbjct: 112 ----VLRGLAYLREKHQIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMANSFVGTR 166
Query: 227 RWMAPE 232
+M+PE
Sbjct: 167 SYMSPE 172
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 25/71 (35%), Positives = 46/71 (64%), Gaps = 3/71 (4%)
Query: 164 HSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA 223
++ +A +IS + +LH +I+RDLK N++L + + +K+ADFG+ +E ++D +T
Sbjct: 102 QAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML-DSEGHIKIADFGMCKEHMVDGVTTRT 160
Query: 224 --GTYRWMAPE 232
GT ++APE
Sbjct: 161 FCGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 26/67 (38%), Positives = 40/67 (59%), Gaps = 8/67 (11%)
Query: 171 DISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMT-----CEAGT 225
+I A+++LH +I+RD+K N+LL + V L DFGL++E + +E C GT
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFC--GT 169
Query: 226 YRWMAPE 232
+MAPE
Sbjct: 170 IEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 5e-07
Identities = 50/176 (28%), Positives = 86/176 (48%), Gaps = 33/176 (18%)
Query: 68 KMIGEGSYSIVYKGFYGC--EPVAVKVI-QPCNALAVSREHKEKFQREVTLLSKMKHENI 124
K IG G+ IV + VA+K + +P ++ H ++ RE+ L+ + H+NI
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ----NQTHAKRAYRELVLMKCVNHKNI 78
Query: 125 LKFVGA-SVQPTM------MIITELMRGETLQRYLWSTRPKRLDLKHS-ISFAL-DISRA 175
+ + + Q ++ ++ ELM Q +++L H +S+ L +
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQMLCG 131
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAP 231
+++LH+ +IHRDLKPSN+++ D +K+ DFGLAR AGT M P
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLAR---------TAGTSFMMTP 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 27/68 (39%), Positives = 44/68 (64%), Gaps = 4/68 (5%)
Query: 168 FALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA--G 224
+ +I A++YLH+ +V++RDLK NL+L +D +K+ DFGL +E + D T + G
Sbjct: 100 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCG 158
Query: 225 TYRWMAPE 232
T ++APE
Sbjct: 159 TPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 6e-07
Identities = 35/120 (29%), Positives = 59/120 (49%), Gaps = 24/120 (20%)
Query: 111 REVTLLSKMKHENILK----FVGASVQPTMMIITELMRGETLQRYLW-----------ST 155
RE+ LL ++KH N++ F+ + + ++ + + LW +
Sbjct: 47 REIALLRELKHPNVISLQKVFLSHADRKVWLLF------DYAEHDLWHIIKFHRASKANK 100
Query: 156 RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLT---EDKKQVKLADFGLAR 212
+P +L S I + YLHAN V+HRDLKP+N+L+ ++ +VK+AD G AR
Sbjct: 101 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 10/168 (5%)
Query: 70 IGEGSYSIVYKGFYGCEPV--AVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
+G+G+Y VYK + V A+K I+ L + + E+ +L K I+ F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR----LELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 128 VGA-SVQPTMMIITELMRGETLQR-YLWSTRPKRLDLKHSISFALDISRAMEYL-HANSV 184
GA ++ + + E M +L + Y + + + + +++L +++
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
IHRD+KP+N+L+ QVKL DFG++ V G +MAPE
Sbjct: 125 IHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 9e-07
Identities = 19/58 (32%), Positives = 34/58 (58%), Gaps = 2/58 (3%)
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
A+ LH +++IH D+K N+L K ++ L D+GL + ++ +C GT + +PE
Sbjct: 121 ALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTPSCYDGTLDYFSPE 176
|
Length = 267 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 89 AVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI--LKFVGASVQPTMMIITELMRGE 146
A+K I+ A VSR E T+L+++ I LKF S + +++ + GE
Sbjct: 22 ALKTIR--KAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79
Query: 147 TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLA 206
R R DL + + ++ A+E LH +VI+RDLKP N+LL + + + L
Sbjct: 80 LFHHL---QREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL-DYQGHIALC 135
Query: 207 DFGLAREEVMDEMTCEA--GTYRWMAPE 232
DFGL + + D+ GT ++APE
Sbjct: 136 DFGLCKLNMKDDDKTNTFCGTPEYLAPE 163
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 32/150 (21%), Positives = 67/150 (44%), Gaps = 19/150 (12%)
Query: 107 EKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSI 166
F +L+S++ H++++K G V+ +++ E ++ L +L + L +
Sbjct: 46 LAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHR-EKNNVSLHWKL 104
Query: 167 SFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ------VKLADFG-----LAREEV 215
A ++ A+ YL ++H ++ N+L+ +KL+D G L+REE
Sbjct: 105 DVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER 164
Query: 216 MDEMTCEAGTYRWMAPENERPSLENLSEDM 245
++ + W+APE R +L+
Sbjct: 165 VERIP-------WIAPECIRNGQASLTIAA 187
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 39/125 (31%), Positives = 64/125 (51%), Gaps = 7/125 (5%)
Query: 111 REVTLLSKMKHENILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
RE+ +L + I+ F GA + I E M G +L + L ++ IS A
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA 107
Query: 170 LDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE-AGTYR 227
+ R + YL ++HRD+KPSN+L+ ++KL DFG++ +++D M GT
Sbjct: 108 --VLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVS-GQLIDSMANSFVGTRS 163
Query: 228 WMAPE 232
+M+PE
Sbjct: 164 YMSPE 168
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 43/167 (25%), Positives = 84/167 (50%), Gaps = 11/167 (6%)
Query: 70 IGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVG 129
+G G+ +V+K + +P + + + L + + + RE+ +L + I+ F G
Sbjct: 13 LGAGNGGVVFKVSH--KPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 130 ASVQP-TMMIITELMRGETLQRYLWSTR--PKRLDLKHSISFALDISRAMEYL-HANSVI 185
A + I E M G +L + L P+++ K SI+ + + + YL + ++
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA----VIKGLTYLREKHKIM 126
Query: 186 HRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
HRD+KPSN+L+ + ++KL DFG++ + + GT +M+PE
Sbjct: 127 HRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 172
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 43/184 (23%), Positives = 77/184 (41%), Gaps = 8/184 (4%)
Query: 30 PLTKACDADDDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVA 89
L + D D + + +E D DAS+ + + I + +SI+ G E A
Sbjct: 52 CLYEDKHMDIDIFDIFADEDESDADASLAL---CAEARAGIEKAGFSILETFTPGAEGFA 108
Query: 90 VKVI--QPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGET 147
I + C + + + E +L + H +I++ G + L R +T
Sbjct: 109 FACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI-LPRYKT 167
Query: 148 LQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLAD 207
Y + + + + ++ + RA++YLH N +IHRD+K N+ + V L D
Sbjct: 168 -DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINH-PGDVCLGD 225
Query: 208 FGLA 211
FG A
Sbjct: 226 FGAA 229
|
Length = 391 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 4e-06
Identities = 43/136 (31%), Positives = 62/136 (45%), Gaps = 22/136 (16%)
Query: 85 CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF--VGASVQPTMMI---- 138
CE + K ++ + A+ E+ E+ L ++ HENILK + S T MI
Sbjct: 192 CERLIAKRVKAGSRAAIQLEN------EILALGRLNHENILKIEEILRSEANTYMITQKY 245
Query: 139 ---ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLL 195
+ M E W RP LK + + + A+EY+H +IHRD+K N+
Sbjct: 246 DFDLYSFMYDEAFD---WKDRPL---LKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIF 299
Query: 196 LTEDKKQVKLADFGLA 211
L D K V L DFG A
Sbjct: 300 LNCDGKIV-LGDFGTA 314
|
Length = 501 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 24/59 (40%), Positives = 34/59 (57%), Gaps = 4/59 (6%)
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKK-QVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
A++ LH IHRDLKP N L+ D +KL DFGL++ ++ G+ +MAPE
Sbjct: 113 AVDALHELGYIHRDLKPENFLI--DASGHIKLTDFGLSK-GIVTYANSVVGSPDYMAPE 168
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 26/65 (40%), Positives = 39/65 (60%), Gaps = 4/65 (6%)
Query: 171 DISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE---AGTYR 227
+I A+E+LH +I+RD+K N+LL + V L DFGL++E DE+ GT
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 228 WMAPE 232
+MAP+
Sbjct: 172 YMAPD 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 51/184 (27%), Positives = 85/184 (46%), Gaps = 28/184 (15%)
Query: 66 LQKMIGEGSYSIVY-----KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK 120
L K++G G+Y V+ G + A+KV+Q AL + E + E +L ++
Sbjct: 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKA-ALVQKAKTVEHTRTERNVLEHVR 62
Query: 121 HENILKFVGASVQPTM---MIITELMRGETL----QRYLWSTRPKRLDLKHSISFALDIS 173
L + + Q +I+ + GE QR +S R ++ +I
Sbjct: 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF-------YSGEII 115
Query: 174 RAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMT-----CEAGTYRW 228
A+E+LH +++RD+K N+LL + V L DFGL++E + +E C GT +
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKERTYSFC--GTIEY 172
Query: 229 MAPE 232
MAPE
Sbjct: 173 MAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 7e-06
Identities = 26/77 (33%), Positives = 42/77 (54%), Gaps = 8/77 (10%)
Query: 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLL 195
+I+ E + GE L+ + S + L+L + +I R + LH+ +IH DL SN++
Sbjct: 74 FIIVMEYIEGEPLKDLINSNGMEELEL------SREIGRLVGKLHSAGIIHGDLTTSNMI 127
Query: 196 LTEDKKQVKLADFGLAR 212
L+ K + L DFGLA
Sbjct: 128 LSGGK--IYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 19/36 (52%), Positives = 26/36 (72%), Gaps = 1/36 (2%)
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210
A++ +H IHRD+KP NLLL + K +KL+DFGL
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLL-DAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 45/172 (26%), Positives = 84/172 (48%), Gaps = 12/172 (6%)
Query: 70 IGEGSYSIVYKG-FYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFV 128
IG G + V Y VA V++ A A S+E + +F ++ ++H NIL+ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE-QNEFLQQGDPYRILQHPNILQCL 61
Query: 129 GASVQ--PTMMIITELMRGETLQRYLWSTRPKRLDLKHSI--SFALDISRAMEYLHANSV 184
G V+ P +++ G+ L+ YL + R + + + A +I+ + ++H ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGD-LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLA----REEVMDEMTCEAGTYRWMAPE 232
+H DL N LT D VK+ D+G+ +E+ ++ + RW+APE
Sbjct: 121 LHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 7e-05
Identities = 43/189 (22%), Positives = 88/189 (46%), Gaps = 43/189 (22%)
Query: 70 IGEGSYSIVYKGF------YG---CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK 120
+G+G+++ ++KG YG V +KV+ R + E F +++S++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD-----KSHRNYSESFFEAASMMSQLS 57
Query: 121 HENILKFVGASVQPTMMI-ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISR----A 175
H++++ G V I + E ++ +L YL K+ +IS+ L++++ A
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL-----KKNKNLINISWKLEVAKQLAWA 112
Query: 176 MEYLHANSVIHRDLKPSNLLLT--EDKKQ-----VKLADFG-----LAREEVMDEMTCEA 223
+ +L + H ++ N+LL ED+K +KL+D G L +E +++ +
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP--- 169
Query: 224 GTYRWMAPE 232
W+ PE
Sbjct: 170 ----WVPPE 174
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 18/36 (50%), Positives = 24/36 (66%), Gaps = 1/36 (2%)
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210
A+E +H IHRD+KP N+L+ D +KL DFGL
Sbjct: 113 AIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 43/183 (23%)
Query: 104 EHKEKFQR--EVTLLSKMKHENILKFVGA---SVQPTMMIITELMRGETLQRYLWSTRPK 158
+ +EK Q EV ++ ++KH+NI++++ + I+ E L R +
Sbjct: 52 KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM 111
Query: 159 RLDLK-HSISFALDISR----AMEYLH-------ANSVIHRDLKPSNLLLTEDKKQV--- 203
++ H+I +DI+R A+ Y H V+HRDLKP N+ L+ + +
Sbjct: 112 FGKIEEHAI---VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168
Query: 204 -------------KLADFGLAREEVMDEM--TCEAGTYRWMAPE---NERPSLENLSEDM 245
K+ DFGL++ ++ M +C Y W +PE +E S ++ S DM
Sbjct: 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYW-SPELLLHETKSYDDKS-DM 226
Query: 246 VAL 248
AL
Sbjct: 227 WAL 229
|
Length = 1021 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 6/102 (5%)
Query: 112 EVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALD 171
E LL ++ H +L + V + + L YL R + L L + A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYL-GARLRPLGLAQVTAVARQ 268
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLT--EDKKQVKLADFGLA 211
+ A++Y+H +IHRD+K N+L+ ED + L DFG A
Sbjct: 269 LLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAA 307
|
Length = 461 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 22/65 (33%), Positives = 36/65 (55%), Gaps = 4/65 (6%)
Query: 171 DISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM---TCEAGTYR 227
++ A+ +H +HRD+KP N+L+ + +KLADFG A ++M GT
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLI-DRTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168
Query: 228 WMAPE 232
++APE
Sbjct: 169 YIAPE 173
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 20/52 (38%), Positives = 32/52 (61%), Gaps = 9/52 (17%)
Query: 168 FALDISR--------AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211
F+ D++R A+E +H IHRD+KP N+L+ + +KL+DFGL+
Sbjct: 98 FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI-DRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 36/148 (24%), Positives = 62/148 (41%), Gaps = 18/148 (12%)
Query: 70 IGEGSYSIVYKGFYGCEPVAVKVIQP----CNALAVSREHKEKFQREVTLLSKMKHENIL 125
IG+G+ + + KG Y +K P L R E+ + E LLS+ + +
Sbjct: 341 IGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELD-ERLRTERTRAEARLLSEARRAGVP 399
Query: 126 KFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSV 184
V V P I+ E + G+ L + L+ + + + LH +
Sbjct: 400 TPVIYDVDPEEKTIVMEYIGGKDL----------KDVLEGNPELVRKVGEIVAKLHKAGI 449
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+H DL SN ++ +D+ + L DFGL +
Sbjct: 450 VHGDLTTSNFIVRDDR--LYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 14/37 (37%), Positives = 24/37 (64%)
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211
A++ LH+ ++HRD+KP N++ +E K+ D G A
Sbjct: 267 ALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 19/33 (57%), Positives = 24/33 (72%), Gaps = 1/33 (3%)
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211
LH ++HRD+KP NLL+T D QVK+ DFG A
Sbjct: 325 LHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 23/68 (33%), Positives = 40/68 (58%), Gaps = 4/68 (5%)
Query: 168 FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMT-CEA--G 224
+ ++ A++ +H+ IHRD+KP N+LL + +KLADFG + + M C+ G
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLL-DKSGHLKLADFGTCMKMNKEGMVRCDTAVG 205
Query: 225 TYRWMAPE 232
T +++PE
Sbjct: 206 TPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 28/101 (27%), Positives = 48/101 (47%), Gaps = 5/101 (4%)
Query: 102 SREHKEKFQREVTLLSKMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRL 160
+ EH + Q EV L +H NI+ + + +I+ M + L + P+ +
Sbjct: 39 TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGM 98
Query: 161 D--LKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED 199
L +I F R + YLH N IHR++K S++L++ D
Sbjct: 99 SEALIGNILFG--ALRGLNYLHQNGYIHRNIKASHILISGD 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 25/70 (35%), Positives = 43/70 (61%), Gaps = 8/70 (11%)
Query: 168 FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE---MTCEA- 223
+ ++ A++ +H+ +IHRD+KP N+LL + +KLADFG + MDE + C+
Sbjct: 147 YTAEVVLALDAIHSMGLIHRDVKPDNMLL-DKHGHLKLADFGTCMK--MDETGMVRCDTA 203
Query: 224 -GTYRWMAPE 232
GT +++PE
Sbjct: 204 VGTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 20/36 (55%), Positives = 26/36 (72%), Gaps = 1/36 (2%)
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210
A++ +H IHRD+KP NLLL + K VKL+DFGL
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLL-DAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 9e-04
Identities = 20/36 (55%), Positives = 26/36 (72%), Gaps = 1/36 (2%)
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210
A++ +H IHRD+KP NLLL + K VKL+DFGL
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLL-DSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.001
Identities = 20/77 (25%), Positives = 35/77 (45%), Gaps = 11/77 (14%)
Query: 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLL 195
I+ E + G+ L + + +I R + LH ++H DL SN++
Sbjct: 72 KTIVMEYIEGKPL-KDVIEEGN--------DELLREIGRLVGKLHKAGIVHGDLTTSNII 122
Query: 196 LTEDKKQVKLADFGLAR 212
+ +DK + L DFGL +
Sbjct: 123 VRDDK--LYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 152 LWSTRPKRLDLKHSI--SFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209
LWS K L++ +A ++ A++ LH ++ RDL P+N+LL +D+ ++L F
Sbjct: 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL-DDRGHIQLTYFS 130
Query: 210 LAREEVMDEMTCEAGTYRWMAPE 232
EV D EA + APE
Sbjct: 131 RWS-EVEDSCDGEAVENMYCAPE 152
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.001
Identities = 42/150 (28%), Positives = 80/150 (53%), Gaps = 11/150 (7%)
Query: 65 LLQKMIGEGSYSIVYKGFYGCEP----VAVKVIQPCNALAVSREHKEKFQREVTLLSKMK 120
L +IG+ ++ +P VAVK I N + S+E + Q+E+ +++
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKI---NLDSCSKEDLKLLQQEIITSRQLQ 57
Query: 121 HENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFAL-DISRAMEY 178
H NIL +V + + + + +++ LM + + L + P+ L + +I+F L D+ A++Y
Sbjct: 58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-ELAIAFILKDVLNALDY 116
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADF 208
+H+ IHR +K S++LL+ D K V L+
Sbjct: 117 IHSKGFIHRSVKASHILLSGDGK-VVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 19/36 (52%), Positives = 26/36 (72%), Gaps = 3/36 (8%)
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKK-QVKLADFG 209
A++ +H+ IHRD+KP N+LL DK +KLADFG
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 18/36 (50%), Positives = 24/36 (66%), Gaps = 1/36 (2%)
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210
A+E +H IHRD+KP N+L+ D +KL DFGL
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 1/43 (2%)
Query: 168 FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210
+ +++ A+E +H IHRD+KP N+L+ D +KL DFGL
Sbjct: 106 YIAELTLAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 40/176 (22%), Positives = 80/176 (45%), Gaps = 12/176 (6%)
Query: 65 LLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQR-EVTLLSKMKHEN 123
+L ++G + + G +P KV+ + ++ E + + R E+ L+ H
Sbjct: 70 VLTTLVGRNPTTAAFVATRGSDP-KEKVV--AKFVMLNDERQAAYARSELHCLAACDHFG 126
Query: 124 ILK-FVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLK-HSISFAL-DISRAMEYLH 180
I+K F +++I E G L + + + L + + + I A++ +H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV----MDEMTCEAGTYRWMAPE 232
+ ++HRDLK +N+ L +KL DFG +++ +D + GT ++APE
Sbjct: 187 SRKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
|
Length = 478 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.004
Identities = 19/78 (24%), Positives = 29/78 (37%), Gaps = 6/78 (7%)
Query: 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN------SVIHRDLKPSNL 194
L R L R L + + + + A R + L A ++H DL P NL
Sbjct: 118 RLRRRLKLLRQLAAALRRLVAAELLDRLAELWERLLAALLALLPALPLVLVHGDLHPGNL 177
Query: 195 LLTEDKKQVKLADFGLAR 212
L+ + + DF A
Sbjct: 178 LVDPGGRVTGVIDFEDAG 195
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 336 | |||
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.98 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.98 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.98 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.98 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.85 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.54 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.53 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.51 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.5 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.46 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.45 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.23 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.2 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.04 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.98 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.95 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.85 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.8 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.64 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.62 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.56 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.53 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.46 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.4 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.35 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.31 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.3 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.17 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.08 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.07 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.04 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.0 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.95 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.83 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.73 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.65 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.59 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.55 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.55 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.51 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.46 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.42 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.38 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.24 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.24 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.21 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.13 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.82 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.78 | |
| PLN02236 | 344 | choline kinase | 96.67 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.55 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.54 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.3 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.25 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.95 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.85 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.62 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 95.39 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 94.73 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 94.6 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 94.52 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.45 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.45 |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=325.42 Aligned_cols=240 Identities=25% Similarity=0.322 Sum_probs=206.6
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
+...+|.++++||+|+||+||.++.. ++.+|+|++++ .........+....|..+|..++||+||++...|++..
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K--~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKK--KKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK 99 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhh--hHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence 55688999999999999999999875 78999999985 34445567889999999999999999999999999876
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
+|+|+||+.||.|...| .+.+.+++..++.++.+|+.||.|||++|||||||||+|||++.+| +++|+|||+|+...
T Consensus 100 LylVld~~~GGeLf~hL--~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G-Hi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHL--QREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG-HIKLTDFGLCKEDL 176 (357)
T ss_pred EEEEEeccCCccHHHHH--HhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC-cEEEeccccchhcc
Confidence 99999999999999999 5557899999999999999999999999999999999999999987 89999999999654
Q ss_pred cc--cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhccCCCC-CCCCcccc
Q 019780 216 MD--EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRSADTP-IPPKLVEI 291 (336)
Q Consensus 216 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~~~~~-~p~~~~~~ 291 (336)
.. ...+.+||+.|||||.+...+++...|+|+|+..++++..+.+|...+- ....+.+.+.-....+. ++++..++
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardl 256 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDL 256 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHH
Confidence 43 3455789999999999999999999999999999999999999986554 44444444433233343 77778888
Q ss_pred cCCCCCCCCccc
Q 019780 292 VDPKSTMNNDCM 303 (336)
Q Consensus 292 ~~~~~~~~~~~~ 303 (336)
+..++..+|+.|
T Consensus 257 l~~LL~rdp~~R 268 (357)
T KOG0598|consen 257 LKKLLKRDPRQR 268 (357)
T ss_pred HHHHhccCHHHh
Confidence 888888888776
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=324.27 Aligned_cols=199 Identities=29% Similarity=0.433 Sum_probs=176.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
.+|.+.+.||+|+||+||+|+++ +..||||.+... ....+..+.+..|+.+|+.++|||||+++++..+++ +|+
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~---~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKK---KLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhh---ccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 57888888999999999999987 789999999742 226677889999999999999999999999998776 999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-C----CceEEeccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED-K----KQVKLADFGLARE 213 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~-~----~~~kl~Dfg~a~~ 213 (336)
|||||.||+|.+|+++. +.+++.+++.++.||+.||++||+++||||||||+|||++.. + -.+||+|||+|+.
T Consensus 87 VMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999999999544 589999999999999999999999999999999999999864 2 3689999999997
Q ss_pred ccccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH
Q 019780 214 EVMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE 265 (336)
Q Consensus 214 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~ 265 (336)
..... ..+.+|++.|||||.++...++...|+|+++..+|+...++-|.-++
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 66554 45678999999999999999999999999999999988777776443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=326.20 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=196.3
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccH--HHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSR--EHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
...|.+.+.||+|+||.|-+|..+ ++.||||++...+....+. .....+.+|+++|++|+|||||++.++|...+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 467889999999999999999876 8999999998654433222 22344689999999999999999999999876
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC--CCceEEeccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED--KKQVKLADFGLARE 213 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~--~~~~kl~Dfg~a~~ 213 (336)
.|+||||+.||+|.+.+ -..+.+.+...+.+++|++.|+.|||++||+||||||+|||++.+ ...+||+|||+|+.
T Consensus 251 ~YmVlE~v~GGeLfd~v--v~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKV--VANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHH--HhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 79999999999999999 445678888899999999999999999999999999999999765 23799999999997
Q ss_pred cccc-cccccCCcccccCCCCCCCCCCCCH---HHHHHHHHHhhccCCCCCCCHhHHHHH-HHHHHHhhccC-----CCC
Q 019780 214 EVMD-EMTCEAGTYRWMAPENERPSLENLS---EDMVALLKSCWAEDPKVRPEFAEITIT-LTNILQNLRSA-----DTP 283 (336)
Q Consensus 214 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~---~di~~l~~~~l~~~p~~RP~~~~i~~~-l~~~~~~~~~~-----~~~ 283 (336)
.... -+.+.|||+.|.|||.+........ .|+|+|++.++....+..|+..+.... +.+.+..-+-. ...
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~ 408 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR 408 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence 6433 3677899999999998887665544 499999999888888887765554333 33322221111 123
Q ss_pred CCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 284 IPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
++.+...+++.++.++|+.|.+..+..+..|
T Consensus 409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 409 ISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred hhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 5555666677777777777766655554443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=317.61 Aligned_cols=264 Identities=23% Similarity=0.279 Sum_probs=222.2
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
+...+.+.++.||+|..|+||+++|+ ++.+|+|++. ...+....+++.+|+++++..+|||||.+|++|..+.
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~----~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL----LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec----ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 33457777899999999999999997 7889999996 3446677889999999999999999999999998765
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
++|+||||+||+|.+++.. .+++++.....++.+++.||.|||+ ++||||||||+|||++..| .|||||||.++.
T Consensus 152 ~isI~mEYMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~ 228 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGI 228 (364)
T ss_pred eEEeehhhcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHH
Confidence 8999999999999999943 3779999999999999999999995 9999999999999999987 899999999998
Q ss_pred cccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC------HhHHHHHHHHHHHhhccC-CCC-CC
Q 019780 214 EVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE------FAEITITLTNILQNLRSA-DTP-IP 285 (336)
Q Consensus 214 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~------~~~i~~~l~~~~~~~~~~-~~~-~p 285 (336)
...+...+..||..|||||.+.+..++...|+|+|+..+|+...++=|- ...+...+..+....... ... .+
T Consensus 229 lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS 308 (364)
T KOG0581|consen 229 LVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFS 308 (364)
T ss_pred hhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCC
Confidence 7777667889999999999999999999999999999999876665543 346777777776643322 222 66
Q ss_pred CCcccccCCCCCCCCccccchhhhcccccccccc--cccchhhhhh
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAITKFNEKGKKR--RSYLPSFLKR 329 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 329 (336)
+++...++..+..+|..|++.+++.....-++.. ..-++.|+..
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd~~~~~~~ 354 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVDMASFVRK 354 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccccHHHHHHH
Confidence 6789999999999999999999999877555544 3335555543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=333.47 Aligned_cols=249 Identities=25% Similarity=0.311 Sum_probs=220.3
Q ss_pred CceeEeeeecCCCcEEEEEeEE--CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
..|..++.||+|||+.||.+++ .++.||+|++.+ .........+.+.+|+++.+.|+|||||+++++|+|.+ +|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk--~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPK--KLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeeh--HHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 6799999999999999999998 389999999984 34446677889999999999999999999999999876 999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
|.|+|..++|..+++ ..+.++|.+++.+++||+.||.|||+++|+|||||..|+|++++. +|||+|||+|......
T Consensus 96 vLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 96 VLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-NVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-cEEecccceeeeecCcc
Confidence 999999999999995 457899999999999999999999999999999999999999887 7999999999865533
Q ss_pred -cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCC
Q 019780 218 -EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~ 295 (336)
...+.||||.|+|||++.....++..|+|++++.++.+.-++.|+-.. +-..+..+...--..+..++.++..++..+
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKL 252 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHH
Confidence 456789999999999999999999999999999999999999998444 556666666665556678888999999999
Q ss_pred CCCCCccccchhhhcccccc
Q 019780 296 STMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~ 315 (336)
+..+|..|+++.++....-.
T Consensus 253 L~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 253 LRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred hcCCcccCCCHHHHhcCHhh
Confidence 99999999999998875433
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=316.28 Aligned_cols=223 Identities=42% Similarity=0.731 Sum_probs=191.0
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEECCcc-EEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEP-VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
...+.++.....+.+.||+|+||+||+|.++++. ||||++.... ......+.|.+|+.+|.+++|||||+++|++.
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~---~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPD---FDDESRKAFRREASLLSRLRHPNIVQFYGACT 109 (362)
T ss_pred ccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchh---cChHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3466777788888888999999999999999888 9999998432 22233789999999999999999999999999
Q ss_pred cCC--EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccccCCCCceeecCCCCceEEeccc
Q 019780 133 QPT--MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS-VIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 133 ~~~--~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
++. .++||||+++|+|.++++......+++..++.++.||+.||.|||+++ ||||||||+|||++.+..++||+|||
T Consensus 110 ~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 110 SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCc
Confidence 875 899999999999999997655678999999999999999999999999 99999999999999875489999999
Q ss_pred ccccccc--ccccccCCcccccCCCCCC--CCC----------------------------------------------C
Q 019780 210 LAREEVM--DEMTCEAGTYRWMAPENER--PSL----------------------------------------------E 239 (336)
Q Consensus 210 ~a~~~~~--~~~~~~~gt~~y~aPE~~~--~~~----------------------------------------------~ 239 (336)
+++.... ...+...||..|||||.++ ..+ .
T Consensus 190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~ 269 (362)
T KOG0192|consen 190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK 269 (362)
T ss_pred cceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence 9986554 3445568999999999554 222 2
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
.++..+.+|+..||..+|..||+|.+++..++.+......
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 3566677799999999999999999999999988776554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=322.67 Aligned_cols=250 Identities=24% Similarity=0.278 Sum_probs=218.6
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQP 134 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 134 (336)
....++|.+++.||.|+|++|++|+.. ++.||||++. +.....+...+.+.+|-.+|.+| .||.|++++..|+|.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~--K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLD--KRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhh--HHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 345679999999999999999999986 8899999997 34555666678889999999999 699999999999987
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. +|+|+||+++|+|.++|+ +.+.+++..++.++.||+.||+|||++|||||||||+|||++.++ +++|+|||.|+.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm-hikITDFGsAK~ 223 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG-HIKITDFGSAKI 223 (604)
T ss_pred cceEEEEEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC-cEEEeecccccc
Confidence 6 999999999999999994 447899999999999999999999999999999999999999998 899999999984
Q ss_pred ccccc---------------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC-HhHHHHHHHHHHHhh
Q 019780 214 EVMDE---------------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE-FAEITITLTNILQNL 277 (336)
Q Consensus 214 ~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~-~~~i~~~l~~~~~~~ 277 (336)
..... ..+++||..|.+||.+...+.+...|||+|+|.++++..+..|. ...=...++.+...-
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 32111 14467999999999999999999999999999999999999997 333344567777776
Q ss_pred ccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 278 RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 278 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
-...+..|+.+.++++.++..+|..|-+..+|..+
T Consensus 304 y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 304 YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 77778889999999999999999999999888763
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=297.18 Aligned_cols=239 Identities=23% Similarity=0.282 Sum_probs=204.6
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
....+|++++.||.|+||.|.+++.+ +..+|+|++.. ......+..+...+|.++|+.+.||+++++++.+.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k--~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDK--QKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCH--HHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 45578999999999999999999986 78999999984 34456677888999999999999999999999999876
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
+|+||||++||.|..+++ +.+++++..++.++.||+.||+|||+++|++|||||+|||+|.+| ++||+|||+|+...
T Consensus 119 lymvmeyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G-~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG-HIKITDFGFAKRVS 195 (355)
T ss_pred EEEEEeccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC-cEEEEeccceEEec
Confidence 999999999999999994 447899999999999999999999999999999999999999988 89999999999865
Q ss_pred cccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCC
Q 019780 216 MDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDP 294 (336)
Q Consensus 216 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~ 294 (336)
.. ..+.|||+.|+|||.+...+++.+.|+|+|+...+++..+..|.+.. -.+..+++...-...+.-.++.+..++..
T Consensus 196 ~r-T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GR-TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred Cc-EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 44 56689999999999999999999999999999999999999998543 34455555555445556666677777766
Q ss_pred CCCCCCccc
Q 019780 295 KSTMNNDCM 303 (336)
Q Consensus 295 ~~~~~~~~~ 303 (336)
++.++-..|
T Consensus 275 LL~vD~t~R 283 (355)
T KOG0616|consen 275 LLQVDLTKR 283 (355)
T ss_pred HHhhhhHhh
Confidence 665554333
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=313.55 Aligned_cols=216 Identities=34% Similarity=0.592 Sum_probs=192.4
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEECCc-cEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCE-PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
...|.++.+.+.+++.||+|.||.||.|.+++. .||+|.++.... ..+.|.+|+.+|++|+|++||++++++.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m------~~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM------SPEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc------ChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 558899999999999999999999999999865 999999985322 2466889999999999999999999999
Q ss_pred cCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 133 QPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 133 ~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
.+. +|||||||+.|+|.+||+...+..+...+.+.++.|||+|++||+++++|||||.++|||++++. .+||+|||+|
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~-~vKIsDFGLA 350 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL-VVKISDFGLA 350 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc-eEEEcccccc
Confidence 866 99999999999999999876778899999999999999999999999999999999999999887 8999999999
Q ss_pred cccccccccccCC---cccccCCC----------------------------------------------CCCCCCCCCH
Q 019780 212 REEVMDEMTCEAG---TYRWMAPE----------------------------------------------NERPSLENLS 242 (336)
Q Consensus 212 ~~~~~~~~~~~~g---t~~y~aPE----------------------------------------------~~~~~~~~~~ 242 (336)
+....+..+...| ...|.||| ..++.|..+|
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP 430 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCP 430 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCC
Confidence 9655555444433 48999999 4568899999
Q ss_pred HHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 243 EDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 243 ~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
..++.+|..||+.+|.+||||..+...++++...
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 9999999999999999999999998888877643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=299.49 Aligned_cols=240 Identities=25% Similarity=0.352 Sum_probs=200.8
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee-Eec-CC-
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA-SVQ-PT- 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~-~~~-~~- 135 (336)
..+|++++.||.|+||+||++... +..+|.|.++.. ..+.+..+....|+.+|++|+|||||+++++ +.+ +.
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~---~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG---MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh---hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 467999999999999999999875 889999999743 3356778889999999999999999999984 333 33
Q ss_pred EEEEEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--cccccCCCCceeecCCCCceEEeccc
Q 019780 136 MMIITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLHA--NS--VIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~--ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
++||||+|.+|+|.+.++. .....+++..+|.++.|+|.||.++|+ .. |+||||||.||+++.+| .+||+|||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfG 173 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFG 173 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccch
Confidence 8999999999999999953 345679999999999999999999999 45 99999999999999887 89999999
Q ss_pred ccccccccc--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCCCCCC--
Q 019780 210 LAREEVMDE--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIP-- 285 (336)
Q Consensus 210 ~a~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~p-- 285 (336)
+++...... ..+.+|||.||+||.+...+++..+|+|+|+|.++++..-+.|...+-+..|..-+.+-. .+++|
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd--~~~~p~~ 251 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD--YPPLPDE 251 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC--CCCCcHH
Confidence 999755443 345679999999999999999999999999999999999999987775555554443321 13355
Q ss_pred ---CCcccccCCCCCCCCccccch
Q 019780 286 ---PKLVEIVDPKSTMNNDCMATV 306 (336)
Q Consensus 286 ---~~~~~~~~~~~~~~~~~~~~~ 306 (336)
..+.+++.....++++.++++
T Consensus 252 ~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 252 HYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HhhhHHHHHHHHHccCCcccCCCc
Confidence 557778888888888888863
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=301.46 Aligned_cols=257 Identities=22% Similarity=0.289 Sum_probs=210.9
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 135 (336)
.....|.+++.||+|+||+|+.|.+. +..||+|++.............+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 44578999999999999999999885 799999977642111111234566779999999999 999999999998765
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
+++||||+.||+|.+++.+ .+++.+..++.+++|+++|++|||++||+||||||+|||++.+.+++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 9999999999999999954 5789999999999999999999999999999999999999988338999999999866
Q ss_pred --ccccccccCCcccccCCCCCCCCC-C-CCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCC-CCCc
Q 019780 215 --VMDEMTCEAGTYRWMAPENERPSL-E-NLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPI-PPKL 288 (336)
Q Consensus 215 --~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~-p~~~ 288 (336)
......+.+||+.|+|||.+.... + +...|+|+++..++.+..+.-|.-.+ +......+...-.....-+ ++++
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~ 251 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEA 251 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHH
Confidence 234567788999999999988766 5 58899999999999999999997543 3333333333333333344 7777
Q ss_pred ccccCCCCCCCCccccchhhhcccccccc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
..++..++..+|..|.++.++....+..+
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 88999999999999999999997777765
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=273.70 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=215.4
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
..++|.+++.||+|.||.||.|+.+ +-.||+|++.+ ...........+.+|+++-+.|+||||+++|++|.+.. +
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfK--sqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFK--SQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeH--HHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 3468999999999999999999986 66899999984 23334455678999999999999999999999999886 9
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
|+++||.++|.|...|+......+++..+..++.|++.||.|+|.+++|||||||+|+|++..+ .+||+|||-+.....
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPS 176 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC-CeeccCCCceeecCC
Confidence 9999999999999999877888899999999999999999999999999999999999999887 799999999988777
Q ss_pred ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhc-cCCCCCCCCcccccCCC
Q 019780 217 DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR-SADTPIPPKLVEIVDPK 295 (336)
Q Consensus 217 ~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~-~~~~~~p~~~~~~~~~~ 295 (336)
+...+.|||..|.+||...+...+...|+|+++..|++..-+..|+-.+.....-+-+.+.. .....++.+..+++..+
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~l 256 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRL 256 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHH
Confidence 77888999999999999999999999999999999999999999987776444333333322 23356777788888888
Q ss_pred CCCCCccccchhhhcccc
Q 019780 296 STMNNDCMATVHAITKFN 313 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~ 313 (336)
+..+|..+..+.++....
T Consensus 257 l~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 257 LVKNPIERLALTEVMDHP 274 (281)
T ss_pred hccCccccccHHHHhhhH
Confidence 888888887776665543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=287.85 Aligned_cols=246 Identities=24% Similarity=0.315 Sum_probs=196.2
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe-cC--C
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV-QP--T 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~--~ 135 (336)
..++..++.||+|+||+||++.+. +...|||.+...+ ....+.+.+|+.+|++++|||||++++... .. .
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~-----~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED-----SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc-----chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 356777899999999999999986 6899999987431 111677999999999999999999999633 33 4
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
+++.|||++||+|.+++.+..+ .+++..++.+.+||+.||+|||++|||||||||+|||++..++.+||+|||+++...
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 8999999999999999976655 899999999999999999999999999999999999999843389999999998654
Q ss_pred c-----ccccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh-----hccCCCCC
Q 019780 216 M-----DEMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN-----LRSADTPI 284 (336)
Q Consensus 216 ~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~-----~~~~~~~~ 284 (336)
. .......||+.|||||...+. ....+.|+|+|+|..+++-++.+|-... ......+... .......+
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~~~P~ip~~l 248 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGREDSLPEIPDSL 248 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccCCCCCCCccc
Confidence 2 223346799999999999852 3335899999999999999999885432 2222222222 22333456
Q ss_pred CCCcccccCCCCCCCCccccchhhhcccc
Q 019780 285 PPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
++++.+.+......+|..|.|..++....
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 66677788888999999999888887644
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=294.18 Aligned_cols=240 Identities=20% Similarity=0.266 Sum_probs=195.8
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
.+..++|.+++.||+|+||.||+|+-+ |..+|+|++++.. -......+.++.|-.+|...++|+||+++..|++..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~--M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSE--MLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHH--HHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 567789999999999999999999875 8999999999533 335567888999999999999999999999999876
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
+||||||++||++..+| .+...|++..++.++.+++.|+.-+|+.|+|||||||+|+|||..| ++||+||||+.-.
T Consensus 215 ~LYLiMEylPGGD~mTLL--~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-HiKLSDFGLs~gl 291 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLL--MRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG-HIKLSDFGLSTGL 291 (550)
T ss_pred eeEEEEEecCCccHHHHH--HhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC-CEeeccccccchh
Confidence 99999999999999999 4457899999999999999999999999999999999999999987 9999999998510
Q ss_pred c----------------------cccc---------------------------cccCCcccccCCCCCCCCCCCCHHHH
Q 019780 215 V----------------------MDEM---------------------------TCEAGTYRWMAPENERPSLENLSEDM 245 (336)
Q Consensus 215 ~----------------------~~~~---------------------------~~~~gt~~y~aPE~~~~~~~~~~~di 245 (336)
. ..+. ...+|||.|+|||++.+..++...|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 0 0000 12359999999999999999999999
Q ss_pred HHHHHHhhccCCCCCCCHhHHHH-HHHHHH---Hhhcc-CCCCCCCCcccccCCCCCCCCccc
Q 019780 246 VALLKSCWAEDPKVRPEFAEITI-TLTNIL---QNLRS-ADTPIPPKLVEIVDPKSTMNNDCM 303 (336)
Q Consensus 246 ~~l~~~~l~~~p~~RP~~~~i~~-~l~~~~---~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~ 303 (336)
|+|++.|++..-+-+|+..+-.. ....+. ..+.- ...++++++.+++.++.. +++.|
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHh
Confidence 99999999999999998554322 222222 22222 224566677777766665 55554
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=299.68 Aligned_cols=198 Identities=31% Similarity=0.455 Sum_probs=177.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||+|+-+ .+.||+|.+.+ ....++..+.+.+|+++++.++||||+.++++|.... +|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K---~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDK---SGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehh---cCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence 46778899999999999999876 67899999974 3345667888999999999999999999999998765 999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|+||+.| +|..++ ...+.++++.+..++.++++||.|||+.+|+|||+||.|||++.++ ++|+||||+|+......
T Consensus 79 Vte~a~g-~L~~il--~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 79 VTEYAVG-DLFTIL--EQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG-TLKLCDFGLARAMSTNT 154 (808)
T ss_pred Eehhhhh-hHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC-ceeechhhhhhhcccCc
Confidence 9999987 999999 5567899999999999999999999999999999999999999877 89999999999654332
Q ss_pred --ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH
Q 019780 219 --MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI 266 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i 266 (336)
.+...||+.|||||...+.+++...|+|+|+|.+++.-.++.|+++.-
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s 204 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS 204 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH
Confidence 344569999999999999999999999999999999999999996653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=299.23 Aligned_cols=241 Identities=20% Similarity=0.250 Sum_probs=202.4
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEec
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQ 133 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 133 (336)
..+...+|.++++||+|+||+|+++..+ ++.+|||++++ ......+..+....|.+++...+ ||++++++.+|++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK--~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT 440 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKK--GDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT 440 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeec--cceeccccHHHHHHHHHHHHHhccCCeEeeccccccc
Confidence 3567789999999999999999999986 78999999995 44556677888999999998886 9999999999998
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
.. +|+||||+.||++.... ....+++..++.++.+|+.||.|||++||||||||.+|||+|.+| ++||+|||+++
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG-h~kiADFGlcK 516 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG-HVKIADFGLCK 516 (694)
T ss_pred CCeEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC-cEEeccccccc
Confidence 76 99999999999944433 346799999999999999999999999999999999999999998 89999999999
Q ss_pred ccc--cccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcc
Q 019780 213 EEV--MDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLV 289 (336)
Q Consensus 213 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~ 289 (336)
... ....++.|||+.|||||.+.+..++.+.|+|+|+..++++..++-|.-.+ =-+.++.++..-...+.-++.+..
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~ 596 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAI 596 (694)
T ss_pred ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHH
Confidence 754 23466789999999999999999999999999999999999999998533 222333343332223344666777
Q ss_pred cccCCCCCCCCccc
Q 019780 290 EIVDPKSTMNNDCM 303 (336)
Q Consensus 290 ~~~~~~~~~~~~~~ 303 (336)
.+++..++.+|+.|
T Consensus 597 ~il~~ll~k~p~kR 610 (694)
T KOG0694|consen 597 AIMRRLLRKNPEKR 610 (694)
T ss_pred HHHHHHhccCcccc
Confidence 78888888888666
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=302.01 Aligned_cols=249 Identities=23% Similarity=0.283 Sum_probs=216.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
.-|.+++.||.|+-|.|-+|++. |+.+|||++... ..........+.+|+-+|+.+.||||+++|+++.+.. +|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~--~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKR--SELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccc--cccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 35788999999999999999986 999999999843 2334445677899999999999999999999999875 999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|+||++||-|++++ ...+++++.+++.++.||+.|+.|+|..+|+||||||+|+|++..+ ++||+|||+|.....+.
T Consensus 90 vlEyv~gGELFdyl--v~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~-nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 90 VLEYVPGGELFDYL--VRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN-NIKIADFGMASLEVPGK 166 (786)
T ss_pred EEEecCCchhHHHH--HhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc-CEeeeccceeecccCCc
Confidence 99999999999999 4447899999999999999999999999999999999999999887 59999999998755543
Q ss_pred -ccccCCcccccCCCCCCCCCC-CCHHHHHHHHHHhhccCCCCCCCHhHHHH-HHHHHHHhhccCCCCCCCCcccccCCC
Q 019780 219 -MTCEAGTYRWMAPENERPSLE-NLSEDMVALLKSCWAEDPKVRPEFAEITI-TLTNILQNLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 219 -~~~~~gt~~y~aPE~~~~~~~-~~~~di~~l~~~~l~~~p~~RP~~~~i~~-~l~~~~~~~~~~~~~~p~~~~~~~~~~ 295 (336)
..+.||++.|.|||..++.++ +.+.|+|+.+..++++..++-|+-++-++ .|.+..+..-.....+|++.+.++..+
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRM 246 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHH
Confidence 567789999999999999886 48999999999999999999998655444 444555555556688999999999999
Q ss_pred CCCCCccccchhhhcccccc
Q 019780 296 STMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~ 315 (336)
+.++|+.|-|+.+|.+...-
T Consensus 247 l~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 247 LDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred hccCccccccHHHHhhCchh
Confidence 99999999999999886543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=287.35 Aligned_cols=246 Identities=21% Similarity=0.285 Sum_probs=210.1
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.++|.+.+.||+|.||.|-+|+.. ++.||||.+++ ....+++..-.+.+|+++|+.|+||||+.++++|...+ +.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrK--dkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRK--DKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhh--hhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 457999999999999999999874 89999999984 44556777888999999999999999999999999776 99
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
|||||..+|.|++|+ ...+.+++.+++.+++||++|+.|+|.++++|||||.+|||+|.++ ++||+|||++......
T Consensus 130 ivMEYaS~GeLYDYi--Ser~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~-NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYI--SERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN-NIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEecCCccHHHHH--HHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC-Ceeeeccchhhhhccc
Confidence 999999999999999 4446799999999999999999999999999999999999999987 7999999999765444
Q ss_pred c-ccccCCcccccCCCCCCCCCCCCH-HHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCCCCCCCCcccccCCC
Q 019780 218 E-MTCEAGTYRWMAPENERPSLENLS-EDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 218 ~-~~~~~gt~~y~aPE~~~~~~~~~~-~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~ 295 (336)
. ..++||++.|.+||...+.|+.-| .|-|+|+..++.+..+--|+-.-=-..|-..+.+-....+..|....-++.-+
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwm 286 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWM 286 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHH
Confidence 3 577899999999999999888654 69999999999998888886332222333333344445677788888889999
Q ss_pred CCCCCccccchhhhcc
Q 019780 296 STMNNDCMATVHAITK 311 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~ 311 (336)
+-+||+.++|+.++..
T Consensus 287 LmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 287 LMVNPERRATIEDIAS 302 (668)
T ss_pred HhcCcccchhHHHHhh
Confidence 9999999999998874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=274.78 Aligned_cols=165 Identities=28% Similarity=0.391 Sum_probs=142.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
+.|..+..+|+|+||.||+++++ |+.||||.+.. ...++...+-.+||+++|++++|+|+|.++++|.... +++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~E---sedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVE---SEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeecc---CCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence 35777788999999999999986 89999999973 3445666777899999999999999999999998765 999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc-cc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV-MD 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~-~~ 217 (336)
|+|||+. ++.+.|. .....++...+..+++|++.|+.|+|++++|||||||+|||++.++ .+||||||+|+... +.
T Consensus 79 VFE~~dh-TvL~eLe-~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 79 VFEYCDH-TVLHELE-RYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-VVKLCDFGFARTLSAPG 155 (396)
T ss_pred Eeeecch-HHHHHHH-hccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-cEEeccchhhHhhcCCc
Confidence 9999987 5555553 3446689999999999999999999999999999999999999987 89999999999755 33
Q ss_pred -cccccCCcccccCCC
Q 019780 218 -EMTCEAGTYRWMAPE 232 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE 232 (336)
.++..+-|.+|+|||
T Consensus 156 d~YTDYVATRWYRaPE 171 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPE 171 (396)
T ss_pred chhhhhhhhhhccChh
Confidence 355567899999999
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=281.09 Aligned_cols=256 Identities=24% Similarity=0.318 Sum_probs=201.5
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCcccc---------ccHHHHHHHHHHHHHHHhCCCCceEee
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALA---------VSREHKEKFQREVTLLSKMKHENILKF 127 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~---------~~~~~~~~~~~E~~~l~~l~hpnIv~~ 127 (336)
...++|.+++.||+|.||.|-+|++. ++.||||++.+..... ......+.+.+|+.+|+++.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 44578999999999999999999986 8899999997421110 011124689999999999999999999
Q ss_pred EeeEecC---CEEEEEEccCCCCHHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCce
Q 019780 128 VGASVQP---TMMIITELMRGETLQRYLWSTRPKR-LDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQV 203 (336)
Q Consensus 128 ~~~~~~~---~~~lv~e~~~gg~L~~~l~~~~~~~-l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~ 203 (336)
+++.-+. .+|+|+|||..|.+... ...+. +++.+++.++++++.||+|||.+|||||||||+|+|++.+| ++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g-~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG-TV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC-cE
Confidence 9998765 39999999998876643 33444 89999999999999999999999999999999999999987 89
Q ss_pred EEeccccccccc-------cccccccCCcccccCCCCCCC----CCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHH
Q 019780 204 KLADFGLAREEV-------MDEMTCEAGTYRWMAPENERP----SLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLT 271 (336)
Q Consensus 204 kl~Dfg~a~~~~-------~~~~~~~~gt~~y~aPE~~~~----~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~ 271 (336)
||+|||.+.... ........||+.|+|||.... ...+...|+|+|+..++.+.-++-|++.+.. +..+
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 999999987431 112334579999999996554 3456788999999999999999999987754 3444
Q ss_pred HHHHhhccCC--CCCCCCcccccCCCCCCCCccccchhhhccccccccc
Q 019780 272 NILQNLRSAD--TPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGKK 318 (336)
Q Consensus 272 ~~~~~~~~~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (336)
+++.....+. +.+.+.+.+++..++..+|+.|.++.+++...+..+.
T Consensus 330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 4444433332 2245567778888888899999999998876655443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=286.96 Aligned_cols=211 Identities=24% Similarity=0.236 Sum_probs=175.0
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP--- 134 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--- 134 (336)
....|..++.||+|.||.||+|++. ++.||+|.++..+ ..........||+.+|++|+||||+++.+...+.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~---~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN---EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc---CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 3457888899999999999999986 7889999998533 2445567789999999999999999999998865
Q ss_pred CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 135 TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 135 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.+|+|+|||+. +|.-++. ..+-.+++.++.-++.|++.||+|||++||+|||||.+|||||.+| .+||+|||+|+..
T Consensus 192 siYlVFeYMdh-DL~GLl~-~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G-~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLS-SPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG-VLKIADFGLARFY 268 (560)
T ss_pred eEEEEEecccc-hhhhhhc-CCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC-CEEeccccceeec
Confidence 49999999987 8988883 3456899999999999999999999999999999999999999887 8999999999964
Q ss_pred cccc---ccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCC-HhHHHHHHHHHHHh
Q 019780 215 VMDE---MTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPE-FAEITITLTNILQN 276 (336)
Q Consensus 215 ~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~-~~~i~~~l~~~~~~ 276 (336)
.... ++..+-|..|+|||.+.+. .++...|+|+++|.+.++-.++.+. -..=+++|..+.+.
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl 335 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL 335 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH
Confidence 4433 6667789999999987764 5789999999999999887776542 11223345555544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=288.25 Aligned_cols=202 Identities=27% Similarity=0.345 Sum_probs=169.8
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC--
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT-- 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-- 135 (336)
..+|.+.+.||.|.||.||+|... +..||||.++.. ... -+.-.-+||+..|++|+ ||||+++.+++.+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~K---f~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKK---FYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhh---hcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 467899999999999999999876 788999999731 111 12334579999999999 999999999998765
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
+|+|||||+. +|+++++.+ +..+++..++.|+.||+.||+|+|.+|+.|||+||+|||+.... .+||+|||+|+...
T Consensus 85 L~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~-~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND-VIKIADFGLAREVR 161 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc-eeEecccccccccc
Confidence 8999999975 999999665 78899999999999999999999999999999999999999654 89999999999765
Q ss_pred ccc-ccccCCcccccCCCCCC-----------------------------------------------------------
Q 019780 216 MDE-MTCEAGTYRWMAPENER----------------------------------------------------------- 235 (336)
Q Consensus 216 ~~~-~~~~~gt~~y~aPE~~~----------------------------------------------------------- 235 (336)
... ++..+.|..|+|||.+.
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 544 55567999999999110
Q ss_pred ----------------CCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 019780 236 ----------------PSLENLSEDMVALLKSCWAEDPKVRPEFAEITIT 269 (336)
Q Consensus 236 ----------------~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~ 269 (336)
....+.+.+..+|+..|+..||.+||++.+.++.
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0113466778889999999999999999998763
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=286.23 Aligned_cols=216 Identities=38% Similarity=0.638 Sum_probs=186.5
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..|.+..+.+.++..||+|.||+||+|+|.| .||||+++. .....+..+.|+.|+.++++-+|.||+-++|++..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv---~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNV---DDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEec---CCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 5788888999999999999999999999976 599999973 444566889999999999999999999999999999
Q ss_pred CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 135 TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 135 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.+.||+-+|.|-+|+.+++... .++...+.+.|++||+.|+.|||.++|||||||..||++.+++ .|||+|||++..-
T Consensus 461 ~~AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~-kVkIgDFGLatvk 538 (678)
T KOG0193|consen 461 PLAIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL-KVKIGDFGLATVK 538 (678)
T ss_pred ceeeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC-cEEEecccceeee
Confidence 9999999999999999997554 6799999999999999999999999999999999999999876 8999999998632
Q ss_pred ----ccccccccCCcccccCCCCCC------------------------------------------------CC----C
Q 019780 215 ----VMDEMTCEAGTYRWMAPENER------------------------------------------------PS----L 238 (336)
Q Consensus 215 ----~~~~~~~~~gt~~y~aPE~~~------------------------------------------------~~----~ 238 (336)
.........|...|||||.++ +. .
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR 618 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence 122233445889999999221 11 1
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
.+++.++..|+..||..++.+||.|.+|+..|+.+...
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 34677889999999999999999999999988877654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=274.79 Aligned_cols=208 Identities=27% Similarity=0.443 Sum_probs=175.2
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
.|..+.+.|.+...||.|.-++||+|+.. ++.||||++... ......+.+.+|+..|+.++||||++++..|..
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE----kc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE----KCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh----hhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 56677889999999999999999999986 899999999742 223347889999999999999999999998886
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
+. +|+||.||.+|++.++++..-...+++..+..|+++++.||.|||.+|.||||||+.||||+.+| .|||+|||.+.
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG-~VkLadFgvsa 174 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG-TVKLADFGVSA 174 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC-cEEEcCceeee
Confidence 55 99999999999999999888778899999999999999999999999999999999999999998 89999999876
Q ss_pred cccccc------ccccCCcccccCCCCCCCC--CCCCHHH----------------------------------------
Q 019780 213 EEVMDE------MTCEAGTYRWMAPENERPS--LENLSED---------------------------------------- 244 (336)
Q Consensus 213 ~~~~~~------~~~~~gt~~y~aPE~~~~~--~~~~~~d---------------------------------------- 244 (336)
...... ..+..||+.|||||..+.. .+++..|
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT 254 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence 432221 1445799999999953222 2233333
Q ss_pred --------------HHHHHHHhhccCCCCCCCHhHHHH
Q 019780 245 --------------MVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 245 --------------i~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++..|++.+|.+||++.++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 445778899999999999998764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=281.19 Aligned_cols=223 Identities=30% Similarity=0.574 Sum_probs=188.3
Q ss_pred cCCceeecCCceeEeeeecCCCcEEEEEeEEC---C---ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEe
Q 019780 53 IDASVLVDHRSVLLQKMIGEGSYSIVYKGFYG---C---EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILK 126 (336)
Q Consensus 53 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~---~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 126 (336)
..+.|.+..++..+.+.||+|+||.||+|... + ..||||..+. ...........+.+|+++|++++|||||+
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~--~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG--SSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecc--cccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 45689999999999999999999999999875 1 2389999873 22345778899999999999999999999
Q ss_pred eEeeEecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEE
Q 019780 127 FVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKL 205 (336)
Q Consensus 127 ~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl 205 (336)
+||+..+.. +++|||+|.||+|.++|+... ..++..+...++.+.+.||+|||++++|||||.++|+|++.++ .+||
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~-~vKI 303 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG-VVKI 303 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC-eEEe
Confidence 999988765 999999999999999996544 3699999999999999999999999999999999999999876 6899
Q ss_pred ecccccccccccccc--ccCCcccccCCC-----------------------------------------------CCCC
Q 019780 206 ADFGLAREEVMDEMT--CEAGTYRWMAPE-----------------------------------------------NERP 236 (336)
Q Consensus 206 ~Dfg~a~~~~~~~~~--~~~gt~~y~aPE-----------------------------------------------~~~~ 236 (336)
+|||+++........ ..--...|+||| ...+
T Consensus 304 SDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 304 SDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP 383 (474)
T ss_pred CccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC
Confidence 999999864321111 112458999999 2234
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
.+...|.++..++..||..+|..||+|.++.+.++.+......
T Consensus 384 ~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 384 IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 4556788888999999999999999999999999988876554
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=272.43 Aligned_cols=261 Identities=25% Similarity=0.309 Sum_probs=202.0
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
...|.+-+.||+|.|+.|+++.+. |+.+|+|++...+. .....+.+.+|+++-+.|+||||+++.+...... .|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~---~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhh---ccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 456888899999999999998876 88999999874332 3336778999999999999999999999887666 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC--CCCceEEeccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE--DKKQVKLADFGLAREEV 215 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~--~~~~~kl~Dfg~a~~~~ 215 (336)
+|+|+|.|++|..-+-.+ ..+++..+..+++||+.||.|+|.+||||||+||+|+++-. .+.-+||+|||+|....
T Consensus 87 lvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999998877322 56789999999999999999999999999999999999943 33469999999999766
Q ss_pred ccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCC----CCCCCCcc
Q 019780 216 MDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSAD----TPIPPKLV 289 (336)
Q Consensus 216 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~----~~~p~~~~ 289 (336)
... .....|||.|||||..+..+++.|.|+|+.+..++-+..+..|.+.+ --+..+.+.+.-.+.+ +.++|+..
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 332 34567999999999999999999999999999888888887787663 2222333333222222 23444444
Q ss_pred cccCCCCCCCCcccc-------------------------chhhhcccccccccccccchhh
Q 019780 290 EIVDPKSTMNNDCMA-------------------------TVHAITKFNEKGKKRRSYLPSF 326 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~ 326 (336)
+++.++++.+|..+. ++.++.+||+++|.++..+..+
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav 306 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTV 306 (355)
T ss_pred HHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHH
Confidence 444445544444332 6777778999998887776543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=283.76 Aligned_cols=247 Identities=20% Similarity=0.236 Sum_probs=196.3
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
...+|.+.+.||+|+||.||+|.+. ++.||+|+++.. ..........+.+|+.+++.++||||+++++++.+++ .
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR--EILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--HHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 4478999999999999999999986 788999999732 1122334567899999999999999999999988765 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||+.||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 94 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG-HVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC-CEEEeeccCceEcCC
Confidence 999999999999999954 35689999999999999999999999999999999999999887 799999999986433
Q ss_pred ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhccCCCCCCCCcccccCCC
Q 019780 217 DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 217 ~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~~~~~~p~~~~~~~~~~ 295 (336)
......||+.|+|||.......+...|+|+|++.++++..+..|....- ......+..........+++.+.+++...
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~ 249 (329)
T PTZ00263 171 -RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL 249 (329)
T ss_pred -CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHH
Confidence 2234569999999999988888999999999999999999988864432 12222222222222233555677788888
Q ss_pred CCCCCccccc-----hhhhccc
Q 019780 296 STMNNDCMAT-----VHAITKF 312 (336)
Q Consensus 296 ~~~~~~~~~~-----~~~~~~~ 312 (336)
+..+|..|.+ +.++...
T Consensus 250 L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 250 LQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred hhcCHHHcCCCCCCCHHHHhcC
Confidence 8888877754 4555543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=278.76 Aligned_cols=245 Identities=21% Similarity=0.267 Sum_probs=196.1
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||+|.+. ++.||+|++.... .........+.+|+.+++.++||||+++++++.+.. .++|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE--VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHH--HhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 6788999999999999999986 7899999987321 112234567889999999999999999999888765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccccc
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM 219 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~ 219 (336)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||++|++||||||+|||++.++ .+||+|||+++.... ..
T Consensus 80 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~-~~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-HIKLTDFGFAKKLRD-RT 155 (291)
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEEecCcchhccC-Cc
Confidence 999999999999954 35689999999999999999999999999999999999999876 799999999876432 23
Q ss_pred cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhccCCCCCCCCcccccCCCCCC
Q 019780 220 TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRSADTPIPPKLVEIVDPKSTM 298 (336)
Q Consensus 220 ~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 298 (336)
....|++.|+|||.......+...|+|+|++.++++..+..|....- ......+...........++.+.+++..++..
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~ 235 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVV 235 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCC
Confidence 34569999999999888888999999999999999999988864322 12222233222233344566778888888888
Q ss_pred CCccccc-----hhhhcccc
Q 019780 299 NNDCMAT-----VHAITKFN 313 (336)
Q Consensus 299 ~~~~~~~-----~~~~~~~~ 313 (336)
+|..|.+ ..++.+..
T Consensus 236 dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 236 DRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred CHHHccCCccCCHHHHhcCc
Confidence 8888873 55555443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=281.33 Aligned_cols=216 Identities=33% Similarity=0.588 Sum_probs=187.9
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC----C--ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEee
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG----C--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~----~--~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 127 (336)
.....+++....+.++||.|-||.||+|... | -.||||..+. ....+..+.|+.|+.+|++++||||+++
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~----d~t~d~tekflqEa~iMrnfdHphIikL 456 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKT----DCTPDDTEKFLQEASIMRNFDHPHIIKL 456 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhcc----CCChhhHHHHHHHHHHHHhCCCcchhhe
Confidence 3456677888888899999999999999875 2 3588898873 2344558899999999999999999999
Q ss_pred EeeEecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEec
Q 019780 128 VGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLAD 207 (336)
Q Consensus 128 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~D 207 (336)
+|++.+...|||||+++.|.|..||+.++ ..++......+++||+.||+|||+..+|||||..+|||+.... .|||+|
T Consensus 457 IGv~~e~P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~-CVKLaD 534 (974)
T KOG4257|consen 457 IGVCVEQPMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ-CVKLAD 534 (974)
T ss_pred eeeeeccceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc-eeeecc
Confidence 99999999999999999999999996554 6789999999999999999999999999999999999999876 899999
Q ss_pred ccccccccccccccc-C--CcccccCCC----------------------------------------------CCCCCC
Q 019780 208 FGLAREEVMDEMTCE-A--GTYRWMAPE----------------------------------------------NERPSL 238 (336)
Q Consensus 208 fg~a~~~~~~~~~~~-~--gt~~y~aPE----------------------------------------------~~~~~~ 238 (336)
||+++.......... . -...||||| ...|.|
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P 614 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCP 614 (974)
T ss_pred cchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCC
Confidence 999997655543222 2 458999999 345788
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
+++|+-+|+|+..||.++|.+||.|.++...|.++.+
T Consensus 615 ~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 615 PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999998876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=288.81 Aligned_cols=242 Identities=24% Similarity=0.322 Sum_probs=206.1
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec-CCEEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ-PTMMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~l 138 (336)
..|.-...||+|+.|.||.|... ++.||||.+... .....+.+.+|+.+|+..+|+|||.+++.|.- +.+|.
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~-----~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR-----KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEec-----cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 45777788999999999999875 778999999742 23346778999999999999999999987664 45999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||++||+|.+.+.. ..+++.++..++++++.||+|||.+||+|||||.+|||++.+| .+||+|||+|......
T Consensus 348 VMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISEEQ 423 (550)
T ss_pred EEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC-cEEEeeeeeeecccccc
Confidence 9999999999999833 4599999999999999999999999999999999999999988 7999999999865443
Q ss_pred -cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCH-hHHHHHHHHHHHhhc---cCCCCCCCCccccc
Q 019780 218 -EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEF-AEITITLTNILQNLR---SADTPIPPKLVEIV 292 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~-~~i~~~l~~~~~~~~---~~~~~~p~~~~~~~ 292 (336)
...+.+||+.|||||......++...|||+||..++++--++.|.+ +.=++.+.-+..+-. .....+++++.+.+
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence 3566789999999999999999999999999999999999999987 444555544444322 23356888999999
Q ss_pred CCCCCCCCccccchhhhccc
Q 019780 293 DPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~ 312 (336)
+..+.++++.|++..++.+.
T Consensus 504 ~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHhhcchhcCCCHHHHhcC
Confidence 99999999999998888763
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=283.74 Aligned_cols=250 Identities=20% Similarity=0.261 Sum_probs=197.6
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC---CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG---CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
..+...+|.+.+.||+|+||.||+|.+. +..||+|++... ..........+.+|+.+++.++||||+++++++.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 102 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS--KIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD 102 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHH--HhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence 3456678999999999999999999864 257999998632 11233445678899999999999999999999987
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
+. .++||||++||+|.+++.+ ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~ikL~DFG~a~ 179 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-FIKMTDFGFAK 179 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEecCCCCe
Confidence 76 8999999999999999954 35689999999999999999999999999999999999999876 89999999997
Q ss_pred ccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHHhhccCCCCCCCCcccc
Q 019780 213 EEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQNLRSADTPIPPKLVEI 291 (336)
Q Consensus 213 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~~~~~~~~~~p~~~~~~ 291 (336)
.... ......||+.|+|||.......+...|+|++++.++++..+..|....-. .....+..........+++.+.++
T Consensus 180 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 180 VVDT-RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred ecCC-CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 5432 23445699999999998888888999999999999999999998744321 122233333223334455666677
Q ss_pred cCCCCCCCCcccc-----chhhhccc
Q 019780 292 VDPKSTMNNDCMA-----TVHAITKF 312 (336)
Q Consensus 292 ~~~~~~~~~~~~~-----~~~~~~~~ 312 (336)
+...+..+|+.|. +..++.+.
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 7777777777773 55555543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=281.61 Aligned_cols=239 Identities=20% Similarity=0.244 Sum_probs=191.0
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccC
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMR 144 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~ 144 (336)
+.||+|+||.||+|.+. ++.||+|+++.. ..........+.+|+.+++.++||||+++++++.++. .++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKE--VIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 46999999999999875 788999999731 1223344567889999999999999999999888765 899999999
Q ss_pred CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--ccccc
Q 019780 145 GETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EMTCE 222 (336)
Q Consensus 145 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~~ 222 (336)
||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .....
T Consensus 79 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 79 GGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCCCcccce
Confidence 9999999943 45789999999999999999999999999999999999999877 7999999998753222 23345
Q ss_pred CCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCCc
Q 019780 223 AGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNND 301 (336)
Q Consensus 223 ~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 301 (336)
.||+.|+|||......++...|+|+|++.++++..+..|.... ....+..+..........+++++.+++..++..+|+
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 6999999999998888899999999999999999998886332 222222222222233345667778888888888888
Q ss_pred ccc-----chhhhcc
Q 019780 302 CMA-----TVHAITK 311 (336)
Q Consensus 302 ~~~-----~~~~~~~ 311 (336)
.|. +..++.+
T Consensus 236 ~R~~~~~~~~~~ll~ 250 (323)
T cd05571 236 QRLGGGPEDAKEIME 250 (323)
T ss_pred HcCCCCCCCHHHHHc
Confidence 887 5665554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=284.69 Aligned_cols=246 Identities=22% Similarity=0.278 Sum_probs=206.5
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC--EE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT--MM 137 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~ 137 (336)
.+|..++.+|+|+||.++.++++ +..+++|.+...+ ..........+|+.++++++|||||.+.+.|..++ .+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~---~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEK---LTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccc---cCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 56788899999999999988876 6789999998533 23444557899999999999999999999998765 79
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
|||+||+||+|.+.+.+.++..+++..+..|+.|++.|+.|||+++|+|||||+.|||++.++ .|+|+|||+|+.....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK-KVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC-ceeecchhhhhhcCCc
Confidence 999999999999999887778899999999999999999999999999999999999999987 6899999999976655
Q ss_pred c--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC-HhHHHHHHHHHHHhh-ccCCCCCCCCcccccC
Q 019780 218 E--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE-FAEITITLTNILQNL-RSADTPIPPKLVEIVD 293 (336)
Q Consensus 218 ~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~-~~~i~~~l~~~~~~~-~~~~~~~p~~~~~~~~ 293 (336)
. ..+..||+.|+.||...+.+++...|+|+|+|.++++...++++ ..+....+.++.+.. .......+.++..++.
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHH
Confidence 3 45567999999999999999999999999999999998888876 334444444444433 3334455666777788
Q ss_pred CCCCCCCccccchhhhcc
Q 019780 294 PKSTMNNDCMATVHAITK 311 (336)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~ 311 (336)
..+..+|+.+++..++..
T Consensus 240 ~~l~~~P~~RPsa~~LL~ 257 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLR 257 (426)
T ss_pred HHhhcCCccCCCHHHHhh
Confidence 888888888887777664
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=276.90 Aligned_cols=214 Identities=30% Similarity=0.575 Sum_probs=167.1
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeE
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFV 128 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~ 128 (336)
|.+..++|.+.+.||+|+||.||+|.+. +..||||+++.. ........+.+|+.++..+ +||||++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 77 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG----ATASEHKALMSELKILIHIGNHLNVVNLL 77 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc----cchHHHHHHHHHHHHHHHhccCcceeeEE
Confidence 5667789999999999999999999752 457999998732 2234456789999999999 899999999
Q ss_pred eeEecCC--EEEEEEccCCCCHHHHHhhcC--------------------------------------------------
Q 019780 129 GASVQPT--MMIITELMRGETLQRYLWSTR-------------------------------------------------- 156 (336)
Q Consensus 129 ~~~~~~~--~~lv~e~~~gg~L~~~l~~~~-------------------------------------------------- 156 (336)
+++.... +++||||+++|+|.+++....
T Consensus 78 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (338)
T cd05102 78 GACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST 157 (338)
T ss_pred eEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccc
Confidence 9877543 899999999999999996432
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc----cccc
Q 019780 157 ----------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCE 222 (336)
Q Consensus 157 ----------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~ 222 (336)
...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... ....
T Consensus 158 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred ccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCC
Confidence 12477888999999999999999999999999999999999876 79999999997543221 1123
Q ss_pred CCcccccCCCCCCCCCC-----------------------------------------------CCHHHHHHHHHHhhcc
Q 019780 223 AGTYRWMAPENERPSLE-----------------------------------------------NLSEDMVALLKSCWAE 255 (336)
Q Consensus 223 ~gt~~y~aPE~~~~~~~-----------------------------------------------~~~~di~~l~~~~l~~ 255 (336)
.++..|+|||....... ..+.++..|+..||+.
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 316 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQG 316 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 35678999993322222 3345666777777777
Q ss_pred CCCCCCCHhHHHHHHHHHHH
Q 019780 256 DPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 256 ~p~~RP~~~~i~~~l~~~~~ 275 (336)
+|.+||++.++++.|+.+.+
T Consensus 317 dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 317 DPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ChhhCcCHHHHHHHHHHHHh
Confidence 77778887777777776553
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=271.36 Aligned_cols=240 Identities=18% Similarity=0.212 Sum_probs=191.4
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
.|.+.+.||+|+||.||+|.+. ++.||+|.+.... .........+.+|+.+++.++|+||+++++++.+++ .++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhh--hhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 3677899999999999999875 7899999987321 112233456789999999999999999999888665 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-c
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-E 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-~ 218 (336)
|||+++|+|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++ .++|+|||++...... .
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-HIRISDLGLAVQIPEGET 157 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcCCCCe
Confidence 9999999999888654555789999999999999999999999999999999999999876 7999999998754322 2
Q ss_pred ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH----HHHHHHHHH-HhhccCCCCCCCCcccccC
Q 019780 219 MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE----ITITLTNIL-QNLRSADTPIPPKLVEIVD 293 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~----i~~~l~~~~-~~~~~~~~~~p~~~~~~~~ 293 (336)
.....|+..|+|||......++...|+|++++.+|++..+..|.... ....+.... .........+++++..++.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 23456899999999998888899999999999999999888885321 111222211 1122233456777888999
Q ss_pred CCCCCCCccccc
Q 019780 294 PKSTMNNDCMAT 305 (336)
Q Consensus 294 ~~~~~~~~~~~~ 305 (336)
..+..+|+.|.+
T Consensus 238 ~~l~~~P~~R~~ 249 (285)
T cd05631 238 MLLTKNPKERLG 249 (285)
T ss_pred HHhhcCHHHhcC
Confidence 999999998875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=278.36 Aligned_cols=246 Identities=21% Similarity=0.255 Sum_probs=193.9
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||+|.+. ++.||||+++.. ..........+.+|+.++..++||||+++++++.+.. .|+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKS--LLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHH--HHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence 36889999999999999999985 789999999742 1112334567889999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||++||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 79 v~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~~~~-~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG-HIKLTDFGLSKGIVT-Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEEEeCcCCccccc-c
Confidence 9999999999999943 35689999999999999999999999999999999999999877 799999999975433 3
Q ss_pred ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh----HHHHHHHHHHHhhccCC-----CCCCCCcc
Q 019780 219 MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA----EITITLTNILQNLRSAD-----TPIPPKLV 289 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~----~i~~~l~~~~~~~~~~~-----~~~p~~~~ 289 (336)
.....||+.|+|||.......+...|+|+|++.++++..+..|... ++...+......+.... ..+++++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 3445699999999999888889999999999999999998888522 22222211111111111 13456677
Q ss_pred cccCCCCCCCCccccchhhhcccc
Q 019780 290 EIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
+++...+..+++.+.++.++.+..
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCc
Confidence 777777777777777777766543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=277.18 Aligned_cols=232 Identities=20% Similarity=0.252 Sum_probs=186.8
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccC
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMR 144 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~ 144 (336)
+.||+|+||.||++... +..||+|+++.. ..........+.+|+.+++.++||||+++++++.++. .|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKE--VIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 46999999999999875 789999999732 1223345567788999999999999999999988765 899999999
Q ss_pred CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--ccccc
Q 019780 145 GETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EMTCE 222 (336)
Q Consensus 145 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~~ 222 (336)
+|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... .....
T Consensus 79 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 79 GGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCCCccccc
Confidence 9999998843 35689999999999999999999999999999999999999876 7999999998753222 22345
Q ss_pred CCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCCc
Q 019780 223 AGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNND 301 (336)
Q Consensus 223 ~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 301 (336)
.||+.|+|||.......+...|+|+|++.++++..+..|.... ....+..+..........+++++.+++..++..+|+
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 6999999999998888899999999999999999888886332 222222233222233445677788888888888888
Q ss_pred ccc
Q 019780 302 CMA 304 (336)
Q Consensus 302 ~~~ 304 (336)
.|.
T Consensus 236 ~R~ 238 (323)
T cd05595 236 QRL 238 (323)
T ss_pred HhC
Confidence 885
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=254.26 Aligned_cols=202 Identities=30% Similarity=0.390 Sum_probs=169.1
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
.+|...+.||+|.||.||+|++. ++.||||.++.++. .........||++.|+.++|+||+.++++|.+.. +.|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~---kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA---KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc---ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence 46778899999999999999986 89999999986533 2223456789999999999999999999998765 999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|+||++. +|...++. +...++..++..++.+++.||+|||++.|+||||||.|+|++.+| .+||+|||+|+......
T Consensus 79 VfEfm~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 79 VFEFMPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG-QLKIADFGLARFFGSPN 155 (318)
T ss_pred EEEeccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-cEEeecccchhccCCCC
Confidence 9999975 99999954 446789999999999999999999999999999999999999988 89999999999654432
Q ss_pred --ccccCCcccccCCCCC--------------------------------------------------------------
Q 019780 219 --MTCEAGTYRWMAPENE-------------------------------------------------------------- 234 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~-------------------------------------------------------------- 234 (336)
.+..+-|..|+|||.+
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 2233688999999900
Q ss_pred -----------CCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 019780 235 -----------RPSLENLSEDMVALLKSCWAEDPKVRPEFAEITIT 269 (336)
Q Consensus 235 -----------~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~ 269 (336)
.......+.|..+|+..+|.+||.+|+++.|.++.
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 01123456788999999999999999999998653
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=279.25 Aligned_cols=197 Identities=22% Similarity=0.249 Sum_probs=168.8
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||+||+|.+. ++.||||++... ..........+.+|+.++..++||||+++++.+.+.. .|+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKA--DMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHH--HHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence 36888999999999999999885 789999999731 1223344567889999999999999999999998765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||++||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~-~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 79 IMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-CEEEeeccCcccccccc
Confidence 9999999999999954 35799999999999999999999999999999999999999887 89999999986422110
Q ss_pred -------------------------------------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCC
Q 019780 219 -------------------------------------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRP 261 (336)
Q Consensus 219 -------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP 261 (336)
....+||+.|+|||......++.+.|+|+|++.++++..+..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 1234699999999999888889999999999999999999988
Q ss_pred CH
Q 019780 262 EF 263 (336)
Q Consensus 262 ~~ 263 (336)
..
T Consensus 236 f~ 237 (363)
T cd05628 236 FC 237 (363)
T ss_pred CC
Confidence 63
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=276.24 Aligned_cols=232 Identities=19% Similarity=0.239 Sum_probs=182.7
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccC
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMR 144 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~ 144 (336)
+.||+|+||.||++.+. ++.||+|++... ..........+.+|+.+++.++||||+++++++.+.+ .++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKE--VIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 46999999999999875 789999999742 2223445677889999999999999999999888765 899999999
Q ss_pred CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc--cccccc
Q 019780 145 GETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM--DEMTCE 222 (336)
Q Consensus 145 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~--~~~~~~ 222 (336)
+|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... ......
T Consensus 79 ~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 79 GGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCcccccccc
Confidence 9999998843 35689999999999999999999999999999999999999877 799999999875322 223345
Q ss_pred CCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCCc
Q 019780 223 AGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNND 301 (336)
Q Consensus 223 ~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 301 (336)
.||+.|+|||.......+...|+|+|++.++++..+..|.... ....+..+...-......+++++.+++...+..+|+
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPN 235 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHH
Confidence 6999999999998888889999999999999999998886332 111122222222222334555666677777777777
Q ss_pred ccc
Q 019780 302 CMA 304 (336)
Q Consensus 302 ~~~ 304 (336)
.|.
T Consensus 236 ~R~ 238 (328)
T cd05593 236 KRL 238 (328)
T ss_pred HcC
Confidence 664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=288.06 Aligned_cols=216 Identities=29% Similarity=0.526 Sum_probs=187.0
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeE
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFV 128 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 128 (336)
...+...+....+.||+|+||.||+|+.. ...||||.++. ..+.+....|+||+++|..++|||||+++
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd----~a~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD----KAENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc----cccHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 44567788888999999999999999864 35699999983 33556788999999999999999999999
Q ss_pred eeEecCC-EEEEEEccCCCCHHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcee
Q 019780 129 GASVQPT-MMIITELMRGETLQRYLWSTR------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLL 195 (336)
Q Consensus 129 ~~~~~~~-~~lv~e~~~gg~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIl 195 (336)
|++.+++ +++|+|||..|||.++|+... ...++..+.+.|+.||+.|+.||-++.+|||||..+|+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 9999876 999999999999999996432 123888999999999999999999999999999999999
Q ss_pred ecCCCCceEEeccccccccccccccccC----CcccccCCC---------------------------------------
Q 019780 196 LTEDKKQVKLADFGLAREEVMDEMTCEA----GTYRWMAPE--------------------------------------- 232 (336)
Q Consensus 196 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~----gt~~y~aPE--------------------------------------- 232 (336)
|+++- .|||+|||+++.....++.-.. -...||+||
T Consensus 636 Vge~l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 636 VGENL-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred eccce-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 99876 8999999999987666654433 348999999
Q ss_pred -------CCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 233 -------NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 233 -------~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
...+.|.++|..+|+||..||+.+|.+||+|.+|-..|....+.
T Consensus 715 Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 715 IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 34577889999999999999999999999999999988877554
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=273.64 Aligned_cols=231 Identities=23% Similarity=0.250 Sum_probs=187.1
Q ss_pred ecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccCCC
Q 019780 70 IGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRGE 146 (336)
Q Consensus 70 lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~gg 146 (336)
||+|+||.||+|.+. ++.||+|+++.. ..........+.+|+.++..++||||+++++++.+.. .++||||++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKA--HIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 699999999999986 678999998731 1223445667889999999999999999999888765 89999999999
Q ss_pred CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--cccccCC
Q 019780 147 TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EMTCEAG 224 (336)
Q Consensus 147 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~~~g 224 (336)
+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .++|+|||+++..... ......|
T Consensus 79 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 79 ELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCccccccC
Confidence 99999954 45689999999999999999999999999999999999999877 7999999998753222 2233469
Q ss_pred cccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCCccc
Q 019780 225 TYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNNDCM 303 (336)
Q Consensus 225 t~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 303 (336)
|+.|+|||.......+...|+|++++.++++..+..|... +....+..+..........+++++.+++...+..+|..|
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 235 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence 9999999999888889999999999999999999888633 222233333333333445567778888888888888888
Q ss_pred cc
Q 019780 304 AT 305 (336)
Q Consensus 304 ~~ 305 (336)
.+
T Consensus 236 ~~ 237 (312)
T cd05585 236 LG 237 (312)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=280.50 Aligned_cols=197 Identities=21% Similarity=0.251 Sum_probs=168.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||+||+|.+. ++.||||++.... .........+.+|+.+|..++||||+++++++.++. .++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSE--MLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence 36888999999999999999985 7899999997321 112344567889999999999999999999998776 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||++||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .++|+|||++.......
T Consensus 79 v~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 79 IMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEeecccceeccccc
Confidence 9999999999999954 35689999999999999999999999999999999999999887 79999999986422110
Q ss_pred ----------------------------------------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCC
Q 019780 219 ----------------------------------------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPK 258 (336)
Q Consensus 219 ----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~ 258 (336)
....+||+.|+|||.......+...|+|+|++.++++-.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 0123589999999998888889999999999999999998
Q ss_pred CCCCH
Q 019780 259 VRPEF 263 (336)
Q Consensus 259 ~RP~~ 263 (336)
..|..
T Consensus 236 ~~Pf~ 240 (364)
T cd05599 236 YPPFC 240 (364)
T ss_pred CCCCC
Confidence 88863
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=271.63 Aligned_cols=250 Identities=21% Similarity=0.261 Sum_probs=199.6
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
+..++|.+.+.||+|+||.||++.+. +..+|+|++.. .........+.+|+.+|+.++||||+++++++.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL----EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 77 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeec----ccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 34578999999999999999999986 77899999873 123445678999999999999999999999988665
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.++||||++|++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .++|+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 154 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL 154 (331)
T ss_pred EEEEeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCcccccc
Confidence 8999999999999999954 34689999999999999999999986 699999999999999887 7999999998765
Q ss_pred ccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH-------------------
Q 019780 215 VMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ------------------- 275 (336)
Q Consensus 215 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~------------------- 275 (336)
.........|+..|+|||.......+...|+|+|++.+|++-.++.|....-...+.....
T Consensus 155 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 155 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred cccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 4444445569999999999988888999999999999999877776642211111111110
Q ss_pred ------------------------hhcc------CCCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 276 ------------------------NLRS------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 276 ------------------------~~~~------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
.+.. .....++++.+++...+..+|+.|++..++.+...-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 0000 011245667889999999999999999998875543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=281.70 Aligned_cols=261 Identities=26% Similarity=0.463 Sum_probs=212.6
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
..++.....+.++||.|.||.|++|+.+ ...||||.++. ...++.+..|+.|+.||-+++||||+++.|+.
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~----GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA----GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc----CccHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 4567788999999999999999999986 45799999984 34567788999999999999999999999998
Q ss_pred ecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 132 VQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 132 ~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
.... .+||+|||++|+|..+|+.+. +.++..+...+++.|++|++||-+.|+|||||.++|||++.+- .+|++|||+
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL-vCKVsDFGL 777 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL-VCKVSDFGL 777 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce-EEEeccccc
Confidence 8766 899999999999999997655 5699999999999999999999999999999999999999887 899999999
Q ss_pred ccccccc---cccccCCc--ccccCCC----------------------------------------------CCCCCCC
Q 019780 211 AREEVMD---EMTCEAGT--YRWMAPE----------------------------------------------NERPSLE 239 (336)
Q Consensus 211 a~~~~~~---~~~~~~gt--~~y~aPE----------------------------------------------~~~~~~~ 239 (336)
++....+ ..++..|. ..|.||| ...|.|.
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM 857 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC
Confidence 9854332 23333343 7899999 4567888
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCC---CCCCCCcccccCCCCCCCCccccchhhhccccccc
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSAD---TPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKG 316 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (336)
++|..++.|+..||+.+..+||.|.||+..|++++.+..+.. ...+.....++++ ....-....++.++.+...++
T Consensus 858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~~lld~-~~~~~~~f~sv~~WL~aIkm~ 936 (996)
T KOG0196|consen 858 DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQPLLDR-SGSDFTPFRSVGDWLEAIKMG 936 (996)
T ss_pred CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcccccCC-CCCCCcccCCHHHHHHHhhhh
Confidence 999999999999999999999999999999999997754433 2222223333332 222334446788888777777
Q ss_pred ccccccch
Q 019780 317 KKRRSYLP 324 (336)
Q Consensus 317 ~~~~~~~~ 324 (336)
+.+..|..
T Consensus 937 rY~~~F~~ 944 (996)
T KOG0196|consen 937 RYKEHFAA 944 (996)
T ss_pred HHHHHHHh
Confidence 77766543
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=271.83 Aligned_cols=239 Identities=19% Similarity=0.211 Sum_probs=187.0
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCC-ceEeeEeeEecCC-EEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE-NILKFVGASVQPT-MMI 138 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~-~~l 138 (336)
+|.+.+.||+|+||.||+|... ++.||||++... ........+.+..|..++..++|+ +|+.+++++.+.+ .|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD--VIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 4788999999999999999986 568999999742 112334556788899999999865 5788888887655 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc--c
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV--M 216 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~--~ 216 (336)
||||++||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .++|+|||+++... .
T Consensus 79 v~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-HIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-CEEEeecCcceecCCCC
Confidence 9999999999999843 35689999999999999999999999999999999999999876 79999999987432 2
Q ss_pred ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCC
Q 019780 217 DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 217 ~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~ 295 (336)
.......||+.|+|||.....+.+...|+|++++.+|++..++.|.... -...+..+..........+++++.+++...
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 235 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 235 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 2233456999999999999888899999999999999999998886322 112222222222223344566666777777
Q ss_pred CCCCCccccch
Q 019780 296 STMNNDCMATV 306 (336)
Q Consensus 296 ~~~~~~~~~~~ 306 (336)
+..+|..|.+.
T Consensus 236 l~~~P~~R~~~ 246 (324)
T cd05587 236 LTKHPAKRLGC 246 (324)
T ss_pred hhcCHHHcCCC
Confidence 88788777643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=278.97 Aligned_cols=196 Identities=19% Similarity=0.219 Sum_probs=166.9
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
.|.+++.||+|+||+||+|.+. ++.||||++... ..........+.+|+.+++.++||||+++++++.+.. .++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKK--DVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 5788999999999999999985 778999999731 1223345677899999999999999999999998766 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-- 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-- 217 (336)
|||++||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++ +++|+|||+++.....
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 80 MDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC-CEEEeeCcCCcccccccc
Confidence 999999999999944 35689999999999999999999999999999999999999876 8999999987521100
Q ss_pred -----------------------------------------------cccccCCcccccCCCCCCCCCCCCHHHHHHHHH
Q 019780 218 -----------------------------------------------EMTCEAGTYRWMAPENERPSLENLSEDMVALLK 250 (336)
Q Consensus 218 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~ 250 (336)
......||+.|+|||......++...|+|+|++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 011246999999999988888889999999999
Q ss_pred HhhccCCCCCCCH
Q 019780 251 SCWAEDPKVRPEF 263 (336)
Q Consensus 251 ~~l~~~p~~RP~~ 263 (336)
.++++..+..|..
T Consensus 237 il~elltG~~Pf~ 249 (381)
T cd05626 237 ILFEMLVGQPPFL 249 (381)
T ss_pred HHHHHHhCCCCCc
Confidence 9999999988863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=272.50 Aligned_cols=242 Identities=24% Similarity=0.291 Sum_probs=190.4
Q ss_pred eeecCCCcEEEEEeEE-----CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEE
Q 019780 68 KMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITE 141 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e 141 (336)
+.||+|+||.||++.. .++.||+|+++.... .........+.+|+.+|+.++||||+++++++.++. .|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI-VRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHH-HhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 6799999999999975 267899999974211 112234556789999999999999999999988765 899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc--c
Q 019780 142 LMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE--M 219 (336)
Q Consensus 142 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~--~ 219 (336)
|++|++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...... .
T Consensus 81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-HVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEeeCcCCeecccCCCcc
Confidence 9999999999943 35688999999999999999999999999999999999999887 79999999987432222 2
Q ss_pred cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCCCCCCcccccCCCCCC
Q 019780 220 TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTPIPPKLVEIVDPKSTM 298 (336)
Q Consensus 220 ~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 298 (336)
....|++.|+|||.......+...|+|+|+..++++..+..|... +....+..+..........+++.+.+++...+..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 334699999999999888888999999999999999999888532 2222333333333333445666677888888888
Q ss_pred CCcccc-----chhhhcccc
Q 019780 299 NNDCMA-----TVHAITKFN 313 (336)
Q Consensus 299 ~~~~~~-----~~~~~~~~~ 313 (336)
+|+.|. +..++....
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCC
Confidence 888886 566655543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=269.92 Aligned_cols=234 Identities=26% Similarity=0.350 Sum_probs=192.8
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-E
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT-M 136 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~ 136 (336)
...|.+.+.||+|.||.||+++.. ++.+|+|++.+... ........+.+|+.+|+.+. ||||+.+++++.+.. +
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~--~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKL--RGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhc--cccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 467899999999999999999986 78899999985322 23335678999999999999 999999999999876 9
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC---CceEEeccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK---KQVKLADFGLARE 213 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~---~~~kl~Dfg~a~~ 213 (336)
++|||++.||.|.+.+... .+++..+..++.|++.+++|||+.|++||||||+|+|+.... ..+|++|||++..
T Consensus 112 ~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 9999999999999999555 399999999999999999999999999999999999996542 2799999999997
Q ss_pred cccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-----------------------HHHH
Q 019780 214 EVMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-----------------------ITIT 269 (336)
Q Consensus 214 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-----------------------i~~~ 269 (336)
.... .....+||+.|+|||.....+++...|+|+++..++.+..+..|+..+ +...
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 6553 456678999999999999999999999999999999888777775433 3444
Q ss_pred HHHHHHhhccCCCCCCCCcccccCCCCCCC
Q 019780 270 LTNILQNLRSADTPIPPKLVEIVDPKSTMN 299 (336)
Q Consensus 270 l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 299 (336)
..+++..+...++..+..+...++++|-..
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~ 298 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKS 298 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence 445555555555555555666666665443
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=271.59 Aligned_cols=235 Identities=20% Similarity=0.259 Sum_probs=186.6
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHH---HhCCCCceEeeEeeEecCC-EE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLL---SKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
|.+.+.||+|+||.||+|.+. ++.||||+++... .......+.+.+|++++ +.++||||+++++++.+.. .|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGD--IIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 567899999999999999885 7889999997421 11233455677776665 5667999999999988765 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc-
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM- 216 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~- 216 (336)
+||||++|++|..++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++....
T Consensus 79 lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-FVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-cEEeCcccCCccCCCC
Confidence 99999999999988833 4689999999999999999999999999999999999999887 799999999874322
Q ss_pred -ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCCCCCCcccccCC
Q 019780 217 -DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTPIPPKLVEIVDP 294 (336)
Q Consensus 217 -~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~p~~~~~~~~~ 294 (336)
.......|++.|+|||.......+...|+|+|++.+|++..+..|... +....+..+..........+++.+.+++..
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 234 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRR 234 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 223345699999999998888888899999999999999988888532 222223333333333344567777888888
Q ss_pred CCCCCCcccc
Q 019780 295 KSTMNNDCMA 304 (336)
Q Consensus 295 ~~~~~~~~~~ 304 (336)
++..+|+.|.
T Consensus 235 ~L~~dP~~R~ 244 (324)
T cd05589 235 LLRRNPERRL 244 (324)
T ss_pred HhhcCHhHcC
Confidence 8888888886
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=265.11 Aligned_cols=245 Identities=22% Similarity=0.215 Sum_probs=197.1
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEECC--ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
...++.++|.+++.||.|.-|+||+++..+ ..+|+|++.+ ......+...+.+.|-+||+.++||.++.+|..++.
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK--~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDK--ESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecH--HHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence 456777899999999999999999999874 7899999984 333445667888999999999999999999999998
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
+. .|+|||||+||+|..+++++.+..+++..++.++.+++.||+|||..|||+|||||+|||+.++| ++.|+||.++.
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG-HIMLsDFDLS~ 227 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG-HIMLSDFDLSL 227 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC-cEEeeeccccc
Confidence 77 89999999999999999999999999999999999999999999999999999999999999988 89999999864
Q ss_pred ccc----------------------------------c-c------------------c-----ccccCCcccccCCCCC
Q 019780 213 EEV----------------------------------M-D------------------E-----MTCEAGTYRWMAPENE 234 (336)
Q Consensus 213 ~~~----------------------------------~-~------------------~-----~~~~~gt~~y~aPE~~ 234 (336)
... . . + ....+||-.|+|||.+
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 100 0 0 0 0123599999999999
Q ss_pred CCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCC--CCCCCCcccccCCCCCCCCccc
Q 019780 235 RPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSAD--TPIPPKLVEIVDPKSTMNNDCM 303 (336)
Q Consensus 235 ~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~--~~~p~~~~~~~~~~~~~~~~~~ 303 (336)
++...+...|+|.|+.-++++..+.-|.-.+ --+.|..++.+-..+. +.++-.+.+++..++..+|..|
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence 9999999999999999999998888885222 2223333433322222 2334455666666666666544
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=279.26 Aligned_cols=196 Identities=20% Similarity=0.217 Sum_probs=166.7
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||+|... ++.||||++... ..........+.+|+.+++.++||||+++++++.++. .|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS--EMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHH--HHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence 36888999999999999999875 788999998631 1123344567889999999999999999999998776 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||++||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .++|+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~-~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 79 IMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEEeeccccccccccc
Confidence 9999999999999943 45689999999999999999999999999999999999999876 89999999985211000
Q ss_pred -------------------------------------------------ccccCCcccccCCCCCCCCCCCCHHHHHHHH
Q 019780 219 -------------------------------------------------MTCEAGTYRWMAPENERPSLENLSEDMVALL 249 (336)
Q Consensus 219 -------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~ 249 (336)
.....||+.|+|||......++.+.|+|+|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0123599999999998888888999999999
Q ss_pred HHhhccCCCCCCC
Q 019780 250 KSCWAEDPKVRPE 262 (336)
Q Consensus 250 ~~~l~~~p~~RP~ 262 (336)
+.++++..+..|.
T Consensus 236 vil~elltG~~Pf 248 (377)
T cd05629 236 AIMFECLIGWPPF 248 (377)
T ss_pred hhhhhhhcCCCCC
Confidence 9999999998885
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=279.82 Aligned_cols=197 Identities=20% Similarity=0.221 Sum_probs=166.7
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||+|.+. ++.||||++... ..........+.+|+.+|+.++||||+++++.+.+++ +++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKA--DVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHH--HHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence 36889999999999999999976 788999998631 1112234567889999999999999999999988766 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc--
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM-- 216 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~-- 216 (336)
||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||+|.....
T Consensus 79 v~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 79 VMDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC-CEEEEeCCCCccccccc
Confidence 9999999999999944 35689999999999999999999999999999999999999877 799999999742100
Q ss_pred -------------------------------------------ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhh
Q 019780 217 -------------------------------------------DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCW 253 (336)
Q Consensus 217 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l 253 (336)
.......||+.|+|||.......+...|+|+|++.++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0011236999999999998888899999999999999
Q ss_pred ccCCCCCCCH
Q 019780 254 AEDPKVRPEF 263 (336)
Q Consensus 254 ~~~p~~RP~~ 263 (336)
++..++.|..
T Consensus 236 ell~G~~Pf~ 245 (376)
T cd05598 236 EMLVGQPPFL 245 (376)
T ss_pred ehhhCCCCCC
Confidence 9999988863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=263.47 Aligned_cols=195 Identities=27% Similarity=0.371 Sum_probs=163.6
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
..+|.+.+.||+|+||.||+|... +..||+|+++... .......+.+|+.+++.++||||+++++++.+.. .+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH----EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLT 79 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc----cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 467999999999999999999875 7889999987422 1222346779999999999999999999988765 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||+++ +|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 80 lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 80 LVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-ELKLADFGLARAKSVP 156 (288)
T ss_pred EEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEECcCcceeeccCC
Confidence 99999985 999988543 34578999999999999999999999999999999999999887 7999999998753322
Q ss_pred --cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 218 --EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 218 --~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
......|++.|+|||...+ ..++.+.|+|++++.++++-.+..|.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf 204 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence 2233458899999998764 56788999999999999998888875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=264.04 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=191.0
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC------------------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG------------------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 121 (336)
...+|.+.+.||+|+||.||+|.+. +..||+|++... ........+.+|+.++..++|
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h 78 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD----ANKNARNDFLKEVKILSRLKD 78 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC----CCHHHHHHHHHHHHHHhhcCC
Confidence 3467889999999999999999753 236999998732 234456779999999999999
Q ss_pred CceEeeEeeEecCC-EEEEEEccCCCCHHHHHhhcC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019780 122 ENILKFVGASVQPT-MMIITELMRGETLQRYLWSTR-----------------PKRLDLKHSISFALDISRAMEYLHANS 183 (336)
Q Consensus 122 pnIv~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~-----------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ 183 (336)
|||+++++++.+.. .++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+.|
T Consensus 79 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 79 PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred CCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999988655 899999999999999985321 124677889999999999999999999
Q ss_pred cccccCCCCceeecCCCCceEEeccccccccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC--
Q 019780 184 VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-- 257 (336)
Q Consensus 184 ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-- 257 (336)
|+||||||+|||++.++ .+||+|||+++....... ....++..|+|||.......+...|+|+|+..+|++-.
T Consensus 159 ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 159 FVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999999876 799999999975433221 12235788999998888888899999999999887532
Q ss_pred CCCC----CHhHHHHHHHHHHHhh-----ccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 258 KVRP----EFAEITITLTNILQNL-----RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 258 ~~RP----~~~~i~~~l~~~~~~~-----~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
...| +..++........... ....+..|+.+.+++...+..+|+.|++..++.+
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 2222 3334433332222111 1123456778889999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=273.05 Aligned_cols=239 Identities=21% Similarity=0.252 Sum_probs=188.2
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccC
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMR 144 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~ 144 (336)
+.||+|+||.||++.+. +..||+|++... ..........+.+|+.++..++||||+++++++.++. .++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKE--VIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 46999999999999875 789999999742 1223344567788999999999999999999888766 899999999
Q ss_pred CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCceEEeccccccccccc--cccc
Q 019780 145 GETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EMTC 221 (336)
Q Consensus 145 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~ 221 (336)
||+|..++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..... ....
T Consensus 79 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 79 GGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCccccc
Confidence 9999998843 3568999999999999999999997 7999999999999999887 7999999998753222 2234
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHH-HHHHHhhccCCCCCCCCcccccCCCCCCCC
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITL-TNILQNLRSADTPIPPKLVEIVDPKSTMNN 300 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 300 (336)
..||+.|+|||.......+...|+|+|++.++++..+..|....-...+ ..+..........+++++.+++..++..+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP 235 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDP 235 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 5699999999998888888999999999999999999888643322222 222222222334566777778888888888
Q ss_pred cccc-----chhhhcc
Q 019780 301 DCMA-----TVHAITK 311 (336)
Q Consensus 301 ~~~~-----~~~~~~~ 311 (336)
+.|. +..++.+
T Consensus 236 ~~R~~~~~~~~~~il~ 251 (325)
T cd05594 236 KQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHhCCCCCCCHHHHhc
Confidence 7774 5555544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=276.96 Aligned_cols=245 Identities=21% Similarity=0.305 Sum_probs=195.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||+||+|.+. ++.||||+++.. ..........+.+|+.++..++||||+++++++.++. .++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKS--DMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHH--HHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence 36889999999999999999987 889999999732 1112244567899999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||++|++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEeecCCCCccCcccC
Confidence 99999999999999544 6789999999999999999999999999999999999999887 79999999987543222
Q ss_pred -------------------------------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-
Q 019780 219 -------------------------------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI- 266 (336)
Q Consensus 219 -------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i- 266 (336)
.....||+.|+|||.......+...|+|+|++.++++..+..|....-
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 223458999999999988888999999999999999999999864321
Q ss_pred HHHHHHHHH--hhcc--CCCCCCCCcccccCCCCCCCCccccc-hhhhccc
Q 019780 267 TITLTNILQ--NLRS--ADTPIPPKLVEIVDPKSTMNNDCMAT-VHAITKF 312 (336)
Q Consensus 267 ~~~l~~~~~--~~~~--~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 312 (336)
......+.. .... ....+++++.+++..++. +|..|.+ ..++.+.
T Consensus 236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 222222222 1111 112356777788877776 7888877 7766653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=272.10 Aligned_cols=234 Identities=25% Similarity=0.291 Sum_probs=185.0
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+||.||+|.+. ++.||||+++.. ..........+..|..++..+ +||||+++++++.+.+ +|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKD--VILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHH--HHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 46999999999999986 678999998732 111233456677888888876 6999999999988765 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--cccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~ 221 (336)
+||+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++ .++|+|||+++..... ....
T Consensus 79 ~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 79 NGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred CCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCCCcccc
Confidence 99999999844 35689999999999999999999999999999999999999887 7999999998753221 2334
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCC
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNN 300 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 300 (336)
..||+.|+|||.......+...|+|+|++.+|++..+..|.... ....+..+..........+++++.+++...+..+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP 235 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNP 235 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 56999999999988888889999999999999999998885322 22222333332222334466677788888888888
Q ss_pred ccccch
Q 019780 301 DCMATV 306 (336)
Q Consensus 301 ~~~~~~ 306 (336)
+.|.+.
T Consensus 236 ~~R~~~ 241 (320)
T cd05590 236 TMRLGS 241 (320)
T ss_pred HHCCCC
Confidence 888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=261.06 Aligned_cols=247 Identities=19% Similarity=0.314 Sum_probs=194.4
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
++..+|++.+.||+|+||.||+|.+. +..||+|.++.. ........+.+|+.+++.++||||+++++++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG----CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC----CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 45678999999999999999999763 468999998732 233445678999999999999999999999886
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
+. .++||||+++|+|.+++... ...+++..++.++.|++.||+|||++|++||||||+||+++.++ .++++|||.+.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~-~~~l~dfg~~~ 155 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQ 155 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC-cEEECCCcccc
Confidence 55 89999999999999999543 35789999999999999999999999999999999999999876 79999999876
Q ss_pred ccccccc---cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccC-CCCCCCHhHHH-HHHHHHHHhh-ccCCCCCCC
Q 019780 213 EEVMDEM---TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAED-PKVRPEFAEIT-ITLTNILQNL-RSADTPIPP 286 (336)
Q Consensus 213 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~-p~~RP~~~~i~-~~l~~~~~~~-~~~~~~~p~ 286 (336)
....... ....++..|+|||.......+...|+|++++.+|+.. .+.+|....-. ..+..+.... .......|.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPN 235 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCH
Confidence 5322211 1223567899999988888899999999999999954 47888643211 1122222211 122334566
Q ss_pred CcccccCCCCCCCCccccchhhhcc
Q 019780 287 KLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.+.+++...|..+|+.|++..++.+
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHH
Confidence 6778888899999999999888765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=278.44 Aligned_cols=196 Identities=19% Similarity=0.213 Sum_probs=167.0
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
.|.+++.||+|+||+||+|+.. ++.||+|++... ..........+.+|+.+++.++||||+++++.+.++. .|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK--DVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHH--HhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 5788999999999999999985 778999998731 1223345677899999999999999999999998766 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-- 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-- 217 (336)
|||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 80 MDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEeECCCCcccccccc
Confidence 999999999999954 35689999999999999999999999999999999999999887 8999999997421000
Q ss_pred -----------------------------------------------cccccCCcccccCCCCCCCCCCCCHHHHHHHHH
Q 019780 218 -----------------------------------------------EMTCEAGTYRWMAPENERPSLENLSEDMVALLK 250 (336)
Q Consensus 218 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~ 250 (336)
.....+||+.|+|||......++...|+|+|++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 011235899999999998888899999999999
Q ss_pred HhhccCCCCCCCH
Q 019780 251 SCWAEDPKVRPEF 263 (336)
Q Consensus 251 ~~l~~~p~~RP~~ 263 (336)
.++++..+..|..
T Consensus 237 il~elltG~~Pf~ 249 (382)
T cd05625 237 ILYEMLVGQPPFL 249 (382)
T ss_pred HHHHHHhCCCCCC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=271.09 Aligned_cols=246 Identities=20% Similarity=0.230 Sum_probs=188.1
Q ss_pred ceeEeeeecCCCcEEEEEeEE-----CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-
Q 019780 63 SVLLQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT- 135 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~- 135 (336)
+|.+.+.||+|+||.||+++. .+..||+|++..... .......+.+.+|+.++..++ ||||+++++++.++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 478899999999999999876 367899999973211 112334567889999999995 999999999888765
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
.++||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 80 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-~~kl~DfG~~~~~~ 156 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-CEEEeeCcCCcccc
Confidence 8999999999999999944 35689999999999999999999999999999999999999887 79999999987532
Q ss_pred cc---cccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHh----HHHHHHH-HHHHhhccCCCCCCC
Q 019780 216 MD---EMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFA----EITITLT-NILQNLRSADTPIPP 286 (336)
Q Consensus 216 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~----~i~~~l~-~~~~~~~~~~~~~p~ 286 (336)
.. ......||+.|+|||..... ..+...|+|+|++.++++..+..|... .....+. .+..........+++
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGP 236 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Confidence 22 12234699999999987754 367789999999999999998888521 1111111 111111112234556
Q ss_pred CcccccCCCCCCCCcccc-----chhhhccc
Q 019780 287 KLVEIVDPKSTMNNDCMA-----TVHAITKF 312 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 312 (336)
.+.+++...+..+|+.|. +..++.+.
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 677788888888888886 45555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=287.24 Aligned_cols=216 Identities=33% Similarity=0.594 Sum_probs=187.0
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC---C----ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG---C----EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~---~----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
+.....++.+.||+|.||.||.|... + ..||||.++. ..+.+....|.+|..+|+.++|||||+++|++
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~----~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR----LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVC 764 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc----cCCHHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence 45788999999999999999999875 2 2488888863 44677889999999999999999999999999
Q ss_pred ecCC-EEEEEEccCCCCHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEE
Q 019780 132 VQPT-MMIITELMRGETLQRYLWSTR-----PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKL 205 (336)
Q Consensus 132 ~~~~-~~lv~e~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl 205 (336)
.+.. .+|++|||.||+|..||++.+ ...++..+.+.++.||+.|+.||+++++|||||.++|+|++... .|||
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r-~VKI 843 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR-VVKI 843 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC-cEEE
Confidence 8865 899999999999999996542 45688999999999999999999999999999999999999886 8999
Q ss_pred eccccccccccccccccC----CcccccCCC----------------------------------------------CCC
Q 019780 206 ADFGLAREEVMDEMTCEA----GTYRWMAPE----------------------------------------------NER 235 (336)
Q Consensus 206 ~Dfg~a~~~~~~~~~~~~----gt~~y~aPE----------------------------------------------~~~ 235 (336)
+|||+|+.....++.... -...||||| ...
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL 923 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence 999999955544443333 347999999 456
Q ss_pred CCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 236 PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 236 ~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
+.|..+|..+|.||..||+.+|.+||+|..++.++..+.+....
T Consensus 924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 77889999999999999999999999999999999888776443
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=273.23 Aligned_cols=243 Identities=19% Similarity=0.249 Sum_probs=190.3
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
.+....|.+.+.||+|+||.||+|.+. ++.||+|... ...+.+|+.+|+.++||||+++++++..+.
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 156 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----------RGGTATEAHILRAINHPSIIQLKGTFTYNK 156 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECC
Confidence 355678999999999999999999986 7889999753 234678999999999999999999988665
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.++|+|++. ++|..++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .++|+|||+|+..
T Consensus 157 ~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~ 232 (391)
T PHA03212 157 FTCLILPRYK-TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAACFP 232 (391)
T ss_pred eeEEEEecCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-CEEEEeCCccccc
Confidence 889999985 689888843 35689999999999999999999999999999999999999877 7999999999743
Q ss_pred cc---ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH--------HHHHHHHHHHhh------
Q 019780 215 VM---DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE--------ITITLTNILQNL------ 277 (336)
Q Consensus 215 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~--------i~~~l~~~~~~~------ 277 (336)
.. .......||+.|+|||......++.+.|+|+|++.+|++..+..|.+.. ....+..+....
T Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred ccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 22 2233456999999999998888999999999999999988877664321 000111111100
Q ss_pred --------------------ccC---------CCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 278 --------------------RSA---------DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 278 --------------------~~~---------~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
... ...+|.++.+++..++..+|..|.+..++.+...-
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 000 01245567778888888899999888888765543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=274.06 Aligned_cols=196 Identities=22% Similarity=0.252 Sum_probs=167.9
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||+|... ++.||+|+++.. ..........+.+|+.++..++||||+++++.+.+.. +|+|
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKA--DMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH--HHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 5788899999999999999885 788999999731 1123345677889999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
|||++||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .++|+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~-~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEeeccCCcccccccc
Confidence 999999999999943 35689999999999999999999999999999999999999877 89999999986321100
Q ss_pred ------------------------------------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 219 ------------------------------------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 219 ------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
....+||+.|+|||......++...|+|+|++.++++..+..|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 11346999999999998888899999999999999999998886
Q ss_pred H
Q 019780 263 F 263 (336)
Q Consensus 263 ~ 263 (336)
.
T Consensus 237 ~ 237 (360)
T cd05627 237 C 237 (360)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=279.24 Aligned_cols=218 Identities=22% Similarity=0.422 Sum_probs=181.8
Q ss_pred cCCceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEe
Q 019780 53 IDASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVG 129 (336)
Q Consensus 53 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~ 129 (336)
++..+.++..++++.+.|.+|||+.||+|... +..||+|++. ..++.....+.+|+++|+.|+ |+|||.+++
T Consensus 28 ~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~-----~~de~~L~~v~~EI~~MK~L~gh~nIV~yid 102 (738)
T KOG1989|consen 28 VGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMY-----VNDEEALNAVKREIDIMKLLSGHKNIVSYID 102 (738)
T ss_pred CceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeee-----cCCHHHHHHHHHHHHHHHHhcCCCceeeEec
Confidence 45678899999999999999999999999986 4899999986 236777889999999999998 999999999
Q ss_pred e-Eec----C---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCC
Q 019780 130 A-SVQ----P---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS--VIHRDLKPSNLLLTED 199 (336)
Q Consensus 130 ~-~~~----~---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDikp~NIll~~~ 199 (336)
. ... + .++|+||||.||.|-+++..+...+|++.+++.|++|+|.|+++||... |||||||-+||||+.+
T Consensus 103 ss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~ 182 (738)
T KOG1989|consen 103 SSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD 182 (738)
T ss_pred cccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC
Confidence 3 221 2 1789999999999999997666677999999999999999999999998 9999999999999988
Q ss_pred CCceEEecccccccccccc-cc----------ccCCcccccCCCC-----------------------------------
Q 019780 200 KKQVKLADFGLAREEVMDE-MT----------CEAGTYRWMAPEN----------------------------------- 233 (336)
Q Consensus 200 ~~~~kl~Dfg~a~~~~~~~-~~----------~~~gt~~y~aPE~----------------------------------- 233 (336)
+ +.||||||.|....... .. ....|+.|+|||.
T Consensus 183 g-~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 183 G-NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred C-CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 7 89999999987432221 00 1137899999992
Q ss_pred ----------CCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 234 ----------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 234 ----------~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
..|....++..+..||..||+.+|.+||++-+++..+..+...
T Consensus 262 g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 262 GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1233345667777789999999999999999999888777643
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=274.01 Aligned_cols=214 Identities=32% Similarity=0.548 Sum_probs=193.7
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
+.|..++.+..+..+||-|.||.||.|.|+ .-.||||.++. +.-..+.|+.|+.+|+.++|||+|+++++|.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE------DtMeveEFLkEAAvMKeikHpNLVqLLGVCT 333 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 333 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh------cchhHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence 578899999999999999999999999997 56799999873 3456788999999999999999999999998
Q ss_pred cCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 133 QPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 133 ~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
.+. +|||+|||.+|+|.+||++.+...++.-..+.++.||.+|+.||..+++|||||..+|+|+.++. .||++|||++
T Consensus 334 ~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh-iVKvADFGLs 412 (1157)
T KOG4278|consen 334 HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-IVKVADFGLS 412 (1157)
T ss_pred cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc-eEEeeccchh
Confidence 765 99999999999999999888777888888999999999999999999999999999999999886 8999999999
Q ss_pred cccccccccccCCc---ccccCCC----------------------------------------------CCCCCCCCCH
Q 019780 212 REEVMDEMTCEAGT---YRWMAPE----------------------------------------------NERPSLENLS 242 (336)
Q Consensus 212 ~~~~~~~~~~~~gt---~~y~aPE----------------------------------------------~~~~~~~~~~ 242 (336)
+....+.++...|. +.|.||| ..+..|..|+
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCP 492 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCC
Confidence 98877777776664 7999999 3456788999
Q ss_pred HHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 243 EDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 243 ~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
+.+|.|+..||+.+|..||+|+++-+.++.+++
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 999999999999999999999999998887764
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=269.31 Aligned_cols=238 Identities=20% Similarity=0.224 Sum_probs=187.0
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-EEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT-MMI 138 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~l 138 (336)
+|.+.+.||+|+||.||+|.+. +..||||++... ..........+..|..++..+. |++|+.+++++.+.+ .++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD--VVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 4778899999999999999886 578999999742 1122334456777888887774 889999999888765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 79 v~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-cEEEccCCCceecCCCC
Confidence 9999999999999843 35689999999999999999999999999999999999999887 8999999998753222
Q ss_pred -cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCC
Q 019780 218 -EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~ 295 (336)
......||+.|+|||.......+...|+|++++.+|++..+..|.... ....+..+..........+++++.+++..+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 235 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 235 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHH
Confidence 233456999999999999888999999999999999999998886332 122222333322223345666677777777
Q ss_pred CCCCCccccc
Q 019780 296 STMNNDCMAT 305 (336)
Q Consensus 296 ~~~~~~~~~~ 305 (336)
+..+|+.|.+
T Consensus 236 l~~~p~~R~~ 245 (323)
T cd05616 236 MTKHPGKRLG 245 (323)
T ss_pred cccCHHhcCC
Confidence 7777777754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=268.43 Aligned_cols=252 Identities=19% Similarity=0.238 Sum_probs=197.8
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
+..++|.+.+.||+|+||.||+|.+. +..+|+|++... ........+.+|+++++.++||||+++++++.+++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 77 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCE
Confidence 34578999999999999999999986 678999988631 23445677999999999999999999999988765
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+|||++.++ .+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~ 154 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL 154 (333)
T ss_pred EEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhh
Confidence 8999999999999999954 35689999999999999999999985 799999999999999876 7999999998754
Q ss_pred ccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHH--------------------
Q 019780 215 VMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL-------------------- 274 (336)
Q Consensus 215 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~-------------------- 274 (336)
.........|+..|+|||.......+...|+|+|++.+|++..+..|....-...+....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 155 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred hhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 333334456899999999998888889999999999999887777664221111111111
Q ss_pred ---------------------Hhhcc-CCC-----CCCCCcccccCCCCCCCCccccchhhhcccccccc
Q 019780 275 ---------------------QNLRS-ADT-----PIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 275 ---------------------~~~~~-~~~-----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
..... ..+ ..++++.+++...+..+|+.|++..++.+....+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 00000 001 13445667889999999999999998876554433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=270.68 Aligned_cols=232 Identities=24% Similarity=0.270 Sum_probs=182.4
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+||.||+|.+. ++.||+|+++.. ..........+..|..++..+ +||||+++++++.++. .|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKD--VILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHH--HhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 46999999999999986 678999999742 112334456677889998866 7999999999998765 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--cccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~ 221 (336)
++|+|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .++|+|||++...... ....
T Consensus 79 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 79 NGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeecccceecccCCccccc
Confidence 99999999843 35689999999999999999999999999999999999999887 7999999998753222 2334
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCC
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNN 300 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 300 (336)
..||+.|+|||.......+...|+|+|++.+|++..+..|.... -...+..+..........+++++.+++...+..+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp 235 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNP 235 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCH
Confidence 46899999999988888889999999999999999988885322 11222222222222233456667777777777777
Q ss_pred cccc
Q 019780 301 DCMA 304 (336)
Q Consensus 301 ~~~~ 304 (336)
+.|.
T Consensus 236 ~~R~ 239 (321)
T cd05591 236 NKRL 239 (321)
T ss_pred HHcC
Confidence 7776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=270.66 Aligned_cols=233 Identities=23% Similarity=0.271 Sum_probs=183.3
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+||.||+|.+. +..||+|+++.. ..........+.+|..++..+ +||||+++++++.+.. .|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKE--LVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 46999999999999985 778999999742 122334456788999999998 6999999999988765 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc--ccccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM--DEMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~--~~~~~ 221 (336)
+||+|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.... .....
T Consensus 79 ~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 79 SGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEECcCccccccccCCCcccc
Confidence 99999998843 35799999999999999999999999999999999999999876 799999999874221 22334
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh---------HHHHH-HHHHHHhhccCCCCCCCCcccc
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA---------EITIT-LTNILQNLRSADTPIPPKLVEI 291 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~---------~i~~~-l~~~~~~~~~~~~~~p~~~~~~ 291 (336)
..||+.|+|||.......+...|+|++++.++++..+..|... ..... ...+..........+++++.++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l 235 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSV 235 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 5699999999999888888999999999999999888887521 01111 1112222222233455566778
Q ss_pred cCCCCCCCCccccc
Q 019780 292 VDPKSTMNNDCMAT 305 (336)
Q Consensus 292 ~~~~~~~~~~~~~~ 305 (336)
+...+..+|..|.+
T Consensus 236 i~~~L~~dP~~R~~ 249 (329)
T cd05588 236 LKGFLNKDPKERLG 249 (329)
T ss_pred HHHHhccCHHHcCC
Confidence 88888888888865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=261.85 Aligned_cols=246 Identities=19% Similarity=0.230 Sum_probs=194.7
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|++.+.||+|+||+||++.+. ++.||+|++.... .........+.+|+.+++.++||||+++++.+.+++ .++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhh--hhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 4778899999999999999875 7899999986311 112233456788999999999999999999887655 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
|||+++|+|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG-HIRISDLGLAVEIPEGET 157 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC-CEEEeeCCCceecCCCCc
Confidence 9999999999988655556799999999999999999999999999999999999999876 79999999987543222
Q ss_pred ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH----HHHHHHHHHHh-hccCCCCCCCCcccccC
Q 019780 219 MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE----ITITLTNILQN-LRSADTPIPPKLVEIVD 293 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~----i~~~l~~~~~~-~~~~~~~~p~~~~~~~~ 293 (336)
.....|+..|+|||.......+...|+|+++..++++..+..|.... ....+...... .......+++.+.+++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 23346899999999988888888899999999999998888885321 11122221111 12223446777888999
Q ss_pred CCCCCCCcccc-----chhhhcc
Q 019780 294 PKSTMNNDCMA-----TVHAITK 311 (336)
Q Consensus 294 ~~~~~~~~~~~-----~~~~~~~ 311 (336)
..+..+|+.|. +..++.+
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 238 QLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred HHccCCHHHhcCCCCCCHHHHhc
Confidence 99999999998 5656654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=269.11 Aligned_cols=235 Identities=22% Similarity=0.245 Sum_probs=182.1
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHh-CCCCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK-MKHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+||.||+|.+. ++.||+|+++... .......+.+..|..++.. .+||||+++++++..+. .++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDV--VLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 46999999999999986 6789999997421 1122334455667777765 47999999999988765 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc--ccccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM--DEMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~--~~~~~ 221 (336)
+||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.... .....
T Consensus 79 ~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 79 NGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCCCcccc
Confidence 99999999844 35689999999999999999999999999999999999999876 799999999975322 22334
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCC
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNN 300 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 300 (336)
..||+.|+|||...+...+...|+|+|++.+|++..+..|.... ....+..+..........+++++.+++...+..+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P 235 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDP 235 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 56999999999998888889999999999999999888885321 11222222222222233456667778888888888
Q ss_pred ccccchh
Q 019780 301 DCMATVH 307 (336)
Q Consensus 301 ~~~~~~~ 307 (336)
+.|.+..
T Consensus 236 ~~R~~~~ 242 (316)
T cd05592 236 TKRLGVD 242 (316)
T ss_pred HHcCCCh
Confidence 8887653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=271.01 Aligned_cols=200 Identities=29% Similarity=0.473 Sum_probs=168.9
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEECC-ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYGC-EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
.+....++|.-...||+|+||.||+|...+ ..||||.+..... .. ...|.+|+.++.+++|||+|+++|+|.+.
T Consensus 69 el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~---~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 69 ELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSG---QG--EREFLNEVEILSRLRHPNLVKLLGYCLEG 143 (361)
T ss_pred HHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCC---cc--hhHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence 444556778877899999999999999875 8999998763211 11 34499999999999999999999999976
Q ss_pred C--EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCCCCceeecCCCCceEEeccc
Q 019780 135 T--MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS---VIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 135 ~--~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
. .+||+||+++|+|.++|+......++|..+..|+.+++.||+|||... ||||||||+|||+|.+. ..||+|||
T Consensus 144 ~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFG 222 (361)
T KOG1187|consen 144 GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFG 222 (361)
T ss_pred CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCcc
Confidence 5 899999999999999996544338899999999999999999999864 99999999999999887 89999999
Q ss_pred ccccccc-cc-cccc-CCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCC
Q 019780 210 LAREEVM-DE-MTCE-AGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRP 261 (336)
Q Consensus 210 ~a~~~~~-~~-~~~~-~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP 261 (336)
+|+.... .. ..+. .||.+|+|||.......+...|+|+++..+++...+++|
T Consensus 223 La~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~ 277 (361)
T KOG1187|consen 223 LAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKA 277 (361)
T ss_pred CcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcc
Confidence 9976543 22 2222 799999999999887888899999999999988777654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=275.22 Aligned_cols=201 Identities=19% Similarity=0.245 Sum_probs=169.6
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..+...+|.+.+.||+|+||.||+|.+. ++.+|+|++... ..........+.+|+.+++.++||||+++++++.++
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF--EMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 4456688999999999999999999986 678999998631 112233456688999999999999999999998877
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. .|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a~~ 191 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-HLKLADFGTCMK 191 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEEeccccee
Confidence 6 8999999999999999943 3588999999999999999999999999999999999999877 799999999975
Q ss_pred ccccc---ccccCCcccccCCCCCCCCC----CCCHHHHHHHHHHhhccCCCCCCCH
Q 019780 214 EVMDE---MTCEAGTYRWMAPENERPSL----ENLSEDMVALLKSCWAEDPKVRPEF 263 (336)
Q Consensus 214 ~~~~~---~~~~~gt~~y~aPE~~~~~~----~~~~~di~~l~~~~l~~~p~~RP~~ 263 (336)
..... .....||+.|+|||...... .+...|+|++++.++++..+..|..
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~ 248 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence 43222 23456999999999776543 5678999999999999999988864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=270.75 Aligned_cols=232 Identities=23% Similarity=0.293 Sum_probs=186.8
Q ss_pred eeecCCCcEEEEEeEE-----CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEE
Q 019780 68 KMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITE 141 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e 141 (336)
+.||+|+||.||++.. .++.+|+|++.... ........+.+|+.++++++||||+++++++.++. .|+|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHH---hhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence 5799999999999875 26889999997321 12234456788999999999999999999988765 899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--cc
Q 019780 142 LMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EM 219 (336)
Q Consensus 142 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~ 219 (336)
|+.+|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||+++..... ..
T Consensus 79 ~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 79 FLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCCCCce
Confidence 9999999999943 45689999999999999999999999999999999999999877 7999999998754332 22
Q ss_pred cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCCCCCCcccccCCCCCC
Q 019780 220 TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTPIPPKLVEIVDPKSTM 298 (336)
Q Consensus 220 ~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 298 (336)
....|++.|+|||.......+...|+|+|++.++++..++.|... +-...+..+..........+++.+.+++...+..
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~ 235 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKR 235 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence 345699999999998888888899999999999999998888532 2222233333333333345667778888889988
Q ss_pred CCccccc
Q 019780 299 NNDCMAT 305 (336)
Q Consensus 299 ~~~~~~~ 305 (336)
+|+.|.+
T Consensus 236 ~P~~R~~ 242 (318)
T cd05582 236 NPANRLG 242 (318)
T ss_pred CHhHcCC
Confidence 9988877
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=269.65 Aligned_cols=234 Identities=23% Similarity=0.292 Sum_probs=181.8
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHH-HHHhCCCCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVT-LLSKMKHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+||+||+|.+. ++.||+|++.... .........+..|.. +++.++||||+++++.+.+.. .++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKA--ILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 46999999999999985 7889999997321 112223344455554 567899999999999888765 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc--ccccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM--DEMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~--~~~~~ 221 (336)
.||+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... .....
T Consensus 79 ~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 79 NGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCCCcccc
Confidence 99999999843 45789999999999999999999999999999999999999887 799999999875322 22334
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCC
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNN 300 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 300 (336)
..||+.|+|||.......+...|+|+|++.++++-.+..|... +.......+........+.+++++.+++...+..++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDR 235 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 4699999999999888889999999999999999998888533 222233333333333445566667777777777777
Q ss_pred ccccch
Q 019780 301 DCMATV 306 (336)
Q Consensus 301 ~~~~~~ 306 (336)
..|.+.
T Consensus 236 ~~R~~~ 241 (323)
T cd05575 236 TKRLGA 241 (323)
T ss_pred HhCCCC
Confidence 777554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=273.98 Aligned_cols=250 Identities=20% Similarity=0.240 Sum_probs=190.5
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..+...+|.+.+.||+|+||.||+|.+. +..||+|++... ..........+.+|+.+++.++||||+++++++.++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF--EMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3456689999999999999999999986 788999999631 111223445678999999999999999999998877
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. .++||||++||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~~kL~DfG~~~~ 191 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMK 191 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC-CEEEEeccceee
Confidence 6 8999999999999999843 3588999999999999999999999999999999999999887 899999999875
Q ss_pred ccccc---ccccCCcccccCCCCCCCC----CCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhcc----CC
Q 019780 214 EVMDE---MTCEAGTYRWMAPENERPS----LENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRS----AD 281 (336)
Q Consensus 214 ~~~~~---~~~~~gt~~y~aPE~~~~~----~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~----~~ 281 (336)
..... .....||+.|+|||..... ..+...|+|+|++.++++..+..|...+- ...+..+...... ..
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCc
Confidence 43221 2345699999999977543 36678999999999999999988864332 2222333221111 11
Q ss_pred CCCCCCcccccCCCCCCCCcc--ccchhhhccc
Q 019780 282 TPIPPKLVEIVDPKSTMNNDC--MATVHAITKF 312 (336)
Q Consensus 282 ~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 312 (336)
..+++++.+++...+..+++. |.++.++.+.
T Consensus 272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 234555666666666655544 5566666543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=255.20 Aligned_cols=193 Identities=27% Similarity=0.279 Sum_probs=162.8
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC---
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT--- 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 135 (336)
.+.|+.+..|++|+||.||+|+++ ++.||+|.++..+ ......-.-+||+.+|.+++|||||.+-.+....+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek---ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK---EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc---ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 357889999999999999999987 7899999998532 12223345689999999999999999999887643
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
+|+|||||+. +|..++..- ..++...++.-++.|++.||+|||.+.|+||||||+|+|++..| .+||+|||+|+...
T Consensus 152 iy~VMe~~Eh-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-ILKIADFGLAREYG 228 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC-cEEecccchhhhhc
Confidence 9999999986 999999543 36899999999999999999999999999999999999999887 79999999999754
Q ss_pred cc--cccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCC
Q 019780 216 MD--EMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKV 259 (336)
Q Consensus 216 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~ 259 (336)
.. .++..+-|..|+|||.+.+. .++.+.|+|+++|.+-++...+
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~k 275 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQK 275 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcC
Confidence 43 35666789999999987765 5788999999999877665444
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=273.83 Aligned_cols=205 Identities=31% Similarity=0.483 Sum_probs=173.7
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
.|.+......-++-||+|+.|.||+|+..++.||||.++. .-..+++-|++|+||||+.|.++|....
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e------------lkETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE------------LKETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh------------hhhhhHHHHHhccCcceeeEeeeecCCc
Confidence 4666666677778899999999999999999999998762 2235678899999999999999999877
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
+|||||||..|-|...|+ .+..+.......|..+|+.|+.|||.+.|||||||.-||||+.+. .|||+|||.++..
T Consensus 186 cyCIiMEfCa~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-VVKISDFGTSKEL 262 (904)
T ss_pred eeEEeeeccccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-eEEeccccchHhh
Confidence 899999999999999994 446788999999999999999999999999999999999999886 8999999999864
Q ss_pred cc-ccccccCCcccccCCCCCCCCC----------------------------------------------CCCHHHHHH
Q 019780 215 VM-DEMTCEAGTYRWMAPENERPSL----------------------------------------------ENLSEDMVA 247 (336)
Q Consensus 215 ~~-~~~~~~~gt~~y~aPE~~~~~~----------------------------------------------~~~~~di~~ 247 (336)
.. .....++||..|||||+++..| .++|..+.-
T Consensus 263 ~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfkl 342 (904)
T KOG4721|consen 263 SDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKL 342 (904)
T ss_pred hhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHH
Confidence 33 3445678999999999554444 445555555
Q ss_pred HHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 248 LLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 248 l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
|+.+||+-.|..||+|.+|+..|+....
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 8899999999999999999988875543
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=269.67 Aligned_cols=235 Identities=22% Similarity=0.276 Sum_probs=182.0
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHH-HHHHhCCCCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREV-TLLSKMKHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+||+||+|.+. ++.||+|++.... .........+..|. .+++.++||||+++++++.+.+ .++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKA--ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--HHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 46999999999999986 6789999997311 11122223344444 4578899999999999988765 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc--ccccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM--DEMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~--~~~~~ 221 (336)
+||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++.... .....
T Consensus 79 ~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 79 NGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCCCCccc
Confidence 99999999943 45688999999999999999999999999999999999999877 799999999875322 22334
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCC
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNN 300 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 300 (336)
..||+.|+|||.......+...|+|+|++.+|++..+..|.... ....+..+........+.+++.+.+++...+..++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDR 235 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCH
Confidence 56999999999988888889999999999999999999886432 22233333333333445667777777777887777
Q ss_pred ccccchh
Q 019780 301 DCMATVH 307 (336)
Q Consensus 301 ~~~~~~~ 307 (336)
..|.+..
T Consensus 236 ~~R~~~~ 242 (325)
T cd05602 236 TKRLGAK 242 (325)
T ss_pred HHCCCCC
Confidence 7776543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=267.18 Aligned_cols=240 Identities=22% Similarity=0.255 Sum_probs=189.1
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+||+||+|.+. ++.||||+++.. ..........+.+|..++..+ +||||+++++++.+.. .++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKD--VILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH--HHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 46999999999999986 678999999732 112234456678899999888 6999999999988765 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--cccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~ 221 (336)
+||+|..++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++..... ....
T Consensus 79 ~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 79 NGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCCCcccc
Confidence 99999999843 35799999999999999999999999999999999999999887 7999999998753222 2233
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCC
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNN 300 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 300 (336)
.+|++.|+|||.......+...|+|++++.++++..+..|.... ....+..+..........+++++.+++...+..+|
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP 235 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNP 235 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCH
Confidence 46899999999998888899999999999999998888885321 11222222222222334466777788888888888
Q ss_pred ccccch-----hhhccc
Q 019780 301 DCMATV-----HAITKF 312 (336)
Q Consensus 301 ~~~~~~-----~~~~~~ 312 (336)
+.|.+. .++.+.
T Consensus 236 ~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 236 EKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHcCCCCCCCHHHHhcC
Confidence 888877 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=261.54 Aligned_cols=247 Identities=16% Similarity=0.180 Sum_probs=195.0
Q ss_pred ecCCceeEe--eeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec--C
Q 019780 59 VDHRSVLLQ--KMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ--P 134 (336)
Q Consensus 59 ~~~~~~~~~--~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~ 134 (336)
++..++... ..||+|++|.||+|.++++.||||.++.. ........+.+.+|+.+|++++||||+++++++.+ +
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKF--HKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccc--ccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 334444444 57999999999999999999999999742 22233445778899999999999999999999876 2
Q ss_pred ---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCceEEecccc
Q 019780 135 ---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 135 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
..++||||++||+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||+++.++ .+||+|||+
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~ 169 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGL 169 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccch
Confidence 37999999999999999954 35688999999999999999999984 999999999999999887 899999999
Q ss_pred ccccccccccccCCcccccCCCCCCC--CCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhh--ccCCCCCC
Q 019780 211 AREEVMDEMTCEAGTYRWMAPENERP--SLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNL--RSADTPIP 285 (336)
Q Consensus 211 a~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~--~~~~~~~p 285 (336)
++.... ......|+..|+|||.... ...+...|+|+|+..+|++..+..|....- ......+.... ...+...|
T Consensus 170 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (283)
T PHA02988 170 EKILSS-PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCP 248 (283)
T ss_pred Hhhhcc-ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCc
Confidence 875332 2234568899999998865 567889999999999999988888853221 11222222211 11223567
Q ss_pred CCcccccCCCCCCCCccccchhhhcc
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+++.+++...|..+|+.|++..++..
T Consensus 249 ~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 249 LEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 88999999999999999998887764
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=265.74 Aligned_cols=238 Identities=21% Similarity=0.245 Sum_probs=182.9
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHh-CCCCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK-MKHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+||.||+|.+. ++.||||+++... ............|..++.. ++||||+++++++.+.. .++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDV--VLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 46999999999999986 6789999997421 1112334556677788876 48999999999988765 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc--ccccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM--DEMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~--~~~~~ 221 (336)
+||+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++ .++|+|||+++.... .....
T Consensus 79 ~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 79 NGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCCCceee
Confidence 99999999943 35688999999999999999999999999999999999999887 799999999875322 22334
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhccCCCCCCCCcccccCCCCCCCC
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRSADTPIPPKLVEIVDPKSTMNN 300 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 300 (336)
..||+.|+|||.......+...|+|++++.+|++-.+..|....- ...+..+..........++.++.+++...+..+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P 235 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREP 235 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCH
Confidence 569999999999988888999999999999999999988853221 1112222111111222345556778888888888
Q ss_pred ccccchh-hhc
Q 019780 301 DCMATVH-AIT 310 (336)
Q Consensus 301 ~~~~~~~-~~~ 310 (336)
+.|.++. ++.
T Consensus 236 ~~R~~~~~~l~ 246 (316)
T cd05619 236 ERRLGVKGDIR 246 (316)
T ss_pred hhcCCChHHHH
Confidence 8887664 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=267.91 Aligned_cols=234 Identities=23% Similarity=0.261 Sum_probs=184.8
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+||.||+|... ++.||+|+++.. ..........+.+|+.++..+ +||||+.+++++.+.. +++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKE--LVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 46999999999999875 678999999742 222334566788999999888 5999999999988765 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc--ccccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM--DEMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~--~~~~~ 221 (336)
+||+|..++.. ...+++..++.++.|++.||+|||++|++||||||+|||++.++ .+||+|||+++.... .....
T Consensus 79 ~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 79 NGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCCCceec
Confidence 99999998843 35699999999999999999999999999999999999999887 799999999875322 22334
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-------HHHHHH-HHHHHhhccCCCCCCCCcccccC
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-------EITITL-TNILQNLRSADTPIPPKLVEIVD 293 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-------~i~~~l-~~~~~~~~~~~~~~p~~~~~~~~ 293 (336)
.+||+.|+|||......++...|+|+|++.++++..+..|... .....+ ..+..........+++.+..++.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 235 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLK 235 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 5699999999999888899999999999999999888888521 111111 12222222233345666777888
Q ss_pred CCCCCCCccccch
Q 019780 294 PKSTMNNDCMATV 306 (336)
Q Consensus 294 ~~~~~~~~~~~~~ 306 (336)
..+..+|+.|.+.
T Consensus 236 ~~L~~dP~~R~~~ 248 (327)
T cd05617 236 GFLNKDPKERLGC 248 (327)
T ss_pred HHhccCHHHcCCC
Confidence 8888888888664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=277.65 Aligned_cols=250 Identities=21% Similarity=0.246 Sum_probs=201.0
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC--
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-- 134 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 134 (336)
...++|.+.+.||+|+||+||+|.+. ++.||||++... .........+.+|+..+..++|+||+++.+.+...
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~---~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDME---GMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecc---cCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34578999999999999999999874 789999999742 22445567789999999999999999988766432
Q ss_pred -------CEEEEEEccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEE
Q 019780 135 -------TMMIITELMRGETLQRYLWST--RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKL 205 (336)
Q Consensus 135 -------~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl 205 (336)
.+++||||+++|+|.+++... ....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~-~vkL 184 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG-LVKL 184 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC-CEEE
Confidence 167999999999999998542 235689999999999999999999999999999999999999876 7999
Q ss_pred eccccccccccc----cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHH-hhcc
Q 019780 206 ADFGLAREEVMD----EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQ-NLRS 279 (336)
Q Consensus 206 ~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~-~~~~ 279 (336)
+|||+++..... ......||+.|+|||......++...|+|+|+..+|++-.+.+|....-. ..+..... ....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 999998753221 12345699999999999988899999999999999999999888643222 22222222 1222
Q ss_pred CCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 280 ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 280 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
....+++++.+++...+..+|+.|++..++...
T Consensus 265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 345677788899999999999999998887654
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=261.38 Aligned_cols=244 Identities=23% Similarity=0.265 Sum_probs=188.1
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||+|++. ++.+|+|++.... ........+.+|+.+++.++||||+++++++.++. .++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE---ENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc---ccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 6889999999999999999986 6789999997421 22334567889999999999999999999887665 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
|||++++.+..+. .....+++..++.++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLE--EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccCccccccccc
Confidence 9999987776554 2335689999999999999999999999999999999999999876 79999999997643221
Q ss_pred --ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh----HHHHHHHHHHHhhc--------c-----
Q 019780 219 --MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA----EITITLTNILQNLR--------S----- 279 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~----~i~~~l~~~~~~~~--------~----- 279 (336)
.....|++.|+|||.......+...|+|+++..++++..++.|... +.+..+..+...+. .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 2234689999999998888888999999999999999888877522 11111111110000 0
Q ss_pred ----------------CCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 280 ----------------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 280 ----------------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
....+++++.+++...+..+|+.|.+..++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 001144556677788888888888887776653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=266.29 Aligned_cols=238 Identities=21% Similarity=0.241 Sum_probs=184.4
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+||.||+|.+. +..||+|+++.... ...........|..++... +||||+++++++.+.+ .|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 46999999999999986 67899999974211 1123345567788887754 8999999999988766 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc--cccccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV--MDEMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~--~~~~~~ 221 (336)
.||+|..++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .++|+|||+++... ......
T Consensus 79 ~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 79 NGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCCCceec
Confidence 99999999844 35689999999999999999999999999999999999999887 79999999987432 222344
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHHhhccCCCCCCCCcccccCCCCCCCC
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQNLRSADTPIPPKLVEIVDPKSTMNN 300 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 300 (336)
..||+.|+|||.......+...|+|++++.++++..+..|...+-. ..+..+..........+++++.+++...+..+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 235 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDP 235 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 5699999999999888888999999999999999988888633221 122222222222223355667778888888888
Q ss_pred ccccch-hhhc
Q 019780 301 DCMATV-HAIT 310 (336)
Q Consensus 301 ~~~~~~-~~~~ 310 (336)
+.|.++ .++.
T Consensus 236 ~~R~~~~~~~~ 246 (316)
T cd05620 236 TRRLGVVGNIR 246 (316)
T ss_pred HHcCCChHHHH
Confidence 888765 3444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=275.98 Aligned_cols=244 Identities=19% Similarity=0.236 Sum_probs=195.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC---CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG---CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
..|.+.+.||+|+||.||+|... +..||+|.+.. ........+.+|+.+|+.++||||+++++++.+++ .|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~-----~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML-----NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc-----CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 45999999999999999999875 45788887642 13344567888999999999999999999988765 89
Q ss_pred EEEEccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 138 IITELMRGETLQRYLWST--RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
+||||++||+|.+++... ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~ 220 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYS 220 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-cEEEEeCcCceecC
Confidence 999999999999988532 345688999999999999999999999999999999999999877 79999999998543
Q ss_pred ccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHH-hhccCCCCCCCCcc
Q 019780 216 MDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQ-NLRSADTPIPPKLV 289 (336)
Q Consensus 216 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~-~~~~~~~~~p~~~~ 289 (336)
... ....+||+.|+|||.......+...|+|+|++.++++..+..|.... ....+..+.. ........+++++.
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 300 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK 300 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHH
Confidence 221 23446999999999998888899999999999999999888885322 2222222222 12222345677788
Q ss_pred cccCCCCCCCCccccchhhhcc
Q 019780 290 EIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+++...+..+|+.|++..++..
T Consensus 301 ~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 301 ALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHhccChhhCcCHHHHHh
Confidence 8999999999999988766643
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=257.72 Aligned_cols=238 Identities=19% Similarity=0.250 Sum_probs=198.8
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
.+--++|..+++||+|.||.|-+++.+ ++.+|||++++ ......+....-+.|-++|...+||++..+-..|+.++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkK--eviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKK--EVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhh--hheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 345567888999999999999999876 88999999984 45566777888899999999999999998877777655
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
+|+||||..||.|.-+| .+...+++...+.+..+|++||.|||+++||+||||.+|+|+|.+| ++||+|||+++..
T Consensus 242 rlCFVMeyanGGeLf~HL--srer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG-HIKitDFGLCKE~ 318 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHL--SRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG-HIKITDFGLCKEE 318 (516)
T ss_pred eEEEEEEEccCceEeeeh--hhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC-ceEeeecccchhc
Confidence 99999999999999998 4456799999999999999999999999999999999999999998 8999999999965
Q ss_pred ccc--cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH-HHHHHHhhccCCCCCCCCcccc
Q 019780 215 VMD--EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITIT-LTNILQNLRSADTPIPPKLVEI 291 (336)
Q Consensus 215 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~-l~~~~~~~~~~~~~~p~~~~~~ 291 (336)
... ...+.|||+.|+|||++....++.+.|+|.++..|+++-.++-|...+=-.. ++-+.-.-...+..++|+...+
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTL 398 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHH
Confidence 433 4567899999999999999999999999999999999999999986543333 2333333334556677777766
Q ss_pred cCCCCCCCC
Q 019780 292 VDPKSTMNN 300 (336)
Q Consensus 292 ~~~~~~~~~ 300 (336)
+.-++...|
T Consensus 399 LsGLL~kdP 407 (516)
T KOG0690|consen 399 LSGLLKKDP 407 (516)
T ss_pred HHHHhhcCh
Confidence 655555554
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=274.66 Aligned_cols=244 Identities=27% Similarity=0.358 Sum_probs=197.6
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
..|...+.||+|+||.||+|.++ ++.||+|++.. .......+.+++|+.+|.+++++||.++|+.+..+. +|+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~L----e~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDL----EEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEech----hhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 45666789999999999999987 78999999973 344566788999999999999999999999888765 999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
+||||.||++.+.+ ..+..+.+..+..++++++.||.|||.++.+|||||+.|||+..+| .+||+|||.+.......
T Consensus 89 iMey~~gGsv~~lL--~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLL--KSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG-DVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHhcCcchhhhh--ccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC-cEEEEecceeeeeechh
Confidence 99999999999999 4444558888999999999999999999999999999999999986 89999999998654432
Q ss_pred --ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH--HHHHH-HHhhccCCCCCCCCcccccC
Q 019780 219 --MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITI--TLTNI-LQNLRSADTPIPPKLVEIVD 293 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~--~l~~~-~~~~~~~~~~~p~~~~~~~~ 293 (336)
..+++||+.|||||++....++...|||+|+..++++..++.|... +-. .+-.+ .......+...++.+.+.+.
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~-~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~ 244 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSK-LHPMRVLFLIPKSAPPRLDGDFSPPFKEFVE 244 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcc-cCcceEEEeccCCCCCccccccCHHHHHHHH
Confidence 3567899999999999999999999999999999999999988532 111 00000 01111122344555666777
Q ss_pred CCCCCCCccccchhhhcccc
Q 019780 294 PKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~ 313 (336)
..+..+|+.|++...+.+..
T Consensus 245 ~CL~k~P~~RpsA~~LLKh~ 264 (467)
T KOG0201|consen 245 ACLDKNPEFRPSAKELLKHK 264 (467)
T ss_pred HHhhcCcccCcCHHHHhhhH
Confidence 78888888888887777643
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=268.48 Aligned_cols=247 Identities=19% Similarity=0.227 Sum_probs=192.5
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||+||+|... ++.||+|+++.. ..........+.+|+.+++.++||||+++++++.+.. .++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKS--VLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 36889999999999999999885 788999999742 1223345677889999999999999999999888765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||++||+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 79 VMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-HIKLADFGSAARLTANK 156 (330)
T ss_pred EECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC-CEEeccCCCCeECCCCC
Confidence 99999999999999543 25689999999999999999999999999999999999999877 79999999997543322
Q ss_pred ---ccccCCcccccCCCCCC------CCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhh--cc--CCCCC
Q 019780 219 ---MTCEAGTYRWMAPENER------PSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNL--RS--ADTPI 284 (336)
Q Consensus 219 ---~~~~~gt~~y~aPE~~~------~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~--~~--~~~~~ 284 (336)
.....||+.|+|||... ....+...|+|+|++.++++..+..|.... ....+..+.... .. ..+.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 12346899999999765 445668899999999999999998886332 122222222211 11 11245
Q ss_pred CCCcccccCCCCCCCCccccchhhhcccc
Q 019780 285 PPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
++++.+++..++. ++..|.+..++....
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 6667777777776 788888777776543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=267.98 Aligned_cols=213 Identities=30% Similarity=0.491 Sum_probs=164.4
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEe
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILK 126 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~ 126 (336)
..+.+..++|.+.+.||+|+||.||+|.+. +..||||+++.. ......+.+.+|+.+|..+ +||||++
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~~Ei~il~~l~~HpnIv~ 103 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHINIVN 103 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCC----cCcHHHHHHHHHHHHHHHhcCCcceee
Confidence 355666778999999999999999999742 457999998732 1233456788999999999 7999999
Q ss_pred eEeeEecCC-EEEEEEccCCCCHHHHHhhcC-------------------------------------------------
Q 019780 127 FVGASVQPT-MMIITELMRGETLQRYLWSTR------------------------------------------------- 156 (336)
Q Consensus 127 ~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~------------------------------------------------- 156 (336)
+++++.+.. .++||||++||+|.++++...
T Consensus 104 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 183 (375)
T cd05104 104 LLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKA 183 (375)
T ss_pred eeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccc
Confidence 999988765 899999999999999985432
Q ss_pred ------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 157 ------------------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 157 ------------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
...+++..++.++.||+.||.|||++|++||||||+|||++.++ .++|+|||+++
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~ 262 (375)
T cd05104 184 DKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-ITKICDFGLAR 262 (375)
T ss_pred ccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-cEEEecCccce
Confidence 12478888999999999999999999999999999999999776 79999999987
Q ss_pred ccccccc----cccCCcccccCCCCCCCCCCC-----------------------------------------------C
Q 019780 213 EEVMDEM----TCEAGTYRWMAPENERPSLEN-----------------------------------------------L 241 (336)
Q Consensus 213 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~-----------------------------------------------~ 241 (336)
....... ....++..|+|||.......+ .
T Consensus 263 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (375)
T cd05104 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECA 342 (375)
T ss_pred eccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCC
Confidence 5432221 112345679999943332222 3
Q ss_pred HHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 019780 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTN 272 (336)
Q Consensus 242 ~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~ 272 (336)
+.++.+|+..||+.+|.+||++.++++.|++
T Consensus 343 ~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 343 PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 4556667777777777777777777666653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=267.73 Aligned_cols=234 Identities=23% Similarity=0.271 Sum_probs=183.6
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+||.||+|.+. ++.||+|+++.. ..........+.+|+.++..+ +||||+++++++.+.. .++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKE--LVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhh--HhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 46999999999999986 678999999742 122334556788899988877 7999999999988765 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--cccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~ 221 (336)
++|+|..++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++..... ....
T Consensus 79 ~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 79 NGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCCCcccc
Confidence 99999998843 35799999999999999999999999999999999999999887 7999999998753221 2234
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh---------HHHHHH-HHHHHhhccCCCCCCCCcccc
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA---------EITITL-TNILQNLRSADTPIPPKLVEI 291 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~---------~i~~~l-~~~~~~~~~~~~~~p~~~~~~ 291 (336)
..||+.|+|||.......+...|+|+|++.++++..+..|... .....+ ..+..........+++++.++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 235 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 235 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 5699999999999888889999999999999999988888521 111111 112222222333455556678
Q ss_pred cCCCCCCCCccccch
Q 019780 292 VDPKSTMNNDCMATV 306 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~ 306 (336)
+...+..+|+.|.+.
T Consensus 236 l~~~L~~dP~~R~~~ 250 (329)
T cd05618 236 LKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHhcCCHHHcCCC
Confidence 888888888888763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=265.02 Aligned_cols=244 Identities=25% Similarity=0.317 Sum_probs=187.2
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC------
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP------ 134 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------ 134 (336)
+|.+.+.||+|+||.||+|.+. +..||||++... .........+.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV---FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechh---hccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 4788999999999999999975 789999998631 11223345788999999999999999999987532
Q ss_pred CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 135 TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 135 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
..|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 78 ~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~ 153 (338)
T cd07859 78 DIYVVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVA 153 (338)
T ss_pred eEEEEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEccCcccccc
Confidence 2799999995 689998843 35689999999999999999999999999999999999999887 7999999999753
Q ss_pred cccc-----ccccCCcccccCCCCCCC--CCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHH---------------
Q 019780 215 VMDE-----MTCEAGTYRWMAPENERP--SLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLT--------------- 271 (336)
Q Consensus 215 ~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~--------------- 271 (336)
.... .....||+.|+|||.... ...+.+.|+|+|++.++++..++.|.... ....+.
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 2211 123468999999998655 56778899999999999998887775211 111110
Q ss_pred --------HHHHhhcc--------CCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 272 --------NILQNLRS--------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 272 --------~~~~~~~~--------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.....+.. ..+..++.+.+++...+..+|+.|++..++.+..
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 00111111 1123556677888889999999999888877644
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=266.05 Aligned_cols=238 Identities=20% Similarity=0.217 Sum_probs=184.5
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-EEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT-MMI 138 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~l 138 (336)
+|.+.+.||+|+||.||+|.+. ++.||+|++... ..........+..|..++..+. |++|+++++++.+.+ .|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD--VVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 3667899999999999999885 788999998731 1122334566788899998886 567778888887665 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||++||+|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|||++.++ .++|+|||+++.....
T Consensus 79 v~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 79 VMEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeccccccccCCCC
Confidence 9999999999999843 35699999999999999999999999999999999999999887 7999999998753222
Q ss_pred -cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCC
Q 019780 218 -EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~ 295 (336)
......||+.|+|||.......+...|+|+++..+|++..+..|.... -...+..+..........+++++.+++...
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~ 235 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 235 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence 223345999999999988888889999999999999999988885332 112222333322223344556666677777
Q ss_pred CCCCCccccc
Q 019780 296 STMNNDCMAT 305 (336)
Q Consensus 296 ~~~~~~~~~~ 305 (336)
+..+|..|.+
T Consensus 236 l~~~p~~R~~ 245 (323)
T cd05615 236 MTKHPSKRLG 245 (323)
T ss_pred cccCHhhCCC
Confidence 7777776654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=271.23 Aligned_cols=201 Identities=19% Similarity=0.247 Sum_probs=169.0
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..+..++|.+.+.||+|+||.||+|.+. ++.+|+|++... ..........+.+|+.+++.++||||+++++++.++
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF--EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHH--HhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 4556689999999999999999999986 778999998631 112233456688999999999999999999998876
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. .++||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a~~ 191 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMK 191 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-CEEEEeCCceeE
Confidence 6 8999999999999999843 3588999999999999999999999999999999999999887 799999999975
Q ss_pred ccccc---ccccCCcccccCCCCCCCCC----CCCHHHHHHHHHHhhccCCCCCCCH
Q 019780 214 EVMDE---MTCEAGTYRWMAPENERPSL----ENLSEDMVALLKSCWAEDPKVRPEF 263 (336)
Q Consensus 214 ~~~~~---~~~~~gt~~y~aPE~~~~~~----~~~~~di~~l~~~~l~~~p~~RP~~ 263 (336)
..... .....||+.|+|||...... .+...|+|+|++.++++..+..|..
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 248 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence 43221 23456999999999876433 5678999999999999998888863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=268.02 Aligned_cols=233 Identities=24% Similarity=0.316 Sum_probs=176.8
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHH-HHHhCCCCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVT-LLSKMKHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+||.||+|.+. ++.+|+|++... ..........+.+|.. +++.++||||+++++.+..++ .++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKK--IVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 46999999999999875 789999999732 1112233445555555 567899999999999888665 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc--ccccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM--DEMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~--~~~~~ 221 (336)
+||+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .....
T Consensus 79 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 79 NGGELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCCCCccc
Confidence 9999999884 345789999999999999999999999999999999999999887 799999999875322 22334
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCC
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNN 300 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 300 (336)
..||+.|+|||.......+...|+|+|++.++++-.+..|.... ....+..+........+..++.+.+++...+..++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p 235 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDR 235 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCH
Confidence 56999999999998888889999999999999999888886332 22222333322222233344455555655665555
Q ss_pred ccccc
Q 019780 301 DCMAT 305 (336)
Q Consensus 301 ~~~~~ 305 (336)
..|.+
T Consensus 236 ~~R~~ 240 (325)
T cd05604 236 QRRLG 240 (325)
T ss_pred HhcCC
Confidence 55543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=266.47 Aligned_cols=232 Identities=23% Similarity=0.282 Sum_probs=178.4
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHH-HHHhCCCCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVT-LLSKMKHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+||.||+|.+. ++.||+|++.... .........+.+|.. +++.++||||+++++++.+.+ .|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKT--ILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--HHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 46999999999999985 7889999997321 112233344555554 678899999999999888765 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc--ccccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM--DEMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~--~~~~~ 221 (336)
+||+|...+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.... .....
T Consensus 79 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 79 NGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCCCcccc
Confidence 99999998843 45688999999999999999999999999999999999999887 799999999875322 12233
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCC
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNN 300 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 300 (336)
..||+.|+|||.......+...|+|+|++.++++..+..|.... .......+...........+.++.+++..++..++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQ 235 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 46899999999998888888999999999999999998886332 22223333333223333445556667777777777
Q ss_pred cccc
Q 019780 301 DCMA 304 (336)
Q Consensus 301 ~~~~ 304 (336)
..|.
T Consensus 236 ~~R~ 239 (321)
T cd05603 236 RRRL 239 (321)
T ss_pred hhcC
Confidence 6664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=260.14 Aligned_cols=247 Identities=25% Similarity=0.289 Sum_probs=187.3
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
..+|.+.+.||+|+||.||+|... ++.||||+++... .......+.+|+.+++.++||||+++++++.+.. .+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE----EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc----ccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence 467999999999999999999985 7889999987421 1222345778999999999999999999988765 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||++ ++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-ELKLADFGLARAKSVP 156 (303)
T ss_pred EEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECCCCcceeccCC
Confidence 9999996 5888887543 35688999999999999999999999999999999999999876 7999999998743221
Q ss_pred --cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCH--hHHHHHHHHHHHhhccCC-----------
Q 019780 218 --EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEF--AEITITLTNILQNLRSAD----------- 281 (336)
Q Consensus 218 --~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~--~~i~~~l~~~~~~~~~~~----------- 281 (336)
......|++.|+|||.... ...+...|+|++++.++++-.+..|.. .+....+..+...+....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 2234568899999998654 456788999999999999988888752 233333333322211100
Q ss_pred ---------------------CCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 282 ---------------------TPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 282 ---------------------~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
...++.+.+++...+..+|..|.+..++.+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 012234456667777777888877777765443
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=254.73 Aligned_cols=243 Identities=26% Similarity=0.426 Sum_probs=195.0
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC--
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-- 134 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 134 (336)
|.++..+|.+.+.||+|+||.||++...+..+++|.++. ....+.+.+|+.+++.++|+|++++++++...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN-------DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCC-------CchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence 456778999999999999999999999999999999862 12345788999999999999999999876533
Q ss_pred CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 135 TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 135 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
..+++|||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||+++..
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~ 152 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA 152 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC-cEEecCCccceec
Confidence 489999999999999999765555689999999999999999999999999999999999999876 7999999998754
Q ss_pred ccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCC----HhHHHHHHHHHHHhh-ccCCCCCCCCc
Q 019780 215 VMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPE----FAEITITLTNILQNL-RSADTPIPPKL 288 (336)
Q Consensus 215 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~----~~~i~~~l~~~~~~~-~~~~~~~p~~~ 288 (336)
.... ....++..|+|||.......+...|+|++++.++++.. ++-|. ..++...+. +.. .......|+.+
T Consensus 153 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 228 (256)
T cd05082 153 SSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE---KGYKMDAPDGCPPVV 228 (256)
T ss_pred cccC-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---cCCCCCCCCCCCHHH
Confidence 3222 23345678999998888888889999999999987764 44443 223322221 111 11224567778
Q ss_pred ccccCCCCCCCCccccchhhhcc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.+++...+..+|+.|++..++.+
T Consensus 229 ~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 229 YDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHH
Confidence 88899999999999998887764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=258.35 Aligned_cols=240 Identities=22% Similarity=0.239 Sum_probs=186.8
Q ss_pred ecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccCCC
Q 019780 70 IGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRGE 146 (336)
Q Consensus 70 lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~gg 146 (336)
||+|+||+||++.+. ++.+|+|.+.... .......+.+..|+.+++.++||||+++.+++.++. .++||||++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKR--LKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHH--HhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 699999999999875 7889999986321 112233456788999999999999999999887665 89999999999
Q ss_pred CHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc--cccc
Q 019780 147 TLQRYLWST--RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE--MTCE 222 (336)
Q Consensus 147 ~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~--~~~~ 222 (336)
+|.+++... ....+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||++....... ....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcccccc
Confidence 999887432 345689999999999999999999999999999999999999876 79999999987533222 2234
Q ss_pred CCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-----HHHHHHHHHHhhccCCCCCCCCcccccCCCCC
Q 019780 223 AGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-----ITITLTNILQNLRSADTPIPPKLVEIVDPKST 297 (336)
Q Consensus 223 ~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-----i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~ 297 (336)
.||+.|+|||.......+...|+|++++.++++..++-|.... .......+..........+|+++.+++...+.
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 6899999999998888899999999999999988877775221 11111111122222234567778889999999
Q ss_pred CCCcccc-----chhhhccc
Q 019780 298 MNNDCMA-----TVHAITKF 312 (336)
Q Consensus 298 ~~~~~~~-----~~~~~~~~ 312 (336)
.+|+.|. +..++.+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcC
Confidence 9999987 55556553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=265.05 Aligned_cols=249 Identities=22% Similarity=0.241 Sum_probs=193.7
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
....+|...+.||+|+||.||+|.+. ++.||||++... ........+.+|+.+++.++|+||+++++++.++.
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN----HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE 146 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC----CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence 34467888899999999999999985 789999998632 23345677899999999999999999999988765
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
+++||||+.+|+|.+.. ..++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 147 ~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~~ 219 (353)
T PLN00034 147 IQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILA 219 (353)
T ss_pred EEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEcccccceecc
Confidence 89999999999986532 356778889999999999999999999999999999999876 79999999987543
Q ss_pred cc--cccccCCcccccCCCCCCC-----CCCCCHHHHHHHHHHhhccCCCCCCCHh----HHHHHHHHHHH-hhccCCCC
Q 019780 216 MD--EMTCEAGTYRWMAPENERP-----SLENLSEDMVALLKSCWAEDPKVRPEFA----EITITLTNILQ-NLRSADTP 283 (336)
Q Consensus 216 ~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~~di~~l~~~~l~~~p~~RP~~~----~i~~~l~~~~~-~~~~~~~~ 283 (336)
.. ......||..|+|||.+.. ...+...|+|+|++.+|++..++.|... +.......+.. ........
T Consensus 220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (353)
T PLN00034 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT 299 (353)
T ss_pred cccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCc
Confidence 22 1234569999999997643 3345689999999999999888887531 22111111111 11122345
Q ss_pred CCCCcccccCCCCCCCCccccchhhhccccccccc
Q 019780 284 IPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGKK 318 (336)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (336)
.++++.+++...+..+++.|.+..++.+.....+.
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 66778889999999999999999988876554443
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=254.07 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=197.3
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
|.+..++|++.+.||+|+||.||+|... +..||+|.+... ....+.+.+|+.+++.++|+||+++++.+.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG------TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE 74 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC------chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3466789999999999999999999875 677999987631 223567899999999999999999999887665
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.+++|||+++++|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~ 153 (261)
T cd05072 75 PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVI 153 (261)
T ss_pred CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-cEEECCCccceec
Confidence 89999999999999999766667789999999999999999999999999999999999999876 7999999999754
Q ss_pred ccccc---cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHH-HHHHHhhc-cCCCCCCCCc
Q 019780 215 VMDEM---TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITL-TNILQNLR-SADTPIPPKL 288 (336)
Q Consensus 215 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l-~~~~~~~~-~~~~~~p~~~ 288 (336)
..... ....++..|+|||.......+...|+|+|++.++++-. +..|....-...+ ..+..... ......|.++
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDEL 233 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 33221 12235678999998887778888999999999999886 7777532211111 11211111 1223456778
Q ss_pred ccccCCCCCCCCccccchhhhccc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.+++...+..+|+.|++..++.+.
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~i~~~ 257 (261)
T cd05072 234 YDIMKTCWKEKAEERPTFDYLQSV 257 (261)
T ss_pred HHHHHHHccCCcccCcCHHHHHHH
Confidence 888899999999999988887653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=261.62 Aligned_cols=247 Identities=21% Similarity=0.351 Sum_probs=193.8
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--Cc----cEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CE----PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
+...+|.+.+.||+|+||.||+|.+. +. .||+|+++. .........+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICL 79 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence 45678999999999999999999863 33 389999863 223445677889999999999999999999998
Q ss_pred cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 133 QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 133 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
....+++++|+++|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 80 ~~~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-~~kl~DfG~a~ 157 (316)
T cd05108 80 TSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-HVKITDFGLAK 157 (316)
T ss_pred CCCceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-cEEEccccccc
Confidence 88889999999999999999543 34688999999999999999999999999999999999999876 79999999998
Q ss_pred ccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHhhc--cCCCCCC
Q 019780 213 EEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQNLR--SADTPIP 285 (336)
Q Consensus 213 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~~~--~~~~~~p 285 (336)
....... ....++..|+|||.......+...|+|+++..+|++.. +..|....-...+..+..... ...+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 237 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCC
Confidence 5433221 11224578999999988888999999999999999765 666643222222233322211 1123345
Q ss_pred CCcccccCCCCCCCCccccchhhhcc
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
..+..++...+..+|+.|++..++..
T Consensus 238 ~~~~~li~~cl~~~p~~Rps~~~l~~ 263 (316)
T cd05108 238 IDVYMIMVKCWMIDADSRPKFRELII 263 (316)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 56777888889899999998887775
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=269.82 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=196.9
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceE
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENIL 125 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv 125 (336)
...|.+..++|.+.+.||+|+||.||+|.+. ...||+|+++.. ........+.+|+.+++.+ +|+||+
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~il~~l~~h~nIv 105 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS----AHTDEREALMSELKILSHLGQHKNIV 105 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCC----CCHHHHHHHHHHHHHHHhhccCCcee
Confidence 4466677889999999999999999999853 247999999732 1234467789999999999 799999
Q ss_pred eeEeeEecCC-EEEEEEccCCCCHHHHHhhcC------------------------------------------------
Q 019780 126 KFVGASVQPT-MMIITELMRGETLQRYLWSTR------------------------------------------------ 156 (336)
Q Consensus 126 ~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~------------------------------------------------ 156 (336)
++++++.+.. .++||||+++|+|.++++...
T Consensus 106 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (374)
T cd05106 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMR 185 (374)
T ss_pred eEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccC
Confidence 9999988765 899999999999999985321
Q ss_pred --------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 157 --------------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 157 --------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
...+++..++.++.||+.||.|||++|++||||||+|||++.++ .++|+|||+++....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~ 264 (374)
T cd05106 186 PVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMN 264 (374)
T ss_pred CccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-eEEEeeceeeeeccC
Confidence 12478888999999999999999999999999999999999776 899999999875432
Q ss_pred cccc----ccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHH-HHHHHHHh-hcc-CCCCCCCCc
Q 019780 217 DEMT----CEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITI-TLTNILQN-LRS-ADTPIPPKL 288 (336)
Q Consensus 217 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~-~l~~~~~~-~~~-~~~~~p~~~ 288 (336)
.... ...++..|+|||.......+...|+|++++.+|++.. +..|....... .+...... ... .....|+++
T Consensus 265 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 344 (374)
T cd05106 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEI 344 (374)
T ss_pred CcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHH
Confidence 2211 1234567999999888888999999999999999874 66664332111 11122211 111 122357788
Q ss_pred ccccCCCCCCCCccccchhhhccc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.+++...+..+|+.|++..++.+.
T Consensus 345 ~~li~~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 345 YSIMKMCWNLEPTERPTFSQISQL 368 (374)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 889999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=256.77 Aligned_cols=196 Identities=26% Similarity=0.311 Sum_probs=159.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC---CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC---CCCceEeeEeeEec--
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG---CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM---KHENILKFVGASVQ-- 133 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~-- 133 (336)
++|.+.+.||+|+||.||+|.+. +..||+|+++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC---CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 36888999999999999999873 57799999874221 122233455677776655 69999999998752
Q ss_pred ----CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 134 ----PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 134 ----~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
...++||||++ ++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.++ .++|+|||
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg 155 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFG 155 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-CEEEcccc
Confidence 23899999997 5999999665556789999999999999999999999999999999999999877 79999999
Q ss_pred ccccccccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 210 LAREEVMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 210 ~a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
+++...... .....|++.|+|||.......+.+.|+|++++.++++-.+..|.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f 209 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCc
Confidence 997543322 23446899999999988888888999999999999988776664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=252.52 Aligned_cols=212 Identities=30% Similarity=0.349 Sum_probs=169.2
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCc-eEeeEeeEecC---
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN-ILKFVGASVQP--- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~--- 134 (336)
...|..++.||+|+||+||+|+.. ++.||+|.++..... +.......+|+.+|+.++|+| |+++++++.+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~---EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE---EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc---cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 345677788999999999999986 889999999853221 223455789999999999999 99999998753
Q ss_pred ----CEEEEEEccCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecc
Q 019780 135 ----TMMIITELMRGETLQRYLWSTRP--KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADF 208 (336)
Q Consensus 135 ----~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Df 208 (336)
.+++|+||++. +|..++..... ..++...++.+++||+.||+|||++||+||||||.|||++.+| .+||+||
T Consensus 87 ~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-~lKlaDF 164 (323)
T KOG0594|consen 87 RGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-VLKLADF 164 (323)
T ss_pred cccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-cEeeecc
Confidence 37899999975 99999965443 3678889999999999999999999999999999999999977 8999999
Q ss_pred ccccccc--cccccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCC---HhHHHHHHHHHHHhhcc
Q 019780 209 GLAREEV--MDEMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPE---FAEITITLTNILQNLRS 279 (336)
Q Consensus 209 g~a~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~---~~~i~~~l~~~~~~~~~ 279 (336)
|+|+... ....+...+|..|.|||.+.+. .++.+.|+|+++|...++-. .||- ..+ .+.+..+...+..
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~-~~~LFpG~se-~~ql~~If~~lGt 239 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT-RRPLFPGDSE-IDQLFRIFRLLGT 239 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh-CCCCCCCCcH-HHHHHHHHHHcCC
Confidence 9998543 2336667899999999988776 78899999999998777655 3332 223 3344455554444
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=256.78 Aligned_cols=246 Identities=23% Similarity=0.375 Sum_probs=195.7
Q ss_pred CCceeEeeeecCCCcEEEEEeEECC-------ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYGC-------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
..+|.+.+.||+|+||.||+|...+ ..+++|.++. .........+.+|+.++..++||||+++++++.+
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~----~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKE----NAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEeccc----CCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 4578889999999999999998752 4689998863 1234456678999999999999999999999886
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRP--------------KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE 198 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~ 198 (336)
.. .+++|||+++++|.+++..... ..+++..++.++.|++.||+|||++|++|+||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 55 8999999999999999954321 45788999999999999999999999999999999999998
Q ss_pred CCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHH
Q 019780 199 DKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNI 273 (336)
Q Consensus 199 ~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~ 273 (336)
++ .++|+|||+++...... .....+++.|+|||.......+...|+|+|++.++++-. +.+|....-...+...
T Consensus 160 ~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 160 GL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 76 79999999987532221 122346788999998887788889999999999999875 7777543222222222
Q ss_pred H-Hh-hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 274 L-QN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 274 ~-~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+ .. ........|+++.+++...+..+|..|++++++.+
T Consensus 239 i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~ 278 (283)
T cd05048 239 IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHT 278 (283)
T ss_pred HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2 11 22233457788999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=253.40 Aligned_cols=192 Identities=31% Similarity=0.365 Sum_probs=163.0
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec-----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ----- 133 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----- 133 (336)
...|...+.||+|+||.|+.|.+. ++.||||.+.. ........++..||+.+|+.++|+||+.+++++..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~---~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN---PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhh---hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 455656799999999999999986 88999998862 23456678889999999999999999999998875
Q ss_pred -CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 -PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
+++|+|+|+| +.+|.+.++ .+..++...+..+++|++.||+|+|+.|++||||||.|++++.+. .+||+|||+|+
T Consensus 98 f~DvYiV~elM-etDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c-~lKI~DFGLAR 173 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC-DLKICDFGLAR 173 (359)
T ss_pred cceeEEehhHH-hhHHHHHHH--cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC-CEEecccccee
Confidence 2389999999 469999994 345599999999999999999999999999999999999999987 79999999999
Q ss_pred ccc----cccccccCCcccccCCCCC-CCCCCCCHHHHHHHHHHhhccCCCC
Q 019780 213 EEV----MDEMTCEAGTYRWMAPENE-RPSLENLSEDMVALLKSCWAEDPKV 259 (336)
Q Consensus 213 ~~~----~~~~~~~~gt~~y~aPE~~-~~~~~~~~~di~~l~~~~l~~~p~~ 259 (336)
... ...++..+-|..|.|||.. ....++...|+|++||.+-++..++
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gk 225 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGK 225 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCC
Confidence 764 3345666789999999964 4567888999999999877766554
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=266.06 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=197.5
Q ss_pred cCCceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCce
Q 019780 53 IDASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENI 124 (336)
Q Consensus 53 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnI 124 (336)
.+..|.++.+.|.+++.||+|+||.||+|.+. ...||||+++.. ......+.+.+|+.+|+.+. ||||
T Consensus 28 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~~Ei~~l~~l~~HpnI 103 (400)
T cd05105 28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT----ARSSEKQALMSELKIMTHLGPHLNI 103 (400)
T ss_pred CCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC----CChHHHHHHHHHHHHHHhcCCCCCe
Confidence 34578888999999999999999999999864 235999998642 23344577999999999996 9999
Q ss_pred EeeEeeEecCC-EEEEEEccCCCCHHHHHhhcC-----------------------------------------------
Q 019780 125 LKFVGASVQPT-MMIITELMRGETLQRYLWSTR----------------------------------------------- 156 (336)
Q Consensus 125 v~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~----------------------------------------------- 156 (336)
+++++++.+.. .++||||+++|+|.++++...
T Consensus 104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (400)
T cd05105 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQA 183 (400)
T ss_pred eeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccc
Confidence 99999998765 999999999999999985421
Q ss_pred -----------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 019780 157 -----------------------------------------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDL 189 (336)
Q Consensus 157 -----------------------------------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDi 189 (336)
...+++..++.++.|++.||+|||+.|++||||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~di 263 (400)
T cd05105 184 DTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDL 263 (400)
T ss_pred cccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 124778888999999999999999999999999
Q ss_pred CCCceeecCCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHh
Q 019780 190 KPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFA 264 (336)
Q Consensus 190 kp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~ 264 (336)
||+|||++.++ .+||+|||+++...... .....++..|+|||.......+...|+|+|+..+|++-. +..|...
T Consensus 264 kp~Nill~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 264 AARNVLLAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred ChHhEEEeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 99999999876 79999999987533221 122346788999999888888899999999999998753 6666433
Q ss_pred HHHH-HH-HHHHHhh-ccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 265 EITI-TL-TNILQNL-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 265 ~i~~-~l-~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.... .+ ..+.... .......|+++.+++...+..+|+.|++..++.+.
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 343 MIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred cchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 2211 11 1111111 11234566778889999999999999988777653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=252.07 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=194.6
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
.+...+|.+.+.||+|+||.||+|.+. ++.||+|.++... ...+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT------MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP 75 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc------ccHHHHHHHHHHHHHCCCCCccceeEEEecCCC
Confidence 456778999999999999999999875 5679999987421 12456889999999999999999999887665
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
.++||||+++++|.+++....+..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~ 154 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLARVIK 154 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-CEEECCcceEEEcc
Confidence 89999999999999999655556789999999999999999999999999999999999999887 79999999987644
Q ss_pred cccccccCC---cccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHH-HHHHHHHhhc-cCCCCCCCCcc
Q 019780 216 MDEMTCEAG---TYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITI-TLTNILQNLR-SADTPIPPKLV 289 (336)
Q Consensus 216 ~~~~~~~~g---t~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~-~l~~~~~~~~-~~~~~~p~~~~ 289 (336)
........| +..|+|||.......+...|+|+|+..++++-. ++.|....-.. .+..+..... ......++.+.
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELY 234 (261)
T ss_pred CCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 322222223 357999999888888899999999999998876 66664222111 1222222111 12344667788
Q ss_pred cccCCCCCCCCccccchhhhcc
Q 019780 290 EIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+++...+..+|+.|++..++.+
T Consensus 235 ~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 235 DIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHhhcCcccCCCHHHHHH
Confidence 8888889999999988877764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=253.07 Aligned_cols=248 Identities=23% Similarity=0.339 Sum_probs=193.9
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCCE
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTM 136 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 136 (336)
.+...+|.+.+.||+|+||.||+|.+. ...||+|.+.... ...+.+.+|+.+++.++||||+++++.+.+...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~------~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~ 75 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI 75 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc------cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCc
Confidence 355678999999999999999999875 4579999987311 123568899999999999999999998877779
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||+++|+|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.++ .++|+|||.++....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~ 154 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIED 154 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence 9999999999999999665556689999999999999999999999999999999999999876 799999999875433
Q ss_pred cccc---ccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHH-HHHHHHhh-ccCCCCCCCCccc
Q 019780 217 DEMT---CEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITIT-LTNILQNL-RSADTPIPPKLVE 290 (336)
Q Consensus 217 ~~~~---~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~-l~~~~~~~-~~~~~~~p~~~~~ 290 (336)
.... ...++..|+|||.......+...|+|+|++.++++.. +.-|........ +..+.... .......|+.+.+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 234 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHH
Confidence 2211 2235678999999888888999999999999999877 333431111111 11121111 1123456777888
Q ss_pred ccCCCCCCCCccccchhhhccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
++...+..+|+.|++..++..+
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~~ 256 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQAF 256 (262)
T ss_pred HHHHHccCCcccCCCHHHHHHH
Confidence 9999999999999888777654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=269.27 Aligned_cols=246 Identities=21% Similarity=0.233 Sum_probs=187.2
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC--
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-- 134 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 134 (336)
.....|.+++.||+|+||.||+|.+. ++.||||.+... .....+|+.+|+.++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~ 133 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---------PQYKNRELLIMKNLNHINIIFLKDYYYTECF 133 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC---------cchHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence 34568999999999999999999985 788999988521 12245799999999999999998876421
Q ss_pred -------CEEEEEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEE
Q 019780 135 -------TMMIITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKL 205 (336)
Q Consensus 135 -------~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl 205 (336)
.+++||||+++ +|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++..+||
T Consensus 134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred ccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceee
Confidence 15789999985 77776642 244678999999999999999999999999999999999999977657999
Q ss_pred eccccccccccc-cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhcc---
Q 019780 206 ADFGLAREEVMD-EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRS--- 279 (336)
Q Consensus 206 ~Dfg~a~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~--- 279 (336)
+|||+|+..... ......||+.|+|||...+ ..++...|+|++++.++++..+..|...+ -...+..+.+.+..
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 999999854332 2234568999999998765 45788999999999999998887775321 11112222111100
Q ss_pred --------------------------CCCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 280 --------------------------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 280 --------------------------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
.....|+++.+++...+..+|..|.+..++.....
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 11124567788889999999999988887776443
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=252.11 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=196.5
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
.++..+|.+.+.||+|+||.||+|... +..+|+|++.. .......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecC------CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence 456678999999999999999999875 78899999863 1223467889999999999999999999887655
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.+++|||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.++ .++|+|||++...
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~ 154 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLM 154 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-cEEeCCCcccccc
Confidence 89999999999999999665556789999999999999999999999999999999999999876 7999999998764
Q ss_pred ccccccc---cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHH-HHHhh-ccCCCCCCCCc
Q 019780 215 VMDEMTC---EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTN-ILQNL-RSADTPIPPKL 288 (336)
Q Consensus 215 ~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~-~~~~~-~~~~~~~p~~~ 288 (336)
....... ..++..|+|||.......+...|+|+|++.++++.. +..|....-...+.. +.... .......|+++
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (263)
T cd05052 155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKV 234 (263)
T ss_pred ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 3322221 224568999998888888889999999999999986 666753322222222 22111 12234567788
Q ss_pred ccccCCCCCCCCccccchhhhcc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.+++...+..+|+.|++..++.+
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHH
Confidence 88999999999999998887764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=251.74 Aligned_cols=201 Identities=38% Similarity=0.702 Sum_probs=162.7
Q ss_pred eEeeeecCCCcEEEEEeEEC------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-CEE
Q 019780 65 LLQKMIGEGSYSIVYKGFYG------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-TMM 137 (336)
Q Consensus 65 ~~~~~lg~G~fg~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~ 137 (336)
.+.+.||.|.||.||+|.+. +..|+||.++. ....+..+.+.+|++.+++++||||+++++++.+. ..+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP----SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST----TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc----ccccccceeeeeccccccccccccccccccccccccccc
Confidence 46688999999999999987 57899999963 23444578899999999999999999999999954 489
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+|+||+++|+|.+++.......+++..+..++.|++.||.|||+++++|+||+++||+++.++ .+||+|||++......
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-EEEEESTTTGEETTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccc
Confidence 999999999999999776567899999999999999999999999999999999999999887 8999999998765221
Q ss_pred c----ccccCCcccccCCC----------------------------------------------CCCCCCCCCHHHHHH
Q 019780 218 E----MTCEAGTYRWMAPE----------------------------------------------NERPSLENLSEDMVA 247 (336)
Q Consensus 218 ~----~~~~~gt~~y~aPE----------------------------------------------~~~~~~~~~~~di~~ 247 (336)
. .....+...|+||| .....+..++.++++
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYS 236 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHH
Confidence 1 12234678999999 112334567889999
Q ss_pred HHHHhhccCCCCCCCHhHHHHHH
Q 019780 248 LLKSCWAEDPKVRPEFAEITITL 270 (336)
Q Consensus 248 l~~~~l~~~p~~RP~~~~i~~~l 270 (336)
++..||..+|.+||++.++++.|
T Consensus 237 li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 237 LIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHhcC
Confidence 99999999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=264.87 Aligned_cols=191 Identities=26% Similarity=0.297 Sum_probs=168.9
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-C-----CceEeeEeeEecC
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-H-----ENILKFVGASVQP 134 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~~~~~~~~~ 134 (336)
+|.+.+.||+|+||.|-+|.+. ++.||||+++. ......+-..|+.+|..|+ | -|+|+++++|...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN------~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN------KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc------ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 8999999999999999999986 78999999984 3445666788999999997 4 3899999999876
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-CCCceEEecccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE-DKKQVKLADFGLAR 212 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~-~~~~~kl~Dfg~a~ 212 (336)
+ +|||+|.+. .+|+++++.++...++...++.++.||+.||.+||+.||||+||||+|||+.. +...|||+|||.|.
T Consensus 261 ~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 261 NHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred cceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 5 999999995 59999999888889999999999999999999999999999999999999954 33479999999998
Q ss_pred ccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCC
Q 019780 213 EEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRP 261 (336)
Q Consensus 213 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP 261 (336)
....... +...+..|+|||.+.+.+++.+.|||+|+|.+-++-.+..-
T Consensus 340 ~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL 387 (586)
T KOG0667|consen 340 FESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL 387 (586)
T ss_pred ccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc
Confidence 7654444 66789999999999999999999999999999998888653
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=243.33 Aligned_cols=204 Identities=26% Similarity=0.409 Sum_probs=168.9
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCcc---ccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNA---LAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT 135 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 135 (336)
..|.-.+.||.|..+.|-++.+. +..+|+|++..... ........+.-.+|+.+|+++. ||+|+.+.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 34556688999999999888775 78899999875321 1123345667789999999986 999999999999887
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
+++|+|.|+.|.|.++| .....+++...+.|++|++.|+.|||.++||||||||+|||++++. +++|+|||+|...
T Consensus 97 F~FlVFdl~prGELFDyL--ts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~-~i~isDFGFa~~l 173 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYL--TSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM-NIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhhcccchHHHHh--hhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc-ceEEeccceeecc
Confidence 78999999999999999 5557899999999999999999999999999999999999999887 7999999999976
Q ss_pred cccc-ccccCCcccccCCCCC------------------------------------------------------CCCCC
Q 019780 215 VMDE-MTCEAGTYRWMAPENE------------------------------------------------------RPSLE 239 (336)
Q Consensus 215 ~~~~-~~~~~gt~~y~aPE~~------------------------------------------------------~~~~~ 239 (336)
...+ ....|||++|+|||.+ .+...
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa 253 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA 253 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence 6654 5667899999999921 12234
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+++.+..+|+.+|++.+|.+|.+..+.++
T Consensus 254 dis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 254 DISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 56667777888888888888888887765
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=249.77 Aligned_cols=249 Identities=20% Similarity=0.263 Sum_probs=196.9
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|++|.||+|... +..+|+|.+...............+.+|+.+++.++||||+++++++.++. .++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999874 789999998753332223344567899999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|+||++|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~-~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceeccccc
Confidence 99999999999998543 4688999999999999999999999999999999999999876 79999999987432211
Q ss_pred c-----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh--hccCCCCCCCCccc
Q 019780 219 M-----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN--LRSADTPIPPKLVE 290 (336)
Q Consensus 219 ~-----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~--~~~~~~~~p~~~~~ 290 (336)
. ....|+..|+|||.......+...|+|+|+..+|++-.++.|.... ........... ........++.+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 1 2345788999999998888889999999999999999998885321 11111111111 11122345666778
Q ss_pred ccCCCCCCCCccccchhhhcccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
++...+..+|+.|++..++.+..
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCC
Confidence 88999999999999888876543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=259.90 Aligned_cols=193 Identities=26% Similarity=0.280 Sum_probs=162.1
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 134 (336)
.++|.+.+.||+|+||.||+|.+. +..||+|++... .........+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccc---ccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 478999999999999999999875 788999998632 12334556788999999999999999999987643
Q ss_pred ---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 135 ---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 135 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
..|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a 170 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA 170 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEecCCCc
Confidence 26999999976 6666662 2478899999999999999999999999999999999999887 7999999999
Q ss_pred ccccccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 212 REEVMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 212 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
+...... .....||+.|+|||...+...+...|+|+|++.+|++-.+..|.
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 222 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 7543322 23346899999999998888889999999999999988777664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=253.26 Aligned_cols=239 Identities=18% Similarity=0.219 Sum_probs=189.2
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~ 140 (336)
|...+.||+|+||+||+|.+. ++.+|+|++.... .........+.+|+.+|+.++|+||+.+.+.+.+++ .++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKR--IKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhh--hhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 567788999999999999885 7889999987421 112233456788999999999999999998887665 89999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-cc
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-EM 219 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-~~ 219 (336)
||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++...... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG-HIRISDLGLAVKIPEGESI 158 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC-CEEEecCCcceecCCCCcc
Confidence 999999999988655555799999999999999999999999999999999999999876 7999999998653222 22
Q ss_pred cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhh----ccCCCCCCCCcccccCC
Q 019780 220 TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNL----RSADTPIPPKLVEIVDP 294 (336)
Q Consensus 220 ~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~----~~~~~~~p~~~~~~~~~ 294 (336)
....|+..|+|||.......+...|+|+++..+|++..+..|....- ......+.... .......++++.+++..
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence 34468999999999888888889999999999999988888853211 11111122211 12234466677888888
Q ss_pred CCCCCCccccc
Q 019780 295 KSTMNNDCMAT 305 (336)
Q Consensus 295 ~~~~~~~~~~~ 305 (336)
.+..+|+.|.+
T Consensus 239 ~l~~~P~~R~~ 249 (285)
T cd05632 239 LLTKDPKQRLG 249 (285)
T ss_pred HccCCHhHcCC
Confidence 88889988887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=254.55 Aligned_cols=245 Identities=22% Similarity=0.262 Sum_probs=195.5
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|++.+.||+|+||.||++.+. ++.+|+|++... ..........+.+|+.+++.++||||+++++++.++. .++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKA--KIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence 36889999999999999999985 789999998732 1223345677899999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG-YIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEeeCCCccccCCC-
Confidence 99999999999999443 6789999999999999999999999999999999999999887 7999999998864433
Q ss_pred ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCCCCCCcccccCCCCC
Q 019780 219 MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTPIPPKLVEIVDPKST 297 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~ 297 (336)
.....|++.|+|||.......+...|+|+|+..++++-.+..|... +-......+...........++.+.+++...+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 3344688999999988888888899999999999999988888522 222222223222222334456677788888888
Q ss_pred CCCcccc-----chhhhccc
Q 019780 298 MNNDCMA-----TVHAITKF 312 (336)
Q Consensus 298 ~~~~~~~-----~~~~~~~~ 312 (336)
.+|..|. ++.++.+.
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CCHHHccCcccCCHHHHHcC
Confidence 8888775 55555543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=251.32 Aligned_cols=213 Identities=27% Similarity=0.410 Sum_probs=169.1
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC----C-
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP----T- 135 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----~- 135 (336)
.|.-.+++|+|+||.||+|... ++.||||.+-..+ +.-.+|+.+|+.+.|||||++..+|... .
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~---------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK---------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC---------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 4666789999999999999886 6899999886322 1235899999999999999998877632 1
Q ss_pred -EEEEEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 136 -MMIITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
..+||||++. +|.++++. ..+..++.-.++-+..||++||+|||+.||+||||||.|+|+|.+.+.+||||||.|+
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 4689999986 99999853 2356788889999999999999999999999999999999999998899999999999
Q ss_pred ccccccc-cccCCcccccCCCC----------------------------------------------------------
Q 019780 213 EEVMDEM-TCEAGTYRWMAPEN---------------------------------------------------------- 233 (336)
Q Consensus 213 ~~~~~~~-~~~~gt~~y~aPE~---------------------------------------------------------- 233 (336)
....++. .+...|..|+|||.
T Consensus 175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 7655543 33457899999990
Q ss_pred ----------CCC------CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCCCCCCCC
Q 019780 234 ----------ERP------SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPK 287 (336)
Q Consensus 234 ----------~~~------~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~p~~ 287 (336)
+.+ .....++|..+|+..++.++|.+|.++.+++. ..+...+...+..+|-.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~--h~fFdelr~~~~~l~~g 322 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA--HPFFDELRDPNTKLPNG 322 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc--chhhHHhhCcCccCcCC
Confidence 111 12346789999999999999999999888764 34455555544444443
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=249.09 Aligned_cols=243 Identities=25% Similarity=0.425 Sum_probs=194.7
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
.++.++|.+.+.||+|+||.||+|...++.||+|.++.. ....+.+.+|+.+++.++|+||+++++++.+.. .
T Consensus 2 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 75 (256)
T cd05039 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDD------STAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL 75 (256)
T ss_pred ccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccc------hhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence 355678999999999999999999999999999998731 114677899999999999999999999988554 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||.++....
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~ 154 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQ 154 (256)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-CEEEccccccccccc
Confidence 9999999999999999665545789999999999999999999999999999999999999876 799999999986532
Q ss_pred ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCC----HhHHHHHHHHHHHh-hccCCCCCCCCccc
Q 019780 217 DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPE----FAEITITLTNILQN-LRSADTPIPPKLVE 290 (336)
Q Consensus 217 ~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~----~~~i~~~l~~~~~~-~~~~~~~~p~~~~~ 290 (336)
. .....++..|+|||.......+...|+|+++..+++.-. +.-|. ..++...+. .. ........|+++.+
T Consensus 155 ~-~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 230 (256)
T cd05039 155 G-QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE---KGYRMEAPEGCPPEVYK 230 (256)
T ss_pred c-cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh---cCCCCCCccCCCHHHHH
Confidence 2 223345678999998887778889999999999887654 33332 233322221 11 11122346777888
Q ss_pred ccCCCCCCCCccccchhhhcc
Q 019780 291 IVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~ 311 (336)
++...+..+|+.|++..++.+
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHhccChhhCcCHHHHHH
Confidence 999999999999998877764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=252.11 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=197.1
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCCE
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTM 136 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 136 (336)
.+..++|++.+.||+|+||.||+|... ++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+...
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 75 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS------MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPI 75 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC------CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCc
Confidence 456788999999999999999999875 6889999987321 123568899999999999999999998877779
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
+++|||+.+++|.+++....+..+++..+..++.|++.||+|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~ 154 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIED 154 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-CEEEccCcceeecCC
Confidence 9999999999999999766666789999999999999999999999999999999999999876 799999999875432
Q ss_pred cccc---ccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHH-HHHHHHhh-ccCCCCCCCCccc
Q 019780 217 DEMT---CEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITIT-LTNILQNL-RSADTPIPPKLVE 290 (336)
Q Consensus 217 ~~~~---~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~-l~~~~~~~-~~~~~~~p~~~~~ 290 (336)
.... ...++..|+|||.......+...|+|+++..+++... +..|....-... ...+.... .......|+++.+
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYE 234 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 2221 2235678999998888888889999999999998876 666642211111 11111111 1222445667888
Q ss_pred ccCCCCCCCCccccchhhhccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
++...+..+|+.|++...+..+
T Consensus 235 li~~~l~~~p~~Rp~~~~l~~~ 256 (260)
T cd05067 235 LMRLCWKEKPEERPTFEYLRSV 256 (260)
T ss_pred HHHHHccCChhhCCCHHHHHHH
Confidence 9999999999999988877653
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=250.63 Aligned_cols=246 Identities=24% Similarity=0.402 Sum_probs=195.0
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCCE
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTM 136 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 136 (336)
|.+..++|.+.+.||+|+||.||++...+..+|+|.++. ......+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKC-------DVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGL 73 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecC-------cchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCc
Confidence 345567899999999999999999998899999999862 1124578899999999999999999999988889
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||+++++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSM 152 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-cEEECCCccceeccc
Confidence 9999999999999999665555789999999999999999999999999999999999999876 799999999875332
Q ss_pred ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHh-hc-cCCCCCCCCcccccC
Q 019780 217 DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQN-LR-SADTPIPPKLVEIVD 293 (336)
Q Consensus 217 ~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~-~~-~~~~~~p~~~~~~~~ 293 (336)
.......+..|+|||.......+...|+|+|+..++++.. +.-|....-...+...... .. ......|+.+.+++.
T Consensus 153 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 231 (254)
T cd05083 153 -GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMT 231 (254)
T ss_pred -cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHH
Confidence 2222335678999998887788889999999999998765 4444322212222222211 11 122345667788888
Q ss_pred CCCCCCCccccchhhhcc
Q 019780 294 PKSTMNNDCMATVHAITK 311 (336)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~ 311 (336)
..+..+|+.|++..++..
T Consensus 232 ~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 232 SCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 899889988888877664
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=262.28 Aligned_cols=198 Identities=21% Similarity=0.262 Sum_probs=165.6
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||++.+. ++.||+|++... ..........+.+|+.++..++|+||+.+++++.++. .|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKW--EMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--HHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence 36889999999999999999986 788999998731 1122334566889999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||++||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||++.......
T Consensus 79 v~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 79 VMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRLLADG 156 (331)
T ss_pred EEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC-CEEEEECCceeecCCCC
Confidence 99999999999999542 35689999999999999999999999999999999999999877 79999999987533222
Q ss_pred ---ccccCCcccccCCCCCCC-----CCCCCHHHHHHHHHHhhccCCCCCCCH
Q 019780 219 ---MTCEAGTYRWMAPENERP-----SLENLSEDMVALLKSCWAEDPKVRPEF 263 (336)
Q Consensus 219 ---~~~~~gt~~y~aPE~~~~-----~~~~~~~di~~l~~~~l~~~p~~RP~~ 263 (336)
.....||+.|+|||.... ...+...|+|++++.+|++..+..|..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 122358999999997753 345677899999999999999998863
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=259.35 Aligned_cols=213 Identities=27% Similarity=0.465 Sum_probs=180.9
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEECC-ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYGC-EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
-..+.+....+.+.||+|-||.|+++...+ ..||||.+++ ......+..|.+|+++|.+++||||+.++++|..+
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~----~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRP----DATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCc----ccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 345667788899999999999999998875 8999999984 23444578899999999999999999999998865
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+ +++|+||+++|+|.+++.++....+.......|+.||++||+||.+.++|||||.+.|+|++.+. ++||+|||+++.
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~ 686 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF-TIKIADFGMSRN 686 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc-cEEecCcccccc
Confidence 5 99999999999999999766544455566777999999999999999999999999999999987 899999999997
Q ss_pred ccccccccc----CCcccccCCC------------------------------------------------------CCC
Q 019780 214 EVMDEMTCE----AGTYRWMAPE------------------------------------------------------NER 235 (336)
Q Consensus 214 ~~~~~~~~~----~gt~~y~aPE------------------------------------------------------~~~ 235 (336)
......... +-...||||| ...
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence 655554332 3458999999 233
Q ss_pred CCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHH
Q 019780 236 PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNI 273 (336)
Q Consensus 236 ~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~ 273 (336)
..|.-++..++.|+..||..+..+||+|+++...|.+.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 55677899999999999999999999999998877654
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=256.54 Aligned_cols=248 Identities=21% Similarity=0.257 Sum_probs=195.8
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||++.+. +..+|+|.+.. .........+.+|+++++.++||||+++++++.+++ .++|
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL----EIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecc----ccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence 5888999999999999999886 67788998863 123445667889999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|||++|++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 ~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM 154 (308)
T ss_pred eeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCcccccccc
Confidence 9999999999999543 568999999999999999999998 5999999999999999876 79999999987544433
Q ss_pred ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhc--------------------
Q 019780 219 MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR-------------------- 278 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~-------------------- 278 (336)
.....|+..|+|||...+...+...|+|+++..++++-.+..|....-...+........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 445568999999998887778889999999999999888877753222222222111100
Q ss_pred --------------cCC-----CCCCCCcccccCCCCCCCCccccchhhhcccccccc
Q 019780 279 --------------SAD-----TPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 279 --------------~~~-----~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
... ..+++++.+++...+..+|+.|++..++.+.....+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 000 113445667888888889999999888887665544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=252.52 Aligned_cols=235 Identities=20% Similarity=0.234 Sum_probs=184.5
Q ss_pred ecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccCCC
Q 019780 70 IGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRGE 146 (336)
Q Consensus 70 lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~gg 146 (336)
||+|+||.||++... ++.+|+|++.... .........+..|+.+++.++||||+++++++.++. .++||||++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKR--LKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHH--hhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 699999999999875 7899999986311 111223345567999999999999999999888665 89999999999
Q ss_pred CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-ccccCCc
Q 019780 147 TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGT 225 (336)
Q Consensus 147 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~gt 225 (336)
+|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.++ .++|+|||++....... .....|+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCceeeccCCC
Confidence 999988655556689999999999999999999999999999999999999876 79999999987543322 2334689
Q ss_pred ccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH-HHHHHHHhh-----ccCCCCCCCCcccccCCCCCCC
Q 019780 226 YRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITI-TLTNILQNL-----RSADTPIPPKLVEIVDPKSTMN 299 (336)
Q Consensus 226 ~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~-~l~~~~~~~-----~~~~~~~p~~~~~~~~~~~~~~ 299 (336)
..|+|||.......+...|+|++++.+|++..+..|....... ....+.... ......+++++.+++...+..+
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 237 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKK 237 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccC
Confidence 9999999988888899999999999999999888885321000 011111111 1112346778889999999999
Q ss_pred Cccccchh
Q 019780 300 NDCMATVH 307 (336)
Q Consensus 300 ~~~~~~~~ 307 (336)
|+.|.+..
T Consensus 238 P~~R~~~~ 245 (277)
T cd05607 238 PEDRLGSR 245 (277)
T ss_pred HhhCCCCc
Confidence 99998773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=254.40 Aligned_cols=250 Identities=24% Similarity=0.288 Sum_probs=192.9
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
..+|.+.+.||+|+||.||+|+.. ++.||+|+++.... ......+.+|+.+++.++||||+++++++.+++ .+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE----EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc----CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence 367899999999999999999875 67899999874221 222345778999999999999999999988665 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||+++ +|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++......
T Consensus 81 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSVP 157 (309)
T ss_pred EEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECccccceecCCC
Confidence 99999975 888887443 34588999999999999999999999999999999999999876 7999999998753222
Q ss_pred --cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhc---------------
Q 019780 218 --EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLR--------------- 278 (336)
Q Consensus 218 --~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~--------------- 278 (336)
......+++.|+|||.... ...+...|+|++++.++++-.+.+|... ...+.+..+...+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 2233458899999997654 4578899999999999999999887522 11111111111100
Q ss_pred ---------------cCCCCCCCCcccccCCCCCCCCccccchhhhcccccccc
Q 019780 279 ---------------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 279 ---------------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
...+.+++++.+++..++..+|..|.+..++.+...-+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 011235667778888899999999999998887655443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=280.75 Aligned_cols=239 Identities=24% Similarity=0.267 Sum_probs=188.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
.+|.+.+.||+|+||.||+|.+. ++.||+|++... .........++.+|+.+++.++||||+++++++.+++ .++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~--l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRED--LSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcc--cccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 47899999999999999999985 788999998732 2223455678999999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 139 ITELMRGETLQRYLWSTR---------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
||||++||+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||+++.++ .++|+|||
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-~vKLiDFG 158 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG-EVVILDWG 158 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC-CEEEEecC
Confidence 999999999999985321 13356677889999999999999999999999999999999887 79999999
Q ss_pred cccccccc--------------------cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 019780 210 LAREEVMD--------------------EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITIT 269 (336)
Q Consensus 210 ~a~~~~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~ 269 (336)
+++..... ......||+.|+|||...+.+.+.+.|+|++++.++++..+..|....-...
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99754110 0112358999999999998899999999999999999999888863321111
Q ss_pred HHHHHHhhcc-----CCCCCCCCcccccCCCCCCCCcccc
Q 019780 270 LTNILQNLRS-----ADTPIPPKLVEIVDPKSTMNNDCMA 304 (336)
Q Consensus 270 l~~~~~~~~~-----~~~~~p~~~~~~~~~~~~~~~~~~~ 304 (336)
+... ..+.. ....+|+.+.+++...+..+|+.|.
T Consensus 239 i~~~-~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ 277 (932)
T PRK13184 239 ISYR-DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERY 277 (932)
T ss_pred hhhh-hhccChhhccccccCCHHHHHHHHHHccCChhhCc
Confidence 1110 11111 1134677788888888888888884
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=246.99 Aligned_cols=246 Identities=21% Similarity=0.278 Sum_probs=198.1
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|++|.||+|... +..|++|.+... .........+.+|+.+++.++||||+++++++.+.. .++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS---KMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehh---hCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence 4778899999999999999885 788999998632 223456678999999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
|||++|++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-CEEEcccccceeccCccc
Confidence 9999999999999765556789999999999999999999999999999999999999876 79999999987543322
Q ss_pred -ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHHh-hccCCCCCCCCcccccCCC
Q 019780 219 -MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQN-LRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 219 -~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~~-~~~~~~~~p~~~~~~~~~~ 295 (336)
.....|++.|+|||.......+...|+|+|+..+|++-.+..|....-. .....+... .......+++.+.+++...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 2234588999999998888888999999999999999888887522211 111222221 1122235567788899999
Q ss_pred CCCCCccccchhhhccc
Q 019780 296 STMNNDCMATVHAITKF 312 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~~ 312 (336)
+..+|+.|++..++.+.
T Consensus 237 l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 237 LTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCCcccCcCHHHHhhC
Confidence 99999999988777653
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=251.40 Aligned_cols=247 Identities=21% Similarity=0.370 Sum_probs=194.1
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--Cc----cEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CE----PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
+...+|.+.+.||+|+||+||+|.+. +. .||+|+++. .........+.+|+.++..++||||+++++++.
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRE----NTSPKANKEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecC----CCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 45678999999999999999999864 33 489999863 223445667889999999999999999999998
Q ss_pred cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 133 QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 133 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
....+++++|+++|+|.++++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||+++
T Consensus 80 ~~~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~~ 157 (279)
T cd05109 80 TSTVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-HVKITDFGLAR 157 (279)
T ss_pred CCCcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCCCcee
Confidence 87889999999999999999543 35689999999999999999999999999999999999998776 79999999987
Q ss_pred ccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHhhc--cCCCCCC
Q 019780 213 EEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQNLR--SADTPIP 285 (336)
Q Consensus 213 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~~~--~~~~~~p 285 (336)
....... ....++..|+|||.......+...|+|+|++.+|++.. +..|....-...+...+.... ......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICT 237 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCC
Confidence 5432221 11234678999999888888889999999999999765 666642211122222332221 1223456
Q ss_pred CCcccccCCCCCCCCccccchhhhcc
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+++.+++...+..+|+.|++..++.+
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 66778888999999999999888875
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=251.14 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=194.0
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCCE
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTM 136 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 136 (336)
.+..++|++.+.||+|+||.||+|... +..+|+|.+..... ..+.+.+|+.+++.++|||++++++++.+...
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~ 75 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM------SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPI 75 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC------CHHHHHHHHHHHHhcCCCceEEEEeEECCCCc
Confidence 455678999999999999999999875 56799999874221 13468899999999999999999998877779
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
+++|||+++++|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~ 154 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIED 154 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc-eEEeCCceeeeeccC
Confidence 9999999999999999765556689999999999999999999999999999999999999876 799999999875433
Q ss_pred cccc---ccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhH-HHHHHHHHHHhhc-cCCCCCCCCccc
Q 019780 217 DEMT---CEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAE-ITITLTNILQNLR-SADTPIPPKLVE 290 (336)
Q Consensus 217 ~~~~---~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~-i~~~l~~~~~~~~-~~~~~~p~~~~~ 290 (336)
.... ...++..|+|||.......+.+.|+|+|+..++++.. +..|.... ....+..+..... ......|..+.+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE 234 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 2211 1235568999998887788889999999999998877 55554221 1222222222111 122345667788
Q ss_pred ccCCCCCCCCccccchhhhccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
++...+..+|+.|++...+.++
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~~ 256 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQSF 256 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHH
Confidence 8888888899998887776543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=262.01 Aligned_cols=198 Identities=21% Similarity=0.244 Sum_probs=165.8
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||++.+. ++.||+|++... ..........+.+|..++..++|+||+++++++.+++ .|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--EMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH--HHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 36889999999999999999986 678999998631 1122334566888999999999999999999988766 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||++||+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 79 v~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 79 VMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-CEEEEeccceeeccCCC
Confidence 99999999999999543 35689999999999999999999999999999999999999876 79999999987543322
Q ss_pred ---ccccCCcccccCCCCCCC-----CCCCCHHHHHHHHHHhhccCCCCCCCH
Q 019780 219 ---MTCEAGTYRWMAPENERP-----SLENLSEDMVALLKSCWAEDPKVRPEF 263 (336)
Q Consensus 219 ---~~~~~gt~~y~aPE~~~~-----~~~~~~~di~~l~~~~l~~~p~~RP~~ 263 (336)
.....||+.|+|||.... ...+...|+|+++..+|++..+..|..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 123469999999997654 345678899999999999999988863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=251.20 Aligned_cols=250 Identities=25% Similarity=0.401 Sum_probs=192.0
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEe
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVG 129 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 129 (336)
|.+..++|.+.+.||+|+||.||+|.+. +..||+|.+.. .........+.+|+.+++.++||||+++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~----~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~ 76 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 3456678999999999999999999864 35699998753 122344567889999999999999999999
Q ss_pred eEecCC-EEEEEEccCCCCHHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC
Q 019780 130 ASVQPT-MMIITELMRGETLQRYLWSTRP--------KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK 200 (336)
Q Consensus 130 ~~~~~~-~~lv~e~~~gg~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~ 200 (336)
++.++. .++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~ 156 (277)
T cd05062 77 VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 156 (277)
T ss_pred EEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC
Confidence 987654 8999999999999999954321 2357788999999999999999999999999999999999876
Q ss_pred CceEEeccccccccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHH
Q 019780 201 KQVKLADFGLAREEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQ 275 (336)
Q Consensus 201 ~~~kl~Dfg~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~ 275 (336)
.++|+|||+++....... ....++..|+|||.......+...|+|+|+..++++.. +..|....-...+.....
T Consensus 157 -~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 157 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred -CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 799999999875332221 12235778999999888888899999999999998876 455542221112211111
Q ss_pred h--hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 276 N--LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 276 ~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
. ........|+.+.+++...+..+|+.|++..++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 273 (277)
T cd05062 236 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273 (277)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 12223445666788889999999999998887754
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=252.88 Aligned_cols=245 Identities=18% Similarity=0.241 Sum_probs=193.1
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~ 140 (336)
|...+.||+|+||.||++.+. ++.+|+|.+.... .........+.+|+.+++.++|++|+.+++.+.+++ .++||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhh--ccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 567788999999999999986 7799999987421 122334456788999999999999999999887665 89999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-c
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-M 219 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~-~ 219 (336)
||++|++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....... .
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeccceeecCCCccc
Confidence 999999999998655555689999999999999999999999999999999999999876 79999999987543222 2
Q ss_pred cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH----HHHHHHHHHHhh-ccCCCCCCCCcccccCC
Q 019780 220 TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE----ITITLTNILQNL-RSADTPIPPKLVEIVDP 294 (336)
Q Consensus 220 ~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~----i~~~l~~~~~~~-~~~~~~~p~~~~~~~~~ 294 (336)
....|+..|+|||.......+...|+|+++..+|++..+..|.... ....+..+.... .......++++.+++..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM 238 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHH
Confidence 3346899999999988888889999999999999998888885421 111122221111 11234567778888888
Q ss_pred CCCCCCccccc-----hhhhcc
Q 019780 295 KSTMNNDCMAT-----VHAITK 311 (336)
Q Consensus 295 ~~~~~~~~~~~-----~~~~~~ 311 (336)
.+..+|+.|.+ ..++.+
T Consensus 239 ~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 239 LLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HhhcCHHHccCCCCCchHHHHc
Confidence 99999998887 445554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=262.19 Aligned_cols=230 Identities=23% Similarity=0.255 Sum_probs=174.3
Q ss_pred ecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC---CCCceEeeEeeEecCC-EEEEEEcc
Q 019780 70 IGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM---KHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 70 lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
||+|+||+||+|.+. ++.||||++... .............|..++... +||||+++++.+.+.. .|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKK--EIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHH--HHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 799999999999986 789999998631 111223344455677777655 6999999999988765 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--cccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~ 221 (336)
++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||++...... ....
T Consensus 79 ~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 79 SGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred CCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCCCCccC
Confidence 99999999843 46789999999999999999999999999999999999999887 7999999998753222 2334
Q ss_pred cCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH-HHHHHHh-hccCCCCCCCCcccccCCCCCC
Q 019780 222 EAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFAEITIT-LTNILQN-LRSADTPIPPKLVEIVDPKSTM 298 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~-l~~~~~~-~~~~~~~~p~~~~~~~~~~~~~ 298 (336)
.+||..|+|||..... ..+...|+|+|++.++++..+..|....-... +..+... .......+++++.+++...+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~ 235 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNR 235 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence 5699999999987654 46788999999999999999999964332221 2222111 1111123455566677777777
Q ss_pred CCcccc
Q 019780 299 NNDCMA 304 (336)
Q Consensus 299 ~~~~~~ 304 (336)
+|..|.
T Consensus 236 ~P~~R~ 241 (330)
T cd05586 236 NPQHRL 241 (330)
T ss_pred CHHHCC
Confidence 777774
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=250.31 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=195.4
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEe
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVG 129 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 129 (336)
|.++.++|.+.+.||+|+||.||+|... +..||+|.+.. .........+.+|+.+++.++||||+++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE----NASMRERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCC----ccCHHHHHHHHHHHHHHHhCCCCceeEEEE
Confidence 3466788999999999999999999875 25799999863 123344567889999999999999999999
Q ss_pred eEecCC-EEEEEEccCCCCHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC
Q 019780 130 ASVQPT-MMIITELMRGETLQRYLWSTR--------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK 200 (336)
Q Consensus 130 ~~~~~~-~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~ 200 (336)
++.+.. .++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.|++||||||+||+++.++
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~ 156 (277)
T cd05032 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL 156 (277)
T ss_pred EEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC
Confidence 988765 899999999999999995432 23468889999999999999999999999999999999999887
Q ss_pred CceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHH-HHHHH
Q 019780 201 KQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITIT-LTNIL 274 (336)
Q Consensus 201 ~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~-l~~~~ 274 (336)
.++|+|||+++...... .....++..|+|||.......+.+.|+|+|++.+++... +..|.-..-... +..+.
T Consensus 157 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 157 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred -CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 79999999987543322 123346789999998887788888999999999999876 666642211111 22222
Q ss_pred Hh-hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 275 QN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 275 ~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.. ........|+++.+++...+..+|+.|++..++..
T Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11 12223446677888999999999999998887764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=264.47 Aligned_cols=251 Identities=22% Similarity=0.252 Sum_probs=208.7
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
...|.+.+.||+|.|+.|.+|++. +..||||++.+. ..+......+.+|+++|+.++|||||+++.+..... +|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt---~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKT---QLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhc---ccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 467999999999999999999986 889999999742 334445556999999999999999999999988654 99
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||+.+|.+++|+. +.+++.+..+..++.|+++|++|||+++|||||||++|||++.+. ++||+|||++......
T Consensus 132 lV~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM-NIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-ceeeeccccceeeccc
Confidence 9999999999999994 446777899999999999999999999999999999999999887 6999999999875544
Q ss_pred c-ccccCCcccccCCCCCCCCCCCCH-HHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh-hccCCCCCCCCcccccCC
Q 019780 218 E-MTCEAGTYRWMAPENERPSLENLS-EDMVALLKSCWAEDPKVRPEFAEITITLTNILQN-LRSADTPIPPKLVEIVDP 294 (336)
Q Consensus 218 ~-~~~~~gt~~y~aPE~~~~~~~~~~-~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~-~~~~~~~~p~~~~~~~~~ 294 (336)
. ..+.+|++.|.|||...+..++-+ .|+|+++..++.+.-+.-|.-.+.+..|..-.-. ....+..++-+...++..
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk 288 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK 288 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHH
Confidence 3 567789999999999988877654 6999999999999999999877766666543221 112344566777788888
Q ss_pred CCCCCCccccchhhhcccccccc
Q 019780 295 KSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
.+-.+|..+.++++|-+..++.-
T Consensus 289 ~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred hhccCccccCCHHHhhhhcccch
Confidence 88888888888888877655543
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=248.53 Aligned_cols=216 Identities=31% Similarity=0.527 Sum_probs=172.3
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceE
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENIL 125 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv 125 (336)
+..+.++.++|.+.+.||+|+||.||++... ...+|+|.+... ........+.+|+.++..+ +||||+
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~ 79 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNII 79 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC----CCHHHHHHHHHHHHHHHhhcCCCCee
Confidence 3467778889999999999999999999864 256899988631 2234456788999999999 799999
Q ss_pred eeEeeEecCC-EEEEEEccCCCCHHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCC
Q 019780 126 KFVGASVQPT-MMIITELMRGETLQRYLWST--------------RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLK 190 (336)
Q Consensus 126 ~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDik 190 (336)
++++++.++. .+++|||+++|+|.+++... ....+++..++.++.|++.||+|||+.|++|||||
T Consensus 80 ~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlk 159 (293)
T cd05053 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA 159 (293)
T ss_pred eEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 9999987665 89999999999999999542 23568899999999999999999999999999999
Q ss_pred CCceeecCCCCceEEeccccccccccccc----cccCCcccccCCCCCCC------------------------------
Q 019780 191 PSNLLLTEDKKQVKLADFGLAREEVMDEM----TCEAGTYRWMAPENERP------------------------------ 236 (336)
Q Consensus 191 p~NIll~~~~~~~kl~Dfg~a~~~~~~~~----~~~~gt~~y~aPE~~~~------------------------------ 236 (336)
|+||+++.++ .++|+|||+++....... ....++..|+|||....
T Consensus 160 p~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 160 ARNVLVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred eeeEEEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 9999999876 899999999975433221 11234578999993221
Q ss_pred ----------------CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHH
Q 019780 237 ----------------SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274 (336)
Q Consensus 237 ----------------~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~ 274 (336)
.+...+.++.+|+..||..+|.+||++.++++.|+.++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 12234567778888888888888888888888877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=270.77 Aligned_cols=197 Identities=26% Similarity=0.366 Sum_probs=168.7
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-----
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT----- 135 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 135 (336)
.+...+.||+|+||.||+|+++ |+.||||.++.. ......++..+|+++|++++|||||+++++-.+..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~----~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKE----SSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhh----cccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 3444577999999999999986 999999999842 24566888999999999999999999999755432
Q ss_pred --EEEEEEccCCCCHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC--C-CceEEeccc
Q 019780 136 --MMIITELMRGETLQRYLWST-RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED--K-KQVKLADFG 209 (336)
Q Consensus 136 --~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~--~-~~~kl~Dfg 209 (336)
..+|||||.||||..++.+. +...+++.+.+.++.+++.||.|||++||+||||||.||++... | ...||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 68999999999999999653 23579999999999999999999999999999999999998532 2 257999999
Q ss_pred ccccccccc-ccccCCcccccCCCCCC-CCCCCCHHHHHHHHHHhhccCCCCCCCH
Q 019780 210 LAREEVMDE-MTCEAGTYRWMAPENER-PSLENLSEDMVALLKSCWAEDPKVRPEF 263 (336)
Q Consensus 210 ~a~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~~di~~l~~~~l~~~p~~RP~~ 263 (336)
.|+....+. ..+..||..|++||... ...++...|+|++|+.+++.-++.+|+.
T Consensus 170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 999765543 56678999999999877 5888999999999999999999999973
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=258.92 Aligned_cols=215 Identities=28% Similarity=0.529 Sum_probs=166.1
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceE
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENIL 125 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv 125 (336)
+..|.+..++|.+.+.||+|+||.||+|.+. +..||+|+++.. ........+.+|+.+|..+. ||||+
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~~E~~~l~~l~~H~niv 104 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST----ARSSEKQALMSELKIMSHLGPHLNIV 104 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCC----CChhHHHHHHHHHHHHHhcCCCCCeE
Confidence 4467788889999999999999999999864 357999999732 12333457889999999998 99999
Q ss_pred eeEeeEecCC-EEEEEEccCCCCHHHHHhhcCC-----------------------------------------------
Q 019780 126 KFVGASVQPT-MMIITELMRGETLQRYLWSTRP----------------------------------------------- 157 (336)
Q Consensus 126 ~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~~----------------------------------------------- 157 (336)
++++++..+. .++||||+++|+|.++++....
T Consensus 105 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (401)
T cd05107 105 NLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKD 184 (401)
T ss_pred EEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCc
Confidence 9999988765 8999999999999999964321
Q ss_pred -------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 019780 158 -------------------------------------------------KRLDLKHSISFALDISRAMEYLHANSVIHRD 188 (336)
Q Consensus 158 -------------------------------------------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrD 188 (336)
..+++..++.++.|++.||+|||++|++|||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrd 264 (401)
T cd05107 185 ESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRD 264 (401)
T ss_pred cccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCccc
Confidence 2356777889999999999999999999999
Q ss_pred CCCCceeecCCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCC------------------------
Q 019780 189 LKPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLEN------------------------ 240 (336)
Q Consensus 189 ikp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~------------------------ 240 (336)
|||+|||++.++ .++|+|||+++...... .....++..|+|||.......+
T Consensus 265 lkp~NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 265 LAARNVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred CCcceEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 999999999876 89999999987532211 1223467889999943333223
Q ss_pred -----------------------CHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHH
Q 019780 241 -----------------------LSEDMVALLKSCWAEDPKVRPEFAEITITLTNI 273 (336)
Q Consensus 241 -----------------------~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~ 273 (336)
++.++.+|+..||+.+|..||++.+++..|+.+
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 344 ELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 345555666666666777777777766666554
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=247.94 Aligned_cols=246 Identities=23% Similarity=0.374 Sum_probs=193.3
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
+.++|.+.+.||+|+||.||+|.+. ...||||.++. .........+.+|+.+++.++||||+++++.+.++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA----GSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCC----CCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence 4567899999999999999999874 34789998863 22344566788999999999999999999988766
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. .++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++ .++|+|||+++.
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~ 155 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRR 155 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-CEEECccchhhc
Confidence 5 899999999999999995533 4789999999999999999999999999999999999999876 799999999986
Q ss_pred ccc--ccccc--cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHh-hc-cCCCCCCC
Q 019780 214 EVM--DEMTC--EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQN-LR-SADTPIPP 286 (336)
Q Consensus 214 ~~~--~~~~~--~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~-~~-~~~~~~p~ 286 (336)
... ....+ ..++..|+|||.......+...|+|+++..++++.. +..|....-...+...... .. ......|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPS 235 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 531 11111 224578999999888888889999999999998665 6667533222222222221 11 12234577
Q ss_pred CcccccCCCCCCCCccccchhhhcc
Q 019780 287 KLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.+.+++...+..+|+.|++..++.+
T Consensus 236 ~l~~li~~cl~~~p~~Rp~~~ei~~ 260 (266)
T cd05033 236 ALYQLMLDCWQKDRNERPTFSQIVS 260 (266)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7888899999999999998887764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=247.16 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=195.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
.+|.+.+.||+|+||.||+|... ++.||||.+... ..........+.+|+.+++.++||||+++++++.+.+ .++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIF--EMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecc--ccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 46889999999999999999874 789999988632 2224455677899999999999999999999888655 899
Q ss_pred EEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 139 ITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||+++++|.+++.. .....+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~~~~ 158 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-CEEECccccceeccc
Confidence 9999999999998843 2334588999999999999999999999999999999999999876 799999999875432
Q ss_pred cc--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH--HHHHHHhhccC---CCCCCCCcc
Q 019780 217 DE--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITIT--LTNILQNLRSA---DTPIPPKLV 289 (336)
Q Consensus 217 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~--l~~~~~~~~~~---~~~~p~~~~ 289 (336)
.. .....|+..|+|||.......+...|+|+++..+|++-.+..|...+.... +.......... ....+..+.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 22 223458899999998887778889999999999999998888864332111 11111111110 113445577
Q ss_pred cccCCCCCCCCccccchhhhcccc
Q 019780 290 EIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
+++...+..+|+.|++..++.+..
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHHH
Confidence 888889999999999988877644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=260.69 Aligned_cols=245 Identities=24% Similarity=0.294 Sum_probs=192.2
Q ss_pred CceeEeeeecCCCcEEEEEeEE--CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-CEEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-TMMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~l 138 (336)
.-|.+.+.||+|.|+.|-+|++ .|..||||++.+.+. +.-....+.+|++.|+.++|||||++|++.... .+||
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl---D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc---chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 3577889999999999999986 499999999986544 344567789999999999999999999987655 4999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
|+|+=+||+|++||.+.. ..+.+..+..++.||+.|+.|+|...+|||||||+|+++.+.-+-|||+|||++....+.
T Consensus 95 iLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999999996654 569999999999999999999999999999999999998777668999999998765444
Q ss_pred cccccCCcccccCCCCCCCCCCCCH-HHHHHHHHHhhccCCCCCCCHhHH--HHHHHHHHHhhccCCCCCCCCcccccCC
Q 019780 218 EMTCEAGTYRWMAPENERPSLENLS-EDMVALLKSCWAEDPKVRPEFAEI--TITLTNILQNLRSADTPIPPKLVEIVDP 294 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~~~~~~~~-~di~~l~~~~l~~~p~~RP~~~~i--~~~l~~~~~~~~~~~~~~p~~~~~~~~~ 294 (336)
...+.||+..|-|||.+.+..++.| .|||+|+..++.+..++-|+ ++. .+.|..+..--...+..++.+..+++..
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PF-qeANDSETLTmImDCKYtvPshvS~eCrdLI~s 252 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPF-QEANDSETLTMIMDCKYTVPSHVSKECRDLIQS 252 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcc-ccccchhhhhhhhcccccCchhhhHHHHHHHHH
Confidence 4677899999999999999888866 69999999999998888885 221 2233333322222333344444445544
Q ss_pred CCCCCCccccchhhhcc
Q 019780 295 KSTMNNDCMATVHAITK 311 (336)
Q Consensus 295 ~~~~~~~~~~~~~~~~~ 311 (336)
++.-.|..++++++|..
T Consensus 253 MLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 253 MLVRDPKKRASLEEIVS 269 (864)
T ss_pred HHhcCchhhccHHHHhc
Confidence 55555555555555443
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=248.17 Aligned_cols=237 Identities=22% Similarity=0.352 Sum_probs=187.3
Q ss_pred eecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCCEEEEEEccC
Q 019780 69 MIGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMR 144 (336)
Q Consensus 69 ~lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~lv~e~~~ 144 (336)
.||+|+||.||+|.+. +..+|+|+++.. .......+.+.+|+.+++.++||||+++++++.++..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND---NNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC---CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCC
Confidence 5899999999999753 678999998632 223455678999999999999999999999988777999999999
Q ss_pred CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccccc-----
Q 019780 145 GETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM----- 219 (336)
Q Consensus 145 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~----- 219 (336)
+++|.+++.. ...+++..++.++.|++.||+|||++|++||||||.||+++.++ .++|+|||+++.......
T Consensus 79 ~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-eEEECCCccccccCCCCCeeeec
Confidence 9999999943 35689999999999999999999999999999999999999876 799999999875432221
Q ss_pred cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHh--hccCCCCCCCCcccccCCCC
Q 019780 220 TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQN--LRSADTPIPPKLVEIVDPKS 296 (336)
Q Consensus 220 ~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~--~~~~~~~~p~~~~~~~~~~~ 296 (336)
....++..|+|||.......+...|+|+|++.++++.. +..|....-...+...+.. ........|+++.+++...+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~ 235 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCW 235 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHh
Confidence 12234578999998887788889999999999999875 6666532211122222222 11223456778889999999
Q ss_pred CCCCccccchhhhcc
Q 019780 297 TMNNDCMATVHAITK 311 (336)
Q Consensus 297 ~~~~~~~~~~~~~~~ 311 (336)
..+|+.|++...+..
T Consensus 236 ~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 236 TYGVDERPGFAVVEL 250 (257)
T ss_pred ccCchhCcCHHHHHH
Confidence 999999998887754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=256.35 Aligned_cols=188 Identities=30% Similarity=0.500 Sum_probs=146.3
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeE
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFV 128 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~ 128 (336)
|.+..++|.+.+.||+|+||.||+|... ++.||+|+++.. ........+.+|+.++.++ +|+||++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~E~~~~~~l~~h~niv~~~ 77 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG----ATASEYKALMTELKILIHIGHHLNVVNLL 77 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC----CCHHHHHHHHHHHHHHHhhccCcchhhee
Confidence 5567788999999999999999999743 367999998631 1233456788899999999 799999999
Q ss_pred eeEecC--CEEEEEEccCCCCHHHHHhhcCC-------------------------------------------------
Q 019780 129 GASVQP--TMMIITELMRGETLQRYLWSTRP------------------------------------------------- 157 (336)
Q Consensus 129 ~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~------------------------------------------------- 157 (336)
+++... .++++|||+++++|.+++.....
T Consensus 78 ~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (337)
T cd05054 78 GACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE 157 (337)
T ss_pred eeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence 987654 38899999999999999854221
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc----ccccC
Q 019780 158 ----------KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEA 223 (336)
Q Consensus 158 ----------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~ 223 (336)
..+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||+++...... .....
T Consensus 158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCC
Confidence 2578899999999999999999999999999999999999876 79999999998543221 12233
Q ss_pred CcccccCCCCCCCCCCCCHHHHHHHH
Q 019780 224 GTYRWMAPENERPSLENLSEDMVALL 249 (336)
Q Consensus 224 gt~~y~aPE~~~~~~~~~~~di~~l~ 249 (336)
++..|+|||......++...|+|+++
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlG 262 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFG 262 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHH
Confidence 56789999954444333334444433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=246.62 Aligned_cols=244 Identities=24% Similarity=0.329 Sum_probs=189.1
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
+..+|.+.+.||+|+||.||+|.+. +..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.. .+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA------MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY 75 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC------ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence 4567889999999999999999886 4589999876321 12356888999999999999999999987665 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||+++|+|.++++... ..+++..++.++.|++.||+|||++|++||||+|+||+++.++ .++|+|||+++.....
T Consensus 76 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-eEEECCCCCccccCCC
Confidence 9999999999999985433 4689999999999999999999999999999999999999876 7999999998754322
Q ss_pred ccc---ccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhH-HHHHHHHHHHhhcc-CCCCCCCCcccc
Q 019780 218 EMT---CEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAE-ITITLTNILQNLRS-ADTPIPPKLVEI 291 (336)
Q Consensus 218 ~~~---~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~-i~~~l~~~~~~~~~-~~~~~p~~~~~~ 291 (336)
... ...++..|+|||.......+...|+|+++..+|++-. ++.|.... ....+..+.+.... .....++++.++
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEV 233 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 221 1235568999999888888899999999999999877 56664222 12222222222111 122345557778
Q ss_pred cCCCCCCCCccccchhhhcc
Q 019780 292 VDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~ 311 (336)
+...+..+|+.|++..++.+
T Consensus 234 i~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 234 MYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 88888888888888777653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=244.47 Aligned_cols=246 Identities=23% Similarity=0.313 Sum_probs=197.2
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC--CEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP--TMMI 138 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~l 138 (336)
.|.+.+.||+|++|.||++.+. ++.+|+|.+.. ........+.+.+|+.+++.++|+|++++++.+... ..++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNL---RNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEeh---hhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence 4788999999999999999875 67899999863 122334566788999999999999999999887643 3789
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
+|||+++++|.+++.......+++.+++.++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQC 156 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC-cEEEecccceEEecccC
Confidence 99999999999999765556789999999999999999999999999999999999999876 7999999998754221
Q ss_pred -cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHh-hccCCCCCCCCcccccCC
Q 019780 218 -EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQN-LRSADTPIPPKLVEIVDP 294 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~-~~~~~~~~p~~~~~~~~~ 294 (336)
......|++.|+|||.......+...|+|+++..++++..++.|... +.......+... +.......++++.+++..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 22334588999999999888888899999999999999888877532 222222222222 223334567778889999
Q ss_pred CCCCCCccccchhhhccc
Q 019780 295 KSTMNNDCMATVHAITKF 312 (336)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~ 312 (336)
.+..+|+.|++..++.+.
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HhccCcccCCCHHHHhcC
Confidence 999999999998887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=252.78 Aligned_cols=251 Identities=26% Similarity=0.360 Sum_probs=193.7
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC---------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceE
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG---------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENIL 125 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv 125 (336)
.+.+...+|.+.+.||+|+||.||+|.+. ...+|+|.++.. ........+.+|+.+++.+ +||||+
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNII 87 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC----CChHHHHHHHHHHHHHHHhcCCCCEe
Confidence 56666789999999999999999999863 245999998732 1234456788899999999 799999
Q ss_pred eeEeeEecCC-EEEEEEccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCC
Q 019780 126 KFVGASVQPT-MMIITELMRGETLQRYLWSTRP--------------KRLDLKHSISFALDISRAMEYLHANSVIHRDLK 190 (336)
Q Consensus 126 ~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDik 190 (336)
++++++.+.. .++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++|++|||||
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 167 (307)
T cd05098 88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA 167 (307)
T ss_pred eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 9999988665 8999999999999999965321 347889999999999999999999999999999
Q ss_pred CCceeecCCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhH
Q 019780 191 PSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAE 265 (336)
Q Consensus 191 p~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~ 265 (336)
|+||+++.++ .++|+|||+++...... .....++..|+|||.......+...|+|+|+..++++.. +..|....
T Consensus 168 p~Nill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 168 ARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred HHheEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 9999999886 89999999987543211 111224568999998888888899999999999998865 55564222
Q ss_pred HHHHHHHHHH-hh-ccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 266 ITITLTNILQ-NL-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 266 i~~~l~~~~~-~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
-...+..... .. .......++++..++...+..+|+.|++..++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 247 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred CHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 1222222221 11 1222345667788888899999999988888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=264.93 Aligned_cols=239 Identities=20% Similarity=0.207 Sum_probs=184.0
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
...|.+.+.||+|+||.||+|.+. ++.||||... ...+.+|+.+|+.++|+||+++++++..+. .+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 457999999999999999999986 6789999643 123568999999999999999999887665 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||+++. ++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .++|+|||+++.....
T Consensus 237 lv~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGS 313 (461)
T ss_pred EEEEccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-CEEEcccCCceecccc
Confidence 9999995 6888888443 34699999999999999999999999999999999999999876 7999999998753222
Q ss_pred c----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhcc------------CCCCCCCHhHHHHHHHHHHHhhccCC
Q 019780 218 E----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAE------------DPKVRPEFAEITITLTNILQNLRSAD 281 (336)
Q Consensus 218 ~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~------------~p~~RP~~~~i~~~l~~~~~~~~~~~ 281 (336)
. .....||..|+|||.......+...|+|+|++.+|++ .+..+|...++...+...........
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 1 1234599999999999888899999999999998875 34556666666655543211100000
Q ss_pred -------------------------------CCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 282 -------------------------------TPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 282 -------------------------------~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
..+++.+.+++..++..++..|++..++.+..
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 01223455566667777777777777766544
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=280.07 Aligned_cols=250 Identities=18% Similarity=0.248 Sum_probs=193.9
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---C
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---T 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~ 135 (336)
..+|.+++.||+|+||+||+|.+. +..+|+|++... .........+.+|+.+|+.++||||++++++|.+. .
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~---~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYR---GLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecc---ccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 468999999999999999999986 678999998742 22345567899999999999999999999988643 3
Q ss_pred EEEEEEccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-------CcccccCCCCceeecCC-------
Q 019780 136 MMIITELMRGETLQRYLWST--RPKRLDLKHSISFALDISRAMEYLHAN-------SVIHRDLKPSNLLLTED------- 199 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~-------~ivHrDikp~NIll~~~------- 199 (336)
+|+||||+++|+|.++|... ....+++..++.|+.||+.||.|||+. +||||||||+|||++.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999542 235699999999999999999999985 49999999999999642
Q ss_pred ---------CCceEEecccccccccccc-ccccCCcccccCCCCCCC--CCCCCHHHHHHHHHHhhccCCCCCCCHh--H
Q 019780 200 ---------KKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPENERP--SLENLSEDMVALLKSCWAEDPKVRPEFA--E 265 (336)
Q Consensus 200 ---------~~~~kl~Dfg~a~~~~~~~-~~~~~gt~~y~aPE~~~~--~~~~~~~di~~l~~~~l~~~p~~RP~~~--~ 265 (336)
...+||+|||++....... .....||+.|+|||.+.. ...+...|+|+|++.+|++..+..|... .
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 1248999999997543322 233469999999998754 4467789999999999999998888521 1
Q ss_pred HHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 266 ITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 266 i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
....+..+...........++++..++..++..+|+.|++..++....
T Consensus 249 ~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~ 296 (1021)
T PTZ00266 249 FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQ 296 (1021)
T ss_pred HHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccH
Confidence 111122221111111233567788899999999999999888877543
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=247.88 Aligned_cols=247 Identities=24% Similarity=0.358 Sum_probs=193.8
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCCEE
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMM 137 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 137 (336)
+....|.+.+.||+|+||.||+|.+. +..+|+|.+.... ...+.+.+|+.+++.++|||++++++++.+...+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT------MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC------ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcE
Confidence 44567889999999999999999876 4579999876321 1235688999999999999999999988777789
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-eEEECCCccceEccCC
Confidence 999999999999999765555689999999999999999999999999999999999999876 7999999999754332
Q ss_pred ccc---ccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHH-HHHHHHHhhc-cCCCCCCCCcccc
Q 019780 218 EMT---CEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITI-TLTNILQNLR-SADTPIPPKLVEI 291 (336)
Q Consensus 218 ~~~---~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~-~l~~~~~~~~-~~~~~~p~~~~~~ 291 (336)
... ...++..|+|||.......+...|+|+|+..++++.. +..|....... .+..+..... ......|+.+.++
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHEL 235 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 211 2235678999998888888899999999999999887 55554322111 1222222211 1123456678888
Q ss_pred cCCCCCCCCccccchhhhccc
Q 019780 292 VDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~ 312 (336)
+...+..+|+.|+++.++.++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~~ 256 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQSF 256 (260)
T ss_pred HHHHccCCcccCcCHHHHHHH
Confidence 888999999999888877654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=259.84 Aligned_cols=198 Identities=20% Similarity=0.257 Sum_probs=165.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||++.+. ++.+|+|++... ..........+.+|+.++..++|+||+++++++.+.. .++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHH--HHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence 36888999999999999999986 678999998631 1122334556889999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .++|+|||++.......
T Consensus 79 v~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 79 VMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEeecchheecccCC
Confidence 99999999999999543 35689999999999999999999999999999999999999876 79999999987532221
Q ss_pred ---ccccCCcccccCCCCCC-----CCCCCCHHHHHHHHHHhhccCCCCCCCH
Q 019780 219 ---MTCEAGTYRWMAPENER-----PSLENLSEDMVALLKSCWAEDPKVRPEF 263 (336)
Q Consensus 219 ---~~~~~gt~~y~aPE~~~-----~~~~~~~~di~~l~~~~l~~~p~~RP~~ 263 (336)
.....||+.|+|||... ...++...|+|++++.+|++..++.|..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 22346999999999765 3456778999999999999999998864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=245.76 Aligned_cols=243 Identities=23% Similarity=0.239 Sum_probs=194.1
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|++.+.||+|+||.||++.+. +..+|+|.++.. ......+.+.+|+.+++.++||||+++++.+.++. .+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP----KSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcC----cchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 4778899999999999999875 788999998632 12345667889999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
|||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGA 155 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC-cEEEcccCcceeeccccc
Confidence 9999999999998665566789999999999999999999999999999999999999876 79999999987543221
Q ss_pred -ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHHh-hccCCCCCCCCcccccCCC
Q 019780 219 -MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQN-LRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 219 -~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~~-~~~~~~~~p~~~~~~~~~~ 295 (336)
.....|+..|+|||.......+...|+|+++..++.+..+..|...+-. ..+..+.+. .......++..+.+++...
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 2234588999999998888888899999999999999999888643322 222222221 1112233555567788888
Q ss_pred CCCCCccccchhhhc
Q 019780 296 STMNNDCMATVHAIT 310 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~ 310 (336)
+..+|+.|++..++.
T Consensus 236 l~~~P~~Rp~~~~il 250 (255)
T cd08219 236 FKRNPRSRPSATTIL 250 (255)
T ss_pred HhCCcccCCCHHHHh
Confidence 888888888877664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=247.74 Aligned_cols=244 Identities=25% Similarity=0.360 Sum_probs=190.3
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
+..+|.+.+.||+|+||.||+|.+. +..+|+|++..... ....+.+|+.+++.++||||+++++++.+.. .+
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIF 75 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceE
Confidence 3456888999999999999999876 45799999863211 2346788999999999999999999887665 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||++|++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++ .++|+|||+++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 76 IVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDD 153 (256)
T ss_pred EEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-cEEECCcccceecccc
Confidence 9999999999999996443 4689999999999999999999999999999999999999876 7999999998754433
Q ss_pred cccccC---CcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHh-HHHHHHHHHHHhhc-cCCCCCCCCcccc
Q 019780 218 EMTCEA---GTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFA-EITITLTNILQNLR-SADTPIPPKLVEI 291 (336)
Q Consensus 218 ~~~~~~---gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~-~i~~~l~~~~~~~~-~~~~~~p~~~~~~ 291 (336)
...... ++..|+|||.......+...|+|+++..+|+... +..|... .-......+..... ......|+++.++
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTI 233 (256)
T ss_pred cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 222222 3457999999888888889999999999999876 4555311 11111222222211 1223467778899
Q ss_pred cCCCCCCCCccccchhhhcc
Q 019780 292 VDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~ 311 (336)
+...+..+|+.|++..++.+
T Consensus 234 i~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 234 MYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999998887764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=252.38 Aligned_cols=244 Identities=26% Similarity=0.392 Sum_probs=195.4
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~ 140 (336)
|++++.||+|+||+||++... ++.+|+|++.... ..........+|+.+++.++||||+++++++.+.. .++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE---IEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT---HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc---ccccccchhhhhhhccccccccccccccccccccccccccc
Confidence 778999999999999999997 5579999998422 22233334456999999999999999999998665 89999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc--ccccc
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDE 218 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~--~~~~~ 218 (336)
|++++++|.+++. ....+++..++.++.|++.||.+||++|++|+||||+||+++.++ .++|+|||.+.. .....
T Consensus 78 ~~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 78 EYCPGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG-EVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEETTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS-EEEESSGTTTEESTSTTSE
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccc
Confidence 9999999999995 335689999999999999999999999999999999999999776 899999999874 22333
Q ss_pred ccccCCcccccCCCCCC-CCCCCCHHHHHHHHHHhhccCCCCCCCHh----HHHHHHHHHHHhhccCC----CCCCCCcc
Q 019780 219 MTCEAGTYRWMAPENER-PSLENLSEDMVALLKSCWAEDPKVRPEFA----EITITLTNILQNLRSAD----TPIPPKLV 289 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~-~~~~~~~~di~~l~~~~l~~~p~~RP~~~----~i~~~l~~~~~~~~~~~----~~~p~~~~ 289 (336)
.....++..|+|||... ....+...|+|+|+..+|++-.+..|... +....+........... ...++++.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR 234 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence 44556899999999988 88889999999999999988777776533 33334433333211111 22236788
Q ss_pred cccCCCCCCCCccccchhhhcccc
Q 019780 290 EIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
+++...+..+|+.|++..++.+..
T Consensus 235 ~li~~~l~~~p~~R~~~~~l~~~~ 258 (260)
T PF00069_consen 235 DLIKKMLSKDPEQRPSAEELLKHP 258 (260)
T ss_dssp HHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred HHHHHHccCChhHCcCHHHHhcCC
Confidence 999999999999999988887643
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=249.10 Aligned_cols=246 Identities=22% Similarity=0.375 Sum_probs=190.4
Q ss_pred CCceeEeeeecCCCcEEEEEeEE------CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..+|++.+.||+|+||.||+|.+ .+..+++|.+.. .........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD----INNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccC----CCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 46788899999999999999985 246799999863 12334556789999999999999999999998876
Q ss_pred C-EEEEEEccCCCCHHHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC
Q 019780 135 T-MMIITELMRGETLQRYLWSTR---------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE 198 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~---------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~ 198 (336)
. .|+||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 5 899999999999999984322 234788899999999999999999999999999999999998
Q ss_pred CCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHH
Q 019780 199 DKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNI 273 (336)
Q Consensus 199 ~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~ 273 (336)
++ .++|+|||+++...... .....++..|+|||.......+...|+|+|+..++++-. +..|....-...+...
T Consensus 160 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 160 QL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CC-cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 76 79999999997543221 222345678999999887778889999999999998876 5556422111111111
Q ss_pred HH--hhccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 274 LQ--NLRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 274 ~~--~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.. .........|+.+.+++...+..+|+.|++..++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 278 (283)
T cd05090 239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHT 278 (283)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 11 112233456777888888889989999988877654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=251.08 Aligned_cols=247 Identities=26% Similarity=0.392 Sum_probs=195.5
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
...+|.+.+.||+|+||.||+|.+. +..||||+++.. ...+....+.+|+++++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 78 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET----ASNDARKDFEREAELLTNFQHENIVKFYGVCT 78 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc----CCHHHHHHHHHHHHHHHhcCCCCchheeeEEe
Confidence 3567888999999999999999863 367999998632 22335678999999999999999999999988
Q ss_pred cCC-EEEEEEccCCCCHHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC
Q 019780 133 QPT-MMIITELMRGETLQRYLWSTR------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED 199 (336)
Q Consensus 133 ~~~-~~lv~e~~~gg~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~ 199 (336)
+.. .++||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC
Confidence 765 999999999999999996432 2457889999999999999999999999999999999999988
Q ss_pred CCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHH-HHHH
Q 019780 200 KKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITIT-LTNI 273 (336)
Q Consensus 200 ~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~-l~~~ 273 (336)
+ .++|+|||+++...... .....+++.|+|||.......+...|+|+|+..++++.. +..|....-... +..+
T Consensus 159 ~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 159 L-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred C-eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 6 89999999987532222 122235688999999888888899999999999999886 777753322222 2222
Q ss_pred HHh-hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 274 LQN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 274 ~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
... ........|.++.+++...+..+|+.|++..++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 211 22223456677888999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=246.03 Aligned_cols=236 Identities=19% Similarity=0.369 Sum_probs=185.2
Q ss_pred ecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCCEEEEEEccCC
Q 019780 70 IGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRG 145 (336)
Q Consensus 70 lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~lv~e~~~g 145 (336)
||+|+||.||+|.+. +..||+|++... ......+.+.+|+.+++.++||||+++++++.....++||||+++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~ 78 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE----NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASG 78 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccc----cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCC
Confidence 899999999999764 346899998632 234456779999999999999999999999887779999999999
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-----cc
Q 019780 146 ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-----MT 220 (336)
Q Consensus 146 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~-----~~ 220 (336)
++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++....... ..
T Consensus 79 ~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 79 GPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEeccCCccccccCCccceeccC
Confidence 9999998533 35789999999999999999999999999999999999999876 79999999987432221 11
Q ss_pred ccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHhh--ccCCCCCCCCcccccCCCCC
Q 019780 221 CEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQNL--RSADTPIPPKLVEIVDPKST 297 (336)
Q Consensus 221 ~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~~--~~~~~~~p~~~~~~~~~~~~ 297 (336)
...++..|+|||.......+...|+|+|+..+|+.-. +..|....-...+...+... .......++++.+++...|.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~ 236 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWI 236 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcC
Confidence 1123578999998877778889999999999998764 77775332222222222221 12234557778889999999
Q ss_pred CCCccccchhhhcc
Q 019780 298 MNNDCMATVHAITK 311 (336)
Q Consensus 298 ~~~~~~~~~~~~~~ 311 (336)
.+++.|++..++.+
T Consensus 237 ~~~~~Rp~~~~i~~ 250 (257)
T cd05115 237 YKWEDRPNFAKVEE 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999998887754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=246.04 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=196.2
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP- 134 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~- 134 (336)
|.++.++|.+.+.||+|+||.||+|... +..+|||.+.... .....+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT------MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE 74 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc------cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC
Confidence 3467789999999999999999999876 5679999987321 1245688999999999999999999998874
Q ss_pred CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 135 TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 135 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
..++||||+++++|.+++....+..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++...
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~ 153 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL-VCKIADFGLARLI 153 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC-CEEECccccceec
Confidence 499999999999999999765556789999999999999999999999999999999999999886 7999999998754
Q ss_pred ccccc---cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhH-HHHHHHHHHHhhc-cCCCCCCCCc
Q 019780 215 VMDEM---TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAE-ITITLTNILQNLR-SADTPIPPKL 288 (336)
Q Consensus 215 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~-i~~~l~~~~~~~~-~~~~~~p~~~ 288 (336)
..... ....++..|+|||.......+...|+|+++..+++.-. +..|.... ....+..+..... ......|+++
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEEL 233 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 32221 12234578999999888888899999999999998876 66664221 1122233322221 1223456778
Q ss_pred ccccCCCCCCCCccccchhhhccc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.+++...+..+|+.|++..++..+
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~l~~~ 257 (261)
T cd05034 234 YDLMLQCWDKDPEERPTFEYLQSF 257 (261)
T ss_pred HHHHHHHcccCcccCCCHHHHHHH
Confidence 888888899999999888777643
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=257.53 Aligned_cols=186 Identities=24% Similarity=0.298 Sum_probs=157.2
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
.+....|.+.+.||+|+||.||+|... +..||+|+... .....|+.+++.++||||+++++++.+..
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 130 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGA 130 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------cccHHHHHHHHhCCCCCCcChhheEEeCC
Confidence 344567999999999999999999986 56899997542 12346899999999999999999988766
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.++|||++. ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++..
T Consensus 131 ~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~ 207 (357)
T PHA03209 131 ITCMVLPHYS-SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFP 207 (357)
T ss_pred eeEEEEEccC-CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEecCcccccc
Confidence 889999995 588888854 345789999999999999999999999999999999999999877 7999999999753
Q ss_pred ccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC
Q 019780 215 VMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP 257 (336)
Q Consensus 215 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p 257 (336)
... ......||..|+|||......++...|+|+|++.+|++..
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~ 251 (357)
T PHA03209 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251 (357)
T ss_pred ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHH
Confidence 222 2234569999999999988888999999999999988754
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=232.51 Aligned_cols=215 Identities=26% Similarity=0.370 Sum_probs=179.4
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEE--CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
+..+.++.++|.+.+.||.|||+-||++.. .+..+|+|.+.- ...+..+..++|++.-++++||||++++++.
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c-----~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC-----HSQEDIEEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeec-----cchHHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence 557789999999999999999999999875 478899999862 2456788899999999999999999998874
Q ss_pred ec----C--CEEEEEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCC
Q 019780 132 VQ----P--TMMIITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLHANS--VIHRDLKPSNLLLTEDKK 201 (336)
Q Consensus 132 ~~----~--~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDikp~NIll~~~~~ 201 (336)
.. . ..|++++|...|+|.+.+.. .++..+++.+++.|+.++++||++||+.. ++||||||.|||++..+
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~- 166 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG- 166 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-
Confidence 42 1 28999999999999999854 34557999999999999999999999998 99999999999999876
Q ss_pred ceEEecccccccccc-----------ccccccCCcccccCCCC-------------------------------------
Q 019780 202 QVKLADFGLAREEVM-----------DEMTCEAGTYRWMAPEN------------------------------------- 233 (336)
Q Consensus 202 ~~kl~Dfg~a~~~~~-----------~~~~~~~gt~~y~aPE~------------------------------------- 233 (336)
.++|.|||.+..... .+......|..|+|||.
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 799999999874321 11233458999999991
Q ss_pred --------------CCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHH
Q 019780 234 --------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274 (336)
Q Consensus 234 --------------~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~ 274 (336)
..|....++..+.+|+..|++.+|.+||+..+++..++.+.
T Consensus 247 ~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 12334457888999999999999999999999988877653
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=249.78 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=191.1
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEe
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVG 129 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 129 (336)
|.++..+|.+.+.||+|+||.||+|... +..||+|.+... ........+.+|+.+++.++||||+++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 76 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES----ASLRERIEFLNEASVMKGFTCHHVVRLLG 76 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 4567789999999999999999999753 347899987631 22334456889999999999999999999
Q ss_pred eEecCC-EEEEEEccCCCCHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC
Q 019780 130 ASVQPT-MMIITELMRGETLQRYLWSTR--------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK 200 (336)
Q Consensus 130 ~~~~~~-~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~ 200 (336)
++.++. .++||||+++|+|.+++.... ....+...++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 77 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~ 156 (288)
T cd05061 77 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF 156 (288)
T ss_pred EEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC
Confidence 887665 899999999999999996422 13346778899999999999999999999999999999999876
Q ss_pred CceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCH----hHHHHHHH
Q 019780 201 KQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEF----AEITITLT 271 (336)
Q Consensus 201 ~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~----~~i~~~l~ 271 (336)
.++|+|||+++...... .....++..|+|||.......+...|+|++++.++++.. +..|.. .++...
T Consensus 157 -~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~-- 233 (288)
T cd05061 157 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF-- 233 (288)
T ss_pred -cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--
Confidence 79999999987533221 122235678999999888888889999999999998765 344432 222221
Q ss_pred HHHHh-hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 272 NILQN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 272 ~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+... ........|+.+.+++...+..+|+.|++..++.+
T Consensus 234 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 234 -VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred -HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1111 11223345677889999999999999999888875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=254.32 Aligned_cols=214 Identities=31% Similarity=0.560 Sum_probs=164.4
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEE-------CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeE
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFV 128 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~ 128 (336)
|.+...+|.+.+.||+|+||.||+|.+ .++.||||+++.. ........+.+|+.++..+ +||||++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 77 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLL 77 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccC----CChHHHHHHHHHHHHHHhccCCccHhhhc
Confidence 455667899999999999999999974 2578999999732 1234456788999999999 689999999
Q ss_pred eeEecC--CEEEEEEccCCCCHHHHHhhcCC-------------------------------------------------
Q 019780 129 GASVQP--TMMIITELMRGETLQRYLWSTRP------------------------------------------------- 157 (336)
Q Consensus 129 ~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~------------------------------------------------- 157 (336)
+++... ..+++|||+++|+|.++++....
T Consensus 78 ~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (343)
T cd05103 78 GACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKS 157 (343)
T ss_pred ceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCc
Confidence 987653 38999999999999999854321
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccccc--
Q 019780 158 ----------------KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM-- 219 (336)
Q Consensus 158 ----------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~-- 219 (336)
..+++..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~ 236 (343)
T cd05103 158 LSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYV 236 (343)
T ss_pred cccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchh
Confidence 2367788899999999999999999999999999999999876 899999999875322211
Q ss_pred --cccCCcccccCCCCCCCCCCC-----------------------------------------------CHHHHHHHHH
Q 019780 220 --TCEAGTYRWMAPENERPSLEN-----------------------------------------------LSEDMVALLK 250 (336)
Q Consensus 220 --~~~~gt~~y~aPE~~~~~~~~-----------------------------------------------~~~di~~l~~ 250 (336)
....++..|+|||.......+ .+.++.+++.
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 316 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 112355779999943322222 2345666667
Q ss_pred HhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 251 SCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 251 ~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
.||+.+|.+||++.+++..|+.+.+
T Consensus 317 ~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 317 DCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 7777778888888887777776654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=245.07 Aligned_cols=244 Identities=25% Similarity=0.355 Sum_probs=190.5
Q ss_pred cCCceeEeeeecCCCcEEEEEeEECC-ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYGC-EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
+.++|.+.+.||+|+||.||+|.+.+ ..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.. .+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS------MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY 75 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc------ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence 45678999999999999999998764 469999886321 12356889999999999999999999987665 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||.++.....
T Consensus 76 lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDD 153 (256)
T ss_pred EEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-CEEECCCccceecCCC
Confidence 9999999999999995533 3689999999999999999999999999999999999999876 7999999998754333
Q ss_pred cccc---cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhH-HHHHHHHHHHhhcc-CCCCCCCCcccc
Q 019780 218 EMTC---EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAE-ITITLTNILQNLRS-ADTPIPPKLVEI 291 (336)
Q Consensus 218 ~~~~---~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~-i~~~l~~~~~~~~~-~~~~~p~~~~~~ 291 (336)
.... ..++..|+|||.......+...|+|+|+..+|++-. +..|.... -......+.+.... .....++.+.++
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAI 233 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 2221 235578999999887788889999999999999876 66664211 11112222222111 123345667888
Q ss_pred cCCCCCCCCccccchhhhcc
Q 019780 292 VDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~ 311 (336)
+...+..+|+.|+++.++.+
T Consensus 234 i~~cl~~~p~~Rp~~~~ll~ 253 (256)
T cd05113 234 MYSCWHEKAEERPTFQQLLS 253 (256)
T ss_pred HHHHcCCCcccCCCHHHHHH
Confidence 88999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=257.87 Aligned_cols=195 Identities=25% Similarity=0.261 Sum_probs=163.4
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC--
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-- 134 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 134 (336)
.-.++|.+.+.||+|+||.||+|.+. ++.+|||.+... .........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 90 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS 90 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCc---ccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence 34578999999999999999999875 788999998632 22344566788999999999999999999987643
Q ss_pred -----CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 135 -----TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 135 -----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 91 ~~~~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-~~kl~Dfg 164 (355)
T cd07874 91 LEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFG 164 (355)
T ss_pred ccccceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-CEEEeeCc
Confidence 26999999976 6777663 2488899999999999999999999999999999999999877 79999999
Q ss_pred ccccccccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 210 LAREEVMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 210 ~a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
+++...... .....||..|+|||.......+...|+|+|++.++++..++.|.
T Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 218 (355)
T cd07874 165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_pred ccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 998643322 23346899999999998888889999999999999988877764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=244.46 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=194.3
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
|.+...+|.+.+.||+|+||.||+|... +..+++|.+.. .....+.+.+|+.+++.++|+||+++++.+.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP------GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP 74 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCC------ChhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCC
Confidence 3456788999999999999999999865 56799998763 1234567889999999999999999999988877
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
.+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~ 153 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIE 153 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCCcceeecc
Confidence 99999999999999999765566788999999999999999999999999999999999999876 89999999987543
Q ss_pred ccccc---ccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhH-HHHHHHHHHHhh-ccCCCCCCCCcc
Q 019780 216 MDEMT---CEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAE-ITITLTNILQNL-RSADTPIPPKLV 289 (336)
Q Consensus 216 ~~~~~---~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~-i~~~l~~~~~~~-~~~~~~~p~~~~ 289 (336)
..... ...++..|+|||.......+...|+|+|+..+++.-. +.-|.... .......+.+.. .......|.++.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 233 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHH
Confidence 22211 2235678999999888888889999999999998876 55553221 111111111111 112244666788
Q ss_pred cccCCCCCCCCccccchhhhcc
Q 019780 290 EIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+++...+..+|+.|++...+.+
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHH
Confidence 8888888889999888776654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=259.04 Aligned_cols=245 Identities=24% Similarity=0.291 Sum_probs=187.4
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC------
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP------ 134 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------ 134 (336)
+|.+.+.||+|+||.||+|.+. ++.||||.+... .........+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV---FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc---ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence 3677899999999999999974 789999998631 12233456788999999999999999999988754
Q ss_pred CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 135 TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 135 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
..|+||||+. ++|.+++. ....+++..++.++.||+.||.|||++|++||||||+|||++.++ .+||+|||+++..
T Consensus 78 ~~~lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~ 153 (372)
T cd07853 78 EIYVVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-VLKICDFGLARVE 153 (372)
T ss_pred eEEEEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-CEEeccccceeec
Confidence 3799999997 58888873 345799999999999999999999999999999999999999876 8999999999754
Q ss_pred cccc---ccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCH----hHHHHHHHH--------------
Q 019780 215 VMDE---MTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEF----AEITITLTN-------------- 272 (336)
Q Consensus 215 ~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~----~~i~~~l~~-------------- 272 (336)
.... .....+++.|+|||...+. .++.+.|+|++++.++++..++.|.. .+.+..+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 3221 2334578999999987664 46788999999999999988877641 111111111
Q ss_pred --HHHhhc-------------cCCCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 273 --ILQNLR-------------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 273 --~~~~~~-------------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
....+. ......++++.+++..++..+|..|.+..++.....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 000000 111234556677888889999999999888876543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=257.73 Aligned_cols=194 Identities=25% Similarity=0.256 Sum_probs=163.1
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP--- 134 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--- 134 (336)
-.++|.+.+.||+|+||.||+|.+. ++.||||++... .........+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcc---ccCchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 3568999999999999999999875 788999998632 12334456788999999999999999999887542
Q ss_pred ----CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 135 ----TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 135 ----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
..|+||||+++ +|.+.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~ 172 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGL 172 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-cEEEEeCCC
Confidence 37999999975 7777773 2478899999999999999999999999999999999999887 799999999
Q ss_pred cccccccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 211 AREEVMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 211 a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
++...... .....||..|+|||.......+...|+|+|++.++++..+..|.
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf 225 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCC
Confidence 98643322 23446899999999998888899999999999999998887774
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=247.47 Aligned_cols=247 Identities=19% Similarity=0.322 Sum_probs=189.6
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--Cc----cEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CE----PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
+...+|.+.+.||+|+||+||+|.+. +. .+++|.+.. .........+..|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~ 79 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD----RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP 79 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc----ccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence 34567888999999999999999874 44 366777642 122334567888888999999999999999987
Q ss_pred cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 133 QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 133 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
....++++||+++|+|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~-~~kl~Dfg~~~ 157 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS-IVQIADFGVAD 157 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEEcCCccce
Confidence 77789999999999999999543 35689999999999999999999999999999999999999876 79999999997
Q ss_pred cccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHhhccC--CCCCC
Q 019780 213 EEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQNLRSA--DTPIP 285 (336)
Q Consensus 213 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~~~~~--~~~~p 285 (336)
...... .....++..|+|||.......+...|+|+++..+|+.-. +..|....-...+.++++..... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICT 237 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCC
Confidence 543222 122346788999999888888899999999999999875 66665332222333333321111 11223
Q ss_pred CCcccccCCCCCCCCccccchhhhcc
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
..+..++...+..+|+.|++..++.+
T Consensus 238 ~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 238 IDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 34556777888889999998888765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=247.75 Aligned_cols=195 Identities=29% Similarity=0.328 Sum_probs=157.5
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC---CCCceEeeEeeEecC---
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM---KHENILKFVGASVQP--- 134 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~--- 134 (336)
+|.+.+.||+|+||+||+|.+. ++.||+|.++.... .......+.+|+.+++.+ +||||+++++++.+.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN---EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC---CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 4788899999999999999986 78899999874211 111122345666666554 799999999987642
Q ss_pred ---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 135 ---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 135 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
..+++|||+++ +|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++
T Consensus 78 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~kl~dfg~~ 155 (288)
T cd07863 78 RETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLA 155 (288)
T ss_pred CCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccCcc
Confidence 27999999985 899988665556689999999999999999999999999999999999999887 7999999998
Q ss_pred ccccccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 212 REEVMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 212 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
+...... .....|+..|+|||.......+.+.|+|++++.++++-.+..|.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f 207 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCc
Confidence 7543322 23345889999999988888889999999999999887666553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=246.04 Aligned_cols=244 Identities=24% Similarity=0.288 Sum_probs=193.2
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|++.+.||+|+||.||+|.+. ++.||+|++... ........+.+|+.+++.++||||+++++.+.... .++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD----ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC----CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 5778899999999999999874 788999998632 23345567899999999999999999999888765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccccc
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM 219 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~ 219 (336)
|||+++++|..+. .+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++........
T Consensus 78 ~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~~~~ 150 (279)
T cd06619 78 TEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIA 150 (279)
T ss_pred EecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-CEEEeeCCcceecccccc
Confidence 9999999997653 468889999999999999999999999999999999999887 799999999986544444
Q ss_pred cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH----HHHHHHHhhcc------CCCCCCCCcc
Q 019780 220 TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITI----TLTNILQNLRS------ADTPIPPKLV 289 (336)
Q Consensus 220 ~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~----~l~~~~~~~~~------~~~~~p~~~~ 289 (336)
....|+..|+|||.......+...|+|++++.+|++-.+.-|....... ......+.... .....++++.
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 5567999999999998888889999999999999988877775321100 00011111111 1123456677
Q ss_pred cccCCCCCCCCccccchhhhcccccccc
Q 019780 290 EIVDPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
+++...+..+|+.|++..++.+......
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 8888899999999999988887654433
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=248.81 Aligned_cols=248 Identities=24% Similarity=0.392 Sum_probs=194.7
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
++.++|.+.+.||+|+||.||++... +..+|+|.+.. ........+.+|+.++++++||||+++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGVC 76 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC-----cCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 45678999999999999999999752 34588888762 1334566789999999999999999999998
Q ss_pred ecCC-EEEEEEccCCCCHHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC
Q 019780 132 VQPT-MMIITELMRGETLQRYLWSTR-----------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED 199 (336)
Q Consensus 132 ~~~~-~~lv~e~~~gg~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~ 199 (336)
.+.. .++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 77 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred ecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 8655 899999999999999995432 2358999999999999999999999999999999999999987
Q ss_pred CCceEEeccccccccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHH-HHHHHHH
Q 019780 200 KKQVKLADFGLAREEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEI-TITLTNI 273 (336)
Q Consensus 200 ~~~~kl~Dfg~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i-~~~l~~~ 273 (336)
+ .++|+|||+++....... ....++..|+|||.......+...|+|+|++.++++-. +..|....- ...+..+
T Consensus 157 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 157 L-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred C-cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 6 799999999875432221 12235678999999888888889999999999998876 666653211 1122222
Q ss_pred HHh-hccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 274 LQN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 274 ~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
... ........|+++.+++...+..+|..|++..++.+.
T Consensus 236 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~ 275 (288)
T cd05093 236 TQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSL 275 (288)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 222 122233567788889999999999999988887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=242.83 Aligned_cols=238 Identities=24% Similarity=0.386 Sum_probs=183.8
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccC
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMR 144 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~ 144 (336)
+.||+|+||.||+|.+. ++.+|+|.+.. ....+....+.+|+.+++.++||||+++++++.+.. .++||||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRE----TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCc----cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 36999999999999874 78899998762 123445677999999999999999999999988665 899999999
Q ss_pred CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccccccc--
Q 019780 145 GETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE-- 222 (336)
Q Consensus 145 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~-- 222 (336)
+++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...........
T Consensus 77 ~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 77 GGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-cEEECccccCcccccccccccCC
Confidence 99999999543 34689999999999999999999999999999999999999876 799999999875332211111
Q ss_pred --CCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHh--hccCCCCCCCCcccccCCCCC
Q 019780 223 --AGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQN--LRSADTPIPPKLVEIVDPKST 297 (336)
Q Consensus 223 --~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~--~~~~~~~~p~~~~~~~~~~~~ 297 (336)
.++..|+|||.......+...|+|+|+..++++.. +..|....-.......... ........|+++.+++...+.
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 234 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWE 234 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcC
Confidence 23457999999888888889999999999998664 4445321111111112111 112223456778888899999
Q ss_pred CCCccccchhhhcc
Q 019780 298 MNNDCMATVHAITK 311 (336)
Q Consensus 298 ~~~~~~~~~~~~~~ 311 (336)
.+|+.|++..++.+
T Consensus 235 ~~p~~Rps~~~~~~ 248 (252)
T cd05084 235 YDPGQRPSFSTVHQ 248 (252)
T ss_pred CChhhCcCHHHHHH
Confidence 99999998888764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=247.91 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=195.9
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
...+|.+.+.||.|+||.||+|.+. +..+++|++... .......+.+|+.+++.++||||+++++++.+.. .+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD-----DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc-----chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 3467889999999999999999986 688999998632 2234567889999999999999999999888765 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||+++++|.+++....+..+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKED 157 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-eEEEccccchhhcCCc
Confidence 999999999999999766666789999999999999999999999999999999999999876 7999999998754322
Q ss_pred c--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHh-HHHHHHHHHHHhhc-cCCCCCCCCccccc
Q 019780 218 E--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFA-EITITLTNILQNLR-SADTPIPPKLVEIV 292 (336)
Q Consensus 218 ~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~-~i~~~l~~~~~~~~-~~~~~~p~~~~~~~ 292 (336)
. .....++..|+|||.......+...|+|+|+..++++-. +..|... .....+..+..... ......|+.+.+++
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 1 122235678999998888888889999999999998876 5666422 11222222222211 22345667788888
Q ss_pred CCCCCCCCccccchhhhcc
Q 019780 293 DPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~ 311 (336)
...+..+|+.|++..++.+
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 8999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=241.80 Aligned_cols=245 Identities=20% Similarity=0.262 Sum_probs=195.1
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|+..+.||.|+||.||.+... +..+++|.+... .........+.+|+.++++++|+||+++++++.+.. .+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLT---RLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeec---ccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence 4788999999999999888764 788999998632 223455667889999999999999999999988766 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-CEEECcCcceEEcccccc
Confidence 9999999999999665556789999999999999999999999999999999999999876 79999999987543222
Q ss_pred -ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHH-hhccCCCCCCCCcccccCCC
Q 019780 219 -MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQ-NLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 219 -~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~-~~~~~~~~~p~~~~~~~~~~ 295 (336)
.....|++.|+|||.......+...|+|+++..+|++..+.+|... +.......+.. .........+.++.+++...
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 2334589999999998887788889999999999999888888532 22222222222 12222234566677788888
Q ss_pred CCCCCccccchhhhcc
Q 019780 296 STMNNDCMATVHAITK 311 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~ 311 (336)
+..+|+.|++..++.+
T Consensus 237 l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 237 LQQDPEKRPTADEVLD 252 (256)
T ss_pred cccCcccCCCHHHHhh
Confidence 8888888887776654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=262.63 Aligned_cols=198 Identities=20% Similarity=0.274 Sum_probs=159.8
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC------CceEe
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH------ENILK 126 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~ 126 (336)
....+...+|.+.+.||+|+||+||+|.+. ++.||||+++.. .........|+.+++.++| ++++.
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 195 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV------PKYTRDAKIEIQFMEKVRQADPADRFPLMK 195 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc------hhhHHHHHHHHHHHHHHhhcCcccCcceee
Confidence 334455678999999999999999999875 778999999631 1223345567777666654 45888
Q ss_pred eEeeEecCC--EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCC--
Q 019780 127 FVGASVQPT--MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKK-- 201 (336)
Q Consensus 127 ~~~~~~~~~--~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~~~-- 201 (336)
+++++.... +++||+++ |++|.+++.. ...+++..+..++.||+.||.|||+ .|||||||||+|||++.++.
T Consensus 196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred eEEEEEcCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccc
Confidence 888887543 78899988 6789998844 3569999999999999999999998 59999999999999986542
Q ss_pred -------------ceEEeccccccccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 202 -------------QVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 202 -------------~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.+||+|||.+.... .......||+.|+|||.+.+..++.+.|+|+|++.+|++..++.|.
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER-HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc-cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 49999999886432 2334567999999999999999999999999999999999888775
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=247.92 Aligned_cols=245 Identities=25% Similarity=0.387 Sum_probs=188.0
Q ss_pred CCceeEeeeecCCCcEEEEEeEE------CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..+|.+.+.||+|+||.||++.. .+..||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 77 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence 46788999999999999999874 2678999998631 334456789999999999999999999976532
Q ss_pred ---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 135 ---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 135 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+||+++.++ .++|+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~ 155 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-RVKIGDFGLT 155 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-eEEECCCccc
Confidence 389999999999999999543 34689999999999999999999999999999999999999877 7999999998
Q ss_pred cccccccc-----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH----------------HHHHH
Q 019780 212 REEVMDEM-----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE----------------ITITL 270 (336)
Q Consensus 212 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~----------------i~~~l 270 (336)
+....... ....++..|+|||.......+...|+|+++..++++-....|.... +...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 85432211 1112345699999988888889999999999998776543332111 11111
Q ss_pred HHHHHhh--ccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 271 TNILQNL--RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 271 ~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.+..... .......|+++.+++...+..+|+.|++..++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1111111 11223466778889999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=246.75 Aligned_cols=249 Identities=21% Similarity=0.322 Sum_probs=196.2
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
.++.++|.+.+.||+|+||.||+|.+. +..|++|.+.. .........+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 77 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILPILHVC 77 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC----CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 356788999999999999999999875 36789998762 22455577889999999999999999999987
Q ss_pred ecC--CEEEEEEccCCCCHHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCce
Q 019780 132 VQP--TMMIITELMRGETLQRYLWSTRP------KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQV 203 (336)
Q Consensus 132 ~~~--~~~lv~e~~~gg~L~~~l~~~~~------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~ 203 (336)
.+. ..+++++|+++++|.+++..... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .+
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-~~ 156 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-QV 156 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-cE
Confidence 753 48999999999999999854322 4589999999999999999999999999999999999999876 89
Q ss_pred EEeccccccccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHh-h
Q 019780 204 KLADFGLAREEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQN-L 277 (336)
Q Consensus 204 kl~Dfg~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~-~ 277 (336)
||+|||+++....... ....++..|+|||.......+...|+|+|++.+|+... ++.|....-...+...... .
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 236 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence 9999999975432221 12346678999999888888999999999999999886 6666532211122222221 1
Q ss_pred c-cCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 278 R-SADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 278 ~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
. ......|+++.+++...+..+|+.|++..++..
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1 122345777888999999999999998877764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=241.78 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=197.8
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||++... +..+|+|.+... .........+.+|+.+++.++||||+++++.+..+. .++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVE---QMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecc---ccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence 4788899999999999999875 788999998742 123345678999999999999999999999887655 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
|||+++++|.+++.......+++..++.++.|++.||+|||++|++|+||+|+||+++.++..++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999999765556689999999999999999999999999999999999998766578999999988643322
Q ss_pred ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh-hccCCCCCCCCcccccCCCC
Q 019780 219 MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN-LRSADTPIPPKLVEIVDPKS 296 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~-~~~~~~~~p~~~~~~~~~~~ 296 (336)
.....|+..|+|||.......+...|+|+++..+|++..+..|.-.. ........... ........++++.+++...+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 237 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSML 237 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHc
Confidence 22345889999999988888888999999999999998887775222 11122222221 22233456778888999999
Q ss_pred CCCCccccchhhhcc
Q 019780 297 TMNNDCMATVHAITK 311 (336)
Q Consensus 297 ~~~~~~~~~~~~~~~ 311 (336)
..+|+.|++..++..
T Consensus 238 ~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 238 NLDPSKRPQLSQIMA 252 (256)
T ss_pred cCChhhCCCHHHHhh
Confidence 999999999888765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=251.00 Aligned_cols=253 Identities=24% Similarity=0.314 Sum_probs=193.5
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC---------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCce
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG---------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENI 124 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI 124 (336)
..|.+...+|.+.+.||+|+||.||+|... ...+|+|+++.. ........+.+|+.+++.+ +||||
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i 80 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN----ATDKDLADLISEMELMKLIGKHKNI 80 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC----CChHHHHHHHHHHHHHHhccCCCCe
Confidence 345566788999999999999999999752 346899988631 2234466788999999999 59999
Q ss_pred EeeEeeEecCC-EEEEEEccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 019780 125 LKFVGASVQPT-MMIITELMRGETLQRYLWSTR--------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDL 189 (336)
Q Consensus 125 v~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDi 189 (336)
+++++++.+.. .+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||++|++||||
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dl 160 (314)
T cd05099 81 INLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDL 160 (314)
T ss_pred eeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence 99999988665 899999999999999995432 245888999999999999999999999999999
Q ss_pred CCCceeecCCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHh
Q 019780 190 KPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFA 264 (336)
Q Consensus 190 kp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~ 264 (336)
||+||+++.++ .+||+|||+++...... .....++..|+|||.......+...|+|+|+..+|++-. +..|...
T Consensus 161 kp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 161 AARNVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred cceeEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 99999999876 79999999997543211 112234568999999888888899999999999988654 5555322
Q ss_pred HHHH-HHHHHHHhh-ccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 265 EITI-TLTNILQNL-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 265 ~i~~-~l~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.-.. .+..+.... .......|.++.+++...+..+|+.|++..++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 240 IPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1111 111121111 12234456678889999999999999998887753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=244.35 Aligned_cols=236 Identities=17% Similarity=0.289 Sum_probs=181.4
Q ss_pred eeecCCCcEEEEEeEEC--------------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 68 KMIGEGSYSIVYKGFYG--------------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
+.||+|+||.||+|... ...+++|++.. ........+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP-----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh-----hhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 35899999999999853 12478888753 123345678899999999999999999999886
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC------ceEEe
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK------QVKLA 206 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~------~~kl~ 206 (336)
+. .++||||+++|+|..++... ...+++..++.++.||+.||+|||++|++||||||+|||++.++. .++++
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 64 89999999999999988543 356899999999999999999999999999999999999986542 28999
Q ss_pred ccccccccccccccccCCcccccCCCCCC-CCCCCCHHHHHHHHHHhhccC-CCCCCCHhHHHHHHHHHHHhhccCCCCC
Q 019780 207 DFGLAREEVMDEMTCEAGTYRWMAPENER-PSLENLSEDMVALLKSCWAED-PKVRPEFAEITITLTNILQNLRSADTPI 284 (336)
Q Consensus 207 Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~di~~l~~~~l~~~-p~~RP~~~~i~~~l~~~~~~~~~~~~~~ 284 (336)
|||++...... ....++..|+|||... ....+...|+|+++..+|++. .+..|...........+.........+.
T Consensus 155 d~g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (262)
T cd05077 155 DPGIPITVLSR--QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPS 232 (262)
T ss_pred CCCCCccccCc--ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCC
Confidence 99998754322 2345788999999875 466788899999999999875 3555543332223333333322233445
Q ss_pred CCCcccccCCCCCCCCccccchhhhcc
Q 019780 285 PPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
++++.+++...+..+|+.|++..++.+
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~ 259 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMR 259 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 567788899999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=248.47 Aligned_cols=251 Identities=20% Similarity=0.255 Sum_probs=197.9
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|++.+.||+|+||.||+|.+. +..+|+|.++. .........+.+|+.+++.++||||+++++.+..+. .++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL----ELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeec----ccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence 5788899999999999999986 78999998863 123344577899999999999999999999887655 8999
Q ss_pred EEccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 140 TELMRGETLQRYLWSTR-PKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
|||++|++|..++.... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVAS 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccCC
Confidence 99999999999985431 2468999999999999999999997 5999999999999999876 7999999998765444
Q ss_pred cccccCCcccccCCCCCCCC------CCCCHHHHHHHHHHhhccCCCCCCCHh----HHHHHHHHHHHh-hccCCCCCCC
Q 019780 218 EMTCEAGTYRWMAPENERPS------LENLSEDMVALLKSCWAEDPKVRPEFA----EITITLTNILQN-LRSADTPIPP 286 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~~~------~~~~~~di~~l~~~~l~~~p~~RP~~~----~i~~~l~~~~~~-~~~~~~~~p~ 286 (336)
......++..|+|||..... ..+...|+|++++.+|++..+..|... .....+..+... .....+..++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCH
Confidence 44445688999999976443 346789999999999999888888522 222222222221 1222334566
Q ss_pred CcccccCCCCCCCCccccchhhhccccccccc
Q 019780 287 KLVEIVDPKSTMNNDCMATVHAITKFNEKGKK 318 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (336)
++..++...+..+|+.|++..++....+..+.
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 67788889999999999999999886654333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=246.52 Aligned_cols=247 Identities=22% Similarity=0.333 Sum_probs=194.5
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
.+|.+.+.||+|+||.||+|... +..++||.+... ..........+.+|+.+++.++||||+++++++.+++ .++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIF--DLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeeh--hhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 35778899999999999999964 789999988632 1223445577889999999999999999999888665 899
Q ss_pred EEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 139 ITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
+|||+++++|.+++.. .....+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~ 158 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEECcchhhhcccc
Confidence 9999999999999853 2335689999999999999999999999999999999999999876 799999999875332
Q ss_pred cc--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc-CC-----CCCCCCc
Q 019780 217 DE--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS-AD-----TPIPPKL 288 (336)
Q Consensus 217 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~-~~-----~~~p~~~ 288 (336)
.. .....|+..|+|||.......+...|+|+++..+|++..+..|....-.. .....+.... .. ...++++
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhhcCCCCCCCcccccHHH
Confidence 21 22345889999999988888888999999999999999888886432211 1111111111 11 2245567
Q ss_pred ccccCCCCCCCCccccchhhhccc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
..++...+..+|+.|+++.++.+.
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~~ 261 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYDV 261 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHHH
Confidence 888888899999999998877653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=248.96 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=192.7
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC---------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceE
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG---------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENIL 125 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv 125 (336)
.|.+...+|.+.+.||+|+||.||+|... +..+|+|.+.. .........+.+|+.+++.+ +||||+
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~----~~~~~~~~~~~~E~~~l~~l~~h~~i~ 84 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD----DATEKDLSDLVSEMEMMKMIGKHKNII 84 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccc----ccchHHHHHHHHHHHHHHhhccCCCch
Confidence 45677889999999999999999999752 23689998862 12234457789999999999 799999
Q ss_pred eeEeeEecCC-EEEEEEccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCC
Q 019780 126 KFVGASVQPT-MMIITELMRGETLQRYLWSTR--------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLK 190 (336)
Q Consensus 126 ~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDik 190 (336)
++++++.+.. .++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++|++|||||
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlk 164 (304)
T cd05101 85 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA 164 (304)
T ss_pred heeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 9999988765 899999999999999996532 2357888899999999999999999999999999
Q ss_pred CCceeecCCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCC---
Q 019780 191 PSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPE--- 262 (336)
Q Consensus 191 p~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~--- 262 (336)
|+||+++.++ .++|+|||+++...... .....++..|+|||......++...|+|+|+..+|++-. +..|.
T Consensus 165 p~Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 165 ARNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred cceEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999876 89999999987543221 122235678999999888888889999999999988765 44443
Q ss_pred -HhHHHHHHHHHHHhh-ccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 263 -FAEITITLTNILQNL-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 263 -~~~i~~~l~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
..++... +.... .......+.++..++...+..+|+.|++..++.+
T Consensus 244 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 244 PVEELFKL---LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred CHHHHHHH---HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2333222 21111 1122346677888899999999999988877764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=247.75 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=195.6
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEe
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILK 126 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~ 126 (336)
..+.+..++|.+.+.||+|+||.||+|... +..+|+|+++.. ......+.+.+|+.+++++ +||||++
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~ 103 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT----AHSSEREALMSELKIMSHLGNHENIVN 103 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc----CChHHHHHHHHHHHHHHhccCCCCcce
Confidence 345667788999999999999999999752 347899988632 1234467789999999999 7999999
Q ss_pred eEeeEecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEE
Q 019780 127 FVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKL 205 (336)
Q Consensus 127 ~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl 205 (336)
+++++.... .++||||+++|+|.++++......+++.++..++.|++.||.|||++|++|+||||+||+++.++ .++|
T Consensus 104 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l 182 (302)
T cd05055 104 LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK-IVKI 182 (302)
T ss_pred EEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC-eEEE
Confidence 999988665 89999999999999999655545589999999999999999999999999999999999999776 8999
Q ss_pred eccccccccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHh-HHHHHHHHHHHhh-c
Q 019780 206 ADFGLAREEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFA-EITITLTNILQNL-R 278 (336)
Q Consensus 206 ~Dfg~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~-~i~~~l~~~~~~~-~ 278 (336)
+|||+++....... ....++..|+|||.......+...|+|+++..+|++.. +..|... .....+....... .
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 262 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence 99999875432211 12235678999999888888899999999999998765 5555321 1111122222211 1
Q ss_pred -cCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 279 -SADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 279 -~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
......++++.+++...+..+|+.|++..++.+
T Consensus 263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 112345667888899999999999998888764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=245.28 Aligned_cols=235 Identities=18% Similarity=0.257 Sum_probs=178.2
Q ss_pred eecCCCcEEEEEeEEC--------------------------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCC
Q 019780 69 MIGEGSYSIVYKGFYG--------------------------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122 (336)
Q Consensus 69 ~lg~G~fg~V~~~~~~--------------------------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 122 (336)
.||+|+||.||+|... ...|++|++... .......+.+|+.+++.++||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~~~~~~~~l~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-----HRDIALAFFETASLMSQVSHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-----HHHHHHHHHHHHHHHhcCCCC
Confidence 5999999999999742 134788887631 223456788899999999999
Q ss_pred ceEeeEeeEecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-
Q 019780 123 NILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK- 200 (336)
Q Consensus 123 nIv~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~- 200 (336)
||+++++++.++. .++||||+++|+|..++... ...+++..+..++.|++.||+|||++||+||||||+||+++..+
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence 9999999988765 89999999999999998543 35789999999999999999999999999999999999997543
Q ss_pred -----CceEEeccccccccccccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhcc-CCCCCCCHhHHHHHHHHH
Q 019780 201 -----KQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAE-DPKVRPEFAEITITLTNI 273 (336)
Q Consensus 201 -----~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~-~p~~RP~~~~i~~~l~~~ 273 (336)
..++++|||++...... ....++..|+|||.... ...+...|+|+++..+|+. ..+..|............
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred ccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 14899999987643222 22357889999997764 5568889999999999887 345555422222222223
Q ss_pred HHhhccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 274 LQNLRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 274 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.........+.++.+.+++...+..+|+.|++..++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~ 271 (274)
T cd05076 234 YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271 (274)
T ss_pred HHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHH
Confidence 33322333445567888899999999999988877653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=242.98 Aligned_cols=247 Identities=21% Similarity=0.334 Sum_probs=195.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
.+|.+.+.||+|+||.||+|... ++.||+|.++... .........+.+|+.+++.++|+||+++++.+.+.+ .++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFE--MMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccc--ccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 47889999999999999999986 8899999987422 223345678999999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 139 ITELMRGETLQRYLWST--RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
||||+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~~~~~ 158 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-VVKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-cEEEeccceeeeccC
Confidence 99999999999998542 235589999999999999999999999999999999999999877 799999999875332
Q ss_pred cc--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH---HHHHHHHHHHhhc-cCC-CCCCCCcc
Q 019780 217 DE--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE---ITITLTNILQNLR-SAD-TPIPPKLV 289 (336)
Q Consensus 217 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~---i~~~l~~~~~~~~-~~~-~~~p~~~~ 289 (336)
.. .....++..|+|||.......+.+.|+|+++..+|++-.+..|...+ +.+..+.+..... ... ...+..+.
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 21 23345889999999988888888999999999999998888875332 1112222221111 111 13445677
Q ss_pred cccCCCCCCCCccccchhhhcc
Q 019780 290 EIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+++...+..+|+.|++..++.+
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 8888899999999998877664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=247.92 Aligned_cols=239 Identities=21% Similarity=0.262 Sum_probs=189.7
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||++.+. ++.|++|.+.... .........+.+|+.+++.++||||+++++.+.++. .++|
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN--LILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh--hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 6788899999999999999986 6789999987421 122344567889999999999999999999988766 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-- 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-- 217 (336)
|||++|++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++.....
T Consensus 80 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 80 MEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-CEEEeeCCCccccCcCcc
Confidence 9999999999999443 5689999999999999999999999999999999999999876 7999999998631110
Q ss_pred ---------------cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH-HHHHHHh---hc
Q 019780 218 ---------------EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITIT-LTNILQN---LR 278 (336)
Q Consensus 218 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~-l~~~~~~---~~ 278 (336)
......|+..|+|||.......+...|+|++++.+|++..+..|....-... +...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 0112347889999999888888899999999999999999888864332222 2222211 11
Q ss_pred cCCCCCCCCcccccCCCCCCCCccccch
Q 019780 279 SADTPIPPKLVEIVDPKSTMNNDCMATV 306 (336)
Q Consensus 279 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 306 (336)
......|+++.+++...+..+|+.|.+.
T Consensus 237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~ 264 (305)
T cd05609 237 EGDEALPADAQDLISRLLRQNPLERLGT 264 (305)
T ss_pred CccccCCHHHHHHHHHHhccChhhccCc
Confidence 1122467778899999999999999763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=256.75 Aligned_cols=189 Identities=22% Similarity=0.258 Sum_probs=161.0
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
..+|.+.+.||+|+||.||++... +..|++|.+... ....+|+.+|+.++||||+++++++....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 457999999999999999999764 467899987621 23468999999999999999999888665
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
.++|||++. ++|.+++ .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++...
T Consensus 161 ~~lv~e~~~-~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~ 236 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLD 236 (392)
T ss_pred EEEEehhcC-CCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEccCccccccC
Confidence 899999996 5898888 3346799999999999999999999999999999999999999877 79999999987543
Q ss_pred ccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCH
Q 019780 216 MDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEF 263 (336)
Q Consensus 216 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~ 263 (336)
... .....||+.|+|||......++...|+|+|++.+|++..+.+|.+
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 288 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 222 123469999999999988888999999999999999988888864
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=254.45 Aligned_cols=203 Identities=23% Similarity=0.297 Sum_probs=177.5
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
+.+..+.|..-++||+||||.||-++.. |+-+|.|.+.+ ............+.|..+|.+++.++||.+-.+|...
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~K--KRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDK--KRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK 257 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHH--HHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence 5667788999999999999999977654 88899998863 2222344456678999999999999999997777766
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+ +++|+..|.||+|.-+|....+..+++..++.++.+|+.||++||+.+||+||+||+|||+|+.| ++.|+|.|+|..
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G-hvRISDLGLAve 336 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG-HVRISDLGLAVE 336 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC-CeEeeccceEEe
Confidence 5 99999999999999999766667899999999999999999999999999999999999999887 899999999997
Q ss_pred ccccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 214 EVMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 214 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
..... ....+||.+|||||.+....+++++|+|+|+|.++++-.++-|.
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPF 386 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPF 386 (591)
T ss_pred cCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCch
Confidence 65544 34458999999999999999999999999999999999999885
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=249.18 Aligned_cols=250 Identities=20% Similarity=0.254 Sum_probs=199.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||+||+|... +..+|+|.+.... .........+.+|+.+++.++||||+++++.+.++. .++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKE--MIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccc--cchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence 36888999999999999999985 6899999997421 222345677899999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||+.|++|.+++.......+++..++.++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-HIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC-CEEEeecchhhcccccc
Confidence 99999999999999665557799999999999999999999999999999999999999876 79999999976432111
Q ss_pred -------------------------------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCH-hHH
Q 019780 219 -------------------------------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEF-AEI 266 (336)
Q Consensus 219 -------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~-~~i 266 (336)
.....|+..|+|||.......+...|+|+|+..+|++-.+..|.. .+-
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 012247889999999888888889999999999999998888852 222
Q ss_pred HHHHHHHHHhhccCC--CCCCCCcccccCCCCCCCCccccc----hhhhccccc
Q 019780 267 TITLTNILQNLRSAD--TPIPPKLVEIVDPKSTMNNDCMAT----VHAITKFNE 314 (336)
Q Consensus 267 ~~~l~~~~~~~~~~~--~~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 314 (336)
...+..+...-.... ..+++++.+++..++..+++.|.+ ..++....+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence 222333322211111 225777899999999999999998 777776543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=247.91 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=189.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--Cc--cEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CE--PVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT- 135 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~- 135 (336)
++|++.+.||+|+||.||+|... +. .+++|.++. .......+.+.+|+.++.++ +||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE----FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc----cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 46888999999999999999875 22 468887762 12334456789999999999 6999999999988665
Q ss_pred EEEEEEccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC
Q 019780 136 MMIITELMRGETLQRYLWSTR--------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK 201 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~ 201 (336)
.++++||+++++|.++++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~- 156 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL- 156 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC-
Confidence 899999999999999995432 13588899999999999999999999999999999999999876
Q ss_pred ceEEecccccccccccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHH-HHHHHHHhhc
Q 019780 202 QVKLADFGLAREEVMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITI-TLTNILQNLR 278 (336)
Q Consensus 202 ~~kl~Dfg~a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~-~l~~~~~~~~ 278 (336)
.+||+|||++....... ......+..|+|||.......+...|+|+|++.++++.. +..|....-.. .+..+.+...
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 79999999986432111 111223567999999888888899999999999999874 66665332111 2222222211
Q ss_pred -cCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 279 -SADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 279 -~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.....+++.+.+++...+..+|..|++..++.+
T Consensus 237 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 237 MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 122346777889999999999999999988854
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=245.49 Aligned_cols=249 Identities=24% Similarity=0.313 Sum_probs=195.1
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
....+.|++++.||+|+||.||+|.+. +..+++|++.. ........+.+|+.+++.++||||+++++.+..+.
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 344577999999999999999999885 68899999863 23455677889999999999999999999877654
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.++||||++|++|..++.+. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~ 160 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKN 160 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-CEEEccCccceec
Confidence 99999999999999887443 35689999999999999999999999999999999999999776 7999999998753
Q ss_pred ccc--cccccCCcccccCCCCCC-----CCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhc---cCCCC
Q 019780 215 VMD--EMTCEAGTYRWMAPENER-----PSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLR---SADTP 283 (336)
Q Consensus 215 ~~~--~~~~~~gt~~y~aPE~~~-----~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~---~~~~~ 283 (336)
... ......++..|+|||... ..+++...|+|+|++.+|++..+..|.... -...+..+.+... .....
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcc
Confidence 221 123345889999999764 445677899999999999999998886332 1111222211111 01123
Q ss_pred CCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 284 IPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
++.++.+++...+..+|+.|++..++.+..
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 270 (292)
T cd06644 241 WSMEFRDFLKTALDKHPETRPSAAQLLEHP 270 (292)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 445677788889999999999998887644
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=243.70 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=193.0
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEECC-----ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYGC-----EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
+...+|.+.+.||+|+||.||+|.+.. ..++||.... .......+.+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~----~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKN----CTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCC----cCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence 456778999999999999999998642 3688998763 1224456789999999999999999999999988
Q ss_pred CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 134 PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 134 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~ 156 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRY 156 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC-CeEEccCceeee
Confidence 8899999999999999999543 34689999999999999999999999999999999999999876 799999999875
Q ss_pred cccccc---cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHH-HHHHHHHHHh-hccCCCCCCCC
Q 019780 214 EVMDEM---TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEI-TITLTNILQN-LRSADTPIPPK 287 (336)
Q Consensus 214 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i-~~~l~~~~~~-~~~~~~~~p~~ 287 (336)
...... ....++..|+|||.......+...|+|+|+..++++-. +..|....- ...+..+... ........|++
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 236 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHH
Confidence 433221 11224568999998887888899999999999988653 555632211 1112222211 11223456778
Q ss_pred cccccCCCCCCCCccccchhhhccc
Q 019780 288 LVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
+.+++...+..+|+.|++..++.+.
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8888999999999999988777653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=246.96 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=190.5
Q ss_pred cCCceeEeeeecCCCcEEEEEeEECC----------------ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCc
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYGC----------------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 123 (336)
..++|.+.+.||+|+||.||++...+ ..||+|.++.. ........+.+|+++++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~ei~~l~~l~h~~ 78 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD----VTKTARNDFLKEIKIMSRLKNPN 78 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC----CCHHHHHHHHHHHHHHHhCCCCC
Confidence 34688999999999999999987632 24899988632 23445667999999999999999
Q ss_pred eEeeEeeEecCC-EEEEEEccCCCCHHHHHhhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCC
Q 019780 124 ILKFVGASVQPT-MMIITELMRGETLQRYLWSTR----------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPS 192 (336)
Q Consensus 124 Iv~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~----------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~ 192 (336)
|+++++++.... .++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+
T Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 79 IIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred cCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 999999987655 899999999999999985421 124688899999999999999999999999999999
Q ss_pred ceeecCCCCceEEeccccccccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC--CCCC----C
Q 019780 193 NLLLTEDKKQVKLADFGLAREEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP--KVRP----E 262 (336)
Q Consensus 193 NIll~~~~~~~kl~Dfg~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p--~~RP----~ 262 (336)
||+++.++ .+||+|||++........ ....++..|+|||.......+...|+|+|+..++++-. +..| +
T Consensus 159 Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 159 NCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999876 799999999875432221 11235678999998888888899999999999887643 2333 3
Q ss_pred HhHHHHHHHHHHHh-----hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 263 FAEITITLTNILQN-----LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 263 ~~~i~~~l~~~~~~-----~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
..++.......... .....+..|+.+.+++...+..+|+.|+++.++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 34444333332221 11223456778889999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=243.40 Aligned_cols=204 Identities=24% Similarity=0.316 Sum_probs=182.2
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEee
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGA 130 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~ 130 (336)
..++.+..++|.++++||+|+|+.|-++++. .+.+|+|++++ ......+....++.|-.+..+. +||++|.+..+
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkk--el~nddedidwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKK--ELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHH--HhcCCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence 4578888999999999999999999999876 78899999984 4444566788899999998887 59999999999
Q ss_pred EecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 131 SVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 131 ~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
|+.+. +++|.||++||+|.-.+ ....+++++.++.+..+|+.||.|||++|||+||||.+|+|++..| ++||+|+|
T Consensus 320 fqtesrlffvieyv~ggdlmfhm--qrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg-hikltdyg 396 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYG 396 (593)
T ss_pred hcccceEEEEEEEecCcceeeeh--hhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC-ceeecccc
Confidence 98765 99999999999999888 4456799999999999999999999999999999999999999987 89999999
Q ss_pred cccccccc--cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 210 LAREEVMD--EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 210 ~a~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
+++..... ..++.+||+.|+|||.+++..+.++.|+|+|+..|+++..++.|.
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspf 451 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 451 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCc
Confidence 99864332 356789999999999999999999999999999999999988884
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=242.53 Aligned_cols=246 Identities=23% Similarity=0.365 Sum_probs=192.6
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccc----cHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAV----SREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
|.+.+.||+|+||.||+|.+. ++.+|+|.+........ .....+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 667789999999999999874 68899998874322111 1233467889999999999999999999988765 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~-~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-GIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC-CEEecccCCCccccc
Confidence 999999999999999944 35688999999999999999999999999999999999999876 799999999875432
Q ss_pred cc--------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh-hccCCCCCCC
Q 019780 217 DE--------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN-LRSADTPIPP 286 (336)
Q Consensus 217 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~-~~~~~~~~p~ 286 (336)
.. .....|+..|+|||.......+...|+|++++.++++-.+..|.... -...+...... ........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISS 238 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCH
Confidence 11 11234788999999888877888899999999999999888885321 11122222111 1122344666
Q ss_pred CcccccCCCCCCCCccccchhhhccc
Q 019780 287 KLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.+.+++...+..+|..|++..++.+.
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 239 EAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhhC
Confidence 77888889999999999888877653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=243.58 Aligned_cols=246 Identities=23% Similarity=0.355 Sum_probs=189.6
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
+..+|.+.+.||+|+||.||+|.+. ...+|+|.++.. ........+.+|+.+++.++||||+++++++.++
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4567889999999999999999863 236899988631 2234567889999999999999999999998765
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+ .++||||+++++|.+++... ...+++.++..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++..
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~~l~dfg~~~~ 155 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRV 155 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC-eEEeCCCCcccc
Confidence 5 89999999999999999543 35689999999999999999999999999999999999999876 799999999875
Q ss_pred cccccc-----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccC-CCCCCCHhHHH-HHHHHHHHhhc-cCCCCCC
Q 019780 214 EVMDEM-----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAED-PKVRPEFAEIT-ITLTNILQNLR-SADTPIP 285 (336)
Q Consensus 214 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~-p~~RP~~~~i~-~~l~~~~~~~~-~~~~~~p 285 (336)
...... ....++..|+|||.......+...|+|+++..+++.- .+..|....-. ..+..+.+... ......|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCP 235 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCC
Confidence 432211 1112346899999988888889999999999999855 47777533211 11222222111 1123456
Q ss_pred CCcccccCCCCCCCCccccchhhhcc
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+.+.+++...+..+|+.|++..++.+
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 236 AALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHHcccCchhCCCHHHHHH
Confidence 67788888888888888888777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=249.44 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=190.0
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--Cc--cEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEec
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CE--PVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQ 133 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 133 (336)
+..++|++.+.||+|+||.||+|.+. +. .+++|.++. .........+.+|+.++.++ +||||+++++++.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc----cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 34468899999999999999999875 33 356666542 12344567788999999999 89999999999887
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC
Q 019780 134 PT-MMIITELMRGETLQRYLWSTR--------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE 198 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~ 198 (336)
+. .++||||+++++|.++++... ...+++..++.++.|++.||+|||++|++||||||+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 65 999999999999999996432 235789999999999999999999999999999999999998
Q ss_pred CCCceEEecccccccccccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhH-HHHHHHHHHH
Q 019780 199 DKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAE-ITITLTNILQ 275 (336)
Q Consensus 199 ~~~~~kl~Dfg~a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~-i~~~l~~~~~ 275 (336)
++ .++|+|||++....... .....++..|+|||.......+...|+|+|+..++++.. +..|.... .......+..
T Consensus 160 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 160 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred CC-cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 76 79999999986422111 111224578999998887788889999999999999875 66664322 1111222211
Q ss_pred hh-ccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 276 NL-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 276 ~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.. .......++.+.+++...+..+|+.|++..++..
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 275 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 275 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 1122346778888999999999999998887765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=245.12 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=190.0
Q ss_pred cCCceeEeeeecCCCcEEEEEeEECC-------ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYGC-------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
..++|.+.+.||+|+||.||+|.+.+ ..|++|.+.. .........+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE----SCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF 79 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCC----CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 34678999999999999999998853 5688887752 122344567899999999999999999999877
Q ss_pred cCC-EEEEEEccCCCCHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC--CceE
Q 019780 133 QPT-MMIITELMRGETLQRYLWSTRP-----KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK--KQVK 204 (336)
Q Consensus 133 ~~~-~~lv~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~--~~~k 204 (336)
+.. .++||||++|++|.+++..... ..+++..++.++.||+.||+|||++|++||||||+||+++.++ ..++
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 654 8999999999999999965432 3588999999999999999999999999999999999998653 3699
Q ss_pred Eecccccccccccccc----ccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHh--h
Q 019780 205 LADFGLAREEVMDEMT----CEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQN--L 277 (336)
Q Consensus 205 l~Dfg~a~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~--~ 277 (336)
|+|||+++........ ...++..|+|||.......+...|+|+|++.++++.. +..|....-...+...... .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 239 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR 239 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999999864322211 1223568999999888888999999999999998664 6556322111122222211 1
Q ss_pred ccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 278 RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 278 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
......+|+++.+++...+..+|+.|++..++.+
T Consensus 240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~ 273 (277)
T cd05036 240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILE 273 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1223456677888999999999999998887754
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=251.79 Aligned_cols=254 Identities=25% Similarity=0.322 Sum_probs=195.5
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC---------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCc
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG---------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHEN 123 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn 123 (336)
+..|.+...+|++++.||+|+||.||+|.+. ...+|+|.++. .........+.+|+.+++++ +|||
T Consensus 4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKD----DATDKDLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccc----ccCHHHHHHHHHHHHHHHhhcCCCC
Confidence 3567788889999999999999999999753 13689998762 12334567889999999999 7999
Q ss_pred eEeeEeeEecCC-EEEEEEccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 019780 124 ILKFVGASVQPT-MMIITELMRGETLQRYLWSTR--------------PKRLDLKHSISFALDISRAMEYLHANSVIHRD 188 (336)
Q Consensus 124 Iv~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrD 188 (336)
|+++++++.+.. .++++||+++|+|.+++.... ...+++..+..++.|++.||+|||++|++|||
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~d 159 (334)
T cd05100 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRD 159 (334)
T ss_pred eeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 999999988765 899999999999999996432 23477888999999999999999999999999
Q ss_pred CCCCceeecCCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCH
Q 019780 189 LKPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEF 263 (336)
Q Consensus 189 ikp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~ 263 (336)
|||+||+++.++ .++|+|||+++...... .....++..|+|||.......+...|+|+|+..+|++-. +..|..
T Consensus 160 lkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 160 LAARNVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred cccceEEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 999999999876 79999999987543221 111234568999999988888899999999999998766 555532
Q ss_pred hHHHHHHH-HHHHhh-ccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 264 AEITITLT-NILQNL-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 264 ~~i~~~l~-~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
..-...+. .+.... .......+.++..++...+..+|+.|++..++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 239 GIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 21111121 121111 12223456678888999999999999988877753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=245.28 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=193.4
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
++.++|.+.+.||+|+||.||++... +..+++|.+.. ........+.+|+++++.++|+||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDFQREAELLTVLQHQHIVRFYGVC 76 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEE
Confidence 34578888999999999999999642 45788888762 2344567899999999999999999999998
Q ss_pred ecCC-EEEEEEccCCCCHHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec
Q 019780 132 VQPT-MMIITELMRGETLQRYLWSTRP-------------KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLT 197 (336)
Q Consensus 132 ~~~~-~~lv~e~~~gg~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~ 197 (336)
.+.. .+++|||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 77 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred ecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 8765 8999999999999999965432 3578999999999999999999999999999999999999
Q ss_pred CCCCceEEeccccccccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhH-HHHHHH
Q 019780 198 EDKKQVKLADFGLAREEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAE-ITITLT 271 (336)
Q Consensus 198 ~~~~~~kl~Dfg~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~-i~~~l~ 271 (336)
.++ .++|+|||++........ ....+++.|+|||.......+...|+|+|++.++++-. +..|.... -...+.
T Consensus 157 ~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05092 157 QGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235 (280)
T ss_pred CCC-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 876 799999999875332221 12235678999998888888899999999999999876 56664221 111222
Q ss_pred HHHHh-hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 272 NILQN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 272 ~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
..... .......+|+.+.+++...+..+|..|++..++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 236 CITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 22221 11223457788889999999999999998888764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=260.57 Aligned_cols=211 Identities=31% Similarity=0.555 Sum_probs=181.0
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC---C--ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEe
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG---C--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVG 129 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 129 (336)
...+|..+...+.+.||+|.||.|++|.|+ + -.||||+++.... ......|++|+.+|.+|+|||++++||
T Consensus 103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l----~~~mddflrEas~M~~L~H~hliRLyG 178 (1039)
T KOG0199|consen 103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL----NAIMDDFLREASHMLKLQHPHLIRLYG 178 (1039)
T ss_pred cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc----chhHHHHHHHHHHHHhccCcceeEEee
Confidence 356677888899999999999999999997 2 4689999985332 226788999999999999999999999
Q ss_pred eEecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 130 ASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 130 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
+..+....+|+|+++.|+|.+.|+......|.......++.||+.||.||.++++|||||..+|+|+-... .|||+|||
T Consensus 179 vVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr-tVKI~DFG 257 (1039)
T KOG0199|consen 179 VVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR-TVKICDFG 257 (1039)
T ss_pred eeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc-eeeeeccc
Confidence 99998899999999999999999876667788999999999999999999999999999999999998755 89999999
Q ss_pred ccccccccc-cccc----CCcccccCCC----------------------------------------------CCCCCC
Q 019780 210 LAREEVMDE-MTCE----AGTYRWMAPE----------------------------------------------NERPSL 238 (336)
Q Consensus 210 ~a~~~~~~~-~~~~----~gt~~y~aPE----------------------------------------------~~~~~~ 238 (336)
+.+.....+ .... --...|.||| ...+.+
T Consensus 258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP 337 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP 337 (1039)
T ss_pred ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCC
Confidence 998654433 2221 1347899999 244677
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITITL 270 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l 270 (336)
..++.|||+++..||..+|.+||+|..|.+.+
T Consensus 338 k~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 338 KYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 88999999999999999999999999987443
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=247.39 Aligned_cols=246 Identities=24% Similarity=0.392 Sum_probs=189.0
Q ss_pred cCCceeEeeeecCCCcEEEEEeEE------CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
+.+.|++.+.||+|+||.||++.. .+..||+|.++.. ........+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE----SGGNHIADLKKEIEILRNLYHENIVKYKGICTE 77 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc----ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 356788999999999999999874 2678999998632 234456779999999999999999999998876
Q ss_pred C---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 134 P---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 134 ~---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
. ..++||||++|++|.+++.+.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||+
T Consensus 78 ~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~ 155 (284)
T cd05079 78 DGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGL 155 (284)
T ss_pred CCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC-CEEECCCcc
Confidence 4 3899999999999999985432 4589999999999999999999999999999999999999876 799999999
Q ss_pred cccccccc-----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH---------------HHHH
Q 019780 211 AREEVMDE-----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI---------------TITL 270 (336)
Q Consensus 211 a~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i---------------~~~l 270 (336)
++...... .....++..|+|||.......+...|+|+|+..|+++.....|..... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 87543221 123346778999998887778888999999999999866443321111 0111
Q ss_pred HHHHHhh--ccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 271 TNILQNL--RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 271 ~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
....... .......++.+.+++...+..+|+.|++..++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1111111 1122345667778888888889999888877754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=246.20 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=194.6
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
..++|.+.+.||+|+||.||+|... ...+++|.+.. ........+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-----PTLAARKDFQREAELLTNLQHEHIVKFYGVCG 77 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence 3467889999999999999999753 34588888752 22344567899999999999999999999988
Q ss_pred cCC-EEEEEEccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec
Q 019780 133 QPT-MMIITELMRGETLQRYLWSTR--------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLT 197 (336)
Q Consensus 133 ~~~-~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~ 197 (336)
+.. .++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 765 899999999999999995432 23488999999999999999999999999999999999999
Q ss_pred CCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHH-HHHH
Q 019780 198 EDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEIT-ITLT 271 (336)
Q Consensus 198 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~-~~l~ 271 (336)
.++ .++|+|||++....... .....++..|+|||.......+...|+|+++..++++-. +.+|....-. ..++
T Consensus 158 ~~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 158 ANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred cCC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 876 89999999987543322 122346788999999888888889999999999999876 8888533211 1222
Q ss_pred HHHHh-hccCCCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 272 NILQN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 272 ~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
.+... ........|..+.+++...+..+|+.|++..++.+.-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 237 CITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred HHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 22221 11122345667888999999999999998888876443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=245.24 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=186.8
Q ss_pred CceeEeeeecCCCcEEEEEeEE------CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP- 134 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~- 134 (336)
++|++.+.||+|+||+||++.. .+..||+|+++.. ........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE----CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc----cChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4568899999999999988653 2568999998732 1233456788999999999999999999987643
Q ss_pred --CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 135 --TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 135 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
..++||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~ 155 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-LVKIGDFGLAK 155 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-cEEEeeccccc
Confidence 27899999999999999954 3589999999999999999999999999999999999999876 79999999987
Q ss_pred ccccccc-----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH---HHHH------------HHH
Q 019780 213 EEVMDEM-----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE---ITIT------------LTN 272 (336)
Q Consensus 213 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~---i~~~------------l~~ 272 (336)
....... ....++..|+|||.......+...|+|+|+..++++-.+..|.... +... +.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 5432211 1223567799999888888888999999999999988777664211 1000 111
Q ss_pred HHHhh--ccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 273 ILQNL--RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 273 ~~~~~--~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
..... .......|+++.+++...+..+|+.|++..++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~ 277 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPI 277 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 11100 01123456778888888898899999888877654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=240.73 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=193.7
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~ 140 (336)
|+..+.||+|+||.||+|... +..|++|.+..........+..+.+.+|+.+++.++||||+++++++.+.. .++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566788999999999999985 789999998753333334556678999999999999999999999888765 89999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-c
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-M 219 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~-~ 219 (336)
||+++++|.+++.+. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ .+||+|||++....... .
T Consensus 82 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 82 ELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-VVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccceeccccccc
Confidence 999999999999543 4688999999999999999999999999999999999999876 79999999987543322 2
Q ss_pred cccCCcccccCCCCCCCCC-CCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHH--hhccCCCCCCCCcccccCCC
Q 019780 220 TCEAGTYRWMAPENERPSL-ENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQ--NLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 220 ~~~~gt~~y~aPE~~~~~~-~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~--~~~~~~~~~p~~~~~~~~~~ 295 (336)
....|+..|+|||...... .+...|+|+++..++++..+..|.-.. -...+..... ........+++.+.+++...
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 238 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKC 238 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHH
Confidence 3455889999999876655 788899999999999999888884221 1111111111 11222234556677788888
Q ss_pred CCCCCccccchhhhccc
Q 019780 296 STMNNDCMATVHAITKF 312 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~~ 312 (336)
+..+|+.|++..++...
T Consensus 239 l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 239 LQRDPSLRPTAAELLEH 255 (258)
T ss_pred hhcCcccCcCHHHHhcC
Confidence 88889999888877654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=240.62 Aligned_cols=198 Identities=26% Similarity=0.370 Sum_probs=167.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---CE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---TM 136 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~ 136 (336)
.+|.+.+.||+|+||.||+|.+. +..||||.+...............+.+|+.+++.++||||+++++++.+. .+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 56888999999999999999875 68899999864322222344567889999999999999999999988763 27
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
+++|||++|++|.+++.+. ..+++.....++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-NVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC-CEEECcCcccccccc
Confidence 8999999999999998543 4578899999999999999999999999999999999999876 799999999874321
Q ss_pred -----ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 217 -----DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 217 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.......|+..|+|||.......+...|+|+|+..+|++..+..|.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 209 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW 209 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCC
Confidence 1223345889999999988877888999999999999999888885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=260.57 Aligned_cols=205 Identities=30% Similarity=0.411 Sum_probs=172.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC---E
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT---M 136 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~ 136 (336)
+.......||+|+|-+||+|.+. |..||--.++. ..........++|..|+.+|+.|+||||+++|++|.+.. +
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~-~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKI-RDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ceeehhhhcccccceeeeeccccccchhhHHHHHhH-HHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 44555678999999999999986 44555333221 123345667799999999999999999999999998754 7
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCCceEEecccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS--VIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.+|+|.+..|+|..|+++. ++++...+..|++||+.||.|||++. |||||||.+||||+.+.+.|||+|+|+|...
T Consensus 119 n~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 8999999999999999554 67889999999999999999999995 9999999999999998889999999999977
Q ss_pred ccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCC-----CHhHHHHHH
Q 019780 215 VMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRP-----EFAEITITL 270 (336)
Q Consensus 215 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP-----~~~~i~~~l 270 (336)
.........|||.|||||... ..++-..|+|++|..||++.+.+=| +.+||.+.+
T Consensus 197 r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV 256 (632)
T KOG0584|consen 197 RKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV 256 (632)
T ss_pred hccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH
Confidence 766666678999999999877 7788999999999999999988887 355555443
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=242.87 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=185.3
Q ss_pred eEeeeecCCCcEEEEEeEECC----ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC------
Q 019780 65 LLQKMIGEGSYSIVYKGFYGC----EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP------ 134 (336)
Q Consensus 65 ~~~~~lg~G~fg~V~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------ 134 (336)
.+++.||+|+||.||+|.+.. ..+|+|.++.. .......+.+.+|+.+++.++||||+++++.+...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA---ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccC---cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 467889999999999998762 25899988632 22445567889999999999999999999876421
Q ss_pred -CEEEEEEccCCCCHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 135 -TMMIITELMRGETLQRYLWST----RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 135 -~~~lv~e~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
..+++|||+.+|+|.+++... ....+++..++.++.|++.||+|||++||+||||||+||+++.++ .++|+|||
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg 157 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFG 157 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-CEEECCCC
Confidence 268999999999999987321 234588999999999999999999999999999999999999876 79999999
Q ss_pred cccccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHH-HHHHHHHHHhh-ccCCC
Q 019780 210 LAREEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEI-TITLTNILQNL-RSADT 282 (336)
Q Consensus 210 ~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i-~~~l~~~~~~~-~~~~~ 282 (336)
+++....... ....+++.|+|||.......+.+.|+|++++.+|++-. +..|....- ......+.... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 9885432221 12235678999999988888999999999999999866 455542211 11122222111 12234
Q ss_pred CCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 283 PIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 283 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
..+..+.+++...+..+|+.|++..++.+
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 45666788888999999999998887764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=248.33 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=191.3
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
+..+|.+.+.||+|+||.||+|... +..||+|+++.. ......+.+.+|+.++..++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 78 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK----AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT 78 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 3456788899999999999999864 367999998731 22344677899999999999999999999988
Q ss_pred cCC-EEEEEEccCCCCHHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec
Q 019780 133 QPT-MMIITELMRGETLQRYLWST--------------RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLT 197 (336)
Q Consensus 133 ~~~-~~lv~e~~~gg~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~ 197 (336)
+.. .++++||+++++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 765 89999999999999998421 123578889999999999999999999999999999999999
Q ss_pred CCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHH-HHH
Q 019780 198 EDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITI-TLT 271 (336)
Q Consensus 198 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~-~l~ 271 (336)
.++ .+||+|||+++...... .....+++.|+|||.......+...|+|+|++.+|++-. +..|....-.. .++
T Consensus 159 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05091 159 DKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237 (283)
T ss_pred CCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 876 79999999987543222 122345689999998887778889999999999998764 55564322111 222
Q ss_pred HHHHh-hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 272 NILQN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 272 ~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.+... ........|+++.+++...+..+|+.|++..++..
T Consensus 238 ~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 238 MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 22221 11223456777888889999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=245.80 Aligned_cols=244 Identities=26% Similarity=0.374 Sum_probs=187.0
Q ss_pred ceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
+|++.+.||+|+||.||+|... ...+++|.+... ........+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC----CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 3677899999999999999864 246888887631 22344577899999999999999999999887665
Q ss_pred -EEEEEEccCCCCHHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCC
Q 019780 136 -MMIITELMRGETLQRYLWSTR----------------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPS 192 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~ 192 (336)
.++++||+.+++|.+++.... ...+++..++.++.|++.||.|||+.|++||||||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ 156 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence 899999999999999985321 134788999999999999999999999999999999
Q ss_pred ceeecCCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHH
Q 019780 193 NLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEIT 267 (336)
Q Consensus 193 NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~ 267 (336)
||+++.++ .++|+|||+++...... .....++..|+|||.......+...|+|+|+..++++.. +..|......
T Consensus 157 nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 157 NVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred eEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999876 89999999987532221 122245678999998888888899999999999999886 6655432222
Q ss_pred HHHHHHHHhhc--cCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 268 ITLTNILQNLR--SADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 268 ~~l~~~~~~~~--~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
..+.+...... ......++++.+++...+..+|+.|++..++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 236 ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 22222222211 112345567778888888888888888877764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=240.98 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=192.0
Q ss_pred ceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCcc-ccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNA-LAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|++.+.||+|+||.||+|... ++.+|+|.+..... ..........+.+|+.+++.++|+||+++++++.+.. .+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3677889999999999999874 77899999874221 1122344567999999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc---
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM--- 216 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~--- 216 (336)
+||++|++|.+++.+. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG-IIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-eEEeccchhhHhhhhccc
Confidence 9999999999999543 4688999999999999999999999999999999999999876 799999999874321
Q ss_pred -----ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHH---hhccCCCCCCCC
Q 019780 217 -----DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQ---NLRSADTPIPPK 287 (336)
Q Consensus 217 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~---~~~~~~~~~p~~ 287 (336)
.......|+..|+|||.......+...|+|+|+..++++..+..|... +-......... .........+++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 112234588999999999888888999999999999999888888532 11111111111 112233345556
Q ss_pred cccccCCCCCCCCccccchhhhccc
Q 019780 288 LVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
+..++...+..+|+.|++..++...
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcC
Confidence 7778888888888888888777653
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=241.48 Aligned_cols=235 Identities=18% Similarity=0.323 Sum_probs=178.5
Q ss_pred eeecCCCcEEEEEeEECCc------------cEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 68 KMIGEGSYSIVYKGFYGCE------------PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~~~------------~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
+.||+|+||.||+|.+... .+++|++... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD------HRDSLAFFETASLMSQLSHKHLVKLYGVCVRDE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc------hhhHHHHHHHHHHHHcCCCcchhheeeEEecCC
Confidence 3689999999999998632 3777776521 111677889999999999999999999888766
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC------ceEEeccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK------QVKLADFG 209 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~------~~kl~Dfg 209 (336)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++.++. .++|+|||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 899999999999999995543 36899999999999999999999999999999999999987652 59999999
Q ss_pred cccccccccccccCCcccccCCCCCCCC--CCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhccCCCCCCC
Q 019780 210 LAREEVMDEMTCEAGTYRWMAPENERPS--LENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRSADTPIPP 286 (336)
Q Consensus 210 ~a~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~~~~~~p~ 286 (336)
++..... .....++..|+|||..... ..+.+.|+|+++..+|++..+..+.+... ................+...
T Consensus 154 ~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (259)
T cd05037 154 IPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCA 231 (259)
T ss_pred ccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCCch
Confidence 9886433 2234477889999988766 77889999999999999866433333222 11111111111111222335
Q ss_pred CcccccCCCCCCCCccccchhhhcc
Q 019780 287 KLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.+.+++...+..+|+.|++..++.+
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 6777888888888888888777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=245.49 Aligned_cols=245 Identities=20% Similarity=0.239 Sum_probs=197.0
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|++.+.||+|+||.||+|.+. +..+|+|++... ........+.+.+|+.++++++||||+++++.+.++. .++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ--KCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehh--hhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 4788999999999999999986 789999999732 2223345678999999999999999999999887665 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-c
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-E 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-~ 218 (336)
+||+.|++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++...... .
T Consensus 79 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 79 VDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-HVHITDFNIATKVTPDTL 155 (258)
T ss_pred EeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-CEEEeecccccccCCCcc
Confidence 9999999999999443 5789999999999999999999999999999999999999887 7999999998754333 2
Q ss_pred ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH---HHHHHHHHH-hhccCCCCCCCCcccccCC
Q 019780 219 MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI---TITLTNILQ-NLRSADTPIPPKLVEIVDP 294 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i---~~~l~~~~~-~~~~~~~~~p~~~~~~~~~ 294 (336)
.....|+..|+|||.......+...|+|+++..++++-.+..|....- ...+..... .........|+.+.+++..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK 235 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHH
Confidence 234458899999998888888899999999999999988888854322 122222222 2223334566778888888
Q ss_pred CCCCCCccccch--hhhccc
Q 019780 295 KSTMNNDCMATV--HAITKF 312 (336)
Q Consensus 295 ~~~~~~~~~~~~--~~~~~~ 312 (336)
.+..+|+.|.+. .++.+.
T Consensus 236 ~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 236 LLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred HccCChhHcCCccHHHHhcC
Confidence 999899888887 655543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=239.98 Aligned_cols=244 Identities=27% Similarity=0.332 Sum_probs=194.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
.+|.+.+.||+|+||.||+|.+. ++.+++|++... .......+.+|+.+++.++||||+++++.+.+.. .++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE-----PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC-----chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence 57889999999999999999875 678999998732 2225678899999999999999999999888665 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
+|||+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 ~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 78 VMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATI 155 (262)
T ss_pred EEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-CEEECccccchhhhhhh
Confidence 99999999999998543 25689999999999999999999999999999999999999876 7999999998754322
Q ss_pred -cccccCCcccccCCCCCCCC---CCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh-hcc----CCCCCCCC
Q 019780 218 -EMTCEAGTYRWMAPENERPS---LENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN-LRS----ADTPIPPK 287 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~---~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~-~~~----~~~~~p~~ 287 (336)
......++..|+|||..... ..+...|+|+++..+|++..+..|.... -.......... +.. .....+++
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 22334588899999988766 7788999999999999999998885331 11111111111 111 11234566
Q ss_pred cccccCCCCCCCCccccchhhhccc
Q 019780 288 LVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
+.+++...+..+|..|++..++...
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcC
Confidence 7888999999999999998887654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=243.54 Aligned_cols=243 Identities=26% Similarity=0.320 Sum_probs=186.9
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
..+|.+.+.||+|+||.||+|.+. ++.||+|+++.. .......+.+|+.+++.++||||+++++.+.+.. .+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-----PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC-----chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 457888899999999999999875 788999998732 1233456789999999999999999999887665 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 83 ICMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-HVKLADFGVSAQITAT 159 (267)
T ss_pred EEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECcceeeeEccCc
Confidence 99999999999999843 35689999999999999999999999999999999999999876 7999999998753322
Q ss_pred --cccccCCcccccCCCCCC---CCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHH-hhccC----CCCCCC
Q 019780 218 --EMTCEAGTYRWMAPENER---PSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQ-NLRSA----DTPIPP 286 (336)
Q Consensus 218 --~~~~~~gt~~y~aPE~~~---~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~-~~~~~----~~~~p~ 286 (336)
......|+..|+|||... ....+...|+|+|++.+|++-.+..|.+..- ...+..... ..... ..++++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN 239 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence 123346899999999763 4456778999999999999988887753221 111111111 11000 112444
Q ss_pred CcccccCCCCCCCCccccchhhhcc
Q 019780 287 KLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.+.+++...+..+|+.|++..++..
T Consensus 240 ~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 240 SFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhc
Confidence 5666777778888888888777654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=242.56 Aligned_cols=247 Identities=20% Similarity=0.369 Sum_probs=191.3
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--C----ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--C----EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
+...+|.+.+.||+|+||.||+|.+. + ..+|+|.+... ........+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE----TSPKANKEILDEAYVMASVDHPHVVRLLGICL 79 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 34578899999999999999999864 2 25889987632 22445677899999999999999999999998
Q ss_pred cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 133 QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 133 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
....++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++ .++|+|||+++
T Consensus 80 ~~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kL~dfg~~~ 157 (279)
T cd05057 80 SSQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-HVKITDFGLAK 157 (279)
T ss_pred cCceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC-eEEECCCcccc
Confidence 877999999999999999995543 4589999999999999999999999999999999999999876 79999999997
Q ss_pred ccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHhhc--cCCCCCC
Q 019780 213 EEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQNLR--SADTPIP 285 (336)
Q Consensus 213 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~~~--~~~~~~p 285 (336)
....... ....++..|+|||.......+...|+|+++..+++.-. +..|....-...+........ ......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICT 237 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCC
Confidence 5432221 11123568999998888888899999999999998776 666643222222222222211 1112234
Q ss_pred CCcccccCCCCCCCCccccchhhhcc
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
..+..++...+..+|..|++..++.+
T Consensus 238 ~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 238 IDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 55667788888889999988887764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=246.04 Aligned_cols=249 Identities=26% Similarity=0.303 Sum_probs=196.8
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||+|.+. +..+|+|++.. ......+.+.+|+.+++.++||||+++++.+.++. .++
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee-----CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence 56888999999999999999885 78899999863 23445567889999999999999999999988665 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 80 LIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTL 157 (280)
T ss_pred EeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC-CEEEccCccchhhcccc
Confidence 99999999999998543 34689999999999999999999999999999999999999876 7999999988643222
Q ss_pred -cccccCCcccccCCCCCC-----CCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhc---cCCCCCCCC
Q 019780 218 -EMTCEAGTYRWMAPENER-----PSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLR---SADTPIPPK 287 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~-----~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~---~~~~~~p~~ 287 (336)
......|+..|+|||... ..+.+...|+|+++..+|++..+..|.... ....+..+..... ......+.+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS 237 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence 122345889999999753 455677899999999999999998886332 1122222221110 112245667
Q ss_pred cccccCCCCCCCCccccchhhhcccccccc
Q 019780 288 LVEIVDPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
+.+++...+..+|+.|++..++.+.....+
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 888889999999999999988887654443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=240.21 Aligned_cols=238 Identities=22% Similarity=0.346 Sum_probs=186.1
Q ss_pred eeecCCCcEEEEEeEEC--C---ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCCEEEEEEc
Q 019780 68 KMIGEGSYSIVYKGFYG--C---EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITEL 142 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~lv~e~ 142 (336)
+.||+|+||.||+|.+. + ..+|+|.+.... .....+.+.+|+.+++.+.||||+++++++.....++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH----IAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEeccccc----chHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEe
Confidence 46999999999999864 2 579999987421 12455678999999999999999999999887779999999
Q ss_pred cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccccc---
Q 019780 143 MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM--- 219 (336)
Q Consensus 143 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~--- 219 (336)
+++++|.+++... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||+++.......
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-cEEeccccccceeecCCcccc
Confidence 9999999999543 4789999999999999999999999999999999999999877 799999999875432221
Q ss_pred --cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHhhc--cCCCCCCCCcccccCC
Q 019780 220 --TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQNLR--SADTPIPPKLVEIVDP 294 (336)
Q Consensus 220 --~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~~~--~~~~~~p~~~~~~~~~ 294 (336)
....++..|+|||.......+...|+|+|+..+|+.-. +..|....-...+...+.... ......|+.+.+++..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLS 233 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 11123467999999888888899999999999999876 667742211111222222211 1223456678889999
Q ss_pred CCCCCCccccchhhhccc
Q 019780 295 KSTMNNDCMATVHAITKF 312 (336)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~ 312 (336)
.+..+|+.|++..++.+.
T Consensus 234 cl~~~p~~Rp~~~~l~~~ 251 (257)
T cd05060 234 CWKYRPEDRPTFSELEST 251 (257)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999988877653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=242.21 Aligned_cols=244 Identities=23% Similarity=0.350 Sum_probs=187.1
Q ss_pred eeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC---
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT--- 135 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 135 (336)
|.+++.||+|+||.||+|... +..||+|.++. ..........+.+|+..++.++||||+++++++.+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL---DIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEecc---CcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence 467889999999999999864 25699999873 2223445677999999999999999999999875432
Q ss_pred ----EEEEEEccCCCCHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEec
Q 019780 136 ----MMIITELMRGETLQRYLWST----RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLAD 207 (336)
Q Consensus 136 ----~~lv~e~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~D 207 (336)
.++++||+++|+|..++... ....+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~d 156 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-TVCVAD 156 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-eEEECC
Confidence 68999999999999998432 224689999999999999999999999999999999999999876 799999
Q ss_pred cccccccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHH-HHHHHHHHh-hccC
Q 019780 208 FGLAREEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEIT-ITLTNILQN-LRSA 280 (336)
Q Consensus 208 fg~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~-~~l~~~~~~-~~~~ 280 (336)
||+++....... ....++..|+|||.......+...|+|++++.++++.. +..|....-. +.++.+... ....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999875432221 11235678999999888888899999999999999876 5566422111 112222211 1112
Q ss_pred CCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 281 DTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 281 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
....++++.+++...+..+|+.|+++.++.+
T Consensus 237 ~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred CcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3446667788888888889988888877664
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=243.41 Aligned_cols=243 Identities=26% Similarity=0.303 Sum_probs=185.1
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
..+|.+.+.||+|+||.||+|... ++.||+|++... .......+.+|+.+++.++||||+++++.+.... .+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-----~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-----PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC-----ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence 467899999999999999999974 778999998632 1223456889999999999999999999987665 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||+++++|.++++. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++ .++|+|||++......
T Consensus 83 iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 83 ICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITAT 159 (267)
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEECcCccceeeccc
Confidence 99999999999999843 35689999999999999999999999999999999999999876 7999999998754322
Q ss_pred c--ccccCCcccccCCCCCC---CCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHH-hhccC----CCCCCC
Q 019780 218 E--MTCEAGTYRWMAPENER---PSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQ-NLRSA----DTPIPP 286 (336)
Q Consensus 218 ~--~~~~~gt~~y~aPE~~~---~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~-~~~~~----~~~~p~ 286 (336)
. .....|+..|+|||... ....+...|+|++++.++++..+..|....- ......+.. ..... ...+++
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS 239 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence 1 23345889999999764 3345678999999999999887776653211 000000000 00000 112345
Q ss_pred CcccccCCCCCCCCccccchhhhcc
Q 019780 287 KLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.+.+++...+..+|+.|++..++.+
T Consensus 240 ~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 240 TFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhc
Confidence 5667777778888888888777654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=242.24 Aligned_cols=249 Identities=24% Similarity=0.286 Sum_probs=194.3
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
.|++.+.||+|+||.||+|.+. +..+++|.+.. ........+.+|+.+++.++||||+++++.+.... .++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT-----KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC-----CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence 4677889999999999999986 56778888752 12345667889999999999999999999887665 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-- 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-- 217 (336)
+||+++++|..++... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 81 IEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred EEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-CEEEcccccccccccccc
Confidence 9999999999987542 35689999999999999999999999999999999999999876 7999999998753322
Q ss_pred cccccCCcccccCCCCCC-----CCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhh---ccCCCCCCCCc
Q 019780 218 EMTCEAGTYRWMAPENER-----PSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNL---RSADTPIPPKL 288 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~---~~~~~~~p~~~ 288 (336)
......++..|+|||... ....+...|+|+++..+|++-.+..|.... -...+..+.... ......+|.++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF 238 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHH
Confidence 123345889999999763 344567899999999999999888885321 111111221111 11123466778
Q ss_pred ccccCCCCCCCCccccchhhhccccccccc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITKFNEKGKK 318 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (336)
.+++...+..+|+.|++..++.+...-...
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 899999999999999999988876654443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=278.61 Aligned_cols=233 Identities=21% Similarity=0.280 Sum_probs=189.3
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..+...+|.++++||+|+||.|..++++ ++.||+|++.+... ........|..|-.+|..-+.+=|+.+..+|+|+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eM--lKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEM--LKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHH--hhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 4567789999999999999999999986 78899999974221 2234567899999999999999999999999987
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. +|+|||||+||+|..++. +..++++..++.++.+|+.||.-+|+.|+|||||||+|||+|..| ++||+|||.|-.
T Consensus 148 ~~LYlVMdY~pGGDlltLlS--k~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G-HikLADFGsClk 224 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLS--KFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG-HIKLADFGSCLK 224 (1317)
T ss_pred cceEEEEecccCchHHHHHh--hcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC-cEeeccchhHHh
Confidence 6 999999999999999993 334899999999999999999999999999999999999999988 999999999875
Q ss_pred cccc---cccccCCcccccCCCCCCC-----CCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh--hccCC-
Q 019780 214 EVMD---EMTCEAGTYRWMAPENERP-----SLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN--LRSAD- 281 (336)
Q Consensus 214 ~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~--~~~~~- 281 (336)
...+ .....+|||.|++||.+.. ..++..-|+|+||..++++..+.-|+.++ ++.....+... ...++
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~ 304 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD 304 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc
Confidence 4432 2345679999999996542 44567789999999999999999999665 45555555433 22222
Q ss_pred -CCCCCCcccccCC
Q 019780 282 -TPIPPKLVEIVDP 294 (336)
Q Consensus 282 -~~~p~~~~~~~~~ 294 (336)
..+++++.+++..
T Consensus 305 ~~~VSeeakdLI~~ 318 (1317)
T KOG0612|consen 305 ETDVSEEAKDLIEA 318 (1317)
T ss_pred ccccCHHHHHHHHH
Confidence 4466666655543
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=240.96 Aligned_cols=245 Identities=23% Similarity=0.359 Sum_probs=189.1
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--C---ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--C---EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
..+|.+.+.||+|+||.||+|... + ..||||++.. .........+..|+.+++.++||||+++++++.++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 78 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS----GYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR 78 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCC----CCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence 456889999999999999999875 2 3599999863 123445678999999999999999999999987665
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~~ 156 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFL 156 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC-cEEECCCcccccc
Confidence 89999999999999999543 35689999999999999999999999999999999999999876 7999999998743
Q ss_pred ccccc----cccC---CcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHH-HHHHHHHhhc-cCCCCC
Q 019780 215 VMDEM----TCEA---GTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITI-TLTNILQNLR-SADTPI 284 (336)
Q Consensus 215 ~~~~~----~~~~---gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~-~l~~~~~~~~-~~~~~~ 284 (336)
..... .... .+..|+|||.......+.+.|+|++++.+++... +..|....-.. ....+..... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 236 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDC 236 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccC
Confidence 22111 1111 2357999999888888899999999999998664 67775332111 1222211111 112345
Q ss_pred CCCcccccCCCCCCCCccccchhhhcc
Q 019780 285 PPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
|+.+.+++...+..+|+.|++..++..
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 666777888888889999988877764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=242.83 Aligned_cols=261 Identities=23% Similarity=0.296 Sum_probs=196.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHH-HHhCCCCceEeeEeeEecCC-EE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTL-LSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
++|.+.+.||+|+||.||+|.+. ++.||+|+++... .......+..|+.+ ++.++||||+++++++..+. .+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV----NSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC----CcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 36888999999999999999985 7899999987421 11223345556654 66778999999999887654 99
Q ss_pred EEEEccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCceEEecccccccc
Q 019780 138 IITELMRGETLQRYLWST--RPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
++|||++ |+|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++ .+||+|||++...
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~ 154 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYL 154 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeeccccccc
Confidence 9999997 5888887432 335689999999999999999999997 999999999999999887 7999999998754
Q ss_pred cccc-ccccCCcccccCCCCCCC----CCCCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHHHhhccC--CCCCC
Q 019780 215 VMDE-MTCEAGTYRWMAPENERP----SLENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNILQNLRSA--DTPIP 285 (336)
Q Consensus 215 ~~~~-~~~~~gt~~y~aPE~~~~----~~~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~~~~~~~--~~~~p 285 (336)
.... .....|+..|+|||...+ ...+...|+|++++.++++..+..|... ...+.+....+..... ...+|
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 3222 222458899999997754 3456788999999999999988888532 2222333333221111 12356
Q ss_pred CCcccccCCCCCCCCccccchhhhcccccccccccc--cchhhhh
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAITKFNEKGKKRRS--YLPSFLK 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 328 (336)
+++.+++...+..+|+.|++..++.......+.+.. ..++|++
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~ 279 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVASFVS 279 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccccHHHHHHHH
Confidence 778889999999999999999999986655555433 4555544
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=243.68 Aligned_cols=248 Identities=23% Similarity=0.309 Sum_probs=193.2
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccc-cccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNAL-AVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
+|+..+.||+|+||.||+|... ++.+|+|++...... .........+.+|+.+++.++||||+++++++.+.. .++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 3677889999999999999874 788999998742211 122335678999999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|+||+.|++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++..++|+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 9999999999999954 34688999999999999999999999999999999999998776579999999987543221
Q ss_pred ------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh-----hccCCCCCCC
Q 019780 219 ------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN-----LRSADTPIPP 286 (336)
Q Consensus 219 ------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~-----~~~~~~~~p~ 286 (336)
.....|+..|+|||.......+...|+|+|++.++++..+..|.... .......+.+. .......+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 11235788999999988888888999999999999998888775321 11111111111 1112223556
Q ss_pred CcccccCCCCCCCCccccchhhhccc
Q 019780 287 KLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
++.+++...+..+|+.|++..++.+.
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 67778888888999999988887654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=251.46 Aligned_cols=193 Identities=28% Similarity=0.351 Sum_probs=160.6
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 134 (336)
.++|.+.+.||+|+||.||+|.+. +..||||++... .........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP---FQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCch---hhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 367889999999999999999875 678999998632 11223455678999999999999999999887532
Q ss_pred ---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 135 ---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 135 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
..|++++++ +++|.+++. ...+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~ 165 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLA 165 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-CEEEcCCccc
Confidence 268899988 779988873 24699999999999999999999999999999999999999887 7999999999
Q ss_pred cccccccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 212 REEVMDEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 212 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
+.... ......||+.|+|||.... ...+.+.|+|+|++.++++..+..|.
T Consensus 166 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 216 (343)
T cd07878 166 RQADD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216 (343)
T ss_pred eecCC-CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC
Confidence 86432 3344568999999998766 46778899999999999988777664
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=243.16 Aligned_cols=246 Identities=24% Similarity=0.291 Sum_probs=198.8
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||+|.+. ++.+++|++... ........+.+|+.+++.++||||+++++.+.... .+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE----INEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecc----cChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 5677789999999999999986 788999998742 12355677899999999999999999999887665 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 78 MEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhHHHH
Confidence 99999999999995443 678999999999999999999999 9999999999999999876 79999999987543333
Q ss_pred ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh------HHHHHHHHHHHhhccCC-C-CCCCCccc
Q 019780 219 MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA------EITITLTNILQNLRSAD-T-PIPPKLVE 290 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~------~i~~~l~~~~~~~~~~~-~-~~p~~~~~ 290 (336)
.....++..|+|||...+...+...|+|+++..++++-.+..|... .....+..+........ . .+++++.+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 3336688999999998888888999999999999999888877532 23333333332211111 1 15667888
Q ss_pred ccCCCCCCCCccccchhhhccccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
++...+..+|+.|++..++.....
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~~~ 259 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEHPF 259 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhCch
Confidence 999999999999999888876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=245.80 Aligned_cols=247 Identities=21% Similarity=0.252 Sum_probs=197.7
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
+.++|++.+.||+|+||+||++.+. +..+|+|++... ........+.+|+.+++.++||||+++++.+.+.. .
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG----AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec----CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence 4568889999999999999999986 788999988631 23345678899999999999999999999988765 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
++||||+++++|.+++.. .+.+++..+..++.+++.||.|||+ .|++||||+|+||+++.++ .++|+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~ 155 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELI 155 (284)
T ss_pred EEEEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchh
Confidence 999999999999999844 3568999999999999999999997 5999999999999999876 79999999987543
Q ss_pred cccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH------------HHHHHHHHHHhhc-cCC-
Q 019780 216 MDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE------------ITITLTNILQNLR-SAD- 281 (336)
Q Consensus 216 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~------------i~~~l~~~~~~~~-~~~- 281 (336)
........|+..|+|||.......+...|+|++++.+++...+..|.... +...+..+..... ...
T Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 156 NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred hhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 33333456899999999887777888999999999999998888775321 1222222222111 111
Q ss_pred CCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 282 TPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 282 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
...|+++.+++...+..+|+.|++..++.+..
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 12556678888999999999999999888743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=241.97 Aligned_cols=245 Identities=26% Similarity=0.308 Sum_probs=185.9
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|++|.||+|.+. +..||+|.++... ........+.+|+.+++.++||||+++++++.++. .++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES---EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc---ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence 4778899999999999999985 7889999986421 12233456788999999999999999999988755 8999
Q ss_pred EEccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTR-PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
|||+. ++|.+++.... +..+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFGIPV 155 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-cEEECcccceeecCCCc
Confidence 99997 58988885433 35689999999999999999999999999999999999999887 7999999998743222
Q ss_pred -cccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHh-----HHHHHHHHH-----------------
Q 019780 218 -EMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFA-----EITITLTNI----------------- 273 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~-----~i~~~l~~~----------------- 273 (336)
......+++.|+|||..... ..+...|+|+|++.++++-.+..|... .+...+..+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 12233578999999976543 457889999999999998887655421 111111100
Q ss_pred HHh--------hccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 274 LQN--------LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 274 ~~~--------~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
... .......+++++.+++...+..+|+.|++..++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 000122356667778888888888888888777654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=241.40 Aligned_cols=249 Identities=27% Similarity=0.313 Sum_probs=199.3
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||.|+||.||+|.+. ++.+|+|++... ........+.+|+.+++.++||||+++++++.++. .++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE----EAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecc----ccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence 5778899999999999999975 788999998632 12344567889999999999999999999888665 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-- 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-- 217 (336)
+||+++++|.+++... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||+++.....
T Consensus 78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 78 MEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEcccccceeeccccc
Confidence 9999999999999432 789999999999999999999999999999999999999877 7999999998764332
Q ss_pred cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhc-cCCCC-CCCCcccccCC
Q 019780 218 EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLR-SADTP-IPPKLVEIVDP 294 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~-~~~~~-~p~~~~~~~~~ 294 (336)
......++..|+|||.......+...|+|+++..+|++-.+..|... +-...+..+..... ..... .|+.+.+++..
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 233 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL 233 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHH
Confidence 22344688899999998888888999999999999999888888522 11112222222211 11122 67778889999
Q ss_pred CCCCCCccccchhhhcccccccccc
Q 019780 295 KSTMNNDCMATVHAITKFNEKGKKR 319 (336)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (336)
.+..+|+.|++..++.+...-.+..
T Consensus 234 ~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 234 CLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HhhCChhhCcCHHHHhhChhhcCCC
Confidence 9999999999999998766554444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=242.51 Aligned_cols=244 Identities=25% Similarity=0.355 Sum_probs=189.7
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecC----
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQP---- 134 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~---- 134 (336)
..|.+.+.||+|+||.||+|... ++.+|+|++... ......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC------CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 45777889999999999999875 778999998632 12345678899999998 699999999988642
Q ss_pred ---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 135 ---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 135 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
..+++|||+++++|.+++.......+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~ 158 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVS 158 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-CEEEccCCCc
Confidence 378999999999999999665556789999999999999999999999999999999999999887 7999999998
Q ss_pred cccccc--cccccCCcccccCCCCCC-----CCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhh--ccCC
Q 019780 212 REEVMD--EMTCEAGTYRWMAPENER-----PSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNL--RSAD 281 (336)
Q Consensus 212 ~~~~~~--~~~~~~gt~~y~aPE~~~-----~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~--~~~~ 281 (336)
...... ......|+..|+|||... ....+...|+|++++.+|++-.+..|....- ........... ....
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence 753221 223446899999999765 3356778999999999999999988863211 11111111110 1111
Q ss_pred CCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 282 TPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 282 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
...+.++.+++...+..+|+.|++..++.+.
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 3355677888889999899999988877654
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=238.80 Aligned_cols=246 Identities=23% Similarity=0.318 Sum_probs=196.3
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---CEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---TMM 137 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~ 137 (336)
+|.+.+.||+|+||.||+|.+. +..+|+|++... .......+.+..|+.+++.++||||+++++.+... ..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG---NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecc---cCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 4778899999999999999875 678999998632 22445567889999999999999999999987643 279
Q ss_pred EEEEccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCcccccCCCCceeecCCCCceEEecccc
Q 019780 138 IITELMRGETLQRYLWST--RPKRLDLKHSISFALDISRAMEYLH-----ANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH-----~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
++|||+++++|.+++... ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||+
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~~kl~d~g~ 156 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGL 156 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-CEEEecccc
Confidence 999999999999998543 2467899999999999999999999 89999999999999999876 899999999
Q ss_pred cccccccc--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh--hccCCCCCCC
Q 019780 211 AREEVMDE--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN--LRSADTPIPP 286 (336)
Q Consensus 211 a~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~--~~~~~~~~p~ 286 (336)
+....... .....|+..|+|||.......+...|+|+|+..++++-.+..|....-...+...... ........++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 88644333 2334689999999998888888999999999999998888888533222222222222 1122334556
Q ss_pred CcccccCCCCCCCCccccchhhhccc
Q 019780 287 KLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.+.+++...+..+|+.|++..++.+.
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhC
Confidence 77788888898999999998888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=244.36 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=190.2
Q ss_pred cCCceeEeeeecCCCcEEEEEeEECC------------------ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYGC------------------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 121 (336)
...+|.+.+.||+|+||.||+|.+.. ..||+|.+... ......+.+.+|+.+++.++|
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~l~~ 78 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD----ASDNAREDFLKEVKILSRLSD 78 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc----cCHHHHHHHHHHHHHHHhcCC
Confidence 34678899999999999999988642 35899998632 233556789999999999999
Q ss_pred CceEeeEeeEecCC-EEEEEEccCCCCHHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCC
Q 019780 122 ENILKFVGASVQPT-MMIITELMRGETLQRYLWSTR---------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKP 191 (336)
Q Consensus 122 pnIv~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp 191 (336)
|||+++++++.++. .+++||++++++|.+++.... ...+++..++.++.|++.||+|||+.|++||||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp 158 (296)
T cd05051 79 PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158 (296)
T ss_pred CCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 99999999988754 899999999999999995432 12689999999999999999999999999999999
Q ss_pred CceeecCCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC--CCCCC---
Q 019780 192 SNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP--KVRPE--- 262 (336)
Q Consensus 192 ~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p--~~RP~--- 262 (336)
+||+++.++ .++|+|||+++...... .....++..|+|||.......+...|+|++++.++++-. +..|.
T Consensus 159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 159 RNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999886 89999999987543222 122346678999998887778889999999999887643 33332
Q ss_pred -HhHHHHHHHHHHHh-----hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 263 -FAEITITLTNILQN-----LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 263 -~~~i~~~l~~~~~~-----~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
..+++..+...... ........|+++.+++...+..+|+.|++..++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 23333333222111 01112334567888888899999999998887754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=239.39 Aligned_cols=237 Identities=30% Similarity=0.467 Sum_probs=189.1
Q ss_pred eeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEE
Q 019780 68 KMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITE 141 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e 141 (336)
+.||+|+||.||+|... +..+++|++.... .......+.+|+..++.++|+||+++++++.+.. .++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA----SEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeecccc----chhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 46999999999999886 6789999987421 2225678999999999999999999999988754 899999
Q ss_pred ccCCCCHHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 142 LMRGETLQRYLWSTR-------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 142 ~~~gg~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
|+++++|.+++.... ...+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+...
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~ 155 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-VVKISDFGLSRDV 155 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-cEEEccccccccc
Confidence 999999999995432 36789999999999999999999999999999999999999886 7999999999865
Q ss_pred cccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCC----HhHHHHHHHHHHHhhccCCCCCC
Q 019780 215 VMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPE----FAEITITLTNILQNLRSADTPIP 285 (336)
Q Consensus 215 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~----~~~i~~~l~~~~~~~~~~~~~~p 285 (336)
.... .....++..|+|||.......+...|+|+|+..++++.. +..|. ..++...+.. .........+|
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~ 233 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--GYRLPKPEYCP 233 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCccCC
Confidence 4322 233457889999998888888899999999999988765 35554 2222222221 11112234567
Q ss_pred CCcccccCCCCCCCCccccchhhhcc
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+++.+++...+..+|+.|++..++.+
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~l~~ 259 (262)
T cd00192 234 DELYELMLSCWQLDPEDRPTFSELVE 259 (262)
T ss_pred hHHHHHHHHHccCCcccCcCHHHHHH
Confidence 78888899999999999998887764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=236.95 Aligned_cols=238 Identities=26% Similarity=0.400 Sum_probs=184.6
Q ss_pred eeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccCC
Q 019780 68 KMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRG 145 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~g 145 (336)
++||+|+||.||+|... +..+|+|.+... ........+.+|+.+++.++||||+++++++.+.. .++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED----LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCc----CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 36899999999999875 678999988632 23344557889999999999999999999988665 8999999999
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccccc---ccc
Q 019780 146 ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM---TCE 222 (336)
Q Consensus 146 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~ 222 (336)
++|.+++... ...+++..++.++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++........ ...
T Consensus 77 ~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 77 GDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-eEEECCCccceeccccccccCCCC
Confidence 9999998543 34688999999999999999999999999999999999999876 799999999875332211 112
Q ss_pred CCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHH-HHHHHHHHhh-ccCCCCCCCCcccccCCCCCCC
Q 019780 223 AGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEIT-ITLTNILQNL-RSADTPIPPKLVEIVDPKSTMN 299 (336)
Q Consensus 223 ~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~-~~l~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~ 299 (336)
.++..|+|||.......+...|+|+++..+++.-. +.-|...... .....+.... ......+|+.+.+++...+..+
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 34577999998887778889999999999998765 4445322111 1112222111 1223457778888999999999
Q ss_pred Cccccchhhhcc
Q 019780 300 NDCMATVHAITK 311 (336)
Q Consensus 300 ~~~~~~~~~~~~ 311 (336)
|+.|++..++.+
T Consensus 235 p~~Rp~~~~l~~ 246 (250)
T cd05085 235 PENRPKFSELQK 246 (250)
T ss_pred cccCCCHHHHHH
Confidence 999998887764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=239.75 Aligned_cols=248 Identities=24% Similarity=0.255 Sum_probs=195.7
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---CEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---TMM 137 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~ 137 (336)
+|...+.||.|++|.||+|.+. ++.+|+|.+... ........+.+|+++++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD----PNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC----CchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 5778899999999999999985 788999998732 1224567789999999999999999999988643 389
Q ss_pred EEEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 138 IITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
+||||++|++|.+++.. .....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~ 156 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV 156 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence 99999999999998743 2345688999999999999999999999999999999999999876 79999999987544
Q ss_pred cccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH------HHHHHHHHHHhhcc-CC------C
Q 019780 216 MDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE------ITITLTNILQNLRS-AD------T 282 (336)
Q Consensus 216 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~------i~~~l~~~~~~~~~-~~------~ 282 (336)
........++..|+|||.......+...|+|+|++.+|++-.+.+|...+ ..+....+...... .. .
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 157 NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred ccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 33333445789999999988888889999999999999998888885332 11222211111100 00 1
Q ss_pred CCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 283 PIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 283 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
..++.+.+++...+..+|+.|++..++.+...-
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 123456788889999999999999998886544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=238.34 Aligned_cols=246 Identities=21% Similarity=0.277 Sum_probs=188.1
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---CE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---TM 136 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~ 136 (336)
.+|...+.||+|+||.||+|.+. +..|++|.+..........+....+.+|+.+++.++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36788899999999999999874 78899999874332233345567889999999999999999999988753 37
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||++|++||||+|+||+++.++ .++|+|||+++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCCCcccccc
Confidence 899999999999999944 34588999999999999999999999999999999999999876 799999999874322
Q ss_pred -----ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccC-----CCCCCC
Q 019780 217 -----DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSA-----DTPIPP 286 (336)
Q Consensus 217 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~-----~~~~p~ 286 (336)
.......++..|+|||.......+...|+|++++.+|++-.+..|.... .....+....... ...+++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY--EAMAAIFKIATQPTNPQLPSHISE 236 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc--chHHHHHHHhcCCCCCCCchhcCH
Confidence 1122235889999999988888888999999999999999888885221 1111122111111 112334
Q ss_pred CcccccCCCCCCCCccccchhhhcccc
Q 019780 287 KLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.+..++ ..+..+|+.|++..++.+..
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~hp 262 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRHP 262 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence 455555 35556888888887776543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=242.53 Aligned_cols=236 Identities=17% Similarity=0.327 Sum_probs=181.3
Q ss_pred eeecCCCcEEEEEeEEC---------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-CEE
Q 019780 68 KMIGEGSYSIVYKGFYG---------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-TMM 137 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~ 137 (336)
+.||+|+||.||+|... ...+++|.+.. ......+.+.+|+.+++.++||||+++++++..+ ..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence 36999999999999874 22477787642 1234456788999999999999999999998875 489
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCc-------eEEecccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ-------VKLADFGL 210 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~-------~kl~Dfg~ 210 (336)
+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.. ++++|||+
T Consensus 76 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred EEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999999995443 468999999999999999999999999999999999999876532 79999999
Q ss_pred ccccccccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHH-HHHHHhhccCCCCCCCCc
Q 019780 211 AREEVMDEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFAEITITL-TNILQNLRSADTPIPPKL 288 (336)
Q Consensus 211 a~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l-~~~~~~~~~~~~~~p~~~ 288 (336)
+...... ....++..|+|||.... ...+...|+|+++..+|++-.+.+|.+......- ............+.++++
T Consensus 155 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (258)
T cd05078 155 SITVLPK--EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTEL 232 (258)
T ss_pred ccccCCc--hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHH
Confidence 8754332 23458899999998875 4467889999999999998877555443322211 111122222233444567
Q ss_pred ccccCCCCCCCCccccchhhhcc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.+++...+..+|+.|++..++.+
T Consensus 233 ~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 233 ANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred HHHHHHHhccChhhCCCHHHHHH
Confidence 78899999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=244.01 Aligned_cols=250 Identities=24% Similarity=0.295 Sum_probs=189.4
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.++|.+.+.||+|+||.||+|.+. ++.||+|.+..... ......+.+|+.+++.++||||+++++++.+.. .+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE----EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc----cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 467899999999999999999875 78899999874221 222345778999999999999999999988765 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||++ ++|.+++... ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIP 157 (301)
T ss_pred EEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC-cEEECcCcchhccCCC
Confidence 9999997 5899888543 34688999999999999999999999999999999999999876 7999999998753222
Q ss_pred --cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhc---------------
Q 019780 218 --EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLR--------------- 278 (336)
Q Consensus 218 --~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~--------------- 278 (336)
......+++.|+|||.... ...+...|+|+|+..++++..+..|... +....+..+...+.
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1223457899999997654 3467789999999999999888766421 11111111111100
Q ss_pred ---------------cCCCCCCCCcccccCCCCCCCCccccchhhhcccccccc
Q 019780 279 ---------------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 279 ---------------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
.....+++.+.+++..++..+|..|.+..++....+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 011234556667888888888888888888776554433
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=239.07 Aligned_cols=238 Identities=24% Similarity=0.378 Sum_probs=188.1
Q ss_pred eeecCCCcEEEEEeEEC---C--ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCCEEEEEEc
Q 019780 68 KMIGEGSYSIVYKGFYG---C--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITEL 142 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~lv~e~ 142 (336)
+.||+|++|.||+|.+. + ..+|||.+..... ....+.+.+|+.++++++||||+++++.+.+...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL----SDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc----HHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEe
Confidence 46899999999999874 2 2589999874221 1567789999999999999999999999888669999999
Q ss_pred cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc----
Q 019780 143 MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE---- 218 (336)
Q Consensus 143 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~---- 218 (336)
+++++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEEecccccccccccccccee
Confidence 9999999999654435689999999999999999999999999999999999999886 89999999987543311
Q ss_pred -ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCC----HhHHHHHHHHHHHhhccCCCCCCCCccccc
Q 019780 219 -MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPE----FAEITITLTNILQNLRSADTPIPPKLVEIV 292 (336)
Q Consensus 219 -~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~----~~~i~~~l~~~~~~~~~~~~~~p~~~~~~~ 292 (336)
.....++..|+|||.......+...|+|+|++.+|++-. +..|. ..++...+.... .........|+.+.+++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li 234 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-ERLERPEACPQDIYNVM 234 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CcCCCCccCCHHHHHHH
Confidence 112346789999998888788888999999999999876 77774 233333222211 11112234567788888
Q ss_pred CCCCCCCCccccchhhhcc
Q 019780 293 DPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~ 311 (336)
...+..+|+.|++..++..
T Consensus 235 ~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 235 LQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHCCCCcccCCCHHHHHH
Confidence 8899999999988887764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=242.27 Aligned_cols=249 Identities=23% Similarity=0.305 Sum_probs=199.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
..|++.+.||.|+||.||+|... ++.|++|.+... .....+.+.+|+.+++.++||||+++++.+.+.. .++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-----KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc-----cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 56999999999999999999864 789999998632 1223567889999999999999999999988665 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|+||+++++|..++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 94 VMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccchhccccc
Confidence 9999999999999843 3589999999999999999999999999999999999999876 79999999987533222
Q ss_pred --ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh---hccCCCCCCCCccccc
Q 019780 219 --MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN---LRSADTPIPPKLVEIV 292 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~---~~~~~~~~p~~~~~~~ 292 (336)
.....|+..|+|||.......+...|+|+++..+|++-.+..|.... -...+..+... .......+++.+.+++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHH
Confidence 22345889999999988888888999999999999999888886331 12222222211 1112234667788888
Q ss_pred CCCCCCCCccccchhhhcccccccccc
Q 019780 293 DPKSTMNNDCMATVHAITKFNEKGKKR 319 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (336)
...+..+|+.|++..++.+...-...+
T Consensus 250 ~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 999999999999999888766554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=243.34 Aligned_cols=246 Identities=22% Similarity=0.290 Sum_probs=194.5
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
..+|.+.+.||+|+||.||+|... +..+++|.+.... ......+.+|+.+++.+.||||+++++.+.++. .+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC-----cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 368999999999999999999874 7889999886321 223466889999999999999999999887654 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPE 169 (296)
T ss_pred EeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEECccccchhcccc
Confidence 99999999999999843 3578999999999999999999999999999999999999876 7999999998753322
Q ss_pred c--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhh-c--cCCCCCCCCcccc
Q 019780 218 E--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNL-R--SADTPIPPKLVEI 291 (336)
Q Consensus 218 ~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~-~--~~~~~~p~~~~~~ 291 (336)
. .....|++.|+|||.......+...|+|++++.++++-.+..|...+- ...+....... . .....+++.+.++
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence 2 223468899999998888878889999999999999998888863321 11111111110 0 1112345567778
Q ss_pred cCCCCCCCCccccchhhhcccccc
Q 019780 292 VDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
+...+..+|+.|++..++.+....
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~~~~ 273 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQHQFL 273 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhChhh
Confidence 888899999999999888875543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=247.31 Aligned_cols=188 Identities=26% Similarity=0.288 Sum_probs=151.0
Q ss_pred eeeecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---CEEEE
Q 019780 67 QKMIGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---TMMII 139 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~lv 139 (336)
++.||+|+||+||+|... +..+|+|.+.... ....+.+|+.+|+.++||||+++++++.+. ..+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 367999999999999864 4679999986311 123467899999999999999999988643 37899
Q ss_pred EEccCCCCHHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---CCCceEEeccc
Q 019780 140 TELMRGETLQRYLWST-------RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE---DKKQVKLADFG 209 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~---~~~~~kl~Dfg 209 (336)
|||+.+ +|.+++... ....+++..++.++.|++.||.|||++||+||||||+|||+.. ..+.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 999864 888887422 1235899999999999999999999999999999999999942 22479999999
Q ss_pred cccccccc-----cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 210 LAREEVMD-----EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 210 ~a~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
+++..... ......||+.|+|||...+ ..++.+.|+|++++.++++-.++.|.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f 216 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCc
Confidence 99753321 1233468999999998766 45788899999999999998887774
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=237.20 Aligned_cols=246 Identities=23% Similarity=0.272 Sum_probs=195.8
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|++.+.||+|+||.||++... ++.+|+|.+... .........+.+|+.+++.++||||+++++++.+.. .++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINIS---KMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhH---hCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence 4788999999999999999875 788999998632 112344567899999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
+||+.+++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEEeeccceeecCcchh
Confidence 9999999999999665555689999999999999999999999999999999999999876 79999999987543322
Q ss_pred -ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh-hccCCCCCCCCcccccCCC
Q 019780 219 -MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN-LRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 219 -~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~-~~~~~~~~p~~~~~~~~~~ 295 (336)
.....|+..|+|||.......+...|+|+++..++++..+..|.... ....+..+... ........++++.+++...
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 12235888999999988888888999999999999998888876332 22222222221 1112234556677888888
Q ss_pred CCCCCccccchhhhccc
Q 019780 296 STMNNDCMATVHAITKF 312 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~~ 312 (336)
+..+|+.|+++.++.+.
T Consensus 237 l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 237 FKRNPRDRPSVNSILEK 253 (256)
T ss_pred hhCChhhCcCHHHHhhC
Confidence 88899999988877653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=259.05 Aligned_cols=194 Identities=26% Similarity=0.388 Sum_probs=163.0
Q ss_pred CceeEeeeecCCCcEEEEEeEECC--ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe-cCCEEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV-QPTMMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~l 138 (336)
..|.|+.-||.|+||.||+|.++. -..|-|++. ..+.+..+.+.-|+.||...+||+||++++.|. ++.+|+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe-----tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE-----TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI 106 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc-----ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence 346677789999999999999873 344667764 345677889999999999999999999998655 666999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
+.|||+||-+...+-. -+..+.+.++..+++|+|.||.|||+++|||||||+.|||+.-+| .++|+|||.+......
T Consensus 107 liEFC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKSTR 184 (1187)
T ss_pred EEeecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC-cEeeecccccccchhHH
Confidence 9999999999988744 346799999999999999999999999999999999999999998 7999999998654332
Q ss_pred -cccccCCcccccCCCC-----CCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 218 -EMTCEAGTYRWMAPEN-----ERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~-----~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
...++.||++|||||+ ....|+++..|+|+|+..+.++.-.+.|.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH 235 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH 235 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc
Confidence 3456789999999995 45789999999999998888776666553
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=241.31 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=195.8
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
..|+..+.||+|+||.||+|.+. +..||+|++... ........+.+|+.+++.++||||+++++++.++. .++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc----ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 35667788999999999999875 788999998631 22345678999999999999999999999988766 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||++|++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++ .++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 80 IMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-CEEEcccccceeccCCc
Confidence 9999999999999843 4588999999999999999999999999999999999999876 79999999987543322
Q ss_pred --ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh--hccCCCCCCCCcccccCC
Q 019780 219 --MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN--LRSADTPIPPKLVEIVDP 294 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~--~~~~~~~~p~~~~~~~~~ 294 (336)
.....++..|+|||.......+...|+|+++..++++..+..|............... ........|+.+.+++..
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDA 235 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHH
Confidence 2233578899999998888888999999999999999999888643221111111111 111122355667788889
Q ss_pred CCCCCCccccchhhhcccccc
Q 019780 295 KSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~ 315 (336)
.+..+|+.|++..++.+....
T Consensus 236 ~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 236 CLNKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred HcccCcccCcCHHHHHhChHh
Confidence 999999999999988765433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=242.95 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=191.3
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
++.++|.+.+.||+|+||.||+|.+. +..+|+|++.. .........+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~----~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~ 77 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMAEFDHPNIVKLLGVC 77 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCC----CcCHHHHHHHHHHHHHHHhcCCCchheEEEEE
Confidence 34577889999999999999999863 46799998863 22344557789999999999999999999998
Q ss_pred ecCC-EEEEEEccCCCCHHHHHhhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCC
Q 019780 132 VQPT-MMIITELMRGETLQRYLWSTR--------------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLK 190 (336)
Q Consensus 132 ~~~~-~~lv~e~~~gg~L~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDik 190 (336)
.++. .+++|||+++|+|.+++.... ...+++..++.++.|++.||.|||++|++|||||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 8765 899999999999999995432 1246788899999999999999999999999999
Q ss_pred CCceeecCCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhH
Q 019780 191 PSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAE 265 (336)
Q Consensus 191 p~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~ 265 (336)
|+||+++.++ .++|+|||++....... .....++..|+|||.......+...|+|+|+..+|++-. +..|....
T Consensus 158 p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 158 TRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred HhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999887 79999999987532221 112234678999998887788889999999999988764 44453221
Q ss_pred HHHH-HHHHHH-hhccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 266 ITIT-LTNILQ-NLRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 266 i~~~-l~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.... +..+.. .........|+++.+++...+..+|+.|++..++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 237 AHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1111 111111 111223456778889999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=236.51 Aligned_cols=198 Identities=24% Similarity=0.370 Sum_probs=166.6
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---CE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---TM 136 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~ 136 (336)
.+|.+.+.||+|+||.||+|.+. +..+|+|++...............+.+|+.+++.++||||+++++++.+. .+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999875 78899998753222222344567899999999999999999999988754 27
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++++||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcccccccccc
Confidence 8999999999999998543 4588999999999999999999999999999999999999876 799999999875321
Q ss_pred -----ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 217 -----DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 217 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.......|+..|+|||.......+...|+|+++..++++..+..|.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 209 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 1122345889999999988887888899999999999999988885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=240.87 Aligned_cols=246 Identities=21% Similarity=0.338 Sum_probs=186.6
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC------------------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCC
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG------------------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 122 (336)
.++|++.+.||+|+||.||++.+. ...+|+|++... ........+.+|+.+++.++|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~~E~~~l~~l~~~ 79 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED----ANKNARNDFLKEIKIMSRLKDP 79 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCC
Confidence 457899999999999999998542 235889988631 2344567889999999999999
Q ss_pred ceEeeEeeEecCC-EEEEEEccCCCCHHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCC
Q 019780 123 NILKFVGASVQPT-MMIITELMRGETLQRYLWSTRP---------KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPS 192 (336)
Q Consensus 123 nIv~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~~---------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~ 192 (336)
||+++++++.+.. .++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.|++|+||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~ 159 (296)
T cd05095 80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR 159 (296)
T ss_pred CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence 9999999988655 8999999999999999954321 24678889999999999999999999999999999
Q ss_pred ceeecCCCCceEEeccccccccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC--CCCC----C
Q 019780 193 NLLLTEDKKQVKLADFGLAREEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP--KVRP----E 262 (336)
Q Consensus 193 NIll~~~~~~~kl~Dfg~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p--~~RP----~ 262 (336)
||+++.++ .++|+|||+++....... ....++..|+|||.......+...|+|+|++.+|++.. +.-| +
T Consensus 160 Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 160 NCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred eEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 99999876 799999999875432221 11234578999998777778889999999999987643 2223 3
Q ss_pred HhHHHHHHHHHHHh-----hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 263 FAEITITLTNILQN-----LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 263 ~~~i~~~l~~~~~~-----~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
..++.......... ........|+.+.+++...+..+|+.|++..++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 33433332222211 11122345667778888889999999998877754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=240.09 Aligned_cols=240 Identities=21% Similarity=0.218 Sum_probs=179.9
Q ss_pred eecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHH---HhCCCCceEeeEeeEecCC-EEEEEEc
Q 019780 69 MIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLL---SKMKHENILKFVGASVQPT-MMIITEL 142 (336)
Q Consensus 69 ~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpnIv~~~~~~~~~~-~~lv~e~ 142 (336)
.||+|+||.||++... ++.+|+|++...... .......+.+|..++ ...+||||+.+++.+..++ .++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--MKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccc--cchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 4899999999999875 788999998742211 112223334444433 3457999999999887654 8999999
Q ss_pred cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccccccc
Q 019780 143 MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE 222 (336)
Q Consensus 143 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~ 222 (336)
++|++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...........
T Consensus 79 ~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~ 155 (279)
T cd05633 79 MNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKKKPHAS 155 (279)
T ss_pred CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC-CEEEccCCcceeccccCccCc
Confidence 999999999843 35699999999999999999999999999999999999999876 799999999875433333345
Q ss_pred CCcccccCCCCCC-CCCCCCHHHHHHHHHHhhccCCCCCCCHhH---HHHHHHHHHHh-hccCCCCCCCCcccccCCCCC
Q 019780 223 AGTYRWMAPENER-PSLENLSEDMVALLKSCWAEDPKVRPEFAE---ITITLTNILQN-LRSADTPIPPKLVEIVDPKST 297 (336)
Q Consensus 223 ~gt~~y~aPE~~~-~~~~~~~~di~~l~~~~l~~~p~~RP~~~~---i~~~l~~~~~~-~~~~~~~~p~~~~~~~~~~~~ 297 (336)
.|+..|+|||... ....+...|+|++++.++++..+..|.... ....+...... -......+++++.+++...+.
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence 6899999999875 455678899999999999998888775321 11122222111 112234567778888999999
Q ss_pred CCCcccc-----chhhhcccc
Q 019780 298 MNNDCMA-----TVHAITKFN 313 (336)
Q Consensus 298 ~~~~~~~-----~~~~~~~~~ 313 (336)
.+|+.|. ++.++.+..
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhCc
Confidence 9999987 466666543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=237.23 Aligned_cols=247 Identities=23% Similarity=0.308 Sum_probs=196.8
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||+|... +..+|+|.+.... ......+.+.+|+.+++.++|+||+++++.+.+.. .++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK---MPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh---ccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence 4778899999999999999985 6789999986421 12234567889999999999999999999887765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
+||+++++|.+++.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++..++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999999665555689999999999999999999999999999999999999876567999999987543322
Q ss_pred -ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHh-hccCCCCCCCCcccccCCC
Q 019780 219 -MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQN-LRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 219 -~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~-~~~~~~~~p~~~~~~~~~~ 295 (336)
.....|+..|+|||.......+...|+|+++..+|+...+..|... +..+.+...... .....+..+.++.+++...
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 237 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQL 237 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHH
Confidence 1223588999999988888888899999999999999888887532 222222222221 2223344566788888889
Q ss_pred CCCCCccccchhhhccc
Q 019780 296 STMNNDCMATVHAITKF 312 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~~ 312 (336)
+..+|+.|+++.++.+.
T Consensus 238 l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 238 FKVSPRDRPSITSILKR 254 (257)
T ss_pred hccChhhCcCHHHHhhC
Confidence 99999999998887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-32 Score=244.69 Aligned_cols=193 Identities=18% Similarity=0.239 Sum_probs=159.5
Q ss_pred EeeeecCC--CcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEE
Q 019780 66 LQKMIGEG--SYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 66 ~~~~lg~G--~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~ 140 (336)
++++||+| +||+||++... ++.||+|++... .........+.+|+.+++.++||||+++++++.+++ .++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLE---ACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechh---hccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 45789999 78999999876 789999998732 123345667889999999999999999999988765 89999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc--
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-- 218 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~-- 218 (336)
||+++|+|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++.++ .++++|||.+.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-cEEEcccchhhcccccccc
Confidence 999999999999655455689999999999999999999999999999999999999877 79999998654321110
Q ss_pred -------ccccCCcccccCCCCCCC--CCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 219 -------MTCEAGTYRWMAPENERP--SLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 219 -------~~~~~gt~~y~aPE~~~~--~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.....++..|+|||.... ..++.+.|+|++++.++++-.+..|.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 210 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 112246788999998765 45778899999999999998888885
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=238.47 Aligned_cols=246 Identities=19% Similarity=0.312 Sum_probs=189.9
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
...+|.+.+.||+|+||.||+|+.. ...+++|.+.. .........+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 78 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK----TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR 78 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCC----ccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC
Confidence 3467889999999999999999864 35689998752 122335677999999999999999999999988
Q ss_pred cCC-EEEEEEccCCCCHHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceE
Q 019780 133 QPT-MMIITELMRGETLQRYLWSTRP-------KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVK 204 (336)
Q Consensus 133 ~~~-~~lv~e~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~k 204 (336)
+.. .++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++|++||||||+||+++.++ .++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~ 157 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR-EVK 157 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC-cEE
Confidence 755 8999999999999999965431 2589999999999999999999999999999999999999876 799
Q ss_pred Eecccccccccccc---ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHH--HHHHHHHHH-hh
Q 019780 205 LADFGLAREEVMDE---MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEI--TITLTNILQ-NL 277 (336)
Q Consensus 205 l~Dfg~a~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i--~~~l~~~~~-~~ 277 (336)
|+|||++....... .....++..|+|||.......+...|+|+|+..++++-. +.-|. .++ ...+..... ..
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~-~~~~~~~~~~~~~~~~~ 236 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF-YGLSDEEVLNRLQAGKL 236 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCc-cccchHHHHHHHHcCCc
Confidence 99999987433222 222346778999998877778889999999999887654 33332 111 111111111 11
Q ss_pred -ccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 278 -RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 278 -~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.......|+.+.+++...+..+|+.|++..++.+
T Consensus 237 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~ 271 (275)
T cd05046 237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271 (275)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1123456777889999999999999998887764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=244.06 Aligned_cols=194 Identities=25% Similarity=0.377 Sum_probs=169.3
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe-cCCEEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV-QPTMMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~lv 139 (336)
-|.++..||+|+||.||+|.++ |..+|||.+.. ....+.+..|+.+|.+.+.|++|++|+.+. ..++|+|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-------cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 4667789999999999999886 88999998862 345677899999999999999999999765 5569999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-- 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-- 217 (336)
||||..|++.+.++. +++.+++.++..+++..+.||+|||...-||||||+.|||++.+| +.||+|||.|......
T Consensus 107 MEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTMA 184 (502)
T ss_pred hhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc-hhhhhhccccchhhhhHH
Confidence 999999999999964 447899999999999999999999999999999999999999987 8999999999865443
Q ss_pred cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH
Q 019780 218 EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI 266 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i 266 (336)
...+..||+.|||||++....+++..|+|+|+....++.-++.| ..++
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PP-YsDI 232 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPP-YSDI 232 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCC-cccc
Confidence 24456799999999999999999999999999999998766544 5554
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=238.53 Aligned_cols=193 Identities=26% Similarity=0.322 Sum_probs=162.8
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||+|.+. ++.|++|++.... ........+.+|+.+++.++||||+++++++.++. .++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR---LEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccc---ccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence 4788999999999999999975 7899999987422 12334567899999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
+||+ +++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 78 MEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEP 154 (286)
T ss_pred eccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC-cEEEeeeeecccccCCCC
Confidence 9999 999999985433 5689999999999999999999999999999999999999876 79999999987543332
Q ss_pred --ccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCC
Q 019780 219 --MTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRP 261 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP 261 (336)
.....|+..|+|||..... ..+.+.|+|++++.++++-.+..|
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~ 200 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPL 200 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcC
Confidence 3345688999999987543 457899999999999998887443
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=236.84 Aligned_cols=246 Identities=23% Similarity=0.371 Sum_probs=189.1
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--C---ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--C---EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..++|...+.||+|+||.||+|... + ..+++|.+... ........+.+|+.+++.++||||+++.+++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG----YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence 3457888899999999999999874 2 26899988631 1334467789999999999999999999998866
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. .++||||+++++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~ 156 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL-ECKVSDFGLSRV 156 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC-cEEECCCcccee
Confidence 5 89999999999999999543 35689999999999999999999999999999999999999876 799999999875
Q ss_pred ccccccc---c--cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHH-HHHHHhhc-cCCCCCC
Q 019780 214 EVMDEMT---C--EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITL-TNILQNLR-SADTPIP 285 (336)
Q Consensus 214 ~~~~~~~---~--~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l-~~~~~~~~-~~~~~~p 285 (336)
....... . ...+..|+|||.......+...|+|+++..+|+.-. +..|....-...+ ..+..... ......|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 236 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCP 236 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCC
Confidence 4322111 1 113457999998887777889999999999998664 7778532211111 11111111 1123456
Q ss_pred CCcccccCCCCCCCCccccchhhhcc
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+.+.+++...+..+|+.|++..++.+
T Consensus 237 ~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 237 SAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 67788888888889999988877764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=242.68 Aligned_cols=244 Identities=25% Similarity=0.312 Sum_probs=184.8
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||+|.+. +..+|+|.++... ........+.+|+.+++.++||||+++++++.+.. .++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccc---ccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence 4778899999999999999985 7889999987421 12223456778999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-- 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-- 217 (336)
+||+++ +|.+++... ...+++..++.++.||+.||.|||++|++||||||+||+++.++ .++|+|||+++.....
T Consensus 78 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 78 FEYCDQ-DLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVR 154 (284)
T ss_pred EecCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-cEEECccchhhccCCCCC
Confidence 999975 888887543 35689999999999999999999999999999999999999876 7999999998753222
Q ss_pred cccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHHHhhc----------------
Q 019780 218 EMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNILQNLR---------------- 278 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~~~~~---------------- 278 (336)
......++..|+|||...+. ..+...|+|++++.++++..+..|.+. +....+..+...+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12334578999999977653 467889999999999999888887421 11122222211110
Q ss_pred -------------cCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 279 -------------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 279 -------------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
...+.+++++.+++...+..+|+.|++..++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0112344556667777777788888777776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=240.01 Aligned_cols=246 Identities=25% Similarity=0.335 Sum_probs=192.1
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEec----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQ---- 133 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~---- 133 (336)
...|.+.+.||+|+||.||+|.+. ++.+|+|++.. .......+..|+.+++.+ +||||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~------~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV------TEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEec------ChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 357888899999999999999985 78899999863 223345688899999998 69999999998752
Q ss_pred ---CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 134 ---PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 134 ---~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
...+++|||+++|+|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||+
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-~~~l~dfg~ 167 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-EVKLVDFGV 167 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCcc
Confidence 2379999999999999999765566788999999999999999999999999999999999999887 799999999
Q ss_pred cccccc--ccccccCCcccccCCCCCC-----CCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhh-c-cC
Q 019780 211 AREEVM--DEMTCEAGTYRWMAPENER-----PSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNL-R-SA 280 (336)
Q Consensus 211 a~~~~~--~~~~~~~gt~~y~aPE~~~-----~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~-~-~~ 280 (336)
+..... .......|+..|+|||... ....+...|+|+|+..+|++..+..|..... ...+..+.... . ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 247 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 247 (282)
T ss_pred hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCc
Confidence 875322 1223345889999999765 3456677999999999999998887753321 11111111111 0 11
Q ss_pred CCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 281 DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 281 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
....|+++.+++...+..+|+.|++..++.+..
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~ 280 (282)
T cd06636 248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHP 280 (282)
T ss_pred ccccCHHHHHHHHHHhCCChhhCcCHHHHhcCC
Confidence 123567788999999999999999988887643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=238.49 Aligned_cols=195 Identities=24% Similarity=0.254 Sum_probs=162.9
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|++.+.||+|+||.||+|.+. ++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.. .++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE---DDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecc---cCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 36888899999999999999985 7889999986321 11223456789999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||+++++|..++. ....+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 78 VFEYCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG-QIKLCDFGFARILTGPG 154 (286)
T ss_pred EEeccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC-cEEECccccceecCCCc
Confidence 999999988888773 335689999999999999999999999999999999999999887 79999999987543322
Q ss_pred --ccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 219 --MTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.....++..|+|||...+ ...+...|+|+++..+|++..+..|.
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~ 201 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW 201 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence 223457889999998765 44678899999999999999888774
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=236.76 Aligned_cols=239 Identities=23% Similarity=0.220 Sum_probs=189.7
Q ss_pred ecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccCCC
Q 019780 70 IGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRGE 146 (336)
Q Consensus 70 lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~gg 146 (336)
||.|+||.||+|.+. ++.+++|++... ........+.+.+|+.+++.++||||+++++.+.++. .++++||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKR--HIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehh--cchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 699999999999987 789999999742 2223345578999999999999999999999987665 89999999999
Q ss_pred CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-ccccCCc
Q 019780 147 TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGT 225 (336)
Q Consensus 147 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~gt 225 (336)
+|.+++.. ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++....... .....|+
T Consensus 79 ~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 79 ELWTILRD--RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred cHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCcccccccccCC
Confidence 99999944 34589999999999999999999999999999999999999887 79999999988654332 2234588
Q ss_pred ccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH---HHHHHHHHH--hhccCCCCCCCCcccccCCCCCCCC
Q 019780 226 YRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI---TITLTNILQ--NLRSADTPIPPKLVEIVDPKSTMNN 300 (336)
Q Consensus 226 ~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i---~~~l~~~~~--~~~~~~~~~p~~~~~~~~~~~~~~~ 300 (336)
..|+|||.......+...|+|+++..++++-.+..|....- ...+..+.. .........++++.+++...+..+|
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 235 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 99999998877778889999999999999888888763322 222222221 1122223346678889999999999
Q ss_pred ccccc-----hhhhcccc
Q 019780 301 DCMAT-----VHAITKFN 313 (336)
Q Consensus 301 ~~~~~-----~~~~~~~~ 313 (336)
+.|.+ +.++.+..
T Consensus 236 ~~R~~~~~~~~~~l~~~~ 253 (262)
T cd05572 236 EERLGNLKGGIKDIKKHK 253 (262)
T ss_pred hhCcCCcccCHHHHhcCh
Confidence 99988 66666533
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=242.78 Aligned_cols=247 Identities=22% Similarity=0.376 Sum_probs=189.8
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--Cc----cEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CE----PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
+...+|...+.||+|+||.||+|.+. +. .+|+|.+.. .........+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~ 79 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE----TTGPKANVEFMDEALIMASMDHPHLVRLLGVCL 79 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 34567888899999999999999874 33 468888763 122334456889999999999999999999998
Q ss_pred cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 133 QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 133 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
....+++++|+++|+|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++
T Consensus 80 ~~~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-~~kL~Dfg~~~ 157 (303)
T cd05110 80 SPTIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-HVKITDFGLAR 157 (303)
T ss_pred CCCceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-ceEEccccccc
Confidence 87788999999999999998543 34688999999999999999999999999999999999998776 79999999997
Q ss_pred ccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHhhcc--CCCCCC
Q 019780 213 EEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQNLRS--ADTPIP 285 (336)
Q Consensus 213 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~~~~--~~~~~p 285 (336)
....... ....++..|+|||.......+...|+|+|+..+|+.-. +..|....-...+..+.+.... ..+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICT 237 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Confidence 5432221 12235678999999888888999999999999998764 6666532222223333322111 112234
Q ss_pred CCcccccCCCCCCCCccccchhhhcc
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
..+..++...+..+|+.|++..++.+
T Consensus 238 ~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 238 IDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 55677788888889999998888664
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=234.94 Aligned_cols=241 Identities=22% Similarity=0.291 Sum_probs=183.6
Q ss_pred EeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEc
Q 019780 66 LQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITEL 142 (336)
Q Consensus 66 ~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~ 142 (336)
....||+|+||.||+|.+. +..|++|.+... .....+.+.+|+.+++.++|+||+++++++.++. .++|+||
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCC-----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 3457999999999999875 567999987631 2344567899999999999999999999988765 8999999
Q ss_pred cCCCCHHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc--
Q 019780 143 MRGETLQRYLWSTRPKRL--DLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-- 218 (336)
Q Consensus 143 ~~gg~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~-- 218 (336)
+++++|.+++.... ..+ ++..+..++.|++.||+|||++||+||||||+||+++.+.+.++|+|||++.......
T Consensus 87 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 87 VPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred CCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 99999999996432 334 7888999999999999999999999999999999998755589999999987532221
Q ss_pred ccccCCcccccCCCCCCCCC--CCCHHHHHHHHHHhhccCCCCCCCHhHH--HHHHHH--HHHhhccCCCCCCCCccccc
Q 019780 219 MTCEAGTYRWMAPENERPSL--ENLSEDMVALLKSCWAEDPKVRPEFAEI--TITLTN--ILQNLRSADTPIPPKLVEIV 292 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~~--~~~~~di~~l~~~~l~~~p~~RP~~~~i--~~~l~~--~~~~~~~~~~~~p~~~~~~~ 292 (336)
.....|+..|+|||...... .+...|+|+++..+|++..+.+|....- ...... ...........+++++..++
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHH
Confidence 22335889999999875433 6678999999999999998888853210 000100 01111112234555677788
Q ss_pred CCCCCCCCccccchhhhccc
Q 019780 293 DPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~ 312 (336)
...+..+|+.|++..++...
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHcCCCchhCCCHHHHHhC
Confidence 88888888888888777643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=231.40 Aligned_cols=192 Identities=27% Similarity=0.336 Sum_probs=162.0
Q ss_pred CceeEe-eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecC---
Q 019780 62 RSVLLQ-KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQP--- 134 (336)
Q Consensus 62 ~~~~~~-~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--- 134 (336)
++|.+. ++||-|-.|.|-.+.++ ++.+|+|++.. .....+|+++--.. .|||||.+++++...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----------SPKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 344443 67999999999998886 78999999862 23456788875555 499999999998743
Q ss_pred -C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC--CceEEecccc
Q 019780 135 -T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK--KQVKLADFGL 210 (336)
Q Consensus 135 -~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~--~~~kl~Dfg~ 210 (336)
. +.+|||.|+||.|+..+..+....+++.++..|+.||+.|+.|||+.+|.||||||+|+|+...+ ..+||+|||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 1 78899999999999999888888899999999999999999999999999999999999996432 3699999999
Q ss_pred ccccc-cccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCH
Q 019780 211 AREEV-MDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEF 263 (336)
Q Consensus 211 a~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~ 263 (336)
|+... .....+.+-|+.|.|||++.+..++.+-|+|+|+..|+-+..+-.|+.
T Consensus 211 AK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 211 AKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred ccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence 99765 345677789999999999999999999999999998887766665543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-33 Score=245.79 Aligned_cols=238 Identities=19% Similarity=0.233 Sum_probs=191.4
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQP 134 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 134 (336)
.+...+|.++.+||+|+||.|.+|..+ .+.+|||++++ .........+--..|-++|.... -|.++++..+|+.-
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkK--DViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKK--DVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhcc--ceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 566678889999999999999999876 56899999984 34445555666677888887765 67888899888876
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+ +|+||||+.||+|...+ +.-+++.+..+..++.+|+.||=+||++|||+||||.+|||++.+| ++||+|||+++.
T Consensus 423 DRLyFVMEyvnGGDLMyhi--QQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG-HiKi~DFGmcKE 499 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHI--QQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKE 499 (683)
T ss_pred hheeeEEEEecCchhhhHH--HHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC-ceEeeecccccc
Confidence 5 99999999999999999 4447788999999999999999999999999999999999999988 899999999997
Q ss_pred ccccc--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCccc
Q 019780 214 EVMDE--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVE 290 (336)
Q Consensus 214 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~ 290 (336)
..... ..+.+||+.|+|||.+..+|++.+.|+|+++..++++..++.|.-.+ --..+..+...-.+....++.+...
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ 579 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVA 579 (683)
T ss_pred cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHH
Confidence 55443 45678999999999999999999999999999999999999997432 2222333333333344455556555
Q ss_pred ccCCCCCCCC
Q 019780 291 IVDPKSTMNN 300 (336)
Q Consensus 291 ~~~~~~~~~~ 300 (336)
+..-.++..|
T Consensus 580 ickg~ltK~P 589 (683)
T KOG0696|consen 580 ICKGLLTKHP 589 (683)
T ss_pred HHHHHhhcCC
Confidence 5544444444
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=242.73 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=195.7
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||+|... ++.||+|.+... .....+.+.+|+.+++.++||||+++++.+..+. .++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ-----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC-----ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 67899999999999999999874 789999998632 1223466889999999999999999999988665 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQ 169 (297)
T ss_pred eecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEECcCccceEccCCc
Confidence 9999999999999843 3578999999999999999999999999999999999999876 79999999987533222
Q ss_pred --ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh-hc--cCCCCCCCCccccc
Q 019780 219 --MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN-LR--SADTPIPPKLVEIV 292 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~-~~--~~~~~~p~~~~~~~ 292 (336)
.....+++.|+|||.......+...|+|+++..++.+-.+..|.... ....+...... .. .....+++.+.+++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHH
Confidence 22345889999999988888888999999999999988887775332 11111111110 00 01123445567788
Q ss_pred CCCCCCCCccccchhhhcccccccccc
Q 019780 293 DPKSTMNNDCMATVHAITKFNEKGKKR 319 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (336)
...+..+|+.|++..++.+.....+.+
T Consensus 250 ~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 250 NRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHccCChhhCcCHHHHhcCchhcccc
Confidence 889999999999999988866554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-33 Score=251.59 Aligned_cols=192 Identities=29% Similarity=0.406 Sum_probs=165.1
Q ss_pred eeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEcc
Q 019780 67 QKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
.+.||+|.||+||-|.++ |+.||||++.+-+- ..+..+.+.+|+.||.++.||.||.+.--|+..+ ++.|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrF---p~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRF---PTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccC---CCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence 378999999999999886 89999999985322 3344588999999999999999999998888765 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC--CceEEecccccccccccc-cc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK--KQVKLADFGLAREEVMDE-MT 220 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~--~~~kl~Dfg~a~~~~~~~-~~ 220 (336)
.| +..+.+-+...+++++.....++.||+.||.|||-++|+|+||||+|||+.... ..+||||||+|+...... ..
T Consensus 646 ~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr 724 (888)
T KOG4236|consen 646 HG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR 724 (888)
T ss_pred cc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence 65 777777677778999999999999999999999999999999999999996532 379999999999765544 44
Q ss_pred ccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 221 CEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 221 ~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
+.+||+.|+|||.++...++.+-|+|+++..++.-..+.=|.
T Consensus 725 sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPF 766 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPF 766 (888)
T ss_pred hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccC
Confidence 567999999999999999999999999999888777777775
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=235.52 Aligned_cols=238 Identities=25% Similarity=0.372 Sum_probs=179.8
Q ss_pred eeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec-C-CEEEEE
Q 019780 68 KMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ-P-TMMIIT 140 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~-~~~lv~ 140 (336)
+.||+|+||.||+|.+. ...+|+|.+.. .........+.+|+.+++.++||||+++++++.. + ..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR----ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCc----cCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 36899999999999863 34689998752 1234456778899999999999999999997653 3 389999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc--
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-- 218 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~-- 218 (336)
||+.+|+|.+++... ....++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||+++......
T Consensus 77 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 77 PYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYY 154 (262)
T ss_pred ecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCccccccccCCcce
Confidence 999999999999543 24567788889999999999999999999999999999999876 79999999987532211
Q ss_pred ----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH--HHHHHHHHHHhh-ccCCCCCCCCcccc
Q 019780 219 ----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE--ITITLTNILQNL-RSADTPIPPKLVEI 291 (336)
Q Consensus 219 ----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~--i~~~l~~~~~~~-~~~~~~~p~~~~~~ 291 (336)
.....++..|+|||.......+...|+|+|++.+|++-.+..|.+.. .......+.... .......|+.+.++
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV 234 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 11223567899999988888889999999999999987654443221 111111111111 11122346667788
Q ss_pred cCCCCCCCCccccchhhhcc
Q 019780 292 VDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~ 311 (336)
+...+..+|+.|++..++.+
T Consensus 235 i~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHcCCChhhCCCHHHHHH
Confidence 88899999999988887764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=236.90 Aligned_cols=239 Identities=24% Similarity=0.328 Sum_probs=180.7
Q ss_pred eeecCCCcEEEEEeEEC--Cc--cEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-EEEEEE
Q 019780 68 KMIGEGSYSIVYKGFYG--CE--PVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-MMIITE 141 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~~lv~e 141 (336)
+.||+|+||.||+|... +. .+++|.++. .........+.+|+.++.++ +||||+++++++.... .++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccc----cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 35899999999999875 22 467887752 12334556788999999999 7999999999988765 899999
Q ss_pred ccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEec
Q 019780 142 LMRGETLQRYLWSTR--------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLAD 207 (336)
Q Consensus 142 ~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~D 207 (336)
|+++|+|.+++.... ...+++..++.++.|++.||+|||++|++||||||+||+++.++ .++|+|
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-~~kl~d 155 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIAD 155 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-eEEECC
Confidence 999999999995432 13478999999999999999999999999999999999999876 899999
Q ss_pred ccccccccccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHH-HHHHHHHHhh-ccCCCC
Q 019780 208 FGLAREEVMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEIT-ITLTNILQNL-RSADTP 283 (336)
Q Consensus 208 fg~a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~-~~l~~~~~~~-~~~~~~ 283 (336)
||++....... ......+..|+|||.......+...|+|+|+..++++.. +..|....-. ..+..+.... ......
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 235 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 235 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCc
Confidence 99986322111 111224567999999888888899999999999999875 6677532211 1122222111 112234
Q ss_pred CCCCcccccCCCCCCCCccccchhhhcc
Q 019780 284 IPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.++++.+++...+..+|..|++..++..
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 5566778888888888888888777653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=238.15 Aligned_cols=239 Identities=21% Similarity=0.262 Sum_probs=185.8
Q ss_pred ecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccCCC
Q 019780 70 IGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRGE 146 (336)
Q Consensus 70 lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~gg 146 (336)
||+|+||+||+|... ++.+|+|++.... .........+.+|+.+++.++||||+++++.+...+ .|+||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKR--LKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhh--hhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 699999999999875 7889999987321 112233556778999999999999999999888655 89999999999
Q ss_pred CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-cccccCCc
Q 019780 147 TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-EMTCEAGT 225 (336)
Q Consensus 147 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~gt 225 (336)
+|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++...... ......++
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCccccccCC
Confidence 999999665545789999999999999999999999999999999999999877 7999999998753322 22334578
Q ss_pred ccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH----HHHHHH-HHHhhccCCCCCCCCcccccCCCCCCCC
Q 019780 226 YRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI----TITLTN-ILQNLRSADTPIPPKLVEIVDPKSTMNN 300 (336)
Q Consensus 226 ~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i----~~~l~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 300 (336)
..|+|||.......+...|+|+++..++++..++.|....- ...+.. ............++.+.+++...+..+|
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCCh
Confidence 89999999887778889999999999999988888752210 111111 1111112223456778888888898899
Q ss_pred cccc-----chhhhcc
Q 019780 301 DCMA-----TVHAITK 311 (336)
Q Consensus 301 ~~~~-----~~~~~~~ 311 (336)
+.|. +..++..
T Consensus 238 ~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 238 EKRLGCRGGSADEVRE 253 (277)
T ss_pred hHccCCCcccHHHHHh
Confidence 8888 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=235.48 Aligned_cols=242 Identities=31% Similarity=0.466 Sum_probs=188.3
Q ss_pred eEeeeecCCCcEEEEEeEECC------ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 65 LLQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 65 ~~~~~lg~G~fg~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
++.+.||.|+||.||++.+.. ..+|+|+++.. ........+..|+.++..++|+||+++++++.+.. .+
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED----ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC----CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 466889999999999999864 77999998742 22235678999999999999999999999988755 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
++|||+++++|.+++.......+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-eEEEcccCCceecccc
Confidence 999999999999999654433389999999999999999999999999999999999999876 8999999998754433
Q ss_pred cccc---cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHh-HHHHHHHHHHHh-hccCCCCCCCCcccc
Q 019780 218 EMTC---EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFA-EITITLTNILQN-LRSADTPIPPKLVEI 291 (336)
Q Consensus 218 ~~~~---~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~-~i~~~l~~~~~~-~~~~~~~~p~~~~~~ 291 (336)
.... ..++..|+|||.......+...|+|+|+..++++-. +..|... .....+..+... ........|.++.++
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 2111 236789999998887888899999999999887765 3334211 111122222221 112223456778888
Q ss_pred cCCCCCCCCccccchhhhcc
Q 019780 292 VDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~ 311 (336)
+...+..+|+.|++..++.+
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 88999999999998877654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=236.44 Aligned_cols=247 Identities=22% Similarity=0.338 Sum_probs=189.4
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccc-----cHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAV-----SREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
+|.+.+.||+|+||.||+|... ++.+|+|.++....... .....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999864 78899998863211111 1223457889999999999999999999887665
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.++||||+++++|.++++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~-~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG-ICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC-eEEEeeccccccc
Confidence 89999999999999999543 5789999999999999999999999999999999999999876 8999999998753
Q ss_pred ccc----cccccCCcccccCCCCCCCCC--CCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhc------cCC
Q 019780 215 VMD----EMTCEAGTYRWMAPENERPSL--ENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLR------SAD 281 (336)
Q Consensus 215 ~~~----~~~~~~gt~~y~aPE~~~~~~--~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~------~~~ 281 (336)
... ......|+..|+|||...... .+...|+|+|+..+|+...+..|... +....+..+..... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 221 122235889999999876544 67789999999999999999888632 22222222111110 011
Q ss_pred CCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 282 TPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 282 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
..++.++.+++...+..+|+.|++..++.+.
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 2345667778888888889888888777654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=233.63 Aligned_cols=243 Identities=23% Similarity=0.321 Sum_probs=189.6
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||+|... +..+++|.++... ........+.+|+.+++.++|+||+++++.+.+.. .++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD---NDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcc---cchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence 4778899999999999999874 7889999987432 22456788999999999999999999999887665 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccccc
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM 219 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~ 219 (336)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 78 MEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEcccccccccCCCCC
Confidence 999999999999944 34588999999999999999999999999999999999999876 799999999875432211
Q ss_pred ------cccCCcccccCCCCCCCCC---CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCCC------CC
Q 019780 220 ------TCEAGTYRWMAPENERPSL---ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADT------PI 284 (336)
Q Consensus 220 ------~~~~gt~~y~aPE~~~~~~---~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~------~~ 284 (336)
....++..|+|||...... .+...|+|+++..+|+...+..|... ................+ .+
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE-LDNEFQIMFHVGAGHKPPIPDSLQL 233 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC-CcchHHHHHHHhcCCCCCCCccccc
Confidence 1235788999999877655 77889999999999999988888421 11111111111111111 22
Q ss_pred CCCcccccCCCCCCCCccccchhhhccc
Q 019780 285 PPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
++.+.+++...+..+|+.|++..++...
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 234 SPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 5556778888888888888888776653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=233.95 Aligned_cols=244 Identities=22% Similarity=0.355 Sum_probs=187.7
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
+..+|++.+.||+|+||.||+|.+. +..+|+|.+..... ....+.+|+.+++.++||||+++++++.... .+
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC 75 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceE
Confidence 3467888999999999999999876 77899998863211 1346889999999999999999999987654 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDD 153 (256)
T ss_pred EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC-eEEECCCcceeecccC
Confidence 9999999999999985433 4688999999999999999999999999999999999999776 8999999998754332
Q ss_pred ccc---ccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHH-HHHHHHHHHhhccC-CCCCCCCcccc
Q 019780 218 EMT---CEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEI-TITLTNILQNLRSA-DTPIPPKLVEI 291 (336)
Q Consensus 218 ~~~---~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i-~~~l~~~~~~~~~~-~~~~p~~~~~~ 291 (336)
... ...++..|+|||.......+...|+|+++..+|++.. +..|....- ...+..+....... ....+..+.++
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYEL 233 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 221 2234578999998887788889999999999998765 555643221 12222222211111 12245667778
Q ss_pred cCCCCCCCCccccchhhhcc
Q 019780 292 VDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~ 311 (336)
+...+..+|+.|++..++.+
T Consensus 234 ~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 234 MQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred HHHHcccChhhCCCHHHHHH
Confidence 88888888888888776653
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=237.73 Aligned_cols=188 Identities=27% Similarity=0.425 Sum_probs=149.3
Q ss_pred eecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEcc
Q 019780 69 MIGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 69 ~lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
.||+|+||.||+|... ...+++|.+.. .........+.+|+.+++.++||||+++++.+.+.. .++||||+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRA----SATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCc----cCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence 5899999999999753 34577777652 223444567889999999999999999999888665 99999999
Q ss_pred CCCCHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc--
Q 019780 144 RGETLQRYLWSTRP---KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-- 218 (336)
Q Consensus 144 ~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~-- 218 (336)
++|+|.+++..... ...++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-cEEEeccccccccccchhe
Confidence 99999999965432 2346778899999999999999999999999999999999887 79999999987532221
Q ss_pred --ccccCCcccccCCCCCC-------CCCCCCHHHHHHHHHHhhccCC-CCCC
Q 019780 219 --MTCEAGTYRWMAPENER-------PSLENLSEDMVALLKSCWAEDP-KVRP 261 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~~-------~~~~~~~~di~~l~~~~l~~~p-~~RP 261 (336)
.....++..|+|||... ....+...|+|++++.+|++.. +..|
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 209 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCC
Confidence 12234567899999643 3455678999999999998776 3444
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=251.24 Aligned_cols=198 Identities=29% Similarity=0.395 Sum_probs=161.9
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
-|.-++-||.|+||.||-|++. .+.||||.+.. ......+....+..|++.|.+++|||++.+-++|..+. .|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsy--SGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccc--cccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 3455678999999999999985 78899999874 22234556778999999999999999999999988665 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccccc
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM 219 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~ 219 (336)
||||-| +-.|++.-.+ +++-+-++..|..+.+.||+|||+.+.||||||+.|||+++.| .|||+|||.|....+ .
T Consensus 105 MEYClG-SAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~~P--A 179 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG-LVKLADFGSASIMAP--A 179 (948)
T ss_pred HHHHhc-cHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC-eeeeccccchhhcCc--h
Confidence 999965 8888874433 6788999999999999999999999999999999999999887 899999999975443 3
Q ss_pred cccCCcccccCCCCCCCC-------------------------------------------------CCCCHHHHHHHHH
Q 019780 220 TCEAGTYRWMAPENERPS-------------------------------------------------LENLSEDMVALLK 250 (336)
Q Consensus 220 ~~~~gt~~y~aPE~~~~~-------------------------------------------------~~~~~~di~~l~~ 250 (336)
.+++|||.|||||++... ...++..+.+++.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence 457799999999932100 1235566777888
Q ss_pred HhhccCCCCCCCHhHHH
Q 019780 251 SCWAEDPKVRPEFAEIT 267 (336)
Q Consensus 251 ~~l~~~p~~RP~~~~i~ 267 (336)
.|++.-|.+||+..+++
T Consensus 260 ~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELL 276 (948)
T ss_pred HHHhhCcccCCcHHHHh
Confidence 89999999998877654
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=242.40 Aligned_cols=244 Identities=27% Similarity=0.358 Sum_probs=193.2
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
.|...+.||+|+||.||+|.+. +..||+|.+... ........+.+|+.+++.++||||+++++.+.++. .++|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccc----cchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 4666788999999999999875 678999998631 22345678999999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 81 MEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-CEEEccccccccccCcch
Confidence 999999999999842 4688999999999999999999999999999999999999876 79999999987543322
Q ss_pred -ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH-h-hccCCCCCCCCcccccCCC
Q 019780 219 -MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ-N-LRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 219 -~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~-~-~~~~~~~~p~~~~~~~~~~ 295 (336)
.....|+..|+|||.......+...|+|+++..+|++..+..|.............. . ........+.++.+++...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEAC 236 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHH
Confidence 122358899999999888888889999999999999998888853221111111111 1 1112233556677888999
Q ss_pred CCCCCccccchhhhccccc
Q 019780 296 STMNNDCMATVHAITKFNE 314 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~ 314 (336)
+..+|+.|++..++.+...
T Consensus 237 l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 237 LNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred ccCCcccCcCHHHHHHhHH
Confidence 9999999999888887543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=236.80 Aligned_cols=194 Identities=28% Similarity=0.370 Sum_probs=160.7
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|++|.||+|... ++.||||.+..... ......+.+|+.+++.++||||+++++++.++. .++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE----EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc----cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 67889999999999999999875 78899999874221 112234678999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||+++ +|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++.....
T Consensus 81 v~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPS 157 (291)
T ss_pred EEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-CEEECccccccccCCCC
Confidence 9999985 9999885443 4689999999999999999999999999999999999999887 7999999998753221
Q ss_pred -cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 218 -EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
......++..|+|||...+ ...+...|+|+++..+|++..+..|.
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~ 204 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence 1222346789999998764 45678899999999999988887775
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=238.09 Aligned_cols=246 Identities=25% Similarity=0.394 Sum_probs=192.2
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec-
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ- 133 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~- 133 (336)
.++|.+.+.||+|+||.||+|.+. +..+|||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG----EEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEecccc----chHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 457788899999999999999864 5689999987421 11456789999999999999999999998876
Q ss_pred -C-CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 134 -P-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 134 -~-~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
. ..+++|||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~ 156 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED-LVKISDFGLA 156 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccccc
Confidence 3 3899999999999999995433 3689999999999999999999999999999999999999886 8999999999
Q ss_pred cccccccc-----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH---------------HHH
Q 019780 212 REEVMDEM-----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITI---------------TLT 271 (336)
Q Consensus 212 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~---------------~l~ 271 (336)
........ ....++..|+|||.......+...|+|+|++.++++..+..|....... .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 86442211 1123456799999888888888999999999999998888775432211 112
Q ss_pred HHHHhhc--cCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 272 NILQNLR--SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 272 ~~~~~~~--~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
....... ......|+++.+++...+..+|+.|++..++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2222111 1123345667788888999999999988877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-34 Score=277.63 Aligned_cols=241 Identities=22% Similarity=0.310 Sum_probs=190.7
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+++-+..||.|.||.||.|.+. |...|+|.++.+.. ..+....+.+|..++..++|||+|+++|+-.+.+ .+|.
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~---~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS---DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc---ccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 3445577999999999999875 88899999875332 2555677899999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-- 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-- 217 (336)
||||.||+|.+.+ ..+...++.....+..|++.|++|||+.|||||||||+||+++.+| .+|+.|||.|......
T Consensus 1313 MEyC~~GsLa~ll--~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLL--EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHhccCcHHHHH--HhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cEEeecccceeEecCchh
Confidence 9999999999999 3345577888888999999999999999999999999999999887 8999999999854332
Q ss_pred ----cccccCCcccccCCCCCCCCC---CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH----hhccCCCCCCC
Q 019780 218 ----EMTCEAGTYRWMAPENERPSL---ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ----NLRSADTPIPP 286 (336)
Q Consensus 218 ----~~~~~~gt~~y~aPE~~~~~~---~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~----~~~~~~~~~p~ 286 (336)
+.....||+.|||||.+.+.. ..-..|+|+|+|..+++-+++|| +.++-..+.-+.. ...+++..+++
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrP-W~~~dne~aIMy~V~~gh~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRP-WAELDNEWAIMYHVAAGHKPQIPERLSS 1468 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCc-hhhccchhHHHhHHhccCCCCCchhhhH
Confidence 233456999999999877654 45779999999999999999999 4554444443333 23334444566
Q ss_pred CcccccCCCCCCCCccccchhhhc
Q 019780 287 KLVEIVDPKSTMNNDCMATVHAIT 310 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~ 310 (336)
+-.+.+++.+.-+|..|=++.++.
T Consensus 1469 ~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred hHHHHHHHHHhcCchhhhHHHHHH
Confidence 666677777777777764444443
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=235.29 Aligned_cols=243 Identities=27% Similarity=0.366 Sum_probs=193.0
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
-|.+.+.||+|+||.||+|.+. +..+|+|++.. .........+.+|+.+++.++||||+++++.+.++. .++|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecc----ccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 4667788999999999999875 67899998763 122344567899999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC-CEEEeecccceecccchh
Confidence 999999999999843 4588999999999999999999999999999999999999876 79999999987543221
Q ss_pred -ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH--hhccCCCCCCCCcccccCCC
Q 019780 219 -MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ--NLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 219 -~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~--~~~~~~~~~p~~~~~~~~~~ 295 (336)
.....++..|+|||.......+...|+|++++.+|++..+.-|....-......... ........+|+++.+++...
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 236 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 223458889999998887777888999999999999998888853221111111111 11122334567788888889
Q ss_pred CCCCCccccchhhhcccc
Q 019780 296 STMNNDCMATVHAITKFN 313 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~ 313 (336)
+..+|+.|++..++.+..
T Consensus 237 l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 237 LNKEPSFRPTAKELLKHK 254 (277)
T ss_pred ccCChhhCcCHHHHHhCH
Confidence 999999999988888743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=231.71 Aligned_cols=244 Identities=26% Similarity=0.371 Sum_probs=193.4
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|++|.||+|.+. ++.+++|.+.... ........+.+|+++++.++|||++++++++.+.. .+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK---IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc---cCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence 4778899999999999999875 6789999997422 22355678999999999999999999999887665 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccccc
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM 219 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~ 219 (336)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 78 LEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSK 154 (254)
T ss_pred EecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-CEEEeccccceecCCCcc
Confidence 9999999999999543 6789999999999999999999999999999999999999876 899999999986443332
Q ss_pred --cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCH--hHHHHHHHHHHHhhccCCCCCCCCcccccCCC
Q 019780 220 --TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEF--AEITITLTNILQNLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 220 --~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~--~~i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~ 295 (336)
....++..|+|||.......+...|+|+++..++++-.+..|.. ....................+++.+.+++...
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 234 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC 234 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 33458899999998877778889999999999998887776642 11111111111222223345666777788888
Q ss_pred CCCCCccccchhhhccc
Q 019780 296 STMNNDCMATVHAITKF 312 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~~ 312 (336)
+..+|+.|++..++...
T Consensus 235 l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 235 FQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HhCChhhCcCHHHHhcC
Confidence 88888888888777653
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=239.31 Aligned_cols=252 Identities=26% Similarity=0.273 Sum_probs=186.4
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||+|.+. ++.||||.+...............+..|+.+++.++|+||+++++++.+.+ .++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3778899999999999999975 789999999753322122334566788999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-- 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-- 217 (336)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC-CEEEccceeeeeccCCCc
Confidence 9999 889999995433 4799999999999999999999999999999999999999876 7999999998754332
Q ss_pred cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccC---------------
Q 019780 218 EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSA--------------- 280 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~--------------- 280 (336)
......++..|+|||.... ...+...|+|++++.++++-.+..|... +-...+..+.......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 2233357788999997643 4567889999999999998877443311 1111122221111000
Q ss_pred -------------CCCCCCCcccccCCCCCCCCccccchhhhcccccccc
Q 019780 281 -------------DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 281 -------------~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
....+.++.+++...+..+|+.|.+..++.......+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 0112334455667777777777877777776554433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=237.46 Aligned_cols=245 Identities=24% Similarity=0.306 Sum_probs=187.6
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||.|+||.||+|.+. ++.||||.+.... ........+.+|+.+++.++||||+++++++.++. .++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc---cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 4778899999999999999885 7889999886321 12223457889999999999999999999988665 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-- 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-- 217 (336)
|||+. ++|..++.......+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR 155 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEeeccchhhcccCcc
Confidence 99996 5899998665567789999999999999999999999999999999999999887 7999999998753322
Q ss_pred cccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhc-----------------
Q 019780 218 EMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLR----------------- 278 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~----------------- 278 (336)
......++..|+|||...+. ..+...|+|+|+..++++-.++.|... +-...+..+.....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 22333578899999976553 347789999999999998888776421 11111111111100
Q ss_pred ------------cCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 279 ------------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 279 ------------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
...+.+++++.+++...+..+|+.|++..++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0112345566678888888899999888877654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=232.91 Aligned_cols=244 Identities=23% Similarity=0.295 Sum_probs=197.0
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|++|.||+|.+. +..+++|++.... .......+.+|+..+..++|+||+++++++.... .++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG----DEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc----chHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence 5788899999999999999986 7889999987421 1245678999999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|||+++++|.+++... ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 78 LEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTL 154 (264)
T ss_pred EEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecccCC
Confidence 9999999999999543 678999999999999999999999 9999999999999999876 79999999987543332
Q ss_pred cc--ccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh----HHHHHHHHHHHhh-ccCCCC-CCCCccc
Q 019780 219 MT--CEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA----EITITLTNILQNL-RSADTP-IPPKLVE 290 (336)
Q Consensus 219 ~~--~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~----~i~~~l~~~~~~~-~~~~~~-~p~~~~~ 290 (336)
.. ...++..|+|||.......+...|+|+|+..+|++-.+..|... ...+.+..+.... ...... .|+.+.+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 22 34578999999998888888999999999999998888777422 1222223332221 112223 5667888
Q ss_pred ccCCCCCCCCccccchhhhcccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
++...+..+++.|++..++....
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~~ 257 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQHP 257 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhCH
Confidence 89999999999999988887654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=236.25 Aligned_cols=242 Identities=21% Similarity=0.210 Sum_probs=180.1
Q ss_pred eecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHH---HHHHHhCCCCceEeeEeeEecCC-EEEEEEc
Q 019780 69 MIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQRE---VTLLSKMKHENILKFVGASVQPT-MMIITEL 142 (336)
Q Consensus 69 ~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~ 142 (336)
.||+|+||.||+|.+. ++.||+|++...... .......+..| +..++...||+|+.+++.+.+.+ .++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccc--cchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence 4899999999999875 678999998742211 11112223333 33455568999999999888765 8999999
Q ss_pred cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccccccc
Q 019780 143 MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE 222 (336)
Q Consensus 143 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~ 222 (336)
+.|++|.+++. ....+++..++.++.|++.||.|||+.+++||||||+||+++.++ .++|+|||++...........
T Consensus 79 ~~g~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~~~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKKKPHAS 155 (278)
T ss_pred CCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCccCCcCc
Confidence 99999999884 345799999999999999999999999999999999999999876 799999999875443334445
Q ss_pred CCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHhH---HHHHHHHHHH-hhccCCCCCCCCcccccCCCCC
Q 019780 223 AGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFAE---ITITLTNILQ-NLRSADTPIPPKLVEIVDPKST 297 (336)
Q Consensus 223 ~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~~---i~~~l~~~~~-~~~~~~~~~p~~~~~~~~~~~~ 297 (336)
.|+..|+|||.... ...+...|+|+++..++++..+..|.... -...+..... .........++++.+++...+.
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~ 235 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhh
Confidence 69999999998764 35678899999999999998888885322 1111111111 1112223356677788888888
Q ss_pred CCCcccc-----chhhhcccccc
Q 019780 298 MNNDCMA-----TVHAITKFNEK 315 (336)
Q Consensus 298 ~~~~~~~-----~~~~~~~~~~~ 315 (336)
.+++.+. +..++.+..+.
T Consensus 236 ~~p~~R~~~~~~~~~~ll~~~~~ 258 (278)
T cd05606 236 RDVNRRLGCLGRGAQEVKEHPFF 258 (278)
T ss_pred cCHHhccCCCCCCHHHHHhCccc
Confidence 8888887 66677654433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=238.44 Aligned_cols=245 Identities=24% Similarity=0.336 Sum_probs=195.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-EE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT-MM 137 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~ 137 (336)
++|.+.+.||+|+||.||+|... +..+++|++... ..........+.+|+.+++.++ ||||+++++++.++. .+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechH--hccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence 36889999999999999999985 789999998742 1223344577889999999999 999999999887665 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+|||++.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~ 155 (280)
T cd05581 79 FVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEecCCccccccCCc
Confidence 999999999999999543 4799999999999999999999999999999999999999877 7999999998743221
Q ss_pred c----------------------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCH-hHHHHHHHHHH
Q 019780 218 E----------------------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEF-AEITITLTNIL 274 (336)
Q Consensus 218 ~----------------------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~-~~i~~~l~~~~ 274 (336)
. .....++..|+|||.......+...|+|+|+..+++.-.+..|.- ..-...+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 1 122347889999998887778889999999999998877766631 11222233333
Q ss_pred HhhccCCCCCCCCcccccCCCCCCCCccccch----hhhcc
Q 019780 275 QNLRSADTPIPPKLVEIVDPKSTMNNDCMATV----HAITK 311 (336)
Q Consensus 275 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 311 (336)
.........+|+.+.+++..++..+|+.|++. .++.+
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 33333445567778889999999999999888 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=232.06 Aligned_cols=238 Identities=27% Similarity=0.402 Sum_probs=185.4
Q ss_pred eeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccCC
Q 019780 68 KMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRG 145 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~g 145 (336)
+.||+|+||.||+|.+. ++.|++|.+... ........+.+|+++++.++||||+++++++.+.. .++||||++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRST----LPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 46999999999999876 789999988732 12245678999999999999999999999988665 8999999999
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccccc----c
Q 019780 146 ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMT----C 221 (336)
Q Consensus 146 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~----~ 221 (336)
++|.+++... ...+++..+..++.+++.||+|||++|++||||+|+||+++.++ .++|+|||++......... .
T Consensus 77 ~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 77 GSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcceecccc
Confidence 9999999543 34688999999999999999999999999999999999999876 8999999998754321111 1
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHhh--ccCCCCCCCCcccccCCCCCC
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQNL--RSADTPIPPKLVEIVDPKSTM 298 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~~--~~~~~~~p~~~~~~~~~~~~~ 298 (336)
..++..|+|||.......+...|+|+|+..++++.. +..|....-........... .......|.++.+++...+..
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 234 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAY 234 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhcc
Confidence 223567999998888888899999999999998775 66664322222222222211 112234567788888888988
Q ss_pred CCccccchhhhcc
Q 019780 299 NNDCMATVHAITK 311 (336)
Q Consensus 299 ~~~~~~~~~~~~~ 311 (336)
+|+.|++..++.+
T Consensus 235 ~p~~Rp~~~ell~ 247 (251)
T cd05041 235 DPENRPSFSEIYN 247 (251)
T ss_pred ChhhCcCHHHHHH
Confidence 9999988877654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=236.77 Aligned_cols=245 Identities=24% Similarity=0.313 Sum_probs=186.3
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEec---
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQ--- 133 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--- 133 (336)
...+|.+.+.||+|+||.||+|... ++.+|+|++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~------~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI------HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc------cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 4578899999999999999999885 788999987631 11235677899999999 69999999998742
Q ss_pred ---CCEEEEEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecc
Q 019780 134 ---PTMMIITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADF 208 (336)
Q Consensus 134 ---~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Df 208 (336)
+..++||||++|++|.+++.. .....+++..++.++.|++.||.|||+.+++||||||+||+++.++ .++|+||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~kl~df 168 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVDF 168 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-CEEEccC
Confidence 238999999999999998753 2335688999999999999999999999999999999999999887 6999999
Q ss_pred cccccccccc--ccccCCcccccCCCCCCC-----CCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhcc-
Q 019780 209 GLAREEVMDE--MTCEAGTYRWMAPENERP-----SLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRS- 279 (336)
Q Consensus 209 g~a~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~- 279 (336)
|++....... .....|+..|+|||.... ...+...|+|++++.+|++..++.|....- ...+.........
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT 248 (286)
T ss_pred CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence 9987543221 223458999999997642 345778999999999999999988863221 1111111111100
Q ss_pred --CCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 280 --ADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 280 --~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.....+.++..++...+..+|+.|++..++.+
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 01113445777888888889999988877664
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=236.48 Aligned_cols=194 Identities=26% Similarity=0.304 Sum_probs=163.8
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||+|.+. ++.|++|+++.. .........+.+|+.+++.++|+||+++++++.+++ .++|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES---EDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhh---cccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence 6889999999999999999986 678999998632 123344577899999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
|||++++.+..+.. ....+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEEeeecccccCCCcc
Confidence 99999877776653 335589999999999999999999999999999999999999876 79999999987543332
Q ss_pred --ccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 219 --MTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.....++..|+|||..... ..+...|+|+++..+|++..+..|.
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~ 202 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 2334578899999988777 7788999999999999988877664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=232.83 Aligned_cols=242 Identities=25% Similarity=0.320 Sum_probs=191.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||+|.+. +..+++|.+.. ....+.+.+|+.+++.++||||+++++.+.+.. .|+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~-------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV-------EEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeec-------HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 57888899999999999999986 67899999863 112678999999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
++||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 76 ~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 76 VMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTM 153 (256)
T ss_pred EEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-cEEEcccccchhcccCc
Confidence 99999999999998543 35789999999999999999999999999999999999999877 79999999987543322
Q ss_pred --ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHHhhc---cCCCCCCCCccccc
Q 019780 219 --MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQNLR---SADTPIPPKLVEIV 292 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~~~~---~~~~~~p~~~~~~~ 292 (336)
.....|+..|+|||.......+...|+|+++..+|++-.+.+|....-. ........... .....++..+.+++
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence 2234488999999988888888899999999999999888888532111 11111100000 01123445677788
Q ss_pred CCCCCCCCccccchhhhccc
Q 019780 293 DPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~ 312 (336)
...+..+|+.|++..++...
T Consensus 234 ~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 234 KKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHhcChhhCcCHHHHhcC
Confidence 88888888888888777653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=237.00 Aligned_cols=246 Identities=22% Similarity=0.238 Sum_probs=185.4
Q ss_pred ceeEeeeecCCCcEEEEEeEE-----CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-
Q 019780 63 SVLLQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT- 135 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~- 135 (336)
+|++.+.||+|+||.||+|.. .+..||+|+++.... .......+.+.+|+.++..+ +|+||+.+++.+..+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 477889999999999999986 368899999873211 12233456788999999999 5999999999888765
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~ 156 (290)
T cd05613 80 LHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-CEEEeeCccceecc
Confidence 78999999999999999543 5688999999999999999999999999999999999999876 89999999987543
Q ss_pred ccc---ccccCCcccccCCCCCCCC--CCCCHHHHHHHHHHhhccCCCCCCCHh-----HHHHHHHHHHHhhccCCCCCC
Q 019780 216 MDE---MTCEAGTYRWMAPENERPS--LENLSEDMVALLKSCWAEDPKVRPEFA-----EITITLTNILQNLRSADTPIP 285 (336)
Q Consensus 216 ~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~di~~l~~~~l~~~p~~RP~~~-----~i~~~l~~~~~~~~~~~~~~p 285 (336)
... .....|+..|+|||..... ..+...|+|+++..++++..+..|... ........+...........+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 236 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCC
Confidence 221 2234588999999987643 356778999999999999888877521 111111111111112223345
Q ss_pred CCcccccCCCCCCCCcccc-----chhhhccc
Q 019780 286 PKLVEIVDPKSTMNNDCMA-----TVHAITKF 312 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 312 (336)
+.+.+++...+..+|+.|. ....+...
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 5677788888888888884 45555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=231.65 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=193.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||.|+||+||+|... +..+++|++.... .......+.+|+.+++.++|+||+++++.+.+.. .++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK----CQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCC----cchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence 36888999999999999999874 6789999986321 1225677999999999999999999999887665 899
Q ss_pred EEEccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRP-KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
|||++++++|.+++..... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~~~ 155 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADG 155 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccchHHHhccC
Confidence 9999999999999965433 5789999999999999999999999999999999999999876 7999999998754332
Q ss_pred c------ccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhcc-CC-----CC
Q 019780 218 E------MTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRS-AD-----TP 283 (336)
Q Consensus 218 ~------~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~-~~-----~~ 283 (336)
. .....|+..|+|||..... ..+...|+|+++..+|++-.+++|.... -...+....+.... .. ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence 1 1223588999999987665 6788899999999999999999996322 11112222221110 00 13
Q ss_pred CCCCcccccCCCCCCCCccccchhhhccc
Q 019780 284 IPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
+++++.+++...+..+|+.|++..++.+.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 45567788888888899999888877654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=237.30 Aligned_cols=245 Identities=22% Similarity=0.259 Sum_probs=187.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||+|.+. ++.+|+|++.... ......+.+.+|+.+++.++||||+++++++.++. .++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE---DDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhcc---CcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 36888899999999999999985 7889999986321 12234566889999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|+||+++++|..+... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 78 VFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPG 154 (286)
T ss_pred EEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-cEEEEeeeeeeeccCCc
Confidence 9999999999887733 34589999999999999999999999999999999999999876 79999999987533222
Q ss_pred --ccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhc----------------
Q 019780 219 --MTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLR---------------- 278 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~---------------- 278 (336)
.....++..|+|||.... ...+.+.|+|+++..+|++..+.+|... .....+..+.....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 223457899999998764 3456789999999999999888766421 11111111111000
Q ss_pred ---------------cCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 279 ---------------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 279 ---------------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
...+.+++.+.+++...+..+|+.|++..++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0112445667778888888888888888776653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=233.87 Aligned_cols=195 Identities=29% Similarity=0.360 Sum_probs=159.5
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
...|.+.+.||+|+||.||+|... +..||+|++.... .......+.+|+.+++.++|+||+++++++.++. .+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT----EEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccC----cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 367899999999999999999875 7899999986321 1122345678999999999999999999988765 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||+. ++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||+++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIP 156 (291)
T ss_pred EEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-cEEEeccccccccCCC
Confidence 9999996 6777776433 34578888999999999999999999999999999999999877 7999999998753221
Q ss_pred --cccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 218 --EMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 218 --~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
......++..|+|||...+. ..+...|+|+|+..+|++..+..|.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f 204 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 12334578999999987653 4677899999999999998887774
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=235.21 Aligned_cols=243 Identities=26% Similarity=0.330 Sum_probs=192.7
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~ 140 (336)
|.-.+.||+|++|.||++... +..+++|++.. ......+.+.+|+.+++.++||||+++++++...+ .++++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~-----~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEec-----cchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 444478999999999999875 67899998862 12234566889999999999999999999887654 89999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--c
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--E 218 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~ 218 (336)
||++|++|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++ .++|+|||++...... .
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 96 EFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred eccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-cEEEcccccchhhccCCcc
Confidence 99999999999844 4689999999999999999999999999999999999999876 8999999987643221 1
Q ss_pred ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhcc---CCCCCCCCcccccCC
Q 019780 219 MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRS---ADTPIPPKLVEIVDP 294 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~---~~~~~p~~~~~~~~~ 294 (336)
.....|+..|+|||.......+...|+|+++..++++..+..|.... -...+..+...... ....+++.+.+++..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR 251 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence 22345889999999988888889999999999999999998885332 22222222222111 112256778889999
Q ss_pred CCCCCCccccchhhhcccccc
Q 019780 295 KSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~ 315 (336)
.+..+|+.|++..++.+....
T Consensus 252 ~l~~~p~~Rpt~~~il~~~~~ 272 (285)
T cd06648 252 MLVRDPAQRATAAELLNHPFL 272 (285)
T ss_pred HcccChhhCcCHHHHccCccc
Confidence 999999999999888875543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=230.05 Aligned_cols=246 Identities=23% Similarity=0.319 Sum_probs=197.4
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||++.+. +..+++|++... .........+.+|+++++.++|||++++.+.+.+.. .++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLS---NMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecc---cCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence 4778899999999999999987 789999998732 223456677899999999999999999999887765 8999
Q ss_pred EEccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 140 TELMRGETLQRYLWSTR--PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||+++++|.+++.... ...+++..+..++.+++.||.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSST 156 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC-cEEECCccceeecccC
Confidence 99999999999996543 46799999999999999999999999999999999999999876 7999999998754333
Q ss_pred c--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh-hccCCCCCCCCcccccC
Q 019780 218 E--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN-LRSADTPIPPKLVEIVD 293 (336)
Q Consensus 218 ~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~-~~~~~~~~p~~~~~~~~ 293 (336)
. .....|++.|+|||.......+...|+|+++..++++-.+..|.... ........... ........+..+.+++.
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 2 22345889999999988888888999999999999988888875222 22222222221 22222345667788888
Q ss_pred CCCCCCCccccchhhhccc
Q 019780 294 PKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~ 312 (336)
..+..+|+.|++..++...
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 237 SLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHcCCChhhCcCHHHHhcC
Confidence 9999999999998887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=250.51 Aligned_cols=194 Identities=27% Similarity=0.454 Sum_probs=158.5
Q ss_pred eecCCCcEEEEEeEECC--ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccCC
Q 019780 69 MIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRG 145 (336)
Q Consensus 69 ~lg~G~fg~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~g 145 (336)
+||+|.||+||.|++.. ..+|||.+. ..+.+..+-+..|+.+-+.|+|.|||+++|.+-+++ +-|.||.++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIp-----ekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIP-----EKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecc-----cccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 59999999999999874 456888875 234456777899999999999999999999988776 6788999999
Q ss_pred CCHHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc--ccccc
Q 019780 146 ETLQRYLWSTRPKRL--DLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM--DEMTC 221 (336)
Q Consensus 146 g~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~--~~~~~ 221 (336)
|+|.+++++.- +++ ++.+.-.+.+||++||.|||++.|||||||-+|+|++.-.+.+||+|||.++.... ....+
T Consensus 657 GSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 657 GSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred CcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 99999996654 445 88899999999999999999999999999999999988777999999999886432 22345
Q ss_pred cCCcccccCCCCCC-------------------------------------------------CCCCCCHHHHHHHHHHh
Q 019780 222 EAGTYRWMAPENER-------------------------------------------------PSLENLSEDMVALLKSC 252 (336)
Q Consensus 222 ~~gt~~y~aPE~~~-------------------------------------------------~~~~~~~~di~~l~~~~ 252 (336)
+.||..|||||.+. +.|..++....+++..|
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 67999999999432 22333444555577888
Q ss_pred hccCCCCCCCHhHHHH
Q 019780 253 WAEDPKVRPEFAEITI 268 (336)
Q Consensus 253 l~~~p~~RP~~~~i~~ 268 (336)
++++|..||++.+++.
T Consensus 816 Fepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cCCCcccCccHHHhcc
Confidence 8888888888888754
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=241.29 Aligned_cols=242 Identities=25% Similarity=0.334 Sum_probs=190.2
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
.|.....||+|+||.||++... +..||||.+.. ......+.+.+|+.+++.++||||+++++.+..++ .++|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec-----chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence 4444577999999999999874 78899998863 12344567889999999999999999999887655 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-- 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-- 217 (336)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 98 ~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 98 MEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccccc
Confidence 999999999998832 3588999999999999999999999999999999999999876 7999999998643221
Q ss_pred cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhcc---CCCCCCCCcccccC
Q 019780 218 EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRS---ADTPIPPKLVEIVD 293 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~---~~~~~p~~~~~~~~ 293 (336)
......|+..|+|||.......+...|+|+++..++++..+..|.... -...+..+...+.. .....++.+..++.
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHH
Confidence 122345889999999988878888999999999999999998886432 11222222221111 11234556777888
Q ss_pred CCCCCCCccccchhhhcccc
Q 019780 294 PKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~ 313 (336)
..+..+|..|++..++.+..
T Consensus 254 ~~l~~~P~~Rpt~~~il~~~ 273 (292)
T cd06658 254 LMLVREPSQRATAQELLQHP 273 (292)
T ss_pred HHccCChhHCcCHHHHhhCh
Confidence 88888999999988887643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=233.16 Aligned_cols=238 Identities=24% Similarity=0.312 Sum_probs=169.7
Q ss_pred eeecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEc
Q 019780 68 KMIGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITEL 142 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~ 142 (336)
+.||+|+||.||+|... ...+|+|.++.. ........+.+|+.+++.++||||+++++++.+.. .++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS----ASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCC----CChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence 35899999999999864 346899987632 12334457889999999999999999999887655 8999999
Q ss_pred cCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 143 MRGETLQRYLWSTR---PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 143 ~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
+++|+|.+++.... ....++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEECCccccccccCcce
Confidence 99999999996432 23456778889999999999999999999999999999999876 89999999987533221
Q ss_pred ---ccccCCcccccCCCCCCCC-------CCCCHHHHHHHHHHhhccCC-CCCCCHh-HHHHHHHHHHHh--hccCC---
Q 019780 219 ---MTCEAGTYRWMAPENERPS-------LENLSEDMVALLKSCWAEDP-KVRPEFA-EITITLTNILQN--LRSAD--- 281 (336)
Q Consensus 219 ---~~~~~gt~~y~aPE~~~~~-------~~~~~~di~~l~~~~l~~~p-~~RP~~~-~i~~~l~~~~~~--~~~~~--- 281 (336)
.....++..|+|||..... ..+.+.|+|+++..+|++.. +..|... .-...+...... .....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc
Confidence 1223467889999976532 24568999999999998764 6556311 101111111111 10011
Q ss_pred -CCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 282 -TPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 282 -~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
...++.+..++...+ .+|+.|++..++.+
T Consensus 236 ~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 123334445666666 46777777766653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=240.70 Aligned_cols=188 Identities=26% Similarity=0.289 Sum_probs=149.9
Q ss_pred eeeecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---CEEEE
Q 019780 67 QKMIGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---TMMII 139 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~lv 139 (336)
+..||+|+||+||+|... +..||+|.+... .....+.+|+.+++.++||||+++++++... ..++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-------GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC-------CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 367999999999999864 467999988631 1123577899999999999999999987642 38999
Q ss_pred EEccCCCCHHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---CCCceEEeccc
Q 019780 140 TELMRGETLQRYLWST-------RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE---DKKQVKLADFG 209 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~---~~~~~kl~Dfg 209 (336)
|||+.+ +|.+++... ....+++..++.++.|++.||.|||++||+||||||+||++.. ..+.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 999875 788877421 1235889999999999999999999999999999999999932 22379999999
Q ss_pred cccccccc-----cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 210 LAREEVMD-----EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 210 ~a~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
+++..... ......||+.|+|||.... ...+...|+|++++.+|++..++.|.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 99754322 1223458899999998765 44688899999999999998887764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=241.62 Aligned_cols=238 Identities=25% Similarity=0.340 Sum_probs=187.1
Q ss_pred EeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEc
Q 019780 66 LQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITEL 142 (336)
Q Consensus 66 ~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~ 142 (336)
....||+|+||.||+|... ++.||+|++... .......+.+|+.+++.++||||+++++.+..+. .++|+||
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR-----KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec-----ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 3457999999999999874 789999998632 1223456889999999999999999999887655 8999999
Q ss_pred cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--ccc
Q 019780 143 MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EMT 220 (336)
Q Consensus 143 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~ 220 (336)
+++++|..++.. ..+++..++.++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++...... ...
T Consensus 100 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 100 LQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-cEEEeechhHhhccccccccc
Confidence 999999998733 4589999999999999999999999999999999999999887 7999999998643222 123
Q ss_pred ccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHh---hccCCCCCCCCcccccCCCC
Q 019780 221 CEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQN---LRSADTPIPPKLVEIVDPKS 296 (336)
Q Consensus 221 ~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~---~~~~~~~~p~~~~~~~~~~~ 296 (336)
...|+..|+|||.......+...|+|++++.++++-.++.|....- ...+..+... ........++.+.+++...+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 3458899999999888888899999999999999998888853221 1111111111 11112345566777888888
Q ss_pred CCCCccccchhhhccc
Q 019780 297 TMNNDCMATVHAITKF 312 (336)
Q Consensus 297 ~~~~~~~~~~~~~~~~ 312 (336)
..+|+.|++..++.+.
T Consensus 256 ~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 256 TREPQERATAQELLDH 271 (297)
T ss_pred cCCcccCcCHHHHhhC
Confidence 8889888888887764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=233.84 Aligned_cols=247 Identities=24% Similarity=0.276 Sum_probs=184.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|++|+||+|.+. ++.||+|.+.... ........+.+|+.+++.++||||+++++++.++. .++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ---EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcc---ccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence 46889999999999999999975 7789999986321 12233466889999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||++ ++|.+++.......+++..++.++.||+.||+|||++|++|+||+|+||+++.++..+||+|||++......
T Consensus 79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 999996 588888855554557888999999999999999999999999999999999866557999999998753222
Q ss_pred -cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhcc---------------
Q 019780 218 -EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRS--------------- 279 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~--------------- 279 (336)
......+++.|+|||.... ...+...|+|+++..++++-.+..|... +-...+..+......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 2233457899999997654 4567889999999999998887666421 111111111111000
Q ss_pred --------------CCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 280 --------------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 280 --------------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
..+.+++++.+++...+..+|+.|++..++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112345556667777777777777777666653
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=236.49 Aligned_cols=195 Identities=26% Similarity=0.257 Sum_probs=160.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---CE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---TM 136 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~ 136 (336)
++|.+.+.||+|+||.||+|.+. ++.+++|.++.... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE---KEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc---cccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 56888899999999999999986 77899999974221 122334577899999999999999999987754 49
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||+++ +|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~ 158 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-ILKICDFGLAREYGS 158 (293)
T ss_pred EEEehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-cEEEeecCceeeccC
Confidence 999999975 9999885433 4689999999999999999999999999999999999999886 799999999875433
Q ss_pred c--cccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 217 D--EMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 217 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
. ......++..|+|||..... ..+...|+|+++..+|++-.+..|.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f 207 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF 207 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCC
Confidence 2 22334578899999987654 3577899999999999988776654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=232.32 Aligned_cols=237 Identities=20% Similarity=0.296 Sum_probs=166.5
Q ss_pred eecCCCcEEEEEeEEC-Cc---cEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEcc
Q 019780 69 MIGEGSYSIVYKGFYG-CE---PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 69 ~lg~G~fg~V~~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
.||+|+||.||+|... +. .+++|.+.. .........+.+|+.+++.++||||+++++.+.+.. .++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKA----NASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecC----CCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence 5999999999999753 32 345565542 122345678999999999999999999999988765 89999999
Q ss_pred CCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc----
Q 019780 144 RGETLQRYLWSTR--PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD---- 217 (336)
Q Consensus 144 ~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~---- 217 (336)
++|+|.++++... ....++..++.++.|++.||+|||+++++||||||+|||++.++ .++|+|||++......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-cEEecccccccccCcchhhh
Confidence 9999999996432 23467778889999999999999999999999999999999876 7999999998642221
Q ss_pred cccccCCcccccCCCCCCC-------CCCCCHHHHHHHHHHhhccCCCCC-CCHh-HHHHHHHHHHHh-hcc-----CCC
Q 019780 218 EMTCEAGTYRWMAPENERP-------SLENLSEDMVALLKSCWAEDPKVR-PEFA-EITITLTNILQN-LRS-----ADT 282 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~di~~l~~~~l~~~p~~R-P~~~-~i~~~l~~~~~~-~~~-----~~~ 282 (336)
......++..|+|||.... ...+...|+|+++..+|++..... |... .-...+..+... ... ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence 1223457899999997642 234567899999999998754333 3211 111122222211 110 111
Q ss_pred CCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 283 PIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 283 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+.++.+.+++...| .+|+.|++..++.+
T Consensus 237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 237 PYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 23333444555555 45777777766643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=243.49 Aligned_cols=249 Identities=21% Similarity=0.286 Sum_probs=187.6
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEe
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASV 132 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 132 (336)
..+.++.+.|++++.||+||.+.||++... .+.+|+|.+. ....+.+...-+..|+..|.+|+ |.+||+++++-.
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~---~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVV---LLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHH---HhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 467888999999999999999999999876 5677887765 35567788899999999999997 999999999977
Q ss_pred cCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 133 QPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 133 ~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
.++ +|+||||=+ .+|...|+... ..++...++.++.|++.|+.++|..||||.||||.|+|+-. | .+||+|||+|
T Consensus 431 ~d~~lYmvmE~Gd-~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G-~LKLIDFGIA 506 (677)
T KOG0596|consen 431 TDGYLYMVMECGD-IDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-G-RLKLIDFGIA 506 (677)
T ss_pred cCceEEEEeeccc-ccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-e-eEEeeeechh
Confidence 655 899999864 69999995543 33343478899999999999999999999999999999985 3 7999999999
Q ss_pred ccccccc----ccccCCcccccCCCCCCCCC-----------CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 212 REEVMDE----MTCEAGTYRWMAPENERPSL-----------ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 212 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~-----------~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
....... ..+.+||+.||+||.+.... -..++|+|+|+|.++++-.++-| |.++...+..+...
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktP-f~~~~n~~aKl~aI 585 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTP-FGQIINQIAKLHAI 585 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCc-hHHHHHHHHHHHhh
Confidence 8644433 23457999999999654332 34678999999999999998877 56655444444332
Q ss_pred hcc----CCCCCCC--CcccccCCCCCCCCccccchhhhcc
Q 019780 277 LRS----ADTPIPP--KLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 277 ~~~----~~~~~p~--~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+.. .-+.+|+ ++..+....+..+|..|.++.++..
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 211 0111222 1444455555556665655555543
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=232.90 Aligned_cols=246 Identities=26% Similarity=0.342 Sum_probs=190.6
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC--
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-- 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-- 135 (336)
.++|.+.+.||+|+||.||+|.+. ++.+++|++... ......+.+|+.+++++ +|+||+++++++.+..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII------EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC------chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 468999999999999999999985 678999998632 22346789999999999 6999999999987533
Q ss_pred -----EEEEEEccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecc
Q 019780 136 -----MMIITELMRGETLQRYLWSTR--PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADF 208 (336)
Q Consensus 136 -----~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Df 208 (336)
.++||||+++++|.+++.... +..+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-~~~l~d~ 157 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-EVKLVDF 157 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-eEEECCC
Confidence 799999999999999985433 56789999999999999999999999999999999999999876 7999999
Q ss_pred ccccccccc--cccccCCcccccCCCCCCC-----CCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhcc-
Q 019780 209 GLAREEVMD--EMTCEAGTYRWMAPENERP-----SLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRS- 279 (336)
Q Consensus 209 g~a~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~- 279 (336)
|++...... ......|+..|+|||.... ...+...|+|+|+..++++..+..|.... -...+..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 998753322 1233458899999997543 33456789999999999999888885321 11222222221110
Q ss_pred C--CCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 280 A--DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 280 ~--~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
. ....++++.+++...+..+|+.|++..++.+..
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~ 273 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHP 273 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCC
Confidence 0 111445677888888999999999988877643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=235.57 Aligned_cols=240 Identities=28% Similarity=0.402 Sum_probs=184.2
Q ss_pred eeecCCCcEEEEEeEECC--------ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 68 KMIGEGSYSIVYKGFYGC--------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
+.||+|+||.||+|.... ..+|+|.+... ........+.+|+.+++.++||||+++++++.+.. .++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI 76 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc----cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence 358999999999998752 56899987531 22344567889999999999999999999887655 899
Q ss_pred EEEccCCCCHHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC----CceEEeccc
Q 019780 139 ITELMRGETLQRYLWST-----RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK----KQVKLADFG 209 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~-----~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~----~~~kl~Dfg 209 (336)
||||+++++|.+++... ....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++ ..++|+|||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999999643 224478899999999999999999999999999999999998754 269999999
Q ss_pred cccccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhH-HHHHHHHHHHh-hccCCC
Q 019780 210 LAREEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAE-ITITLTNILQN-LRSADT 282 (336)
Q Consensus 210 ~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~-i~~~l~~~~~~-~~~~~~ 282 (336)
+++....... ....++..|+|||.......+...|+|+|+..+|++-. +..|.... -...+..+... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPE 236 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcc
Confidence 9875432221 12235688999999888888899999999999998764 66663211 11111211111 112234
Q ss_pred CCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 283 PIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 283 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.+|+.+.+++...+..+|+.|+++.++.+
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 237 NCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 56777888999999999999999888764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=234.71 Aligned_cols=247 Identities=24% Similarity=0.301 Sum_probs=191.8
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC---CCceEeeEeeEecCC-E
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK---HENILKFVGASVQPT-M 136 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~-~ 136 (336)
.|.+.+.||+|+||.||+|.+. +..+|+|++... ........+.+|+.+++.++ |||++++++++.++. .
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCC----CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence 4677889999999999999975 788999998632 22344567889999999986 999999999887665 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||++|++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~ 153 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-CEEEccCCceeecCC
Confidence 999999999999999843 3689999999999999999999999999999999999999876 899999999875433
Q ss_pred cc--ccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh--ccCCC-CCCCCccc
Q 019780 217 DE--MTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL--RSADT-PIPPKLVE 290 (336)
Q Consensus 217 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~--~~~~~-~~p~~~~~ 290 (336)
.. .....|+..|+|||.... ...+...|+|+++..+|++..+..|....-........... ..... ..++++.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE 233 (277)
T ss_pred CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHH
Confidence 22 233458899999997653 45577899999999999998888885322111111111111 11111 25566778
Q ss_pred ccCCCCCCCCccccchhhhcccccccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
++...+..+|+.|++..++.+....++
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 888899999999999988887665433
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=233.15 Aligned_cols=244 Identities=24% Similarity=0.386 Sum_probs=184.3
Q ss_pred eeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC---
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT--- 135 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 135 (336)
|.+.+.||+|+||.||+|... +..+|||++.. ........+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA---DIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecc---ccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 456788999999999999863 57899999863 2223445677899999999999999999999876421
Q ss_pred ----EEEEEEccCCCCHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEec
Q 019780 136 ----MMIITELMRGETLQRYLWST----RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLAD 207 (336)
Q Consensus 136 ----~~lv~e~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~D 207 (336)
.+++++|+.+|+|.+++... ....+++..++.++.|++.||+|||+.|++||||||+||+++.++ .++|+|
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-~~kl~d 156 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVAD 156 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-CEEECc
Confidence 47889999999999887432 123578899999999999999999999999999999999999876 799999
Q ss_pred ccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHhhc--cC
Q 019780 208 FGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQNLR--SA 280 (336)
Q Consensus 208 fg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~~~--~~ 280 (336)
||+++...... .....++..|++||.......+...|+|+|++.+|++.. +..|....-...+........ ..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 99988543221 112235678999999888888889999999999999876 555532221112222221111 11
Q ss_pred CCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 281 DTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 281 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
....++.+.+++...+..+|+.|++..++..
T Consensus 237 ~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2345567788888888888988888777654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=241.26 Aligned_cols=193 Identities=25% Similarity=0.261 Sum_probs=161.0
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 134 (336)
.+.|.+.+.||+|+||.||+|.+. ++.||+|++... .........+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP---FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcc---ccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 467999999999999999999975 789999998631 12334456678899999999999999999987643
Q ss_pred ---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 135 ---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 135 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
..|+||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~ 165 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA 165 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCccc
Confidence 26999999965 88888732 288999999999999999999999999999999999999887 7999999999
Q ss_pred ccccccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 212 REEVMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 212 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
+...... .....++..|+|||.......+...|+|++++.++++..+.-|.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf 217 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCC
Confidence 8643322 22345889999999988888889999999999999887766553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=236.10 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=190.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-EE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT-MM 137 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~ 137 (336)
.+|...+.||+|+||.||++.+. ++.+|+|.+.... .......+.+|+.++.++. ||||+++++++.++. .+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV----DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW 79 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc----ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence 45667788999999999999985 7889999986321 2245667889999999996 999999999877654 88
Q ss_pred EEEEccCCCCHHHH---HhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCceEEeccccccc
Q 019780 138 IITELMRGETLQRY---LWSTRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 138 lv~e~~~gg~L~~~---l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
++|||+.+ +|.++ +.......+++..+..++.|++.||+|||+. |++||||||+||+++.++ .++|+|||+++.
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~ 157 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQ 157 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHH
Confidence 99999864 55543 3333446799999999999999999999975 999999999999999876 799999999875
Q ss_pred ccccc-ccccCCcccccCCCCCCCC---CCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCC--------
Q 019780 214 EVMDE-MTCEAGTYRWMAPENERPS---LENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSAD-------- 281 (336)
Q Consensus 214 ~~~~~-~~~~~gt~~y~aPE~~~~~---~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~-------- 281 (336)
..... .....|+..|+|||..... ..+...|+|+++..+|+...++.|.... ....+.+.+......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW-NSVFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc-chHHHHHhhhcCCCCCcCCCcCC
Confidence 43222 2334588999999987765 5778899999999999999888885321 112222222111111
Q ss_pred CCCCCCcccccCCCCCCCCccccchhhhcccccccc
Q 019780 282 TPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 282 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
..+++++.+++...+..+|+.|++..++.+...-++
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 135566788899999999999999999888665443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=234.19 Aligned_cols=232 Identities=23% Similarity=0.309 Sum_probs=183.2
Q ss_pred ecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccCCC
Q 019780 70 IGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRGE 146 (336)
Q Consensus 70 lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~gg 146 (336)
||+|+||.||++.+. ++.+++|++... ..........+.+|+.+++.++||||+++++.+.++. .|+++||++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKA--DMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecch--hhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 689999999999986 789999998632 1222355678999999999999999999998887665 89999999999
Q ss_pred CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc---------
Q 019780 147 TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--------- 217 (336)
Q Consensus 147 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--------- 217 (336)
+|.+++.+. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 79 ~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 79 DLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccccccccc
Confidence 999999543 3689999999999999999999999999999999999999887 7999999998753322
Q ss_pred -cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH-HHHHHHHhhccCCCC--CCCCcccccC
Q 019780 218 -EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITI-TLTNILQNLRSADTP--IPPKLVEIVD 293 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~-~l~~~~~~~~~~~~~--~p~~~~~~~~ 293 (336)
......++..|+|||.......+...|+|+|+..++++-.+..|....-.. .+..+.......... +++.+..++.
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 235 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLIS 235 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHH
Confidence 122335788999999888888889999999999999988887775222111 122222111111111 3667788888
Q ss_pred CCCCCCCccccch
Q 019780 294 PKSTMNNDCMATV 306 (336)
Q Consensus 294 ~~~~~~~~~~~~~ 306 (336)
..+..+|+.|++.
T Consensus 236 ~~l~~~p~~Rpt~ 248 (265)
T cd05579 236 KLLVPDPEKRLGA 248 (265)
T ss_pred HHhcCCHhhcCCC
Confidence 8888889888887
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=235.96 Aligned_cols=251 Identities=27% Similarity=0.259 Sum_probs=187.0
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---C
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---T 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~ 135 (336)
..+|.+.+.||+|+||.||+|.+. ++.||+|+++.... .......+.+|+.+++.++|+||+++++++.+. .
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE---RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC---CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 467999999999999999999985 78999999874221 112233456899999999999999999998754 3
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
.++||||+.+ +|.+++... ...+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~~~ 159 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLARTYG 159 (309)
T ss_pred EEEEEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccceeeecC
Confidence 8999999975 888888543 35689999999999999999999999999999999999999876 79999999987543
Q ss_pred cc--cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCC----------
Q 019780 216 MD--EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSAD---------- 281 (336)
Q Consensus 216 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~---------- 281 (336)
.. ......++..|+|||...+ ...+...|+|+|+..+|++-.+..|... +-...+..+........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 32 1222346788999998754 4567889999999999998887776521 11122222222111000
Q ss_pred --------------------CCCCCCcccccCCCCCCCCccccchhhhcccccccc
Q 019780 282 --------------------TPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 282 --------------------~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
...++++.+++...+..+|+.|++..++....+-.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 112444556677777778888888887776554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=227.28 Aligned_cols=244 Identities=25% Similarity=0.316 Sum_probs=197.2
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC--C-EE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP--T-MM 137 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~-~~ 137 (336)
+|.+.+.||+|++|.||+|.+. +..+++|++.... ......+.+.+|+.++++++||||+++++.+.+. . .+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSG---DSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 3677899999999999999986 7889999987422 1245678899999999999999999999998876 4 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+++||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 78 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-VVKLADFGCAKRLGDI 154 (260)
T ss_pred EEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEcccccEEecccc
Confidence 999999999999999543 3789999999999999999999999999999999999999876 7999999998765443
Q ss_pred c----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH--HHHHHHHHH--HhhccCCCCCCCCcc
Q 019780 218 E----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE--ITITLTNIL--QNLRSADTPIPPKLV 289 (336)
Q Consensus 218 ~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~--i~~~l~~~~--~~~~~~~~~~p~~~~ 289 (336)
. .....++..|+|||.......+...|+|+|+..++++-.+..|.... ....+..+. ..........++.+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHH
Confidence 3 23446889999999988888899999999999999988887774221 222222222 122233345567788
Q ss_pred cccCCCCCCCCccccchhhhccc
Q 019780 290 EIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
+++...+..+|+.|++..++.+.
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 235 DFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHHhCcCChhhCCCHHHHhhC
Confidence 88888888899999888877653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=234.99 Aligned_cols=249 Identities=15% Similarity=0.203 Sum_probs=179.0
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEECC-----ccEEEEEeecCccccccHHH------HHHHHHHHHHHHhCCCCceEee
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYGC-----EPVAVKVIQPCNALAVSREH------KEKFQREVTLLSKMKHENILKF 127 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~------~~~~~~E~~~l~~l~hpnIv~~ 127 (336)
+..+.|.+.+.||+|+||+||+|...+ ..+|+|+....+........ ......+...+..++|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 445789999999999999999998753 35667764422211111100 1112334455667789999999
Q ss_pred EeeEecCC-----EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCc
Q 019780 128 VGASVQPT-----MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ 202 (336)
Q Consensus 128 ~~~~~~~~-----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~ 202 (336)
+++..... .+++++++. .++.+.+.. ....++..+..++.|++.||+|||++|++||||||+|||++.++ .
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~-~ 164 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN-R 164 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-c
Confidence 98765432 367778774 467776632 23467888999999999999999999999999999999999876 7
Q ss_pred eEEeccccccccccc---------cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-----HHHH
Q 019780 203 VKLADFGLAREEVMD---------EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-----EITI 268 (336)
Q Consensus 203 ~kl~Dfg~a~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-----~i~~ 268 (336)
++|+|||+|+..... ......||+.|+|||.......+...|+|++++.++++..+..|.-. ++..
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999753211 11223599999999999888899999999999999999988888421 1111
Q ss_pred H-HHHHHHhhcc---CCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 269 T-LTNILQNLRS---ADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 269 ~-l~~~~~~~~~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
. ..++...+.. ..+..|+++.++++..+..+++.+++..++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1 1122222221 22455777888999999999999999888765
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=230.28 Aligned_cols=246 Identities=21% Similarity=0.262 Sum_probs=194.7
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||++.+. +..+++|.+.... ........+.+|+.+++.++|+||+++.+++.+.. .++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS---MSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhh---ccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence 4778899999999999999875 6789999987422 23345667789999999999999999998887665 8999
Q ss_pred EEccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 140 TELMRGETLQRYLWST--RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||+++++|.+++... ....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGISKVLKKN 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC-cEEEeeccchhhhccC
Confidence 9999999999998542 235689999999999999999999999999999999999999876 7999999999765444
Q ss_pred cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH--hhccCCCCCCCCcccccCCC
Q 019780 218 EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ--NLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~--~~~~~~~~~p~~~~~~~~~~ 295 (336)
......++..|+|||.......+...|+|+++..+|++..+..|.-..-...+..... .........+.++.+++...
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSM 236 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHH
Confidence 3334558899999999888888889999999999999888877752221111211111 12222234566678888889
Q ss_pred CCCCCccccchhhhccc
Q 019780 296 STMNNDCMATVHAITKF 312 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~~ 312 (336)
+..+|+.|++..++...
T Consensus 237 l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 237 LQVKPKLRPNCDKILAS 253 (256)
T ss_pred cCCCcccCCCHHHHhcC
Confidence 98899999888777653
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=229.83 Aligned_cols=248 Identities=21% Similarity=0.349 Sum_probs=192.9
Q ss_pred ceeEeeeecCCCcEEEEEeEEC---CccEEEEEeecCccc-----cccHHHHHHHHHHHHHHHh-CCCCceEeeEeeEec
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG---CEPVAVKVIQPCNAL-----AVSREHKEKFQREVTLLSK-MKHENILKFVGASVQ 133 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~---~~~vavK~~~~~~~~-----~~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~ 133 (336)
+|++.+.||+|+||.||+|.+. +..+|+|.+...... .........+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 3677889999999999999985 478999988642211 1233445667788888865 789999999998887
Q ss_pred CC-EEEEEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCceEEeccc
Q 019780 134 PT-MMIITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
+. .+++|||++|++|.+++.. .....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l~dfg 159 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTITDFG 159 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEEeccc
Confidence 65 8999999999999998843 234568999999999999999999996 7899999999999999887 79999999
Q ss_pred cccccccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhc-cC-CCCCC
Q 019780 210 LAREEVMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLR-SA-DTPIP 285 (336)
Q Consensus 210 ~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~-~~-~~~~p 285 (336)
++...... ......|+..|+|||.......+...|+|+|+..+|++-.+..|.... .......+..... .. ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 160 LAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred ceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 98764433 233446889999999988887888999999999999999888885322 2222222222211 11 12456
Q ss_pred CCcccccCCCCCCCCccccchhhhcc
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+++.+++...+..+|+.|+++.++..
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 77888999999999999999887764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=231.38 Aligned_cols=194 Identities=30% Similarity=0.385 Sum_probs=160.3
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|++.+.||.|++|.||+|.+. +..||||+++... .......+.+|+.+++.++||||+++++++.+.+ .++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA----EEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccc----cccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence 4788899999999999999985 7889999987422 1223456778999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTR-PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
|||+++ +|.+++.... ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++......
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPV 154 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcCCc
Confidence 999985 8888885432 34689999999999999999999999999999999999999876 7999999998743222
Q ss_pred -cccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 218 -EMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
......++..|++||..... ..+...|+|+++..+|++-.+..|.
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~ 201 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 12334578899999977553 4577899999999999988887764
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=234.35 Aligned_cols=246 Identities=25% Similarity=0.275 Sum_probs=188.5
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
+.|.+.+.||+|+||+||+|... ++.||+|++... ..........+.+|+.+++.++||||+++.+++.+.. .++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecc--ccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 55888899999999999999875 789999998632 1223445567889999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|+||++ |+|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 93 VMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSASLVSPA- 168 (307)
T ss_pred EHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC-CEEEeecCcceecCCC-
Confidence 999997 4777776433 34689999999999999999999999999999999999999887 7999999998754322
Q ss_pred ccccCCcccccCCCCCC---CCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh-hccC-CCCCCCCccccc
Q 019780 219 MTCEAGTYRWMAPENER---PSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN-LRSA-DTPIPPKLVEIV 292 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~---~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~-~~~~-~~~~p~~~~~~~ 292 (336)
....++..|+|||... ....+...|+|+++..+|++..+..|.... ....+..+... .... ....+.++.+++
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV 247 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHH
Confidence 3345889999999763 345677899999999999999888885432 11111111111 0000 112344567788
Q ss_pred CCCCCCCCccccchhhhccccc
Q 019780 293 DPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
...+..+|+.|++..++.....
T Consensus 248 ~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 248 DSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred HHHhcCChhhCcCHHHHhcChh
Confidence 8888888888888888876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=231.37 Aligned_cols=245 Identities=24% Similarity=0.310 Sum_probs=187.4
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecC---
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQP--- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--- 134 (336)
..+|.+.+.||+|+||.||+|... ++.+|+|++... ......+.+|+.++.++ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~------~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI------SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc------ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 567999999999999999999985 788999998632 12245677899999998 799999999987642
Q ss_pred ---CEEEEEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 135 ---TMMIITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 135 ---~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
..++||||++|++|.++++. .....+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-~~kl~dfg 173 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFG 173 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeecc
Confidence 37999999999999998853 2345689999999999999999999999999999999999999876 79999999
Q ss_pred ccccccccc--ccccCCcccccCCCCCCCC-----CCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhcc--
Q 019780 210 LAREEVMDE--MTCEAGTYRWMAPENERPS-----LENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRS-- 279 (336)
Q Consensus 210 ~a~~~~~~~--~~~~~gt~~y~aPE~~~~~-----~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~-- 279 (336)
++....... .....|+..|+|||..... ..+...|+|+++..+|++..+..|.... -...+..+......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 987543222 2234588999999976433 2467899999999999999887775322 11122222111100
Q ss_pred -CCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 280 -ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 280 -~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.....++.+.+++...+..+|+.|++..++...
T Consensus 254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 112233456677888888899999888887764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=232.90 Aligned_cols=246 Identities=22% Similarity=0.243 Sum_probs=183.3
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC----
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT---- 135 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~---- 135 (336)
+|.+.+.||+|+||.||+|.+. ++.||+|.+.... ........+.+|+.+++.+. ||||+++++++....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM---DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc---cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 5888899999999999999975 7889999986421 11223456788999999995 699999999876432
Q ss_pred --EEEEEEccCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 136 --MMIITELMRGETLQRYLWSTR---PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 136 --~~lv~e~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
.|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++|++||||+|+||+++.+++.++|+|||+
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 6999999986 8988885432 346899999999999999999999999999999999999998445899999999
Q ss_pred ccccccc--cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhc--------
Q 019780 211 AREEVMD--EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLR-------- 278 (336)
Q Consensus 211 a~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~-------- 278 (336)
+...... ......+++.|+|||.... ...+...|+|+++..++++..+..|...+ -...+..+...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8753221 1223347789999997654 45678899999999999988887765321 1111211111110
Q ss_pred --------------------cCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 279 --------------------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 279 --------------------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
...+.+++++.+++...+..+|..|++..++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0112356667777778888888888887776654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=225.73 Aligned_cols=243 Identities=29% Similarity=0.397 Sum_probs=194.1
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|...+.||+|++|.||++.+. +..+++|++.... ......+.+|+.+++.++||||+++++.+..+. .+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES-----KEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 4677899999999999999986 7889999987421 135678999999999999999999999988665 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
+||+++++|.+++.... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC-eEEEeecccccccccccc
Confidence 99999999999985432 5789999999999999999999999999999999999999876 79999999987654433
Q ss_pred ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh-hccCCCC--CCCCcccccCC
Q 019780 219 MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN-LRSADTP--IPPKLVEIVDP 294 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~-~~~~~~~--~p~~~~~~~~~ 294 (336)
.....++..|+|||.......+...|+|+++..++++-.+..|.... ....+...... ......+ .+..+.+++..
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 23446889999999888777888899999999999888877775332 22222222221 1111122 26667888889
Q ss_pred CCCCCCccccchhhhccc
Q 019780 295 KSTMNNDCMATVHAITKF 312 (336)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~ 312 (336)
.+..+|+.|++..++.+.
T Consensus 234 ~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HccCChhhCCCHHHHhcC
Confidence 999999999888877654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=251.79 Aligned_cols=196 Identities=20% Similarity=0.207 Sum_probs=150.9
Q ss_pred CceeEeeeecCCCcEEEEEeEEC---CccEEEEEeecC------------ccccccHHHHHHHHHHHHHHHhCCCCceEe
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG---CEPVAVKVIQPC------------NALAVSREHKEKFQREVTLLSKMKHENILK 126 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~---~~~vavK~~~~~------------~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 126 (336)
.+|.+++.||+|+||+||++... +...+.|.+... +...........+.+|+.+|+.++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 57999999999999999998754 222222211100 001112234567889999999999999999
Q ss_pred eEeeEecCC-EEEEEEccCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCc
Q 019780 127 FVGASVQPT-MMIITELMRGETLQRYLWSTR---PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ 202 (336)
Q Consensus 127 ~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~ 202 (336)
+++++.+.+ .|+|++++. ++|..++.... ........++.++.||+.||.|||++|||||||||+|||++.++ .
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~-~ 305 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG-K 305 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-C
Confidence 999998766 889999985 57877774321 12334667888999999999999999999999999999999887 7
Q ss_pred eEEecccccccccccc---ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCC
Q 019780 203 VKLADFGLAREEVMDE---MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKV 259 (336)
Q Consensus 203 ~kl~Dfg~a~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~ 259 (336)
+||+|||+++...... .....||..|+|||......++...|+|+|++.+|++..+.
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~ 365 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 9999999997543221 22346999999999998888999999999999999876544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=232.44 Aligned_cols=160 Identities=32% Similarity=0.556 Sum_probs=134.9
Q ss_pred CCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHH--hCCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS--KMKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~--~l~hpnIv~~~~~~~~~---- 134 (336)
.++..+.+.||+|.||.||+|.++|+.||||++.. .+...+.+|.++.. .|+|+||+.+++.-..+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~s--------rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSS--------RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecc--------cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 46788999999999999999999999999999962 22345667777765 46999999999875532
Q ss_pred -CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCCCCceeecCCCCceEE
Q 019780 135 -TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN--------SVIHRDLKPSNLLLTEDKKQVKL 205 (336)
Q Consensus 135 -~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--------~ivHrDikp~NIll~~~~~~~kl 205 (336)
++|||++|-+.|||+|||.+ ..++....++++.-+++||+|||.. .|.|||||..|||+..++ .+-|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~I 357 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCI 357 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEE
Confidence 28999999999999999944 5699999999999999999999954 599999999999999987 8999
Q ss_pred eccccccccccc------cccccCCcccccCCC
Q 019780 206 ADFGLAREEVMD------EMTCEAGTYRWMAPE 232 (336)
Q Consensus 206 ~Dfg~a~~~~~~------~~~~~~gt~~y~aPE 232 (336)
+|+|+|...... .....+||..|||||
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPE 390 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPE 390 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChH
Confidence 999999753322 133457999999999
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=228.39 Aligned_cols=232 Identities=21% Similarity=0.276 Sum_probs=177.5
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHH-HhCCCCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLL-SKMKHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+||.||+|... ++.||+|++..... ........+..|..++ ...+|||++++++++.+++ .++|+||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM--IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh--hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 56999999999999885 78999999863211 1122233344555444 4558999999999988765 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccccccccC
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA 223 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 223 (336)
+|++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..... .....
T Consensus 80 ~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~--~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE--NKKFV 154 (260)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEeecccceeccc--cccCC
Confidence 99999999944 35689999999999999999999999999999999999999876 799999999875332 23345
Q ss_pred CcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhcc----CCCCCCCCcccccCCCCCC
Q 019780 224 GTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRS----ADTPIPPKLVEIVDPKSTM 298 (336)
Q Consensus 224 gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~----~~~~~p~~~~~~~~~~~~~ 298 (336)
|+..|+|||.......+...|+|+++..++++..+..|.... ....+..+...... ....+|+++.+++...+..
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 889999999888777788999999999999988877775221 11122222221111 1124677888899999999
Q ss_pred CCccccch
Q 019780 299 NNDCMATV 306 (336)
Q Consensus 299 ~~~~~~~~ 306 (336)
+|+.|.+.
T Consensus 235 ~p~~R~~~ 242 (260)
T cd05611 235 DPAKRLGA 242 (260)
T ss_pred CHHHccCC
Confidence 99999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=209.78 Aligned_cols=213 Identities=29% Similarity=0.369 Sum_probs=177.1
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
.|...+.||+|.||+||+|++. ++.||+|.++.. ..++.......+|+.+|+.++|.|||+++++...+. +.+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrld---dddegvpssalreicllkelkhknivrl~dvlhsdkkltlv 79 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLD---DDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEecc---CCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence 4556788999999999999986 789999999853 223334567889999999999999999999987654 9999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-- 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-- 217 (336)
+|||+. +|..|..+ -++.++...++.++.|++.||.|+|++++.|||+||.|.+|+.+| .+|++|||+++.....
T Consensus 80 fe~cdq-dlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng-elkladfglarafgipvr 156 (292)
T KOG0662|consen 80 FEFCDQ-DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG-ELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHHhhH-HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC-cEEecccchhhhcCCceE
Confidence 999975 89888844 457799999999999999999999999999999999999999988 8999999999854322
Q ss_pred cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCH--hHHHHHHHHHHHhhccCC
Q 019780 218 EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEF--AEITITLTNILQNLRSAD 281 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~--~~i~~~l~~~~~~~~~~~ 281 (336)
..+...-|..|.+|..+.+ ..++.+.|+|+-+|..-+..-.-||-| .++.+.+..+...+....
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ 223 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCc
Confidence 3455678899999997665 468899999999999888888888864 467777777776655443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-33 Score=248.60 Aligned_cols=268 Identities=20% Similarity=0.226 Sum_probs=210.8
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEECCcc--EEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYGCEP--VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
.+...++..+..||-|+||.|-++..+++. +|+|++++ ....+.+..+.+..|-++|...+.|+||++|..|.++.
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK--~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKK--KHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhH--hhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 345567778889999999999998887554 89999984 55667778889999999999999999999999999886
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
+|++||-|-||.|...+ +..+.++..+++.++..+++|++|||++|||+|||||+|++++.+| .+||.|||+|+..
T Consensus 494 yvYmLmEaClGGElWTiL--rdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G-y~KLVDFGFAKki 570 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTIL--RDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG-YLKLVDFGFAKKI 570 (732)
T ss_pred hhhhhHHhhcCchhhhhh--hhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC-ceEEeehhhHHHh
Confidence 89999999999999999 4457899999999999999999999999999999999999999988 7999999999976
Q ss_pred cccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC-HhHHHHHHHHHHHhhc--cCCCCCCCCccc
Q 019780 215 VMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE-FAEITITLTNILQNLR--SADTPIPPKLVE 290 (336)
Q Consensus 215 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~-~~~i~~~l~~~~~~~~--~~~~~~p~~~~~ 290 (336)
.... .-++|||+.|.|||.+.....+.+.|.|+|+..++++..+..|. ..+-+.....+++.+. ..+..++.....
T Consensus 571 ~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~ 650 (732)
T KOG0614|consen 571 GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATD 650 (732)
T ss_pred ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHH
Confidence 6554 34678999999999999999999999999999999999998885 2233333333443322 233456666666
Q ss_pred ccCCCCCCCCcccc-----ch------hhhcccccccccccccchhhhhhc
Q 019780 291 IVDPKSTMNNDCMA-----TV------HAITKFNEKGKKRRSYLPSFLKRF 330 (336)
Q Consensus 291 ~~~~~~~~~~~~~~-----~~------~~~~~~~~~~~~~~~~~~~~~~~~ 330 (336)
++.++=.-+|..|- .+ .++..|++-+=+.+...+.|....
T Consensus 651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~v 701 (732)
T KOG0614|consen 651 LIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSV 701 (732)
T ss_pred HHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccC
Confidence 66666565665542 23 333345555444455555454443
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=235.39 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=195.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
.+|.+.+.||+|+||.||++... +..+++|.+... .....+.+.+|+.+++.++||||+++++.+.... .|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-----QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-----cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 67888999999999999999864 678999998521 2233567889999999999999999999887665 999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-CEEEccCcceecccccc
Confidence 9999999999999843 3578899999999999999999999999999999999999876 79999999886433222
Q ss_pred --ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh-hcc--CCCCCCCCccccc
Q 019780 219 --MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN-LRS--ADTPIPPKLVEIV 292 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~-~~~--~~~~~p~~~~~~~ 292 (336)
.....|++.|+|||.......+...|+|+++..+|+.-.+..|...+ ....+..+... ... ....+++.+.+++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 249 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHH
Confidence 22335888999999887777788999999999999998888875322 11111111110 000 1122455677888
Q ss_pred CCCCCCCCccccchhhhcccccccccc
Q 019780 293 DPKSTMNNDCMATVHAITKFNEKGKKR 319 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (336)
...+..+|+.|++..++.....-.+.+
T Consensus 250 ~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 250 NRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999998877655555
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=235.87 Aligned_cols=255 Identities=22% Similarity=0.231 Sum_probs=188.1
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHH---------HHHHHHHHHHHHHhCCCCceEeeE
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSRE---------HKEKFQREVTLLSKMKHENILKFV 128 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~---------~~~~~~~E~~~l~~l~hpnIv~~~ 128 (336)
..+++.+.+.||+|+||+||+|.+. ++.||||+++.......... ....+.+|+.+++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 3445556788999999999999875 78899999874322110000 112477899999999999999999
Q ss_pred eeEecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEec
Q 019780 129 GASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLAD 207 (336)
Q Consensus 129 ~~~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~D 207 (336)
+++.... .++||||+. |+|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~-~~kl~d 162 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG-ICKIAD 162 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC-CEEECC
Confidence 9988665 899999997 599999843 45689999999999999999999999999999999999999876 799999
Q ss_pred cccccccc----------------cccccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHH
Q 019780 208 FGLAREEV----------------MDEMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFA-EITIT 269 (336)
Q Consensus 208 fg~a~~~~----------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~ 269 (336)
||++.... ........++..|+|||...+. ..+...|+|+|++.++++..+..|... +-...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99987533 1112223467899999987653 357889999999999999887776521 11112
Q ss_pred HHHHHHhhcc----------------------------CCCCCCCCcccccCCCCCCCCccccchhhhccccccccc
Q 019780 270 LTNILQNLRS----------------------------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGKK 318 (336)
Q Consensus 270 l~~~~~~~~~----------------------------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (336)
+..+...... .....++++.+++...+..+|+.|++..++....+.+..
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 2222111100 011234556677788888899999998888876655433
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=232.44 Aligned_cols=246 Identities=25% Similarity=0.233 Sum_probs=184.7
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 134 (336)
..+|.+.+.||+|+||.||+|.+. ++.||+|+++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE---KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc---ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 467888999999999999999985 78899999874221 222345677899999999999999999987653
Q ss_pred -------CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEec
Q 019780 135 -------TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLAD 207 (336)
Q Consensus 135 -------~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~D 207 (336)
..++|+||+++ ++..++... ...+++..++.++.|++.||+|||+.||+|+||+|+||+++.++ .+||+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~kl~d 159 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLAD 159 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-cEEeCc
Confidence 38999999986 777777433 35689999999999999999999999999999999999999876 799999
Q ss_pred ccccccccccc---ccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCH-hHHHHHHHHHHHhhcc---
Q 019780 208 FGLAREEVMDE---MTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEF-AEITITLTNILQNLRS--- 279 (336)
Q Consensus 208 fg~a~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~-~~i~~~l~~~~~~~~~--- 279 (336)
||++....... .....++..|+|||.... ...+...|+|++++.+|++-.+..|.- .+....+..+.+....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99987543322 122346788999997654 345778999999999999887765542 2222233222221111
Q ss_pred ---------------------------CCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 280 ---------------------------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 280 ---------------------------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
....+|+.+.+++...+..+|+.|++..++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011356667777788888888888777766554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=259.94 Aligned_cols=240 Identities=25% Similarity=0.333 Sum_probs=177.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec------
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ------ 133 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------ 133 (336)
.+|..++.||+||||.||+++++ |+.||||.+.. .. +......+.+|+..|.+|+|||||+++..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl---~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPL---KA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccC---ch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 35677789999999999999987 99999999973 22 56677889999999999999999999861000
Q ss_pred --------------------------------------------------------------------------------
Q 019780 134 -------------------------------------------------------------------------------- 133 (336)
Q Consensus 134 -------------------------------------------------------------------------------- 133 (336)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 019780 134 -------------------------P--------T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179 (336)
Q Consensus 134 -------------------------~--------~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~l 179 (336)
+ . +||-||||+..+|.++++++.... .....+.+++||+.||+|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence 0 1 478899999988888885443211 4778999999999999999
Q ss_pred HhCCcccccCCCCceeecCCCCceEEeccccccccc--------------------cccccccCCcccccCCCCCCCCC-
Q 019780 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV--------------------MDEMTCEAGTYRWMAPENERPSL- 238 (336)
Q Consensus 180 H~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~--------------------~~~~~~~~gt~~y~aPE~~~~~~- 238 (336)
|++|||||||||.||+++.++ .|||+|||+|.... ....+..+||.-|+|||......
T Consensus 714 H~~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred HhCceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999999876 79999999997510 11234567999999999776655
Q ss_pred --CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCCCCCC--------CCcccccCCCCCCCCccccchhh
Q 019780 239 --ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIP--------PKLVEIVDPKSTMNNDCMATVHA 308 (336)
Q Consensus 239 --~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~p--------~~~~~~~~~~~~~~~~~~~~~~~ 308 (336)
++-+.|+|+||...+++-..--++++- ...|. +++....|.| +.-..++..+.+-+|..|++..+
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~yPF~TsMER-a~iL~----~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLYPFGTSMER-ASILT----NLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhccCCchHHH-HHHHH----hcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 889999999999999886543233332 22233 3333333333 22233455555556677776666
Q ss_pred hccc
Q 019780 309 ITKF 312 (336)
Q Consensus 309 ~~~~ 312 (336)
+.+.
T Consensus 868 LL~s 871 (1351)
T KOG1035|consen 868 LLNS 871 (1351)
T ss_pred Hhhc
Confidence 6543
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=232.85 Aligned_cols=243 Identities=20% Similarity=0.237 Sum_probs=185.6
Q ss_pred ceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT- 135 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~- 135 (336)
+|.+.+.||+|+||.||++... +..+|||+++.... .........+.+|+.++..+ +||||+++++.+..+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 3778899999999999998753 57899999873211 11233456788999999999 5999999998887665
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||+++...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 156 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-HVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEEECccccccc
Confidence 8899999999999999843 35688999999999999999999999999999999999999876 79999999987533
Q ss_pred ccc---ccccCCcccccCCCCCCCCC--CCCHHHHHHHHHHhhccCCCCCCCHh-----HHHHHHHHHHHhhccCCCCCC
Q 019780 216 MDE---MTCEAGTYRWMAPENERPSL--ENLSEDMVALLKSCWAEDPKVRPEFA-----EITITLTNILQNLRSADTPIP 285 (336)
Q Consensus 216 ~~~---~~~~~gt~~y~aPE~~~~~~--~~~~~di~~l~~~~l~~~p~~RP~~~-----~i~~~l~~~~~~~~~~~~~~p 285 (336)
... .....|+..|+|||...... .+...|+|+++..++++..+..|... ........+...........+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMS 236 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccC
Confidence 322 12235889999999866544 56789999999999999888887521 111111122222222233456
Q ss_pred CCcccccCCCCCCCCccccchhhh
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAI 309 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~ 309 (336)
+.+.+++...+..+|+.|++...+
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~ 260 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGA 260 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchH
Confidence 677888888898899998875443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=237.13 Aligned_cols=243 Identities=28% Similarity=0.331 Sum_probs=183.9
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-----
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP----- 134 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 134 (336)
++|.+.+.||+|+||.||+|.+. ++.||+|++... ........+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF----EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc----ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 57999999999999999999875 788999998631 1233456678899999999999999999876543
Q ss_pred -CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 -TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 -~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
..++|+||+.+ +|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++..
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~ 155 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKICDFGLARI 155 (336)
T ss_pred ceEEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEECcccceee
Confidence 27999999975 88888732 4689999999999999999999999999999999999999876 799999999875
Q ss_pred ccccc-----ccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHh----------
Q 019780 214 EVMDE-----MTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQN---------- 276 (336)
Q Consensus 214 ~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~---------- 276 (336)
..... .....|+..|+|||.... ...+...|+|+++..++++-.+..|... +....+..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 33221 122358899999997543 4567889999999999998877655421 111111100000
Q ss_pred ----------hc-----------cCCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 277 ----------LR-----------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 277 ----------~~-----------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.. ...+..++++.+++...+..+|+.|.+..++.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp 293 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 00 01123456677888888888999998888877643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=230.21 Aligned_cols=244 Identities=25% Similarity=0.288 Sum_probs=185.3
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~ 140 (336)
|++.+.||.|++|.||+|.+. +..||+|++.... ........+.+|+.+++.++|||++++++++.++. .+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET---EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccc---ccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence 456788999999999999875 8899999987421 12233456788999999999999999999988765 89999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--c
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--E 218 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~ 218 (336)
||++ ++|.+++.......+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++...... .
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRT 155 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-cEEEeecccccccCCCccc
Confidence 9995 6999998655545789999999999999999999999999999999999999876 8999999998753222 1
Q ss_pred ccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHh--------------------
Q 019780 219 MTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQN-------------------- 276 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~-------------------- 276 (336)
.....++..|+|||..... ..+...|+|+++..+|++-.+..|... +....+..+.+.
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 2233568899999976553 457889999999999998888776421 111111111110
Q ss_pred ---------hccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 277 ---------LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 277 ---------~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.....+.+++.+.+++...+..+|+.|++..++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011123445566777778888888888888777654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=232.67 Aligned_cols=239 Identities=26% Similarity=0.332 Sum_probs=190.1
Q ss_pred eeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEcc
Q 019780 67 QKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
...||+|+||.||++... +..||||.+... .......+.+|+.+++.++|+||+++++.+..++ .++||||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 467999999999999885 788999987521 2334667899999999999999999999888665 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--cccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~ 221 (336)
++++|.+++.. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++...... ....
T Consensus 100 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 100 EGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEcccccceecccccccccc
Confidence 99999998732 3588999999999999999999999999999999999999886 7999999988643322 1223
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhc---cCCCCCCCCcccccCCCCC
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLR---SADTPIPPKLVEIVDPKST 297 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~---~~~~~~p~~~~~~~~~~~~ 297 (336)
..|+..|+|||.......+...|+|+++..++++..+..|.... ....+..+..... .....+++.+.+++...+.
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 45889999999887777788999999999999999888885322 1222222222211 1223467778888999999
Q ss_pred CCCccccchhhhccccc
Q 019780 298 MNNDCMATVHAITKFNE 314 (336)
Q Consensus 298 ~~~~~~~~~~~~~~~~~ 314 (336)
.+|..|.+..++.....
T Consensus 256 ~~P~~R~~~~~ll~~~~ 272 (292)
T cd06657 256 RDPAQRATAAELLKHPF 272 (292)
T ss_pred CCcccCcCHHHHhcChH
Confidence 99999999988887543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=208.91 Aligned_cols=223 Identities=25% Similarity=0.350 Sum_probs=172.7
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEE--CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEec
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQ 133 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 133 (336)
+.+...+..-+..||+|++|.|-+-++ .|+..|+|.+.. ..+.+..+++++|+++..+. ..|++|.+|+...+
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~----tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRA----TVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehh----hcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 455556666678899999998866665 489999999972 34566778889999986554 69999999998665
Q ss_pred -CCEEEEEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCceEEeccc
Q 019780 134 -PTMMIITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 134 -~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
.+.|+.||.|+- ||..+-+. ..+..+++...-+|+..+..||.|||++ .+||||+||+||||+.+| ++|+||||
T Consensus 117 egdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFG 194 (282)
T KOG0984|consen 117 EGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFG 194 (282)
T ss_pred cccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccc
Confidence 569999999964 88776532 3567899999999999999999999988 899999999999999998 89999999
Q ss_pred cccccccccccc-cCCcccccCCCCCCC----CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCCCCC
Q 019780 210 LAREEVMDEMTC-EAGTYRWMAPENERP----SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPI 284 (336)
Q Consensus 210 ~a~~~~~~~~~~-~~gt~~y~aPE~~~~----~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~ 284 (336)
++-....+-..+ ..|...|||||.+.+ ..++..+|+|+|+..++++....-|- ...--.++++.+......+.+
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY-~~w~tpF~qLkqvVeep~P~L 273 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPY-ESWGTPFQQLKQVVEEPSPQL 273 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccc-cccCCHHHHHHHHhcCCCCCC
Confidence 998765554333 569999999996543 46788999999999999998777662 222223344444444444444
Q ss_pred CC
Q 019780 285 PP 286 (336)
Q Consensus 285 p~ 286 (336)
|.
T Consensus 274 p~ 275 (282)
T KOG0984|consen 274 PA 275 (282)
T ss_pred cc
Confidence 43
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=230.29 Aligned_cols=244 Identities=24% Similarity=0.342 Sum_probs=194.6
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
..|...+.||+|+||.||+|.+. +..+++|++..... ....+.+|+.+++.++|+||+++++.+.... .++
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 55778899999999999999986 78899999974211 4567889999999999999999999888665 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
++||++|++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC-CEEECccchhhhhccch
Confidence 999999999999996543 4789999999999999999999999999999999999999876 7999999987643322
Q ss_pred -cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh-hccCC--CCCCCCccccc
Q 019780 218 -EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN-LRSAD--TPIPPKLVEIV 292 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~-~~~~~--~~~p~~~~~~~ 292 (336)
......++..|+|||.......+...|+|+++..++++..+..|.... -......+... ..... ..+|.++.+++
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence 122334788999999988888888999999999999998888874321 11111112111 11111 12667788899
Q ss_pred CCCCCCCCccccchhhhcccc
Q 019780 293 DPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~ 313 (336)
...+..+|+.|++..++....
T Consensus 251 ~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 251 NKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred HHHhccChhhCcCHHHHhhCh
Confidence 999999999999998887644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=228.07 Aligned_cols=237 Identities=19% Similarity=0.201 Sum_probs=178.5
Q ss_pred ceeEeee--ecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-E
Q 019780 63 SVLLQKM--IGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-M 136 (336)
Q Consensus 63 ~~~~~~~--lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~ 136 (336)
.|.+.+. ||+|+||.||++... +..+|+|++..... . ..|+.....+ +||||+++++.+..++ .
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~---~-------~~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF---N-------AIEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc---c-------hhhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 4444454 599999999999875 77899999863211 0 0122222222 6999999999988665 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++..++|+|||++.....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 9999999999999999543 47899999999999999999999999999999999999998765799999999875432
Q ss_pred ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH--HHHHHHHhh---ccCCCCCCCCcccc
Q 019780 217 DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITI--TLTNILQNL---RSADTPIPPKLVEI 291 (336)
Q Consensus 217 ~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~--~l~~~~~~~---~~~~~~~p~~~~~~ 291 (336)
. ....|+..|+|||.......+...|+|+++..++++-.+.-|....-.. .+..+.... .......++.+.++
T Consensus 163 ~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T PHA03390 163 P--SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDF 240 (267)
T ss_pred C--ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHH
Confidence 2 2345889999999988888888999999999999988887775321100 112222221 12223466778888
Q ss_pred cCCCCCCCCccccc-hhhhcccc
Q 019780 292 VDPKSTMNNDCMAT-VHAITKFN 313 (336)
Q Consensus 292 ~~~~~~~~~~~~~~-~~~~~~~~ 313 (336)
+...+..+|..|.+ +.++.+..
T Consensus 241 i~~~l~~~p~~R~~~~~~~l~h~ 263 (267)
T PHA03390 241 VQSMLKYNINYRLTNYNEIIKHP 263 (267)
T ss_pred HHHHhccChhhCCchHHHHhcCC
Confidence 88999999999874 57776544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=226.00 Aligned_cols=232 Identities=25% Similarity=0.284 Sum_probs=186.6
Q ss_pred ecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccCCC
Q 019780 70 IGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRGE 146 (336)
Q Consensus 70 lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~gg 146 (336)
||+|+||.||++... ++.+++|++... ..........+..|+.+++.++||||+++++.+.++. .++||||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKK--KIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehh--hhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 699999999999986 789999998742 2223345678899999999999999999999887665 89999999999
Q ss_pred CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--cccccCC
Q 019780 147 TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EMTCEAG 224 (336)
Q Consensus 147 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~~~g 224 (336)
+|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...... ......+
T Consensus 79 ~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 79 ELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCcccCCcC
Confidence 999999443 4689999999999999999999999999999999999999876 7999999998764432 2334458
Q ss_pred cccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCCccc
Q 019780 225 TYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNNDCM 303 (336)
Q Consensus 225 t~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 303 (336)
+..|+|||.......+...|+|+|+..+|+.-.+..|... +.......+.+.........|..+.+++...+..+|+.|
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R 235 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence 8999999998888888899999999999988877777522 112222223222223344557778889999999899888
Q ss_pred cch
Q 019780 304 ATV 306 (336)
Q Consensus 304 ~~~ 306 (336)
.+.
T Consensus 236 ~~~ 238 (250)
T cd05123 236 LGS 238 (250)
T ss_pred CCc
Confidence 887
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=231.26 Aligned_cols=259 Identities=25% Similarity=0.290 Sum_probs=197.1
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEee
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGA 130 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~ 130 (336)
+..+.++..+|.+.+.||+|+||.||+|.+. ++.||||.++... .......+.+|+.++.... ||||++++++
T Consensus 7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----NKEENKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred ceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC----ChHHHHHHHHHHHHHHhccCCCchHhhhee
Confidence 3456677788999999999999999999987 8899999987321 2233455667777776665 9999999999
Q ss_pred EecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCceEEecc
Q 019780 131 SVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKKQVKLADF 208 (336)
Q Consensus 131 ~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~~~~~kl~Df 208 (336)
+.+.. .++||||+. ++|.+++... ...+++..+..++.|++.||+|||+ .|++||||+|+||+++.++ .++|+||
T Consensus 83 ~~~~~~~~~v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~df 159 (296)
T cd06618 83 FITDSDVFICMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDF 159 (296)
T ss_pred eecCCeEEEEeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECcc
Confidence 88765 899999985 4777776442 3478999999999999999999997 5999999999999999876 8999999
Q ss_pred cccccccccc-ccccCCcccccCCCCCCCCC----CCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHHHhhc-cC
Q 019780 209 GLAREEVMDE-MTCEAGTYRWMAPENERPSL----ENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNILQNLR-SA 280 (336)
Q Consensus 209 g~a~~~~~~~-~~~~~gt~~y~aPE~~~~~~----~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~~~~~-~~ 280 (336)
|++....... .....++..|+|||...... .+...|+|+++..++++..+..|... +-.+.+........ ..
T Consensus 160 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T cd06618 160 GISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239 (296)
T ss_pred ccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC
Confidence 9987543221 22334788999999876443 66789999999999999988888532 11222222222111 11
Q ss_pred --CCCCCCCcccccCCCCCCCCccccchhhhcccccccccc
Q 019780 281 --DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGKKR 319 (336)
Q Consensus 281 --~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (336)
....++++.+++...+..+|+.|++..++.......+.+
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 112466688899999999999999999998877655544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=229.36 Aligned_cols=248 Identities=22% Similarity=0.277 Sum_probs=188.8
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
+|.+.+.||+|+||.||++.+. +..+++|+++..............+.+|+.+++.++||||+++++++.+.. .++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999876 445677777642222223334456778999999999999999999887655 8999
Q ss_pred EEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 140 TELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||+++++|.+++.. .....+++..++.++.|++.||.|||+.|++|+||+|+||+++. + .++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~-~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-N-LLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-C-CEeecccCceeecCCC
Confidence 999999999998854 23457899999999999999999999999999999999999985 3 6999999998754322
Q ss_pred c--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh-hccCCCCCCCCcccccC
Q 019780 218 E--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN-LRSADTPIPPKLVEIVD 293 (336)
Q Consensus 218 ~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~-~~~~~~~~p~~~~~~~~ 293 (336)
. .....|+..|+|||.......+...|+|+++..+|++-.+..|.... ........... ........++++.+++.
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence 2 22345888999999887777788899999999999887777665322 22222222211 11222345667778888
Q ss_pred CCCCCCCccccchhhhccc
Q 019780 294 PKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~ 312 (336)
..+..+|+.|++..++.+.
T Consensus 239 ~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHhcCChhhCcCHHHHhhC
Confidence 8888899999888877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=236.45 Aligned_cols=246 Identities=28% Similarity=0.325 Sum_probs=191.4
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC------
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP------ 134 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------ 134 (336)
+|.+.+.||+|+||.||+|... +..+|||.+... .......+.+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV---FDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccc---cccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 4788899999999999999975 689999998732 11244567789999999999999999999988765
Q ss_pred CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 135 TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 135 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
..|++|+|+++ +|.+++.. ...+++..++.++.|++.||+|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus 78 ~~~lv~e~~~~-~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~ 153 (330)
T cd07834 78 DVYIVTELMET-DLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGV 153 (330)
T ss_pred ceEEEecchhh-hHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccCceEee
Confidence 48999999974 89998843 34799999999999999999999999999999999999999886 8999999998864
Q ss_pred cccc-----ccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhh----------
Q 019780 215 VMDE-----MTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNL---------- 277 (336)
Q Consensus 215 ~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~---------- 277 (336)
.... .....++..|+|||..... ..+...|+|+++..++++-.+..|... .....+..+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 4332 2334578899999988777 788899999999999988776655311 1111111111110
Q ss_pred ---------------------ccCCCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 278 ---------------------RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 278 ---------------------~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
....+.+++++.+++...+..+|+.|++..++.....-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 292 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence 00123356677788889999999999998888875443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=229.68 Aligned_cols=249 Identities=26% Similarity=0.306 Sum_probs=191.4
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~ 140 (336)
|...+.||+|+||+||+|... +..+++|++.... .........+.+|+.+++.++|||++++++++.+.. .|+||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSG--KQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccc--cCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 555678999999999999874 7889999986321 223344567889999999999999999999988765 89999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccccc
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMT 220 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~ 220 (336)
||+. |+|.+++... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.... ...
T Consensus 101 e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~--~~~ 175 (313)
T cd06633 101 EYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS--PAN 175 (313)
T ss_pred ecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-CEEEeecCCCcccC--CCC
Confidence 9996 4787777433 35689999999999999999999999999999999999999876 79999999986432 223
Q ss_pred ccCCcccccCCCCCC---CCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh-hc-cCCCCCCCCcccccCC
Q 019780 221 CEAGTYRWMAPENER---PSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN-LR-SADTPIPPKLVEIVDP 294 (336)
Q Consensus 221 ~~~gt~~y~aPE~~~---~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~-~~-~~~~~~p~~~~~~~~~ 294 (336)
...|+..|+|||... ....+...|+|+++..+|++-.+.+|.... -...+...... .. ......+..+.+++..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 446889999999863 355677899999999999999888886432 12222222211 11 1112344567778888
Q ss_pred CCCCCCccccchhhhcccccccccc
Q 019780 295 KSTMNNDCMATVHAITKFNEKGKKR 319 (336)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (336)
.+..+|..|++..++......++.+
T Consensus 256 ~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 256 CLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999988888766554433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=227.52 Aligned_cols=193 Identities=28% Similarity=0.301 Sum_probs=160.7
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---CEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---TMMI 138 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~l 138 (336)
|.+.+.||+|+||.||+|... ++.+|+|++.... ........+.+|+.+++.++|||++++++++.+. ..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 567889999999999999986 6889999998421 2233456688999999999999999999998866 4999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|+||+++ +|.+++... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 78 VFEYMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-VLKLADFGLARPYTKRN 154 (287)
T ss_pred Eeccccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-CEEEccccceeeccCCC
Confidence 9999975 898888443 25789999999999999999999999999999999999999877 79999999987544332
Q ss_pred ---ccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 219 ---MTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 219 ---~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.....++..|+|||...+ ...+...|+|+++..+|++-.+..|.
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~ 202 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCC
Confidence 233457889999997654 45678899999999999988887774
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=241.45 Aligned_cols=202 Identities=21% Similarity=0.254 Sum_probs=172.0
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
..+..-|..++.||-|+||.|.+++.. ...||+|.+++ ...........++.|-.||...+.+-||++|..|+|.+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrK--aDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRK--ADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 702 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHH--HHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence 455667888999999999999998754 66799999984 33445566778999999999999999999999999876
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
+|+||+|++||++..+| .+-+.+++..++.++.++..|+++.|..|+|||||||+|||||.+| ++||+|||+|.-.
T Consensus 703 nLYFVMdYIPGGDmMSLL--IrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG-HIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLL--IRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGF 779 (1034)
T ss_pred ceEEEEeccCCccHHHHH--HHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC-ceeeeeccccccc
Confidence 99999999999999998 4457799999999999999999999999999999999999999998 8999999998510
Q ss_pred c---------------------ccc-----------------------ccccCCcccccCCCCCCCCCCCCHHHHHHHHH
Q 019780 215 V---------------------MDE-----------------------MTCEAGTYRWMAPENERPSLENLSEDMVALLK 250 (336)
Q Consensus 215 ~---------------------~~~-----------------------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~ 250 (336)
. ..+ ....+||+.|+|||++....++..-|+|+++.
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 0 000 01225999999999999999999999999999
Q ss_pred HhhccCCCCCCCHh
Q 019780 251 SCWAEDPKVRPEFA 264 (336)
Q Consensus 251 ~~l~~~p~~RP~~~ 264 (336)
.++++.-++-|..+
T Consensus 860 il~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLA 873 (1034)
T ss_pred HHHHHhhCCCCccC
Confidence 99998888777433
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=234.04 Aligned_cols=245 Identities=24% Similarity=0.275 Sum_probs=186.5
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC---
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT--- 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 135 (336)
..+|++.+.||+|+||.||+|... +..||||++... .........+.+|+.+|+.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc---ccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 456999999999999999999875 788999998632 123334567889999999999999999999887532
Q ss_pred ----EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 136 ----MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 136 ----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
+++||+|+ |++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~ 165 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLA 165 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccc
Confidence 58999998 6799988842 4689999999999999999999999999999999999999876 7999999998
Q ss_pred cccccccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHH--------------
Q 019780 212 REEVMDEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQ-------------- 275 (336)
Q Consensus 212 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~-------------- 275 (336)
..... ......+++.|+|||.... ...+...|+|+|+..+++.-.+..|.... ....+..+..
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 166 RQTDS-EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ccccc-CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 75432 2233457899999997765 34678899999999999888877775211 0111111100
Q ss_pred ---------h--------hccCCCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 276 ---------N--------LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 276 ---------~--------~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
. +......+++++.+++...+..+|+.|.+..++.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~ 300 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 0 01112345566677777888888888888877775443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=237.04 Aligned_cols=251 Identities=24% Similarity=0.289 Sum_probs=189.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec-----C
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ-----P 134 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~ 134 (336)
.+|.+.+.||+|+||.||+|... +..||+|++... .........+.+|+.+|+.++||||+++++++.. .
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA---FDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccc---cccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 67888999999999999999875 789999998732 1122345667889999999999999999887653 2
Q ss_pred CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 135 TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 135 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
..++||||+. ++|.+++. ....+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhh-hhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence 3799999996 58999884 345699999999999999999999999999999999999999887 7999999998754
Q ss_pred cccc------ccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHH----------------
Q 019780 215 VMDE------MTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITL---------------- 270 (336)
Q Consensus 215 ~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l---------------- 270 (336)
.... .....|+..|+|||.... ...+...|+|+++..++++..+..|.... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 3221 123468899999997654 44678899999999999987666654111 00001
Q ss_pred -------HHHHHhhcc--------CCCCCCCCcccccCCCCCCCCccccchhhhcccccccccc
Q 019780 271 -------TNILQNLRS--------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGKKR 319 (336)
Q Consensus 271 -------~~~~~~~~~--------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (336)
....+.... ..+..++++.+++...+..+|+.|.+..++....+-.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 011111110 0123567788889999999999999988887755444433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=230.59 Aligned_cols=245 Identities=27% Similarity=0.304 Sum_probs=189.1
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
+.|...+.||+|+||.||+|.+. +..+|+|++.... ....+....+.+|+.+++.++|||++++++++.++. .++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCC--CCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 34777889999999999999874 7889999986321 223345567889999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||+.| +|.+++... ...+++..+..++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++.....
T Consensus 103 v~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 103 VMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASIASP-- 177 (317)
T ss_pred EEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC-CEEEecCCCccccCC--
Confidence 9999975 787777433 35689999999999999999999999999999999999999876 799999999875332
Q ss_pred ccccCCcccccCCCCCC---CCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhc--cCCCCCCCCccccc
Q 019780 219 MTCEAGTYRWMAPENER---PSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLR--SADTPIPPKLVEIV 292 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~---~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~--~~~~~~p~~~~~~~ 292 (336)
.....|+..|+|||... ....+...|+|+++..+|++..+..|.+... ...+..+..... ......++.+.+++
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 23345889999999863 3456778999999999999998888864431 111222222111 11123455677788
Q ss_pred CCCCCCCCccccchhhhcccc
Q 019780 293 DPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~ 313 (336)
...+..+|..|++..++.+..
T Consensus 258 ~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 258 DSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred HHHccCCcccCcCHHHHHhCh
Confidence 888988999999888887643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=229.17 Aligned_cols=196 Identities=23% Similarity=0.264 Sum_probs=156.9
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC--
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-- 135 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-- 135 (336)
+.++|.+.+.||+|+||.||+|... ++.||||.+.... ........+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccC---CcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 3467999999999999999999985 7899999986321 12222345678999999999999999999876432
Q ss_pred -------EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecc
Q 019780 136 -------MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADF 208 (336)
Q Consensus 136 -------~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Df 208 (336)
.++||||+.+ +|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+||
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~df 163 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADF 163 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-cEEECcC
Confidence 5999999975 888887433 34689999999999999999999999999999999999999876 7999999
Q ss_pred cccccccccc------ccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCC
Q 019780 209 GLAREEVMDE------MTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRP 261 (336)
Q Consensus 209 g~a~~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP 261 (336)
|++....... .....++..|+|||..... ..+...|+|+++..++++-.+..|
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~ 223 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI 223 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCC
Confidence 9987533221 1233477899999976553 356789999999999988765544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=235.47 Aligned_cols=247 Identities=26% Similarity=0.298 Sum_probs=187.9
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-----
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP----- 134 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 134 (336)
+.|.+.+.||+|+||+||+|.+. +..||||.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF---DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc---cccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 46888999999999999999975 7899999987321 1223345677899999999999999999887643
Q ss_pred -CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 -TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 -~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
..++|+||+. ++|.+++. ....+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++..
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcCccccc
Confidence 2799999996 68998884 346799999999999999999999999999999999999999876 799999999975
Q ss_pred cccc--cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHH---------------
Q 019780 214 EVMD--EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNIL--------------- 274 (336)
Q Consensus 214 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~--------------- 274 (336)
.... ......++..|+|||.... ...+...|+|+|+..++++..+..|... +....+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 4332 1223457889999997654 4577889999999999998877766421 1111111000
Q ss_pred --------Hhh--------ccCCCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 275 --------QNL--------RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 275 --------~~~--------~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
+.. ....+.+++++.+++...+..+|+.|.+..++.+...-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~ 294 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence 000 00113456677788888899999999988887765443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=238.89 Aligned_cols=199 Identities=24% Similarity=0.282 Sum_probs=165.8
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCcccccc---HHHHHHHHHHHHHHHhCC---CCceEeeEeeEe
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVS---REHKEKFQREVTLLSKMK---HENILKFVGASV 132 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~ 132 (336)
..+|..++.+|.|+||.|++|.++ ...|+||.+.+.+..... ....-.+-.|+.||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346899999999999999999997 567899988743221110 011122456999999997 999999999999
Q ss_pred cCC-EEEEEEcc-CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 133 QPT-MMIITELM-RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 133 ~~~-~~lv~e~~-~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
+++ +||+||-- +|.+|++++ .....+++.++..|+.|++.|+++||++||||||||-+|+.++.+| -+||+|||.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~I--E~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g-~~klidfgs 716 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFI--EFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG-FVKLIDFGS 716 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhh--hccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC-eEEEeeccc
Confidence 887 78888865 467999999 4446799999999999999999999999999999999999999988 799999999
Q ss_pred ccccccccccccCCcccccCCCCCCCCCC-CCHHHHHHHHHHhhccCCCCCCC
Q 019780 211 AREEVMDEMTCEAGTYRWMAPENERPSLE-NLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 211 a~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
|..........++||..|.|||.+.+.++ +.+.|||+|+..++..-..+-|-
T Consensus 717 aa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 717 AAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred hhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 98877777778899999999999988765 57899999999888766665553
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=226.19 Aligned_cols=241 Identities=21% Similarity=0.253 Sum_probs=178.5
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecC--C-EE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQP--T-MM 137 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~-~~ 137 (336)
|.+.+.||+|+||.||+|... +..+|+|+++... ... ......+|+.++.++. ||||+++++++.++ . .+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~---~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF---KSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhcc---CCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 567889999999999999875 7889999987321 111 1223457888898886 99999999998865 3 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||+++ +|.+.+... ...+++..++.++.|++.||.|||+.|++||||+|+||+++. + .++|+|||++......
T Consensus 77 lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 77 LVFELMDM-NLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYSK 152 (282)
T ss_pred EEEecCCc-cHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C-CeEEEecccccccccC
Confidence 99999975 888887543 256899999999999999999999999999999999999998 5 8999999999754322
Q ss_pred c-ccccCCcccccCCCCCC-CCCCCCHHHHHHHHHHhhccCCCCCCCH----hHHHHHHHHHHHh--------h------
Q 019780 218 E-MTCEAGTYRWMAPENER-PSLENLSEDMVALLKSCWAEDPKVRPEF----AEITITLTNILQN--------L------ 277 (336)
Q Consensus 218 ~-~~~~~gt~~y~aPE~~~-~~~~~~~~di~~l~~~~l~~~p~~RP~~----~~i~~~l~~~~~~--------~------ 277 (336)
. .....++..|+|||... ....+...|+|++++.++++-.+..|.- .+....+...... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 2 23345789999999653 3456778999999999998876655541 1222222111100 0
Q ss_pred ------------ccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 278 ------------RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 278 ------------~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
......++.++.+++...+..+|+.|++..++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00012345667778888888888888888777654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=233.92 Aligned_cols=191 Identities=22% Similarity=0.280 Sum_probs=155.5
Q ss_pred eeecCC--CcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEc
Q 019780 68 KMIGEG--SYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITEL 142 (336)
Q Consensus 68 ~~lg~G--~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~ 142 (336)
..||+| +||+||+|.+. ++.||+|++... .......+.+.+|+.+++.++||||+++++++..+. .++|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLE---NCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccc---cCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence 346666 99999999884 899999998742 223345678999999999999999999999998765 8999999
Q ss_pred cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc----
Q 019780 143 MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE---- 218 (336)
Q Consensus 143 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~---- 218 (336)
+.+++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.++ .++++||+.+.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhccCcccc
Confidence 9999999999665555689999999999999999999999999999999999999876 79999998643211110
Q ss_pred -----ccccCCcccccCCCCCCCC--CCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 219 -----MTCEAGTYRWMAPENERPS--LENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 219 -----~~~~~gt~~y~aPE~~~~~--~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.....++..|+|||..... ..+...|+|++++.++++-.+..|.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 210 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 0111245679999988653 3567899999999999998887775
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=246.31 Aligned_cols=217 Identities=35% Similarity=0.590 Sum_probs=182.2
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC---------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCc
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG---------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HEN 123 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn 123 (336)
+..|.++.++..+.+.||+|.||.|++|... ...||||.++. .......+.+..|+.+|+.+. |||
T Consensus 288 ~~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~----~~~~~~~~~~~~El~~m~~~g~H~n 363 (609)
T KOG0200|consen 288 DPKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKE----NASSSEKKDLMSELNVLKELGKHPN 363 (609)
T ss_pred CCceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccc----ccCcHHHHHHHHHHHHHHHhcCCcc
Confidence 3378899999999999999999999999743 34689999873 223367889999999999996 999
Q ss_pred eEeeEeeEecC-CEEEEEEccCCCCHHHHHhhcC------C--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 019780 124 ILKFVGASVQP-TMMIITELMRGETLQRYLWSTR------P--------KRLDLKHSISFALDISRAMEYLHANSVIHRD 188 (336)
Q Consensus 124 Iv~~~~~~~~~-~~~lv~e~~~gg~L~~~l~~~~------~--------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrD 188 (336)
|+.+++++.+. ..++|+||+..|+|.++++..+ . ..++....+.++.||+.|++||++.++||||
T Consensus 364 iv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRD 443 (609)
T KOG0200|consen 364 IVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRD 443 (609)
T ss_pred hhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchh
Confidence 99999998874 4999999999999999996554 0 1388999999999999999999999999999
Q ss_pred CCCCceeecCCCCceEEeccccccccccccccc---cCC--cccccCCC-------------------------------
Q 019780 189 LKPSNLLLTEDKKQVKLADFGLAREEVMDEMTC---EAG--TYRWMAPE------------------------------- 232 (336)
Q Consensus 189 ikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~---~~g--t~~y~aPE------------------------------- 232 (336)
|.++|||+..+. .+||+|||+|+......... ..| ...|||||
T Consensus 444 LAaRNVLi~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 444 LAARNVLITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hhhhhEEecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence 999999999876 89999999999644433322 122 35699999
Q ss_pred ----------------CCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 233 ----------------NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 233 ----------------~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
.....|..++.++|.++..||+.+|.+||+|.++...++..++
T Consensus 523 p~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 523 PGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1335567788999999999999999999999999999998654
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=232.49 Aligned_cols=245 Identities=27% Similarity=0.299 Sum_probs=183.2
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 134 (336)
.++|.+.+.||+|+||.||+|... ++.||+|++.... ........+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 477999999999999999999864 7889999986421 1233456688999999999999999999987532
Q ss_pred ---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 135 ---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 135 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
..+++++++ |++|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++ .++|+|||++
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~dfg~~ 167 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLA 167 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-CEEEeccccc
Confidence 267777776 7799888732 3589999999999999999999999999999999999999887 7999999998
Q ss_pred cccccccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHH--------------
Q 019780 212 REEVMDEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQ-------------- 275 (336)
Q Consensus 212 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~-------------- 275 (336)
+.... ......++..|+|||.... ...+.+.|+|++++.++++-.+..|... +....+..+..
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 168 RHTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred ccccc-cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 75432 2333468899999997655 4567789999999999998877776421 11111111111
Q ss_pred ---------hhccC--------CCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 276 ---------NLRSA--------DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 276 ---------~~~~~--------~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
.+... ....++++.+++...+..+|+.|.+..++.....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 10000 0123455667777778888888887777765443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=227.90 Aligned_cols=249 Identities=24% Similarity=0.298 Sum_probs=188.0
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC--C
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP--T 135 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~ 135 (336)
..++|.+.+.||.|+||.||+|... +..||+|++.... ........+.+|+.+++.++||||+++++++... .
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF---STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc---cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3467999999999999999999875 7889999886321 1223456678999999999999999999988753 4
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
.++++||+ +++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC-DLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-CEEeCccccccccC
Confidence 89999998 5689888832 4578888999999999999999999999999999999999876 79999999987532
Q ss_pred cccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHhH----HHHHHHHH-----------------
Q 019780 216 MDEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFAE----ITITLTNI----------------- 273 (336)
Q Consensus 216 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~~----i~~~l~~~----------------- 273 (336)
. ......++..|+|||.... ...+...|+|++++.++++-.+..|.... ....+.+.
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 160 P-QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred C-CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 2 2233457889999998654 56788899999999999888776664211 11111110
Q ss_pred ---HHhhcc--------CCCCCCCCcccccCCCCCCCCccccchhhhcccccccc
Q 019780 274 ---LQNLRS--------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 274 ---~~~~~~--------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
...+.. ..+.+++++.+++...+..+|+.|++..++.......+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 111110 01234566777888888889999998888877654433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=224.90 Aligned_cols=194 Identities=28% Similarity=0.328 Sum_probs=158.5
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC---CCCceEeeEeeEecCC---
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM---KHENILKFVGASVQPT--- 135 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~--- 135 (336)
|.+.+.||+|+||.||+|.+. +..+|+|+++.... .......+.+|+.+++.+ +||||+++++++.+..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS---EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc---cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 567889999999999999986 78999999974221 222334566777776655 6999999999987543
Q ss_pred ---EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 136 ---MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 136 ---~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
.+++|||+.+ +|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.
T Consensus 78 ~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~-~~~l~dfg~~~ 155 (287)
T cd07838 78 ELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLAR 155 (287)
T ss_pred CceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC-CEEEeccCcce
Confidence 7999999975 899988655445689999999999999999999999999999999999999886 89999999987
Q ss_pred cccccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 213 EEVMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 213 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
...... .....++..|+|||.......+.+.|+|++++.++++-.+..|.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~ 206 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF 206 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcc
Confidence 643322 22334788999999998888889999999999999987775553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=228.44 Aligned_cols=195 Identities=24% Similarity=0.249 Sum_probs=156.8
Q ss_pred ceeEeeeecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC--C-
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP--T- 135 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~- 135 (336)
.|.+.+.||+|+||.||+|... +..||+|.+..... ........+.+|+.+++.++||||+++++++.+. .
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 3778899999999999999984 58899999974221 1223345678899999999999999999998876 4
Q ss_pred EEEEEEccCCCCHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC----CCCceEEecc
Q 019780 136 MMIITELMRGETLQRYLWST---RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE----DKKQVKLADF 208 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~----~~~~~kl~Df 208 (336)
.++||||+++ +|.+++... ....+++..++.++.|++.||.|||+.|++||||||+||+++. ++ .+||+||
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~-~~kl~Df 156 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG-VVKIGDL 156 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc-eEEECCC
Confidence 8999999975 777776422 2236899999999999999999999999999999999999998 65 7999999
Q ss_pred cccccccccc-----ccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCC
Q 019780 209 GLAREEVMDE-----MTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRP 261 (336)
Q Consensus 209 g~a~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP 261 (336)
|++....... .....++..|+|||.... ...+...|+|+|+..++++-.+..|
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 215 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence 9987532221 122357889999997655 3467889999999999988776655
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=229.39 Aligned_cols=246 Identities=26% Similarity=0.289 Sum_probs=183.0
Q ss_pred ceeEeeeecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEec----
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQ---- 133 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~---- 133 (336)
+|.+.+.||+|+||.||++... +..||+|++... .......+.+.+|+.+++.++ ||||+++++....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNV---FSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccc---cccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 4778899999999999999986 458999998631 112234566788999999994 9999999986432
Q ss_pred -CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 -PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
...+++++++. ++|.+++. ....+++..++.++.|++.||.|||++|++||||||+|||++.++ .++|+|||+++
T Consensus 78 ~~~~~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~ 153 (332)
T cd07857 78 FNELYLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-ELKICDFGLAR 153 (332)
T ss_pred CCcEEEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence 23788888886 58999884 345789999999999999999999999999999999999999876 79999999987
Q ss_pred cccccc------ccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHh--------
Q 019780 213 EEVMDE------MTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQN-------- 276 (336)
Q Consensus 213 ~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~-------- 276 (336)
...... .....|+..|+|||.... ...+...|+|+++..++++-.+..|... +....+..+...
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 532211 122358899999997654 5678889999999999988777666411 111111111110
Q ss_pred ---------------h--------ccCCCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 277 ---------------L--------RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 277 ---------------~--------~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
. ....+..++.+.+++...+..+|..|.+..++......
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~ 295 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 0 01112345567778888899999999998888765544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=233.10 Aligned_cols=246 Identities=22% Similarity=0.245 Sum_probs=184.8
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-----
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP----- 134 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 134 (336)
.+|.+.+.||.|+||.||+|... +..||+|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-----CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 67899999999999999999885 7889999986422 23456788999999999999999998765543
Q ss_pred ----------CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceE
Q 019780 135 ----------TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVK 204 (336)
Q Consensus 135 ----------~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~k 204 (336)
..++||||++ ++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++..++
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEE
Confidence 3689999997 589888832 46899999999999999999999999999999999999986665799
Q ss_pred Eecccccccccccc-----ccccCCcccccCCCCCC-CCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHH--
Q 019780 205 LADFGLAREEVMDE-----MTCEAGTYRWMAPENER-PSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQ-- 275 (336)
Q Consensus 205 l~Dfg~a~~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~-- 275 (336)
|+|||++....... .....++..|+|||... +...+...|+|+|++.+|++..+..|.... -...+..+..
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999987532211 12235788999999653 455677899999999999988887775211 0011111100
Q ss_pred -----------------hhc-----------cCCCCCCCCcccccCCCCCCCCccccchhhhccccccc
Q 019780 276 -----------------NLR-----------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKG 316 (336)
Q Consensus 276 -----------------~~~-----------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (336)
... ...+.++.++.+++...+..+|+.|.+..++.......
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 000 00123445566778888888899998888887765544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=219.14 Aligned_cols=250 Identities=22% Similarity=0.271 Sum_probs=189.8
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEee
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGA 130 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~ 130 (336)
+.....+.++.+.+..||+|+-|.||++++. +...|||.+.. ..+.+..++++..+.++..-+ .|+||+++|+
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~r----t~Nkee~kRILmDldvv~~s~dcpyIV~c~Gy 159 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRR----TGNKEENKRILMDLDVVLKSHDCPYIVQCFGY 159 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecc----cCCHHHHHHHHHhhhHHhhccCCCeeeeeeeE
Confidence 3445566677788889999999999999987 58899999973 456777888999999887665 8999999999
Q ss_pred EecC-CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCceEEecc
Q 019780 131 SVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADF 208 (336)
Q Consensus 131 ~~~~-~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~~~~~~~kl~Df 208 (336)
|..+ +.++.||.|. ..+..++++ ..+.+++..+-.+...++.||.||.++ ||+|||+||+|||+|..| ++|||||
T Consensus 160 Fi~n~dV~IcMelMs-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDF 236 (391)
T KOG0983|consen 160 FITNTDVFICMELMS-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDF 236 (391)
T ss_pred EeeCchHHHHHHHHH-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeecc
Confidence 9866 4899999984 356666644 346699999999999999999999865 899999999999999887 7999999
Q ss_pred ccccccccccc-cccCCcccccCCCCCCCC---CCCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHHHhhccCC-
Q 019780 209 GLAREEVMDEM-TCEAGTYRWMAPENERPS---LENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNILQNLRSAD- 281 (336)
Q Consensus 209 g~a~~~~~~~~-~~~~gt~~y~aPE~~~~~---~~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~~~~~~~~- 281 (336)
|++.....+.. +...|.+.|||||.+.+. .+++..|+|+|+..+.++.+++-|... .=...|..+.+......
T Consensus 237 GIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~ 316 (391)
T KOG0983|consen 237 GISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLP 316 (391)
T ss_pred cccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCC
Confidence 99987655543 334699999999987765 577899999999999999999988533 22223344433221110
Q ss_pred --CCCCCCcccccCCCCCCCCccccchhhhc
Q 019780 282 --TPIPPKLVEIVDPKSTMNNDCMATVHAIT 310 (336)
Q Consensus 282 --~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (336)
...+|...+.++..++.++..|+...++.
T Consensus 317 ~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll 347 (391)
T KOG0983|consen 317 GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLL 347 (391)
T ss_pred cccCcCHHHHHHHHHHhhcCcccCcchHHHh
Confidence 11344455666666666666666554444
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=227.49 Aligned_cols=249 Identities=18% Similarity=0.211 Sum_probs=186.9
Q ss_pred eeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEc
Q 019780 64 VLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITEL 142 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~ 142 (336)
+.+++.+|.|+++.|+++...++.||||++... .........+.+|+.+++.++||||+++++++.+.. .+++|||
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLD---SCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEecc---ccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 345566777788888887777899999999742 123456678999999999999999999999988765 8999999
Q ss_pred cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc----
Q 019780 143 MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE---- 218 (336)
Q Consensus 143 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~---- 218 (336)
+++|+|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||.+.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC-ceEEecCccceeecccccccc
Confidence 9999999999765556789999999999999999999999999999999999999876 79999999886432211
Q ss_pred -----ccccCCcccccCCCCCCCC--CCCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHHHhhcc---------C
Q 019780 219 -----MTCEAGTYRWMAPENERPS--LENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNILQNLRS---------A 280 (336)
Q Consensus 219 -----~~~~~gt~~y~aPE~~~~~--~~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~~~~~~---------~ 280 (336)
.....++..|+|||..... .++.+.|+|++++.+|++-.+..|... .....++........ .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 1223467889999987653 466789999999999999888887532 111111211110000 0
Q ss_pred C------------------------CCCCCCcccccCCCCCCCCccccchhhhccccccc
Q 019780 281 D------------------------TPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKG 316 (336)
Q Consensus 281 ~------------------------~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (336)
. ..+++++.+++...+..+|+.|++..++.+.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~ 299 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence 0 00112234466677888999999999888766443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=224.46 Aligned_cols=193 Identities=27% Similarity=0.254 Sum_probs=158.3
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-EEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT-MMII 139 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~lv 139 (336)
|.+.+.||+|+||+||+|... ++.|+||.+.... .........+|+..++.++ ||||+++++++.++. .++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF----YSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhc----cchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence 567889999999999999985 6789999986311 1122334567899999999 999999999888765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
|||+ +|+|.+++.......+++..++.++.|++.+|.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPP 154 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-CEEEeecccceeccCCCC
Confidence 9999 78999998665545789999999999999999999999999999999999999876 79999999987543322
Q ss_pred ccccCCcccccCCCCCC-CCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 219 MTCEAGTYRWMAPENER-PSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~-~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.....++..|+|||... ....+...|+|+++..+|++-.+..|.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~ 199 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc
Confidence 23345889999999764 445678899999999999887776543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=228.24 Aligned_cols=249 Identities=25% Similarity=0.276 Sum_probs=189.7
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
..|...+.||+|+||.||+|... +..+++|.+.... .........+.+|+.+++.++|+|++++++++.+.. .++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccc--ccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 44667788999999999999985 6789999886321 123344567889999999999999999999888765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||+. |+|.+++... ...+++..+..++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++.....
T Consensus 93 v~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP-- 167 (308)
T ss_pred EEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-cEEECCcccceeecC--
Confidence 999997 5888777433 35589999999999999999999999999999999999999876 799999999875432
Q ss_pred ccccCCcccccCCCCCC---CCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhcc--CCCCCCCCccccc
Q 019780 219 MTCEAGTYRWMAPENER---PSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRS--ADTPIPPKLVEIV 292 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~---~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~--~~~~~p~~~~~~~ 292 (336)
.....|+..|+|||... ....+...|+|+|++.+|++..+..|.... -...+......... .....+..+.+++
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence 23345889999999753 344567899999999999999888885331 11111222211111 1224556677888
Q ss_pred CCCCCCCCccccchhhhcccccccc
Q 019780 293 DPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
...+..+|+.|++..++.+...-.+
T Consensus 248 ~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 248 DSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHhhCCcccCCCHHHHhhCccccc
Confidence 8899889999998888876554333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=238.48 Aligned_cols=166 Identities=33% Similarity=0.518 Sum_probs=143.6
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEe-----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASV----- 132 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~----- 132 (336)
...+.+.+.||.|.+|.||++.+. ++..|+|++.. ..+..+.+..|.++|+... |||++.+++++.
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~------~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP------TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC------CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 345778899999999999998765 88999999874 2334566788999998885 999999999876
Q ss_pred -cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 133 -QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 133 -~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
++++|||||||.||+..|+++...+.++.|..+..|++.++.||.+||...++|||||-.|||++.++ .|||+|||++
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~-~VKLvDFGvS 170 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA-EVKLVDFGVS 170 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-cEEEeeeeee
Confidence 23499999999999999999887788999999999999999999999999999999999999999988 7999999998
Q ss_pred cccccc--cccccCCcccccCCCC
Q 019780 212 REEVMD--EMTCEAGTYRWMAPEN 233 (336)
Q Consensus 212 ~~~~~~--~~~~~~gt~~y~aPE~ 233 (336)
.....+ ...+..||+.|||||+
T Consensus 171 aQldsT~grRnT~iGtP~WMAPEV 194 (953)
T KOG0587|consen 171 AQLDSTVGRRNTFIGTPYWMAPEV 194 (953)
T ss_pred eeeecccccccCcCCCccccccee
Confidence 865443 3455679999999993
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=231.08 Aligned_cols=244 Identities=25% Similarity=0.294 Sum_probs=184.1
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecC---C
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQP---T 135 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~---~ 135 (336)
.+|.+.+.||+|+||.||+|.+. ++.+|+|.+... .........+.+|+.+++++ +||||+++++++... .
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA---FRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccc---cCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 56888899999999999999875 788999988531 11233445677899999999 999999999987643 3
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
.++||||++ ++|.+++... .+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~~~ 158 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLS 158 (337)
T ss_pred EEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccchhccc
Confidence 799999997 4999988432 678899999999999999999999999999999999999887 89999999987533
Q ss_pred ccc-------ccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh----HHHHHHHH-----------
Q 019780 216 MDE-------MTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA----EITITLTN----------- 272 (336)
Q Consensus 216 ~~~-------~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~----~i~~~l~~----------- 272 (336)
... .....|+..|+|||.... ...+...|+|+++..+|++-.+..|... +....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 221 122358899999997654 4466789999999999988887765411 11111000
Q ss_pred ---------HHHhh--------ccCCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 273 ---------ILQNL--------RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 273 ---------~~~~~--------~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
+.... ....+..++++.+++...+..+|+.|.+..++.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~ 296 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence 00000 011123566677788888888999998888877654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=242.27 Aligned_cols=207 Identities=28% Similarity=0.534 Sum_probs=176.5
Q ss_pred ceeEeeeecCCCcEEEEEeEEC------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCCE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTM 136 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 136 (336)
.....++||+|+||+||+|.+- ..+||||++.. ....+....++.|+-+|.+++|||++++++++.....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~----~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE----FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTL 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeec----cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchH
Confidence 3445588999999999999874 45899999873 3345567789999999999999999999999999989
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
.||++|+++|+|.+|++.++ ..+.....+.|..||++||.|||.+++|||||..+|+|+..-. ++||+|||+|+....
T Consensus 773 qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~-hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN-HVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC-eEEEEecchhhccCc
Confidence 99999999999999997654 6788999999999999999999999999999999999998765 899999999986544
Q ss_pred cc--ccccCC--cccccCCC----------------------------------------------CCCCCCCCCHHHHH
Q 019780 217 DE--MTCEAG--TYRWMAPE----------------------------------------------NERPSLENLSEDMV 246 (336)
Q Consensus 217 ~~--~~~~~g--t~~y~aPE----------------------------------------------~~~~~~~~~~~di~ 246 (336)
.. .....| .+.|||-| ...++|..++.|+|
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy 930 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVY 930 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHH
Confidence 33 222222 36777777 23567888999999
Q ss_pred HHHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 247 ALLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 247 ~l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
.++..||..++..||+|.++...+..+.+
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 99999999999999999999999887764
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=229.83 Aligned_cols=242 Identities=25% Similarity=0.286 Sum_probs=184.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-----
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP----- 134 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 134 (336)
.+|.+.+.||+|+||.||+|.+. ++.||+|++.... ........+.+|+.+++.++||||+++++++...
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF---QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc---ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 57888999999999999999874 7899999986321 1223345678999999999999999999987643
Q ss_pred --CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 135 --TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 135 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
.+++|++|+.. +|..++ ...+++..+..++.|++.||+|||+.|++||||||+||+++.++ .++|+|||+++
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~ 165 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR 165 (342)
T ss_pred CceEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCCCCc
Confidence 26899999964 777765 23589999999999999999999999999999999999999887 79999999987
Q ss_pred ccccccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhh-------------
Q 019780 213 EEVMDEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNL------------- 277 (336)
Q Consensus 213 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~------------- 277 (336)
.... ......++..|+|||.... ...+...|+|+|+..++++..++.|... +....+..+....
T Consensus 166 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 166 HADA-EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCCC-CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 5422 2233457889999998765 4577889999999999999888887522 1111222111100
Q ss_pred ----------c--------cCCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 278 ----------R--------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 278 ----------~--------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
. ...+..++.+.+++...+..+|+.|.+..++....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~ 298 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHP 298 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 0 00123445567788888888998888887777543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=231.19 Aligned_cols=245 Identities=25% Similarity=0.297 Sum_probs=187.7
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC---
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT--- 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 135 (336)
.++|.+.+.||+|+||.||+|.+. +..||+|++... .........+.+|+.+++.++||||+++.+++....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP---FQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccc---cchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 457899999999999999999985 678999988632 122334566788999999999999999988765432
Q ss_pred ----EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 136 ----MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 136 ----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~ 165 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLA 165 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEcccccc
Confidence 78999998 5699999843 4689999999999999999999999999999999999999876 7999999998
Q ss_pred cccccccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhc-----------
Q 019780 212 REEVMDEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLR----------- 278 (336)
Q Consensus 212 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~----------- 278 (336)
..... ......++..|+|||.... ...+...|+|+|+..++++..+..|... +....+..+.....
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 166 RHTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccccc-cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 75432 2334457889999997654 3567889999999999998887776421 11112222111110
Q ss_pred --------------------cCCCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 279 --------------------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 279 --------------------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
......++.+.+++...+..+|+.|++..++.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~ 300 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence 001234666777888888889999999888876443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=229.41 Aligned_cols=187 Identities=32% Similarity=0.481 Sum_probs=154.2
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHh--CCCCceEeeEeeEec
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK--MKHENILKFVGASVQ 133 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~ 133 (336)
+-+++....++.++||+|.||.||+|...++.||||++. .+..+.++.|-+|.+. ++|+||++++++-..
T Consensus 204 spl~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp--------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr 275 (534)
T KOG3653|consen 204 SPLLELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP--------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKR 275 (534)
T ss_pred cccccCCchhhHHHhhcCccceeehhhccCceeEEEecC--------HHHHHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence 344556778888999999999999999999999999996 4567788999888776 479999999987553
Q ss_pred C-----CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccccCCCCceeecCC
Q 019780 134 P-----TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN---------SVIHRDLKPSNLLLTED 199 (336)
Q Consensus 134 ~-----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---------~ivHrDikp~NIll~~~ 199 (336)
. .++||++|.+.|+|.+||.. ..++|....+++.-++.||+|||+- .|+|||||..|||+..|
T Consensus 276 ~t~~~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D 352 (534)
T KOG3653|consen 276 GTADRMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND 352 (534)
T ss_pred CCccccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence 2 38999999999999999944 4689999999999999999999964 69999999999999998
Q ss_pred CCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCC------CHHHHHHHHHHhhc
Q 019780 200 KKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLEN------LSEDMVALLKSCWA 254 (336)
Q Consensus 200 ~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~------~~~di~~l~~~~l~ 254 (336)
. ++.|+|||+|....... ....+||..|||||.+.+...- ...|+|+++..+|+
T Consensus 353 l-TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWE 416 (534)
T KOG3653|consen 353 L-TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWE 416 (534)
T ss_pred C-cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHH
Confidence 7 89999999998654332 2335799999999976544321 24577777777665
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=224.31 Aligned_cols=243 Identities=23% Similarity=0.249 Sum_probs=184.2
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~ 140 (336)
|.+.+.||+|++|.||+|... ++.+++|.+.... ........+.+|+.+++.++||||+++++++.++. .++|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccc---ccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence 456688999999999999875 7889999987421 22234567889999999999999999999887665 89999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc--
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-- 218 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~-- 218 (336)
||+++ +|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 78 e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 78 EFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRP 154 (283)
T ss_pred eccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCCCccc
Confidence 99975 8888885433 5789999999999999999999999999999999999999876 79999999987543322
Q ss_pred ccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCH-hHHHHHHHHHHHhhcc-----------------
Q 019780 219 MTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEF-AEITITLTNILQNLRS----------------- 279 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~-~~i~~~l~~~~~~~~~----------------- 279 (336)
.....++..|+|||..... ..+...|+|+|+..++++-.+..|.. .+....+..+...+..
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2234578899999987766 67889999999999999888876641 1111222222111110
Q ss_pred -------------CCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 280 -------------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 280 -------------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
..+.+++++.+++...+..+|..|++..++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 112245556677777777777777777766543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=225.07 Aligned_cols=196 Identities=25% Similarity=0.298 Sum_probs=157.4
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 134 (336)
..+|.+.+.||+|+||.||+|.+. ++.+|+|++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE---KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC---CCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 478999999999999999999986 78899999864221 111234567899999999999999999876532
Q ss_pred -----CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 135 -----TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 135 -----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
.+++|++|+.+ +|...+.. ....+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg 160 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG-ILKIADFG 160 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECcCc
Confidence 26899999975 77777643 335799999999999999999999999999999999999999887 79999999
Q ss_pred ccccccccc-------------ccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 210 LAREEVMDE-------------MTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 210 ~a~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
+++...... .+...+++.|+|||...+ ...+...|+|+++..++++..+..|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 987432211 112246788999997654 34677899999999999998887764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=220.14 Aligned_cols=187 Identities=27% Similarity=0.406 Sum_probs=154.9
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+|+.|-.+... +..+|||++.+. ....+.++.+|++++...+ |+||+.++++|.++. +|||||-|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm 158 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM 158 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC-----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence 67999999999887754 889999999742 3345788999999999997 999999999999876 99999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC--CceEEeccccccc--------
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK--KQVKLADFGLARE-------- 213 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~--~~~kl~Dfg~a~~-------- 213 (336)
.||+|...|+.+ ..+++.++..+..+|++||.|||.+||.||||||+|||-..-. .-||||||.++.-
T Consensus 159 ~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 159 RGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred cCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999999999544 5699999999999999999999999999999999999986433 1489999988652
Q ss_pred -cccccccccCCcccccCCCCCC-----CCCCCCHHHHHHHHHHhhccCCCCCC
Q 019780 214 -EVMDEMTCEAGTYRWMAPENER-----PSLENLSEDMVALLKSCWAEDPKVRP 261 (336)
Q Consensus 214 -~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~di~~l~~~~l~~~p~~RP 261 (336)
....+..+.+|+..|||||+.. ...++..-|+|+|+..++-+..+-.|
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP 290 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP 290 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence 1222345667999999999543 34566777999999888877666655
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-31 Score=220.48 Aligned_cols=215 Identities=26% Similarity=0.352 Sum_probs=172.7
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHH-HhCCCCceEeeEee
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLL-SKMKHENILKFVGA 130 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~ 130 (336)
...+.+...+.+-+..||.|+||+|++-.++ ++..|||.++.. .......+++.|.+.. +.-+.||||++||+
T Consensus 56 ~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~----n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 56 AHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSN----NIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred ccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeec----cchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 3456666777777889999999999999887 889999999843 2356677888888875 44569999999998
Q ss_pred Ee-cCCEEEEEEccCCCCHHHHH---hhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCceEE
Q 019780 131 SV-QPTMMIITELMRGETLQRYL---WSTRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKL 205 (336)
Q Consensus 131 ~~-~~~~~lv~e~~~gg~L~~~l---~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~~~~~~~kl 205 (336)
.. +++.|++||+|+ .+|..+. .......+++.-.-.|....+.||.||... .|||||+||+|||++..| .+||
T Consensus 132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKL 209 (361)
T KOG1006|consen 132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKL 209 (361)
T ss_pred hhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEee
Confidence 55 566999999996 4665543 344567899999999999999999999865 899999999999999987 7999
Q ss_pred eccccccccccc-cccccCCcccccCCCCCCCCC--CCCHHHHHHHHHHhhccCCCCCCC--HhHHHHHHHHHH
Q 019780 206 ADFGLAREEVMD-EMTCEAGTYRWMAPENERPSL--ENLSEDMVALLKSCWAEDPKVRPE--FAEITITLTNIL 274 (336)
Q Consensus 206 ~Dfg~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~di~~l~~~~l~~~p~~RP~--~~~i~~~l~~~~ 274 (336)
||||++.....+ ..+...|..+|||||.+.+.. +++.+|+|+|+..+++..++.=|- +..+.+.+.+..
T Consensus 210 CDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv 283 (361)
T KOG1006|consen 210 CDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV 283 (361)
T ss_pred ecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH
Confidence 999998754443 234456999999999887654 678999999999999999999884 555555554443
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=222.77 Aligned_cols=243 Identities=26% Similarity=0.281 Sum_probs=184.7
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~ 140 (336)
|.+.+.||+|+||.||+|... ++.+|+|++.... ........+..|+.+++.++|+||+++++++.+.. .++|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc---ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence 456788999999999999986 7899999997422 22334566788999999999999999999888665 89999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc--
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-- 218 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~-- 218 (336)
||++ ++|.+++.... ..+++..++.++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++.......
T Consensus 78 e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 78 EYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLRT 154 (282)
T ss_pred cCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC-CEEEecCCcccccCCCccc
Confidence 9998 59999995542 4689999999999999999999999999999999999999876 79999999987543322
Q ss_pred ccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhc------------------
Q 019780 219 MTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLR------------------ 278 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~------------------ 278 (336)
.....++..|+|||..... ..+...|+|+|+..+|+...+..|... .....+..+.+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2233467889999987655 677889999999999998887666422 12222222221110
Q ss_pred -----------cCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 279 -----------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 279 -----------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
...+..++.+.+++...+..+|+.|++..++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0112235556777777788888888777776654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=229.26 Aligned_cols=249 Identities=23% Similarity=0.283 Sum_probs=190.4
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccc--cHHHHHHHHHHHHHHHhCCCCceEeeEeeEe-cC-
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAV--SREHKEKFQREVTLLSKMKHENILKFVGASV-QP- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~- 134 (336)
..+|.++.+||+|||+.||+|.+- .+.||||+-..++.+.. .....+...+|.+|-+.|.||.||++|++|. +.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 457888999999999999999875 78899999876544332 2234566789999999999999999999987 33
Q ss_pred CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccccCCCCceeecCCC--CceEEecccc
Q 019780 135 TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN--SVIHRDLKPSNLLLTEDK--KQVKLADFGL 210 (336)
Q Consensus 135 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--~ivHrDikp~NIll~~~~--~~~kl~Dfg~ 210 (336)
.+|-|+|||+|.+|.-||+ ....+++.+++.|+.||+.||.||.+. .|||-||||.|||+-... +.+||+|||+
T Consensus 542 sFCTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 3899999999999999994 346689999999999999999999977 599999999999996432 3799999999
Q ss_pred cccccccc---------ccccCCcccccCCCCCC----CCCCCCHHHHHHHHHHhhccCCCCCCCHhH-----HHHHHHH
Q 019780 211 AREEVMDE---------MTCEAGTYRWMAPENER----PSLENLSEDMVALLKSCWAEDPKVRPEFAE-----ITITLTN 272 (336)
Q Consensus 211 a~~~~~~~---------~~~~~gt~~y~aPE~~~----~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-----i~~~l~~ 272 (336)
++...... .+...||.+|++||.+. |..-+...|+|+++...++-..++.|+-.+ |++.-..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 98543322 23346999999999543 344567789999999999988999996333 3332222
Q ss_pred HHHhhccC--CCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 273 ILQNLRSA--DTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 273 ~~~~~~~~--~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+...-.++ .+-++++....+.+.+...-+.+.+++++..
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 21111111 1345566777778888888888888888775
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=208.43 Aligned_cols=191 Identities=23% Similarity=0.407 Sum_probs=164.5
Q ss_pred cCCceeEeeeecCCCcEEEEEeEE--CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT- 135 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~- 135 (336)
...+|++.+.+|+|.|+.||.|.+ +++.++||++++ -..+.+.+|+.+|..|. ||||++++++..++.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 457899999999999999999985 478999999984 23567899999999998 999999999988764
Q ss_pred --EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 136 --MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 136 --~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
..+|+||+.+.+...+. ..++...++.++.|++.||.|+|+.||+|||+||.|++|+.....++|+|+|+|..
T Consensus 108 ktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred cCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhh
Confidence 78999999998888776 45778889999999999999999999999999999999998877899999999987
Q ss_pred cccc-cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCH
Q 019780 214 EVMD-EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEF 263 (336)
Q Consensus 214 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~ 263 (336)
..+. +....+.+..|--||.+-. ..++++-|+|+|+|.+-.+--.++|.|
T Consensus 183 YHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 183 YHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred cCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 6554 3445567788999997654 457899999999998877777777754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-28 Score=215.53 Aligned_cols=150 Identities=22% Similarity=0.397 Sum_probs=126.5
Q ss_pred CCcccCCceeeecCCceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHh
Q 019780 41 DDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118 (336)
Q Consensus 41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~ 118 (336)
+.++|....+..+.-...+...+|.+.++||.|.|++||++.+. .+.||+|+.+. .+...+....|+.+|++
T Consensus 57 ~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS------AqhYtEaAlDEIklL~~ 130 (590)
T KOG1290|consen 57 DPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS------AQHYTEAALDEIKLLQQ 130 (590)
T ss_pred ChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh------hhHHHHHHHHHHHHHHH
Confidence 34455556666666667778899999999999999999999986 78899999982 34457778899999999
Q ss_pred CC-----C---CceEeeEeeEecC-----CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-Cc
Q 019780 119 MK-----H---ENILKFVGASVQP-----TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN-SV 184 (336)
Q Consensus 119 l~-----h---pnIv~~~~~~~~~-----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~i 184 (336)
++ | .+||++++.|... .+|+|+|++ |.+|..+|.......++...++.|++||+.||.|||.. ||
T Consensus 131 v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgI 209 (590)
T KOG1290|consen 131 VREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGI 209 (590)
T ss_pred HHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCc
Confidence 84 2 3699999998853 289999999 66999999877778899999999999999999999976 99
Q ss_pred ccccCCCCceeec
Q 019780 185 IHRDLKPSNLLLT 197 (336)
Q Consensus 185 vHrDikp~NIll~ 197 (336)
||.||||+|||+.
T Consensus 210 IHTDlKPENvLl~ 222 (590)
T KOG1290|consen 210 IHTDLKPENVLLC 222 (590)
T ss_pred cccCCCcceeeee
Confidence 9999999999984
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=212.59 Aligned_cols=216 Identities=15% Similarity=0.113 Sum_probs=163.6
Q ss_pred CCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccCCCCHH
Q 019780 73 GSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRGETLQ 149 (336)
Q Consensus 73 G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~gg~L~ 149 (336)
|.||.||++.+. ++.+|+|.+... ..+.+|...+....||||+++++++.+.. .++||||++||+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~----------~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKS----------SEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecch----------hhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 899999999985 788999998732 12334555556667999999999988765 89999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccccccccCCccccc
Q 019780 150 RYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWM 229 (336)
Q Consensus 150 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~ 229 (336)
+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++++|||.+...... .....++..|+
T Consensus 74 ~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~-~~~~~~~~~y~ 149 (237)
T cd05576 74 SHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS-CDGEAVENMYC 149 (237)
T ss_pred HHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEecccchhccccc-cccCCcCcccc
Confidence 998543 4589999999999999999999999999999999999999887 7999999987653322 22344677899
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCCccccc
Q 019780 230 APENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNNDCMAT 305 (336)
Q Consensus 230 aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 305 (336)
|||.......+...|+|+++..++++..+..|....-. .... .........+++.+..++...+..+|+.|.+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~ 222 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS-GINT--HTTLNIPEWVSEEARSLLQQLLQFNPTERLG 222 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch-hccc--ccccCCcccCCHHHHHHHHHHccCCHHHhcC
Confidence 99998877788899999999999998877655321100 0000 0000112234555666777777777777765
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=249.14 Aligned_cols=174 Identities=21% Similarity=0.288 Sum_probs=133.3
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~ 140 (336)
+...+.||+|+||.||+|... +..||||.+..... ....|+..+++++||||+++++++.+.. .++||
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 445578999999999999974 78999998863211 1134588899999999999999998765 89999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH---ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
||+++|+|.++++ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ ..++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT- 834 (968)
T ss_pred eCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-ceEEE-ecccccccc-
Confidence 9999999999993 3889999999999999999999 67999999999999999775 56654 665543221
Q ss_pred cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhcc
Q 019780 218 EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAE 255 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~ 255 (336)
.....|+..|+|||......++...|+|+++..+|++
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el 871 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIEL 871 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHH
Confidence 1223588999999965544444444554444433333
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=233.43 Aligned_cols=248 Identities=17% Similarity=0.144 Sum_probs=156.7
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee--
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA-- 130 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~-- 130 (336)
...++|.+.+.||+|+||.||+|.+. +..||+|.+.... ..+....+ .+....+.++..+...
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-------~~e~~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-------AVEIWMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-------hhHHHHHH--HHHhhchhhHHHHHHhhh
Confidence 45678999999999999999999975 4689999876211 01111111 1122222222222111
Q ss_pred -----EecCCEEEEEEccCCCCHHHHHhhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 019780 131 -----SVQPTMMIITELMRGETLQRYLWSTRPK------------------RLDLKHSISFALDISRAMEYLHANSVIHR 187 (336)
Q Consensus 131 -----~~~~~~~lv~e~~~gg~L~~~l~~~~~~------------------~l~~~~~~~i~~qi~~aL~~lH~~~ivHr 187 (336)
..+...++|+||+++++|.+++...... ......+..++.|++.||.|||++||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 1233489999999999999998543210 11233466799999999999999999999
Q ss_pred cCCCCceeecCCCCceEEeccccccccccc---cccccCCcccccCCCCCCCCC----------------------CCCH
Q 019780 188 DLKPSNLLLTEDKKQVKLADFGLAREEVMD---EMTCEAGTYRWMAPENERPSL----------------------ENLS 242 (336)
Q Consensus 188 Dikp~NIll~~~~~~~kl~Dfg~a~~~~~~---~~~~~~gt~~y~aPE~~~~~~----------------------~~~~ 242 (336)
||||+|||++.+.+.+||+|||+|+..... ......+++.|+|||...... .+..
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 999999999865458999999999753221 223456899999999543211 1123
Q ss_pred HHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh------hcc-CCCCCCCC--------------cccccCCCCCCCCc
Q 019780 243 EDMVALLKSCWAEDPKVRPEFAEITITLTNILQN------LRS-ADTPIPPK--------------LVEIVDPKSTMNND 301 (336)
Q Consensus 243 ~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~------~~~-~~~~~p~~--------------~~~~~~~~~~~~~~ 301 (336)
.|+|++++.+|++-....|+-.++......+... ... .....+++ ..+++..++..+|.
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 4999999999987655444433333222111110 000 00111111 12466777778888
Q ss_pred cccchhhhcccccc
Q 019780 302 CMATVHAITKFNEK 315 (336)
Q Consensus 302 ~~~~~~~~~~~~~~ 315 (336)
.|.+..++.+...-
T Consensus 440 kR~ta~e~L~Hpff 453 (566)
T PLN03225 440 QRISAKAALAHPYF 453 (566)
T ss_pred cCCCHHHHhCCcCc
Confidence 88877777765443
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=235.62 Aligned_cols=168 Identities=26% Similarity=0.419 Sum_probs=143.7
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
.+|.+.+.||+|+||+||+|.+. ++.||||+++.. ..........+.+|+.++..++||||+++++++.+.. .|+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~--~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA--DMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehh--hccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 57899999999999999999987 789999999742 2234455678999999999999999999998887655 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++......
T Consensus 82 VmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g-~vkL~DFGls~~~~~~~ 158 (669)
T cd05610 82 VMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSKVTLNRE 158 (669)
T ss_pred EEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC-CEEEEeCCCCccccCCc
Confidence 9999999999999944 35688999999999999999999999999999999999999876 89999999998644332
Q ss_pred --ccccCCcccccCCCCC
Q 019780 219 --MTCEAGTYRWMAPENE 234 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~ 234 (336)
.....+|+.|++||..
T Consensus 159 ~~~~~~~~t~~~~~pe~~ 176 (669)
T cd05610 159 LNMMDILTTPSMAKPKND 176 (669)
T ss_pred ccccccccCccccCcccc
Confidence 3345689999999843
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-29 Score=212.39 Aligned_cols=187 Identities=27% Similarity=0.291 Sum_probs=149.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec--
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ-- 133 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-- 133 (336)
..|...+.||+|.||.||+|... ...+|||.++..+. .........+|+.+++.++||||+.+..++..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd---~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD---GTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC---CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 46788899999999999999643 23789999874321 11223456799999999999999999888775
Q ss_pred CCEEEEEEccCCCCHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC---CceEEec
Q 019780 134 PTMMIITELMRGETLQRYLWST---RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK---KQVKLAD 207 (336)
Q Consensus 134 ~~~~lv~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~---~~~kl~D 207 (336)
..+++++||.+. +|...|+-. ....++...+..|+.||+.|+.|||++=|+||||||.|||+..++ +.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 349999999986 999998422 235689999999999999999999999999999999999998762 3899999
Q ss_pred ccccccccccc-----ccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHh
Q 019780 208 FGLAREEVMDE-----MTCEAGTYRWMAPENERPS-LENLSEDMVALLKSC 252 (336)
Q Consensus 208 fg~a~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~ 252 (336)
||+++.....- ....+-|..|.|||.+.+. -++...|+|+++|..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIf 230 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIF 230 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHH
Confidence 99998543221 2223478999999987765 467788999999853
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=221.87 Aligned_cols=224 Identities=21% Similarity=0.218 Sum_probs=182.4
Q ss_pred cccCCceeeecCCceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC
Q 019780 43 EEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK 120 (336)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 120 (336)
.|++.+.++.+.-..++ ...|.+....|+|-||+|.+|.+. ++.||||++.. ++...+.=++|+++|++|+
T Consensus 414 NWdDaEGYYrv~igE~L-D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn------NE~M~KtGl~EleiLkKL~ 486 (752)
T KOG0670|consen 414 NWDDAEGYYRVRIGELL-DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN------NEVMHKTGLKELEILKKLN 486 (752)
T ss_pred CcccccceEEEehhhhh-cceeEEEeccccceeeeeeeccccCCCCeeEEEEeec------chHHhhhhhHHHHHHHHhh
Confidence 34444555555444444 457888899999999999999886 78999999984 3344566789999999996
Q ss_pred C------CceEeeEeeEecC-CEEEEEEccCCCCHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCC
Q 019780 121 H------ENILKFVGASVQP-TMMIITELMRGETLQRYLWST-RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPS 192 (336)
Q Consensus 121 h------pnIv~~~~~~~~~-~~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~ 192 (336)
. -++++++..|... .+|+|+|.+. .+|.+.|... .+..|....++.++.|++.||..|..+||+|.||||+
T Consensus 487 ~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPD 565 (752)
T KOG0670|consen 487 DADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPD 565 (752)
T ss_pred ccCchhhhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCcc
Confidence 3 3688888777655 5999999885 5999999653 3456889999999999999999999999999999999
Q ss_pred ceeecCCCCceEEeccccccccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCC----CHhHHHH
Q 019780 193 NLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRP----EFAEITI 268 (336)
Q Consensus 193 NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP----~~~~i~~ 268 (336)
|||+++....+||||||.|.....++.+....+..|.|||.+.+.+++++.|+|+++|.++++-+++=. +-.+.+.
T Consensus 566 NiLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 566 NILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred ceEeccCcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 999999888999999999998888787777788999999999999999999999999999998887753 2345555
Q ss_pred HHHHHH
Q 019780 269 TLTNIL 274 (336)
Q Consensus 269 ~l~~~~ 274 (336)
.+.++.
T Consensus 646 l~me~K 651 (752)
T KOG0670|consen 646 LFMELK 651 (752)
T ss_pred HHHHhc
Confidence 544443
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-30 Score=211.46 Aligned_cols=170 Identities=28% Similarity=0.396 Sum_probs=137.0
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec-
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ- 133 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~- 133 (336)
.......|.-..+||+|.||.||+|+.+ ++.||+|.+-..+ .....-....+|+.+|..++|+|++.+++.+..
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen---eKeGfpitalreikiL~~lkHenv~nliEic~tk 88 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN---EKEGFPITALREIKILQLLKHENVVNLIEICRTK 88 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc---cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence 3445567777889999999999999876 6778888764211 222334556899999999999999998877542
Q ss_pred ----C----CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEE
Q 019780 134 ----P----TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKL 205 (336)
Q Consensus 134 ----~----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl 205 (336)
. .+|+|+.+|+. +|.-++ ++...+++..++..++.+++.||.|+|+..|+|||+||+|+||+.++ .+||
T Consensus 89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlL-sn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-ilkl 165 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEH-DLAGLL-SNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-ILKL 165 (376)
T ss_pred cCCcccccceeeeeHHHhhh-hHHHHh-cCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-eEEe
Confidence 1 28999999976 888888 33447899999999999999999999999999999999999999987 8999
Q ss_pred eccccccccccc------cccccCCcccccCCC
Q 019780 206 ADFGLAREEVMD------EMTCEAGTYRWMAPE 232 (336)
Q Consensus 206 ~Dfg~a~~~~~~------~~~~~~gt~~y~aPE 232 (336)
+|||+++..... ..+..+-|..|++||
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppE 198 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPE 198 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHH
Confidence 999999743322 244455699999999
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=227.08 Aligned_cols=196 Identities=28% Similarity=0.455 Sum_probs=150.8
Q ss_pred eeEeeeecCCCcEE-EEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-EEEEE
Q 019780 64 VLLQKMIGEGSYSI-VYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 64 ~~~~~~lg~G~fg~-V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~lv~ 140 (336)
|.-.+++|.|+-|+ ||+|...++.||||++- .+......+|+..|+.-+ |||||++++.-.+.+ .||+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll--------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLL--------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHh--------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 34446799999985 79999999999999885 345667889999999886 999999999888877 89999
Q ss_pred EccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---CC-CceEEecccccccc
Q 019780 141 ELMRGETLQRYLWST--RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE---DK-KQVKLADFGLAREE 214 (336)
Q Consensus 141 e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~---~~-~~~kl~Dfg~a~~~ 214 (336)
|.|.. +|.+++... .......-..+.++.|+++||++||+.+||||||||.||||+. ++ ..++|+|||+++..
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 99965 999999542 1111111345788999999999999999999999999999976 23 47999999999965
Q ss_pred cccc-----ccccCCcccccCCCCCCCCCCCCHH----------------------------------------------
Q 019780 215 VMDE-----MTCEAGTYRWMAPENERPSLENLSE---------------------------------------------- 243 (336)
Q Consensus 215 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~---------------------------------------------- 243 (336)
.... ..+..||-+|+|||++.......+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchH
Confidence 4332 3345699999999954433333333
Q ss_pred HHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 244 DMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 244 di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+||..|++++|..||++.+++.
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 3455777777788888887777653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=210.19 Aligned_cols=201 Identities=19% Similarity=0.254 Sum_probs=167.7
Q ss_pred eeeecCCceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC--C--
Q 019780 49 FVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH--E-- 122 (336)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p-- 122 (336)
.++..++.. ..+|.+.+.+|+|.||.|-.+.+. +..||||+++. -....+..+-|+++|.++.+ |
T Consensus 79 ~v~~~gD~l---~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~------V~kYreAa~iEi~vLqki~~~DP~g 149 (415)
T KOG0671|consen 79 YVYQVGDIL---TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN------VDKYREAALIEIEVLQKINESDPNG 149 (415)
T ss_pred EEEEecccc---ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH------HHHHhhHHHHHHHHHHHHHhcCCCC
Confidence 455555433 678999999999999999998876 67899999973 34567778889999999942 3
Q ss_pred --ceEeeEeeEecC-CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC
Q 019780 123 --NILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED 199 (336)
Q Consensus 123 --nIv~~~~~~~~~-~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~ 199 (336)
-++.+.++|.-. ..|||+|.+ |-|+.+++..++...++..+++.+++|++.+++|||+.+++|.||||+|||+...
T Consensus 150 ~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss 228 (415)
T KOG0671|consen 150 KFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSS 228 (415)
T ss_pred ceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEecc
Confidence 256677777644 489999998 5699999988888889999999999999999999999999999999999998421
Q ss_pred -------------------CCceEEeccccccccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCC
Q 019780 200 -------------------KKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVR 260 (336)
Q Consensus 200 -------------------~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~R 260 (336)
...|+|+|||.|+...... ++.+.|..|.|||.+.+.+++.+-|+|+++|.+.++-.+..
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 1258999999998754433 55678999999999999999999999999999998888877
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-29 Score=229.57 Aligned_cols=199 Identities=29% Similarity=0.433 Sum_probs=167.6
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-CEE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-TMM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~ 137 (336)
..+|.++..+|+|.||.||+|++. ++..|+|+++.. .....+-+++|+-+++..+||||+.+++.+... ..|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe-----p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE-----PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeecc-----CCccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 357888899999999999999986 889999999842 233456688999999999999999999987754 599
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
++||||.||+|.+.. .-.+.+++.++....++.+.||+|||++|-+|||||-.||+++..| .+|++|||.+......
T Consensus 89 icMEycgggslQdiy--~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g-DvklaDfgvsaqitat 165 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG-DVKLADFGVSAQITAT 165 (829)
T ss_pred EEEEecCCCccccee--eecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC-ceeecccCchhhhhhh
Confidence 999999999999987 4447799999999999999999999999999999999999999887 7999999998754332
Q ss_pred --cccccCCcccccCCCC----------------------------------------------------CCCCCCCCHH
Q 019780 218 --EMTCEAGTYRWMAPEN----------------------------------------------------ERPSLENLSE 243 (336)
Q Consensus 218 --~~~~~~gt~~y~aPE~----------------------------------------------------~~~~~~~~~~ 243 (336)
....+.||+.|||||+ ....+..++.
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 3456779999999991 0112234667
Q ss_pred HHHHHHHHhhccCCCCCCCHhHHH
Q 019780 244 DMVALLKSCWAEDPKVRPEFAEIT 267 (336)
Q Consensus 244 di~~l~~~~l~~~p~~RP~~~~i~ 267 (336)
-+-.|+..+|..+|.+||+...++
T Consensus 246 ~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhhe
Confidence 788899999999999999987654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=224.61 Aligned_cols=239 Identities=22% Similarity=0.214 Sum_probs=182.1
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-E
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-M 136 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~ 136 (336)
...|.+...+|.|+|+.|..+.+. ++..++|++... .....+|+.++... +||||+++.+.+.++. .
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc---------ccccccccchhhhhcCCCcceeecceecCCcee
Confidence 456777788999999999998875 788999999732 22345677665555 5999999999998875 9
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec-CCCCceEEeccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLT-EDKKQVKLADFGLAREEV 215 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~-~~~~~~kl~Dfg~a~~~~ 215 (336)
|+|||.+.|+-|.+.+.... .....+..|+++|+.|+.|||++|+|||||||+|||++ ..+ +++|+|||.++...
T Consensus 392 ~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELE 467 (612)
T ss_pred eeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC-cEEEEEechhhhCc
Confidence 99999999999999884432 22377888999999999999999999999999999995 554 89999999998755
Q ss_pred cccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhc--cCCCCCCCCcccccC
Q 019780 216 MDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR--SADTPIPPKLVEIVD 293 (336)
Q Consensus 216 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~--~~~~~~p~~~~~~~~ 293 (336)
.. ..+.+-|..|.|||......++...|+|+|+..++++..+..|...-=-. .++.+.+. .....++++..+++.
T Consensus 468 ~~-~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 468 RS-CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFSECVSDEAKDLLQ 544 (612)
T ss_pred hh-hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccccccCHHHHHHHH
Confidence 44 34456789999999999999999999999999999999999875321111 11222211 122455666666666
Q ss_pred CCCCCCCccccchhhhcccccc
Q 019780 294 PKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
.++.++|..|.+..++....+.
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhccCChhhCcChhhhccCcch
Confidence 6666677666666666554443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=212.95 Aligned_cols=166 Identities=18% Similarity=0.215 Sum_probs=126.5
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC---CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEe-eEeeEecC
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG---CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILK-FVGASVQP 134 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~-~~~~~~~~ 134 (336)
.-...|.+.+.||+|+||+||+|++. ++.+|||++...............+.+|+.+|+.++|+|++. +++. +
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence 34567999999999999999999874 566899987521111113345677999999999999999985 4442 4
Q ss_pred CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccC-CCCceeecCCCCceEEeccccccc
Q 019780 135 TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDL-KPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDi-kp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
..|+||||++|++|.. + .. .. ...++.|++.||.|||++||+|||| ||+|||++.++ .++|+|||+|+.
T Consensus 92 ~~~LVmE~~~G~~L~~-~--~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~-~ikLiDFGlA~~ 161 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-A--RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG-EAAVIDFQLASV 161 (365)
T ss_pred CcEEEEEccCCCCHHH-h--Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC-CEEEEECcccee
Confidence 5899999999999973 2 11 11 1467899999999999999999999 99999998776 799999999984
Q ss_pred ccccc----------ccccCCcccccCCCCCCCC
Q 019780 214 EVMDE----------MTCEAGTYRWMAPENERPS 237 (336)
Q Consensus 214 ~~~~~----------~~~~~gt~~y~aPE~~~~~ 237 (336)
..... .+...+++.|+|||...+.
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 32221 1334578889999965443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-26 Score=192.06 Aligned_cols=193 Identities=33% Similarity=0.522 Sum_probs=158.1
Q ss_pred ecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccCCC
Q 019780 70 IGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRGE 146 (336)
Q Consensus 70 lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~gg 146 (336)
||+|++|.||++... ++.+++|++..... ......+.+|+..++.++|++|+++++++.... .++++|+++|+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS----SSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccc----hhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 689999999999997 88999999974211 114578999999999999999999999988754 89999999999
Q ss_pred CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-CCCceEEecccccccccccc--ccccC
Q 019780 147 TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE-DKKQVKLADFGLAREEVMDE--MTCEA 223 (336)
Q Consensus 147 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~-~~~~~kl~Dfg~a~~~~~~~--~~~~~ 223 (336)
+|.+++.... ..+++..++.++.+++.+|.+||+.|++|+||+|.||+++. ++ .++|+|||.+....... .....
T Consensus 77 ~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 77 SLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchhhccc
Confidence 9999995432 46889999999999999999999999999999999999998 55 89999999988654432 34455
Q ss_pred CcccccCCCCCCCC-CCCCHHHHHHHH-------------HHhhccCCCCCCCHhHHHH
Q 019780 224 GTYRWMAPENERPS-LENLSEDMVALL-------------KSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 224 gt~~y~aPE~~~~~-~~~~~~di~~l~-------------~~~l~~~p~~RP~~~~i~~ 268 (336)
+...|++||..... ..+...|+|+++ ..|+..+|..||++.+++.
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l~~~~~~l~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHHHHHHHHHHHHhhCCcccCcCHHHHhh
Confidence 88999999987766 666777888765 4566667777777666543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=219.08 Aligned_cols=203 Identities=21% Similarity=0.222 Sum_probs=144.8
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEE------------------CCccEEEEEeecCcccccc---------HHHHHHHHH
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFY------------------GCEPVAVKVIQPCNALAVS---------REHKEKFQR 111 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~------------------~~~~vavK~~~~~~~~~~~---------~~~~~~~~~ 111 (336)
...++|.+.++||+|+||+||+|.. .++.||||.+......... ....+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4577999999999999999999964 1457999998632110000 001223445
Q ss_pred HHHHHHhCCCCce-----EeeEeeEe---------cCCEEEEEEccCCCCHHHHHhhcCC--------------------
Q 019780 112 EVTLLSKMKHENI-----LKFVGASV---------QPTMMIITELMRGETLQRYLWSTRP-------------------- 157 (336)
Q Consensus 112 E~~~l~~l~hpnI-----v~~~~~~~---------~~~~~lv~e~~~gg~L~~~l~~~~~-------------------- 157 (336)
|+.++.+++|.++ +++++++. .+..++|+||+++++|.++++...+
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777888876654 55666544 2348999999999999999853211
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-cc--ccCCcccccCCC
Q 019780 158 --KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MT--CEAGTYRWMAPE 232 (336)
Q Consensus 158 --~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~--~~~gt~~y~aPE 232 (336)
..+++..++.++.|++.||.|||+++|+||||||+|||++.++ .++|+|||+++...... .. ...+++.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1245677889999999999999999999999999999999886 79999999987532221 11 123578999999
Q ss_pred CCCCCC--------------------CCC--HHHHHHHHHHhhccCCCC-CCC
Q 019780 233 NERPSL--------------------ENL--SEDMVALLKSCWAEDPKV-RPE 262 (336)
Q Consensus 233 ~~~~~~--------------------~~~--~~di~~l~~~~l~~~p~~-RP~ 262 (336)
...... ++. ..|+|++++.++++.... +|.
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 764221 111 259999999999886544 443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-29 Score=210.26 Aligned_cols=184 Identities=28% Similarity=0.422 Sum_probs=152.5
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC------
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT------ 135 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 135 (336)
.+-.+.||-|+||.||.+++. ++.||+|.+.. ...+-...+++.+|+.+|..++|.|++..+++.+..+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn---vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN---VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcch---HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 344578999999999998875 88999998762 2223445678999999999999999999999877543
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
+|.++|++.. +|...+ -....++.+.+.-+++||+.||+|||+.||.||||||.|.|++.+- .+||||||+|+...
T Consensus 132 iYV~TELmQS-DLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee 207 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKII--VSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-ILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHHHh-hhhhee--ccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc-eEEecccccccccc
Confidence 6888999865 888888 5667899999999999999999999999999999999999999886 89999999999654
Q ss_pred ccc---ccccCCcccccCCCCCCCCC-CCCHHHHHHHHHHhhc
Q 019780 216 MDE---MTCEAGTYRWMAPENERPSL-ENLSEDMVALLKSCWA 254 (336)
Q Consensus 216 ~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~di~~l~~~~l~ 254 (336)
..+ ++...-|..|.|||.+++.. ++-..|+|+++|..-+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaE 250 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAE 250 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHH
Confidence 433 45556889999999888754 5677899999885433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=198.06 Aligned_cols=231 Identities=29% Similarity=0.369 Sum_probs=181.8
Q ss_pred CcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-CEEEEEEccCCCCHHH
Q 019780 74 SYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-TMMIITELMRGETLQR 150 (336)
Q Consensus 74 ~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~lv~e~~~gg~L~~ 150 (336)
+||.||+|... ++.+++|++..... ......+.+|+..++.++|+||+++++.+... ..++++|++++++|.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKI----KKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccc----ccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 58999999986 58899999874221 11167899999999999999999999988765 4899999999999999
Q ss_pred HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-cccccCCccccc
Q 019780 151 YLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-EMTCEAGTYRWM 229 (336)
Q Consensus 151 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~gt~~y~ 229 (336)
++.... .+++..++.++.+++.+|.+||+.|++|+||+|+||+++.++ .++|+|||.+...... ......++..|+
T Consensus 77 ~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 77 LLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCCcCCC
Confidence 995433 388999999999999999999999999999999999999886 7999999998865433 234455889999
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHHHhhccCCCC---CCCCcccccCCCCCCCCcccc
Q 019780 230 APENERPSLENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNILQNLRSADTP---IPPKLVEIVDPKSTMNNDCMA 304 (336)
Q Consensus 230 aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~~~~~~~~~~---~p~~~~~~~~~~~~~~~~~~~ 304 (336)
+||.......+.+.|+|+++..+++.-.+..|... +....++.+.......... ++.++.+++...+..+|+.|+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence 99988777778899999999999888877666422 2222222222222211111 667788889999998999998
Q ss_pred chhhhcc
Q 019780 305 TVHAITK 311 (336)
Q Consensus 305 ~~~~~~~ 311 (336)
+..++.+
T Consensus 234 ~~~~~~~ 240 (244)
T smart00220 234 TAEEALQ 240 (244)
T ss_pred CHHHHhh
Confidence 8877765
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-25 Score=187.16 Aligned_cols=193 Identities=35% Similarity=0.442 Sum_probs=161.6
Q ss_pred eeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~ 140 (336)
|.+.+.||+|++|.||++... +..+++|.+...... .....+.+|+..++.++|+|++++++.+.... .++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence 456788999999999999986 588999999742211 35678899999999999999999999887654 89999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc---
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--- 217 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--- 217 (336)
|++++++|.+++..... .+++.....++.+++.+|.+||+.|++|+||+|.||+++.++ .++|+|||.+......
T Consensus 77 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 77 EYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG-LVKLADFGLARFIHRDLAA 154 (225)
T ss_pred eccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeCceeeEecCcccc
Confidence 99999999999954322 188999999999999999999999999999999999999876 8999999998764433
Q ss_pred cccccCCcccccCCCCC-CCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 218 EMTCEAGTYRWMAPENE-RPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~-~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
......++..|++||.. ...+.+...|+|+++..++++-.++.|.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf 200 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPF 200 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCc
Confidence 22334578899999987 6666677999999999999988876665
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=197.65 Aligned_cols=190 Identities=27% Similarity=0.318 Sum_probs=160.4
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP--- 134 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--- 134 (336)
...+|.-++.+|.|.- .|..|.+. +++||+|.+... .......++..+|..++..++|+||++++.+|.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p---f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP---FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc---cccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 3456777889999998 66666664 889999988643 23355677889999999999999999999998743
Q ss_pred ----CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 135 ----TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 135 ----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
+.|+|||+|.. +|.+.++ ..++..++..++.|++.|++|||+.||+||||||+||++..+. .+||.|||+
T Consensus 91 ~~~~e~y~v~e~m~~-nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~-~lKi~dfg~ 164 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDA-NLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC-TLKILDFGL 164 (369)
T ss_pred HHHHhHHHHHHhhhh-HHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh-heeeccchh
Confidence 37999999975 9999884 4578889999999999999999999999999999999999887 899999999
Q ss_pred ccccccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCC
Q 019780 211 AREEVMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKV 259 (336)
Q Consensus 211 a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~ 259 (336)
|+..... ..+....|..|.|||.+.+..+....|||++||.+=++-.+.
T Consensus 165 ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~ 214 (369)
T KOG0665|consen 165 ARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGT 214 (369)
T ss_pred hcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhce
Confidence 9976665 556667999999999999998999999999999776654443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=192.73 Aligned_cols=218 Identities=25% Similarity=0.462 Sum_probs=180.7
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEee
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 127 (336)
+...+...++++..++-+|.||.||.|.+. .+.|-+|.++. ..++-....++.|.-++..+.|||+..+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----~AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----HASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----cccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 345667778888899999999999999765 34567787762 3345567889999999999999999999
Q ss_pred EeeEecCC--EEEEEEccCCCCHHHHHhhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC
Q 019780 128 VGASVQPT--MMIITELMRGETLQRYLWST------RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED 199 (336)
Q Consensus 128 ~~~~~~~~--~~lv~e~~~gg~L~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~ 199 (336)
.++..+.. .+.++.++.-|+|..++... ....++..+...++.|++.|++|||+.|+||.||..+|++|++.
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh
Confidence 98877543 78889999999999999621 22346667788899999999999999999999999999999977
Q ss_pred CCceEEecccccccccccccccc----CCcccccCCC-------------------------------------------
Q 019780 200 KKQVKLADFGLAREEVMDEMTCE----AGTYRWMAPE------------------------------------------- 232 (336)
Q Consensus 200 ~~~~kl~Dfg~a~~~~~~~~~~~----~gt~~y~aPE------------------------------------------- 232 (336)
- .+||+|-.+++...+..+.+. -....||+||
T Consensus 433 L-qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 433 L-QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred e-eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 5 899999999998777665443 2458999999
Q ss_pred ---CCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh
Q 019780 233 ---NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277 (336)
Q Consensus 233 ---~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~ 277 (336)
....+|.++|++++.++..||...|++||++.|+..-|.++...+
T Consensus 512 kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 512 KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 344678899999999999999999999999999999888876554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=179.61 Aligned_cols=142 Identities=17% Similarity=0.194 Sum_probs=108.4
Q ss_pred eeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccH---------------------HHHHHHHHHHHHHHhCCCCce
Q 019780 67 QKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSR---------------------EHKEKFQREVTLLSKMKHENI 124 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~---------------------~~~~~~~~E~~~l~~l~hpnI 124 (336)
...||+|+||.||+|... ++.||||+++......... -......+|+..+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 367999999999999975 8899999998532211110 011234569999999987776
Q ss_pred EeeEeeEecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCCCceeecCCCCce
Q 019780 125 LKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL-HANSVIHRDLKPSNLLLTEDKKQV 203 (336)
Q Consensus 125 v~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~ivHrDikp~NIll~~~~~~~ 203 (336)
....... ....++||||++|+++..... ....++...+..++.|++.+|.++ |+.||+||||||+|||++. + .+
T Consensus 82 ~~p~~~~-~~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~-~v 156 (190)
T cd05147 82 PCPEPIL-LKSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G-KL 156 (190)
T ss_pred CCCcEEE-ecCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C-cE
Confidence 4332222 223589999999987765542 235689999999999999999999 7999999999999999984 4 79
Q ss_pred EEeccccccc
Q 019780 204 KLADFGLARE 213 (336)
Q Consensus 204 kl~Dfg~a~~ 213 (336)
+|+|||+|..
T Consensus 157 ~LiDFG~a~~ 166 (190)
T cd05147 157 YIIDVSQSVE 166 (190)
T ss_pred EEEEcccccc
Confidence 9999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-25 Score=185.19 Aligned_cols=190 Identities=20% Similarity=0.272 Sum_probs=147.9
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEee-EecCC-E
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGA-SVQPT-M 136 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~-~~~~~-~ 136 (336)
..|.+.+.||+|.||.+-++.++ .+.+++|.+.. .......|.+|..---.|. |.||+.-|++ |+..+ +
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~------p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR------PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc------chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 46888899999999999999997 67899998863 3345677999988766665 8999998775 55555 7
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee-cCCCCceEEeccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLL-TEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll-~~~~~~~kl~Dfg~a~~~~ 215 (336)
++++||++.|+|..-+ ....+.+.....++.|+++||.|||++++||||||.+|||| +.+..+|||||||+.+...
T Consensus 98 vF~qE~aP~gdL~snv---~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNV---EAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEeeccCccchhhhhc---CcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 7899999999999887 23568899999999999999999999999999999999998 4455689999999987533
Q ss_pred cccccccCCcccccCCCCCCCC-----CCCCHHHHHHHHHHhhccCCCCCC
Q 019780 216 MDEMTCEAGTYRWMAPENERPS-----LENLSEDMVALLKSCWAEDPKVRP 261 (336)
Q Consensus 216 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~di~~l~~~~l~~~p~~RP 261 (336)
..- .-.--+..|.+||..... ..+.+.|+|.++...+....+.-|
T Consensus 175 ~tV-~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~P 224 (378)
T KOG1345|consen 175 TTV-KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFP 224 (378)
T ss_pred cee-hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCc
Confidence 221 111245678899854332 234678999988776666666555
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-24 Score=191.47 Aligned_cols=244 Identities=21% Similarity=0.294 Sum_probs=179.7
Q ss_pred ceeEeeeecCCCcEEEEEeEECC---ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC----CceEeeEeeEe-cC
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYGC---EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH----ENILKFVGASV-QP 134 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~~~~~~~-~~ 134 (336)
.|.+.+.||+|+||.||.+.... ..+|+|+...... .. ...+..|..++..+.. +++..+++... .+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~----~~-~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELG----SK-PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEeccc----CC-CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 89999999999999999999864 3689998763111 11 1157788888888873 58888888884 44
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC----CceEEeccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK----KQVKLADFG 209 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~----~~~kl~Dfg 209 (336)
. .++||+.+ |.+|.++........++..++..++.|++.+|.+||+.|++||||||+|+++.... ..+.|.|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 4 78888888 77999988655568899999999999999999999999999999999999998653 469999999
Q ss_pred ccc--cccccc----------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC--Hh--HHHHHHHHH
Q 019780 210 LAR--EEVMDE----------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE--FA--EITITLTNI 273 (336)
Q Consensus 210 ~a~--~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~--~~--~i~~~l~~~ 273 (336)
+|+ ...... .....||..|.++........+..+|+|+++..+.+..-+.-|- .. .....+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 311111 12345999999999999999999999999999888887776662 11 112222222
Q ss_pred HHhhccC--CCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 274 LQNLRSA--DTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 274 ~~~~~~~--~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
....... ....|++...+.......+....+....+..+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 2222211 12244556666666666677777766666543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=174.88 Aligned_cols=143 Identities=17% Similarity=0.167 Sum_probs=110.4
Q ss_pred eeeecCCCcEEEEEeEEC-CccEEEEEeecCcccccc---------------------HHHHHHHHHHHHHHHhCCCCce
Q 019780 67 QKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVS---------------------REHKEKFQREVTLLSKMKHENI 124 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~hpnI 124 (336)
.+.||+|+||.||+|.+. ++.||||+++........ ......+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999985 899999999864211100 0112345789999999999987
Q ss_pred EeeEeeEecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCce
Q 019780 125 LKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKKQV 203 (336)
Q Consensus 125 v~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~~~~~ 203 (336)
.....+... ..++||||++|+++..... ....++...+..++.|++.+|.++|+ +||+||||||+||+++ ++ .+
T Consensus 82 ~~p~~~~~~-~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~-~~ 156 (190)
T cd05145 82 PVPEPILLK-KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG-KP 156 (190)
T ss_pred CCceEEEec-CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC-CE
Confidence 543333323 3589999999886544321 22457888999999999999999999 9999999999999998 54 79
Q ss_pred EEecccccccc
Q 019780 204 KLADFGLAREE 214 (336)
Q Consensus 204 kl~Dfg~a~~~ 214 (336)
+|+|||+++..
T Consensus 157 ~liDFG~a~~~ 167 (190)
T cd05145 157 YIIDVSQAVEL 167 (190)
T ss_pred EEEEcccceec
Confidence 99999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=190.87 Aligned_cols=192 Identities=26% Similarity=0.337 Sum_probs=158.3
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecC
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQP 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 134 (336)
.+.|...++||.|.|++||+|... ...||+|.+.. .....++..|+++|..+. +.||+++.+++..+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~-------ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR-------TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc-------ccCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 467888899999999999999753 57899999873 234567999999999997 99999999998876
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+ ..+|+||++.....++. ..++...+..+++.++.||+++|.+|||||||||.|+|++...+.-.|.|||+|..
T Consensus 108 d~v~ivlp~~~H~~f~~l~-----~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLY-----RSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CeeEEEecccCccCHHHHH-----hcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 5 89999999999999988 34678899999999999999999999999999999999998888899999999851
Q ss_pred -----------------ccc-----------------cc------------ccccCCcccccCCCCCCCCC-CCCHHHHH
Q 019780 214 -----------------EVM-----------------DE------------MTCEAGTYRWMAPENERPSL-ENLSEDMV 246 (336)
Q Consensus 214 -----------------~~~-----------------~~------------~~~~~gt~~y~aPE~~~~~~-~~~~~di~ 246 (336)
... .. .....||++|.|||++...+ .+-+.|+|
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 000 00 01124999999999876555 45678999
Q ss_pred HHHHHhhccCCCCCCCHh
Q 019780 247 ALLKSCWAEDPKVRPEFA 264 (336)
Q Consensus 247 ~l~~~~l~~~p~~RP~~~ 264 (336)
+.+..++......-|.|.
T Consensus 263 s~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFK 280 (418)
T ss_pred eccceeehhhcccccccc
Confidence 999888887777766543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=170.61 Aligned_cols=194 Identities=22% Similarity=0.301 Sum_probs=156.5
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC-CceEeeEeeEecCC
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH-ENILKFVGASVQPT 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~ 135 (336)
+-...|.+++.||+|+||.+|.|... +..||||+-.. ......+..|..+.+.|++ ..|..+..+..+..
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-------~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-------KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-------cCCCcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 44578999999999999999999875 89999998652 1123457789999999984 56777777766655
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC--CCceEEecccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED--KKQVKLADFGLAR 212 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~--~~~~kl~Dfg~a~ 212 (336)
-.+||+++ |.+|.++.. -....++..+++-++-|++.-++|+|.+++|||||||+|+|..-+ .+.+.++|||+|+
T Consensus 85 ynvlVMdLL-GPsLEdLfn-fC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFN-FCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred cceeeeecc-CccHHHHHH-HHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 78999998 679998873 234568999999999999999999999999999999999998543 3468999999998
Q ss_pred ccccc---------cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCC
Q 019780 213 EEVMD---------EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRP 261 (336)
Q Consensus 213 ~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP 261 (336)
..... +.....||..|.+--...+...+-.+|+.+++..++-.+.+.-|
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LP 220 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLP 220 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCc
Confidence 53221 22344699999998877777778889999999999988888777
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=171.27 Aligned_cols=169 Identities=11% Similarity=0.134 Sum_probs=127.6
Q ss_pred CCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHH------HHHHHHHHHhCCCCceEeeEeeEec-
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEK------FQREVTLLSKMKHENILKFVGASVQ- 133 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~------~~~E~~~l~~l~hpnIv~~~~~~~~- 133 (336)
..+|.+.+++|.|+||.||++...+..+|||++.+... ..+..... +.+|+..+.+++||+|....+++..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~--~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVK--RTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcC--chHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 57899999999999999999877778999999985322 22333333 6899999999999999998877552
Q ss_pred --------CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEE
Q 019780 134 --------PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKL 205 (336)
Q Consensus 134 --------~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl 205 (336)
+..+++|||++|.+|.+.. .+++ ....+++.+|..+|+.|++|||++|+||+++.++ ++|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~l 175 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRI 175 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEE
Confidence 2378999999999998874 1233 2456999999999999999999999999999765 999
Q ss_pred eccccccccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhh
Q 019780 206 ADFGLAREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCW 253 (336)
Q Consensus 206 ~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l 253 (336)
+|||..+......... ........+..+|+|+|+..+.
T Consensus 176 iDfg~~~~~~e~~a~d----------~~vler~y~~~~di~~lg~~~~ 213 (232)
T PRK10359 176 IDLSGKRCTAQRKAKD----------RIDLERHYGIKNEIKDLGYYLL 213 (232)
T ss_pred EECCCcccccchhhHH----------HHHHHhHhcccccccceeEeeh
Confidence 9999876432111110 0222333456789999876543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=170.43 Aligned_cols=195 Identities=24% Similarity=0.351 Sum_probs=156.3
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQP 134 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 134 (336)
.+-.-.|.++++||.|+||..+.|.+- +++||||.-.. +...-.+..|.+..+.|. .++|...+.+...+
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-------kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-------KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccc-------cCCcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 344567999999999999999999874 89999997542 223445778888888886 68899888777666
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC----CCCceEEeccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE----DKKQVKLADFG 209 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~----~~~~~kl~Dfg 209 (336)
. ..||||++ |.+|.|+. .-.+.+++..++..++.|++.-++|+|++.+|+|||||+|+||.. +.+.+.|+|||
T Consensus 97 ~~NiLVidLL-GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred chhhhhhhhh-CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEecc
Confidence 4 67899988 67998877 334578999999999999999999999999999999999999964 33469999999
Q ss_pred cccccccc---------cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCC
Q 019780 210 LAREEVMD---------EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRP 261 (336)
Q Consensus 210 ~a~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP 261 (336)
+|+..... +..+..||..||+--...+...+-.+|+.+|+...+-...+.-|
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLP 235 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 235 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCc
Confidence 99854322 23445699999999988888888899999998876655444444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=164.68 Aligned_cols=196 Identities=21% Similarity=0.285 Sum_probs=134.6
Q ss_pred eeecCCCcEEEEEeEECCccEEEEEeecCcccc---ccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe-cCCEEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALA---VSREHKEKFQREVTLLSKMKHENILKFVGASV-QPTMMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~lv~e~~ 143 (336)
+.||+|++|.||+|.+.+..+++|+........ ........+.+|+.++..+.|++|.....++. ....+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 579999999999999998999999876321111 11123456889999999999998766555444 34589999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccccccccC
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA 223 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 223 (336)
+|++|.+++... .. ....++.+++.+|.++|+.|++|+|++|.|||++ ++ .++|+|||.+.........
T Consensus 82 ~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~~~~~~~~--- 150 (211)
T PRK14879 82 EGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG-KIYLIDFGLAEFSKDLEDR--- 150 (211)
T ss_pred CCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC-CEEEEECCcccCCCcHHhh---
Confidence 999999998432 12 7888999999999999999999999999999999 44 7999999998753211110
Q ss_pred CcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 224 GTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 224 gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
+...+..++......+....+++.....-+.. ...++..++...+..+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~f~~gY~~--~~~~~~~~~~~~~~~i~~~ 201 (211)
T PRK14879 151 AVDLHVLLRSLESTHPDWAEELFEAFLEGYRE--VMGEKAEEVLERVKEIRLR 201 (211)
T ss_pred hccHHHHHHHhhccCcchHHHHHHHHHHHHHH--hhcccHHHHHHHHHHHHHh
Confidence 11111111111112223444555554444442 1136677777777777654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=162.74 Aligned_cols=133 Identities=16% Similarity=0.231 Sum_probs=101.8
Q ss_pred eeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-----CCCceEeeEeeEecCC-----EE
Q 019780 68 KMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-----KHENILKFVGASVQPT-----MM 137 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~-----~~ 137 (336)
+.||+|+||.||... .....+||++.... ....+.+.+|+.+++.+ .||||+++++++.++. +.
T Consensus 8 ~~LG~G~~~~Vy~hp-~~~~k~IKv~~~~~-----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 8 SPLGTGRHRKCYAHP-EDAQRCIKIVYHRG-----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred ceecCCCceEEEECC-CCcCeEEEEEeccc-----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 679999999999622 23334788886421 12346789999999999 5799999999998763 33
Q ss_pred EEEEc--cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCcccccCCCCceeecCC---CCceEEeccccc
Q 019780 138 IITEL--MRGETLQRYLWSTRPKRLDLKHSISFALDISRAM-EYLHANSVIHRDLKPSNLLLTED---KKQVKLADFGLA 211 (336)
Q Consensus 138 lv~e~--~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL-~~lH~~~ivHrDikp~NIll~~~---~~~~kl~Dfg~a 211 (336)
+|+|| +.+|+|.+++.. ..+++. ..++.|++.++ +|||+++|+||||||+|||++.. ...++|+||+-+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 557999999943 236555 35678888888 89999999999999999999742 237999995433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=160.35 Aligned_cols=134 Identities=16% Similarity=0.169 Sum_probs=104.9
Q ss_pred EeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCCEEEEEEccC
Q 019780 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPTMMIITELMR 144 (336)
Q Consensus 66 ~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~lv~e~~~ 144 (336)
....|++|+||+||.+...+.+++.+.+...... ...-....+.+|+++|++++ |+++++++++ +..+++|+|+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~-~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWW-LRGVAWWLARREALALRQLDGLPRTPRLLHW---DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhh-hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeeec
Confidence 3467999999999988777888887777521110 01112336889999999996 5789999885 45799999999
Q ss_pred CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccC-CCCceeecCCCCceEEeccccccc
Q 019780 145 GETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDL-KPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 145 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDi-kp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
|.+|...+. . . ...++.|++.+|.++|++||+|||| ||+|||++.++ .++|+|||+|..
T Consensus 82 G~~L~~~~~--~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~ 141 (218)
T PRK12274 82 GAAMYQRPP--R------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVR 141 (218)
T ss_pred CccHHhhhh--h------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-CEEEEECCCcee
Confidence 999876441 1 1 1357889999999999999999999 79999999776 799999999984
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-20 Score=168.23 Aligned_cols=195 Identities=30% Similarity=0.416 Sum_probs=161.0
Q ss_pred eeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCC-ceEeeEeeEecCC-EEEEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE-NILKFVGASVQPT-MMIITE 141 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~-~~lv~e 141 (336)
|.+.+.||.|+||.||++.+. ..+++|.+.... .........+.+|+.++..+.|+ +|+++.+.+.... .+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~--~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKL--ESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhh--ccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 677889999999999999987 788999987422 11223577899999999999988 7999999997666 699999
Q ss_pred ccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc---
Q 019780 142 LMRGETLQRYLWSTRP-KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--- 217 (336)
Q Consensus 142 ~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--- 217 (336)
++.++++.+++..... ..++......++.|++.++.|+|+.|++|||+||+||+++..+..++++|||.++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977743221 268999999999999999999999999999999999999987646999999998743322
Q ss_pred -----cccccCCcccccCCCCCCC---CCCCCHHHHHHHHHHhhccCCCCCC
Q 019780 218 -----EMTCEAGTYRWMAPENERP---SLENLSEDMVALLKSCWAEDPKVRP 261 (336)
Q Consensus 218 -----~~~~~~gt~~y~aPE~~~~---~~~~~~~di~~l~~~~l~~~p~~RP 261 (336)
......|+..|+|||.... .......|+|+++..++....+..|
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p 210 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 1345569999999998887 5788899999999877776666666
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-21 Score=160.70 Aligned_cols=190 Identities=19% Similarity=0.255 Sum_probs=126.6
Q ss_pred eecCCCcEEEEEeEECCccEEEEEeecCcccc---ccHHHHHHHHHHHHHHHhCCCCceEeeEeeE-ecCCEEEEEEccC
Q 019780 69 MIGEGSYSIVYKGFYGCEPVAVKVIQPCNALA---VSREHKEKFQREVTLLSKMKHENILKFVGAS-VQPTMMIITELMR 144 (336)
Q Consensus 69 ~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~lv~e~~~ 144 (336)
.||+|+||.||+|.+.+..+++|+........ .......++.+|+.++..++|+++.....++ .++..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 38999999999999889999999976321111 1122346788999999999987654333222 3445789999999
Q ss_pred CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccccccccCC
Q 019780 145 GETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAG 224 (336)
Q Consensus 145 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~g 224 (336)
|++|.+++.... . .++.+++.+|.+||+.|++|+|++|.||+++ ++ .++++|||++........ .+
T Consensus 81 g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~~~~~~~---~~ 146 (199)
T TIGR03724 81 GKPLKDVIEEGN--D-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKYSDEIED---KA 146 (199)
T ss_pred CccHHHHHhhcH--H-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC-cEEEEECCCCcCCCcHHh---hh
Confidence 999999873321 1 7899999999999999999999999999999 44 799999999875322111 11
Q ss_pred cccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 225 TYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 225 t~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
...+..++...........+++..+..-+. ..++...++...+..+.+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~fl~~Y~---~~~~~~~~~~~~i~~~~~ 194 (199)
T TIGR03724 147 VDLHVLKRSLESTHPDKAEELFEAFLEGYR---EEFGEAKDVLERVKEIEL 194 (199)
T ss_pred chHHHHHHHHhhhCchhHHHHHHHHHHHHH---hhcccHHHHHHHHHHHHh
Confidence 111222222222223345566665555444 234444445555555543
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=167.67 Aligned_cols=148 Identities=18% Similarity=0.202 Sum_probs=113.1
Q ss_pred ecCCceeEeeeecCCCcEEEEEeE-E--CCccEEEEEeecCcccccc-------------------HHHHHHHHHHHHHH
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGF-Y--GCEPVAVKVIQPCNALAVS-------------------REHKEKFQREVTLL 116 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~-~--~~~~vavK~~~~~~~~~~~-------------------~~~~~~~~~E~~~l 116 (336)
-....|.+.+.||+|+||.||+|. + .++.||+|+++........ ......+.+|+.++
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 334468889999999999999998 3 4899999999853211100 01224567899999
Q ss_pred HhCCCC--ceEeeEeeEecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccccCCCCc
Q 019780 117 SKMKHE--NILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS-VIHRDLKPSN 193 (336)
Q Consensus 117 ~~l~hp--nIv~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-ivHrDikp~N 193 (336)
..+.+. .++++++. ...++||||++|++|..... ....+....+..++.|++.+|.+||++| ++||||||+|
T Consensus 105 ~~L~~~~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N 179 (237)
T smart00090 105 QRLYEAGVPVPKPIAW---RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN 179 (237)
T ss_pred HHHHhcCCCCCeeeEe---cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence 999753 33444442 34689999999988876542 2234566677899999999999999999 9999999999
Q ss_pred eeecCCCCceEEeccccccc
Q 019780 194 LLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 194 Ill~~~~~~~kl~Dfg~a~~ 213 (336)
|+++ ++ .++|+|||.+..
T Consensus 180 Ili~-~~-~i~LiDFg~a~~ 197 (237)
T smart00090 180 ILVH-DG-KVVIIDVSQSVE 197 (237)
T ss_pred EEEE-CC-CEEEEEChhhhc
Confidence 9999 44 799999998874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.6e-22 Score=198.37 Aligned_cols=193 Identities=13% Similarity=0.169 Sum_probs=127.7
Q ss_pred hCCC-CceEeeEeeEe--------cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 019780 118 KMKH-ENILKFVGASV--------QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRD 188 (336)
Q Consensus 118 ~l~h-pnIv~~~~~~~--------~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrD 188 (336)
.++| +||.++++++. +..+++++|++ +++|.+++... ...+++.+++.++.||+.||+|||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 3444 46666666651 12367778877 56999999532 35699999999999999999999999999999
Q ss_pred CCCCceeecCCC------------------CceEEeccccccccccc------------------cccccCCcccccCCC
Q 019780 189 LKPSNLLLTEDK------------------KQVKLADFGLAREEVMD------------------EMTCEAGTYRWMAPE 232 (336)
Q Consensus 189 ikp~NIll~~~~------------------~~~kl~Dfg~a~~~~~~------------------~~~~~~gt~~y~aPE 232 (336)
|||+|||++..+ ..+|++|||+++..... ......||+.|+|||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 999999995322 25677777777532100 001134788999999
Q ss_pred CCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccC-CCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 233 NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSA-DTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 233 ~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
......++.+.|+|++++.++++.....|. ......+..+....... .....+....++...+..+|..|+++.++.+
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSR-EEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCch-hhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 999888999999999999999987655443 32222222222211110 0011122333444456667777777777665
Q ss_pred cc
Q 019780 312 FN 313 (336)
Q Consensus 312 ~~ 313 (336)
..
T Consensus 265 h~ 266 (793)
T PLN00181 265 SE 266 (793)
T ss_pred ch
Confidence 43
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.3e-20 Score=176.70 Aligned_cols=139 Identities=24% Similarity=0.344 Sum_probs=111.0
Q ss_pred eeEeeeecCCCcEEEEEeEECCccEEEEEeecCcccc---ccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec-CCEEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALA---VSREHKEKFQREVTLLSKMKHENILKFVGASVQ-PTMMII 139 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~lv 139 (336)
|...+.||+|+||+||+|.+.+..+++|+........ ......+++.+|+++++.++|++++....+..+ ...++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 4557899999999999999887777776643211110 112234678999999999999998876655554 358899
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
|||++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||++ ++ .++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~-~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD-RLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC-cEEEEeCcccccC
Confidence 99999999999883 3567899999999999999999999999999994 44 7999999999863
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-20 Score=181.86 Aligned_cols=189 Identities=26% Similarity=0.320 Sum_probs=146.6
Q ss_pred cCCceeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC---CCceEeeE
Q 019780 53 IDASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK---HENILKFV 128 (336)
Q Consensus 53 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~ 128 (336)
......+....|.|.+.||+|+||+||+|... ++.||+|+-++.+.+.. .--.+++.+|+ -+.|..+.
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf--------YI~~q~~~RLk~~~~~~~~~~~ 760 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF--------YICLQVMERLKPQMLPSIMHIS 760 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee--------eehHHHHHhhchhhhcchHHHH
Confidence 34456778889999999999999999999876 88999999887554321 11223344444 12334443
Q ss_pred eeEe-cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC------CCC
Q 019780 129 GASV-QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE------DKK 201 (336)
Q Consensus 129 ~~~~-~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~------~~~ 201 (336)
.+.. .+.-+||++|.+.|+|.+++ +..+.+++..+..+..|++..+++||..+|||+||||+|+||.. +..
T Consensus 761 ~a~~~~~~S~lv~ey~~~Gtlld~~--N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 761 SAHVFQNASVLVSEYSPYGTLLDLI--NTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred HHHccCCcceeeeeccccccHHHhh--ccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCccc
Confidence 3333 34478999999999999999 56678999999999999999999999999999999999999942 233
Q ss_pred ceEEecccccccccc----ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHH
Q 019780 202 QVKLADFGLAREEVM----DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKS 251 (336)
Q Consensus 202 ~~kl~Dfg~a~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~ 251 (336)
.++|+|||.+..... ......++|-.+-.+|.+.+.+|++..|++.|+..
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~ 892 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAAT 892 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHH
Confidence 599999999874221 23445678999999999999999999998876653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=151.18 Aligned_cols=141 Identities=21% Similarity=0.216 Sum_probs=108.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCcccccc-----------------HHHHHHHHHHHHHHHhCCCCc
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVS-----------------REHKEKFQREVTLLSKMKHEN 123 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~-----------------~~~~~~~~~E~~~l~~l~hpn 123 (336)
..|.+.+.||+|+||.||++... ++.||||++......... ........+|+.++..+.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 34777899999999999999884 889999998743211000 011234678899999998774
Q ss_pred --eEeeEeeEecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC
Q 019780 124 --ILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK 201 (336)
Q Consensus 124 --Iv~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~ 201 (336)
++..++ ....++||||++|++|..... ......++.+++.++.++|+.|++||||+|+||+++.++
T Consensus 95 i~v~~~~~---~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~- 162 (198)
T cd05144 95 FPVPKPID---WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE- 162 (198)
T ss_pred CCCCceee---cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-
Confidence 444443 244689999999999987641 024567889999999999999999999999999999876
Q ss_pred ceEEecccccccc
Q 019780 202 QVKLADFGLAREE 214 (336)
Q Consensus 202 ~~kl~Dfg~a~~~ 214 (336)
.++|+|||++...
T Consensus 163 ~~~liDfg~~~~~ 175 (198)
T cd05144 163 KIYIIDWPQMVST 175 (198)
T ss_pred cEEEEECCccccC
Confidence 8999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.1e-20 Score=177.76 Aligned_cols=166 Identities=24% Similarity=0.294 Sum_probs=123.2
Q ss_pred eEeeeecCCCcEEEEEeEEC--CccEEEEEeecC-ccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEE
Q 019780 65 LLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPC-NALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 65 ~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~ 140 (336)
....++|.|++|.|+.+... ...++.|..... ............+..|+.+-..+.|||++..+....+.. ....|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45578999999977776553 333444433210 011222233334778888889999999988777666543 44459
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc----
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM---- 216 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~---- 216 (336)
|||++ +|..++.+ ...+....+.-++.|++.|++|+|+.|+.|||+||+|+++..++ .+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g-~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG-ILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC-ceEEeecCcceeeccCcch
Confidence 99999 99999943 35788889999999999999999999999999999999999987 899999999864222
Q ss_pred --ccccccCCcccccCCCCC
Q 019780 217 --DEMTCEAGTYRWMAPENE 234 (336)
Q Consensus 217 --~~~~~~~gt~~y~aPE~~ 234 (336)
......+|+.+|+|||..
T Consensus 477 ~~~~~~g~~gS~pY~apE~~ 496 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVL 496 (601)
T ss_pred hhhhhcCcccCCcCcCcccc
Confidence 123445799999999943
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.9e-20 Score=154.32 Aligned_cols=208 Identities=25% Similarity=0.415 Sum_probs=162.0
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
++-....+.-+|.....|..|+|++.+..++.|++.. ..........|..|.-.|+.+.||||+.+++.+..+. +.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~v---r~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNV---REVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhh---hhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 3445566677899999999999999999999998863 3334555677999999999999999999999998764 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCCceEEeccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS--VIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
++..||+.|+|+..++...+...+..++..++.+++.|++|||+.. |.---|....+++|++- +.+|. .+-++...
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-taris-mad~kfsf 341 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARIS-MADTKFSF 341 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhhee-cccceeee
Confidence 9999999999999998888778899999999999999999999984 44446788899998775 44442 11122111
Q ss_pred cccccccCCcccccCCCC-------------------------------------------------CCCCCCCCHHHHH
Q 019780 216 MDEMTCEAGTYRWMAPEN-------------------------------------------------ERPSLENLSEDMV 246 (336)
Q Consensus 216 ~~~~~~~~gt~~y~aPE~-------------------------------------------------~~~~~~~~~~di~ 246 (336)
.. ....-.+.||+||. ....|+.++..+.
T Consensus 342 qe--~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~ 419 (448)
T KOG0195|consen 342 QE--VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMN 419 (448)
T ss_pred ec--cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHH
Confidence 11 11124588999991 1234566778888
Q ss_pred HHHHHhhccCCCCCCCHhHHHHHHHHH
Q 019780 247 ALLKSCWAEDPKVRPEFAEITITLTNI 273 (336)
Q Consensus 247 ~l~~~~l~~~p~~RP~~~~i~~~l~~~ 273 (336)
.|+..|+..+|++||.|+.++..|+.+
T Consensus 420 klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 420 KLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred HHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 899999999999999999998887765
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.7e-18 Score=146.51 Aligned_cols=138 Identities=18% Similarity=0.197 Sum_probs=105.9
Q ss_pred eeec-CCCcEEEEEeEECCccEEEEEeecCcc--------ccccHHHHHHHHHHHHHHHhCCCCce--EeeEeeEecC-C
Q 019780 68 KMIG-EGSYSIVYKGFYGCEPVAVKVIQPCNA--------LAVSREHKEKFQREVTLLSKMKHENI--LKFVGASVQP-T 135 (336)
Q Consensus 68 ~~lg-~G~fg~V~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~~~E~~~l~~l~hpnI--v~~~~~~~~~-~ 135 (336)
..|| .||.|+||.+...+..++||.+..... .........++.+|+.++..++|++| +..+++.... .
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 788899999888889999998863221 01112345678999999999998775 5666654322 1
Q ss_pred ----EEEEEEccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 136 ----MMIITELMRG-ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 136 ----~~lv~e~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
.++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||++||+||||||+|||++.++ .++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~-~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG-KFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-CEEEEECCC
Confidence 3599999997 699998843 345544 357899999999999999999999999999876 799999998
Q ss_pred ccc
Q 019780 211 ARE 213 (336)
Q Consensus 211 a~~ 213 (336)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.2e-20 Score=169.88 Aligned_cols=192 Identities=23% Similarity=0.303 Sum_probs=158.7
Q ss_pred eecCCCcEEEEEeE-----ECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecC-CEEEEEE
Q 019780 69 MIGEGSYSIVYKGF-----YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQP-TMMIITE 141 (336)
Q Consensus 69 ~lg~G~fg~V~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~-~~~lv~e 141 (336)
.+|+|+||.|++++ +.+.-+|+|++++........ .....|..++...+ ||.++++...++.+ +.+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~---~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR---THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc---cccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 37999999999754 237789999988533222222 26677888888887 99999998887755 5999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccccccc
Q 019780 142 LMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTC 221 (336)
Q Consensus 142 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~ 221 (336)
+..||+|...+ .....+.+.....+...++.+++++|+.|++|||+|++||+++.+| ++++.|||+++........
T Consensus 78 ~~rgg~lft~l--~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 78 FLRGGDLFTRL--SKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred hcccchhhhcc--ccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-ccccCCchhhhHhHhhhhc-
Confidence 99999999888 4556678888899999999999999999999999999999999998 8999999999876555444
Q ss_pred cCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 019780 222 EAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITL 270 (336)
Q Consensus 222 ~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l 270 (336)
+||..|||||... ....+.|.|+++..++++..+--|...+++..+
T Consensus 154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~~I 199 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMKRI 199 (612)
T ss_pred -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHHHH
Confidence 7999999999888 667788999999999999999888877554443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=6e-18 Score=141.27 Aligned_cols=139 Identities=24% Similarity=0.296 Sum_probs=97.3
Q ss_pred eeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHH-------------------HHHHHHHHHHHHhCCCCc--e
Q 019780 67 QKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREH-------------------KEKFQREVTLLSKMKHEN--I 124 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~-------------------~~~~~~E~~~l~~l~hpn--I 124 (336)
.+.||+|+||+||+|... ++.||||+++........... ......|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999987 889999998753211111000 011245666666665433 3
Q ss_pred EeeEeeEecCCEEEEEEccCCCCHHHH-HhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCc
Q 019780 125 LKFVGASVQPTMMIITELMRGETLQRY-LWSTRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKKQ 202 (336)
Q Consensus 125 v~~~~~~~~~~~~lv~e~~~gg~L~~~-l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~~~~ 202 (336)
.+.++. ...++||||++|+.+... +.... .. ..+..++.+++.++.++|+ +|++|+||||+||+++ ++ .
T Consensus 82 ~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-~ 152 (187)
T cd05119 82 PKPIDL---NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG-K 152 (187)
T ss_pred CceEec---CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC-c
Confidence 444443 346899999999543321 11100 11 5678899999999999999 9999999999999999 54 7
Q ss_pred eEEecccccccc
Q 019780 203 VKLADFGLAREE 214 (336)
Q Consensus 203 ~kl~Dfg~a~~~ 214 (336)
++|+|||.+...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=147.61 Aligned_cols=142 Identities=27% Similarity=0.385 Sum_probs=109.4
Q ss_pred CCCceEeeEeeEecC----------------------------CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHH
Q 019780 120 KHENILKFVGASVQP----------------------------TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALD 171 (336)
Q Consensus 120 ~hpnIv~~~~~~~~~----------------------------~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~q 171 (336)
+|||||++..+|.+. .+|+||.-++. +|..|+..+ ..+....+-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC---CCchHHHHHHHHH
Confidence 599999998765431 16899988865 999999654 3566778889999
Q ss_pred HHHHHHHHHhCCcccccCCCCceeecCCC---CceEEecccccccccc--------ccccccCCcccccCCC--------
Q 019780 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDK---KQVKLADFGLAREEVM--------DEMTCEAGTYRWMAPE-------- 232 (336)
Q Consensus 172 i~~aL~~lH~~~ivHrDikp~NIll~~~~---~~~kl~Dfg~a~~~~~--------~~~~~~~gt~~y~aPE-------- 232 (336)
+++|+.|||.+||.|||+|.+|||+.-+. ..+.|+|||.+--... +..-...|...-||||
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 99999999999999999999999994332 3588999998753211 1122334778899999
Q ss_pred --------------------------------------------CCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH
Q 019780 233 --------------------------------------------NERPSLENLSEDMVALLKSCWAEDPKVRPEFAE 265 (336)
Q Consensus 233 --------------------------------------------~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~ 265 (336)
++...+..+++++.+|+..+++.+|.+|++..-
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 233446678899999999999999999998543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=138.10 Aligned_cols=154 Identities=18% Similarity=0.152 Sum_probs=117.7
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccccccccCCc
Q 019780 146 ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT 225 (336)
Q Consensus 146 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~gt 225 (336)
|+|.+++... +..+++..++.++.|++.||.|||+++ ||+|||++.++ .+++ ||+++..... ...||
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~---~~~g~ 67 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPE---QSRVD 67 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeeccc---cCCCc
Confidence 6899999543 356999999999999999999999999 99999999876 7888 9998754332 23589
Q ss_pred ccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHHHhhccCCCC-------CCC--CcccccCC
Q 019780 226 YRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNILQNLRSADTP-------IPP--KLVEIVDP 294 (336)
Q Consensus 226 ~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~~~~~~~~~~-------~p~--~~~~~~~~ 294 (336)
+.|+|||......++...|+|++++.+|++..++.|... .+...+..+...+....+. +++ ++.+++..
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 999999999998999999999999999999988888532 2233334444333322111 112 46778888
Q ss_pred CCCCCCccccchhhhccc
Q 019780 295 KSTMNNDCMATVHAITKF 312 (336)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~ 312 (336)
.+..+|+.|++..++.+.
T Consensus 148 cl~~~p~~Rp~~~~ll~~ 165 (176)
T smart00750 148 CASRLPQRREAANHYLAH 165 (176)
T ss_pred HHhcccccccCHHHHHHH
Confidence 888888888888777653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.9e-17 Score=129.02 Aligned_cols=131 Identities=21% Similarity=0.262 Sum_probs=108.4
Q ss_pred EeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC--CceEeeEeeEecC-CEEEEEEc
Q 019780 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH--ENILKFVGASVQP-TMMIITEL 142 (336)
Q Consensus 66 ~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~-~~~lv~e~ 142 (336)
+.+.||+|.++.||++...+..+++|+...... ...+.+|+..+..++| .++++++.+.... ..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 347799999999999999888999999863211 4568899999999976 5888888876654 48999999
Q ss_pred cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCCCCceeecCCCCceEEeccccccc
Q 019780 143 MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN---SVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 143 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
++|+.+..+ +......++.+++.+|+++|.. +++|+|++|+||+++..+ .++++|||.+..
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence 998776543 4566777899999999999985 799999999999999755 799999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.8e-18 Score=165.47 Aligned_cols=198 Identities=25% Similarity=0.337 Sum_probs=147.8
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCCEEE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMI 138 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~l 138 (336)
..+|..++.|..|+||.||.++++ .+.+|+|+-+. +. +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~l----------ilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NL----------ILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-ch----------hhhc--cccccCCccee-------------
Confidence 357888899999999999999887 78899954331 11 1110 23333334333
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|+-...+ ...+.++... +.+++|||+.||+|||+||+|.+|..-| ++|++|||+.+......
T Consensus 136 -------gDc~tll--k~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 -------GDCATLL--KNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred -------chhhhhc--ccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecc-cccccchhhhhhhhhhc
Confidence 5666666 3334454432 7799999999999999999999999876 89999999987421111
Q ss_pred -----------------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-----HHHHHHHHHHh
Q 019780 219 -----------------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-----ITITLTNILQN 276 (336)
Q Consensus 219 -----------------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-----i~~~l~~~~~~ 276 (336)
....+||+.|+|||++.-+.++.|.|+|+++...++.+-+.-|.+.+ +-..+.+.+ .
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i-~ 276 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI-E 276 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc-c
Confidence 12347999999999999999999999999999999999999998887 333333333 3
Q ss_pred hccCCCCCCCCcccccCCCCCCCCccc
Q 019780 277 LRSADTPIPPKLVEIVDPKSTMNNDCM 303 (336)
Q Consensus 277 ~~~~~~~~p~~~~~~~~~~~~~~~~~~ 303 (336)
....+.+.|++++++++.++..++-++
T Consensus 277 wpE~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 277 WPEEDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred ccccCcCCCHHHHHHHHHHHHhChHhh
Confidence 344478899999999999999998777
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.1e-18 Score=163.92 Aligned_cols=196 Identities=20% Similarity=0.173 Sum_probs=148.8
Q ss_pred ceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITE 141 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e 141 (336)
++...+.||++.|=+|.+|.+....|+||++.+..... +-....+-.+|++ ...++|||++.+.-+...+. .|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~-sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTI-SLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCC-CchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 56667889999999999999987779999998644322 2223333344455 66778999999887765554 788888
Q ss_pred ccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc----
Q 019780 142 LMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD---- 217 (336)
Q Consensus 142 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~---- 217 (336)
|+.. +|+|.+ ....-+..-+.+.|+.|++.||.-+|..||.|||||.+||||+..++ +.|+||..-+.....
T Consensus 102 yvkh-nLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW-~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKH-NLYDRL--STRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW-LYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhh-hhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech-hhhhcccccCCccCCCCCc
Confidence 8865 999999 44456778888999999999999999999999999999999998875 889999876642221
Q ss_pred -ccc----ccCCcccccCCCCCCC----------CC-CCCHHHHHHHHHHhhccCCCCCCCHh
Q 019780 218 -EMT----CEAGTYRWMAPENERP----------SL-ENLSEDMVALLKSCWAEDPKVRPEFA 264 (336)
Q Consensus 218 -~~~----~~~gt~~y~aPE~~~~----------~~-~~~~~di~~l~~~~l~~~p~~RP~~~ 264 (336)
..+ +...-..|+|||.+-. .+ -..+.||+++||...++-.+.||-|.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 111 1123367999995433 12 34567999999999999999999653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.61 E-value=8e-15 Score=128.15 Aligned_cols=189 Identities=22% Similarity=0.256 Sum_probs=118.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC----------CceEeeEe
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH----------ENILKFVG 129 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------pnIv~~~~ 129 (336)
+.+..++.||.|+++.||.+++. ++.+|+|+..... .......+.+.+|.-....+.+ -.++..++
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~--~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d 89 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA--DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD 89 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS--TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEeccc--ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence 45677789999999999999997 6999999987543 2233346666666655444322 12222222
Q ss_pred eE---------e---cC------CEEEEEEccCCCCHHHHHh---hcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 019780 130 AS---------V---QP------TMMIITELMRGETLQRYLW---STRPK--RLDLKHSISFALDISRAMEYLHANSVIH 186 (336)
Q Consensus 130 ~~---------~---~~------~~~lv~e~~~gg~L~~~l~---~~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivH 186 (336)
.. . +. +.+++|+-+. ++|.+++. ..... .+.......+..|++..+++||+.|++|
T Consensus 90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVH 168 (288)
T PF14531_consen 90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVH 168 (288)
T ss_dssp EEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEe
Confidence 11 1 11 2367777775 58888863 22211 2333344566689999999999999999
Q ss_pred ccCCCCceeecCCCCceEEeccccccccccccccccCCcccccCCCCCC--------CCCCCCHHHHHHHHHHhhcc
Q 019780 187 RDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENER--------PSLENLSEDMVALLKSCWAE 255 (336)
Q Consensus 187 rDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~di~~l~~~~l~~ 255 (336)
+||+|+|++++.+| .+.|+||+........... ...+..|.+||... ....+.+.|.|+|+..++..
T Consensus 169 gdi~~~nfll~~~G-~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDG-GVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS--EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCC-CEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999987 7999999877653332221 34557788888432 23467788999999866643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.1e-15 Score=138.33 Aligned_cols=143 Identities=21% Similarity=0.283 Sum_probs=96.9
Q ss_pred eeecCCCcEEEEEeEEC-CccEEEEEeecCccccccH-----------------------------HHH------HHHHH
Q 019780 68 KMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSR-----------------------------EHK------EKFQR 111 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~-----------------------------~~~------~~~~~ 111 (336)
+.||+|++|.||+|+.. |+.||||+.+++-...... +.. -.+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999985 8999999998642111100 000 12455
Q ss_pred HHHHHHhC----CCCceEeeEeeEe--cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 019780 112 EVTLLSKM----KHENILKFVGASV--QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISR-AMEYLHANSV 184 (336)
Q Consensus 112 E~~~l~~l----~hpnIv~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~-aL~~lH~~~i 184 (336)
|+..+..+ +|.+-+.+-.++. ....++||||++|++|.++..... ...+ ...++.+++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 66666555 2332233322222 234799999999999998764321 1122 2345555555 4678999999
Q ss_pred ccccCCCCceeecCCCCceEEeccccccccc
Q 019780 185 IHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 185 vHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
+|+|++|.||+++.++ .++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~g-~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDG-KIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence 9999999999998876 79999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.2e-14 Score=117.63 Aligned_cols=128 Identities=20% Similarity=0.190 Sum_probs=95.9
Q ss_pred eeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCce-EeeEeeEecCCEEEEEEccCC
Q 019780 67 QKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI-LKFVGASVQPTMMIITELMRG 145 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~lv~e~~~g 145 (336)
.+.|+.|.++.||++...+..+++|+...... ....+.+|+.+++.+.+.++ .+++... ....++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~-~~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFD-PETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEe-CCCCeEEEEecCC
Confidence 36789999999999999889999999763211 12345788888888865444 3455443 3346899999999
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----ccccCCCCceeecCCCCceEEeccccccc
Q 019780 146 ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSV-----IHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 146 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i-----vHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.++.+.- . ....++.+++.+|+.||+.++ +|+|++|.||+++ ++ .++++|||.+..
T Consensus 76 ~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAGM 136 (170)
T ss_pred Ccccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC-eEEEEecccccC
Confidence 8876420 1 112456789999999999985 9999999999999 44 699999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.3e-13 Score=114.57 Aligned_cols=139 Identities=17% Similarity=0.210 Sum_probs=100.0
Q ss_pred eeecCCCcEEEEEeEEC--------CccEEEEEeecCcccccc-----------------HHHHHH----HHHHHHHHHh
Q 019780 68 KMIGEGSYSIVYKGFYG--------CEPVAVKVIQPCNALAVS-----------------REHKEK----FQREVTLLSK 118 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--------~~~vavK~~~~~~~~~~~-----------------~~~~~~----~~~E~~~l~~ 118 (336)
..||.|-=+.||.|... +..+|||+.+........ ...... ..+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 56899999999999754 368999998742211100 011222 3489999999
Q ss_pred CCC--CceEeeEeeEecCCEEEEEEccCCCCHHH-HHhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCCCce
Q 019780 119 MKH--ENILKFVGASVQPTMMIITELMRGETLQR-YLWSTRPKRLDLKHSISFALDISRAMEYL-HANSVIHRDLKPSNL 194 (336)
Q Consensus 119 l~h--pnIv~~~~~~~~~~~~lv~e~~~gg~L~~-~l~~~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~ivHrDikp~NI 194 (336)
+.. -+++..+++ ...++||||+.++.+.. .+ ....++......+..+++.+|..| |..|+||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 863 455666654 45789999998754432 22 112355566778889999999998 899999999999999
Q ss_pred eecCCCCceEEecccccccc
Q 019780 195 LLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 195 ll~~~~~~~kl~Dfg~a~~~ 214 (336)
+++. + .+.|+|||.+...
T Consensus 157 L~~~-~-~v~iIDF~qav~~ 174 (197)
T cd05146 157 LWHD-G-KVWFIDVSQSVEP 174 (197)
T ss_pred EEEC-C-cEEEEECCCceeC
Confidence 9984 3 6999999988753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.7e-13 Score=109.81 Aligned_cols=148 Identities=25% Similarity=0.314 Sum_probs=111.4
Q ss_pred EeeeecCCCcEEEEEeEECCccEEEEEeecC--c-cccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-CEEEEEE
Q 019780 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPC--N-ALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-TMMIITE 141 (336)
Q Consensus 66 ~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~--~-~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~lv~e 141 (336)
.+..|-+|+-+.|+++.+.|+.+.||.-... . .....+-...+..+|++.|.++.--.|.--.-++.|. ...|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 3577999999999999999999888865421 1 1112233567889999999888644443322223333 3789999
Q ss_pred ccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCce--EEeccccccc
Q 019780 142 LMRG-ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQV--KLADFGLARE 213 (336)
Q Consensus 142 ~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~--kl~Dfg~a~~ 213 (336)
|++| .++.+++...............++.+|-..+.-||..+|+|+||..+||++..+++.+ .++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 5888998766555554455578999999999999999999999999999998777655 8999999864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.4e-14 Score=137.67 Aligned_cols=144 Identities=18% Similarity=0.217 Sum_probs=92.7
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccc-----------------------------cHHHHHH---
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAV-----------------------------SREHKEK--- 108 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~-----------------------------~~~~~~~--- 108 (336)
.|.. +.||+|++|.||+|+.. |+.||||+.+++-.... -.+..+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4554 78999999999999985 79999999986421100 0011222
Q ss_pred ---HHHHHHHHHhCC----CCceEeeEeeEe--cCCEEEEEEccCCCCHHHHHhhcCCC----CCCHHHHHHHHHHHHHH
Q 019780 109 ---FQREVTLLSKMK----HENILKFVGASV--QPTMMIITELMRGETLQRYLWSTRPK----RLDLKHSISFALDISRA 175 (336)
Q Consensus 109 ---~~~E~~~l~~l~----hpnIv~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~----~l~~~~~~~i~~qi~~a 175 (336)
+.+|+..+.++. +.+.+.+-.++. ....++||||+.|+.+.++-.-...+ .+....+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 344444444442 333344333333 23478999999999998753111111 23333344444444
Q ss_pred HHHHHhCCcccccCCCCceeecCCC---CceEEecccccccc
Q 019780 176 MEYLHANSVIHRDLKPSNLLLTEDK---KQVKLADFGLAREE 214 (336)
Q Consensus 176 L~~lH~~~ivHrDikp~NIll~~~~---~~~kl~Dfg~a~~~ 214 (336)
...|++|+|++|.||+++.++ +.++++|||++...
T Consensus 277 ----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 277 ----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred ----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 468999999999999998765 36999999998743
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.7e-13 Score=108.33 Aligned_cols=135 Identities=25% Similarity=0.408 Sum_probs=100.7
Q ss_pred eeecCCCcEEEEEeEECCccEEEEEeecCccc----cccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-CEEEEEEc
Q 019780 68 KMIGEGSYSIVYKGFYGCEPVAVKVIQPCNAL----AVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-TMMIITEL 142 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~lv~e~ 142 (336)
..+++|+=+.+|.+.+.+.++++|.-.+ +.. ....-...+..+|++++..+.--.|..-+=+..+. ...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~-K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIP-KRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecC-cccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 4588999999999988777777776543 111 11222356788999999988754443332233343 36899999
Q ss_pred cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 143 MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 143 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
++|..|.+++... ...++..+-.-+.-||..||+|+||.++||+++.+ .+.++|||++...
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCccccc
Confidence 9999999999433 24567778888889999999999999999999865 4999999999753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.8e-13 Score=127.21 Aligned_cols=158 Identities=35% Similarity=0.549 Sum_probs=122.5
Q ss_pred HHhCCCCceEeeEeeEecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-ccccCCCCc
Q 019780 116 LSKMKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSV-IHRDLKPSN 193 (336)
Q Consensus 116 l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i-vHrDikp~N 193 (336)
|+.+.|.|+.++++.+.++. .+.|.+||..|+|.+.+.. ..-.+++.....++++++.||.|+|+..| .|+.+++.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 45788999999999988776 8889999999999999944 45678888899999999999999998866 999999999
Q ss_pred eeecCCCCceEEecccccccccc----ccccccCCcccccCCCCC-----------------------------------
Q 019780 194 LLLTEDKKQVKLADFGLAREEVM----DEMTCEAGTYRWMAPENE----------------------------------- 234 (336)
Q Consensus 194 Ill~~~~~~~kl~Dfg~a~~~~~----~~~~~~~gt~~y~aPE~~----------------------------------- 234 (336)
++++.. +.+||+|||+...... .......-..-|.|||..
T Consensus 80 Clvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 80 CLVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred ceeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999976 5899999999765422 111111234678888811
Q ss_pred ------------------------CCCCC---CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 235 ------------------------RPSLE---NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 235 ------------------------~~~~~---~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
+|..+ ..+.++..++..||..+|..||++.++...+..+..
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 11111 233467789999999999999999988776665543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.4e-14 Score=130.99 Aligned_cols=165 Identities=27% Similarity=0.319 Sum_probs=120.0
Q ss_pred EEEEEEccCCCCHHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 MMIITELMRGETLQRYLW-STRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~-~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
+||.|++|...+|.+.|. +......+......++.|++.|+.| +|.+|+|+||.||++..+. .+||.|||+....
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-QLKIGDFGLVTSQ 406 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-hhhhhhhhheeec
Confidence 789999999999999995 3344567788899999999999999 9999999999999998876 7999999997643
Q ss_pred ccc--------cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc--CCCCC
Q 019780 215 VMD--------EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS--ADTPI 284 (336)
Q Consensus 215 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~--~~~~~ 284 (336)
... ..+...||..||+||++.+..++...|||+|+..++++...-+ +..+-...+.++...... ...+.
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~-T~~er~~t~~d~r~g~ip~~~~~d~ 485 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFS-TQFERIATLTDIRDGIIPPEFLQDY 485 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhc-cHHHHHHhhhhhhcCCCChHHhhcC
Confidence 222 2344569999999999999999999999999998877643211 122333344444433222 11222
Q ss_pred CCCcccccCCCCCCCCccccch
Q 019780 285 PPKLVEIVDPKSTMNNDCMATV 306 (336)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~~~ 306 (336)
|. -..++..++..+|.+++..
T Consensus 486 p~-e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 486 PE-EYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred cH-HHHHHHHhcCCCcccCchH
Confidence 22 2235555666677777633
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.9e-15 Score=141.90 Aligned_cols=253 Identities=21% Similarity=0.215 Sum_probs=181.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC---CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-E
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG---CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT-M 136 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~ 136 (336)
..|.+.+.||+|+|+.|-..... ...+|+|.+... ............|..+-+.+. |+|++.+++...+.+ .
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~---~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIP---PKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCC---CCccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 45666677999999999877653 334555555421 123444556667888888887 999999999988776 7
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH-ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
++++++..|+++.+.+........+...+..++.|+..++.|+| ..++.|+||||+|.+++..+..++++|||+|....
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 88999999999998883222225667778889999999999999 99999999999999999876469999999998544
Q ss_pred c-cc----ccccCC-cccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHH--HHHHHh----hccCCC
Q 019780 216 M-DE----MTCEAG-TYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFAEITITL--TNILQN----LRSADT 282 (336)
Q Consensus 216 ~-~~----~~~~~g-t~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l--~~~~~~----~~~~~~ 282 (336)
. .. ....+| ++.|+|||.... .....+.|+|+++.....+.+++-|........- ...... ....-.
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN 256 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence 4 22 223458 999999998776 4567778999999999998888877633322210 011111 011123
Q ss_pred CCCCCcccccCCCCCCCCccccchhhhcccccccc
Q 019780 283 PIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 283 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
.+.......+......+++.+.++.++..-++...
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCChhhhhcccccccCCchhccccccccccccccc
Confidence 45556666666666677888888877776655444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1e-11 Score=115.76 Aligned_cols=171 Identities=27% Similarity=0.279 Sum_probs=128.1
Q ss_pred eeecCCceeEeeeecC--CCcEEEEEeEE--C--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEe
Q 019780 57 VLVDHRSVLLQKMIGE--GSYSIVYKGFY--G--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVG 129 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~--G~fg~V~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~ 129 (336)
.......+.+.+.+|. |.+|.||.+.. . ...+|+|.-+.. ........+=.+|+...+.++ |+|.++.+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p---~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP---FSPPLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC---CCCccccccccchhhcccccCccccccccCc
Confidence 3344456667788999 99999999877 3 667888874421 112223334456777777776 999999888
Q ss_pred eEecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCcccccCCCCceeecCCCCceE
Q 019780 130 ASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISR----AMEYLHANSVIHRDLKPSNLLLTEDKKQVK 204 (336)
Q Consensus 130 ~~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~----aL~~lH~~~ivHrDikp~NIll~~~~~~~k 204 (336)
.+.+.+ .++-+|++ +.+|..+.+.. ..-++...++..+.+..+ ||.++|+.+++|-|+||+||+...+...++
T Consensus 186 ~~e~~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 186 AWEGSGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred ccccCCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceee
Confidence 888777 56666666 57999988433 234788889999999999 999999999999999999999998844899
Q ss_pred Eecccccccccccccc-------ccCCcccccCCC
Q 019780 205 LADFGLAREEVMDEMT-------CEAGTYRWMAPE 232 (336)
Q Consensus 205 l~Dfg~a~~~~~~~~~-------~~~gt~~y~aPE 232 (336)
++|||+.......... ...|...|++||
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke 298 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKE 298 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChh
Confidence 9999998754443311 114778999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.4e-11 Score=101.69 Aligned_cols=139 Identities=19% Similarity=0.300 Sum_probs=102.9
Q ss_pred eeecCCCcEEEEEeEECC-ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC--CceEeeEeeEecC----CEEEEE
Q 019780 68 KMIGEGSYSIVYKGFYGC-EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH--ENILKFVGASVQP----TMMIIT 140 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~----~~~lv~ 140 (336)
+.|+.|..+.||++...+ ..+++|+...... ......+.+|+.++..+.+ .++.+++.+.... ..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~----~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGAL----LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCccc----CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 568999999999998875 8999999763211 1134568899999999975 3456666665542 468999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA--------------------------------------- 181 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--------------------------------------- 181 (336)
||++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99999888765411 346666677777777777777773
Q ss_pred -----------------CCcccccCCCCceeecCC-CCceEEeccccccc
Q 019780 182 -----------------NSVIHRDLKPSNLLLTED-KKQVKLADFGLARE 213 (336)
Q Consensus 182 -----------------~~ivHrDikp~NIll~~~-~~~~kl~Dfg~a~~ 213 (336)
..++|+|+.|.||+++.+ ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246999999999999873 23688999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.7e-10 Score=99.79 Aligned_cols=137 Identities=15% Similarity=0.112 Sum_probs=95.1
Q ss_pred EEEEEeEECCccEEEEEeecCccccccH------HHHHHHHHHHHHHHhCCCCce--EeeEeeEec------CCEEEEEE
Q 019780 76 SIVYKGFYGCEPVAVKVIQPCNALAVSR------EHKEKFQREVTLLSKMKHENI--LKFVGASVQ------PTMMIITE 141 (336)
Q Consensus 76 g~V~~~~~~~~~vavK~~~~~~~~~~~~------~~~~~~~~E~~~l~~l~hpnI--v~~~~~~~~------~~~~lv~e 141 (336)
..|.+....|+.+.||..........-. .....+.+|...+..+..-+| +..+++... ...+||||
T Consensus 36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 3466777778889999764321100000 111247788888888753333 233333332 23789999
Q ss_pred ccCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC------CCCceEEecccccc
Q 019780 142 LMRGE-TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE------DKKQVKLADFGLAR 212 (336)
Q Consensus 142 ~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~------~~~~~kl~Dfg~a~ 212 (336)
++++. +|.+++........+......++.+++..+.-||+.||+|+|+++.|||++. +...+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99986 8999884322344566777899999999999999999999999999999975 23479999999875
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=7.9e-11 Score=111.21 Aligned_cols=159 Identities=22% Similarity=0.218 Sum_probs=120.4
Q ss_pred CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHH
Q 019780 85 CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLK 163 (336)
Q Consensus 85 ~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~ 163 (336)
+.+|.|.+.+..+ ....+...+-+..|+.++||||+++++.+.... .|+|+|-+. .|..++.+ +...
T Consensus 37 ~~~vsVF~~~~~~-----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~ 104 (690)
T KOG1243|consen 37 GGPVSVFVYKRSN-----GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKE 104 (690)
T ss_pred CCceEEEEEeCCC-----chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHH
Confidence 6788888887322 244566788889999999999999999888665 999999985 78888833 3366
Q ss_pred HHHHHHHHHHHHHHHHH-hCCcccccCCCCceeecCCCCceEEeccccccccccccc--cccCCcccccCCCCCCCCCCC
Q 019780 164 HSISFALDISRAMEYLH-ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM--TCEAGTYRWMAPENERPSLEN 240 (336)
Q Consensus 164 ~~~~i~~qi~~aL~~lH-~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~ 240 (336)
.+...+.||+.||.||| +.+++|++|.-+.++++..| ..||++|-++........ .....-..|..|+...+..
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence 77788999999999997 66899999999999999987 899999988754322211 1111224466676544333
Q ss_pred CHHHHHHHHHHhhccCCC
Q 019780 241 LSEDMVALLKSCWAEDPK 258 (336)
Q Consensus 241 ~~~di~~l~~~~l~~~p~ 258 (336)
++.|.|.|++.+|+.--+
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 788999999999986554
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.9e-10 Score=95.30 Aligned_cols=129 Identities=23% Similarity=0.278 Sum_probs=83.5
Q ss_pred EEEEeEEC-CccEEEEEeecCccc---------------------cccHHHHHHHHHHHHHHHhCCCC--ceEeeEeeEe
Q 019780 77 IVYKGFYG-CEPVAVKVIQPCNAL---------------------AVSREHKEKFQREVTLLSKMKHE--NILKFVGASV 132 (336)
Q Consensus 77 ~V~~~~~~-~~~vavK~~~~~~~~---------------------~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~ 132 (336)
.||.|... +..+|||+.+..... ...........+|.+.|..+..- ++++.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38888874 778999998743111 11122345688999999999865 456666542
Q ss_pred cCCEEEEEEccC--CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 133 QPTMMIITELMR--GETLQRYLWSTRPKRLDLKHSISFALDISRAMEY-LHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 133 ~~~~~lv~e~~~--gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~-lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
...+||||++ |..+..+.... ++......++.+++..+.. +|..|++|+||++.||+++.+ .+.|+|||
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~ 151 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFG 151 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GT
T ss_pred --CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecC
Confidence 4579999999 66665544211 1133456677788885555 589999999999999999975 59999999
Q ss_pred ccccc
Q 019780 210 LAREE 214 (336)
Q Consensus 210 ~a~~~ 214 (336)
.+...
T Consensus 152 qav~~ 156 (188)
T PF01163_consen 152 QAVDS 156 (188)
T ss_dssp TEEET
T ss_pred cceec
Confidence 88753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.6e-10 Score=100.50 Aligned_cols=154 Identities=21% Similarity=0.334 Sum_probs=109.5
Q ss_pred HHHHHhCCCCceEeeEeeEecCC------EEEEEEccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 019780 113 VTLLSKMKHENILKFVGASVQPT------MMIITELMRGETLQRYLWST--RPKRLDLKHSISFALDISRAMEYLHANS- 183 (336)
Q Consensus 113 ~~~l~~l~hpnIv~~~~~~~~~~------~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~- 183 (336)
...|-++-|.||+++..++.+.. ..+++||+..|+|..+|++. ....+....+.+|+.||++||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 34455667999999998877532 68899999999999999653 4567888999999999999999999985
Q ss_pred -cccccCCCCceeecCCCCceEEeccccccc------cccccccccCCcccccCCCCCCCCCCCCHHHHHH---------
Q 019780 184 -VIHRDLKPSNLLLTEDKKQVKLADFGLARE------EVMDEMTCEAGTYRWMAPENERPSLENLSEDMVA--------- 247 (336)
Q Consensus 184 -ivHrDikp~NIll~~~~~~~kl~Dfg~a~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~--------- 247 (336)
|+|+++..+.|++..+| -+|+.--.-... ....+.....+-++|.|||.-.-..-+-+.||+.
T Consensus 198 piihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 99999999999999776 566532111000 0011122234678999999433333233333332
Q ss_pred ---------------------------------HHHHhhccCCCCCCCHhHHH
Q 019780 248 ---------------------------------LLKSCWAEDPKVRPEFAEIT 267 (336)
Q Consensus 248 ---------------------------------l~~~~l~~~p~~RP~~~~i~ 267 (336)
++..|++..|..||++..++
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhh
Confidence 56678899999999888754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.9e-10 Score=107.41 Aligned_cols=148 Identities=24% Similarity=0.195 Sum_probs=114.3
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC---CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEec-CC
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG---CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQ-PT 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~-~~ 135 (336)
..+|.++..||.|.|+.|+....+ +..|++|.+...- . .......-..|+.+...+. |.++++.+..|.. .+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~-~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--A-TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--c-chHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 356778899999999999987644 5678888776321 1 1222333455666666665 8888887766554 45
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.|+-.|||.++++...+ .....+.+...+.+..|++.++.++|+..++|+|++|+||++..++...++.|||.+..
T Consensus 341 ~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred ccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 78889999999988776 33345788889999999999999999999999999999999998655789999999864
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.8e-09 Score=87.06 Aligned_cols=144 Identities=14% Similarity=0.111 Sum_probs=104.3
Q ss_pred ecCCCcEEEEEeEECCccEEEEEeecCcccccc-HHHHHHHHHHHHHHHhCCCCc--eEeeEeeEe--cC---CEEEEEE
Q 019780 70 IGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVS-REHKEKFQREVTLLSKMKHEN--ILKFVGASV--QP---TMMIITE 141 (336)
Q Consensus 70 lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~--~~---~~~lv~e 141 (336)
-|+||-+.|++....+..+-+|.-......... +-....|.+|+..+..+..-+ +.+...... .+ ..+||+|
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 467899999998888777888876521111111 335677999999999886332 444442211 22 1689999
Q ss_pred ccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC-ceEEeccccccc
Q 019780 142 LMRG-ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK-QVKLADFGLARE 213 (336)
Q Consensus 142 ~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~-~~kl~Dfg~a~~ 213 (336)
-++| .+|.+++....-...+......++.+++..++-||+.|+.|+|+.+.||+++.++. .+.++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7764 68988885443445677888899999999999999999999999999999985551 399999986653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.2e-08 Score=86.35 Aligned_cols=107 Identities=24% Similarity=0.350 Sum_probs=81.4
Q ss_pred HHHHHHHHHHHHHhCCCCc--eEeeEeeEecC-----CEEEEEEccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHH
Q 019780 105 HKEKFQREVTLLSKMKHEN--ILKFVGASVQP-----TMMIITELMRG-ETLQRYLWSTRPKRLDLKHSISFALDISRAM 176 (336)
Q Consensus 105 ~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~-----~~~lv~e~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL 176 (336)
...+..+|...+..+..-. ++..+++.... ..++|+|+++| .+|.+++.... ..+......++.+++..+
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLI 131 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHH
Confidence 3456788888887775333 33444444432 25899999998 48999984422 266777889999999999
Q ss_pred HHHHhCCcccccCCCCceeecCCC--CceEEeccccccc
Q 019780 177 EYLHANSVIHRDLKPSNLLLTEDK--KQVKLADFGLARE 213 (336)
Q Consensus 177 ~~lH~~~ivHrDikp~NIll~~~~--~~~kl~Dfg~a~~ 213 (336)
+-||++||+|+|+++.|||++.++ ..+.++||+.++.
T Consensus 132 ~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999998764 3589999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=5e-09 Score=89.60 Aligned_cols=139 Identities=23% Similarity=0.240 Sum_probs=101.2
Q ss_pred eeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCcccccc-----------------HHHHHHHHHHHHHHHhCCCC--c
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVS-----------------REHKEKFQREVTLLSKMKHE--N 123 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~-----------------~~~~~~~~~E~~~l~~l~hp--n 123 (336)
..++..||-|-=|.||.|... +.++|||.=+.+...... .-.+...++|...|..|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456788999999999999986 899999986543221111 11233467899999998754 5
Q ss_pred eEeeEeeEecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCce
Q 019780 124 ILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQV 203 (336)
Q Consensus 124 Iv~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~ 203 (336)
|.+.++ .+...+|||+++|..|...- ++....-.++..|+.-+..+-..|+||+|+++=||+++++| .+
T Consensus 173 VP~P~~---~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg-~~ 241 (304)
T COG0478 173 VPKPIA---WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG-DI 241 (304)
T ss_pred CCCccc---cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC-CE
Confidence 665555 34578999999996665421 23444555666677777766689999999999999999987 69
Q ss_pred EEeccccccc
Q 019780 204 KLADFGLARE 213 (336)
Q Consensus 204 kl~Dfg~a~~ 213 (336)
.++||-.+..
T Consensus 242 ~vIDwPQ~v~ 251 (304)
T COG0478 242 VVIDWPQAVP 251 (304)
T ss_pred EEEeCccccc
Confidence 9999976653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.4e-08 Score=90.41 Aligned_cols=187 Identities=12% Similarity=0.148 Sum_probs=126.2
Q ss_pred EEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe-----cCCEEEEEEccCC-CC
Q 019780 76 SIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV-----QPTMMIITELMRG-ET 147 (336)
Q Consensus 76 g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~lv~e~~~g-g~ 147 (336)
.+.|++..+ |..|++|++...+... ....-.-+++++++.|+|||++.+++. +..+++|++|.++ ++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~-----~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQS-----TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccC-----cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 578899875 8889999984211111 111234467899999999999988876 3348999999985 68
Q ss_pred HHHHHhhc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 148 LQRYLWST-------------RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 148 L~~~l~~~-------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
|.++-... .+...++...|.++.|+..||.++|+.|+..+-|.|.+|+++.+. +++|...|..-..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDVL 443 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecccceeee
Confidence 88775322 234578899999999999999999999999999999999999765 7888877765422
Q ss_pred ccccccc-------------------cCCccc-c--cCC-CC-CCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 019780 215 VMDEMTC-------------------EAGTYR-W--MAP-EN-ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITIT 269 (336)
Q Consensus 215 ~~~~~~~-------------------~~gt~~-y--~aP-E~-~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~ 269 (336)
..+.... .+|+.. | -++ +. .......++.|++.++.-+...++.+ -+..+++..
T Consensus 444 ~~d~~~~le~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 444 QEDPTEPLESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred cCCCCcchhHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 2211000 001100 0 000 00 12223467889999998888888875 445555443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.85 E-value=8.4e-08 Score=80.45 Aligned_cols=138 Identities=17% Similarity=0.197 Sum_probs=91.5
Q ss_pred CCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHH------HHHHHHHHHHhCC---CCceEeeEeeE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKE------KFQREVTLLSKMK---HENILKFVGAS 131 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~------~~~~E~~~l~~l~---hpnIv~~~~~~ 131 (336)
..+|.+.+.+-......|.+-...+..+.+|..+..... ...... ...+++..+..++ --....++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r--~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRR--PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhh--HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 467888888888888888888888999999998742111 111111 1233444333332 22222222221
Q ss_pred e------cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEE
Q 019780 132 V------QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKL 205 (336)
Q Consensus 132 ~------~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl 205 (336)
. ....+++|||++|..|.+.. .+++ .+...+..++.-+|+.|+.|+|..|.|++++.+ .+++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~------~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~i 175 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE------DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRI 175 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch------hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEE
Confidence 1 22367899999998887654 1222 244667788999999999999999999999965 4999
Q ss_pred ecccccc
Q 019780 206 ADFGLAR 212 (336)
Q Consensus 206 ~Dfg~a~ 212 (336)
+||+..+
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.1e-08 Score=93.21 Aligned_cols=143 Identities=20% Similarity=0.268 Sum_probs=92.5
Q ss_pred eeecCCCcEEEEEeEEC-CccEEEEEeecCccccccH-----------------------------HHHH------HHHH
Q 019780 68 KMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSR-----------------------------EHKE------KFQR 111 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~-----------------------------~~~~------~~~~ 111 (336)
..|+.++-|.||+|+.. |+.||||+.+++-...... +..+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999987 8999999998642211110 0111 1345
Q ss_pred HHHHHHhCC----CCceEeeEeeEe--cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 019780 112 EVTLLSKMK----HENILKFVGASV--QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVI 185 (336)
Q Consensus 112 E~~~l~~l~----hpnIv~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iv 185 (336)
|+..+.++. ...-+.+-.++. ...-.++|||++|..+.+...-.. ...+...+...+.++ -+..+-..|+.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgff 287 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCcc
Confidence 555555542 222233333332 345789999999999998852222 345544333333322 22333347999
Q ss_pred cccCCCCceeecCCCCceEEecccccccc
Q 019780 186 HRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 186 HrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
|.|.+|.||+++.++ .+.+.|||+....
T Consensus 288 HaDpHpGNi~v~~~g-~i~~lDfGi~g~l 315 (517)
T COG0661 288 HADPHPGNILVRSDG-RIVLLDFGIVGRL 315 (517)
T ss_pred ccCCCccceEEecCC-cEEEEcCcceecC
Confidence 999999999999987 7999999997643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.5e-07 Score=78.58 Aligned_cols=138 Identities=20% Similarity=0.217 Sum_probs=92.8
Q ss_pred eeecCCCcEEEEEeEEC-CccEEEEEeecCcccccc-------------------HHHHHHHHHHHHHHHhCCC--CceE
Q 019780 68 KMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVS-------------------REHKEKFQREVTLLSKMKH--ENIL 125 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~-------------------~~~~~~~~~E~~~l~~l~h--pnIv 125 (336)
..|++|--+.||+|... +..+|+|+++........ ........+|+.-|+++.. -.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 46888888899999875 889999999842211111 1122335677777877753 3333
Q ss_pred eeEeeEecCCEEEEEEccCCCCHHH-HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCce
Q 019780 126 KFVGASVQPTMMIITELMRGETLQR-YLWSTRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKKQV 203 (336)
Q Consensus 126 ~~~~~~~~~~~~lv~e~~~gg~L~~-~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~~~~~ 203 (336)
+-+.+. +..|||||+....+-. .| +...+....+..+..+++..+.-|-. .|+||+||+.=|||+. ++ .+
T Consensus 134 ~Pi~~~---~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~-~p 205 (268)
T COG1718 134 EPIAFR---NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG-EP 205 (268)
T ss_pred Cceeec---CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC-eE
Confidence 344332 3579999996531100 11 11223344677788899999988766 8999999999999999 44 69
Q ss_pred EEeccccccc
Q 019780 204 KLADFGLARE 213 (336)
Q Consensus 204 kl~Dfg~a~~ 213 (336)
.|+|||.|..
T Consensus 206 ~iID~~QaV~ 215 (268)
T COG1718 206 YIIDVSQAVT 215 (268)
T ss_pred EEEECccccc
Confidence 9999998874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=7.5e-09 Score=102.33 Aligned_cols=201 Identities=19% Similarity=0.197 Sum_probs=141.6
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe-cCCE
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV-QPTM 136 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~ 136 (336)
....+.+.+.+-+|+++.++.+.-. +...++|+....... .....+...++-.++....+|.++...-.+. ....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i--~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKI--RTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhh--ccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 3456667788999999999877654 333444444321111 1111222333333444445677776555433 3448
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
+++++|..|++|...++. .+..+..-++.+...+..++++||+..++|+|++|.|+++..++ +.+++|||.......
T Consensus 880 ~L~~~~~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG-HRPLTDFGTLSKVGL 956 (1205)
T ss_pred chhhHHhccCCchhhhhc--CCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC-CcccCcccccccccc
Confidence 999999999999999944 34566777778888899999999999999999999999999887 899999984321000
Q ss_pred ----------------------------c-----cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCH
Q 019780 217 ----------------------------D-----EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEF 263 (336)
Q Consensus 217 ----------------------------~-----~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~ 263 (336)
. ......||+.|.+||...+.......|+|+++...++...+.-|.-
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0112248999999999999999999999999999999888887754
Q ss_pred hH
Q 019780 264 AE 265 (336)
Q Consensus 264 ~~ 265 (336)
++
T Consensus 1037 a~ 1038 (1205)
T KOG0606|consen 1037 AE 1038 (1205)
T ss_pred Cc
Confidence 33
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.9e-07 Score=76.74 Aligned_cols=77 Identities=16% Similarity=0.282 Sum_probs=56.6
Q ss_pred eeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCC--ceEeeEeeEecC----CEEEEE
Q 019780 67 QKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE--NILKFVGASVQP----TMMIIT 140 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~----~~~lv~ 140 (336)
++.|+.|..+.||+....+..+++|.... ......+.+|..+++.+... .+.+++...... ..+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~-------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRP-------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESS-------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCC-------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 36799999999999999888999999752 24556778888888887532 355666543322 268999
Q ss_pred EccCCCCHHH
Q 019780 141 ELMRGETLQR 150 (336)
Q Consensus 141 e~~~gg~L~~ 150 (336)
++++|..+..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.8e-06 Score=76.97 Aligned_cols=205 Identities=16% Similarity=0.195 Sum_probs=132.5
Q ss_pred eEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEee--------EecCC
Q 019780 65 LLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGA--------SVQPT 135 (336)
Q Consensus 65 ~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~--------~~~~~ 135 (336)
..++.||+|+-+.+|-.-.-+ ..+-|++...... ... +.+..|... .||-+-.-+.+ -....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~-d~VAKIYh~Pppa-----~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR-DQVAKIYHAPPPA-----AQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchhh-chhheeecCCCch-----HHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 345789999999999542222 2345666532111 111 112233333 45543321211 11122
Q ss_pred EEEEEEccCCC-CHHHHH----hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 136 MMIITELMRGE-TLQRYL----WSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 136 ~~lv~e~~~gg-~L~~~l----~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
+.++|..+.|. ....++ ++.......|....+.++.++++.+.||..|.+-+|+.++|+|+++++ .|.|.|-..
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDs 163 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS-KVVLVDSDS 163 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-eEEEEcccc
Confidence 67888888764 233333 122334568889999999999999999999999999999999999887 788887443
Q ss_pred cc-ccccccccccCCcccccCCC---------------------------------------------------------
Q 019780 211 AR-EEVMDEMTCEAGTYRWMAPE--------------------------------------------------------- 232 (336)
Q Consensus 211 a~-~~~~~~~~~~~gt~~y~aPE--------------------------------------------------------- 232 (336)
-. ........+.+|...|.+||
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 22 12233455677999999999
Q ss_pred ---------CCCCCC-----CCCHHHHHHHHHHhhcc--CCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 233 ---------NERPSL-----ENLSEDMVALLKSCWAE--DPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 233 ---------~~~~~~-----~~~~~di~~l~~~~l~~--~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
..++.| .-+++++.+|..+|+.. ++.-||+.+..+..|..+.+.+..
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 111222 22568899999999975 456899999999888888776554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.2e-06 Score=75.19 Aligned_cols=135 Identities=19% Similarity=0.223 Sum_probs=80.0
Q ss_pred eeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCc--eEeeEeeEecCC-EEEEEEccC
Q 019780 68 KMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN--ILKFVGASVQPT-MMIITELMR 144 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~-~~lv~e~~~ 144 (336)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++..+.. ..+||++++
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999984 35567888876311 2234688999998886433 456666665544 688999999
Q ss_pred CCC-HH--------------HH-------HhhcCCCCCCHHHHHH-HHH----------HHHH-HHHHHH----hCCccc
Q 019780 145 GET-LQ--------------RY-------LWSTRPKRLDLKHSIS-FAL----------DISR-AMEYLH----ANSVIH 186 (336)
Q Consensus 145 gg~-L~--------------~~-------l~~~~~~~l~~~~~~~-i~~----------qi~~-aL~~lH----~~~ivH 186 (336)
|.+ +. .. ++.......+...... +.. .+.. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 11 11 1111111111111111 100 0111 111222 124789
Q ss_pred ccCCCCceeecCCCCceEEeccccccc
Q 019780 187 RDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 187 rDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+|+.|.||+++.++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~--~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG--TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC--cEEEechhcCc
Confidence 99999999998754 88999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.1e-06 Score=83.51 Aligned_cols=144 Identities=17% Similarity=0.204 Sum_probs=88.5
Q ss_pred eeecCCCcEEEEEeEEC-CccEEEEEeecCcccccc--------------------------HHHHHH------HHHHHH
Q 019780 68 KMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVS--------------------------REHKEK------FQREVT 114 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~--------------------------~~~~~~------~~~E~~ 114 (336)
+.||..+.|.||+|+.. |+.||||+-+++-..... .+..+. |.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 67999999999999987 888999998863221100 011111 334444
Q ss_pred HHHhC----CCCce---EeeEeeEec--CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 019780 115 LLSKM----KHENI---LKFVGASVQ--PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVI 185 (336)
Q Consensus 115 ~l~~l----~hpnI---v~~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iv 185 (336)
...++ .|-+. |.+-.++.+ ..-.|+||||+|..+.+.-. -....++...+..-+.+...-+ +=..|++
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~-i~~~gi~~~~i~~~l~~~~~~q--If~~Gff 323 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA-IDKRGISPHDILNKLVEAYLEQ--IFKTGFF 323 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH-HHHcCCCHHHHHHHHHHHHHHH--HHhcCCc
Confidence 43332 34441 112223332 34789999999987776542 1223455554443333322222 3356899
Q ss_pred cccCCCCceeecC---CCCceEEecccccccc
Q 019780 186 HRDLKPSNLLLTE---DKKQVKLADFGLAREE 214 (336)
Q Consensus 186 HrDikp~NIll~~---~~~~~kl~Dfg~a~~~ 214 (336)
|+|-.|.||+++. .+..+.+-|||+....
T Consensus 324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred cCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 9999999999994 3457999999998743
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.9e-06 Score=69.43 Aligned_cols=131 Identities=24% Similarity=0.305 Sum_probs=92.0
Q ss_pred ceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceE-eeEeeEecCCEEEEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL-KFVGASVQPTMMIITE 141 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~lv~e 141 (336)
.....+.|++|.+|.||++.+.+..+|+|+-+. ...+..+..|+++|..++-.++- +++.+.. .++.||
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~-------ds~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me 92 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGGEVALKVRRR-------DSPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRME 92 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCceEEEEEecC-------CcchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhh
Confidence 344457799999999999999999999999873 33467799999999999866653 3454433 235599
Q ss_pred ccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCC-CCceeecCCCCceEEeccccccc
Q 019780 142 LMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLK-PSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 142 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDik-p~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
|+.|..|.+.-. . .+..+. ..+++.---|-..||-|+.|. |..+++..++ .+.|+||..|+.
T Consensus 93 ~i~G~~L~~~~~--~---~~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~ 155 (201)
T COG2112 93 YIDGRPLGKLEI--G---GDRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR-DVYIIDFDSATF 155 (201)
T ss_pred hhcCcchhhhhh--c---ccHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence 999988887651 1 123333 344444444667799999886 4444444444 699999998873
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.35 E-value=9.3e-06 Score=67.47 Aligned_cols=129 Identities=22% Similarity=0.319 Sum_probs=92.2
Q ss_pred CceeEeeeecCCCc-EEEEEeEECCccEEEEEeec---Cccc------ccc-------HHHHHHHHHHHHHHHhCC---C
Q 019780 62 RSVLLQKMIGEGSY-SIVYKGFYGCEPVAVKVIQP---CNAL------AVS-------REHKEKFQREVTLLSKMK---H 121 (336)
Q Consensus 62 ~~~~~~~~lg~G~f-g~V~~~~~~~~~vavK~~~~---~~~~------~~~-------~~~~~~~~~E~~~l~~l~---h 121 (336)
.+++.++.||.|.- |.||++...+..+|+|+.+. .... ... .-...-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67888999999999 99999999999999999432 1110 000 023445788888877665 4
Q ss_pred Cce--EeeEeeEe-c---------------C---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 019780 122 ENI--LKFVGASV-Q---------------P---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH 180 (336)
Q Consensus 122 pnI--v~~~~~~~-~---------------~---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH 180 (336)
.++ ++++|+.. + . -..||-||++... .+.. .-+.+|.+-|..+|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHHH
Confidence 456 89998853 1 0 0467888876533 1222 23567888899999
Q ss_pred hCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 181 ~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
..||+-+|+++.|.. .-+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~------~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR------GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc------CCEEEecccC
Confidence 999999999999974 2479999864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.9e-06 Score=71.40 Aligned_cols=75 Identities=13% Similarity=0.131 Sum_probs=51.6
Q ss_pred eecCCCc-EEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecC-CEEEEEEccCC
Q 019780 69 MIGEGSY-SIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQP-TMMIITELMRG 145 (336)
Q Consensus 69 ~lg~G~f-g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~-~~~lv~e~~~g 145 (336)
.|..|.. +.||+....+..+.+|+..... ...+.+|+.+++.+. +-.+.+++++...+ ..++||++++|
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3455555 7899987767788888875211 234677888888875 33455677766554 37899999999
Q ss_pred CCHHHH
Q 019780 146 ETLQRY 151 (336)
Q Consensus 146 g~L~~~ 151 (336)
.+|...
T Consensus 77 ~~l~~~ 82 (244)
T cd05150 77 VPAAAL 82 (244)
T ss_pred ccHhHh
Confidence 877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.30 E-value=8.9e-06 Score=82.91 Aligned_cols=77 Identities=17% Similarity=0.242 Sum_probs=55.0
Q ss_pred eeeecCCCcEEEEEeEECC----ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCce--EeeEeeEecC----C
Q 019780 67 QKMIGEGSYSIVYKGFYGC----EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENI--LKFVGASVQP----T 135 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnI--v~~~~~~~~~----~ 135 (336)
.+.++.|.++.+|+....+ ..+++|+...... ......+.+|+.+|+.+. |+++ .+++.++.+. .
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~----~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL----LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc----CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 4678999999999987653 4677777543211 112346889999999996 6654 6777777653 4
Q ss_pred EEEEEEccCCCC
Q 019780 136 MMIITELMRGET 147 (336)
Q Consensus 136 ~~lv~e~~~gg~ 147 (336)
.|+||||++|..
T Consensus 119 ~flVME~v~G~~ 130 (822)
T PLN02876 119 AFYIMEYLEGRI 130 (822)
T ss_pred ceEEEEecCCcc
Confidence 789999999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.17 E-value=5.2e-05 Score=63.42 Aligned_cols=137 Identities=21% Similarity=0.355 Sum_probs=91.3
Q ss_pred eeecCCCcEEEEEeEECCccEEEEEeecCccccc-----------cHHHHHHHHHHHHHHHhCC------CCceEeeEee
Q 019780 68 KMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAV-----------SREHKEKFQREVTLLSKMK------HENILKFVGA 130 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~ 130 (336)
..||+|+.-.||.. -.+....||+..+...... .........+|+.-...+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQH-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEEC-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 56999999999952 2356789999985430000 0112345666666655555 7889999999
Q ss_pred EecCC-EEEEEEccCC------CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC--C
Q 019780 131 SVQPT-MMIITELMRG------ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK--K 201 (336)
Q Consensus 131 ~~~~~-~~lv~e~~~g------g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~--~ 201 (336)
..++. ..+|+|.+.. .+|.++++. ..++. ... ..+-.-..||-+.+|+.+|++|.||++...+ .
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 88764 8888887642 468888833 23554 333 3333455678899999999999999996432 2
Q ss_pred -ceEEec-ccccc
Q 019780 202 -QVKLAD-FGLAR 212 (336)
Q Consensus 202 -~~kl~D-fg~a~ 212 (336)
.+.|+| ||...
T Consensus 159 ~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 159 FRLVLIDGLGEKE 171 (199)
T ss_pred eEEEEEeCCCCcc
Confidence 467777 66443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.7e-06 Score=86.25 Aligned_cols=129 Identities=16% Similarity=0.068 Sum_probs=88.3
Q ss_pred ccccCCCC-ceeecCCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCC
Q 019780 185 IHRDLKPS-NLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKV 259 (336)
Q Consensus 185 vHrDikp~-NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~ 259 (336)
.+++..|. |++++..+ ..++.|||.++...... .....||+.|+|||.+.+..++.+.|+|++++.+|++..+.
T Consensus 499 ~~~~~~p~~~~~~~p~~-~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~ 577 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQ-VKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGI 577 (669)
T ss_pred CCCCCCCCCceeECCcc-ccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 45666666 45555544 67889999887533221 23346999999999999999999999999999999999998
Q ss_pred CCCHhH-HHHHHHHHHHhh---ccCCCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 260 RPEFAE-ITITLTNILQNL---RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 260 RP~~~~-i~~~l~~~~~~~---~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
+|.... ....+..+.... ......+++.+..++..++..+|+.|++..++.+..+
T Consensus 578 ~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~dP~~R~ta~e~l~h~~ 636 (669)
T cd05610 578 PPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636 (669)
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhHCcCHHHHHhCHh
Confidence 886332 222222222211 1111234555666788888889999998888877554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.5e-05 Score=67.57 Aligned_cols=72 Identities=11% Similarity=0.182 Sum_probs=45.2
Q ss_pred eeecCCCcE-EEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCC---ceEeeEeeEecC----CEEEE
Q 019780 68 KMIGEGSYS-IVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE---NILKFVGASVQP----TMMII 139 (336)
Q Consensus 68 ~~lg~G~fg-~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~----~~~lv 139 (336)
+.|+.|+.. .||+. +..+++|.... ......+.+|+.++..+... .+...++..... ..+++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~-------~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSA-------AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCc-------cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457877776 58875 34577786542 11244688999999887532 334444433321 24889
Q ss_pred EEccCCCCHH
Q 019780 140 TELMRGETLQ 149 (336)
Q Consensus 140 ~e~~~gg~L~ 149 (336)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999997663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.04 E-value=7.4e-05 Score=66.95 Aligned_cols=76 Identities=14% Similarity=0.142 Sum_probs=56.2
Q ss_pred EeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC---CceEeeEeeEec----CCEEE
Q 019780 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH---ENILKFVGASVQ----PTMMI 138 (336)
Q Consensus 66 ~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~~~~~~~~----~~~~l 138 (336)
-.+.||.|..+.||+....+..+.+|..+. ......+..|+..|+.+.. -.+.++++++.+ +..++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-------~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGNPMPLMARS-------FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEcCCCCEEEEEecc-------cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 346799999999999877655678887541 1123578999999998863 357778876653 33899
Q ss_pred EEEccCCCCH
Q 019780 139 ITELMRGETL 148 (336)
Q Consensus 139 v~e~~~gg~L 148 (336)
|||+++|+++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.3e-06 Score=81.27 Aligned_cols=181 Identities=18% Similarity=0.171 Sum_probs=123.2
Q ss_pred eEeeeecCCCcEEEEEeEECC-ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCc-eEeeEeeEecCC-EEEEEE
Q 019780 65 LLQKMIGEGSYSIVYKGFYGC-EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN-ILKFVGASVQPT-MMIITE 141 (336)
Q Consensus 65 ~~~~~lg~G~fg~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~-~~lv~e 141 (336)
....-+++|+++.++|.+... +....+.+.. . ....-++++|.+++||| .+..++-+..+. .+++++
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~--------~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ--------T--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeecc--------c--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 334568899999999987652 2233444431 1 23445788999999999 555555554433 789999
Q ss_pred ccCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-cc
Q 019780 142 LMRGE-TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-EM 219 (336)
Q Consensus 142 ~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-~~ 219 (336)
++.++ +-.... ......+..-+...+.+.-..+|+++|+--=+|+| ||+..++ ..+..||+........ ..
T Consensus 315 i~s~~rs~~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~ 387 (829)
T KOG0576|consen 315 ICSTGRSSALEM-TVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKP 387 (829)
T ss_pred hhcCCccccccC-ChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--ccccccccCCcccCccccc
Confidence 99877 222211 01112233444555667778899999998878998 8888764 5899999988754433 24
Q ss_pred cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 220 TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 220 ~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.+..+++.|+|||........-.++.|++.....+.-|+..|.
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 4567999999999888777777778888877666666766664
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.95 E-value=3.4e-05 Score=64.16 Aligned_cols=100 Identities=19% Similarity=0.227 Sum_probs=78.1
Q ss_pred HHHHHHHHhCCC-CceEeeEeeEecCCEEEEEEccCCCCHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Q 019780 110 QREVTLLSKMKH-ENILKFVGASVQPTMMIITELMRGETLQRYLWS-TRPKRLDLKHSISFALDISRAMEYLHA---NSV 184 (336)
Q Consensus 110 ~~E~~~l~~l~h-pnIv~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~i 184 (336)
..|.-+|..+++ +++++++|++- .++|+||.+.+++...-.. ..-...+|..+..|+.+++..+.+++. ..+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG---~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG---RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC---CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 457888899986 68999999883 4678999987765421000 111246899999999999999999987 358
Q ss_pred ccccCCCCceeecCCCCceEEeccccccc
Q 019780 185 IHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 185 vHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.-+|++|+|+.++.++ ++|++|...+..
T Consensus 84 ~lcDv~~~nfgv~~~~-~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDG-RLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCC-cEEEEechhcch
Confidence 8899999999999876 799999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.83 E-value=2.8e-06 Score=81.29 Aligned_cols=139 Identities=16% Similarity=0.236 Sum_probs=89.4
Q ss_pred HHHHHHHHHHhC-CcccccCCCCceeecCCCCceEEecccccccccc-cc-----cc-----ccCCcccccCCCCCCCCC
Q 019780 171 DISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM-DE-----MT-----CEAGTYRWMAPENERPSL 238 (336)
Q Consensus 171 qi~~aL~~lH~~-~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~-~~-----~~-----~~~gt~~y~aPE~~~~~~ 238 (336)
+++.||.|+|.. ++||++|.|++|.++.++ .+||+.|+.+..... .+ +. ...-...|.|||...+..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 444899999965 899999999999999887 799999998764332 11 11 112457899999999988
Q ss_pred CCCHHHHHHHHHHhhccC-CCCCCCHhH---HHHHHHHHHHhhcc--CCCCCCCCcccccCCCCCCCCccccchhhhc
Q 019780 239 ENLSEDMVALLKSCWAED-PKVRPEFAE---ITITLTNILQNLRS--ADTPIPPKLVEIVDPKSTMNNDCMATVHAIT 310 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~-p~~RP~~~~---i~~~l~~~~~~~~~--~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (336)
.+...|.++++..++... .+++..... +...++........ ...++|+++.+-+....+.+...+.+++.+.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 888999999998665554 555544322 11111111111111 1245666666666665555555555444333
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00027 Score=63.64 Aligned_cols=143 Identities=16% Similarity=0.202 Sum_probs=96.2
Q ss_pred EeeeecCCCcEEEEEeEEC-CccEEEEEeecCcccccc---------------------HHHHHHHHHHHHHHHhCCCCc
Q 019780 66 LQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVS---------------------REHKEKFQREVTLLSKMKHEN 123 (336)
Q Consensus 66 ~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~hpn 123 (336)
+-.+|..|--+.||.|... |..+|||+++-.-....+ .-..-....|++-|++|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 3357888999999999875 788999998732111111 112234567888888887655
Q ss_pred eEeeEeeEecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCCCceeecCCCCc
Q 019780 124 ILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL-HANSVIHRDLKPSNLLLTEDKKQ 202 (336)
Q Consensus 124 Iv~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~ivHrDikp~NIll~~~~~~ 202 (336)
|. +-.-..-....|||+|+.+.....-. -+...++...+..+-.|++.-+.-| |.+++||.||+-=|+|+.. | .
T Consensus 228 IP-~PePIlLk~hVLVM~FlGrdgw~aPk--LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G-~ 302 (520)
T KOG2270|consen 228 IP-CPEPILLKNHVLVMEFLGRDGWAAPK--LKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-G-K 302 (520)
T ss_pred CC-CCCceeeecceEeeeeccCCCCcCcc--cccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-C-E
Confidence 33 11111123468999999642222111 1234577778888888888877766 5679999999999999984 3 7
Q ss_pred eEEeccccccc
Q 019780 203 VKLADFGLARE 213 (336)
Q Consensus 203 ~kl~Dfg~a~~ 213 (336)
+.|+|.+.+..
T Consensus 303 lyiIDVSQSVE 313 (520)
T KOG2270|consen 303 LYIIDVSQSVE 313 (520)
T ss_pred EEEEEcccccc
Confidence 99999998764
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00096 Score=61.87 Aligned_cols=79 Identities=16% Similarity=0.157 Sum_probs=53.2
Q ss_pred eeecCCCcEEEEEeEECC--ccEEEEEeecCccc-ccc-HHHHHHHHHHHHHHHhCC---CCceEeeEeeEecCCEEEEE
Q 019780 68 KMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNAL-AVS-REHKEKFQREVTLLSKMK---HENILKFVGASVQPTMMIIT 140 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~~--~~vavK~~~~~~~~-~~~-~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~lv~ 140 (336)
+.||.|.+..||++...+ +.++||.-.+.-.. ... .-..++...|.+.|..+. ..++++++.+.. ...++||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~-~~~~lVM 110 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE-ELAVTVM 110 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-CCCEEEE
Confidence 569999999999998874 38999985421110 011 124567778888888763 245677777633 3478999
Q ss_pred EccCCCC
Q 019780 141 ELMRGET 147 (336)
Q Consensus 141 e~~~gg~ 147 (336)
|++++..
T Consensus 111 E~L~~~~ 117 (401)
T PRK09550 111 EDLSDHK 117 (401)
T ss_pred ecCCCcc
Confidence 9998643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0011 Score=57.16 Aligned_cols=72 Identities=21% Similarity=0.159 Sum_probs=46.2
Q ss_pred eeecCCCcEEEEEeEEC---CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCc-eEeeEeeEecCCEEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG---CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN-ILKFVGASVQPTMMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~lv~e~~ 143 (336)
+.|..|-...+|+.... +..+++|+....... .....+|+.+++.+...+ .++++.... -.++|||+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~------~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~~~l~e~i 74 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL------IIDRERELRIHKLLSKHGLAPKLYATFQ---NGLIYEFI 74 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc------eecHHHHHHHHHHHHhCCCCCeEEEEeC---CcEEEEee
Confidence 56888888899998765 467889976532111 112346888888875333 344444332 24799999
Q ss_pred CCCCH
Q 019780 144 RGETL 148 (336)
Q Consensus 144 ~gg~L 148 (336)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0012 Score=59.41 Aligned_cols=140 Identities=19% Similarity=0.245 Sum_probs=80.1
Q ss_pred EeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCC--ceEeeEeeE-------ecCCE
Q 019780 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE--NILKFVGAS-------VQPTM 136 (336)
Q Consensus 66 ~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~-------~~~~~ 136 (336)
..+.++.|....+|+....+..+++|+..... . ...+..|..++..|... .+.+++... .++..
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~----~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVGRYILTLYEKRV----K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred eccccCCccccceEEEEeCCCcEEEEEecCCC----C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 35668888888999987766678899875311 1 22345566666666422 233433321 12347
Q ss_pred EEEEEccCCCCHH-----------HH---HhhcCCC---C----CCHHHHH---------------HHHHHHHHHHHHHH
Q 019780 137 MIITELMRGETLQ-----------RY---LWSTRPK---R----LDLKHSI---------------SFALDISRAMEYLH 180 (336)
Q Consensus 137 ~lv~e~~~gg~L~-----------~~---l~~~~~~---~----l~~~~~~---------------~i~~qi~~aL~~lH 180 (336)
+++++|++|..+. .. ++....+ . ....... .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999985432 11 1211100 0 0001000 00112233455553
Q ss_pred -------hCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 181 -------ANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 181 -------~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
..+++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~~ 217 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFACT 217 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCc-eEEEeecccccC
Confidence 25899999999999999765 568999998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00059 Score=61.03 Aligned_cols=138 Identities=18% Similarity=0.185 Sum_probs=81.6
Q ss_pred eeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCC--ceEeeEee-------EecCCEE
Q 019780 67 QKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE--NILKFVGA-------SVQPTMM 137 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~-------~~~~~~~ 137 (336)
.+.|..|....+|+....+..+++|+... .....+..|+.++..+.+. .+.+.+.. ...+..+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK--------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC--------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 46688888889999877777899998752 1134566777777777432 23444331 1123478
Q ss_pred EEEEccCCCCHHH-----------H---HhhcC-C--C------CCCHHHH----------HHHHHHHHHHHHHHHh---
Q 019780 138 IITELMRGETLQR-----------Y---LWSTR-P--K------RLDLKHS----------ISFALDISRAMEYLHA--- 181 (336)
Q Consensus 138 lv~e~~~gg~L~~-----------~---l~~~~-~--~------~l~~~~~----------~~i~~qi~~aL~~lH~--- 181 (336)
+|+++++|..+.. . ++... . . ...+... ......+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866421 1 11110 0 0 0011000 0011112234444443
Q ss_pred ----CCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 182 ----NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 182 ----~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.+++|+|+.|.||+++.++ .+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDE-LSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCc-eEEEeehhhhcC
Confidence 4799999999999999764 568999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00084 Score=58.75 Aligned_cols=134 Identities=20% Similarity=0.223 Sum_probs=76.7
Q ss_pred ecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCce-EeeEeeEecCCEEEEEEccCCCCH
Q 019780 70 IGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI-LKFVGASVQPTMMIITELMRGETL 148 (336)
Q Consensus 70 lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~lv~e~~~gg~L 148 (336)
+..|-.+.+|+....+..+++|+....... ..-...+|..+++.+....+ .+++... .-++|++|++|..+
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~-----~~~~r~~E~~~l~~l~~~g~~P~~i~~~---~~~~v~e~i~G~~~ 75 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKA-----LGVDRQREYQILQALSALGLAPKPILVN---EHWLLVEWLEGEVI 75 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccccc-----ccCcHHHHHHHHHHHHhcCCCCceEEEe---CCEEEEEeccCccc
Confidence 566777899988877888999876421111 00124678888888764323 3344332 23689999998665
Q ss_pred HH--------------H---HhhcC--CCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCcccccCCC
Q 019780 149 QR--------------Y---LWSTR--PKRLDLK-HSISFALDI---------SRAMEYLHA--------NSVIHRDLKP 191 (336)
Q Consensus 149 ~~--------------~---l~~~~--~~~l~~~-~~~~i~~qi---------~~aL~~lH~--------~~ivHrDikp 191 (336)
.. . +|... ...++.. ....+..++ ...+..+-. ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 32 1 12111 1112221 111221111 111222211 2589999999
Q ss_pred CceeecCCCCceEEeccccccc
Q 019780 192 SNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 192 ~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.||+++.++ +.|+||..|..
T Consensus 156 ~Nil~~~~~--~~lIDwE~a~~ 175 (256)
T TIGR02721 156 YNLVVTPQG--LKLIDWEYASD 175 (256)
T ss_pred CcEEEeCCC--CEEEeccccCc
Confidence 999999764 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=7.7e-05 Score=65.99 Aligned_cols=138 Identities=17% Similarity=0.207 Sum_probs=93.6
Q ss_pred ceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHH-----------------HHHHHHHHHHHHHhCC-CC-
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSRE-----------------HKEKFQREVTLLSKMK-HE- 122 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~-----------------~~~~~~~E~~~l~~l~-hp- 122 (336)
-+.++..||-|.-+.||.+.+. |++.++|.-+.+.....+-+ .+-...+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3566788999999999999887 88888887554332221111 1112457888888875 32
Q ss_pred ceEeeEeeEecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCc
Q 019780 123 NILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ 202 (336)
Q Consensus 123 nIv~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~ 202 (336)
.+++.++ .+..++|||++.|-.|...-+ ..+..+ +...+..-+.-|-.+|+||+|..-=||++..++ .
T Consensus 173 pVPkpiD---~~RH~Vvmelv~g~Pl~~v~~-----v~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~-~ 240 (465)
T KOG2268|consen 173 PVPKPID---HNRHCVVMELVDGYPLRQVRH-----VEDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD-K 240 (465)
T ss_pred CCCCccc---ccceeeHHHhhcccceeeeee-----cCChHH---HHHHHHHHHHHHHHcCceecccchheeEEecCC-C
Confidence 2333443 234789999999988876531 122332 334444555667889999999999999999776 7
Q ss_pred eEEecccccc
Q 019780 203 VKLADFGLAR 212 (336)
Q Consensus 203 ~kl~Dfg~a~ 212 (336)
++++||-...
T Consensus 241 i~vIDFPQmv 250 (465)
T KOG2268|consen 241 IVVIDFPQMV 250 (465)
T ss_pred EEEeechHhh
Confidence 9999997543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0013 Score=58.36 Aligned_cols=31 Identities=32% Similarity=0.601 Sum_probs=25.6
Q ss_pred CcccccCCCCceeecCCCCceEEeccccccc
Q 019780 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 183 ~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.++|+|++|.||+++.++...-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 5899999999999996443456999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0039 Score=56.39 Aligned_cols=31 Identities=35% Similarity=0.484 Sum_probs=25.9
Q ss_pred CCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 182 ~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.|++|+|+.|.||+++.+. ..-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCc-eEEEEecccccC
Confidence 3899999999999998553 457999998864
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00061 Score=62.71 Aligned_cols=78 Identities=15% Similarity=0.102 Sum_probs=50.7
Q ss_pred eeeecCCCcEEEEEeEEC--CccEEEEEeecCcccc-ccHHHHHHHHHHHHHHHhCC--CC-ceEeeEeeEecCCEEEEE
Q 019780 67 QKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALA-VSREHKEKFQREVTLLSKMK--HE-NILKFVGASVQPTMMIIT 140 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~~~~~lv~ 140 (336)
.+.||.|.-..||++... ++.++||.-.+.-... .-+-..++..-|...|+... -| .+++++.+ -.....+||
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D~e~~~~vM 112 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-DSVMNCCVM 112 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-CcHHhhHHH
Confidence 467999999999999975 5679998765321111 11334567777888887764 34 45555553 333467888
Q ss_pred EccCC
Q 019780 141 ELMRG 145 (336)
Q Consensus 141 e~~~g 145 (336)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 88853
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.003 Score=56.65 Aligned_cols=134 Identities=20% Similarity=0.257 Sum_probs=77.8
Q ss_pred eeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC--CceEeeEeeEecCC---EEEEEEc
Q 019780 68 KMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH--ENILKFVGASVQPT---MMIITEL 142 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~---~~lv~e~ 142 (336)
+.+..|---.+|.....++.++++ ... ............+|+.+++.+.- ..+...++.+.++. .+.||+|
T Consensus 31 ~~~~~G~sn~t~~~~~~~~~~vlR-~P~---~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 31 EEISGGWSNDTFRLGDTGQKYVLR-KPP---RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeccCCcccceEEEecCCceEEEe-cCC---ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 334333334555555557778888 221 12233445667888888888763 23344555555433 6899999
Q ss_pred cCCCCHHHHHhhcCCCCCCHHHHHHHHH-HHHHHHHHHH-----------------------------------------
Q 019780 143 MRGETLQRYLWSTRPKRLDLKHSISFAL-DISRAMEYLH----------------------------------------- 180 (336)
Q Consensus 143 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~-qi~~aL~~lH----------------------------------------- 180 (336)
+.|..+.+.+.. .+.. ..++. .+...|+-||
T Consensus 107 veGe~~~~~~~~-----~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 107 VEGEVVWSALPP-----ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred ecceeccCcCCc-----ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 998433322200 0000 11111 2333333333
Q ss_pred ---------hC--------CcccccCCCCceeecCCCCceEEeccccccc
Q 019780 181 ---------AN--------SVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 181 ---------~~--------~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
++ .++|+|+++.|++++.++ -+-|.||+++..
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l 228 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGR-PTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence 22 589999999999999887 488999999875
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0021 Score=57.70 Aligned_cols=73 Identities=23% Similarity=0.251 Sum_probs=45.2
Q ss_pred eeecCCCcEEEEEeEEC--------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCce-EeeEeeEecCCEEE
Q 019780 68 KMIGEGSYSIVYKGFYG--------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI-LKFVGASVQPTMMI 138 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~l 138 (336)
+.+..|-...||+.... +..+++|+..... .......+|..++..+....+ .++++.+.+ .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~------~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~---~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV------ELLIDRERELVVFARLSERNLGPKLYGIFPN---GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC------cceechHHHHHHHHHHHhCCCCCceEEEeCC---Cc
Confidence 45666777788988764 3688999875321 112345678878777753322 345554432 35
Q ss_pred EEEccCCCCHH
Q 019780 139 ITELMRGETLQ 149 (336)
Q Consensus 139 v~e~~~gg~L~ 149 (336)
|++|++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 78998887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0028 Score=57.76 Aligned_cols=83 Identities=12% Similarity=0.127 Sum_probs=50.8
Q ss_pred eecCCCcEEEEEeEECC--ccEEEEEeecCccc-c-ccHHHHHHHHHHHHHHHhCC--CC-ceEeeEeeEecCCEEEEEE
Q 019780 69 MIGEGSYSIVYKGFYGC--EPVAVKVIQPCNAL-A-VSREHKEKFQREVTLLSKMK--HE-NILKFVGASVQPTMMIITE 141 (336)
Q Consensus 69 ~lg~G~fg~V~~~~~~~--~~vavK~~~~~~~~-~-~~~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~~~~~lv~e 141 (336)
.||.|....||++...+ +.++||.-.+.-.. . .-+-..++...|...|+... -| .+++++.+ -.....+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-DTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-ccccceehHh
Confidence 37999999999998763 57999876531111 1 11233456667788887764 34 34555543 3344678999
Q ss_pred ccCC-CCHHHHH
Q 019780 142 LMRG-ETLQRYL 152 (336)
Q Consensus 142 ~~~g-g~L~~~l 152 (336)
+++. ..|...|
T Consensus 81 dL~~~~ilR~~L 92 (370)
T TIGR01767 81 DLSHHKIARKGL 92 (370)
T ss_pred hCccchHHHHHH
Confidence 9854 3344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.016 Score=53.90 Aligned_cols=85 Identities=18% Similarity=0.154 Sum_probs=55.0
Q ss_pred eeeecCCCcEEEEEeEECCccEEEEEeecCcccccc--HHHHHHHHHHHHHHHhCC---CCceEeeEeeEecCCEEEEEE
Q 019780 67 QKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVS--REHKEKFQREVTLLSKMK---HENILKFVGASVQPTMMIITE 141 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~lv~e 141 (336)
.+.||.|....||+....+..++||.-.+....... +-...+-..|+..|+.+. ..++++++.+..+ ..+++||
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded-~~vlvME 115 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT-MALIGMR 115 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC-CCEEEEe
Confidence 467999999999998887778999986632111100 012444555567776654 2467778887764 3678899
Q ss_pred ccCC--CCHHHHH
Q 019780 142 LMRG--ETLQRYL 152 (336)
Q Consensus 142 ~~~g--g~L~~~l 152 (336)
++++ ..+.+.+
T Consensus 116 ~L~~~~~ilr~~L 128 (418)
T PLN02756 116 YLEPPHIILRKGL 128 (418)
T ss_pred ecCCcceehhhhh
Confidence 9977 3455433
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.015 Score=52.99 Aligned_cols=142 Identities=18% Similarity=0.216 Sum_probs=77.9
Q ss_pred CceeEeeeecCCCcEEEEEeEECC-----ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCce-EeeEeeEecCC
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYGC-----EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI-LKFVGASVQPT 135 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~ 135 (336)
..+.+ +.|..|-...+|+....+ ..|++|+........ -.-.+|..+++.+..-++ .++++++. +.
T Consensus 15 ~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~------IdR~~E~~il~~l~~~gl~P~~l~~~~-~G 86 (330)
T PLN02421 15 SDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV------IDRERELQAIKYLSAAGFGAKLLGVFG-NG 86 (330)
T ss_pred CceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE------echHHHHHHHHHHHhcCCCCceeEEeC-Cc
Confidence 34444 445557777899886543 278889876422211 112467777777764444 34555543 22
Q ss_pred EEEEEEccCCCCHHH--------------H---HhhcC--C-CCC-CHHHHHHHHHHH----------------------
Q 019780 136 MMIITELMRGETLQR--------------Y---LWSTR--P-KRL-DLKHSISFALDI---------------------- 172 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~--------------~---l~~~~--~-~~l-~~~~~~~i~~qi---------------------- 172 (336)
+|.+|++|..|.. . +|... . ... .+..+..+..++
T Consensus 87 --~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l 164 (330)
T PLN02421 87 --MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEEL 164 (330)
T ss_pred --EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHH
Confidence 4888888765521 1 12111 0 111 122222222221
Q ss_pred HHHHHH----HHhC----CcccccCCCCceeecCCCCceEEeccccccc
Q 019780 173 SRAMEY----LHAN----SVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 173 ~~aL~~----lH~~----~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
..-+.. +.+. -+.|+|+.+.|||++++++.++++||..|..
T Consensus 165 ~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 165 RDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111111 1122 3799999999999976544799999998864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0059 Score=62.55 Aligned_cols=155 Identities=17% Similarity=0.147 Sum_probs=104.6
Q ss_pred HHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-----EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 019780 104 EHKEKFQREVTLLSKMKHENILKFVGASVQPT-----MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178 (336)
Q Consensus 104 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~ 178 (336)
........|...+..+.|+|++.++.+..... ..+..+++.+.++...+ ..-..++..+.+.+..++..||+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~--q~v~~i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL--QSVGSIPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH--hhccccCHHHHHHHHHHHhhhHHH
Confidence 44555667788889999999999988866432 33456788888888888 344678899999999999999999
Q ss_pred HHhCCcccccCCCC---ceeecCCCCceEEe--cccccccccccc-ccccCCcccccCCCCCCCCCCCCH--HHHHHHHH
Q 019780 179 LHANSVIHRDLKPS---NLLLTEDKKQVKLA--DFGLAREEVMDE-MTCEAGTYRWMAPENERPSLENLS--EDMVALLK 250 (336)
Q Consensus 179 lH~~~ivHrDikp~---NIll~~~~~~~kl~--Dfg~a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~--~di~~l~~ 250 (336)
+|+....|.-+..+ +-..+..+ .+.++ ||+..+...... ......+..+.+||.........+ .++|.++.
T Consensus 302 ~h~~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 302 LHSLSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred HHHhccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 99997666655555 33333333 45555 887776543322 222335567778886655554444 57777776
Q ss_pred HhhccCCCCCC
Q 019780 251 SCWAEDPKVRP 261 (336)
Q Consensus 251 ~~l~~~p~~RP 261 (336)
......-+.++
T Consensus 381 l~~~~~~~~~i 391 (1351)
T KOG1035|consen 381 LLLQLSQGEDI 391 (1351)
T ss_pred HHhhhhhcCcc
Confidence 66655444443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.019 Score=52.59 Aligned_cols=143 Identities=13% Similarity=0.189 Sum_probs=80.3
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCce-EeeEeeEec
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI-LKFVGASVQ 133 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~ 133 (336)
.....+ ..|-.|-...+|++... +..+++|+........ .. -.+|..+++.+..-++ .++++.+..
T Consensus 36 ~~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-----id-R~~E~~~~~~l~~~gl~P~~~~~~~~ 108 (344)
T PLN02236 36 DEALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-----FD-RDDEIRTFECMSRHGQGPRLLGRFPN 108 (344)
T ss_pred cCcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-----ec-hHHHHHHHHHHHHcCCCCceEEEECC
Confidence 344444 45655888899998743 2578899876422111 12 2567888877764333 345555533
Q ss_pred CCEEEEEEccCCCCHHHH-----------------HhhcC--CCC-C-CHHHHHHHHHHH-----------------HHH
Q 019780 134 PTMMIITELMRGETLQRY-----------------LWSTR--PKR-L-DLKHSISFALDI-----------------SRA 175 (336)
Q Consensus 134 ~~~~lv~e~~~gg~L~~~-----------------l~~~~--~~~-l-~~~~~~~i~~qi-----------------~~a 175 (336)
. .|.+|++|.+|... +|... ... . ...++..++.++ ...
T Consensus 109 g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~ 185 (344)
T PLN02236 109 G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDE 185 (344)
T ss_pred c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHH
Confidence 2 57899887665421 11111 001 1 122222222111 111
Q ss_pred HHHH----H----hCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 176 MEYL----H----ANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 176 L~~l----H----~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+..| . ...++|+|+++.|||++.+++.+.++||..|..
T Consensus 186 ~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 186 INLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1111 1 236899999999999986444799999998864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.081 Score=47.66 Aligned_cols=30 Identities=23% Similarity=0.294 Sum_probs=26.2
Q ss_pred CcccccCCCCceeecCCCCceEEeccccccc
Q 019780 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 183 ~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+++|+|+.++|++++.++ .+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR-GGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence 799999999999998776 688999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.051 Score=48.84 Aligned_cols=30 Identities=27% Similarity=0.443 Sum_probs=25.4
Q ss_pred CCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 182 ~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.+++|+|+.+.||+++. + .+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-C-cEEEEECccccc
Confidence 47899999999999986 3 588999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.026 Score=50.15 Aligned_cols=75 Identities=13% Similarity=0.127 Sum_probs=46.9
Q ss_pred eeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC---CCceEeeEeeEecC-CEEEE
Q 019780 64 VLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK---HENILKFVGASVQP-TMMII 139 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~-~~~lv 139 (336)
.+-.+.++.|....+|+....++.+.||+-. ......|..|+.-|+.|. --.+++.+++.... ..+||
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~--------~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNS--------ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEE--------GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecC--------hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3345779999999999988778899999865 223456888888888884 33567777776543 47999
Q ss_pred EEccCCC
Q 019780 140 TELMRGE 146 (336)
Q Consensus 140 ~e~~~gg 146 (336)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999866
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.00048 Score=72.02 Aligned_cols=183 Identities=12% Similarity=-0.035 Sum_probs=117.4
Q ss_pred EEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---CEEEEEEccCCCCHHHHHhhcCCC--CCCH
Q 019780 88 VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---TMMIITELMRGETLQRYLWSTRPK--RLDL 162 (336)
Q Consensus 88 vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~lv~e~~~gg~L~~~l~~~~~~--~l~~ 162 (336)
+.+++.+...-....+-..+....|.+.++...|+++...+.-..+. ..+..++++.+|.+.+.+-+.... .+..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 45555542222222233345566666677778899988766543322 268899999999999998543322 2233
Q ss_pred HHHHHHHHHHHHHHHHHHhC-----CcccccCCCCceeecCCCCceEEecccccc-cccc-ccccccCCcccccCCCCCC
Q 019780 163 KHSISFALDISRAMEYLHAN-----SVIHRDLKPSNLLLTEDKKQVKLADFGLAR-EEVM-DEMTCEAGTYRWMAPENER 235 (336)
Q Consensus 163 ~~~~~i~~qi~~aL~~lH~~-----~ivHrDikp~NIll~~~~~~~kl~Dfg~a~-~~~~-~~~~~~~gt~~y~aPE~~~ 235 (336)
.-+.....+.+.+..-+|++ -.+|+++|+-|.+|..+. .+++.++|+.+ .... .......+++.|++|+...
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N 1413 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN 1413 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHH
Confidence 33333333447777777765 279999999999999876 79999999998 3222 1234456788899998666
Q ss_pred CCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 019780 236 PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLT 271 (336)
Q Consensus 236 ~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~ 271 (336)
....+..+|+|...+.++...-+.-+....+...++
T Consensus 1414 ~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lk 1449 (2724)
T KOG1826|consen 1414 EIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALK 1449 (2724)
T ss_pred HHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHc
Confidence 555666688888777766665555444444333333
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.13 Score=47.71 Aligned_cols=78 Identities=19% Similarity=0.231 Sum_probs=46.0
Q ss_pred CceeEeeeecCCCcEEEEEeEECC---cc-----EEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCce-EeeEeeEe
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYGC---EP-----VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI-LKFVGASV 132 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~~---~~-----vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~ 132 (336)
....+ +.|..|-...+|++...+ .. |.+++....... .-.-.+|+.+++.+...++ .++++.+.
T Consensus 51 ~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l------~IdR~~E~~i~~~Ls~~glgP~l~~~f~ 123 (383)
T PTZ00384 51 EFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSL------VIDNDLQYNIAKLLGDNNFGPKIIGRFG 123 (383)
T ss_pred ccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCce------EeccHHHHHHHHHHHhCCCCCeEEEecC
Confidence 34444 556668888999987542 12 344432211111 1122578889988875544 45666554
Q ss_pred cCCEEEEEEccCCCCHH
Q 019780 133 QPTMMIITELMRGETLQ 149 (336)
Q Consensus 133 ~~~~~lv~e~~~gg~L~ 149 (336)
.+++.||++|..|.
T Consensus 124 ---~g~l~efIeGr~l~ 137 (383)
T PTZ00384 124 ---DFTIQEWVEGNTMG 137 (383)
T ss_pred ---CEEEEEEeccccCC
Confidence 36889999987654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.032 Score=50.61 Aligned_cols=71 Identities=23% Similarity=0.348 Sum_probs=52.3
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.|++|++- |+++. .+ ......++..++.+.+..++-+..+ ..-|||+.-.||+|+ +| +|.|+||-+++..
T Consensus 301 ~yl~~kdh-gt~is-~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDfklsRl~ 371 (488)
T COG5072 301 LYLHFKDH-GTPIS-II-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDFKLSRLS 371 (488)
T ss_pred EEEEEecC-Cceee-ee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEeeeeecc
Confidence 45555554 34433 22 2345778888999888887777665 689999999999999 55 7999999999854
Q ss_pred c
Q 019780 215 V 215 (336)
Q Consensus 215 ~ 215 (336)
.
T Consensus 372 ~ 372 (488)
T COG5072 372 Y 372 (488)
T ss_pred c
Confidence 3
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.036 Score=51.04 Aligned_cols=62 Identities=21% Similarity=0.274 Sum_probs=42.7
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCCCceeecCCC
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL-HANSVIHRDLKPSNLLLTEDK 200 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~ivHrDikp~NIll~~~~ 200 (336)
..++-+|..|.++..++.. ...++.....++.-...||--| --.+++|.|+.|.||++..+.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~---~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW---KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred ceeeeeccccccHHhhhhc---ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 4567778889999998833 2345555555555555555433 456899999999999996543
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.026 Score=52.89 Aligned_cols=29 Identities=28% Similarity=0.448 Sum_probs=22.8
Q ss_pred cccccCCCCceeecCCCC----ceEEecccccc
Q 019780 184 VIHRDLKPSNLLLTEDKK----QVKLADFGLAR 212 (336)
Q Consensus 184 ivHrDikp~NIll~~~~~----~~kl~Dfg~a~ 212 (336)
++|+||...|||++.++. -..|+||-.+.
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh 302 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVH 302 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHhh
Confidence 799999999999998553 35678886543
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.73 E-value=0.049 Score=48.25 Aligned_cols=38 Identities=18% Similarity=0.281 Sum_probs=33.4
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
+..++..+..++..||+.+|.+||++.+++..|+.+..
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 34678899999999999999999999999999887643
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.041 Score=47.88 Aligned_cols=37 Identities=30% Similarity=0.654 Sum_probs=32.7
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNI 273 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~ 273 (336)
.+...+..+++++..||..+|.+||++.++.+.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 3456789999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.056 Score=47.85 Aligned_cols=39 Identities=38% Similarity=0.796 Sum_probs=34.6
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
.+...+.++++++..||+.+|.+||++.+++..|+++..
T Consensus 250 ~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 250 RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 345677899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.23 Score=42.19 Aligned_cols=123 Identities=17% Similarity=0.160 Sum_probs=73.2
Q ss_pred HHHHHHHHHHHHhCCCCceEeeEeeEecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CC
Q 019780 106 KEKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA--NS 183 (336)
Q Consensus 106 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ 183 (336)
...+..+.+++.++. .|+++..- ..-++.++.|.|-... ..... ++..=+.+|.-.|+ .+
T Consensus 102 ~~~y~nky~v~Armh--GilrL~ND-n~~~yGvIlE~Cy~~~-----------i~~~N----~i~agi~~L~~fH~~~~~ 163 (308)
T PF07387_consen 102 DALYFNKYRVFARMH--GILRLKND-NNYKYGVILERCYKIK-----------INFSN----FITAGIKDLMDFHSENQH 163 (308)
T ss_pred hhhhhhhhhHHHHhh--heeEeecC-CCceeEEEEeeccCcc-----------cchhH----HHHHhHHHHHHhhccCCC
Confidence 345677888888775 47777632 1112788999884311 11111 11112456677784 47
Q ss_pred cccccCCCCceeecCCCCceEEeccccccccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCC
Q 019780 184 VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVR 260 (336)
Q Consensus 184 ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~R 260 (336)
.+|+|..|+|||-|..| .+||.|-+.--. .+..|.--|+ ..-+..++...++..|++.-...|
T Consensus 164 ~lHGD~np~NiM~D~~G-~lKlVDP~~Ll~----------~~V~~vN~~Y---~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 164 CLHGDCNPDNIMCDKFG-YLKLVDPVCLLE----------NQVNMVNIEY---ESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred eecCCCChhheeecCCC-CEEecChhhhhh----------heeeEEeeec---cccChHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999988 799999874321 1111221111 112344566777777777655444
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.6 Score=39.93 Aligned_cols=76 Identities=18% Similarity=0.262 Sum_probs=55.1
Q ss_pred EeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCC---ceEeeEeeEecCC-EEEEEE
Q 019780 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE---NILKFVGASVQPT-MMIITE 141 (336)
Q Consensus 66 ~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~~-~~lv~e 141 (336)
..+.+..|..-..|...+...++-||+-. ......|..|+.-|..|.-. .+.+.+.+..+.. .|+||+
T Consensus 20 er~~v~gG~inea~~v~dg~~~~FvK~n~--------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle 91 (286)
T COG3001 20 EREEVSGGDINEAWRLRDGTDPFFVKCNQ--------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLE 91 (286)
T ss_pred cccccCCccccceeEeecCCcceEEEecc--------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEe
Confidence 33556677777888888888899999853 44567888898888777544 4666676655544 899999
Q ss_pred ccCCCCHH
Q 019780 142 LMRGETLQ 149 (336)
Q Consensus 142 ~~~gg~L~ 149 (336)
|++-+.+.
T Consensus 92 ~L~~~~~d 99 (286)
T COG3001 92 YLPTGPLD 99 (286)
T ss_pred eccCCCCC
Confidence 99875554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 336 | ||||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-26 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-26 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-26 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-25 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-24 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-23 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-23 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-23 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-23 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-23 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-23 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-23 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-22 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-19 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-19 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-19 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-19 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-19 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-19 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-19 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-19 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-19 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-19 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-18 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-18 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-17 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-17 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-17 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-16 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-16 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-15 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-13 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-13 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-10 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-07 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 7e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-06 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 3e-06 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 3e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 4e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-06 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 4e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-06 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 7e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-05 |
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 3e-82
Identities = 76/295 (25%), Positives = 131/295 (44%), Gaps = 60/295 (20%)
Query: 58 LVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
++D++ + +++++G G++ +V K + + VA+K I+ S ++ F E+ LS
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE-------SESERKAFIVELRQLS 56
Query: 118 KMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPK-RLDLKHSISFALDISRAM 176
++ H NI+K GA + P + ++ E G +L L P H++S+ L S+ +
Sbjct: 57 RVNHPNIVKLYGACLNP-VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 177 EYLHA---NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE- 232
YLH+ ++IHRDLKP NLLL +K+ DFG A + MT G+ WMAPE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-THMTNNKGSAAWMAPEV 174
Query: 233 ---------------------------------------------NERPSL-ENLSEDMV 246
RP L +NL + +
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234
Query: 247 ALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNND 301
+L+ CW++DP RP EI +T++++ AD P+ + P +
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVE 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 7e-78
Identities = 64/283 (22%), Positives = 113/283 (39%), Gaps = 63/283 (22%)
Query: 51 FDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGC--EPVAVKVI--QPCNALAVSREHK 106
F + + +K IG+G + +V+KG VA+K + E
Sbjct: 8 FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 107 EKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSI 166
++FQREV ++S + H NI+K G P ++ E + L L + + +
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYGLMHNP-PRMVMEFVPCGDLYHRLLD-KAHPIKWSVKL 125
Query: 167 SFALDISRAMEYLHANS--VIHRDLKPSNLLLTEDKKQ----VKLADFGLAREEVMDEMT 220
LDI+ +EY+ + ++HRDL+ N+ L + K+ADFGL+++ V ++
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-HSVS 184
Query: 221 CEAGTYRWMAPE------------------------------------------------ 232
G ++WMAPE
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 233 -NERPSL-ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNI 273
RP++ E+ + +++ CW+ DPK RP F+ I L+ +
Sbjct: 245 EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 5e-77
Identities = 64/288 (22%), Positives = 117/288 (40%), Gaps = 70/288 (24%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+ + + ++IG+G + VY G + VA+++I + + + F+REV +
Sbjct: 30 IPFEQLEIGELIGKGRFGQVYHGRW-HGEVAIRLIDIER---DNEDQLKAFKREVMAYRQ 85
Query: 119 MKHENILKFVGASVQ-PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+HEN++ F+GA + P + IIT L +G TL + + LD+ + A +I + M
Sbjct: 86 TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMG 144
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM-------DEMTCEAGTYRWMA 230
YLHA ++H+DLK N+ D +V + DFGL + D++ + G +A
Sbjct: 145 YLHAKGILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 231 PE-----------------------------------------------------NERPS 237
PE +P+
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262
Query: 238 L--ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTP 283
L + +++ +L CWA + + RP F ++ L + + R P
Sbjct: 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 3e-76
Identities = 75/272 (27%), Positives = 112/272 (41%), Gaps = 61/272 (22%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+D + L+++IG G + VY+ F+ + VAVK + + + E ++E L +
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARH-DPDEDISQTIENVRQEAKLFAM 62
Query: 119 MKHENILKFVGASVQ-PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+KH NI+ G ++ P + ++ E RG L R L KR+ +++A+ I+R M
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMN 119
Query: 178 YLHAN---SVIHRDLKPSNLLLTE-------DKKQVKLADFGLAREEVMDEMTCEAGTYR 227
YLH +IHRDLK SN+L+ + K +K+ DFGLARE AG Y
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA 179
Query: 228 WMAPE---------------------------------------------NERPSL-ENL 241
WMAPE +
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239
Query: 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTNI 273
E L++ CW DP RP F I LT I
Sbjct: 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-74
Identities = 72/271 (26%), Positives = 123/271 (45%), Gaps = 56/271 (20%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+ + +++ IG GS+ V++ + VAVK++ E +F REV ++ +
Sbjct: 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKIL---MEQDFHAERVNEFLREVAIMKR 90
Query: 119 MKHENILKFVGASVQ-PTMMIITELMRGETLQRYLWSTRPKR-LDLKHSISFALDISRAM 176
++H NI+ F+GA Q P + I+TE + +L R L + + LD + +S A D+++ M
Sbjct: 91 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 177 EYLHANS--VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE--MTCEAGTYRWMAPE 232
YLH + ++HR+LK NLL+ + VK+ DFGL+R + AGT WMAPE
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYT-VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209
Query: 233 ---------------------------------------------NERPSL-ENLSEDMV 246
+R + NL+ +
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269
Query: 247 ALLKSCWAEDPKVRPEFAEITITLTNILQNL 277
A+++ CW +P RP FA I L ++++
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 7e-73
Identities = 52/271 (19%), Positives = 91/271 (33%), Gaps = 61/271 (22%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+D + + + E ++KG + + VKV++ + S F E L
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRD---WSTRKSRDFNEECPRLRI 63
Query: 119 MKHENILKFVGASVQP---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRA 175
H N+L +GA P +IT M +L L +D ++ FALD++R
Sbjct: 64 FSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARG 123
Query: 176 MEYLHA--NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE- 232
M +LH + L ++++ ED +++ + + W+APE
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMT-ARISMADVKFSF---QSPGRMYAPAWVAPEA 179
Query: 233 -----------------------------------------------NERPSL-ENLSED 244
RP++ +S
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239
Query: 245 MVALLKSCWAEDPKVRPEFAEITITLTNILQ 275
+ L+K C EDP RP+F I L +
Sbjct: 240 VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 3e-70
Identities = 75/274 (27%), Positives = 116/274 (42%), Gaps = 63/274 (22%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+ + + + IG GS+ VYKG + VAVK++ + + + F+ EV +L K
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTA---PTPQQLQAFKNEVGVLRK 76
Query: 119 MKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
+H NIL F+G S P + I+T+ G +L +L ++ K ++K I A +R M+Y
Sbjct: 77 TRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDY 135
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE----VMDEMTCEAGTYRWMAPE-- 232
LHA S+IHRDLK +N+ L ED VK+ DFGLA E+ + +G+ WMAPE
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNT-VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 233 -----------------------------------------------NERPSL----ENL 241
+ P L N
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254
Query: 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275
+ M L+ C + RP F I + + +
Sbjct: 255 PKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 8e-65
Identities = 66/299 (22%), Positives = 115/299 (38%), Gaps = 74/299 (24%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLL 116
++ +++G+G + K + E + +K + + E + F +EV ++
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE-----ETQRTFLKEVKVM 61
Query: 117 SKMKHENILKFVGASVQ-PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRA 175
++H N+LKF+G + + ITE ++G TL+ + + + +SFA DI+
Sbjct: 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASG 120
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE----------------M 219
M YLH+ ++IHRDL N L+ E+K V +ADFGLAR V ++
Sbjct: 121 MAYLHSMNIIHRDLNSHNCLVRENKN-VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 220 TCEAGTYRWMAPE----------------------------------------------N 233
G WMAPE
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239
Query: 234 ERPSL-ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVEI 291
N + C DP+ RP F ++ L + +L + P+ P+L ++
Sbjct: 240 LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL-AGHLPLGPQLEQL 297
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-55
Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 35/204 (17%)
Query: 62 RSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQRE--VTLLSKM 119
R + L + +G+G Y V++G + E VAVK+ S ++ + RE + +
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIF--------SSRDEKSWFRETELYNTVML 59
Query: 120 KHENILKFVGASV-----QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISR 174
+HENIL F+ + + + +IT +L YL + LD + L I+
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIAS 116
Query: 175 AMEYLHA--------NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE------VMDEMT 220
+ +LH ++ HRDLK N+L+ ++ Q +AD GLA +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 221 CEAGTYRWMAPE--NERPSLENLS 242
GT R+MAPE +E ++
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFD 199
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 15/67 (22%), Positives = 27/67 (40%), Gaps = 10/67 (14%)
Query: 217 DEMTCEAGTYRWM----APENERPSLENLSED------MVALLKSCWAEDPKVRPEFAEI 266
++ ++ M + +RP++ N + L+K CW ++P R I
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 267 TITLTNI 273
TLT I
Sbjct: 294 KKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 5e-55
Identities = 54/195 (27%), Positives = 85/195 (43%), Gaps = 33/195 (16%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQRE--VTLL 116
+ + + K IG+G Y V+ G + E VAVKV + + RE +
Sbjct: 34 TIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVF--------FTTEEASWFRETEIYQT 85
Query: 117 SKMKHENILKFVGASVQPT-----MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALD 171
M+HENIL F+ A ++ T + +IT+ +L YL + LD K + A
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYS 142
Query: 172 ISRAMEYLHA--------NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE----- 218
+ +LH ++ HRDLK N+L+ ++ +AD GLA + + D
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDI 201
Query: 219 -MTCEAGTYRWMAPE 232
GT R+M PE
Sbjct: 202 PPNTRVGTKRYMPPE 216
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 13/89 (14%), Positives = 29/89 (32%), Gaps = 6/89 (6%)
Query: 195 LLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPSL------ENLSEDMVAL 248
+ + ++ L +++ + + RPS + M L
Sbjct: 245 VARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKL 304
Query: 249 LKSCWAEDPKVRPEFAEITITLTNILQNL 277
+ CWA +P R + TL + ++
Sbjct: 305 MTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-51
Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 33/194 (17%)
Query: 60 DHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQRE--VTLLS 117
R+++LQ+ IG+G + V++G + E VAVK+ S + + RE +
Sbjct: 40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIF--------SSREERSWFREAEIYQTV 91
Query: 118 KMKHENILKFVGAS-----VQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDI 172
++HENIL F+ A + ++++ +L YL + ++ I AL
Sbjct: 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALST 148
Query: 173 SRAMEYLHAN--------SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE------ 218
+ + +LH ++ HRDLK N+L+ ++ +AD GLA
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIA 207
Query: 219 MTCEAGTYRWMAPE 232
GT R+MAPE
Sbjct: 208 PNHRVGTKRYMAPE 221
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 9e-06
Identities = 13/87 (14%), Positives = 30/87 (34%), Gaps = 6/87 (6%)
Query: 195 LLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPSLENLSED------MVAL 248
+ D+ L +++ + + + RP++ N + M +
Sbjct: 250 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI 309
Query: 249 LKSCWAEDPKVRPEFAEITITLTNILQ 275
++ CW + R I TL+ + Q
Sbjct: 310 MRECWYANGAARLTALRIKKTLSQLSQ 336
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-50
Identities = 70/273 (25%), Positives = 113/273 (41%), Gaps = 59/273 (21%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLL 116
++H ++L + IG G++ V+ G VAVK + + + K KF +E +L
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE----TLPPDLKAKFLQEARIL 166
Query: 117 SKMKHENILKFVG-ASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRA 175
+ H NI++ +G + + + I+ EL++G +L T RL +K + D +
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAG 225
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT----YRWMAP 231
MEYL + IHRDL N L+TE +K++DFG++REE G +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
Query: 232 E---------------------------------------------NER-PSLENLSEDM 245
E R P E + +
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV 344
Query: 246 VALLKSCWAEDPKVRPEFAEITITLTNILQNLR 278
L++ CWA +P RP F+ I L +I + R
Sbjct: 345 FRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 9e-50
Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 29/186 (15%)
Query: 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
L ++ G + V+K E VAVK+ + + + + EV L MKHENIL
Sbjct: 28 LLEVKARGRFGCVWKAQLLNEYVAVKI------FPIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 126 KFVGASVQPT-----MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH 180
+F+GA + T + +IT +L +L + + A ++R + YLH
Sbjct: 82 QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLH 138
Query: 181 AN----------SVIHRDLKPSNLLLTEDKKQVKLADFGLAR----EEVMDEMTCEAGTY 226
+ ++ HRD+K N+LL + +ADFGLA + + + GT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 227 RWMAPE 232
R+MAPE
Sbjct: 198 RYMAPE 203
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 8/51 (15%), Positives = 19/51 (37%), Gaps = 6/51 (11%)
Query: 231 PENERPSLEN------LSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275
+ +RP L + + ++ CW D + R + +T + +
Sbjct: 268 HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-49
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 39/201 (19%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQRE--VTLL 116
+D ++ L ++IG G Y VYKG PVAVKV S +++ F E + +
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVF--------SFANRQNFINEKNIYRV 61
Query: 117 SKMKHENILKFVGASVQPT------MMIITELMRGETLQRYLWSTRPKRLDLKHSISFAL 170
M+H+NI +F+ + T +++ E +L +YL D S A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAH 118
Query: 171 DISRAMEYLHA---------NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE--- 218
++R + YLH ++ HRDL N+L+ D ++DFGL+ +
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNRLVR 177
Query: 219 -------MTCEAGTYRWMAPE 232
E GT R+MAPE
Sbjct: 178 PGEEDNAAISEVGTIRYMAPE 198
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 10/62 (16%), Positives = 21/62 (33%), Gaps = 7/62 (11%)
Query: 232 ENERPSL-ENLSED------MVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPI 284
E +RP E E+ + ++ CW +D + R + ++ +
Sbjct: 268 EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
Query: 285 PP 286
P
Sbjct: 328 PT 329
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-48
Identities = 76/304 (25%), Positives = 122/304 (40%), Gaps = 76/304 (25%)
Query: 57 VLVDHRSVLLQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKEKFQR 111
VL+ + L +M+G+G + V + VAVK+ A ++ E+F R
Sbjct: 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKM---LKADIIASSDIEEFLR 74
Query: 112 EVTLLSKMKHENILKFVGASVQ-------PTMMIITELMRGETLQRYLWSTRP----KRL 160
E + + H ++ K VG S++ P M+I M+ L +L ++R L
Sbjct: 75 EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 161 DLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMT 220
L+ + F +DI+ MEYL + + IHRDL N +L ED V +ADFGL+R ++
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTVCVADFGLSR-KIYSGDY 192
Query: 221 CEAGTY-----RWMAPEN------------------------------------------ 233
G +W+A E+
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252
Query: 234 ------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPK 287
++P E++ L+ CW+ DPK RP F + + L NIL +L T P
Sbjct: 253 IGGNRLKQP--PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310
Query: 288 LVEI 291
+ I
Sbjct: 311 YINI 314
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-47
Identities = 63/270 (23%), Positives = 110/270 (40%), Gaps = 61/270 (22%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
V ++ L + +G G + V+ G+Y G VAVK ++ + + F E L+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS------MSPDAFLAEANLMK 63
Query: 118 KMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+++H+ +++ Q + IITE M +L +L + +L + + A I+ M
Sbjct: 64 QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPEN- 233
++ + IHRDL+ +N+L+++ K+ADFGLAR +E T G +W APE
Sbjct: 124 FIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 234 -----------------------------------------------ERPSLENLSEDMV 246
RP +N E++
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP--DNCPEELY 240
Query: 247 ALLKSCWAEDPKVRPEFAEITITLTNILQN 276
L++ CW E P+ RP F + L +
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-47
Identities = 63/274 (22%), Positives = 112/274 (40%), Gaps = 67/274 (24%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
++ + + L + IG+G + V G Y VAVK I+ + F E +++++
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN-------DATAQAFLAEASVMTQ 242
Query: 119 MKHENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
++H N+++ +G V+ + I+TE M +L YL S L + F+LD+ AM
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPEN 233
EYL N+ +HRDL N+L++ED K++DFGL + + + + +W APE
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEA 357
Query: 234 ------------------------------------------------ERPSLENLSEDM 245
+ P + +
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP--DGCPPAV 415
Query: 246 VALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279
++K+CW D RP F ++ L +I +
Sbjct: 416 YDVMKNCWHLDAATRPTFLQLREQLEHIRTHELH 449
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-47
Identities = 57/278 (20%), Positives = 116/278 (41%), Gaps = 62/278 (22%)
Query: 58 LVDHRSVLLQKMIGEGSYSIVYKGFYGCE------PVAVKVIQPCNALAVSREHKEKFQR 111
++ K++G G++ VYKG + E PVA+K ++ A S + ++
Sbjct: 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILD 66
Query: 112 EVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALD 171
E +++ + + ++ + +G + T+ +IT+LM L Y+ + + ++ +++ +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 125
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE-EVMDEMTCEAGT---YR 227
I++ M YL ++HRDL N+L+ + VK+ DFGLA+ ++ G +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 228 WMAPE---------------------------------------------NER-PSLENL 241
WMA E ER P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 244
Query: 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279
+ D+ +++ CW D RP+F E+ I + + ++ +
Sbjct: 245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQR 282
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-46
Identities = 63/271 (23%), Positives = 113/271 (41%), Gaps = 67/271 (24%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
++ + + L + IG+G + V G Y VAVK I+ + F E +++++
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN-------DATAQAFLAEASVMTQ 70
Query: 119 MKHENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
++H N+++ +G V+ + I+TE M +L YL S L + F+LD+ AM
Sbjct: 71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPEN 233
EYL N+ +HRDL N+L++ED K++DFGL + + + + +W APE
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEA 185
Query: 234 ------------------------------------------------ERPSLENLSEDM 245
+ P + +
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP--DGCPPAV 243
Query: 246 VALLKSCWAEDPKVRPEFAEITITLTNILQN 276
++K+CW D +RP F ++ L +I +
Sbjct: 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-46
Identities = 74/272 (27%), Positives = 112/272 (41%), Gaps = 63/272 (23%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLL 116
++ + ++ +G G Y VY+G + VAVK ++ E+F +E ++
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVM 63
Query: 117 SKMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRA 175
++KH N+++ +G + +P IITE M L YL + + + A IS A
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPE 232
MEYL + IHRDL N L+ E+ VK+ADFGL+R D T AG +W APE
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 233 N------------------------------------------------ERPSLENLSED 244
+ ERP E E
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP--EGCPEK 240
Query: 245 MVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
+ L+++CW +P RP FAEI + Q
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-46
Identities = 65/270 (24%), Positives = 105/270 (38%), Gaps = 61/270 (22%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+ S+ L+K +G G + V+ Y VAVK ++P + E F E ++
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS------MSVEAFLAEANVMK 238
Query: 118 KMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
++H+ ++K + + IITE M +L +L S + L I F+ I+ M
Sbjct: 239 TLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPEN- 233
++ + IHRDL+ +N+L++ K+ADFGLAR +E T G +W APE
Sbjct: 299 FIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 357
Query: 234 -----------------------------------------------ERPSLENLSEDMV 246
RP EN E++
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP--ENCPEELY 415
Query: 247 ALLKSCWAEDPKVRPEFAEITITLTNILQN 276
++ CW P+ RP F I L +
Sbjct: 416 NIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-46
Identities = 68/289 (23%), Positives = 122/289 (42%), Gaps = 75/289 (25%)
Query: 57 VLVDHRSVLLQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKEKFQR 111
V++D ++L K++GEG + V +G VAVK ++ N+ S+ E+F
Sbjct: 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS---SQREIEEFLS 85
Query: 112 EVTLLSKMKHENILKFVGASVQ------PTMMIITELMRGETLQRYLWSTRP----KRLD 161
E + H N+++ +G ++ P M+I M+ L YL +R K +
Sbjct: 86 EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 162 LKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTC 221
L+ + F +DI+ MEYL + +HRDL N +L +D V +ADFGL++ ++
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD-MTVCVADFGLSK-KIYSGDYY 203
Query: 222 EAGTY-----RWMAPEN------------------------------------------- 233
G +W+A E+
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263
Query: 234 -----ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277
++P E+ +++ ++ SCW DP RP F+ + + L +L++L
Sbjct: 264 HGHRLKQP--EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 9e-46
Identities = 67/307 (21%), Positives = 115/307 (37%), Gaps = 68/307 (22%)
Query: 29 CPLTKACDADDDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFY-GCEP 87
LT C + + ++I S+ L+ +G+G + V+ G + G
Sbjct: 241 HRLTTVCPTSKPQTQGL-AKDAWEIP------RESLRLEVKLGQGCFGEVWMGTWNGTTR 293
Query: 88 VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGET 147
VA+K ++P E F +E ++ K++HE +++ + + I+TE M +
Sbjct: 294 VAIKTLKPGT------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGS 347
Query: 148 LQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLAD 207
L +L K L L + A I+ M Y+ + +HRDL+ +N+L+ E+ K+AD
Sbjct: 348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVAD 406
Query: 208 FGLAREEVMDEMTCEAGT---YRWMAPEN------------------------------- 233
FGLAR +E T G +W APE
Sbjct: 407 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 466
Query: 234 -----------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
P E + L+ CW ++P+ RP F + L + +
Sbjct: 467 GMVNREVLDQVERGYRMPCP--PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524
Query: 277 LRSADTP 283
P
Sbjct: 525 TEPQYQP 531
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 67/313 (21%), Positives = 116/313 (37%), Gaps = 68/313 (21%)
Query: 23 NTGDTSCPLTKACDADDDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGF 82
+ LT C + + ++I S+ L+ +G+G + V+ G
Sbjct: 152 HADGLCHRLTTVCPTSKPQTQGL-AKDAWEIP------RESLRLEVKLGQGCFGEVWMGT 204
Query: 83 Y-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITE 141
+ G VA+K ++P E F +E ++ K++HE +++ + + I+TE
Sbjct: 205 WNGTTRVAIKTLKPGT------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE 258
Query: 142 LMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK 201
M +L +L K L L + A I+ M Y+ + +HRDL+ +N+L+ E+
Sbjct: 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-L 317
Query: 202 QVKLADFGLAREEVMDEMTCEAGT---YRWMAPEN------------------------- 233
K+ADFGLAR +E T G +W APE
Sbjct: 318 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377
Query: 234 -----------------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITL 270
P E + L+ CW ++P+ RP F + L
Sbjct: 378 GRVPYPGMVNREVLDQVERGYRMPCP--PECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
Query: 271 TNILQNLRSADTP 283
+ + P
Sbjct: 436 EDYFTSTEPQYQP 448
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-45
Identities = 62/271 (22%), Positives = 107/271 (39%), Gaps = 63/271 (23%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+D + + IG G + +V+ G++ + VA+K I+ +E F E ++
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------SEEDFIEEAEVMM 58
Query: 118 KMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
K+ H +++ G Q + ++TE M L YL + R + + LD+ M
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGM 117
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPE- 232
YL VIHRDL N L+ E+ + +K++DFG+ R + D+ T GT +W +PE
Sbjct: 118 AYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176
Query: 233 ----------------------------------N-------------ERPSLENLSEDM 245
N +P S +
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP--RLASTHV 234
Query: 246 VALLKSCWAEDPKVRPEFAEITITLTNILQN 276
++ CW E P+ RP F+ + L I ++
Sbjct: 235 YQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 73/272 (26%), Positives = 112/272 (41%), Gaps = 63/272 (23%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCE-PVAVKVIQPCNALAVSREHKEKFQREVTLL 116
++ + ++ +G G Y VY+G + VAVK ++ E+F +E ++
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVM 270
Query: 117 SKMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRA 175
++KH N+++ +G + +P IITE M L YL + + + A IS A
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPE 232
MEYL + IHR+L N L+ E+ VK+ADFGL+R D T AG +W APE
Sbjct: 331 MEYLEKKNFIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 233 N------------------------------------------------ERPSLENLSED 244
+ ERP E E
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP--EGCPEK 447
Query: 245 MVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
+ L+++CW +P RP FAEI + Q
Sbjct: 448 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-45
Identities = 64/271 (23%), Positives = 107/271 (39%), Gaps = 63/271 (23%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+D + + K +G G + +V G + G VA+K+I+ + +++F E ++
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS------MSEDEFIEEAKVMM 74
Query: 118 KMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
+ HE +++ G + Q + IITE M L YL R + + + D+ AM
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAM 133
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPEN 233
EYL + +HRDL N L+ + VK++DFGL+R + DE T G+ RW PE
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 192
Query: 234 ------------------------------------------------ERPSLENLSEDM 245
RP SE +
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP--HLASEKV 250
Query: 246 VALLKSCWAEDPKVRPEFAEITITLTNILQN 276
++ SCW E RP F + + +++
Sbjct: 251 YTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-45
Identities = 71/308 (23%), Positives = 120/308 (38%), Gaps = 75/308 (24%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQR 111
V +++ L + +G G++ VY+G VAVK + ++ + F
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELD-FLM 82
Query: 112 EVTLLSKMKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPK-----RLDLKHS 165
E ++SK H+NI++ +G S+Q I+ ELM G L+ +L TRP+ L +
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 166 ISFALDISRAMEYLHANSVIHRDLKPSNLLLTE--DKKQVKLADFGLAREEVMDEMTCEA 223
+ A DI+ +YL N IHRD+ N LLT + K+ DFG+AR ++
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-DIYRASYYRK 201
Query: 224 GTY-----RWMAPEN--------------------------------------------- 233
G +WM PE
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261
Query: 234 ---ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVE 290
+ P +N + ++ CW P+ RP FA I + Q+ +T +P +
Sbjct: 262 GRMDPP--KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGP 319
Query: 291 IVDPKSTM 298
+V+ + +
Sbjct: 320 LVEEEEKV 327
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-44
Identities = 71/275 (25%), Positives = 112/275 (40%), Gaps = 60/275 (21%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKEKFQREV 113
+ + L + IGEG + V++G Y VA+K + C S +EKF +E
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----SDSVREKFLQEA 67
Query: 114 TLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDIS 173
+ + H +I+K +G + + II EL L+ +L + LDL I +A +S
Sbjct: 68 LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLS 126
Query: 174 RAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMA 230
A+ YL + +HRD+ N+L++ + VKL DFGL+R + +WMA
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 185
Query: 231 PE---------------------------------------------NER-PSLENLSED 244
PE ER P N
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 245
Query: 245 MVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279
+ +L+ CWA DP RP F E+ L+ IL+ ++
Sbjct: 246 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 280
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-44
Identities = 58/305 (19%), Positives = 120/305 (39%), Gaps = 62/305 (20%)
Query: 58 LVDHRSVLLQKMIGEGSYSIVYKGFYGCE------PVAVKVIQPCNALAVSREHKEKFQR 111
++ K++G G++ VYKG + E PVA+K ++ S + ++
Sbjct: 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILD 66
Query: 112 EVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALD 171
E +++ + + ++ + +G + T+ +IT+LM L Y+ + + ++ +++ +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 125
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT----YR 227
I++ M YL ++HRDL N+L+ + VK+ DFGLA+ +E A +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 228 WMAPE---------------------------------------------NER-PSLENL 241
WMA E ER P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 244
Query: 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNND 301
+ D+ ++ CW D RP+F E+ I + + ++ + + + + P +
Sbjct: 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYR 304
Query: 302 CMATV 306
+
Sbjct: 305 ALMDE 309
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-44
Identities = 63/270 (23%), Positives = 108/270 (40%), Gaps = 63/270 (23%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+ + L K +G G + +V G + G VAVK+I+ + +++F +E +
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM------SEDEFFQEAQTMM 58
Query: 118 KMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
K+ H ++KF G S + + I+TE + L YL S L+ + D+ M
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGM 117
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMAPEN 233
+L ++ IHRDL N L+ D VK++DFG+ R + D+ GT +W APE
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEV 176
Query: 234 ------------------------------------------------ERPSLENLSEDM 245
RP S+ +
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP--HLASDTI 234
Query: 246 VALLKSCWAEDPKVRPEFAEITITLTNILQ 275
++ SCW E P+ RP F ++ ++ + +
Sbjct: 235 YQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-44
Identities = 76/355 (21%), Positives = 128/355 (36%), Gaps = 81/355 (22%)
Query: 2 AEPVVKKEGESFELSFPLFDDNTGDTSCPLTKACDADDDDDEEYDNEFVFDIDASVLVDH 61
E + + EL P + + TS +T + + ++
Sbjct: 17 TENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRK----- 71
Query: 62 RSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQREVT 114
++ L + +G G++ VY+G VAVK + ++ + F E
Sbjct: 72 -NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELD-FLMEAL 126
Query: 115 LLSKMKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPK-----RLDLKHSISF 168
++SK H+NI++ +G S+Q I+ ELM G L+ +L TRP+ L + +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 169 ALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ--VKLADFGLAREEVMDEMTCEAGTY 226
A DI+ +YL N IHRD+ N LLT K+ DFG+AR ++ G
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-DIYRAGYYRKGGC 245
Query: 227 -----RWMAPEN------------------------------------------------ 233
+WM PE
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305
Query: 234 ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKL 288
+ P +N + ++ CW P+ RP FA I + Q+ +T +P +
Sbjct: 306 DPP--KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEY 358
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-44
Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 60/275 (21%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKEKFQREV 113
+ V+L +++GEG + VY+G Y VAVK + + ++KEKF E
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKK----DCTLDNKEKFMSEA 64
Query: 114 TLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDIS 173
++ + H +I+K +G + II EL L YL + L + + ++L I
Sbjct: 65 VIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQIC 123
Query: 174 RAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---YRWMA 230
+AM YL + + +HRD+ N+L+ + VKL DFGL+R ++ + T +WM+
Sbjct: 124 KAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 182
Query: 231 PE---------------------------------------------NER-PSLENLSED 244
PE +R P +
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV 242
Query: 245 MVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279
+ L+ CW DP RP F E+ +L+++ Q +
Sbjct: 243 LYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-44
Identities = 67/281 (23%), Positives = 106/281 (37%), Gaps = 61/281 (21%)
Query: 58 LVDHRSVLLQKMIGEGSYSIVYKGFYGCE-----PVAVKVIQPCNALAVSREHKEKFQRE 112
L+ + + L + +G+GS+ +V +G + VAVK ++P E + F RE
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS--QPEAMDDFIRE 71
Query: 113 VTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDI 172
V + + H N+++ G + P M ++TEL +L L L +A+ +
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQV 130
Query: 173 SRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGT---YR 227
+ M YL + IHRDL NLLL VK+ DFGL R + D + +
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189
Query: 228 WMAPE----------------------------------------------NER-PSLEN 240
W APE ER P E+
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249
Query: 241 LSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSAD 281
+D+ ++ CWA P+ RP F + L A+
Sbjct: 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRAE 290
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 58/299 (19%), Positives = 106/299 (35%), Gaps = 70/299 (23%)
Query: 41 DDEEYDNEFVFDIDASVLVDHRSVL-LQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQ 94
D + E V + V+ ++ ++IG G + VY G AVK +
Sbjct: 3 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 62
Query: 95 PCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ--PTMMIITELMRGETLQRYL 152
+F E ++ H N+L +G ++ + +++ M+ L+ ++
Sbjct: 63 RIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118
Query: 153 WSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+ +K I F L +++ M+YL + +HRDL N +L E VK+ADFGLAR
Sbjct: 119 RNETH-NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT-VKVADFGLAR 176
Query: 213 EEVMDEMTCEAGTY------RWMAPEN--------------------------------- 233
+ E +WMA E+
Sbjct: 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236
Query: 234 ---------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277
+P E + + ++ CW ++RP F+E+ ++ I
Sbjct: 237 NTFDITVYLLQGRRLLQP--EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-43
Identities = 54/304 (17%), Positives = 106/304 (34%), Gaps = 75/304 (24%)
Query: 39 DDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFY-----GCEPVAVKVI 93
+ + + V + ++ ++IG G + VY G AVK +
Sbjct: 72 NPELVQAVQHVVIGPSSLIVH------FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 125
Query: 94 QPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ--PTMMIITELMRGETLQRY 151
+F E ++ H N+L +G ++ + +++ M+ L+ +
Sbjct: 126 NRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 181
Query: 152 LWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211
+ + +K I F L +++ M++L + +HRDL N +L E VK+ADFGLA
Sbjct: 182 IRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLA 239
Query: 212 RE-EVMDEMTCEAGTY-----RWMAPEN-------------------------------- 233
R+ + + T +WMA E+
Sbjct: 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299
Query: 234 ----------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277
+P E + + ++ CW ++RP F+E+ ++ I
Sbjct: 300 VNTFDITVYLLQGRRLLQP--EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357
Query: 278 RSAD 281
Sbjct: 358 IGEH 361
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-43
Identities = 74/303 (24%), Positives = 125/303 (41%), Gaps = 91/303 (30%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQR 111
++++L K +GEG + V K G VAVK+ A E ++
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM---LKENASPSELRD-LLS 75
Query: 112 EVTLLSKMKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRP------------- 157
E +L ++ H +++K GA Q +++I E + +L+ +L +R
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 158 ---------KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADF 208
+ L + ISFA IS+ M+YL ++HRDL N+L+ E +K +K++DF
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK-MKISDF 194
Query: 209 GLAREEVMDEMTCEAGT-----YRWMAPEN------------------------------ 233
GL+R +V +E + + +WMA E+
Sbjct: 195 GLSR-DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 234 ------------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275
ERP +N SE+M L+ CW ++P RP FA+I+ L ++
Sbjct: 254 PGIPPERLFNLLKTGHRMERP--DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311
Query: 276 NLR 278
R
Sbjct: 312 KRR 314
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-43
Identities = 61/272 (22%), Positives = 108/272 (39%), Gaps = 61/272 (22%)
Query: 64 VLLQKMIGEGSYSIVYKGFY----GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
L K +G G++ V KG+Y + VAVK+++ A K++ E ++ ++
Sbjct: 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---ANDPALKDELLAEANVMQQL 75
Query: 120 KHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
+ I++ +G + M++ E+ L +YL + + + K+ I +S M+YL
Sbjct: 76 DNPYIVRMIGICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT-----YRWMAPE-- 232
++ +HRDL N+LL K++DFGL++ DE +A T +W APE
Sbjct: 134 EESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 233 -------------------------------------------NER-PSLENLSEDMVAL 248
ER +M L
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 252
Query: 249 LKSCWAEDPKVRPEFAEITITLTNILQNLRSA 280
+ CW D + RP FA + + L N ++ +
Sbjct: 253 MNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-43
Identities = 66/301 (21%), Positives = 112/301 (37%), Gaps = 70/301 (23%)
Query: 43 EEYDNEFVFDIDASVLVDHRSVL-LQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQPC 96
+ D+ + ++ ++ R V ++IG+G + +VY G Y A+K +
Sbjct: 1 RDLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI 60
Query: 97 NALAVSREHKEKFQREVTLLSKMKHENILKFVGASV--QPTMMIITELMRGETLQRYLWS 154
+ E F RE L+ + H N+L +G + + ++ M L +++ S
Sbjct: 61 ----TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS 116
Query: 155 TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214
+ +K ISF L ++R MEYL +HRDL N +L E VK+ADFGLAR+
Sbjct: 117 PQRN-PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT-VKVADFGLARDI 174
Query: 215 VMDEMTCEAGTY------RWMAPEN----------------------------------- 233
+ E +W A E+
Sbjct: 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234
Query: 234 -------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSA 280
+P E + + +++ CW DP VRP F + + I+ L
Sbjct: 235 FDLTHFLAQGRRLPQP--EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292
Query: 281 D 281
Sbjct: 293 H 293
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-43
Identities = 63/305 (20%), Positives = 107/305 (35%), Gaps = 69/305 (22%)
Query: 29 CPLTKACDADDDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFY----- 83
P A ++ F +I+AS + ++K+IG G V G
Sbjct: 22 EPQFYAEPHTYEEPGRAGRSFTREIEAS------RIHIEKIIGSGDSGEVCYGRLRVPGQ 75
Query: 84 GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA-SVQPTMMIITEL 142
PVA+K ++ + + F E +++ + H NI++ G + MI+TE
Sbjct: 76 RDVPVAIKALKAG----YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEY 131
Query: 143 MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ 202
M +L +L T + + + + M YL +HRDL N+L+ +
Sbjct: 132 MENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN-LV 189
Query: 203 VKLADFGLAREEVMDEMTCEAGT-----YRWMAPE------------------------- 232
K++DFGL+R D T RW APE
Sbjct: 190 CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
Query: 233 --------------------NER-PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLT 271
R P+ + L+ CW +D RP F++I L
Sbjct: 250 YGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
Query: 272 NILQN 276
++++
Sbjct: 310 ALIRS 314
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-43
Identities = 70/288 (24%), Positives = 117/288 (40%), Gaps = 79/288 (27%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQR 111
V + + + +G+GS+ +VY+G VA+K N A RE E F
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT---VNEAASMRERIE-FLN 77
Query: 112 EVTLLSKMKHENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRPK--------RLD 161
E +++ + ++++ +G Q P ++I ELM L+ YL S RP
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 162 LKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTC 221
L I A +I+ M YL+AN +HRDL N ++ ED VK+ DFG+ R ++ +
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTR-DIYETDYY 194
Query: 222 EAGTY-----RWMAPEN------------------------------------------- 233
G RWM+PE+
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254
Query: 234 -----ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
++P +N + + L++ CW +PK+RP F EI ++ ++
Sbjct: 255 EGGLLDKP--DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-43
Identities = 53/275 (19%), Positives = 109/275 (39%), Gaps = 62/275 (22%)
Query: 58 LVDHRSVLLQKMIGEGSYSIVYKGFYGCE------PVAVKVIQPCNALAVSREHKEKFQR 111
+ + K++G G + V+KG + E PV +KVI+ + R+ +
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS----GRQSFQAVTD 64
Query: 112 EVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALD 171
+ + + H +I++ +G ++ ++T+ + +L ++ R L + +++ +
Sbjct: 65 HMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQ 123
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE-EVMDEMTCEAGT---YR 227
I++ M YL + ++HR+L N+LL QV++ADFG+A D+ + +
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSP-SQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 228 WMAPE---------------------------------------------NER-PSLENL 241
WMA E ER +
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQIC 242
Query: 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
+ D+ ++ CW D +RP F E+ T + ++
Sbjct: 243 TIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 79/329 (24%), Positives = 124/329 (37%), Gaps = 66/329 (20%)
Query: 2 AEPVVKKEGESFELSFPLFDDNTGDTSCPLTKACDADDDDDEEYDNEFVFDIDASVLVDH 61
E + + +T S A D++D + ++I
Sbjct: 336 GERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRE----- 390
Query: 62 RSVLLQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKEKFQREVTLL 116
+ L + IGEG + V++G Y VA+K + C S +EKF +E +
Sbjct: 391 -RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT----SDSVREKFLQEALTM 445
Query: 117 SKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
+ H +I+K +G + + II EL L+ +L + LDL I +A +S A+
Sbjct: 446 RQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTAL 504
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE-EVMDEMTCEAGTY--RWMAPE- 232
YL + +HRD+ N+L++ + VKL DFGL+R E G +WMAPE
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 563
Query: 233 ----------------------------------NER-----------PSLENLSEDMVA 247
N P N + +
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 623
Query: 248 LLKSCWAEDPKVRPEFAEITITLTNILQN 276
L+ CWA DP RP F E+ L+ IL+
Sbjct: 624 LMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-42
Identities = 70/296 (23%), Positives = 110/296 (37%), Gaps = 86/296 (29%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQR 111
+ L K +G G++ V + C VAVK+ A EH+
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM---LKEGATHSEHRA-LMS 79
Query: 112 EVTLLSKM-KHENILKFVGASVQPT--MMIITELMRGETLQRYLWSTRP----------- 157
E+ +L + H N++ +GA +P +M+I E + L YL S R
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 158 ---KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214
L L+H I ++ +++ ME+L + IHRDL N+LL+E VK+ DFGLAR +
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLAR-D 197
Query: 215 VMDEMTCEAGT-----YRWMAPEN------------------------------------ 233
+ + +WMAPE
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 234 -------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
P + + +M + CW +P RP F+E+ L N+LQ
Sbjct: 258 EEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-42
Identities = 67/301 (22%), Positives = 115/301 (38%), Gaps = 86/301 (28%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY---------GCEPVAVKVIQPCNALAVSREHKEKF 109
+ L K +GEG++ V VAVK+ A ++ +
Sbjct: 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSD-L 87
Query: 110 QREVTLLSKM-KHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRP---------- 157
E+ ++ + KH+NI+ +GA Q + +I E L+ YL + RP
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 158 ----KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213
+++ K +S ++R MEYL + IHRDL N+L+TE+ +K+ADFGLAR
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLAR- 205
Query: 214 EVMDEMTCEAGT-----YRWMAPEN----------------------------------- 233
++ + + T +WMAPE
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265
Query: 234 -------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSA 280
++P N + ++ +++ CW P RP F ++ L IL +
Sbjct: 266 EELFKLLKEGHRMDKP--ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 281 D 281
+
Sbjct: 324 E 324
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-42
Identities = 68/297 (22%), Positives = 113/297 (38%), Gaps = 88/297 (29%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY---------GCEPVAVKVIQPCNALAVSREHKEKF 109
+ L K +GEG + V VAVK+ A ++ +
Sbjct: 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSD-L 133
Query: 110 QREVTLLSKM-KHENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRP--------- 157
E+ ++ + KH+NI+ +GA Q P + +I E L+ YL + RP
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 158 -----KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+++ K +S ++R MEYL + IHRDL N+L+TE+ +K+ADFGLAR
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLAR 251
Query: 213 EEVMDEMTCEAGT-----YRWMAPEN---------------------------------- 233
++ + + T +WMAPE
Sbjct: 252 -DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310
Query: 234 --------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
++P N + ++ +++ CW P RP F ++ L IL
Sbjct: 311 VEELFKLLKEGHRMDKP--ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-42
Identities = 52/278 (18%), Positives = 106/278 (38%), Gaps = 62/278 (22%)
Query: 59 VDHRSVLLQKM-IGEGSYSIVYKGFY----GCEPVAVKVIQPCNALAVSREHKEKFQREV 113
+ ++L+ + +G G++ V +G Y VA+KV++ + E+ RE
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREA 61
Query: 114 TLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDIS 173
++ ++ + I++ +G +M++ E+ G L ++L + + + + + +S
Sbjct: 62 QIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVS 120
Query: 174 RAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT-----YRW 228
M+YL + +HRDL N+LL K++DFGL++ D+ A + +W
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179
Query: 229 MAPE---------------------------------------------NER-PSLENLS 242
APE +R
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 239
Query: 243 EDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSA 280
++ AL+ CW + RP+F + + +L S
Sbjct: 240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-41
Identities = 64/293 (21%), Positives = 112/293 (38%), Gaps = 85/293 (29%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQR 111
+ R ++L+ +GEG++ V+ VAVK ++ S ++ FQR
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQR 92
Query: 112 EVTLLSKMKHENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRP------------ 157
E LL+ ++H++I++F G + P ++++ E MR L R+L S P
Sbjct: 93 EAELLTMLQHQHIVRFFGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 158 -KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216
L L ++ A ++ M YL +HRDL N L+ + VK+ DFG++R ++
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG-LVVKIGDFGMSR-DIY 209
Query: 217 DEMTCEAGTY-----RWMAPEN-------------------------------------- 233
G RWM PE+
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269
Query: 234 ----------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
ERP ++ A+++ CW +P+ R ++ L + Q
Sbjct: 270 IDCITQGRELERP--RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-41
Identities = 68/292 (23%), Positives = 112/292 (38%), Gaps = 80/292 (27%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY----GCEPVAVKVIQPCNALAVSREHKEKFQREVT 114
+D + Q +IGEG++ V K A+K A +H++ F E+
Sbjct: 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR---MKEYASKDDHRD-FAGELE 77
Query: 115 LLSKM-KHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRP--------------K 158
+L K+ H NI+ +GA + + E L +L +R
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 159 RLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218
L + + FA D++R M+YL IHRDL N+L+ E+ K+ADFGL+R + +
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKIADFGLSRGQ--EV 194
Query: 219 MTCEAGT---YRWMAPE------------------------------------------- 232
+ RWMA E
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
Query: 233 -----NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279
E+P N +++ L++ CW E P RP FA+I ++L +L+ ++
Sbjct: 255 PQGYRLEKP--LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 66/298 (22%), Positives = 110/298 (36%), Gaps = 89/298 (29%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQR 111
+ K +G G++ V + VAVK+++P +A +E
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SA---HLTEREALMS 75
Query: 112 EVTLLSKM-KHENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRPKR--------- 159
E+ +LS + H NI+ +GA P ++ITE L +L R
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 160 -------LDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
LDL+ +SF+ +++ M +L + + IHRDL N+LLT + K+ DFGLAR
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI-TKICDFGLAR 193
Query: 213 EEVMDEMTCEAGT-----YRWMAPEN---------------------------------- 233
++ ++ +WMAPE+
Sbjct: 194 -DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 234 ---------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
P E+ +M ++K+CW DP RP F +I + +
Sbjct: 253 VDSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-41
Identities = 59/294 (20%), Positives = 110/294 (37%), Gaps = 85/294 (28%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQR 111
++ K +G G++ V + VAVK+++ A + E +
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST---AHADEKEA-LMS 98
Query: 112 EVTLLSKM-KHENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRP----------- 157
E+ ++S + +HENI+ +GA P +++ITE L +L
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 158 -KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216
+ + F+ +++ M +L + + IHRD+ N+LLT K+ DFGLAR ++M
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV-AKIGDFGLAR-DIM 215
Query: 217 DEMTCEAGT-----YRWMAPEN-------------------------------------- 233
++ +WMAPE+
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275
Query: 234 -----------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
+P +++ +++++CWA +P RP F +I L Q
Sbjct: 276 FYKLVKDGYQMAQP--AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 68/296 (22%), Positives = 116/296 (39%), Gaps = 86/296 (29%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY---------GCEPVAVKVIQPCNALAVSREHKEKF 109
+ ++L K +GEG++ V VAVK+ + A ++ +
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSD-L 121
Query: 110 QREVTLLSKM-KHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRP---------- 157
E+ ++ + KH+NI+ +GA + + +I E L+ YL + RP
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 158 ----KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213
++L K +S A ++R MEYL + IHRDL N+L+TED +K+ADFGLAR
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV-MKIADFGLAR- 239
Query: 214 EVMDEMTCEAGT-----YRWMAPEN----------------------------------- 233
++ + T +WMAPE
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299
Query: 234 -------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
++P N + ++ +++ CW P RP F ++ L I+
Sbjct: 300 EELFKLLKEGHRMDKP--SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-41
Identities = 64/294 (21%), Positives = 112/294 (38%), Gaps = 86/294 (29%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQR 111
+ R ++L++ +GEG++ V+ VAVK ++ + ++ FQR
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-----TLAARKDFQR 66
Query: 112 EVTLLSKMKHENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRP------------ 157
E LL+ ++HE+I+KF G P ++++ E M+ L ++L + P
Sbjct: 67 EAELLTNLQHEHIVKFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 158 --KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215
L L + A I+ M YL + +HRDL N L+ + VK+ DFG++R +V
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN-LLVKIGDFGMSR-DV 183
Query: 216 MDEMTCEAGTY-----RWMAPEN------------------------------------- 233
G + RWM PE+
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243
Query: 234 -----------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
ERP +++ ++ CW +P+ R EI L + +
Sbjct: 244 VIECITQGRVLERP--RVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-41
Identities = 68/298 (22%), Positives = 115/298 (38%), Gaps = 70/298 (23%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQRE 112
+ V QK+IG G + VYKG PVA+K ++ + + + F E
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA----GYTEKQRVDFLGE 96
Query: 113 VTLLSKMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALD 171
++ + H NI++ G S MMIITE M L ++L + + +
Sbjct: 97 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRG 155
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGT---Y 226
I+ M+YL + +HRDL N+L+ + K++DFGL+R E+ + +G
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 227 RWMAPE---------------------------------------------NER-PSLEN 240
RW APE R P+ +
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 274
Query: 241 LSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVEIVDPKSTM 298
+ L+ CW ++ RP+FA+I L +++ P K + DP+ ++
Sbjct: 275 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA------PDSLKTLADFDPRVSI 326
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 72/325 (22%), Positives = 123/325 (37%), Gaps = 94/325 (28%)
Query: 37 ADDDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVA 89
D++ Y + ++ D ++ K++G G++ V VA
Sbjct: 20 GSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA 79
Query: 90 VKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQ--PTMMIITELMRGE 146
VK+++ A S E + E+ +++++ HENI+ +GA P + +I E
Sbjct: 80 VKMLKEK---ADSSEREA-LMSELKMMTQLGSHENIVNLLGACTLSGP-IYLIFEYCCYG 134
Query: 147 TLQRYLWSTRPKR---------------------LDLKHSISFALDISRAMEYLHANSVI 185
L YL S R K L + + FA +++ ME+L S +
Sbjct: 135 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 194
Query: 186 HRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT-----YRWMAPEN------- 233
HRDL N+L+T K VK+ DFGLAR ++M + +WMAPE+
Sbjct: 195 HRDLAARNVLVTHGKV-VKICDFGLAR-DIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 252
Query: 234 ------------------------------------------ERPSLENLSEDMVALLKS 251
++P +E++ +++S
Sbjct: 253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQS 310
Query: 252 CWAEDPKVRPEFAEITITLTNILQN 276
CWA D + RP F +T L L +
Sbjct: 311 CWAFDSRKRPSFPNLTSFLGCQLAD 335
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 65/302 (21%), Positives = 103/302 (34%), Gaps = 93/302 (30%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQR 111
++ + IGEG++ V++ VAVK+ A + + FQR
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM---LKEEASADMQAD-FQR 99
Query: 112 EVTLLSKMKHENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRP------------ 157
E L+++ + NI+K +G P M ++ E M L +L S P
Sbjct: 100 EAALMAEFDNPNIVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 158 ----------KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLAD 207
L + A ++ M YL +HRDL N L+ E+ VK+AD
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIAD 217
Query: 208 FGLAREEVMDEMTCEAGTY-----RWMAPEN----------------------------- 233
FGL+R + +A RWM PE+
Sbjct: 218 FGLSR-NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
Query: 234 -------------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274
P EN ++ L++ CW++ P RP F I L +
Sbjct: 277 YYGMAHEEVIYYVRDGNILACP--ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334
Query: 275 QN 276
+
Sbjct: 335 ER 336
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-40
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 38 DDDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFY---GCEPVAVKVIQ 94
DD E + D R + IG GS+ VYKG E VA +Q
Sbjct: 6 QQQDDIEELETKAVGMSN----DGRFLKFDIEIGRGSFKTVYKGLDTETTVE-VAWCELQ 60
Query: 95 PCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV-----QPTMMIITELMRGETLQ 149
+++ +++F+ E +L ++H NI++F + + ++++TELM TL+
Sbjct: 61 DRK---LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117
Query: 150 RYLWSTRPKRLDLKHSISFALDISRAMEYLHANS--VIHRDLKPSNLLLTEDKKQVKLAD 207
YL R K + +K S+ I + +++LH + +IHRDLK N+ +T VK+ D
Sbjct: 118 TYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175
Query: 208 FGLAREEVMDEMTCEAGTYRWMAPE 232
GLA + GT +MAPE
Sbjct: 176 LGLATLKRASFAKAVIGTPEFMAPE 200
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (371), Expect = 9e-40
Identities = 56/303 (18%), Positives = 113/303 (37%), Gaps = 67/303 (22%)
Query: 32 TKACDADDDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFY----GCEP 87
T ++ D EE ++ +F L ++ +G G++ V +G Y
Sbjct: 312 TSVFESPFSDPEELKDKKLF------LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQID 365
Query: 88 VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMIITELMRGET 147
VA+KV++ + E+ RE ++ ++ + I++ +G +M++ E+ G
Sbjct: 366 VAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGP 421
Query: 148 LQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLAD 207
L ++L + + + + + +S M+YL + +HR+L N+LL K++D
Sbjct: 422 LHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR-HYAKISD 479
Query: 208 FGLAREEVMDEMTCEAGT-----YRWMAPE------------------------------ 232
FGL++ D+ A + +W APE
Sbjct: 480 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
Query: 233 ---------------NER-PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
+R ++ AL+ CW + RP+F + + +
Sbjct: 540 YKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599
Query: 277 LRS 279
L S
Sbjct: 600 LAS 602
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 21/188 (11%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYG------CEPVAVKVIQPCNALAVSREHKEKFQRE 112
+ R + + +G+G++ V Y E VAVK +Q + EH F+RE
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFERE 92
Query: 113 VTLLSKMKHENILKFVGASVQPT---MMIITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
+ +L ++H+NI+K+ G + +I E + +L+ YL + R+D + +
Sbjct: 93 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYT 151
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTY--- 226
I + MEYL IHRDL N+L+ + +VK+ DFGL + D+ +
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEYYKVKEPGES 210
Query: 227 --RWMAPE 232
W APE
Sbjct: 211 PIFWYAPE 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 21/188 (11%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQRE 112
+ R + +G+G++ V Y VAVK +Q + + FQRE
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQRDFQRE 74
Query: 113 VTLLSKMKHENILKFVGASVQPT---MMIITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
+ +L + + I+K+ G S P + ++ E + L+ +L R RLD + ++
Sbjct: 75 IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYS 133
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---- 225
I + MEYL + +HRDL N+L+ + VK+ADFGLA+ +D+
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESE-AHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 226 -YRWMAPE 232
W APE
Sbjct: 193 PIFWYAPE 200
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 13/50 (26%), Positives = 21/50 (42%), Gaps = 2/50 (4%)
Query: 234 ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTP 283
P ++ L+K CWA P+ RP F+ + L + R +T
Sbjct: 264 PAP--PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH 311
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-39
Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 20/188 (10%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQRE 112
+ R + + +GEG + V Y E VAVK ++P + H ++E
Sbjct: 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKE 73
Query: 113 VTLLSKMKHENILKFVGASVQPT---MMIITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
+ +L + HENI+K+ G + + +I E + +L+ YL +++LK + +A
Sbjct: 74 IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYA 132
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTY--- 226
+ I + M+YL + +HRDL N+L+ + QVK+ DFGL + D+
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 227 --RWMAPE 232
W APE
Sbjct: 192 PVFWYAPE 199
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 52/188 (27%), Positives = 81/188 (43%), Gaps = 22/188 (11%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQRE 112
R + + +GEG + V Y E VAVK ++ +H+ +++E
Sbjct: 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA----GPQHRSGWKQE 83
Query: 113 VTLLSKMKHENILKFVGASVQPT---MMIITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
+ +L + HE+I+K+ G + ++ E + +L+ YL + L + FA
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFA 140
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTY--- 226
I M YLHA IHRDL N+LL D + VK+ DFGLA+
Sbjct: 141 QQICEGMAYLHAQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 227 --RWMAPE 232
W APE
Sbjct: 200 PVFWYAPE 207
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-39
Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 21/188 (11%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYG------CEPVAVKVIQPCNALAVSREHKEKFQRE 112
+ R + + +G+G++ V Y E VAVK +Q + EH F+RE
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFERE 61
Query: 113 VTLLSKMKHENILKFVGASVQPT---MMIITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
+ +L ++H+NI+K+ G + +I E + +L+ YL +R+D + +
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYT 120
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT---- 225
I + MEYL IHRDL N+L+ + +VK+ DFGL + D+ +
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 226 -YRWMAPE 232
W APE
Sbjct: 180 PIFWYAPE 187
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-39
Identities = 56/285 (19%), Positives = 101/285 (35%), Gaps = 63/285 (22%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKEKFQREV 113
+D ++ + K++G G + V G VA+K ++ + + + F E
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----TEKQRRDFLGEA 97
Query: 114 TLLSKMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDI 172
+++ + H NI++ G + +MI+TE M +L +L + + + I
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGI 156
Query: 173 SRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT-----YR 227
+ M+YL +HRDL N+L+ + K++DFGL R D R
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 228 WMAPE---------------------------------------------NER-PSLENL 241
W +PE R P +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275
Query: 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPP 286
+ L+ CW +D RP+F +I L +++N S
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSA 320
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-39
Identities = 60/290 (20%), Positives = 101/290 (34%), Gaps = 85/290 (29%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQR 111
+ +V + +GE + VYKG + VA+K ++ +E+F+
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK----AEGPLREEFRH 61
Query: 112 EVTLLSKMKHENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRP------------ 157
E L ++++H N++ +G + P + +I L +L P
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 158 --KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215
L+ + I+ MEYL ++ V+H+DL N+L+ + VK++D GL R EV
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN-VKISDLGLFR-EV 178
Query: 216 MDEMTCEAGTY-----RWMAPEN------------------------------------- 233
+ RWMAPE
Sbjct: 179 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 238
Query: 234 -----------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTN 272
P ++ + AL+ CW E P RP F +I L
Sbjct: 239 VVEMIRNRQVLPCP--DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 286
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-38
Identities = 60/260 (23%), Positives = 108/260 (41%), Gaps = 70/260 (26%)
Query: 67 QKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI 124
++IG G + V+K + +K + + + EK +REV L+K+ H NI
Sbjct: 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRV---------KYNNEKAEREVKALAKLDHVNI 66
Query: 125 LKFVGA-----------------SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSIS 167
+ + G S + I E TL++++ R ++LD ++
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 168 FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE-EVMDEMTCEAGTY 226
I++ ++Y+H+ +I+RDLKPSN+ L + KQVK+ DFGL + + T GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 227 RWMAPE--NERP--------SL------------------------------ENLSEDMV 246
R+M+PE + + +L + +
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEK 245
Query: 247 ALLKSCWAEDPKVRPEFAEI 266
LL+ ++ P+ RP +EI
Sbjct: 246 TLLQKLLSKKPEDRPNTSEI 265
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-38
Identities = 36/191 (18%), Positives = 89/191 (46%), Gaps = 25/191 (13%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY---------GCEPVAVKVIQPCNALAVSREHKEKF 109
+ + ++ + +G+G+++ ++KG V +KV+ R + E F
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----HRNYSESF 59
Query: 110 QREVTLLSKMKHENILKFVG-ASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISF 168
+++SK+ H++++ G +++ E ++ +L YL + +++ +
Sbjct: 60 FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEV 118
Query: 169 ALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ-------VKLADFGLAREEVMDEMTC 221
A ++ AM +L N++IH ++ N+LL ++ + +KL+D G++ + ++
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 222 EAGTYRWMAPE 232
E W+ PE
Sbjct: 179 ER--IPWVPPE 187
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 42/185 (22%), Positives = 83/185 (44%), Gaps = 16/185 (8%)
Query: 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVT 114
S+ V R + K IG G S V++ + A+K + N + + ++ E+
Sbjct: 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV---NLEEADNQTLDSYRNEIA 78
Query: 115 LLSKMKH--ENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALD 171
L+K++ + I++ + + ++ E + L +L + K +D S+ +
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWL--KKKKSIDPWERKSYWKN 135
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR----EEVMDEMTCEAGTYR 227
+ A+ +H + ++H DLKP+N L+ +KL DFG+A + + GT
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 228 WMAPE 232
+M PE
Sbjct: 194 YMPPE 198
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 52/249 (20%), Positives = 85/249 (34%), Gaps = 55/249 (22%)
Query: 66 LQKMIGEGSYSIVYKGFY---GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KH 121
+G GSY V+K G AVK + + + + EV K+ +H
Sbjct: 61 RLSRLGHGSYGEVFKVRSKEDGRL-YAVKRS---MSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 122 ENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH 180
++ A + + + TEL LQ++ L + D A+ +LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPS-LQQHC-EAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE-EVMDEMTCEAGTYRWMAPE------- 232
+ ++H D+KP+N+ L + KL DFGL E + G R+MAPE
Sbjct: 175 SQGLVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYG 233
Query: 233 ----------------------------------NERPSL-ENLSEDMVALLKSCWAEDP 257
P LS ++ ++L DP
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDP 293
Query: 258 KVRPEFAEI 266
K+R +
Sbjct: 294 KLRATAEAL 302
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 41/184 (22%), Positives = 82/184 (44%), Gaps = 16/184 (8%)
Query: 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTL 115
+ V R + K IG G S V++ + A+K + N + + ++ E+
Sbjct: 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV---NLEEADNQTLDSYRNEIAY 60
Query: 116 LSKMKH--ENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDI 172
L+K++ + I++ + + ++ E + L +L + K +D S+ ++
Sbjct: 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWL--KKKKSIDPWERKSYWKNM 117
Query: 173 SRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR----EEVMDEMTCEAGTYRW 228
A+ +H + ++H DLKP+N L+ +KL DFG+A + + GT +
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175
Query: 229 MAPE 232
M PE
Sbjct: 176 MPPE 179
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 64/295 (21%), Positives = 104/295 (35%), Gaps = 85/295 (28%)
Query: 68 KMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
+ +G G + +V++ A+K I+ L +EK REV L+K++H I+
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIR----LPNRELAREKVMREVKALAKLEHPGIV 66
Query: 126 KFVGA-------------SVQPTMMIITELMRGETLQRYLWSTRPKR-LDLKHSISFALD 171
++ A S + + I +L R E L+ ++ + + L
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR--------------EEVMD 217
I+ A+E+LH+ ++HRDLKPSN+ T D VK+ DFGL
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 218 EMTCEAGTYRWMAPE------------------------------NER------------ 235
T + GT +M+PE ER
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKF 245
Query: 236 -PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLV 289
P +++ + P RP NI++N D P K V
Sbjct: 246 PPLFTQKYPCEYVMVQDMLSPSPMERP-------EAINIIENAVFEDLDFPGKTV 293
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 63/307 (20%), Positives = 105/307 (34%), Gaps = 83/307 (27%)
Query: 51 FDIDASVLVDHRSVLLQKMIGEGSYSIVY--KGFYGCEPVAVKVIQPCNALAVSREHKEK 108
+ V++D++ L + +GEG +S V +G + A+K I L ++ +E+
Sbjct: 18 YFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI-----LCHEQQDREE 72
Query: 109 FQREVTLLSKMKHENILKFVGASVQPT-----MMIITELMRGETLQRYL--WSTRPKRLD 161
QRE + H NIL+ V ++ ++ + TL + + L
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132
Query: 162 LKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE-------- 213
+ L I R +E +HA HRDLKP+N+LL ++ Q L D G +
Sbjct: 133 EDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGS 191
Query: 214 ---EVMDEMTCEAGTYRWMAPE----------NER------------------------- 235
+ + + T + APE +ER
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251
Query: 236 ---------------PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSA 280
P S + LL S DP RP + +L L +
Sbjct: 252 KGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP-------HIPLLLSQLEAL 304
Query: 281 DTPIPPK 287
P P +
Sbjct: 305 QPPAPGQ 311
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 5e-34
Identities = 40/185 (21%), Positives = 81/185 (43%), Gaps = 16/185 (8%)
Query: 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVT 114
+ V R + K IG G S V++ + A+K + N + + ++ E+
Sbjct: 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV---NLEEADNQTLDSYRNEIA 106
Query: 115 LLSKMKH--ENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALD 171
L+K++ + I++ + + ++ E + L +L + K +D S+ +
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWL--KKKKSIDPWERKSYWKN 163
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR----EEVMDEMTCEAGTYR 227
+ A+ +H + ++H DLKP+N L+ +KL DFG+A + + G
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221
Query: 228 WMAPE 232
+M PE
Sbjct: 222 YMPPE 226
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-34
Identities = 62/309 (20%), Positives = 124/309 (40%), Gaps = 72/309 (23%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ IGEGS+ +K I N +S + +E+ +REV +L+ MKH N
Sbjct: 28 RLQKIGEGSFGKAILVKSTEDGRQYVIKEI---NISRMSSKEREESRREVAVLANMKHPN 84
Query: 124 ILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
I+++ + + ++ I+ + G L + + + + + + + I A++++H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA----GTYRWMAPE--NERP 236
++HRD+K N+ LT+D V+L DFG+AR V++ A GT +++PE +P
Sbjct: 145 KILHRDIKSQNIFLTKD-GTVQLGDFGIAR--VLNSTVELARACIGTPYYLSPEICENKP 201
Query: 237 --------SL-----------------------------------ENLSEDMVALLKSCW 253
+L + S D+ +L+ +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261
Query: 254 AEDPKVRPEFAEITITLTNILQNLRSADTP-IPPKLVEIVDPKSTMNNDCMATVHAITKF 312
+P+ RP ++ +IL+ I ++ + + P+ C+ T
Sbjct: 262 KRNPRDRP-------SVNSILEK------GFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQ 308
Query: 313 NEKGKKRRS 321
K+ S
Sbjct: 309 PIPAKRPAS 317
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 51/267 (19%), Positives = 91/267 (34%), Gaps = 74/267 (27%)
Query: 68 KMIGEGSYSIVYKGFY---GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHEN 123
+ IG G + V+K GC A+K + A ++ REV + + +H +
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCI-YAIKRSKKPLA---GSVDEQNALREVYAHAVLGQHSH 72
Query: 124 ILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSI--SFALDISRAMEYLH 180
++++ A + M+I E G +L + K + L + R + Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 181 ANSVIHRDLKPSNLLLTED------------------KKQVKLADFGLAREEVMDEMTCE 222
+ S++H D+KPSN+ ++ K K+ D G + E
Sbjct: 133 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-RISSPQVEE 191
Query: 223 AGTYRWMAPE------------------------------------------NERPSL-E 239
G R++A E P + +
Sbjct: 192 -GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQ 250
Query: 240 NLSEDMVALLKSCWAEDPKVRPEFAEI 266
LS++ LLK DP+ RP +
Sbjct: 251 VLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 45/199 (22%), Positives = 76/199 (38%), Gaps = 40/199 (20%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
++G+G++ V K A+K I+ + E EV LL+ + H+
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLASLNHQY 63
Query: 124 ILKFVGA--------------SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
++++ A + T+ I E TL + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWRLF 122
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR----------------E 213
I A+ Y+H+ +IHRDLKP N+ + E + VK+ DFGLA+
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 214 EVMDEMTCEAGTYRWMAPE 232
D +T GT ++A E
Sbjct: 182 GSSDNLTSAIGTAMYVATE 200
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-33
Identities = 57/258 (22%), Positives = 108/258 (41%), Gaps = 62/258 (24%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
++K IG G +S VY+ PVA+K +Q + + + + +E+ LL ++ H N
Sbjct: 36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM--DAKARADCIKEIDLLKQLNHPN 93
Query: 124 ILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHS--ISFALDISRAMEYLH 180
++K+ + ++ + I+ EL L R + + ++ + + + + A+E++H
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYR----WMAPE--NE 234
+ V+HRD+KP+N+ +T VKL D GL R T A + +M+PE +E
Sbjct: 154 SRRVMHRDIKPANVFITATGV-VKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERIHE 210
Query: 235 RP--------SL--------------------------------------ENLSEDMVAL 248
SL ++ SE++ L
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 270
Query: 249 LKSCWAEDPKVRPEFAEI 266
+ C DP+ RP+ +
Sbjct: 271 VNMCINPDPEKRPDVTYV 288
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 52/179 (29%), Positives = 84/179 (46%), Gaps = 26/179 (14%)
Query: 69 MIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFV 128
+GEG + +VYKG+ VAVK + + ++ F +E+ +++K +HEN+++ +
Sbjct: 38 KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ-FDQEIKVMAKCQHENLVELL 96
Query: 129 GASVQPT-MMIITELMRGETLQRYL----------WSTRPKRLDLKHSISFALDISRAME 177
G S + ++ M +L L W R K I A + +
Sbjct: 97 GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK-------I--AQGAANGIN 147
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM----TCEAGTYRWMAPE 232
+LH N IHRD+K +N+LL E K++DFGLAR + GT +MAPE
Sbjct: 148 FLHENHHIHRDIKSANILLDEA-FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 47/227 (20%), Positives = 83/227 (36%), Gaps = 22/227 (9%)
Query: 16 SFPLFDDNTGDTSCPLTKACDADDDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSY 75
S S L + +D++ E + +D + + Q +G GS+
Sbjct: 12 SLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSF 71
Query: 76 SIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133
V++ AVK ++ E+ + + I+ GA +
Sbjct: 72 GEVHRMKDKQTGFQCAVKKVRLEVFR----------VEELVACAGLSSPRIVPLYGAVRE 121
Query: 134 PTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPS 192
+ I EL+ G +L + + + L ++ + +EYLH ++H D+K
Sbjct: 122 GPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKAD 179
Query: 193 NLLLTEDKKQVKLADFGLAREEVMDEMTCEA-------GTYRWMAPE 232
N+LL+ D + L DFG A D + GT MAPE
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 46/171 (26%), Positives = 84/171 (49%), Gaps = 11/171 (6%)
Query: 68 KMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
++G+G+Y IVY G +A+K I + + E+ L +KH+NI+
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPE-----RDSRYSQPLHEEIALHKHLKHKNIV 82
Query: 126 KFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSIS-FALDISRAMEYLHANS 183
+++G+ + + I E + G +L L S D + +I + I ++YLH N
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 184 VIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGTYRWMAPE 232
++HRD+K N+L+ +K++DFG ++ + GT ++MAPE
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE 193
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 14/177 (7%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
L ++G+G+ + V++G + + A+KV + + RE +L K+ H+N
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----FLRPVDVQMREFEVLKKLNHKN 68
Query: 124 ILKFVGASVQPT---MMIITELMRGETLQRYLWS-TRPKRLDLKHSISFALDISRAMEYL 179
I+K + T ++I E +L L + L + D+ M +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 180 HANSVIHRDLKPSNLLLT---EDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
N ++HR++KP N++ + + KL DFG ARE DE GT ++ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 28/181 (15%)
Query: 67 QKMIGEGSYSIVYKGFY---GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
K+IG GS+ +VY+ G E VA+K + + K RE+ ++ K+ H N
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSG-ELVAIKKV---------LQDKRFKNRELQIMRKLDHCN 108
Query: 124 I--LKFVGASVQPTMM-----IITELMRGETLQRYL--WSTRPKRLDLKHSISFALDISR 174
I L++ S ++ + + ET+ R +S + L + + + + R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGT--YRWMAP 231
++ Y+H+ + HRD+KP NLLL D +KL DFG A++ V E + YR AP
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--AP 225
Query: 232 E 232
E
Sbjct: 226 E 226
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-31
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 38 DDDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSY-SIVYKGFYGCEPVAVKVIQPC 96
DD DEE V I S + ++G G+ +IVY+G + VAVK I
Sbjct: 9 QDDGDEETSVVIVGKI---------SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI--- 56
Query: 97 NALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPTMM-IITELMRGETLQRYLWS 154
E REV LL + +H N++++ I EL LQ Y+
Sbjct: 57 -----LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAAT-LQEYV-E 109
Query: 155 TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ----VKLADFGL 210
+ I+ + + +LH+ +++HRDLKP N+L++ ++DFGL
Sbjct: 110 QKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169
Query: 211 AREEVMDE-----MTCEAGTYRWMAPE 232
++ + + GT W+APE
Sbjct: 170 CKKLAVGRHSFSRRSGVPGTEGWIAPE 196
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 53/180 (29%), Positives = 94/180 (52%), Gaps = 21/180 (11%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHE 122
L +++G G+Y VYKG + + A+KV+ V+ + +E+ ++E+ +L K H
Sbjct: 28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMD------VTGDEEEEIKQEINMLKKYSHHR 81
Query: 123 NILKFVGA-------SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFAL-DISR 174
NI + GA + + ++ E ++ + +T+ L + I++ +I R
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-IAYICREILR 140
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
+ +LH + VIHRD+K N+LLTE+ +VKL DFG++ + + GT WMAPE
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 29/181 (16%)
Query: 67 QKMIGEGSYSIVYKGFYGCEP---VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
K+IG GS+ +V++ VA+K + + K RE+ ++ +KH N
Sbjct: 45 CKVIGNGSFGVVFQAK--LVESDEVAIKKV---------LQDKRFKNRELQIMRIVKHPN 93
Query: 124 I--LKFVGASVQPT-----MMIITELMRGETLQRYL--WSTRPKRLDLKHSISFALDISR 174
+ LK S + ++ E + ET+ R ++ + + + + + R
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGT--YRWMAP 231
++ Y+H+ + HRD+KP NLLL +KL DFG A+ + E + YR AP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--AP 210
Query: 232 E 232
E
Sbjct: 211 E 211
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-30
Identities = 46/178 (25%), Positives = 81/178 (45%), Gaps = 16/178 (8%)
Query: 66 LQKMIGEGSYSIVYKGFY---GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
L ++G+G+ + V++G + G + A+KV + L + RE +L K+ H+
Sbjct: 13 LSDILGQGATANVFRGRHKKTG-DLFAIKVFNNISFL----RPVDVQMREFEVLKKLNHK 67
Query: 123 NILKFVGASVQPT---MMIITELMRGETLQRYLWS-TRPKRLDLKHSISFALDISRAMEY 178
NI+K + T ++I E +L L + L + D+ M +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 179 LHANSVIHRDLKPSNLLLT---EDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
L N ++HR++KP N++ + + KL DFG ARE DE GT ++ P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-30
Identities = 56/260 (21%), Positives = 94/260 (36%), Gaps = 63/260 (24%)
Query: 66 LQKMIGEGSYSIVYKG--FYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ IG GSY K + + K + + +++ K+ EV LL ++KH N
Sbjct: 10 VLYTIGTGSYGRCQKIRRKSDGKILVWKEL---DYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 124 ILKFVGASVQPT---MMIITELMRGETLQRYLWSTRPKRLDLKHS--ISFALDISRAMEY 178
I+++ + T + I+ E G L + +R L + ++ A++
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 179 LH-----ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGTYRWMAP 231
H ++V+HRDLKP+N+ L + VKL DFGLAR GT +M+P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 232 E--NERP---------------------------SLENL----------------SEDMV 246
E N S + L S+++
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 245
Query: 247 ALLKSCWAEDPKVRPEFAEI 266
++ RP EI
Sbjct: 246 EIITRMLNLKDYHRPSVEEI 265
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 58/271 (21%), Positives = 105/271 (38%), Gaps = 65/271 (23%)
Query: 66 LQKMIGEGSYSIVYKGF---YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
++ I G +Y PV +K + + E + E L+++ H
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH----SGDAEAQAMAMAERQFLAEVVHP 139
Query: 123 NILK---FV---GASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
+I++ FV P I+ E + G++L+R ++L + +I++ L+I A+
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPAL 195
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE---- 232
YLH+ +++ DLKP N++LTE+ Q+KL D G ++ GT + APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSR--INSFGYLYGTPGFQAPEIVRT 251
Query: 233 ---------------------------------NERPSLENLSEDMVALLKSCWAEDPKV 259
E + + LL+ DP+
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQ 311
Query: 260 RP----EFAEITITLTNILQNLRSADTPIPP 286
R E + LT +L+ + + DT +P
Sbjct: 312 RFTTAEEMSA---QLTGVLREVVAQDTGVPR 339
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 56/180 (31%), Positives = 90/180 (50%), Gaps = 34/180 (18%)
Query: 70 IGEGSYSIVYKGFY---GCEPVAVKVIQ--------PCNALAVSREHKEKFQREVTLLSK 118
IGEG+Y +VYK G E VA+K I+ P A+ RE++LL +
Sbjct: 11 IGEGTYGVVYKARNKLTG-EVVALKKIRLDTETEGVPSTAI-----------REISLLKE 58
Query: 119 MKHENILKFVGASVQPT-MMIITELMRGET-LQRYLWSTRPKRLDLKHSISFALDISRAM 176
+ H NI+K + + ++ E + L++++ ++ + L S+ + + +
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFL--HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGT--YRWMAPE 232
+ H++ V+HRDLKP NLL+ + +KLADFGLAR + T E T YR APE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR--APE 173
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 4e-29
Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 21/182 (11%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+++ +G G + V + E VA+K + +S +++E++ E+ ++ K+ H N
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERWCLEIQIMKKLNHPN 73
Query: 124 ILKFV-------GASVQPTMMIITELMRGETLQRYLWS-TRPKRLDLKHSISFALDISRA 175
++ + ++ E G L++YL L + DIS A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQ--VKLADFGLAREEVMDEMT---CEAGTYRWMA 230
+ YLH N +IHRDLKP N++L ++ K+ D G A+E E+ GT +++A
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQYLA 191
Query: 231 PE 232
PE
Sbjct: 192 PE 193
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 51/183 (27%), Positives = 88/183 (48%), Gaps = 21/183 (11%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
LQ++IG G+ ++V + E VA+K I L + ++ +E+ +S+ H N
Sbjct: 19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRIN----LEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 124 ILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHS-----ISFAL-DISRAM 176
I+ + + V+ + ++ +L+ G ++ + K I+ L ++ +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCE-----AGTYRWM 229
EYLH N IHRD+K N+LL ED V++ADFG++ D + GT WM
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 230 APE 232
APE
Sbjct: 194 APE 196
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 58/173 (33%), Positives = 92/173 (53%), Gaps = 15/173 (8%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ IG+GS+ V+KG + VA+K+I L + + E Q+E+T+LS+
Sbjct: 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 124 ILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFAL-DISRAMEYLHA 181
+ K+ G+ + II E + G + L P LD I+ L +I + ++YLH+
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQ-IATILREILKGLDYLHS 137
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
IHRD+K +N+LL+E +VKLADFG+A + + + GT WMAPE
Sbjct: 138 EKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 189
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 44/192 (22%), Positives = 84/192 (43%), Gaps = 33/192 (17%)
Query: 66 LQKMIGEGSYS-IVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HEN 123
+K++G GS +V++G + PVAVK + + + E+ LL++ H N
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRML--------IDFCDIALMEIKLLTESDDHPN 70
Query: 124 ILKFVGASVQPTMM-IITELMRGE----TLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
++++ + + I EL + + K + IS I+ + +
Sbjct: 71 VIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 179 LHANSVIHRDLKPSNLLLTEDKK------------QVKLADFGLAREEVMDE------MT 220
LH+ +IHRDLKP N+L++ + ++ ++DFGL ++ + +
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 221 CEAGTYRWMAPE 232
+GT W APE
Sbjct: 191 NPSGTSGWRAPE 202
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-29
Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 16/178 (8%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVIQP---CNALAVSREHKEKFQREVTLLSKMK 120
+ K +G G+ V F C+ VA+K+I A + + E+ +L K+
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 121 HENILKFVGASVQPTMMIITELMR-GETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
H I+K I+ ELM GE + KRL + + A++YL
Sbjct: 74 HPCIIKIKNFFDAEDYYIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 180 HANSVIHRDLKPSNLLLT--EDKKQVKLADFGLAREEVMDE---MTCEAGTYRWMAPE 232
H N +IHRDLKP N+LL+ E+ +K+ DFG ++ ++ E M GT ++APE
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGTPTYLAPE 186
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 39/182 (21%), Positives = 76/182 (41%), Gaps = 20/182 (10%)
Query: 66 LQKMIGEG--SYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121
L +IG+G V Y E V V+ I N A S E Q E+ + H
Sbjct: 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI---NLEACSNEMVTFLQGELHVSKLFNH 85
Query: 122 ENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFAL-DISRAMEYL 179
NI+ + + + ++T M + + + + ++ + +I++ L + +A++Y+
Sbjct: 86 PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELAIAYILQGVLKALDYI 144
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLA---------REEVMDEMTCEAGTYRWMA 230
H +HR +K S++L++ D +V L+ + V D W++
Sbjct: 145 HHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 231 PE 232
PE
Sbjct: 204 PE 205
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 49/179 (27%), Positives = 77/179 (43%), Gaps = 33/179 (18%)
Query: 70 IGEGSYSIVYKGFY---GCEPVAVKVIQ--------PCNALAVSREHKEKFQREVTLLSK 118
IGEGSY +V+K G + VA+K AL RE+ +L +
Sbjct: 11 IGEGSYGVVFKCRNRDTG-QIVAIKKFLESEDDPVIKKIAL-----------REIRMLKQ 58
Query: 119 MKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+KH N++ + + + ++ E T+ L + + S +A+
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCD-HTVLHEL-DRYQRGVPEHLVKSITWQTLQAVN 116
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGT--YRWMAPE 232
+ H ++ IHRD+KP N+L+T +KL DFG AR D E T YR +PE
Sbjct: 117 FCHKHNCIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPE 172
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-29
Identities = 51/177 (28%), Positives = 83/177 (46%), Gaps = 14/177 (7%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQP---CNALAVSREHKEKFQREVTLLSKMK 120
+ K +G G+ V F C+ VA+++I A + + E+ +L K+
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 121 HENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH 180
H I+K I+ ELM G L + KRL + + A++YLH
Sbjct: 199 HPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLH 256
Query: 181 ANSVIHRDLKPSNLLLTEDKK--QVKLADFGLAREEVMDE---MTCEAGTYRWMAPE 232
N +IHRDLKP N+LL+ ++ +K+ DFG ++ ++ E M GT ++APE
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGTPTYLAPE 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-29
Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 32/181 (17%)
Query: 69 MIGEGSYSIVYKGF-YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
+IG G + VYKG VA+K P ++ +E F+ E+ LS +H +++
Sbjct: 46 LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG----IEE-FETEIETLSFCRHPHLVSL 100
Query: 128 VGASVQPT-MMIITELMRGETLQRYL-----------WSTRPKRLDLKHSISFALDISRA 175
+G + M++I + M L+R+L W R + I + +R
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE-------I--CIGAARG 151
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM----TCEAGTYRWMAP 231
+ YLH ++IHRD+K N+LL ++ K+ DFG++++ + T GT ++ P
Sbjct: 152 LHYLHTRAIIHRDVKSINILL-DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDP 210
Query: 232 E 232
E
Sbjct: 211 E 211
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 33/179 (18%)
Query: 70 IGEGSYSIVYKGF--YGCEPVAVKVIQ--------PCNALAVSREHKEKFQREVTLLSKM 119
IGEG+Y V+K E VA+K ++ P +AL RE+ LL ++
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-----------REICLLKEL 58
Query: 120 KHENILKFVGASVQPT-MMIITELMRGET-LQRYLWSTRPKRLDLKHSISFALDISRAME 177
KH+NI++ + ++ E + L++Y + LD + SF + + +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFC--DQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGT--YRWMAPE 232
+ H+ +V+HRDLKP NLL+ ++KLA+FGLAR + + E T YR P+
Sbjct: 116 FCHSRNVLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPD 171
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 55/304 (18%), Positives = 106/304 (34%), Gaps = 82/304 (26%)
Query: 56 SVLVDHRSVLLQKMIGEGSYSIVY--KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREV 113
+V + + +++++ EG ++ VY + A+K + L+ E +EV
Sbjct: 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL-----LSNEEEKNRAIIQEV 76
Query: 114 TLLSKMK-HENILKFVGASVQPT---------MMIITELMRGETLQRYLWSTRPKRLDLK 163
+ K+ H NI++F A+ +++TEL +G+ ++ L
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD 136
Query: 164 HSISFALDISRAMEYLHANS--VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM----- 216
+ RA++++H +IHRDLK NLLL+ +KL DFG A
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYS 195
Query: 217 ----------DEMTCEAGTYRWMAPE----------NER--------------------- 235
+E+T T + PE E+
Sbjct: 196 WSAQRRALVEEEITR-NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
Query: 236 --------------PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSAD 281
P + +L+++ +P+ R AE+ + + R+ +
Sbjct: 255 DGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV-VHQLQEIAAARNVN 313
Query: 282 TPIP 285
P
Sbjct: 314 PKSP 317
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 54/182 (29%), Positives = 81/182 (44%), Gaps = 40/182 (21%)
Query: 70 IGEGSYSIVYKGFY--GCEPVAVKVIQ--------PCNALAVSREHKEKFQREVTLLSKM 119
+GEG+Y +VYK G VA+K I+ P A+ RE++LL ++
Sbjct: 29 VGEGTYGVVYKAKDSQG-RIVALKRIRLDAEDEGIPSTAI-----------REISLLKEL 76
Query: 120 KHENILK----FVGASVQPTMMIITELMRGET-LQRYLWSTRPKRLDLKHSISFALDISR 174
H NI+ + ++ E M E L++ L L + + R
Sbjct: 77 HHPNIVSLIDVIHSER---CLTLVFEFM--EKDLKKVL-DENKTGLQDSQIKIYLYQLLR 130
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGT--YRWMA 230
+ + H + ++HRDLKP NLL+ +KLADFGLAR + T E T YR A
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--A 187
Query: 231 PE 232
P+
Sbjct: 188 PD 189
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 3e-28
Identities = 56/179 (31%), Positives = 88/179 (49%), Gaps = 34/179 (18%)
Query: 70 IGEGSYSIVYKGFY--GCEPVAVKVIQ--------PCNALAVSREHKEKFQREVTLLSKM 119
IGEG+Y +VYK G E A+K I+ P + RE+++L ++
Sbjct: 10 IGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTI-----------REISILKEL 57
Query: 120 KHENILKFVGASVQPT-MMIITELMRGET-LQRYLWSTRPKRLDLKHSISFALDISRAME 177
KH NI+K ++++ E + + L++ L L+ + SF L + +
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHL--DQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIA 114
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGT--YRWMAPE 232
Y H V+HRDLKP NLL+ + ++K+ADFGLAR + + T E T YR AP+
Sbjct: 115 YCHDRRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APD 170
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 40/183 (21%), Positives = 80/183 (43%), Gaps = 25/183 (13%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLL 116
L++K +G G YS V++ E V VK+++P K+K +RE+ +L
Sbjct: 34 NQDDYQLVRK-LGRGKYSEVFEAINITNNEKVVVKILKP--------VKKKKIKREIKIL 84
Query: 117 SKMK-HENILKFVGASVQPTMM----IITELMRGETLQRYLWSTRPKRLDLKHSISFALD 171
++ NI+ P + + ++ + L + +
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVN-NTDFKQLY-----QTLTDYDIRFYMYE 138
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR-EEVMDEMTCEAGTYRWM- 229
I +A++Y H+ ++HRD+KP N+++ + ++++L D+GLA E + R+
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFK 197
Query: 230 APE 232
PE
Sbjct: 198 GPE 200
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 57/176 (32%), Positives = 88/176 (50%), Gaps = 24/176 (13%)
Query: 70 IGEGSYSIVYKGFY---GCEPVAVKVIQPCNALAVSREHKEKF----QREVTLLSKMKHE 122
+GEG ++ VYK + VA+K I+ L E K+ RE+ LL ++ H
Sbjct: 18 LGEGQFATVYKARDKNTN-QIVAIKKIK----LGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 123 NILKFVGASVQPT-MMIITELMRGET-LQRYLWSTRPKRLDLKHSISFALDISRAMEYLH 180
NI+ + A + + ++ + M ET L+ + L H ++ L + +EYLH
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFM--ETDLEVII-KDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGT--YRWMAPE 232
+ ++HRDLKP+NLLL + +KLADFGLA+ T + T YR APE
Sbjct: 130 QHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR--APE 182
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 44 EYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAV 101
+ E +D A L IG G+Y V K + + +AVK I+ V
Sbjct: 10 KISPEQHWDFTAEDLK------DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR----STV 59
Query: 102 SREHKEKFQREV-TLLSKMKHENILKFVGASVQPTMM-IITELMRG--ETLQRYLWSTRP 157
+ +++ ++ ++ I++F GA + I ELM + +Y++S
Sbjct: 60 DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLD 119
Query: 158 KRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216
+ + L +A+ +L N +IHRD+KPSN+LL +KL DFG++ + V
Sbjct: 120 DVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR-SGNIKLCDFGISGQLV- 177
Query: 217 DEM--TCEAGTYRWMAPE 232
D + T +AG +MAPE
Sbjct: 178 DSIAKTRDAGCRPYMAPE 195
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-28
Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 32/178 (17%)
Query: 70 IGEGSYSIVYKGFYGC--EPVAVKVIQ-------PCNALAVSREHKEKFQREVTLLSKMK 120
+GEG+Y+ VYKG VA+K I+ PC A+ REV+LL +K
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-----------REVSLLKDLK 58
Query: 121 HENILKFVGASVQPT-MMIITELMRGET-LQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
H NI+ + ++ E + + L++YL +++ + F + R + Y
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYL--DKDLKQYL-DDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGT--YRWMAPE 232
H V+HRDLKP NLL+ ++ ++KLADFGLAR E T YR P+
Sbjct: 116 CHRQKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--PPD 170
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 14/173 (8%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ +G+G++ VYK A KVI+ S E E + E+ +L+ H
Sbjct: 23 IVGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYIVEIEILATCDHPY 77
Query: 124 ILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFAL-DISRAMEYLHA 181
I+K +GA + I+ E G + + + L I + A+ +LH+
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQ-IQVVCRQMLEALNFLHS 135
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
+IHRDLK N+L+T + ++LADFG++ + + + + GT WMAPE
Sbjct: 136 KRIIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-28
Identities = 56/187 (29%), Positives = 89/187 (47%), Gaps = 17/187 (9%)
Query: 56 SVLVDHRSV---LLQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQ 110
VLVD RS + + +G+G ++ ++ E A K++ +L + +EK
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP--KSLLLKPHQREKMS 63
Query: 111 REVTLLSKMKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
E+++ + H++++ F G + ++ EL R +L R K L + +
Sbjct: 64 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYL 121
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM----TCEAGT 225
I +YLH N VIHRDLK NL L ED +VK+ DFGLA + D C GT
Sbjct: 122 RQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLC--GT 178
Query: 226 YRWMAPE 232
++APE
Sbjct: 179 PNYIAPE 185
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-28
Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 12/171 (7%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ IG GS+ VY E VA+K + + S E + +EV L K++H N
Sbjct: 58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 124 ILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFAL-DISRAMEYLHA 181
+++ G ++ ++ E G L K L I+ + + YLH+
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVE-IAAVTHGALQGLAYLHS 172
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
+++IHRD+K N+LL+E VKL DFG A M GT WMAPE
Sbjct: 173 HNMIHRDVKAGNILLSEP-GLVKLGDFGSASI--MAPANSFVGTPYWMAPE 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 17/188 (9%)
Query: 55 ASVLVDHRSV---LLQKMIGEGSYSIVYKG--FYGCEPVAVKVIQPCNALAVSREHKEKF 109
VLVD RS + + +G+G ++ ++ E A K++ +L + +EK
Sbjct: 31 PEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP--KSLLLKPHQREKM 88
Query: 110 QREVTLLSKMKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISF 168
E+++ + H++++ F G + ++ EL R +L R K L + +
Sbjct: 89 SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYY 146
Query: 169 ALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM----TCEAG 224
I +YLH N VIHRDLK NL L ED +VK+ DFGLA + D C G
Sbjct: 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLC--G 203
Query: 225 TYRWMAPE 232
T ++APE
Sbjct: 204 TPNYIAPE 211
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 54/187 (28%), Positives = 75/187 (40%), Gaps = 29/187 (15%)
Query: 66 LQKMIGEGSYSIVYKGFYGC-EPVAVKVIQPCNALAVSREHKEKFQ---------REVTL 115
+Q+ I GSY V G PVA+K + + RE+ L
Sbjct: 26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVS---DGRTVNILSDSFLCKRVLREIRL 82
Query: 116 LSKMKHENILKFVGASVQPTMM------IITELMRGET-LQRYLWSTRPKRLDLKHSISF 168
L+ H NIL V ++TELM T L + + R + +H F
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIV-ISPQHIQYF 139
Query: 169 ALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-EMTCEAGT-- 225
I + LH V+HRDL P N+LL ++ + + DF LARE+ D T
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNND-ITICDFNLAREDTADANKTHYVTHRW 198
Query: 226 YRWMAPE 232
YR APE
Sbjct: 199 YR--APE 203
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 41/185 (22%)
Query: 70 IGEGSYSIVYKGFYGC--EPVAVKVIQ-------PCNALAVSREHKEKFQREVTLLSKMK 120
+G G+Y+ VYKG VA+K ++ P A+ RE++L+ ++K
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-----------REISLMKELK 61
Query: 121 HENILK----FVGASVQPTMMIITELMRGET-LQRYL----WSTRPKRLDLKHSISFALD 171
HENI++ + + ++ E M + L++Y+ P+ L+L F
Sbjct: 62 HENIVRLYDVIHTEN---KLTLVFEFM--DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGT--YR 227
+ + + + H N ++HRDLKP NLL+ + Q+KL DFGLAR ++ + E T YR
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR 175
Query: 228 WMAPE 232
AP+
Sbjct: 176 --APD 178
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 46/172 (26%), Positives = 81/172 (47%), Gaps = 14/172 (8%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ IG+G+ VY + VA++ + + KE E+ ++ + K+ N
Sbjct: 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKKELIINEILVMRENKNPN 78
Query: 124 ILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
I+ ++ + V + ++ E + G +L + +D + + +A+E+LH+N
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
VIHRD+K N+LL D VKL DFG + + + GT WMAPE
Sbjct: 136 QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 17/176 (9%)
Query: 66 LQKMIGEGSYSIVYKGFYGCE----PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121
+ +G G S VY VA+K I E ++F+REV S++ H
Sbjct: 15 IVDKLGGGGMSTVYLAE--DTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQLSH 70
Query: 122 ENILKF--VGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
+NI+ V ++ E + G TL Y+ L + +I+F I +++
Sbjct: 71 QNIVSMIDVD-EEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHA 127
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA---GTYRWMAPE 232
H ++HRD+KP N+L+ + K +K+ DFG+A+ +T GT ++ +PE
Sbjct: 128 HDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 47/188 (25%), Positives = 77/188 (40%), Gaps = 34/188 (18%)
Query: 66 LQKMIGEGSYSIVYKGFY---GCEPVAVKVIQPCNALAVSREHKEKFQREV---TLLSKM 119
+++M G+G++ V G G VA+K + + RE+ L+ +
Sbjct: 27 VERMAGQGTFGTVQLGKEKSTG-MSVAIKKV---------IQDPRFRNRELQIMQDLAVL 76
Query: 120 KHENI--LKFVGASVQPTMM------IITELMRGETLQRYL--WSTRPKRLDLKHSISFA 169
H NI L+ ++ ++ E + +TL R + R F
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 170 LDISRAMEYLHANS--VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGT- 225
+ R++ LH S V HRD+KP N+L+ E +KL DFG A++ E +
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195
Query: 226 -YRWMAPE 232
YR APE
Sbjct: 196 YYR--APE 201
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 33/179 (18%)
Query: 70 IGEGSYSIVYKGFY---GCEPVAVKVIQ--------PCNALAVSREHKEKFQREVTLLSK 118
+GEGSY +V K G VA+K A+ RE+ LL +
Sbjct: 33 VGEGSYGMVMKCRNKDTG-RIVAIKKFLESDDDKMVKKIAM-----------REIKLLKQ 80
Query: 119 MKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
++HEN++ + + ++ E + T+ L P LD + + I +
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVD-HTILDDL-ELFPNGLDYQVVQKYLFQIINGIG 138
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGT--YRWMAPE 232
+ H++++IHRD+KP N+L+++ VKL DFG AR + E T YR APE
Sbjct: 139 FCHSHNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APE 194
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 43/198 (21%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 39 DDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPC 96
+ + V ++ +G G+ +V+K + +A K+I
Sbjct: 16 RLEAFLTQKQKVGELKDDDFE------KISELGAGNGGVVFKVSHKPSGLVMARKLIH-- 67
Query: 97 NALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMM-IITELMRGETLQRYLWST 155
L + + + RE+ +L + I+ F GA + I E M G +L + L
Sbjct: 68 --LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--K 123
Query: 156 RPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214
+ R+ + ++ + + + YL ++HRD+KPSN+L+ + ++KL DFG++ +
Sbjct: 124 KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQL 182
Query: 215 VMDEMTCEAGTYRWMAPE 232
+ GT +M+PE
Sbjct: 183 IDSMANSFVGTRSYMSPE 200
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 16/173 (9%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ + +GEGSY VYK + + VA+K + ++ +E++++ + +
Sbjct: 33 VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-------ESDLQEIIKEISIMQQCDSPH 85
Query: 124 ILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFAL-DISRAMEYLHA 181
++K+ G+ + I+ E ++ + R K L I+ L + +EYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDE-IATILQSTLKGLEYLHF 143
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
IHRD+K N+LL + KLADFG+A + + M + GT WMAPE
Sbjct: 144 MRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 195
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
IGEGS IV VAVK++ + +E EV ++ +H N
Sbjct: 49 SYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHFN 103
Query: 124 ILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
+++ + V + ++ E ++G L + RL+ + + + +A+ YLHA
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
VIHRD+K ++LLT D +VKL+DFG + + + + GT WMAPE
Sbjct: 161 GVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 211
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-27
Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 21/181 (11%)
Query: 66 LQKMIGEGSYSIVYKGFYGCE----PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121
L +++G G S V+ VAVKV++ LA +F+RE + + H
Sbjct: 16 LGEILGFGGMSEVHLAR--DLRDHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAALNH 71
Query: 122 ENILKF--VG---ASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
I+ G P I+ E + G TL+ + + K +I D +A+
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQAL 129
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEA---GTYRWMAP 231
+ H N +IHRD+KP+N++++ VK+ DFG+AR + + +T A GT ++++P
Sbjct: 130 NFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 232 E 232
E
Sbjct: 189 E 189
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 55/183 (30%), Positives = 83/183 (45%), Gaps = 30/183 (16%)
Query: 70 IGEGSYSIVYKGFY---GCEPVAVKVIQPCNALAVSREHKEKFQ----REVTLLSKMK-- 120
IG G+Y VYK G VA+K ++ + REV LL +++
Sbjct: 17 IGVGAYGTVYKARDPHSG-HFVALKSVR----VPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 121 -HENILK----FVGASV--QPTMMIITELMRGET-LQRYLWSTRPKRLDLKHSISFALDI 172
H N+++ + + + ++ E + + L+ YL P L +
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHV--DQDLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 173 SRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE-EVMDEMTCEAGT--YRWM 229
R +++LHAN ++HRDLKP N+L+T VKLADFGLAR +T T YR
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYR-- 186
Query: 230 APE 232
APE
Sbjct: 187 APE 189
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 40/187 (21%)
Query: 70 IGEGSYSIVYKGF---YGCEPVAVKVIQ--------PCNALAVSREHKEKFQREVTLLSK 118
IGEG+Y V+K G VA+K ++ P + + REV +L
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-----------REVAVLRH 67
Query: 119 MK---HENILK----FVGASV--QPTMMIITELMRGET-LQRYLWSTRPKRLDLKHSISF 168
++ H N+++ + + + ++ E + + L YL + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV--DQDLTTYLDKVPEPGVPTETIKDM 125
Query: 169 ALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE-EVMDEMTCEAGT-- 225
+ R +++LH++ V+HRDLKP N+L+T Q+KLADFGLAR +T T
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLW 184
Query: 226 YRWMAPE 232
YR APE
Sbjct: 185 YR--APE 189
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 37/185 (20%)
Query: 69 MIGEGSYSIVYKGFYGC-EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127
++G G + VYKG VAVK ++ + FQ EV ++S H N+L+
Sbjct: 37 ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ----FQTEVEMISMAVHRNLLRL 92
Query: 128 VGASVQPTM-MIITELMRGETLQRYL-----------WSTRPKRLDLKHSISFALDISRA 175
G + PT +++ M ++ L W R + I AL +R
Sbjct: 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR-------I--ALGSARG 143
Query: 176 MEYLHANS---VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM-----TCEAGTYR 227
+ YLH + +IHRD+K +N+LL E+ + + DFGLA+ +MD T GT
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAK--LMDYKDTHVTTAVRGTIG 200
Query: 228 WMAPE 232
+APE
Sbjct: 201 HIAPE 205
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 51/190 (26%), Positives = 91/190 (47%), Gaps = 20/190 (10%)
Query: 51 FDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEK 108
++ A L +G G+Y +V K + + +AVK I+ V+ + +++
Sbjct: 2 MEVKADDLEP------IMELGRGAYGVVEKMRHVPSGQIMAVKRIR----ATVNSQEQKR 51
Query: 109 FQREVT-LLSKMKHENILKFVGASVQPTMM-IITELMRGETLQRY-LWSTRPKRLDLKHS 165
++ + + + F GA + + I ELM + Y + + +
Sbjct: 52 LLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDIL 111
Query: 166 ISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE-- 222
A+ I +A+E+LH+ SVIHRD+KPSN+L+ QVK+ DFG++ V D++ +
Sbjct: 112 GKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLV-DDVAKDID 169
Query: 223 AGTYRWMAPE 232
AG +MAPE
Sbjct: 170 AGCKPYMAPE 179
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 23/183 (12%)
Query: 66 LQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
L ++IG+G +S+V + C + AVK++ + E +RE ++ +
Sbjct: 28 LCEVIGKGPFSVVRR----CINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 120 KHENILKFVGASVQPTMM-IITELMRG-----ETLQRYLWSTRPKRLDLKHSISFALDIS 173
KH +I++ + M+ ++ E M G E ++R + + + I
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR---ADAGFVYSEAVASHYMRQIL 140
Query: 174 RAMEYLHANSVIHRDLKPSNLLLT--EDKKQVKLADFGLARE--EVMDEMTCEAGTYRWM 229
A+ Y H N++IHRD+KP +LL E+ VKL FG+A + E GT +M
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 230 APE 232
APE
Sbjct: 201 APE 203
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-26
Identities = 42/222 (18%), Positives = 78/222 (35%), Gaps = 37/222 (16%)
Query: 43 EEYDNEFVFDIDASVL-------VDHRSVLLQKMIGEGSYSIVYKGFYGC-------EPV 88
Y N F + + + + V + ++GEG+++ VY+ G +
Sbjct: 39 SSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKF 98
Query: 89 AVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMM-IITELMRGET 147
+KV +P N + L +KF A + ++ EL T
Sbjct: 99 VLKVQKPANPWEFYIGTQLM-----ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 148 LQRYLWSTRP---KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLT------- 197
L + + K + ISFA+ + +E +H +IH D+KP N +L
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213
Query: 198 ---EDKKQVKLADFGLAREEVM----DEMTCEAGTYRWMAPE 232
+ + L D G + + + T + T + E
Sbjct: 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE 255
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 37/187 (19%), Positives = 81/187 (43%), Gaps = 21/187 (11%)
Query: 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVI------------QPCNALAVSREHKEKFQREV 113
+ + + +G ++ + + A+K + N + + F+ E+
Sbjct: 35 IIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 114 TLLSKMKHENILKFVGASVQPTMM-IITELMRGETLQRYL------WSTRPKRLDLKHSI 166
+++ +K+E L G + II E M +++ ++ + ++
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 167 SFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGT 225
+ + Y+H ++ HRD+KPSN+L+ ++ +VKL+DFG + V ++ GT
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN-GRVKLSDFGESEYMVDKKIKGSRGT 213
Query: 226 YRWMAPE 232
Y +M PE
Sbjct: 214 YEFMPPE 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 53/177 (29%), Positives = 90/177 (50%), Gaps = 23/177 (12%)
Query: 68 KMIGEGSYSIVYK------GFYGCEPVAVKVIQPCNALAVSREH-KEKFQREVTLLSKMK 120
++G+GS++ VY+ G VA+K+I + A+ + ++ Q EV + ++K
Sbjct: 17 NLLGKGSFAGVYRAESIHTGL----EVAIKMI---DKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 121 HENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
H +IL+ + ++ E+ + RYL R K + F I M YL
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGMLYL 128
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLA-REEVMDEM---TCEAGTYRWMAPE 232
H++ ++HRDL SNLLLT + +K+ADFGLA + ++ E C GT +++PE
Sbjct: 129 HSHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPE 182
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 17/176 (9%)
Query: 66 LQKMIGEGSYSIVYKGFYGCE----PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121
L++++G G VY+ VA+K++ L+ + + QRE +++
Sbjct: 38 LRRLVGRGGMGDVYEAE--DTVRERIVALKLMSE--TLSSDPVFRTRMQREARTAGRLQE 93
Query: 122 ENILKF--VGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
+++ G + + + L+ G L L R L +++ I A++
Sbjct: 94 PHVVPIHDFG-EIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAA 150
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA---GTYRWMAPE 232
HA HRD+KP N+L++ D L DFG+A +++T GT +MAPE
Sbjct: 151 HAAGATHRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 37/183 (20%)
Query: 70 IGEGSYSIVYKGFYGC--EPVAVKVIQ--------PCNALAVSREHKEKFQREVTLLSKM 119
+GEG+Y VYK E VA+K I+ P A+ REV+LL ++
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI-----------REVSLLKEL 90
Query: 120 KHENILKFVGASVQPT-MMIITELMRGET-LQRYLWSTRPKRLDLKHSISFALDISRAME 177
+H NI++ + +I E E L++Y+ + ++ SF + +
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYA--ENDLKKYMDKNPD--VSMRVIKSFLYQLINGVN 146
Query: 178 YLHANSVIHRDLKPSNLLLT----EDKKQVKLADFGLARE--EVMDEMTCEAGT--YRWM 229
+ H+ +HRDLKP NLLL+ + +K+ DFGLAR + + T E T YR
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR-- 204
Query: 230 APE 232
PE
Sbjct: 205 PPE 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 36/177 (20%), Positives = 80/177 (45%), Gaps = 22/177 (12%)
Query: 66 LQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
+ + +G G + IV++ C + K + V + ++E+++L+
Sbjct: 9 IAEDLGRGEFGIVHR----CVETSSKKTYMAKFV------KVKGTDQVLVKKEISILNIA 58
Query: 120 KHENILKFVGASVQPTMM-IITELMRG-ETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+H NIL + + +I E + G + +R T L+ + +S+ + A++
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQ 116
Query: 178 YLHANSVIHRDLKPSNLLL-TEDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
+LH++++ H D++P N++ T +K+ +FG AR+ + + APE
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-26
Identities = 49/178 (27%), Positives = 87/178 (48%), Gaps = 21/178 (11%)
Query: 66 LQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
+++ +G+G++S+V + C A K+I N +S +K +RE + K+
Sbjct: 10 VKEELGKGAFSVVRR----CVHKTTGLEFAAKII---NTKKLSARDFQKLEREARICRKL 62
Query: 120 KHENILKFVGASVQPTMM-IITELMR-GETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+H NI++ + + + ++ +L+ GE + + + I ++
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIA 119
Query: 178 YLHANSVIHRDLKPSNLLLTEDKK--QVKLADFGLARE-EVMDEMTCEAGTYRWMAPE 232
Y H+N ++HR+LKP NLLL K VKLADFGLA E + AGT +++PE
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 177
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-26
Identities = 50/175 (28%), Positives = 77/175 (44%), Gaps = 12/175 (6%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
++ +G G++ V+ +K I S+ E+ + E+ +L + H N
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTI----NKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 124 ILKFVGASVQPTMM-IITELMR-GETLQRYL-WSTRPKRLDLKHSISFALDISRAMEYLH 180
I+K M I+ E GE L+R + R K L + + A+ Y H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 181 ANSVIHRDLKPSNLLLT--EDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
+ V+H+DLKP N+L +K+ DFGLA DE T AGT +MAPE
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-26
Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 22/177 (12%)
Query: 66 LQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
+++G G++S V+ + A+K I + E+ +L K+
Sbjct: 13 FMEVLGSGAFSEVFL----VKQRLTGKLFALKCI-----KKSPAFRDSSLENEIAVLKKI 63
Query: 120 KHENILKFVGASVQPTMM-IITELMR-GETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
KHENI+ T ++ +L+ GE R L D I + A++
Sbjct: 64 KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI---QQVLSAVK 120
Query: 178 YLHANSVIHRDLKPSNLLL--TEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
YLH N ++HRDLKP NLL E+ ++ + DFGL++ E M+ GT ++APE
Sbjct: 121 YLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPE 177
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 52/174 (29%), Positives = 79/174 (45%), Gaps = 13/174 (7%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ M+G+GS+ V K + AVKVI N + + REV LL K+ H N
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVI---NKASAKNKDTSTILREVELLKKLDHPN 82
Query: 124 ILKFVGASVQPTMM-IITELMR-GETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
I+K + I+ EL GE + KR + + + Y+H
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 182 NSVIHRDLKPSNLLLT--EDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
++++HRDLKP N+LL E +K+ DFGL+ + M GT ++APE
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 62/199 (31%), Positives = 85/199 (42%), Gaps = 53/199 (26%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQ---------REVT 114
L+ ++GEG+Y +V + E VA+K I+P F RE+
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP-------------FDKPLFALRTLREIK 61
Query: 115 LLSKMKHENILKFVGASVQPTMM------IITELMRGET-LQRYLWSTRPKRLDLKHSIS 167
+L KHENI+ + II ELM +T L R + + L H
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVI---STQMLSDDHIQY 116
Query: 168 FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR------------EEV 215
F RA++ LH ++VIHRDLKPSNLL+ + +K+ DFGLAR
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLARIIDESAADNSEPTGQ 175
Query: 216 MDEMTCEAGT--YRWMAPE 232
M T YR APE
Sbjct: 176 QSGMVEFVATRWYR--APE 192
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 30/183 (16%)
Query: 65 LLQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK-MKH 121
L ++++G G V + F + A+K++ K ++EV +
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLL----------YDSPKARQEVDHHWQASGG 81
Query: 122 ENILKFVGA-----SVQPTMMIITELMR-GETLQRYLWSTRPKRLDLKHSISFALDISR- 174
+I+ + + ++II E M GE R +R D + A +I R
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ-----ERGDQAFTEREAAEIMRD 136
Query: 175 ---AMEYLHANSVIHRDLKPSNLLLT--EDKKQVKLADFGLAREEVMDEMTCEAGTYRWM 229
A+++LH++++ HRD+KP NLL T E +KL DFG A+E + + T ++
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYV 196
Query: 230 APE 232
APE
Sbjct: 197 APE 199
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 44/211 (20%)
Query: 47 NEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSRE 104
N FD + R + L+ +G G +V+ + VA+K I + +V
Sbjct: 3 NIHGFD------LGSRYMDLKP-LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA 55
Query: 105 HKEKFQREVTLLSKMKHENILK----FVGASVQPTMM-----------IITELMRGET-L 148
RE+ ++ ++ H+NI+K + Q T I+ E M ET L
Sbjct: 56 L-----REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDL 108
Query: 149 QRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADF 208
L L +H+ F + R ++Y+H+ +V+HRDLKP+NL + + +K+ DF
Sbjct: 109 ANVL---EQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165
Query: 209 GLAR-----EEVMDEMTCEAGT--YRWMAPE 232
GLAR ++ T YR +P
Sbjct: 166 GLARIMDPHYSHKGHLSEGLVTKWYR--SPR 194
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 38/156 (24%), Positives = 78/156 (50%), Gaps = 17/156 (10%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
++ +IG GSY V + + VA+K I + K RE+ +L+++ H++
Sbjct: 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL--RVFEDLIDCKRIL-REIAILNRLNHDH 113
Query: 124 ILKFVGASVQPTMM------IITELMRGET-LQRYLWSTRPKRLDLKHSISFALDISRAM 176
++K + + + ++ E+ ++ ++ + L H + ++ +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVY--LTELHIKTLLYNLLVGV 169
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
+Y+H+ ++HRDLKP+N L+ +D VK+ DFGLAR
Sbjct: 170 KYVHSAGILHRDLKPANCLVNQD-CSVKVCDFGLAR 204
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 20/176 (11%)
Query: 66 LQKMIGEGSYSIVYK------GFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
+ + +G+G + VY F +A+KV+ EH+ +REV + S +
Sbjct: 13 IGRPLGKGKFGNVYLAREKQSKFI----LALKVLFKAQLEKAGVEHQ--LRREVEIQSHL 66
Query: 120 KHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
+H NIL+ G T + +I E T+ R L + + D + + ++ +++ A+ Y
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 124
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA--REEVMDEMTCEAGTYRWMAPE 232
H+ VIHRD+KP NLLL ++K+ADFG + C GT ++ PE
Sbjct: 125 CHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTDLC--GTLDYLPPE 177
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 41/189 (21%)
Query: 70 IGEGSYSIVYKG--FYGCEPVAVKVIQPCNALAVSREHKEK--F----QREVTLLSKMKH 121
IG+G++ V+K + VA+K + EK F RE+ +L +KH
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV---------LMENEKEGFPITALREIKILQLLKH 75
Query: 122 ENILK---------FVGASVQPTMMIITELMRGET-LQRYLWSTRPKRLDLKHSISFALD 171
EN++ + ++ ++ + E L L S + L
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFC--EHDLAGLL-SNVLVKFTLSEIKRVMQM 132
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE------EVMDEMTCEAGT 225
+ + Y+H N ++HRD+K +N+L+T +KLADFGLAR + T T
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 226 --YRWMAPE 232
YR PE
Sbjct: 192 LWYR--PPE 198
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 49/178 (27%), Positives = 87/178 (48%), Gaps = 21/178 (11%)
Query: 66 LQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
+++ +G+G++S+V + C A K+I N +S +K +RE + K+
Sbjct: 33 VKEELGKGAFSVVRR----CVHKTTGLEFAAKII---NTKKLSARDFQKLEREARICRKL 85
Query: 120 KHENILKFVGASVQPTMM-IITELMR-GETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+H NI++ + + + ++ +L+ GE + + + I ++
Sbjct: 86 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIA 142
Query: 178 YLHANSVIHRDLKPSNLLLTEDKK--QVKLADFGLARE-EVMDEMTCEAGTYRWMAPE 232
Y H+N ++HR+LKP NLLL K VKLADFGLA E + AGT +++PE
Sbjct: 143 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 200
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-25
Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 14/177 (7%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVI----QPCNALAVSREHKEKFQREVTLLSKM 119
++++G G S+V + + C+ AVK+I + +E +E +EV +L K+
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 120 K-HENILKFVGASVQPTMM-IITELMR-GETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
H NI++ T ++ +LM+ GE T L K + + +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVI 137
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
LH +++HRDLKP N+LL +D +KL DFG + + E + GT ++APE
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 51/176 (28%), Positives = 88/176 (50%), Gaps = 13/176 (7%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVI---QPCNALAVSREHKEKFQREVTLLSKMK 120
+ +IG G S+V + + AVK++ + E +E +RE +L ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 121 -HENILKFVGASVQPTMM-IITELMR-GETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
H +I+ + + + M ++ +LMR GE T L K + S + A+
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSIMRSLLEAVS 214
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
+LHAN+++HRDLKP N+LL +D Q++L+DFG + E + GT ++APE
Sbjct: 215 FLHANNIVHRDLKPENILL-DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-25
Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 15/170 (8%)
Query: 70 IGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREV-TLLSKMKHENILK 126
+G G+ V+K + +AVK ++ + ++E ++ ++ +L I++
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMR----RSGNKEENKRILMDLDVVLKSHDCPYIVQ 88
Query: 127 FVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA-NSV 184
G + T + I ELM + + + + I +A+ YL + V
Sbjct: 89 CFGTFITNTDVFIAMELMGTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHGV 146
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM--TCEAGTYRWMAPE 232
IHRD+KPSN+LL E + Q+KL DFG++ V D+ AG +MAPE
Sbjct: 147 IHRDVKPSNILLDE-RGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPE 194
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 47/189 (24%), Positives = 89/189 (47%), Gaps = 19/189 (10%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
++ +IG GSY VY + + VA+K + + K RE+T+L+++K +
Sbjct: 30 IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN--RMFEDLIDCKRIL-REITILNRLKSDY 86
Query: 124 ILKFVGASVQPTMM------IITELMRGET-LQRYLWSTRPKRLDLKHSISFALDISRAM 176
I++ + ++ I+ E+ ++ L++ + P L +H + ++
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKT--PIFLTEEHIKTILYNLLLGE 142
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERP 236
++H + +IHRDLKP+N LL +D VK+ DFGLAR ++ E P
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCS-VKVCDFGLAR--TINSEKDTNIVNDLEENEEPGP 199
Query: 237 SLENLSEDM 245
+NL + +
Sbjct: 200 HNKNLKKQL 208
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 50/184 (27%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLL 116
+ V +G G+Y V E VA+K + K + RE+ LL
Sbjct: 22 LPKTYVSPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLS--RPFQSEIFAKRAY-RELLLL 77
Query: 117 SKMKHENILKFVGASVQPTMM-------IITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
M+HEN++ + + + ++ M LQ+ + + +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGL----KFSEEKIQYLV 132
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRW- 228
+ + ++Y+H+ V+HRDLKP NL + ED + +K+ DFGLAR EMT T RW
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLAR-HADAEMTGYVVT-RWY 189
Query: 229 MAPE 232
APE
Sbjct: 190 RAPE 193
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 45/208 (21%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 39 DDDDEEYDNEFVFDIDASVLVDHRSVL----LQKMIGEGSYSIVYKGFYGC------EPV 88
+D D+ Y++ + + V V SV + + +G G++ +V++ C
Sbjct: 24 NDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHR----CVEKATGRVF 79
Query: 89 AVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMM-IITELMRG-E 146
K I K + E+++++++ H ++ A M +I E + G E
Sbjct: 80 VAKFIN-----TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134
Query: 147 TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLL-TEDKKQVKL 205
R ++ I++ ++++H +S++H D+KP N++ T+ VK+
Sbjct: 135 LFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKI 192
Query: 206 ADFGLAREEVMDE-MTCEAGTYRWMAPE 232
DFGLA + DE + T + APE
Sbjct: 193 IDFGLATKLNPDEIVKVTTATAEFAAPE 220
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 48/192 (25%), Positives = 80/192 (41%), Gaps = 44/192 (22%)
Query: 70 IGEGSYSIVYKG----FYGCEPVAVKVIQ----PCNALAVSREHKEKFQREVTLLSKMKH 121
+G G+Y VYK + A+K I+ +A RE+ LL ++KH
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----------REIALLRELKH 77
Query: 122 ENILKFVGASVQPTMMIIT-----------ELMRGETLQRYLWSTRPKRLDLKHSISFAL 170
N++ + + ++ + + + +P +L S
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHII--KFHRASKANKKPVQLPRGMVKSLLY 135
Query: 171 DISRAMEYLHANSVIHRDLKPSNLLLTEDKK---QVKLADFGLARE-----EVMDEMTCE 222
I + YLHAN V+HRDLKP+N+L+ + +VK+AD G AR + + ++
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 223 AGT--YRWMAPE 232
T YR APE
Sbjct: 196 VVTFWYR--APE 205
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 49/215 (22%), Positives = 80/215 (37%), Gaps = 48/215 (22%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
L+ IG+GSY +V A+K++ ++ + E+ + EV L+ K+ H N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 124 ILKFVGASVQPTMM-IITELMRG------------------------------------- 145
I + + ++ EL G
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 146 -ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK-QV 203
+ K + I A+ YLH + HRD+KP N L + +K ++
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEI 209
Query: 204 KLADFGLAREEVMDE------MTCEAGTYRWMAPE 232
KL DFGL++E MT +AGT ++APE
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 62/184 (33%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLL 116
V R L +G G+Y V F VAVK + K + RE+ LL
Sbjct: 27 VPERYQNLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTY-RELRLL 82
Query: 117 SKMKHENILKFVGASVQPTMM-------IITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
MKHEN++ + + ++T LM G L + + ++L H
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTDDHVQFLI 138
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRW- 228
I R ++Y+H+ +IHRDLKPSNL + ED + +K+ DFGLAR DEMT T RW
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR-HTADEMTGYVAT-RWY 195
Query: 229 MAPE 232
APE
Sbjct: 196 RAPE 199
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 61/192 (31%), Positives = 87/192 (45%), Gaps = 46/192 (23%)
Query: 66 LQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQ---------REVT 114
IGEG+Y +V + VA+K I P F+ RE+
Sbjct: 31 NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-------------FEHQTYCQRTLREIK 77
Query: 115 LLSKMKHENILKFVGASVQPTMM------IITELMRGET-LQRYLWSTRPKRLDLKHSIS 167
+L + +HENI+ PT+ I+ +LM ET L + L + + L H
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLL---KTQHLSNDHICY 132
Query: 168 FALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR-----EEVMDEMTCE 222
F I R ++Y+H+ +V+HRDLKPSNLLL +K+ DFGLAR + +T
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEY 191
Query: 223 AGT--YRWMAPE 232
T YR APE
Sbjct: 192 VATRWYR--APE 201
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 21/183 (11%)
Query: 60 DHRSVLLQKMIGEGSYSIVYKGFYGCE------PVAVKVIQPCNALAVSREHKEKFQREV 113
+V +++G G + V+K CE +A K+I+ + KE+ + E+
Sbjct: 87 SFYTVSKTEILGGGRFGQVHK----CEETATGLKLAAKIIK-----TRGMKDKEEVKNEI 137
Query: 114 TLLSKMKHENILKFVGASVQPTMM-IITELMRG-ETLQRYLWSTRPKRLDLKHSISFALD 171
++++++ H N+++ A + ++ E + G E R + L +I F
Sbjct: 138 SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII--DESYNLTELDTILFMKQ 195
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLL-TEDKKQVKLADFGLAREEVMDE-MTCEAGTYRWM 229
I + ++H ++H DLKP N+L D KQ+K+ DFGLAR E + GT ++
Sbjct: 196 ICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFL 255
Query: 230 APE 232
APE
Sbjct: 256 APE 258
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 20/177 (11%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ +G G+Y V G VA+K + K + RE+ LL M+HEN
Sbjct: 29 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY--RPFQSELFAKRAY-RELRLLKHMRHEN 85
Query: 124 ILKFVGASVQPTMM-------IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
++ + + ++ M G L + + + ++L + + +
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDRIQFLVYQMLKGL 141
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWM-APE 232
Y+HA +IHRDLKP NL + ED + +K+ DFGLAR + EMT T RW APE
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLAR-QADSEMTGYVVT-RWYRAPE 195
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 36/197 (18%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVI---------------------QPCNALAVS 102
L+ IG+GSY +V + A+KV+
Sbjct: 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 103 REHKEKFQREVTLLSKMKHENILKFV---GASVQPTMMIITELMRGETLQRYLWSTRPKR 159
R E+ +E+ +L K+ H N++K V + + ++ EL+ + K
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKP 133
Query: 160 LDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM 219
L + + D+ + +EYLH +IHRD+KPSNLL+ ED +K+ADFG++ E +
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED-GHIKIADFGVSNEFKGSDA 192
Query: 220 ----TCEAGTYRWMAPE 232
T GT +MAPE
Sbjct: 193 LLSNTV--GTPAFMAPE 207
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 24/204 (11%), Positives = 51/204 (25%), Gaps = 38/204 (18%)
Query: 62 RSVLLQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
R + L + + G S+V+ E A+KV SR E+ +++
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTM--GAENSRSELERLHEATFAAARL 119
Query: 120 KHENILKFVGAS---------------------------VQPTMMIITELMRGETLQRY- 151
E+ + +++ + +
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFS 179
Query: 152 ---LWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADF 208
+ + R L + ++H P NL + D ++ L D
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD-GRLMLGDV 238
Query: 209 GLAREEVMDEMTCEAGTYRWMAPE 232
+ + AP
Sbjct: 239 SALWKV--GTRGPASSVPVTYAPR 260
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 54/180 (30%), Positives = 83/180 (46%), Gaps = 20/180 (11%)
Query: 66 LQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREH--KEKFQREVTLLS 117
+ + +G G ++IV K C A K I SR +E+ +REV++L
Sbjct: 16 IGEELGSGQFAIVKK----CREKSTGLEYAAKFI-KKRQSRASRRGVSREEIEREVSILR 70
Query: 118 KMKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
++ H N++ T + +I EL+ G L +L + + L + + SF I +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGV 128
Query: 177 EYLHANSVIHRDLKPSNLLL---TEDKKQVKLADFGLARE-EVMDEMTCEAGTYRWMAPE 232
YLH + H DLKP N++L +KL DFGLA E E E GT ++APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 44/213 (20%), Positives = 78/213 (36%), Gaps = 58/213 (27%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
L K +G GS+ IV + F + A+K + + RE+ ++ + H N
Sbjct: 11 LGKTLGTGSFGIVCEVFDIESGKRFALKKV---------LQDPRYKNRELDIMKVLDHVN 61
Query: 124 ILK--------------------------------FVGASVQPTMM-------IITELMR 144
I+K +I E +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV- 120
Query: 145 GETLQRYL--WSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ 202
+TL + L + + + + + + RA+ ++H+ + HRD+KP NLL+
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 203 VKLADFGLAREEVMDE-MTCEAGT--YRWMAPE 232
+KL DFG A++ + E + YR APE
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICSRFYR--APE 211
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-24
Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 15/174 (8%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
L+ IG GS+ V A K I E ++F++E+ ++ + H N
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-----EDVDRFKQEIEIMKSLDHPN 67
Query: 124 ILKFVGASVQPTMM-IITELMR-GETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
I++ T + ++ EL GE +R + + + D+ A+ Y H
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHK 124
Query: 182 NSVIHRDLKPSNLLLT--EDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
+V HRDLKP N L +KL DFGLA + M + GT +++P+
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 37/177 (20%), Positives = 77/177 (43%), Gaps = 21/177 (11%)
Query: 66 LQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
+ + +G G++ +V++ A K + KE ++E+ +S +
Sbjct: 161 IHEELGTGAFGVVHR----VTERATGNNFAAKFVM-----TPHESDKETVRKEIQTMSVL 211
Query: 120 KHENILKFVGASVQPTMM-IITELMRG-ETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+H ++ A M +I E M G E ++ ++ ++ + + + +
Sbjct: 212 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLC 269
Query: 178 YLHANSVIHRDLKPSNLLL-TEDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
++H N+ +H DLKP N++ T+ ++KL DFGL + + GT + APE
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 326
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 55/180 (30%), Positives = 83/180 (46%), Gaps = 20/180 (11%)
Query: 66 LQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREH--KEKFQREVTLLS 117
+ + +G G ++IV K C A K I SR +E+ +REV++L
Sbjct: 16 IGEELGSGQFAIVKK----CREKSTGLEYAAKFI-KKRQSRASRRGVCREEIEREVSILR 70
Query: 118 KMKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
++ H NI+ T + +I EL+ G L +L + + L + + SF I +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGV 128
Query: 177 EYLHANSVIHRDLKPSNLLL---TEDKKQVKLADFGLARE-EVMDEMTCEAGTYRWMAPE 232
YLH + H DLKP N++L +KL DFGLA E E E GT ++APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-24
Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 30/181 (16%)
Query: 66 LQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
+++ IG GSYS+ + C AVK+I + K E+ +L +
Sbjct: 26 VKEDIGVGSYSVCKR----CIHKATNMEFAVKII---------DKSKRDPTEEIEILLRY 72
Query: 120 -KHENILKFVGASVQPTMM-IITELMR-GETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
+H NI+ + ++TELM+ GE L + R K + + + I++ +
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI---LRQKFFSEREASAVLFTITKTV 129
Query: 177 EYLHANSVIHRDLKPSNLLLT---EDKKQVKLADFGLAREEVMDE--MTCEAGTYRWMAP 231
EYLHA V+HRDLKPSN+L + + +++ DFG A++ + + T ++AP
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
Query: 232 E 232
E
Sbjct: 190 E 190
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 31/184 (16%)
Query: 65 LLQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KH 121
+ +++G G V + F E A+K++ + K +REV L + +
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKML----------QDCPKARREVELHWRASQC 114
Query: 122 ENILKFVGA-----SVQPTMMIITELMRG-ETLQRYLWSTRPKRLDLKHSISFALDISR- 174
+I++ V + + ++I+ E + G E R R D + A +I +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-----DRGDQAFTEREASEIMKS 169
Query: 175 ---AMEYLHANSVIHRDLKPSNLLLTEDKK--QVKLADFGLAREEVMDE-MTCEAGTYRW 228
A++YLH+ ++ HRD+KP NLL T + +KL DFG A+E +T T +
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 229
Query: 229 MAPE 232
+APE
Sbjct: 230 VAPE 233
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 52/173 (30%), Positives = 80/173 (46%), Gaps = 11/173 (6%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ M+G+GS+ V K + AVKVI N + + REV LL K+ H N
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVI---NKASAKNKDTSTILREVELLKKLDHPN 82
Query: 124 ILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
I+K + I+ EL G L + KR + + + Y+H +
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH 140
Query: 183 SVIHRDLKPSNLLLTEDKK--QVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
+++HRDLKP N+LL +K +K+ DFGL+ + M GT ++APE
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 7e-24
Identities = 53/180 (29%), Positives = 86/180 (47%), Gaps = 20/180 (11%)
Query: 66 LQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREH--KEKFQREVTLLS 117
+ + +G G ++IV K C + A K I L+ SR +E+ +REV +L
Sbjct: 9 MGEELGSGQFAIVRK----CRQKGTGKEYAAKFI-KKRRLSSSRRGVSREEIEREVNILR 63
Query: 118 KMKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
+++H NI+ T + +I EL+ G L +L + L + F I +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGV 121
Query: 177 EYLHANSVIHRDLKPSNLLL---TEDKKQVKLADFGLARE-EVMDEMTCEAGTYRWMAPE 232
YLH+ + H DLKP N++L ++KL DFG+A + E +E GT ++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-24
Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 20/176 (11%)
Query: 66 LQKMIGEGSYSIVYK------GFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
+ + +G+G + VY F +A+KV+ EH+ +RE+ + S +
Sbjct: 18 IGRPLGKGKFGNVYLAREKQNKFI----MALKVLFKSQLEKEGVEHQ--LRREIEIQSHL 71
Query: 120 KHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
+H NIL+ + ++ E L + L + R D + S +F +++ A+ Y
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHY 129
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA--REEVMDEMTCEAGTYRWMAPE 232
H VIHRD+KP NLL+ ++K+ADFG + + C GT ++ PE
Sbjct: 130 CHERKVIHRDIKPENLLMGYK-GELKIADFGWSVHAPSLRRRTMC--GTLDYLPPE 182
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-24
Identities = 39/179 (21%), Positives = 74/179 (41%), Gaps = 18/179 (10%)
Query: 65 LLQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
L K +G G +++V + C + A K + ++ + + E+ +L
Sbjct: 32 LTSKELGRGKFAVVRQ----CISKSTGQEYAAKFL---KKRRRGQDCRAEILHEIAVLEL 84
Query: 119 MKH-ENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
K ++ + + +I E G + + + I I +
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 177 EYLHANSVIHRDLKPSNLLLT--EDKKQVKLADFGLARE-EVMDEMTCEAGTYRWMAPE 232
YLH N+++H DLKP N+LL+ +K+ DFG++R+ E+ GT ++APE
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPE 203
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
Q+++G+GS+ V + AVKVI + KE REV LL ++ H N
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 124 ILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
I+K ++ E+ G L + S KR + + + Y+H N
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKN 145
Query: 183 SVIHRDLKPSNLLLTEDKK--QVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
++HRDLKP NLLL K +++ DFGL+ + M + GT ++APE
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 54/181 (29%), Positives = 81/181 (44%), Gaps = 28/181 (15%)
Query: 65 LLQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
L K +GEGS+SI K C + AVK+I S+ + Q+E+T L
Sbjct: 14 LKDKPLGEGSFSICRK----CVHKKSNQAFAVKII--------SKRMEANTQKEITALKL 61
Query: 119 MK-HENILKFVGASVQPTMM-IITELMRG-ETLQRYLWSTRPKRLDLKHSISFALDISRA 175
+ H NI+K ++ EL+ G E +R + K + + A
Sbjct: 62 CEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK---KKKHFSETEASYIMRKLVSA 118
Query: 176 MEYLHANSVIHRDLKPSNLLLT--EDKKQVKLADFGLAREEVMD--EMTCEAGTYRWMAP 231
+ ++H V+HRDLKP NLL T D ++K+ DFG AR + D + T + AP
Sbjct: 119 VSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 232 E 232
E
Sbjct: 179 E 179
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 30/164 (18%)
Query: 65 LLQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KH 121
+ +++G G V + F E A+K++ + K +REV L + +
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKML----------QDCPKARREVELHWRASQC 70
Query: 122 ENILKFVGA-----SVQPTMMIITELMR-GETLQRYLWSTRPKRLDLKHSISFALDISR- 174
+I++ V + + ++I+ E + GE R R D + A +I +
Sbjct: 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-----DRGDQAFTEREASEIMKS 125
Query: 175 ---AMEYLHANSVIHRDLKPSNLLLT--EDKKQVKLADFGLARE 213
A++YLH+ ++ HRD+KP NLL T +KL DFG A+E
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 3e-23
Identities = 25/203 (12%), Positives = 60/203 (29%), Gaps = 35/203 (17%)
Query: 62 RSVLLQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEK----------- 108
R+++ ++G+ + E V V + + K
Sbjct: 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 132
Query: 109 ------------FQREVTLLSKMKHENILKFVGASVQPTMM---IITELMRGETLQR--- 150
F L+ + + +++ ++ + M+
Sbjct: 133 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 192
Query: 151 -YLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209
S+ K L + L + R + LH ++H L+P +++L + V L F
Sbjct: 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR-GGVFLTGFE 251
Query: 210 LAREEVMDEMTCEAGTYRWMAPE 232
+ ++ + + PE
Sbjct: 252 HLVRDGARVVSS--VSRGFEPPE 272
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 53/179 (29%), Positives = 85/179 (47%), Gaps = 22/179 (12%)
Query: 66 LQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
L + +G+G++S+V + C + A +I N +S +K +RE + +
Sbjct: 15 LFEELGKGAFSVVRR----CVKVLAGQEYAAMII---NTKKLSARDHQKLEREARICRLL 67
Query: 120 KHENILKFVGASVQPTMM-IITELMRG-ETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
KH NI++ + + +I +L+ G E + + D H I I A+
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI---QQILEAVL 124
Query: 178 YLHANSVIHRDLKPSNLLLTEDKK--QVKLADFGLAREEVMDE--MTCEAGTYRWMAPE 232
+ H V+HR+LKP NLLL K VKLADFGLA E ++ AGT +++PE
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 16/181 (8%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVI--------QPCNALAVSREHKEKFQREVTL 115
+ +G G+Y V G A+KVI + + + E+ E++L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 116 LSKMKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISR 174
L + H NI+K ++TE G L + + + D + + I
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILS 157
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKK--QVKLADFGLAREEVMDE-MTCEAGTYRWMAP 231
+ YLH ++++HRD+KP N+LL +K+ DFGL+ D + GT ++AP
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 232 E 232
E
Sbjct: 218 E 218
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 46/173 (26%), Positives = 74/173 (42%), Gaps = 11/173 (6%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
K +G G+Y V A+K+I +VS K EV +L + H N
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKII---RKTSVSTSSNSKLLEEVAVLKLLDHPN 97
Query: 124 ILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
I+K ++ E +G L + + + + + + YLH +
Sbjct: 98 IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 183 SVIHRDLKPSNLLLTEDKK--QVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
+++HRDLKP NLLL +K +K+ DFGL+ + M GT ++APE
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE 208
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-23
Identities = 45/188 (23%), Positives = 80/188 (42%), Gaps = 32/188 (17%)
Query: 65 LLQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
L + ++GEG+++ V C + AVK+I+ + + REV +L +
Sbjct: 16 LQEDVLGEGAHARVQT----CINLITSQEYAVKIIEKQ-----PGHIRSRVFREVEMLYQ 66
Query: 119 MK-HENILKFVGA-SVQPTMMIITELMR-GETLQRYLWSTRPKRLDLKHSISFALDISRA 175
+ H N+L+ + + ++ E MR G L + + + + D++ A
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI---HKRRHFNELEASVVVQDVASA 123
Query: 176 MEYLHANSVIHRDLKPSNLLLT--EDKKQVKLADFGLAR---------EEVMDEMTCEAG 224
+++LH + HRDLKP N+L VK+ DF L E+ G
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 225 TYRWMAPE 232
+ +MAPE
Sbjct: 184 SAEYMAPE 191
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-23
Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 22/181 (12%)
Query: 66 LQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREH--KEKFQREVTLLS 117
+ +G G +++V K C A K I SR +E +REV++L
Sbjct: 15 TGEELGSGQFAVVKK----CREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILK 69
Query: 118 KMKHENILKFVGASVQPTMM-IITELMRG-ETLQRYLWSTRPKRLDLKHSISFALDISRA 175
+++H N++ T + +I EL+ G E + L + + F I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNG 126
Query: 176 MEYLHANSVIHRDLKPSNLLL---TEDKKQVKLADFGLARE-EVMDEMTCEAGTYRWMAP 231
+ YLH+ + H DLKP N++L K ++K+ DFGLA + + +E GT ++AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 232 E 232
E
Sbjct: 187 E 187
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 7e-23
Identities = 52/185 (28%), Positives = 79/185 (42%), Gaps = 22/185 (11%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLL 116
V R L+ IG G+ IV + VA+K + K + RE+ L+
Sbjct: 23 VLKRYQNLKP-IGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAY-RELVLM 78
Query: 117 SKMKHENILK----FVGASVQPTMM---IITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
+ H+NI+ F I+ ELM L + + LD +
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM----ELDHERMSYLL 133
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR-EEVMDEMTCEAGTYRW 228
+ +++LH+ +IHRDLKPSN+++ D +K+ DFGLAR MT T R+
Sbjct: 134 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVT-RY 191
Query: 229 M-APE 232
APE
Sbjct: 192 YRAPE 196
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 9e-23
Identities = 52/186 (27%), Positives = 78/186 (41%), Gaps = 24/186 (12%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLL 116
V R L+ IG G+ IV + VA+K + K + RE+ L+
Sbjct: 60 VLKRYQNLKP-IGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAY-RELVLM 115
Query: 117 SKMKHENILK----FVGASVQPTMM---IITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
+ H+NI+ F ++ ELM + L LD +
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DA---NLCQVIQMELDHERMSYLL 170
Query: 170 LDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR-EEVMDEMTCEAGT--Y 226
+ +++LH+ +IHRDLKPSN+++ D +K+ DFGLAR MT T Y
Sbjct: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRYY 229
Query: 227 RWMAPE 232
R APE
Sbjct: 230 R--APE 233
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 14/173 (8%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
L K IG+G+++ V + VA+K+I + ++ +K REV ++ + H N
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKII---DKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 124 ILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
I+K + +I E G + YL R+ K + S I A++Y H
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM---TCEAGTYRWMAPE 232
++HRDLK NLLL D +K+ADFG + E + C G + APE
Sbjct: 134 RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFC--GAPPYAAPE 183
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 1e-22
Identities = 42/224 (18%), Positives = 73/224 (32%), Gaps = 60/224 (26%)
Query: 102 SREHKEKFQREVTLLSKMKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPK-R 159
S + ++ + +N + + S + I +L R E L+ ++
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 160 LDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR------- 212
+ + + I+ A+E+LH+ ++HRDLKPSN+ T D VK+ DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEE 219
Query: 213 -------EEVMDEMTCEAGTYRWMAPE------------------------------NER 235
T + GT +M+PE ER
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER 279
Query: 236 -------------PSLENLSEDMVALLKSCWAEDPKVRPEFAEI 266
+++ + P RPE +I
Sbjct: 280 VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-22
Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 17/174 (9%)
Query: 66 LQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
++ +G G+ SIVY+ +P A+KV++ K+ + E+ +L ++ H N
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPN 109
Query: 124 ILKFVGASVQPTMM-IITELMR-GETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
I+K PT + ++ EL+ GE R + D ++ I A+ YLH
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV---KQILEAVAYLHE 166
Query: 182 NSVIHRDLKPSNLLLT--EDKKQVKLADFGLARE-EVMDEMTCEAGTYRWMAPE 232
N ++HRDLKP NLL +K+ADFGL++ E M GT + APE
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 16/154 (10%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HE 122
L K +G+G+Y IV+K E VAVK I +A S + + F RE+ +L+++ HE
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF--DAFQNSTDAQRTF-REIMILTELSGHE 69
Query: 123 NILKFVGASVQPTMM---IITELMRGET-LQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
NI+ + ++ + M ET L + R L+ H + + ++Y
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVI---RANILEPVHKQYVVYQLIKVIKY 124
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212
LH+ ++HRD+KPSN+LL + VK+ADFGL+R
Sbjct: 125 LHSGGLLHRDMKPSNILLNAE-CHVKVADFGLSR 157
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-22
Identities = 36/153 (23%), Positives = 67/153 (43%), Gaps = 9/153 (5%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSR-EHKEKFQREVTLLSKMKHE 122
+ ++G G + VY G PVA+K ++ + + EV LL K+
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 123 --NILKFVGASVQPTMM-IITELMRGE-TLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
+++ + +P +I E L ++ T L + + SF + A+ +
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRH 164
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211
H V+HRD+K N+L+ ++ ++KL DFG
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-22
Identities = 41/179 (22%), Positives = 81/179 (45%), Gaps = 16/179 (8%)
Query: 65 LLQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE 122
L+ ++GEGSY V + AVK++ L + ++E+ LL +++H+
Sbjct: 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKIL-KKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 123 NILKF--VGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
N+++ V + + M ++ E + KR + + + + +EYL
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYL 125
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLA---REEVMDEM---TCEAGTYRWMAPE 232
H+ ++H+D+KP NLLLT +K++ G+A D+ + G+ + PE
Sbjct: 126 HSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQ--GSPAFQPPE 181
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 7e-22
Identities = 50/178 (28%), Positives = 74/178 (41%), Gaps = 25/178 (14%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREH--KEKFQREVTLLSKMKH 121
K IG G++ + E VAVK I R E QRE+ ++H
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYI--------ERGAAIDENVQREIINHRSLRH 75
Query: 122 ENILKF--VGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
NI++F V + PT + II E G L + R + F + + Y
Sbjct: 76 PNIVRFKEVILT--PTHLAIIMEYASGGELYERI--CNAGRFSEDEARFFFQQLLSGVSY 131
Query: 179 LHANSVIHRDLKPSNLLLTEDKK-QVKLADFGLAREEVMDEM---TCEAGTYRWMAPE 232
H+ + HRDLK N LL ++K+ DFG ++ V+ T GT ++APE
Sbjct: 132 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPE 187
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-22
Identities = 44/179 (24%), Positives = 73/179 (40%), Gaps = 17/179 (9%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSR-EHKEKFQREVTLLSKM--- 119
L ++G+G + V+ G VA+KVI L S EV LL K+
Sbjct: 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 120 -KHENILKFVGASVQPTMM-IITEL-MRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
H +++ + ++ E + + L Y+ T L S F + A+
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--TEKGPLGEGPSRCFFGQVVAAI 152
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA---REEVMDEMTCEAGTYRWMAPE 232
++ H+ V+HRD+K N+L+ + KL DFG +E + GT + PE
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FD--GTRVYSPPE 208
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-22
Identities = 50/176 (28%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
L + +GEG+Y V E VAVK++ A+ + E ++E+ + + HEN
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV----DCPENIKKEICINKMLNHEN 66
Query: 124 ILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
++KF G + + + E G L + + + F + + YLH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLA---REEVMDEM---TCEAGTYRWMAPE 232
+ HRD+KP NLLL E +K++DFGLA R + + C GT ++APE
Sbjct: 125 GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPE 177
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-21
Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 15/177 (8%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVI---QPCNALAVSREHKEKFQREVTLLSKMK 120
+G G++ V+ + V VK I + + K E+ +LS+++
Sbjct: 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 121 HENILKFVGASVQPTMM-IITEL-MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
H NI+K + ++ E G L ++ R RLD + + A+ Y
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI--DRHPRLDEPLASYIFRQLVSAVGY 145
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM---TCEAGTYRWMAPE 232
L +IHRD+K N+++ ED +KL DFG A ++ C GT + APE
Sbjct: 146 LRLKDIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKLFYTFC--GTIEYCAPE 199
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 51/175 (29%), Positives = 83/175 (47%), Gaps = 17/175 (9%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
L +G G++ V G + VAVK++ S + K +RE+ L +H +
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 124 ILKF--VGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH 180
I+K V ++ PT ++ E + G L Y+ + R++ + I A++Y H
Sbjct: 73 IIKLYQVIST--PTDFFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM---TCEAGTYRWMAPE 232
+ V+HRDLKP N+LL K+ADFGL+ E +C G+ + APE
Sbjct: 129 RHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPE 180
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 54/175 (30%), Positives = 87/175 (49%), Gaps = 18/175 (10%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+++ +GEGS+ V + + VA+K I L + + +RE++ L ++H +
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFIS--RQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 124 ILKF--VGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH 180
I+K V + PT + ++ E GE L Y+ KR+ F I A+EY H
Sbjct: 71 IIKLYDVITT--PTDIVMVIEYAGGE-LFDYI--VEKKRMTEDEGRRFFQQIICAIEYCH 125
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM---TCEAGTYRWMAPE 232
+ ++HRDLKP NLLL + VK+ADFGL+ +C G+ + APE
Sbjct: 126 RHKIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAPE 177
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 50/176 (28%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
L + +GEG+Y V E VAVK++ A+ + E ++E+ + + HEN
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV----DCPENIKKEICINKMLNHEN 66
Query: 124 ILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
++KF G + + + E G L + + + F + + YLH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLA---REEVMDEM---TCEAGTYRWMAPE 232
+ HRD+KP NLLL E +K++DFGLA R + + C GT ++APE
Sbjct: 125 GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPE 177
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 5e-21
Identities = 27/205 (13%), Positives = 61/205 (29%), Gaps = 39/205 (19%)
Query: 62 RSVLLQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVT----- 114
R+++ ++G+ + E V V ++ + EV
Sbjct: 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYF--TERPPSNAIKQMKEEVLRLRLL 135
Query: 115 --------------------LLSKMKHENILKFVGASVQPTMMIITELM-----RGETLQ 149
L+ + + +++ ++ L +T
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 150 RYL--WSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLAD 207
L S+ K L + L + R + LH ++H L+P +++L + V L
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR-GGVFLTG 254
Query: 208 FGLAREEVMDEMTCEAGTYRWMAPE 232
F + ++ + PE
Sbjct: 255 FEHLVRDGASAVSPIGRGF--APPE 277
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 5e-21
Identities = 42/176 (23%), Positives = 65/176 (36%), Gaps = 58/176 (32%)
Query: 155 TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214
L L+H I ++ +++ ME+L + IHRDL N+LL+E VK+ DFGLAR +
Sbjct: 185 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLAR-D 242
Query: 215 VMDEMTCEAGT-----YRWMAPEN------------------------------------ 233
+ + +WMAPE
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 302
Query: 234 -------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
P + + +M + CW +P RP F+E+ L N+LQ
Sbjct: 303 EEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 36/150 (24%), Positives = 62/150 (41%), Gaps = 20/150 (13%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQR 111
+ L K +G G++ V + C VAVK+++ A EH+
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRA-LMS 74
Query: 112 EVTLLSKM-KHENILKFVGASVQPT--MMIITELMRGETLQRYLWSTRPKRLDLKHSISF 168
E+ +L + H N++ +GA +P +M+I E + L YL S R + + K +
Sbjct: 75 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK---TK 131
Query: 169 ALDISRAMEYLHANSVIHRDLKPSNLLLTE 198
+ +Y+ A I DLK +T
Sbjct: 132 GARFRQGKDYVGA---IPVDLKRRLDSITS 158
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 17/175 (9%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
L +G G++ V G + VAVK++ S + K +RE+ L +H +
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILN--RQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 124 ILKF--VGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH 180
I+K V ++ P+ + ++ E + G L Y+ + RLD K S I ++Y H
Sbjct: 78 IIKLYQVIST--PSDIFMVMEYVSGGELFDYI--CKNGRLDEKESRRLFQQILSGVDYCH 133
Query: 181 ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEM---TCEAGTYRWMAPE 232
+ V+HRDLKP N+LL K+ADFGL+ E +C G+ + APE
Sbjct: 134 RHMVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPE 185
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 26/170 (15%), Positives = 55/170 (32%), Gaps = 25/170 (14%)
Query: 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCE----PVAVKVIQPCNALAVSREHKEKFQ 110
+ + + R LL G ++ VA+ + P + + ++
Sbjct: 25 GARIANGRYRLLIF-HGGVPPLQFWQAL--DTALDRQVALTFVDP--QGVLPDDVLQETL 79
Query: 111 REVTLLSKMKHENILKFVGASV------QPTMMIITELMRGETLQRYLWSTRPKRLDLKH 164
LS++ + A V + +++ E +RG +LQ +
Sbjct: 80 SRTLRLSRIDKPGV-----ARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVG 130
Query: 165 SISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214
+I ++ A + H V PS + ++ D V LA +
Sbjct: 131 AIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID-GDVVLAYPATMPDA 179
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 45/179 (25%), Positives = 78/179 (43%), Gaps = 22/179 (12%)
Query: 66 LQKMIGEGSYSIVY-------KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
K++GEGS+S V Y A+K+++ + RE ++S+
Sbjct: 34 FGKILGEGSFSTVVLARELATSREY-----AIKILE--KRHIIKENKVPYVTRERDVMSR 86
Query: 119 MKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+ H +K + + L +Y+ + D + + +I A+E
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALE 144
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA----GTYRWMAPE 232
YLH +IHRDLKP N+LL ED +++ DFG A+ + A GT ++++PE
Sbjct: 145 YLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-17
Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 27/195 (13%)
Query: 50 VFDIDASVLVDHRSVLLQKMIGEGSYSIVY-------KGFYGCEPVAVKVIQPCNALAVS 102
VFD + V DH +L + IG+GS+ V K Y A+K + V
Sbjct: 5 VFDENEDVNFDHFEIL--RAIGKGSFGKVCIVQKNDTKKMY-----AMKYMN--KQKCVE 55
Query: 103 REHKEKFQREVTLLSKMKHENI--LKFVGASVQPT--MMIITELMRGETLQRYLWSTRPK 158
R +E+ ++ ++H + L + S Q M ++ +L+ G L RY +
Sbjct: 56 RNEVRNVFKELQIMQGLEHPFLVNLWY---SFQDEEDMFMVVDLLLGGDL-RYHLQ-QNV 110
Query: 159 RLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218
+ F ++ A++YL +IHRD+KP N+LL E V + DF +A +
Sbjct: 111 HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIAAMLPRET 169
Query: 219 MTCE-AGTYRWMAPE 232
AGT +MAPE
Sbjct: 170 QITTMAGTKPYMAPE 184
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 33/167 (19%), Positives = 61/167 (36%), Gaps = 21/167 (12%)
Query: 66 LQKMIGEGSYSIVYKGF----------YGCEPVAVKV----IQPCNALAV-SREHKEKFQ 110
L+ + I+Y+ + ++K+ + N R K
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 111 REVTLLSKMKHENILKFVGASVQP---TMMIITELMRGETLQRYLWSTRPKRLDLKHSIS 167
+ L I +G V +++ L G +LQ L + L + +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQ 163
Query: 168 FALDISRAMEYLHANSVIHRDLKPSNLLL-TEDKKQVKLADFGLARE 213
A + A+E+LH N +H ++ N+ + ED+ QV LA +G A
Sbjct: 164 VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-15
Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 25/169 (14%)
Query: 66 LQKMIGEGSYSIVYKGFYGC-------EPVAVKVIQPCNALAVSREHK-------EKFQR 111
+ IG+G + +Y P VKV +P + + E K + +
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQIQ 97
Query: 112 EVTLLSKMKHENILKFVGASVQPT------MMIITELMRGETLQRYLWSTRPKRLDLKHS 165
+ K+K+ + K+ G+ + MI+ G LQ ++ KR K
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQ-KIYEANAKRFSRKTV 154
Query: 166 ISFALDISRAMEYLHANSVIHRDLKPSNLLL-TEDKKQVKLADFGLARE 213
+ +L I +EY+H + +H D+K SNLLL ++ QV L D+GLA
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 139 ITELMRGETL--QRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLL 196
+ +M G + Y +I + I +E+LH ++I+RDLKP N+LL
Sbjct: 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL 322
Query: 197 TEDKKQVKLADFGLAREEVMDEMTCE--AGTYRWMAPE 232
+D V+++D GLA E + + AGT +MAPE
Sbjct: 323 DDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 38/156 (24%), Positives = 75/156 (48%), Gaps = 17/156 (10%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ K IG G++ + G Y E VA+K ++P + A + +F +++ +
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQL-----GSGDG 66
Query: 124 ILKFVGASVQP--TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
I + M++ L G +L+ L+ + LK + A+ + MEY+H+
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL--GPSLE-DLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 182 NSVIHRDLKPSNLLL----TEDKKQVKLADFGLARE 213
++I+RD+KP N L+ + ++ + + DF LA+E
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 46/180 (25%), Positives = 88/180 (48%), Gaps = 30/180 (16%)
Query: 68 KMIGEGSYSIVY-------KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK 120
K++G+G++ V +Y A+K+++ + ++++ E +L +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYY-----AMKILR--KEVIIAKDEVAHTVTESRVLQNTR 63
Query: 121 HENI--LKFVGASVQPT--MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
H + LK+ + Q + + E G L +L +R + + + + +I A+
Sbjct: 64 HPFLTALKY---AFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSAL 118
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMT----CEAGTYRWMAPE 232
EYLH+ V++RD+K NL+L +D +K+ DFGL +E + D T C GT ++APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC--GTPEYLAPE 175
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 39/174 (22%), Positives = 67/174 (38%), Gaps = 38/174 (21%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQ--REVTLLSKM-K 120
L K IG G + ++Y F E A V+ E++E E+ ++ K
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVV--------KVEYQENGPLFSELKFYQRVAK 92
Query: 121 HENILKFVGASVQPTM--------------------MIITELMRGETLQRYLWSTRPKRL 160
+ I K++ + M++ L G LQ+
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG--TF 148
Query: 161 DLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLL-TEDKKQVKLADFGLARE 213
+ + + +EY+H N +H D+K +NLLL ++ QV LAD+GL+
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 29/81 (35%), Positives = 47/81 (58%), Gaps = 7/81 (8%)
Query: 156 RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215
+ +R D + +A +I A+ +LH +I+RDLK N+LL + KLADFG+ +E +
Sbjct: 117 KSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGI 175
Query: 216 MDEMT----CEAGTYRWMAPE 232
+ +T C GT ++APE
Sbjct: 176 CNGVTTATFC--GTPDYIAPE 194
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 29/81 (35%), Positives = 48/81 (59%), Gaps = 7/81 (8%)
Query: 156 RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215
R ++L +H+ ++ +IS A+ YLH +I+RDLK N+LL + +KL D+G+ +E +
Sbjct: 103 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGL 161
Query: 216 MDEMT----CEAGTYRWMAPE 232
T C GT ++APE
Sbjct: 162 RPGDTTSTFC--GTPNYIAPE 180
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE 198
I +LM G L +L ++ +A +I +E++H V++RDLKP+N+LL E
Sbjct: 270 ILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 327
Query: 199 DKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
V+++D GLA + + GT+ +MAPE
Sbjct: 328 H-GHVRISDLGLACDFSKKKPHASVGTHGYMAPE 360
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 38/176 (21%), Positives = 74/176 (42%), Gaps = 21/176 (11%)
Query: 68 KMIGEGSYSIVY-------KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK 120
+++G+G + V Y A K ++ R+ + E +L K+
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMY-----ACKKLE--KKRIKKRKGEAMALNEKQILEKVN 242
Query: 121 HENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
++ A + ++ LM G L+ +++ ++ +A +I +E L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMT---CEAGTYRWMAPE 232
H +++RDLKP N+LL + ++++D GLA + GT +MAPE
Sbjct: 303 HRERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPE 355
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-14
Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 21/157 (13%)
Query: 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEK----FQREVTLLSKMKH 121
L + IG GS+ +Y G I +A+ E + E + M+
Sbjct: 13 LGRKIGSGSFGDIYLGTD---------IAAGEEVAIKLECVKTKHPQLHIESKIYKMMQG 63
Query: 122 -ENILKFVGASVQP--TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
I + +M++ L G +L+ L++ ++ LK + A + +EY
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL--GPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 179 LHANSVIHRDLKPSNLLL--TEDKKQVKLADFGLARE 213
+H+ + IHRD+KP N L+ + V + DFGLA++
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-14
Identities = 28/159 (17%), Positives = 66/159 (41%), Gaps = 23/159 (14%)
Query: 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEK----FQREVTLLSKMKH 121
+ + IGEGS+ ++++G + +A+ E + + E +
Sbjct: 14 VGRRIGEGSFGVIFEGTN---------LLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAG 64
Query: 122 -ENILKFVGASVQP--TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
I + +++I L G +L+ L ++ +K A + ++
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLL--GPSLE-DLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 179 LHANSVIHRDLKPSNLLL----TEDKKQVKLADFGLARE 213
+H S+++RD+KP N L+ +++ + + DFG+ +
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 26/81 (32%), Positives = 48/81 (59%), Gaps = 7/81 (8%)
Query: 156 RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215
+ R H++ +A +I+ + +L + +I+RDLK N++L + +K+ADFG+ +E +
Sbjct: 114 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENI 172
Query: 216 MDEMT----CEAGTYRWMAPE 232
D +T C GT ++APE
Sbjct: 173 WDGVTTKTFC--GTPDYIAPE 191
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 50/229 (21%), Positives = 90/229 (39%), Gaps = 36/229 (15%)
Query: 26 DTSCPLTKACDADDDDDEEYDNEFVFDIDASVLVDHRSVL------LQKMIGEGSYSIVY 79
D + + A + ++Y +F+ + V+ L + K+IG G++S V
Sbjct: 19 DLLLGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVA 78
Query: 80 -------KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI--LKFVGA 130
Y A+K++ + R F+ E +L I L F
Sbjct: 79 VVKMKQTGQVY-----AMKIMN--KWDMLKRGEVSCFREERDVLVNGDRRWITQLHF--- 128
Query: 131 SVQPTMMI--ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRD 188
+ Q + + E G L L S +R+ + + + +I A++ +H +HRD
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187
Query: 189 LKPSNLLLTEDKKQVKLADFGLAREEVMDEMT-----CEAGTYRWMAPE 232
+KP N+LL ++LADFG + D GT +++PE
Sbjct: 188 IKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAV--GTPDYLSPE 233
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 29/81 (35%), Positives = 48/81 (59%), Gaps = 7/81 (8%)
Query: 156 RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215
R ++L +H+ ++ +IS A+ YLH +I+RDLK N+LL + +KL D+G+ +E +
Sbjct: 146 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGL 204
Query: 216 MDEMT----CEAGTYRWMAPE 232
T C GT ++APE
Sbjct: 205 RPGDTTSTFC--GTPNYIAPE 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 26/81 (32%), Positives = 48/81 (59%), Gaps = 7/81 (8%)
Query: 156 RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215
+ R H++ +A +I+ + +L + +I+RDLK N++L + +K+ADFG+ +E +
Sbjct: 435 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENI 493
Query: 216 MDEMT----CEAGTYRWMAPE 232
D +T C GT ++APE
Sbjct: 494 WDGVTTKTFC--GTPDYIAPE 512
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 6e-14
Identities = 26/81 (32%), Positives = 48/81 (59%), Gaps = 7/81 (8%)
Query: 156 RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215
+ DL + +A +I +++LH+ +++RDLK N+LL +D +K+ADFG+ +E +
Sbjct: 111 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENM 169
Query: 216 MDEMT----CEAGTYRWMAPE 232
+ + C GT ++APE
Sbjct: 170 LGDAKTNTFC--GTPDYIAPE 188
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 43/226 (19%), Positives = 86/226 (38%), Gaps = 32/226 (14%)
Query: 26 DTSCPLTKACDADDDDDEEYDNEFVFDIDASVLVDHRSVL------LQKMIGEGSYSIVY 79
D L D + + F+ ++ + + K+IG G++ V
Sbjct: 27 DGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQ 86
Query: 80 -------KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132
+ Y A+K++ + R F E +++ +++ A
Sbjct: 87 LVRHKSTRKVY-----AMKLLS--KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139
Query: 133 QPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKP 191
+ ++ E M G L + + K + + ++ A++ +H+ IHRD+KP
Sbjct: 140 DDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 196
Query: 192 SNLLLTEDKKQVKLADFGLAREEVMDEMT-----CEAGTYRWMAPE 232
N+LL + +KLADFG + + M GT +++PE
Sbjct: 197 DNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAV--GTPDYISPE 239
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 8e-14
Identities = 28/63 (44%), Positives = 37/63 (58%), Gaps = 3/63 (4%)
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA--GTYRWM 229
IS A+ +LH +I+RDLKP N++L VKL DFGL +E + D GT +M
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTIEYM 188
Query: 230 APE 232
APE
Sbjct: 189 APE 191
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 9e-14
Identities = 45/229 (19%), Positives = 88/229 (38%), Gaps = 36/229 (15%)
Query: 26 DTSCPLTKACDADDDDDEEYDNEFVFDIDASVLVDHRSVL------LQKMIGEGSYSIVY 79
D L C+ E+ E++ + L + K+IG G++ V
Sbjct: 32 DILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVA 91
Query: 80 -------KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI--LKFVGA 130
+ A+K++ + R F+ E +L + I L +
Sbjct: 92 VVKLKNADKVF-----AMKILN--KWEMLKRAETACFREERDVLVNGDSKWITTLHY--- 141
Query: 131 SVQPT--MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRD 188
+ Q + ++ + G L L S RL + + + ++ A++ +H +HRD
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200
Query: 189 LKPSNLLLTEDKKQVKLADFGLAREEVMDEMT-----CEAGTYRWMAPE 232
+KP N+L+ + ++LADFG + + D GT +++PE
Sbjct: 201 IKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAV--GTPDYISPE 246
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 28/66 (42%), Positives = 39/66 (59%), Gaps = 8/66 (12%)
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMT-----CEAGTY 226
I A+E+LH +I+RD+K N+LL + V L DFGL++E V DE C GT
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFC--GTI 224
Query: 227 RWMAPE 232
+MAP+
Sbjct: 225 EYMAPD 230
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 28/81 (34%), Positives = 45/81 (55%), Gaps = 7/81 (8%)
Query: 156 RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215
R + + +A +I+ A+ YLH+ ++++RDLKP N+LL + L DFGL +E +
Sbjct: 132 RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENI 190
Query: 216 MDEMT----CEAGTYRWMAPE 232
T C GT ++APE
Sbjct: 191 EHNSTTSTFC--GTPEYLAPE 209
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 27/63 (42%), Positives = 43/63 (68%), Gaps = 3/63 (4%)
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA--GTYRWM 229
++ A+++LH+ +I+RDLKP N+LL E+ +KL DFGL++E + E + GT +M
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 193
Query: 230 APE 232
APE
Sbjct: 194 APE 196
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 21/176 (11%)
Query: 66 LQKMIGEGSYSIVY-------KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
K +G GS+ V Y A+K++ V + E E +L
Sbjct: 45 RIKTLGTGSFGRVMLVKHKESGNHY-----AMKILD--KQKVVKLKQIEHTLNEKRILQA 97
Query: 119 MKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+ ++K + + + ++ E + G + +L R R H+ +A I E
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFE 155
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMT-CEAGTYRWMAPE 232
YLH+ +I+RDLKP NLL+ + +++ DFG A+ T C GT +APE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGRTWTLC--GTPEALAPE 208
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 44/183 (24%), Positives = 79/183 (43%), Gaps = 32/183 (17%)
Query: 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEK----FQREVTLLSKMK- 120
L + IG GS+ +Y G IQ +A+ E+ + E + ++
Sbjct: 11 LGRKIGSGSFGEIYLGTN---------IQTNEEVAIKLENVKTKHPQLLYESKIYRILQG 61
Query: 121 HENILKFVGASVQP--TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
I V+ ++++ L G +L+ L++ ++L LK + A + +E+
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL--GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 179 LHANSVIHRDLKPSNLLL--TEDKKQVKLADFGLAREEVMDEMTCE----------AGTY 226
+H+ S +HRD+KP N L+ QV + DFGLA+ + D T + GT
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-KYRDTSTHQHIPYRENKNLTGTA 177
Query: 227 RWM 229
R+
Sbjct: 178 RYA 180
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 1e-12
Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 21/176 (11%)
Query: 66 LQKMIGEGSYSIVY-------KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+ + +G GS+ V+ +Y A+KV++ + V + E E +LS
Sbjct: 10 ILRTLGTGSFGRVHLIRSRHNGRYY-----AMKVLK--KEIVVRLKQVEHTNDERLMLSI 62
Query: 119 MKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+ H I++ G + +I + + G L L + +R + +A ++ A+E
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCLALE 120
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMT-CEAGTYRWMAPE 232
YLH+ +I+RDLKP N+LL ++ +K+ DFG A+ T C GT ++APE
Sbjct: 121 YLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPDVTYTLC--GTPDYIAPE 173
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 55/246 (22%), Positives = 106/246 (43%), Gaps = 37/246 (15%)
Query: 6 VKKEGESFELSFPLFDDNTGDTSCPLTKACDADDDDDEEYDNEFVFDIDASVLVDHRSVL 65
+E E + + D + + D DN +++ S+ V
Sbjct: 92 TPEEREEWTTAIQTVADGLKKQAAA-----EMDFRSGSPSDNSGAEEMEVSLAKPKHRVT 146
Query: 66 LQ-----KMIGEGSYSIVY-------KGFYGCEPVAVKVIQPCNALAVSREHKEKFQREV 113
+ K++G+G++ V +Y A+K+++ + V+++ E
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYY-----AMKILK--KEVIVAKDEVAHTLTEN 199
Query: 114 TLLSKMKHENI--LKFVGASVQPT--MMIITELMRGETLQRYLWSTRPKRLDLKHSISFA 169
+L +H + LK+ S Q + + E G L +L +R + + +
Sbjct: 200 RVLQNSRHPFLTALKY---SFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYG 254
Query: 170 LDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEA--GTY 226
+I A++YLH+ +V++RDLK NL+L +D +K+ DFGL +E + D T + GT
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 227 RWMAPE 232
++APE
Sbjct: 314 EYLAPE 319
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 43/189 (22%), Positives = 84/189 (44%), Gaps = 38/189 (20%)
Query: 41 DDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGC------EPVAVKVIQ 94
DD++ +V + VL K+IG+GS+ V K + VA+K+++
Sbjct: 81 DDDQGS--YVQVPH-DHVAYRYEVL--KVIGKGSFGQVVK----AYDHKVHQHVALKMVR 131
Query: 95 PCNALAVSREHKEKFQR----EVTLLSKMKHE------NILKFVGASV-QPTMMIITELM 143
++++F R E+ +L ++ + N++ + + + + EL+
Sbjct: 132 ----------NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL 181
Query: 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK-Q 202
L + + + L FA I + ++ LH N +IH DLKP N+LL + +
Sbjct: 182 -SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 203 VKLADFGLA 211
+K+ DFG +
Sbjct: 241 IKVIDFGSS 249
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 41/199 (20%), Positives = 80/199 (40%), Gaps = 40/199 (20%)
Query: 39 DDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPC 96
D Y F + D R +L++K +G G +S V+ VA+K+++
Sbjct: 1 DYRPGGYHPAFKGE----PYKDARYILVRK-LGWGHFSTVWLAKDMVNNTHVAMKIVR-- 53
Query: 97 NALAVSREH-KEKFQREVTLLSKMK-----------HENILK------FVGASVQPTMMI 138
+ E + E+ LL ++ +ILK G + +++
Sbjct: 54 -----GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH-VVM 107
Query: 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLT 197
+ E++ GE L + + + L + + + ++Y+H +IH D+KP N+L+
Sbjct: 108 VFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166
Query: 198 EDKKQ-----VKLADFGLA 211
+K+AD G A
Sbjct: 167 IVDSPENLIQIKIADLGNA 185
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 7e-11
Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 40/209 (19%)
Query: 23 NTGDTSCPLTKACDADDDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGF 82
+S + D DD+ YD ++ +D + +IG+GS+ V K
Sbjct: 20 FQSMSSHKKERKVYNDGYDDDNYD--YIVKNG-EKWMDRYEID--SLIGKGSFGQVVK-- 72
Query: 83 YGC------EPVAVKVIQPCNALAVSREHKEKFQR----EVTLLSKMKHE------NILK 126
E VA+K+I+ +K+ F EV LL M I+
Sbjct: 73 --AYDRVEQEWVAIKIIK----------NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120
Query: 127 FVGASV-QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN--S 183
+ + + ++ E++ L L +T + + L + FA + A+ +L S
Sbjct: 121 LKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS 179
Query: 184 VIHRDLKPSNLLLTEDKKQ-VKLADFGLA 211
+IH DLKP N+LL K+ +K+ DFG +
Sbjct: 180 IIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 9e-11
Identities = 31/188 (16%), Positives = 57/188 (30%), Gaps = 48/188 (25%)
Query: 70 IGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHK---EKFQREVTLLSKM------- 119
IGEG + V++ PVA+K+I V+ H+ E+ E+ + ++
Sbjct: 28 IGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87
Query: 120 --KHENILKFVGASV-------------------------------QPTMMIITELMRGE 146
+ E + + I+ E G
Sbjct: 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG 147
Query: 147 TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKL 205
+ + K L + S ++ ++ A+ HRDL N+LL KL
Sbjct: 148 IDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK-KTSLKKL 203
Query: 206 ADFGLARE 213
+
Sbjct: 204 HYTLNGKS 211
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 44/202 (21%), Positives = 79/202 (39%), Gaps = 48/202 (23%)
Query: 40 DDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGF---YGCEPVAVKVIQPC 96
+DD+E V I L + ++ +GEG++ V + G VA+K+I+
Sbjct: 2 EDDKEGH--LVCRIG-DWLQERYEIV--GNLGEGTFGKVVECLDHARGKSQVALKIIR-- 54
Query: 97 NALAVSREHKEKFQR----EVTLLSKMKHE------NILKFVGA-SVQPTMMIITELMRG 145
+ K++ E+ +L K+K + + + M I EL+ G
Sbjct: 55 --------NVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-G 105
Query: 146 ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ--- 202
+ +L + L H A + A+ +LH N + H DLKP N+L + +
Sbjct: 106 KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY 165
Query: 203 ---------------VKLADFG 209
+++ADFG
Sbjct: 166 NEHKSCEEKSVKNTSIRVADFG 187
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 8e-09
Identities = 46/312 (14%), Positives = 101/312 (32%), Gaps = 72/312 (23%)
Query: 58 LVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNA--LAVSREHKEK--FQREV 113
L ++VL+ ++G G + C V+ L + + + +
Sbjct: 147 LRPAKNVLIDGVLGSGKTWVALDV---CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ 203
Query: 114 TLLSKMKHENILKFVGASVQPTMMI------ITELMRGETLQRYL------WSTRP-KRL 160
LL ++ N S + I + L++ + + L + +
Sbjct: 204 KLLYQIDP-NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF 262
Query: 161 DLKHSISFALDISR---AMEYLHANSVIHRDLKPSNLLLTEDK------KQVKLADFGLA 211
+L I L +R ++L A + H L ++ LT D+ K + L
Sbjct: 263 NLSCKI---LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP 319
Query: 212 RE-------------EVMDEMTCEAGTYRWMAPEN-ERPSLENLSEDMVALLKSCWAE-D 256
RE E + + W +N + + + L+ +++S +
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLA-----TW---DNWKHVNCDKLTT----IIESSLNVLE 367
Query: 257 PK-VRPEFAEITITLTNILQNLRSADTPIPPKLVEIV--DPKSTMNNDCMATVHAITKFN 313
P R F +++ IP L+ ++ D + + +H +
Sbjct: 368 PAEYRKMFDRLSV--------FPP-SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE 418
Query: 314 EKGKKRRSYLPS 325
++ K+ +PS
Sbjct: 419 KQPKESTISIPS 430
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-09
Identities = 33/175 (18%), Positives = 66/175 (37%), Gaps = 43/175 (24%)
Query: 67 QKMIGEGSYSIVYKGF---YGCEPVAVKVIQPCNALAVSREHKEKFQR----EVTLLSKM 119
+GEG++ V + G VAVK+++ + +++ E+ +L +
Sbjct: 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVK----------NVDRYCEAARSEIQVLEHL 68
Query: 120 KHE------NILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDI 172
++ + + I+ EL+ G + ++ L H A I
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 173 SRAMEYLHANSVIHRDLKPSNLLLTED------------------KKQVKLADFG 209
+++ +LH+N + H DLKP N+L + +K+ DFG
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 46/253 (18%), Positives = 95/253 (37%), Gaps = 42/253 (16%)
Query: 36 DADDDDDEE----YDNE--FVFDIDASVLVDHRSVLLQKMIGEGSYSIVY--KGFYGCEP 87
DDD++E Y + I L + R +++K+ G G +S V+ G +
Sbjct: 8 LGSDDDEQEDPNDYCKGGYHLVKIGD--LFNGRYHVIRKL-GWGHFSTVWLSWDIQGKKF 64
Query: 88 VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMM---------- 137
VA+KV + E E+ LL +++ + + ++
Sbjct: 65 VAMKV---VKSAEHYTETA---LDEIRLLKSVRNSDP-NDPNREMVVQLLDDFKISGVNG 117
Query: 138 ----IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPS 192
++ E++ G L +++ + + L L + + ++YLH +IH D+KP
Sbjct: 118 THICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPE 176
Query: 193 NLLLTEDKKQVKLADFGLAREEVMDE--------MTCEAGTYRWMAPENERPSLENLSED 244
N+LL+ +++ ++ + T A ++ E + E L
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236
Query: 245 MVALLKSCWAEDP 257
+ L +CW
Sbjct: 237 IADLGNACWVHKH 249
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 46/212 (21%), Positives = 83/212 (39%), Gaps = 60/212 (28%)
Query: 38 DDDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFYGC------EPVAVK 91
DDE F + +L + V+ + +G+G++ V C + AVK
Sbjct: 16 FQGDDEIVH--FSWKKG-MLLNNAFLVI--RKMGDGTFGRVLL----CQHIDNKKYYAVK 66
Query: 92 VIQPCNALAVSREHKEKFQR----EVTLLSKMKHE-----NILKFVGA-SVQPTMMIITE 141
V++ + +K+ R E +L K++++ NI+K+ G M +I E
Sbjct: 67 VVR----------NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116
Query: 142 LMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE--- 198
+ G +L + ++ + ++I +A+ YL S+ H DLKP N+LL +
Sbjct: 117 PL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYF 175
Query: 199 ---------------------DKKQVKLADFG 209
+KL DFG
Sbjct: 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 336 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.03 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.87 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.84 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.59 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.39 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.36 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.35 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.19 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.96 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.76 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.7 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.6 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.54 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.2 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.18 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.14 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.99 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.81 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.7 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 96.69 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 96.52 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 96.48 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.48 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.78 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 95.41 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 95.2 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 95.09 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 94.83 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 94.62 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 94.24 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.22 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.16 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 94.03 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 94.01 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 93.9 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 93.85 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 93.59 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 93.45 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 93.42 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 93.04 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 92.86 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 92.61 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 92.25 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 92.22 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 92.18 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 91.95 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 91.69 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 90.76 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 90.18 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 90.04 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 89.92 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 89.8 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 89.64 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 89.54 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 89.3 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 89.25 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 89.17 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 89.16 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 89.13 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 89.08 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 89.02 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 88.87 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 88.79 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 88.71 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 88.59 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 88.46 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 88.42 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 88.32 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.2 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 88.16 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 88.15 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 88.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 87.7 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 87.64 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 87.61 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 87.5 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 87.38 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 87.31 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 87.29 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 87.26 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 87.21 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 87.21 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 87.18 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 87.14 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 87.13 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 87.04 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 87.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 86.88 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 86.86 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 86.85 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 86.84 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 86.76 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 86.68 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 86.59 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 86.44 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 86.43 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 86.27 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 86.2 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 86.08 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 86.06 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 86.05 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 85.93 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 85.82 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 85.68 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 85.6 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 85.59 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 85.53 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 85.48 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 85.36 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 85.3 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 85.3 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 85.27 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 85.2 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 85.18 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 85.15 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 84.77 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 84.73 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 84.72 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 84.69 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 84.67 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 84.6 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 84.56 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 84.54 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 84.38 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 84.34 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 84.22 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 84.21 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 84.19 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 84.18 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 84.1 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 84.03 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 84.02 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 83.98 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 83.96 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 83.74 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 83.63 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 83.57 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 83.54 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 83.49 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 83.48 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 83.38 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 83.17 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 83.13 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 83.09 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 83.03 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 82.95 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 82.89 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 82.8 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 82.72 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 82.61 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 82.59 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 82.49 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 82.47 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.45 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 82.4 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 82.36 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 82.35 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 82.33 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 82.04 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 81.87 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 81.64 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 81.57 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 81.46 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 81.23 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 80.98 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 80.79 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 80.73 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 80.7 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 80.48 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 80.38 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 80.22 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 80.2 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 80.15 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=369.75 Aligned_cols=250 Identities=22% Similarity=0.255 Sum_probs=206.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+++.||+|+||+||+|++. ++.||||++.... ......+.+.+|+.+|+.++|||||++++++.+++ +||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR---MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTT---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHH---CCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 68999999999999999999986 8899999997532 24456788999999999999999999999998776 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|||||+||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+......
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC-CEEECSTTEESCCCHHH
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-CEEEcccccceeecCCc
Confidence 99999999999999777767789999999999999999999999999999999999999887 79999999998654332
Q ss_pred --ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHh-hccCCCCCCCCcccccCC
Q 019780 219 --MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQN-LRSADTPIPPKLVEIVDP 294 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~-~~~~~~~~p~~~~~~~~~ 294 (336)
..+.+||+.|||||.+.+..++.+.|+|+|++.+|++..++.|... ...+.+..+... .......+|+++.+++..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 3445799999999999999999999999999999999999998733 223333333332 223345577788899999
Q ss_pred CCCCCCccccchhhhcccccc
Q 019780 295 KSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~ 315 (336)
++..+|+.|.+..++.+..+.
T Consensus 260 ~L~~dP~~R~s~~e~l~hp~~ 280 (350)
T 4b9d_A 260 LFKRNPRDRPSVNSILEKGFI 280 (350)
T ss_dssp HTCSSGGGSCCHHHHHTSHHH
T ss_pred HccCChhHCcCHHHHhcCHHh
Confidence 999999999999988775443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=364.85 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=207.3
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.++|.+++.||+|+||+||+|++. ++.||||++.+.. .......+.+.+|+++|+.++|||||++++++.+++ +|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHH--CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 367999999999999999999986 7899999997421 122334678999999999999999999999999876 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+.....
T Consensus 109 ivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTT
T ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-CEEEEEcCCceecCCC
Confidence 999999999999999543 5799999999999999999999999999999999999999887 8999999999864322
Q ss_pred ----cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCCCCCCccccc
Q 019780 218 ----EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTPIPPKLVEIV 292 (336)
Q Consensus 218 ----~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~p~~~~~~~ 292 (336)
...+.+||+.|||||.+.+.+++.+.|+|+|++.++++..+..|... .....+..+...-......+++++.+++
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli 265 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLV 265 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHH
Confidence 23456899999999999989999999999999999999999999743 3333444444444445566788888899
Q ss_pred CCCCCCCCccccchhhhcc
Q 019780 293 DPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~ 311 (336)
..++..+|+.|.+..++..
T Consensus 266 ~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 266 EKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHSCSSGGGSTTSGGGTC
T ss_pred HHHccCCHhHCcChHHHcC
Confidence 9999999999988776543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=352.15 Aligned_cols=215 Identities=32% Similarity=0.517 Sum_probs=180.3
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..|.++.+++.+.+.||+|+||+||+|++.+ .||||+++.. ....+..+.|.+|+.+|++++|||||++++++.++
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~---~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 104 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVV---DPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD 104 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCS---SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEec---CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC
Confidence 4678899999999999999999999998865 5999999742 23456678899999999999999999999999888
Q ss_pred CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 135 TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 135 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.++||||||+||+|.++|+.. ...+++..+..|+.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~ 182 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL-TVKIGDFGLATVK 182 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE-EEEECCCSSCBC-
T ss_pred eEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC-cEEEeeccCceec
Confidence 899999999999999999643 35799999999999999999999999999999999999999886 8999999999854
Q ss_pred ccc----cccccCCcccccCCCCCC-----------------------------------------------------CC
Q 019780 215 VMD----EMTCEAGTYRWMAPENER-----------------------------------------------------PS 237 (336)
Q Consensus 215 ~~~----~~~~~~gt~~y~aPE~~~-----------------------------------------------------~~ 237 (336)
... .....+||+.|||||.+. ..
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 321 234457999999999211 11
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
+.+++.++++|+..||+.+|.+||++.+++..|+.+..
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 23466778889999999999999999999988876643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=349.94 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=203.1
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec----
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ---- 133 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---- 133 (336)
+.+.|.+.+.||+|+||+||+|.+. +..||+|++... .......+.+.+|+.+|+.++|||||++++++.+
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 100 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR---KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG---GSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchh---hCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC
Confidence 3455688889999999999999986 778999999742 2345567889999999999999999999999864
Q ss_pred -CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCCceEEecccc
Q 019780 134 -PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS--VIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 134 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
..+|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||++| ||||||||+|||++...+.+||+|||+
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred CcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcC
Confidence 2289999999999999999543 57999999999999999999999999 999999999999985334899999999
Q ss_pred ccccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHHHhhc--cCCCCCCC
Q 019780 211 AREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNILQNLR--SADTPIPP 286 (336)
Q Consensus 211 a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~~~~~--~~~~~~p~ 286 (336)
|+........+.+||+.|||||...+ .++.+.|+|+|++.+|++..++.|... .....+..+..... ......++
T Consensus 179 a~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (290)
T 3fpq_A 179 ATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp GGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred CEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCH
Confidence 98655555667789999999998865 588999999999999999999999632 22222222222111 12234567
Q ss_pred CcccccCCCCCCCCccccchhhhcccccc
Q 019780 287 KLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
++.+++...+..+|+.|.+..++.+..+.
T Consensus 258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 78889999999999999999988876544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=349.84 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=193.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
.+|++++.||+|+||+||+|++. ++.||||++.... .........+.+|+.+|+.++||||+++++++.+++ +|+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKV--LAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHH--cCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 47999999999999999999986 8899999997422 223344678999999999999999999999998776 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||+ +|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+.....
T Consensus 91 vmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-CEEECCSSCC-------
T ss_pred EEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC-CEEEeecCCCeecCCCC
Confidence 99999 67999999543 5799999999999999999999999999999999999999887 7999999999864433
Q ss_pred cccccCCcccccCCCCCCCCCC-CCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCC
Q 019780 218 EMTCEAGTYRWMAPENERPSLE-NLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~~~~~-~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~ 295 (336)
...+.+||+.|+|||.+.+..+ +.+.|+|+|++.++++..+..|...+ ....+..+..........+++++.+++...
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 246 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 2445689999999999888775 57999999999999999999986332 222333444444444456778888999999
Q ss_pred CCCCCccccchhhhcccccc
Q 019780 296 STMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~ 315 (336)
+..+|+.|.+..++.+..+.
T Consensus 247 L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp SCSSGGGSCCHHHHHHCHHH
T ss_pred ccCChhHCcCHHHHHcCccc
Confidence 99999999999998876544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=361.30 Aligned_cols=242 Identities=19% Similarity=0.172 Sum_probs=199.6
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
....+.|.+.+.||+|+||+||+|++. ++.||||+++.... ..+|+.+|+.++|||||++++++.+++
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 344578999999999999999999986 78999999974211 247999999999999999999998776
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
+|||||||+||+|.++++.. +.+++..++.++.||+.||+|||++|||||||||+|||++.++.++||+|||+|+..
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 89999999999999999544 569999999999999999999999999999999999999988757999999999864
Q ss_pred cccc-------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHHh---hccCCCC
Q 019780 215 VMDE-------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQN---LRSADTP 283 (336)
Q Consensus 215 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~~---~~~~~~~ 283 (336)
.... ....+||+.|||||.+.+.+++.+.|+|+|++.+|++..+..|....-. ..+..+... .....+.
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 281 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPS 281 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTT
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCcc
Confidence 3321 1234699999999999999999999999999999999999998533211 111222222 2234566
Q ss_pred CCCCcccccCCCCCCCCccccchhhhcc
Q 019780 284 IPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+|+++.+++...+..+|+.|++..++.+
T Consensus 282 ~s~~~~~li~~~L~~dP~~R~sa~el~~ 309 (336)
T 4g3f_A 282 CAPLTAQAIQEGLRKEPVHRASAMELRR 309 (336)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 7888889999999999999999888754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=358.29 Aligned_cols=247 Identities=26% Similarity=0.311 Sum_probs=207.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
..|.+++.||+|+||+||+|++. ++.||||++...+. ...+.+.+|+.+|+.++|||||++++++.+++ +||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-----SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56999999999999999999986 88999999974221 22456889999999999999999999998776 999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
|||||+||+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 149 vmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSS
T ss_pred EEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-CEEEecCcCceecCCCC
Confidence 9999999999999954 4599999999999999999999999999999999999999887 8999999999864332
Q ss_pred -cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhcc---CCCCCCCCccccc
Q 019780 218 -EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRS---ADTPIPPKLVEIV 292 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~---~~~~~p~~~~~~~ 292 (336)
...+.+||+.|||||.+....++.+.|+|+|++.++++..+..|...+ ..+.+..+...... ....+++++.+++
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli 304 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 304 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHH
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence 345678999999999999999999999999999999999999997443 22333333333221 1134677888899
Q ss_pred CCCCCCCCccccchhhhcccccccc
Q 019780 293 DPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
..++..+|+.|.+..++.+..+..+
T Consensus 305 ~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 305 DRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp HHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHcCCChhHCcCHHHHhcCHhhcC
Confidence 9999999999999999988665544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=357.75 Aligned_cols=249 Identities=23% Similarity=0.274 Sum_probs=199.8
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
++.++|++++.||+|+||+||+|++. ++.||||+++..... ......+.+|+.+|+.++|||||++++++.+
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK---VRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE---EEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC---hHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 45578999999999999999999873 568999999743221 1223468899999999999999999999987
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
++ +|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~ 174 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSK 174 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-CEEEESSEEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-CEEecccccce
Confidence 76 99999999999999999543 5799999999999999999999999999999999999999887 79999999998
Q ss_pred cccc--ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCCCCCCcc
Q 019780 213 EEVM--DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTPIPPKLV 289 (336)
Q Consensus 213 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~p~~~~ 289 (336)
.... ....+.+||+.|||||.+...+++.+.|+|+|++.++++..+..|... +..+.+..+.+........+|+++.
T Consensus 175 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 254 (304)
T 3ubd_A 175 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 254 (304)
T ss_dssp C-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred eccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 5432 234456899999999999999999999999999999999999999633 2333344444444445566788889
Q ss_pred cccCCCCCCCCccccc-----hhhhcccc
Q 019780 290 EIVDPKSTMNNDCMAT-----VHAITKFN 313 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~-----~~~~~~~~ 313 (336)
+++..++..+|+.|.+ ++++.+..
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp 283 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHS 283 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHTSG
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHcCc
Confidence 9999999999999976 34555433
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=350.17 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=203.2
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
.++.++|.+.+.||+|+||+||+|.+. +..||||+++. ......+.|.+|+.+|++++|||||+++++
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 83 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGV 83 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC-----CChHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 467789999999999999999999864 56799999973 234556789999999999999999999999
Q ss_pred EecCC-EEEEEEccCCCCHHHHHhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC
Q 019780 131 SVQPT-MMIITELMRGETLQRYLWST-----------RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE 198 (336)
Q Consensus 131 ~~~~~-~~lv~e~~~gg~L~~~l~~~-----------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~ 198 (336)
+.+++ .++|||||+||+|.++|+.. ....+++..++.++.||+.||+|||+++||||||||+|||++.
T Consensus 84 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~ 163 (299)
T 4asz_A 84 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 163 (299)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECC
Confidence 98765 99999999999999999653 2357999999999999999999999999999999999999998
Q ss_pred CCCceEEeccccccccccccc----cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhH-HHHHHHH
Q 019780 199 DKKQVKLADFGLAREEVMDEM----TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAE-ITITLTN 272 (336)
Q Consensus 199 ~~~~~kl~Dfg~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~-i~~~l~~ 272 (336)
++ .+||+|||+|+....... ....||+.|||||......++.+.|+|+++..+|++-. ++.|.... ..+.+..
T Consensus 164 ~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 242 (299)
T 4asz_A 164 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 242 (299)
T ss_dssp GG-CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred CC-cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 87 899999999985433321 22358999999999988899999999999999999987 67775332 1122222
Q ss_pred HHHh-hccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 273 ILQN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 273 ~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
+.+. ....+..+|+++.+++...|..+|+.|++..++...
T Consensus 243 i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~ 283 (299)
T 4asz_A 243 ITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTL 283 (299)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3222 223345678889999999999999999998887643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=350.26 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=200.9
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeE
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFV 128 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 128 (336)
...++.+++.+.+.||+|+||+||+|++. ++.||||+++. ......+.|.+|+.+|++++|||||+++
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-----~~~~~~~~f~~E~~il~~l~HpnIV~l~ 109 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDFQREAELLTMLQHQHIVRFF 109 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-----CSHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-----CCHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 34567789999999999999999999864 56799999973 2445667899999999999999999999
Q ss_pred eeEecCC-EEEEEEccCCCCHHHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCce
Q 019780 129 GASVQPT-MMIITELMRGETLQRYLWSTR-------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNL 194 (336)
Q Consensus 129 ~~~~~~~-~~lv~e~~~gg~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NI 194 (336)
+++.++. +++|||||++|+|.++++... ...+++.+++.|+.||+.||+|||+++||||||||+||
T Consensus 110 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NI 189 (329)
T 4aoj_A 110 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNC 189 (329)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred EEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhE
Confidence 9998765 999999999999999996532 24689999999999999999999999999999999999
Q ss_pred eecCCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhH-HHH
Q 019780 195 LLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAE-ITI 268 (336)
Q Consensus 195 ll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~-i~~ 268 (336)
|++.++ .+||+|||+|+...... .....||+.|||||......++...|+|+++..+|++-. ++.|.... ..+
T Consensus 190 Ll~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~ 268 (329)
T 4aoj_A 190 LVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268 (329)
T ss_dssp EEETTT-EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred EECCCC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 999886 89999999998543322 233569999999999999999999999999999999887 67775321 112
Q ss_pred HHHHHHHhh-ccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 269 TLTNILQNL-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 269 ~l~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.+..+.+.. ......+|+++.+++...|..+|+.|++..++.+.
T Consensus 269 ~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 269 AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 222333321 22335678889999999999999999998888653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=362.03 Aligned_cols=247 Identities=26% Similarity=0.310 Sum_probs=208.1
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
+.|.+++.||+|+||.||+|++. ++.||||++...+. ...+.+.+|+.+|+.++|||||++++++.+++ +||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-----SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-----hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence 56999999999999999999986 88999999974322 22456889999999999999999999998776 999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
|||||+||+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 226 VmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-CEEECCCTTCEECCSSC
T ss_pred EEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEecCccceECCCCC
Confidence 9999999999999954 4599999999999999999999999999999999999999887 7999999999864332
Q ss_pred -cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhc---cCCCCCCCCccccc
Q 019780 218 -EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLR---SADTPIPPKLVEIV 292 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~---~~~~~~p~~~~~~~ 292 (336)
...+.+||+.|||||.+....++.+.|+|+|++.++++..++.|...+ ..+.+..+..... .....+++++.+++
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli 381 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 381 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence 345667999999999999999999999999999999999999997443 2333333333322 12245677888999
Q ss_pred CCCCCCCCccccchhhhcccccccc
Q 019780 293 DPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
..++..+|+.|.+..++.+..+..+
T Consensus 382 ~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 382 DRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp HHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHcCCChhHCcCHHHHhcCHHhcC
Confidence 9999999999999999988665443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=347.53 Aligned_cols=248 Identities=21% Similarity=0.315 Sum_probs=200.6
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
+...++++.+.||+|+||+||+|.+. ++.||||+++.. ......+.|.+|+.+|++++|||||++++++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~----~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK----AEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-----CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc----cChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 45678889999999999999999863 568999999732 2334467899999999999999999999999
Q ss_pred ecCC-EEEEEEccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee
Q 019780 132 VQPT-MMIITELMRGETLQRYLWSTR--------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLL 196 (336)
Q Consensus 132 ~~~~-~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll 196 (336)
.++. +++|||||++|+|.++|+... ...+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 8765 899999999999999995432 2458999999999999999999999999999999999999
Q ss_pred cCCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHH-HH
Q 019780 197 TEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITI-TL 270 (336)
Q Consensus 197 ~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~-~l 270 (336)
+.++ .+||+|||+|+...... .....||+.|||||.+....++.+.|+|+++..+|++-. +.+|....-.. .+
T Consensus 179 ~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 179 YDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp CGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred CCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9887 89999999998643332 234569999999999888899999999999999999876 67775322111 12
Q ss_pred HHHHHh-hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 271 TNILQN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 271 ~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
..+... .......+|+++.+++...|..+|+.|++..++.+
T Consensus 258 ~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~ 299 (308)
T 4gt4_A 258 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHS 299 (308)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 222222 12233457777888999999999999999888764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=339.64 Aligned_cols=244 Identities=25% Similarity=0.299 Sum_probs=183.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC----
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT---- 135 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 135 (336)
.+|.+++.||+|+||+||+|++. ++.||||+++.. ......+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP----NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC----SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 36899999999999999999986 889999999742 23455678999999999999999999999987432
Q ss_pred ---------EEEEEEccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEE
Q 019780 136 ---------MMIITELMRGETLQRYLWSTRP-KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKL 205 (336)
Q Consensus 136 ---------~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl 205 (336)
+|+|||||+||+|.+++..... ...++..++.++.||+.||+|||++|||||||||+|||++.++ .+||
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl 159 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKV 159 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEE
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEE
Confidence 6899999999999999954322 2345677899999999999999999999999999999999887 8999
Q ss_pred ecccccccccccc--------------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh--HHHHH
Q 019780 206 ADFGLAREEVMDE--------------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA--EITIT 269 (336)
Q Consensus 206 ~Dfg~a~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~ 269 (336)
+|||+|+...... .++.+||+.|||||.+.+.+++.+.|+|+|++.+|++.. |... +....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 9999998543221 233569999999999999999999999999999998864 5422 22222
Q ss_pred HHHHHHhh-ccCCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 270 LTNILQNL-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 270 l~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
+..+.... .......++.+..++..++..+|+.|++..++.+..
T Consensus 237 ~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~ 281 (299)
T 4g31_A 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA 281 (299)
T ss_dssp HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 22222110 000011234455678888899999999888877643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=341.46 Aligned_cols=217 Identities=30% Similarity=0.535 Sum_probs=183.1
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEECC-------ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC-CceEe
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYGC-------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH-ENILK 126 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~ 126 (336)
..|.++.++|++++.||+|+||+||+|.+.+ +.||||.++.. ......+.+.+|+.+|.+++| ||||+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~----~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc----cChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 3578899999999999999999999998752 46999999732 234456789999999999975 89999
Q ss_pred eEeeEecC--CEEEEEEccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCC
Q 019780 127 FVGASVQP--TMMIITELMRGETLQRYLWSTR--------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLK 190 (336)
Q Consensus 127 ~~~~~~~~--~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDik 190 (336)
+++++.+. .+++|||||++|+|.++|+... ...+++..++.++.||+.||+|||+++|||||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK 212 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 212 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccC
Confidence 99998753 3899999999999999996532 2458999999999999999999999999999999
Q ss_pred CCceeecCCCCceEEecccccccccccc----ccccCCcccccCCC----------------------------------
Q 019780 191 PSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPE---------------------------------- 232 (336)
Q Consensus 191 p~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE---------------------------------- 232 (336)
|+|||++.++ .+||+|||+|+...... ....+||+.|||||
T Consensus 213 ~~NILl~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 213 ARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp GGGEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccceeeCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 9999999887 89999999998643322 23346899999999
Q ss_pred -------------CCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 233 -------------NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 233 -------------~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
...+.|..+++++++|+..||+.+|.+||++.++++.|+.+++.
T Consensus 292 ~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 292 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 12234556788899999999999999999999999999888765
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=338.77 Aligned_cols=248 Identities=23% Similarity=0.274 Sum_probs=194.6
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec------
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ------ 133 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------ 133 (336)
++|.+++.||+|+||+||+|++. ++.||||+++.. .......+.+.+|+.+|+.++|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNA---FDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTT---TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcc---ccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 57999999999999999999986 889999999742 2234556788999999999999999999998763
Q ss_pred -CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 -PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
+.+|+|||||+ |+|.+++. ....+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCB
T ss_pred CCEEEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC-CEEEeecceee
Confidence 24899999996 58999994 456799999999999999999999999999999999999999887 79999999998
Q ss_pred cccc------ccccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccC----
Q 019780 213 EEVM------DEMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSA---- 280 (336)
Q Consensus 213 ~~~~------~~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~---- 280 (336)
.... ....+.+||+.|+|||...+. .++.+.|+|++|+.++++..++.|... .-...+..+.......
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 5422 123456899999999987764 568999999999999999999888622 1222222222211110
Q ss_pred ---------------------------CCCCCCCcccccCCCCCCCCccccchhhhccccccc
Q 019780 281 ---------------------------DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKG 316 (336)
Q Consensus 281 ---------------------------~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (336)
.+.+++++.+++..++..+|..|.|..++.+..+-.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 349 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA 349 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence 112345566677778888888888777777654443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=354.16 Aligned_cols=244 Identities=20% Similarity=0.194 Sum_probs=198.8
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCcccc-ccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALA-VSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
+..++|.+++.||+|+||+||+|++. ++.||||++.+..... ...........++.+++.++|||||++++++.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 44578999999999999999999986 8899999997422111 11122223344566777889999999999999876
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
+|+|||||+||+|.++|... +.+++..++.++.||+.||+|||++|||||||||+|||++.+| ++||+|||+|+..
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G-~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDF 342 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC-CEEecccceeeec
Confidence 99999999999999999543 5799999999999999999999999999999999999999887 8999999999876
Q ss_pred ccccccccCCcccccCCCCCC-CCCCCCHHHHHHHHHHhhccCCCCCCCHh----HHHHHHHHHHHhhccCCCCCCCCcc
Q 019780 215 VMDEMTCEAGTYRWMAPENER-PSLENLSEDMVALLKSCWAEDPKVRPEFA----EITITLTNILQNLRSADTPIPPKLV 289 (336)
Q Consensus 215 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~di~~l~~~~l~~~p~~RP~~~----~i~~~l~~~~~~~~~~~~~~p~~~~ 289 (336)
......+.+||+.|||||.+. +..++.+.|+|+||+.++++..+..|... +.......+..........+++++.
T Consensus 343 ~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~ 422 (689)
T 3v5w_A 343 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422 (689)
T ss_dssp SSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHH
Confidence 666667788999999999885 56889999999999999999999999743 2222233333333334456778888
Q ss_pred cccCCCCCCCCccccc
Q 019780 290 EIVDPKSTMNNDCMAT 305 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~ 305 (336)
+++..++..+|..|.+
T Consensus 423 dLI~~lL~~dP~~Rl~ 438 (689)
T 3v5w_A 423 SLLEGLLQRDVNRRLG 438 (689)
T ss_dssp HHHHHHTCSCGGGCTT
T ss_pred HHHHHHccCCHhHCCC
Confidence 8999999999988865
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=323.46 Aligned_cols=162 Identities=30% Similarity=0.486 Sum_probs=134.4
Q ss_pred CceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-----CE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-----TM 136 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~ 136 (336)
++|.+.+.||+|+||+||+|.++++.||||++.. ..........|+..+..++|||||++++++.++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~------~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSS------REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECG------GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECc------cchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 5689999999999999999999999999999863 112223344566677889999999999998754 27
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCCCCceeecCCCCceEEecc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN--------SVIHRDLKPSNLLLTEDKKQVKLADF 208 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--------~ivHrDikp~NIll~~~~~~~kl~Df 208 (336)
|||||||+||+|.++++. ..+++..+..++.|++.||+|||++ +||||||||+|||++.++ ++||+||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DF 152 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred EEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeC
Confidence 999999999999999964 3589999999999999999999987 999999999999999887 8999999
Q ss_pred cccccccccc------ccccCCcccccCCCC
Q 019780 209 GLAREEVMDE------MTCEAGTYRWMAPEN 233 (336)
Q Consensus 209 g~a~~~~~~~------~~~~~gt~~y~aPE~ 233 (336)
|+|+...... ....+||+.|||||.
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~ 183 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHH
T ss_pred CCCccccCCCCceeeecccccccccccCHHH
Confidence 9998543322 123469999999993
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=324.33 Aligned_cols=190 Identities=24% Similarity=0.339 Sum_probs=162.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT 135 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 135 (336)
+.|.+.+.||+|+||+||+|+++ ++.||||.+... ....++.+|+++|+.+ +||||+++++++.+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-------~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-------SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-------SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-------cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 56999999999999999999863 568999998632 1235678999999998 5999999999998766
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
+|+||||++||+|.+++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+..
T Consensus 94 ~~~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 89999999999999999 358999999999999999999999999999999999999887558999999999743
Q ss_pred ccc------------------------------cccccCCcccccCCCCCCCCC-CCCHHHHHHHHHHhhccCCCCCCCH
Q 019780 215 VMD------------------------------EMTCEAGTYRWMAPENERPSL-ENLSEDMVALLKSCWAEDPKVRPEF 263 (336)
Q Consensus 215 ~~~------------------------------~~~~~~gt~~y~aPE~~~~~~-~~~~~di~~l~~~~l~~~p~~RP~~ 263 (336)
... ..++.+||+.|+|||.+.+.+ ++.+.|+|++++.++++..++.|.+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 211 123457999999999887654 7899999999999999999888863
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=338.93 Aligned_cols=246 Identities=20% Similarity=0.279 Sum_probs=202.7
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+++.||+|+||.||+|.+. ++.||+|++... .....+.+.+|+.+|+.++||||+++++++.++. +|+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999986 889999999742 2344677899999999999999999999999876 999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-CCceEEeccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED-KKQVKLADFGLAREEVMD 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~-~~~~kl~Dfg~a~~~~~~ 217 (336)
|||||+||+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ .+.+||+|||+|+.....
T Consensus 232 v~E~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 232 IYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EEECCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EEeecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999999999943 33579999999999999999999999999999999999999854 247999999999865443
Q ss_pred -cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCC----CCCCCCcccc
Q 019780 218 -EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSAD----TPIPPKLVEI 291 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~----~~~p~~~~~~ 291 (336)
.....+||+.|||||.+.+.+++.+.|+|+|++.++++..+..|.... ....+..+........ ..+++++.++
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 345568999999999999999999999999999999999998886332 2222333332211111 3466777888
Q ss_pred cCCCCCCCCccccchhhhcccc
Q 019780 292 VDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
+..++..+|..|.+..++.+..
T Consensus 391 i~~~L~~dp~~R~t~~e~l~Hp 412 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALEHP 412 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHHST
T ss_pred HHHHccCChhHCcCHHHHhcCc
Confidence 8899999999998888776543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=301.80 Aligned_cols=248 Identities=23% Similarity=0.262 Sum_probs=199.5
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
..+|.+.+.||+|+||.||+|.+. ++.||||++... .........+.+|+.+|+.++||||+++++++.+.. .|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKT---QLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG---GSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhh---cCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 357999999999999999999985 889999999742 224556778999999999999999999999998765 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||++||+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC-CEEEeeccCceecCCC
Confidence 999999999999999544 5699999999999999999999999999999999999999887 7999999999754333
Q ss_pred -cccccCCcccccCCCCCCCCCCC-CHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhccCCCCCCCCcccccCC
Q 019780 218 -EMTCEAGTYRWMAPENERPSLEN-LSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRSADTPIPPKLVEIVDP 294 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~~~-~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~~~~~~p~~~~~~~~~ 294 (336)
.....+||+.|+|||......+. ...|+|+|++.++++-.+..|....- ......+..........+++++.+++..
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 247 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKR 247 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 34556799999999988776654 68999999999999888888753221 2222222222222334456667777777
Q ss_pred CCCCCCccccchhhhccccc
Q 019780 295 KSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~ 314 (336)
.+..+|..|++..++.+..+
T Consensus 248 ~L~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 248 FLVLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp HCCSSTTTSCCHHHHTTCTT
T ss_pred HCCCChhHCcCHHHHhcCHh
Confidence 77888888887777766443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=303.29 Aligned_cols=247 Identities=19% Similarity=0.228 Sum_probs=201.2
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
..++|.+++.||+|+||+||+|++. ++.||||+++.. ..........+.+|+.+|+.++||||+++++++.+.. .
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE--VIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHH--HhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence 4578999999999999999999986 789999999732 1112234567889999999999999999999998766 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++....
T Consensus 81 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC-CEEEeeccchhhccc
Confidence 9999999999999999543 5689999999999999999999999999999999999999887 899999999985322
Q ss_pred --ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccC
Q 019780 217 --DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVD 293 (336)
Q Consensus 217 --~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~ 293 (336)
......+||+.|+|||......++.+.|+|+|++.++++..+..|.... .......+..........+++++.+++.
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 237 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 2344567999999999999888999999999999999998888886432 2222333333333344556777888888
Q ss_pred CCCCCCCcccc-----chhhhcc
Q 019780 294 PKSTMNNDCMA-----TVHAITK 311 (336)
Q Consensus 294 ~~~~~~~~~~~-----~~~~~~~ 311 (336)
.++..+|..|. +..++.+
T Consensus 238 ~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 238 GLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHhhcCHHHhcCCCCCCHHHHHc
Confidence 88888888886 5665554
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=290.23 Aligned_cols=216 Identities=29% Similarity=0.470 Sum_probs=181.1
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..+..++|.+++.||+|+||+||+|.+. +..||+|++.. ......+.+.+|+.+++.++||||+++++++.++
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 4566789999999999999999999986 78899998852 2456678899999999999999999999998876
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. .++||||++||+|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~ 157 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK-NVVVADFGLARL 157 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS-CEEECCCTTCEE
T ss_pred CeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC-CEEEeeccccee
Confidence 5 89999999999999999653 45699999999999999999999999999999999999999876 799999999975
Q ss_pred cccccc----------------cccCCcccccCCCCCCCCCCCCHH----------------------------------
Q 019780 214 EVMDEM----------------TCEAGTYRWMAPENERPSLENLSE---------------------------------- 243 (336)
Q Consensus 214 ~~~~~~----------------~~~~gt~~y~aPE~~~~~~~~~~~---------------------------------- 243 (336)
...... ....||+.|+|||.......+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~ 237 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence 322211 145699999999954444444444
Q ss_pred -------------HHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 244 -------------DMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 244 -------------di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
.+.+|+..||+.+|.+||++.++++.|+.+...+..
T Consensus 238 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 238 GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 455577789999999999999999999988876554
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=305.07 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=203.5
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..+...+|.+++.||+|+||.||+|.+. ++.||+|++... ..........+.+|+.+|+.++||||+++++++.+.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~--~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQ--KCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehh--hcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3455688999999999999999999986 678999999732 111223456788999999999999999999999876
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. .|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~ 164 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVHITDFNIAAM 164 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC-CEEEeccceeee
Confidence 5 8999999999999999943 46799999999999999999999999999999999999999887 899999999986
Q ss_pred cccc-cccccCCcccccCCCCCCC---CCCCCHHHHHHHHHHhhccCCCCCCCH----hHHHHHHHHHHHhhccCCCCCC
Q 019780 214 EVMD-EMTCEAGTYRWMAPENERP---SLENLSEDMVALLKSCWAEDPKVRPEF----AEITITLTNILQNLRSADTPIP 285 (336)
Q Consensus 214 ~~~~-~~~~~~gt~~y~aPE~~~~---~~~~~~~di~~l~~~~l~~~p~~RP~~----~~i~~~l~~~~~~~~~~~~~~p 285 (336)
.... .....+||+.|+|||.... ..++.+.|+|+|++.+|++..+..|.. ......+..+..........++
T Consensus 165 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s 244 (384)
T 4fr4_A 165 LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244 (384)
T ss_dssp CCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC
Confidence 4332 3455679999999998763 457889999999999999988888863 2233333334444444455677
Q ss_pred CCcccccCCCCCCCCccccc-hhhhcc
Q 019780 286 PKLVEIVDPKSTMNNDCMAT-VHAITK 311 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~-~~~~~~ 311 (336)
+++..++..++..+|+.|.+ ..++.+
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 78888999999999999976 555544
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=305.71 Aligned_cols=245 Identities=23% Similarity=0.251 Sum_probs=194.6
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEec
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQ 133 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 133 (336)
..+..++|.+.+.||+|+||.||+|++. ++.||||+++.. ..........+.+|..++..+ +||||+++++++.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~--~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~ 95 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKD--VILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT 95 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH--HHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHH--HhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe
Confidence 3455678999999999999999999986 789999999731 112333456788999999988 69999999999987
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
.. .|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-~ikL~DFG~a~ 172 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCK 172 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-CEEEcccccee
Confidence 76 89999999999999999543 5699999999999999999999999999999999999999887 89999999998
Q ss_pred ccccc--cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcc
Q 019780 213 EEVMD--EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLV 289 (336)
Q Consensus 213 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~ 289 (336)
..... .....+||+.|+|||......++.+.|+|+|++.++++..+..|...+ ....+..+..........+++++.
T Consensus 173 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 252 (353)
T 3txo_A 173 EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDAT 252 (353)
T ss_dssp CSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred ecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 53322 234567999999999888888899999999999999998888886332 223333444443334455677788
Q ss_pred cccCCCCCCCCccccch
Q 019780 290 EIVDPKSTMNNDCMATV 306 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~ 306 (336)
+++..++..+|..|.+.
T Consensus 253 ~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGS 269 (353)
T ss_dssp HHHHHHTCSSGGGSTTS
T ss_pred HHHHHHhhhCHHHccCC
Confidence 88888888888888765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=297.89 Aligned_cols=247 Identities=21% Similarity=0.261 Sum_probs=200.3
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
...+|.+.+.||+|+||.||+|++. ++.||+|+++.. ........+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKE--IVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence 3478999999999999999999986 789999999731 1112234567889999999999999999999998775 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 82 ~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS
T ss_pred EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC-CEEEeecCcceecCC
Confidence 999999999999999954 35699999999999999999999999999999999999999887 899999999986432
Q ss_pred ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCCCCCCcccccCCC
Q 019780 217 DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 217 ~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~ 295 (336)
.....+||+.|+|||......++.+.|+|+|++.++++..+..|... +....+..+..........+++++.+++..+
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l 237 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 237 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 33456799999999999888899999999999999999888888632 2223334444433333455667777888888
Q ss_pred CCCCCcccc-----chhhhccc
Q 019780 296 STMNNDCMA-----TVHAITKF 312 (336)
Q Consensus 296 ~~~~~~~~~-----~~~~~~~~ 312 (336)
+..+|..|. +..++.+.
T Consensus 238 L~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 238 ITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTS
T ss_pred hccCHHHcCCCcCCCHHHHhcC
Confidence 888888776 55555543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=305.24 Aligned_cols=245 Identities=22% Similarity=0.259 Sum_probs=196.9
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEec
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQ 133 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 133 (336)
..+..++|.+++.||+|+||.||+|++. ++.||||+++.. ..........+.+|..++..+ +||||+++++++.+
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~--~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~ 124 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKE--LVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT 124 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGG--GTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhh--hccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE
Confidence 3456689999999999999999999986 678999999842 222334456688999999887 79999999999987
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
.. .|+||||++||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+|+
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFGla~ 201 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCK 201 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred CCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-CEEEeecceee
Confidence 76 89999999999999999543 5699999999999999999999999999999999999999887 89999999998
Q ss_pred ccc--cccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh---------H-HHHHHHHHHHhhccC
Q 019780 213 EEV--MDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA---------E-ITITLTNILQNLRSA 280 (336)
Q Consensus 213 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~---------~-i~~~l~~~~~~~~~~ 280 (336)
... .....+.+||+.|+|||......++.+.|+|+|++.++++..+..|... . .......+.......
T Consensus 202 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 281 (396)
T 4dc2_A 202 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 281 (396)
T ss_dssp CCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC
T ss_pred ecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC
Confidence 532 2234556799999999999999999999999999999999888888621 0 111222233333334
Q ss_pred CCCCCCCcccccCCCCCCCCccccch
Q 019780 281 DTPIPPKLVEIVDPKSTMNNDCMATV 306 (336)
Q Consensus 281 ~~~~p~~~~~~~~~~~~~~~~~~~~~ 306 (336)
...+++++.+++..++..+|..|.+.
T Consensus 282 p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 282 PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 45567777888888888888888663
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=297.04 Aligned_cols=243 Identities=22% Similarity=0.268 Sum_probs=197.7
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 135 (336)
+...+|.+.+.||+|+||.||+|++. ++.||||+++.. ..........+.+|..++..+ +||||+++++++.+..
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKE--LVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGG--GSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhH--HhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 34578999999999999999999986 788999999842 223455677889999999988 7999999999998765
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEG 160 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCGGGCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEEeccccccc
Confidence 89999999999999999543 4699999999999999999999999999999999999999887 8999999999853
Q ss_pred cc--ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh---------H-HHHHHHHHHHhhccCCC
Q 019780 215 VM--DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA---------E-ITITLTNILQNLRSADT 282 (336)
Q Consensus 215 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~---------~-i~~~l~~~~~~~~~~~~ 282 (336)
.. ......+||+.|+|||......++.+.|+|+|++.++++..+..|... . .......+.........
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 240 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 240 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT
T ss_pred cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC
Confidence 22 234456799999999999888899999999999999999888888632 1 11112222233233344
Q ss_pred CCCCCcccccCCCCCCCCccccch
Q 019780 283 PIPPKLVEIVDPKSTMNNDCMATV 306 (336)
Q Consensus 283 ~~p~~~~~~~~~~~~~~~~~~~~~ 306 (336)
.+++++.+++..++..+|..|.+.
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCC
Confidence 566677788888888888888663
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=294.87 Aligned_cols=219 Identities=29% Similarity=0.495 Sum_probs=180.8
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC---------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCce
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG---------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENI 124 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI 124 (336)
..+.+..++|.+++.||+|+||.||+|.+. +..||||+++.. ......+.+.+|+.+|+.+ +||||
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnI 149 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNI 149 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT----CBHHHHHHHHHHHHHHHHSCCCTTB
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC----cCHHHHHHHHHHHHHHHHhcCCCCE
Confidence 345677789999999999999999999863 346999999732 2455677899999999999 89999
Q ss_pred EeeEeeEecCC-EEEEEEccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 019780 125 LKFVGASVQPT-MMIITELMRGETLQRYLWSTR--------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDL 189 (336)
Q Consensus 125 v~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDi 189 (336)
+++++++.+.. .|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||
T Consensus 150 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 229 (370)
T 2psq_A 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 229 (370)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred eeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 99999988765 899999999999999996543 235889999999999999999999999999999
Q ss_pred CCCceeecCCCCceEEecccccccccccc----ccccCCcccccCCCCC-------------------------------
Q 019780 190 KPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENE------------------------------- 234 (336)
Q Consensus 190 kp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~------------------------------- 234 (336)
||+|||++.++ .+||+|||+++...... .....+|+.|+|||..
T Consensus 230 kp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 230 AARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp CGGGEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred chhhEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999887 79999999998543221 2233577899999921
Q ss_pred ---------------CCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhc
Q 019780 235 ---------------RPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR 278 (336)
Q Consensus 235 ---------------~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~ 278 (336)
...+..++.+++.|+..||+.+|.+||++.++++.|+.+.....
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 309 IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp CCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 12234566788888899999999999999999999988876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=300.22 Aligned_cols=249 Identities=20% Similarity=0.259 Sum_probs=198.4
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQP 134 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 134 (336)
.+..++|.+.+.||+|+||.||+|++. ++.||||+++... .........+..|..++..+ +||||+++++++.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV--VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHH--hhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 355688999999999999999999986 7889999997421 11123456678899999876 899999999999876
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. .|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++.
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~ 167 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKE 167 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-CEEEeEChhhhh
Confidence 5 89999999999999999543 5699999999999999999999999999999999999999887 899999999985
Q ss_pred ccc--ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCccc
Q 019780 214 EVM--DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVE 290 (336)
Q Consensus 214 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~ 290 (336)
... ......+||+.|+|||......++...|+|+|++.++++..+..|.... ....+..+..........+++++.+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 247 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHH
Confidence 322 2344567999999999998888999999999999999998888885322 2222333333323333446677788
Q ss_pred ccCCCCCCCCccccchh-hhcc
Q 019780 291 IVDPKSTMNNDCMATVH-AITK 311 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~-~~~~ 311 (336)
++..++..+|+.|.+.. ++.+
T Consensus 248 li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHhcCCHhHcCCChHHHHc
Confidence 88888888888887665 4443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=292.45 Aligned_cols=254 Identities=27% Similarity=0.412 Sum_probs=198.6
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..+.+...+|.+.+.||+|+||+||+|.+.++.||||++... .........+.+|+.+++.++||||+++++++.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQ---DFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCC---CCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCC---CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 456677889999999999999999999999999999999742 23455567899999999999999999999999876
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCCceEEecccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRP-KRLDLKHSISFALDISRAMEYLHANS--VIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
. .++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++| |+||||||+||+++.++ .+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~ 185 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-TVKVCDFGL 185 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-CEEECCCC-
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC-cEEECCCCC
Confidence 5 8999999999999999954321 23899999999999999999999999 99999999999999886 799999999
Q ss_pred cccccccc--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHH-HHHHHh--hccCCCCCC
Q 019780 211 AREEVMDE--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITL-TNILQN--LRSADTPIP 285 (336)
Q Consensus 211 a~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l-~~~~~~--~~~~~~~~p 285 (336)
++...... .....||+.|+|||.......+.+.|+|+|++.+|++-.+..|....-...+ ..+... .......++
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN 265 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence 97533321 3345699999999999888889999999999999999888888533211111 111111 122335577
Q ss_pred CCcccccCCCCCCCCccccchhhhccc
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
+++.+++...+..+|+.|++..++.+.
T Consensus 266 ~~l~~li~~~l~~dP~~Rps~~~ll~~ 292 (309)
T 3p86_A 266 PQVAAIIEGCWTNEPWKRPSFATIMDL 292 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 788899999999999999998887753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=299.00 Aligned_cols=248 Identities=21% Similarity=0.217 Sum_probs=202.4
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
....+|.+++.||+|+||.||+|.+. ++.||||++.... .......+.+.+|+.+|+.++||||+++++++.+..
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK--VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHH--hccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 44578999999999999999999986 7899999997321 112234567889999999999999999999998765
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
.|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECS
T ss_pred EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC-CEEEcccccceecc
Confidence 89999999999999999553 4699999999999999999999999999999999999999887 89999999998643
Q ss_pred cccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCC
Q 019780 216 MDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDP 294 (336)
Q Consensus 216 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~ 294 (336)
. .....+||+.|+|||......++...|+|+|++.++++..+..|.... ....+..+..........+++++.+++..
T Consensus 193 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 271 (350)
T 1rdq_E 193 G-RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp S-CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred C-CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 3 234457999999999988888999999999999999998888885332 22233334433333445677778888888
Q ss_pred CCCCCCccccc-----hhhhccc
Q 019780 295 KSTMNNDCMAT-----VHAITKF 312 (336)
Q Consensus 295 ~~~~~~~~~~~-----~~~~~~~ 312 (336)
++..+|..|.+ ..++.+.
T Consensus 272 lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 272 LLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HhhcCHHhccCCccCCHHHHHhC
Confidence 88888888865 5555543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=298.11 Aligned_cols=252 Identities=20% Similarity=0.253 Sum_probs=198.4
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.+.|.+.+.||+|+||.||+|.+. ++.||||++.............+.+.+|+.+++.++||||+++++++.++. .|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999986 789999999742211111123567899999999999999999999988765 89
Q ss_pred EEEEccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC--CceEEeccccccc
Q 019780 138 IITELMRGETLQRYLWST--RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK--KQVKLADFGLARE 213 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~--~~~kl~Dfg~a~~ 213 (336)
+||||++|++|.+++... .+..+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||+++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999888532 344689999999999999999999999999999999999998654 2499999999986
Q ss_pred ccccc--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCC----CCCCCC
Q 019780 214 EVMDE--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSAD----TPIPPK 287 (336)
Q Consensus 214 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~----~~~p~~ 287 (336)
..... .....||+.|+|||......++.+.|+|+|++.++++..+..|....-...+..+........ ..++++
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 262 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISES 262 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccccCCHH
Confidence 44332 234569999999999988888999999999999999988888864433233333332221111 345667
Q ss_pred cccccCCCCCCCCccccchhhhccc
Q 019780 288 LVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
+.+++..++..+|+.|.+..++.+.
T Consensus 263 ~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 263 AKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 7777788888888888777766653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=298.36 Aligned_cols=242 Identities=19% Similarity=0.206 Sum_probs=197.0
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 135 (336)
+...+|.+.+.||+|+||.||+|.+. ++.||||+++... .......+.+.+|..++..+ +||||+++++++.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~--~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV--VIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 45678999999999999999999987 6789999997421 11223456788999999988 7999999999998765
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-cEEEEeCCccccc
Confidence 89999999999999999543 4699999999999999999999999999999999999999887 8999999999853
Q ss_pred cc--ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccc
Q 019780 215 VM--DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEI 291 (336)
Q Consensus 215 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~ 291 (336)
.. ......+||+.|+|||......++.+.|+|+|++.++++..+..|.... ....+..+..........+++++.++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 251 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 22 2344567999999999998888999999999999999998888886332 22233334443333445677778888
Q ss_pred cCCCCCCCCccccc
Q 019780 292 VDPKSTMNNDCMAT 305 (336)
Q Consensus 292 ~~~~~~~~~~~~~~ 305 (336)
+..++..+|..|.+
T Consensus 252 i~~lL~~dP~~R~~ 265 (353)
T 2i0e_A 252 CKGLMTKHPGKRLG 265 (353)
T ss_dssp HHHHTCSCTTSCTT
T ss_pred HHHHhhcCHHHcCC
Confidence 88888888888863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=301.49 Aligned_cols=213 Identities=30% Similarity=0.529 Sum_probs=181.8
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..|.++.++|.+.+.||+|+||.||+|.+.++.||||+++... ..+.+.+|+.+|+.++||||+++++++.+.
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 4677889999999999999999999999999999999997421 346789999999999999999999997754
Q ss_pred --CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 135 --TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 135 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
..++||||+++|+|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~ 337 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTK 337 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS-CEEECCCTTCE
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-CEEEeeCCCcc
Confidence 489999999999999999766555689999999999999999999999999999999999999876 89999999998
Q ss_pred ccccccccccCCcccccCCCC----------------------------------------------CCCCCCCCHHHHH
Q 019780 213 EEVMDEMTCEAGTYRWMAPEN----------------------------------------------ERPSLENLSEDMV 246 (336)
Q Consensus 213 ~~~~~~~~~~~gt~~y~aPE~----------------------------------------------~~~~~~~~~~di~ 246 (336)
..... .....++..|+|||. ..+.+..++.+++
T Consensus 338 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 416 (450)
T 1k9a_A 338 EASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 416 (450)
T ss_dssp ECC-------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccc-ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 54322 223357889999991 1233456788999
Q ss_pred HHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 247 ALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 247 ~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
+|+..||..+|.+||++.+++..|+.+...
T Consensus 417 ~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 417 DVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999887654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=295.78 Aligned_cols=199 Identities=28% Similarity=0.360 Sum_probs=171.5
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccc-cHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAV-SREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
..|.+++.||+|+||.||+|.+. ++.||+|+++....... .....+.+.+|+.+|+.++||||+++++++.+.. .+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 57999999999999999999986 78999999985332111 1123567899999999999999999999998766 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC---ceEEecccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK---QVKLADFGLAREE 214 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~---~~kl~Dfg~a~~~ 214 (336)
+||||++||+|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++..
T Consensus 92 lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 92 LILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 9999999999999993 4467999999999999999999999999999999999999987653 6999999999864
Q ss_pred ccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 215 VMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 215 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
... ......||+.|+|||......++.+.|+|+|+..++++..+..|.
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf 218 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 433 234567999999999998888999999999999999988888775
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=296.17 Aligned_cols=217 Identities=31% Similarity=0.562 Sum_probs=184.0
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
...|.++.++|.+.+.||+|+||.||+|.+. ++.||||+++.. ........+.+|+.+|+.++||||+++++++
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 181 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT----SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc----CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3467888999999999999999999999986 788999998732 2345566789999999999999999999999
Q ss_pred ecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 132 VQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 132 ~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
.+.. .++||||+++|+|.++++.. +..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 182 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~ 259 (377)
T 3cbl_A 182 TQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN-VLKISDFGM 259 (377)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGG
T ss_pred ecCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC-cEEECcCCC
Confidence 8765 89999999999999999643 34689999999999999999999999999999999999999877 899999999
Q ss_pred ccccccccccc----cCCcccccCCC----------------------------------------------CCCCCCCC
Q 019780 211 AREEVMDEMTC----EAGTYRWMAPE----------------------------------------------NERPSLEN 240 (336)
Q Consensus 211 a~~~~~~~~~~----~~gt~~y~aPE----------------------------------------------~~~~~~~~ 240 (336)
++......... ..+++.|+||| ...+.+..
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 339 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPEL 339 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 98543322221 12467899999 11233456
Q ss_pred CHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 241 LSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 241 ~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
++.++++|+..||+.+|.+||++.++++.|+.+.++
T Consensus 340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 788999999999999999999999999999988764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=303.41 Aligned_cols=214 Identities=29% Similarity=0.521 Sum_probs=181.1
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
..|.+..++|.+.+.||+|+||.||+|.+. +..||||+++... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS------MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS------BCHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC------ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC
Confidence 467888999999999999999999999986 7789999997422 135679999999999999999999999987
Q ss_pred CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 134 PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 134 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+..++||||+++|+|.++++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~ 333 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARV 333 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-CEEECSTTGGGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC-cEEEeeCCCceE
Confidence 7799999999999999999654445689999999999999999999999999999999999999876 899999999986
Q ss_pred cccccc---cccCCcccccCCCC----------------------------------------------CCCCCCCCHHH
Q 019780 214 EVMDEM---TCEAGTYRWMAPEN----------------------------------------------ERPSLENLSED 244 (336)
Q Consensus 214 ~~~~~~---~~~~gt~~y~aPE~----------------------------------------------~~~~~~~~~~d 244 (336)
...... ....++..|+|||. ..+.+..++.+
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 413 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE 413 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 433222 22346788999991 12334567788
Q ss_pred HHHHHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 245 MVALLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 245 i~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
+++|+..||..+|.+||++.+++..|+.+..
T Consensus 414 l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 8999999999999999999998888776543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=285.61 Aligned_cols=216 Identities=25% Similarity=0.480 Sum_probs=179.5
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
..+...+|.+.+.||+|+||.||+|.+. +..||||+++. .......+.+.+|+.+++.++||||+++++++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 119 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA----GYTERQRRDFLSEASIMGQFDHPNIIRLEGVV 119 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECT----TCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCC----CCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3456789999999999999999999985 34599999973 22455667899999999999999999999999
Q ss_pred ecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 132 VQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 132 ~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
.++. .++||||++||+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~ 197 (325)
T 3kul_A 120 TRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGL 197 (325)
T ss_dssp CGGGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCSS
T ss_pred EeCCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC-CEEECCCCc
Confidence 8765 89999999999999999543 35799999999999999999999999999999999999999876 899999999
Q ss_pred cccccccc-----ccccCCcccccCCCC----------------------------------------------CCCCCC
Q 019780 211 AREEVMDE-----MTCEAGTYRWMAPEN----------------------------------------------ERPSLE 239 (336)
Q Consensus 211 a~~~~~~~-----~~~~~gt~~y~aPE~----------------------------------------------~~~~~~ 239 (336)
++...... .....+|+.|+|||. ..+.+.
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPM 277 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCC
Confidence 98543221 122236778999991 123345
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhc
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR 278 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~ 278 (336)
.++.++..|+..||..+|.+||++.++++.|+.+.....
T Consensus 278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 678889999999999999999999999999998876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=294.23 Aligned_cols=249 Identities=23% Similarity=0.280 Sum_probs=201.5
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
..+|.+.+.||+|+||.||+|.+. ++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.. .|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK---LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 357999999999999999999986 7899999997422 23455678999999999999999999999998776 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC--CceEEeccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK--KQVKLADFGLAREEV 215 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~--~~~kl~Dfg~a~~~~ 215 (336)
+||||++||+|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||++....
T Consensus 105 lv~e~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEECCCCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999999994 346799999999999999999999999999999999999998643 359999999998644
Q ss_pred ccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhccCC----CCCCCCcc
Q 019780 216 MDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRSAD----TPIPPKLV 289 (336)
Q Consensus 216 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~~~----~~~p~~~~ 289 (336)
... .....||+.|+|||......++.+.|+|+|++.+|++..+..|....- ...+..+........ ..+|+++.
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 332 344579999999999988889999999999999999998888863322 122222222221111 23567778
Q ss_pred cccCCCCCCCCccccchhhhccccc
Q 019780 290 EIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
+++..++..+|+.|.+..++.+..+
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred HHHHHHcCCChhhCcCHHHHhcCcc
Confidence 8888888889988888877776543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=289.91 Aligned_cols=247 Identities=18% Similarity=0.287 Sum_probs=201.5
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.++|.+.+.||+|+||.||+|.+. +..+|+|++.. .......+.+|+.+++.++||||+++++++.+.. .+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC------CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec------CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 367999999999999999999986 78899999863 2234567899999999999999999999998765 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-CCceEEecccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED-KKQVKLADFGLAREEVM 216 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~-~~~~kl~Dfg~a~~~~~ 216 (336)
+||||++||+|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.+ .+.+||+|||+++....
T Consensus 78 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99999999999999943 23569999999999999999999999999999999999999862 34899999999986433
Q ss_pred c-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhccCC----CCCCCCccc
Q 019780 217 D-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRSAD----TPIPPKLVE 290 (336)
Q Consensus 217 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~~~----~~~p~~~~~ 290 (336)
. ......||+.|+|||.......+...|+|+|++.++++..+..|....- ...+..+........ ..+|+++.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T 1tki_A 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence 3 2344569999999999888888899999999999999988888863322 222233333222222 357788889
Q ss_pred ccCCCCCCCCccccchhhhccccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
++..++..+|..|++..++.+..+
T Consensus 237 li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 237 FVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHHcCCChhHCcCHHHHhcChh
Confidence 999999999999999888776443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=298.54 Aligned_cols=243 Identities=21% Similarity=0.260 Sum_probs=190.3
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHH-HHhCCCCceEeeEeeEecCC
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTL-LSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~ 135 (336)
+...+|.+++.||+|+||.||+|++. +..||||+++... .........+.+|..+ ++.++||||+++++++.+..
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~--~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKA--ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGG--BC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 34578999999999999999999986 6789999998422 2233345566777776 57789999999999998766
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++..
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCBCGGG
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEeeCcccccc
Confidence 89999999999999999543 5689999999999999999999999999999999999999887 8999999999853
Q ss_pred cc--ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCCCCCCcccc
Q 019780 215 VM--DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTPIPPKLVEI 291 (336)
Q Consensus 215 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~p~~~~~~ 291 (336)
.. ......+||+.|+|||......++...|+|+|++.++++..+..|... .....+..+..........+++++.++
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 269 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHL 269 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHH
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Confidence 22 234456799999999999888999999999999999999988888632 222333444444444455677778888
Q ss_pred cCCCCCCCCccccch
Q 019780 292 VDPKSTMNNDCMATV 306 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~ 306 (336)
+..++..+|..|.+.
T Consensus 270 i~~lL~~dp~~R~~~ 284 (373)
T 2r5t_A 270 LEGLLQKDRTKRLGA 284 (373)
T ss_dssp HHHHTCSSGGGSTTT
T ss_pred HHHHcccCHHhCCCC
Confidence 888888888888654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=292.03 Aligned_cols=249 Identities=22% Similarity=0.266 Sum_probs=191.8
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEE-----CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
+..++|.+.+.||+|+||.||+|+. .++.||+|+++.... .........+.+|+.+|+.++||||+++++++.+
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI-VRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 4567899999999999999999987 378899999974221 1123345678899999999999999999999987
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
.. .|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS-CEEECCCSCC-
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC-cEEEEeCCccc
Confidence 65 99999999999999999543 4689999999999999999999999999999999999999887 89999999997
Q ss_pred ccccc--cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCCCCCCcc
Q 019780 213 EEVMD--EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTPIPPKLV 289 (336)
Q Consensus 213 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~p~~~~ 289 (336)
..... ......||+.|+|||.......+...|+|+|++.+|++..+..|... .....+..+..........+++++.
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 53322 23345699999999998888889999999999999999888888632 2222334444444444456777788
Q ss_pred cccCCCCCCCCcccc-----chhhhcc
Q 019780 290 EIVDPKSTMNNDCMA-----TVHAITK 311 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~-----~~~~~~~ 311 (336)
+++..++..+|..|. +..++.+
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 899999999998886 4445544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=288.16 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=200.6
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.++|.+.+.||+|+||+||+|.+. ++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++ .+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-----CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence 467999999999999999999875 7899999997422 122466889999999999999999999988765 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||++||+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCST
T ss_pred EEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-CEEEeeCCCceecCCc
Confidence 999999999999999543 589999999999999999999999999999999999999887 7999999998754332
Q ss_pred --cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhc---cCCCCCCCCcccc
Q 019780 218 --EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLR---SADTPIPPKLVEI 291 (336)
Q Consensus 218 --~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~---~~~~~~p~~~~~~ 291 (336)
......||+.|+|||......++.+.|+|+|++.+|++-.+..|.... -...+..+..... .....+++.+.++
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence 234457999999999988888899999999999999998888886332 1112222222211 1123456667888
Q ss_pred cCCCCCCCCccccchhhhccccccc
Q 019780 292 VDPKSTMNNDCMATVHAITKFNEKG 316 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (336)
+...+..+|+.|++..++.+.....
T Consensus 250 i~~~l~~dp~~Rps~~ell~h~~~~ 274 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQHQFLK 274 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred HHHHccCChhHCcCHHHHhhChhhc
Confidence 9999999999999998888765443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=300.28 Aligned_cols=248 Identities=23% Similarity=0.257 Sum_probs=194.9
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.++|.+.+.||+|+||.||+|.+. ++.+|+|++.... ......+.+.+|+.+++.++||||+++++++.++. .+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK---LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS---CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 357999999999999999999985 7899999997422 23455678999999999999999999999998776 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC--CCceEEeccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED--KKQVKLADFGLAREEV 215 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~--~~~~kl~Dfg~a~~~~ 215 (336)
+||||+.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ ++.+||+|||+++...
T Consensus 87 lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999999999543 569999999999999999999999999999999999999842 3479999999997544
Q ss_pred ccc--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhccCC----CCCCCCc
Q 019780 216 MDE--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRSAD----TPIPPKL 288 (336)
Q Consensus 216 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~~~----~~~p~~~ 288 (336)
... .....||+.|+|||......++.+.|+|+|++.++++..+..|...+- ...+..+........ ..+++++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 322 334579999999999988889999999999999999888887753321 112222222211111 2456667
Q ss_pred ccccCCCCCCCCccccchhhhcccc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.+++..++..+|+.|.+..++.+..
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCc
Confidence 7777777777777777776666543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=277.06 Aligned_cols=213 Identities=26% Similarity=0.494 Sum_probs=176.7
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
..|.++.++|.+.+.||+|+||.||+|.+. ++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 76 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB------CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc------CHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 357788899999999999999999999985 77899999974221 23568999999999999999999999987
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
+. .++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~ 154 (269)
T 4hcu_A 77 QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTR 154 (269)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEEECCTTGGG
T ss_pred CCceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-CEEeccccccc
Confidence 65 89999999999999999543 35689999999999999999999999999999999999998876 79999999998
Q ss_pred cccccc---ccccCCcccccCCCCCC----------------------------------------------CCCCCCHH
Q 019780 213 EEVMDE---MTCEAGTYRWMAPENER----------------------------------------------PSLENLSE 243 (336)
Q Consensus 213 ~~~~~~---~~~~~gt~~y~aPE~~~----------------------------------------------~~~~~~~~ 243 (336)
...... .....+++.|+|||... ..+...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T 4hcu_A 155 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 234 (269)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred cccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCH
Confidence 543332 22334678899999211 12334567
Q ss_pred HHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 244 DMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 244 di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
++.+++..||+.+|.+||++.++++.|.++.+
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 235 HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 78888888999999999999999988887764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=290.58 Aligned_cols=230 Identities=30% Similarity=0.509 Sum_probs=186.7
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeE
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFV 128 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 128 (336)
...+..++|.+.+.||+|+||.||+|.+. +..||||+++. .........+.+|+.+++.++||||++++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 140 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLMEALIISKFNHQNIVRCI 140 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCS----SCCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccc----ccChhhHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34466789999999999999999999853 45799999863 22345566789999999999999999999
Q ss_pred eeEecCC-EEEEEEccCCCCHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC--
Q 019780 129 GASVQPT-MMIITELMRGETLQRYLWSTR-----PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK-- 200 (336)
Q Consensus 129 ~~~~~~~-~~lv~e~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~-- 200 (336)
+++.+.. .++||||++||+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 220 (367)
T 3l9p_A 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220 (367)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCC
Confidence 9998765 899999999999999996543 24689999999999999999999999999999999999998543
Q ss_pred CceEEeccccccccccc----cccccCCcccccCCCC-------------------------------------------
Q 019780 201 KQVKLADFGLAREEVMD----EMTCEAGTYRWMAPEN------------------------------------------- 233 (336)
Q Consensus 201 ~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~------------------------------------------- 233 (336)
..+||+|||+++..... ......||+.|+|||.
T Consensus 221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 25999999999743221 2233457899999991
Q ss_pred ---CCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCCCCCCCCcc
Q 019780 234 ---ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLV 289 (336)
Q Consensus 234 ---~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~p~~~~ 289 (336)
....+..++..+++|+..||+.+|.+||++.++++.++.+.+.......++|.+..
T Consensus 301 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~~~~p~~~~ 359 (367)
T 3l9p_A 301 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYG 359 (367)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTCCCCCC--
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhccCCCccccC
Confidence 11234457788899999999999999999999999999988776666666665543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=281.90 Aligned_cols=218 Identities=33% Similarity=0.632 Sum_probs=175.2
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCCEEE
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTMMI 138 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~l 138 (336)
++.++|.+.+.||+|+||.||+|.+.++.||||++.. ....+.+.+|+.+++.++||||+++++++.+ ..++
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~l 76 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIES-------ESERKAFIVELRQLSRVNHPNIVKLYGACLN-PVCL 76 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSS-------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-TTEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecC-------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CcEE
Confidence 5678999999999999999999999999999999862 2345678999999999999999999998774 4899
Q ss_pred EEEccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 139 ITELMRGETLQRYLWSTRP-KRLDLKHSISFALDISRAMEYLHA---NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
||||++||+|.+++..... ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++..+||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 9999999999999964432 247899999999999999999999 899999999999999987755899999999753
Q ss_pred ccccccccCCcccccCCCCCCCC-----------------------------------------------CCCCHHHHHH
Q 019780 215 VMDEMTCEAGTYRWMAPENERPS-----------------------------------------------LENLSEDMVA 247 (336)
Q Consensus 215 ~~~~~~~~~gt~~y~aPE~~~~~-----------------------------------------------~~~~~~di~~ 247 (336)
.. ......||+.|+|||..... +..++..+.+
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
T 2eva_A 157 QT-HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHH
T ss_pred cc-ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHH
Confidence 32 23344699999999932222 2345667777
Q ss_pred HHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCCCCCC
Q 019780 248 LLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIP 285 (336)
Q Consensus 248 l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~p 285 (336)
|+..||+.+|.+||++.++++.|+.+.+.......+.+
T Consensus 236 li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~ 273 (307)
T 2eva_A 236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273 (307)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred HHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence 88899999999999999999999988777655444433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=302.13 Aligned_cols=251 Identities=18% Similarity=0.241 Sum_probs=193.9
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..+..++|.+.+.||+|+||+||+|++. ++.||+|+++... .........+.+|..++..++||||+++++++.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--MLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH--HHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHH--hhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3456689999999999999999999986 6789999997311 11112233488999999999999999999999877
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. .|+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-~vkL~DFGla~~ 224 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLK 224 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-CEEEcchhhhhh
Confidence 6 89999999999999999542 46799999999999999999999999999999999999999887 899999999975
Q ss_pred ccccc---ccccCCcccccCCCCCC-----CCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHh---hc--c
Q 019780 214 EVMDE---MTCEAGTYRWMAPENER-----PSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQN---LR--S 279 (336)
Q Consensus 214 ~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~---~~--~ 279 (336)
..... ....+||+.|+|||... ...++.+.|+|+|++.+|++..+..|... +....+..+... .. .
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence 43322 23357999999999875 55678899999999999999999888632 222223333221 11 1
Q ss_pred CCCCCCCCcccccCCCCCCCCcc--ccchhhhcc
Q 019780 280 ADTPIPPKLVEIVDPKSTMNNDC--MATVHAITK 311 (336)
Q Consensus 280 ~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~ 311 (336)
....+++++.+++..++..+++. +.++.++.+
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11346677777777777655444 445544444
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=281.03 Aligned_cols=213 Identities=28% Similarity=0.559 Sum_probs=176.0
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEE------CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
.+..++|++.+.||+|+||+||+|++ .++.||||++.. ......+.+.+|+.+++.++||||+++++++
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-----STEEHLRDFEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC-----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc-----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 35678999999999999999999984 378899999873 2345567899999999999999999999998
Q ss_pred ec---CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecc
Q 019780 132 VQ---PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADF 208 (336)
Q Consensus 132 ~~---~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Df 208 (336)
.. ...++||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+||
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Df 158 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDF 158 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCC
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-eEEEccC
Confidence 64 3489999999999999999654 34589999999999999999999999999999999999999886 8999999
Q ss_pred cccccccccc-----ccccCCcccccCCCC--------------------------------------------------
Q 019780 209 GLAREEVMDE-----MTCEAGTYRWMAPEN-------------------------------------------------- 233 (336)
Q Consensus 209 g~a~~~~~~~-----~~~~~gt~~y~aPE~-------------------------------------------------- 233 (336)
|+++...... .....++..|+|||.
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 9998543321 222347788999991
Q ss_pred -----------CCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh
Q 019780 234 -----------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277 (336)
Q Consensus 234 -----------~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~ 277 (336)
..+.+..++.++++|+..||+.+|.+||++.++++.|+.+...+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11234567788999999999999999999999999999887654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=287.75 Aligned_cols=170 Identities=31% Similarity=0.447 Sum_probs=145.9
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..+.++..+|++.+.||+|+||+||+|.+.++.||||++.. .........+|+.+++.++||||+++++++.+.
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPI------QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECG------GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeec------CchHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 45678889999999999999999999999999999999963 223345567799999999999999999998864
Q ss_pred C-----EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcccccCCCCceeecCC
Q 019780 135 T-----MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN----------SVIHRDLKPSNLLLTED 199 (336)
Q Consensus 135 ~-----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----------~ivHrDikp~NIll~~~ 199 (336)
. +++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. ||+||||||+|||++.+
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred CCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence 3 6999999999999999955 3489999999999999999999999 99999999999999987
Q ss_pred CCceEEecccccccccccc----ccccCCcccccCCCCC
Q 019780 200 KKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENE 234 (336)
Q Consensus 200 ~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~ 234 (336)
+ .+||+|||+++...... .....||+.|+|||..
T Consensus 168 ~-~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 205 (322)
T 3soc_A 168 L-TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205 (322)
T ss_dssp C-CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHH
T ss_pred C-eEEEccCCcccccccccCccccccCccCccccCHhhc
Confidence 6 89999999997543222 2335699999999943
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=302.25 Aligned_cols=251 Identities=19% Similarity=0.230 Sum_probs=195.9
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
+.+...+|.+.+.||+|+||+||+|++. ++.||+|+++... .........+.+|+.+++.++||||+++++++.+.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~--~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE--MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhh--hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3456689999999999999999999986 7889999997311 11112234578999999999999999999999987
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. +|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+.
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFG~a~~ 217 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMK 217 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC-CEEEeccceeEe
Confidence 6 8999999999999999954 3589999999999999999999999999999999999999887 899999999976
Q ss_pred ccccc---ccccCCcccccCCCCCCCCC----CCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHh---hcc-CC
Q 019780 214 EVMDE---MTCEAGTYRWMAPENERPSL----ENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQN---LRS-AD 281 (336)
Q Consensus 214 ~~~~~---~~~~~gt~~y~aPE~~~~~~----~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~---~~~-~~ 281 (336)
..... ..+.+||+.|+|||...... ++.+.|+|+|++.++++..+..|... .....+..+... ... ..
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence 43332 33567999999999876655 67899999999999999999888633 222233333322 111 11
Q ss_pred CCCCCCcccccCCCCCCCCcc--ccchhhhcccc
Q 019780 282 TPIPPKLVEIVDPKSTMNNDC--MATVHAITKFN 313 (336)
Q Consensus 282 ~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 313 (336)
..+++++.+++..++..++.. +.+..++.+..
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 356777777777777655554 56666665533
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=308.40 Aligned_cols=252 Identities=17% Similarity=0.232 Sum_probs=204.7
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
+..++|.+.+.||+|+||.||+|.+. ++.||||++.... .........+.+|+.+|+.++||||+++++++.+..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~--~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHh--hhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 56788999999999999999999985 8899999997321 112233566889999999999999999999998766
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
.|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++...
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-~vKL~DFGla~~~~ 337 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-HIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC-CeEEEecccceecc
Confidence 89999999999999999665556699999999999999999999999999999999999999887 89999999998654
Q ss_pred cc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH----HHHHHHHHH-HhhccCCCCCCCCcc
Q 019780 216 MD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE----ITITLTNIL-QNLRSADTPIPPKLV 289 (336)
Q Consensus 216 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~----i~~~l~~~~-~~~~~~~~~~p~~~~ 289 (336)
.. .....+||+.|+|||......++.+.|+|+|++.++++..+..|.... ....+...+ .........+++++.
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~ 417 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR 417 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHH
Confidence 33 234567999999999998888999999999999999998888886432 112222222 222233455777888
Q ss_pred cccCCCCCCCCcccc-----chhhhcccc
Q 019780 290 EIVDPKSTMNNDCMA-----TVHAITKFN 313 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~-----~~~~~~~~~ 313 (336)
+++..++..+|..|. +..++.+..
T Consensus 418 dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 418 SLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp HHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred HHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 888889998998887 556665543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=278.86 Aligned_cols=218 Identities=27% Similarity=0.508 Sum_probs=182.8
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
..|.+..++|.+.+.||+|+||.||+|.+. +..||+|++.... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 79 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS------MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc------ccHHHHHHHHHHHHhCCCcCcceEEEEEcC
Confidence 467788899999999999999999999987 5689999987422 124678999999999999999999999988
Q ss_pred CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 134 PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 134 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+..++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++..
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARL 158 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-CEEECCCccccc
Confidence 8899999999999999999543334699999999999999999999999999999999999999876 799999999986
Q ss_pred cccccc---cccCCcccccCCCC----------------------------------------------CCCCCCCCHHH
Q 019780 214 EVMDEM---TCEAGTYRWMAPEN----------------------------------------------ERPSLENLSED 244 (336)
Q Consensus 214 ~~~~~~---~~~~gt~~y~aPE~----------------------------------------------~~~~~~~~~~d 244 (336)
...... ....++..|+|||. ....+..++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHH
Confidence 443322 22346788999991 11223456788
Q ss_pred HHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 245 MVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 245 i~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
+.+|+..||..+|.+||++.++++.|+.+......
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 99999999999999999999999999998876543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=277.58 Aligned_cols=216 Identities=31% Similarity=0.531 Sum_probs=171.2
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
.+.+..++|.+.+.||+|+||.||+|.+. +..||+|+++. .......+.+.+|+.+++.++||||++++++
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 84 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIGV 84 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT----TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCccceEEEE
Confidence 34566789999999999999999999875 34589998863 2245567789999999999999999999999
Q ss_pred EecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 131 SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 131 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
+.++..++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~ 162 (281)
T 1mp8_A 85 ITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGL 162 (281)
T ss_dssp ECSSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC---
T ss_pred EccCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC-CEEECcccc
Confidence 9877899999999999999999643 35689999999999999999999999999999999999999876 899999999
Q ss_pred cccccccc---ccccCCcccccCCCCC----------------------------------------------CCCCCCC
Q 019780 211 AREEVMDE---MTCEAGTYRWMAPENE----------------------------------------------RPSLENL 241 (336)
Q Consensus 211 a~~~~~~~---~~~~~gt~~y~aPE~~----------------------------------------------~~~~~~~ 241 (336)
++...... .....+++.|+|||.. .+.+..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 242 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCC
Confidence 97543322 2223467899999911 1233456
Q ss_pred HHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh
Q 019780 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277 (336)
Q Consensus 242 ~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~ 277 (336)
+.++.+++..||+.+|.+||++.++++.|+.+....
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 788888999999999999999999999888887653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=286.84 Aligned_cols=250 Identities=22% Similarity=0.279 Sum_probs=194.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccc-cHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAV-SREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
..|.+.+.||+|+||.||+|.+. ++.||+|++........ .....+.+.+|+.+|+.++||||+++++++.+.. .+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 57999999999999999999986 78999999985322111 1123567899999999999999999999998765 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC---ceEEecccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK---QVKLADFGLAREE 214 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~---~~kl~Dfg~a~~~ 214 (336)
+||||++|++|.+++. ....+++..++.++.|++.||.|||++||+||||||+|||++.++. .+||+|||+++..
T Consensus 91 lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 9999999999999994 3467999999999999999999999999999999999999987652 6999999999864
Q ss_pred cc-ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHHhhccCC----CCCCCCc
Q 019780 215 VM-DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQNLRSAD----TPIPPKL 288 (336)
Q Consensus 215 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~~~~~~~----~~~p~~~ 288 (336)
.. .......||+.|+|||.......+.+.|+|+|++.++++..+..|....-. ..+..+........ ..+++.+
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 248 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHH
Confidence 32 233455799999999999888899999999999999999888888532211 11122211111111 2345556
Q ss_pred ccccCCCCCCCCccccchhhhcccc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.+++..++..+|+.|++..++.+..
T Consensus 249 ~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 249 KDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred HHHHHHHccCChhhCCCHHHHhcCC
Confidence 6666777777777777666666533
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=285.03 Aligned_cols=246 Identities=22% Similarity=0.332 Sum_probs=195.1
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.++|.+.+.||+|+||.||+|.+. +..||+|++... ........+.+.+|+.+++.++||||+++++++.+++ .+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP--PREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECC--SSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccC--ccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 467999999999999999999986 789999998742 2334566788999999999999999999999998766 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||++|++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 88 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCSSSTTC---
T ss_pred EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEEeCCCccccccc
Confidence 999999999999999544 4699999999999999999999999999999999999999887 7999999999754332
Q ss_pred c---ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHh-----hccCCCCCCCCc
Q 019780 218 E---MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQN-----LRSADTPIPPKL 288 (336)
Q Consensus 218 ~---~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~-----~~~~~~~~p~~~ 288 (336)
. .....||+.|+|||.......+...|+|+|+..+|++-.+..|....- .......... .......+|+.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence 2 223469999999999888888999999999999999988888853221 1111111111 112335577888
Q ss_pred ccccCCCCCCCCcccc-chhhhcc
Q 019780 289 VEIVDPKSTMNNDCMA-TVHAITK 311 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~-~~~~~~~ 311 (336)
.+++...+..+|..|. +..++.+
T Consensus 245 ~~li~~~l~~dp~~R~~~~~~l~~ 268 (294)
T 4eqm_A 245 SNVILRATEKDKANRYKTIQEMKD 268 (294)
T ss_dssp HHHHHHHSCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhcCCHhHccccHHHHHH
Confidence 8899999999998885 5555543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=298.07 Aligned_cols=213 Identities=28% Similarity=0.510 Sum_probs=176.7
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
..|.+..++|.+.+.||+|+||.||+|.+. +..||||+++.... ..+.+.+|+.+|+.++||||+++++++.+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 467788899999999999999999999997 46799999974221 24578999999999999999999999988
Q ss_pred CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 134 PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 134 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+..++||||+++|+|.+++....+..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~ 329 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARL 329 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC-
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC-CEEECCCcccee
Confidence 7799999999999999999654445689999999999999999999999999999999999999876 799999999986
Q ss_pred cccccc---cccCCcccccCCCC----------------------------------------------CCCCCCCCHHH
Q 019780 214 EVMDEM---TCEAGTYRWMAPEN----------------------------------------------ERPSLENLSED 244 (336)
Q Consensus 214 ~~~~~~---~~~~gt~~y~aPE~----------------------------------------------~~~~~~~~~~d 244 (336)
...... ....++..|+|||. ..+.+..++..
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 409 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 409 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 433222 22346789999991 12334567788
Q ss_pred HHHHHHHhhccCCCCCCCHhHHHHHHHHHH
Q 019780 245 MVALLKSCWAEDPKVRPEFAEITITLTNIL 274 (336)
Q Consensus 245 i~~l~~~~l~~~p~~RP~~~~i~~~l~~~~ 274 (336)
+.+|+..||+.+|.+||++.+++..|+.+.
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999988877654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=292.94 Aligned_cols=253 Identities=26% Similarity=0.343 Sum_probs=204.9
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC---------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCc
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG---------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHEN 123 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn 123 (336)
...|.+..++|.+.+.||+|+||.||+|.+. +..||||+++.. ........+.+|+.+++.+ +|||
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpn 136 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKN 136 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc----cCHHHHHHHHHHHHHHHHhcCCch
Confidence 3456778899999999999999999999863 246999999732 3455667899999999999 8999
Q ss_pred eEeeEeeEecCC-EEEEEEccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 019780 124 ILKFVGASVQPT-MMIITELMRGETLQRYLWSTR--------------PKRLDLKHSISFALDISRAMEYLHANSVIHRD 188 (336)
Q Consensus 124 Iv~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrD 188 (336)
|+++++++.++. .++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++||+|||
T Consensus 137 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 216 (382)
T 3tt0_A 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 216 (382)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred hhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 999999998765 899999999999999996543 24589999999999999999999999999999
Q ss_pred CCCCceeecCCCCceEEeccccccccccc----cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCH
Q 019780 189 LKPSNLLLTEDKKQVKLADFGLAREEVMD----EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEF 263 (336)
Q Consensus 189 ikp~NIll~~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~ 263 (336)
|||+|||++.++ .+||+|||+++..... ......+|+.|+|||.......+...|+|+|++.++++-. +..|..
T Consensus 217 lkp~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 217 LAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp CCGGGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCcceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999887 7999999999854332 2233457889999999888888999999999999998877 666653
Q ss_pred hHHHHHHHHHHHh--hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 264 AEITITLTNILQN--LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 264 ~~i~~~l~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
..-...+...+.. .......+++++.+++...+..+|+.|++..++.+
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 345 (382)
T 3tt0_A 296 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345 (382)
T ss_dssp TCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3222222222222 12223457778888999999999999998888775
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=280.17 Aligned_cols=246 Identities=24% Similarity=0.301 Sum_probs=191.6
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||+||+|.+. ++.||||++.... ........+.+|+.+++.++||||+++++++.++. .++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC---CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence 57999999999999999999986 7889999997432 23445577889999999999999999999998766 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc--
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM-- 216 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~-- 216 (336)
||||+++ +|.+++.. ....+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus 79 v~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 79 VFEFCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCSCC
T ss_pred EEecCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecCCcc
Confidence 9999986 66666543 346799999999999999999999999999999999999999887 799999999975432
Q ss_pred ccccccCCcccccCCCCCCCCC-CCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHHHhhccCC------------
Q 019780 217 DEMTCEAGTYRWMAPENERPSL-ENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNILQNLRSAD------------ 281 (336)
Q Consensus 217 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~~~~~~~~------------ 281 (336)
.......||+.|+|||...... ++.+.|+|+|++.++++-.+.+|.+. +....+..+........
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 2234456899999999876655 78999999999999999988887422 22223333333221111
Q ss_pred -----------------CCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 282 -----------------TPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 282 -----------------~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
+.+++++.+++..++..+|+.|.+..++.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 284 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence 12344455677777777888887777776544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=303.72 Aligned_cols=250 Identities=24% Similarity=0.314 Sum_probs=201.3
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
...+|.+++.||+|+||.||+|.+. ++.||||++.... .........+.+|+.+++.++||||+++++++.+.. .
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK--IRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH--HHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh--ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3467999999999999999999986 8899999997321 111223567899999999999999999999998765 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||++||+|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 92 ~lv~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~-~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-CEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-CeEEEeccchhhccc
Confidence 99999999999999994 446799999999999999999999999999999999999999887 799999999986443
Q ss_pred c-cccccCCcccccCCCCCCCCCC-CCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccC
Q 019780 217 D-EMTCEAGTYRWMAPENERPSLE-NLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVD 293 (336)
Q Consensus 217 ~-~~~~~~gt~~y~aPE~~~~~~~-~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~ 293 (336)
. ...+.+||+.|+|||...+..+ +...|+|+|++.++++..+..|...+ ....+..+..........+++++.+++.
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 248 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLK 248 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHH
Confidence 3 2345679999999998877665 57899999999999988888775332 2222233333333333446677788888
Q ss_pred CCCCCCCccccchhhhccccc
Q 019780 294 PKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~ 314 (336)
..+..+|..|++..++.+..+
T Consensus 249 ~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 249 HMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp HHTCSSTTTSCCHHHHHTCHH
T ss_pred HHcCCCchhCcCHHHHHhCHH
Confidence 888888888888888776443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=304.48 Aligned_cols=250 Identities=19% Similarity=0.226 Sum_probs=194.7
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
.+..++|.+.+.||+|+||.||+|.+. ++.||||+++.. ..........+.+|+.+++.++||||+++++++.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKE--VIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH--HHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhh--hhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 345678999999999999999999986 789999999731 1123344567889999999999999999999998766
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.++||||++||+|.+++... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a~~ 298 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKE 298 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCCCT
T ss_pred EEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCcee
Confidence 89999999999999999543 569999999999999999999998 9999999999999999887 899999999985
Q ss_pred ccc--ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCccc
Q 019780 214 EVM--DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVE 290 (336)
Q Consensus 214 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~ 290 (336)
... ......+||+.|+|||......++.+.|+|+|++.++++..+..|.... ....+..+..........+++++.+
T Consensus 299 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 378 (446)
T 4ejn_A 299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 378 (446)
T ss_dssp TCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence 322 2244567999999999988888999999999999999998888886332 2222333333333344567788888
Q ss_pred ccCCCCCCCCcccc-----chhhhccc
Q 019780 291 IVDPKSTMNNDCMA-----TVHAITKF 312 (336)
Q Consensus 291 ~~~~~~~~~~~~~~-----~~~~~~~~ 312 (336)
++..++..+|..|. +..++.+.
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 99999999999987 77776653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=297.68 Aligned_cols=250 Identities=20% Similarity=0.235 Sum_probs=195.9
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..+..++|.+.+.||+|+||.||+|++. ++.||||+++.. ..........+.+|..++..++||||+++++++.+.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~--~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW--DMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--HHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH--HhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 3456789999999999999999999985 889999999731 111222345588999999999999999999999977
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. .|+||||++||+|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++.
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-~vkL~DFGla~~ 211 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSCLK 211 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC-CEEEeechhhee
Confidence 6 89999999999999999643 24699999999999999999999999999999999999999887 899999999986
Q ss_pred ccccc---ccccCCcccccCCCCCC-------CCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHH---hhc-
Q 019780 214 EVMDE---MTCEAGTYRWMAPENER-------PSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQ---NLR- 278 (336)
Q Consensus 214 ~~~~~---~~~~~gt~~y~aPE~~~-------~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~---~~~- 278 (336)
..... ....+||+.|+|||... ...++.+.|+|+|++.++++..+..|.... ....+..+.. ...
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC
Confidence 43332 23457999999999765 456789999999999999999888886332 2222223322 111
Q ss_pred -cCCCCCCCCcccccCCCCCCCCccc---cchhhhcc
Q 019780 279 -SADTPIPPKLVEIVDPKSTMNNDCM---ATVHAITK 311 (336)
Q Consensus 279 -~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 311 (336)
.....+|+++.+++..++. +|..| .+..++.+
T Consensus 292 p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1124578888888888887 77776 34555443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=296.09 Aligned_cols=247 Identities=24% Similarity=0.315 Sum_probs=193.6
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
.+|.+.+.||+|+||.||+|.+. ++.||||++... ..........+.+|+.+++.++||||+++++++.+.. .++
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQ--LLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH--HHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehH--HccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 57999999999999999999984 789999999731 1111222457899999999999999999999998766 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||+ +|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-CEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-CEEEEEeccceeccCCc
Confidence 99999 67999998543 5699999999999999999999999999999999999999887 79999999998543332
Q ss_pred -ccccCCcccccCCCCCCCCCC-CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHH-HHHHhhccCCCCCCCCcccccCCC
Q 019780 219 -MTCEAGTYRWMAPENERPSLE-NLSEDMVALLKSCWAEDPKVRPEFAEITITLT-NILQNLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 219 -~~~~~gt~~y~aPE~~~~~~~-~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~-~~~~~~~~~~~~~p~~~~~~~~~~ 295 (336)
....+||+.|+|||...+..+ +...|+|+|++.++++-.+..|...+....+. .+..........+++++.+++...
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 242 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRM 242 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTT
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHH
Confidence 345679999999999887775 67899999999999988888775332111100 000001112233566677788888
Q ss_pred CCCCCccccchhhhccccc
Q 019780 296 STMNNDCMATVHAITKFNE 314 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~ 314 (336)
+..+|..|++..++.+..+
T Consensus 243 L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 243 IVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp SCSSGGGSCCHHHHTTCHH
T ss_pred cCCChhHCcCHHHHHhChh
Confidence 8888888888887776443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=289.58 Aligned_cols=214 Identities=25% Similarity=0.490 Sum_probs=170.8
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
.++..+|.+.+.||+|+||.||+|.+. +..||||+++.. ......+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 116 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG----YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT 116 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 456688999999999999999999864 567999999732 24456678999999999999999999999998
Q ss_pred cCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 133 QPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 133 ~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
+.. .++||||+++|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a 194 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLG 194 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC---
T ss_pred eCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-CEEECcCccc
Confidence 765 89999999999999999543 35699999999999999999999999999999999999999887 7999999999
Q ss_pred ccccccc-----ccccCCcccccCCCCC----------------------------------------------CCCCCC
Q 019780 212 REEVMDE-----MTCEAGTYRWMAPENE----------------------------------------------RPSLEN 240 (336)
Q Consensus 212 ~~~~~~~-----~~~~~gt~~y~aPE~~----------------------------------------------~~~~~~ 240 (336)
+...... .....+++.|+|||.. .+.+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 274 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTT
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 8543221 1112356789999911 122345
Q ss_pred CHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh
Q 019780 241 LSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277 (336)
Q Consensus 241 ~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~ 277 (336)
++..+..|+..||+.+|.+||++.++++.|+.+....
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 6788899999999999999999999999999988754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=290.58 Aligned_cols=246 Identities=23% Similarity=0.294 Sum_probs=190.7
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC----
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT---- 135 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 135 (336)
.+|.+.+.||+|+||.||+|.+. ++.||||+++... .....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS----TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC----chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 57899999999999999999986 7899999997422 3345678999999999999999999999875432
Q ss_pred ------------------------------------------------------EEEEEEccCCCCHHHHHhhcCC-CCC
Q 019780 136 ------------------------------------------------------MMIITELMRGETLQRYLWSTRP-KRL 160 (336)
Q Consensus 136 ------------------------------------------------------~~lv~e~~~gg~L~~~l~~~~~-~~l 160 (336)
.++||||++|++|.+++..... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 7999999999999999965332 335
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--------------cccccCCcc
Q 019780 161 DLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--------------EMTCEAGTY 226 (336)
Q Consensus 161 ~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~gt~ 226 (336)
++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++..... ......||+
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 6677899999999999999999999999999999999887 8999999999854332 123346999
Q ss_pred cccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh-ccCCCCCCCCcccccCCCCCCCCccccc
Q 019780 227 RWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL-RSADTPIPPKLVEIVDPKSTMNNDCMAT 305 (336)
Q Consensus 227 ~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 305 (336)
.|+|||.......+.+.|+|+|++.++++-.+..|... ....+....... .......++++.+++...+..+|..|++
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence 99999998888889999999999999998877666433 222222222110 0011223455667788888888888888
Q ss_pred hhhhcccc
Q 019780 306 VHAITKFN 313 (336)
Q Consensus 306 ~~~~~~~~ 313 (336)
..++.+..
T Consensus 320 ~~~~l~~~ 327 (332)
T 3qd2_B 320 ATDIIENA 327 (332)
T ss_dssp HHHHHHST
T ss_pred HHHHhhch
Confidence 87776543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=283.22 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=200.4
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
..++|.+.+.||+|+||.||+|.+. +..||+|++... ..........+.+|+.+++.++||||+++++++.+.. .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--HHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecc--ccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 4578999999999999999999987 668999998631 1112223567899999999999999999999998776 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS-CEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC-CEEEEeccccccCCc
Confidence 9999999999999999543 5689999999999999999999999999999999999999887 799999999876555
Q ss_pred ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCC
Q 019780 217 DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 217 ~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~ 295 (336)
.......|++.|+|||.......+...|+|+|+..++++-.+..|.... .......+..........+++.+.+++...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 241 (279)
T 3fdn_A 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 241 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHH
Confidence 5555667999999999988888899999999999999988777775322 222222333333333445677788899999
Q ss_pred CCCCCccccchhhhccccc
Q 019780 296 STMNNDCMATVHAITKFNE 314 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~ 314 (336)
+..+|..|++..++.+...
T Consensus 242 l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 242 LKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp CCSSGGGSCCHHHHHHCHH
T ss_pred hccChhhCCCHHHHhhCcc
Confidence 9999999999988887543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=274.09 Aligned_cols=212 Identities=24% Similarity=0.358 Sum_probs=178.1
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP- 134 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~- 134 (336)
...++.++|.+.+.||+|+||.||+|.+.++.||||+++.. .......+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVR---DWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCT---TCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEeccc---ccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 34566789999999999999999999999999999999742 23445567899999999999999999999998875
Q ss_pred --CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCCceEEecccc
Q 019780 135 --TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS--VIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 135 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
..++||||+++|+|.+++.......+++..++.++.|++.||.|||++| ++||||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~ 159 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TARISMADV 159 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS-CEEEEGGGS
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc-ceeEEeccc
Confidence 3799999999999999997655557999999999999999999999999 99999999999999876 799998888
Q ss_pred ccccccccccccCCcccccCCCCC-------------------------------------------------CCCCCCC
Q 019780 211 AREEVMDEMTCEAGTYRWMAPENE-------------------------------------------------RPSLENL 241 (336)
Q Consensus 211 a~~~~~~~~~~~~gt~~y~aPE~~-------------------------------------------------~~~~~~~ 241 (336)
+.... .....||+.|+|||.. ...+..+
T Consensus 160 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3kmu_A 160 KFSFQ---SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236 (271)
T ss_dssp CCTTS---CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTC
T ss_pred eeeec---ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCC
Confidence 75422 2334689999999921 1223456
Q ss_pred HHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHH
Q 019780 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274 (336)
Q Consensus 242 ~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~ 274 (336)
+.++.+++..||+.+|.+||++.++++.|+.+.
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 237 SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 777888888899999999999998888887653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=283.44 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=193.9
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccc---------------------cHHHHHHHHHHHHHH
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAV---------------------SREHKEKFQREVTLL 116 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~---------------------~~~~~~~~~~E~~~l 116 (336)
..++|.+.+.||+|+||.||+|.+. ++.||||++........ .....+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3468999999999999999999985 78899999975321110 112246689999999
Q ss_pred HhCCCCceEeeEeeEecC---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 019780 117 SKMKHENILKFVGASVQP---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSN 193 (336)
Q Consensus 117 ~~l~hpnIv~~~~~~~~~---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~N 193 (336)
+.++||||+++++++.+. ..++||||+++++|.+++ ....+++..++.++.|++.||.|||++||+||||||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999998863 389999999999998865 23579999999999999999999999999999999999
Q ss_pred eeecCCCCceEEecccccccccccc--ccccCCcccccCCCCCCCCCC---CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 194 LLLTEDKKQVKLADFGLAREEVMDE--MTCEAGTYRWMAPENERPSLE---NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 194 Ill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~gt~~y~aPE~~~~~~~---~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
||++.++ .+||+|||+++...... .....||+.|+|||....... +...|+|+|++.+|++..+..|....-..
T Consensus 168 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 168 LLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 9999887 79999999997543322 344569999999998876653 66789999999999998888886433222
Q ss_pred HH-HHHHHhhcc--CCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 269 TL-TNILQNLRS--ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 269 ~l-~~~~~~~~~--~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.+ ..+...... ....+++++.+++..++..+|+.|.+..++.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 22 222222111 1235677888999999999999999998887654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=277.70 Aligned_cols=220 Identities=28% Similarity=0.499 Sum_probs=182.5
Q ss_pred cCCceeecCCceeEeeeecCCCcEEEEEeEE------CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEe
Q 019780 53 IDASVLVDHRSVLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILK 126 (336)
Q Consensus 53 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 126 (336)
++....++.++|.+++.||+|+||+||++.+ .++.||||+++.. ........+.+|+.+++.++||||++
T Consensus 22 pg~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~ 97 (318)
T 3lxp_A 22 PGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD----AGPQHRSGWKQEIDILRTLYHEHIIK 97 (318)
T ss_dssp --CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT----CCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc----cChHHHHHHHHHHHHHHhCCCcchhh
Confidence 3445556777889999999999999998865 3678999999732 34456778999999999999999999
Q ss_pred eEeeEecC---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCce
Q 019780 127 FVGASVQP---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQV 203 (336)
Q Consensus 127 ~~~~~~~~---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~ 203 (336)
+++++.+. ..++||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+
T Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-~~ 173 (318)
T 3lxp_A 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LV 173 (318)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CE
T ss_pred EEEEEecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC-CE
Confidence 99998864 389999999999999999543 489999999999999999999999999999999999999886 79
Q ss_pred EEecccccccccccc-----ccccCCcccccCCCC---------------------------------------------
Q 019780 204 KLADFGLAREEVMDE-----MTCEAGTYRWMAPEN--------------------------------------------- 233 (336)
Q Consensus 204 kl~Dfg~a~~~~~~~-----~~~~~gt~~y~aPE~--------------------------------------------- 233 (336)
+|+|||++....... .....|+..|+|||.
T Consensus 174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 253 (318)
T 3lxp_A 174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253 (318)
T ss_dssp EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCH
T ss_pred EECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccccc
Confidence 999999998643322 223457888999991
Q ss_pred ---------------CCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccC
Q 019780 234 ---------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSA 280 (336)
Q Consensus 234 ---------------~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~ 280 (336)
..+.+..++.++.+|+..||+.+|.+||++.++++.|+.+.+.+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 254 QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred chhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 12334567889999999999999999999999999999998877643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=303.64 Aligned_cols=245 Identities=21% Similarity=0.245 Sum_probs=200.7
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
+...+|.+.+.||+|+||.||+|++. ++.||||++.... .........+.+|+.+|+.++||||+++++++.+..
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~--~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR--LKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHH--hhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 45678999999999999999999985 7899999997321 112233567889999999999999999999998765
Q ss_pred EEEEEEccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTR--PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++.
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-~vkL~DFGla~~ 338 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVE 338 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC-CEEEeecceeee
Confidence 899999999999999996543 45699999999999999999999999999999999999999887 899999999986
Q ss_pred ccccc--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-----HHHHHHHHHHhhccCCCCCCC
Q 019780 214 EVMDE--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-----ITITLTNILQNLRSADTPIPP 286 (336)
Q Consensus 214 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-----i~~~l~~~~~~~~~~~~~~p~ 286 (336)
..... ....+||+.|+|||......++.+.|+|+|++.+|++..+..|.... .......+..........+++
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~ 418 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence 43332 23357999999999999889999999999999999998888886331 122223333333344456778
Q ss_pred CcccccCCCCCCCCccccch
Q 019780 287 KLVEIVDPKSTMNNDCMATV 306 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~ 306 (336)
++.+++..++..+|+.|.+.
T Consensus 419 ~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCC
T ss_pred HHHHHHHHhccCCHhHCCCC
Confidence 88888988999899888753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=274.62 Aligned_cols=210 Identities=35% Similarity=0.620 Sum_probs=163.1
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
++..+|.+.+.||+|+||.||+|.+.++.||||+++.... .......+.+.+|+.+++.++||||+++++++.++. .+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPD-EDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCc-ccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 5568899999999999999999999999999999874211 112334577899999999999999999999988765 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCCCCceeecCC-------CCceEEec
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS---VIHRDLKPSNLLLTED-------KKQVKLAD 207 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDikp~NIll~~~-------~~~~kl~D 207 (336)
+||||++|++|.+++. ...+++..++.++.|++.||.|||++| ++||||||+||+++.+ .+.++|+|
T Consensus 83 lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999999983 357999999999999999999999999 8999999999999862 33799999
Q ss_pred cccccccccccccccCCcccccCCCCC----------------------------------------------CCCCCCC
Q 019780 208 FGLAREEVMDEMTCEAGTYRWMAPENE----------------------------------------------RPSLENL 241 (336)
Q Consensus 208 fg~a~~~~~~~~~~~~gt~~y~aPE~~----------------------------------------------~~~~~~~ 241 (336)
||++............||+.|+|||.. .+.+..+
T Consensus 160 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3dtc_A 160 FGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239 (271)
T ss_dssp CCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred CCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence 999986554444456799999999921 1233456
Q ss_pred HHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 019780 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTN 272 (336)
Q Consensus 242 ~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~ 272 (336)
+.++.+++..||+.+|.+||++.++++.|+.
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 6778888888888888888888888877753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=288.64 Aligned_cols=204 Identities=19% Similarity=0.231 Sum_probs=175.9
Q ss_pred CceeecCCceeEeeeecCC--CcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 55 ASVLVDHRSVLLQKMIGEG--SYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G--~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
..+..+..+|.+.+.||+| +||.||+|.+. ++.||||++... .........+.+|+.+++.++||||++++++
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE---ACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGG---GSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccc---ccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 4566677899999999999 99999999986 889999999742 2345667889999999999999999999999
Q ss_pred EecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 131 SVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 131 ~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
+.+++ .++||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~kl~dfg 173 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLR 173 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCGG
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccc
Confidence 98766 89999999999999999776667799999999999999999999999999999999999999887 89999999
Q ss_pred cccccccc---------cccccCCcccccCCCCCCC--CCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 210 LAREEVMD---------EMTCEAGTYRWMAPENERP--SLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 210 ~a~~~~~~---------~~~~~~gt~~y~aPE~~~~--~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.+...... ......||+.|+|||.... ..++.+.|+|+|++.++++-.+..|.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 237 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 88643211 1222368999999998776 56788999999999999887777774
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=289.80 Aligned_cols=246 Identities=19% Similarity=0.254 Sum_probs=199.6
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
.+|.+.+.||+|+||.||+|.+. ++.||+|++... .......+.+|+.+|+.++||||+++++++.+.. .++
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-----chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 57999999999999999999986 788999998732 2334567899999999999999999999998765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-CCceEEeccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED-KKQVKLADFGLAREEVMD 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~-~~~~kl~Dfg~a~~~~~~ 217 (336)
||||+.||+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+++.....
T Consensus 126 v~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 126 ILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999999943 23569999999999999999999999999999999999999753 347999999999864433
Q ss_pred c-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccC----CCCCCCCcccc
Q 019780 218 E-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSA----DTPIPPKLVEI 291 (336)
Q Consensus 218 ~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~----~~~~p~~~~~~ 291 (336)
. .....||+.|+|||.......+...|+|+|++.+|++..+..|.... ....+..+....... ...+++++.++
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 284 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 2 33456999999999998888899999999999999999888886332 222233332221111 13467778888
Q ss_pred cCCCCCCCCccccchhhhcccc
Q 019780 292 VDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
+..++..+|..|.+..++.+..
T Consensus 285 i~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 285 IKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp HHTTSCSSGGGSCCHHHHHTST
T ss_pred HHHHcCCChhHCcCHHHHhhCc
Confidence 8899999999998888877644
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=278.04 Aligned_cols=217 Identities=30% Similarity=0.540 Sum_probs=181.6
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEee
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 127 (336)
..+.+..++|.+.+.||+|+||.||+|.+. +..||||+++. .......+.+.+|+.+++.++||||+++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 91 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE----NASPSELRDLLSEFNVLKQVNHPHVIKL 91 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCT----TCCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccC----CCCHHHHHHHHHHHHHHhhCCCCceeeE
Confidence 456677899999999999999999999862 36899999973 2245566789999999999999999999
Q ss_pred EeeEecCC-EEEEEEccCCCCHHHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 019780 128 VGASVQPT-MMIITELMRGETLQRYLWSTRP----------------------KRLDLKHSISFALDISRAMEYLHANSV 184 (336)
Q Consensus 128 ~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~~lH~~~i 184 (336)
++++.+.. .++||||++|++|.+++..... ..+++..++.++.|++.||.|||++||
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 171 (314)
T 2ivs_A 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL 171 (314)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred EEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 99988765 8999999999999999965432 348999999999999999999999999
Q ss_pred ccccCCCCceeecCCCCceEEecccccccccccc----ccccCCcccccCCCC---------------------------
Q 019780 185 IHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPEN--------------------------- 233 (336)
Q Consensus 185 vHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~--------------------------- 233 (336)
+||||||+||+++.++ .+||+|||+++...... .....+++.|+|||.
T Consensus 172 vH~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 172 VHRDLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp ECCCCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred cccccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999876 89999999997543222 223347789999991
Q ss_pred -------------------CCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 234 -------------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 234 -------------------~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
....+..++.++.+|+..||+.+|.+||++.++++.|+.+..+
T Consensus 251 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 251 NPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 1123345778899999999999999999999999999888764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=277.69 Aligned_cols=254 Identities=23% Similarity=0.283 Sum_probs=206.3
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.++|.+.+.||+|+||.||+|.+. ++.||+|++... .........+.+|+.+++.++||||+++++++.++. .+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK---KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG---GCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecc---cCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 467999999999999999999986 789999999742 224556678999999999999999999999998776 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC--CceEEeccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK--KQVKLADFGLAREEV 215 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~--~~~kl~Dfg~a~~~~ 215 (336)
+||||++|++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ ..+||+|||++....
T Consensus 82 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999999999998544 5689999999999999999999999999999999999997654 249999999997544
Q ss_pred ccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHH-HHHHHhhccCC----CCCCCCcc
Q 019780 216 MDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITL-TNILQNLRSAD----TPIPPKLV 289 (336)
Q Consensus 216 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l-~~~~~~~~~~~----~~~p~~~~ 289 (336)
... .....||+.|+|||.......+.+.|+|+|+..++++-.+..|....-...+ ..+........ ..+++++.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 332 2345699999999999888889999999999999999888888633322222 22222221111 35677888
Q ss_pred cccCCCCCCCCccccchhhhcccccccccc
Q 019780 290 EIVDPKSTMNNDCMATVHAITKFNEKGKKR 319 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (336)
+++...+..+|+.|++..++.+.....+.+
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 899999999999999999998866554443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=274.25 Aligned_cols=213 Identities=28% Similarity=0.495 Sum_probs=174.3
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
.|.++.++|.+.+.||+|+||.||+|.+. +..||+|+++.... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB------CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC------CHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 56778899999999999999999999987 55899999974221 135688999999999999999999999876
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. .++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||+++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~ 169 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRY 169 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS-CEEECSTTGGGG
T ss_pred CCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC-CEEEcccccccc
Confidence 5 89999999999999999542 35699999999999999999999999999999999999999877 799999999985
Q ss_pred ccccc---ccccCCcccccCCCCC----------------------------------------------CCCCCCCHHH
Q 019780 214 EVMDE---MTCEAGTYRWMAPENE----------------------------------------------RPSLENLSED 244 (336)
Q Consensus 214 ~~~~~---~~~~~gt~~y~aPE~~----------------------------------------------~~~~~~~~~d 244 (336)
..... .....+|+.|+|||.. ...+...+.+
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 249 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHH
Confidence 43332 2233467889999921 1123345677
Q ss_pred HHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 245 MVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 245 i~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
+.+|+..||+.+|.+||++.++++.|.++...
T Consensus 250 l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 250 VYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 88888899999999999999998888877653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.91 Aligned_cols=212 Identities=35% Similarity=0.595 Sum_probs=165.1
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
.+.+...+|.+.+.||+|+||+||+|.+.+ .+|+|+++.. .......+.+.+|+.+++.++||||++++++..++.
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT---APTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ 93 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCS---SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEecc---CCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCc
Confidence 455778899999999999999999998765 5999999742 234566788999999999999999999999887777
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||+++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKS 171 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC------
T ss_pred cEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEEccceeccccc
Confidence 99999999999999999543 46699999999999999999999999999999999999999886 89999999987533
Q ss_pred c----ccccccCCcccccCCCCCC---CCC--------------------------------------------------
Q 019780 216 M----DEMTCEAGTYRWMAPENER---PSL-------------------------------------------------- 238 (336)
Q Consensus 216 ~----~~~~~~~gt~~y~aPE~~~---~~~-------------------------------------------------- 238 (336)
. .......||+.|+|||... ..+
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence 2 1223346999999999332 111
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNI 273 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~ 273 (336)
..++.++..|+..||+.+|.+||++.++++.|+++
T Consensus 252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 23456666777777888888888888877777654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=281.38 Aligned_cols=254 Identities=24% Similarity=0.240 Sum_probs=193.0
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC---CCCceEeeEeeEecC
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM---KHENILKFVGASVQP 134 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~ 134 (336)
..++|.+.+.||+|+||+||+|++. ++.||||++...............+.+|+.+++.+ +||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3568999999999999999999974 78999999974322111222233456677776665 599999999998764
Q ss_pred C------EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecc
Q 019780 135 T------MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADF 208 (336)
Q Consensus 135 ~------~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Df 208 (336)
. .++||||+. ++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Df 164 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADF 164 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS-CEEECSC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEEeeC
Confidence 3 789999997 5999999766666699999999999999999999999999999999999999887 7999999
Q ss_pred ccccccccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccC------
Q 019780 209 GLAREEVMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSA------ 280 (336)
Q Consensus 209 g~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~------ 280 (336)
|+++..... ......||+.|+|||......++.+.|+|+|++.++++-.+..|.... -...+..+.......
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 999754332 234456999999999988888899999999999999999888886221 122223333222111
Q ss_pred ---------------------CCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 281 ---------------------DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 281 ---------------------~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
.+.+++++.+++..++..+|+.|.+..++.+..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~ 300 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence 12344555667788888888888888877765543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=281.51 Aligned_cols=256 Identities=19% Similarity=0.235 Sum_probs=206.3
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
+..++|.+.+.||+|+||.||+|.+. +..||+|++.... .........+.+|+.+++.++||||+++++++.+..
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ--LEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccc--cchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 34578999999999999999999986 6789999987311 111223467899999999999999999999998765
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
.++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC-CEEECCCTTCEECS
T ss_pred EEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC-CEEEecccccccCc
Confidence 89999999999999999554 4689999999999999999999999999999999999999877 79999999987654
Q ss_pred cccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCC
Q 019780 216 MDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDP 294 (336)
Q Consensus 216 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~ 294 (336)
........|++.|+|||.......+...|+|+|+..++++-.+..|.... .......+..........+++++.+++..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (284)
T 2vgo_A 166 SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245 (284)
T ss_dssp SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence 44445567999999999988888899999999999999988777775221 12222223322223334567778889999
Q ss_pred CCCCCCccccchhhhcccccccccc
Q 019780 295 KSTMNNDCMATVHAITKFNEKGKKR 319 (336)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (336)
.+..+|+.|.+..++.+...-....
T Consensus 246 ~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 246 LLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 9999999999999888765544433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=280.88 Aligned_cols=211 Identities=21% Similarity=0.300 Sum_probs=173.4
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 135 (336)
+-..+|.+.+.||+|+||.||+|.+. ++.||||++..... ...+.+|+.+++.+ +||||+++++++.+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 34578999999999999999999974 88999999874211 23578999999999 8999999999988766
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCc-----eEEeccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ-----VKLADFG 209 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~-----~kl~Dfg 209 (336)
.++||||+ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++ . +||+|||
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg 155 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFA 155 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTCTTSEEECCCT
T ss_pred ccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCC-CCCCceEEEEEcc
Confidence 79999999 89999999654 46799999999999999999999999999999999999998765 5 9999999
Q ss_pred ccccccccc---------ccccCCcccccCCCCCCCCCCCCHH-------------------------------------
Q 019780 210 LAREEVMDE---------MTCEAGTYRWMAPENERPSLENLSE------------------------------------- 243 (336)
Q Consensus 210 ~a~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~------------------------------------- 243 (336)
+++...... .....||+.|+|||.......+...
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 998533221 2345699999999943322222222
Q ss_pred --------------HHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 244 --------------DMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 244 --------------di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
++..++..||+.+|.+||++.++.+.|.++......
T Consensus 236 ~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 236 KRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 666777888899999999999999999988877543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=298.28 Aligned_cols=212 Identities=31% Similarity=0.531 Sum_probs=180.3
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
..|.+...+|.+.+.||+|+||.||+|.+. +..||||+++... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 286 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS------SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc------cchHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 457788899999999999999999999987 7789999997421 12567899999999999999999999998
Q ss_pred cCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 133 QPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 133 ~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
+.. .++||||+++|+|.++++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 287 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a 365 (495)
T 1opk_A 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVKVADFGLS 365 (495)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCE
T ss_pred cCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC-cEEEeecccc
Confidence 765 89999999999999999776667799999999999999999999999999999999999999876 7999999999
Q ss_pred cccccccc---cccCCcccccCCCC----------------------------------------------CCCCCCCCH
Q 019780 212 REEVMDEM---TCEAGTYRWMAPEN----------------------------------------------ERPSLENLS 242 (336)
Q Consensus 212 ~~~~~~~~---~~~~gt~~y~aPE~----------------------------------------------~~~~~~~~~ 242 (336)
+....... ....++..|+|||. ....+..++
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 445 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 86433322 22346789999991 112345677
Q ss_pred HHHHHHHHHhhccCCCCCCCHhHHHHHHHHH
Q 019780 243 EDMVALLKSCWAEDPKVRPEFAEITITLTNI 273 (336)
Q Consensus 243 ~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~ 273 (336)
.++++|+..||+.+|.+||++.++++.|+.+
T Consensus 446 ~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 446 EKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 8899999999999999999999998877654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=281.44 Aligned_cols=246 Identities=18% Similarity=0.354 Sum_probs=199.8
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--C-------ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEe
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--C-------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVG 129 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~-------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 129 (336)
+..++|.+.+.||+|+||+||+|.+. + ..||+|++.. ......+.+.+|+.+++.++||||+++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 79 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-----AHRNYSESFFEAASMMSKLSHKHLVLNYG 79 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECG-----GGGGGHHHHHHHHHHHHTSCCTTBCCEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccc-----ccHHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 55688999999999999999999876 2 4699999863 12344577999999999999999999999
Q ss_pred eEecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCc------
Q 019780 130 ASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ------ 202 (336)
Q Consensus 130 ~~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~------ 202 (336)
++.++. .++||||++||+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++..
T Consensus 80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 80 VCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp EECCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred EEEeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 988765 89999999999999999653 3448999999999999999999999999999999999999877621
Q ss_pred -eEEeccccccccccccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhcc
Q 019780 203 -VKLADFGLAREEVMDEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRS 279 (336)
Q Consensus 203 -~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~ 279 (336)
+||+|||++...... ....||+.|+|||.... ...+.+.|+|+|++.+|++-.+.+|.+... .............
T Consensus 159 ~~kl~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK--DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236 (289)
T ss_dssp EEEECCCCSCTTTSCH--HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred eeeeccCcccccccCc--cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC
Confidence 999999998754332 22347899999998776 667889999999999999888666554332 1222233344444
Q ss_pred CCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 280 ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 280 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
...+.++++.+++...+..+|+.|++..++.+.
T Consensus 237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 556778889999999999999999988887753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=284.35 Aligned_cols=217 Identities=31% Similarity=0.550 Sum_probs=176.9
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEe
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILK 126 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~ 126 (336)
..|.+..++|.+.+.||+|+||.||+|.+. ++.||||+++.. ......+.+.+|+.++..+ +||||++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc----CCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 356778899999999999999999999842 478999999732 2345567899999999999 7999999
Q ss_pred eEeeEecCC--EEEEEEccCCCCHHHHHhhcCC-----------------------------------------------
Q 019780 127 FVGASVQPT--MMIITELMRGETLQRYLWSTRP----------------------------------------------- 157 (336)
Q Consensus 127 ~~~~~~~~~--~~lv~e~~~gg~L~~~l~~~~~----------------------------------------------- 157 (336)
+++++.+.+ .++||||++||+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999988643 8999999999999999965432
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc---
Q 019780 158 -----------------KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--- 217 (336)
Q Consensus 158 -----------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--- 217 (336)
..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTC
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccc
Confidence 1289999999999999999999999999999999999999876 7999999999754222
Q ss_pred -cccccCCcccccCCCCCC-----------------------------------------------CCCCCCHHHHHHHH
Q 019780 218 -EMTCEAGTYRWMAPENER-----------------------------------------------PSLENLSEDMVALL 249 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~-----------------------------------------------~~~~~~~~di~~l~ 249 (336)
......||+.|+|||... ..+..++.++.+++
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 329 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM 329 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 122345788999999211 12234567788888
Q ss_pred HHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 250 KSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 250 ~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
..||+.+|.+||++.++++.|+.+.+.
T Consensus 330 ~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 330 LDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 899999999999999999888887754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=287.47 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=201.8
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEECC-------ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEe
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYGC-------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVG 129 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 129 (336)
+.+..++|.+.+.||+|+||.||+|.+.+ +.||||+++.. ......+.+.+|+.+++.++||||+++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 117 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAALMAEFDNPNIVKLLG 117 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45667899999999999999999999853 78999999732 23456778999999999999999999999
Q ss_pred eEecCC-EEEEEEccCCCCHHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 019780 130 ASVQPT-MMIITELMRGETLQRYLWSTR----------------------PKRLDLKHSISFALDISRAMEYLHANSVIH 186 (336)
Q Consensus 130 ~~~~~~-~~lv~e~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH 186 (336)
++.+.. .++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 197 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 988765 899999999999999996542 256899999999999999999999999999
Q ss_pred ccCCCCceeecCCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCC
Q 019780 187 RDLKPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRP 261 (336)
Q Consensus 187 rDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP 261 (336)
|||||+||+++.++ .+||+|||+++...... .....||+.|+|||.......+...|+|+|+..+|++-. +..|
T Consensus 198 ~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 198 RDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp SCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 99999999999877 79999999987543221 223457899999998877778899999999999999887 7777
Q ss_pred CHhHHHHHHHH-HHHh-hccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 262 EFAEITITLTN-ILQN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 262 ~~~~i~~~l~~-~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
....-...+.. +... .......+|+++.+++...+..+|+.|++..++.+.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 277 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 54322222222 2221 122334567788889999999999999988877653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=275.04 Aligned_cols=215 Identities=31% Similarity=0.538 Sum_probs=182.9
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
.|.+...+|.+.+.||+|+||.||+|.+. +..||+|++.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS------CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 56677899999999999999999999987 77899999873 22245678999999999999999999999987
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
.. .++||||++|++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~ 159 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSR 159 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-CEEECCCCGGG
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-CEEEccCccce
Confidence 65 89999999999999999776667799999999999999999999999999999999999999876 79999999997
Q ss_pred ccccccc---cccCCcccccCCCC----------------------------------------------CCCCCCCCHH
Q 019780 213 EEVMDEM---TCEAGTYRWMAPEN----------------------------------------------ERPSLENLSE 243 (336)
Q Consensus 213 ~~~~~~~---~~~~gt~~y~aPE~----------------------------------------------~~~~~~~~~~ 243 (336)
....... ....+++.|+|||. ....+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 239 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCH
Confidence 5443322 22336788999991 1123345678
Q ss_pred HHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh
Q 019780 244 DMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277 (336)
Q Consensus 244 di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~ 277 (336)
++.+|+..||..+|.+||++.++++.|..+.+..
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 8889999999999999999999999998887653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=290.25 Aligned_cols=249 Identities=23% Similarity=0.281 Sum_probs=190.2
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
..+..+|.+.+.||+|+||+||+|.+. ++.||||++..... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA------IDENVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT------SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc------ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 345678999999999999999999986 78899999974221 2355789999999999999999999998766
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-CceEEeccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK-KQVKLADFGLARE 213 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~-~~~kl~Dfg~a~~ 213 (336)
.++||||++||+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++ ..+||+|||+++.
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 89999999999999999543 4699999999999999999999999999999999999998664 2499999999974
Q ss_pred ccc-ccccccCCcccccCCCCCCCCCCCCH-HHHHHHHHHhhccCCCCCCCHh-----HHHHHHHHHHHhhccCC--CCC
Q 019780 214 EVM-DEMTCEAGTYRWMAPENERPSLENLS-EDMVALLKSCWAEDPKVRPEFA-----EITITLTNILQNLRSAD--TPI 284 (336)
Q Consensus 214 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~di~~l~~~~l~~~p~~RP~~~-----~i~~~l~~~~~~~~~~~--~~~ 284 (336)
... .......||+.|+|||......+... .|+|+|++.++++-.+..|... .....+..+........ ..+
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI 247 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCC
T ss_pred ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCC
Confidence 322 22344569999999998776666545 7999999999998888877532 12223333322211111 245
Q ss_pred CCCcccccCCCCCCCCccccchhhhccccc
Q 019780 285 PPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
++++.+++...+..+|..|.+..++.+..+
T Consensus 248 s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 248 SPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 677788888889999999988888876544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=275.16 Aligned_cols=219 Identities=30% Similarity=0.506 Sum_probs=181.4
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEE-------CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceE
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENIL 125 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv 125 (336)
...+.+..++|.+.+.||+|+||.||+|.+ .+..||||+++.. ......+.+.+|+.+++.+ +||||+
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~ 90 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHMNIV 90 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc----hhHHHHHHHHHHHHHHhhcccCCCee
Confidence 345677788999999999999999999985 2578999999742 2344567899999999999 899999
Q ss_pred eeEeeEecCC-EEEEEEccCCCCHHHHHhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 019780 126 KFVGASVQPT-MMIITELMRGETLQRYLWSTRP----------------KRLDLKHSISFALDISRAMEYLHANSVIHRD 188 (336)
Q Consensus 126 ~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrD 188 (336)
++++++.++. .++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++|++|||
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 170 (313)
T 1t46_A 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD 170 (313)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred eEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 9999988765 8999999999999999965432 2489999999999999999999999999999
Q ss_pred CCCCceeecCCCCceEEeccccccccccccc----cccCCcccccCCCCC------------------------------
Q 019780 189 LKPSNLLLTEDKKQVKLADFGLAREEVMDEM----TCEAGTYRWMAPENE------------------------------ 234 (336)
Q Consensus 189 ikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~----~~~~gt~~y~aPE~~------------------------------ 234 (336)
|||+||+++.++ .+||+|||+++....... ....||+.|+|||..
T Consensus 171 lkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 171 LAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp CSGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CccceEEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999876 899999999975433321 223467889999911
Q ss_pred -----------------CCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh
Q 019780 235 -----------------RPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277 (336)
Q Consensus 235 -----------------~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~ 277 (336)
...+...+.++.+|+..||+.+|.+||++.++++.|++++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1123446778888999999999999999999999998887653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=277.87 Aligned_cols=221 Identities=30% Similarity=0.518 Sum_probs=183.5
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC---------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCc
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG---------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHEN 123 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn 123 (336)
...|.+..++|.+.+.||+|+||.||+|.+. +..||||+++.. ........+.+|+.+++.+ +|||
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~ 102 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKN 102 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT----CCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC----CcHHHHHHHHHHHHHHHHhhcCCC
Confidence 4567788899999999999999999999863 457999999732 2445667899999999999 8999
Q ss_pred eEeeEeeEecCC-EEEEEEccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 019780 124 ILKFVGASVQPT-MMIITELMRGETLQRYLWSTRP--------------KRLDLKHSISFALDISRAMEYLHANSVIHRD 188 (336)
Q Consensus 124 Iv~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrD 188 (336)
|+++++++.+.+ .++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++||+|||
T Consensus 103 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 182 (334)
T 2pvf_A 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 182 (334)
T ss_dssp BCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 999999988765 8999999999999999965432 3489999999999999999999999999999
Q ss_pred CCCCceeecCCCCceEEecccccccccccc----ccccCCcccccCCCC-------------------------------
Q 019780 189 LKPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPEN------------------------------- 233 (336)
Q Consensus 189 ikp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~------------------------------- 233 (336)
|||+||+++.++ .+||+|||+++...... .....+++.|+|||.
T Consensus 183 lkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 183 LAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp CSGGGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CccceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 999999999876 79999999997543321 223347789999991
Q ss_pred ---------------CCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 234 ---------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 234 ---------------~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
....+..++.++..++..||..+|.+||++.++++.|+.+......
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp TCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred cCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1123345678899999999999999999999999999998876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=282.18 Aligned_cols=245 Identities=24% Similarity=0.315 Sum_probs=199.4
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
.|...+.||+|+||.||+|.+. ++.||||++.... ....+.+.+|+.+++.++||||+++++++.... .++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-----QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 4777789999999999999985 8899999997422 223567889999999999999999999988765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-- 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-- 217 (336)
|||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 121 ~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp ECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSC
T ss_pred EecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccCcc
Confidence 999999999999842 4699999999999999999999999999999999999999887 7999999998754332
Q ss_pred cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhcc---CCCCCCCCcccccC
Q 019780 218 EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRS---ADTPIPPKLVEIVD 293 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~---~~~~~p~~~~~~~~ 293 (336)
......||+.|+|||.......+...|+|+|+..+|++-.+..|....- ...+..+...... ....+++++.+++.
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 276 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence 2344569999999999988888999999999999999998888864322 1222222222111 11245677888999
Q ss_pred CCCCCCCccccchhhhccccccc
Q 019780 294 PKSTMNNDCMATVHAITKFNEKG 316 (336)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~ 316 (336)
..+..+|+.|++..++.+...-.
T Consensus 277 ~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 277 RMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGG
T ss_pred HHccCChhhCcCHHHHhcChhhc
Confidence 99999999999999988755443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=280.99 Aligned_cols=218 Identities=30% Similarity=0.492 Sum_probs=173.4
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceE
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENIL 125 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv 125 (336)
...|.+..++|.+.+.||+|+||.||+|.+. +..||||++... ......+.+.+|+.+++.+ +||||+
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv 112 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK----ADSSEREALMSELKMMTQLGSHENIV 112 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccc----cCHHHHHHHHHHHHHHHhhcCCCCee
Confidence 3457788899999999999999999999972 457999999732 1234457899999999999 899999
Q ss_pred eeEeeEecCC-EEEEEEccCCCCHHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019780 126 KFVGASVQPT-MMIITELMRGETLQRYLWSTRP---------------------KRLDLKHSISFALDISRAMEYLHANS 183 (336)
Q Consensus 126 ~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~~lH~~~ 183 (336)
++++++.+.+ .++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++|
T Consensus 113 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 192 (344)
T 1rjb_A 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192 (344)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999988765 8999999999999999965432 24789999999999999999999999
Q ss_pred cccccCCCCceeecCCCCceEEecccccccccccc----ccccCCcccccCCCCCC------------------------
Q 019780 184 VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENER------------------------ 235 (336)
Q Consensus 184 ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~------------------------ 235 (336)
|+||||||+||+++.++ .+||+|||++....... .....||+.|+|||...
T Consensus 193 ivH~Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 193 CVHRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp EEETTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred cccCCCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence 99999999999999876 89999999997543322 12234678899999211
Q ss_pred -----------------------CCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 236 -----------------------PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 236 -----------------------~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
..+...+.++.+|+..||..+|.+||++.++++.|..+...
T Consensus 272 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 12334567788888888888888888888888887766544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=311.17 Aligned_cols=244 Identities=19% Similarity=0.206 Sum_probs=200.0
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecC
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQP 134 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 134 (336)
.+...+|.+++.||+|+||.||+|.+. ++.||||+++.. ........+.+..|..++..+ +||+|+.+++++.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD--VVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHH--HHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecc--ccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 455678999999999999999999986 678999999731 111233456788999999988 699999999999876
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. +|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+.
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-~ikL~DFGla~~ 491 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKE 491 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-CEEECCCTTCEE
T ss_pred CEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-cEEEeecceeec
Confidence 5 89999999999999999554 5699999999999999999999999999999999999999887 899999999985
Q ss_pred ccc--ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCCCCCCccc
Q 019780 214 EVM--DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTPIPPKLVE 290 (336)
Q Consensus 214 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~p~~~~~ 290 (336)
... ......+||+.|+|||.+....++.+.|+|+|+..++++..+..|... +....+..+..........+++++.+
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 571 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA 571 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHH
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence 322 234456799999999999999999999999999999999998888633 22333444444444445567788888
Q ss_pred ccCCCCCCCCccccch
Q 019780 291 IVDPKSTMNNDCMATV 306 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~ 306 (336)
++..++..+|+.|.+.
T Consensus 572 li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGC 587 (674)
T ss_dssp HHHHHSCSSSTTCTTC
T ss_pred HHHHHccCCHHHCCCC
Confidence 8988999899888765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=280.45 Aligned_cols=248 Identities=22% Similarity=0.237 Sum_probs=190.3
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
.++|.+.+.||+|+||+||+|.+. ++.||+|++... .........+.+|+.+++.++||||+++++++.++. .++
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLD---AEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecc---cccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 478999999999999999999985 789999999742 222334567889999999999999999999998765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc--
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM-- 216 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~-- 216 (336)
||||+++ +|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 97 v~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEECCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEETTSCC
T ss_pred EEcCCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-CEEEccCcCceecCCCc
Confidence 9999985 88888854 335699999999999999999999999999999999999999887 799999999985432
Q ss_pred ccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCH----hHHHHHHHHHHHhhc-------------
Q 019780 217 DEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEF----AEITITLTNILQNLR------------- 278 (336)
Q Consensus 217 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~----~~i~~~l~~~~~~~~------------- 278 (336)
.......||+.|+|||...+ ..++.+.|+|+|++.++++..+..|.. .+.+..+........
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 22344568999999998765 567899999999999999887777642 222222222211100
Q ss_pred --------------cCCCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 279 --------------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 279 --------------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
...+..++++.+++..++..+|+.|++..++.+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 001223445566777888888888888887776543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=283.95 Aligned_cols=246 Identities=24% Similarity=0.291 Sum_probs=185.0
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.+.|.+.+.||+|+||.||+|.+. ++.||||+++.. ...+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-------VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-------hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 467999999999999999999986 678999999731 23456889999999999999999999998765 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---CCCceEEecccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE---DKKQVKLADFGLAREE 214 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~---~~~~~kl~Dfg~a~~~ 214 (336)
+||||++||+|.+++. ....+++..++.++.|++.||.|||++||+||||||+|||++. ++ .+||+|||+++..
T Consensus 125 lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 125 LVLELVTGGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDA-PLKIADFGLSKIV 201 (349)
T ss_dssp EEECCCCSCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTC-CEEECCCC-----
T ss_pred EEEEeCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCC-CEEEccCcccccc
Confidence 9999999999999994 3456999999999999999999999999999999999999974 44 7999999999854
Q ss_pred cccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH--HHHHHHHHhhccC----CCCCCCC
Q 019780 215 VMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT--ITLTNILQNLRSA----DTPIPPK 287 (336)
Q Consensus 215 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~--~~l~~~~~~~~~~----~~~~p~~ 287 (336)
.... .....||+.|+|||.......+...|+|+|++.+|++..+..|....-. ..+..+....... ...++++
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred CcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 3322 3345699999999999888899999999999999999888888633211 1222222221111 1346667
Q ss_pred cccccCCCCCCCCccccchhhhccccccc
Q 019780 288 LVEIVDPKSTMNNDCMATVHAITKFNEKG 316 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (336)
+.+++..++..+|+.|.+..++.+.....
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 310 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVT 310 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 88899999999999999988887654433
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=271.06 Aligned_cols=215 Identities=30% Similarity=0.538 Sum_probs=176.3
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEECC-----ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYGC-----EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
.+.+..++|.+.+.||+|+||.||+|.+.+ ..||+|++... ......+.+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 81 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD----CTLDNKEKFMSEAVIMKNLDHPHIVKLIGI 81 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT----SCHHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc----cCchHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 455667899999999999999999998642 24999998742 234556789999999999999999999999
Q ss_pred EecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 131 SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 131 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
+.++..++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+
T Consensus 82 ~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~ 159 (281)
T 3cc6_A 82 IEEEPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGL 159 (281)
T ss_dssp ECSSSCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-EEEECCCCG
T ss_pred EcCCCCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-cEEeCccCC
Confidence 9888899999999999999999653 35689999999999999999999999999999999999999876 899999999
Q ss_pred cccccccc---ccccCCcccccCCCCC----------------------------------------------CCCCCCC
Q 019780 211 AREEVMDE---MTCEAGTYRWMAPENE----------------------------------------------RPSLENL 241 (336)
Q Consensus 211 a~~~~~~~---~~~~~gt~~y~aPE~~----------------------------------------------~~~~~~~ 241 (336)
+....... .....+++.|+|||.. .+.+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (281)
T 3cc6_A 160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC 239 (281)
T ss_dssp GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTC
T ss_pred CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCC
Confidence 97543322 2234578899999921 1223346
Q ss_pred HHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 242 ~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
+.++.+++..||..+|.+||++.+++..|+.+.+.
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 67788888889999999999999998888877654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=287.05 Aligned_cols=249 Identities=20% Similarity=0.332 Sum_probs=194.0
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--Ccc----EEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEP----VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~----vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
-.+...+|.+.+.||+|+||+||+|.+. ++. ||+|.+.. .........+.+|+.+++.++||||++++++
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 85 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 3456788999999999999999999975 333 57777652 2233456789999999999999999999999
Q ss_pred EecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 131 SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 131 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
+.++..++|++|+.+|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~ 163 (327)
T 3poz_A 86 CLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGL 163 (327)
T ss_dssp EESSSEEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTH
T ss_pred EecCCeEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC-CEEEccCcc
Confidence 9998899999999999999999654 35699999999999999999999999999999999999999877 899999999
Q ss_pred cccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHhh--ccCCCC
Q 019780 211 AREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQNL--RSADTP 283 (336)
Q Consensus 211 a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~~--~~~~~~ 283 (336)
++...... .....||+.|+|||......++...|+|+|++.+|++-. +..|....-...+....... ......
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 243 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 243 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCcc
Confidence 97543222 222346889999999888888999999999999999877 77775322111222222221 122344
Q ss_pred CCCCcccccCCCCCCCCccccchhhhcc
Q 019780 284 IPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.++++..++...+..+|+.|++..++.+
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~ 271 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELII 271 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 6667888899999999999998887764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=273.56 Aligned_cols=210 Identities=29% Similarity=0.561 Sum_probs=174.3
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEE------CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
+..+.|++.+.||+|+||.||+|.+ .++.||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 4567899999999999999999984 37899999997421 2234567899999999999999999999988
Q ss_pred cC---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 133 QP---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 133 ~~---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
+. ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .++|+|||
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg 171 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFG 171 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-CEEECccc
Confidence 64 3899999999999999995443 5699999999999999999999999999999999999999876 89999999
Q ss_pred ccccccccc-----ccccCCcccccCCCC---------------------------------------------------
Q 019780 210 LAREEVMDE-----MTCEAGTYRWMAPEN--------------------------------------------------- 233 (336)
Q Consensus 210 ~a~~~~~~~-----~~~~~gt~~y~aPE~--------------------------------------------------- 233 (336)
++....... .....||..|+|||.
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 997543322 223458888999991
Q ss_pred ---------CCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHH
Q 019780 234 ---------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274 (336)
Q Consensus 234 ---------~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~ 274 (336)
..+.+..++.++++|+..||+.+|.+||++.++++.|+.++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11234567788999999999999999999999999988765
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=282.25 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=204.3
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.++|.+.+.||+|+||.||++.+. ++.+|+|++... ........+.+.+|+.+++.++||||+++++++.+.+ .+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKS--LLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG--GCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechh--hhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 468999999999999999999986 678999999742 2234556788999999999999999999999998776 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 118 lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC-CEEEeeccCceecccC
Confidence 999999999999998543 5689999999999999999999999999999999999999886 7999999999754322
Q ss_pred --cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCC
Q 019780 218 --EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDP 294 (336)
Q Consensus 218 --~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~ 294 (336)
......||+.|+|||.......+...|+|+|++.+|++..+..|.... ....+..+..........+++++.+++..
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 233456999999999888888899999999999999988888775322 22222333333333445567778889999
Q ss_pred CCCCCCccccchhhhcccc
Q 019780 295 KSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~ 313 (336)
.+..+|+.|.+..++.+..
T Consensus 275 ~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 275 MLQTDPTARPTINELLNDE 293 (335)
T ss_dssp HTCSSGGGSCCGGGGGGSH
T ss_pred HccCChhHCcCHHHHhcCc
Confidence 9999999999988888643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.63 Aligned_cols=250 Identities=19% Similarity=0.366 Sum_probs=201.3
Q ss_pred ceeecCCceeEee-eecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 56 SVLVDHRSVLLQK-MIGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 56 ~~~~~~~~~~~~~-~lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
.+.+..++|.+.+ .||+|+||.||+|.+. +..||||+++.. ......+.+.+|+.+++.++||||++++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 78 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGV 78 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc----cchhHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 4556677888877 9999999999999863 667999999742 245567789999999999999999999999
Q ss_pred EecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 131 SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 131 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
+.++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~ 156 (287)
T 1u59_A 79 CQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGL 156 (287)
T ss_dssp EESSSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred ecCCCcEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-CEEECcccc
Confidence 987789999999999999999953 345699999999999999999999999999999999999999876 899999999
Q ss_pred cccccccc-----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHh--hccCCC
Q 019780 211 AREEVMDE-----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQN--LRSADT 282 (336)
Q Consensus 211 a~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~--~~~~~~ 282 (336)
++...... .....||+.|+|||.......+...|+|+|++.+|++-. +..|....-...+...+.. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 236 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 236 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCC
Confidence 97543221 122346899999998877778889999999999999886 7777532111111122221 122345
Q ss_pred CCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 283 PIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 283 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.+|+++.+++...+..+|+.|++..++.+
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 265 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQ 265 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67788889999999999999998888775
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=275.76 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=203.7
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.++|.+.+.||+|+||.||+|.+. ++.+|+|++... ........+.+.+|+.+++.++||||+++++++.+.+ .+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKS--LLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG--GCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechh--hccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 468999999999999999999986 778999998742 2234556778999999999999999999999998776 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 92 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC-CEEEEeccCceecccC
Confidence 999999999999998543 4689999999999999999999999999999999999999877 7999999999754322
Q ss_pred --cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCC
Q 019780 218 --EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDP 294 (336)
Q Consensus 218 --~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~ 294 (336)
......||+.|+|||.......+...|+|+|+..++++-.+..|.... ....+..+..........+++++.+++..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 233456899999999988888899999999999999988887775322 12222223333233344567778889999
Q ss_pred CCCCCCccccchhhhcccc
Q 019780 295 KSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~ 313 (336)
.+..+|+.|++..++.+..
T Consensus 249 ~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDE 267 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSH
T ss_pred HcccChhhCcCHHHHhhCh
Confidence 9999999999998888744
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=282.33 Aligned_cols=245 Identities=22% Similarity=0.247 Sum_probs=186.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.+++.++||||+++++++.++. .++
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc----ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 67999999999999999999986 7899999997422 2233467889999999999999999999998776 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||++||+|.+++ .....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 83 v~e~~~~~~L~~~l--~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 83 FLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEECCTTEEGGGGS--BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETT
T ss_pred EEEcCCCCcHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC-CEEEEEeeccceeccCC
Confidence 99999999999999 4446699999999999999999999999999999999999999877 7999999999753222
Q ss_pred ---cccccCCcccccCCCCCCCCCC-CCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHHHhhccC--CCCCCCCcc
Q 019780 218 ---EMTCEAGTYRWMAPENERPSLE-NLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNILQNLRSA--DTPIPPKLV 289 (336)
Q Consensus 218 ---~~~~~~gt~~y~aPE~~~~~~~-~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~~~~~~~--~~~~p~~~~ 289 (336)
......||+.|+|||....... +.+.|+|+|++.++++-.+..|... ................ ...+++++.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence 1234569999999998766554 5678999999999988777776421 1001111111111111 123455566
Q ss_pred cccCCCCCCCCccccchhhhcccc
Q 019780 290 EIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
+++...+..+|+.|.+..++.+..
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred HHHHHHccCChhhCcCHHHHhhCh
Confidence 666677777777777766666533
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=283.14 Aligned_cols=248 Identities=20% Similarity=0.255 Sum_probs=191.9
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC--
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-- 134 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 134 (336)
+..++|.+.+.||+|+||+||+|.+. ++.||||++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc----ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 44678999999999999999999987 7899999997321 122356678999999999999999999998754
Q ss_pred -CEEEEEEccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee----cCCCCceEEecc
Q 019780 135 -TMMIITELMRGETLQRYLWSTR-PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLL----TEDKKQVKLADF 208 (336)
Q Consensus 135 -~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll----~~~~~~~kl~Df 208 (336)
..++||||++|++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++ .+||+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Df 160 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDF 160 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE-EEEECCC
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc-eEEEccC
Confidence 3799999999999999996533 2349999999999999999999999999999999999998 5554 7999999
Q ss_pred cccccccccc-ccccCCcccccCCCCCC--------CCCCCCHHHHHHHHHHhhccCCCCCCCH-----hHHHHHHHHHH
Q 019780 209 GLAREEVMDE-MTCEAGTYRWMAPENER--------PSLENLSEDMVALLKSCWAEDPKVRPEF-----AEITITLTNIL 274 (336)
Q Consensus 209 g~a~~~~~~~-~~~~~gt~~y~aPE~~~--------~~~~~~~~di~~l~~~~l~~~p~~RP~~-----~~i~~~l~~~~ 274 (336)
|+++...... .....||+.|+|||... ...++...|+|+|++.+|++-.+..|.. ......+..+.
T Consensus 161 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred CCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 9998643332 34456999999999654 5677889999999999999988888752 23333344443
Q ss_pred HhhccC-----------------C--------CCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 275 QNLRSA-----------------D--------TPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 275 ~~~~~~-----------------~--------~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
...... . ..+++.+.+++..++..+|+.|.+..++.+
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~ 302 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence 322110 0 011223455667777788888877777654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=287.68 Aligned_cols=248 Identities=18% Similarity=0.297 Sum_probs=195.9
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--Ccc----EEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEP----VAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~----vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
.+...+|.+.+.||+|+||+||+|.+. ++. ||+|.+.... .......+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS----GRQSFQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT----SCSCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc----cHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 355678999999999999999999985 444 6777765321 112234577899999999999999999999
Q ss_pred ecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 132 VQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 132 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
.++..++||||+.+|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 85 ~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a 162 (325)
T 3kex_A 85 PGSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVA 162 (325)
T ss_dssp CBSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-CEEECSCSGG
T ss_pred cCCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC-eEEECCCCcc
Confidence 888899999999999999999543 35689999999999999999999999999999999999999877 7999999999
Q ss_pred ccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHh--hccCCCCC
Q 019780 212 REEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQN--LRSADTPI 284 (336)
Q Consensus 212 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~--~~~~~~~~ 284 (336)
+...... .....|+..|+|||......++.+.|+|+|++.+|++-. +..|....-...+...... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQIC 242 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTB
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcC
Confidence 8643322 233457889999999887888999999999999999877 7777533222222222222 12233457
Q ss_pred CCCcccccCCCCCCCCccccchhhhcc
Q 019780 285 PPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
++++..++...+..+|..|++..++.+
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~el~~ 269 (325)
T 3kex_A 243 TIDVYMVMVKCWMIDENIRPTFKELAN 269 (325)
T ss_dssp CTTTTHHHHHHTCSCTTTSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 788999999999999999998888775
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=273.12 Aligned_cols=218 Identities=27% Similarity=0.511 Sum_probs=179.6
Q ss_pred ceeecCCceeEee-eecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 56 SVLVDHRSVLLQK-MIGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 56 ~~~~~~~~~~~~~-~lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
.+.++.++|.+.+ .||+|+||.||+|.+. +..||||+++.. .......+.+.+|+.+++.++||||++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---ANDPALKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccc---ccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4556778999998 9999999999999653 578999999742 2234456789999999999999999999999
Q ss_pred EecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 131 SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 131 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
+.++..++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||+
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~ 163 (291)
T 1xbb_A 87 CEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGL 163 (291)
T ss_dssp EESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTT
T ss_pred ECCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC-cEEEccCCc
Confidence 9777799999999999999999553 5699999999999999999999999999999999999999876 899999999
Q ss_pred cccccccc-----ccccCCcccccCCCC----------------------------------------------CCCCCC
Q 019780 211 AREEVMDE-----MTCEAGTYRWMAPEN----------------------------------------------ERPSLE 239 (336)
Q Consensus 211 a~~~~~~~-----~~~~~gt~~y~aPE~----------------------------------------------~~~~~~ 239 (336)
+....... .....+++.|+|||. ....+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 243 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 97543322 122346788999991 112235
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
.++.++.+++..||+.+|.+||++.++++.|+.+......
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 5788999999999999999999999999999998876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=279.03 Aligned_cols=213 Identities=25% Similarity=0.507 Sum_probs=172.1
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccE----EEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPV----AVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~v----avK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
.+...+|.+.+.||+|+||.||+|.+. ++.+ |+|.+.. .........+.+|+.+++.++||||+++++++
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECC----CSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecc----ccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 456788999999999999999999985 4444 6666642 12233467789999999999999999999999
Q ss_pred ecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 132 VQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 132 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
.++..++|++|+.+|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kL~DfG~a 164 (327)
T 3lzb_A 87 LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLA 164 (327)
T ss_dssp ESSSEEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTC-
T ss_pred ecCCceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC-CEEEccCcce
Confidence 998899999999999999999654 35699999999999999999999999999999999999999876 8999999999
Q ss_pred ccccccc----ccccCCcccccCCCC----------------------------------------------CCCCCCCC
Q 019780 212 REEVMDE----MTCEAGTYRWMAPEN----------------------------------------------ERPSLENL 241 (336)
Q Consensus 212 ~~~~~~~----~~~~~gt~~y~aPE~----------------------------------------------~~~~~~~~ 241 (336)
+...... .....+|+.|+|||. ..+.+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 244 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTB
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccC
Confidence 7543221 222346789999991 12233456
Q ss_pred HHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 242 ~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
+.++..|+..||..+|.+||++.++++.|..+...
T Consensus 245 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 77888899999999999999999999999988754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=284.26 Aligned_cols=196 Identities=23% Similarity=0.271 Sum_probs=170.2
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-----CCceEeeEeeE
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-----HENILKFVGAS 131 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~~~~~~ 131 (336)
+-.++|.+.+.||+|+||+||+|.+. ++.||||+++. .......+..|+.+++.++ ||||+++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN------IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc------chhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 34578999999999999999999984 78899999862 2345667788999999996 99999999998
Q ss_pred ecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC------------
Q 019780 132 VQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE------------ 198 (336)
Q Consensus 132 ~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~------------ 198 (336)
...+ .++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence 8765 89999999 899999997766667999999999999999999999999999999999999974
Q ss_pred ------------CCCceEEeccccccccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 199 ------------DKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 199 ------------~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
....+||+|||+++.... ......||+.|+|||......++.+.|+|+|++.+|++-.+..|.
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 134799999999985332 334557999999999998888999999999999999988887775
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=274.46 Aligned_cols=212 Identities=30% Similarity=0.527 Sum_probs=172.1
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP- 134 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~- 134 (336)
.|.++.++|.+.+.||+|+||.||+|.+.++.||||+++.. ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC-------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecch-------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 56677899999999999999999999999999999998731 1356789999999999999999999987644
Q ss_pred -CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 -TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 -~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
..++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++..
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~ 166 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKE 166 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC---
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-cEEEeecccccc
Confidence 489999999999999999654434488999999999999999999999999999999999999876 799999999875
Q ss_pred cccccccccCCcccccCCCCC----------------------------------------------CCCCCCCHHHHHH
Q 019780 214 EVMDEMTCEAGTYRWMAPENE----------------------------------------------RPSLENLSEDMVA 247 (336)
Q Consensus 214 ~~~~~~~~~~gt~~y~aPE~~----------------------------------------------~~~~~~~~~di~~ 247 (336)
.... .....+++.|+|||.. ...+..++..+.+
T Consensus 167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 245 (278)
T 1byg_A 167 ASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 245 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHH
T ss_pred cccc-ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHH
Confidence 4332 2334578899999911 1123456778888
Q ss_pred HHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 248 LLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 248 l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
++..||..+|.+||++.++++.|+.+...
T Consensus 246 li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 246 VMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 99999999999999999999988887654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=288.75 Aligned_cols=190 Identities=26% Similarity=0.374 Sum_probs=161.4
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 134 (336)
.++|.+.+.||+|+||.||+|.+. ++.||||++.. ........+++.+|+.+|+.++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~---~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---TTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCc---hhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 468999999999999999999986 78899999973 223455677899999999999999999999998754
Q ss_pred --CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 135 --TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 135 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
..|+||||++ ++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~~kL~DFGla~ 177 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLAR 177 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred CCeEEEEEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC-CEEEccCCCcc
Confidence 3899999987 59999994 346799999999999999999999999999999999999999887 79999999998
Q ss_pred ccccc------------------------cccccCCcccccCCCCC-CCCCCCCHHHHHHHHHHhhccCC
Q 019780 213 EEVMD------------------------EMTCEAGTYRWMAPENE-RPSLENLSEDMVALLKSCWAEDP 257 (336)
Q Consensus 213 ~~~~~------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~di~~l~~~~l~~~p 257 (336)
..... ..+..+||+.|+|||.. ....++.+.|+|+|++.++++..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~ 247 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHh
Confidence 54322 12456799999999974 56678999999999999998875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=279.18 Aligned_cols=252 Identities=24% Similarity=0.292 Sum_probs=199.4
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccc-cHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAV-SREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
.+.|.+.+.||+|+||.||+|.+. ++.||+|++........ .....+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 357999999999999999999986 78999999985322111 1123567899999999999999999999998765 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC---ceEEeccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK---QVKLADFGLARE 213 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~---~~kl~Dfg~a~~ 213 (336)
++||||++|++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++. .++|+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 999999999999999943 457899999999999999999999999999999999999987653 699999999976
Q ss_pred cccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHHhhccCC----CCCCCC
Q 019780 214 EVMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQNLRSAD----TPIPPK 287 (336)
Q Consensus 214 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~~~~~~~----~~~p~~ 287 (336)
.... ......||+.|+|||.......+...|+|+|++.++++..+..|....-. ..+..+........ ...|+.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred cCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHH
Confidence 4332 23445699999999998888889999999999999999888888633211 12222222111111 345666
Q ss_pred cccccCCCCCCCCccccchhhhccccc
Q 019780 288 LVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
+.+++..++..+|+.|++..++.+...
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 778888888888888888877776443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=275.09 Aligned_cols=249 Identities=23% Similarity=0.301 Sum_probs=198.6
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
+.+..++|.+.+.||+|+||.||+|.+. +..||+|+++.... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM------SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY 76 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC------cHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4567789999999999999999999987 55799999974221 2356899999999999999999999998765
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYV 154 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC-CEEECCTTCEEEC
T ss_pred ceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC-CEEEccCccceec
Confidence 89999999999999999553 34589999999999999999999999999999999999999887 7999999999754
Q ss_pred ccccc---cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHH-HHHHHHHHHhhc-cCCCCCCCCc
Q 019780 215 VMDEM---TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEI-TITLTNILQNLR-SADTPIPPKL 288 (336)
Q Consensus 215 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i-~~~l~~~~~~~~-~~~~~~p~~~ 288 (336)
..... ....+|+.|+|||.......+.+.|+|+|+..++++-. +..|....- ......+..... ......|+++
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTI 234 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHH
Confidence 33322 22346678999998887778889999999999998877 666642211 112222222211 1223456778
Q ss_pred ccccCCCCCCCCccccchhhhcccc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.+++...+..+|+.|++..++.+.-
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~L 259 (268)
T 3sxs_A 235 YQIMYSCWHELPEKRPTFQQLLSSI 259 (268)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHH
Confidence 8899999999999999888877543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=301.95 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=204.5
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
...|.+..++|.+.+.||+|+||.||+|.+. +..||||+++.... ..+.+.+|+.+|+.++||||+++++++.
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~ 332 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVS 332 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3467888999999999999999999999997 46799999974221 2457899999999999999999999998
Q ss_pred cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 133 QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 133 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
++..++||||+.+|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 333 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~ 411 (535)
T 2h8h_A 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLAR 411 (535)
T ss_dssp SSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCTTSTT
T ss_pred eccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-cEEEcccccce
Confidence 87899999999999999999654445689999999999999999999999999999999999999876 79999999998
Q ss_pred cccccc---ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHH-HHHHHHHHhhc-cCCCCCCC
Q 019780 213 EEVMDE---MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEIT-ITLTNILQNLR-SADTPIPP 286 (336)
Q Consensus 213 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~-~~l~~~~~~~~-~~~~~~p~ 286 (336)
...... .....++..|+|||.......+...|+|+|+..+|++.. +..|...... +.+..+..... .....+|+
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 491 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 491 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 643322 122346789999998877788899999999999999988 5666432211 12222222211 12345677
Q ss_pred CcccccCCCCCCCCccccchhhhccc
Q 019780 287 KLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
++.+++...|..+++.|++..++.++
T Consensus 492 ~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 492 SLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 78889999999999999998887754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=281.71 Aligned_cols=211 Identities=25% Similarity=0.417 Sum_probs=170.2
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
..++|.+.+.||+|+||.||+|.+. ++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+ .+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 4578999999999999999999976 789999988642 2234667899999999999999999999988665 89
Q ss_pred EEEEccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 138 IITELMRGETLQRYLWSTR--PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++...
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF-VPKITDFGISKKGT 190 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC-CEEECCCTTCEECS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC-CEEEeecccccccc
Confidence 9999999999999985433 23589999999999999999999999999999999999999876 89999999997532
Q ss_pred ccc----ccccCCcccccCCCCCCCCCCCC--------------------------------------------------
Q 019780 216 MDE----MTCEAGTYRWMAPENERPSLENL-------------------------------------------------- 241 (336)
Q Consensus 216 ~~~----~~~~~gt~~y~aPE~~~~~~~~~-------------------------------------------------- 241 (336)
... .....||+.|+|||.......+.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 211 22334899999999332222222
Q ss_pred -----------HHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 242 -----------SEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 242 -----------~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
+.++.+++..||+.+|.+||++.++++.|+.+.+.
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 34455666678888888888888888888776543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=276.27 Aligned_cols=246 Identities=23% Similarity=0.279 Sum_probs=187.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
++|.+.+.||+|+||+||+|.+. ++.||+|++..... .......+.+|+.+++.++||||+++++++.+.. .++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG---GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc---ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999986 78999999974321 2223466889999999999999999999998765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc--c
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM--D 217 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~--~ 217 (336)
|||+++ +|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.... .
T Consensus 79 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC---
T ss_pred EEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEeECccccccCcccc
Confidence 999986 999988543 35689999999999999999999999999999999999999887 799999999875332 2
Q ss_pred cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccC---------------
Q 019780 218 EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSA--------------- 280 (336)
Q Consensus 218 ~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~--------------- 280 (336)
......||+.|+|||.... ...+.+.|+|+|++.++++-.+..|... .-...+..+.......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 2334568999999998765 4578999999999999998888777522 1112222222221111
Q ss_pred --------------CCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 281 --------------DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 281 --------------~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
...+++++.+++..++..+|+.|.+..++.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 012344455677777788888888877776544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=285.19 Aligned_cols=245 Identities=23% Similarity=0.315 Sum_probs=193.0
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
.+...+.||+|+||.||+|.+. ++.||+|+++.. .....+.+.+|+.+|+.++||||+++++++.+.. .++|
T Consensus 90 ~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR-----GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEEEEEECC-----CEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc-----ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3444678999999999999985 789999999742 2345678999999999999999999999998765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-CCCceEEecccccccccccc
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE-DKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~-~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+.. +.+.+||+|||+++......
T Consensus 165 ~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9999999999988543 346899999999999999999999999999999999999942 23489999999998644332
Q ss_pred -ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccC----CCCCCCCccccc
Q 019780 219 -MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSA----DTPIPPKLVEIV 292 (336)
Q Consensus 219 -~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~----~~~~p~~~~~~~ 292 (336)
.....||+.|+|||.......+.+.|+|+|++.+|++..+..|.... -...+..+....... ...+++++.+++
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence 33456999999999988888899999999999999998888886322 222333333322111 145778889999
Q ss_pred CCCCCCCCccccchhhhcccc
Q 019780 293 DPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~ 313 (336)
..++..+|..|.+..++.+..
T Consensus 324 ~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHcCCChhhCCCHHHHhcCc
Confidence 999999999999988887643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=270.31 Aligned_cols=212 Identities=26% Similarity=0.477 Sum_probs=174.4
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~- 134 (336)
...|.+.+.||+|+||.||+|.+. ...+|+|.+.. .......+.+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT----CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc----CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 457899999999999999999864 22488898863 23455677899999999999999999999986543
Q ss_pred -CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 -TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 -~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~a~~ 177 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARD 177 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSCGGGCC
T ss_pred CceEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-CEEECccccccc
Confidence 48999999999999999954 346689999999999999999999999999999999999999876 899999999975
Q ss_pred ccccc------ccccCCcccccCCCCC----------------------------------------------CCCCCCC
Q 019780 214 EVMDE------MTCEAGTYRWMAPENE----------------------------------------------RPSLENL 241 (336)
Q Consensus 214 ~~~~~------~~~~~gt~~y~aPE~~----------------------------------------------~~~~~~~ 241 (336)
..... .....||+.|+|||.. ...+..+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 257 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccC
Confidence 43222 2233477899999911 1223456
Q ss_pred HHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhc
Q 019780 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR 278 (336)
Q Consensus 242 ~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~ 278 (336)
+.++.+++..||+.+|.+||++.++++.|+.+...+.
T Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 258 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 7889999999999999999999999999998887643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=276.74 Aligned_cols=219 Identities=32% Similarity=0.560 Sum_probs=167.7
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEECC-----ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYGC-----EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
.+.+..++|.+.+.||+|+||.||+|.+.. ..||||+++.. .......+.+.+|+.+++.++||||++++++
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD---IIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccc---ccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 455677899999999999999999998762 27999998742 2233456789999999999999999999999
Q ss_pred EecCC-------EEEEEEccCCCCHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC
Q 019780 131 SVQPT-------MMIITELMRGETLQRYLWSTR----PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED 199 (336)
Q Consensus 131 ~~~~~-------~~lv~e~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~ 199 (336)
+.+.. .++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 87654 289999999999999995432 2358999999999999999999999999999999999999988
Q ss_pred CCceEEecccccccccccc----ccccCCcccccCCCC------------------------------------------
Q 019780 200 KKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPEN------------------------------------------ 233 (336)
Q Consensus 200 ~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~------------------------------------------ 233 (336)
+ .+||+|||+++...... .....+++.|+|||.
T Consensus 174 ~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 174 M-TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp S-CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred C-CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 6 79999999997543322 122346788999991
Q ss_pred ----CCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhc
Q 019780 234 ----ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR 278 (336)
Q Consensus 234 ----~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~ 278 (336)
....+..++.++.+|+..||+.+|.+||++.++++.++++.....
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 253 IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 123344567888899999999999999999999999998887643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=286.01 Aligned_cols=245 Identities=24% Similarity=0.294 Sum_probs=184.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecC---C
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQP---T 135 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~---~ 135 (336)
++|.+.+.||+|+||.||+|.+. ++.||||++.. ..........+.+|+.+++.+. ||||+++++++... .
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~---~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD---AFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecc---cccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 67999999999999999999986 78999999863 2234556778889999999998 99999999998743 3
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
+|+||||++ ++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 86 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEESS
T ss_pred EEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC-CEEecCCccccccc
Confidence 899999998 599999854 4689999999999999999999999999999999999999887 79999999997432
Q ss_pred c-----------------------ccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHH
Q 019780 216 M-----------------------DEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITL 270 (336)
Q Consensus 216 ~-----------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l 270 (336)
. ...+..+||+.|+|||...+ ..++.+.|+|+|++.++++-.+..|... +-...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1 11233569999999998765 6788999999999999998888776521 111112
Q ss_pred HHHHHhhc-----------------------------------------------cCCCCCCCCcccccCCCCCCCCccc
Q 019780 271 TNILQNLR-----------------------------------------------SADTPIPPKLVEIVDPKSTMNNDCM 303 (336)
Q Consensus 271 ~~~~~~~~-----------------------------------------------~~~~~~p~~~~~~~~~~~~~~~~~~ 303 (336)
..+...+. ......++++.+++..++..+|+.|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 22211110 0112456677788888888888888
Q ss_pred cchhhhccccc
Q 019780 304 ATVHAITKFNE 314 (336)
Q Consensus 304 ~~~~~~~~~~~ 314 (336)
.+..++.+...
T Consensus 321 ~t~~e~l~Hp~ 331 (388)
T 3oz6_A 321 ISANDALKHPF 331 (388)
T ss_dssp CCHHHHTTSTT
T ss_pred CCHHHHhCCHH
Confidence 88877776543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=278.24 Aligned_cols=246 Identities=21% Similarity=0.188 Sum_probs=191.4
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-E
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-M 136 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~ 136 (336)
.++|.+.+.||+|+||+||+|.+. ++.||||++... ............|+..+..+ +||||+++++++.++. .
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP---FRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSS---CCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccc---ccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 368999999999999999999986 789999998632 22333444555566555554 8999999999998766 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||+ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG-CEEECCCTTCEECC-
T ss_pred EEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEccceeeeeccc
Confidence 9999999 66999988554 35699999999999999999999999999999999999999887 799999999876433
Q ss_pred cc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhc--cCCCCCCCCcccccC
Q 019780 217 DE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR--SADTPIPPKLVEIVD 293 (336)
Q Consensus 217 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~--~~~~~~p~~~~~~~~ 293 (336)
.. .....||+.|+|||...+ .++.+.|+|+|++.+|++..+.+|.+..- ....+..... .....+++++.+++.
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--GWQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--HHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHhccCCCcccccCCCHHHHHHHH
Confidence 32 334469999999998776 67889999999999999887766554321 1222221111 112456778888999
Q ss_pred CCCCCCCccccchhhhcccccc
Q 019780 294 PKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
..+..+|+.|++..++.+..+.
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~ 308 (311)
T 3p1a_A 287 MMLEPDPKLRATAEALLALPVL 308 (311)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHcCCChhhCcCHHHHHhCccc
Confidence 9999999999999888876543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=267.78 Aligned_cols=212 Identities=26% Similarity=0.503 Sum_probs=175.6
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
.|.++.++|.+.+.||+|+||.||+|.+. +..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB------CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 46778899999999999999999999985 67899999974221 235689999999999999999999998876
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. .++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++..
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~ 153 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRF 153 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-CEEECCTTGGGG
T ss_pred CCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-CEEEcccccccc
Confidence 5 89999999999999999654 35689999999999999999999999999999999999999876 799999999975
Q ss_pred ccccc---ccccCCcccccCCCCCC----------------------------------------------CCCCCCHHH
Q 019780 214 EVMDE---MTCEAGTYRWMAPENER----------------------------------------------PSLENLSED 244 (336)
Q Consensus 214 ~~~~~---~~~~~gt~~y~aPE~~~----------------------------------------------~~~~~~~~d 244 (336)
..... .....++..|+|||... ..+...+.+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 233 (267)
T 3t9t_A 154 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 233 (267)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred cccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHH
Confidence 43322 22335778999999211 123345677
Q ss_pred HHHHHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 245 MVALLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 245 i~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
+.+++..||..+|.+||++.++++.|..+.+
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8888888899999999999988888887764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=268.81 Aligned_cols=173 Identities=29% Similarity=0.519 Sum_probs=144.2
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHH---HHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREH---KEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
.+..++|.+.+.||+|+||.||+|.+. ++.||+|++....... .... .+.+.+|+.+++.++||||+++++++.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG-ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTC-CHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeecccccc-chhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 355688999999999999999999985 7889999987432211 1111 267899999999999999999999987
Q ss_pred cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCC----ceEEe
Q 019780 133 QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS--VIHRDLKPSNLLLTEDKK----QVKLA 206 (336)
Q Consensus 133 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDikp~NIll~~~~~----~~kl~ 206 (336)
+.. ++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++| |+||||||+||+++.++. .+||+
T Consensus 94 ~~~-~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP-RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT-EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC-eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 665 799999999999998854 3457999999999999999999999999 999999999999987652 29999
Q ss_pred ccccccccccccccccCCcccccCCCCC
Q 019780 207 DFGLAREEVMDEMTCEAGTYRWMAPENE 234 (336)
Q Consensus 207 Dfg~a~~~~~~~~~~~~gt~~y~aPE~~ 234 (336)
|||+++.... ......||+.|+|||..
T Consensus 172 Dfg~~~~~~~-~~~~~~g~~~y~aPE~~ 198 (287)
T 4f0f_A 172 DFGLSQQSVH-SVSGLLGNFQWMAPETI 198 (287)
T ss_dssp CCTTCBCCSS-CEECCCCCCTTSCGGGS
T ss_pred CCCccccccc-cccccCCCccccCchhh
Confidence 9999985333 34456799999999954
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=275.75 Aligned_cols=218 Identities=26% Similarity=0.453 Sum_probs=177.9
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEECC-------ccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEe
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYGC-------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILK 126 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~ 126 (336)
..+.+..++|.+.+.||+|+||.||+|.+.+ ..||+|++... ......+.+.+|+.+++.+ +||||++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~ 114 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST----AHADEKEALMSELKIMSHLGQHENIVN 114 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc----cChHHHHHHHHHHHHHHhhcCCCCeee
Confidence 3566778999999999999999999999752 36999999732 2345567899999999999 8999999
Q ss_pred eEeeEecCC-EEEEEEccCCCCHHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 019780 127 FVGASVQPT-MMIITELMRGETLQRYLWSTR------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSN 193 (336)
Q Consensus 127 ~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~N 193 (336)
+++++.+.. .++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 194 (333)
T 2i1m_A 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARN 194 (333)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccce
Confidence 999988765 899999999999999995432 3468999999999999999999999999999999999
Q ss_pred eeecCCCCceEEecccccccccccc----ccccCCcccccCCCCCC----------------------------------
Q 019780 194 LLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENER---------------------------------- 235 (336)
Q Consensus 194 Ill~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~---------------------------------- 235 (336)
||++.++ .+||+|||+++...... .....||+.|+|||...
T Consensus 195 Il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 195 VLLTNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp CEEEGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred EEECCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 9999876 89999999998543322 12234678899999211
Q ss_pred -------------CCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh
Q 019780 236 -------------PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277 (336)
Q Consensus 236 -------------~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~ 277 (336)
..+...+.++.+|+..||+.+|.+||++.++++.|+++....
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 274 SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 112335677888889999999999999999988888776543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=284.84 Aligned_cols=245 Identities=22% Similarity=0.278 Sum_probs=189.8
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC---
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT--- 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 135 (336)
.++|.+.+.||+|+||.||+|.+. ++.||||+++.. ..........+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTT--TTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcc--ccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 467999999999999999999975 789999999742 2234556778999999999999999999999877542
Q ss_pred --EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 136 --MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 136 --~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.|+||||++|++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~ 165 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-CEEECCCSCC--
T ss_pred cccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-CEEEeeccCccc
Confidence 49999999999999999543 4689999999999999999999999999999999999999887 799999999975
Q ss_pred cccc-----cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHHhhc----cCCCC
Q 019780 214 EVMD-----EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQNLR----SADTP 283 (336)
Q Consensus 214 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~~~~----~~~~~ 283 (336)
.... ......||+.|+|||.......+...|+|+|+..+|++-.++.|....-. ........... .....
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 3322 12234589999999998888889999999999999999888888532211 11111221111 11234
Q ss_pred CCCCcccccCCCCCCCCccccchhhhc
Q 019780 284 IPPKLVEIVDPKSTMNNDCMATVHAIT 310 (336)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (336)
+|+++..++...+..+|+.|.+..+..
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l 272 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEM 272 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHH
Confidence 677788889999999998886544433
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=273.11 Aligned_cols=251 Identities=26% Similarity=0.361 Sum_probs=200.4
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
...+.+.|.+.+.||+|+||.||+|.+. +..||+|++.. ........+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~---~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (290)
T 1t4h_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD---RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEG---GGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecc---hhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc
Confidence 3445678999999999999999999986 67899999873 223455678899999999999999999999987642
Q ss_pred -----CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCCceEEec
Q 019780 135 -----TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS--VIHRDLKPSNLLLTEDKKQVKLAD 207 (336)
Q Consensus 135 -----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDikp~NIll~~~~~~~kl~D 207 (336)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++| ++||||||+||+++.+.+.+||+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~D 175 (290)
T 1t4h_A 98 VKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred cCCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEee
Confidence 289999999999999999543 56899999999999999999999999 999999999999984334899999
Q ss_pred cccccccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHHHhh--ccCCCC
Q 019780 208 FGLAREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNILQNL--RSADTP 283 (336)
Q Consensus 208 fg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~~~~--~~~~~~ 283 (336)
||++............||+.|+|||.... ..+.+.|+|+|++.++++-.+..|... ........+.... ......
T Consensus 176 fg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (290)
T 1t4h_A 176 LGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp TTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred CCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCC
Confidence 99997655555555679999999998764 478899999999999998888877532 2222222222211 112234
Q ss_pred CCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 284 IPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.++++.+++...+..+|+.|++..++.+..
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 556788889999999999999988887654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=294.65 Aligned_cols=201 Identities=24% Similarity=0.268 Sum_probs=164.0
Q ss_pred cCCceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 53 IDASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 53 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
.+.....-.++|.+++.||+|+||+||+|.+. ++.||||++... .........+.+|+.+|+.++||||++++++
T Consensus 53 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 129 (464)
T 3ttj_A 53 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129 (464)
T ss_dssp C--CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG---GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred cCCcceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc---ccChHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 33333344578999999999999999999986 788999999732 2345567789999999999999999999999
Q ss_pred EecC-------CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCce
Q 019780 131 SVQP-------TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQV 203 (336)
Q Consensus 131 ~~~~-------~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~ 203 (336)
+... ..|+||||+++ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 130 ~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-~~ 203 (464)
T 3ttj_A 130 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TL 203 (464)
T ss_dssp ECSCCSTTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CE
T ss_pred EccCCccccCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-CE
Confidence 8753 26999999986 5766662 2489999999999999999999999999999999999999887 79
Q ss_pred EEeccccccccccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 204 KLADFGLAREEVMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 204 kl~Dfg~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
||+|||+|+..... .....+||+.|+|||...+..++.+.|+|+|++.++++..++.|.
T Consensus 204 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF 263 (464)
T 3ttj_A 204 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263 (464)
T ss_dssp EECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred EEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999865433 234567999999999998889999999999999999987776664
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=289.80 Aligned_cols=190 Identities=23% Similarity=0.349 Sum_probs=151.8
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 134 (336)
..+|.+++.||+|+||+||+|.+. ++.||||++.. ........+.+.+|+.+|+.++||||+++++++...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~---~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR---VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECS---TTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEech---hhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 367999999999999999999886 78999999863 223455677899999999999999999999998532
Q ss_pred --CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 135 --TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 135 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
.+|+||||+. ++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 129 ~~~~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~ 204 (458)
T 3rp9_A 129 FDELYVVLEIAD-SDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLAR 204 (458)
T ss_dssp CCCEEEEECCCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCB
T ss_pred CceEEEEEeccc-cchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC-CEeecccccch
Confidence 3899999985 69999994 346799999999999999999999999999999999999999887 89999999998
Q ss_pred ccccc-----------------------------cccccCCcccccCCCCC-CCCCCCCHHHHHHHHHHhhccCC
Q 019780 213 EEVMD-----------------------------EMTCEAGTYRWMAPENE-RPSLENLSEDMVALLKSCWAEDP 257 (336)
Q Consensus 213 ~~~~~-----------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~di~~l~~~~l~~~p 257 (336)
..... ..+..+||+.|+|||.+ ....++.+.|+|+|++.++++..
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 54211 12344689999999964 56678999999999999998865
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=276.16 Aligned_cols=251 Identities=20% Similarity=0.183 Sum_probs=193.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||+||+|.+. ++.||||++... .......+.+.+|+.+++.++||||+++++++.+.. .++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES---EDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCC---CC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecc---ccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 57999999999999999999986 789999998642 234455678899999999999999999999998765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||+++++|.+++. ....+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||++......
T Consensus 80 v~e~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 80 VFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEECCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC---
T ss_pred EEEeCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC-CEEEeeCCCchhccCcc
Confidence 999999999999884 345699999999999999999999999999999999999999877 8999999999754322
Q ss_pred -cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCH----hHHHHHHHHHHHhh--------------
Q 019780 218 -EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEF----AEITITLTNILQNL-------------- 277 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~----~~i~~~l~~~~~~~-------------- 277 (336)
......||+.|+|||...+ ...+.+.|+|+|+..++++-.+..|.. .+....+.......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 2334568999999998765 567889999999999999888777742 22222222111100
Q ss_pred cc--------------CCCCCCCCcccccCCCCCCCCccccchhhhccccccccc
Q 019780 278 RS--------------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGKK 318 (336)
Q Consensus 278 ~~--------------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (336)
.. ..+.+++++.+++...+..+|+.|++..++.+...-.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 00 012355557778888899999999998888876554443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=279.15 Aligned_cols=249 Identities=24% Similarity=0.319 Sum_probs=180.2
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
..+|.+.+.||+|+||.||+|.+. ++.||+|+++... .......+.+|+.+++.++||||+++++++.+++ .+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS----EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS----TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc----ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence 467899999999999999999876 7899999997432 1223456789999999999999999999998765 89
Q ss_pred EEEEccCCCCHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 138 IITELMRGETLQRYLWSTR----PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+||||++ |+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARA 157 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence 9999998 59999985432 24589999999999999999999999999999999999999887 799999999975
Q ss_pred cccc--cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhcc----------
Q 019780 214 EVMD--EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRS---------- 279 (336)
Q Consensus 214 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~---------- 279 (336)
.... ......||+.|+|||.... ..++.+.|+|+|++.++++..+..|.... -...+..+...+..
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 4322 2344568999999998765 46789999999999999998888775221 11122222221111
Q ss_pred ------------------------CCCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 280 ------------------------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 280 ------------------------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
....+++++.+++..++..+|+.|.+..++.+...-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f 297 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhh
Confidence 111345556677778888888888888887765443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=276.85 Aligned_cols=237 Identities=24% Similarity=0.288 Sum_probs=166.6
Q ss_pred eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-EEEEEEcc
Q 019780 68 KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+.||+|+||.||+|.+. ++.||||++.. .....+.+|+.+++.+. ||||+++++++.+.. .|+||||+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--------~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 88 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK--------RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL 88 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG--------GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh--------hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence 78999999999999986 78999999862 23456789999999997 999999999998776 89999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC--ceEEeccccccccccc--cc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK--QVKLADFGLAREEVMD--EM 219 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~--~~kl~Dfg~a~~~~~~--~~ 219 (336)
+||+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++. .+||+|||+++..... ..
T Consensus 89 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 89 NGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp CSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 999999999543 57999999999999999999999999999999999999976542 6999999999754332 23
Q ss_pred cccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH--------HHHHHHHHHHhhccCC----CCCCCC
Q 019780 220 TCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE--------ITITLTNILQNLRSAD----TPIPPK 287 (336)
Q Consensus 220 ~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~--------i~~~l~~~~~~~~~~~----~~~p~~ 287 (336)
....||+.|+|||......++.+.|+|+|++.++++-.+..|.... ....+..+........ ..++++
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQE 246 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHH
Confidence 4456899999999999888999999999999999988887775321 1111111111110001 124555
Q ss_pred cccccCCCCCCCCccccchhhhccccc
Q 019780 288 LVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
+.+++...+..+|..|.+..++.+..+
T Consensus 247 ~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 247 AKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp HHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred HHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 566666666666666666666655443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=286.79 Aligned_cols=244 Identities=20% Similarity=0.235 Sum_probs=187.1
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccc---cHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAV---SREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
++|.+.+.||+|+||.||+|.+. ++.||||++........ .......+.+|+.+++.++||||+++++++.+..
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 67999999999999999999875 78899999985322111 1123345778999999999999999999998776
Q ss_pred EEEEEEccCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 MMIITELMRGE-TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 ~~lv~e~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.++||||+.+| +|.+++. ....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 104 ~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-TIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-cEEEeecccceEC
Confidence 89999999766 9999994 345699999999999999999999999999999999999999886 7999999999864
Q ss_pred cccc-ccccCCcccccCCCCCCCCCC-CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCCCCCCCCccccc
Q 019780 215 VMDE-MTCEAGTYRWMAPENERPSLE-NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVEIV 292 (336)
Q Consensus 215 ~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~p~~~~~~~ 292 (336)
.... .....||+.|+|||....... +...|+|+|++.+|++-.+..|.... .............+++++.+++
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~~~~~~~~~~l~~li 255 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL-----EETVEAAIHPPYLVSKELMSLV 255 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG-----GGGTTTCCCCSSCCCHHHHHHH
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH-----HHHHhhccCCCcccCHHHHHHH
Confidence 3332 344569999999998877766 67789999999999988877775321 1111111112223445555566
Q ss_pred CCCCCCCCccccchhhhcccc
Q 019780 293 DPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~ 313 (336)
...+..+|+.|++..++.+..
T Consensus 256 ~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 256 SGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp HHHTCSSGGGSCCHHHHHHCT
T ss_pred HHHccCChhhCcCHHHHhcCc
Confidence 666666666666665555433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=276.65 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=175.9
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||+|.+. ++.||||++.... .........+.+|+.+++.++||||+++++++.+.. .++
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA--MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh--hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 57999999999999999999974 7899999997311 111223467899999999999999999999998766 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC-CEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEEeecceeeccCCC
Confidence 99999999999999543 35789999999999999999999999999999999999999877 7999999999754322
Q ss_pred -cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCC
Q 019780 218 -EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPK 295 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~ 295 (336)
......||+.|+|||.......+...|+|+|+..++++..+..|.... ....+......-......+++++.+++...
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHH
Confidence 223456899999999998888888999999999999887777764221 111111111111112233556677788888
Q ss_pred CCCCCccccchhhhccccc
Q 019780 296 STMNNDCMATVHAITKFNE 314 (336)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~ 314 (336)
+..+|+.|++..++.+...
T Consensus 247 l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 247 LRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp SCSSGGGSCCHHHHTTSTT
T ss_pred cccCHhhCCCHHHHhcCcc
Confidence 8888888888888876543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=276.27 Aligned_cols=244 Identities=21% Similarity=0.282 Sum_probs=195.7
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||+|.+. ++.||+|+++... ......+.+|+.+++.++||||+++++++.+.. .++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-----AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-----ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 57999999999999999999986 8899999997421 223456889999999999999999999988766 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee---cCCCCceEEeccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLL---TEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll---~~~~~~~kl~Dfg~a~~~~ 215 (336)
||||++|++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||++ +.++ .++|+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 84 VMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS-KIMITDFGLSKMEQ 160 (304)
T ss_dssp EECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTTCCCC
T ss_pred EEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC-CEEEccCCcceecC
Confidence 99999999999998543 468999999999999999999999999999999999999 5454 79999999997654
Q ss_pred cccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHHhhccC----CCCCCCCccc
Q 019780 216 MDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQNLRSA----DTPIPPKLVE 290 (336)
Q Consensus 216 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~~~~~~----~~~~p~~~~~ 290 (336)
........|++.|+|||.......+...|+|+|++.++++-.+..|....-. ..+..+....... ...+|+++.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 4444445699999999999988889999999999999998888887533221 1222232222111 1346677788
Q ss_pred ccCCCCCCCCccccchhhhcccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
++...+..+|+.|++..++.+..
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 241 FICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSH
T ss_pred HHHHHcCCChhHCcCHHHHhcCc
Confidence 88888888999998888877643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=272.65 Aligned_cols=216 Identities=28% Similarity=0.518 Sum_probs=174.7
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEECC------ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
..+..++|.+.+.||+|+||.||+|.+.. ..||||+++.. ........+.+|+.+++.++||||++++++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 114 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG----YTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 114 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 45677899999999999999999998752 34999999732 234556779999999999999999999999
Q ss_pred EecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 131 SVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 131 ~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
+.+.. .++||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||
T Consensus 115 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg 192 (333)
T 1mqb_A 115 ISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFG 192 (333)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCC
T ss_pred EecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC-cEEECCCC
Confidence 88765 89999999999999999543 35799999999999999999999999999999999999999876 89999999
Q ss_pred ccccccccc-----ccccCCcccccCCCC----------------------------------------------CCCCC
Q 019780 210 LAREEVMDE-----MTCEAGTYRWMAPEN----------------------------------------------ERPSL 238 (336)
Q Consensus 210 ~a~~~~~~~-----~~~~~gt~~y~aPE~----------------------------------------------~~~~~ 238 (336)
+++...... .....+|+.|+|||. ..+.+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~ 272 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 272 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCc
Confidence 997543221 112236788999991 11233
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhc
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR 278 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~ 278 (336)
..++.++..|+..||+.+|.+||++.++++.|+.+.....
T Consensus 273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 4567888899999999999999999999999988876533
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=274.36 Aligned_cols=183 Identities=30% Similarity=0.484 Sum_probs=145.6
Q ss_pred CCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHh--CCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK--MKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~---- 134 (336)
.++|.+.+.||+|+||+||+|.+.++.||||++.. .....+.+|.+++.. ++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~--------~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSS--------RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECG--------GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecc--------ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 47899999999999999999999999999999863 123445566666666 7899999999986542
Q ss_pred -CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccccCCCCceeecCCCCceEE
Q 019780 135 -TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH--------ANSVIHRDLKPSNLLLTEDKKQVKL 205 (336)
Q Consensus 135 -~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH--------~~~ivHrDikp~NIll~~~~~~~kl 205 (336)
..++||||+++|+|.++++. ..+++..++.++.|++.||+||| ++||+||||||+|||++.++ .+||
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-~~kl 154 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCI 154 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-CEEE
T ss_pred ceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-CEEE
Confidence 28999999999999999932 46999999999999999999999 99999999999999999887 8999
Q ss_pred ecccccccccccc------ccccCCcccccCCCCCCCCC------CCCHHHHHHHHHHhhcc
Q 019780 206 ADFGLAREEVMDE------MTCEAGTYRWMAPENERPSL------ENLSEDMVALLKSCWAE 255 (336)
Q Consensus 206 ~Dfg~a~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~di~~l~~~~l~~ 255 (336)
+|||+++...... .....||+.|+|||...... .+.+.|+|+|++.+|++
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el 216 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHH
Confidence 9999997533222 22346999999999654431 22345555555555544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=294.30 Aligned_cols=218 Identities=22% Similarity=0.482 Sum_probs=178.7
Q ss_pred ceeecCCceeEee-eecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 56 SVLVDHRSVLLQK-MIGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 56 ~~~~~~~~~~~~~-~lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
.+.+...++.+.+ .||+|+||.||+|.+. +..||||+++.. ......+.+.+|+.+|+.++||||++++++
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 404 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGV 404 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC----CSSTTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC----CChHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3455666777766 8999999999999874 456999999742 123346779999999999999999999999
Q ss_pred EecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 131 SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 131 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
+.++..++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 405 ~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkL~DFGl 482 (613)
T 2ozo_A 405 CQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGL 482 (613)
T ss_dssp EESSSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCST
T ss_pred eccCCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-cEEEeeccC
Confidence 9988899999999999999999543 45699999999999999999999999999999999999999876 899999999
Q ss_pred cccccccc-----ccccCCcccccCCCC----------------------------------------------CCCCCC
Q 019780 211 AREEVMDE-----MTCEAGTYRWMAPEN----------------------------------------------ERPSLE 239 (336)
Q Consensus 211 a~~~~~~~-----~~~~~gt~~y~aPE~----------------------------------------------~~~~~~ 239 (336)
++...... .....+++.|+|||. ....+.
T Consensus 483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~ 562 (613)
T 2ozo_A 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 562 (613)
T ss_dssp TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT
T ss_pred cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 98643221 112235689999991 123345
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
.++.++++|+..||..+|.+||++.++++.|+.+......
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 6789999999999999999999999999999998876543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=286.83 Aligned_cols=243 Identities=22% Similarity=0.258 Sum_probs=184.2
Q ss_pred CceeEe-eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHH-HhCCCCceEeeEeeEec----
Q 019780 62 RSVLLQ-KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLL-SKMKHENILKFVGASVQ---- 133 (336)
Q Consensus 62 ~~~~~~-~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~---- 133 (336)
.+|.+. +.||+|+||+||+|.+. ++.||||+++. ...+.+|+.++ +..+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----------chhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 345555 78999999999999986 78899999962 13466788887 45589999999998764
Q ss_pred C-CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC--CCceEEecccc
Q 019780 134 P-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED--KKQVKLADFGL 210 (336)
Q Consensus 134 ~-~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~--~~~~kl~Dfg~ 210 (336)
. .+|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+ .+.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 2 38999999999999999976555679999999999999999999999999999999999999872 23799999999
Q ss_pred ccccccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-----HHHHHHHHhhccCC---
Q 019780 211 AREEVMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-----ITLTNILQNLRSAD--- 281 (336)
Q Consensus 211 a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-----~~l~~~~~~~~~~~--- 281 (336)
++..... .....+||+.|+|||......++...|+|+|++.+|++..+..|....-. .....+........
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 9864332 23456799999999999999999999999999999999888877532110 01111211111111
Q ss_pred -CCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 282 -TPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 282 -~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
..+++++.+++..++..+|+.|.+..++.+..+
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 346777888999999999999998888876443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=267.02 Aligned_cols=212 Identities=30% Similarity=0.528 Sum_probs=175.5
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--C---ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--C---EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
..|.+.+.||+|+||+||+|.+. + ..+|+|++.. .......+.+.+|+.+++.++||||+++++++.+.+
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR----ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT----CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc----cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence 35667799999999999999863 2 2699999863 234456788999999999999999999999987654
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.++||||+.+|+|.+++.. ....+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||+++..
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDI 174 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECCTTSSCTT
T ss_pred CcEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEeCcCCCcccc
Confidence 5899999999999999954 346789999999999999999999999999999999999999876 7999999999753
Q ss_pred ccc------cccccCCcccccCCCCCC----------------------------------------------CCCCCCH
Q 019780 215 VMD------EMTCEAGTYRWMAPENER----------------------------------------------PSLENLS 242 (336)
Q Consensus 215 ~~~------~~~~~~gt~~y~aPE~~~----------------------------------------------~~~~~~~ 242 (336)
... ......+++.|+|||... +.+..++
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCP 254 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCC
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccch
Confidence 222 122345789999999221 2334466
Q ss_pred HHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 243 EDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 243 ~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
.++.+|+..||+.+|.+||++.++++.|+++...+..
T Consensus 255 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 255 DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 7788899999999999999999999999999887543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=281.26 Aligned_cols=250 Identities=19% Similarity=0.274 Sum_probs=191.3
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC--CceEeeEeeEe
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH--ENILKFVGASV 132 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~ 132 (336)
.+.+..+.|.+.+.||+|+||.||+|.+. ++.||||++... .......+.+.+|+.+|+.++| |||+++++++.
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE---EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECT---TCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecc---ccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 45677889999999999999999999886 778999999742 2345566789999999999986 99999999998
Q ss_pred cCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 133 QPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 133 ~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
++. .++||| +.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++. + .+||+|||++
T Consensus 80 ~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~-~~kl~DFG~a 154 (343)
T 3dbq_A 80 TDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G-MLKLIDFGIA 154 (343)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T-EEEECCCSSS
T ss_pred eCCEEEEEEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C-cEEEeecccc
Confidence 776 899999 5678999999553 56899999999999999999999999999999999999973 4 7999999999
Q ss_pred ccccccc----ccccCCcccccCCCCCCC-----------CCCCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHH
Q 019780 212 REEVMDE----MTCEAGTYRWMAPENERP-----------SLENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNIL 274 (336)
Q Consensus 212 ~~~~~~~----~~~~~gt~~y~aPE~~~~-----------~~~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~ 274 (336)
+...... .....||+.|+|||.... ..++.+.|+|+|++.+|++..+..|... +-...+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 8643322 234569999999997643 5677889999999999999888888532 1122222222
Q ss_pred Hhhcc--CCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 275 QNLRS--ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 275 ~~~~~--~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
..... .....++++.+++...+..+|..|++..++.+..
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 21111 1122334577788888888888888887776543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=270.59 Aligned_cols=220 Identities=30% Similarity=0.545 Sum_probs=173.2
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEe
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVG 129 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 129 (336)
..+.++.++|.+.+.||+|+||.||+|.+. +..||+|++... .......+.+.+|+.+++.++||||+++++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD---NSSQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC------CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecc---ccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 466778899999999999999999999864 347999998742 224555678999999999999999999999
Q ss_pred eEecCC------EEEEEEccCCCCHHHHHhh----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC
Q 019780 130 ASVQPT------MMIITELMRGETLQRYLWS----TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED 199 (336)
Q Consensus 130 ~~~~~~------~~lv~e~~~gg~L~~~l~~----~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~ 199 (336)
++.+.. .++||||+++|+|.+++.. .....+++..++.++.|++.||.|||++||+||||||+||+++.+
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD 183 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC
Confidence 987643 5999999999999999843 234679999999999999999999999999999999999999988
Q ss_pred CCceEEecccccccccccc----ccccCCcccccCCCCC-----------------------------------------
Q 019780 200 KKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENE----------------------------------------- 234 (336)
Q Consensus 200 ~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~----------------------------------------- 234 (336)
+ .+||+|||+++...... .....+++.|+|||..
T Consensus 184 ~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 262 (313)
T 3brb_A 184 M-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262 (313)
T ss_dssp S-CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred C-cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 6 79999999997543321 2233478899999921
Q ss_pred -----CCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhc
Q 019780 235 -----RPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR 278 (336)
Q Consensus 235 -----~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~ 278 (336)
...+..++.++.+++..||..+|.+||++.+++..|+.+.+.+.
T Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 263 LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 12234566788889999999999999999999999998887653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=275.98 Aligned_cols=255 Identities=22% Similarity=0.229 Sum_probs=200.7
Q ss_pred cCCceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 53 IDASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 53 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
.+..+.++.++|.+.+.||+|+||.||+|.+. ++.||||++.. ......+.+.+|+.+++.++||||++++++
T Consensus 20 ~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (317)
T 2buj_A 20 QGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-----HEQQDREEAQREADMHRLFNHPNILRLVAY 94 (317)
T ss_dssp EEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE-----SSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred cccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec-----CCHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34567788999999999999999999999974 78999999863 234567789999999999999999999998
Q ss_pred Eec-----CCEEEEEEccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCce
Q 019780 131 SVQ-----PTMMIITELMRGETLQRYLWST--RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQV 203 (336)
Q Consensus 131 ~~~-----~~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~ 203 (336)
+.. ...++||||+++|+|.+++... ....+++..++.++.|++.||.|||++||+||||||+||+++.++ .+
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-~~ 173 (317)
T 2buj_A 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QP 173 (317)
T ss_dssp EEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CE
T ss_pred EEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-CE
Confidence 862 2389999999999999999542 356799999999999999999999999999999999999999877 79
Q ss_pred EEecccccccccccc-----------ccccCCcccccCCCCCCCCC---CCCHHHHHHHHHHhhccCCCCCCCHhHHHH-
Q 019780 204 KLADFGLAREEVMDE-----------MTCEAGTYRWMAPENERPSL---ENLSEDMVALLKSCWAEDPKVRPEFAEITI- 268 (336)
Q Consensus 204 kl~Dfg~a~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~---~~~~~di~~l~~~~l~~~p~~RP~~~~i~~- 268 (336)
+|+|||++....... .....||+.|+|||...... .+...|+|+|+..+|++-.+..|.......
T Consensus 174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 253 (317)
T 2buj_A 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253 (317)
T ss_dssp EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence 999999987532111 12234799999999877554 578999999999999999988886321110
Q ss_pred -HHHHHHHh-h-ccCCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 269 -TLTNILQN-L-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 269 -~l~~~~~~-~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.+...... . .......|+++.+++...+..+|..|++..++.+.-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 254 DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 11111111 1 112245677788899999999999999988877643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=272.65 Aligned_cols=251 Identities=24% Similarity=0.285 Sum_probs=194.7
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
+..++|.+.+.||+|+||.||+|.+. ++.||||++.... .........+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK--IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc--ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 34578999999999999999999986 8899999997311 112233567899999999999999999999988765
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
.++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-CEEECCCCGGGCCC
T ss_pred EEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-CEEEeecccccccC
Confidence 89999999999999999544 4689999999999999999999999999999999999999877 79999999987643
Q ss_pred ccc-ccccCCcccccCCCCCCCCCC-CCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCccccc
Q 019780 216 MDE-MTCEAGTYRWMAPENERPSLE-NLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIV 292 (336)
Q Consensus 216 ~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~ 292 (336)
... .....|++.|+|||....... +...|+|+|+..++++-.+..|.... ....+..+..........+++++.+++
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 242 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242 (276)
T ss_dssp C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHH
Confidence 322 234468999999998877665 57899999999999988777775322 222233333333333445677788899
Q ss_pred CCCCCCCCccccchhhhccccc
Q 019780 293 DPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
...+..+|+.|++..++.+...
T Consensus 243 ~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 243 MHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp HHHTCSSGGGSCCHHHHHHSHH
T ss_pred HHHccCChhhCCCHHHHHhChh
Confidence 9999999999999998887543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=271.99 Aligned_cols=247 Identities=18% Similarity=0.230 Sum_probs=196.8
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-EE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-MM 137 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~~ 137 (336)
.+|.+.+.||+|+||+||+|.+. ++.||||++.... ........+.+|+..+..+ +||||+++++++.+++ .+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL---AGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCC---TTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccc---cccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 57999999999999999999986 8899999997421 2334567788999999999 8999999999998765 89
Q ss_pred EEEEccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC---------------
Q 019780 138 IITELMRGETLQRYLWSTR--PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK--------------- 200 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~--------------- 200 (336)
+||||++|++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+||+++.++
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 9999999999999995432 25689999999999999999999999999999999999998432
Q ss_pred ---CceEEeccccccccccccccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 201 ---KQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 201 ---~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
..++|+|||++...... ....||+.|+|||..... ..+.+.|+|+|++.++++..+..|....- ....+...
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~ 243 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--QWHEIRQG 243 (289)
T ss_dssp --CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--HHHHHHTT
T ss_pred CCceEEEEcccccccccCCc--cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--HHHHHHcC
Confidence 36999999999864432 234599999999987655 44568999999999999987776543221 12222222
Q ss_pred -hccCCCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 277 -LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 277 -~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
.......+++++.+++...+..+|+.|++..++.+...-
T Consensus 244 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 283 (289)
T 1x8b_A 244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283 (289)
T ss_dssp CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence 223345677788889999999999999999888875543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=275.46 Aligned_cols=246 Identities=20% Similarity=0.283 Sum_probs=193.4
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.++|.+.+.||+|+||.||+|.+. ++.||+|++... ........+.+.+|+.+++.++||||+++++++.++. .+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSET--LSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGG--GGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcc--cccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 368999999999999999999985 788999999732 2234555688999999999999999999999988765 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||++|++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-FAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC-CEEEecCccCcccccc
Confidence 999999999999999543 4689999999999999999999999999999999999999876 7999999998754332
Q ss_pred c---ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh----ccCCCCCCCCccc
Q 019780 218 E---MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL----RSADTPIPPKLVE 290 (336)
Q Consensus 218 ~---~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~----~~~~~~~p~~~~~ 290 (336)
. .....|++.|+|||.......+...|+|+|+..+|++-.+..|....-...+....... ......+|+++.+
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 267 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA 267 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence 2 23446899999999998888889999999999999998888886444333333333321 2234567888999
Q ss_pred ccCCCCCCCCcccc-chhhhcc
Q 019780 291 IVDPKSTMNNDCMA-TVHAITK 311 (336)
Q Consensus 291 ~~~~~~~~~~~~~~-~~~~~~~ 311 (336)
++...+..+|+.|. +..++.+
T Consensus 268 li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 268 VIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHhccCCHHHHHHhHHHHHH
Confidence 99999999999997 7776664
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=296.64 Aligned_cols=216 Identities=28% Similarity=0.520 Sum_probs=176.7
Q ss_pred ceeecCCceeEe-eeecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 56 SVLVDHRSVLLQ-KMIGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 56 ~~~~~~~~~~~~-~~lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
.+.++...+.+. +.||+|+||.||+|.+. ++.||||+++.. .......+.+.+|+.+|+.++||||++++++
T Consensus 362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~ 438 (635)
T 4fl3_A 362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---ANDPALKDELLAEANVMQQLDNPYIVRMIGI 438 (635)
T ss_dssp SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGG---GGCGGGHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccc---cCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 445566666664 48999999999999663 568999999742 2234456789999999999999999999999
Q ss_pred EecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 131 SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 131 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
+.++..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 439 ~~~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-~~kL~DFGl 515 (635)
T 4fl3_A 439 CEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGL 515 (635)
T ss_dssp EESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCTTH
T ss_pred EecCCEEEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-CEEEEEcCC
Confidence 988889999999999999999954 35689999999999999999999999999999999999999887 899999999
Q ss_pred cccccccc-----ccccCCcccccCCCC----------------------------------------------CCCCCC
Q 019780 211 AREEVMDE-----MTCEAGTYRWMAPEN----------------------------------------------ERPSLE 239 (336)
Q Consensus 211 a~~~~~~~-----~~~~~gt~~y~aPE~----------------------------------------------~~~~~~ 239 (336)
++...... .....+|+.|+|||. ....+.
T Consensus 516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~ 595 (635)
T 4fl3_A 516 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 595 (635)
T ss_dssp HHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 97543222 222346788999991 123345
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~ 277 (336)
.++.++++|+..||+.+|.+||++.+++..|.++...+
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 67888999999999999999999999999999887654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=284.06 Aligned_cols=243 Identities=22% Similarity=0.302 Sum_probs=191.8
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-E
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-M 136 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~ 136 (336)
.++|.+.+.||+|+||.||+|.+. ++.||||++..... ...+|+.++..+ +||||+++++++.++. .
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 357999999999999999999986 78899999974321 234688888887 7999999999998776 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC---CceEEeccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK---KQVKLADFGLARE 213 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~---~~~kl~Dfg~a~~ 213 (336)
|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..+. ..+||+|||+++.
T Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999999999943 45699999999999999999999999999999999999985432 2599999999985
Q ss_pred cccc--cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh----HHHHHHHHHHHhhccCC----CC
Q 019780 214 EVMD--EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA----EITITLTNILQNLRSAD----TP 283 (336)
Q Consensus 214 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~----~i~~~l~~~~~~~~~~~----~~ 283 (336)
.... .....+||+.|+|||......++...|+|+|++.++++..+..|... .....+..+........ ..
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 4332 23456799999999988776677889999999999998888887532 12222222222211111 34
Q ss_pred CCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 284 IPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
+++++.+++..++..+|+.|.+..++.+..+
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 6777788888888889999988887776443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=285.88 Aligned_cols=252 Identities=21% Similarity=0.223 Sum_probs=195.7
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEE-----CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeE
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGAS 131 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 131 (336)
.+...+|.+.+.||+|+||.||+|+. .++.||||+++.... .........+.+|+.+++.+ +||||+++++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEE-EEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHh-hhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 44557999999999999999999998 478999999874211 11122345577899999999 699999999998
Q ss_pred ecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 132 VQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 132 ~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
.+.. .++||||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~ 205 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGL 205 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-cEEEeeCCC
Confidence 8765 89999999999999999543 4689999999999999999999999999999999999999887 799999999
Q ss_pred ccccccc---cccccCCcccccCCCCCCC--CCCCCHHHHHHHHHHhhccCCCCCCCHh-----HHHHHHHHHHHhhccC
Q 019780 211 AREEVMD---EMTCEAGTYRWMAPENERP--SLENLSEDMVALLKSCWAEDPKVRPEFA-----EITITLTNILQNLRSA 280 (336)
Q Consensus 211 a~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~di~~l~~~~l~~~p~~RP~~~-----~i~~~l~~~~~~~~~~ 280 (336)
++..... ......||+.|+|||.... ...+...|+|+|++.+|++..+..|... ........+.......
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC
Confidence 9753322 2233469999999998774 4467889999999999998888887531 1222222233333333
Q ss_pred CCCCCCCcccccCCCCCCCCcccc-----chhhhcccc
Q 019780 281 DTPIPPKLVEIVDPKSTMNNDCMA-----TVHAITKFN 313 (336)
Q Consensus 281 ~~~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 313 (336)
...+++.+.+++...+..+|..|. +..++.+..
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 445666677888889999999997 777776543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=272.02 Aligned_cols=245 Identities=21% Similarity=0.223 Sum_probs=196.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||+|.+. +..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.. .++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-----VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-----CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-----cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 57999999999999999999986 5689999987421 123567899999999999999999999998776 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee---cCCCCceEEeccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLL---TEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll---~~~~~~~kl~Dfg~a~~~~ 215 (336)
||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||++ +.++ .++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 84 VMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLAARFK 160 (277)
T ss_dssp EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEECC
T ss_pred EEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC-cEEEEecccceecc
Confidence 99999999999998543 568999999999999999999999999999999999999 5554 79999999997543
Q ss_pred cc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCC----CCCCCCcc
Q 019780 216 MD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSAD----TPIPPKLV 289 (336)
Q Consensus 216 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~----~~~p~~~~ 289 (336)
.. ......||+.|+|||...+. .+...|+|+|+..++++-.+..|.... -...+..+........ ..+++++.
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 32 23445699999999987655 788999999999999887777774221 1112222222221111 25677888
Q ss_pred cccCCCCCCCCccccchhhhcccccc
Q 019780 290 EIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
+++...+..+|+.|.+..++.+...-
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h~~~ 265 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEHEWF 265 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHH
Confidence 99999999999999998888765443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=280.48 Aligned_cols=201 Identities=20% Similarity=0.269 Sum_probs=170.7
Q ss_pred cCCceeecCCceeEeeeecCCCcEEEEEeE-----E--CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC---CC
Q 019780 53 IDASVLVDHRSVLLQKMIGEGSYSIVYKGF-----Y--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK---HE 122 (336)
Q Consensus 53 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~-----~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp 122 (336)
....+.+..++|.+.+.||+|+||+||+|. . .++.||||++... ....+.+|+.++..++ |+
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~~~~l~~~~~~ 127 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--------NPWEFYIGTQLMERLKPSMQH 127 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--------CHHHHHHHHHHHHHSCGGGGG
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--------ChhHHHHHHHHHHHhhhhhhh
Confidence 345677888999999999999999999994 2 3789999999732 2345778888888887 89
Q ss_pred ceEeeEeeEecCC-EEEEEEccCCCCHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC
Q 019780 123 NILKFVGASVQPT-MMIITELMRGETLQRYLWST---RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE 198 (336)
Q Consensus 123 nIv~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~ 198 (336)
||+.+++++...+ .++||||++||+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 128 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN 207 (365)
T ss_dssp GBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred hhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecc
Confidence 9999999988654 99999999999999999532 3467999999999999999999999999999999999999987
Q ss_pred -----------CCCceEEeccccccccc----cccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 199 -----------DKKQVKLADFGLAREEV----MDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 199 -----------~~~~~kl~Dfg~a~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
++ .+||+|||+|+... .......+||+.|+|||...+..++...|+|+|++.+|++..++.|.
T Consensus 208 ~~~~~~~~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 208 GFLEQDDEDDLSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp GGTCC------CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred cccCccccccccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcc
Confidence 55 89999999997432 22344567999999999999888999999999999999988777664
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=283.07 Aligned_cols=253 Identities=23% Similarity=0.258 Sum_probs=194.7
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.++|.+.+.||+|+||.||+|.+. +..||+|++.............+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 478999999999999999999986 678999999743222223445678999999999999999999999998776 89
Q ss_pred EEEEccCCCCHHHHHhhc--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 019780 138 IITELMRGETLQRYLWST--------------------------------------RPKRLDLKHSISFALDISRAMEYL 179 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~--------------------------------------~~~~l~~~~~~~i~~qi~~aL~~l 179 (336)
+||||++||+|.+++... ....+++..++.++.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998421 012246778889999999999999
Q ss_pred HhCCcccccCCCCceeecCCCC-ceEEeccccccccccc------cccccCCcccccCCCCCCC--CCCCCHHHHHHHHH
Q 019780 180 HANSVIHRDLKPSNLLLTEDKK-QVKLADFGLAREEVMD------EMTCEAGTYRWMAPENERP--SLENLSEDMVALLK 250 (336)
Q Consensus 180 H~~~ivHrDikp~NIll~~~~~-~~kl~Dfg~a~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~~di~~l~~ 250 (336)
|++||+||||||+||+++.++. .+||+|||+++..... ......||+.|+|||.... ...+...|+|+|++
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 9999999999999999986542 6999999999753221 1234569999999998754 56778999999999
Q ss_pred HhhccCCCCCCCHh-HHHHHHHHHHHhhccCC----CCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 251 SCWAEDPKVRPEFA-EITITLTNILQNLRSAD----TPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 251 ~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.+|++..+..|... .-...+..+........ ..+++++.+++...+..+|+.|.+..++.+..
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 99999888888522 11222333333222111 12577788899999999999999988887644
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=280.49 Aligned_cols=244 Identities=23% Similarity=0.277 Sum_probs=189.2
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 134 (336)
...|.+.+.||+|+||.||+|.+. ++.||||++... .......+.+.+|+.+|+.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSST---TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc---ccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 467999999999999999999985 789999998632 23455677899999999999999999999998754
Q ss_pred ---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 135 ---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 135 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
.+|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a 175 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLA 175 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred cCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-CEEEEeeecc
Confidence 259999999 7899999954 4689999999999999999999999999999999999999887 7999999999
Q ss_pred cccccccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhh------------
Q 019780 212 REEVMDEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNL------------ 277 (336)
Q Consensus 212 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~------------ 277 (336)
+... .......||+.|+|||.... ..++...|+|+|++.++++..++.|... +....+..+....
T Consensus 176 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 176 RQAD-SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp EECC-SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred cccc-cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 8643 23445679999999997765 6788899999999999998888877521 1112222222111
Q ss_pred -------------------ccCCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 278 -------------------RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 278 -------------------~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
....+..++++.+++..++..+|+.|.+..++.+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 111234566677788888888999998887776643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=278.59 Aligned_cols=247 Identities=25% Similarity=0.283 Sum_probs=197.9
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
+.|.+.+.||+|+||+||+|.+. ++.||||++.... .......+.+.+|+.+++.++||||+++++++.++. .++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCS--SCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccc--ccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 56899999999999999999974 7899999997422 223445678999999999999999999999988765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||+. |+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 132 v~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS--
T ss_pred EEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEeeccCceecCC--
Confidence 999997 5888887543 35689999999999999999999999999999999999999876 899999999975433
Q ss_pred ccccCCcccccCCCCC---CCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhcc--CCCCCCCCccccc
Q 019780 219 MTCEAGTYRWMAPENE---RPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRS--ADTPIPPKLVEIV 292 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~---~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~--~~~~~p~~~~~~~ 292 (336)
.....||+.|+|||.. .....+...|+|+|++.+|++..+..|.... ....+..+...... .....|+.+.+++
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 2345699999999976 3566788999999999999998888885321 22222333322111 1234566788889
Q ss_pred CCCCCCCCccccchhhhcccccc
Q 019780 293 DPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
...+..+|+.|++..++.+....
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHHH
T ss_pred HHHcccChhhCcCHHHHhhChhh
Confidence 99999999999999888875543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=272.31 Aligned_cols=215 Identities=29% Similarity=0.537 Sum_probs=176.9
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEE------CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
-.++.++|.+.+.||+|+||.||+|.+ .+..||||++... .....+.+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 92 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQRDFQREIQILKALHSDFIVKYRGV 92 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-----CHHHHHHHHHHHHHHHhcCCCceeEEEEE
Confidence 346778999999999999999999984 2678999998732 34556779999999999999999999998
Q ss_pred EecC---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEec
Q 019780 131 SVQP---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLAD 207 (336)
Q Consensus 131 ~~~~---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~D 207 (336)
+... ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~-~~kl~D 170 (327)
T 3lxl_A 93 SYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIAD 170 (327)
T ss_dssp EECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECC
T ss_pred EecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC-CEEEcc
Confidence 8632 3899999999999999996432 4689999999999999999999999999999999999999877 899999
Q ss_pred ccccccccccc-----ccccCCcccccCCCC-------------------------------------------------
Q 019780 208 FGLAREEVMDE-----MTCEAGTYRWMAPEN------------------------------------------------- 233 (336)
Q Consensus 208 fg~a~~~~~~~-----~~~~~gt~~y~aPE~------------------------------------------------- 233 (336)
||+++...... .....||..|+|||.
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred cccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence 99998543222 223357888999991
Q ss_pred -----------CCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhc
Q 019780 234 -----------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR 278 (336)
Q Consensus 234 -----------~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~ 278 (336)
..+.+..++.++.+|+..||+.+|.+||++.++++.|+.+.....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 112344677889999999999999999999999999988766543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=288.57 Aligned_cols=253 Identities=23% Similarity=0.269 Sum_probs=189.0
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCcccc---ccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALA---VSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
.++|.+.+.||+|+||+||+|.+. ++.||||++....... ........+.+|+.+|+.++||||+++++++..+.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 213 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCc
Confidence 367999999999999999999986 6899999997532111 11223345889999999999999999999998888
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC--CceEEeccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK--KQVKLADFGLARE 213 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~--~~~kl~Dfg~a~~ 213 (336)
.++||||+++|+|.+++ .....+++..++.++.|++.||+|||++||+||||||+|||++.++ ..+||+|||+++.
T Consensus 214 ~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEECCTTCBGGGGT--SSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred eEEEEEcCCCCcHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 99999999999999998 4446799999999999999999999999999999999999997543 2599999999986
Q ss_pred ccccc-ccccCCcccccCCCCCCC---CCCCCHHHHHHHHHHhhccCCCCCCCHhH--HHHHHHHHHHhhcc----CCCC
Q 019780 214 EVMDE-MTCEAGTYRWMAPENERP---SLENLSEDMVALLKSCWAEDPKVRPEFAE--ITITLTNILQNLRS----ADTP 283 (336)
Q Consensus 214 ~~~~~-~~~~~gt~~y~aPE~~~~---~~~~~~~di~~l~~~~l~~~p~~RP~~~~--i~~~l~~~~~~~~~----~~~~ 283 (336)
..... ....+||+.|+|||.... ..++.+.|+|+|++.++++..+..|.... .......+...... ....
T Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 371 (419)
T 3i6u_A 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371 (419)
T ss_dssp CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence 44332 344579999999998753 45567899999999999988877774221 00011111111111 1134
Q ss_pred CCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 284 IPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
+++++.+++..++..+|+.|.+..++.+..+.
T Consensus 372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 67778888888889999999888888765544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=273.27 Aligned_cols=243 Identities=20% Similarity=0.346 Sum_probs=194.5
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecC-
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQP- 134 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~- 134 (336)
....+|.+.+.||+|+||+||+|.+. ++.||||+++.. ..+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--------KKKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 45688999999999999999999875 789999998731 2356889999999997 99999999999863
Q ss_pred --CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 135 --TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 135 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
..++||||+.+++|.+++. .+++..++.++.|++.||+|||++||+||||||+|||++.++..+||+|||+++
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CCceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 3899999999999999983 388999999999999999999999999999999999999776689999999997
Q ss_pred ccccc-cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-----HHHHHHHHH---------HHh
Q 019780 213 EEVMD-EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-----EITITLTNI---------LQN 276 (336)
Q Consensus 213 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-----~i~~~l~~~---------~~~ 276 (336)
..... ......|+..|+|||.... ...+.+.|+|+|++.++++-.+..|.+. +.+..+... ...
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 180 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred EcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 54332 3344569999999998766 6688999999999999998888877521 111111111 111
Q ss_pred hccC-------------------------CCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 277 LRSA-------------------------DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 277 ~~~~-------------------------~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
.... ...+++++.+++..++..+|+.|.+..++.+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 0000 0115777888999999999999999888877543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=272.92 Aligned_cols=247 Identities=22% Similarity=0.274 Sum_probs=192.8
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
+.|.+.+.||+|+||.||+|.+. +..+|+|++.... .....+.+.+|+.+++.++||||+++++++.+.. .++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR----SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG----CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc----cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 57999999999999999999986 7889999997422 2223567899999999999999999999998765 899
Q ss_pred EEEccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC--CCceEEecccccccc
Q 019780 139 ITELMRGETLQRYLWST--RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED--KKQVKLADFGLAREE 214 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~--~~~~kl~Dfg~a~~~ 214 (336)
||||+++|+|.+++... ....+++..++.++.|++.||+|||++||+||||||+||+++.+ .+.+||+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999999998532 34679999999999999999999999999999999999999532 237999999999754
Q ss_pred ccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh----hccCCCCCCCCcc
Q 019780 215 VMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN----LRSADTPIPPKLV 289 (336)
Q Consensus 215 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~----~~~~~~~~p~~~~ 289 (336)
... ......||+.|+|||.... ..+.+.|+|+|++.++++-.+..|....-...+...... ......++++++.
T Consensus 178 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (285)
T 3is5_A 178 KSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV 256 (285)
T ss_dssp ---------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred CCcccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence 332 2344569999999998754 567889999999999998888877533222222222211 1112234677888
Q ss_pred cccCCCCCCCCccccchhhhcccc
Q 019780 290 EIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
+++...+..+|+.|++..++.+..
T Consensus 257 ~li~~~L~~dP~~Rps~~e~l~hp 280 (285)
T 3is5_A 257 DLLKQMLTKDPERRPSAAQVLHHE 280 (285)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred HHHHHHccCChhhCcCHHHHhcCH
Confidence 899999999999999988887654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=279.01 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=202.0
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEee
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF 127 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 127 (336)
..|.+..++|.+.+.||+|+||.||+|.+. +..||||++.. .........+.+|+.+++.++||||+++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT----TSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccc----ccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 356677889999999999999999999864 56799999873 2234456679999999999999999999
Q ss_pred EeeEecCC-EEEEEEccCCCCHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC
Q 019780 128 VGASVQPT-MMIITELMRGETLQRYLWSTR--------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE 198 (336)
Q Consensus 128 ~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~ 198 (336)
++++.+.. .++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 173 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcC
Confidence 99988765 899999999999999995422 245789999999999999999999999999999999999998
Q ss_pred CCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHH-HHHH
Q 019780 199 DKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITI-TLTN 272 (336)
Q Consensus 199 ~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~-~l~~ 272 (336)
++ .+||+|||+++...... .....||+.|+|||.......+...|+|+|++.+|++-. +..|....-.. ....
T Consensus 174 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 174 DF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp TC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CC-eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 86 79999999997543322 122346889999998887788899999999999998876 55554221111 1122
Q ss_pred HHH-hhccCCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 273 ILQ-NLRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 273 ~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
+.. ........+|+.+.+++...+..+|+.|++..++.+.-
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L 294 (322)
T 1p4o_A 253 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294 (322)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 221 12233456777788899999999999999988887643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=283.75 Aligned_cols=251 Identities=19% Similarity=0.269 Sum_probs=194.1
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC--CCceEeeEeeE
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK--HENILKFVGAS 131 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~ 131 (336)
..+.+..+.|.+.+.||+|+||.||+|.+. ++.||||++... .........+.+|+.+|+.++ ||||+++++++
T Consensus 49 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE---EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp CCEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECT---TCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred ccccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecc---cccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 345667788999999999999999999876 788999999742 224556788999999999997 59999999998
Q ss_pred ecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 132 VQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 132 ~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
..+. +++||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||+
T Consensus 126 ~~~~~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~-~~kl~DFG~ 200 (390)
T 2zmd_A 126 ITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G-MLKLIDFGI 200 (390)
T ss_dssp ECSSEEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S-CEEECCCSS
T ss_pred ecCCEEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C-eEEEEecCc
Confidence 8766 899999 5678999999554 47899999999999999999999999999999999999964 4 799999999
Q ss_pred cccccccc----ccccCCcccccCCCCCCC-----------CCCCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHH
Q 019780 211 AREEVMDE----MTCEAGTYRWMAPENERP-----------SLENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNI 273 (336)
Q Consensus 211 a~~~~~~~----~~~~~gt~~y~aPE~~~~-----------~~~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~ 273 (336)
++...... ....+||+.|+|||.... ..++...|+|+|++.+|++..+..|... +....+..+
T Consensus 201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~ 280 (390)
T 2zmd_A 201 ANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280 (390)
T ss_dssp SCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred cccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH
Confidence 98643322 234569999999997654 3577889999999999999888888632 122223333
Q ss_pred HHhhcc--CCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 274 LQNLRS--ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 274 ~~~~~~--~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
...... .....++++.+++...+..+|..|++..++.+..
T Consensus 281 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 281 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 221111 1122344577788888888888888888777543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=277.87 Aligned_cols=212 Identities=25% Similarity=0.478 Sum_probs=167.7
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~- 134 (336)
...|.+.+.||+|+||.||+|.+. ...||+|.++. .......+.+.+|+.+++.++||||+++++++.+.
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCS----CSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC----CCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 345788999999999999999864 23589998863 22345677899999999999999999999986543
Q ss_pred -CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 -TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 -~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~ 241 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARD 241 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC-----
T ss_pred CCeEEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC-CEEEeecccccc
Confidence 48999999999999999954 345688999999999999999999999999999999999999876 799999999975
Q ss_pred ccccc------ccccCCcccccCCCC----------------------------------------------CCCCCCCC
Q 019780 214 EVMDE------MTCEAGTYRWMAPEN----------------------------------------------ERPSLENL 241 (336)
Q Consensus 214 ~~~~~------~~~~~gt~~y~aPE~----------------------------------------------~~~~~~~~ 241 (336)
..... .....+++.|+|||. ....+..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~ 321 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 321 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTC
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 43221 122347789999991 11223457
Q ss_pred HHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhc
Q 019780 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR 278 (336)
Q Consensus 242 ~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~ 278 (336)
+..+++++..||+.+|.+||++.++++.|+.+...+.
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 7889999999999999999999999999999887654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=272.01 Aligned_cols=228 Identities=31% Similarity=0.514 Sum_probs=181.5
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEe
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVG 129 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 129 (336)
..+..++|.+.+.||+|+||.||+|.+. +..||||++.. .........+.+|+.+++.++||||+++++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCS----SCCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecc----ccchhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence 3456789999999999999999999842 56799999863 223455667899999999999999999999
Q ss_pred eEecCC-EEEEEEccCCCCHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC--C
Q 019780 130 ASVQPT-MMIITELMRGETLQRYLWSTRP-----KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK--K 201 (336)
Q Consensus 130 ~~~~~~-~~lv~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~--~ 201 (336)
++.+.. .++||||++|++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 998765 8999999999999999965432 4589999999999999999999999999999999999998432 3
Q ss_pred ceEEecccccccccccc----ccccCCcccccCCCCC-------------------------------------------
Q 019780 202 QVKLADFGLAREEVMDE----MTCEAGTYRWMAPENE------------------------------------------- 234 (336)
Q Consensus 202 ~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~------------------------------------------- 234 (336)
.++|+|||+++...... .....|++.|+|||..
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 69999999987432221 2234578899999911
Q ss_pred ---CCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCCCCCCCCc
Q 019780 235 ---RPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKL 288 (336)
Q Consensus 235 ---~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~p~~~ 288 (336)
...+..++..+..++..||+.+|.+||++.++++.+..+.+.........|.+.
T Consensus 261 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~ 317 (327)
T 2yfx_A 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEY 317 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTCCCCCC-
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHhcccccccc
Confidence 122345677888999999999999999999999999988876655555555543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=285.17 Aligned_cols=253 Identities=20% Similarity=0.244 Sum_probs=202.0
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
..+..++|.+.+.||+|+||.||+|.+. +..||+|++... ........+.+|+.+++.++||||+++++++.++
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC----CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc----cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 3456688999999999999999999987 789999999742 2455677899999999999999999999998876
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCceEEecccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
. .++||||++|++|.+++... ..+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++.
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~ 180 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSG 180 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCH
T ss_pred CEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCc
Confidence 5 89999999999999999543 4689999999999999999999996 999999999999999887 79999999997
Q ss_pred ccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCH----hHHHH--------------------
Q 019780 213 EEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEF----AEITI-------------------- 268 (336)
Q Consensus 213 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~----~~i~~-------------------- 268 (336)
...........||+.|+|||.......+...|+|+|++.++++-.+..|.. .++..
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 181 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 654444455679999999999988888999999999999998877776642 22111
Q ss_pred -------------------HHHHHHHhhccC--CCCCCCCcccccCCCCCCCCccccchhhhccccccc
Q 019780 269 -------------------TLTNILQNLRSA--DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKG 316 (336)
Q Consensus 269 -------------------~l~~~~~~~~~~--~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (336)
.+..+....... ...+++++.+++...+..+|+.|++..++.+.....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 329 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 111111111111 122456677888889999999999998888755443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=293.31 Aligned_cols=248 Identities=23% Similarity=0.297 Sum_probs=194.5
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||+||+|.+. ++.||||++.... ........+.+|+.+|+.++||||+++++++.+.. .++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS---AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHH---HBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 67999999999999999999986 7899999997321 12223567899999999999999999999998776 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC--CCceEEecccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED--KKQVKLADFGLAREEVM 216 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~--~~~~kl~Dfg~a~~~~~ 216 (336)
||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.. ...+||+|||+++....
T Consensus 99 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999998544 569999999999999999999999999999999999999643 23699999999975433
Q ss_pred c-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhccCC----CCCCCCccc
Q 019780 217 D-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRSAD----TPIPPKLVE 290 (336)
Q Consensus 217 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~~~----~~~p~~~~~ 290 (336)
. ......||+.|+|||...+. ++.+.|+|+|++.++++..+..|....- ...+..+........ ..+++++.+
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 255 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (486)
T ss_dssp C----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred CCccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence 2 23455799999999988764 7889999999999999888888853321 112222222211111 235666777
Q ss_pred ccCCCCCCCCccccchhhhcccccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
++...+..+|..|++..++.+..+.
T Consensus 256 li~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 256 LIRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred HHHHHcCCChhhCcCHHHHhcCHhh
Confidence 8888888888888888777765443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=271.38 Aligned_cols=217 Identities=31% Similarity=0.545 Sum_probs=178.1
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEee
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKF 127 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~ 127 (336)
.+.+..++|.+.+.||+|+||.||+|.+. ++.||||+++.. ........+.+|+.++..+ +||||+++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC----CCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 55677889999999999999999999852 478999999732 2344567899999999999 69999999
Q ss_pred EeeEecCC--EEEEEEccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCC
Q 019780 128 VGASVQPT--MMIITELMRGETLQRYLWSTRP--------------KRLDLKHSISFALDISRAMEYLHANSVIHRDLKP 191 (336)
Q Consensus 128 ~~~~~~~~--~~lv~e~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp 191 (336)
++++.+.+ .++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++||+||||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp 176 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence 99987643 8999999999999999965432 2288999999999999999999999999999999
Q ss_pred CceeecCCCCceEEecccccccccccc----ccccCCcccccCCCCC---------------------------------
Q 019780 192 SNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENE--------------------------------- 234 (336)
Q Consensus 192 ~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~--------------------------------- 234 (336)
+||+++.++ .+||+|||+++...... .....||+.|+|||..
T Consensus 177 ~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 177 RNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999876 79999999997543221 1223478899999911
Q ss_pred --------------CCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh
Q 019780 235 --------------RPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277 (336)
Q Consensus 235 --------------~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~ 277 (336)
...+...+.++.+++..||+.+|.+||++.++++.|..+.+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1123446778888999999999999999999999998887653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=292.01 Aligned_cols=252 Identities=21% Similarity=0.248 Sum_probs=195.0
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccc--------cHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAV--------SREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
...|.+++.||+|+||+||+|.+. ++.||||++........ .....+.+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 367999999999999999999986 67899999974221100 01235678999999999999999999999
Q ss_pred EecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC--ceEEec
Q 019780 131 SVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK--QVKLAD 207 (336)
Q Consensus 131 ~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~--~~kl~D 207 (336)
+.+.. .++||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 98876 89999999999999999543 56999999999999999999999999999999999999987653 599999
Q ss_pred cccccccccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHHhhccCC----
Q 019780 208 FGLAREEVMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQNLRSAD---- 281 (336)
Q Consensus 208 fg~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~~~~~~~---- 281 (336)
||+++..... ......||+.|+|||.... .++.+.|+|+|++.+|++..+..|....-. ..+..+........
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 9999864333 3345579999999998764 578899999999999998888887532211 12222222211111
Q ss_pred CCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 282 TPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 282 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
..+++++.+++..++..+|..|++..++.+..+.
T Consensus 272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 3467778888888888888888888777765443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=294.18 Aligned_cols=249 Identities=22% Similarity=0.266 Sum_probs=198.1
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
..+|.+.+.||+|+||.||+|.+. ++.||||++..... ........+.+|+.+++.++||||+++++++.+.. .+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQV--KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhc--ccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999986 78999999974321 12334677999999999999999999999998766 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec---CCCCceEEecccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLT---EDKKQVKLADFGLAREE 214 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~---~~~~~~kl~Dfg~a~~~ 214 (336)
+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++ .+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDA-NIRIIDFGLSTHF 179 (484)
T ss_dssp EEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC-CEEECCTTHHHHB
T ss_pred EEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCC-cEEEEeeeeeEEc
Confidence 99999999999999943 45799999999999999999999999999999999999994 344 7999999999754
Q ss_pred ccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCC----CCCCCCc
Q 019780 215 VMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSAD----TPIPPKL 288 (336)
Q Consensus 215 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~----~~~p~~~ 288 (336)
... ......||+.|+|||...+ .++.+.|+|+|++.+|++-.+..|.... ....+..+........ ..+++++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 180 EASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp CCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred ccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 332 2344579999999998765 5788999999999999988888775322 1222222322211111 2456778
Q ss_pred ccccCCCCCCCCccccchhhhcccccc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
.+++..++..+|..|++..++.+..+.
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 888888999999999888877765443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=269.17 Aligned_cols=214 Identities=28% Similarity=0.555 Sum_probs=178.8
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEE------CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
..+..++|.+.+.||+|+||.||+|.+ .++.||||++... .....+.+.+|+.+++.++||||++++++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-----CSHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 345567899999999999999999984 3788999998732 34556789999999999999999999998
Q ss_pred EecC---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEec
Q 019780 131 SVQP---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLAD 207 (336)
Q Consensus 131 ~~~~---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~D 207 (336)
+... ..++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kL~D 188 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGD 188 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECC
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-cEEEec
Confidence 7653 489999999999999999654 35689999999999999999999999999999999999999876 899999
Q ss_pred ccccccccccc-----ccccCCcccccCCCC-------------------------------------------------
Q 019780 208 FGLAREEVMDE-----MTCEAGTYRWMAPEN------------------------------------------------- 233 (336)
Q Consensus 208 fg~a~~~~~~~-----~~~~~gt~~y~aPE~------------------------------------------------- 233 (336)
||+++...... .....++..|+|||.
T Consensus 189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 99998543322 122347788999991
Q ss_pred ------------CCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh
Q 019780 234 ------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277 (336)
Q Consensus 234 ------------~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~ 277 (336)
..+.+..++.++.+|+..||+.+|.+||++.++++.|+.+...+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 01234567789999999999999999999999999999887764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=292.67 Aligned_cols=246 Identities=20% Similarity=0.254 Sum_probs=191.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
+.|.+++.||+|+||+||+|.+. +..||+|++..... .......+.+|+.+++.++||||+++++++.+.. .|+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV---STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC--------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc---CchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 47999999999999999999986 78899999974221 1223567899999999999999999999998775 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC--CceEEecccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK--KQVKLADFGLAREEVM 216 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~--~~~kl~Dfg~a~~~~~ 216 (336)
||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+||+|||+++....
T Consensus 114 v~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999999999998543 5689999999999999999999999999999999999997543 3599999999975433
Q ss_pred c-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHHhhccCC----CCCCCCccc
Q 019780 217 D-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQNLRSAD----TPIPPKLVE 290 (336)
Q Consensus 217 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~~~~~~~----~~~p~~~~~ 290 (336)
. ......||+.|+|||... ..++.+.|+|+|++.+|++..+..|....-. ..+..+........ ..+++++.+
T Consensus 192 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 192 QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 2 334567999999999876 4578899999999999998888887532211 12222222211111 346677778
Q ss_pred ccCCCCCCCCccccchhhhcccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
++..++..+|..|.+..++.+..
T Consensus 271 li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 271 LIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCH
T ss_pred HHHHHCCCChhhCccHHHHhcCc
Confidence 88888888888888887776543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=269.38 Aligned_cols=250 Identities=24% Similarity=0.292 Sum_probs=198.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccc-cHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAV-SREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
++|.+.+.||+|+||.||+|.+. ++.||+|+++....... .....+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57999999999999999999986 78999999985322111 1123577899999999999999999999998765 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC---ceEEecccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK---QVKLADFGLAREE 214 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~---~~kl~Dfg~a~~~ 214 (336)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++. .++|+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999999543 56899999999999999999999999999999999999986642 6999999999754
Q ss_pred ccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHHhhccC----CCCCCCCc
Q 019780 215 VMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQNLRSA----DTPIPPKL 288 (336)
Q Consensus 215 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~~~~~~----~~~~p~~~ 288 (336)
... ......|++.|+|||.......+...|+|+|+..++++..+..|....-. ..+..+....... ....|+.+
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 242 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHH
Confidence 332 23345699999999998888889999999999999998888888533211 1222222211111 13567778
Q ss_pred ccccCCCCCCCCccccchhhhcccc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.+++...+..+|+.|++..++.+..
T Consensus 243 ~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 243 KDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred HHHHHHHccCCHhHCcCHHHHHhCH
Confidence 8999999999999999988887644
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=293.52 Aligned_cols=216 Identities=31% Similarity=0.533 Sum_probs=178.2
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEe
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVG 129 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 129 (336)
..+.+...+|.+.+.||+|+||.||+|.+. +..||||.++. .......+.+.+|+.+++.++||||+++++
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 458 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIG 458 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSS----TTCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecc----cCCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 345667789999999999999999999875 34689998863 224456678999999999999999999999
Q ss_pred eEecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 130 ASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 130 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
++.++..++||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 459 ~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~-~vkL~DFG 536 (656)
T 2j0j_A 459 VITENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFG 536 (656)
T ss_dssp EECSSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred EEecCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC-CEEEEecC
Confidence 99887899999999999999999643 35689999999999999999999999999999999999999876 89999999
Q ss_pred ccccccccc---ccccCCcccccCCCCC----------------------------------------------CCCCCC
Q 019780 210 LAREEVMDE---MTCEAGTYRWMAPENE----------------------------------------------RPSLEN 240 (336)
Q Consensus 210 ~a~~~~~~~---~~~~~gt~~y~aPE~~----------------------------------------------~~~~~~ 240 (336)
+++...... .....+|+.|+|||.. .+.+..
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 616 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 616 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTT
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 998643322 1223477899999911 123455
Q ss_pred CHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 241 LSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 241 ~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
++.++.+|+..||+.+|.+||++.++++.|..+...
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 678888899999999999999999999988887654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=270.72 Aligned_cols=253 Identities=23% Similarity=0.246 Sum_probs=189.1
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
+.+..++|.+.+.||+|+||+||+|.+. ++.||+|+++.. .........+.++...++.++||||+++++++.++
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~ 78 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT---VNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE 78 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecc---cCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence 3466789999999999999999999984 889999999732 12333445556666668889999999999999876
Q ss_pred C-EEEEEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCceEEecccc
Q 019780 135 T-MMIITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
. .++||||++| +|.+++.. .....+++..++.++.|++.||.|||++ |++||||||+||+++.++ .+||+|||+
T Consensus 79 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~ 156 (290)
T 3fme_A 79 GDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGI 156 (290)
T ss_dssp SSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC--
T ss_pred CCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCC
Confidence 5 9999999985 88887743 2456799999999999999999999998 999999999999999877 899999999
Q ss_pred cccccccc-ccccCCcccccCCCCC----CCCCCCCHHHHHHHHHHhhccCCCCCCCH--hHHHHHHHHHHHhhccC--C
Q 019780 211 AREEVMDE-MTCEAGTYRWMAPENE----RPSLENLSEDMVALLKSCWAEDPKVRPEF--AEITITLTNILQNLRSA--D 281 (336)
Q Consensus 211 a~~~~~~~-~~~~~gt~~y~aPE~~----~~~~~~~~~di~~l~~~~l~~~p~~RP~~--~~i~~~l~~~~~~~~~~--~ 281 (336)
++...... .....||+.|+|||.. .....+.+.|+|+|++.++++-.+..|.. ..-...+.......... .
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence 97543332 2334699999999984 56667889999999999999888887752 22222333333322111 2
Q ss_pred CCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 282 TPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 282 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
..+++++.+++...+..+|+.|++..++.+...
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 346777888999999999999999998887443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=282.87 Aligned_cols=250 Identities=20% Similarity=0.262 Sum_probs=192.7
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCcccccc------HHHHHHHHHHHHHHHhCCCCceE
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVS------REHKEKFQREVTLLSKMKHENIL 125 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv 125 (336)
+..++|.+.+.||+|+||.||+|.+. ++.||||++......... ......+.+|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 34578999999999999999999885 368999998743211000 00112344566778888999999
Q ss_pred eeEeeEecC-----CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec--C
Q 019780 126 KFVGASVQP-----TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLT--E 198 (336)
Q Consensus 126 ~~~~~~~~~-----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~--~ 198 (336)
++++++.+. ..++||||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 999998753 279999999 99999999653 46799999999999999999999999999999999999998 6
Q ss_pred CCCceEEecccccccccccc---------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH----
Q 019780 199 DKKQVKLADFGLAREEVMDE---------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE---- 265 (336)
Q Consensus 199 ~~~~~kl~Dfg~a~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~---- 265 (336)
++ .+||+|||+++...... .....||+.|+|||.......+...|+|+|++.+|++..+..|....
T Consensus 190 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 190 PD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp TT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 55 89999999997533221 12345999999999999888999999999999999999888886532
Q ss_pred -HHHHH--------HHHHHhhccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 266 -ITITL--------TNILQNLRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 266 -i~~~l--------~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
..... ..+.... -.....|+++..++...+..+|+.|++..++.+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKC-FPAANAPGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHH-SCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHh-cccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 11111 1111111 0125678899999999999999999998888753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=273.23 Aligned_cols=245 Identities=17% Similarity=0.206 Sum_probs=197.7
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 135 (336)
+..++|.+.+.||+|+||.||+|.+. ++.||||++.... ....+.+|+.+++.+ +|+|++++++++.+..
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-------ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 44678999999999999999999964 8899999986321 223578899999999 6999999999988765
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC----ceEEecccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK----QVKLADFGL 210 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~----~~kl~Dfg~ 210 (336)
.++||||+ +++|.+++... +..+++..++.++.|++.||.|||++||+||||||+||+++.++. .+||+|||+
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred eeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 89999999 89999999643 356999999999999999999999999999999999999986541 399999999
Q ss_pred cccccccc---------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh----HHHHHHHHHHHh-
Q 019780 211 AREEVMDE---------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA----EITITLTNILQN- 276 (336)
Q Consensus 211 a~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~----~i~~~l~~~~~~- 276 (336)
++...... .....||+.|+|||.......+...|+|+|+..++++-.+..|... +....+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 97543321 2344699999999999888889999999999999998888877532 222222222221
Q ss_pred ----hccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 277 ----LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 277 ----~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.......+|+++.+++...+..+|+.|++..++.+.
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 122234678899999999999999999998888764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=277.26 Aligned_cols=248 Identities=23% Similarity=0.267 Sum_probs=182.2
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
..++|.+.+.||+|+||+||+|.+. ++.||||+++.. .........+.+|+.+++.++||||+++++++.++. .
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE---HEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCC---C--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccc---ccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 3468999999999999999999875 789999999742 223344567889999999999999999999998776 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC----CceEEecccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK----KQVKLADFGLAR 212 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~----~~~kl~Dfg~a~ 212 (336)
++||||++| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||+++
T Consensus 109 ~lv~e~~~~-~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 109 HLIFEYAEN-DLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEECCSE-EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEecCCC-CHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 999999985 999999543 4699999999999999999999999999999999999995332 259999999997
Q ss_pred cccc--ccccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCC-----
Q 019780 213 EEVM--DEMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTP----- 283 (336)
Q Consensus 213 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~----- 283 (336)
.... .......||+.|+|||..... .++.+.|+|+|++.++++..+..|... .-...+..+..........
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 5432 223445689999999987764 478999999999999998887777522 1222233333222111110
Q ss_pred -------------------------CCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 284 -------------------------IPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 284 -------------------------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
+++++.+++..++..+|+.|.+..++.+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 344555677777777888887777776544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=271.76 Aligned_cols=162 Identities=33% Similarity=0.524 Sum_probs=134.4
Q ss_pred CceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhC--CCCceEeeEeeEecC-----
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM--KHENILKFVGASVQP----- 134 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~~~~~~~----- 134 (336)
++|.+.+.||+|+||.||+|.+.++.||||++... ......+|.+++..+ +||||+++++++.+.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT--------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG--------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEecc--------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 68999999999999999999999999999998621 123345555555554 899999999998765
Q ss_pred CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCCCCceeecCCCCceEEe
Q 019780 135 TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN--------SVIHRDLKPSNLLLTEDKKQVKLA 206 (336)
Q Consensus 135 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--------~ivHrDikp~NIll~~~~~~~kl~ 206 (336)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEEC
T ss_pred ceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEE
Confidence 38999999999999999954 3589999999999999999999999 999999999999999877 89999
Q ss_pred ccccccccccccc------cccCCcccccCCCCCC
Q 019780 207 DFGLAREEVMDEM------TCEAGTYRWMAPENER 235 (336)
Q Consensus 207 Dfg~a~~~~~~~~------~~~~gt~~y~aPE~~~ 235 (336)
|||+++....... ....||+.|+|||...
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 219 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcc
Confidence 9999975433221 2446999999999543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=274.53 Aligned_cols=250 Identities=21% Similarity=0.236 Sum_probs=195.1
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
..++|.+.+.||+|+||.||+|.+. ++.||||++... .........+.+|+.+++.++||||+++++++.+.. .
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES---DDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESC---SSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecC---CCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 3478999999999999999999986 789999998742 234455677889999999999999999999998776 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||+++++|.+++. ....+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus 100 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAA 176 (331)
T ss_dssp EEEEECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCTTC-----
T ss_pred EEEEecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC-cEEEEeCCCceeecC
Confidence 99999999999998873 345699999999999999999999999999999999999999887 899999999975432
Q ss_pred c--cccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhc--------------
Q 019780 217 D--EMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLR-------------- 278 (336)
Q Consensus 217 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~-------------- 278 (336)
. ......||+.|+|||..... ..+.+.|+|+|++.++++-.+..|.... -...+..+.....
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 2 23345699999999987764 6788999999999999988887775221 1111111111100
Q ss_pred -----------------cCCCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 279 -----------------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 279 -----------------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
...+.+++++.+++...+..+|+.|++..++.+...-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 0012456778888889999999999999888875433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=269.10 Aligned_cols=239 Identities=25% Similarity=0.337 Sum_probs=198.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec------
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ------ 133 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------ 133 (336)
.+|.+.+.||+|+||.||+|.+. ++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 57999999999999999999986 8899999997421 246789999999999999999998753
Q ss_pred -----------CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCc
Q 019780 134 -----------PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQ 202 (336)
Q Consensus 134 -----------~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~ 202 (336)
...++||||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.++ .
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~ 160 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-Q 160 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-E
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-C
Confidence 2279999999999999999766567799999999999999999999999999999999999999876 8
Q ss_pred eEEeccccccccccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCC
Q 019780 203 VKLADFGLAREEVMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSAD 281 (336)
Q Consensus 203 ~kl~Dfg~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 281 (336)
++|+|||++...... ......|++.|+|||.......+...|+|+|+..+|++-.+..|.... ......+... ...
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~--~~~ 237 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-SKFFTDLRDG--IIS 237 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-HHHHHHHHTT--CCC
T ss_pred EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-HHHHHHhhcc--ccc
Confidence 999999998764433 233456999999999888888899999999999999999888875432 2222222221 233
Q ss_pred CCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 282 TPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 282 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
...|+++.+++...+..+|+.|++..++.+.-
T Consensus 238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l 269 (284)
T 2a19_B 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269 (284)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 45677788899999999999999988887643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=270.40 Aligned_cols=246 Identities=27% Similarity=0.349 Sum_probs=200.9
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.+.|.+.+.||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT----CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc----cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 456899999999999999999885 7899999997432 1234677999999999999999999999988765 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 97 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECBTT
T ss_pred EEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-CEEEeecccceecCcc
Confidence 99999999999999942 5689999999999999999999999999999999999999877 7999999999754332
Q ss_pred c--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHh-hccCCCCCCCCcccccC
Q 019780 218 E--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQN-LRSADTPIPPKLVEIVD 293 (336)
Q Consensus 218 ~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~-~~~~~~~~p~~~~~~~~ 293 (336)
. .....|++.|+|||.......+...|+|+|+..+|++..+..|....- ...+..+... ........|+.+.+++.
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 252 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 252 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHH
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHH
Confidence 2 334568999999999888888899999999999999888887753221 1111112111 12233456777888999
Q ss_pred CCCCCCCccccchhhhccccc
Q 019780 294 PKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~ 314 (336)
..+..+|+.|++..++.+...
T Consensus 253 ~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 253 ACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp HHCCSSGGGSCCHHHHTTCHH
T ss_pred HHcCCChhhCcCHHHHhhChh
Confidence 999999999999999887543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=268.23 Aligned_cols=246 Identities=22% Similarity=0.236 Sum_probs=196.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.+++.++||||+++++++.+.. .++
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG----CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc----chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 57999999999999999999986 7899999997422 2234577899999999999999999999998765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||+++++|.+++ .....+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 83 FLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEECCTTEEGGGGS--BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETT
T ss_pred EEEecCCCcHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-CEEEeeCCCccccCCCc
Confidence 99999999999998 3445799999999999999999999999999999999999999876 7999999998753222
Q ss_pred ---cccccCCcccccCCCCCCCCCC-CCHHHHHHHHHHhhccCCCCCCCHhH--HHHHHHHHHHhhccC--CCCCCCCcc
Q 019780 218 ---EMTCEAGTYRWMAPENERPSLE-NLSEDMVALLKSCWAEDPKVRPEFAE--ITITLTNILQNLRSA--DTPIPPKLV 289 (336)
Q Consensus 218 ---~~~~~~gt~~y~aPE~~~~~~~-~~~~di~~l~~~~l~~~p~~RP~~~~--i~~~l~~~~~~~~~~--~~~~p~~~~ 289 (336)
......|++.|+|||....... +...|+|+|+..++++-.+..|.... ....+.......... ...+++.+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence 1234568999999998876654 56799999999999988877775221 111122222211111 134677788
Q ss_pred cccCCCCCCCCccccchhhhccccc
Q 019780 290 EIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
+++...+..+|+.|++..++.+...
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 240 ALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred HHHHHHCCCCchhCCCHHHHhcCcc
Confidence 8899999999999999888876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=276.94 Aligned_cols=247 Identities=23% Similarity=0.297 Sum_probs=186.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+++.||+|+||+||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++.+.. .++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH----EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc----ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence 47999999999999999999986 7889999997321 1112224567999999999999999999998765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||++| +|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 78 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 78 VFEYLDK-DLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPT 154 (324)
T ss_dssp EEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC-CEEECSSSEEECC----
T ss_pred Eeccccc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC-CEEEccCcccccccCCc
Confidence 9999985 999988543 35689999999999999999999999999999999999999887 7999999998754322
Q ss_pred -cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccC--------------
Q 019780 218 -EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSA-------------- 280 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~-------------- 280 (336)
......||+.|+|||...+ ..++.+.|+|+|++.++++-.+..|... .....+..+...+...
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 2334468999999998765 5678999999999999998888777522 1122222222211111
Q ss_pred ----------------CCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 281 ----------------DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 281 ----------------~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
.+.+++++.+++..++..+|+.|.+..++.+..+-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 285 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence 12345566778888888899999888887764443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=267.40 Aligned_cols=208 Identities=28% Similarity=0.457 Sum_probs=166.6
Q ss_pred eeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEc
Q 019780 64 VLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITEL 142 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~ 142 (336)
|..++.||+|+||.||+|.+.++.||||++..... .......+.+.+|+.+++.++||||+++++++.+.+ .++||||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 111 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY 111 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTT-SCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccC-cchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence 44558899999999999999999999999874221 223445678999999999999999999999988765 8999999
Q ss_pred cCCCCHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc---
Q 019780 143 MRGETLQRYLWST-RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE--- 218 (336)
Q Consensus 143 ~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~--- 218 (336)
+++++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++......
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSCSSCE
T ss_pred cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC-cEEEeecccccccccccccc
Confidence 9999999999543 235689999999999999999999999999999999999999876 89999999987533221
Q ss_pred -ccccCCcccccCCCCCCCC----------------------------------------------------------CC
Q 019780 219 -MTCEAGTYRWMAPENERPS----------------------------------------------------------LE 239 (336)
Q Consensus 219 -~~~~~gt~~y~aPE~~~~~----------------------------------------------------------~~ 239 (336)
.....||+.|+|||...+. +.
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS 270 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCH
T ss_pred cccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccch
Confidence 2234689999999932211 01
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNI 273 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~ 273 (336)
..+..+++++..||+.+|.+||++.++++.|+++
T Consensus 271 ~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 271 TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1234566777788888888888888887777665
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=268.05 Aligned_cols=216 Identities=25% Similarity=0.355 Sum_probs=164.5
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeE
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGAS 131 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~ 131 (336)
..+.+...+|.+.+.||+|+||.||+|.+. ++.||||++... .......+.+|+.++..+. ||||+++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 95 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----chHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence 466777889999999999999999999984 789999998632 3455677899999999996 99999999988
Q ss_pred ec-------C--CEEEEEEccCCCCHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCC
Q 019780 132 VQ-------P--TMMIITELMRGETLQRYLWS-TRPKRLDLKHSISFALDISRAMEYLHANS--VIHRDLKPSNLLLTED 199 (336)
Q Consensus 132 ~~-------~--~~~lv~e~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDikp~NIll~~~ 199 (336)
.. . .+++||||+. |+|.+++.. .....+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 96 SIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp EECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT
T ss_pred cccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC
Confidence 41 1 1789999996 699998854 23456999999999999999999999999 9999999999999987
Q ss_pred CCceEEecccccccccccc--------------ccccCCcccccCCCCC---CCCCCCCHHHHHH---------------
Q 019780 200 KKQVKLADFGLAREEVMDE--------------MTCEAGTYRWMAPENE---RPSLENLSEDMVA--------------- 247 (336)
Q Consensus 200 ~~~~kl~Dfg~a~~~~~~~--------------~~~~~gt~~y~aPE~~---~~~~~~~~~di~~--------------- 247 (336)
+ .+||+|||+++...... .....||+.|+|||.. .....+...|+|+
T Consensus 175 ~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 253 (337)
T 3ll6_A 175 G-TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253 (337)
T ss_dssp S-CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred C-CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 7 79999999997543221 1134589999999965 3344444555554
Q ss_pred ---------------------------HHHHhhccCCCCCCCHhHHHHHHHHHHHhh
Q 019780 248 ---------------------------LLKSCWAEDPKVRPEFAEITITLTNILQNL 277 (336)
Q Consensus 248 ---------------------------l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~ 277 (336)
|+..||+.+|.+||++.++++.|..+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 254 EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cchhHHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 677799999999999999999988887653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=269.61 Aligned_cols=214 Identities=31% Similarity=0.548 Sum_probs=173.1
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--Ccc--EEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEec
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEP--VAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQ 133 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~--vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 133 (336)
++.++|.+.+.||+|+||.||+|.+. +.. +|+|.++. .........+.+|+.+++.+ +||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~----~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 97 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEEC----C------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecc----ccchHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence 45678999999999999999999875 443 48998873 12334456789999999999 89999999999987
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC
Q 019780 134 PT-MMIITELMRGETLQRYLWSTR--------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE 198 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~ 198 (336)
.+ .++||||+++++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 66 899999999999999995432 247899999999999999999999999999999999999998
Q ss_pred CCCceEEeccccccccccc-cccccCCcccccCCCC--------------------------------------------
Q 019780 199 DKKQVKLADFGLAREEVMD-EMTCEAGTYRWMAPEN-------------------------------------------- 233 (336)
Q Consensus 199 ~~~~~kl~Dfg~a~~~~~~-~~~~~~gt~~y~aPE~-------------------------------------------- 233 (336)
++ .+||+|||+++..... ......+++.|+|||.
T Consensus 178 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~ 256 (327)
T 1fvr_A 178 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256 (327)
T ss_dssp GG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CC-eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence 76 7999999998743222 1233347889999991
Q ss_pred --CCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh
Q 019780 234 --ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277 (336)
Q Consensus 234 --~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~ 277 (336)
....+..++.++.+|+..||..+|.+||++.+++..|..+....
T Consensus 257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 11223456788999999999999999999999999999887654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=274.51 Aligned_cols=250 Identities=19% Similarity=0.243 Sum_probs=195.4
Q ss_pred CceeEe-eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-E
Q 019780 62 RSVLLQ-KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT-M 136 (336)
Q Consensus 62 ~~~~~~-~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~ 136 (336)
..|.+. +.||+|+||.||+|.+. ++.||+|++.... ........+.+|+.++..+. ||||+++++++.+.. .
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR---RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEE---TTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhh---cchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 455555 89999999999999986 8899999997422 12233567899999999995 699999999998766 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---CCCceEEeccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE---DKKQVKLADFGLARE 213 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~---~~~~~kl~Dfg~a~~ 213 (336)
++||||+.||+|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++. ++ .+||+|||+++.
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~-~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLG-DIKIVDFGMSRK 183 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBC-CEEECCGGGCEE
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCC-cEEEeeCccccc
Confidence 99999999999999986555678999999999999999999999999999999999999987 44 799999999986
Q ss_pred cccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccC----CCCCCCC
Q 019780 214 EVMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSA----DTPIPPK 287 (336)
Q Consensus 214 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~----~~~~p~~ 287 (336)
.... ......||+.|+|||.......+...|+|+|++.++++-.+..|.... ....+..+....... ...+++.
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 263 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263 (327)
T ss_dssp C---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred cCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHH
Confidence 4332 233456999999999998888999999999999999988888875222 111222222221111 1346666
Q ss_pred cccccCCCCCCCCccccchhhhcccccc
Q 019780 288 LVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
+.+++...+..+|+.|++..++.+...-
T Consensus 264 ~~~li~~~L~~dP~~Rpt~~~ll~h~~~ 291 (327)
T 3lm5_A 264 ATDFIQSLLVKNPEKRPTAEICLSHSWL 291 (327)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred HHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence 7788888999999999998888765543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=278.07 Aligned_cols=198 Identities=28% Similarity=0.330 Sum_probs=157.7
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.++|.+.+.||+|+||.||+|.+. ++.||||++...............+.+|+.+++.++||||+++++++.+.. .+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 468999999999999999999986 788999999743222212222356889999999999999999999988665 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||+++ +|.+++.. ....+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 89 lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSC
T ss_pred EEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-CEEEEecccceeccCC
Confidence 99999986 89988843 335688999999999999999999999999999999999999887 7999999999864322
Q ss_pred --cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCC
Q 019780 218 --EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRP 261 (336)
Q Consensus 218 --~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP 261 (336)
......||+.|+|||.... ..++...|+|+|++.++++..+..|
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~ 212 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 212 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 2344569999999998754 4578889999999999988766555
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=271.63 Aligned_cols=250 Identities=20% Similarity=0.298 Sum_probs=198.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---CE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---TM 136 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~ 136 (336)
++|.+.+.||+|+||.||+|.+. +..||+|+++.... .........+.+|+.+++.++||||+++++++.+. ..
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKL-RRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHH-HHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccc-cccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 57899999999999999999985 77899999974211 11123457799999999999999999999998532 48
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||++++ |.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++.....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISALGVAEALHP 161 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-cEEeeccccccccCc
Confidence 9999999876 88888666667899999999999999999999999999999999999999876 799999999975432
Q ss_pred ----ccccccCCcccccCCCCCCCCCC--CCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcc
Q 019780 217 ----DEMTCEAGTYRWMAPENERPSLE--NLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLV 289 (336)
Q Consensus 217 ----~~~~~~~gt~~y~aPE~~~~~~~--~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~ 289 (336)
.......||+.|+|||....... +...|+|+|+..++++-.+..|.... ....+..+...........++++.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence 12234569999999998765443 67899999999999988888875332 222233333333334455677788
Q ss_pred cccCCCCCCCCccccchhhhccccc
Q 019780 290 EIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
+++...+..+|+.|.+..++.+...
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred HHHHHHccCChhhCCCHHHHhcCcc
Confidence 8999999999999998888876443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=273.87 Aligned_cols=173 Identities=30% Similarity=0.471 Sum_probs=144.5
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP 134 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 134 (336)
.+.+..++|.+.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEecccc----CchHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 45667789999999999999999999875 7899999997422 112223689999999999999999999998876
Q ss_pred C-EEEEEEccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCCCCceeecCCCCceEEecc
Q 019780 135 T-MMIITELMRGETLQRYLWSTR--PKRLDLKHSISFALDISRAMEYLHAN---SVIHRDLKPSNLLLTEDKKQVKLADF 208 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDikp~NIll~~~~~~~kl~Df 208 (336)
. .++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Df 178 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDF 178 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCC
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccC
Confidence 5 899999999999999996543 33589999999999999999999999 999999999999999876 7999999
Q ss_pred ccccccccc---cccccCCcccccCCCC
Q 019780 209 GLAREEVMD---EMTCEAGTYRWMAPEN 233 (336)
Q Consensus 209 g~a~~~~~~---~~~~~~gt~~y~aPE~ 233 (336)
|+++..... ......||+.|+|||.
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~ 206 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEY 206 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHH
T ss_pred ccccccCcccccccccccCCcCccCHHH
Confidence 999754322 1233459999999993
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=278.56 Aligned_cols=256 Identities=19% Similarity=0.212 Sum_probs=201.8
Q ss_pred cCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccc------------cHHHHHHHHHHHHHHHhCCCCceEee
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAV------------SREHKEKFQREVTLLSKMKHENILKF 127 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~~~~~E~~~l~~l~hpnIv~~ 127 (336)
..++|.+.+.||+|+||.||+|.+.++.||||++........ .....+.+.+|+.+++.++||||+++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 346899999999999999999999999999999974211100 00112779999999999999999999
Q ss_pred EeeEecCC-EEEEEEccCCCCHHHH------HhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCC
Q 019780 128 VGASVQPT-MMIITELMRGETLQRY------LWSTRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTED 199 (336)
Q Consensus 128 ~~~~~~~~-~~lv~e~~~gg~L~~~------l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~ 199 (336)
++++.+.+ .++||||+++++|.++ +.......+++..++.++.|++.||.|||+ +|++||||||+||+++.+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence 99998765 8999999999999998 644336789999999999999999999999 999999999999999988
Q ss_pred CCceEEeccccccccccccccccCCcccccCCCCCCCC-CCCC-HHHHHHHHHHhhccCCCCCCCHhHH--HHHHHHHHH
Q 019780 200 KKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPS-LENL-SEDMVALLKSCWAEDPKVRPEFAEI--TITLTNILQ 275 (336)
Q Consensus 200 ~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~di~~l~~~~l~~~p~~RP~~~~i--~~~l~~~~~ 275 (336)
+ .++|+|||++............|++.|+|||..... ..+. ..|+|+|++.++++-.+..|....- ...+..+..
T Consensus 189 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~ 267 (348)
T 2pml_X 189 G-RVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267 (348)
T ss_dssp S-CEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS
T ss_pred C-cEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence 7 799999999986544455556799999999988776 4444 8999999999999888877753211 112222222
Q ss_pred hhccCC-------------------CCCCCCcccccCCCCCCCCccccchhhhccccccc
Q 019780 276 NLRSAD-------------------TPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKG 316 (336)
Q Consensus 276 ~~~~~~-------------------~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (336)
...... ..+|+++.+++..++..+|+.|++..++.+...-.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~ 327 (348)
T 2pml_X 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327 (348)
T ss_dssp CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence 211111 34667778888889999999999888888755443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=265.30 Aligned_cols=246 Identities=22% Similarity=0.239 Sum_probs=187.9
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec------
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ------ 133 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------ 133 (336)
.+|.+.+.||+|+||.||+|.+. ++.||||++.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 57899999999999999999985 78999999862 34456789999999999999999999998754
Q ss_pred --------CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEE
Q 019780 134 --------PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKL 205 (336)
Q Consensus 134 --------~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl 205 (336)
...++||||++||+|.+++... ...+++..++.++.|++.||+|||++|++||||||+||+++.++ .++|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~-~~kl 157 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKI 157 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEE
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-CEEE
Confidence 2379999999999999999643 35678899999999999999999999999999999999999887 7999
Q ss_pred ecccccccccc----------------ccccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 206 ADFGLAREEVM----------------DEMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 206 ~Dfg~a~~~~~----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+|||++..... .......|++.|+|||...+. ..+...|+|+|++.+|++-..-.+ ..+...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~~-~~~~~~ 236 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST-GMERVN 236 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCSS-HHHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhccCC-chhHHH
Confidence 99999875321 112334589999999987654 678899999999999887752221 222222
Q ss_pred HHHHHHHhhccCC----CCCCCCcccccCCCCCCCCccccchhhhccccccc
Q 019780 269 TLTNILQNLRSAD----TPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKG 316 (336)
Q Consensus 269 ~l~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (336)
.+..+........ ...++.+.+++...+..+|+.|++..++.+..+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence 2222222211111 22333467788899999999999999888765543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=276.53 Aligned_cols=245 Identities=20% Similarity=0.228 Sum_probs=188.7
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC--
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-- 134 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 134 (336)
...++|.+.+.||+|+||.||+|.+. ++.||||++..... ...+|+.+|+.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---------~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---------YKNRELDIMKVLDHVNIIKLVDYFYTTGD 74 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---------hHHHHHHHHHHcCCCCccchhheeeecCc
Confidence 44678999999999999999999985 78999999874211 123799999999999999999987432
Q ss_pred ------------------------------------C-EEEEEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHH
Q 019780 135 ------------------------------------T-MMIITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRA 175 (336)
Q Consensus 135 ------------------------------------~-~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~a 175 (336)
. .++||||+++ +|.+.+.. .....+++..++.++.||+.|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp -----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence 1 7899999985 88777743 345679999999999999999
Q ss_pred HHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-cccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhh
Q 019780 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD-EMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCW 253 (336)
Q Consensus 176 L~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l 253 (336)
|+|||++||+||||||+|||++...+.+||+|||+|+..... ......||+.|+|||...+. .++.+.|+|++++.++
T Consensus 154 L~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 154 VGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 999999999999999999999854448999999999854333 23445689999999987654 4789999999999999
Q ss_pred ccCCCCCCCHh-HHHHHHHHHHHhhcc-----------------------------CCCCCCCCcccccCCCCCCCCccc
Q 019780 254 AEDPKVRPEFA-EITITLTNILQNLRS-----------------------------ADTPIPPKLVEIVDPKSTMNNDCM 303 (336)
Q Consensus 254 ~~~p~~RP~~~-~i~~~l~~~~~~~~~-----------------------------~~~~~p~~~~~~~~~~~~~~~~~~ 303 (336)
++-.+..|... .-...+..+.+.+.. .....|+++.+++...+..+|..|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 98888777522 122222222221110 122356678889999999999999
Q ss_pred cchhhhcccc
Q 019780 304 ATVHAITKFN 313 (336)
Q Consensus 304 ~~~~~~~~~~ 313 (336)
.+..++.+..
T Consensus 314 ~t~~e~l~hp 323 (383)
T 3eb0_A 314 INPYEAMAHP 323 (383)
T ss_dssp CCHHHHHTSG
T ss_pred CCHHHHhcCH
Confidence 9888877644
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=264.32 Aligned_cols=215 Identities=29% Similarity=0.539 Sum_probs=168.2
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC---Cc--cEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG---CE--PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA 130 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 130 (336)
...+..++|.+.+.||+|+||+||+|.+. ++ .||||+++... .......+.+.+|+.+++.++||||++++++
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV--LSQPEAMDDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCc--cCCHHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 34566789999999999999999999863 22 58999987421 1234566789999999999999999999999
Q ss_pred EecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 131 SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 131 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
+.++..++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+
T Consensus 90 ~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~ 167 (291)
T 1u46_A 90 VLTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGL 167 (291)
T ss_dssp ECSSSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTT
T ss_pred EccCCceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-CEEEccccc
Confidence 9988899999999999999999653 25689999999999999999999999999999999999999876 899999999
Q ss_pred cccccccc-----ccccCCcccccCCCC-----------------------------------------------CCCCC
Q 019780 211 AREEVMDE-----MTCEAGTYRWMAPEN-----------------------------------------------ERPSL 238 (336)
Q Consensus 211 a~~~~~~~-----~~~~~gt~~y~aPE~-----------------------------------------------~~~~~ 238 (336)
+....... .....++..|+|||. ..+.+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 247 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCC
Confidence 87543322 123347789999991 11223
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~ 274 (336)
..++.++.+++..||..+|.+||++.++++.|.++.
T Consensus 248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 457788999999999999999999999988877654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=291.24 Aligned_cols=248 Identities=16% Similarity=0.120 Sum_probs=192.1
Q ss_pred eecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHH---HHHHhCCCCceEeeE----
Q 019780 58 LVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREV---TLLSKMKHENILKFV---- 128 (336)
Q Consensus 58 ~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpnIv~~~---- 128 (336)
....++|.+.+.||+|+||+||+|.+. ++.||||++.... .......+.+.+|+ .+|+.++||||++++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTE--RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC---CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecc--ccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 344678999999999999999999964 8899999997422 22334567899999 455566899999988
Q ss_pred ---eeEecC------------------CEEEEEEccCCCCHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC
Q 019780 129 ---GASVQP------------------TMMIITELMRGETLQRYLWSTRP-----KRLDLKHSISFALDISRAMEYLHAN 182 (336)
Q Consensus 129 ---~~~~~~------------------~~~lv~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~ 182 (336)
+++.+. ..|+||||+ +|+|.+++..... ..+++..++.++.||+.||+|||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 555543 278999999 5799999964321 1233478888999999999999999
Q ss_pred CcccccCCCCceeecCCCCceEEeccccccccccccccccCCcccccCCCCCCCC-----------CCCCHHHHHHHHHH
Q 019780 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPS-----------LENLSEDMVALLKS 251 (336)
Q Consensus 183 ~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~di~~l~~~ 251 (336)
||+||||||+|||++.++ .+||+|||+++.... ......| +.|+|||..... .++.+.|+|+|++.
T Consensus 226 ~ivHrDikp~NIll~~~~-~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp TEECSCCCGGGEEECTTC-CEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCC-CEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999887 899999999986332 3345568 999999988776 78899999999999
Q ss_pred hhccCCCCCCCHhHHHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 252 CWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 252 ~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
+|++-.+..|....-. .............+|+++.+++...+..+|+.|++..++.+...
T Consensus 303 l~elltg~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 362 (377)
T 3byv_A 303 IYWIWCADLPITKDAA---LGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362 (377)
T ss_dssp HHHHHHSSCCC---------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred HHHHHHCCCCCccccc---ccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence 9999988888643321 11222233334678888999999999999999999988876543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=269.09 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=190.1
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
..+|.+.+.||+|+||.||+|.+. +..||||++... ..........+.+|+.+++.++||||+++++++.+.+ .+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIF--DLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTT--SSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehh--hccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 357999999999999999999975 789999999742 2234556788999999999999999999999988765 89
Q ss_pred EEEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 138 IITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
+||||+++++|.+++.. .....+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCC-------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-CEEEEeccceeeec
Confidence 99999999999999853 2346689999999999999999999999999999999999999877 79999999987543
Q ss_pred ccc--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH---HHHHHHHHHh-hcc-CCCCCCCCc
Q 019780 216 MDE--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI---TITLTNILQN-LRS-ADTPIPPKL 288 (336)
Q Consensus 216 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i---~~~l~~~~~~-~~~-~~~~~p~~~ 288 (336)
... .....|++.|+|||.......+...|+|+|+..+|++..+..|....- ......+... ... ....+|+++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 322 233468999999998888888999999999999999988888864321 1111111111 111 113466778
Q ss_pred ccccCCCCCCCCccccchhhhcccc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.+++...+..+|+.|++..++.+.-
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~l 292 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDVA 292 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHH
Confidence 8899999999999999988877643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=275.95 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=198.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCcccc---ccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALA---VSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT 135 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 135 (336)
.+|.+.+.||+|+||.||+|.+. ++.||||++....... ......+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 57999999999999999999985 8899999998532211 1123456788999999999 7999999999988765
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.++||||++|++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEEecCccccc
Confidence 89999999999999999543 5699999999999999999999999999999999999999887 7999999998764
Q ss_pred ccc-cccccCCcccccCCCCCC------CCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCC----C
Q 019780 215 VMD-EMTCEAGTYRWMAPENER------PSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSAD----T 282 (336)
Q Consensus 215 ~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~----~ 282 (336)
... ......||+.|+|||... ...++...|+|+|++.+|++-.+..|.... -...+..+........ .
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 330 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 432 234567999999999654 335678899999999999998888885322 1122222222211111 3
Q ss_pred CCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 283 PIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 283 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
..++++.+++...+..+|+.|.+..++.+...
T Consensus 331 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 45667888899999999999999888876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=269.35 Aligned_cols=211 Identities=27% Similarity=0.475 Sum_probs=165.8
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHH--HHhCCCCceEeeEeeEec-
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTL--LSKMKHENILKFVGASVQ- 133 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~~~~~~~~- 133 (336)
..++.++|.+.+.||+|+||.||+|...++.||||++... ....+..|..+ +..++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA--------NRQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGG--------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeecc--------chhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 3456789999999999999999999999999999999731 12233344444 556899999999975432
Q ss_pred ---C--CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccccCCCCceeecCC
Q 019780 134 ---P--TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN---------SVIHRDLKPSNLLLTED 199 (336)
Q Consensus 134 ---~--~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---------~ivHrDikp~NIll~~~ 199 (336)
+ .+++||||+++|+|.+++... ..++..++.++.|++.||.|||++ ||+||||||+|||++.+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 1 278999999999999999543 358899999999999999999999 99999999999999987
Q ss_pred CCceEEeccccccccccc----------cccccCCcccccCCCCCCCC-------C------------------------
Q 019780 200 KKQVKLADFGLAREEVMD----------EMTCEAGTYRWMAPENERPS-------L------------------------ 238 (336)
Q Consensus 200 ~~~~kl~Dfg~a~~~~~~----------~~~~~~gt~~y~aPE~~~~~-------~------------------------ 238 (336)
+ .+||+|||+++..... ......||+.|+|||...+. .
T Consensus 157 ~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 157 G-TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp S-CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred C-cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 6 7999999999753321 12234699999999933220 0
Q ss_pred ------------------------------------C----------CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 019780 239 ------------------------------------E----------NLSEDMVALLKSCWAEDPKVRPEFAEITITLTN 272 (336)
Q Consensus 239 ------------------------------------~----------~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~ 272 (336)
. ..+.++.+|+..||+.+|.+||++.++++.|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 0 022368888899999999999999999999998
Q ss_pred HHHhhcc
Q 019780 273 ILQNLRS 279 (336)
Q Consensus 273 ~~~~~~~ 279 (336)
+...+..
T Consensus 316 ll~~~~~ 322 (336)
T 3g2f_A 316 LMMIWER 322 (336)
T ss_dssp HHHCCCC
T ss_pred HHHHHHh
Confidence 8876554
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=276.82 Aligned_cols=245 Identities=27% Similarity=0.300 Sum_probs=176.9
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 134 (336)
.++|.+.+.||+|+||.||+|.+. ++.||||++... .........+.+|+.+|+.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc---ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 478999999999999999999875 789999998632 23445677889999999999999999999998653
Q ss_pred ---CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 135 ---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 135 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
..++|+|++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kL~DFG~a 179 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLA 179 (367)
T ss_dssp GCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC----
T ss_pred cCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-CEEEeecccc
Confidence 379999999 6799998843 5699999999999999999999999999999999999999887 7999999999
Q ss_pred cccccccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHh-------------
Q 019780 212 REEVMDEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQN------------- 276 (336)
Q Consensus 212 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~------------- 276 (336)
+.... ......||+.|+|||.... ..++...|+|+|++.++++-.+..|... +-...+..+...
T Consensus 180 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 180 RHTAD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred ccccc-cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 86432 3445579999999998766 6778899999999999998888777521 111122222111
Q ss_pred ----------hcc--------CCCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 277 ----------LRS--------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 277 ----------~~~--------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
+.. ..+..++++.+++..++..+|+.|.+..++.+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 110 01234566777888888889998888877776443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=281.91 Aligned_cols=194 Identities=22% Similarity=0.278 Sum_probs=166.8
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC------CCCceEeeEeeEe
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM------KHENILKFVGASV 132 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~~~ 132 (336)
..+|.+.+.||+|+||+||+|.+. ++.||||+++. .......+.+|+.+++.+ +|+||+++++++.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN------EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC------ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 467999999999999999999886 68999999973 234456677888888776 5779999999988
Q ss_pred cCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC-ceEEecccc
Q 019780 133 QPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK-QVKLADFGL 210 (336)
Q Consensus 133 ~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~-~~kl~Dfg~ 210 (336)
... .++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 665 899999996 59999997766667999999999999999999999999999999999999998762 299999999
Q ss_pred ccccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 211 AREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 211 a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
++... .......||+.|+|||......++.+.|+|+|++.+|++-.+..|.
T Consensus 249 a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf 299 (429)
T 3kvw_A 249 SCYEH-QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299 (429)
T ss_dssp CEETT-CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ceecC-CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCC
Confidence 97543 2344567999999999988888999999999999999988887764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=263.56 Aligned_cols=209 Identities=21% Similarity=0.321 Sum_probs=166.9
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe-cCC-E
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV-QPT-M 136 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~-~ 136 (336)
.++|.+.+.||+|+||.||+|.+. ++.||||++... .....+.+|+.+++.++|++++..+..+. +.. .
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-------TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc-------ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 367999999999999999999974 789999987632 12235788999999999888777666553 443 7
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee---cCCCCceEEeccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLL---TEDKKQVKLADFGLARE 213 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll---~~~~~~~kl~Dfg~a~~ 213 (336)
++||||+ +++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||+ +.++ .+||+|||+++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKK 157 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEE
T ss_pred EEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC-eEEEecCcccee
Confidence 9999999 89999999543 3569999999999999999999999999999999999999 5555 799999999985
Q ss_pred ccccc---------ccccCCcccccCCCCCCCCC----------------------------------------------
Q 019780 214 EVMDE---------MTCEAGTYRWMAPENERPSL---------------------------------------------- 238 (336)
Q Consensus 214 ~~~~~---------~~~~~gt~~y~aPE~~~~~~---------------------------------------------- 238 (336)
..... .....||+.|+|||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 43321 22446999999999322111
Q ss_pred ------CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 239 ------ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 239 ------~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
..++.++.+|+..||+.+|.+||++.++++.|.++......
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 23467788889999999999999999999999999877553
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=273.93 Aligned_cols=248 Identities=20% Similarity=0.285 Sum_probs=190.0
Q ss_pred CceeEe-eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-E
Q 019780 62 RSVLLQ-KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-M 136 (336)
Q Consensus 62 ~~~~~~-~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~ 136 (336)
..|.+. +.||+|+||+||+|.+. ++.||||++.... ......+.+|+.++.++ +||||+++++++.+++ .
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 456664 78999999999999875 7899999997421 22356788999999985 6999999999998765 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC--ceEEecccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK--QVKLADFGLAREE 214 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~--~~kl~Dfg~a~~~ 214 (336)
++||||++||+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++. .+||+|||++...
T Consensus 87 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999999999554 46899999999999999999999999999999999999987652 3999999998753
Q ss_pred ccc---------cccccCCcccccCCCCCCC-----CCCCCHHHHHHHHHHhhccCCCCCCCHhH---------------
Q 019780 215 VMD---------EMTCEAGTYRWMAPENERP-----SLENLSEDMVALLKSCWAEDPKVRPEFAE--------------- 265 (336)
Q Consensus 215 ~~~---------~~~~~~gt~~y~aPE~~~~-----~~~~~~~di~~l~~~~l~~~p~~RP~~~~--------------- 265 (336)
... ......||+.|+|||.... ..++.+.|+|+|++.++++-.+..|....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 211 1223459999999997654 44677899999999999988888775321
Q ss_pred -HHHHHHHHHHhhccCC----CCCCCCcccccCCCCCCCCccccchhhhccccccc
Q 019780 266 -ITITLTNILQNLRSAD----TPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKG 316 (336)
Q Consensus 266 -i~~~l~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (336)
....+..+........ ..+++++.+++..++..+|+.|++..++.+.....
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 1111222222211111 24677788899999999999999998888755443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=265.94 Aligned_cols=251 Identities=22% Similarity=0.268 Sum_probs=199.2
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCcccc----ccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEec
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALA----VSREHKEKFQREVTLLSKMK-HENILKFVGASVQ 133 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 133 (336)
.++|.+.+.||+|+||.||+|.+. ++.||||++....... ......+.+.+|+.+++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999985 7899999997532111 12344677899999999996 9999999999987
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
+. .++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-cEEEecccchh
Confidence 66 89999999999999999543 5689999999999999999999999999999999999999887 79999999997
Q ss_pred ccccc-cccccCCcccccCCCCCC------CCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCC---
Q 019780 213 EEVMD-EMTCEAGTYRWMAPENER------PSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSAD--- 281 (336)
Q Consensus 213 ~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~--- 281 (336)
..... ......|++.|+|||... ....+...|+|+|+..++++-.+..|.... ....+..+........
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccc
Confidence 54332 234456999999999653 456678999999999999988888875322 1112222222221111
Q ss_pred -CCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 282 -TPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 282 -~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
..+|+++.+++...+..+|+.|++..++.+...
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286 (298)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence 235667888899999999999999888887543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=268.97 Aligned_cols=249 Identities=25% Similarity=0.283 Sum_probs=197.9
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec---CC
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ---PT 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~ 135 (336)
.++|.+.+.||+|+||.||+|.+. ++.||+|++... .......+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG---SMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECT---TCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcc---cCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 468999999999999999999986 788999999742 2244567789999999999999999999998753 23
Q ss_pred EEEEEEccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccccCCCCceeecCCCCceEEecc
Q 019780 136 MMIITELMRGETLQRYLWST--RPKRLDLKHSISFALDISRAMEYLHANS-----VIHRDLKPSNLLLTEDKKQVKLADF 208 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivHrDikp~NIll~~~~~~~kl~Df 208 (336)
.++||||+++++|.+++... ....+++..++.++.|++.||.|||++| ++||||||+||+++.++ .+||+||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~df 160 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF 160 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-CEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-CEEEecC
Confidence 89999999999999999543 2345899999999999999999999999 99999999999999877 7999999
Q ss_pred cccccccccc--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHh-hccCCCCC
Q 019780 209 GLAREEVMDE--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQN-LRSADTPI 284 (336)
Q Consensus 209 g~a~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~-~~~~~~~~ 284 (336)
|+++...... .....|++.|+|||.......+...|+|+|+..+|++-.+..|....- ......+... ........
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCccc
Confidence 9987543222 223458999999998888888899999999999999888877752211 1112222222 22333456
Q ss_pred CCCcccccCCCCCCCCccccchhhhcccc
Q 019780 285 PPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
|+++.+++...+..+|+.|++..++.+..
T Consensus 241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 241 SDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 77888999999999999999988887644
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=274.14 Aligned_cols=246 Identities=19% Similarity=0.214 Sum_probs=189.8
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 134 (336)
..+|.+.+.||+|+||.||+|.+. ++.||||++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC---SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc---cccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 368999999999999999999985 78999999864322 222345678999999999999999999988753
Q ss_pred -----CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 135 -----TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 135 -----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
..++||||+++ +|.+.+.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg 169 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFG 169 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred ccCCceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-CEEEccch
Confidence 37999999986 77777743 335699999999999999999999999999999999999999887 79999999
Q ss_pred ccccccc------ccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCH----hHHHHHHHHHHHhhc
Q 019780 210 LAREEVM------DEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEF----AEITITLTNILQNLR 278 (336)
Q Consensus 210 ~a~~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~----~~i~~~l~~~~~~~~ 278 (336)
+++.... .......||+.|+|||...+ ..++.+.|+|+|++.++++-.+..|.. .+....+.... .
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC---G 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH---C
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh---C
Confidence 9975321 12334568999999997765 457899999999999999877777642 22222222222 1
Q ss_pred cCCCCC--------------------------------CCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 279 SADTPI--------------------------------PPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 279 ~~~~~~--------------------------------p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
...+.. ++++.+++..++..+|+.|.+..++.+...-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence 111111 3345567778888888888888887765544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=274.27 Aligned_cols=246 Identities=27% Similarity=0.316 Sum_probs=190.8
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 134 (336)
..+|.+.+.||+|+||.||+|.+. +..||||++.. .........+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc----ccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 468999999999999999999986 77899999973 22445567899999999999999999999998653
Q ss_pred --CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 135 --TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 135 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
..++||||+.+ +|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 102 ~~~~~iv~e~~~~-~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~ 176 (364)
T 3qyz_A 102 MKDVYIVQDLMET-DLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLAR 176 (364)
T ss_dssp CCCEEEEEECCSE-EHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred cceEEEEEcccCc-CHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-CEEEEeCcceE
Confidence 38999999975 99999854 3599999999999999999999999999999999999999887 79999999998
Q ss_pred cccccc-----ccccCCcccccCCCCCC-CCCCCCHHHHHHHHHHhhccCCCCCCC----HhHHHHHHHHHHHh------
Q 019780 213 EEVMDE-----MTCEAGTYRWMAPENER-PSLENLSEDMVALLKSCWAEDPKVRPE----FAEITITLTNILQN------ 276 (336)
Q Consensus 213 ~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~~di~~l~~~~l~~~p~~RP~----~~~i~~~l~~~~~~------ 276 (336)
...... .....||+.|+|||... ....+.+.|+|+|++.++++-.+..|. ..+.+..+......
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 543322 23347999999999754 455788999999999999887777664 22222222111100
Q ss_pred --------------h--------ccCCCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 277 --------------L--------RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 277 --------------~--------~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
. ....+.+++++.+++..++..+|+.|.+..++.+....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 0 00113355667777778888888888877777664433
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=269.46 Aligned_cols=247 Identities=23% Similarity=0.301 Sum_probs=185.9
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccc---cccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCCE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNAL---AVSREHKEKFQREVTLLSKMKHENILKFVGASVQPTM 136 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 136 (336)
++|.+.+.||+|+||.||+|.+. ++.||||++...... .........+.+|+.+++.++||||+++++++.++..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 89 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence 57999999999999999999986 688999999742211 1122334568899999999999999999999988889
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC--ceEEecccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK--QVKLADFGLAREE 214 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~--~~kl~Dfg~a~~~ 214 (336)
++||||+++++|.+++ .....+++..++.++.|++.||.|||++||+||||||+||+++.++. .+||+|||+++..
T Consensus 90 ~lv~e~~~~~~L~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 90 YIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EEEEECCTTEETHHHH--STTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 9999999999999999 34567999999999999999999999999999999999999986542 4999999999864
Q ss_pred cccc-ccccCCcccccCCCCC---CCCCCCCHHHHHHHHHHhhccCCCCCCCHh-----HHHHHHHHHHHhhcc----CC
Q 019780 215 VMDE-MTCEAGTYRWMAPENE---RPSLENLSEDMVALLKSCWAEDPKVRPEFA-----EITITLTNILQNLRS----AD 281 (336)
Q Consensus 215 ~~~~-~~~~~gt~~y~aPE~~---~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-----~i~~~l~~~~~~~~~----~~ 281 (336)
.... .....||+.|+|||.. .....+...|+|+|++.++++..+..|... ++...+ ...... ..
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~ 244 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI---TSGKYNFIPEVW 244 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH---HHTCCCCCHHHH
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH---HhCccccCchhh
Confidence 3322 2334589999999974 355677899999999998888777776421 111111 111000 11
Q ss_pred CCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 282 TPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 282 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
..+++++.+++...+..+|+.|.+..++.+..
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~ 276 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHP 276 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence 23556666777777777777777776666533
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=275.35 Aligned_cols=253 Identities=20% Similarity=0.233 Sum_probs=191.1
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccH------HHHHHHHHHHHHHHhCCCCceEeeE
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSR------EHKEKFQREVTLLSKMKHENILKFV 128 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~ 128 (336)
..++|.+.+.||+|+||.||+|.+. +..+|||++.......... .....+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 4578999999999999999999984 5789999987432111000 1123467889999999999999999
Q ss_pred eeEec----CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-Cc
Q 019780 129 GASVQ----PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK-KQ 202 (336)
Q Consensus 129 ~~~~~----~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~-~~ 202 (336)
+++.+ .. .++||||+ |++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ..
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc
Confidence 99876 33 89999999 99999999543 3799999999999999999999999999999999999998654 27
Q ss_pred eEEecccccccccccc---------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH------HH
Q 019780 203 VKLADFGLAREEVMDE---------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE------IT 267 (336)
Q Consensus 203 ~kl~Dfg~a~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~------i~ 267 (336)
+||+|||+++...... .....||+.|+|||.......+...|+|+|++.+|++-.+..|.... +.
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 9999999997542221 13446999999999988888899999999999999998888886331 11
Q ss_pred HHHHHHHHhhcc------CCCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 268 ITLTNILQNLRS------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 268 ~~l~~~~~~~~~------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
............ .....|+++.+++...+..+|+.|++..++.+.-+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP 325 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111111111111 112678889999999999999999999888865443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=277.74 Aligned_cols=244 Identities=21% Similarity=0.212 Sum_probs=188.9
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP--- 134 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--- 134 (336)
....|.+.+.||+|+||.||+|.+. ++.||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---------hhHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence 3457999999999999999999985 7899999987421 1234799999999999999999987531
Q ss_pred --C--EEEEEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecc
Q 019780 135 --T--MMIITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADF 208 (336)
Q Consensus 135 --~--~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Df 208 (336)
. +++||||+++ +|.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+||
T Consensus 123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccc
Confidence 1 6789999986 67666532 344679999999999999999999999999999999999999977657899999
Q ss_pred ccccccccc-cccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhcc------
Q 019780 209 GLAREEVMD-EMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRS------ 279 (336)
Q Consensus 209 g~a~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~------ 279 (336)
|+++..... ......||+.|+|||..... .++...|+|+|++.++++..++.|... .-...+..+++.+..
T Consensus 202 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp TTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999864332 23345689999999987654 688999999999999999888877521 112222222221100
Q ss_pred -----------------------CCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 280 -----------------------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 280 -----------------------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
....+++++.+++..++..+|..|.+..++.+..
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 1123567788889999999999998887776543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=274.71 Aligned_cols=194 Identities=21% Similarity=0.282 Sum_probs=165.7
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC--------CCceEeeEee
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK--------HENILKFVGA 130 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~~~~~ 130 (336)
..+|.+.+.||+|+||+||+|++. ++.||||+++. .....+.+.+|+.+++.++ |+||++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS------AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec------CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 578999999999999999999885 78899999963 2345677899999999985 7889999998
Q ss_pred Ee----cC-CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCC----
Q 019780 131 SV----QP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDK---- 200 (336)
Q Consensus 131 ~~----~~-~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~~~~---- 200 (336)
+. +. ..++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence 87 22 389999999 56777777555556799999999999999999999999 999999999999998664
Q ss_pred --------------------------------------------CceEEeccccccccccccccccCCcccccCCCCCCC
Q 019780 201 --------------------------------------------KQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERP 236 (336)
Q Consensus 201 --------------------------------------------~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~ 236 (336)
..+||+|||+++.... ......||+.|+|||....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-~~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-HFTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-CSCSCCSCGGGCCHHHHHT
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-cCccCCCCCcccCChhhcC
Confidence 2699999999986433 3445579999999999888
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
..++.+.|+|+|++.+|++..+..|.
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf 293 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLF 293 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCC
Confidence 88999999999999999988887775
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=277.23 Aligned_cols=241 Identities=14% Similarity=0.143 Sum_probs=192.6
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC----------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEe----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG----------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILK---- 126 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~---- 126 (336)
.++|.+.+.||+|+||.||+|.+. ++.||||++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhhh
Confidence 579999999999999999999875 578999998731 35789999999999999887
Q ss_pred -----------eEeeEec--CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 019780 127 -----------FVGASVQ--PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSN 193 (336)
Q Consensus 127 -----------~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~N 193 (336)
+++++.. ...++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 5566654 3489999999 9999999976545679999999999999999999999999999999999
Q ss_pred eeecCCC-CceEEecccccccccccc---------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCH
Q 019780 194 LLLTEDK-KQVKLADFGLAREEVMDE---------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEF 263 (336)
Q Consensus 194 Ill~~~~-~~~kl~Dfg~a~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~ 263 (336)
||++.++ ..+||+|||+++...... .....||+.|+|||.......+...|+|+|++.+|++..+..|..
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999764 269999999997543221 123469999999999888888999999999999999888888854
Q ss_pred hH------HHHHHHHHHHhhccCC------CCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 264 AE------ITITLTNILQNLRSAD------TPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 264 ~~------i~~~l~~~~~~~~~~~------~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.. +......+........ ..+|+++.+++...+..+|+.|++..++.+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 32 2222222222221111 1357888999999999999999998888753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=270.73 Aligned_cols=248 Identities=19% Similarity=0.215 Sum_probs=193.8
Q ss_pred CCceeEeeeecCCCcEEEEEeEE---CCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCC------ceEeeEeeE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFY---GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE------NILKFVGAS 131 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp------nIv~~~~~~ 131 (336)
..+|.+.+.||+|+||.||+|.+ .++.||||+++. .....+.+.+|+.+++.++|+ +++++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN------VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec------CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 46899999999999999999987 278899999863 234567788999999888765 499999998
Q ss_pred ecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-----------
Q 019780 132 VQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED----------- 199 (336)
Q Consensus 132 ~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~----------- 199 (336)
.+.+ .++||||+ +++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 8765 89999999 8899999977665679999999999999999999999999999999999999863
Q ss_pred -------CCceEEeccccccccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCH----hHHHH
Q 019780 200 -------KKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEF----AEITI 268 (336)
Q Consensus 200 -------~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~----~~i~~ 268 (336)
...+||+|||+++.... ......||+.|+|||.......+.+.|+|+|++.++++-.+..|.. .+...
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred cccccccCCCceEeeCcccccCcc-ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 23699999999976332 3344579999999999888889999999999999998877777652 22333
Q ss_pred HHHHHHHhhcc-----------------------------------------CCCCCCCCcccccCCCCCCCCccccchh
Q 019780 269 TLTNILQNLRS-----------------------------------------ADTPIPPKLVEIVDPKSTMNNDCMATVH 307 (336)
Q Consensus 269 ~l~~~~~~~~~-----------------------------------------~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (336)
.+......... .....++++.+++..++..+|..|++..
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 33222211000 0011123456788888888999998888
Q ss_pred hhccccccc
Q 019780 308 AITKFNEKG 316 (336)
Q Consensus 308 ~~~~~~~~~ 316 (336)
++.+...-.
T Consensus 325 ell~hp~f~ 333 (339)
T 1z57_A 325 EALKHPFFD 333 (339)
T ss_dssp HHTTSGGGG
T ss_pred HHhcCHHHH
Confidence 887755443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=270.78 Aligned_cols=195 Identities=25% Similarity=0.258 Sum_probs=158.2
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC--
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-- 134 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 134 (336)
.-.++|.+.+.||+|+||.||+|.+. ++.||||++... .........+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 98 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECT---TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccc---cCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence 34578999999999999999999986 788999999742 22455667889999999999999999999998754
Q ss_pred -----CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 135 -----TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 135 -----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
..++||||+++ +|.+++. ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 99 ~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg 172 (371)
T 2xrw_A 99 LEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFG 172 (371)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCC
T ss_pred cccccceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEEEee
Confidence 37999999975 7888883 3489999999999999999999999999999999999999887 79999999
Q ss_pred cccccccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 210 LAREEVMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 210 ~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
+++..... ......||+.|+|||......++.+.|+|+|++.++++-.+..|.
T Consensus 173 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 226 (371)
T 2xrw_A 173 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226 (371)
T ss_dssp C----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred cccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 99864332 233456999999999888888888999999999998887777764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=268.87 Aligned_cols=250 Identities=21% Similarity=0.300 Sum_probs=192.7
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
..+.|.+.+.||+|+||.||+|.+. +..||+|++... .......+.+|+.+++.++||||+++++++.+.. .
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-----CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 3468999999999999999999986 788999998632 2234567899999999999999999999988765 9
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++.....
T Consensus 92 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLK 169 (302)
T ss_dssp EEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-CEEEEECCCCccccc
Confidence 9999999999999998543 35699999999999999999999999999999999999999877 799999998764221
Q ss_pred --ccccccCCcccccCCCCC-----CCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhc---cCCCCCC
Q 019780 217 --DEMTCEAGTYRWMAPENE-----RPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLR---SADTPIP 285 (336)
Q Consensus 217 --~~~~~~~gt~~y~aPE~~-----~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~---~~~~~~p 285 (336)
.......||+.|+|||.. .....+...|+|+|+..+|++..+..|.... ....+..+..... .....+|
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 249 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC
Confidence 122344699999999976 4667788999999999999988777775321 1111222222111 1123345
Q ss_pred CCcccccCCCCCCCCccccchhhhccccccc
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAITKFNEKG 316 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (336)
+++.+++...+..+|+.|++..++.+.....
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 280 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVS 280 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTT
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcChHHh
Confidence 6677888888888999999888887755433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=278.56 Aligned_cols=170 Identities=26% Similarity=0.377 Sum_probs=142.9
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC--
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-- 134 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 134 (336)
...+.|.+.+.||+|+||+||+|.+. ++.||||++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc----ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 34678999999999999999999987 7899999997321 122356778999999999999999999998754
Q ss_pred -CEEEEEEccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee----cCCCCceEEecc
Q 019780 135 -TMMIITELMRGETLQRYLWSTR-PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLL----TEDKKQVKLADF 208 (336)
Q Consensus 135 -~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll----~~~~~~~kl~Df 208 (336)
..++||||++||+|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++ .+||+||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DF 160 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDF 160 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE-EEEECCG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce-eEEEecC
Confidence 3799999999999999995432 2349999999999999999999999999999999999998 5544 7999999
Q ss_pred cccccccccc-ccccCCcccccCCCC
Q 019780 209 GLAREEVMDE-MTCEAGTYRWMAPEN 233 (336)
Q Consensus 209 g~a~~~~~~~-~~~~~gt~~y~aPE~ 233 (336)
|+++...... .....||+.|+|||.
T Consensus 161 G~a~~~~~~~~~~~~~gt~~y~aPE~ 186 (396)
T 4eut_A 161 GAARELEDDEQFVSLYGTEEYLHPDM 186 (396)
T ss_dssp GGCEECCCGGGSSCSSSCCTTCCHHH
T ss_pred CCceEccCCCccccccCCccccCHHH
Confidence 9998643332 344569999999994
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=264.49 Aligned_cols=248 Identities=20% Similarity=0.258 Sum_probs=192.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
..|.....||+|+||.||+|.+. +..||||++... .....+.+.+|+.+++.++||||+++++++.+.. .++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-----DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-----CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-----chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence 34444568999999999999985 778999998742 2344577899999999999999999999998765 899
Q ss_pred EEEccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTR-PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+++...+.++|+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999999996543 3456789999999999999999999999999999999999873348999999999754322
Q ss_pred --cccccCCcccccCCCCCCCCC--CCCHHHHHHHHHHhhccCCCCCCCHhH--HHHHHHHH--HHhhccCCCCCCCCcc
Q 019780 218 --EMTCEAGTYRWMAPENERPSL--ENLSEDMVALLKSCWAEDPKVRPEFAE--ITITLTNI--LQNLRSADTPIPPKLV 289 (336)
Q Consensus 218 --~~~~~~gt~~y~aPE~~~~~~--~~~~~di~~l~~~~l~~~p~~RP~~~~--i~~~l~~~--~~~~~~~~~~~p~~~~ 289 (336)
......|++.|+|||...... .+...|+|+|+..+|++-.+..|.... ....+... ..........+++++.
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 256 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHH
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHH
Confidence 123456999999999775543 677899999999999999888886321 11111111 1111223345677788
Q ss_pred cccCCCCCCCCccccchhhhccccc
Q 019780 290 EIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
+++...+..+|+.|++..++.+...
T Consensus 257 ~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 257 AFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHccCChhhCCCHHHHhcChh
Confidence 8999999999999999888876443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=269.49 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=191.9
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEec--
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQ-- 133 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-- 133 (336)
...+.|.+.+.||+|+||.||+|.+. ++.||||++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc------ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 34678999999999999999999984 8899999987421 1245688999999999 79999999999875
Q ss_pred -----CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecc
Q 019780 134 -----PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADF 208 (336)
Q Consensus 134 -----~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Df 208 (336)
...++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~kl~Df 173 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDF 173 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC-CEEEeeC
Confidence 2389999999999999999766556799999999999999999999999999999999999999876 7999999
Q ss_pred ccccccccc--cccccCCcccccCCCCCC-----CCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhc--
Q 019780 209 GLAREEVMD--EMTCEAGTYRWMAPENER-----PSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLR-- 278 (336)
Q Consensus 209 g~a~~~~~~--~~~~~~gt~~y~aPE~~~-----~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~-- 278 (336)
|++...... ......|++.|+|||... ....+...|+|+|++.+|++..+..|.... -...+..+.....
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 2x7f_A 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 253 (326)
T ss_dssp TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence 998754322 233456999999999775 556778899999999999998888775321 1111222222111
Q ss_pred cCCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 279 SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 279 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.....+|+.+.+++...+..+|+.|++..++.+..
T Consensus 254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred CCccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 11234667788899999999999999888887644
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=270.78 Aligned_cols=244 Identities=23% Similarity=0.288 Sum_probs=189.0
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC---
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT--- 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 135 (336)
.++|.+.+.||+|+||.||+|.+. ++.||||++... .........+.+|+.+++.++||||+++++++....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP---FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccc---ccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 468999999999999999999986 789999999742 234556778999999999999999999999988654
Q ss_pred ----EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 136 ----MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 136 ----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
.++||||+. ++|.+++ . ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~--~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a 191 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIM--G--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLA 191 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHT--T--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSTTCC
T ss_pred cceeEEEEEcccc-ccHHHHh--h--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC-CEEEEecCcc
Confidence 399999997 5888887 2 3499999999999999999999999999999999999999887 7999999999
Q ss_pred cccccccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHh-------------
Q 019780 212 REEVMDEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQN------------- 276 (336)
Q Consensus 212 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~------------- 276 (336)
+... .......||+.|+|||.... ...+.+.|+|+|++.++++-.+..|... +....+..+...
T Consensus 192 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 192 RHAD-AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred cccc-cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 8543 23445578999999998776 6788899999999999998877777521 111112222111
Q ss_pred ----------hcc--------CCCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 277 ----------LRS--------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 277 ----------~~~--------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
+.. ..+..++++.+++..++..+|+.|.+..++.+...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 000 11235667777888888888888888777766443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=265.78 Aligned_cols=247 Identities=22% Similarity=0.265 Sum_probs=191.9
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
..+.|.+.+.||+|+||.||+|.+. ++.||||++.... ....+.+|+.+++.++||||+++++++.+.. .
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 3567999999999999999999986 7899999997421 2356889999999999999999999988765 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 100 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBT
T ss_pred EEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhh
Confidence 9999999999999999532 35799999999999999999999999999999999999999887 799999999975433
Q ss_pred c--cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhcc---CCCCCCCCccc
Q 019780 217 D--EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRS---ADTPIPPKLVE 290 (336)
Q Consensus 217 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~---~~~~~p~~~~~ 290 (336)
. ......|++.|+|||.......+...|+|+|++.++++..+..|.... -...+..+...... .....|+.+.+
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 2 233456899999999988888889999999999999988888775321 11111111111110 11224566778
Q ss_pred ccCCCCCCCCccccchhhhcccccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
++...+..+|..|++..++.+...-
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred HHHHHccCChhhCcCHHHHHhCHHH
Confidence 8888899999999988888765433
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=268.50 Aligned_cols=242 Identities=19% Similarity=0.232 Sum_probs=191.4
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe-cCC-E
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV-QPT-M 136 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~-~ 136 (336)
.++|.+.+.||+|+||.||+|.+. ++.||||++..... ...+.+|+.+++.++|++++..+..+. +.. .
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-------CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-------hhHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 468999999999999999999974 88999999874221 235889999999999888776665543 333 7
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec---CCCCceEEeccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLT---EDKKQVKLADFGLARE 213 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~---~~~~~~kl~Dfg~a~~ 213 (336)
++||||+ +++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++ .++ .+||+|||+++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKK 157 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCccc
Confidence 9999999 89999999533 35799999999999999999999999999999999999994 454 799999999985
Q ss_pred ccccc---------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-------HHHHHHHHH-HH-
Q 019780 214 EVMDE---------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-------EITITLTNI-LQ- 275 (336)
Q Consensus 214 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-------~i~~~l~~~-~~- 275 (336)
..... .....||+.|+|||.......+...|+|+|+..++++-.++.|... +....+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 43322 2344699999999999888889999999999999998877777432 122222211 11
Q ss_pred hhccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 276 NLRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 276 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
........+|+++.+++...+..+|+.|++..++.+.
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 1111225678889999999999999999998887764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=269.49 Aligned_cols=197 Identities=19% Similarity=0.194 Sum_probs=158.1
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccc---cccHHHHHHHHHHHHHHHhCC---------CCceEe
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNAL---AVSREHKEKFQREVTLLSKMK---------HENILK 126 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~---------hpnIv~ 126 (336)
+..++|.+.+.||+|+||+||+|+++++.||||++...... .......+.+.+|+.+|+.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 34578999999999999999999999999999999853221 012233467888999988885 777777
Q ss_pred eEeeEe-------------------------------cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHH
Q 019780 127 FVGASV-------------------------------QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRA 175 (336)
Q Consensus 127 ~~~~~~-------------------------------~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~a 175 (336)
+.+++. ....|+||||+++|++.+.+.. ..+++..++.++.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 766542 3459999999999977776622 568999999999999999
Q ss_pred HHHHH-hCCcccccCCCCceeecCCC-------------------CceEEeccccccccccccccccCCcccccCCCCCC
Q 019780 176 MEYLH-ANSVIHRDLKPSNLLLTEDK-------------------KQVKLADFGLAREEVMDEMTCEAGTYRWMAPENER 235 (336)
Q Consensus 176 L~~lH-~~~ivHrDikp~NIll~~~~-------------------~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~ 235 (336)
|.||| ++||+||||||+|||++.++ ..+||+|||+|+..... ...||+.|+|||...
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGC
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhc
Confidence 99999 99999999999999999764 27999999999864432 336999999999988
Q ss_pred CCCCCCHHHHHHHHHH-hhccCCCCCCC
Q 019780 236 PSLENLSEDMVALLKS-CWAEDPKVRPE 262 (336)
Q Consensus 236 ~~~~~~~~di~~l~~~-~l~~~p~~RP~ 262 (336)
+.. +...|+|+++.. ....-++..|.
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~ 277 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPY 277 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred CCC-ccceehhhhhCCCCcccccccCCC
Confidence 777 889999998777 45555565664
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=262.82 Aligned_cols=245 Identities=21% Similarity=0.224 Sum_probs=188.2
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec-----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ----- 133 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----- 133 (336)
..+|.+.+.||+|+||.||+|.+. ++.||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-----ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 468999999999999999999987 789999998732 34556789999999999999999999998742
Q ss_pred ----------CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCce
Q 019780 134 ----------PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQV 203 (336)
Q Consensus 134 ----------~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~ 203 (336)
...++||||++ |+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++..+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence 23799999998 599999832 5689999999999999999999999999999999999998555589
Q ss_pred EEeccccccccccc-----cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh
Q 019780 204 KLADFGLAREEVMD-----EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN 276 (336)
Q Consensus 204 kl~Dfg~a~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~ 276 (336)
||+|||+++..... ......++..|+|||.... ...+...|+|+|++.++++-.+..|.... -...+..+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999854321 1233457899999997643 66788899999999999988888775221 11122222211
Q ss_pred h------------------------------ccCCCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 277 L------------------------------RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 277 ~------------------------------~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
. ....+.+++++.+++...+..+|+.|.+..++.+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 1 0112347788899999999999999999988876543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=270.70 Aligned_cols=255 Identities=22% Similarity=0.282 Sum_probs=179.7
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
.+.+..++|.+.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK----CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEES
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh----cchhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 45677889999999999999999999874 7899999986321 23345678899999999999999999999887
Q ss_pred CC-EEEEEEccCCCCHHHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEe
Q 019780 134 PT-MMIITELMRGETLQRYLWS------TRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLA 206 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~------~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~ 206 (336)
.+ .++||||++|++|.+++.. .....+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~ 163 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIA 163 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEEC
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-CEEEE
Confidence 65 8999999999999999853 1345689999999999999999999999999999999999999887 79999
Q ss_pred ccccccccccc-------cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhh
Q 019780 207 DFGLAREEVMD-------EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNL 277 (336)
Q Consensus 207 Dfg~a~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~ 277 (336)
|||++...... ......||+.|+|||.... ...+...|+|+|++.++++-.+..|.... ....+.......
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence 99998643221 1223468999999997654 45688999999999999988887775221 001111111111
Q ss_pred c----------cCCCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 278 R----------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 278 ~----------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
. ......++++.+++...+..+|+.|++..++.+...-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 291 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 0 0112345567778888899999999998888875543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=263.03 Aligned_cols=250 Identities=23% Similarity=0.230 Sum_probs=192.0
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC---CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC---CCCceEeeEeeEe-
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG---CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM---KHENILKFVGASV- 132 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~- 132 (336)
..++|.+.+.||+|+||.||+|.+. ++.||+|+++..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE---EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT---TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc---ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 3478999999999999999999983 678999999742211 11122455677666655 8999999999886
Q ss_pred ----c-CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEec
Q 019780 133 ----Q-PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLAD 207 (336)
Q Consensus 133 ----~-~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~D 207 (336)
. ...++||||+. |+|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~-~~kl~D 163 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLAD 163 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECS
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-CEEEec
Confidence 2 23899999998 5999999776666799999999999999999999999999999999999999887 799999
Q ss_pred cccccccccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhc-------
Q 019780 208 FGLAREEVMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLR------- 278 (336)
Q Consensus 208 fg~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~------- 278 (336)
||+++..... ......||+.|+|||.......+.+.|+|+|++.+|++-.+..|... .-...+..+.....
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 9999754332 23445699999999998888889999999999999998877777521 11122223322111
Q ss_pred --------------------cCCCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 279 --------------------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 279 --------------------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
.....+++.+.+++...+..+|+.|.+..++.+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 111335555667888888889999988887776443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=267.72 Aligned_cols=246 Identities=26% Similarity=0.292 Sum_probs=191.1
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec-----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ----- 133 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----- 133 (336)
.++|.+.+.||+|+||.||+|.+. ++.||||++.. .........+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc----cccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 468999999999999999999986 78899999963 2244556778899999999999999999998764
Q ss_pred -CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 -PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
...++||||+. ++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~ 160 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLAR 160 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred cceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC-cEEEEeccccc
Confidence 34899999997 599999854 4689999999999999999999999999999999999999877 79999999997
Q ss_pred cccccc------------ccccCCcccccCCCCCC-CCCCCCHHHHHHHHHHhhccCCCCCCCHh----HHHHHHHHHH-
Q 019780 213 EEVMDE------------MTCEAGTYRWMAPENER-PSLENLSEDMVALLKSCWAEDPKVRPEFA----EITITLTNIL- 274 (336)
Q Consensus 213 ~~~~~~------------~~~~~gt~~y~aPE~~~-~~~~~~~~di~~l~~~~l~~~p~~RP~~~----~i~~~l~~~~- 274 (336)
...... .....||+.|+|||... ....+...|+|+|++.++++-.+..|... +.+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 533211 12346899999999754 46678899999999999988777776421 1111111111
Q ss_pred --------------------Hhhcc--------CCCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 275 --------------------QNLRS--------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 275 --------------------~~~~~--------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
..+.. ..+.+++++.+++..++..+|+.|++..++.+...-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 11000 113466677788888888899999888888764433
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=263.19 Aligned_cols=246 Identities=24% Similarity=0.310 Sum_probs=195.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||.||+|.+. ++.||+|++.... ........+.+|+.+++.++||||+++++++.+.. .++
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS---AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---BSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccc---cchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 57999999999999999999985 7899999997422 12234567899999999999999999999998765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC--CceEEecccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK--KQVKLADFGLAREEVM 216 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~--~~~kl~Dfg~a~~~~~ 216 (336)
||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ ..+||+|||++.....
T Consensus 99 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999999999998543 4689999999999999999999999999999999999997643 2699999999875433
Q ss_pred cc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHHhhccCC----CCCCCCccc
Q 019780 217 DE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQNLRSAD----TPIPPKLVE 290 (336)
Q Consensus 217 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~~~~~~~----~~~p~~~~~ 290 (336)
.. .....|++.|+|||...+. .+...|+|+|+..+|++..+..|....-. ..+..+........ ..+|+++.+
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred CCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence 22 2233588999999987654 78899999999999998888777532211 12222222211111 346777888
Q ss_pred ccCCCCCCCCccccchhhhcccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
++...+..+|+.|++..++.+..
T Consensus 256 li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSH
T ss_pred HHHHHcccChhhCcCHHHHhcCH
Confidence 99999999999999988887643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=272.50 Aligned_cols=245 Identities=18% Similarity=0.183 Sum_probs=185.6
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC---
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT--- 135 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 135 (336)
...+|.+.+.||+|+||.||+|.+. +..+|+|.+..... ...+|+.+|+.++||||+++++++....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---------hHHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 3467999999999999999999985 55689998863221 1237999999999999999999885321
Q ss_pred ----EEEEEEccCCCCHHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 136 ----MMIITELMRGETLQRYLW-STRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 136 ----~~lv~e~~~gg~L~~~l~-~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
.++||||++++.+..... ......+++..++.++.||+.||+|||++||+||||||+|||++...+.+||+|||+
T Consensus 109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 789999998754433321 223467999999999999999999999999999999999999994334899999999
Q ss_pred ccccccc-cccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhc---------
Q 019780 211 AREEVMD-EMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLR--------- 278 (336)
Q Consensus 211 a~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~--------- 278 (336)
|+..... ......||+.|+|||...+. .++...|+|++++.++++-.+..|... .-...+..+.+.+.
T Consensus 189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9864332 23445689999999987654 578999999999999998888877522 11122222222110
Q ss_pred --------------------cCCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 279 --------------------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 279 --------------------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
......++++.+++..++..+|..|.+..++.+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence 01223667788888899999999998887777643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=272.54 Aligned_cols=250 Identities=19% Similarity=0.186 Sum_probs=200.6
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccc-cHHHHHHHHHHHHHHHhCC--CCceEeeEeeEec
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAV-SREHKEKFQREVTLLSKMK--HENILKFVGASVQ 133 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~ 133 (336)
.-..+|.+.+.||+|+||.||+|.+. ++.||||++........ .......+.+|+.+++.++ ||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34578999999999999999999885 78899999975322110 0012345678999999996 5999999999987
Q ss_pred CC-EEEEEEccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 134 PT-MMIITELMRG-ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 134 ~~-~~lv~e~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
.. .++|||++.+ ++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.+.+.+||+|||++
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 65 8999999976 8999999543 568999999999999999999999999999999999999844448999999999
Q ss_pred cccccccccccCCcccccCCCCCCCCCC-CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCCCCCCCCccc
Q 019780 212 REEVMDEMTCEAGTYRWMAPENERPSLE-NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVE 290 (336)
Q Consensus 212 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~p~~~~~ 290 (336)
+...........||+.|+|||....... +.+.|+|+|++.+|++..+..|.... .............+|+++.+
T Consensus 198 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-----~~~~~~~~~~~~~~~~~~~~ 272 (320)
T 3a99_A 198 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EEIIRGQVFFRQRVSSECQH 272 (320)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHHHHCCCCCSSCCCHHHHH
T ss_pred cccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh-----hhhhcccccccccCCHHHHH
Confidence 8765555555679999999997765554 56789999999999999888886432 12233333445677888899
Q ss_pred ccCCCCCCCCccccchhhhcccccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
++...+..+|+.|++..++.+....
T Consensus 273 li~~~l~~dp~~Rps~~~ll~hp~~ 297 (320)
T 3a99_A 273 LIRWCLALRPSDRPTFEEIQNHPWM 297 (320)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHccCChhhCcCHHHHhcCHhh
Confidence 9999999999999999888775543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=268.46 Aligned_cols=199 Identities=20% Similarity=0.222 Sum_probs=168.9
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-----------CCc
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-----------HEN 123 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpn 123 (336)
..+...+|.+.+.||+|+||+||+|.+. ++.||||++.. .......+.+|+.+++.++ |||
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC------CccchhhhhHHHHHHHHhhcccccchhccccch
Confidence 3456688999999999999999999975 78999999863 2344567889999998886 899
Q ss_pred eEeeEeeEecC-----CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeec
Q 019780 124 ILKFVGASVQP-----TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLT 197 (336)
Q Consensus 124 Iv~~~~~~~~~-----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~ 197 (336)
|+++++++... ..++|||++ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence 99999988753 378999999 88999999776667799999999999999999999998 999999999999995
Q ss_pred CC-----CCceEEeccccccccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCH
Q 019780 198 ED-----KKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEF 263 (336)
Q Consensus 198 ~~-----~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~ 263 (336)
.+ ...+||+|||+++.... ......||+.|+|||.......+...|+|+|++.++++-.+..|..
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred ccCCCcCcceEEEcccccccccCC-CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 32 22699999999976432 3344579999999999888888999999999999999988887753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=268.24 Aligned_cols=253 Identities=23% Similarity=0.267 Sum_probs=186.7
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccc------cccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNAL------AVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
-..+|.+.+.||+|+||.||+|.+. +..||||++...... .......+.+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 3578999999999999999999876 788999998642211 123344578999999999999999999999875
Q ss_pred cC------CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEe
Q 019780 133 QP------TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLA 206 (336)
Q Consensus 133 ~~------~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~ 206 (336)
.. ..++||||+. |+|.+++.. ....+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~ 176 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITIC 176 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEEC
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-CEEEE
Confidence 31 2799999998 588888853 345799999999999999999999999999999999999999877 79999
Q ss_pred ccccccccccc-cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCC----HhHHHHHHHHHHHh----
Q 019780 207 DFGLAREEVMD-EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPE----FAEITITLTNILQN---- 276 (336)
Q Consensus 207 Dfg~a~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~----~~~i~~~l~~~~~~---- 276 (336)
|||+++..... ......||+.|+|||.... ...+...|+|+|++.++++-.+..|. ..+.+..+......
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 99999753332 2334568999999997765 66889999999999999887776664 22222222211100
Q ss_pred -------------h------------ccCCCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 277 -------------L------------RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 277 -------------~------------~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
. ....+..++.+.+++..++..+|+.|++..++.+...-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 320 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence 0 00112345567778888888888888888877765443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=266.60 Aligned_cols=256 Identities=21% Similarity=0.265 Sum_probs=179.0
Q ss_pred cCCceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHH-HHHhCCCCceEeeEe
Q 019780 53 IDASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVT-LLSKMKHENILKFVG 129 (336)
Q Consensus 53 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~ 129 (336)
....|.+..++|.+.+.||+|+||.||+|.+. ++.||||++... ........+.+|+. +++.++||||+++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~~~~h~niv~~~~ 88 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST----VDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECC----CCHHHHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecc----cCchHHHHHHHHHHHHHHcCCCCcEeeeee
Confidence 34566777899999999999999999999986 889999999742 12334445556665 777889999999999
Q ss_pred eEecCC-EEEEEEccCCCCHHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCceE
Q 019780 130 ASVQPT-MMIITELMRGETLQRYLWS---TRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVK 204 (336)
Q Consensus 130 ~~~~~~-~~lv~e~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~~~~~~~k 204 (336)
++.+++ .++||||+++ +|.+++.. .....+++..++.++.|++.||.|||++ |++||||||+||+++.++ .+|
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~k 166 (327)
T 3aln_A 89 ALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIK 166 (327)
T ss_dssp EEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEE
T ss_pred EEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEE
Confidence 988765 8999999986 88877742 2356799999999999999999999999 999999999999999876 899
Q ss_pred Eecccccccccccc-ccccCCcccccCCCCC----CCCCCCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHHHhh
Q 019780 205 LADFGLAREEVMDE-MTCEAGTYRWMAPENE----RPSLENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNILQNL 277 (336)
Q Consensus 205 l~Dfg~a~~~~~~~-~~~~~gt~~y~aPE~~----~~~~~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~~~~ 277 (336)
|+|||+++...... .....||+.|+|||.. .....+...|+|+|++.+|++-.+..|... .....+..+....
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (327)
T 3aln_A 167 LCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246 (327)
T ss_dssp ECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC
T ss_pred EccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC
Confidence 99999997643332 2233699999999987 456678899999999999999888888532 1111111111100
Q ss_pred c-cC----CCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 278 R-SA----DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 278 ~-~~----~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
. .. ....++.+.+++...+..+|+.|++..++.+...
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 0 00 1235666778888999999999999888876443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=269.55 Aligned_cols=244 Identities=20% Similarity=0.234 Sum_probs=169.4
Q ss_pred CceeEe-eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec----C
Q 019780 62 RSVLLQ-KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ----P 134 (336)
Q Consensus 62 ~~~~~~-~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~ 134 (336)
++|.+. +.||+|+||+||+|.+. ++.||||++... .. ...+....++.++||||+++++++.. .
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 457774 57999999999999987 889999998631 11 12223334667799999999998874 2
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC--CceEEeccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK--KQVKLADFGLA 211 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~--~~~kl~Dfg~a 211 (336)
. .++||||++||+|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.++ ..+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 2 79999999999999999766556799999999999999999999999999999999999997532 35999999999
Q ss_pred cccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHH----H-HHHhhccC----CC
Q 019780 212 REEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLT----N-ILQNLRSA----DT 282 (336)
Q Consensus 212 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~----~-~~~~~~~~----~~ 282 (336)
+...........||+.|+|||......++.+.|+|+|++.++++..+..|....-...+. . +....... ..
T Consensus 179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (336)
T 3fhr_A 179 KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS 258 (336)
T ss_dssp EEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTST
T ss_pred eeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhc
Confidence 865555555667999999999998888888999999999999998888886443222211 1 11110011 13
Q ss_pred CCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 283 PIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 283 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
.+++++.+++...+..+|..|++..++.+..+
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 46777888999999999999999888886443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=267.85 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=189.6
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC---
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT--- 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 135 (336)
.++|.+.+.||+|+||.||+|.+. ++.||||++... .........+.+|+.+++.++||||+++++++.+..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP---FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccc---ccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 367999999999999999999986 789999999742 234456678999999999999999999999988653
Q ss_pred ----EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 136 ----MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 136 ----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
.++||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~ 173 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLA 173 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC-CEEECSTTCT
T ss_pred cceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC-cEEEeecccc
Confidence 499999997 58888762 3489999999999999999999999999999999999999887 7999999999
Q ss_pred cccccccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHh-------------
Q 019780 212 REEVMDEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQN------------- 276 (336)
Q Consensus 212 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~------------- 276 (336)
+.... ......||+.|+|||.... ...+...|+|+|++.++++-.+..|... +....+..+...
T Consensus 174 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 174 RHADA-EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp TC---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred cCCCC-CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 86432 3344578999999997765 6678899999999999998888877521 111122222111
Q ss_pred ----------h--------ccCCCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 277 ----------L--------RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 277 ----------~--------~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
+ ....+..++++.+++..++..+|+.|.+..++.+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0 0111345666778888888889999988877776443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=260.82 Aligned_cols=162 Identities=30% Similarity=0.517 Sum_probs=139.4
Q ss_pred CCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHh--CCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK--MKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~---- 134 (336)
.++|.+.+.||+|+||.||+|.+.++.||||++.. .....+.+|.+++.. ++||||+++++++.+.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~--------~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSS--------REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECG--------GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCc--------hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 36899999999999999999999999999999862 123567788888887 7899999999998865
Q ss_pred -CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccccCCCCceeecCCCCceEE
Q 019780 135 -TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH--------ANSVIHRDLKPSNLLLTEDKKQVKL 205 (336)
Q Consensus 135 -~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH--------~~~ivHrDikp~NIll~~~~~~~kl 205 (336)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.||| ++||+||||||+|||++.++ .+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~kL 188 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCI 188 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CEEE
T ss_pred ceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CEEE
Confidence 48999999999999999954 35899999999999999999999 89999999999999999887 7999
Q ss_pred ecccccccccccc------ccccCCcccccCCCCC
Q 019780 206 ADFGLAREEVMDE------MTCEAGTYRWMAPENE 234 (336)
Q Consensus 206 ~Dfg~a~~~~~~~------~~~~~gt~~y~aPE~~ 234 (336)
+|||++....... .....||+.|+|||..
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 223 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHH
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhh
Confidence 9999997543322 2334699999999943
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=274.92 Aligned_cols=191 Identities=26% Similarity=0.276 Sum_probs=145.3
Q ss_pred ceeE-eeeecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec--C-
Q 019780 63 SVLL-QKMIGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ--P- 134 (336)
Q Consensus 63 ~~~~-~~~lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~- 134 (336)
.|.+ +++||+|+||+||+|.+. +..||||++.... ....+.+|+.+|+.++||||+++++++.+ .
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-------ISMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-------CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-------CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 3554 568999999999999964 6789999997321 12357899999999999999999999864 2
Q ss_pred CEEEEEEccCCCCHHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee----cCCCCce
Q 019780 135 TMMIITELMRGETLQRYLWST-------RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLL----TEDKKQV 203 (336)
Q Consensus 135 ~~~lv~e~~~gg~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll----~~~~~~~ 203 (336)
..++||||+.+ +|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++ .+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~ 171 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RV 171 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT-CE
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC-cE
Confidence 38999999975 888887421 22358999999999999999999999999999999999999 4444 89
Q ss_pred EEeccccccccccc-----cccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 204 KLADFGLAREEVMD-----EMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 204 kl~Dfg~a~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
||+|||+++..... ......||+.|+|||.... ..++.+.|+|+|++.++++..+..|.
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 236 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCC
Confidence 99999999854321 2334569999999998776 44788999999999999988877775
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=271.57 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=196.2
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
.+.+..++|.+.+.||+|+||.||+|.+.+ .+|+|+++.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERD---NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSC---CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCC---CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 556778899999999999999999999875 599999874321 2223355778999999999999999999988765
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.++||||++|++|.+++... ...+++..++.++.|++.||+|||++|++||||||+||+++ ++ .++|+|||+++..
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-KVVITDFGLFSIS 179 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC--
T ss_pred ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-CEEEeecCCcccc
Confidence 89999999999999999443 35689999999999999999999999999999999999998 44 7999999998643
Q ss_pred cc-------ccccccCCcccccCCCCCCC---------CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH-HHHHHHHhh
Q 019780 215 VM-------DEMTCEAGTYRWMAPENERP---------SLENLSEDMVALLKSCWAEDPKVRPEFAEITI-TLTNILQNL 277 (336)
Q Consensus 215 ~~-------~~~~~~~gt~~y~aPE~~~~---------~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~-~l~~~~~~~ 277 (336)
.. .......|++.|+|||.... ...+...|+|+|++.+|++-.+..|....-.. .+..+....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 21 11233458999999997653 34677899999999999988887775322211 122222222
Q ss_pred ccC--CCCCCCCcccccCCCCCCCCccccchhhhccccccc
Q 019780 278 RSA--DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKG 316 (336)
Q Consensus 278 ~~~--~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (336)
... ...+|+++.+++...+..+|+.|++..++.+.-+.-
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l 300 (319)
T 2y4i_B 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300 (319)
T ss_dssp CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111 134778899999999999999999988888654333
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=272.18 Aligned_cols=248 Identities=13% Similarity=0.068 Sum_probs=175.8
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC--CCCceEeeE-------
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM--KHENILKFV------- 128 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~------- 128 (336)
....|.+.+.||+|+||.||+|.+. ++.||||++.... .......+.+.+|+.+++.+ +||||++++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGA--ENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCS--TTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecc--cccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 3456999999999999999999976 7889999998532 22345566788885544444 699988755
Q ss_pred eeEec------------------CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHH------HHHHHHHHHHHHHHHhCCc
Q 019780 129 GASVQ------------------PTMMIITELMRGETLQRYLWSTRPKRLDLKHS------ISFALDISRAMEYLHANSV 184 (336)
Q Consensus 129 ~~~~~------------------~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~------~~i~~qi~~aL~~lH~~~i 184 (336)
+++.. ...|+||||++ |+|.+++.... ..+++... ..++.||+.||+|||++||
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i 215 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGL 215 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence 33332 22799999998 79999996532 23344445 6777999999999999999
Q ss_pred ccccCCCCceeecCCCCceEEeccccccccccccccccCCcccccCCCCCCC--CCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 185 IHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERP--SLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 185 vHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
+||||||+|||++.++ .+||+|||+++...... ....+|+.|+|||.... ..++.+.|+|+|++.+|++-.+..|.
T Consensus 216 vHrDikp~NIll~~~~-~~kL~DFG~a~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDG-RLMLGDVSALWKVGTRG-PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp EETTCSGGGEEECTTS-CEEECCGGGEEETTCEE-EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred ccCcCCHHHEEECCCC-CEEEEecceeeecCCCc-cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999887 79999999998643322 23457799999998877 67889999999999999988877775
Q ss_pred HhHHHHHHHHHHHh----------h-ccCCCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 263 FAEITITLTNILQN----------L-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 263 ~~~i~~~l~~~~~~----------~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
......... .... . ......+|+++.+++...+..+|+.|.+..++.+...
T Consensus 294 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 294 GLVTPGIKG-SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp TBCCTTCTT-CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred CCcCccccc-chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 332110000 0000 0 0011355677888888888899999988888776443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=260.58 Aligned_cols=253 Identities=19% Similarity=0.264 Sum_probs=195.4
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC--CCceEeeEeeE
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK--HENILKFVGAS 131 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~ 131 (336)
+.+.+..++|.+.+.||+|+||.||+|.+. ++.||||++... .........+.+|+.+++.++ ||||+++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE---EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECS---SCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccc---cccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 356778889999999999999999999886 788999999742 224556788999999999997 59999999998
Q ss_pred ecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccc
Q 019780 132 VQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 132 ~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
.+.. .++||| +.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++. + .+||+|||+
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~-~~kL~Dfg~ 172 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G-MLKLIDFGI 172 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T-EEEECCCSS
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C-eEEEeeccc
Confidence 8766 889999 5678999999543 56899999999999999999999999999999999999974 4 899999999
Q ss_pred cccccccc----ccccCCcccccCCCCCCC-----------CCCCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHH
Q 019780 211 AREEVMDE----MTCEAGTYRWMAPENERP-----------SLENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNI 273 (336)
Q Consensus 211 a~~~~~~~----~~~~~gt~~y~aPE~~~~-----------~~~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~ 273 (336)
++...... .....|++.|+|||.... ...+...|+|+|+..+|++..+..|... +-...+...
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 98543322 123468999999997654 4667789999999999999888888532 112222222
Q ss_pred HHhhc--cCCCCCCCCcccccCCCCCCCCccccchhhhcccccc
Q 019780 274 LQNLR--SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 274 ~~~~~--~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
..... ......++++.+++...+..+|+.|++..++.+...-
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 22111 1122345567888999999999999999888775443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=261.38 Aligned_cols=193 Identities=22% Similarity=0.274 Sum_probs=164.4
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--C-ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCc------eEeeEeeE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--C-EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN------ILKFVGAS 131 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~~ 131 (336)
.++|.+.+.||+|+||+||+|.+. + ..||+|+++. .....+.+.+|+.+++.++|++ ++.+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN------VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc------cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 578999999999999999999985 3 6899999963 2345677889999999987665 88888888
Q ss_pred ecCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee--------------
Q 019780 132 VQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLL-------------- 196 (336)
Q Consensus 132 ~~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll-------------- 196 (336)
.... .++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 7655 89999999 6688888866655679999999999999999999999999999999999999
Q ss_pred -----cCCCCceEEeccccccccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 197 -----TEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 197 -----~~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
+.++ .+||+|||+++... .......||+.|+|||.......+.+.|+|+|++.++++-.+..|.
T Consensus 171 ~~~~~~~~~-~~kl~Dfg~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 171 CEEKSVKNT-SIRVADFGSATFDH-EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp CCEEEESCC-CEEECCCTTCEETT-SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccCCC-cEEEeecCcccccc-ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 3444 79999999997533 2334557999999999988888999999999999999988888775
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=267.54 Aligned_cols=250 Identities=20% Similarity=0.195 Sum_probs=191.6
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccc-cHHHHHHHHHHHHHHHhC----CCCceEeeEeeEec
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAV-SREHKEKFQREVTLLSKM----KHENILKFVGASVQ 133 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l----~hpnIv~~~~~~~~ 133 (336)
.++|.+.+.||+|+||.||+|.+. ++.||||++........ .......+.+|+.++..+ +||||+++++++.+
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 467999999999999999999884 78899999974322111 112334567899999988 89999999999876
Q ss_pred CC-EEEEEEc-cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 134 PT-MMIITEL-MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 134 ~~-~~lv~e~-~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
.+ .++|||+ +.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.+.+.++|+|||++
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred CCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 54 8999999 7899999999553 468999999999999999999999999999999999999833348999999999
Q ss_pred cccccccccccCCcccccCCCCCCCCCC-CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCCCCCCCCccc
Q 019780 212 REEVMDEMTCEAGTYRWMAPENERPSLE-NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVE 290 (336)
Q Consensus 212 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~p~~~~~ 290 (336)
+...........|+..|+|||....... +...|+|+|++.+|++-.+..|.... ..+..........+++++.+
T Consensus 188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~~~~~~~~~~~~~ 262 (312)
T 2iwi_A 188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----QEILEAELHFPAHVSPDCCA 262 (312)
T ss_dssp EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHHHHTCCCCCTTSCHHHHH
T ss_pred hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----HHHhhhccCCcccCCHHHHH
Confidence 8765555556679999999997655444 45799999999999998888886332 12223333344567777888
Q ss_pred ccCCCCCCCCccccchhhhcccccccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKFNEKGK 317 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
++...+..+++.|.+..++.+......
T Consensus 263 li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 263 LIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred HHHHHccCChhhCcCHHHHhcChhhcC
Confidence 888888888888888888876544433
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=276.08 Aligned_cols=242 Identities=19% Similarity=0.251 Sum_probs=190.6
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCc-eEeeEeeEecCC-E
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN-ILKFVGASVQPT-M 136 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~-~ 136 (336)
.++|.+.+.||+|+||.||+|.+. ++.||||++..... ...+.+|+.+++.++|++ |..+..++.+.. .
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-------~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-------SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 467999999999999999999975 88999999874221 234789999999998754 445555555544 7
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee---cCCCCceEEeccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLL---TEDKKQVKLADFGLARE 213 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll---~~~~~~~kl~Dfg~a~~ 213 (336)
++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .+||+|||+++.
T Consensus 79 ~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~ 155 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKK 155 (483)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEE
T ss_pred EEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC-eEEEEeCCccee
Confidence 9999999 89999999543 3579999999999999999999999999999999999999 4554 899999999985
Q ss_pred ccccc---------ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh----HHHHHHHHHHHh----
Q 019780 214 EVMDE---------MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA----EITITLTNILQN---- 276 (336)
Q Consensus 214 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~----~i~~~l~~~~~~---- 276 (336)
..... .....||+.|+|||.......+...|+|+|++.+|++..+..|... .....+..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 43322 1245699999999999988899999999999999999888888522 222222222221
Q ss_pred -hccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 277 -LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 277 -~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.......+|+++.+++...+..+++.|++..++.++
T Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~ 272 (483)
T 3sv0_A 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRL 272 (483)
T ss_dssp CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 111225678899999999999999999988877753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=258.28 Aligned_cols=254 Identities=23% Similarity=0.245 Sum_probs=183.9
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
..+....++|.+.+.||+|+||.||+|.+. ++.||||++.... ........+.++..+++.++||||+++++++.
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG---NKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS---CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 456667789999999999999999999985 7899999997422 22333445556666788899999999999998
Q ss_pred cCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCceEEecccc
Q 019780 133 QPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 133 ~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
++. .++||||+ ++.+..+.. .....+++..++.++.|++.||.|||++ |++||||||+||+++.++ .+||+|||+
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~ 171 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGI 171 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred cCCcEEEEEecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCC
Confidence 765 89999999 556665553 3346799999999999999999999996 999999999999999887 799999999
Q ss_pred cccccccc-ccccCCcccccCCCCCC-----CCCCCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHHHhhccC--
Q 019780 211 AREEVMDE-MTCEAGTYRWMAPENER-----PSLENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNILQNLRSA-- 280 (336)
Q Consensus 211 a~~~~~~~-~~~~~gt~~y~aPE~~~-----~~~~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~~~~~~~-- 280 (336)
+....... .....|++.|+|||... ....+...|+|+|++.+|++..+..|... .-...+..+.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP 251 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC
Confidence 97543322 23346999999999874 45677899999999999999888877532 2223333333332211
Q ss_pred -CCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 281 -DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 281 -~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
...+|+++.+++...+..+|..|++..++.+...
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 252 GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 1246778889999999999999999988887543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=263.93 Aligned_cols=194 Identities=25% Similarity=0.292 Sum_probs=165.0
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CC-----ceEeeEeeEe
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HE-----NILKFVGASV 132 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~~~~~~~ 132 (336)
.++|.+.+.||+|+||+||+|.+. ++.||||+++. .......+.+|+.+++.++ |+ +|+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN------KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec------cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 478999999999999999999986 77899999973 2334566788899888885 55 4999999888
Q ss_pred cCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCCCCceeecC-CCCceEEecc
Q 019780 133 QPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH--ANSVIHRDLKPSNLLLTE-DKKQVKLADF 208 (336)
Q Consensus 133 ~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivHrDikp~NIll~~-~~~~~kl~Df 208 (336)
... .++||||+++ +|.+++.......+++..++.++.|++.||.||| +.||+||||||+|||++. ..+.+||+||
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 665 8999999965 9999997766567999999999999999999999 579999999999999954 2237999999
Q ss_pred ccccccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 209 GLAREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 209 g~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
|+++... .......||+.|+|||......++.+.|+|+|++.++++..+..|.
T Consensus 206 G~a~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf 258 (382)
T 2vx3_A 206 GSSCQLG-QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258 (382)
T ss_dssp TTCEETT-CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCceecc-cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9998643 2334567999999999998888999999999999999998888875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=262.00 Aligned_cols=248 Identities=18% Similarity=0.149 Sum_probs=175.3
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-C-
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP-T- 135 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~- 135 (336)
..++|.+.+.||+|+||.||+|.+. ++.||||++.... .......+++..+..++||||+++++++... .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP------RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCT------TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc------cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 3468999999999999999999986 7899999986421 1223466788888999999999999998642 1
Q ss_pred ------EEEEEEccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCCCCceeecCCCCceEE
Q 019780 136 ------MMIITELMRGETLQRYLWS--TRPKRLDLKHSISFALDISRAMEYLH--ANSVIHRDLKPSNLLLTEDKKQVKL 205 (336)
Q Consensus 136 ------~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivHrDikp~NIll~~~~~~~kl 205 (336)
.++||||+++ +|...+.. .....+++..++.++.|++.||.||| ++||+||||||+|||++...+.+||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 7899999986 55544422 34567899999999999999999999 9999999999999999973348999
Q ss_pred ecccccccccccc-ccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhh-----
Q 019780 206 ADFGLAREEVMDE-MTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNL----- 277 (336)
Q Consensus 206 ~Dfg~a~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~----- 277 (336)
+|||+++...... .....||+.|+|||..... ..+...|+|+|++.+|++-.+..|.... -...+..+....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 9999998644332 3345689999999987554 4789999999999999988887775221 111122222110
Q ss_pred ---------------------------ccCCCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 278 ---------------------------RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 278 ---------------------------~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
.......++++.+++..++..+|..|.+..++.+..+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 0111123456777888888888888888777776443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=276.59 Aligned_cols=197 Identities=26% Similarity=0.358 Sum_probs=166.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec------
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ------ 133 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------ 133 (336)
.+|.+.+.||+|+||.||+|.+. ++.||||+++. .......+.+.+|+.+++.++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~----~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ----ELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCS----CCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecc----cCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 67999999999999999999875 78999999873 2245567789999999999999999999998654
Q ss_pred C-CEEEEEEccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC--ceEEeccc
Q 019780 134 P-TMMIITELMRGETLQRYLWSTR-PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK--QVKLADFG 209 (336)
Q Consensus 134 ~-~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~--~~kl~Dfg 209 (336)
+ ..++||||++||+|.+++.... ...+++..++.++.|++.||+|||++||+||||||+||+++.++. .++|+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 2 3799999999999999996533 236899999999999999999999999999999999999987652 48999999
Q ss_pred ccccccccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 210 LAREEVMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 210 ~a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
++....... .....||+.|+|||......++.+.|+|+|++.+|++-.+..|.
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf 223 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 998644332 33456999999999998888899999999999999888887775
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=269.97 Aligned_cols=197 Identities=26% Similarity=0.372 Sum_probs=155.0
Q ss_pred ceeecCCceeEeeeecCCCcEE-EEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEec
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSI-VYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQ 133 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~-V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 133 (336)
.+.+...+|.+.+.||+|+||+ ||++...++.||||++..... ..+.+|+.+|+.+ +||||+++++++.+
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--------~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 89 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--------SFADREVQLLRESDEHPNVIRYFCTEKD 89 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--------EECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred cEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--------HHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 5667778899999999999998 455666789999999964221 1256899999999 79999999999987
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC----CceEEecc
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK----KQVKLADF 208 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~----~~~kl~Df 208 (336)
.. .|+||||+. |+|.+++.... ....+..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+||
T Consensus 90 ~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 90 RQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp TTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred CCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 76 899999997 59999995443 3455556788999999999999999999999999999995321 25889999
Q ss_pred ccccccccc-----cccccCCcccccCCCCCC---CCCCCCHHHHHHHHHHhhccCC-CCCCC
Q 019780 209 GLAREEVMD-----EMTCEAGTYRWMAPENER---PSLENLSEDMVALLKSCWAEDP-KVRPE 262 (336)
Q Consensus 209 g~a~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~~di~~l~~~~l~~~p-~~RP~ 262 (336)
|+|+..... ......||+.|+|||... ....+.+.|+|+|++.++++-. +..|.
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf 230 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTT
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence 999754322 233456999999999887 4556779999999999998877 55554
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=280.25 Aligned_cols=203 Identities=26% Similarity=0.372 Sum_probs=163.5
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC---CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC--
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG---CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-- 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-- 135 (336)
..+|.+.+.||+|+||.||+|.+. ++.||||++.. .........+.+|+.+++.++||||+++++++.+..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH----SGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCS----SCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCc----cCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 478999999999999999999974 68899999863 223456678899999999999999999999987543
Q ss_pred ----EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 136 ----MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 136 ----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
.|+||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a 228 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAV 228 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccc
Confidence 5999999999999988732 69999999999999999999999999999999999999974 6999999999
Q ss_pred cccccccccccCCcccccCCCCCCCCCCCCH--------------------------------------HHHHHHHHHhh
Q 019780 212 REEVMDEMTCEAGTYRWMAPENERPSLENLS--------------------------------------EDMVALLKSCW 253 (336)
Q Consensus 212 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--------------------------------------~di~~l~~~~l 253 (336)
+..... ....||+.|+|||.....+ +.. ..+..|+..||
T Consensus 229 ~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 305 (681)
T 2pzi_A 229 SRINSF--GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAI 305 (681)
T ss_dssp EETTCC--SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHHHHHT
T ss_pred hhcccC--CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHHhhhc
Confidence 864332 4456999999999332211 222 45666788899
Q ss_pred ccCCCCCCC-HhHHHHHHHHHHHh
Q 019780 254 AEDPKVRPE-FAEITITLTNILQN 276 (336)
Q Consensus 254 ~~~p~~RP~-~~~i~~~l~~~~~~ 276 (336)
+.+|.+||+ ..++...+..+...
T Consensus 306 ~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 306 DPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp CSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred cCChhhCCCHHHHHHHHHHHHHHH
Confidence 999999996 55666666655443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=267.07 Aligned_cols=240 Identities=23% Similarity=0.295 Sum_probs=166.9
Q ss_pred CceeEeeeecCCCcEEEEEe-EECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKG-FYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~~l 138 (336)
+.|.+.+.||+|+||+||.+ ...++.||||++.. ...+.+.+|+.+|+.+ +||||+++++++.++. .++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~--------~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--------DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG--------GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH--------HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 45677899999999999754 44589999999863 1234578999999876 8999999999988766 899
Q ss_pred EEEccCCCCHHHHHhhcCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC------------CC
Q 019780 139 ITELMRGETLQRYLWSTRPKR-----LDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED------------KK 201 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~-----l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~------------~~ 201 (336)
||||+. |+|.+++....... .++..++.++.||+.||+|||++||+||||||+|||++.+ ..
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999996 59999995433211 1233457899999999999999999999999999999753 23
Q ss_pred ceEEecccccccccccc------ccccCCcccccCCCCCCC-------CCCCCHHHHHHHHHHhhccCC-CCCCCHhHHH
Q 019780 202 QVKLADFGLAREEVMDE------MTCEAGTYRWMAPENERP-------SLENLSEDMVALLKSCWAEDP-KVRPEFAEIT 267 (336)
Q Consensus 202 ~~kl~Dfg~a~~~~~~~------~~~~~gt~~y~aPE~~~~-------~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~ 267 (336)
.+||+|||+++...... .....||+.|+|||.... ...+.+.|+|+|++.++++-. +..|......
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 79999999998643322 223469999999997754 567899999999999999877 6666422211
Q ss_pred HHHHHHHHhhccCCC-------CCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 268 ITLTNILQNLRSADT-------PIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 268 ~~l~~~~~~~~~~~~-------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.. ..+......... .+++++.+++..++..+|..|++..++.+
T Consensus 246 ~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RE-SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH-HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hH-HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 112221111110 11234555666666666666666665554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-32 Score=239.93 Aligned_cols=210 Identities=12% Similarity=0.086 Sum_probs=165.3
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
+-..+|.+.+.||+|+||.||+|.+. ++.||||++... ..........+.+|+.++..++||||+++++++.+++
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 105 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQ--GVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG 105 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTT--CCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcc--cccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCc
Confidence 33467999999999999999999987 789999999742 2233556788999999999999999999999998765
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
.|+||||++|++|.+++.. + .....+..++.|++.||+|||++||+||||||+|||++.++ .+||+++|......
T Consensus 106 ~~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-~~kl~~~~~~~~~~ 180 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-DVVLAYPATMPDAN 180 (286)
T ss_dssp EEEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-CEEECSCCCCTTCC
T ss_pred EEEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-CEEEEeccccCCCC
Confidence 8999999999999999932 2 35667889999999999999999999999999999999887 79999887654211
Q ss_pred ccc---------ccccCCcccccCCCC----------CC-------CCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 019780 216 MDE---------MTCEAGTYRWMAPEN----------ER-------PSLENLSEDMVALLKSCWAEDPKVRPEFAEITIT 269 (336)
Q Consensus 216 ~~~---------~~~~~gt~~y~aPE~----------~~-------~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~ 269 (336)
... .....|...|..... .. .....++.++.+|+..||+.+|.+| ++.++++.
T Consensus 181 ~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred chhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 100 000114444432211 01 1124678899999999999999999 99999999
Q ss_pred HHHHHHh
Q 019780 270 LTNILQN 276 (336)
Q Consensus 270 l~~~~~~ 276 (336)
|..+...
T Consensus 260 L~~~~~~ 266 (286)
T 3uqc_A 260 MQQATAV 266 (286)
T ss_dssp HHHHHC-
T ss_pred HHHHhcc
Confidence 9887644
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-32 Score=240.82 Aligned_cols=196 Identities=24% Similarity=0.357 Sum_probs=154.9
Q ss_pred ceeEe-eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHH-HhCCCCceEeeEeeEec----C
Q 019780 63 SVLLQ-KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLL-SKMKHENILKFVGASVQ----P 134 (336)
Q Consensus 63 ~~~~~-~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~----~ 134 (336)
+|.+. +.||+|+||.||+|.+. ++.||+|+++. ...+.+|+.++ +.++||||+++++++.+ .
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 45555 88999999999999985 78999999962 13467888887 66689999999998875 3
Q ss_pred -CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC--CCceEEeccccc
Q 019780 135 -TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED--KKQVKLADFGLA 211 (336)
Q Consensus 135 -~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~--~~~~kl~Dfg~a 211 (336)
..++||||++||+|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.+ .+.++|+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 38999999999999999977666689999999999999999999999999999999999999972 237999999999
Q ss_pred cccccccccc--------------cCCcccccCCC-------C---CC----CCC----CCCHHHHHHHHHHhhccCCCC
Q 019780 212 REEVMDEMTC--------------EAGTYRWMAPE-------N---ER----PSL----ENLSEDMVALLKSCWAEDPKV 259 (336)
Q Consensus 212 ~~~~~~~~~~--------------~~gt~~y~aPE-------~---~~----~~~----~~~~~di~~l~~~~l~~~p~~ 259 (336)
........+. ..|...|.... . .. ..+ ..++.++.+|+..||+.+|.+
T Consensus 168 ~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 247 (299)
T 3m2w_A 168 KETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 247 (299)
T ss_dssp EECTTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTT
T ss_pred cccccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhh
Confidence 7543322111 11444442211 0 00 111 457889999999999999999
Q ss_pred CCCHhHHHH
Q 019780 260 RPEFAEITI 268 (336)
Q Consensus 260 RP~~~~i~~ 268 (336)
||++.++++
T Consensus 248 Rps~~e~l~ 256 (299)
T 3m2w_A 248 RMTITEFMN 256 (299)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-33 Score=262.39 Aligned_cols=244 Identities=15% Similarity=0.160 Sum_probs=181.3
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC-Cce-----------
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH-ENI----------- 124 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnI----------- 124 (336)
...+.|...+.||+|+||.||+|.+. ++.||||++.... .......+.+.+|+.+++.++| .|.
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~--~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTE--RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSC--C----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCC--CccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 45567899999999999999999987 8899999987322 2223346779999999999987 211
Q ss_pred ----Ee------eEeeEec------CCEEEEEEccCCCCHHHHHh-----hcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019780 125 ----LK------FVGASVQ------PTMMIITELMRGETLQRYLW-----STRPKRLDLKHSISFALDISRAMEYLHANS 183 (336)
Q Consensus 125 ----v~------~~~~~~~------~~~~lv~e~~~gg~L~~~l~-----~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ 183 (336)
+. +..++.. ...+++|+++ +++|.+++. ......+++..++.++.|++.||+|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 11 1111111 1256666665 679999984 223455788899999999999999999999
Q ss_pred cccccCCCCceeecCCCCceEEeccccccccccccccccCCcccccCCCCC----------CCCCCCCHHHHHHHHHHhh
Q 019780 184 VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENE----------RPSLENLSEDMVALLKSCW 253 (336)
Q Consensus 184 ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~di~~l~~~~l 253 (336)
|+||||||+|||++.++ .+||+|||+++..... ....+| +.|+|||.. ....++...|+|+|++.+|
T Consensus 232 iiHrDiKp~NILl~~~~-~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp EECSCCCGGGEEECTTC-CEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCC-eEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 99999999999999887 7999999998864333 445568 999999987 5556778999999999999
Q ss_pred ccCCCCCCCHhHHHHHHHHHHHhhccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 254 AEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 254 ~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
++-.++.|....-.. ............+|+++.+++...+..+|+.|.+..++.+
T Consensus 309 elltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAAL---GGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGG---SCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchh---hhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 998888886432111 1112222233567888999999999999999988777665
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=262.54 Aligned_cols=179 Identities=14% Similarity=0.091 Sum_probs=124.0
Q ss_pred eeecCCCcEEEEEeEE--CCccEEEEEeecCccc-----cccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEecCC-EEE
Q 019780 68 KMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNAL-----AVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-~~l 138 (336)
...+.|++|.+..++. -++.+++|++...... .......+.+.+|+++|+++ .|+||+++++++.++. .||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3467777777766554 3899999999743211 12234456799999999999 5999999999999876 999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||++|++|.++|.+ .+.+++. .|+.||+.||+|+|++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-HARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-CEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-CEEEeecccCeeCCCCC
Confidence 9999999999999954 4567664 4889999999999999999999999999999887 7999999999854332
Q ss_pred -cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhh
Q 019780 218 -EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCW 253 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l 253 (336)
...+.+||+.|+|||...+.. ....|+|+++..++
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~~-~~~~d~~s~g~~~~ 429 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAENK-SWNGFWRSAPVHPF 429 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------C
T ss_pred ccccCceechhhccHHHhCCCC-CCcccccccccchh
Confidence 234557999999999887653 44566776655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-29 Score=242.21 Aligned_cols=157 Identities=22% Similarity=0.242 Sum_probs=119.6
Q ss_pred eEeeeecCCCcEEEEEeEECCccEEEEEeecCcccc---ccHHHHHHHHHHHHHHHhCCCCceEe--eEeeEecCCEEEE
Q 019780 65 LLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALA---VSREHKEKFQREVTLLSKMKHENILK--FVGASVQPTMMII 139 (336)
Q Consensus 65 ~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~--~~~~~~~~~~~lv 139 (336)
...+.||+|+||.||+|...+..+++|......... ......+++.+|+.+|++++||||++ +++. ..+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-DLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-ETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-eCCccEEE
Confidence 345789999999999998889999999876422111 12223567899999999999999994 4444 33458999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
|||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCccc
Confidence 999999999999943 5689999999999999999999999999999996 69999999998654322
Q ss_pred --------ccccCCcccccCCCCCC
Q 019780 219 --------MTCEAGTYRWMAPENER 235 (336)
Q Consensus 219 --------~~~~~gt~~y~aPE~~~ 235 (336)
.....||+.|+|||.+.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~ 509 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWE 509 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred cccchhhhhhhhcCCCCcCCHHHHH
Confidence 12456999999999654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=202.60 Aligned_cols=139 Identities=19% Similarity=0.230 Sum_probs=110.1
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCcccccc----H---------HHHHHHHHHHHHHHhCCCCceEe
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVS----R---------EHKEKFQREVTLLSKMKHENILK 126 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~----~---------~~~~~~~~E~~~l~~l~hpnIv~ 126 (336)
...|.+++.||+|+||.||+|.+. ++.||||+++........ . .....+.+|+.+|+.++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 345567799999999999999985 789999999742211100 0 24567899999999999 4 55
Q ss_pred eEeeEecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEe
Q 019780 127 FVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLA 206 (336)
Q Consensus 127 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~ 206 (336)
+.+++..+..++||||++|++|.+ +.. .....++.|++.||.|||++||+||||||+|||++ ++ .+||+
T Consensus 166 v~~~~~~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~-~vkl~ 234 (282)
T 1zar_A 166 VPKVYAWEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE-GIWII 234 (282)
T ss_dssp SCCEEEEETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT-EEEEC
T ss_pred cCeEEeccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC-cEEEE
Confidence 555555566899999999999998 511 22457999999999999999999999999999999 65 89999
Q ss_pred ccccccc
Q 019780 207 DFGLARE 213 (336)
Q Consensus 207 Dfg~a~~ 213 (336)
|||+|+.
T Consensus 235 DFG~a~~ 241 (282)
T 1zar_A 235 DFPQSVE 241 (282)
T ss_dssp CCTTCEE
T ss_pred ECCCCeE
Confidence 9999973
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-23 Score=181.17 Aligned_cols=141 Identities=18% Similarity=0.159 Sum_probs=108.4
Q ss_pred CceeEeeeecCCCcEEEEEeEE--CCcc--EEEEEeecCccccc-------------------cHHHHHHHHHHHHHHHh
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFY--GCEP--VAVKVIQPCNALAV-------------------SREHKEKFQREVTLLSK 118 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~--~~~~--vavK~~~~~~~~~~-------------------~~~~~~~~~~E~~~l~~ 118 (336)
.-|.+.+.||+|+||.||+|.+ .++. ||||+++....... .......+.+|+.+|..
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3477889999999999999998 5888 99999864211100 11223468899999999
Q ss_pred CCCCce--EeeEeeEecCCEEEEEEccCC-C----CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCC
Q 019780 119 MKHENI--LKFVGASVQPTMMIITELMRG-E----TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH-ANSVIHRDLK 190 (336)
Q Consensus 119 l~hpnI--v~~~~~~~~~~~~lv~e~~~g-g----~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivHrDik 190 (336)
+.|+++ +..++. ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| ++||+|||||
T Consensus 127 l~~~~i~~p~~~~~---~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 127 AKEAGVSVPQPYTY---MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HHHTTCCCCCEEEE---ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HHhCCCCCCeEEEc---CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 988754 334432 357899999943 3 77776522 234567889999999999999 9999999999
Q ss_pred CCceeecCCCCceEEeccccccc
Q 019780 191 PSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 191 p~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
|+|||++. .++|+|||+|..
T Consensus 199 p~NILl~~---~~~liDFG~a~~ 218 (258)
T 1zth_A 199 EYNIMYID---KVYFIDMGQAVT 218 (258)
T ss_dssp TTSEEESS---SEEECCCTTCEE
T ss_pred HHHEEEcC---cEEEEECccccc
Confidence 99999986 699999999975
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.8e-20 Score=169.28 Aligned_cols=140 Identities=16% Similarity=0.141 Sum_probs=101.7
Q ss_pred ceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccc------------cH-----HHHHHHHHHHHHHHhCCCCce
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAV------------SR-----EHKEKFQREVTLLSKMKHENI 124 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~------------~~-----~~~~~~~~E~~~l~~l~hpnI 124 (336)
-|.+++.||+|+||.||+|... |+.||||+++....... .. ...-...+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3889999999999999999975 88999999874321100 00 011123467777877765543
Q ss_pred E--eeEeeEecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC-
Q 019780 125 L--KFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK- 201 (336)
Q Consensus 125 v--~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~- 201 (336)
. ..++ ....+|||||++|++|..+.. . .....++.|++.+|.+||++|||||||||.|||++.++.
T Consensus 176 ~vp~p~~---~~~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 176 PVPEPIA---QSRHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp SCCCEEE---EETTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCeeee---ccCceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 2 2222 223589999999998876431 1 234568899999999999999999999999999987652
Q ss_pred --------ceEEeccccccc
Q 019780 202 --------QVKLADFGLARE 213 (336)
Q Consensus 202 --------~~kl~Dfg~a~~ 213 (336)
.+.|+||+.+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 388999998864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=120.49 Aligned_cols=138 Identities=15% Similarity=0.090 Sum_probs=107.4
Q ss_pred ceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-EEEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~lv~ 140 (336)
.|.+...++.|+.+.||++...+..+++|+...... .....+.+|+.+++.+. +..+.+++++..+.. .|+||
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~-----~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYK-----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGT-----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccC-----CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 477778889999999999987788999999863110 11235889999999885 667788888877654 89999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA--------------------------------------- 181 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--------------------------------------- 181 (336)
|+++|.+|.+.+. +......++.+++.+|+.||+
T Consensus 90 e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 90 SEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp ECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 9999999987641 112234678899999999998
Q ss_pred --------------------CCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 182 --------------------NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 182 --------------------~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.+++|+|++|.||+++.++ .+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhccc
Confidence 4589999999999998643 567999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.5e-11 Score=111.89 Aligned_cols=140 Identities=13% Similarity=0.204 Sum_probs=105.8
Q ss_pred EeeeecCCCcEEEEEeEECCccEEEEEee--cCccccccHHHHHHHHHHHHHHHhCC--CCceEeeEeeEecCC----EE
Q 019780 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQ--PCNALAVSREHKEKFQREVTLLSKMK--HENILKFVGASVQPT----MM 137 (336)
Q Consensus 66 ~~~~lg~G~fg~V~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~----~~ 137 (336)
..+.|+.|.++.||+....+..+++|+.. .... ......+.+|+.+++.+. +..+++++.++.+.. .+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~----~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL----LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCC----CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 34779999999999998888889999875 3211 112356889999999987 445778888776652 78
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA------------------------------------ 181 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~------------------------------------ 181 (336)
+||||++|..+.+.. ...++......++.+++..|+.||+
T Consensus 118 ~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999999998775421 1346788888999999999999997
Q ss_pred ----------------------CCcccccCCCCceeecCCCC-ceEEeccccccc
Q 019780 182 ----------------------NSVIHRDLKPSNLLLTEDKK-QVKLADFGLARE 213 (336)
Q Consensus 182 ----------------------~~ivHrDikp~NIll~~~~~-~~kl~Dfg~a~~ 213 (336)
.+++|+|++|.|||++.++. .+.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999987652 468999999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=2.1e-11 Score=105.41 Aligned_cols=132 Identities=16% Similarity=0.089 Sum_probs=93.7
Q ss_pred ceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCc--eEeeEeeEecC-CEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN--ILKFVGASVQP-TMMI 138 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~-~~~l 138 (336)
.+.+....+.|..+.||++... +..+++|+.... ....+.+|+.+++.+.+.+ +.+++++..++ ..++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 3444343345666999998765 567999997631 1234778999998886444 55678777654 4899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS----------------------------------- 183 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~----------------------------------- 183 (336)
||||++|.+|. . . ..+ ...++.+++..|..||+..
T Consensus 93 v~e~i~G~~l~--~--~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 93 LLGEVPGQDLL--S--S---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEECCSSEETT--T--S---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEecCCcccC--c--C---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99999998884 2 1 112 1256677777888888643
Q ss_pred -----------------------cccccCCCCceeecCCCCceEEeccccccc
Q 019780 184 -----------------------VIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 184 -----------------------ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
++|+|++|.||+++.++ .+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhccc
Confidence 99999999999998653 566999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.87 E-value=1e-08 Score=90.94 Aligned_cols=132 Identities=21% Similarity=0.295 Sum_probs=97.7
Q ss_pred eeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCc--eEeeEeeEecCC----EEEEE
Q 019780 68 KMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HEN--ILKFVGASVQPT----MMIIT 140 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn--Iv~~~~~~~~~~----~~lv~ 140 (336)
+.++.|....||+.. ..+++|+... ......+.+|+.+|+.+. +.. +.+.+....+.. .|+||
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~-------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH-------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS-------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC-------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 458999999999863 6799998652 234577899999998874 332 344554433332 48899
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA--------------------------------------- 181 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--------------------------------------- 181 (336)
++++|.+|..... ..++..+...++.+++..|+.||+
T Consensus 96 ~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 96 TKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp ECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999988876432 236777777888888888888885
Q ss_pred -------------------CCcccccCCCCceeecCC-CCceEEeccccccc
Q 019780 182 -------------------NSVIHRDLKPSNLLLTED-KKQVKLADFGLARE 213 (336)
Q Consensus 182 -------------------~~ivHrDikp~NIll~~~-~~~~kl~Dfg~a~~ 213 (336)
..++|+|++|.||+++.+ +..+.|+||+.+..
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 247999999999999974 43678999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=8.4e-08 Score=85.14 Aligned_cols=132 Identities=21% Similarity=0.231 Sum_probs=91.4
Q ss_pred eeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCC---ceEeeEeeEe--cCCEEEEEEc
Q 019780 68 KMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE---NILKFVGASV--QPTMMIITEL 142 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~--~~~~~lv~e~ 142 (336)
+.++.|....||+. +..+++|+.. .......+.+|+.+|+.+.+. .+.+.+.+.. ++..++||++
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~-------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPK-------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEES-------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eecCCCcceeEEEE---CCEEEEEecC-------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 55788898999987 6789999853 233457899999999999742 3455565554 2337899999
Q ss_pred cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 019780 143 MRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN---------------------------------------- 182 (336)
Q Consensus 143 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---------------------------------------- 182 (336)
++|.+|..... ..++......++.++...|+.||+.
T Consensus 95 i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 95 VQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred cCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 99988876321 1234444444445555555444432
Q ss_pred --------------------CcccccCCCCceeecC---CCCceEEeccccccc
Q 019780 183 --------------------SVIHRDLKPSNLLLTE---DKKQVKLADFGLARE 213 (336)
Q Consensus 183 --------------------~ivHrDikp~NIll~~---~~~~~kl~Dfg~a~~ 213 (336)
.++|+|++|.||+++. ++..+.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 4699999999999987 343458999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=5.6e-07 Score=78.02 Aligned_cols=129 Identities=16% Similarity=0.153 Sum_probs=88.6
Q ss_pred ecCCCcE-EEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-EEEEEEccC
Q 019780 70 IGEGSYS-IVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT-MMIITELMR 144 (336)
Q Consensus 70 lg~G~fg-~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~lv~e~~~ 144 (336)
+..|..| .||+.... +..+.+|+-.. .....+.+|...|+.+. +-.+.+++.++.+.+ .++||++++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG--------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET--------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC--------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 4444444 68987654 56799998652 23456888999998885 334667777777655 899999999
Q ss_pred CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 019780 145 GETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN------------------------------------------ 182 (336)
Q Consensus 145 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~------------------------------------------ 182 (336)
|.++.+..... ......+..++...|.-||+.
T Consensus 104 G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 104 GKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp SEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred CccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 98887765221 112234455555556655531
Q ss_pred ----------------CcccccCCCCceeecCCCCceEEeccccccc
Q 019780 183 ----------------SVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 183 ----------------~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.++|+|+.+.|||++.++ .+-|+||+.+..
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~~ 223 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECccccc
Confidence 268999999999998654 567999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.5e-06 Score=79.89 Aligned_cols=79 Identities=13% Similarity=0.128 Sum_probs=49.3
Q ss_pred eeeecCCCcEEEEEeEE--CCccEEEEEeecCcc-cccc-HHHHHHHHHHHHHHHhCCC--C-ceEeeEeeEecCCEEEE
Q 019780 67 QKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNA-LAVS-REHKEKFQREVTLLSKMKH--E-NILKFVGASVQPTMMII 139 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~--~~~~vavK~~~~~~~-~~~~-~~~~~~~~~E~~~l~~l~h--p-nIv~~~~~~~~~~~~lv 139 (336)
.+.||.|.++.||++.. .+..++||...+... .... .....++..|..+|+.+.. | .+.+++.+ ..+..++|
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~~~~~lv 113 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTV 113 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cCCccEEE
Confidence 46799999999999964 367899998753211 0000 0123456778888887742 3 34455544 33447899
Q ss_pred EEccCCC
Q 019780 140 TELMRGE 146 (336)
Q Consensus 140 ~e~~~gg 146 (336)
||+++|.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=7.6e-07 Score=80.53 Aligned_cols=82 Identities=7% Similarity=0.056 Sum_probs=53.3
Q ss_pred Eeeee-cCCCcEEEEEeEEC--------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-C--CceEeeEeeEec
Q 019780 66 LQKMI-GEGSYSIVYKGFYG--------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-H--ENILKFVGASVQ 133 (336)
Q Consensus 66 ~~~~l-g~G~fg~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~ 133 (336)
..+.| +.|....+|+.... +..+++|+.......... ....+.+|+.+|+.+. + -.+.+++.+..+
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~--~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVF--PTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSS--SCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccC--chhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 34678 88989999988764 567889886532100000 0134677888887775 2 346677776655
Q ss_pred C----CEEEEEEccCCCCHH
Q 019780 134 P----TMMIITELMRGETLQ 149 (336)
Q Consensus 134 ~----~~~lv~e~~~gg~L~ 149 (336)
. ..++|||+++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 268999999986543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.19 E-value=2.1e-05 Score=70.25 Aligned_cols=31 Identities=26% Similarity=0.362 Sum_probs=26.8
Q ss_pred CCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 182 ~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.+++|+|+++.||+++.++ .+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGG-CEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCC-cEEEEehhhccc
Confidence 5799999999999997655 699999998753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.96 E-value=4.6e-05 Score=70.48 Aligned_cols=78 Identities=12% Similarity=0.186 Sum_probs=45.7
Q ss_pred eeeecCCCcEEEEEeEECCccEEEEEeecCcc-cccc---HHHHHHHHHHHHHHH-hCCCCceEeeEeeEecCCEEEEEE
Q 019780 67 QKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNA-LAVS---REHKEKFQREVTLLS-KMKHENILKFVGASVQPTMMIITE 141 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~-~~~~---~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~lv~e 141 (336)
.+.||.|..+.||++...+..++||...+... .... ......+..|+..+. ......+.+++.+. .+..++|||
T Consensus 39 i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~-~~~~~lv~e 117 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD-RTMALIGMR 117 (420)
T ss_dssp EEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE-TTTTEEEEC
T ss_pred EEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC-CCccEEEEe
Confidence 46789999999999977677899995432111 0000 001223333333322 12234566666655 455899999
Q ss_pred cc-CC
Q 019780 142 LM-RG 145 (336)
Q Consensus 142 ~~-~g 145 (336)
++ +|
T Consensus 118 ~l~~g 122 (420)
T 2pyw_A 118 YLEPP 122 (420)
T ss_dssp CCCTT
T ss_pred ecCCc
Confidence 99 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.93 E-value=7.2e-05 Score=66.22 Aligned_cols=75 Identities=13% Similarity=0.140 Sum_probs=57.8
Q ss_pred EeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC---CCceEeeEeeEecC-CEEEEEE
Q 019780 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK---HENILKFVGASVQP-TMMIITE 141 (336)
Q Consensus 66 ~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~-~~~lv~e 141 (336)
-.+.|+.|....+|+....+..+++|+... .....+.+|+..|+.|. ...+++.+.+.... ..++|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~--------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINER--------SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEG--------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCc--------ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 346799999999999887778899998752 12567889999888874 25677777776654 4899999
Q ss_pred ccCCCCH
Q 019780 142 LMRGETL 148 (336)
Q Consensus 142 ~~~gg~L 148 (336)
+++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00015 Score=63.68 Aligned_cols=71 Identities=8% Similarity=0.107 Sum_probs=43.2
Q ss_pred eeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCce-EeeEeeEecCCEEEEEEcc-C
Q 019780 67 QKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI-LKFVGASVQPTMMIITELM-R 144 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~lv~e~~-~ 144 (336)
.+.|+.|....+|+. ..+++|+........ ....+|+.+++.+....+ .+++... .+.-+++++|+ +
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~------~~r~~E~~~l~~l~~~g~~P~~~~~~-~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY------INRANEAVAAREAAKAGVSPEVLHVD-PATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----C------CCHHHHHHHHHHHHHTTSSCCEEEEC-TTTCCEEEECCTT
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccce------eCHHHHHHHHHHHHHcCCCCceEEEE-CCCCEEEEeecCC
Confidence 477889999999998 679999886421111 112457777666642222 3455433 22357899999 6
Q ss_pred CCCH
Q 019780 145 GETL 148 (336)
Q Consensus 145 gg~L 148 (336)
|.+|
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.70 E-value=7.7e-05 Score=65.16 Aligned_cols=78 Identities=15% Similarity=0.120 Sum_probs=54.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCC---ceEeeEeeEecCCEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE---NILKFVGASVQPTMM 137 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~~~~ 137 (336)
..+.-.+.+|.|..+.||+.... |+.+.+|+...... .....+.+|+..|+.|... .+++++.+ +..+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-----ALDGLFRAEALGLDWLGRSFGSPVPQVAGW---DDRT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-----CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---ETTE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-----chhhHHHHHHHHHHHHHhhCCCCcceEEec---cCce
Confidence 34555678999999999999875 78999998653211 1134578899999888521 34445543 2357
Q ss_pred EEEEccCCCC
Q 019780 138 IITELMRGET 147 (336)
Q Consensus 138 lv~e~~~gg~ 147 (336)
+||||++++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00057 Score=60.43 Aligned_cols=140 Identities=18% Similarity=0.194 Sum_probs=77.4
Q ss_pred EeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCc--eEeeEee-------EecCCE
Q 019780 66 LQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN--ILKFVGA-------SVQPTM 136 (336)
Q Consensus 66 ~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~-------~~~~~~ 136 (336)
-.+.|+.|....+|+....+..+++|+.... .....+..|+.++..+.... +.+++.. ...+..
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~-------~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKDPLILTLYEKR-------VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEECC---EEEEEEEESSCCEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred EeeccCCCcccceEEEEeCCccEEEEEeCCC-------CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 3467888988999999877668999998631 11233556777766654211 2333321 123347
Q ss_pred EEEEEccCCCCHH-----------H---HHhhcC-C--CC----CCHHHHHHHH---------------HHHHHHHHHHH
Q 019780 137 MIITELMRGETLQ-----------R---YLWSTR-P--KR----LDLKHSISFA---------------LDISRAMEYLH 180 (336)
Q Consensus 137 ~lv~e~~~gg~L~-----------~---~l~~~~-~--~~----l~~~~~~~i~---------------~qi~~aL~~lH 180 (336)
++++++++|..+. . .++... . .. .........+ ..+...+..++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8999999986431 1 112110 0 00 1111111100 11333445554
Q ss_pred h-------CCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 181 A-------NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 181 ~-------~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+ .+++|+|+.+.|||++.++ .+.|+||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence 2 3799999999999998653 457999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00016 Score=64.39 Aligned_cols=33 Identities=30% Similarity=0.420 Sum_probs=27.2
Q ss_pred hCCcccccCCCCceeecCC---CCceEEeccccccc
Q 019780 181 ANSVIHRDLKPSNLLLTED---KKQVKLADFGLARE 213 (336)
Q Consensus 181 ~~~ivHrDikp~NIll~~~---~~~~kl~Dfg~a~~ 213 (336)
...++|+|+.+.|||++.+ ...+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999864 13689999998864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00065 Score=61.72 Aligned_cols=137 Identities=12% Similarity=0.181 Sum_probs=79.0
Q ss_pred eeecCCCcEEEEEeEEC---------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCCEE
Q 019780 68 KMIGEGSYSIVYKGFYG---------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPTMM 137 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~ 137 (336)
+.|..|-...+|+.... +..+++|+... . ......+.+|..+++.+. +.-..++++.+.+ .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--I----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE---G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT---E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--c----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---c
Confidence 56777888889998763 36788888532 1 112345568999988875 3223556665543 3
Q ss_pred EEEEccCCCCHHH--------------H---HhhcC---CCCCC--HHHHHHHHHHHHH-------------------HH
Q 019780 138 IITELMRGETLQR--------------Y---LWSTR---PKRLD--LKHSISFALDISR-------------------AM 176 (336)
Q Consensus 138 lv~e~~~gg~L~~--------------~---l~~~~---~~~l~--~~~~~~i~~qi~~-------------------aL 176 (336)
+||||++|..|.. . ++... ..... +.++..+..++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999999855431 1 12211 11112 3444445444321 22
Q ss_pred HHHH----h----CCcccccCCCCceeecCC---CCceEEeccccccc
Q 019780 177 EYLH----A----NSVIHRDLKPSNLLLTED---KKQVKLADFGLARE 213 (336)
Q Consensus 177 ~~lH----~----~~ivHrDikp~NIll~~~---~~~~kl~Dfg~a~~ 213 (336)
..|. . ..++|+|+.+.||+++.+ .+.+.|+||..|..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 2 259999999999999876 23799999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00098 Score=61.68 Aligned_cols=71 Identities=11% Similarity=0.129 Sum_probs=47.0
Q ss_pred eeeecCCCcEEEEEeEEC---------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCce-EeeEeeEecCCE
Q 019780 67 QKMIGEGSYSIVYKGFYG---------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI-LKFVGASVQPTM 136 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~ 136 (336)
.+.|+.|....||++... +..+++|+.... .. ...+.+|..+++.+...++ +++++.+.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~--- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG--- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC---
Confidence 467888989999999864 367889987421 01 1334578888887753333 456665432
Q ss_pred EEEEEccCCCC
Q 019780 137 MIITELMRGET 147 (336)
Q Consensus 137 ~lv~e~~~gg~ 147 (336)
.+|++|++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 38899998744
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0014 Score=59.15 Aligned_cols=73 Identities=14% Similarity=0.041 Sum_probs=42.4
Q ss_pred eeeecCCCcEEEEEeEECC----------ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCc-eEeeEeeEecCC
Q 019780 67 QKMIGEGSYSIVYKGFYGC----------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN-ILKFVGASVQPT 135 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~ 135 (336)
.+.|+.|....+|+....+ ..+++|+........ .....|..+++.+...+ +.++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~------~~~~~E~~~l~~L~~~g~~P~~~~~~--~- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL------YNTISEFEVYKTMSKYKIAPQLLNTF--N- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT------SCHHHHHHHHHHHHHTTSSCCEEEEE--T-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce------ecHHHHHHHHHHHHhcCCCCceEEec--C-
Confidence 3568888888999988753 678888875321111 11356777777765223 34555443 2
Q ss_pred EEEEEEccCCCCH
Q 019780 136 MMIITELMRGETL 148 (336)
Q Consensus 136 ~~lv~e~~~gg~L 148 (336)
-++||+|++|..+
T Consensus 109 ~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 GGRIEEWLYGDPL 121 (369)
T ss_dssp TEEEEECCCSEEC
T ss_pred CcEEEEEecCCcC
Confidence 3689999998543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0051 Score=54.31 Aligned_cols=136 Identities=17% Similarity=0.179 Sum_probs=75.7
Q ss_pred eeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCC--ceEeeEee-----E-ecCCEEE
Q 019780 68 KMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHE--NILKFVGA-----S-VQPTMMI 138 (336)
Q Consensus 68 ~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~-----~-~~~~~~l 138 (336)
..++ |....||+.... ++.+++|+..+... ....+..|..++..+... .+++++.. . .++..++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~------~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC------CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 3466 777899987664 55799999863211 123456677777766421 23334332 1 1233678
Q ss_pred EEEccCCCCHH-----------HH---Hhhc-C------CCCCCHHHH----------------------HHHHHHHHHH
Q 019780 139 ITELMRGETLQ-----------RY---LWST-R------PKRLDLKHS----------------------ISFALDISRA 175 (336)
Q Consensus 139 v~e~~~gg~L~-----------~~---l~~~-~------~~~l~~~~~----------------------~~i~~qi~~a 175 (336)
+|++++|..+. .. ++.. . ...++.... ...+.+++..
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 99999885431 11 1110 0 011222111 1111122222
Q ss_pred HHHH----HhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 176 MEYL----HANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 176 L~~l----H~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+.-+ ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~ 223 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D--GPMFVDLDDARN 223 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence 2222 234689999999999998 4 589999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.016 Score=54.00 Aligned_cols=73 Identities=21% Similarity=0.163 Sum_probs=47.3
Q ss_pred eeeecCCCcEEEEEeEECC--ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCce-EeeEeeEecCCEEEEEEcc
Q 019780 67 QKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI-LKFVGASVQPTMMIITELM 143 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~lv~e~~ 143 (336)
.+.|+.|-...+|+....+ ..+++|+.........+ ..+|..+++.|...++ .++++.+. + .+|++|+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id------R~~E~~vl~~L~~~gl~P~ll~~~~-~--G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN------REREKKISCILYNKNIAKKIYVFFT-N--GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC------HHHHHHHHHHHTTSSSBCCEEEEET-T--EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC------HHHHHHHHHHHHhcCCCCCEEEEeC-C--eEEEEee
Confidence 4678888889999998875 78999987532111111 2578888888874444 45666652 2 3599999
Q ss_pred CCCCH
Q 019780 144 RGETL 148 (336)
Q Consensus 144 ~gg~L 148 (336)
+|.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.002 Score=57.41 Aligned_cols=41 Identities=17% Similarity=0.510 Sum_probs=36.1
Q ss_pred CCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 236 PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 236 ~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
+.|..++.++++|+..||+.+|.+||++.+++..|+.+.+.
T Consensus 280 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 280 ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 34567889999999999999999999999999999887653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0018 Score=57.02 Aligned_cols=38 Identities=32% Similarity=0.588 Sum_probs=33.6
Q ss_pred CCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 019780 235 RPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTN 272 (336)
Q Consensus 235 ~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~ 272 (336)
.+.|..++.++++|+..||+.+|.+||+|.++++.|+.
T Consensus 266 ~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 266 LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 34567889999999999999999999999999888764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0025 Score=55.85 Aligned_cols=41 Identities=20% Similarity=0.511 Sum_probs=35.9
Q ss_pred CCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 236 PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 236 ~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
+.|..++.++++|+..||+.+|.+||++.++...|+.+.+.
T Consensus 250 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 250 QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 34567899999999999999999999999999988877654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.025 Score=50.35 Aligned_cols=31 Identities=16% Similarity=0.352 Sum_probs=26.6
Q ss_pred CCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 182 ~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.+++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence 3699999999999998665 689999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.78 E-value=0.057 Score=49.61 Aligned_cols=73 Identities=14% Similarity=0.087 Sum_probs=46.1
Q ss_pred eeeecCCCcEEEEEeEEC---------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCCE
Q 019780 67 QKMIGEGSYSIVYKGFYG---------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPTM 136 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 136 (336)
.+.+..|-...+|+.... +..+++|+......... ...+|..+++.+. +.-..++++.+ . -
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i------dR~~E~~~l~~L~~~gi~P~l~~~~--~-~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY------DSKVELDVFRYLSNINIAPNIIADF--P-E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC------CHHHHHHHHHHHHHTTSSCCEEEEE--T-T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc------CHHHHHHHHHHHHhcCCCCCEEEEc--C-C
Confidence 356777888899998876 57899998653221111 1346777777764 22234455433 2 3
Q ss_pred EEEEEccCCCCH
Q 019780 137 MIITELMRGETL 148 (336)
Q Consensus 137 ~lv~e~~~gg~L 148 (336)
++|++|++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 788999998653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=95.41 E-value=0.019 Score=51.06 Aligned_cols=46 Identities=11% Similarity=0.110 Sum_probs=38.9
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCCC
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADT 282 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~ 282 (336)
.+..++.++.+|+..||+.+|.+||++.|+++.+....+.......
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~h 323 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKS 323 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCS
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccC
Confidence 3457889999999999999999999999999999888877655433
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=95.20 E-value=0.025 Score=48.79 Aligned_cols=39 Identities=10% Similarity=0.257 Sum_probs=35.8
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhc
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR 278 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~ 278 (336)
.++.++.+|+..||+.+|.+||++.++.+.|.++.....
T Consensus 248 ~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 248 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 577999999999999999999999999999999987754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=95.09 E-value=0.031 Score=48.17 Aligned_cols=41 Identities=10% Similarity=0.272 Sum_probs=36.5
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
..++.++.+|+..||+.+|.+||++.++++.|..+......
T Consensus 244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 45678999999999999999999999999999998877543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=94.83 E-value=0.02 Score=50.18 Aligned_cols=40 Identities=30% Similarity=0.667 Sum_probs=35.1
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
.+..++.++.+|+..||+.+|.+||++.++++.|..+.+.
T Consensus 260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 3456789999999999999999999999999999888755
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=94.62 E-value=0.038 Score=47.49 Aligned_cols=43 Identities=21% Similarity=0.423 Sum_probs=37.9
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
.+..++.++.+++..||..+|.+||++.++++.+..+......
T Consensus 234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 234 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 3457889999999999999999999999999999998876554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.24 E-value=0.048 Score=49.18 Aligned_cols=43 Identities=21% Similarity=0.546 Sum_probs=37.7
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
.+..++.++..|+..||+.+|.+||++.++++.|+.+......
T Consensus 314 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 314 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 3456789999999999999999999999999999998876543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.22 E-value=0.47 Score=39.16 Aligned_cols=59 Identities=14% Similarity=0.132 Sum_probs=43.4
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCCCceeecCCCCceEEe
Q 019780 146 ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH-ANSVIHRDLKPSNLLLTEDKKQVKLA 206 (336)
Q Consensus 146 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivHrDikp~NIll~~~~~~~kl~ 206 (336)
-+|.+.|... +.++++.++|.++.|.+.+|.-+- .+.-..+=+.|..|++..+| .|.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~ 92 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLA 92 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEEC
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceecc
Confidence 4799999544 478999999999999999988762 12222334457889998887 57655
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.16 E-value=0.23 Score=45.13 Aligned_cols=30 Identities=33% Similarity=0.538 Sum_probs=24.5
Q ss_pred cccccCCCCceeecC-----CCCceEEeccccccc
Q 019780 184 VIHRDLKPSNLLLTE-----DKKQVKLADFGLARE 213 (336)
Q Consensus 184 ivHrDikp~NIll~~-----~~~~~kl~Dfg~a~~ 213 (336)
++|+|+.+.|||+.. ++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 679999999999932 334799999998864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.03 E-value=0.069 Score=47.45 Aligned_cols=40 Identities=30% Similarity=0.370 Sum_probs=36.2
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
.++.++.+|+..||+.+|.+||++.++++.|..+.+....
T Consensus 301 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 301 RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 5679999999999999999999999999999999877653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=94.01 E-value=0.079 Score=47.35 Aligned_cols=41 Identities=15% Similarity=0.203 Sum_probs=36.8
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
..++.++..++..||..+|.+||++.++.+.|..+......
T Consensus 293 ~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 293 ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 46789999999999999999999999999999999887544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=93.90 E-value=0.032 Score=49.24 Aligned_cols=40 Identities=28% Similarity=0.578 Sum_probs=34.4
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
.+..++.++.+|+..||+.+|.+||++.++++.|+.+.+.
T Consensus 297 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 297 CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 3456789999999999999999999999999988877654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=93.85 E-value=0.057 Score=47.52 Aligned_cols=41 Identities=24% Similarity=0.600 Sum_probs=35.7
Q ss_pred CCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 236 PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 236 ~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
+.+..++.++..++..||+.+|.+||++.+++..|..+...
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 34556788999999999999999999999999999887653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=93.59 E-value=0.057 Score=46.90 Aligned_cols=40 Identities=20% Similarity=0.378 Sum_probs=35.6
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhc
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR 278 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~ 278 (336)
..++.++.+|+..||..+|.+||++.++++.+..+.....
T Consensus 261 ~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 261 DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 4578899999999999999999999999999998876644
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=93.45 E-value=0.029 Score=47.65 Aligned_cols=37 Identities=24% Similarity=0.556 Sum_probs=32.2
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~ 274 (336)
+...+.++.+++..||+.+|.+||++.++++.|+.+.
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 3456789999999999999999999999998887654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.42 E-value=0.05 Score=47.41 Aligned_cols=36 Identities=25% Similarity=0.320 Sum_probs=31.9
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNI 273 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~ 273 (336)
...++.+++.|+..||+.+|.+||++.++++.|..+
T Consensus 269 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 269 SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 456789999999999999999999999998887654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=93.04 E-value=0.06 Score=47.27 Aligned_cols=38 Identities=24% Similarity=0.586 Sum_probs=32.8
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
..++.++..++..||+.+|.+||++.++++.|..+...
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 240 QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 34566788999999999999999999999999887643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.86 E-value=0.04 Score=48.08 Aligned_cols=38 Identities=21% Similarity=0.522 Sum_probs=31.2
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~ 277 (336)
.++.++.+++..||..+|.+||++.++++.|+.+....
T Consensus 267 ~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 267 GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 46778999999999999999999999999888776553
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=92.61 E-value=0.066 Score=45.66 Aligned_cols=38 Identities=26% Similarity=0.338 Sum_probs=32.6
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
..++.++.+|+..||..+|.+||++.++++.+..+.+.
T Consensus 238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 34678899999999999999999999999988876544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=92.25 E-value=0.067 Score=50.75 Aligned_cols=39 Identities=26% Similarity=0.625 Sum_probs=33.6
Q ss_pred CCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHH
Q 019780 236 PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274 (336)
Q Consensus 236 ~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~ 274 (336)
+.+..++.++.+|+..||+.+|.+||++.+++..|+.+.
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 345578899999999999999999999999988877654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.22 E-value=0.075 Score=47.09 Aligned_cols=33 Identities=9% Similarity=0.189 Sum_probs=30.0
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTN 272 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~ 272 (336)
.++.++.+++..||..+|.+||++.++++.|+.
T Consensus 293 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 293 SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP 325 (345)
T ss_dssp SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 678899999999999999999999999887754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=92.18 E-value=0.082 Score=46.10 Aligned_cols=38 Identities=29% Similarity=0.704 Sum_probs=32.9
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~ 274 (336)
.+..++.++.+|+..||+.+|.+||++.++++.|....
T Consensus 261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 261 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 34577899999999999999999999999998876553
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=91.95 E-value=0.17 Score=47.35 Aligned_cols=38 Identities=5% Similarity=0.253 Sum_probs=34.4
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~ 277 (336)
.++.++.+|+..||+.+|.+||++.++.+.|..+....
T Consensus 243 ~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 243 GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 56789999999999999999999999999999887653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=91.69 E-value=0.052 Score=46.57 Aligned_cols=36 Identities=22% Similarity=0.540 Sum_probs=30.5
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
..+.++.+|+..||+.+|.+||++.++++.|+.+..
T Consensus 240 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 240 PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 446678999999999999999999999988876643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.76 E-value=0.044 Score=48.06 Aligned_cols=72 Identities=7% Similarity=-0.057 Sum_probs=49.6
Q ss_pred CHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHh-hc-----cCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 241 LSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQN-LR-----SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 241 ~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~-~~-----~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.+.|+|+++..+|++..++.|... .-...+...... .. .....+|+++.+++...|..+|+.|++..++.+.
T Consensus 216 ~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 216 FQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred cHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 468999999999999999999632 111122222222 11 1224466778889999999999999998887653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=90.18 E-value=0.17 Score=43.45 Aligned_cols=31 Identities=26% Similarity=0.218 Sum_probs=27.7
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..+++++.+|+..||+.+|.+||++.++++
T Consensus 232 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 3467899999999999999999999999865
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=90.04 E-value=0.17 Score=42.99 Aligned_cols=32 Identities=28% Similarity=0.371 Sum_probs=28.0
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.+..++.++.+|+..||+.+|.+||++.++++
T Consensus 248 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 248 IPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 34567899999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=89.92 E-value=0.068 Score=47.87 Aligned_cols=74 Identities=11% Similarity=0.059 Sum_probs=51.5
Q ss_pred CCCCHHHHHHHHHHhhccCC-CCCCCHh-HHHHHHHHHHHh-h-ccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 238 LENLSEDMVALLKSCWAEDP-KVRPEFA-EITITLTNILQN-L-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p-~~RP~~~-~i~~~l~~~~~~-~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.++.+.|+|++++.+|++-. +..|... .....+...+.. . .......|+++.+++...|..+|+.|++..++.+
T Consensus 263 ~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~ 340 (353)
T 4ase_A 263 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 340 (353)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 46778999999999999986 6777532 111222222222 1 1233457778899999999999999999888875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=89.80 E-value=0.23 Score=42.59 Aligned_cols=35 Identities=17% Similarity=0.055 Sum_probs=29.5
Q ss_pred CCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 234 ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 234 ~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
........+.++.+|+..||+.+|.+||++.++++
T Consensus 248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 33445568899999999999999999999998764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=89.64 E-value=0.19 Score=42.64 Aligned_cols=33 Identities=15% Similarity=0.153 Sum_probs=28.5
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITIT 269 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~ 269 (336)
.+..++.++.+++..||+.+|.+||++.++++.
T Consensus 236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 345678999999999999999999999998753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=89.54 E-value=0.29 Score=42.39 Aligned_cols=32 Identities=28% Similarity=0.432 Sum_probs=27.7
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.+...+.++.+|+..||+.+|.+||++.++++
T Consensus 261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 34455789999999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.30 E-value=0.25 Score=42.28 Aligned_cols=31 Identities=23% Similarity=0.486 Sum_probs=27.5
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++.++.+|+..||+.+|.+||++.+++.
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 4567899999999999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.25 E-value=0.22 Score=43.05 Aligned_cols=30 Identities=30% Similarity=0.436 Sum_probs=27.0
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||+.+|.+||++.++++
T Consensus 255 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 255 PNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 467889999999999999999999998864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=89.17 E-value=0.14 Score=44.44 Aligned_cols=30 Identities=7% Similarity=0.225 Sum_probs=26.2
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...++++.+|+..||+.+|.+||++.++++
T Consensus 253 ~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 345678999999999999999999998864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.16 E-value=0.23 Score=42.78 Aligned_cols=31 Identities=23% Similarity=0.433 Sum_probs=27.4
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...++.++.+|+..||+.+|.+||++.++++
T Consensus 262 ~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 262 QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 3467899999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=89.13 E-value=0.22 Score=44.48 Aligned_cols=32 Identities=22% Similarity=0.332 Sum_probs=28.6
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.+..++.++.+|+..||+.||.+||++.++++
T Consensus 245 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 34568899999999999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.02 E-value=0.33 Score=41.74 Aligned_cols=32 Identities=19% Similarity=0.196 Sum_probs=28.2
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITIT 269 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~ 269 (336)
+..++.++.+|+..||..+|.+||++.++++.
T Consensus 233 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 233 PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 34678899999999999999999999998753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=88.87 E-value=0.36 Score=43.07 Aligned_cols=31 Identities=16% Similarity=-0.008 Sum_probs=27.9
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...++.++.+|+..||+.+|.+||++.++++
T Consensus 322 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 322 CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 3578899999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=88.79 E-value=0.25 Score=41.97 Aligned_cols=32 Identities=19% Similarity=0.296 Sum_probs=28.3
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITIT 269 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~ 269 (336)
+...+.++.+|+..||+.+|.+||++.++++.
T Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 44578899999999999999999999998763
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.71 E-value=0.38 Score=42.42 Aligned_cols=34 Identities=26% Similarity=0.399 Sum_probs=28.7
Q ss_pred CCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 019780 236 PSLENLSEDMVALLKSCWAEDPKVRPEFAEITIT 269 (336)
Q Consensus 236 ~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~ 269 (336)
..+...+.++.+|+..||+.+|.+||++.+++..
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 3445567899999999999999999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=88.59 E-value=0.29 Score=41.90 Aligned_cols=31 Identities=26% Similarity=0.267 Sum_probs=27.4
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
....+.++.+|+..||+.+|.+||++.++++
T Consensus 250 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 3467899999999999999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=88.46 E-value=0.26 Score=41.95 Aligned_cols=30 Identities=17% Similarity=0.248 Sum_probs=27.4
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 232 DTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 467889999999999999999999999876
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.42 E-value=0.27 Score=42.57 Aligned_cols=30 Identities=23% Similarity=0.564 Sum_probs=27.4
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 467899999999999999999999999876
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=88.32 E-value=0.3 Score=42.48 Aligned_cols=30 Identities=17% Similarity=0.213 Sum_probs=26.6
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 271 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 271 PGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 456789999999999999999999998764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.20 E-value=0.04 Score=51.29 Aligned_cols=61 Identities=18% Similarity=0.133 Sum_probs=16.5
Q ss_pred EeeeecCCCcEEEEEeEECC--ccEEE------EEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 66 LQKMIGEGSYSIVYKGFYGC--EPVAV------KVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 66 ~~~~lg~G~fg~V~~~~~~~--~~vav------K~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
+.+.|| ||.||+|.+.+ .+||+ |..+. .....+....+.+|..+++.++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~---~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQ---DGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC--------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCcccccc---ccccccccccccccccccccccccccCCCcceEE
Confidence 345566 99999999864 57888 66542 1223344567888999999999999998876543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=88.16 E-value=0.3 Score=41.29 Aligned_cols=31 Identities=26% Similarity=0.308 Sum_probs=27.5
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++..+.+++..||+.+|.+||++.++++
T Consensus 231 ~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 231 PEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 3456789999999999999999999999876
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=88.15 E-value=0.37 Score=41.15 Aligned_cols=29 Identities=34% Similarity=0.511 Sum_probs=26.2
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..+.++.+|+..||+.+|.+||++.+++.
T Consensus 250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 46789999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=88.00 E-value=0.26 Score=42.78 Aligned_cols=37 Identities=14% Similarity=0.199 Sum_probs=31.7
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCC-CHhHHHHHHHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRP-EFAEITITLTNIL 274 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP-~~~~i~~~l~~~~ 274 (336)
+..++.++.+++..||+.+|.+|| ++.+++..|....
T Consensus 258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 456788999999999999999999 8999888777554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=87.70 E-value=0.22 Score=43.03 Aligned_cols=31 Identities=26% Similarity=0.275 Sum_probs=27.1
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++..+.+|+..||+.+|.+||++.++++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 3457789999999999999999999998864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=87.64 E-value=0.47 Score=42.78 Aligned_cols=32 Identities=28% Similarity=0.458 Sum_probs=27.6
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITIT 269 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~ 269 (336)
+...+.++.+|+..||+.+|.+||++.+++..
T Consensus 290 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 44457899999999999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=87.61 E-value=0.39 Score=41.57 Aligned_cols=29 Identities=21% Similarity=0.192 Sum_probs=26.4
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.++.++.+|+..||+.+|.+||++.++++
T Consensus 267 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 267 HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 46789999999999999999999998865
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=87.50 E-value=0.32 Score=42.45 Aligned_cols=31 Identities=19% Similarity=0.495 Sum_probs=27.8
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...++.++.+|+..||+.+|.+||++.++++
T Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 255 EREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 3467899999999999999999999999865
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.38 E-value=0.37 Score=41.62 Aligned_cols=30 Identities=17% Similarity=0.090 Sum_probs=26.8
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 267 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 267 PEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 457889999999999999999999998764
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=87.31 E-value=0.38 Score=41.23 Aligned_cols=30 Identities=27% Similarity=0.205 Sum_probs=26.8
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 254 ~~~~~~~~~li~~~L~~dP~~Rpt~~~~l~ 283 (299)
T 2r3i_A 254 PPLDEDGRSLLSQMLHYDPNKRISAKAALA 283 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 357889999999999999999999998865
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.29 E-value=0.53 Score=42.48 Aligned_cols=37 Identities=16% Similarity=0.187 Sum_probs=33.1
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
..+..+.+++..||+.+|.+||++.++++.+..++..
T Consensus 274 ~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 274 GLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 4567888999999999999999999999999888765
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=87.26 E-value=0.3 Score=41.84 Aligned_cols=31 Identities=26% Similarity=0.533 Sum_probs=27.4
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...++.++.+|+..||+.+|.+||++.++++
T Consensus 257 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 257 LKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 3467789999999999999999999998864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.21 E-value=0.35 Score=41.95 Aligned_cols=30 Identities=23% Similarity=0.364 Sum_probs=26.8
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 356789999999999999999999998864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=87.21 E-value=0.34 Score=42.60 Aligned_cols=31 Identities=26% Similarity=0.214 Sum_probs=27.3
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+...+.++.+|+..||..+|.+||++.++++
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 3457899999999999999999999998865
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.18 E-value=0.46 Score=41.03 Aligned_cols=31 Identities=35% Similarity=0.660 Sum_probs=27.6
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++.++.+|+..||+.+|.+||++.+++.
T Consensus 253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 3467889999999999999999999999865
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=87.14 E-value=0.28 Score=44.07 Aligned_cols=32 Identities=16% Similarity=0.381 Sum_probs=26.2
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.+..++.++.+|+..||+.+|.+||++.++++
T Consensus 302 ~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 302 YHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 44567899999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.13 E-value=0.25 Score=41.87 Aligned_cols=31 Identities=16% Similarity=0.152 Sum_probs=27.0
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++.++.+|+..||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 3457889999999999999999999988754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.04 E-value=0.43 Score=41.98 Aligned_cols=31 Identities=13% Similarity=0.247 Sum_probs=27.6
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++.++.+|+..||+.+|.+||++.++++
T Consensus 244 ~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 244 PYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4457899999999999999999999998865
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=87.00 E-value=0.3 Score=41.66 Aligned_cols=30 Identities=23% Similarity=0.591 Sum_probs=27.3
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 457889999999999999999999999876
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=86.88 E-value=0.26 Score=43.91 Aligned_cols=30 Identities=23% Similarity=0.333 Sum_probs=26.8
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.||.+||++.++++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 457899999999999999999999988754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=86.86 E-value=0.29 Score=42.67 Aligned_cols=30 Identities=33% Similarity=0.565 Sum_probs=27.0
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 457899999999999999999999998864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=86.85 E-value=0.42 Score=42.35 Aligned_cols=30 Identities=13% Similarity=0.452 Sum_probs=27.1
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 295 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 295 GVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 347889999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=86.84 E-value=0.51 Score=40.27 Aligned_cols=31 Identities=16% Similarity=0.161 Sum_probs=27.0
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+...+..+.+|+..||+.+|.+||++.++++
T Consensus 253 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 253 DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 3456788999999999999999999998864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=86.76 E-value=0.45 Score=40.95 Aligned_cols=31 Identities=16% Similarity=0.223 Sum_probs=27.7
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...++.++.+|+..||..+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3467899999999999999999999999865
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=86.68 E-value=0.57 Score=41.71 Aligned_cols=32 Identities=22% Similarity=0.321 Sum_probs=28.0
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITIT 269 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~ 269 (336)
...++.++.+|+..||+.+|.+||++.+++..
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 34578999999999999999999999998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=86.59 E-value=0.22 Score=43.70 Aligned_cols=30 Identities=40% Similarity=0.545 Sum_probs=27.1
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 277 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 277 PKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 467899999999999999999999998765
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=86.44 E-value=0.37 Score=41.13 Aligned_cols=30 Identities=17% Similarity=0.247 Sum_probs=27.4
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||..+|.+||++.++++
T Consensus 247 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 247 RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 457889999999999999999999999876
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.43 E-value=0.65 Score=40.28 Aligned_cols=35 Identities=14% Similarity=0.149 Sum_probs=29.9
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNI 273 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~ 273 (336)
...+..+.+|+..||+.+|.+||++.++++...+.
T Consensus 273 ~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 273 RGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 34567888999999999999999999998877654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=86.27 E-value=0.46 Score=41.92 Aligned_cols=30 Identities=13% Similarity=0.240 Sum_probs=27.0
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||..+|.+||++.++++
T Consensus 262 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 262 SAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 456789999999999999999999998865
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=86.20 E-value=0.3 Score=41.99 Aligned_cols=31 Identities=23% Similarity=0.351 Sum_probs=26.6
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++.++.+|+..||..+|.+||++.++++
T Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 3456789999999999999999999988753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.08 E-value=0.28 Score=42.40 Aligned_cols=30 Identities=20% Similarity=0.182 Sum_probs=27.3
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 276 PGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 467899999999999999999999999865
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=86.06 E-value=0.43 Score=41.94 Aligned_cols=30 Identities=23% Similarity=0.326 Sum_probs=27.5
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||..+|.+||++.++++
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 467899999999999999999999999876
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=86.05 E-value=0.32 Score=41.09 Aligned_cols=30 Identities=23% Similarity=0.397 Sum_probs=26.4
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 232 KKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 356789999999999999999999988754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=85.93 E-value=0.48 Score=41.12 Aligned_cols=31 Identities=19% Similarity=0.180 Sum_probs=27.5
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...++..+.+|+..||..+|.+||++.+++.
T Consensus 266 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 266 VTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 4567899999999999999999999998864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=85.68 E-value=0.35 Score=42.63 Aligned_cols=30 Identities=20% Similarity=0.158 Sum_probs=27.1
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||..+|.+||++.++++
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 276 PRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 467899999999999999999999998865
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=85.60 E-value=0.42 Score=41.63 Aligned_cols=30 Identities=20% Similarity=0.230 Sum_probs=26.3
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||+.+|.+||++.++++
T Consensus 299 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 299 DVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp SHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 445788999999999999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=85.59 E-value=0.42 Score=40.46 Aligned_cols=29 Identities=21% Similarity=0.235 Sum_probs=26.5
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.++.++.+|+..||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 233 NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 56789999999999999999999999865
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.53 E-value=0.72 Score=40.67 Aligned_cols=32 Identities=19% Similarity=0.088 Sum_probs=28.1
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.....+.++.+|+..||+.+|.+||++.+++.
T Consensus 274 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 274 LFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 34567899999999999999999999998864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=85.48 E-value=0.5 Score=42.16 Aligned_cols=30 Identities=20% Similarity=0.094 Sum_probs=26.9
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||+.+|.+||++.++++
T Consensus 294 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 294 PRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 457899999999999999999999998864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=85.36 E-value=0.53 Score=41.84 Aligned_cols=30 Identities=20% Similarity=0.236 Sum_probs=26.9
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||+.+|.+||++.++++
T Consensus 284 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 284 PNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 456789999999999999999999999865
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=85.30 E-value=0.35 Score=41.58 Aligned_cols=32 Identities=22% Similarity=0.465 Sum_probs=28.2
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITIT 269 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~ 269 (336)
+..++..+.+|+..||..+|.+||++.++++.
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 34678899999999999999999999998763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.30 E-value=0.32 Score=42.52 Aligned_cols=31 Identities=16% Similarity=0.078 Sum_probs=27.5
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...++.++.+|+..||+.+|.+||++.++++
T Consensus 251 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 251 APRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 3467889999999999999999999999865
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=85.27 E-value=0.43 Score=40.57 Aligned_cols=31 Identities=16% Similarity=0.105 Sum_probs=27.8
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++.++.+|+..||+.+|.+||++.++++
T Consensus 232 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 232 PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 3467899999999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=85.20 E-value=0.32 Score=41.55 Aligned_cols=29 Identities=7% Similarity=0.219 Sum_probs=25.7
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..+.++.+|+..||+.+|.+||++.++++
T Consensus 254 ~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 45578999999999999999999998864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.18 E-value=0.47 Score=43.41 Aligned_cols=31 Identities=26% Similarity=0.365 Sum_probs=27.5
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++.++.+|+..||+.||.+||++.++++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 4567899999999999999999999988754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=85.15 E-value=0.55 Score=42.98 Aligned_cols=29 Identities=24% Similarity=0.239 Sum_probs=25.9
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..+.++.+|+..||+.+|.+||++.++++
T Consensus 380 ~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp CCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 34788999999999999999999999865
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.77 E-value=0.39 Score=41.52 Aligned_cols=30 Identities=20% Similarity=0.444 Sum_probs=26.8
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||..+|.+||++.+++.
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 346789999999999999999999999865
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=84.73 E-value=0.38 Score=42.48 Aligned_cols=31 Identities=26% Similarity=0.280 Sum_probs=27.6
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++.++.+|+..||..+|.+||++.++++
T Consensus 228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 4457899999999999999999999999865
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=84.72 E-value=0.48 Score=42.38 Aligned_cols=30 Identities=17% Similarity=0.060 Sum_probs=27.6
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 330 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 330 KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 567899999999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=84.69 E-value=0.48 Score=41.56 Aligned_cols=29 Identities=21% Similarity=0.237 Sum_probs=25.5
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..+.++.+|+..||+.+|.+||++.++++
T Consensus 305 ~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 305 LEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 44678999999999999999999998753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=84.67 E-value=0.62 Score=41.64 Aligned_cols=31 Identities=16% Similarity=0.242 Sum_probs=27.2
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
....+++..+|+..||+.||.+|||+.|+++
T Consensus 322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 322 WNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 3467889999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=84.60 E-value=0.38 Score=41.88 Aligned_cols=30 Identities=17% Similarity=0.265 Sum_probs=26.6
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||+.+|.+||++.++++
T Consensus 264 ~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 264 EPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp SCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 357789999999999999999999988754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=84.56 E-value=0.43 Score=40.48 Aligned_cols=30 Identities=27% Similarity=0.259 Sum_probs=27.1
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+..+.+|+..||..+|.+||++.+++.
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 356788999999999999999999999876
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=84.54 E-value=0.63 Score=40.75 Aligned_cols=29 Identities=17% Similarity=-0.004 Sum_probs=26.4
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.++.++.+|+..||+.+|.+||++.++++
T Consensus 302 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 302 VLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 46789999999999999999999999865
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=84.38 E-value=0.59 Score=40.63 Aligned_cols=30 Identities=30% Similarity=0.315 Sum_probs=26.7
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||..+|.+||++.+++.
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 356789999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=84.34 E-value=0.54 Score=41.01 Aligned_cols=30 Identities=20% Similarity=0.266 Sum_probs=26.6
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++..+.+|+..||+.+|.+||++.++++
T Consensus 265 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 265 HKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 356788999999999999999999998865
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=84.22 E-value=0.62 Score=40.48 Aligned_cols=30 Identities=13% Similarity=0.134 Sum_probs=26.6
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+..+.+|+..||..+|.+||++.+++.
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 356788999999999999999999998864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=84.21 E-value=0.52 Score=42.21 Aligned_cols=26 Identities=19% Similarity=0.051 Sum_probs=23.6
Q ss_pred HHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 243 EDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 243 ~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.++.+|+..||+.+|.+||++.++++
T Consensus 347 ~~~~dli~~mL~~dP~~Rpta~e~L~ 372 (382)
T 2vx3_A 347 LKFKDLILRMLDYDPKTRIQPYYALQ 372 (382)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHhcCCChhhCCCHHHHhc
Confidence 57899999999999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.19 E-value=0.46 Score=41.32 Aligned_cols=31 Identities=16% Similarity=0.391 Sum_probs=27.5
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...++..+.+|+..||..+|.+||++.++++
T Consensus 256 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 3457889999999999999999999998865
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=84.18 E-value=0.38 Score=41.19 Aligned_cols=32 Identities=19% Similarity=0.367 Sum_probs=28.0
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITIT 269 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~ 269 (336)
+...+..+.+|+..||+.+|.+||++.+++..
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 34677899999999999999999999998763
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=84.10 E-value=0.42 Score=42.39 Aligned_cols=31 Identities=23% Similarity=0.317 Sum_probs=27.4
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITIT 269 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~ 269 (336)
..++.++.+|+..||+.+|.+||++.++++.
T Consensus 276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 4578899999999999999999999998653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=84.03 E-value=0.5 Score=41.93 Aligned_cols=30 Identities=13% Similarity=0.303 Sum_probs=26.4
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||+.+|.+||++.++++
T Consensus 304 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 304 KDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred cchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 346778999999999999999999999865
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=84.02 E-value=0.43 Score=41.89 Aligned_cols=30 Identities=20% Similarity=0.211 Sum_probs=26.7
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 293 ~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 293 NFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 567899999999999999999999998864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.98 E-value=0.54 Score=41.12 Aligned_cols=30 Identities=20% Similarity=0.214 Sum_probs=26.7
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+..+.+|+..||+.+|.+||++.++++
T Consensus 242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 356788999999999999999999998865
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=83.96 E-value=0.55 Score=41.04 Aligned_cols=31 Identities=16% Similarity=0.257 Sum_probs=27.3
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...++..+.+|+..||+.+|.+||++.++++
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 3467889999999999999999999988764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=83.74 E-value=0.59 Score=41.26 Aligned_cols=31 Identities=16% Similarity=-0.001 Sum_probs=27.5
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
....+.++.+|+..||+.+|.+||++.++++
T Consensus 284 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 284 SLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 4457889999999999999999999998865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.63 E-value=0.86 Score=41.96 Aligned_cols=30 Identities=17% Similarity=0.221 Sum_probs=27.3
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 238 DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 467899999999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=83.57 E-value=0.64 Score=42.52 Aligned_cols=30 Identities=23% Similarity=0.279 Sum_probs=27.2
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||..+|.+||++.++++
T Consensus 332 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 332 PSISDDGINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 457899999999999999999999998865
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=83.54 E-value=0.45 Score=41.62 Aligned_cols=28 Identities=21% Similarity=0.217 Sum_probs=25.4
Q ss_pred CHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 241 LSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 241 ~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
++.++.+|+..||+.+|.+||++.++++
T Consensus 291 ~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 291 LDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 6788999999999999999999998764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=83.49 E-value=0.91 Score=41.22 Aligned_cols=29 Identities=17% Similarity=0.048 Sum_probs=25.5
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.++.++.+|+..||+.+|.+||++.++++
T Consensus 335 ~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 335 NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 56799999999999999999999777643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=83.48 E-value=0.49 Score=41.33 Aligned_cols=29 Identities=14% Similarity=0.166 Sum_probs=26.8
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.++.++.+|+..||..+|.+||++.++++
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 56789999999999999999999999876
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=83.38 E-value=0.39 Score=41.86 Aligned_cols=30 Identities=17% Similarity=0.097 Sum_probs=26.8
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 290 ~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 290 HLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp GGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 347899999999999999999999998864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=83.17 E-value=0.82 Score=40.72 Aligned_cols=30 Identities=17% Similarity=0.206 Sum_probs=26.6
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||+.+|.+||++.++++
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 356788999999999999999999999865
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=83.13 E-value=0.54 Score=41.62 Aligned_cols=30 Identities=10% Similarity=0.050 Sum_probs=26.7
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+..+.+|+..||+.+|.+||++.++++
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 287 PTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 456788999999999999999999998864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.09 E-value=0.59 Score=41.37 Aligned_cols=30 Identities=20% Similarity=0.182 Sum_probs=27.0
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||..+|.+||++.++++
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 467899999999999999999999988764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=83.03 E-value=0.54 Score=42.12 Aligned_cols=31 Identities=19% Similarity=0.157 Sum_probs=27.8
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+...+.++.+|+..||..+|.+||++.++++
T Consensus 291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 4457889999999999999999999999874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=82.95 E-value=0.48 Score=41.15 Aligned_cols=27 Identities=19% Similarity=0.202 Sum_probs=23.3
Q ss_pred HHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 242 SEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 242 ~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+++..+|+..||+.+|.+||++.++++
T Consensus 253 ~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 253 YPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 356778999999999999999998764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=82.89 E-value=1 Score=39.27 Aligned_cols=27 Identities=22% Similarity=0.250 Sum_probs=24.1
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEF 263 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~ 263 (336)
.+..+++++.+|+..||+.+|.+||++
T Consensus 245 ~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 245 MPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 355688999999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=82.80 E-value=0.76 Score=40.66 Aligned_cols=29 Identities=24% Similarity=0.225 Sum_probs=26.5
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.++.++.+|+..||+.+|.+||++.++++
T Consensus 258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 258 HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 56789999999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=82.72 E-value=0.47 Score=42.43 Aligned_cols=29 Identities=17% Similarity=0.090 Sum_probs=25.4
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..+.++.+|+..||+.+|.+||++.++++
T Consensus 363 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 363 EEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 34677899999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=82.61 E-value=0.6 Score=40.50 Aligned_cols=28 Identities=18% Similarity=0.254 Sum_probs=24.5
Q ss_pred CHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 241 LSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 241 ~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.++++.+|+..||+.+|.+||++.++++
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 3467889999999999999999998864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=82.59 E-value=0.38 Score=41.20 Aligned_cols=30 Identities=17% Similarity=0.224 Sum_probs=26.6
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.+++.
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 357889999999999999999999988754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=82.49 E-value=0.76 Score=40.59 Aligned_cols=31 Identities=19% Similarity=0.187 Sum_probs=27.7
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...++.++.+|+..||..+|.+||++.++++
T Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 247 WNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 3467899999999999999999999998865
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.47 E-value=0.67 Score=42.04 Aligned_cols=30 Identities=17% Similarity=0.132 Sum_probs=26.7
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||..||.+|||+.++++
T Consensus 315 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 315 PGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 456789999999999999999999998764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.45 E-value=3.3 Score=34.02 Aligned_cols=82 Identities=10% Similarity=0.034 Sum_probs=53.1
Q ss_pred CCCceEeeEeeEecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHH-HHHhCCcccccCCCCceeecC
Q 019780 120 KHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME-YLHANSVIHRDLKPSNLLLTE 198 (336)
Q Consensus 120 ~hpnIv~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~-~lH~~~ivHrDikp~NIll~~ 198 (336)
.||++ ..--...++.+.+.++.-+++.=...+ ..++....++++.+|+.... ++ ..-+|--|.|+||+++.
T Consensus 48 ~~~~f-~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~ 119 (219)
T 4ano_A 48 VDPCI-VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNR 119 (219)
T ss_dssp SCSSS-EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECT
T ss_pred cCCCC-CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeC
Confidence 57777 332223334466666655443333344 34778888888888776554 33 45577889999999998
Q ss_pred CCCceEEecccc
Q 019780 199 DKKQVKLADFGL 210 (336)
Q Consensus 199 ~~~~~kl~Dfg~ 210 (336)
++ .++|.-.|+
T Consensus 120 ~~-~p~i~hRGi 130 (219)
T 4ano_A 120 AL-EPFFLHVGV 130 (219)
T ss_dssp TC-CEEESCCEE
T ss_pred CC-cEEEEEcCC
Confidence 87 799886664
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=82.40 E-value=0.92 Score=41.69 Aligned_cols=30 Identities=27% Similarity=0.259 Sum_probs=27.0
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||..+|.+||++.++++
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 456899999999999999999999998865
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=82.36 E-value=1.1 Score=39.79 Aligned_cols=32 Identities=28% Similarity=0.171 Sum_probs=28.1
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.....+.++.+|+..||..+|.+||++.++++
T Consensus 276 ~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 276 ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 34567899999999999999999999998865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=82.35 E-value=0.62 Score=40.67 Aligned_cols=30 Identities=23% Similarity=0.397 Sum_probs=26.6
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 457789999999999999999999988764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=82.04 E-value=0.51 Score=41.40 Aligned_cols=31 Identities=19% Similarity=0.379 Sum_probs=27.5
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++.++.+|+..||+.+|.+||++.++++
T Consensus 261 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 261 PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3456789999999999999999999999876
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=81.87 E-value=0.59 Score=41.93 Aligned_cols=30 Identities=17% Similarity=0.203 Sum_probs=26.8
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||..+|.+||++.++++
T Consensus 299 ~~~~~~~~dll~~~L~~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 299 ADCNEEALDLLDKLLQFNPNKRISANDALK 328 (388)
T ss_dssp CCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccCCHHHHHHHHHhhccCcccCCCHHHHhC
Confidence 367889999999999999999999988764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=81.64 E-value=1.2 Score=41.49 Aligned_cols=31 Identities=26% Similarity=0.372 Sum_probs=27.5
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++.++.+|+..||+.+|.+||++.+++.
T Consensus 236 p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 3456789999999999999999999999876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=81.57 E-value=0.36 Score=41.31 Aligned_cols=72 Identities=11% Similarity=0.099 Sum_probs=49.2
Q ss_pred CCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHhh--ccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 240 NLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQNL--RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+...|+|+|+..+|++-. +..|....-...+...+... ......+|+++.+++...+..+|+.|++..++.+
T Consensus 198 ~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 198 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 346899999999999887 77775332222222222221 2223456778889999999999999998887764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=81.46 E-value=0.49 Score=41.83 Aligned_cols=27 Identities=33% Similarity=0.377 Sum_probs=24.1
Q ss_pred HHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 242 SEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 242 ~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+.++.+|+..||+.+|.+||++.++++
T Consensus 329 ~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 329 HELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 477889999999999999999998763
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=81.23 E-value=1.1 Score=40.86 Aligned_cols=29 Identities=31% Similarity=0.326 Sum_probs=26.3
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.++.++.+|+..||+.+|.+||++.++++
T Consensus 371 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 371 EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 56789999999999999999999998765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.98 E-value=0.36 Score=41.81 Aligned_cols=70 Identities=9% Similarity=0.041 Sum_probs=47.5
Q ss_pred HHHHHHHHHHhhccCCCCCCCHh---HHHHHHHHHHHh-hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 242 SEDMVALLKSCWAEDPKVRPEFA---EITITLTNILQN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 242 ~~di~~l~~~~l~~~p~~RP~~~---~i~~~l~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
..|+|+|+..++++-.+..|... ............ .......+|+.+.+++...+..+|+.|++..++.+
T Consensus 183 ~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 57999999999999888888532 111111111111 12223456777888999999999999998888765
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=80.79 E-value=0.84 Score=40.67 Aligned_cols=27 Identities=19% Similarity=0.105 Sum_probs=25.0
Q ss_pred HHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 242 SEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 242 ~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+.++.+|+..||..+|.+||++.++++
T Consensus 292 ~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 292 ASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 678999999999999999999999876
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.73 E-value=0.37 Score=43.07 Aligned_cols=75 Identities=8% Similarity=-0.044 Sum_probs=51.2
Q ss_pred CCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHhh--ccCCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 239 ENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQNL--RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.+...|+|+|++.+|++-. +..|....-...+...+... ......+|+.+.+++...+..+|+.|++..++.+.-
T Consensus 263 ~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l 340 (367)
T 3l9p_A 263 FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340 (367)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 4567899999999999876 66665332222222222221 223345677788999999999999999988887644
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.70 E-value=0.27 Score=43.03 Aligned_cols=75 Identities=11% Similarity=0.060 Sum_probs=50.7
Q ss_pred CCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHH-HHHHHhh-ccCCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 239 ENLSEDMVALLKSCWAEDP-KVRPEFAEITITL-TNILQNL-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l-~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.+...|+|+|++.+|++-. +..|....-...+ ..+.... ......+|+++.+++...+..+|+.|++..++.+.-
T Consensus 231 ~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L 308 (325)
T 3kul_A 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308 (325)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 3456899999999999877 7777533222222 2222221 122345677888899999999999999888877643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=80.48 E-value=1.9 Score=37.13 Aligned_cols=30 Identities=30% Similarity=0.321 Sum_probs=25.5
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||+..+.+.
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 457899999999999999999998666543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=80.38 E-value=0.37 Score=40.62 Aligned_cols=73 Identities=8% Similarity=0.022 Sum_probs=47.4
Q ss_pred CCHHHHHHHHHHhhccCC-CCCCCHhHHH-HHHHHHHHhhcc-CCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 240 NLSEDMVALLKSCWAEDP-KVRPEFAEIT-ITLTNILQNLRS-ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p-~~RP~~~~i~-~~l~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
+.+.|+|+|+..++++-. +..|....-. ..+..+...... .....++.+.+++...+..+|+.|++..++.+.
T Consensus 185 ~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 185 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 346799999999998877 6666532221 222222222221 223456678888999999999999988877653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=80.22 E-value=0.54 Score=41.13 Aligned_cols=29 Identities=21% Similarity=0.386 Sum_probs=25.9
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.++.++.+|+..||+.+|.+||++.+++.
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 46789999999999999999999988753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=80.20 E-value=0.79 Score=41.32 Aligned_cols=30 Identities=17% Similarity=0.162 Sum_probs=26.8
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||+.+|.+||++.+++.
T Consensus 292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 292 PRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp TTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 347789999999999999999999998865
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=80.15 E-value=0.86 Score=41.22 Aligned_cols=31 Identities=19% Similarity=0.344 Sum_probs=27.9
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITIT 269 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~ 269 (336)
..++.++.+|+..||..+|.+||++.+++..
T Consensus 292 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 4678999999999999999999999998763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 336 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-41 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-39 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-04 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-34 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-28 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-26 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-25 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 6e-50
Identities = 73/276 (26%), Positives = 116/276 (42%), Gaps = 63/276 (22%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+ + + + IG GS+ VYKG + VAVK++ N A + + + F+ EV +L K
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWH-GDVAVKML---NVTAPTPQQLQAFKNEVGVLRK 60
Query: 119 MKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
+H NIL F+G S P + I+T+ G +L +L + ++ I A ++ M+Y
Sbjct: 61 TRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDY 119
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR----EEVMDEMTCEAGTYRWMAPE-- 232
LHA S+IHRDLK +N+ L ED VK+ DFGLA + +G+ WMAPE
Sbjct: 120 LHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 233 -----------------------------------------------NERPSLENL---- 241
P L +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277
+ M L+ C + RP F +I ++ + ++L
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 5e-46
Identities = 63/266 (23%), Positives = 111/266 (41%), Gaps = 57/266 (21%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
++ + + L + IG+G + V G Y VAVK I+ + + F E +++++
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-------NDATAQAFLAEASVMTQ 56
Query: 119 MKHENILKFVGASVQP--TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
++H N+++ +G V+ + I+TE M +L YL S L + F+LD+ AM
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE---- 232
EYL N+ +HRDL N+L++ED K++DFGL + E +W APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTK-EASSTQDTGKLPVKWTAPEALRE 174
Query: 233 -----------------------------------------NERPSL-ENLSEDMVALLK 250
+ + + ++K
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 251 SCWAEDPKVRPEFAEITITLTNILQN 276
+CW D +RP F ++ L +I +
Sbjct: 235 NCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 5e-46
Identities = 61/279 (21%), Positives = 111/279 (39%), Gaps = 62/279 (22%)
Query: 57 VLVDHRSVLLQ-KMIGEGSYSIVYKGFY----GCEPVAVKVIQPCNALAVSREHKEKFQR 111
V +D + + L+ K +G G++ V KG+Y + VAVK+++ A K++
Sbjct: 1 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---ANDPALKDELLA 57
Query: 112 EVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALD 171
E ++ ++ + I++ +G + M++ E+ L +YL + + + K+ I
Sbjct: 58 EANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQ 115
Query: 172 ISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR-----EEVMDEMTCEAGTY 226
+S M+YL ++ +HRDL N+LL K++DFGL++ E T
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 227 RWMAPE---------------------------------------------NERPSL-EN 240
+W APE ER
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 234
Query: 241 LSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279
+M L+ CW D + RP FA + + L N ++ +
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-46
Identities = 59/266 (22%), Positives = 104/266 (39%), Gaps = 57/266 (21%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
V ++ L + +G G + V+ G+Y G VAVK ++ + F E L+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ------GSMSPDAFLAEANLMK 63
Query: 118 KMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
+++H+ +++ Q + IITE M +L +L + +L + + A I+ M
Sbjct: 64 QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR---EEVMDEMTCEAGTYRWMAP--- 231
++ + IHRDL+ +N+L++ D K+ADFGLAR + +W AP
Sbjct: 124 FIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 232 ------------------------------------------ENERPSL-ENLSEDMVAL 248
R +N E++ L
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 249 LKSCWAEDPKVRPEFAEITITLTNIL 274
++ CW E P+ RP F + L +
Sbjct: 243 MRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 6e-45
Identities = 54/248 (21%), Positives = 97/248 (39%), Gaps = 52/248 (20%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ + +G+G + VY +A+KV+ A + + +REV + S ++H N
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFK--AQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 124 ILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
IL+ G T + +I E T+ R L + + D + + ++ +++ A+ Y H+
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHSK 125
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE---------- 232
VIHRD+KP NLLL ++K+ADFG + T GT ++ PE
Sbjct: 126 RVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 184
Query: 233 ---------------------------------NERPSL-ENLSEDMVALLKSCWAEDPK 258
+ + ++E L+ +P
Sbjct: 185 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 244
Query: 259 VRPEFAEI 266
RP E+
Sbjct: 245 QRPMLREV 252
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-44
Identities = 49/271 (18%), Positives = 100/271 (36%), Gaps = 61/271 (22%)
Query: 64 VLLQKMIGEGSYSIVYKGFY----GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM 119
++ +G G++ V +G Y VA+KV++ + E+ RE ++ ++
Sbjct: 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----GTEKADTEEMMREAQIMHQL 66
Query: 120 KHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
+ I++ +G +M++ E+ G L ++L R + + + + +S M+YL
Sbjct: 67 DNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYL 125
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR-----EEVMDEMTCEAGTYRWMAP--- 231
+ +HRDL N+LL K++DFGL++ + + +W AP
Sbjct: 126 EEKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 232 ------------------------------------------ENERPSL-ENLSEDMVAL 248
+ +R ++ AL
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 244
Query: 249 LKSCWAEDPKVRPEFAEITITLTNILQNLRS 279
+ CW + RP+F + + +L S
Sbjct: 245 MSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 6e-44
Identities = 58/262 (22%), Positives = 106/262 (40%), Gaps = 60/262 (22%)
Query: 60 DHRSVLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
D R + IG GS+ VYKG VA +Q +++ +++F+ E +L
Sbjct: 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---LTKSERQRFKEEAEMLK 63
Query: 118 KMKHENILKFVGA-----SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDI 172
++H NI++F + + ++++TELM TL+ YL R K + +K S+ I
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQI 121
Query: 173 SRAMEYLHANS--VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMA 230
+ +++LH + +IHRDLK N+ +T VK+ D GLA + GT +MA
Sbjct: 122 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMA 181
Query: 231 PE--------------------------------------------NERPSL--ENLSED 244
PE +P+ + +
Sbjct: 182 PEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 245 MVALLKSCWAEDPKVRPEFAEI 266
+ +++ C ++ R ++
Sbjct: 242 VKEIIEGCIRQNKDERYSIKDL 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 6e-43
Identities = 63/251 (25%), Positives = 97/251 (38%), Gaps = 59/251 (23%)
Query: 68 KMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
+ IG GS+ VY E VA+K + + S E + +EV L K++H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTI 78
Query: 126 KFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSV 184
++ G ++ T ++ E G L K L + + + YLH++++
Sbjct: 79 QYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE------------ 232
IHRD+K N+LL+E VKL DFG A +M GT WMAPE
Sbjct: 137 IHRDVKAGNILLSEP-GLVKLGDFGSAS--IMAPANSFVGTPYWMAPEVILAMDEGQYDG 193
Query: 233 -----------------------------------NERPSLE--NLSEDMVALLKSCWAE 255
NE P+L+ + SE + SC +
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253
Query: 256 DPKVRPEFAEI 266
P+ RP +
Sbjct: 254 IPQDRPTSEVL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-42
Identities = 60/275 (21%), Positives = 105/275 (38%), Gaps = 57/275 (20%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+ S+ L+ +G+G + V+ G + G VA+K ++P E F +E ++
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP------GTMSPEAFLQEAQVMK 67
Query: 118 KMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
K++HE +++ + + I+TE M +L +L K L L + A I+ M
Sbjct: 68 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR---EEVMDEMTCEAGTYRWMAPE-- 232
Y+ + +HRDL+ +N+L+ E+ K+ADFGLAR + +W APE
Sbjct: 128 YVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 233 --------------------------------------------NERPSLENLSEDMVAL 248
P E + L
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 246
Query: 249 LKSCWAEDPKVRPEFAEITITLTNILQNLRSADTP 283
+ CW ++P+ RP F + L + + P
Sbjct: 247 MCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-42
Identities = 59/258 (22%), Positives = 90/258 (34%), Gaps = 64/258 (24%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ +G+G++ VYK A KVI S E E + E+ +L+ H N
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDT-----KSEEELEDYMVEIDILASCDHPN 70
Query: 124 ILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
I+K + A + I+ E G + + + L A+ YLH N
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN 129
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGTYRWMAPE-------- 232
+IHRDLK N+L T D +KLADFG++ + GT WMAPE
Sbjct: 130 KIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 233 -----------------------------------------NERPSLE---NLSEDMVAL 248
+E P+L S +
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 249 LKSCWAEDPKVRPEFAEI 266
LK C ++ R +++
Sbjct: 249 LKKCLEKNVDARWTTSQL 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 2e-41
Identities = 68/275 (24%), Positives = 107/275 (38%), Gaps = 59/275 (21%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLL 116
++ + ++ +G G Y VY+G + VAVK ++ E+F +E ++
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVM 67
Query: 117 SKMKHENILKFVGASVQ-PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRA 175
++KH N+++ +G + P IITE M L YL + + + A IS A
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR---EEVMDEMTCEAGTYRWMAPE 232
MEYL + IHRDL N L+ E+ VK+ADFGL+R + +W APE
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 233 NER----------------------------------------------PSLENLSEDMV 246
+ E E +
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246
Query: 247 ALLKSCWAEDPKVRPEFAEITITLTNILQNLRSAD 281
L+++CW +P RP FAEI + Q +D
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-41
Identities = 71/275 (25%), Positives = 110/275 (40%), Gaps = 60/275 (21%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKEKFQREV 113
+ + L + IGEG + V++G Y VA+K + C S +EKF +E
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----SDSVREKFLQEA 59
Query: 114 TLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDIS 173
+ + H +I+K +G + + II EL L R R LDL I +A +S
Sbjct: 60 LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLS 118
Query: 174 RAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE---MTCEAGTYRWMA 230
A+ YL + +HRD+ N+L++ + VKL DFGL+R + +WMA
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 231 PE---------------------------------------------NERPSL-ENLSED 244
PE ER + N
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 237
Query: 245 MVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279
+ +L+ CWA DP RP F E+ L+ IL+ ++
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-41
Identities = 42/171 (24%), Positives = 81/171 (47%), Gaps = 11/171 (6%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+G G+ +V+K + +A K+I L + + + RE+ +L +
Sbjct: 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIH----LEIKPAIRNQIIRELQVLHECNSPY 65
Query: 124 ILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLH-A 181
I+ F GA + I E M G +L + L + R+ + ++ + + + YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
+ ++HRD+KPSN+L+ ++KL DFG++ + + GT +M+PE
Sbjct: 124 HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 173
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 9e-41
Identities = 59/266 (22%), Positives = 98/266 (36%), Gaps = 59/266 (22%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLS 117
+D + + K +G G + +V G + G VA+K+I+ +++F E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE------GSMSEDEFIEEAKVMM 54
Query: 118 KMKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
+ HE +++ G + + IITE M L YL R + + D+ AM
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAM 113
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE---MTCEAGTYRWMAPEN 233
EYL + +HRDL N L+ + VK++DFGL+R + DE RW PE
Sbjct: 114 EYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 234 ER----------------------------------------------PSLENLSEDMVA 247
SE +
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 232
Query: 248 LLKSCWAEDPKVRPEFAEITITLTNI 273
++ SCW E RP F + + ++
Sbjct: 233 IMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-40
Identities = 56/270 (20%), Positives = 103/270 (38%), Gaps = 59/270 (21%)
Query: 58 LVDHRSVLLQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLL 116
++D + + IG G + +V+ G++ + VA+K I+ +E F E ++
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE------GAMSEEDFIEEAEVM 54
Query: 117 SKMKHENILKFVGASVQPTMM-IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRA 175
K+ H +++ G ++ + ++ E M L Y T+ + + LD+
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEG 113
Query: 176 MEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE---AGTYRWMAPE 232
M YL VIHRDL N L+ E+ + +K++DFG+ R + D+ T +W +PE
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 233 ---------------------------------------------NERPSL-ENLSEDMV 246
R S +
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 232
Query: 247 ALLKSCWAEDPKVRPEFAEITITLTNILQN 276
++ CW E P+ RP F+ + L I ++
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 141 bits (356), Expect = 8e-40
Identities = 60/341 (17%), Positives = 120/341 (35%), Gaps = 73/341 (21%)
Query: 45 YDNEFVFDIDASVL-----VDHRSVL----LQKMIGEGSYSIVYKGFY--GCEPVAVKVI 93
YDN +VFDI + H VL + + +G G++ +V++ A K +
Sbjct: 1 YDN-YVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV 59
Query: 94 QPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRGETLQRYL 152
+ KE ++E+ +S ++H ++ A M++I E M G L +
Sbjct: 60 MTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 114
Query: 153 WSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK-QVKLADFGLA 211
++ ++ + + + + ++H N+ +H DLKP N++ T + ++KL DFGL
Sbjct: 115 AD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173
Query: 212 RE-EVMDEMTCEAGTYRWMAPE-------------------------------------- 232
+ + GT + APE
Sbjct: 174 AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 233
Query: 233 ----------NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEIT----ITLTNILQNLR 278
+ + +SED ++ DP R + +T N
Sbjct: 234 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 279 SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGKKR 319
+ K+ + + K + + + I+ ++ K R
Sbjct: 294 QIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHR 334
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 8e-40
Identities = 65/311 (20%), Positives = 113/311 (36%), Gaps = 86/311 (27%)
Query: 37 ADDDDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGF-------YGCEPVA 89
D++ Y + ++ D ++ K++G G++ V VA
Sbjct: 12 GSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA 71
Query: 90 VKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQPT-MMIITELMRGET 147
VK+++ +E E+ +++++ HENI+ +GA + +I E
Sbjct: 72 VKMLKE----KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 127
Query: 148 LQRYLWSTRPK---------------------RLDLKHSISFALDISRAMEYLHANSVIH 186
L YL S R K L + + FA +++ ME+L S +H
Sbjct: 128 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187
Query: 187 RDLKPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPEN--------- 233
RDL N+L+T K VK+ DFGLAR+ + D +WMAPE+
Sbjct: 188 RDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246
Query: 234 --------------------------------------ERPSLENLSEDMVALLKSCWAE 255
+ +E++ +++SCWA
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 306
Query: 256 DPKVRPEFAEI 266
D + RP F +
Sbjct: 307 DSRKRPSFPNL 317
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-39
Identities = 64/268 (23%), Positives = 104/268 (38%), Gaps = 61/268 (22%)
Query: 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKEKFQ 110
+ L+ + + L + +G+GS+ +V +G + VAVK ++P + E + F
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP--DVLSQPEAMDDFI 59
Query: 111 REVTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFAL 170
REV + + H N+++ G + P M ++TEL +L L L +A+
Sbjct: 60 REVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAV 118
Query: 171 DISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-----MTCEAGT 225
++ M YL + IHRDL NLLL VK+ DFGL R ++
Sbjct: 119 QVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 226 YRWMAP----------------------------------------------ENER-PSL 238
+ W AP E ER P
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237
Query: 239 ENLSEDMVALLKSCWAEDPKVRPEFAEI 266
E+ +D+ ++ CWA P+ RP F +
Sbjct: 238 EDCPQDIYNVMVQCWAHKPEDRPTFVAL 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 1e-39
Identities = 61/296 (20%), Positives = 109/296 (36%), Gaps = 71/296 (23%)
Query: 40 DDDEEYDNEFVFDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQ 94
+D E EF +ID S + ++++IG G + V G VA+K ++
Sbjct: 10 EDPNEAVREFAKEIDISCVK------IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 95 PCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRGETLQRYLW 153
+ + + F E +++ + H N++ G + T +MIITE M +L +
Sbjct: 64 S----GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-L 118
Query: 154 STRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR- 212
+ + + I+ M+YL + +HRDL N+L+ + K++DFGL+R
Sbjct: 119 RQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN-LVCKVSDFGLSRF 177
Query: 213 ------EEVMDEMTCEAGTYRWMAPENER------------------------------- 235
+ RW APE +
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 236 ---------------PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
P + + L+ CW +D RP+F +I TL +++N
Sbjct: 238 TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-39
Identities = 54/256 (21%), Positives = 89/256 (34%), Gaps = 62/256 (24%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
L + +GEG+Y V E VAVK++ + + E ++E+ + + HEN
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHEN 64
Query: 124 ILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
++KF G + + E G L + + + F + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPE------ 232
+ HRD+KP NLLL E +K++DFGLA + + GT ++APE
Sbjct: 123 GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 233 ------------------------------------------NERPSLENLSEDMVALLK 250
+ + +ALL
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 251 SCWAEDPKVRPEFAEI 266
E+P R +I
Sbjct: 242 KILVENPSARITIPDI 257
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-38
Identities = 55/260 (21%), Positives = 94/260 (36%), Gaps = 63/260 (24%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ IG GSY K + + K + + ++ K+ EV LL ++KH N
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---MTEAEKQMLVSEVNLLRELKHPN 64
Query: 124 ILKFVGASVQPT---MMIITELMRGETLQRYLWSTRPKR--LDLKHSISFALDISRAMEY 178
I+++ + T + I+ E G L + +R LD + + ++ A++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 179 LH-----ANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE--MTCEAGTYRWMAP 231
H ++V+HRDLKP+N+ L + VKL DFGLAR D GT +M+P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 232 E--------------------------------------------NERPSL-ENLSEDMV 246
E + + S+++
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 243
Query: 247 ALLKSCWAEDPKVRPEFAEI 266
++ RP EI
Sbjct: 244 EIITRMLNLKDYHRPSVEEI 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 138 bits (348), Expect = 1e-38
Identities = 47/285 (16%), Positives = 105/285 (36%), Gaps = 63/285 (22%)
Query: 39 DDDDEEYDNEFVFDIDASVLVDHRSVL----LQKMIGEGSYSIVYKGFY--GCEPVAVKV 92
+D D+ Y++ + + V V SV + + +G G++ +V++ K
Sbjct: 2 NDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF 61
Query: 93 IQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELMRGETLQRY 151
I K + E+++++++ H ++ A M++I E + G L
Sbjct: 62 INT-----PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR 116
Query: 152 LWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK-QVKLADFGL 210
+ + ++ I++ ++++H +S++H D+KP N++ K VK+ DFGL
Sbjct: 117 I-AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 175
Query: 211 AREEVMDEMT-CEAGTYRWMAPEN------------------------------------ 233
A + DE+ T + APE
Sbjct: 176 ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235
Query: 234 ------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI 266
+ + ++S + +K+ ++P+ R +
Sbjct: 236 TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-38
Identities = 57/253 (22%), Positives = 95/253 (37%), Gaps = 61/253 (24%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ IG+G+ VY + VA++ + + KE E+ ++ + K+ N
Sbjct: 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-----QPKKELIINEILVMRENKNPN 78
Query: 124 ILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
I+ ++ + + + ++ E + G +L + T D + + +A+E+LH+N
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSN 135
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE--MTCEAGTYRWMAPE-------- 232
VIHRD+K N+LL D VKL DFG + ++ + GT WMAPE
Sbjct: 136 QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 233 ------------------------------------NERPSL---ENLSEDMVALLKSCW 253
N P L E LS L C
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 254 AEDPKVRPEFAEI 266
D + R E+
Sbjct: 255 DMDVEKRGSAKEL 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 8e-38
Identities = 56/284 (19%), Positives = 111/284 (39%), Gaps = 54/284 (19%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
K++G G++ VYKG + E V + V A S + ++ E +++ + + +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 124 ILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS 183
+ + +G + T+ +IT+LM L Y+ + ++ +++ + I++ M YL
Sbjct: 73 VCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 184 VIHRDLKPSNLLLTEDKKQVKLADFGLAR----EEVMDEMTCEAGTYRWMAPE------- 232
++HRDL N+L+ + VK+ DFGLA+ EE +WMA E
Sbjct: 132 LVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 233 --------------------------------------NERPSL-ENLSEDMVALLKSCW 253
ER + D+ ++ CW
Sbjct: 191 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCW 250
Query: 254 AEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVEIVDPKST 297
D RP+F E+ I + + ++ + + + + P +
Sbjct: 251 MIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-37
Identities = 65/293 (22%), Positives = 106/293 (36%), Gaps = 81/293 (27%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQR 111
+ K +G G++ V + VAVK+++P + +E
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP----SAHLTEREALMS 75
Query: 112 EVTLLSKMK-HENILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPK----------- 158
E+ +LS + H NI+ +GA ++ITE L +L R
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 159 -----RLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213
LDL+ +SF+ +++ M +L + + IHRDL N+LLT + K+ DFGLAR+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARD 194
Query: 214 EVMDE----MTCEAGTYRWMAPENER---------------------------------- 235
D +WMAPE+
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 236 -------------PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275
S E+ +M ++K+CW DP RP F +I + +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-36
Identities = 69/290 (23%), Positives = 113/290 (38%), Gaps = 73/290 (25%)
Query: 66 LQKMIGEGSYSIVYKGFY----GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-K 120
Q +IGEG++ V K A+K ++ S++ F E+ +L K+
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGH 69
Query: 121 HENILKFVGASVQPT-MMIITELMRGETLQRYL--------------WSTRPKRLDLKHS 165
H NI+ +GA + + E L +L ++ L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 166 ISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR-EEVMDEMTCEAG 224
+ FA D++R M+YL IHRDL N+L+ E+ K+ADFGL+R +EV + T
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRL 188
Query: 225 TYRWMAPE---------------------------------------------NERPSL- 238
RWMA E R
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 248
Query: 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS-ADTPIPPK 287
N +++ L++ CW E P RP FA+I ++L +L+ ++ +T + K
Sbjct: 249 LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEK 298
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 1e-36
Identities = 50/246 (20%), Positives = 89/246 (36%), Gaps = 46/246 (18%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSR-EHKEKFQREVTLLSKMK-- 120
+ ++G G + VY G PVA+K ++ + + EV LL K+
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 121 HENILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
+++ + +P + ++I E + R L + + SF + A+ +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHC 126
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE------- 232
H V+HRD+K N+L+ ++ ++KL DFG T GT + PE
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRY 186
Query: 233 --------------------------------NERPSLENLSEDMVALLKSCWAEDPKVR 260
+ + +S + L++ C A P R
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDR 246
Query: 261 PEFAEI 266
P F EI
Sbjct: 247 PTFEEI 252
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-36
Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 29/190 (15%)
Query: 62 RSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH 121
R+++LQ+ IG+G + V++G + E VAVK+ E + E+ ++H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSS------REERSWFREAEIYQTVMLRH 56
Query: 122 ENILKFVGASVQP-----TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
ENIL F+ A + + ++++ +L YL + ++ I AL + +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGL 113
Query: 177 EYLHA--------NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCE------ 222
+LH ++ HRDLK N+L+ ++ +AD GLA T +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHR 172
Query: 223 AGTYRWMAPE 232
GT R+MAPE
Sbjct: 173 VGTKRYMAPE 182
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 8e-04
Identities = 9/42 (21%), Positives = 15/42 (35%)
Query: 234 ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275
R M +++ CW + R I TL+ + Q
Sbjct: 256 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-36
Identities = 54/275 (19%), Positives = 95/275 (34%), Gaps = 62/275 (22%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY------GCEPVAVKVIQPCNALAVSREHKEKFQRE 112
+ V QK+IG G + VYKG PVA+K ++ + + + F E
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA----GYTEKQRVDFLGE 59
Query: 113 VTLLSKMKHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDI 172
++ + H NI++ G + M+I + + + I
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 119
Query: 173 SRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR-----EEVMDEMTCEAGTYR 227
+ M+YL + +HRDL N+L+ + K++DFGL+R E + R
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 228 WMAPEN----------------------------------------------ERPSLENL 241
W APE P+ +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 238
Query: 242 SEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276
+ L+ CW ++ RP+FA+I L +++
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 8e-36
Identities = 48/252 (19%), Positives = 85/252 (33%), Gaps = 56/252 (22%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
K++GEGS+S V A+K+++ + + RE ++S++ H
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHII--KENKVPYVTRERDVMSRLDHPF 69
Query: 124 ILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
+K + + L +Y+ + D + + +I A+EYLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPE------ 232
+IHRDLKP N+LL ED +++ DFG A+ + GT ++++PE
Sbjct: 128 GIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 233 -------------------------------------NERPSL-ENLSEDMVALLKSCWA 254
E L++
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 246
Query: 255 EDPKVRPEFAEI 266
D R E+
Sbjct: 247 LDATKRLGCEEM 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-35
Identities = 58/284 (20%), Positives = 99/284 (34%), Gaps = 69/284 (24%)
Query: 53 IDASVLVDHRSVLLQKMIGEGSYSIVYKGFY-----GCEPVAVKVIQPCNALAVSREHKE 107
I S L+ H ++IG G + VY G AVK +
Sbjct: 22 IGPSSLIVH----FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVS 73
Query: 108 KFQREVTLLSKMKHENILKFVGASVQP--TMMIITELMRGETLQRYLWSTRPKRLDLKHS 165
+F E ++ H N+L +G ++ + +++ M+ L+ + +K
Sbjct: 74 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF-IRNETHNPTVKDL 132
Query: 166 ISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE------M 219
I F L +++ M++L + +HRDL N +L E VK+ADFGLAR+ E
Sbjct: 133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNK 191
Query: 220 TCEAGTYRWMAPE---------------------------------------------NE 234
T +WMA E
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 251
Query: 235 RPSL-ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL 277
R E + + ++ CW ++RP F+E+ ++ I
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-35
Identities = 42/278 (15%), Positives = 104/278 (37%), Gaps = 65/278 (23%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ + +G G + IV++ + K ++ V + ++E+++L+ +H N
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVK------VKGTDQVLVKKEISILNIARHRN 62
Query: 124 ILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
IL + +++I E + G + + +T L+ + +S+ + A+++LH++
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 183 SVIHRDLKPSNLLLTEDK-KQVKLADFGLARE-EVMDEMTCEAGTYRWMAPENER----- 235
++ H D++P N++ + +K+ +FG AR+ + D + APE +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 236 -------------------------------------------PSLENLSEDMVALLKSC 252
+ + +S + + +
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241
Query: 253 WAEDPKVRPEFAEITITLTN--ILQNLRSADTPIPPKL 288
++ K R +E L + + Q + T + L
Sbjct: 242 LVKERKSRMTASEA---LQHPWLKQKIERVSTKVIRTL 276
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (321), Expect = 3e-35
Identities = 64/290 (22%), Positives = 102/290 (35%), Gaps = 85/290 (29%)
Query: 66 LQKMIGEGSYSIVYKG-------FYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK 118
+ IGEG++ V++ + VAVK+++ S + + FQRE L+++
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMAE 72
Query: 119 MKHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTR--------------------- 156
+ NI+K +G M ++ E M L +L S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 157 -PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR--- 212
P L + A ++ M YL +HRDL N L+ E+ VK+ADFGL+R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADFGLSRNIY 191
Query: 213 -EEVMDEMTCEAGTYRWMAPE--------------------------------------- 232
+ +A RWM PE
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 233 -------NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275
N EN ++ L++ CW++ P RP F I L + +
Sbjct: 252 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 8e-35
Identities = 70/291 (24%), Positives = 109/291 (37%), Gaps = 78/291 (26%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQR 111
+ L K +G G++ V + C VAVK+++ A EH+
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSE 66
Query: 112 EVTLLSKMKHENILKFVGASVQP--TMMIITELMRGETLQRYLWSTRPK----------- 158
L+ H N++ +GA +P +M+I E + L YL S R +
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 159 ---RLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215
L L+H I ++ +++ ME+L + IHRDL N+LL+E VK+ DFGLAR+
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIY 185
Query: 216 MDE----MTCEAGTYRWMAP---------------------------------------- 231
D +WMAP
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 232 ------ENERPSL-ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275
E R + + +M + CW +P RP F+E+ L N+LQ
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (317), Expect = 1e-34
Identities = 51/290 (17%), Positives = 104/290 (35%), Gaps = 64/290 (22%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ ++G G++S V + VA+K I + + E+ +L K+KH N
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK----KALEGKEGSMENEIAVLHKIKHPN 68
Query: 124 ILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
I+ + +I +L+ G L + + + + A++YLH
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 183 SVIHRDLKPSNLLLT--EDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAP-------- 231
++HRDLKP NLL ++ ++ ++DFGL++ E ++ GT ++AP
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 186
Query: 232 ----------------------------------------ENERPSLENLSEDMVALLKS 251
E + P +++S+ ++
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246
Query: 252 CWAEDPKVRPEFAEITITLTN-ILQNLRSADTPIPPKLVEIVDPKSTMNN 300
+DP+ R + L + + + D I + E + +
Sbjct: 247 LMEKDPEKRFTCEQA---LQHPWIAGDTALDKNIHQSVSEQIKKNFAKSK 293
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 7e-34
Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 23/256 (8%)
Query: 51 FDIDASVLVDHRSVLLQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEK 108
I + ++D V +++G G V + F E A+K++Q C K
Sbjct: 2 LQIKKNAIIDDYKVT-SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PK 50
Query: 109 FQREVTLLSKM-KHENILKFVGA-----SVQPTMMIITELMRGETLQRYLWSTRPKRLDL 162
+REV L + + +I++ V + + ++I+ E + G L + +
Sbjct: 51 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 110
Query: 163 KHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE--DKKQVKLADFGLAREEVMDEMT 220
+ + I A++YLH+ ++ HRD+KP NLL T +KL DFG A+E
Sbjct: 111 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170
Query: 221 CE-AGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITI-TLTNILQNLR 278
T ++APE P + S DM +L + P ++ + + +R
Sbjct: 171 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 230
Query: 279 SADTPIPPKLVEIVDP 294
P V
Sbjct: 231 MGQYEFPNPEWSEVSE 246
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 3e-33
Identities = 64/283 (22%), Positives = 111/283 (39%), Gaps = 71/283 (25%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY-------GCEPVAVKVIQPCNALAVSREHKEKFQR 111
V + + + +G+GS+ +VY+G VA+K + A S + +F
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLN 72
Query: 112 EVTLLSKMKHENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKR--------LDL 162
E +++ + ++++ +G S ++I ELM L+ YL S RP L
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 163 KHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE----EVMDE 218
I A +I+ M YL+AN +HRDL N ++ ED VK+ DFG+ R+ + +
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRK 191
Query: 219 MTCEAGTYRWMAPE---------------------------------------------- 232
RWM+PE
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251
Query: 233 NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275
+N + + L++ CW +PK+RP F EI ++ ++
Sbjct: 252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 120 bits (301), Expect = 1e-32
Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 12/176 (6%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVS----REHKEKFQREVTLLSKM 119
++++G G S+V + + C+ AVK+I + S +E +E +EV +L K+
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 120 K-HENILKFVGA-SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
H NI++ ++ +LM+ L YL T L K + + +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVIC 124
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
LH +++HRDLKP N+LL +D +KL DFG + + E + GT ++APE
Sbjct: 125 ALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-32
Identities = 55/257 (21%), Positives = 97/257 (37%), Gaps = 58/257 (22%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSRE-HKEKFQREVTLLSKMKHE 122
+ +G G +++V K A K I+ + R +E +REV++L +++H
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 123 NILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
N++ T +++I EL+ G L +L + L + + F I + YLH+
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHS 131
Query: 182 NSVIHRDLKPSNLLLTED---KKQVKLADFGLARE-EVMDEMTCEAGTYRWMAPE----- 232
+ H DLKP N++L + K ++K+ DFGLA + + +E GT ++APE
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 233 -------------------------------------------NERPSLENLSEDMVALL 249
E N S +
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 250 KSCWAEDPKVRPEFAEI 266
+ +DPK R +
Sbjct: 252 RRLLVKDPKKRMTIQDS 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 9e-32
Identities = 48/246 (19%), Positives = 95/246 (38%), Gaps = 55/246 (22%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK-MKHE 122
L KM+G+GS+ V+ + + A+K ++ + + + E E +LS +H
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 123 NILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
+ + + E + G L ++ + DL + +A +I +++LH+
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE--MTCEAGTYRWMAPE------- 232
+++RDLK N+LL +D K+ADFG+ +E ++ + GT ++APE
Sbjct: 122 KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 233 ------------------------------------NERPSL-ENLSEDMVALLKSCWAE 255
+ P L ++ LL +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 256 DPKVRP 261
+P+ R
Sbjct: 241 EPEKRL 246
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 117 bits (295), Expect = 1e-31
Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 65/260 (25%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
L +++G G S V+ VAVKV++ LA +F+RE + + H
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAALNHPA 68
Query: 124 ILKFVGA-----SVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
I+ P I+ E + G TL+ + + K +I D +A+ +
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNF 126
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR-----EEVMDEMTCEAGTYRWMAPE- 232
H N +IHRD+KP+N++++ VK+ DFG+AR + + GT ++++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 233 -----------------------------------------------NERPSLENLSEDM 245
E LS D+
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 246 VALLKSCWAEDPKVRPEFAE 265
A++ A++P+ R + A
Sbjct: 246 DAVVLKALAKNPENRYQTAA 265
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (295), Expect = 2e-31
Identities = 53/250 (21%), Positives = 93/250 (37%), Gaps = 53/250 (21%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ + +G GS+ V+ + A+KV++ + V + E E +LS + H
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK--EIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 124 ILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
I++ G + +I + + G L L ++ + +A ++ A+EYLH+
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYLHSK 123
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE---------- 232
+I+RDLKP N+LL ++ +K+ DFG A+ V D GT ++APE
Sbjct: 124 DIIYRDLKPENILLDKN-GHIKITDFGFAK-YVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 233 ----------------------------------NERPSLENLSEDMVALLKSCWAEDPK 258
E +ED+ LL D
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLS 241
Query: 259 VRPEFAEITI 268
R +
Sbjct: 242 QRLGNLQNGT 251
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-31
Identities = 68/292 (23%), Positives = 111/292 (38%), Gaps = 80/292 (27%)
Query: 59 VDHRSVLLQKMIGEGSYSIVYKGFY---------GCEPVAVKVIQPCNALAVSREHKEKF 109
+ ++L K +GEG++ V VAVK+++ + +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS----DATEKDLSDL 65
Query: 110 QREVTLLSKM-KHENILKFVGASVQPT-MMIITELMRGETLQRYLWSTRP---------- 157
E+ ++ + KH+NI+ +GA Q + +I E L+ YL + RP
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 158 ----KRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR- 212
++L K +S A ++R MEYL + IHRDL N+L+TED K+ADFGLAR
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLARD 184
Query: 213 ---EEVMDEMTCEAGTYRWMAPE------------------------------------- 232
+ + T +WMAPE
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244
Query: 233 --------NERPSL-ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275
R N + ++ +++ CW P RP F ++ L I+
Sbjct: 245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 116 bits (291), Expect = 2e-30
Identities = 50/228 (21%), Positives = 92/228 (40%), Gaps = 8/228 (3%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNA-LAVSREHKEKFQREVTLLSKMKHE 122
+ ++IG G + VY + A+K + + + ++L+S
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 123 NILKFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
I+ A P + I +LM G L +L ++ +A +I +E++H
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPSLE-N 240
V++RDLKP+N+LL E V+++D GLA + + GT+ +MAPE + + +
Sbjct: 126 RFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 241 LSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKL 288
S D +L + P T I + + +P
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 3e-30
Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 8/170 (4%)
Query: 68 KMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
+GEG ++ VYK + VA+K I+ + RE+ LL ++ H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 126 KFVGASVQPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSV 184
+ A + + ++ + M + + L H ++ L + +EYLH + +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLARE--EVMDEMTCEAGTYRWMAPE 232
+HRDLKP+NLLL E+ +KLADFGLA+ T + T + APE
Sbjct: 122 LHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-29
Identities = 54/180 (30%), Positives = 85/180 (47%), Gaps = 22/180 (12%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
IGEG+Y +V + VA+K I P + + ++ RE+ +L + +HEN
Sbjct: 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHEN 67
Query: 124 ILKFVGASVQPTM------MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
I+ PT+ ++T LM + + + + L H F I R ++
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL----KTQHLSNDHICYFLYQILRGLK 123
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR-----EEVMDEMTCEAGTYRWMAPE 232
Y+H+ +V+HRDLKPSNLLL +K+ DFGLAR + +T T + APE
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-29
Identities = 43/177 (24%), Positives = 77/177 (43%), Gaps = 19/177 (10%)
Query: 68 KMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENIL 125
K+IG GS+ +VY+ E VA+K + + K RE+ ++ K+ H NI+
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIMRKLDHCNIV 76
Query: 126 KFVGASVQPT-------MMIITELMRGETLQRYLWSTRPK-RLDLKHSISFALDISRAME 177
+ + ++ + + + +R K L + + + + R++
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENE 234
Y+H+ + HRD+KP NLLL D +KL DFG A++ V E R+
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 3e-29
Identities = 59/301 (19%), Positives = 105/301 (34%), Gaps = 61/301 (20%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
K++G+G++ V A+K+++ + ++++ E +L +H
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRK--EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 124 ILKFVGASVQP-TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
+ A + + E G L +L R + + + + +I A+EYLH+
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR 124
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE--MTCEAGTYRWMAPE-------- 232
V++RD+K NL+L +D +K+ DFGL +E + D M GT ++APE
Sbjct: 125 DVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 233 -----------------------------------NERPSL-ENLSEDMVALLKSCWAED 256
E LS + +LL +D
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 257 PKVRPEFAEITIT-------LTNILQNLRSADTPIPPKLVEIVDPKSTMNNDCMATVHAI 309
PK R +I +PP ++ T D T +I
Sbjct: 244 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSI 303
Query: 310 T 310
T
Sbjct: 304 T 304
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 110 bits (275), Expect = 2e-28
Identities = 39/174 (22%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HE 122
L + +G G YS V++ E V VK+++P K+K +RE+ +L ++
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------VKKKKIKREIKILENLRGGP 90
Query: 123 NILKFVGASVQP---TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
NI+ P T ++ E + ++ + L + +I +A++Y
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYC 145
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE 232
H+ ++HRD+KP N+++ + ++++L D+GLA + + + PE
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 199
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 108 bits (271), Expect = 4e-28
Identities = 38/280 (13%), Positives = 83/280 (29%), Gaps = 74/280 (26%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ + IGEGS+ ++++G + VA+K R + + E +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-------RRSDAPQLRDEYRTYKLLAGCT 61
Query: 124 ILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS 183
+ V Q + + + L ++ +K A + ++ +H S
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 184 VIHRDLKPSNLLLTEDKKQ----VKLADFGLAR---------EEVMDEMTCEAGTYRWMA 230
+++RD+KP N L+ + + + DFG+ + E +GT R+M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 231 PE------------------------------------------------NERPSLENL- 241
+ L L
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 242 ---SEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR 278
E+ + P++ + + +L+ L
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 4e-28
Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 8/171 (4%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ IGEG+Y +VYK E VA+K I+ + RE++LL ++ H N
Sbjct: 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPN 62
Query: 124 ILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS 183
I+K + + + + L++++ ++ + L S+ + + + + H++
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 184 VIHRDLKPSNLLLTEDKKQVKLADFGLAR--EEVMDEMTCEAGTYRWMAPE 232
V+HRDLKP NLL+ + +KLADFGLAR + T E T + APE
Sbjct: 123 VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (270), Expect = 6e-28
Identities = 47/279 (16%), Positives = 90/279 (32%), Gaps = 76/279 (27%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
L + IG GS+ +Y G E VA+K+ + + E + M+
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-------KTKHPQLHIESKIYKMMQGGV 63
Query: 124 ILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA 181
+ + +++ EL+ L++ ++ LK + A + +EY+H+
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 182 NSVIHRDLKPSNLLLTEDK--KQVKLADFGLAR---------EEVMDEMTCEAGTYRWMA 230
+ IHRD+KP N L+ K V + DFGLA+ E GT R+ +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 231 PENERPSLENLSEDMVAL------------------------------------------ 248
++ +D+ +L
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 249 ----------LKSCWAEDPKVRPEFAEITITLTNILQNL 277
L C + +P+++ + N+
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-27
Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 18/180 (10%)
Query: 66 LQKMIGEGSYSIVYKGFY---GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-- 120
IGEG+Y V+K G VA+K ++ REV +L ++
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---EEGMPLSTIREVAVLRHLETF 67
Query: 121 -HENILKFVGASVQPT------MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDIS 173
H N+++ + ++ E + + YL + + +
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLL 126
Query: 174 RAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE-EVMDEMTCEAGTYRWMAPE 232
R +++LH++ V+HRDLKP N+L+T Q+KLADFGLAR +T T + APE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 105 bits (263), Expect = 1e-26
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 12/226 (5%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
K +G GS+ V + A+K++ V + E E +L +
Sbjct: 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 124 ILKFVGASV-QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN 182
++K + + ++ E + G + +L R R H+ +A I EYLH+
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 183 SVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPSLENLS 242
+I+RDLKP NLL+ + +++ DFG A+ T GT +APE N +
Sbjct: 161 DLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGRTWTLC-GTPEALAPEIILSKGYNKA 218
Query: 243 EDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKL 288
D AL + P FA+ I + + S P
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVRFPSHF 261
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 7e-26
Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 23/184 (12%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
IG+G++ V+K + + VA+K + N RE+ +L +KHEN
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKILQLLKHEN 70
Query: 124 ILKFVGASVQP---------TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISR 174
++ + ++ ++ + + L S + L +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIKRVMQMLLN 128
Query: 175 AMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE------EVMDEMTCEAGTYRW 228
+ Y+H N ++HRD+K +N+L+T D +KLADFGLAR + T T +
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 229 MAPE 232
PE
Sbjct: 188 RPPE 191
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 101 bits (252), Expect = 1e-25
Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 8/170 (4%)
Query: 66 LQKMIGEGSYSIVYKGFY-GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI 124
+ IGEG+Y +VYK E A+K I+ RE+++L ++KH NI
Sbjct: 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNI 62
Query: 125 LKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSV 184
+K +++ + L++ L L+ + SF L + + Y H V
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 185 IHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYR--WMAPE 232
+HRDLKP NLL+ + ++K+ADFGLAR + + AP+
Sbjct: 122 LHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (248), Expect = 7e-25
Identities = 45/171 (26%), Positives = 81/171 (47%), Gaps = 9/171 (5%)
Query: 66 LQKMIGEGSYSIVYKGFY--GCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ IGEG+Y V+K E VA+K ++ + RE+ LL ++KH+N
Sbjct: 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKN 62
Query: 124 ILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS 183
I++ + + + + + + LD + SF + + + + H+ +
Sbjct: 63 IVRLHDVLHSDKKLTLVF-EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 184 VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE--MTCEAGTYRWMAPE 232
V+HRDLKP NLL+ + ++KLA+FGLAR + + E T + P+
Sbjct: 122 VLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 3e-24
Identities = 53/236 (22%), Positives = 100/236 (42%), Gaps = 17/236 (7%)
Query: 66 LQKMIGEGSYSIVYKGFYGC-----EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK 120
L K++G G+Y V+ + A+KV++ + + E + E +L ++
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT-IVQKAKTTEHTRTERQVLEHIR 86
Query: 121 HENILKFVGASVQ--PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEY 178
L + + Q + +I + + G L +L + +R + +I A+E+
Sbjct: 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEH 144
Query: 179 LHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMT---CEAGTYRWMAPENER 235
LH +I+RD+K N+LL + V L DFGL++E V DE GT +MAP+ R
Sbjct: 145 LHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 236 PSLENLSE--DMVALLKSCWAEDPKVRPEFAEITI-TLTNILQNLRSADTPIPPKL 288
+ D +L + P + + I + + ++ P P ++
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (245), Expect = 4e-24
Identities = 53/239 (22%), Positives = 94/239 (39%), Gaps = 22/239 (9%)
Query: 66 LQKMIGEGSYSIVYKGFYGC--EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
K IG G+ IV + VA+K + ++ H ++ RE+ L+ + H+N
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKN 77
Query: 124 ILKFVGASVQPTMM-------IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
I+ + + ++ ELM Q +R+ + +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM-----SYLLYQMLCGI 132
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPENER 235
++LH+ +IHRDLKPSN+++ D +K+ DFGLAR MT T + APE
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 236 PSLENLSEDMVALLKSCWAEDPKVRPEFAEITI--TLTNILQNLRSADTPIPPKLVEIV 292
+ D+ + + E + + F +++ L + KL V
Sbjct: 192 GMGYKENVDIWS-VGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 7e-24
Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 18/176 (10%)
Query: 66 LQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+ +G G+Y V G VA+K + S ++ RE+ LL M+HEN
Sbjct: 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ---SELFAKRAYRELRLLKHMRHEN 78
Query: 124 ILKFVGASVQPT-------MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAM 176
++ + ++ M + + + ++L + + +
Sbjct: 79 VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM----KHEKLGEDRIQFLVYQMLKGL 134
Query: 177 EYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPE 232
Y+HA +IHRDLKP NL + ED + K+ DFGLAR + EMT T + APE
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLAR-QADSEMTGYVVTRWYRAPE 188
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 2e-22
Identities = 57/272 (20%), Positives = 96/272 (35%), Gaps = 18/272 (6%)
Query: 66 LQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHEN 123
+G G+Y V F VAVK + S H ++ RE+ LL MKHEN
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHEN 78
Query: 124 ILKFVGASVQP------TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAME 177
++ + + + + G L + ++L H I R ++
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLK 135
Query: 178 YLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPS 237
Y+H+ +IHRDLKPSNL + ED + K+ DFGLAR + A +
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVEIVDPKST 297
N + D+ ++ + L+ + +L++ + +S
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGT---DHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 298 MNNDCMATVHAITKFNEKGKKRRSYLPSFLKR 329
N T F L++
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 283
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.4 bits (213), Expect = 9e-21
Identities = 24/154 (15%), Positives = 52/154 (33%), Gaps = 12/154 (7%)
Query: 66 LQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPC-----NALAVSREHKEKFQREVTLLSKM 119
+ K++GEG S V+ + VK + F ++
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 120 KHENILKFVGASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYL 179
+ + K G +V L + + R+ +++ I +
Sbjct: 64 EFRALQKLQGLAVPKVY----AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 180 HANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213
+ ++H DL N+L++E+ + + DF + E
Sbjct: 120 YHRGIVHGDLSQYNVLVSEE--GIWIIDFPQSVE 151
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.5 bits (205), Expect = 1e-18
Identities = 42/270 (15%), Positives = 90/270 (33%), Gaps = 32/270 (11%)
Query: 57 VLVDHRSVLLQKMIGEGSYSIVYKGF--YGCEPVAVKVIQPCNALAVSREHKEKFQREVT 114
D R +L++K +G G +S V+ VA+K+++ + + E + E+
Sbjct: 9 PYKDARYILVRK-LGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIK 61
Query: 115 LLSKMKHENILKFVGASVQ---------------PTMMIITELMRGETLQRYLWSTRPKR 159
LL ++ + K +++ + GE L + +
Sbjct: 62 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 121
Query: 160 LDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLAR----EE 214
+ L + + + ++Y+H +IH D+KP N+L+ L +A
Sbjct: 122 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 181
Query: 215 VMDEMTCEAGTYRWMAPENERPSLENLSEDMVAL---LKSCWAEDPKVRPEFAEITITLT 271
+ T T + +PE + D+ + + D P+
Sbjct: 182 YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 272 NILQNLRSADTPIPPKLVEIVDPKSTMNND 301
+ + + +P L+ T N
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNS 271
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 336 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.67 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.95 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.9 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.84 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.83 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.68 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 95.9 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 95.44 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 95.4 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 92.62 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 91.88 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 91.73 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 91.65 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 91.45 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 91.12 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 91.06 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 90.93 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 90.88 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 90.72 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 90.64 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 90.48 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 90.4 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 90.26 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 89.95 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 89.88 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 89.82 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 89.79 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 89.58 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 89.56 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 89.54 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 89.54 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 89.25 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 89.02 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 89.01 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 89.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 88.79 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 88.76 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 88.67 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 88.49 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 88.33 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 87.92 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 87.29 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 87.28 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 87.22 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 87.15 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 86.94 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 86.83 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 86.63 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 86.49 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 86.44 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 86.42 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 86.33 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 85.6 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 85.59 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 85.31 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 84.63 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 84.52 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 84.09 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 83.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 82.69 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 81.09 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=346.55 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=207.9
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+++.||+|+||+||+|++. ++.||+|++... ..........+.+|+.+|+.++||||+++++++.+++ .|+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchH--HccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999986 788999999732 1122334567899999999999999999999999876 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 84 vmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCSCSCCCCCC
T ss_pred EEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC-CEeecccceeeecCCCc
Confidence 99999999999999543 5699999999999999999999999999999999999999887 79999999998766555
Q ss_pred ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCCCC
Q 019780 219 MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPKST 297 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~ 297 (336)
.....||+.|+|||...+.+++.+.|+|+|++.+|++-.++.|.... ....+..+.+.-......+|+++.+++...+.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 240 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 240 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHcc
Confidence 66678999999999999999999999999999999999999886332 22223333333333344577788889999999
Q ss_pred CCCccccchhhhcccc
Q 019780 298 MNNDCMATVHAITKFN 313 (336)
Q Consensus 298 ~~~~~~~~~~~~~~~~ 313 (336)
.+|+.|.+..++.+..
T Consensus 241 ~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 241 HNPSQRPMLREVLEHP 256 (263)
T ss_dssp SSGGGSCCHHHHHTCH
T ss_pred CCHhHCcCHHHHHcCc
Confidence 9999999998887654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-48 Score=337.56 Aligned_cols=215 Identities=33% Similarity=0.536 Sum_probs=178.5
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT 135 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 135 (336)
.|.++.++|.+++.||+|+||+||+|++++ .||||+++.. .......+.+.+|+.+|++++||||+++++++.++.
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 77 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT---APTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ 77 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCS---SCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcc---cCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccE
Confidence 467888999999999999999999998765 5999999742 223445778999999999999999999999988888
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEV 215 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~ 215 (336)
+++||||++||+|.+++... ...+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+...
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKS 155 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-SEEECCCCCSCC--
T ss_pred EEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC-CEEEccccceeecc
Confidence 99999999999999999543 35699999999999999999999999999999999999999887 89999999997543
Q ss_pred cc----cccccCCcccccCCCCCC-----------------------------------------------------CCC
Q 019780 216 MD----EMTCEAGTYRWMAPENER-----------------------------------------------------PSL 238 (336)
Q Consensus 216 ~~----~~~~~~gt~~y~aPE~~~-----------------------------------------------------~~~ 238 (336)
.. ......||+.|+|||.+. ..+
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 235 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence 22 233456999999999321 112
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
.+++.++++|+..||+.+|.+||++.++++.|+.+.+.
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 34566777889999999999999999999988877654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=340.68 Aligned_cols=247 Identities=22% Similarity=0.238 Sum_probs=198.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|++++.||+|+||+||+|++. ++.||||++.... ..+..+.+.+|+.+|+.++||||+++++++.+++ .|+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh----cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 57999999999999999999986 7899999997422 2233467899999999999999999999999876 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||++||+|.+++ .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 81 vmEy~~gg~L~~~l--~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTTEEGGGGS--BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECEETT
T ss_pred EEeccCCCcHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-CEEEccchhheeeccCC
Confidence 99999999999999 3446799999999999999999999999999999999999999887 7999999999854322
Q ss_pred ---cccccCCcccccCCCCCCCCCC-CCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHHHhhcc--CCCCCCCCcc
Q 019780 218 ---EMTCEAGTYRWMAPENERPSLE-NLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNILQNLRS--ADTPIPPKLV 289 (336)
Q Consensus 218 ---~~~~~~gt~~y~aPE~~~~~~~-~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~~~~~~--~~~~~p~~~~ 289 (336)
.....+||+.|+|||....... +.+.|+|+|++.++++..++.|... +....+......... ....+++++.
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHH
Confidence 2345579999999998877665 5678999999999999888887522 112222222222111 1234677788
Q ss_pred cccCCCCCCCCccccchhhhcccccc
Q 019780 290 EIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
+++...+..+|+.|.+..++.+..+-
T Consensus 238 ~li~~~L~~dP~~R~t~~eil~hpwf 263 (271)
T d1nvra_ 238 ALLHKILVENPSARITIPDIKKDRWY 263 (271)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred HHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 89999999999999999988875543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=334.28 Aligned_cols=215 Identities=27% Similarity=0.516 Sum_probs=185.7
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
++.|.++.++|.+.+.||+|+||+||+|.++ ++.||||+++... ...+.+.+|+.+|++++|||||++++++.
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS------MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS------SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc------CCHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 4577788899999999999999999999987 5789999997422 12456999999999999999999999998
Q ss_pred cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 133 QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 133 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
++..++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 79 ~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~ 157 (272)
T d1qpca_ 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLAR 157 (272)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-ceeeccccceE
Confidence 88899999999999999988655555699999999999999999999999999999999999999887 89999999998
Q ss_pred cccccc---ccccCCcccccCCC----------------------------------------------CCCCCCCCCHH
Q 019780 213 EEVMDE---MTCEAGTYRWMAPE----------------------------------------------NERPSLENLSE 243 (336)
Q Consensus 213 ~~~~~~---~~~~~gt~~y~aPE----------------------------------------------~~~~~~~~~~~ 243 (336)
...... .....||+.|+||| .....+..++.
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~ 237 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred EccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChH
Confidence 654332 23346889999999 12234567888
Q ss_pred HHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 244 DMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 244 di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
++.+|+..||+.+|.+||++.++++.|+++..
T Consensus 238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999999999999999988764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=341.43 Aligned_cols=248 Identities=21% Similarity=0.300 Sum_probs=204.5
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
.++|++++.||+|+||+||+|++. ++.||||++.... .......+.+.+|+.+|++++||||+++++++.+++ +|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHH--ccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 467999999999999999999986 7899999997321 122334567999999999999999999999998776 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~ 217 (336)
+||||++||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 85 ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECC--
T ss_pred EEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc-eEEecccccceecccC
Confidence 999999999999998543 5799999999999999999999999999999999999999887 7999999999864322
Q ss_pred ----cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCCCCCCccccc
Q 019780 218 ----EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTPIPPKLVEIV 292 (336)
Q Consensus 218 ----~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~p~~~~~~~ 292 (336)
...+.+||+.|+|||...+..++.+.|+|+||+.++++..+..|... .....+..+.+.-......+++++.+++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 23345799999999999888999999999999999999999988632 2233334444333334456788888899
Q ss_pred CCCCCCCCccccchhhhcccc
Q 019780 293 DPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~ 313 (336)
..++..+|..|.+..++....
T Consensus 242 ~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTCHH
T ss_pred HHHccCCHhHCcCHHHHcCCH
Confidence 999999999999988765543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-47 Score=335.52 Aligned_cols=212 Identities=31% Similarity=0.538 Sum_probs=181.6
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
.|.++.++|.+.+.||+|+||+||+|.+. ++.||||+++... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc------chHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 57788899999999999999999999986 7789999987421 234578999999999999999999999987
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
++ .++||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~ 163 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSR 163 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCCTT
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-cEEEcccccee
Confidence 65 89999999999999999777777899999999999999999999999999999999999999887 89999999998
Q ss_pred ccccccc---cccCCcccccCCCC----------------------------------------------CCCCCCCCHH
Q 019780 213 EEVMDEM---TCEAGTYRWMAPEN----------------------------------------------ERPSLENLSE 243 (336)
Q Consensus 213 ~~~~~~~---~~~~gt~~y~aPE~----------------------------------------------~~~~~~~~~~ 243 (336)
....... ....|++.|+|||. ..+.+..++.
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 243 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 243 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchH
Confidence 6543322 22347899999991 1233456788
Q ss_pred HHHHHHHHhhccCCCCCCCHhHHHHHHHHHH
Q 019780 244 DMVALLKSCWAEDPKVRPEFAEITITLTNIL 274 (336)
Q Consensus 244 di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~ 274 (336)
++.+|+..||+.+|.+||++.++++.|+.+.
T Consensus 244 ~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 8889999999999999999999988776553
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=336.11 Aligned_cols=246 Identities=22% Similarity=0.286 Sum_probs=204.1
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+.+.||+|+||+||+|.+. ++.||||+++.... ...+.+.+|+.+|+.++||||+++++++.+++ +|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-----hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence 57999999999999999999976 88999999974221 22467899999999999999999999998766 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 95 vmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTT
T ss_pred EEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-cEeeccchhheeecccc
Confidence 9999999999998854 3599999999999999999999999999999999999999887 7999999999864332
Q ss_pred -cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhc---cCCCCCCCCccccc
Q 019780 218 -EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLR---SADTPIPPKLVEIV 292 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~---~~~~~~p~~~~~~~ 292 (336)
.....+||+.|+|||.....+++.+.|+|+||+.+|++-.+..|.... -...+..+..... .....+++++.+++
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 250 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHH
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHH
Confidence 244557999999999999989999999999999999999998886322 2222333332211 11234677788899
Q ss_pred CCCCCCCCccccchhhhccccccc
Q 019780 293 DPKSTMNNDCMATVHAITKFNEKG 316 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~ 316 (336)
...+..+|+.|.+..++.+....+
T Consensus 251 ~~~L~~dP~~R~s~~eil~Hp~~~ 274 (293)
T d1yhwa1 251 NRCLDMDVEKRGSAKELLQHQFLK 274 (293)
T ss_dssp HHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred HHHccCChhHCcCHHHHhcCHhhC
Confidence 999999999999999988766543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=330.81 Aligned_cols=248 Identities=26% Similarity=0.374 Sum_probs=200.9
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP--- 134 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--- 134 (336)
+.+.|.+.+.||+|+||+||+|++. +..||+|.+... .......+.+.+|+++|++++||||+++++++.+.
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~---~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 83 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR---KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG---GSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchh---hCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc
Confidence 4456788889999999999999986 678999998742 22445577899999999999999999999998641
Q ss_pred --CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCCceEEecccc
Q 019780 135 --TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANS--VIHRDLKPSNLLLTEDKKQVKLADFGL 210 (336)
Q Consensus 135 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDikp~NIll~~~~~~~kl~Dfg~ 210 (336)
.+|+||||++||+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+.+.+||+|||+
T Consensus 84 ~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 84 KKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred CCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 279999999999999999543 56999999999999999999999999 999999999999975334899999999
Q ss_pred ccccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh--HHHHHHHHHHHhhc--cCCCCCCC
Q 019780 211 AREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA--EITITLTNILQNLR--SADTPIPP 286 (336)
Q Consensus 211 a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~--~i~~~l~~~~~~~~--~~~~~~p~ 286 (336)
|+........+.+||+.|+|||...+ .++.+.|+|+|++.+|++-.++.|... ........+..... ......++
T Consensus 162 a~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (270)
T d1t4ha_ 162 ATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240 (270)
T ss_dssp GGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence 98655555566789999999998765 588999999999999999999888532 12222222222111 12234677
Q ss_pred CcccccCCCCCCCCccccchhhhcccc
Q 019780 287 KLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
++.+++...+..+|+.|.+..++.+..
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~Hp 267 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLNHA 267 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhCCc
Confidence 788899999999999999998887654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=324.92 Aligned_cols=217 Identities=23% Similarity=0.498 Sum_probs=184.0
Q ss_pred eeecCCceeEeee-ecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 57 VLVDHRSVLLQKM-IGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 57 ~~~~~~~~~~~~~-lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
+.++.+++.+.+. ||+|+||+||+|.+. +..||||+++.. ......+.+.+|+.+|++++|||||++++++
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~ 78 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVC 78 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh----cCHHHHHHHHHHHHHHHhCCCCCEeeEeeee
Confidence 4567788988885 999999999999874 346999999742 2455677899999999999999999999999
Q ss_pred ecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 132 VQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 132 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
.++.+|+||||++||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 79 ~~~~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla 156 (285)
T d1u59a_ 79 QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLS 156 (285)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTC
T ss_pred ccCeEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-ceeeccchhh
Confidence 888899999999999999998433 35799999999999999999999999999999999999999887 8999999999
Q ss_pred ccccccc-----ccccCCcccccCCC----------------------------------------------CCCCCCCC
Q 019780 212 REEVMDE-----MTCEAGTYRWMAPE----------------------------------------------NERPSLEN 240 (336)
Q Consensus 212 ~~~~~~~-----~~~~~gt~~y~aPE----------------------------------------------~~~~~~~~ 240 (336)
+...... .....||+.|+||| ...+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 236 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 236 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTT
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence 8543322 22345889999999 12234567
Q ss_pred CHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhcc
Q 019780 241 LSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRS 279 (336)
Q Consensus 241 ~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~ 279 (336)
++.++++|+..||+.+|.+||++.++.+.|......+.+
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 889999999999999999999999999999887765443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=339.93 Aligned_cols=240 Identities=20% Similarity=0.233 Sum_probs=200.8
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
.-++|.+++.||+|+||.||+|++. ++.||||+++.. ........+.+.+|+.+|+.++||||+++++++.+++ +
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~--~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE--VIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchh--hccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 3468999999999999999999986 889999999732 1122334677899999999999999999999999876 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 81 ~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCC
T ss_pred ccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC-CEEEeeccccccccc
Confidence 9999999999999999543 5689999999999999999999999999999999999999887 899999999986433
Q ss_pred c--cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhccCCCCCCCCcccccC
Q 019780 217 D--EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRSADTPIPPKLVEIVD 293 (336)
Q Consensus 217 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~~~~~~p~~~~~~~~ 293 (336)
. .....+||+.|+|||...+..++.+.|+|+||+.++++..+++|....- ...+..+..........+++++.+++.
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~ 237 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence 2 2345679999999999999999999999999999999999998864432 222333444444445667888888888
Q ss_pred CCCCCCCcccc
Q 019780 294 PKSTMNNDCMA 304 (336)
Q Consensus 294 ~~~~~~~~~~~ 304 (336)
.++..+|..|.
T Consensus 238 ~~L~~dP~~R~ 248 (337)
T d1o6la_ 238 GLLKKDPKQRL 248 (337)
T ss_dssp HHTCSSTTTST
T ss_pred hhccCCchhhc
Confidence 88888888886
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=332.91 Aligned_cols=247 Identities=25% Similarity=0.287 Sum_probs=195.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC---CE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---TM 136 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~ 136 (336)
++|++++.||+|+||+||+|++. ++.||||++.... ......+.+.+|+.+|++++||||+++++++.+. .+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT---SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhh---CCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 57999999999999999999986 7899999997432 2445577899999999999999999999998653 38
Q ss_pred EEEEEccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccccCCCCceeecCCCCceEEeccc
Q 019780 137 MIITELMRGETLQRYLWST--RPKRLDLKHSISFALDISRAMEYLHANS-----VIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
|+|||||+||+|.+++... ....+++..++.++.|++.||+|||++| |+||||||+|||++.++ .+||+|||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DFG 159 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFG 159 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-CEEECCHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-cEEEeecc
Confidence 9999999999999998542 3467999999999999999999999976 99999999999999887 79999999
Q ss_pred ccccccccc--ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh-hccCCCCCC
Q 019780 210 LAREEVMDE--MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN-LRSADTPIP 285 (336)
Q Consensus 210 ~a~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~-~~~~~~~~p 285 (336)
+|+...... .....||+.|+|||.+....++.+.|+|+|++.+|++-.+++|.... ..+.+..+... .......+|
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s 239 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 239 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred ceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence 998643322 34467999999999998888999999999999999999998886322 22222233222 223345677
Q ss_pred CCcccccCCCCCCCCccccchhhhccc
Q 019780 286 PKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
+++.+++...+..+|..|++..++.+.
T Consensus 240 ~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 240 DELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 888999999999999999999888764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=346.48 Aligned_cols=249 Identities=19% Similarity=0.260 Sum_probs=200.2
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT- 135 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 135 (336)
+..++|++++.||+|+||+||+|++. ++.||+|+++.. ........+.+|+.+|+.++|||||++++++.++.
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~----~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 78 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 78 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECC----CCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChh----hCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 45678999999999999999999986 789999999742 23344578899999999999999999999999776
Q ss_pred EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN-SVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
+|+||||++||+|.+++.+. +.+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+|+..
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHH
T ss_pred EEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCcccc
Confidence 99999999999999999544 5699999999999999999999975 999999999999999887 7999999999876
Q ss_pred ccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH----HHHHH--------------------
Q 019780 215 VMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE----ITITL-------------------- 270 (336)
Q Consensus 215 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~----i~~~l-------------------- 270 (336)
......+.+||+.|+|||...+.+++.+.|+|++|+.++++..++.|.... .....
T Consensus 156 ~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 156 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp HHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred CCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 555556678999999999999999999999999999999998888885321 00000
Q ss_pred ---------------HHHHHhhcc-CCC-----CCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 271 ---------------TNILQNLRS-ADT-----PIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 271 ---------------~~~~~~~~~-~~~-----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
.+....... ..+ ..++++.+++...+..+|..|.|..++.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence 000001111 111 13345667888899999999999988887543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=323.78 Aligned_cols=209 Identities=26% Similarity=0.499 Sum_probs=168.9
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
++.++|.+++.||+|+||+||+|++. ++.||||+++... ...+.+.+|+.+++.++||||+++++++.+++ .
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA------MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS------SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc------CcHHHHHHHHHHHHhcCCCCcccccceeccCCce
Confidence 56788999999999999999999986 6779999987421 12356899999999999999999999988654 9
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+|+....
T Consensus 76 ~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD 153 (263)
T ss_dssp EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-CEEECSCC-------
T ss_pred EEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-CeEecccchheeccC
Confidence 9999999999999998543 36689999999999999999999999999999999999999887 799999999985433
Q ss_pred cc---ccccCCcccccCCCCC----------------------------------------------CCCCCCCHHHHHH
Q 019780 217 DE---MTCEAGTYRWMAPENE----------------------------------------------RPSLENLSEDMVA 247 (336)
Q Consensus 217 ~~---~~~~~gt~~y~aPE~~----------------------------------------------~~~~~~~~~di~~ 247 (336)
.. .....||+.|+|||.+ ...+..++.++++
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 233 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 233 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHH
Confidence 32 2234589999999922 2234456677788
Q ss_pred HHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 248 LLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 248 l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
|+..||+.+|.+||++.++++.|+++.+
T Consensus 234 li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 234 IMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999888754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-46 Score=336.02 Aligned_cols=245 Identities=22% Similarity=0.264 Sum_probs=203.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+++.||+|+||+||+|++. ++.||||+++.. ........+.+.+|+.+|+.++||||+++++++.+++ +|+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~--~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKE--IVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchH--HccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 57999999999999999999986 789999999732 1122334677999999999999999999999999876 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||+.||+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... .
T Consensus 82 vmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~~~~-~ 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD-V 157 (316)
T ss_dssp EECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS-C
T ss_pred EeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC-CEEEecCccceEecc-c
Confidence 9999999999999844 45688999999999999999999999999999999999999887 899999999986433 3
Q ss_pred ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCCCCC
Q 019780 219 MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDPKST 297 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~ 297 (336)
..+.+||+.|+|||...+.+++.+.|+|+||+.++++..+.+|.... ....+..+...-....+.+|+++.+++..++.
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 237 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 237 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 44568999999999999999999999999999999999999996332 22333344444334445677788888888888
Q ss_pred CCCcccc-----chhhhccc
Q 019780 298 MNNDCMA-----TVHAITKF 312 (336)
Q Consensus 298 ~~~~~~~-----~~~~~~~~ 312 (336)
.+|..|. +..++.+.
T Consensus 238 ~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 238 RDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp SCTTTCTTSSTTTTHHHHTS
T ss_pred hCHHhccccchhhHHHHHcC
Confidence 8888774 66666553
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-46 Score=334.85 Aligned_cols=246 Identities=20% Similarity=0.264 Sum_probs=187.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
+.|.+.+.||+|+||+||+|++. ++.||||++..... ......+.+|+.+|+.++||||+++++++.+++ +|+
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL----EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45999999999999999999986 78899999974221 223456889999999999999999999998776 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC--CCCceEEecccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE--DKKQVKLADFGLAREEVM 216 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~--~~~~~kl~Dfg~a~~~~~ 216 (336)
|||||+||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+.. +.+.+||+|||+|+....
T Consensus 85 vmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999999943 467999999999999999999999999999999999999953 234799999999986543
Q ss_pred cc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhccCC----CCCCCCccc
Q 019780 217 DE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRSAD----TPIPPKLVE 290 (336)
Q Consensus 217 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~~~----~~~p~~~~~ 290 (336)
.. ..+.+||+.|+|||...+.+++.+.|+|+||+.++++..+..|...+- ......+........ ..+|+++.+
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence 32 345679999999999999999999999999999999999999964332 222333333222222 346777888
Q ss_pred ccCCCCCCCCccccchhhhcccc
Q 019780 291 IVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
++...+..+|+.|.+..++.+..
T Consensus 243 li~~~L~~dP~~R~s~~eil~hp 265 (307)
T d1a06a_ 243 FIRHLMEKDPEKRFTCEQALQHP 265 (307)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHST
T ss_pred HHHHHccCCHhHCcCHHHHhcCH
Confidence 99999999999999998887643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=333.66 Aligned_cols=247 Identities=24% Similarity=0.297 Sum_probs=200.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
+.|.+++.||+|+||+||+|++. ++.||||++... .....+.+.+|+.+|+.++||||+++++++.+++ .++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence 46899999999999999999986 788999999742 2233567889999999999999999999998765 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||++||+|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 87 vmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHHHH
T ss_pred EEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-CEEEEechhhhccCCCc
Confidence 99999999999998543 35699999999999999999999999999999999999999887 7999999999754332
Q ss_pred -cccccCCcccccCCCCC-----CCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhh---ccCCCCCCCC
Q 019780 218 -EMTCEAGTYRWMAPENE-----RPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNL---RSADTPIPPK 287 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~-----~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~---~~~~~~~p~~ 287 (336)
...+..||+.|+|||.+ ...+++.+.|+|+|++.+|++-.++.|.... -.+.+..+.... ......+|++
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHH
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHH
Confidence 23456799999999975 3456788999999999999998888885321 112223333221 1112356777
Q ss_pred cccccCCCCCCCCccccchhhhcccccc
Q 019780 288 LVEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
+.+++...+..+|+.|.+..++.+....
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 8889999999999999999998875443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-45 Score=324.51 Aligned_cols=212 Identities=27% Similarity=0.522 Sum_probs=169.7
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--Cc---cEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CE---PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~---~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
++..+|.+.+.||+|+||+||+|.+. ++ .||||.+.. .......+.+.+|+.+|++++|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS----GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS----SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECc----ccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 55678999999999999999999985 22 478888763 2244566789999999999999999999999987
Q ss_pred CC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 134 PT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
++ .++|||||+||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~ 176 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFGLSR 176 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC----
T ss_pred CCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC-cEEECCcccce
Confidence 65 99999999999999988543 35699999999999999999999999999999999999999887 89999999998
Q ss_pred cccccc-------ccccCCcccccCCC----------------------------------------------CCCCCCC
Q 019780 213 EEVMDE-------MTCEAGTYRWMAPE----------------------------------------------NERPSLE 239 (336)
Q Consensus 213 ~~~~~~-------~~~~~gt~~y~aPE----------------------------------------------~~~~~~~ 239 (336)
...... .....||+.|+||| ...+.+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 256 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 543221 11234789999999 1223455
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
.++..+++|+..||+.+|.+||++.++++.|+.+++.
T Consensus 257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 6788889999999999999999999999999888764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=321.29 Aligned_cols=212 Identities=28% Similarity=0.528 Sum_probs=174.4
Q ss_pred ecCCceeEe-eeecCCCcEEEEEeEEC----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 59 VDHRSVLLQ-KMIGEGSYSIVYKGFYG----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 59 ~~~~~~~~~-~~lg~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
++.+.+.+. +.||+|+||+||+|.+. ++.||||+++.. ..+....+.+.+|+.+|++++||||+++++++.+
T Consensus 3 ld~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~ 79 (277)
T d1xbba_ 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---ANDPALKDELLAEANVMQQLDNPYIVRMIGICEA 79 (277)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES
T ss_pred echhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChh---hCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc
Confidence 344555554 46999999999999864 357999999632 2344556789999999999999999999999988
Q ss_pred CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 134 PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 134 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+..++||||+++|+|.++++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 80 ~~~~lvmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~ 156 (277)
T d1xbba_ 80 ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKA 156 (277)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEE
T ss_pred CCEEEEEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC-cccccchhhhhh
Confidence 8899999999999999999543 5699999999999999999999999999999999999999887 899999999985
Q ss_pred ccccc-----ccccCCcccccCCC----------------------------------------------CCCCCCCCCH
Q 019780 214 EVMDE-----MTCEAGTYRWMAPE----------------------------------------------NERPSLENLS 242 (336)
Q Consensus 214 ~~~~~-----~~~~~gt~~y~aPE----------------------------------------------~~~~~~~~~~ 242 (336)
..... .....||+.|+||| ...+.+..++
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~ 236 (277)
T d1xbba_ 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 236 (277)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence 43221 22345899999999 1224456788
Q ss_pred HHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 243 EDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 243 ~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
.++++|+..||+.+|.+||++.++...|+.....
T Consensus 237 ~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 237 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 9999999999999999999999999888876543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-46 Score=331.18 Aligned_cols=246 Identities=25% Similarity=0.286 Sum_probs=201.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
+.|.+++.||+|+||+||+|++. ++.||||++.... .......+.+.+|+.+|++++|||||++++++.+++ .|+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS--SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhh--ccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 35899999999999999999986 7889999997422 223455678999999999999999999999998765 999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|||||.||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 93 v~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS--
T ss_pred EEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC-CEEEeecccccccCC--
Confidence 9999999999877633 35799999999999999999999999999999999999999876 899999999986433
Q ss_pred ccccCCcccccCCCCCCC---CCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhcc--CCCCCCCCccccc
Q 019780 219 MTCEAGTYRWMAPENERP---SLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRS--ADTPIPPKLVEIV 292 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~---~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~--~~~~~p~~~~~~~ 292 (336)
.....||+.|+|||...+ ..++.+.|+|+||+.+|++-.+..|.... -...+..+...... ....+|+++.+++
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li 247 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 344579999999997653 45778999999999999999999886432 22233333332211 2234677888999
Q ss_pred CCCCCCCCccccchhhhccccc
Q 019780 293 DPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
...+..+|+.|++..++.+...
T Consensus 248 ~~~L~~dP~~Rpt~~ell~Hp~ 269 (309)
T d1u5ra_ 248 DSCLQKIPQDRPTSEVLLKHRF 269 (309)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHH
T ss_pred HHHCcCChhHCcCHHHHHhCHH
Confidence 9999999999999998877543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-45 Score=332.89 Aligned_cols=246 Identities=19% Similarity=0.252 Sum_probs=203.6
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
.+|.+++.||+|+||+||+|++. ++.||||+++.. .......+.+|+.+|+.++||||+++++++.+++ +|+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc-----chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46999999999999999999986 889999999742 2334567889999999999999999999998776 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-CCCceEEeccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE-DKKQVKLADFGLAREEVMD 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~-~~~~~kl~Dfg~a~~~~~~ 217 (336)
|||||+||+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+.+||+|||+|+.....
T Consensus 104 vmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 104 ILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999999998743 3456999999999999999999999999999999999999973 2348999999999865443
Q ss_pred c-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccC----CCCCCCCcccc
Q 019780 218 E-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSA----DTPIPPKLVEI 291 (336)
Q Consensus 218 ~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~----~~~~p~~~~~~ 291 (336)
. .....||+.|+|||...+.+++.+.|+|+||+.++++..+..|... .....+..+....... ...+|+++.++
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 3 3456799999999999999999999999999999999999988633 2222333333322221 23577788899
Q ss_pred cCCCCCCCCccccchhhhcccc
Q 019780 292 VDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
+..++..+|+.|.+..++.+..
T Consensus 263 i~~~L~~dp~~R~s~~eil~Hp 284 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEHP 284 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTST
T ss_pred HHHHccCChhHCcCHHHHhcCH
Confidence 9999999999999998887643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=325.32 Aligned_cols=252 Identities=21% Similarity=0.253 Sum_probs=206.6
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCcccc-ccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALA-VSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~ 137 (336)
++|.+++.||+|+||+||+|++. ++.||||++....... ......+.+.+|+.+|+.++||||+++++++.++. +|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56999999999999999999986 7899999997533222 12224678999999999999999999999999876 89
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC---ceEEecccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKK---QVKLADFGLAREE 214 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~---~~kl~Dfg~a~~~ 214 (336)
+|||||+||+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++. .+||+|||+|+..
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999554 46999999999999999999999999999999999999987653 5999999999865
Q ss_pred ccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccC----CCCCCCCc
Q 019780 215 VMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSA----DTPIPPKL 288 (336)
Q Consensus 215 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~----~~~~p~~~ 288 (336)
... ...+..||+.|+|||......++.+.|+|++|+.++++-.++.|...+ ..+.+..+....... ...+|+++
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 247 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 247 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHH
Confidence 433 344567999999999999889999999999999999999999886432 222233333221111 14567778
Q ss_pred ccccCCCCCCCCccccchhhhcccccc
Q 019780 289 VEIVDPKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
.+++...+..+|+.|.+..++.+...-
T Consensus 248 ~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 248 KDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCccc
Confidence 899999999999999999988865443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.2e-46 Score=335.79 Aligned_cols=245 Identities=21% Similarity=0.216 Sum_probs=205.5
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+++.||+|+||.||+|++. ++.||||++... ........+.+.+|+.+|+.++||||+++++++.+.. .++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~--~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchH--HccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 68999999999999999999986 889999998732 1122334567899999999999999999999998776 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
||||+.||+|..++... +.+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+.... .
T Consensus 119 v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~~~~~-~ 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKG-R 194 (350)
T ss_dssp EEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSS-C
T ss_pred ccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC-CEEeeeceeeeeccc-c
Confidence 99999999999999544 4699999999999999999999999999999999999999887 899999999986533 3
Q ss_pred ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCCCCCCCCcccccCCCCC
Q 019780 219 MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSADTPIPPKLVEIVDPKST 297 (336)
Q Consensus 219 ~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~p~~~~~~~~~~~~ 297 (336)
..+..||+.|+|||...+..++.+.|+|+||+.+|++..+.+|... +....+..+..........+++++.+++..++.
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 274 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSC
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhh
Confidence 4456799999999999999999999999999999999999999633 233344445555445556788889999998898
Q ss_pred CCCcccc-----chhhhccc
Q 019780 298 MNNDCMA-----TVHAITKF 312 (336)
Q Consensus 298 ~~~~~~~-----~~~~~~~~ 312 (336)
.+|..|. +..++.+.
T Consensus 275 ~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 275 VDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHTS
T ss_pred hCHHhccccccccHHHHHcC
Confidence 8888773 66666653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=333.20 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=201.4
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEECC-------ccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceE
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYGC-------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENIL 125 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv 125 (336)
+..|.++.++|.+++.||+|+||+||+|++.+ ..||+|.+... ........+.+|+.+|.++ +|||||
T Consensus 29 ~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~HpnIv 104 (325)
T d1rjba_ 29 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK----ADSSEREALMSELKMMTQLGSHENIV 104 (325)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred CccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc----cCHHHHHHHHHHHHHHHHhcCCCcEe
Confidence 44677888999999999999999999998752 25899988632 2334456789999999998 899999
Q ss_pred eeEeeEecCC-EEEEEEccCCCCHHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019780 126 KFVGASVQPT-MMIITELMRGETLQRYLWSTRP---------------------KRLDLKHSISFALDISRAMEYLHANS 183 (336)
Q Consensus 126 ~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~~lH~~~ 183 (336)
++++++.+.+ .++|||||+||+|.++++.... ..+++..++.++.||+.||+|||++|
T Consensus 105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~ 184 (325)
T d1rjba_ 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 184 (325)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999998765 9999999999999999965432 35899999999999999999999999
Q ss_pred cccccCCCCceeecCCCCceEEecccccccccccc----ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-C
Q 019780 184 VIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-K 258 (336)
Q Consensus 184 ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~ 258 (336)
||||||||+|||++.++ .+||+|||+|+...... ..+..||+.|+|||.+....++.+.|+|++++.+|++-. +
T Consensus 185 IiHRDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263 (325)
T ss_dssp EEETTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred eeeccCchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence 99999999999999887 89999999998644332 123457999999998888888999999999999999876 6
Q ss_pred CCCCHh-HHHHHHHHHHHhhc--cCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 259 VRPEFA-EITITLTNILQNLR--SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 259 ~RP~~~-~i~~~l~~~~~~~~--~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
..|... .....+..+...-. .....+|+++.+++...+..+|+.|++..++.+.
T Consensus 264 ~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 777422 11122333333321 2234567778899999999999999999887653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-45 Score=333.61 Aligned_cols=245 Identities=19% Similarity=0.277 Sum_probs=200.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+++.||+|+||+||+|++. ++.||||++... .....+.+.+|+.+|+.++||||+++++++.+++ +|+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 47999999999999999999986 889999999732 2345678999999999999999999999998775 999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-CCceEEeccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED-KKQVKLADFGLAREEVMD 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~-~~~~kl~Dfg~a~~~~~~ 217 (336)
|||||+||+|.+++... ...+++..++.++.||+.||+|||++|||||||||+|||++.+ .+.+||+|||+|+.....
T Consensus 101 vmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 101 IYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp EECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999999998433 3569999999999999999999999999999999999999643 247999999999864433
Q ss_pred -cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccCC----CCCCCCcccc
Q 019780 218 -EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSAD----TPIPPKLVEI 291 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~~----~~~p~~~~~~ 291 (336)
...+..||+.|+|||...+.+++.+.|+|+||+.++++..+..|... ...+.+..+........ ..+++++.++
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 34456799999999999988999999999999999999998888532 12222333333221111 2466677778
Q ss_pred cCCCCCCCCccccchhhhccc
Q 019780 292 VDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~ 312 (336)
+..++..+|+.|.+..++.+.
T Consensus 260 i~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 888888899999888887663
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=327.88 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=203.0
Q ss_pred CceeecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEec
Q 019780 55 ASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQ 133 (336)
Q Consensus 55 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 133 (336)
+.|.++.++|.+++.||+|+||+||+|++. ++.||||+++... ...+.+.+|+.+|++++|||||++++++.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc------CCHHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence 456678899999999999999999999987 5679999997422 123579999999999999999999999988
Q ss_pred CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 134 PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 134 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
++.++||||+++|+|..++.......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~ 162 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARL 162 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC-
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-cEEEcccchhhh
Confidence 8899999999999999999665556799999999999999999999999999999999999999886 799999999985
Q ss_pred ccccc---ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH--HHHHHHHHHHhhc-cCCCCCCCC
Q 019780 214 EVMDE---MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE--ITITLTNILQNLR-SADTPIPPK 287 (336)
Q Consensus 214 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~--i~~~l~~~~~~~~-~~~~~~p~~ 287 (336)
..... .....||+.|+|||.......+.+.|+|++++.+|++-.+.+|.+.. ..+.+..+..... .....+|++
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 242 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHH
Confidence 43322 23346899999999988888899999999999999988877764332 1222333332222 344567778
Q ss_pred cccccCCCCCCCCccccchhhhcc
Q 019780 288 LVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+.+++...+..+|+.|++..++.+
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQA 266 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHH
Confidence 889999999999999999988865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=316.99 Aligned_cols=212 Identities=29% Similarity=0.536 Sum_probs=173.7
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEECC------ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYGC------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
++...|.+.++||+|+||+||+|.+.+ ..||||++.. .........+.+|+.+|++++|||||++++++.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA----GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECc----ccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 556789999999999999999998752 3699999863 223445667999999999999999999999998
Q ss_pred cCC-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 133 QPT-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 133 ~~~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
+.. .++||||+.++++.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla 157 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLS 157 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC-
T ss_pred cCCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-eEEEcccchh
Confidence 755 89999999999999988543 36799999999999999999999999999999999999999887 8999999999
Q ss_pred ccccccc-----ccccCCcccccCCC----------------------------------------------CCCCCCCC
Q 019780 212 REEVMDE-----MTCEAGTYRWMAPE----------------------------------------------NERPSLEN 240 (336)
Q Consensus 212 ~~~~~~~-----~~~~~gt~~y~aPE----------------------------------------------~~~~~~~~ 240 (336)
+...... .....||+.|+||| ...+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 237 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchh
Confidence 8543221 12235899999999 12244556
Q ss_pred CHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 241 LSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 241 ~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
++..+++|+..||+.+|.+||++.++++.|+.+.+.
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 788899999999999999999999999998887653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=316.41 Aligned_cols=214 Identities=32% Similarity=0.546 Sum_probs=173.1
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
|.++.++|.+++.||+|+||.||+|.+. +..||||.++. .......+.+.+|+.+|++++||||+++++++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT----TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecc----ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 5677889999999999999999999875 23577887752 23455677899999999999999999999999
Q ss_pred ecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 132 VQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 132 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
.++..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+|
T Consensus 78 ~~~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a 155 (273)
T d1mp8a_ 78 TENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLS 155 (273)
T ss_dssp CSSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC----
T ss_pred ecCeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC-cEEEccchhh
Confidence 888899999999999999988543 45789999999999999999999999999999999999999887 8999999999
Q ss_pred cccccc---cccccCCcccccCCC----------------------------------------------CCCCCCCCCH
Q 019780 212 REEVMD---EMTCEAGTYRWMAPE----------------------------------------------NERPSLENLS 242 (336)
Q Consensus 212 ~~~~~~---~~~~~~gt~~y~aPE----------------------------------------------~~~~~~~~~~ 242 (336)
+..... ......||+.|+||| ...+.+.+++
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 235 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 854322 223345899999999 1224456788
Q ss_pred HHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 243 EDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 243 ~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
.++.+|+..||+.+|.+||++.++++.|+.+.+.
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 8899999999999999999999999999887654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-45 Score=315.77 Aligned_cols=211 Identities=30% Similarity=0.534 Sum_probs=175.2
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP- 134 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~- 134 (336)
.|.++.++|.+++.||+|+||.||+|.++++.||||+++.. ...+.+.+|+.++++++||||+++++++.++
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~-------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC-------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH-------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 37788899999999999999999999999999999999731 2346789999999999999999999988653
Q ss_pred -CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 -TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 -~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.+++||||+++|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++.
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~ 152 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKE 152 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC---
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC-CEeeccccccee
Confidence 389999999999999999665445689999999999999999999999999999999999999887 799999999986
Q ss_pred cccccccccCCcccccCCCC----------------------------------------------CCCCCCCCHHHHHH
Q 019780 214 EVMDEMTCEAGTYRWMAPEN----------------------------------------------ERPSLENLSEDMVA 247 (336)
Q Consensus 214 ~~~~~~~~~~gt~~y~aPE~----------------------------------------------~~~~~~~~~~di~~ 247 (336)
... ......++..|+|||. ..+.+..+++.+.+
T Consensus 153 ~~~-~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 153 ASS-TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHH
T ss_pred cCC-CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 433 2334568999999991 12334557788889
Q ss_pred HHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 248 LLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 248 l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
|+..||..+|.+||++.++++.|+.+..
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999887754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-45 Score=333.41 Aligned_cols=249 Identities=20% Similarity=0.198 Sum_probs=196.3
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCcccc-ccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALA-VSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
-++|.+++.||+|+||.||+|++. ++.||||++....... ..........+|+.+++.++||||+++++++.+++ +
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999986 7899999997321111 11111222334577788889999999999998776 9
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-CEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-cEEEeeeceeeecCC
Confidence 9999999999999999543 5689999999999999999999999999999999999999887 799999999987666
Q ss_pred ccccccCCcccccCCCCCC-CCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhh----ccCCCCCCCCcccc
Q 019780 217 DEMTCEAGTYRWMAPENER-PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNL----RSADTPIPPKLVEI 291 (336)
Q Consensus 217 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~----~~~~~~~p~~~~~~ 291 (336)
......+||+.|+|||.+. ...++.+.|+|+||+.++++..+++|....-......+.... ......+++++.++
T Consensus 160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (364)
T d1omwa3 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239 (364)
T ss_dssp SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHH
T ss_pred CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHH
Confidence 5666678999999999875 566889999999999999999999986322111111222222 22234577788889
Q ss_pred cCCCCCCCCccccc-----hhhhccc
Q 019780 292 VDPKSTMNNDCMAT-----VHAITKF 312 (336)
Q Consensus 292 ~~~~~~~~~~~~~~-----~~~~~~~ 312 (336)
+..++..+|..|.+ .+++.+.
T Consensus 240 i~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 240 LEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHcccCHHHhCCCcccCHHHHHcC
Confidence 99999999999987 3555543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-45 Score=324.72 Aligned_cols=245 Identities=20% Similarity=0.273 Sum_probs=198.7
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHH-hCCCCceEeeEeeEecCC-EE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLS-KMKHENILKFVGASVQPT-MM 137 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~-~~ 137 (336)
++|.+++.||+|+||+||+|.+. ++.||||++++. ........+.+.+|..++. .++||||+++++++.+++ +|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~--~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKD--VVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchh--hccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 47999999999999999999995 889999999731 1112233456667777665 689999999999999876 99
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc-
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM- 216 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~- 216 (336)
+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 80 ivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCT
T ss_pred EEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC-ceeccccchhhhcccc
Confidence 999999999999999543 5689999999999999999999999999999999999999877 899999999985433
Q ss_pred -ccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhhccCCCCCCCCcccccCC
Q 019780 217 -DEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNLRSADTPIPPKLVEIVDP 294 (336)
Q Consensus 217 -~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~p~~~~~~~~~ 294 (336)
.......||+.|+|||.....+++.+.|+|+||+.+|++..++.|...+ ....+..+...-......+|+++.+++..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 236 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 2234457999999999999999999999999999999999999986332 22222333333333344577888889999
Q ss_pred CCCCCCccccchh-hhcc
Q 019780 295 KSTMNNDCMATVH-AITK 311 (336)
Q Consensus 295 ~~~~~~~~~~~~~-~~~~ 311 (336)
.+..+|+.|.+.. ++.+
T Consensus 237 ~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 237 LFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HSCSSGGGSBTTBSCGGG
T ss_pred hcccCCCCCcCHHHHHHh
Confidence 9999999998774 4544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=314.71 Aligned_cols=245 Identities=25% Similarity=0.359 Sum_probs=197.1
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-E
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-M 136 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~ 136 (336)
++.++|++++.||+|+||+||+|+++ ++.||||+++.... ..+.+.+|+.+++.++||||+++++++.+++ +
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~------~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~ 74 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 74 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS------CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC------CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Confidence 35678999999999999999999996 56899999984221 2356899999999999999999999988754 9
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVM 216 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~ 216 (336)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSS
T ss_pred EEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-cEEECcchhheeccC
Confidence 9999999999999997543 35689999999999999999999999999999999999999876 899999999975433
Q ss_pred cc---ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHH-HHHhhc-cCCCCCCCCccc
Q 019780 217 DE---MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTN-ILQNLR-SADTPIPPKLVE 290 (336)
Q Consensus 217 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~-~~~~~~-~~~~~~p~~~~~ 290 (336)
.. .....||+.|+|||......++.+.|+|+++..+|++-. ++-|.-..-...+.. +.+... ......|+++.+
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 232 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 232 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHH
Confidence 32 223458999999999888888999999999999999866 444532211222222 222222 223446667889
Q ss_pred ccCCCCCCCCccccchhhhcc
Q 019780 291 IVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~ 311 (336)
++...|..+|+.|++..++.+
T Consensus 233 li~~cl~~dP~~RPt~~eil~ 253 (258)
T d1k2pa_ 233 IMYSCWHEKADERPTFKILLS 253 (258)
T ss_dssp HHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHH
Confidence 999999999999999887754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-43 Score=310.70 Aligned_cols=250 Identities=22% Similarity=0.279 Sum_probs=202.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCcccccc----HHHHHHHHHHHHHHHhCC-CCceEeeEeeEecC
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVS----REHKEKFQREVTLLSKMK-HENILKFVGASVQP 134 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 134 (336)
++|++.+.||+|+||+||+|++. ++.||||++......... ....+.+.+|+.+|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 67999999999999999999985 789999999864332222 334567899999999997 99999999999987
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
+ +|+||||++||+|.++++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC-CeEEccchheeE
Confidence 6 89999999999999999543 5699999999999999999999999999999999999999887 799999999986
Q ss_pred cccc-cccccCCcccccCCCCCC------CCCCCCHHHHHHHHHHhhccCCCCCCCHhHHH-HHHHHHHHhhccCC----
Q 019780 214 EVMD-EMTCEAGTYRWMAPENER------PSLENLSEDMVALLKSCWAEDPKVRPEFAEIT-ITLTNILQNLRSAD---- 281 (336)
Q Consensus 214 ~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~-~~l~~~~~~~~~~~---- 281 (336)
.... ......||+.|+|||... ....+.+.|+|++++.++++-.++.|....-. ..+..+...-....
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 4433 344567999999999543 34467899999999999999988888643322 22222332221111
Q ss_pred CCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 282 TPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 282 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
..+|+++.+++...+..+|+.|.+..++.+..+
T Consensus 240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~ 272 (277)
T d1phka_ 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272 (277)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 257778888999999999999999888876543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=314.31 Aligned_cols=216 Identities=31% Similarity=0.563 Sum_probs=170.1
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEee
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKF 127 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~ 127 (336)
.|.+..++|.+++.||+|+||.||+|.+. ++.||||+++. .......+.+.+|..++.++ +|+||+.+
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~----~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcc----ccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 46677889999999999999999999864 35799999873 22344556778888888776 58999999
Q ss_pred EeeEecC--CEEEEEEccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCC
Q 019780 128 VGASVQP--TMMIITELMRGETLQRYLWSTR--------------PKRLDLKHSISFALDISRAMEYLHANSVIHRDLKP 191 (336)
Q Consensus 128 ~~~~~~~--~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp 191 (336)
++++.+. .+++|||||++|+|.++++... ...+++..++.++.||+.||+|||++|||||||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp 162 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 162 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCc
Confidence 9987754 3899999999999999996432 23588999999999999999999999999999999
Q ss_pred CceeecCCCCceEEecccccccccccc----ccccCCcccccCCCC----------------------------------
Q 019780 192 SNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPEN---------------------------------- 233 (336)
Q Consensus 192 ~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~---------------------------------- 233 (336)
+|||++.++ .+||+|||+|+...... .....||+.|+|||.
T Consensus 163 ~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 163 RNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGEEECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceeECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 999999887 89999999997533221 234469999999991
Q ss_pred -------------CCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 234 -------------ERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 234 -------------~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
....+..+++++.+|+..||+.+|.+||++.++++.|+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 242 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1233455778899999999999999999999999999888653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=319.53 Aligned_cols=244 Identities=18% Similarity=0.305 Sum_probs=201.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+++.||+|+||+||+|.+. ++.||||+++.. ......+.+|+.+|+.++||||+++++++.+++ +|+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC------cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 56999999999999999999986 788999999742 233456889999999999999999999998765 999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-CceEEeccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDK-KQVKLADFGLAREEVMD 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~-~~~kl~Dfg~a~~~~~~ 217 (336)
|||||+||+|.+++... +..+++.+++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+++.....
T Consensus 79 vmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 79 IFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 99999999999999433 34799999999999999999999999999999999999997542 37999999999865433
Q ss_pred c-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhccCC----CCCCCCcccc
Q 019780 218 E-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRSAD----TPIPPKLVEI 291 (336)
Q Consensus 218 ~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~~~----~~~p~~~~~~ 291 (336)
. .....||+.|+|||......++.+.|+|+||+.++++..+..|...+- ...+..+........ ..+++++.++
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHH
Confidence 2 344569999999999988889999999999999999999998863322 222333333222222 3577788899
Q ss_pred cCCCCCCCCccccchhhhccc
Q 019780 292 VDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~ 312 (336)
+..++..+|+.|.+..++.+.
T Consensus 238 i~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999998887653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=314.83 Aligned_cols=211 Identities=26% Similarity=0.509 Sum_probs=175.3
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--Cc----cEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEe
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CE----PVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASV 132 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 132 (336)
+...+|.+++.||+|+||+||+|.+. ++ .||+|.++. ....+..+.+.+|+.+|++++|||||++++++.
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~ 81 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICL 81 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecc----ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 44567999999999999999999985 33 588888763 123334677999999999999999999999999
Q ss_pred cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 133 QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 133 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
++..+++++++.+|+|.+++... ...+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+
T Consensus 82 ~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-~~kl~DFGla~ 159 (317)
T d1xkka_ 82 TSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAK 159 (317)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCCSHHH
T ss_pred cCCeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-CeEeeccccce
Confidence 99999999999999999988554 46799999999999999999999999999999999999999887 89999999998
Q ss_pred cccccc----ccccCCcccccCCC----------------------------------------------CCCCCCCCCH
Q 019780 213 EEVMDE----MTCEAGTYRWMAPE----------------------------------------------NERPSLENLS 242 (336)
Q Consensus 213 ~~~~~~----~~~~~gt~~y~aPE----------------------------------------------~~~~~~~~~~ 242 (336)
...... .....||+.|+||| ...+.+..++
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~ 239 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBC
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence 643322 22235899999999 1224456678
Q ss_pred HHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHH
Q 019780 243 EDMVALLKSCWAEDPKVRPEFAEITITLTNILQ 275 (336)
Q Consensus 243 ~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~ 275 (336)
.+++.|+..||+.+|.+||++.+++..+..+.+
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 889999999999999999999999999887754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=319.74 Aligned_cols=247 Identities=19% Similarity=0.196 Sum_probs=203.7
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccc-cHHHHHHHHHHHHHHHhCC--CCceEeeEeeEecCC-
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAV-SREHKEKFQREVTLLSKMK--HENILKFVGASVQPT- 135 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~- 135 (336)
++|++++.||+|+||+||+|++. ++.||||++........ ......++.+|+.+|++++ ||||+++++++.+++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999986 78999999974322111 1112344678999999987 899999999998876
Q ss_pred EEEEEEccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 MMIITELMRG-ETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 ~~lv~e~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.++||||+.+ +++.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+++.+||+|||+|+..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 8999999976 6888888543 579999999999999999999999999999999999999876558999999999876
Q ss_pred ccccccccCCcccccCCCCCCCCCC-CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhccCCCCCCCCcccccC
Q 019780 215 VMDEMTCEAGTYRWMAPENERPSLE-NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLRSADTPIPPKLVEIVD 293 (336)
Q Consensus 215 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~p~~~~~~~~ 293 (336)
.....++..||+.|+|||...+... +.+.|+|+||+.++++-.+..|...+ +.+..........+|+++.+++.
T Consensus 162 ~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~i~~~~~~~~~~~s~~~~~li~ 236 (273)
T d1xwsa_ 162 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EEIIRGQVFFRQRVSSECQHLIR 236 (273)
T ss_dssp CSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHHHHCCCCCSSCCCHHHHHHHH
T ss_pred ccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-----hHHhhcccCCCCCCCHHHHHHHH
Confidence 5555667789999999998776554 56789999999999999999987442 23344444556778899999999
Q ss_pred CCCCCCCccccchhhhcccccc
Q 019780 294 PKSTMNNDCMATVHAITKFNEK 315 (336)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
..+..+|+.|.+..++.+..+-
T Consensus 237 ~~L~~dp~~R~s~~eil~hp~~ 258 (273)
T d1xwsa_ 237 WCLALRPSDRPTFEEIQNHPWM 258 (273)
T ss_dssp HHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHccCCHhHCcCHHHHhcCHhh
Confidence 9999999999999998875543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=308.32 Aligned_cols=212 Identities=30% Similarity=0.551 Sum_probs=168.9
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeE
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGAS 131 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 131 (336)
..++.++|++.+.||+|+||+||+|++. ...||||+++.. .....+..+.+.+|+.+|++++||||+++++++
T Consensus 3 ~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~--~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD--VLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred eEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChh--hcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3567789999999999999999999864 236899998742 223445567899999999999999999999999
Q ss_pred ecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 132 VQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 132 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
.++..++||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 81 ~~~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-~vkl~DfGl~ 158 (273)
T d1u46a_ 81 LTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLM 158 (273)
T ss_dssp CSSSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTC
T ss_pred eecchheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc-ceeeccchhh
Confidence 888899999999999999988543 35699999999999999999999999999999999999999887 8999999999
Q ss_pred ccccccc-----ccccCCcccccCCC-----------------------------------------------CCCCCCC
Q 019780 212 REEVMDE-----MTCEAGTYRWMAPE-----------------------------------------------NERPSLE 239 (336)
Q Consensus 212 ~~~~~~~-----~~~~~gt~~y~aPE-----------------------------------------------~~~~~~~ 239 (336)
+...... .....|+..|+||| ...+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 238 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCT
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcc
Confidence 8643221 12235788999999 1123446
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITITLTN 272 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~ 272 (336)
.++.++.+|+..||..+|.+||++.++.+.|.+
T Consensus 239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 688999999999999999999999999887765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.4e-44 Score=313.59 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=193.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC----
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT---- 135 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 135 (336)
++|.+.+.||+|+||+||+|++. ++.||||+++.. ...+......+.+|+.+|+.++||||+++++++.+..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECST--TTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchh--hccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 56999999999999999999986 889999999742 2334566778999999999999999999999887532
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.|+||||++|++|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||.+...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-CEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc-cceeehhhhhhhh
Confidence 78999999999999998543 5699999999999999999999999999999999999999887 7999999998643
Q ss_pred ccc-----cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHhh----ccCCCCC
Q 019780 215 VMD-----EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQNL----RSADTPI 284 (336)
Q Consensus 215 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~~----~~~~~~~ 284 (336)
... .....+||+.|+|||......++...|+|+|++.++++..+..|...+ -.+.+......- ......+
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 222 233456999999999999888999999999999999999999986322 222223333221 1223457
Q ss_pred CCCcccccCCCCCCCCcccc-chhhhc
Q 019780 285 PPKLVEIVDPKSTMNNDCMA-TVHAIT 310 (336)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~-~~~~~~ 310 (336)
|+++.+++...+..+|+.|. +..++.
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~ 268 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMR 268 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHH
Confidence 78888899999999998886 566554
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-43 Score=311.31 Aligned_cols=212 Identities=30% Similarity=0.506 Sum_probs=177.6
Q ss_pred eeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEe
Q 019780 57 VLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVG 129 (336)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 129 (336)
+.+..++|.+.+.||+|+||+||+|++. ++.||||+++. .......+.+.+|+.+|+.++||||+++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~----~~~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT----TCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEECh----hcChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 4455678999999999999999999874 35799999873 223455778999999999999999999999
Q ss_pred eEecCC-EEEEEEccCCCCHHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 019780 130 ASVQPT-MMIITELMRGETLQRYLWSTR----------------------PKRLDLKHSISFALDISRAMEYLHANSVIH 186 (336)
Q Consensus 130 ~~~~~~-~~lv~e~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH 186 (336)
++.+.. .+++|||+++|+|.+++.... ...+++..++.++.|++.||+|||++|+||
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivH 163 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 163 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEe
Confidence 988765 999999999999999995432 234889999999999999999999999999
Q ss_pred ccCCCCceeecCCCCceEEecccccccccccc----ccccCCcccccCCC------------------------------
Q 019780 187 RDLKPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPE------------------------------ 232 (336)
Q Consensus 187 rDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE------------------------------ 232 (336)
|||||+|||++.++ .+||+|||+|+...... ..+..|++.|+|||
T Consensus 164 rDlKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 164 RDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp SCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eEEcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999887 79999999997543322 23446889999999
Q ss_pred ----------------CCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHH
Q 019780 233 ----------------NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNI 273 (336)
Q Consensus 233 ----------------~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~ 273 (336)
...+.+.+++.++++|+..||+.+|.+||++.++.+.|+++
T Consensus 243 ~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 12234567889999999999999999999999999888765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=319.57 Aligned_cols=240 Identities=22% Similarity=0.289 Sum_probs=189.0
Q ss_pred CceeEe-eeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHh-CCCCceEeeEeeEec----
Q 019780 62 RSVLLQ-KMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSK-MKHENILKFVGASVQ---- 133 (336)
Q Consensus 62 ~~~~~~-~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~---- 133 (336)
.+|.+. +.||+|+||+||+|++. ++.||||+++. ...+.+|+.++.+ .+||||+++++++.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 357665 57999999999999985 78999999973 2346789988655 589999999999875
Q ss_pred -CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC--CCceEEecccc
Q 019780 134 -PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED--KKQVKLADFGL 210 (336)
Q Consensus 134 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~--~~~~kl~Dfg~ 210 (336)
..+|+|||||+||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 238999999999999999976555679999999999999999999999999999999999999853 23699999999
Q ss_pred ccccccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHH-HHHHHHHHHhhccCC-------
Q 019780 211 AREEVMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFAEI-TITLTNILQNLRSAD------- 281 (336)
Q Consensus 211 a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i-~~~l~~~~~~~~~~~------- 281 (336)
|+..... ......||+.|+|||...+..++.+.|+|+||+.+|++..+..|...+- ......+........
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 9864433 3445679999999999999999999999999999999999998864321 111222222222111
Q ss_pred -CCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 282 -TPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 282 -~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
..+++++.+++...+..+|+.|.+..++.+
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 124566777788888888888888877765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-42 Score=305.50 Aligned_cols=218 Identities=31% Similarity=0.523 Sum_probs=178.2
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEECC---------ccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCc
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYGC---------EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHEN 123 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn 123 (336)
+..|.++.++|.+++.||+|+||.||+|+..+ ..||||+++. .........+.+|...+.++ +|||
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS----DATEKDLSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCT----TCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECc----ccChHHHHHHHHHHHHHHHhcCCCe
Confidence 34578889999999999999999999998642 3699999873 22445567788999999888 7999
Q ss_pred eEeeEeeEecCC-EEEEEEccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 019780 124 ILKFVGASVQPT-MMIITELMRGETLQRYLWSTR--------------PKRLDLKHSISFALDISRAMEYLHANSVIHRD 188 (336)
Q Consensus 124 Iv~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrD 188 (336)
|+++++++.++. .++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||||||
T Consensus 81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrD 160 (299)
T d1fgka_ 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 160 (299)
T ss_dssp BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeee
Confidence 999999998766 999999999999999996443 24689999999999999999999999999999
Q ss_pred CCCCceeecCCCCceEEecccccccccccc----ccccCCcccccCCC--------------------------------
Q 019780 189 LKPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPE-------------------------------- 232 (336)
Q Consensus 189 ikp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE-------------------------------- 232 (336)
|||+|||++.++ .+||+|||+++...... .....|++.|+|||
T Consensus 161 iKp~NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 161 LAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp CSGGGEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ecccceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 999999999887 79999999998644332 23346899999999
Q ss_pred --------------CCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 233 --------------NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 233 --------------~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
...+.+..++.++.+|+..||+.+|.+||++.++++.|+.+...
T Consensus 240 ~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 240 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp TCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 12234456778889999999999999999999999999887643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=308.44 Aligned_cols=213 Identities=31% Similarity=0.538 Sum_probs=175.5
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEEC--Cc--cEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceEeeEeeEec
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYG--CE--PVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENILKFVGASVQ 133 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 133 (336)
++.++|++.+.||+|+||+||+|++. +. .||||.++. .......+.+.+|+.+|+++ +||||+++++++.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEEC----C------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECc----ccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 56689999999999999999999985 33 467777752 12334566799999999999 69999999999987
Q ss_pred CC-EEEEEEccCCCCHHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC
Q 019780 134 PT-MMIITELMRGETLQRYLWST--------------RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTE 198 (336)
Q Consensus 134 ~~-~~lv~e~~~gg~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~ 198 (336)
++ .++||||++||+|.++++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 162 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence 76 89999999999999999643 2467999999999999999999999999999999999999998
Q ss_pred CCCceEEecccccccccccc-ccccCCcccccCCC---------------------------------------------
Q 019780 199 DKKQVKLADFGLAREEVMDE-MTCEAGTYRWMAPE--------------------------------------------- 232 (336)
Q Consensus 199 ~~~~~kl~Dfg~a~~~~~~~-~~~~~gt~~y~aPE--------------------------------------------- 232 (336)
++ .+||+|||+|+...... .....||..|+|||
T Consensus 163 ~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 163 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp GG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CC-ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 87 79999999997543332 23346899999999
Q ss_pred -CCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 233 -NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 233 -~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
...+.+..++.++.+|+..||+.+|.+||++.++++.|+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 12233456788999999999999999999999999999988764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=306.74 Aligned_cols=218 Identities=30% Similarity=0.505 Sum_probs=183.2
Q ss_pred CCceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC-CCCceE
Q 019780 54 DASVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM-KHENIL 125 (336)
Q Consensus 54 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv 125 (336)
+..|.++.++|.+++.||+|+||.||+|++. ++.||||+++.. ........+.+|+.+++.+ +||||+
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~E~~~~~~l~~HpnIv 90 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHMNIV 90 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc----cCHHHHHHHHHHHHHHHhccCCCCEE
Confidence 3467788899999999999999999999863 457999999742 2345567899999999999 699999
Q ss_pred eeEeeEecCC-EEEEEEccCCCCHHHHHhhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 019780 126 KFVGASVQPT-MMIITELMRGETLQRYLWSTR----------------PKRLDLKHSISFALDISRAMEYLHANSVIHRD 188 (336)
Q Consensus 126 ~~~~~~~~~~-~~lv~e~~~gg~L~~~l~~~~----------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrD 188 (336)
++++++.+++ .++|||||++|+|.++++... ...+++..+..++.||+.||+|||++|+||||
T Consensus 91 ~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrD 170 (311)
T d1t46a_ 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD 170 (311)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 9999998765 899999999999999996543 23689999999999999999999999999999
Q ss_pred CCCCceeecCCCCceEEecccccccccccc----ccccCCcccccCCC--------------------------------
Q 019780 189 LKPSNLLLTEDKKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPE-------------------------------- 232 (336)
Q Consensus 189 ikp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE-------------------------------- 232 (336)
|||+||+++.++ .++|+|||+++...... .....||+.|+|||
T Consensus 171 LKp~NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 171 LAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp CSGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccccccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 999999999876 89999999998543322 22345899999999
Q ss_pred ---------------CCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 233 ---------------NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 233 ---------------~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
.....+...+.++.+|+..||+.+|.+||++.++++.|++++..
T Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 11233456778899999999999999999999999999887654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=307.67 Aligned_cols=213 Identities=29% Similarity=0.519 Sum_probs=179.4
Q ss_pred ceeecCCceeEeeeecCCCcEEEEEeEEC-------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeE
Q 019780 56 SVLVDHRSVLLQKMIGEGSYSIVYKGFYG-------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFV 128 (336)
Q Consensus 56 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 128 (336)
.|.++.++|.+++.||+|+||+||+|.+. ++.||||+++. .........+.+|+.++++++||||++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~----~~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT----TSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECc----ccChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 57888899999999999999999999874 46899999873 22445567899999999999999999999
Q ss_pred eeEecCC-EEEEEEccCCCCHHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC
Q 019780 129 GASVQPT-MMIITELMRGETLQRYLWST--------RPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED 199 (336)
Q Consensus 129 ~~~~~~~-~~lv~e~~~gg~L~~~l~~~--------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~ 199 (336)
+++..+. .++||||+++|+|.+++... ....+++..+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 169 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC
Confidence 9988654 99999999999999998532 12357899999999999999999999999999999999999988
Q ss_pred CCceEEecccccccccccc----ccccCCcccccCCC-------------------------------------------
Q 019780 200 KKQVKLADFGLAREEVMDE----MTCEAGTYRWMAPE------------------------------------------- 232 (336)
Q Consensus 200 ~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE------------------------------------------- 232 (336)
+ ++||+|||+|+...... .....||+.|+|||
T Consensus 170 ~-~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 170 F-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp C-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred c-eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 7 89999999998543322 22335889999999
Q ss_pred ---CCCCCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHH
Q 019780 233 ---NERPSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNI 273 (336)
Q Consensus 233 ---~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~ 273 (336)
...+.+..++..+..|+..||+.+|.+||++.++++.|++.
T Consensus 249 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 12344567888999999999999999999999998876544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=308.52 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=193.2
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+++.||+|+||+||+|.+. ++.||||+++... ........+.+|+++|++++||||+++++++.++. +|+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh---cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence 47999999999999999999986 7899999997421 22334567899999999999999999999999876 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc-
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD- 217 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~- 217 (336)
||||+.+ ++.+++.......+++..++.++.|++.||.|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 79 v~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 79 VFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHCCCS
T ss_pred EEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-cceeccCCcceeccCCc
Confidence 9999976 555566555667899999999999999999999999999999999999999887 8999999999864332
Q ss_pred -cccccCCcccccCCCCCCCCC-CCCHHHHHHHHHHhhccCCCCCCCH-hHHHHHHHHHHHhhccC--------------
Q 019780 218 -EMTCEAGTYRWMAPENERPSL-ENLSEDMVALLKSCWAEDPKVRPEF-AEITITLTNILQNLRSA-------------- 280 (336)
Q Consensus 218 -~~~~~~gt~~y~aPE~~~~~~-~~~~~di~~l~~~~l~~~p~~RP~~-~~i~~~l~~~~~~~~~~-------------- 280 (336)
......||+.|+|||...... .+.+.|+|++|..++++-.+++|.- ..-...+..+.......
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 233456999999999765554 5789999999999999999988852 11122222222221111
Q ss_pred ---------------CCCCCCCcccccCCCCCCCCccccchhhhccccccccc
Q 019780 281 ---------------DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNEKGKK 318 (336)
Q Consensus 281 ---------------~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (336)
..++++++.+++..++..+|..|.+..++.+...-...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 01233445556777788888888888888775544433
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=312.32 Aligned_cols=245 Identities=25% Similarity=0.274 Sum_probs=184.5
Q ss_pred eeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEEEEcc
Q 019780 67 QKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
+++||+|+||+||+|++. ++.||||+++..............+.+|+.+|+.++||||+++++++.+++ +|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999985 789999999753322222333467899999999999999999999998765 99999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccccccc--cccc
Q 019780 144 RGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMD--EMTC 221 (336)
Q Consensus 144 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~ 221 (336)
.|+++..+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..... ....
T Consensus 83 ~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 83 ETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp SEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCCCCCCC
T ss_pred cchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC-ccccccCccccccCCCcccccc
Confidence 998877766 4456799999999999999999999999999999999999999887 7999999999764332 2334
Q ss_pred cCCcccccCCCCCC-CCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhccC-------------------
Q 019780 222 EAGTYRWMAPENER-PSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRSA------------------- 280 (336)
Q Consensus 222 ~~gt~~y~aPE~~~-~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~~------------------- 280 (336)
.+||+.|+|||... ...++.+.|+|++|+.++++-.+..|... .-.+.+..+.+.+...
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 57999999999765 44678899999999999999888776521 1122222232221110
Q ss_pred ---------CCCCCCCcccccCCCCCCCCccccchhhhccccc
Q 019780 281 ---------DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFNE 314 (336)
Q Consensus 281 ---------~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (336)
...+++++.+++..++..+|+.|.+..++.+...
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 0123445556677777778888888877776543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-41 Score=299.64 Aligned_cols=206 Identities=26% Similarity=0.498 Sum_probs=172.5
Q ss_pred EeeeecCCCcEEEEEeEECC-----ccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC--CEEE
Q 019780 66 LQKMIGEGSYSIVYKGFYGC-----EPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP--TMMI 138 (336)
Q Consensus 66 ~~~~lg~G~fg~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~l 138 (336)
+.++||+|+||+||+|++.. ..||||+++. ..+....+.+.+|+++|++++||||+++++++.+. ..++
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECC----CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence 36789999999999999752 2589999863 23456678899999999999999999999987653 4899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|||||++|+|.+++.. ....+++..++.++.|++.||.|||+.||+||||||+|||++.++ .+||+|||+++......
T Consensus 107 v~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKE 184 (311)
T ss_dssp EEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSSGGGCCTTTTT
T ss_pred EEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC-CEEEecccchhhccccc
Confidence 9999999999999854 345678889999999999999999999999999999999999876 89999999998643322
Q ss_pred ------ccccCCcccccCCC----------------------------------------------CCCCCCCCCHHHHH
Q 019780 219 ------MTCEAGTYRWMAPE----------------------------------------------NERPSLENLSEDMV 246 (336)
Q Consensus 219 ------~~~~~gt~~y~aPE----------------------------------------------~~~~~~~~~~~di~ 246 (336)
.....||+.|+||| .....+..++.+++
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~ 264 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHH
Confidence 22235899999999 11233456778999
Q ss_pred HHHHHhhccCCCCCCCHhHHHHHHHHHHHhh
Q 019780 247 ALLKSCWAEDPKVRPEFAEITITLTNILQNL 277 (336)
Q Consensus 247 ~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~ 277 (336)
+|+..||+.+|.+||++.++++.|+.+.+..
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 9999999999999999999999999887653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-41 Score=296.56 Aligned_cols=205 Identities=28% Similarity=0.457 Sum_probs=163.1
Q ss_pred CceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-----E
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-----M 136 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~ 136 (336)
++|.+.+.||+|+||+||+|+++++.||||+++. ..........|+..+..++||||+++++++.+.+ +
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~------~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSS------REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECG------GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECc------cchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 5789999999999999999999999999999862 1122223345556667889999999999987532 7
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccccCCCCceeecCCCCceEEecc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA--------NSVIHRDLKPSNLLLTEDKKQVKLADF 208 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--------~~ivHrDikp~NIll~~~~~~~kl~Df 208 (336)
|+||||+++|+|.+++++. .+++..++.++.|++.||+|+|+ +|||||||||+|||++.++ .+||+||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DF 152 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCC
T ss_pred EEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEec
Confidence 9999999999999999653 58999999999999999999996 5999999999999999887 8999999
Q ss_pred cccccccccc------ccccCCcccccCCCCCCCC---------------------------------------------
Q 019780 209 GLAREEVMDE------MTCEAGTYRWMAPENERPS--------------------------------------------- 237 (336)
Q Consensus 209 g~a~~~~~~~------~~~~~gt~~y~aPE~~~~~--------------------------------------------- 237 (336)
|+++...... .....||+.|+|||...+.
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 9998543322 2345699999999921110
Q ss_pred ---------------------CC------CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 238 ---------------------LE------NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 238 ---------------------~~------~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
.. .....+.+|+..||+.+|.+||++.++++.|+++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 00 0123477888889999999999999998888877654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-41 Score=297.47 Aligned_cols=248 Identities=22% Similarity=0.208 Sum_probs=188.1
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC---CccEEEEEeecCccccccHHHHHHHHHHHHHHHhC---CCCceEeeEeeEec-
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG---CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKM---KHENILKFVGASVQ- 133 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~- 133 (336)
.++|++++.||+|+||+||+|++. ++.||||+++.... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC---TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc---cchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 468999999999999999999984 45799999974221 111223355677766555 89999999998853
Q ss_pred -----CCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecc
Q 019780 134 -----PTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADF 208 (336)
Q Consensus 134 -----~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Df 208 (336)
...+++|||+.++++.... ......+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-~~kl~df 160 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADF 160 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSC
T ss_pred ccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-Ceeecch
Confidence 1379999999887665444 34557799999999999999999999999999999999999999877 7999999
Q ss_pred ccccccccc-cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhcc-------
Q 019780 209 GLAREEVMD-EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRS------- 279 (336)
Q Consensus 209 g~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~------- 279 (336)
|+++..... ......||+.|+|||.....+++.+.|+|++++.++++-.++.|... .-...+..+.+....
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 998854333 34556799999999999999999999999999999999998888522 122223333222111
Q ss_pred --------------------CCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 280 --------------------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 280 --------------------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
....+++.+.+++..++..+|+.|.+..++.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hp 294 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 294 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence 1122344455677777888888888887776643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.5e-41 Score=296.12 Aligned_cols=195 Identities=26% Similarity=0.313 Sum_probs=164.1
Q ss_pred CceeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMII 139 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~lv 139 (336)
++|.+++.||+|+||+||+|++. ++.||||+++.... .....+.+.+|+.+|+.++||||+++++++.+++ .+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG---GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 47999999999999999999987 78999999974321 2334577999999999999999999999998765 8999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc-
Q 019780 140 TELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE- 218 (336)
Q Consensus 140 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~- 218 (336)
|+++.++.+..+. .....+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|.......
T Consensus 79 ~e~~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-CEEecccccceecccCcc
Confidence 9999887777766 4447799999999999999999999999999999999999999887 79999999997643322
Q ss_pred -ccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 219 -MTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 219 -~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.....|++.|+|||.... .+.+...|+|+|++.++++-.++-|.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf 201 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC
Confidence 233458999999998764 45689999999999999998888775
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=298.76 Aligned_cols=241 Identities=21% Similarity=0.200 Sum_probs=186.6
Q ss_pred ceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC------
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP------ 134 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------ 134 (336)
+|..+++||+|+||+||+|++. ++.||||++..... ...+|+.+|+.++||||+++++++...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 6889999999999999999986 78999999974321 234799999999999999999988532
Q ss_pred -CEEEEEEccCCCCHHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 135 -TMMIITELMRGETLQRYLW-STRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 135 -~~~lv~e~~~gg~L~~~l~-~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
.+++||||++++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+++
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 1689999998764444332 23456799999999999999999999999999999999999999876689999999998
Q ss_pred ccccc-cccccCCcccccCCCCCC-CCCCCCHHHHHHHHHHhhccCCCCCCCH-hHHHHHHHHHHHhhc-----------
Q 019780 213 EEVMD-EMTCEAGTYRWMAPENER-PSLENLSEDMVALLKSCWAEDPKVRPEF-AEITITLTNILQNLR----------- 278 (336)
Q Consensus 213 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~~di~~l~~~~l~~~p~~RP~~-~~i~~~l~~~~~~~~----------- 278 (336)
..... ...+..||+.|+|||... ...++.+.|+|++|+.++++-.++.|.. ......+..+.+.+.
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred hccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 64433 344567999999999765 4568999999999999999998888752 112222222222110
Q ss_pred ------------------cCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 279 ------------------SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 279 ------------------~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
......++++.+++..++..+|+.|.+..++.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0112345566677888889999999888888763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-40 Score=295.88 Aligned_cols=193 Identities=30% Similarity=0.368 Sum_probs=160.0
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC----
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT---- 135 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 135 (336)
.+|.+++.||+|+||+||+|++. ++.||||++... ......+.+.+|+.+|+.++||||+++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh----cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 35999999999999999999986 889999999742 23455678899999999999999999999987542
Q ss_pred -EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccc
Q 019780 136 -MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREE 214 (336)
Q Consensus 136 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~ 214 (336)
.+++++++.||+|.+++.. ..+++..++.++.|++.||+|||++|||||||||+|||++.++ .+||+|||+|+..
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVA 159 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred ceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-CEEEcccCceeec
Confidence 4566677779999999954 3599999999999999999999999999999999999999877 8999999999754
Q ss_pred cccc-----ccccCCcccccCCCCC-CCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 215 VMDE-----MTCEAGTYRWMAPENE-RPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 215 ~~~~-----~~~~~gt~~y~aPE~~-~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.... ....+||+.|+|||.. ....++.+.|+|++++.++++..+..|.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf 213 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 213 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC
Confidence 3322 2344699999999987 4456688899999999999988877774
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=299.30 Aligned_cols=243 Identities=24% Similarity=0.283 Sum_probs=186.3
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC---
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT--- 135 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 135 (336)
.++|.+++.||+|+||+||+|.+. ++.||||+++.. .......+.+.+|+.+|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSST---TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchh---hcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 468999999999999999999986 889999999742 234556788999999999999999999999987543
Q ss_pred ----EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccc
Q 019780 136 ----MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 136 ----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a 211 (336)
+|+||||+ +++|..+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a 168 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLA 168 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred ccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc-ccccccccce
Confidence 69999999 5688887743 4699999999999999999999999999999999999999887 7999999999
Q ss_pred cccccccccccCCcccccCCCCCCC-CCCCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHHh-------------
Q 019780 212 REEVMDEMTCEAGTYRWMAPENERP-SLENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQN------------- 276 (336)
Q Consensus 212 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~~------------- 276 (336)
+... ...+...||+.|+|||.+.+ ...+.+.|+|++|+.++++..+..|.... -...+......
T Consensus 169 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 169 RQAD-SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp EECC-SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred eccC-CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 8643 34456679999999998765 45688999999999999998888875221 11111111110
Q ss_pred ----------h--------ccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 277 ----------L--------RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 277 ----------~--------~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
. ......+++++.+++..++..+|+.|.|..++.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 01112345556667778888888888888877653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.7e-40 Score=297.29 Aligned_cols=190 Identities=24% Similarity=0.389 Sum_probs=163.7
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecC--
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQP-- 134 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~-- 134 (336)
+.++|++++.||+|+||+||+|++. ++.||||+++.. ..+.+.+|+.+|+.++ ||||+++++++...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--------KKKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 3468999999999999999999986 889999998732 2356889999999996 99999999998743
Q ss_pred -CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 -TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 -~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.+++||||+.+++|..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+|+.
T Consensus 105 ~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp CSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred CceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence 389999999999997764 46999999999999999999999999999999999999997766799999999986
Q ss_pred cccc-cccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 214 EVMD-EMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 214 ~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.... ......||+.|+|||..... .++.+.|+|++++.+++...+..|.
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf 230 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred ccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCC
Confidence 5433 34456799999999986654 4689999999999999988887774
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=287.58 Aligned_cols=195 Identities=26% Similarity=0.322 Sum_probs=168.4
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecCC-EEE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQPT-MMI 138 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~l 138 (336)
++|.+++.||+|+||+||+|++. ++.||||+++... ........+.+|+.+|+.++||||+++++++.+.. .++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh---CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence 47999999999999999999986 7889999997432 23456788999999999999999999999999876 899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccccccccc
Q 019780 139 ITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAREEVMDE 218 (336)
Q Consensus 139 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~~~~~~ 218 (336)
|++++.|++|..++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||.|+......
T Consensus 79 v~~~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 79 VFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEECCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSCC
T ss_pred Eeeeccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC-ceeeeecchhhcccCCC
Confidence 999999999988874 446789999999999999999999999999999999999999876 79999999998643322
Q ss_pred --ccccCCcccccCCCCCCCCC-CCCHHHHHHHHHHhhccCCCCCCC
Q 019780 219 --MTCEAGTYRWMAPENERPSL-ENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 219 --~~~~~gt~~y~aPE~~~~~~-~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.....+++.|+|||...... .+.+.|+|++++.++++..+.+|.
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 202 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCC
Confidence 23335778999999766554 688999999999999999999984
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.4e-40 Score=291.13 Aligned_cols=242 Identities=18% Similarity=0.215 Sum_probs=191.5
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC-CceEeeEeeEecCC-E
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH-ENILKFVGASVQPT-M 136 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~-~ 136 (336)
.++|++++.||+|+||+||+|++. ++.||||++.... ....+.+|++.++.++| +|++.+++++.++. .
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-------CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 467999999999999999999986 7899999986321 12346789999999975 89999999888766 8
Q ss_pred EEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC----CCceEEecccccc
Q 019780 137 MIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED----KKQVKLADFGLAR 212 (336)
Q Consensus 137 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~----~~~~kl~Dfg~a~ 212 (336)
++||||+ +++|.+++... +..+++.++..++.|++.||+|||++||+||||||+|||++.+ .+.+||+|||+|+
T Consensus 77 ~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 8999998 68999988543 4579999999999999999999999999999999999999642 2379999999998
Q ss_pred ccccc---------cccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCCH----hHHHHHHHHHHH---h
Q 019780 213 EEVMD---------EMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPEF----AEITITLTNILQ---N 276 (336)
Q Consensus 213 ~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~~----~~i~~~l~~~~~---~ 276 (336)
..... ......||+.|+|||...+..++.+.|+|+|+..+|++..+..|.. .........+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 53221 1234569999999999999999999999999999999888888752 112222222211 1
Q ss_pred --hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 277 --LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 277 --~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.......+|+++.+++...+..+++.+++.+.+.+
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 22233568889999998888889999987766655
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=292.08 Aligned_cols=196 Identities=21% Similarity=0.237 Sum_probs=162.7
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 134 (336)
.++|.+++.||+|+||+||+|++. ++.||||++..... .......+.+|+.+|+.++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C---TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 378999999999999999999986 78999999864222 233456688999999999999999999987542
Q ss_pred -----CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 135 -----TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 135 -----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
..|+||||+.++.+..+. .....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-~~kl~dfg 162 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFG 162 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred cccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC-cEEeeecc
Confidence 379999999887766555 4556799999999999999999999999999999999999999887 79999999
Q ss_pred cccccccc------cccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 210 LAREEVMD------EMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 210 ~a~~~~~~------~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
+++..... .....+||+.|+|||..... .++.+.|+|++|+.++++-.++.|.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf 222 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC
Confidence 99743221 22334699999999987654 6789999999999999998888875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-39 Score=285.20 Aligned_cols=206 Identities=21% Similarity=0.318 Sum_probs=157.1
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEee-EeeEecCC-EE
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKF-VGASVQPT-MM 137 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~-~~~~~~~~-~~ 137 (336)
++|++++.||+|+||.||+|++. ++.||||++.... ....+.+|+++++.++|+|++.. .+++.+++ .+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-------~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-------TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-------cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 46999999999999999999986 7899999987421 12347889999999987776554 45555554 78
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC--CCceEEeccccccccc
Q 019780 138 IITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTED--KKQVKLADFGLAREEV 215 (336)
Q Consensus 138 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~--~~~~kl~Dfg~a~~~~ 215 (336)
+||||+. ++|.+.+.. ....+++..++.++.|++.||+|||++||+||||||+|||++.. +..++|+|||+|+...
T Consensus 80 ivme~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 80 MVMELLG-PSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEECCC-CBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEcC-Cchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 8999984 577776643 34679999999999999999999999999999999999997542 3369999999998543
Q ss_pred cc---------cccccCCcccccCCCCCCCCCC-----------------------------------------------
Q 019780 216 MD---------EMTCEAGTYRWMAPENERPSLE----------------------------------------------- 239 (336)
Q Consensus 216 ~~---------~~~~~~gt~~y~aPE~~~~~~~----------------------------------------------- 239 (336)
.. ......||+.|+|||...+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 22 1234469999999994333333
Q ss_pred -----CCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHh
Q 019780 240 -----NLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQN 276 (336)
Q Consensus 240 -----~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~ 276 (336)
++|+++++++..||+.+|.+||++.++.+.|+.+...
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 3455566677777888888888877777777666543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=293.46 Aligned_cols=245 Identities=26% Similarity=0.280 Sum_probs=187.3
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC----
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP---- 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 134 (336)
.++|.+++.||+|+||+||+|++. ++.||||++... ..+....+.+.+|+.+|+.++||||+++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECch---hcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence 467999999999999999999986 889999999742 23445567889999999999999999999988632
Q ss_pred --CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 135 --TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 135 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
..+++|+|+.||+|.+++.. .++++..++.++.||+.||+|||++||+||||||+|||++.++ .+|++|||++.
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-~~kl~dfg~a~ 169 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR 169 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC----
T ss_pred cCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-cccccccchhc
Confidence 35777888889999999943 4699999999999999999999999999999999999999887 79999999997
Q ss_pred ccccccccccCCcccccCCCCCCCC-CCCCHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHhhcc-----------
Q 019780 213 EEVMDEMTCEAGTYRWMAPENERPS-LENLSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQNLRS----------- 279 (336)
Q Consensus 213 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~~~~----------- 279 (336)
... ....+..|++.|+|||..... ..+.+.|+|+||+.++++-.+..|... +.......+......
T Consensus 170 ~~~-~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 170 HTD-DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp CCT-GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred ccC-cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 543 334456799999999975554 568899999999999999888877421 111111111111100
Q ss_pred --------------------CCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 280 --------------------ADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 280 --------------------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
....+++++.+++..++..+|..|.+..++.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp 302 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCH
Confidence 0123455666777778888888888877776644
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=288.72 Aligned_cols=192 Identities=24% Similarity=0.266 Sum_probs=155.3
Q ss_pred CceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEeeEecC-----
Q 019780 62 RSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGASVQP----- 134 (336)
Q Consensus 62 ~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 134 (336)
++|.+++.||+|+||+||+|++. ++.||||++... ........++.+|+.+|+.++||||+++++++...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~---~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEEST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChh---hcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 56999999999999999999986 899999999742 23455677899999999999999999999998632
Q ss_pred --CEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEecccccc
Q 019780 135 --TMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLAR 212 (336)
Q Consensus 135 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~ 212 (336)
.+|+||||+.++.+ +.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .++++|||+++
T Consensus 94 ~~~~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~-~~kl~df~~~~ 167 (355)
T d2b1pa1 94 FQDVYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLAR 167 (355)
T ss_dssp CCEEEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC--
T ss_pred CceeEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc-ceeeechhhhh
Confidence 38999999977544 4441 4589999999999999999999999999999999999999887 79999999987
Q ss_pred cccccc-ccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 213 EEVMDE-MTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 213 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
...... .....||+.|+|||...+..++.+.|+|++++.++++..++.|.
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF 218 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCC
Confidence 544332 34456999999999999999999999999999999988887763
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-40 Score=292.92 Aligned_cols=248 Identities=21% Similarity=0.229 Sum_probs=193.8
Q ss_pred CCceeEeeeecCCCcEEEEEeEEC-----CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC-CceEeeEeeEecC
Q 019780 61 HRSVLLQKMIGEGSYSIVYKGFYG-----CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH-ENILKFVGASVQP 134 (336)
Q Consensus 61 ~~~~~~~~~lg~G~fg~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~ 134 (336)
.++|.+++.||+|+||+||+|.+. ++.||||+++.... ..+....+.+.+|+.+|++++| |||+++++++.+.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEE-EEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHh-ccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 467999999999999999999872 67899999874221 1122335668899999999976 8999999999876
Q ss_pred C-EEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 135 T-MMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 135 ~-~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
. .+++|||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKE 178 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEE
T ss_pred CceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC-CEEEeeccchhh
Confidence 6 89999999999999999544 4678999999999999999999999999999999999999887 799999999975
Q ss_pred cccc---cccccCCcccccCCCCCCCC--CCCCHHHHHHHHHHhhccCCCCCCCHh----HHHHHHHHH-HHhhccCCCC
Q 019780 214 EVMD---EMTCEAGTYRWMAPENERPS--LENLSEDMVALLKSCWAEDPKVRPEFA----EITITLTNI-LQNLRSADTP 283 (336)
Q Consensus 214 ~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~di~~l~~~~l~~~p~~RP~~~----~i~~~l~~~-~~~~~~~~~~ 283 (336)
.... ...+..|++.|+|||..... ..+.+.|+|+||+.++++-.+..|... +....+... ..........
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 4322 23345699999999987654 456789999999999999888887522 222222222 1222223345
Q ss_pred CCCCcccccCCCCCCCCcccc-----chhhhccc
Q 019780 284 IPPKLVEIVDPKSTMNNDCMA-----TVHAITKF 312 (336)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 312 (336)
+++++.+++...+..+|+.|. |.+++.+.
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 677788899999999999996 45666553
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.6e-33 Score=253.06 Aligned_cols=196 Identities=19% Similarity=0.197 Sum_probs=157.8
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC--CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-----------CCceEe
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-----------HENILK 126 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~ 126 (336)
...+|++++.||+|+||+||+|++. ++.||||+++. .....+.+.+|+.+++.++ |+||++
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~------~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~ 84 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 84 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec------cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEE
Confidence 3456999999999999999999985 88999999973 2234466788998888775 478999
Q ss_pred eEeeEecC---CEEEEEEccCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCC
Q 019780 127 FVGASVQP---TMMIITELMRGE-TLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA-NSVIHRDLKPSNLLLTEDKK 201 (336)
Q Consensus 127 ~~~~~~~~---~~~lv~e~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDikp~NIll~~~~~ 201 (336)
+++++... ..+++++++.++ +............+++..++.++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp CCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred EEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCc
Confidence 99887643 256666665543 44444445566789999999999999999999998 89999999999999986542
Q ss_pred -----ceEEeccccccccccccccccCCcccccCCCCCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 019780 202 -----QVKLADFGLAREEVMDEMTCEAGTYRWMAPENERPSLENLSEDMVALLKSCWAEDPKVRPE 262 (336)
Q Consensus 202 -----~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~di~~l~~~~l~~~p~~RP~ 262 (336)
.++++|||.+..... ......||+.|+|||......++.+.|+|++++.++++..++.|.
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF 229 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229 (362)
T ss_dssp TTTEEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccccceeeEeeccccccccc-ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCC
Confidence 389999999975433 334567999999999988888999999999999999887777664
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.8e-25 Score=184.36 Aligned_cols=137 Identities=20% Similarity=0.235 Sum_probs=106.7
Q ss_pred eeEeeeecCCCcEEEEEeEEC-CccEEEEEeecCcccc-------------ccHHHHHHHHHHHHHHHhCCCCceEeeEe
Q 019780 64 VLLQKMIGEGSYSIVYKGFYG-CEPVAVKVIQPCNALA-------------VSREHKEKFQREVTLLSKMKHENILKFVG 129 (336)
Q Consensus 64 ~~~~~~lg~G~fg~V~~~~~~-~~~vavK~~~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 129 (336)
+.+++.||+|+||+||+|.+. ++.||||+++...... ..........+|...+..+.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 357899999999999999875 8899999986422110 01122345667899999999999998876
Q ss_pred eEecCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCceEEeccc
Q 019780 130 ASVQPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHANSVIHRDLKPSNLLLTEDKKQVKLADFG 209 (336)
Q Consensus 130 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDikp~NIll~~~~~~~kl~Dfg 209 (336)
+. ..+++|||+++..+.+ ++...+..++.|++.+|+|||++||+||||||+|||++++ .++|+|||
T Consensus 82 ~~---~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG 147 (191)
T d1zara2 82 WE---GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFP 147 (191)
T ss_dssp EE---TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCT
T ss_pred ec---CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECC
Confidence 53 2479999999865433 3344567899999999999999999999999999999965 48999999
Q ss_pred ccccc
Q 019780 210 LAREE 214 (336)
Q Consensus 210 ~a~~~ 214 (336)
+|+..
T Consensus 148 ~a~~~ 152 (191)
T d1zara2 148 QSVEV 152 (191)
T ss_dssp TCEET
T ss_pred CcccC
Confidence 98753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.67 E-value=3.5e-08 Score=83.17 Aligned_cols=138 Identities=14% Similarity=0.081 Sum_probs=89.2
Q ss_pred ceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEeeEecCC-EEEEE
Q 019780 63 SVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVGASVQPT-MMIIT 140 (336)
Q Consensus 63 ~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~lv~ 140 (336)
.|.+.+..+.++.+.||+....++.+.+|+...... .....+.+|...+..+. +-.+.+++.+..+++ .++||
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~-----~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYK-----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGT-----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcc-----cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 455555555555678999887788899998763211 11234677888877764 333566777666554 89999
Q ss_pred EccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 019780 141 ELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHA--------------------------------------- 181 (336)
Q Consensus 141 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--------------------------------------- 181 (336)
++++|.++....... .. ...++.++...|+.||+
T Consensus 90 ~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 90 SEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp ECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred Eeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 999998886654110 11 12233344444444442
Q ss_pred --------------------CCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 182 --------------------NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 182 --------------------~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
..++|+|+.|.|||++.++ .+-|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~-~~~lIDwe~a~~ 213 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSGR 213 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCc-eEEEeechhccc
Confidence 1379999999999998654 456999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.95 E-value=6.5e-06 Score=73.29 Aligned_cols=80 Identities=13% Similarity=0.147 Sum_probs=48.2
Q ss_pred eeeecCCCcEEEEEeEEC--CccEEEEEeecCccc-cc-cHHHHHHHHHHHHHHHhCC-C--CceEeeEeeEecCCEEEE
Q 019780 67 QKMIGEGSYSIVYKGFYG--CEPVAVKVIQPCNAL-AV-SREHKEKFQREVTLLSKMK-H--ENILKFVGASVQPTMMII 139 (336)
Q Consensus 67 ~~~lg~G~fg~V~~~~~~--~~~vavK~~~~~~~~-~~-~~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~~~~lv 139 (336)
.+.||.|....||++... ++.++||.-.+.-.. .. -.....+...|...|+.+. + ..+++++.+. ....++|
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-~~~~~lv 109 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-TEMAVTV 109 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-TTTTEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-CCCCEEE
Confidence 356899999999998754 567899975431100 00 0112334566777777663 2 3455666543 3446789
Q ss_pred EEccCCCC
Q 019780 140 TELMRGET 147 (336)
Q Consensus 140 ~e~~~gg~ 147 (336)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.90 E-value=1.3e-05 Score=66.47 Aligned_cols=72 Identities=14% Similarity=0.049 Sum_probs=47.2
Q ss_pred eecCCC-cEEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCC--CceEeeEeeEecCC-EEEEEEcc
Q 019780 69 MIGEGS-YSIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKH--ENILKFVGASVQPT-MMIITELM 143 (336)
Q Consensus 69 ~lg~G~-fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~-~~lv~e~~ 143 (336)
.+..|. -+.||+.... +..+++|...... ...+..|...++.+.. -.+.+++.+..+++ .++||+++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT--------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC--------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence 344444 3679998876 5568889876321 1236677777776643 23566777666554 89999999
Q ss_pred CCCCH
Q 019780 144 RGETL 148 (336)
Q Consensus 144 ~gg~L 148 (336)
+|.++
T Consensus 89 ~G~~~ 93 (255)
T d1nd4a_ 89 PGQDL 93 (255)
T ss_dssp SSEET
T ss_pred ecccc
Confidence 98665
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.84 E-value=0.0035 Score=53.02 Aligned_cols=31 Identities=35% Similarity=0.456 Sum_probs=26.6
Q ss_pred CCcccccCCCCceeecCCCCceEEeccccccc
Q 019780 182 NSVIHRDLKPSNLLLTEDKKQVKLADFGLARE 213 (336)
Q Consensus 182 ~~ivHrDikp~NIll~~~~~~~kl~Dfg~a~~ 213 (336)
.|+||+|+.++|++++.+. ..-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE-LSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred cccccCCcchhhhhccccc-ceeEeccccccc
Confidence 3799999999999999764 568999998864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.83 E-value=0.0028 Score=54.06 Aligned_cols=65 Identities=14% Similarity=0.114 Sum_probs=39.4
Q ss_pred EEEEEeEEC-CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCce--EeeEe-----e-EecCCEEEEEEccCCC
Q 019780 76 SIVYKGFYG-CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENI--LKFVG-----A-SVQPTMMIITELMRGE 146 (336)
Q Consensus 76 g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI--v~~~~-----~-~~~~~~~lv~e~~~gg 146 (336)
-.||++... |+.+++|+.+++.. ..+.+..|...+..|....+ +..+. . ..++..+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~------s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC------CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 579998864 78899999875321 23456678877777642222 11111 1 1233377889998863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.68 E-value=0.0029 Score=55.53 Aligned_cols=78 Identities=12% Similarity=0.109 Sum_probs=49.1
Q ss_pred cCCceeEeeeecCCCcEEEEEeEEC---------CccEEEEEeecCccccccHHHHHHHHHHHHHHHhCC-CCceEeeEe
Q 019780 60 DHRSVLLQKMIGEGSYSIVYKGFYG---------CEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMK-HENILKFVG 129 (336)
Q Consensus 60 ~~~~~~~~~~lg~G~fg~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~ 129 (336)
+.+.+.+ +.|+.|-.-.+|++... ...|.+++.-. . .. .....+|..+++.+. +.-..++++
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~--~~---~idr~~E~~i~~~ls~~gl~Pkll~ 112 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--P--ET---ESHLVAESVIFTLLSERHLGPKLYG 112 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--C--CC---HHHHHHHHHHHHHHHHTTSSSCEEE
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--c--ch---hhHHHHHHHHHHHHHhCCCCCeEEE
Confidence 3345554 66888888999998864 23466666531 1 11 123457888888876 333346777
Q ss_pred eEecCCEEEEEEccCCCCH
Q 019780 130 ASVQPTMMIITELMRGETL 148 (336)
Q Consensus 130 ~~~~~~~~lv~e~~~gg~L 148 (336)
++.+ .+|++|++|..|
T Consensus 113 ~~~~---g~I~efi~g~~l 128 (395)
T d1nw1a_ 113 IFSG---GRLEEYIPSRPL 128 (395)
T ss_dssp EETT---EEEECCCCEEEC
T ss_pred EcCC---ceEEEEeccccC
Confidence 6643 578999987544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.90 E-value=0.0018 Score=53.47 Aligned_cols=35 Identities=26% Similarity=0.501 Sum_probs=31.0
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLT 271 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~ 271 (336)
.+...+..+++|+..||+.+|.+||++.++++.|.
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 44567889999999999999999999999988764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.44 E-value=0.0038 Score=52.24 Aligned_cols=38 Identities=24% Similarity=0.575 Sum_probs=32.9
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNIL 274 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~ 274 (336)
.+..++..+..|+..||+.+|.+||++.+++..|+...
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 45567899999999999999999999999988776654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.40 E-value=0.0053 Score=52.27 Aligned_cols=36 Identities=31% Similarity=0.589 Sum_probs=32.1
Q ss_pred CCCCCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 019780 236 PSLENLSEDMVALLKSCWAEDPKVRPEFAEITITLT 271 (336)
Q Consensus 236 ~~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~ 271 (336)
+.+..++.++.+|+..||+.+|.+||++.++++.|.
T Consensus 287 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 287 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 445678899999999999999999999999998874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.62 E-value=0.03 Score=45.96 Aligned_cols=32 Identities=16% Similarity=0.152 Sum_probs=28.2
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.+..++.++.+|+..||+.+|.+||++.++++
T Consensus 234 ~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 44568899999999999999999999998863
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.88 E-value=0.012 Score=48.98 Aligned_cols=73 Identities=11% Similarity=0.060 Sum_probs=49.4
Q ss_pred CCCHHHHHHHHHHhhccCC-CCCCCHhHHH-HHHHHHHHh-hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 239 ENLSEDMVALLKSCWAEDP-KVRPEFAEIT-ITLTNILQN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p-~~RP~~~~i~-~~l~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
++...|+|+++..+|++-. ++.|....-. +.+..+... .......+|+++.+++...|..+|+.|++..++.+
T Consensus 189 ~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~ 264 (285)
T d1u59a_ 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 264 (285)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 3557899999999999765 7777432111 112222222 12334567888899999999999999988877754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=91.73 E-value=0.019 Score=47.99 Aligned_cols=75 Identities=12% Similarity=0.077 Sum_probs=51.3
Q ss_pred CCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHH-HHHHHHhh-ccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 238 LENLSEDMVALLKSCWAEDP-KVRPEFAEITIT-LTNILQNL-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~-l~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.++...|+|++++.+|++-. +++|....-... +..+.+.. ......+|+++.+++...|..+|+.|++..++.+.
T Consensus 209 ~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 209 KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 45667899999999999876 677753322222 22222221 22334567778899999999999999998887653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.65 E-value=0.011 Score=48.74 Aligned_cols=71 Identities=11% Similarity=0.070 Sum_probs=50.6
Q ss_pred CCCCHHHHHHHHHHhhccCC-CCCCC----HhHHHHHHHHHHHh-hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 238 LENLSEDMVALLKSCWAEDP-KVRPE----FAEITITLTNILQN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p-~~RP~----~~~i~~~l~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.++.+.|+|+++..+|++-. +..|. ..++... +... .....+.+|+++.+++...|..+|+.|++..++.+
T Consensus 185 ~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~ 261 (273)
T d1mp8a_ 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261 (273)
T ss_dssp CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH---HHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 45667899999999998755 55553 3333322 2222 22344567888999999999999999999988864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.45 E-value=0.045 Score=44.71 Aligned_cols=31 Identities=19% Similarity=0.309 Sum_probs=27.7
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++.++.+|+..||+.+|.+||++.++++
T Consensus 224 p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 3467899999999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.12 E-value=0.046 Score=44.89 Aligned_cols=31 Identities=32% Similarity=0.523 Sum_probs=27.4
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++.++.+|+..||+.+|.+|||+.++++
T Consensus 224 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 224 RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 3467899999999999999999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.06 E-value=0.04 Score=45.73 Aligned_cols=31 Identities=16% Similarity=0.258 Sum_probs=27.2
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++.++.+|+..||+.+|.+||++.++++
T Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3467899999999999999999999998753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=90.93 E-value=0.078 Score=44.30 Aligned_cols=32 Identities=13% Similarity=0.244 Sum_probs=28.2
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
....+++++.+|+..||+.+|.+||++.++++
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 34578899999999999999999999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=90.88 E-value=0.087 Score=43.13 Aligned_cols=36 Identities=31% Similarity=0.401 Sum_probs=30.7
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCC-CHhHHHHHHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRP-EFAEITITLTNI 273 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP-~~~~i~~~l~~~ 273 (336)
...++.++.+|+..||+.+|.+|| +++++...|..+
T Consensus 238 ~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 346789999999999999999999 688887777654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=90.72 E-value=0.074 Score=43.76 Aligned_cols=32 Identities=25% Similarity=0.230 Sum_probs=28.0
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.....+.++.+|+..||+.||.+||++.|+++
T Consensus 249 ~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 34567899999999999999999999998863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=90.64 E-value=0.023 Score=47.53 Aligned_cols=76 Identities=9% Similarity=0.007 Sum_probs=51.6
Q ss_pred CCCCHHHHHHHHHHhhccCCCCC-CCHhHH-HHHHHHHHHh-hccCCCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 238 LENLSEDMVALLKSCWAEDPKVR-PEFAEI-TITLTNILQN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~R-P~~~~i-~~~l~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
.++.+.|+|+++..+|++..+.. |....- .+.+..+... .......+|+++.+++...|..+|+.|++..++.++-
T Consensus 218 ~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L 296 (301)
T d1lufa_ 218 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296 (301)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 35678899999999999866654 432221 1222222222 2223446788899999999999999999988887643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.48 E-value=0.036 Score=45.29 Aligned_cols=73 Identities=7% Similarity=0.049 Sum_probs=48.4
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhH--HHHHHHHHHHhhccC-CCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAE--ITITLTNILQNLRSA-DTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~--i~~~l~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
+...|+|+++..+|++-...+|.+.. ..+.+..+....... ....|+++.+++...|..+|+.|++..++.+.
T Consensus 180 ~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 44589999999999987755553321 112223333322222 23456778889999999999999998887653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.40 E-value=0.023 Score=46.51 Aligned_cols=72 Identities=10% Similarity=0.066 Sum_probs=50.5
Q ss_pred CCCHHHHHHHHHHhhccCCCCCC-----CHhHHHHHHHHHHH-hhccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRP-----EFAEITITLTNILQ-NLRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP-----~~~~i~~~l~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.+.+.|+|++++.+|++-...+| +..++...+ .. .........|+++.+++...|..+|..|++..++.+.
T Consensus 177 ~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH---TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 45678999999999998764444 233443332 22 1223345677889999999999999999999888764
Q ss_pred c
Q 019780 313 N 313 (336)
Q Consensus 313 ~ 313 (336)
-
T Consensus 254 L 254 (262)
T d1byga_ 254 L 254 (262)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.26 E-value=0.027 Score=46.49 Aligned_cols=72 Identities=10% Similarity=0.013 Sum_probs=50.3
Q ss_pred CHHHHHHHHHHhhccCCCCCCCHh-HHHHHHHHHHHh------hccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 241 LSEDMVALLKSCWAEDPKVRPEFA-EITITLTNILQN------LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 241 ~~~di~~l~~~~l~~~p~~RP~~~-~i~~~l~~~~~~------~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
...|+|+++..+|++-.++.|... .-...+...... .......+|+++.+++...|..+|+.|++..++.+.
T Consensus 188 ~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 467999999999999999988532 111112222221 122345677888999999999999999998887654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.95 E-value=0.093 Score=43.46 Aligned_cols=30 Identities=13% Similarity=0.240 Sum_probs=26.7
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||+.||.+|||+.|+++
T Consensus 250 ~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 250 SAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 356789999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.88 E-value=0.09 Score=43.56 Aligned_cols=30 Identities=27% Similarity=0.205 Sum_probs=26.9
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||+.+|.+||++.|+++
T Consensus 253 ~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 253 PPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 357789999999999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.82 E-value=0.094 Score=43.47 Aligned_cols=32 Identities=19% Similarity=0.146 Sum_probs=27.7
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.....+.++.+|+..||+.+|.+|||+.++++
T Consensus 261 ~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 261 FVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 34567889999999999999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.79 E-value=0.061 Score=44.67 Aligned_cols=31 Identities=26% Similarity=0.272 Sum_probs=27.2
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++.++.+|+..||+.+|.+||++.++++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3457899999999999999999999998753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.58 E-value=0.094 Score=44.69 Aligned_cols=28 Identities=18% Similarity=0.146 Sum_probs=25.4
Q ss_pred CHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 241 LSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 241 ~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.+.++++|+..||..+|.+|||++++++
T Consensus 283 ~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 283 KASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 5678999999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.56 E-value=0.038 Score=45.54 Aligned_cols=73 Identities=11% Similarity=0.090 Sum_probs=49.3
Q ss_pred CCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHh--hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 239 ENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQN--LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
++.+.|+|+++..+|++-. ++.|....-...+...+.. .......+|+++.+++...|..+|+.|++..++.+
T Consensus 187 ~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262 (277)
T ss_dssp EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 3457899999999999765 6777432111122222222 12233557788899999999999999999887753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.54 E-value=0.06 Score=44.15 Aligned_cols=29 Identities=7% Similarity=0.219 Sum_probs=26.0
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++++.+|+..||+.+|.+||++.|+++
T Consensus 237 ~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 46788999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=89.54 E-value=0.067 Score=44.77 Aligned_cols=30 Identities=23% Similarity=0.330 Sum_probs=27.1
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.++++
T Consensus 237 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 457889999999999999999999999865
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.25 E-value=0.13 Score=43.51 Aligned_cols=31 Identities=29% Similarity=0.195 Sum_probs=27.8
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
....++++.+|+..||..+|.+|||+.++++
T Consensus 270 ~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 270 LTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 4567889999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.02 E-value=0.033 Score=45.78 Aligned_cols=73 Identities=10% Similarity=0.010 Sum_probs=50.0
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhH--HHHHHHHHHHhhcc-CCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAE--ITITLTNILQNLRS-ADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~--i~~~l~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
++.+.|+|+++..+|++-.+.+|.+.. ....+..+...... ....+|+++.+++...+..+|+.|++..++.+
T Consensus 187 ~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 456789999999999998876664332 22222223222221 23457778889999999999999999888764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=89.01 E-value=0.072 Score=43.81 Aligned_cols=31 Identities=16% Similarity=0.209 Sum_probs=27.3
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++++++.+|+..||+.+|.+||++.++++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 3468899999999999999999999988753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=89.00 E-value=0.27 Score=40.40 Aligned_cols=40 Identities=10% Similarity=0.251 Sum_probs=34.9
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHHHHhhc
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITITLTNILQNLR 278 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~~l~~~~~~~~ 278 (336)
.++|+++..++..||..+|.+||++..+.+.+.++.++..
T Consensus 242 ~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 4567899999999999999999999999988888876654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.79 E-value=0.087 Score=43.13 Aligned_cols=29 Identities=24% Similarity=0.434 Sum_probs=25.9
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEIT 267 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~ 267 (336)
..++.++.+|+..||+.+|.+||++.+++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 45678999999999999999999998874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.76 E-value=0.085 Score=43.62 Aligned_cols=30 Identities=20% Similarity=0.214 Sum_probs=26.9
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.+++.
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 457889999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.67 E-value=0.1 Score=43.77 Aligned_cols=29 Identities=14% Similarity=0.477 Sum_probs=26.5
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..+.++.+|+..||..||.+|||+.|+++
T Consensus 269 ~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 269 VFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp TBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 36789999999999999999999999876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.49 E-value=0.045 Score=45.56 Aligned_cols=74 Identities=9% Similarity=-0.008 Sum_probs=49.3
Q ss_pred CCCCHHHHHHHHHHhhccCC-CCCCCHhHHHHHHHHHHHh--hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 238 LENLSEDMVALLKSCWAEDP-KVRPEFAEITITLTNILQN--LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p-~~RP~~~~i~~~l~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
+++.+.|+|+|+..+|++-. +..|....-...+...+.. .......+|+++.+++...+..+|..|++..++.+
T Consensus 213 ~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 213 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 35667899999999999875 4555422222222222222 12233456777889999999999999999888865
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.33 E-value=0.047 Score=44.85 Aligned_cols=73 Identities=12% Similarity=0.090 Sum_probs=48.9
Q ss_pred CCHHHHHHHHHHhhccCC-CCCCCHh-HHHHHHHHHHHhhc--cCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 240 NLSEDMVALLKSCWAEDP-KVRPEFA-EITITLTNILQNLR--SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p-~~RP~~~-~i~~~l~~~~~~~~--~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
+...|+|+++..+|++-. +.-|... ...+.+..+...-. .....+|+++.+++...|..+|+.|++..++.++
T Consensus 192 ~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~ 268 (273)
T d1u46a_ 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268 (273)
T ss_dssp EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 446899999999998776 5556422 12222333332211 2234577888899999999999999998887653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.92 E-value=0.11 Score=42.67 Aligned_cols=32 Identities=19% Similarity=0.119 Sum_probs=27.7
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.....+..+.+|+..||+.+|.+|||+.|+++
T Consensus 251 ~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 251 VVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 44567889999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.29 E-value=0.042 Score=46.19 Aligned_cols=70 Identities=10% Similarity=0.038 Sum_probs=48.9
Q ss_pred CCCHHHHHHHHHHhhccCC-CCCCCH----hHHHHHHHHHHHhh-ccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 239 ENLSEDMVALLKSCWAEDP-KVRPEF----AEITITLTNILQNL-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p-~~RP~~----~~i~~~l~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
++.+.|+|++++.+|++-. +..|.. .++... +.+.. ......+|+++.+++...|..+|..|++..++.+
T Consensus 190 ~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~---i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 265 (317)
T d1xkka_ 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELII 265 (317)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH---HHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHH---HHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHH
Confidence 5678999999999999876 455532 233222 22222 1223456777888999999999999999888764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.28 E-value=0.063 Score=44.23 Aligned_cols=74 Identities=9% Similarity=0.045 Sum_probs=48.9
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhH--HHHHHHHHHHhhc-cCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAE--ITITLTNILQNLR-SADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~--i~~~l~~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
.++.+.|+|++++.+|++-....|.+.. ..+.+..+..... .....+|+++.+++...|..+|+.|++..++.+
T Consensus 189 ~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 189 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 3556789999999999987655553221 1111222222221 223446677889999999999999999888865
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.22 E-value=0.18 Score=41.89 Aligned_cols=27 Identities=15% Similarity=0.131 Sum_probs=24.0
Q ss_pred HHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 242 SEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 242 ~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
++++.+|+..||+.+|.+|||+.+++.
T Consensus 278 ~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 278 DPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 467788999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=87.15 E-value=0.13 Score=43.56 Aligned_cols=30 Identities=13% Similarity=0.303 Sum_probs=26.0
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
...+.++.+|+..||..||.+|||+.++++
T Consensus 298 ~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 298 KDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred cccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 345678999999999999999999998754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=86.94 E-value=0.12 Score=43.43 Aligned_cols=30 Identities=17% Similarity=0.097 Sum_probs=26.6
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||..+|.+|||+.++++
T Consensus 289 ~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 289 HLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 456789999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.83 E-value=0.2 Score=42.29 Aligned_cols=29 Identities=21% Similarity=0.369 Sum_probs=26.4
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.++.++.+|+..||+.+|.+||++.+++.
T Consensus 243 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 46789999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=86.63 E-value=0.068 Score=44.18 Aligned_cols=73 Identities=12% Similarity=0.107 Sum_probs=49.6
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhH-HHHHHHHHHH-hh-ccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAE-ITITLTNILQ-NL-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~-i~~~l~~~~~-~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
++.+.|+|++++.+|++-.+..|.+.. -...+.+.+. .. ......+|+++.+++...+..+|+.|++..++.+
T Consensus 193 ~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 456799999999999987765553221 1112222222 22 1223457788899999999999999999888765
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=86.49 E-value=0.16 Score=43.13 Aligned_cols=32 Identities=13% Similarity=0.275 Sum_probs=28.2
Q ss_pred CCCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 237 SLENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 237 ~~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
....++.++.+|+..||+.+|.+||++.+++.
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 34568899999999999999999999998864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.44 E-value=0.15 Score=43.25 Aligned_cols=31 Identities=16% Similarity=0.086 Sum_probs=27.5
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
....++++.+|+..||..||.+|||+.|+++
T Consensus 272 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 272 RPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3457889999999999999999999999865
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.42 E-value=0.2 Score=42.30 Aligned_cols=30 Identities=20% Similarity=0.236 Sum_probs=26.8
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.+.++++.+|+..||+.||.+||++.++++
T Consensus 265 ~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 265 PNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 456788999999999999999999999865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.33 E-value=0.061 Score=44.64 Aligned_cols=74 Identities=9% Similarity=0.036 Sum_probs=48.9
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhH--HHHHHHHHHHh-h-ccCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAE--ITITLTNILQN-L-RSADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~--i~~~l~~~~~~-~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
++.+.|+|++++.+|++-...+|.+.. ....+...+.. . ......+|+++.+++...+..+|+.|++..++.+.
T Consensus 213 ~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 213 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 466789999999999986654432221 11122222222 1 22234577788899999999999999998888753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=85.60 E-value=0.18 Score=42.85 Aligned_cols=30 Identities=20% Similarity=0.279 Sum_probs=26.9
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
..++.++.+|+..||+.+|.+||++.+++.
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 357789999999999999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.59 E-value=0.05 Score=45.55 Aligned_cols=73 Identities=5% Similarity=-0.070 Sum_probs=49.8
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhH--HHHHHHHHHHh-hccCCCCCCCCcccccCCCCCCCCccccchhhhcc
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAE--ITITLTNILQN-LRSADTPIPPKLVEIVDPKSTMNNDCMATVHAITK 311 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~--i~~~l~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (336)
++.+.|+|+++..+|++-.+..|.+.. ..+.+..+.+. .......+|+++.+++...|..+|+.|++..++.+
T Consensus 203 ~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 278 (309)
T d1fvra_ 203 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 278 (309)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 456789999999999987766543321 11122222221 12223457788899999999999999999888875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.31 E-value=0.17 Score=42.34 Aligned_cols=29 Identities=14% Similarity=0.166 Sum_probs=26.7
Q ss_pred CCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 240 NLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 240 ~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.++.++.+|+..||..+|.+||++.++++
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 56889999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.63 E-value=0.19 Score=42.34 Aligned_cols=30 Identities=20% Similarity=0.059 Sum_probs=26.9
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
.+.+.++.+|+..||+.||.+|||+.++++
T Consensus 271 ~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 271 IGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 457789999999999999999999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.52 E-value=0.072 Score=44.54 Aligned_cols=76 Identities=9% Similarity=0.122 Sum_probs=50.8
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhH--HHHHHHHHHHh-hccC-CCCCCCCcccccCCCCCCCCccccchhhhcccc
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAE--ITITLTNILQN-LRSA-DTPIPPKLVEIVDPKSTMNNDCMATVHAITKFN 313 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~--i~~~l~~~~~~-~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (336)
..+...|+|+|++.+|++-....|.+.. ....+..++.. .... ....|+++.+++...|..+|..|++..++.+.-
T Consensus 223 ~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L 302 (311)
T d1t46a_ 223 VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (311)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 3577899999999999987644443221 11223333322 2222 245677888999999999999999998877543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.09 E-value=0.093 Score=43.88 Aligned_cols=74 Identities=12% Similarity=0.105 Sum_probs=50.7
Q ss_pred CCCHHHHHHHHHHhhccCCCCCCCHhHHH--HHHHHHHHhhc-cCCCCCCCCcccccCCCCCCCCccccchhhhccc
Q 019780 239 ENLSEDMVALLKSCWAEDPKVRPEFAEIT--ITLTNILQNLR-SADTPIPPKLVEIVDPKSTMNNDCMATVHAITKF 312 (336)
Q Consensus 239 ~~~~~di~~l~~~~l~~~p~~RP~~~~i~--~~l~~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (336)
.+.+.|+|+++..+|++-.+.+|...... +....+..... .....+|+++.+++...|..+|+.|++..++.+.
T Consensus 211 ~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 45678999999999999887777644321 11222222211 1224566778999999999999999999888764
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=83.00 E-value=2.9 Score=34.21 Aligned_cols=143 Identities=13% Similarity=0.114 Sum_probs=80.5
Q ss_pred ecCCceeEeeeecCCCcEEEEEeEECCccEEEEEeecCccccccHHHHHHHHHHHHHHHhCCCCceEeeEee--------
Q 019780 59 VDHRSVLLQKMIGEGSYSIVYKGFYGCEPVAVKVIQPCNALAVSREHKEKFQREVTLLSKMKHENILKFVGA-------- 130 (336)
Q Consensus 59 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~-------- 130 (336)
++.+.++.++.=-+|+-|..| +...+..++||.-. ....+.+..++...-.+.-|...-+...
T Consensus 66 ~~l~~~K~i~~s~~Gs~Gv~F-V~~e~gaiVlK~s~--------tta~E~y~~eLAr~LGvpvPqmRvI~~~~~E~~~~~ 136 (342)
T d1cjaa_ 66 KNLQQFKGIERSEKGTEGLFF-VETESGVFIVKRST--------NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNML 136 (342)
T ss_dssp TCGGGEEEEEECCSTTSCEEE-EEESSCEEEEECCT--------THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHH
T ss_pred hhHHhhhceEEeecCCceEEE-EEcCCceEEEecCC--------chHHHHHHHHHHHHhCCCCCceEEecCCCHHHHHHH
Confidence 344556555655556666555 45556667777532 2445777777777777888876554310
Q ss_pred ---------Ee------cCCEEEEEEccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccC-CC
Q 019780 131 ---------SV------QPTMMIITELMRGETLQRYLWSTRPKRLDLKHSISFALDISRAMEYLHAN---SVIHRDL-KP 191 (336)
Q Consensus 131 ---------~~------~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDi-kp 191 (336)
.. .....++|||++|..|.+.-.......+....+..+. .|+.-=.+++.. .+++|+- .+
T Consensus 137 ~~~l~~~e~d~~I~sel~~A~~liMeYvpG~~l~e~~~~~a~~~fs~~~l~~LG-kIiaFDifInN~DR~PL~Wrn~GN~ 215 (342)
T d1cjaa_ 137 ECLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG-SLMALDVIVNNSDRLPIAWTNEGNL 215 (342)
T ss_dssp HHHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH-HHHHHHHHHTCCSSSCSSSCSCCCG
T ss_pred HHHhcCCChhHHHHHHHhcccceeeeccCCccccccccccchhhhcHHHHHHhh-hHHHHHHHHcCCccccccccCCCCc
Confidence 00 1237899999999876543210000112232222211 122222245544 3566632 89
Q ss_pred CceeecCCCCceEEeccccc
Q 019780 192 SNLLLTEDKKQVKLADFGLA 211 (336)
Q Consensus 192 ~NIll~~~~~~~kl~Dfg~a 211 (336)
.||++..++..+..+|=|..
T Consensus 216 ~Niml~~n~~~~~~IDs~i~ 235 (342)
T d1cjaa_ 216 DNIMLSERGATVVPIDSKII 235 (342)
T ss_dssp GGEEEESBTTCEEECSCCCC
T ss_pred cceEEecCCcEEEEecCCcc
Confidence 99999988878888886655
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.69 E-value=0.19 Score=41.32 Aligned_cols=31 Identities=16% Similarity=0.069 Sum_probs=27.3
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPEFAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~~~~i~~ 268 (336)
+..++.++.+|+..||+.+|.+|||+.++..
T Consensus 230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 3467899999999999999999999998754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=81.09 E-value=0.5 Score=40.11 Aligned_cols=31 Identities=19% Similarity=0.239 Sum_probs=26.0
Q ss_pred CCCCHHHHHHHHHHhhccCCCCCCC-----HhHHHH
Q 019780 238 LENLSEDMVALLKSCWAEDPKVRPE-----FAEITI 268 (336)
Q Consensus 238 ~~~~~~di~~l~~~~l~~~p~~RP~-----~~~i~~ 268 (336)
+..+++++.+|+..||+.+|.+||+ +.++++
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 229 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 4568899999999999999999999 456543
|